#BioGRID Chemical Interaction ID BioGRID Gene ID Entrez Gene ID Systematic Name Official Symbol Synonyms Organism ID Organism Action Interaction Type Author Pubmed ID BioGRID Publication ID BioGRID Chemical ID Chemical Name Chemical Synonyms Chemical Brands Chemical Source Chemical Source ID Molecular Formula Chemical Type ATC Codes CAS Number Curated By 8847 35583 855465 YNL256W FOL1 trifunctional dihydropteroate synthetase/dihydrohydroxymethylpterin pyrophosphokinase/dihydroneopterin aldolase FOL1|L000000620 559292 Saccharomyces cerevisiae inhibitor target Patel OG (2004) 14700578 177461 624 Sulfacetamide N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide sulfacetamide sodium and predn DRUGBANK DB00634 C8H10N2O3S small molecule D10AF06|S01AB04 144-80-9 DRUGBANK 27388 36434 856398 YHR007C ERG11 CYP51|sterol 14-demethylase|L000000577 559292 Saccharomyces cerevisiae unknown target Berman HM (2000) 10592235 172122 5710 (2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE - - DRUGBANK DB06890 C15H16N2O small molecule - - DRUGBANK 27397 36434 856398 YHR007C ERG11 CYP51|sterol 14-demethylase|L000000577 559292 Saccharomyces cerevisiae unknown target Berman HM (2000) 10592235 172122 6369 N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide - - DRUGBANK DB07560 C17H25N3O2 small molecule - - DRUGBANK 27400 36434 856398 YHR007C ERG11 CYP51|sterol 14-demethylase|L000000577 559292 Saccharomyces cerevisiae unknown target Berman HM (2000) 10592235 172122 6380 3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate - - DRUGBANK DB07572 C16H19N3O4S small molecule - - DRUGBANK 27401 36434 856398 YHR007C ERG11 CYP51|sterol 14-demethylase|L000000577 559292 Saccharomyces cerevisiae unknown target Berman HM (2000) 10592235 172122 6441 bis(4-hydroxyphenyl)methanone - - DRUGBANK DB07635 C13H10O3 small molecule - - DRUGBANK 27398 36434 856398 YHR007C ERG11 CYP51|sterol 14-demethylase|L000000577 559292 Saccharomyces cerevisiae unknown target Berman HM (2000) 10592235 172122 6376 (2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE - - DRUGBANK DB07568 C19H15N5O3S2 small molecule - - DRUGBANK 27399 36434 856398 YHR007C ERG11 CYP51|sterol 14-demethylase|L000000577 559292 Saccharomyces cerevisiae unknown target Berman HM (2000) 10592235 172122 6377 CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE - - DRUGBANK DB07569 C18H27N3O2S small molecule - - DRUGBANK 11095 37567 172105 F21F3.5 unc-38 CELE_F21F3.5|tmr-2 6239 Caenorhabditis elegans activator target Culetto E (2004) 15280391 178680 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11096 37567 172105 F21F3.5 unc-38 CELE_F21F3.5|tmr-2 6239 Caenorhabditis elegans activator target Rayes D (2007) 17314321 178679 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11093 37611 172150 Y110A7A.3 unc-63 CELE_Y110A7A.3|tmr-3|lev-7 6239 Caenorhabditis elegans activator target Culetto E (2004) 15280391 178680 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11094 37611 172150 Y110A7A.3 unc-63 CELE_Y110A7A.3|tmr-3|lev-7 6239 Caenorhabditis elegans activator target Rayes D (2007) 17314321 178679 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11089 38136 172703 T08G11.5 unc-29 CELE_T08G11.5|unc-21|tmr-4|unc-56 6239 Caenorhabditis elegans activator target Culetto E (2004) 15280391 178680 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11090 38136 172703 T08G11.5 unc-29 CELE_T08G11.5|unc-21|tmr-4|unc-56 6239 Caenorhabditis elegans activator target Rayes D (2007) 17314321 178679 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11091 43360 178269 CELE_F09E8.7 lev-1 - 6239 Caenorhabditis elegans activator target Culetto E (2004) 15280391 178680 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11092 43360 178269 CELE_F09E8.7 lev-1 - 6239 Caenorhabditis elegans activator target Rayes D (2007) 17314321 178679 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 8742 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens inhibitor target Maxfield FR (1979) 42903 177414 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 8743 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens inhibitor target Gliemann J (1983) 6187372 177415 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 8744 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens inhibitor target Dickson RB (1981) 6165617 177416 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 8745 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens inhibitor target Dickson RB (1981) 6162847 177412 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 8746 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens inhibitor target Hanover JA (1983) 6184373 177413 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 1258 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens unknown target Bonner JC (1995) 7541796 172406 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 1259 106524 2 - A2M A2MD|CPAMD5|FWP007|S863-7 9606 Homo sapiens unknown target Lizonova A (1990) 1697862 172407 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 21003 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3204 Coa-S-Acetyl 5-Bromotryptamine - - DRUGBANK DB03341 C33H47BrN9O17P3S small molecule - - DRUGBANK 21004 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3204 Coa-S-Acetyl 5-Bromotryptamine - - DRUGBANK DB03341 C33H47BrN9O17P3S small molecule - - DRUGBANK 21005 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3204 Coa-S-Acetyl 5-Bromotryptamine - - DRUGBANK DB03341 C33H47BrN9O17P3S small molecule - - DRUGBANK 20153 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2809 Coa-S-Acetyl Tryptamine - - DRUGBANK DB02931 C33H47N9O17P3S small molecule - - DRUGBANK 20154 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2809 Coa-S-Acetyl Tryptamine - - DRUGBANK DB02931 C33H47N9O17P3S small molecule - - DRUGBANK 20155 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2809 Coa-S-Acetyl Tryptamine - - DRUGBANK DB02931 C33H47N9O17P3S small molecule - - DRUGBANK 17769 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1710 Coa-S-Trimethylene-Acetyl-Tryptamine - - DRUGBANK DB01777 C36H53N9O17P3S small molecule - - DRUGBANK 17770 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1710 Coa-S-Trimethylene-Acetyl-Tryptamine - - DRUGBANK DB01777 C36H53N9O17P3S small molecule - - DRUGBANK 17771 106533 15 - AANAT DSPS|SNAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1710 Coa-S-Trimethylene-Acetyl-Tryptamine - - DRUGBANK DB01777 C36H53N9O17P3S small molecule - - DRUGBANK 3490 106534 16 - AARS CMT2N 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3491 106534 16 - AARS CMT2N 9606 Homo sapiens unknown target McClain WH (1996) 8601277 173846 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3492 106534 16 - AARS CMT2N 9606 Homo sapiens unknown target Buechter DD (1995) 7742303 173845 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3493 106534 16 - AARS CMT2N 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3494 106534 16 - AARS CMT2N 9606 Homo sapiens unknown target Nagan MC (2000) 10871402 173847 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 13554 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Valdizan EM (1999) 10206175 180027 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 13555 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target French JA (1999) 10530689 180026 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 13556 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Molina PE (1999) 10503933 180025 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 13557 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Arndt CF (1999) 10214744 180024 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 13558 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 13559 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Weber OM (1999) 10195585 180028 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 17588 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1634 (4e)-4-Aminohex-4-Enoic Acid - - DRUGBANK DB01699 C6H11NO2 small molecule - - DRUGBANK 17589 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1634 (4e)-4-Aminohex-4-Enoic Acid - - DRUGBANK DB01699 C6H11NO2 small molecule - - DRUGBANK 17590 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1634 (4e)-4-Aminohex-4-Enoic Acid - - DRUGBANK DB01699 C6H11NO2 small molecule - - DRUGBANK 10379 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Todd KG (1995) 8749840 178187 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10380 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Todd KG (2009) 19203467 178349 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10381 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target McKenna KF (1991) 1881457 178348 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10382 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target McManus DJ (1992) 1610412 178352 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10383 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target MacKenzie EM (2008) 17768678 178353 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10384 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Tanay VA (2001) 11775064 178350 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10385 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target McKenna KF (1994) 7931216 178351 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 22873 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4063 4-Amino Hexanoic Acid - - DRUGBANK DB04235 C6H13NO2 small molecule - - DRUGBANK 22874 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4063 4-Amino Hexanoic Acid - - DRUGBANK DB04235 C6H13NO2 small molecule - - DRUGBANK 22875 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4063 4-Amino Hexanoic Acid - - DRUGBANK DB04235 C6H13NO2 small molecule - - DRUGBANK 5417 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Semba J (1989) 2559361 175107 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5418 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Bruni J (1979) 110294 175108 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5419 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Rosenberg G (2007) 17514356 175109 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5420 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5421 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Loescher W (1982) 6805473 175106 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5422 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5423 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Ha JH (2000) 11025174 175110 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 1727 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Schmidt C (2006) 16435204 172698 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1728 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1729 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Andersen G (2007) 17355287 72343 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1409 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Hwang IK (2007) 17531224 172470 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1410 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Liu W (2005) 15723541 172473 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1411 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Markova M (2005) 16096275 172475 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1412 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Sulaiman SA (2003) 14567543 172474 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1413 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Storici P (2004) 14534310 172476 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1414 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2351 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2352 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2353 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Far SR (1996) 8979623 173216 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2354 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Haeppoelae O (1987) 3299141 173214 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2355 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens unknown target Imai H (1991) 1983997 173215 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 3474 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3475 106536 18 hCG_1984265 ABAT GABA-AT|GABAT|NPD009 9606 Homo sapiens inhibitor target Amadasi A (2007) 17504214 173854 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3720 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens unknown target Zarubica A (2007) 16858612 174023 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3721 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens unknown target Porchay I (2006) 17135600 174024 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3722 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens unknown target Badeau R (2007) 17224860 174025 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 12762 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Nieland TJ (2004) 15102890 179672 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12763 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Agassandian M (2004) 15039140 179670 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12764 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Muehl H (2003) 14660039 179671 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12765 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Reddy ST (2002) 12426219 179667 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12766 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Lamkanfi M (2009) 19805629 179669 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12767 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Alder-Baerens N (2005) 15905177 179668 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 17301 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Shichiri M (2010) 19427182 181582 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 17302 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target de la Llera-Moya M (2010) 20075420 181581 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 17303 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Sirtori CR (1991) 1868500 181580 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 17304 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Arakawa R (2009) 19458386 181578 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 17305 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Yamamoto A (2008) 19075491 181579 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 17306 106537 19 - ABCA1 ABC-1|ABC1|CERP|HDLDT1|TGD 9606 Homo sapiens inhibitor target Favari E (2004) 15514211 181577 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 22097 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3715 N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide - - DRUGBANK DB03878 C22H18N6O small molecule - - DRUGBANK 24042 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Maekawa T (2007) 17929114 182055 4668 Nilotinib Nilotinibum tasigna DRUGBANK DB04868 C28H22F3N7O small molecule L01XE08 641571-10-0 DRUGBANK 24043 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Kantarjian HM (2007) 17715389 182041 4668 Nilotinib Nilotinibum tasigna DRUGBANK DB04868 C28H22F3N7O small molecule L01XE08 641571-10-0 DRUGBANK 24044 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Weisberg E (2006) 16721371 181947 4668 Nilotinib Nilotinibum tasigna DRUGBANK DB04868 C28H22F3N7O small molecule L01XE08 641571-10-0 DRUGBANK 24045 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Swords R (2009) 19920925 182135 4668 Nilotinib Nilotinibum tasigna DRUGBANK DB04868 C28H22F3N7O small molecule L01XE08 641571-10-0 DRUGBANK 24046 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Rosti G (2009) 19822896 182130 4668 Nilotinib Nilotinibum tasigna DRUGBANK DB04868 C28H22F3N7O small molecule L01XE08 641571-10-0 DRUGBANK 26063 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6836 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA - - DRUGBANK DB08043 C19H14F3N3O2 small molecule - - DRUGBANK 26619 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7360 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide - - DRUGBANK DB08583 C21H22N6O small molecule - - DRUGBANK 8659 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Dewar AL (2005) 15917650 177323 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8660 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Haberler C (2006) 16205964 177326 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8661 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Agirre X (2005) 15949566 177327 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8662 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Brueggemeier SB (2005) 16153117 177324 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8663 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Hoerth E (2004) 15799618 177325 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 26262 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 15409 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens multitarget target Piccaluga PP (2007) 17701954 180863 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15410 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens multitarget target Imming P (2006) 17016423 171742 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15411 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 26966 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Iqbal Z (2013) 23409026 182230 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 3686 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3687 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3688 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 26381 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7125 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE - - DRUGBANK DB08339 C21H16Cl2N4O2 small molecule - - DRUGBANK 26397 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7135 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE - - DRUGBANK DB08350 C22H20N4O2 small molecule - - DRUGBANK 25849 106543 25 RP11-83J21.1 ABL1 ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6628 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE - - DRUGBANK DB07831 C23H22F3N3O2 small molecule - - DRUGBANK 8413 106544 26 - AOC1 ABP|ABP1|DAO|DAO1|KAO 9606 Homo sapiens inhibitor target Padiglia A (2000) 10850957 177164 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8414 106544 26 - AOC1 ABP|ABP1|DAO|DAO1|KAO 9606 Homo sapiens inhibitor target Padiglia A (1999) 10938536 177163 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 21588 106544 26 - AOC1 ABP|ABP1|DAO|DAO1|KAO 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3456 Diminazene Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate - DRUGBANK DB03608 C14H15N7 small molecule - 536-71-0 DRUGBANK 3675 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3676 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3677 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 25668 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6470 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE - - DRUGBANK DB07664 C15H13F2N7O2S2 small molecule - - DRUGBANK 15400 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens multitarget target Imming P (2006) 17016423 171742 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15401 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15402 106545 27 RP11-177A2.3 ABL2 ABLL|ARG 9606 Homo sapiens multitarget target Lindauer M (2010) 20072833 180857 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 23812 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4484 GALACTOSE GREASE - - DRUGBANK DB04680 C16H30O8 small molecule - - DRUGBANK 21902 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3613 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol - - DRUGBANK DB03772 C12H24O5 small molecule - - DRUGBANK 21903 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3613 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol - - DRUGBANK DB03772 C12H24O5 small molecule - - DRUGBANK 21904 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3613 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol - - DRUGBANK DB03772 C12H24O5 small molecule - - DRUGBANK 25636 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6439 octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside - - DRUGBANK DB07633 C20H38O9 small molecule - - DRUGBANK 21218 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21219 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 25396 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6194 4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL - - DRUGBANK DB07378 C14H29NO5 small molecule - - DRUGBANK 21416 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Nguyen HP (2003) 12972418 181831 3356 Uridine Diphosphate Galactose UDP-D-Galactopyranose|UDP-galactose|GDU|UPG|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-d-galactose|UDP-galactopyranose|UDP-gal|Uridine pyrophosphogalactose|UDP-d-galactose|Uridine diphosphate-d-galactose|GALACTOSE-URIDINE-5'-DIPHOSPHATE|Uridine 5'-diphosphate galactose|Uridine 5'-diphosphogalactose|Uridinediphosphate galactose|UDP galactose - DRUGBANK DB03501 C15H24N2O17P2 small molecule - 2956-16-3 DRUGBANK 25346 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6157 octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside - - DRUGBANK DB07341 C20H39NO8 small molecule - - DRUGBANK 22667 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 22668 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 22669 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 18706 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18707 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 25364 106546 28 - ABO A3GALNT|A3GALT1|GTB|NAGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6173 4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL - - DRUGBANK DB07357 C12H25NO5 small molecule - - DRUGBANK 27474 106548 30 - ACAA1 ACAA|PTHIO|THIO 9606 Homo sapiens inhibitor target Kantor PF (2000) 10720420 188547 7818 Trimetazidine 1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride - DRUGBANK DB09069 C14H22N2O3 small molecule C01EB15 5011-34-7 DRUGBANK 1794 106549 31 - ACACA ACAC|ACACAD|ACC|ACC1|ACCA 9606 Homo sapiens unknown target Brownsey RW (2006) 16545081 172747 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1795 106549 31 - ACACA ACAC|ACACAD|ACC|ACC1|ACCA 9606 Homo sapiens unknown target Aoki H (2006) 16636450 172750 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1796 106549 31 - ACACA ACAC|ACACAD|ACC|ACC1|ACCA 9606 Homo sapiens unknown target Leonard E (2007) 17468269 172751 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1797 106549 31 - ACACA ACAC|ACACAD|ACC|ACC1|ACCA 9606 Homo sapiens unknown target Bilder P (2006) 16460018 172749 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1798 106549 31 - ACACA ACAC|ACACAD|ACC|ACC1|ACCA 9606 Homo sapiens unknown target Santoro N (2006) 16707089 172748 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 20038 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2741 Soraphen A - - DRUGBANK DB02859 C29H44O8 small molecule - 122547-72-2 DRUGBANK 20039 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2741 Soraphen A - - DRUGBANK DB02859 C29H44O8 small molecule - 122547-72-2 DRUGBANK 20040 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2741 Soraphen A - - DRUGBANK DB02859 C29H44O8 small molecule - 122547-72-2 DRUGBANK 21916 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3621 2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid - - DRUGBANK DB03781 C15H12Cl2O4 small molecule - - DRUGBANK 3810 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Witters LA (1987) 2880560 174050 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3811 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3812 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3813 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Rasmussen JT (1993) 8318018 174048 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3814 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Itani SI (2003) 12829626 174049 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3815 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 1810 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Liu Y (2007) 17477831 172755 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 25902 106550 32 - ACACB ACC2|ACCB|HACC275 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6667 (2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID - - DRUGBANK DB07870 C15H11ClF3NO4 small molecule - - DRUGBANK 20123 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 20124 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 20125 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 21163 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3272 3-Thiaoctanoyl-Coenzyme A - - DRUGBANK DB03415 C28H48N7O17P3S2 small molecule - - DRUGBANK 21164 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3272 3-Thiaoctanoyl-Coenzyme A - - DRUGBANK DB03415 C28H48N7O17P3S2 small molecule - - DRUGBANK 21165 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3272 3-Thiaoctanoyl-Coenzyme A - - DRUGBANK DB03415 C28H48N7O17P3S2 small molecule - - DRUGBANK 20606 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20607 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20608 106552 34 RP4-682C21.1 ACADM ACAD1|MCAD|MCADH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 3036 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3037 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 20399 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 20400 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 20401 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 20614 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20615 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20616 106553 35 - ACADS ACAD3|SCAD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 3620 106554 36 RP11-162A23.1 ACADSB 2-MEBCAD|ACAD7|SBCAD 9606 Homo sapiens unknown target Korman SH (2006) 16950638 173957 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3621 106554 36 RP11-162A23.1 ACADSB 2-MEBCAD|ACAD7|SBCAD 9606 Homo sapiens unknown target Madsen PP (2006) 16317551 173959 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3622 106554 36 RP11-162A23.1 ACADSB 2-MEBCAD|ACAD7|SBCAD 9606 Homo sapiens unknown target Korman SH (2005) 15615815 173958 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 5415 106554 36 RP11-162A23.1 ACADSB 2-MEBCAD|ACAD7|SBCAD 9606 Homo sapiens inhibitor target Bazinet RP (2006) 16344985 175104 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5416 106554 36 RP11-162A23.1 ACADSB 2-MEBCAD|ACAD7|SBCAD 9606 Homo sapiens inhibitor target Ito M (1990) 2112956 175105 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 10557 106556 38 - ACAT1 ACAT|MAT|T2|THIL 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10558 106556 38 - ACAT1 ACAT|MAT|T2|THIL 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10559 106556 38 - ACAT1 ACAT|MAT|T2|THIL 9606 Homo sapiens inhibitor target Faison LD (1992) 1357724 178413 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 18055 106557 39 - ACAT2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18056 106557 39 - ACAT2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18269 106557 39 - ACAT2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18270 106557 39 - ACAT2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 8424 106558 40 - ASIC2 ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1 9606 Homo sapiens inhibitor target Peng BG (2004) 15537887 177173 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8425 106558 40 - ASIC2 ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1 9606 Homo sapiens inhibitor target Berdiev BK (2003) 12584187 177172 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8426 106558 40 - ASIC2 ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1 9606 Homo sapiens inhibitor target Ugawa S (2003) 14686475 177176 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8427 106558 40 - ASIC2 ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1 9606 Homo sapiens inhibitor target Ugawa S (2003) 12736332 177175 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8428 106558 40 - ASIC2 ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1 9606 Homo sapiens inhibitor target Vila-Carriles WH (2006) 16704974 177174 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8419 106559 41 - ASIC1 ACCN2|ASIC|BNaC2 9606 Homo sapiens inhibitor target Jones NG (2004) 15574747 177091 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8420 106559 41 - ASIC1 ACCN2|ASIC|BNaC2 9606 Homo sapiens inhibitor target Petruska JC (2002) 12401318 177171 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8421 106559 41 - ASIC1 ACCN2|ASIC|BNaC2 9606 Homo sapiens inhibitor target Wang W (2006) 16319075 177170 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8422 106559 41 - ASIC1 ACCN2|ASIC|BNaC2 9606 Homo sapiens inhibitor target Sugiura T (2005) 15758172 177168 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8423 106559 41 - ASIC1 ACCN2|ASIC|BNaC2 9606 Homo sapiens inhibitor target Xiong ZG (2006) 16685601 177169 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8313 106559 41 - ASIC1 ACCN2|ASIC|BNaC2 9606 Homo sapiens inhibitor target Voilley N (2001) 11588175 177099 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 23692 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4366 3-[(1s)-1-(Dimethylamino)Ethyl]Phenol - - DRUGBANK DB04556 C10H15NO small molecule - - DRUGBANK 16162 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Singh AK (1998) 9568379 181170 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 9400 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target da Costa VL (2001) 11350858 177753 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9401 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Quistad GB (2000) 10898598 177752 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9402 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Pang YP (2003) 12837382 177751 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9403 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Ashani Y (1990) 1692236 177750 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9404 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9405 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Malatova Z (1999) 10378121 177749 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9256 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Blesa R (2000) 10971049 177720 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9257 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9258 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Greenblatt HM (1999) 10606746 177721 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9259 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9260 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 27570 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9261 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Tonkopii VD (1976) 1026294 177722 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9262 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Guillou C (2000) 10762042 177723 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9263 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9264 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9265 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Stahl SM (2000) 11078030 177717 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9266 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9267 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 22591 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3946 3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine - - DRUGBANK DB04114 C18H19ClN2 small molecule - - DRUGBANK 1822 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens product of target Anzai J (2006) 17139155 172765 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1823 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens product of target Longobardi F (2005) 16302752 172767 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1824 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens product of target Amenta F (2006) 16297435 172766 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1825 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens product of target Durcan N (2006) 16456188 172769 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1826 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens product of target Alkondon M (2006) 16565162 172768 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 18764 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2138 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium - - DRUGBANK DB02226 C42H45N8 small molecule - - DRUGBANK 18765 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2138 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium - - DRUGBANK DB02226 C42H45N8 small molecule - - DRUGBANK 18766 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2138 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium - - DRUGBANK DB02226 C42H45N8 small molecule - - DRUGBANK 20903 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3148 beta-L-fucose 6-Deoxy-Beta-L-Galactose - DRUGBANK DB03283 C6H12O5 small molecule - 2438-80-4 DRUGBANK 20904 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3148 beta-L-fucose 6-Deoxy-Beta-L-Galactose - DRUGBANK DB03283 C6H12O5 small molecule - 2438-80-4 DRUGBANK 20905 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3148 beta-L-fucose 6-Deoxy-Beta-L-Galactose - DRUGBANK DB03283 C6H12O5 small molecule - 2438-80-4 DRUGBANK 20555 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2997 Acetylcholine Acetylcholine Chloride miochol e|miogan pws 20mg/vial DRUGBANK DB03128 C7H16NO2 small molecule S01EB09 51-84-3 DRUGBANK 20556 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2997 Acetylcholine Acetylcholine Chloride miochol e|miogan pws 20mg/vial DRUGBANK DB03128 C7H16NO2 small molecule S01EB09 51-84-3 DRUGBANK 20557 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2997 Acetylcholine Acetylcholine Chloride miochol e|miogan pws 20mg/vial DRUGBANK DB03128 C7H16NO2 small molecule S01EB09 51-84-3 DRUGBANK 24028 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Hatip-Al-Khatib I (2005) 15951830 181894 4659 Zanapezil Zanepezil - DRUGBANK DB04859 C25H32N2O small molecule - 142852-50-4 DRUGBANK 22016 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22017 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22018 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 11047 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Sugimoto H (2002) 11893059 178648 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11048 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Jann MW (2000) 10641971 178649 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11049 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11050 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Ki YS (2010) 20522977 178644 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11051 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Kryger G (1999) 10368299 178645 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11052 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Shepherd G (1999) 10466911 178646 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11053 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Repantis D (2010) 20193764 178647 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11054 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Kosasa T (1999) 10513568 175704 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11055 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Davis KL (1999) 10024872 175705 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 10682 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Duarte CD (2007) 18045214 178462 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10683 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Contreras JM (1999) 10052979 178463 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 25764 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6557 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL - - DRUGBANK DB07756 C20H18F4N2O2S small molecule - - DRUGBANK 21022 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target He XC (2007) 17126020 181976 3211 Huperzine B HupB|HUB - DRUGBANK DB03348 C16H20N2O small molecule - 103548-82-9 DRUGBANK 21023 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3211 Huperzine B HupB|HUB - DRUGBANK DB03348 C16H20N2O small molecule - 103548-82-9 DRUGBANK 12467 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 971 Physostigmine Physostol|Antilirium|Eserine|Physostigmine physostigmine salicylate|antil DRUGBANK DB00981 C15H21N3O2 small molecule S01EB05|V03AB19 57-47-6 DRUGBANK 12468 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Blasina MF (2000) 10741458 179489 971 Physostigmine Physostol|Antilirium|Eserine|Physostigmine physostigmine salicylate|antil DRUGBANK DB00981 C15H21N3O2 small molecule S01EB05|V03AB19 57-47-6 DRUGBANK 12469 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Nguyen PV (1999) 10368402 179488 971 Physostigmine Physostol|Antilirium|Eserine|Physostigmine physostigmine salicylate|antil DRUGBANK DB00981 C15H21N3O2 small molecule S01EB05|V03AB19 57-47-6 DRUGBANK 12470 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Bolognesi ML (2001) 11141093 179487 971 Physostigmine Physostol|Antilirium|Eserine|Physostigmine physostigmine salicylate|antil DRUGBANK DB00981 C15H21N3O2 small molecule S01EB05|V03AB19 57-47-6 DRUGBANK 12471 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Tuovinen K (1999) 10403635 179486 971 Physostigmine Physostol|Antilirium|Eserine|Physostigmine physostigmine salicylate|antil DRUGBANK DB00981 C15H21N3O2 small molecule S01EB05|V03AB19 57-47-6 DRUGBANK 12472 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Monnet-Tschudi F (2000) 10873710 179490 971 Physostigmine Physostol|Antilirium|Eserine|Physostigmine physostigmine salicylate|antil DRUGBANK DB00981 C15H21N3O2 small molecule S01EB05|V03AB19 57-47-6 DRUGBANK 19681 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2563 (4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium - - DRUGBANK DB02673 C32H37N2O5 small molecule - - DRUGBANK 19682 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2563 (4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium - - DRUGBANK DB02673 C32H37N2O5 small molecule - - DRUGBANK 19683 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2563 (4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium - - DRUGBANK DB02673 C32H37N2O5 small molecule - - DRUGBANK 15349 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Seto Y (1988) 3190453 176404 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15350 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Sinha BK (1975) 239236 180826 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15351 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Robaire B (1975) 1207670 176408 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15352 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Wu CS (1989) 2913485 180827 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15353 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Hallek M (1988) 3345199 180828 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 17808 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 17809 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 17810 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 12530 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Greig NH (2003) 12636181 179548 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 27794 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Naik RS (2009) 19470293 195992 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12531 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Goldblum D (2000) 10673128 179540 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12532 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Birks J (2009) 19370562 179541 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12533 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Lalli S (2008) 18671661 179542 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12534 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Grossberg GT (2000) 10713582 179543 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12535 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Gottwald MD (1999) 11139819 179544 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12536 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Onor ML (2007) 18044073 179545 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12537 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Kennedy JS (1999) 10587286 179546 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12538 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Farlow MR (2003) 14587496 179547 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12539 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Stahl SM (2000) 11078030 177717 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12540 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 25870 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6643 1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE - - DRUGBANK DB07846 C22H27N3O3 small molecule - - DRUGBANK 13974 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Papp MI (2006) 15982786 180269 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 13975 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Kenakin TP (1985) 2857786 180268 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 13976 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 13977 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Lockhart B (2001) 11330337 180265 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 13978 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Bolognesi ML (2003) 13679187 180267 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 13979 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Hodge AS (1992) 1588924 180266 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 13980 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Webb GD (1965) 5833399 180270 1110 Ambenonium Ambenonium base|Ambenonum|Ambenonium - DRUGBANK DB01122 C28H42Cl2N4O2 small molecule N07AA30 7648-98-8 DRUGBANK 22406 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3854 MF268 - - DRUGBANK DB04021 C15H30N2O2 small molecule - - DRUGBANK 18991 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2248 3,6,9,12,15-Pentaoxaheptadecane - - DRUGBANK DB02343 C12H26O5 small molecule - 4353-28-0 DRUGBANK 25842 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6620 (1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE - - DRUGBANK DB07822 C7H17O2P small molecule - - DRUGBANK 27013 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Ishitani R (1972) 4539395 181672 7731 Dimetacrine Miroistonil|Istonil|3-(9,9-dimethylacridin-10-yl)-N,N-dimethyl-propan-1-amine|Linostil|Dimetacrine|Istonyl - DRUGBANK DB08996 C20H26N2 small molecule N06AA18 4757-55-5 DRUGBANK 7396 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Robaire B (1975) 1207670 176408 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7397 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Seto Y (1988) 3190453 176404 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7398 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Radic Z (1999) 10421444 176405 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7399 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Radic Z (2001) 11920914 176406 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7400 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Bourgeois JP (1978) 417864 176407 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7401 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Elsinghorst PW (2007) 17944454 176403 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7001 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Nakamura M (1993) 8446367 176143 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 12145 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 934 Demecarium Demecarium - DRUGBANK DB00944 C32H52N4O4 small molecule S01EB04 - DRUGBANK 12146 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Ward DA (2003) 12641839 179236 934 Demecarium Demecarium - DRUGBANK DB00944 C32H52N4O4 small molecule S01EB04 - DRUGBANK 20014 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2727 Methylphosphinic Acid - - DRUGBANK DB02845 CH5O2P small molecule - 4206-94-4 DRUGBANK 20015 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2727 Methylphosphinic Acid - - DRUGBANK DB02845 CH5O2P small molecule - 4206-94-4 DRUGBANK 20016 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2727 Methylphosphinic Acid - - DRUGBANK DB02845 CH5O2P small molecule - 4206-94-4 DRUGBANK 26405 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7142 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE - - DRUGBANK DB08357 C8H18O3 small molecule - - DRUGBANK 21832 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 21833 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 21834 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 23770 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4422 (R)-tacrine(10)-hupyridone - - DRUGBANK DB04614 C32H44N4O small molecule - - DRUGBANK 26646 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7392 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM - - DRUGBANK DB08615 C16H17N2OS small molecule - - DRUGBANK 19973 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2707 Methylphosphonic Acid Ester Group - - DRUGBANK DB02825 CH4O2P small molecule - - DRUGBANK 19974 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2707 Methylphosphonic Acid Ester Group - - DRUGBANK DB02825 CH4O2P small molecule - - DRUGBANK 19975 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2707 Methylphosphonic Acid Ester Group - - DRUGBANK DB02825 CH4O2P small molecule - - DRUGBANK 16439 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Naves LA (2001) 11313435 181299 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 16440 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Zhang B (2009) 19257799 181298 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 16441 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 16442 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Takeuchi K (2000) 11819669 181301 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 16443 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Trevisani GT (2000) 10826417 181300 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 16444 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Minic J (2003) 12522088 181303 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 16445 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Beck KD (2003) 12726885 181302 1350 Neostigmine Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate pms-neostigmine methylsulfate DRUGBANK DB01400 C12H19N2O2 small molecule N07AA01|S01EB06|N07AA51 59-99-4 DRUGBANK 26190 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6959 3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM - - DRUGBANK DB08167 C16H18N3S small molecule - - DRUGBANK 20279 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2881 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium - - DRUGBANK DB03005 C42H45N8 small molecule - - DRUGBANK 20280 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2881 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium - - DRUGBANK DB03005 C42H45N8 small molecule - - DRUGBANK 20281 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2881 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium - - DRUGBANK DB03005 C42H45N8 small molecule - - DRUGBANK 24092 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Klein J (2007) 17594192 182024 4692 Phenserine (-)-eseroline phenylcarbamate|(-)-phenserine - DRUGBANK DB04892 C20H23N3O2 small molecule - 101246-66-6 DRUGBANK 24093 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Greig NH (2005) 16248851 181915 4692 Phenserine (-)-eseroline phenylcarbamate|(-)-phenserine - DRUGBANK DB04892 C20H23N3O2 small molecule - 101246-66-6 DRUGBANK 27681 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4664 Huperzine A L-huperzine A|()-huperazine A|()-selagine|selagine - DRUGBANK DB04864 C15H18N2O small molecule - 102518-79-6 DRUGBANK 23771 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4423 (S)-tacrine(10)-hupyridone - - DRUGBANK DB04615 C32H44N4O small molecule - - DRUGBANK 21037 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3221 M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene - - DRUGBANK DB03359 C11H15F3NO2 small molecule - - DRUGBANK 21038 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3221 M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene - - DRUGBANK DB03359 C11H15F3NO2 small molecule - - DRUGBANK 21039 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3221 M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene - - DRUGBANK DB03359 C11H15F3NO2 small molecule - - DRUGBANK 25707 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6505 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE - - DRUGBANK DB07701 C24H29NO3 small molecule - - DRUGBANK 23773 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4425 (9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM - - DRUGBANK DB04617 C21H33N3 small molecule - - DRUGBANK 18654 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2082 Propidium - - DRUGBANK DB02166 C27H34N4 small molecule - 36015-30-2 DRUGBANK 18655 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2082 Propidium - - DRUGBANK DB02166 C27H34N4 small molecule - 36015-30-2 DRUGBANK 18656 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2082 Propidium - - DRUGBANK DB02166 C27H34N4 small molecule - 36015-30-2 DRUGBANK 7923 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Sinton CM (2000) 10814558 176801 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7924 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Servatius RJ (2000) 10869589 176802 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7925 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Prasad V (2000) 10685600 176803 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7926 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Drake-Baumann R (1999) 10366222 176804 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7927 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Ricordel I (2000) 10669805 176805 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7928 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7929 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Sinton CM (2000) 10814558 176801 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7930 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Servatius RJ (2000) 10869589 176802 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7931 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Prasad V (2000) 10685600 176803 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7932 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Drake-Baumann R (1999) 10366222 176804 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7933 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Ricordel I (2000) 10669805 176805 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7934 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 23772 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4424 TACRINE(8)-4-AMINOQUINOLINE - - DRUGBANK DB04616 C30H36N4 small molecule - - DRUGBANK 9938 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens activator target Wong L (2000) 10801325 178083 723 Pralidoxime Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim duodote|protopam chloride - DRUGBANK DB00733 C7H9N2O small molecule V03AB04 6735-59-7 DRUGBANK 9939 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens activator target Kovacic P (2003) 14529460 178086 723 Pralidoxime Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim duodote|protopam chloride - DRUGBANK DB00733 C7H9N2O small molecule V03AB04 6735-59-7 DRUGBANK 9940 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens activator target Jokanovic M (2009) 19519385 178084 723 Pralidoxime Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim duodote|protopam chloride - DRUGBANK DB00733 C7H9N2O small molecule V03AB04 6735-59-7 DRUGBANK 9941 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens activator target Jokanovic M (2009) 19651196 178085 723 Pralidoxime Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim duodote|protopam chloride - DRUGBANK DB00733 C7H9N2O small molecule V03AB04 6735-59-7 DRUGBANK 12709 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Ravelli RB (1998) 10089512 179638 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12710 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Keymer JE (1999) 10103097 179639 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12711 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Luo C (1999) 10421446 179636 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12712 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Huby F (1999) 10363282 179637 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12713 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12714 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Martin-Biosca Y (2009) 19472276 179641 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12715 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Luo C (1999) 10433700 179640 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 14755 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Gupta RC (1992) 1475066 180588 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14756 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Radic Z (1999) 10421444 176405 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14757 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Radic Z (2001) 11920914 176406 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14758 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Bianchi DA (2005) 15878275 180589 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14759 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Golicnik M (2002) 11823003 180587 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 25567 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6364 1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine - - DRUGBANK DB07555 C13H19AsF3NO3 small molecule - - DRUGBANK 6303 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6304 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Traykov L (1999) 10210906 175711 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6305 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Wang H (1999) 10208549 175708 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6306 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Villarroya M (2004) 15544507 175709 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6307 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Du DM (2004) 15544504 175710 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6308 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Marco JL (2003) 12871155 175702 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6309 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Wang H (1998) 10375753 175703 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6310 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Krustev AD (2006) 17218977 175701 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6311 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Takatori Y (2006) 16880719 175706 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6312 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Ahmed M (2006) 16860785 175707 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6313 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Kosasa T (1999) 10513568 175704 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6314 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens inhibitor target Davis KL (1999) 10024872 175705 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 19152 106561 43 - ACHE ACEE|ARACHE|N-ACHE|YT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2307 1-Deoxy-1-Thio-Heptaethylene Glycol - - DRUGBANK DB02404 C14H30O7S small molecule - - DRUGBANK 22468 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3904 Alpha-Methylisocitric Acid - - DRUGBANK DB04072 C7H10O7 small molecule - - DRUGBANK 22469 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3904 Alpha-Methylisocitric Acid - - DRUGBANK DB04072 C7H10O7 small molecule - - DRUGBANK 22470 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3904 Alpha-Methylisocitric Acid - - DRUGBANK DB04072 C7H10O7 small molecule - - DRUGBANK 23186 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4175 Aconitate Ion - - DRUGBANK DB04351 C6H3O6 small molecule - - DRUGBANK 23187 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4175 Aconitate Ion - - DRUGBANK DB04351 C6H3O6 small molecule - - DRUGBANK 23188 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4175 Aconitate Ion - - DRUGBANK DB04351 C6H3O6 small molecule - - DRUGBANK 22293 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3799 4-Hydroxy-Aconitate Ion - - DRUGBANK DB03964 C6H3O7 small molecule - - DRUGBANK 22294 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3799 4-Hydroxy-Aconitate Ion - - DRUGBANK DB03964 C6H3O7 small molecule - - DRUGBANK 22295 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3799 4-Hydroxy-Aconitate Ion - - DRUGBANK DB03964 C6H3O7 small molecule - - DRUGBANK 17673 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17674 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17675 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 23705 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4372 Tricarballylic Acid - - DRUGBANK DB04562 C6H8O6 small molecule - - DRUGBANK 23706 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4372 Tricarballylic Acid - - DRUGBANK DB04562 C6H8O6 small molecule - - DRUGBANK 23707 106566 50 RP3-347H13.8 ACO2 ACONM|ICRD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4372 Tricarballylic Acid - - DRUGBANK DB04562 C6H8O6 small molecule - - DRUGBANK 25957 106567 51 - ACOX1 ACOX|PALMCOX|SCOX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6726 (3R)-3-HYDROXYDODECANOIC ACID - - DRUGBANK DB07930 C12H24O3 small molecule - - DRUGBANK 20660 106567 51 - ACOX1 ACOX|PALMCOX|SCOX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 3816 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3817 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3818 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3819 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Wang S (2000) 10684601 50701 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3820 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Magherini F (2004) 15358193 20131 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3821 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Ostanin K (1995) 7629177 33867 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 22814 106568 52 - ACP1 HAAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4042 4-Nitrophenyl Phosphate - - DRUGBANK DB04214 C6H6NO6P small molecule - 330-13-2 DRUGBANK 27651 106570 54 - ACP5 SPENCDI|TRAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 21090 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3249 N-Propyl-Tartramic Acid - - DRUGBANK DB03390 C7H13NO5 small molecule - - DRUGBANK 21091 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3249 N-Propyl-Tartramic Acid - - DRUGBANK DB03390 C7H13NO5 small molecule - - DRUGBANK 21525 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3426 Alpha-Benzyl-Aminobenzyl-Phosphonic Acid - - DRUGBANK DB03577 C14H16NO3P small molecule - - DRUGBANK 21526 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3426 Alpha-Benzyl-Aminobenzyl-Phosphonic Acid - - DRUGBANK DB03577 C14H16NO3P small molecule - - DRUGBANK 21527 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3426 Alpha-Benzyl-Aminobenzyl-Phosphonic Acid - - DRUGBANK DB03577 C14H16NO3P small molecule - - DRUGBANK 27880 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens antagonist target Rini BI (2006) 16736512 195968 8083 Sipuleucel-T Sipuleucel-T provenge DRUGBANK DB06688 - biologic L03AX17 917381-47-6 DRUGBANK 27881 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens antagonist target Burch PA (2004) 15176049 195961 8083 Sipuleucel-T Sipuleucel-T provenge DRUGBANK DB06688 - biologic L03AX17 917381-47-6 DRUGBANK 27882 106571 55 - ACPP 5-NT|ACP-3|ACP3 9606 Homo sapiens antagonist target Mulders PF (2015) 26025563 196026 8083 Sipuleucel-T Sipuleucel-T provenge DRUGBANK DB06688 - biologic L03AX17 917381-47-6 DRUGBANK 21601 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3464 Kabiramide C - - DRUGBANK DB03616 C48H75N5O14 small molecule - - DRUGBANK 21602 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3464 Kabiramide C - - DRUGBANK DB03616 C48H75N5O14 small molecule - - DRUGBANK 21603 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3464 Kabiramide C - - DRUGBANK DB03616 C48H75N5O14 small molecule - - DRUGBANK 20328 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2895 Ulapualide A - - DRUGBANK DB03021 C46H66N4O13 small molecule - - DRUGBANK 20329 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2895 Ulapualide A - - DRUGBANK DB03021 C46H66N4O13 small molecule - - DRUGBANK 20330 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2895 Ulapualide A - - DRUGBANK DB03021 C46H66N4O13 small molecule - - DRUGBANK 22068 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3687 Jaspisamide A - - DRUGBANK DB03850 C44H64N4O13 small molecule - - DRUGBANK 22069 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3687 Jaspisamide A - - DRUGBANK DB03850 C44H64N4O13 small molecule - - DRUGBANK 22070 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3687 Jaspisamide A - - DRUGBANK DB03850 C44H64N4O13 small molecule - - DRUGBANK 19891 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19892 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19893 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 22151 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3740 Tmr - - DRUGBANK DB03903 C28H25N3O5 small molecule - - DRUGBANK 22152 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3740 Tmr - - DRUGBANK DB03903 C28H25N3O5 small molecule - - DRUGBANK 22153 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3740 Tmr - - DRUGBANK DB03903 C28H25N3O5 small molecule - - DRUGBANK 23778 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4435 Aplyronine A - - DRUGBANK DB04629 C59H101N3O14 small molecule - - DRUGBANK 23281 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23282 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23283 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23877 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4576 Reidispongiolide A - - DRUGBANK DB04774 C54H87NO13 small molecule - - DRUGBANK 23878 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4577 Reidispongiolide C - - DRUGBANK DB04775 C51H84O12 small molecule - - DRUGBANK 23883 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4585 Sphinxolide B - - DRUGBANK DB04783 C53H85NO14 small molecule - - DRUGBANK 26109 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6873 LATRUNCULIN B - - DRUGBANK DB08080 C20H29NO5S small molecule - - DRUGBANK 22722 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3981 4-Methyl-Histidine - - DRUGBANK DB04151 C7H11N3O2 small molecule - - DRUGBANK 22723 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3981 4-Methyl-Histidine - - DRUGBANK DB04151 C7H11N3O2 small molecule - - DRUGBANK 22724 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3981 4-Methyl-Histidine - - DRUGBANK DB04151 C7H11N3O2 small molecule - - DRUGBANK 27801 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens inhibitor target Coue M (1987) 3556584 196043 2513 Latrunculin A LAT-A|LatA|(+)-latrunculin A|(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one - DRUGBANK DB02621 C22H31NO5S small molecule - 76343-93-6 DRUGBANK 19555 106573 58 RP5-1068B5.2 ACTA1 ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2513 Latrunculin A LAT-A|LatA|(+)-latrunculin A|(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one - DRUGBANK DB02621 C22H31NO5S small molecule - 76343-93-6 DRUGBANK 3730 106605 90 - ACVR1 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3731 106605 90 - ACVR1 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 26629 106605 90 - ACVR1 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7374 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine - - DRUGBANK DB08597 C24H25N5O small molecule - - DRUGBANK 3698 106606 91 - ACVR1B ACTRIB|ACVRLK4|ALK4|SKR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3699 106606 91 - ACVR1B ACTRIB|ACVRLK4|ALK4|SKR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3694 106609 94 - ACVRL1 ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3695 106609 94 - ACVRL1 ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 24397 106610 95 - ACY1 ACY-1|ACY1D|HEL-S-5 9606 Homo sapiens ligand target Uttamsingh V (1998) 9671543 181730 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 1994 106610 95 - ACY1 ACY-1|ACY1D|HEL-S-5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1995 106610 95 - ACY1 ACY-1|ACY1D|HEL-S-5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1996 106610 95 - ACY1 ACY-1|ACY1D|HEL-S-5 9606 Homo sapiens unknown target Mitta M (1992) 1284246 172929 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 18115 106613 98 - ACYP2 ACYM|ACYP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 19979 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2712 FR236913 - - DRUGBANK DB02830 C24H26N6O3 small molecule - - DRUGBANK 12423 106614 100 - ADA - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 22831 106614 100 - ADA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4046 1-Deaza-Adenosine - - DRUGBANK DB04218 C11H14N4O4 small molecule - - DRUGBANK 22832 106614 100 - ADA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4046 1-Deaza-Adenosine - - DRUGBANK DB04218 C11H14N4O4 small molecule - - DRUGBANK 22833 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4046 1-Deaza-Adenosine - - DRUGBANK DB04218 C11H14N4O4 small molecule - - DRUGBANK 21049 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3231 FR239087 - - DRUGBANK DB03370 C15H17Cl2N3O2 small molecule - - DRUGBANK 25814 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6585 1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE - - DRUGBANK DB07786 C22H21ClN4O3 small molecule - - DRUGBANK 25811 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6582 1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE - - DRUGBANK DB07783 C25H27N5O3 small molecule - - DRUGBANK 23389 106614 100 - ADA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4255 Purine Riboside - - DRUGBANK DB04440 C10H13N4O4 small molecule - 550-33-4 DRUGBANK 23390 106614 100 - ADA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4255 Purine Riboside - - DRUGBANK DB04440 C10H13N4O4 small molecule - 550-33-4 DRUGBANK 23391 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4255 Purine Riboside - - DRUGBANK DB04440 C10H13N4O4 small molecule - 550-33-4 DRUGBANK 21517 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3421 FR230513 - - DRUGBANK DB03572 C18H19N3O2 small molecule - - DRUGBANK 25813 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6584 1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE - - DRUGBANK DB07785 C19H21N3O3 small molecule - - DRUGBANK 25716 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6514 (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol - - DRUGBANK DB07711 C14H23N5O small molecule - - DRUGBANK 20317 106614 100 - ADA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2890 6-Hydroxy-1,6-Dihydro Purine Nucleoside - - DRUGBANK DB03015 C10H15N4O5 small molecule - - DRUGBANK 20318 106614 100 - ADA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2890 6-Hydroxy-1,6-Dihydro Purine Nucleoside - - DRUGBANK DB03015 C10H15N4O5 small molecule - - DRUGBANK 20319 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2890 6-Hydroxy-1,6-Dihydro Purine Nucleoside - - DRUGBANK DB03015 C10H15N4O5 small molecule - - DRUGBANK 8003 106614 100 - ADA - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 542 Pentostatin Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent nipent pws 10mg/vial|nipent DRUGBANK DB00552 C11H16N4O4 small molecule L01XX08 53910-25-1 DRUGBANK 8004 106614 100 - ADA - 9606 Homo sapiens inhibitor target Newman DJ (2007) 17309302 176840 542 Pentostatin Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent nipent pws 10mg/vial|nipent DRUGBANK DB00552 C11H16N4O4 small molecule L01XX08 53910-25-1 DRUGBANK 8005 106614 100 - ADA - 9606 Homo sapiens inhibitor target Cabanillas F (2000) 10887639 176841 542 Pentostatin Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent nipent pws 10mg/vial|nipent DRUGBANK DB00552 C11H16N4O4 small molecule L01XX08 53910-25-1 DRUGBANK 8006 106614 100 - ADA - 9606 Homo sapiens inhibitor target Jackson RC (1986) 2433905 176842 542 Pentostatin Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent nipent pws 10mg/vial|nipent DRUGBANK DB00552 C11H16N4O4 small molecule L01XX08 53910-25-1 DRUGBANK 20773 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3088 FR233623 - - DRUGBANK DB03220 C19H21N3O2 small molecule - - DRUGBANK 19552 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2508 FR117016 - - DRUGBANK DB02616 C16H15N7S2 small molecule - - DRUGBANK 18520 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2016 FR221647 1-[(2R)-1-hydroxy-4-phenylbutan-2-yl]-1H-imidazole-4-carboxamide - DRUGBANK DB02096 C14H17N3O2 small molecule - - DRUGBANK 19269 106614 100 - ADA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2372 6-Hydroxy-7,8-Dihydro Purine Nucleoside - - DRUGBANK DB02472 C10H14N4O5 small molecule - - DRUGBANK 19270 106614 100 - ADA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2372 6-Hydroxy-7,8-Dihydro Purine Nucleoside - - DRUGBANK DB02472 C10H14N4O5 small molecule - - DRUGBANK 19271 106614 100 - ADA - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2372 6-Hydroxy-7,8-Dihydro Purine Nucleoside - - DRUGBANK DB02472 C10H14N4O5 small molecule - - DRUGBANK 3705 106621 107 - ADCY1 AC1|DFNB44 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3706 106621 107 - ADCY1 AC1|DFNB44 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 2131 106621 107 - ADCY1 AC1|DFNB44 9606 Homo sapiens product of target Chen X (2002) 11752352 171740 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2132 106621 107 - ADCY1 AC1|DFNB44 9606 Homo sapiens product of target Nicol X (2006) 17229090 173055 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2133 106621 107 - ADCY1 AC1|DFNB44 9606 Homo sapiens product of target Yang ZF (2006) 16895552 173056 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 19494 106622 108 - ADCY2 AC2|HBAC2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2481 Colforsin Forskolin - DRUGBANK DB02587 C22H34O7 small molecule - 66575-29-9 DRUGBANK 24868 106622 108 - ADCY2 AC2|HBAC2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5664 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE - - DRUGBANK DB06843 C10H14N5O5P small molecule - - DRUGBANK 19493 106624 111 - ADCY5 AC5|FDFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2481 Colforsin Forskolin - DRUGBANK DB02587 C22H34O7 small molecule - 66575-29-9 DRUGBANK 24867 106624 111 - ADCY5 AC5|FDFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5664 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE - - DRUGBANK DB06843 C10H14N5O5P small molecule - - DRUGBANK 3275 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Bieganowski P (2006) 16760478 70877 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3276 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Manriquez D (2006) 16897483 71149 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 14899 106636 124 - ADH1A ADH1 9606 Homo sapiens inhibitor target Mukherjee PK (2006) 16790752 71152 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14900 106636 124 - ADH1A ADH1 9606 Homo sapiens inhibitor target Betten DP (2006) 16946442 172237 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14901 106636 124 - ADH1A ADH1 9606 Homo sapiens inhibitor target Brent J (2009) 19458366 180651 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14902 106636 124 - ADH1A ADH1 9606 Homo sapiens inhibitor target Calello DP (2006) 16871118 180652 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14903 106636 124 - ADH1A ADH1 9606 Homo sapiens inhibitor target Nussrallah BA (1989) 2789998 180655 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14904 106636 124 - ADH1A ADH1 9606 Homo sapiens inhibitor target Nagata H (1996) 8997246 180656 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 19769 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 19770 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 22455 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3897 N-Cyclopentyl-N-Cyclobutylformamide - - DRUGBANK DB04065 C10H17NO small molecule - - DRUGBANK 22456 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3897 N-Cyclopentyl-N-Cyclobutylformamide - - DRUGBANK DB04065 C10H17NO small molecule - - DRUGBANK 22457 106636 124 - ADH1A ADH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3897 N-Cyclopentyl-N-Cyclobutylformamide - - DRUGBANK DB04065 C10H17NO small molecule - - DRUGBANK 3052 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Manriquez D (2006) 16897483 71149 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21758 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3547 Cyclohexanol - - DRUGBANK DB03703 C6H12O small molecule - 108-93-0 DRUGBANK 21759 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3547 Cyclohexanol - - DRUGBANK DB03703 C6H12O small molecule - 108-93-0 DRUGBANK 22575 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3937 N-Heptylformamide - - DRUGBANK DB04105 C8H17NO small molecule - - DRUGBANK 22576 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3937 N-Heptylformamide - - DRUGBANK DB04105 C8H17NO small molecule - - DRUGBANK 14893 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens inhibitor target Betten DP (2006) 16946442 172237 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14894 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens inhibitor target Eriksson CJ (2001) 11391066 180650 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14895 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens inhibitor target Brent J (2009) 19458366 180651 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14896 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens inhibitor target Calello DP (2006) 16871118 180652 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14897 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens inhibitor target Kassam JP (1989) 2573502 180653 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14898 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens inhibitor target Yin SJ (1992) 1590750 180654 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 19771 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 19772 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 22495 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22496 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22497 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 19282 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2379 N-Benzylformamide - - DRUGBANK DB02481 C8H9NO small molecule - 6343-54-0 DRUGBANK 19283 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2379 N-Benzylformamide - - DRUGBANK DB02481 C8H9NO small molecule - 6343-54-0 DRUGBANK 21288 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21289 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21290 106637 125 - ADH1B ADH2|HEL-S-117 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3061 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3062 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Plapp BV (2003) 12604203 173658 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3063 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 18590 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2050 N-1-Methylheptylformamide - - DRUGBANK DB02131 C9H19NO small molecule - - DRUGBANK 18591 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2050 N-1-Methylheptylformamide - - DRUGBANK DB02131 C9H19NO small molecule - - DRUGBANK 23449 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4262 2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene - - DRUGBANK DB04448 C7H6F2O small molecule - - DRUGBANK 23450 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4262 2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene - - DRUGBANK DB04448 C7H6F2O small molecule - - DRUGBANK 23451 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4262 2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene - - DRUGBANK DB04448 C7H6F2O small molecule - - DRUGBANK 17640 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1646 2,3,4,5,6-Pentafluorobenzyl Alcohol - - DRUGBANK DB01711 C7H3F5O small molecule - 440-60-8 DRUGBANK 17641 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1646 2,3,4,5,6-Pentafluorobenzyl Alcohol - - DRUGBANK DB01711 C7H3F5O small molecule - 440-60-8 DRUGBANK 17642 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1646 2,3,4,5,6-Pentafluorobenzyl Alcohol - - DRUGBANK DB01711 C7H3F5O small molecule - 440-60-8 DRUGBANK 22465 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3903 Cpad - - DRUGBANK DB04071 C21H27N7O14P2 small molecule - - DRUGBANK 22466 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3903 Cpad - - DRUGBANK DB04071 C21H27N7O14P2 small molecule - - DRUGBANK 22467 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3903 Cpad - - DRUGBANK DB04071 C21H27N7O14P2 small molecule - - DRUGBANK 19962 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2704 Para-Bromobenzyl Alcohol - - DRUGBANK DB02822 C7H7BrO small molecule - 873-75-6 DRUGBANK 19963 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2704 Para-Bromobenzyl Alcohol - - DRUGBANK DB02822 C7H7BrO small molecule - 873-75-6 DRUGBANK 19964 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2704 Para-Bromobenzyl Alcohol - - DRUGBANK DB02822 C7H7BrO small molecule - 873-75-6 DRUGBANK 19858 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2642 Pyrazole 1,2-Diazole - DRUGBANK DB02757 C3H4N2 small molecule - 288-13-1 DRUGBANK 19859 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2642 Pyrazole 1,2-Diazole - DRUGBANK DB02757 C3H4N2 small molecule - 288-13-1 DRUGBANK 19860 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2642 Pyrazole 1,2-Diazole - DRUGBANK DB02757 C3H4N2 small molecule - 288-13-1 DRUGBANK 14889 106638 126 - ADH1C ADH3 9606 Homo sapiens inhibitor target Eriksson CJ (2001) 11391066 180650 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14890 106638 126 - ADH1C ADH3 9606 Homo sapiens inhibitor target Brent J (2009) 19458366 180651 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14891 106638 126 - ADH1C ADH3 9606 Homo sapiens inhibitor target Calello DP (2006) 16871118 180652 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14892 106638 126 - ADH1C ADH3 9606 Homo sapiens inhibitor target Betten DP (2006) 16946442 172237 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 19773 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 19774 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 19775 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2609 4-Iodopyrazole - - DRUGBANK DB02721 C3H2IN2 small molecule - 3469-69-0 DRUGBANK 22588 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3945 N-Formylpiperidine - - DRUGBANK DB04113 C6H11NO small molecule - - DRUGBANK 22589 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3945 N-Formylpiperidine - - DRUGBANK DB04113 C6H11NO small molecule - - DRUGBANK 22590 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3945 N-Formylpiperidine - - DRUGBANK DB04113 C6H11NO small molecule - - DRUGBANK 20408 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2932 (R)-N-(1-Methyl-Hexyl)-Formamide - - DRUGBANK DB03061 C8H17NO small molecule - - DRUGBANK 20409 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2932 (R)-N-(1-Methyl-Hexyl)-Formamide - - DRUGBANK DB03061 C8H17NO small molecule - - DRUGBANK 20410 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2932 (R)-N-(1-Methyl-Hexyl)-Formamide - - DRUGBANK DB03061 C8H17NO small molecule - - DRUGBANK 20058 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2753 3-Butylthiolane 1-Oxide - - DRUGBANK DB02871 C8H16OS small molecule - - DRUGBANK 20789 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3094 Trifluoroethanol - - DRUGBANK DB03226 C2H3F3O small molecule - - DRUGBANK 20790 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3094 Trifluoroethanol - - DRUGBANK DB03226 C2H3F3O small molecule - - DRUGBANK 20791 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3094 Trifluoroethanol - - DRUGBANK DB03226 C2H3F3O small molecule - - DRUGBANK 20325 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2894 5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide - - DRUGBANK DB03020 C21H27N7O14P2 small molecule - - DRUGBANK 20326 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2894 5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide - - DRUGBANK DB03020 C21H27N7O14P2 small molecule - - DRUGBANK 20327 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2894 5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide - - DRUGBANK DB03020 C21H27N7O14P2 small molecule - - DRUGBANK 21497 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3408 Cyclohexylformamide - - DRUGBANK DB03559 C7H13NO small molecule - - DRUGBANK 21498 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3408 Cyclohexylformamide - - DRUGBANK DB03559 C7H13NO small molecule - - DRUGBANK 21499 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3408 Cyclohexylformamide - - DRUGBANK DB03559 C7H13NO small molecule - - DRUGBANK 19644 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23036 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4137 2,3-Difluorobenzyl Alcohol - - DRUGBANK DB04312 C7H6F2O small molecule - - DRUGBANK 23037 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4137 2,3-Difluorobenzyl Alcohol - - DRUGBANK DB04312 C7H6F2O small molecule - - DRUGBANK 23038 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4137 2,3-Difluorobenzyl Alcohol - - DRUGBANK DB04312 C7H6F2O small molecule - - DRUGBANK 18794 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2158 2-Ethoxyethanol - - DRUGBANK DB02249 C4H10O2 small molecule - 110-80-5 DRUGBANK 18795 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2158 2-Ethoxyethanol - - DRUGBANK DB02249 C4H10O2 small molecule - 110-80-5 DRUGBANK 18796 106638 126 - ADH1C ADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2158 2-Ethoxyethanol - - DRUGBANK DB02249 C4H10O2 small molecule - 110-80-5 DRUGBANK 3002 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3003 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3004 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Thielen J (1991) 1938903 25707 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3005 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Widenius TV (1987) 3593480 173636 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3006 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Plapp BV (2001) 11306066 173637 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21494 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3408 Cyclohexylformamide - - DRUGBANK DB03559 C7H13NO small molecule - - DRUGBANK 21495 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3408 Cyclohexylformamide - - DRUGBANK DB03559 C7H13NO small molecule - - DRUGBANK 21496 106639 127 - ADH4 ADH-2|HEL-S-4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3408 Cyclohexylformamide - - DRUGBANK DB03559 C7H13NO small molecule - - DRUGBANK 3123 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Baeumchen C (2007) 17619232 173685 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3124 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Baron R (2006) 16821840 173684 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3125 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Schirwitz K (2007) 17525463 173687 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3126 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Okochi M (2007) 17092593 173686 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21760 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3548 12-Hydroxydodecanoic Acid - - DRUGBANK DB03704 C12H24O3 small molecule - 505-95-3 DRUGBANK 21761 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3548 12-Hydroxydodecanoic Acid - - DRUGBANK DB03704 C12H24O3 small molecule - 505-95-3 DRUGBANK 21762 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3548 12-Hydroxydodecanoic Acid - - DRUGBANK DB03704 C12H24O3 small molecule - 505-95-3 DRUGBANK 27666 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27667 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27668 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 22728 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3983 S-Hydroxymethyl Glutathione - - DRUGBANK DB04153 C11H19N3O7S small molecule - - DRUGBANK 22729 106640 128 - ADH5 ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3983 S-Hydroxymethyl Glutathione - - DRUGBANK DB04153 C11H19N3O7S small molecule - - DRUGBANK 3240 106643 131 - ADH7 ADH4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3241 106643 131 - ADH7 ADH4 9606 Homo sapiens unknown target Suzuki Y (1993) 8490052 173728 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3242 106643 131 - ADH7 ADH4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3243 106643 131 - ADH7 ADH4 9606 Homo sapiens unknown target Dalfo D (2007) 17608724 173635 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3244 106643 131 - ADH7 ADH4 9606 Homo sapiens unknown target Kim DS (2001) 11410692 173729 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 10737 106644 132 - ADK AK 9606 Homo sapiens activator target Wu JZ (2005) 15917509 178480 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 10738 106644 132 - ADK AK 9606 Homo sapiens activator target Kumarapperuma SC (2007) 17379518 178481 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 2129 106644 132 - ADK AK 9606 Homo sapiens product of target Park J (2008) 18560757 173053 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2130 106644 132 - ADK AK 9606 Homo sapiens product of target Leoncini R (2006) 17065073 173054 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 25181 106644 132 - ADK AK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5990 7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE - - DRUGBANK DB07173 C11H13IN4O3 small molecule - - DRUGBANK 25294 106644 132 - ADK AK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6096 5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE - - DRUGBANK DB07280 C23H24N6O small molecule - - DRUGBANK 8875 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Trincavelli ML (2010) 20370662 177502 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8876 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Ezeamuzie CI (2007) 17321471 177503 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8877 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Buenestado A (2010) 20136829 177500 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8878 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Schenone S (2010) 20370661 177501 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8879 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Funakoshi H (2007) 17438146 177498 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8880 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Haschemi A (2007) 17442976 177499 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 10708 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 15027 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Yamamoto S (2003) 12735630 180711 1211 Aminophylline Somophyllin|Theophylline ethylenediamine|Aminophyllin aminophylline tab 100mg|aminop DRUGBANK DB01223 C16H24N10O4 small molecule R03DA55|R03DB05|R03DA05 317-34-0 DRUGBANK 15028 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Lerman BB (1993) 8425287 180712 1211 Aminophylline Somophyllin|Theophylline ethylenediamine|Aminophyllin aminophylline tab 100mg|aminop DRUGBANK DB01223 C16H24N10O4 small molecule R03DA55|R03DB05|R03DA05 317-34-0 DRUGBANK 24174 106646 134 - ADORA1 RDC7 9606 Homo sapiens unknown target Bianchi G (1993) 8405101 181699 4729 Defibrotide - defitelio DRUGBANK DB04932 - biologic B01AX01 83712-60-1 DRUGBANK 15807 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Nantwi KD (2004) 14992338 174820 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15808 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 4191 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4192 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Gaytan SP (2006) 16702031 174337 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4193 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Listos J (2006) 17085856 174336 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4194 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Wang SJ (2007) 17372967 174340 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4195 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Mustafa S (2006) 17162470 174338 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4196 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Rieg T (2007) 17126319 174339 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4197 106646 134 - ADORA1 RDC7 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4198 106646 134 - ADORA1 RDC7 9606 Homo sapiens multitarget target Gaytan SP (2006) 16702031 174337 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4199 106646 134 - ADORA1 RDC7 9606 Homo sapiens multitarget target Listos J (2006) 17085856 174336 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4200 106646 134 - ADORA1 RDC7 9606 Homo sapiens multitarget target Wang SJ (2007) 17372967 174340 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4201 106646 134 - ADORA1 RDC7 9606 Homo sapiens multitarget target Mustafa S (2006) 17162470 174338 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4202 106646 134 - ADORA1 RDC7 9606 Homo sapiens multitarget target Rieg T (2007) 17126319 174339 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 5034 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Nantwi KD (2004) 14992338 174820 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5035 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 12586 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target De Vry J (2004) 15140630 179580 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12587 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Kralic JE (2005) 15765150 179579 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12588 106646 134 - ADORA1 RDC7 9606 Homo sapiens agonist target Zuchora B (2005) 15572277 179578 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 9002 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Schwabe U (1985) 2997628 177567 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 24229 106646 134 - ADORA1 RDC7 9606 Homo sapiens unknown target Ellenbogen KA (2005) 15956124 181895 4748 Tecadenoson - - DRUGBANK DB04954 C14H19N5O5 small molecule - 204512-90-3 DRUGBANK 24230 106646 134 - ADORA1 RDC7 9606 Homo sapiens unknown target Peterman C (2005) 16230891 181913 4748 Tecadenoson - - DRUGBANK DB04954 C14H19N5O5 small molecule - 204512-90-3 DRUGBANK 24231 106646 134 - ADORA1 RDC7 9606 Homo sapiens unknown target Prystowsky EN (2003) 13678937 181832 4748 Tecadenoson - - DRUGBANK DB04954 C14H19N5O5 small molecule - 204512-90-3 DRUGBANK 16585 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Wang SJ (2007) 17372967 174340 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16586 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Chou CC (2003) 12602592 181374 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16587 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Fisone G (2004) 15095008 181372 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16588 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Listos J (2006) 17085856 174336 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16589 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Gaytan SP (2006) 16702031 174337 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16590 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Mustafa S (2006) 17162470 174338 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16591 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Rieg T (2007) 17126319 174339 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16592 106646 134 - ADORA1 RDC7 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 10844 106646 134 - ADORA1 RDC7 9606 Homo sapiens unknown target Linden J (1999) 10496952 178559 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 8881 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Trincavelli ML (2010) 20370662 177502 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8882 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Ezeamuzie CI (2007) 17321471 177503 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8883 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Buenestado A (2010) 20136829 177500 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8884 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Schenone S (2010) 20370661 177501 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8885 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Kreckler LM (2009) 19749080 177504 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8886 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Kreckler LM (2006) 16339914 177505 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8887 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Funakoshi H (2007) 17438146 177498 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8888 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Haschemi A (2007) 17442976 177499 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 10710 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Kreth S (2010) 19997047 178470 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 24173 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens unknown target Bianchi G (1993) 8405101 181699 4729 Defibrotide - defitelio DRUGBANK DB04932 - biologic B01AX01 83712-60-1 DRUGBANK 15811 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15812 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Pechlivanova DM (2005) 16357952 174830 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 24014 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens unknown target Cerqueira MD (2006) 16524538 181933 4654 Binodenoson 2-((Cyclohexylmethylene)hydrazino)adenosine|MRE 0470 - DRUGBANK DB04853 C17H25N7O4 small molecule - 144348-08-3 DRUGBANK 24015 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens unknown target Hodgson JM (2007) 17531571 182017 4654 Binodenoson 2-((Cyclohexylmethylene)hydrazino)adenosine|MRE 0470 - DRUGBANK DB04853 C17H25N7O4 small molecule - 144348-08-3 DRUGBANK 4245 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4247 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Riksen NP (2007) 17558310 174345 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4246 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Cornelis MC (2007) 17616786 174343 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4248 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Zhao G (2007) 17577101 174344 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4249 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4251 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens multitarget target Riksen NP (2007) 17558310 174345 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4250 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens multitarget target Cornelis MC (2007) 17616786 174343 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4252 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens multitarget target Zhao G (2007) 17577101 174344 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 5047 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5048 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Pechlivanova DM (2005) 16357952 174830 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5934 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Gillespie RJ (2008) 18406614 175466 350 Mefloquine [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina mefloquine|lariam tab 250mg|me DRUGBANK DB00358 C17H16F6N2O small molecule P01BF02|P01BC02 53230-10-7 DRUGBANK 9012 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Schwabe U (1985) 2997628 177567 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 24428 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens agonist target Zoghbi GJ (2012) 22130964 182196 5532 Regadenoson Regadenoson anhydrous lexiscan DRUGBANK DB06213 C15H18N8O5 small molecule C01EB21 313348-27-5 DRUGBANK 16579 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Chou CC (2003) 12602592 181374 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16580 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16581 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Fisone G (2004) 15095008 181372 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16582 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Cornelis MC (2007) 17616786 174343 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16583 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Riksen NP (2007) 17558310 174345 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16584 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens antagonist target Zhao G (2007) 17577101 174344 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 26769 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7542 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol - - DRUGBANK DB08770 C16H15N7O2 small molecule - - DRUGBANK 10853 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens unknown target Linden J (1999) 10496952 178559 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 27688 106647 135 - ADORA2A A2aR|ADORA2|RDC8 9606 Homo sapiens unknown target Cerqueira MD (2006) 16524538 181933 4796 Apadenoson - - DRUGBANK DB05009 C23H30N6O6 small molecule - 250386-15-3 DRUGBANK 5036 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5037 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Philipp S (2006) 16545350 174821 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5038 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Holgate ST (2005) 15980878 174822 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5039 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Phelps PT (2006) 16581066 174823 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5040 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Fozard JR (2003) 12954362 174824 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5041 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Daly JW (1987) 3588607 174819 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 8897 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Trincavelli ML (2010) 20370662 177502 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8898 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Ezeamuzie CI (2007) 17321471 177503 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8899 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Buenestado A (2010) 20136829 177500 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8900 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Schenone S (2010) 20370661 177501 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8901 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Kreckler LM (2006) 16339914 177505 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8902 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Funakoshi H (2007) 17438146 177498 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8903 106648 136 - ADORA2B ADORA2 9606 Homo sapiens agonist target Haschemi A (2007) 17442976 177499 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 24175 106648 136 - ADORA2B ADORA2 9606 Homo sapiens unknown target Bianchi G (1993) 8405101 181699 4729 Defibrotide - defitelio DRUGBANK DB04932 - biologic B01AX01 83712-60-1 DRUGBANK 10845 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Holgate ST (2005) 15980878 174822 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10846 106648 136 - ADORA2B ADORA2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 8889 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Trincavelli ML (2010) 20370662 177502 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8890 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Ezeamuzie CI (2007) 17321471 177503 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8891 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Buenestado A (2010) 20136829 177500 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8892 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Schenone S (2010) 20370661 177501 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8893 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Kreckler LM (2006) 16339914 177505 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8894 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8895 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Funakoshi H (2007) 17438146 177498 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 8896 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens agonist target Haschemi A (2007) 17442976 177499 630 Adenosine Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine the prestige bb spf25 pa 2plus DRUGBANK DB00640 C10H13N5O4 small molecule C01EB10 58-61-7 DRUGBANK 15024 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens antagonist target Stella L (1998) 9806324 180709 1211 Aminophylline Somophyllin|Theophylline ethylenediamine|Aminophyllin aminophylline tab 100mg|aminop DRUGBANK DB01223 C16H24N10O4 small molecule R03DA55|R03DB05|R03DA05 317-34-0 DRUGBANK 10854 106650 140 RP11-552M11.7 ADORA3 A3AR 9606 Homo sapiens unknown target Linden J (1999) 10496952 178559 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 19729 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 25815 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6586 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE - - DRUGBANK DB07787 C23H24FN3O2 small molecule - - DRUGBANK 21800 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3565 3,4-Dihydro-5-Methyl-Isoquinolinone - - DRUGBANK DB03722 C10H11NO small molecule - - DRUGBANK 21801 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3565 3,4-Dihydro-5-Methyl-Isoquinolinone - - DRUGBANK DB03722 C10H11NO small molecule - - DRUGBANK 21802 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3565 3,4-Dihydro-5-Methyl-Isoquinolinone - - DRUGBANK DB03722 C10H11NO small molecule - - DRUGBANK 21422 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3364 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide - - DRUGBANK DB03509 C15H10ClN3O small molecule - - DRUGBANK 21423 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3364 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide - - DRUGBANK DB03509 C15H10ClN3O small molecule - - DRUGBANK 21424 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3364 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide - - DRUGBANK DB03509 C15H10ClN3O small molecule - - DRUGBANK 19706 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2579 NU1025 - - DRUGBANK DB02690 C9H8N2O2 small molecule - 90417-38-2 DRUGBANK 19343 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2395 Carba-Nicotinamide-Adenine-Dinucleotide - - DRUGBANK DB02498 C22H29N7O13P2 small molecule - - DRUGBANK 19344 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2395 Carba-Nicotinamide-Adenine-Dinucleotide - - DRUGBANK DB02498 C22H29N7O13P2 small molecule - - DRUGBANK 19345 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2395 Carba-Nicotinamide-Adenine-Dinucleotide - - DRUGBANK DB02498 C22H29N7O13P2 small molecule - - DRUGBANK 22382 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3844 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide - - DRUGBANK DB04010 C15H13N3O2 small molecule - - DRUGBANK 25108 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5914 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE - - DRUGBANK DB07096 C12H8N2O2 small molecule - - DRUGBANK 25242 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6048 Veliparib 2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide|(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium - DRUGBANK DB07232 C13H16N4O small molecule - 912444-00-9 DRUGBANK 20426 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2944 3-Methoxybenzamide - - DRUGBANK DB03073 C8H9NO2 small molecule - - DRUGBANK 20427 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2944 3-Methoxybenzamide - - DRUGBANK DB03073 C8H9NO2 small molecule - - DRUGBANK 20428 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2944 3-Methoxybenzamide - - DRUGBANK DB03073 C8H9NO2 small molecule - - DRUGBANK 20423 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2943 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone - - DRUGBANK DB03072 C23H24FN3O small molecule - - DRUGBANK 20424 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2943 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone - - DRUGBANK DB03072 C23H24FN3O small molecule - - DRUGBANK 20425 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2943 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone - - DRUGBANK DB03072 C23H24FN3O small molecule - - DRUGBANK 27479 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens inhibitor target Verhagen CV (2015) 25981132 188550 7821 Olaparib 4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one lynparza DRUGBANK DB09074 - small molecule L01XX46 763113-22-0 DRUGBANK 25336 106652 142 RP11-125A15.2 PARP1 ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6146 trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium - - DRUGBANK DB07330 C16H22N4O small molecule - - DRUGBANK 5829 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target McVary KT (2006) 16613526 175397 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5830 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Roehrborn CG (2001) 11750253 175396 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5831 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5832 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Kenny BA (1996) 8799556 175399 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5833 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Andersson KE (1997) 9122046 175398 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5834 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Elhilali MM (2006) 16553574 175401 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5835 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Faure C (1994) 8196478 175400 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5836 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Lowe FC (2004) 15639685 175405 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 7125 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 14064 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Koshimizu TA (2004) 15306222 180304 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14065 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Van Tassell BW (2008) 18657662 180309 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 7087 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Yamamoto Y (2001) 11682453 176202 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7088 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Nagaoka Y (2008) 18187928 176201 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7089 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 5555 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24021 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens unknown target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 24422 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 5528 Silodosin Rapaflo|KMD 3213|Urief|KAD 3213 rapaflo DRUGBANK DB06207 C25H32F3N3O4 small molecule G04CA04 160970-54-7 DRUGBANK 3933 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3934 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 16185 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 16186 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 9673 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9674 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Michel MC (2004) 14680444 177923 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9675 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Taguchi K (1997) 8996174 177933 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9676 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Tomiyama Y (2006) 16518087 177932 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9677 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Lowe FC (2006) 16986050 177931 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9678 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Noble AJ (1997) 9117115 177930 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9679 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Ishiguro M (2002) 12270758 176197 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 10626 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens unknown target Martin SW (1995) 7670737 178447 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 13271 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 11966 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Minneman KP (1994) 7969082 179130 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 6160 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6161 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens binder target Wikstroem HV (2002) 12109911 175612 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6162 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 9201 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Du L (2010) 20412040 177674 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9202 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Jensen BC (2010) 20857090 177675 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9203 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Cotecchia S (2010) 20954794 177676 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9204 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Shieh JP (2009) 19730427 177677 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 15071 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14257 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14586 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7334 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens unknown target Huerta-Bahena J (1983) 6135146 176341 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 4339 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Altenbach RJ (2002) 12238918 174411 204 Midodrine 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid midodrine hydrochloride|midodr DRUGBANK DB00211 C12H18N2O4 small molecule C01CA17 42794-76-3 DRUGBANK 8373 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Greco KA (2008) 19002123 177129 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8374 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Lepor H (2008) 18231614 177133 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8375 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Martin DJ (1999) 10393471 177125 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8376 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Shannon R (2006) 17070143 177131 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8713 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 16483 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16484 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 14149 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14150 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14151 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 9853 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens binder target Zeng A (2009) 19493707 178051 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 14385 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 8461 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Sassard J (1983) 6355664 177183 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8462 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Shiraishi K (1992) 1358746 177189 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8463 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target van Zwieten PA (1993) 7684671 177184 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8464 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Rosendorff C (1993) 8104240 177185 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8465 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Pedersen ME (2007) 17686376 177191 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8466 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Nakamura T (1999) 10529655 177190 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8467 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Bernstein JS (1989) 2696507 177192 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 10355 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10356 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 27517 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens partial agonist target Ruffolo RR (1982) 6123592 188557 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 27518 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens partial agonist target Horie K (1995) 8564227 188556 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 4809 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens binder target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24495 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Testa R (1995) 7674815 175584 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24496 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Kenny BA (1995) 7582530 175582 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24497 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Du L (2010) 20412040 177674 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24498 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Bishop MJ (2007) 17266602 175573 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24374 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens unknown target Lindstroem E (2006) 16925508 181962 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 14786 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 24652 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 7876 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6079 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6080 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6081 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Bishop MJ (2007) 17266602 175573 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6082 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6083 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Kenny BA (1995) 7582530 175582 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6084 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Cleary L (2004) 15451776 175583 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6085 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Testa R (1995) 7674815 175584 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6741 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6742 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 7845 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 9593 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens partial agonist target Goernemann T (2008) 18066532 177880 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 12066 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12067 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12088 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Akinaga J (2013) 23364786 179195 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12089 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12090 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens agonist target Gaulton A (2012) 21948594 174478 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 5251 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 5252 106656 146 - ADRA1D ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 15217 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 5820 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target McVary KT (2006) 16613526 175397 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5821 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Roehrborn CG (2001) 11750253 175396 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5822 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5823 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Kenny BA (1996) 8799556 175399 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5824 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Andersson KE (1997) 9122046 175398 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5825 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Elhilali MM (2006) 16553574 175401 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5826 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Faure C (1994) 8196478 175400 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5827 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Lowe FC (2004) 15639685 175405 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5828 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Beique L (1998) 9870119 175404 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 9424 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 7092 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 14063 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Koshimizu TA (2004) 15306222 180304 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 10345 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10346 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5516 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24025 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 4724 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27919 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Oosterhof CA (2014) 25225185 196022 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 24421 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Lepor H (2010) 21114397 182179 5528 Silodosin Rapaflo|KMD 3213|Urief|KAD 3213 rapaflo DRUGBANK DB06207 C25H32F3N3O4 small molecule G04CA04 160970-54-7 DRUGBANK 3935 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3936 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 16187 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 16188 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 17322 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1546 Propericiazine 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina neuleptil 5mg capsules|neulept DRUGBANK DB01608 C21H23N3OS small molecule N05AC01 2622-26-6 DRUGBANK 17323 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1546 Propericiazine 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina neuleptil 5mg capsules|neulept DRUGBANK DB01608 C21H23N3OS small molecule N05AC01 2622-26-6 DRUGBANK 17324 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1546 Propericiazine 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina neuleptil 5mg capsules|neulept DRUGBANK DB01608 C21H23N3OS small molecule N05AC01 2622-26-6 DRUGBANK 9680 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9681 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Michel MC (2004) 14680444 177923 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9682 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Michel MC (1994) 7911719 177935 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9683 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richardson CD (1997) 9294627 177934 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9684 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Taguchi K (1997) 8996174 177933 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9685 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Ishiguro M (2002) 12270758 176197 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 10622 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Martin SW (1995) 7670737 178447 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 9959 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9960 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9961 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9962 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9963 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9964 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Eltze M (1996) 8925876 176194 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9848 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Waugh DJ (2001) 11331292 178047 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9849 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9850 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Simpson P (1985) 2988814 178050 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9851 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Tsujimoto G (1989) 2546049 178048 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9852 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Oleksa LM (1996) 8635240 178049 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 13272 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5644 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5645 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5646 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5647 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 9888 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 11973 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Minneman KP (1994) 7969082 179130 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 10039 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 10040 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens partial agonist target Chen CR (2007) 17681557 178152 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 10041 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 6163 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6164 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens binder target Wikstroem HV (2002) 12109911 175612 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6165 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 9196 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Du L (2010) 20412040 177674 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9197 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Jensen BC (2010) 20857090 177675 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9198 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Cotecchia S (2010) 20954794 177676 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9199 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Shieh JP (2009) 19730427 177677 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 15031 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15032 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 9587 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens partial agonist target Goernemann T (2008) 18066532 177880 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 14258 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14604 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7319 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7335 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Huerta-Bahena J (1983) 6135146 176341 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 4338 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Altenbach RJ (2004) 15163201 174408 204 Midodrine 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid midodrine hydrochloride|midodr DRUGBANK DB00211 C12H18N2O4 small molecule C01CA17 42794-76-3 DRUGBANK 8367 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Greco KA (2008) 19002123 177129 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8368 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Lepor H (2008) 18231614 177133 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8369 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Martin DJ (1999) 10393471 177125 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8370 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Shannon R (2006) 17070143 177131 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8722 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 16467 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16468 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 14104 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14105 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14106 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14202 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14203 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14204 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14379 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14380 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Boyle P (2001) 11711348 180428 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14381 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Vincent J (1992) 1358918 180427 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14382 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Simpson P (1985) 2988814 178050 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 8468 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Sassard J (1983) 6355664 177183 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8469 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Shiraishi K (1992) 1358746 177189 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8470 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target van Zwieten PA (1993) 7684671 177184 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8471 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Rosendorff C (1993) 8104240 177185 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8472 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Pedersen ME (2007) 17686376 177191 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8473 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nakamura T (1999) 10529655 177190 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8474 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Bernstein JS (1989) 2696507 177192 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 6377 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 380 Phenylephrine R(-)-Phenylephrine|Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)-|(-)-m-Hydroxy--(methylaminomethyl)benzyl alcohol|Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-|Phenylephrine|Fenilefrina|(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol|l-(3-Hydroxyphenyl)-N-methylethanolamine|Phenylephrinum|Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)- tylenol cold and flu nighttime DRUGBANK DB00388 C9H13NO2 small molecule R01AA04|R01BA03|R01BA53|R01AB01|S01GA55|C01CA06|S01GA05|S01FB01 59-42-7 DRUGBANK 15525 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nourian Z (2008) 18542932 178093 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15526 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15527 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15528 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15529 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15530 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cohen LJ (1994) 7524043 180924 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15531 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15532 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Eltze M (1996) 8925876 176194 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 27509 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens partial agonist target Ruffolo RR (1982) 6123592 188557 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 27510 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens partial agonist target Horie K (1995) 8564227 188556 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 4840 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens binder target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24509 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Izzo NJ (1994) 8166240 175593 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24510 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Bishop MJ (2007) 17266602 175573 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24511 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Du L (2010) 20412040 177674 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24512 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Testa R (1995) 7773533 175592 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24373 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens unknown target Lindstroem E (2006) 16925508 181962 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 17345 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 5968 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 14805 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 17396 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 24655 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 5253 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 5254 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 15434 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1243 Lisdexamfetamine Lisdexamfetamine|NRP104|lisdexamfetamine dimesylate vyvanse DRUGBANK DB01255 C15H25N3O small molecule N06BA12 608137-32-2 DRUGBANK 15435 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1243 Lisdexamfetamine Lisdexamfetamine|NRP104|lisdexamfetamine dimesylate vyvanse DRUGBANK DB01255 C15H25N3O small molecule N06BA12 608137-32-2 DRUGBANK 7877 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17088 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Bray GA (2005) 16265126 181539 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17089 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Bray GA (2000) 11054601 180046 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17090 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17091 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17092 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17093 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Rothman RB (2006) 17017961 178585 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 6105 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6106 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6107 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6108 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Bishop MJ (2007) 17266602 175573 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6109 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Izzo NJ (1994) 8294418 175594 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6110 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Izzo NJ (1994) 8166240 175593 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6111 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Testa R (1995) 7773533 175592 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6724 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6725 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 7831 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 17030 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17031 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17032 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 12068 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12069 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12094 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Akinaga J (2013) 23364786 179195 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12095 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12096 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens agonist target Gaulton A (2012) 21948594 174478 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 7078 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7079 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Sharpe IA (2003) 12824165 176198 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7080 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Al-Damluji S (2001) 11156594 176199 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7081 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7082 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7083 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Ishiguro M (2002) 12270758 176197 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7084 106657 147 - ADRA1B ADRA1|ALPHA1BAR 9606 Homo sapiens antagonist target Eltze M (1996) 8925876 176194 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 5248 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 5249 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Eltze M (1997) 9401944 175040 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 5250 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 291 Dapiprazole Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol - DRUGBANK DB00298 C19H27N5 small molecule S01EX02 72822-12-9 DRUGBANK 10074 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Dupont LJ (1996) 8836655 178183 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 16167 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Wellman PJ (2003) 12557268 181172 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16168 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Ma G (2007) 17405867 181173 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16169 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 5809 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target McVary KT (2006) 16613526 175397 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5810 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Roehrborn CG (2001) 11750253 175396 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5811 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5812 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Kenny BA (1996) 8799556 175399 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5813 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Andersson KE (1997) 9122046 175398 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5814 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Elhilali MM (2006) 16553574 175401 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5815 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Faure C (1994) 8196478 175400 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5816 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Martin DJ (1997) 9223558 175403 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5817 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Lee M (2003) 12892027 175402 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5818 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Lowe FC (2004) 15639685 175405 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 5819 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Beique L (1998) 9870119 175404 338 Alfuzosin Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina alfuzosin hydrochloride extend DRUGBANK DB00346 C19H27N5O4 small molecule G04CA01|G04CA51 81403-80-7 DRUGBANK 9422 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9423 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 14480 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Fabre V (2003) 12876551 180470 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14481 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Bareggi SR (2007) 17916059 174434 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 7115 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7116 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 14061 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14062 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 10343 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10344 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5540 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5541 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24017 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 4746 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4747 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Andersohn F (2010) 20075651 174625 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 10930 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Fujinaga M (1994) 8150214 178590 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10931 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10932 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10933 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Huerta-Bahena J (1983) 6135146 176341 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 15517 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nourian Z (2008) 18542932 178093 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15518 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15519 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15520 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15521 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15522 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cohen LJ (1994) 7524043 180924 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15523 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15524 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Eltze M (1996) 8925876 176194 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 24420 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Lepor H (2010) 21114397 182179 5528 Silodosin Rapaflo|KMD 3213|Urief|KAD 3213 rapaflo DRUGBANK DB06207 C25H32F3N3O4 small molecule G04CA04 160970-54-7 DRUGBANK 3937 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3938 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 8587 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 600 Metaraminol Hydroxynorephedrine|1-Metaraminol|(-)-Erythro-metaraminol|2-Amino-1-(m-hydroxyphenyl)-1-propanol|Mtaraminol|m-Hydroxypropadrine|Metaraminolum|alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol|1-(m-Hydroxyphenyl)-2-amino-1-propanol|3-Hydroxyphenylisopropanolamine|alpha-(m-Hydroxyphenyl)-beta-aminopropanol|m-Hydroxy norephedrine|m-Hydroxyphenylpropanolamine|Metaraminol|L-Metaraminol - DRUGBANK DB00610 C9H13NO2 small molecule C01CA09 54-49-9 DRUGBANK 8588 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 600 Metaraminol Hydroxynorephedrine|1-Metaraminol|(-)-Erythro-metaraminol|2-Amino-1-(m-hydroxyphenyl)-1-propanol|Mtaraminol|m-Hydroxypropadrine|Metaraminolum|alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol|1-(m-Hydroxyphenyl)-2-amino-1-propanol|3-Hydroxyphenylisopropanolamine|alpha-(m-Hydroxyphenyl)-beta-aminopropanol|m-Hydroxy norephedrine|m-Hydroxyphenylpropanolamine|Metaraminol|L-Metaraminol - DRUGBANK DB00610 C9H13NO2 small molecule C01CA09 54-49-9 DRUGBANK 8589 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Tatsuta M (1998) 9663612 177277 600 Metaraminol Hydroxynorephedrine|1-Metaraminol|(-)-Erythro-metaraminol|2-Amino-1-(m-hydroxyphenyl)-1-propanol|Mtaraminol|m-Hydroxypropadrine|Metaraminolum|alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol|1-(m-Hydroxyphenyl)-2-amino-1-propanol|3-Hydroxyphenylisopropanolamine|alpha-(m-Hydroxyphenyl)-beta-aminopropanol|m-Hydroxy norephedrine|m-Hydroxyphenylpropanolamine|Metaraminol|L-Metaraminol - DRUGBANK DB00610 C9H13NO2 small molecule C01CA09 54-49-9 DRUGBANK 11240 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 11241 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 9665 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chen Y (2009) 19427736 177928 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9666 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Lee E (1997) 9352700 177929 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9667 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9668 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Michel MC (2004) 14680444 177923 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9669 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chapple CR (1996) 8647141 177924 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9670 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Schulman CC (1996) 8647140 177925 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9671 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Abrams P (1997) 9352698 177926 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 9672 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Na YJ (1999) 10503165 177927 696 Tamsulosin (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin jamp-tamsulosin|tamsulosin cr| DRUGBANK DB00706 C20H28N2O5S small molecule G04CA02|G04CA53|G04CA52 106133-20-4 DRUGBANK 10621 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Martin SW (1995) 7670737 178447 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 24199 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 12345 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Freedman KA (2005) 15937427 179380 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12346 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Kawasaki A (2008) 18454417 179379 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12347 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Chen PL (2006) 16935593 179378 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12348 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Watts P (2007) 17572343 179377 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12349 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Sueke H (2010) 20399934 179376 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12350 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Mirzai H (2006) 16921219 179375 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12351 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Moodley AA (2007) 17824139 179374 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 24719 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Parker EM (1988) 3129549 147713 5588 Isometheptene Isometheptene nodolor|prodrin|isometheptene DRUGBANK DB06706 C9H19N small molecule A03AX10 503-01-5 DRUGBANK 24720 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Valdivia LF (2004) 15094323 181847 5588 Isometheptene Isometheptene nodolor|prodrin|isometheptene DRUGBANK DB06706 C9H19N small molecule A03AX10 503-01-5 DRUGBANK 24726 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Jastak JT (1983) 6355236 181678 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 27702 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24727 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Yang HT (1996) 8894610 179193 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24728 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Hersh EV (2010) 20831932 182165 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 9843 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Sattar MA (1994) 7511752 178046 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9844 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Hoang TV (1996) 8986981 178044 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9845 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Suzuki E (1990) 1978244 178045 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9846 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Satoh M (1994) 7875228 178042 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 9847 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Piascik MT (1991) 1680715 178043 713 Methoxamine Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina vasoxyl inj 20mg/ml DRUGBANK DB00723 C11H17NO3 small molecule C01CA10 390-28-3 DRUGBANK 13270 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5685 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5686 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 7015 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Zupko I (2003) 12505540 176151 442 Droperidol Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo inapsine|droperidol|innovar in DRUGBANK DB00450 C22H22FN3O2 small molecule N05AD08 548-73-2 DRUGBANK 11960 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Michel MC (1994) 7911719 177935 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11961 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Suzuki E (1990) 1978244 178045 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11962 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Stam WB (1999) 10401556 136712 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11963 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Salles J (1996) 8935707 179128 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11964 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Yu Y (2003) 12818701 179129 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 27121 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Alvarez-Guerra M (1999) 10027088 177898 689 Nicergoline Nicergolina|Nicergoline|Nicergolin|Sermion|Nicergolinum - DRUGBANK DB00699 C24H26BrN3O3 small molecule C04AE02 27848-84-6 DRUGBANK 6116 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens binder target Millan MJ (2000) 10762339 175610 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6157 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6158 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens binder target Wikstroem HV (2002) 12109911 175612 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6159 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 7829 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nojimoto FD (2010) 20363235 175181 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7830 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 6061 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6064 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Bishop MJ (2007) 17266602 175573 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6062 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6065 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Lachnit WG (1997) 9138687 175574 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6063 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Burt RP (1996) 8825367 175572 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 27385 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Spiller H (2008) 18259967 188522 7778 Tetryzoline Tetrizolina|Tetryzolin|Ttryzoline|Tetryzolinum|(RS)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole|Tetrahydrozoline visine multi-symptom|major red DRUGBANK DB06764 C13H16N2 small molecule R01AA06|S01GA52|R01AB03|S01GA02 84-22-0 DRUGBANK 15057 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15058 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 9584 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9585 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9586 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens partial agonist target Goernemann T (2008) 18066532 177880 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 14256 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14581 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7333 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Huerta-Bahena J (1983) 6135146 176341 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7344 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 4335 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Buckner SA (2002) 12163120 174410 204 Midodrine 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid midodrine hydrochloride|midodr DRUGBANK DB00211 C12H18N2O4 small molecule C01CA17 42794-76-3 DRUGBANK 4336 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Altenbach RJ (2004) 15163201 174408 204 Midodrine 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid midodrine hydrochloride|midodr DRUGBANK DB00211 C12H18N2O4 small molecule C01CA17 42794-76-3 DRUGBANK 4337 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Taniguchi N (1996) 9007522 174409 204 Midodrine 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid midodrine hydrochloride|midodr DRUGBANK DB00211 C12H18N2O4 small molecule C01CA17 42794-76-3 DRUGBANK 8358 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Martin DJ (1999) 10393471 177125 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8359 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Yono M (2004) 15573147 177126 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8360 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Michel MC (1996) 8736427 177127 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8361 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Ishizuka O (1997) 9205965 177128 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8362 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Greco KA (2008) 19002123 177129 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8363 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8364 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Roehrborn CG (2004) 14767264 177132 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8365 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Shannon R (2006) 17070143 177131 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8366 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Bae JH (2005) 16225542 177130 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 8718 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 4363 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens binder target Bareggi SR (2007) 17916059 174434 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 7009 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Tomiyama Y (2007) 17658513 175725 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 7010 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Sanbe A (2007) 17603545 176147 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 14134 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14135 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14136 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14200 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Taylor DP (1995) 7649970 180360 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14201 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14373 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Lee E (1997) 9352700 177929 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14374 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chapple CR (1998) 9732824 180426 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14375 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Michel MC (1996) 8736427 177127 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14376 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14377 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Roehrborn CG (2004) 14767264 177132 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 14378 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Na YJ (1999) 10503165 177927 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 8454 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Sassard J (1983) 6355664 177183 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8455 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Shiraishi K (1992) 1358746 177189 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8456 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target van Zwieten PA (1993) 7684671 177184 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8457 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Rosendorff C (1993) 8104240 177185 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8458 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Pedersen ME (2007) 17686376 177191 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8459 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nakamura T (1999) 10529655 177190 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8460 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Bernstein JS (1989) 2696507 177192 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 15768 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Shiraishi K (1992) 1358746 177189 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 6375 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Tomiyama Y (2007) 17658513 175725 380 Phenylephrine R(-)-Phenylephrine|Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)-|(-)-m-Hydroxy--(methylaminomethyl)benzyl alcohol|Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-|Phenylephrine|Fenilefrina|(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol|l-(3-Hydroxyphenyl)-N-methylethanolamine|Phenylephrinum|Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)- tylenol cold and flu nighttime DRUGBANK DB00388 C9H13NO2 small molecule R01AA04|R01BA03|R01BA53|R01AB01|S01GA55|C01CA06|S01GA05|S01FB01 59-42-7 DRUGBANK 6376 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Martinez-Salas SG (2007) 17584443 175726 380 Phenylephrine R(-)-Phenylephrine|Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)-|(-)-m-Hydroxy--(methylaminomethyl)benzyl alcohol|Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-|Phenylephrine|Fenilefrina|(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol|l-(3-Hydroxyphenyl)-N-methylethanolamine|Phenylephrinum|Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)- tylenol cold and flu nighttime DRUGBANK DB00388 C9H13NO2 small molecule R01AA04|R01BA03|R01BA53|R01AB01|S01GA55|C01CA06|S01GA05|S01FB01 59-42-7 DRUGBANK 5990 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 27507 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Ruffolo RR (1982) 6123592 188557 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 27508 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Horie K (1995) 8564227 188556 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 10584 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Song W (2002) 11938943 178428 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 10585 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Teskin O (2006) 16368348 178429 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 10586 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 10587 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 4803 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens binder target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 9887 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 17415 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Khalifa AE (2003) 12957216 181606 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 6473 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6474 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Buckner SA (2002) 12163120 174410 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6475 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Altenbach RJ (2004) 15163201 174408 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6476 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Moya-Huff FA (1987) 2881994 175801 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6477 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Wellman PJ (1997) 9164583 175804 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 24484 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Du L (2010) 20412040 177674 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24485 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Bishop MJ (2007) 17266602 175573 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24486 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Burt RP (1996) 8825367 175572 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24487 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Senard JM (2001) 11482743 181774 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24488 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Lachnit WG (1997) 9138687 175574 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24371 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Hietala J (2001) 11594443 181778 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24372 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Lindstroem E (2006) 16925508 181962 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24437 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24742 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Hrometz SL (1999) 10381812 181737 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24743 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Kai T (1999) 10459292 181739 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24744 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Leonardi A (2005) 16083326 181903 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24745 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Bogacka E (1999) 10481510 181740 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24746 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Piletz JE (1996) 8930173 177889 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24747 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Ogidigben MJ (2001) 11180982 181768 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 17344 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 9568 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Bylund DB (1992) 1346768 177681 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9569 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Giussani DA (1995) 7562640 177849 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9570 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Saeed M (1982) 6176798 177844 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 11165 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11166 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Wellington K (2002) 11772135 178699 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11167 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 14780 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 17395 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 24649 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 24650 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Yang HT (1996) 8894610 179193 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 13455 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13456 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 11328 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11329 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 15398 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Zhu F (2010) 19933260 178527 1241 Ergonovine Ergobasine|N-(alpha-(Hydroxymethyl)ethyl)-D-lysergamide|9,10-Didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-methylergoline-8-beta-carboxamide|Ergonovine|9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8beta(S)-carboxamide|Ergometrinum|[8beta(S)]-9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide|Ergometrina|D-Lysergic acid 1-hydroxymethylethylamide|Ergometrine|(6AR,9R)-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((S)-2-hydroxy-1-methyl-ethyl)-amide|N-(2-Hydroxy-1-methylethyl)-D(+)-lysergamide|Ergotrate maleate|D-Lysergic acid-L-propanolamide ergotrate maleate tablet 1572 DRUGBANK DB01253 C19H23N3O2 small molecule G02AB03 60-79-7 DRUGBANK 15399 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Gibson A (1988) 2897449 180856 1241 Ergonovine Ergobasine|N-(alpha-(Hydroxymethyl)ethyl)-D-lysergamide|9,10-Didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-methylergoline-8-beta-carboxamide|Ergonovine|9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8beta(S)-carboxamide|Ergometrinum|[8beta(S)]-9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide|Ergometrina|D-Lysergic acid 1-hydroxymethylethylamide|Ergometrine|(6AR,9R)-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((S)-2-hydroxy-1-methyl-ethyl)-amide|N-(2-Hydroxy-1-methylethyl)-D(+)-lysergamide|Ergotrate maleate|D-Lysergic acid-L-propanolamide ergotrate maleate tablet 1572 DRUGBANK DB01253 C19H23N3O2 small molecule G02AB03 60-79-7 DRUGBANK 12082 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Shibata K (2001) 11774707 179189 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12083 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Yang HT (1996) 8894610 179193 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12084 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Furukawa K (1995) 8564226 179192 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12085 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Deplanne V (1996) 8768700 179191 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12086 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Gonzalez-Espinosa C (2001) 11527538 179190 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 16762 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16763 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 12064 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12065 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 9953 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nourian Z (2008) 18542932 178093 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9954 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9955 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9956 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9957 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9958 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Eltze M (1996) 8925876 176194 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 7883 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7875 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7884 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17083 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17084 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Rothman RB (2006) 17017961 178585 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17085 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17086 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Bray GA (2005) 16265126 181539 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 17087 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Bray GA (2000) 11054601 180046 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 9192 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Tomiyama Y (2007) 17658513 175725 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9193 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Sanbe A (2007) 17603545 176147 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9194 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Du L (2010) 20412040 177674 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9195 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Jensen BC (2010) 20857090 177675 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 16189 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 16190 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 9052 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 17028 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17029 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 15235 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 6722 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6723 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 16465 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16466 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 7070 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Tomiyama Y (2007) 17658513 175725 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7071 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7072 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Suzuki Y (2000) 10771044 176192 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7073 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Zacharia J (2004) 14980979 176193 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7074 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Sleight AJ (1993) 7691623 176191 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7075 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Chang HK (2003) 12841945 176196 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7076 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Eltze M (1996) 8925876 176194 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7077 106658 148 - ADRA1A ADRA1C|ADRA1L1|ALPHA1AAR 9606 Homo sapiens antagonist target Morris DP (2004) 15258254 176195 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 8838 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Fairbanks CA (2002) 11752127 176993 623 Dexmedetomidine Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole dexmedetomidine|dexmedetomidin DRUGBANK DB00633 C13H16N2 small molecule N05CM18 113775-47-6 DRUGBANK 8839 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Ozdogan UK (2004) 15306201 176995 623 Dexmedetomidine Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole dexmedetomidine|dexmedetomidin DRUGBANK DB00633 C13H16N2 small molecule N05CM18 113775-47-6 DRUGBANK 8840 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Davies MF (2004) 14583739 177451 623 Dexmedetomidine Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole dexmedetomidine|dexmedetomidin DRUGBANK DB00633 C13H16N2 small molecule N05CM18 113775-47-6 DRUGBANK 8841 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Dawson C (2004) 15087625 177452 623 Dexmedetomidine Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole dexmedetomidine|dexmedetomidin DRUGBANK DB00633 C13H16N2 small molecule N05CM18 113775-47-6 DRUGBANK 8842 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Menon DV (2007) 17692748 177453 623 Dexmedetomidine Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole dexmedetomidine|dexmedetomidin DRUGBANK DB00633 C13H16N2 small molecule N05CM18 113775-47-6 DRUGBANK 8843 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Scheibner J (2002) 11834617 177454 623 Dexmedetomidine Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole dexmedetomidine|dexmedetomidin DRUGBANK DB00633 C13H16N2 small molecule N05CM18 113775-47-6 DRUGBANK 10078 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Dupont LJ (1996) 8836655 178183 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 8352 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 16183 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 16184 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 4401 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Noshiro T (1989) 2545383 174457 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4402 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Noshiro T (1990) 1962798 174456 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 15232 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 5508 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Villalon CM (2004) 14744615 175174 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 16363 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Ozdogan UK (2006) 16325800 181266 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16364 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Laurila JM (2007) 17558432 181264 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16365 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Paul BZ (1999) 10506165 181265 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16366 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Zadori ZS (2007) 17664022 181263 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16367 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Kalkman HO (2003) 12591093 181256 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16368 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 14085 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Koshimizu TA (2004) 15306222 180304 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 7090 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens binder target Uhlen S (1991) 1666366 176190 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 5535 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Ozdogan UK (2004) 14757140 175191 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5536 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24023 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 8800 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Bockman CS (1993) 7903385 177438 619 Guanabenz Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo - DRUGBANK DB00629 C8H8Cl2N4 small molecule - 5051-62-7 DRUGBANK 8801 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target van Zwieten PA (1997) 9050980 177436 619 Guanabenz Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo - DRUGBANK DB00629 C8H8Cl2N4 small molecule - 5051-62-7 DRUGBANK 8802 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Bockman CS (1996) 8819507 177437 619 Guanabenz Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo - DRUGBANK DB00629 C8H8Cl2N4 small molecule - 5051-62-7 DRUGBANK 8803 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Piletz JE (1993) 8263811 177434 619 Guanabenz Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo - DRUGBANK DB00629 C8H8Cl2N4 small molecule - 5051-62-7 DRUGBANK 8804 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Galeotti N (2004) 15265636 177435 619 Guanabenz Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo - DRUGBANK DB00629 C8H8Cl2N4 small molecule - 5051-62-7 DRUGBANK 4742 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 15557 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 3931 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3932 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 24653 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Petrusewicz J (1985) 2868542 181663 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 24654 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 17321 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Tsukamoto T (1984) 6149771 181308 1546 Propericiazine 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina neuleptil 5mg capsules|neulept DRUGBANK DB01608 C21H23N3OS small molecule N05AC01 2622-26-6 DRUGBANK 11238 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 11239 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 10631 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10632 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10633 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Martin SW (1995) 7670737 178447 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 24210 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Strang J (1999) 10598217 181744 4742 Lofexidine Lofexidinum|Lofexidina|2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline - DRUGBANK DB04948 C11H12Cl2N2O small molecule N07BC04 31036-80-3 DRUGBANK 24211 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Erb S (2000) 10882840 181755 4742 Lofexidine Lofexidinum|Lofexidina|2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline - DRUGBANK DB04948 C11H12Cl2N2O small molecule N07BC04 31036-80-3 DRUGBANK 24212 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Jin Y (1992) 1357064 181638 4742 Lofexidine Lofexidinum|Lofexidina|2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline - DRUGBANK DB04948 C11H12Cl2N2O small molecule N07BC04 31036-80-3 DRUGBANK 16156 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Kobayashi S (2003) 14570629 181168 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16157 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Rothman RB (2003) 12954796 174149 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16158 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 12334 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Wikberg-Matsson A (2001) 11481271 176420 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12335 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12336 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Chen PL (2006) 16935593 179378 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12337 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12338 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Sueke H (2010) 20399934 179376 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12339 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Mirzai H (2006) 16921219 179375 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12340 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Moodley AA (2007) 17824139 179374 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12341 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Costa VP (2003) 14575724 179373 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12342 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Unknown Authors (2003) 12630335 179372 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12343 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Scheinfeld N (2005) 15748550 179371 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 12344 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Watts P (2007) 17572343 179377 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 24592 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Swedberg MD (1988) 2901483 181665 5563 Flupirtine Flupirtine - DRUGBANK DB06623 C15H17FN4O2 small molecule N02BG07 56995-20-1 DRUGBANK 9752 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 13274 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5675 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 9906 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens desensitize the target target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 11972 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Frang H (2001) 11395517 179127 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 17425 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Khalifa AE (2003) 12957216 181606 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 6166 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Anttila SA (2001) 11607047 175618 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6167 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Garcia-Sevilla JA (2004) 14628003 175623 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6168 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Rogoz Z (2003) 12523492 175625 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6169 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Schreiber S (2002) 11931344 175624 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6170 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Rogoz Z (2002) 11939713 175627 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6171 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Besson A (2000) 10793320 175626 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6097 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6098 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6099 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6100 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Nash DT (1990) 1980236 175570 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6101 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Hieble JP (1998) 9836297 175588 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6102 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target MacLennan SJ (2000) 10742288 175589 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6103 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Nyroenen T (2001) 11306720 175591 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6104 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Giovannoni MP (2009) 18680204 175590 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 9063 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9064 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9065 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 15051 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15052 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14264 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens binder target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14605 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14606 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7337 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Bylund DB (1988) 2835476 176342 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 12381 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Head GA (1999) 10415926 179404 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12382 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target van Zwieten PA (1996) 8743022 179401 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12383 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Sica DA (2007) 17485976 179400 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12384 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Velliquette RA (2003) 14557373 179403 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12385 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Kawasaki H (1997) 9284427 179402 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12386 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target van Zwieten PA (1992) 1363322 179399 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12387 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 12388 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 16462 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16463 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16464 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Tsukamoto T (1984) 6149771 181308 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 7007 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 7008 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 14118 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14220 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 8193 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Lavand'homme PM (2002) 12357167 176992 565 Clonidine 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline clonidine|teva-clonidine|catap DRUGBANK DB00575 C9H9Cl2N3 small molecule N02CX02|C02LC01|S01EA04|C02LC51|C02AC01 4205-90-7 DRUGBANK 8194 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Fairbanks CA (2002) 11752127 176993 565 Clonidine 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline clonidine|teva-clonidine|catap DRUGBANK DB00575 C9H9Cl2N3 small molecule N02CX02|C02LC01|S01EA04|C02LC51|C02AC01 4205-90-7 DRUGBANK 8195 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Ozdogan UK (2004) 14757140 175191 565 Clonidine 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline clonidine|teva-clonidine|catap DRUGBANK DB00575 C9H9Cl2N3 small molecule N02CX02|C02LC01|S01EA04|C02LC51|C02AC01 4205-90-7 DRUGBANK 8196 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Wang XM (2002) 12098614 176994 565 Clonidine 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline clonidine|teva-clonidine|catap DRUGBANK DB00575 C9H9Cl2N3 small molecule N02CX02|C02LC01|S01EA04|C02LC51|C02AC01 4205-90-7 DRUGBANK 8197 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Ozdogan UK (2004) 15306201 176995 565 Clonidine 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline clonidine|teva-clonidine|catap DRUGBANK DB00575 C9H9Cl2N3 small molecule N02CX02|C02LC01|S01EA04|C02LC51|C02AC01 4205-90-7 DRUGBANK 24465 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5985 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4964 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4841 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4842 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Newman-Tancredi A (2002) 12388667 174663 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4843 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 6470 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6471 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6472 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Flavahan NA (2005) 15608085 175803 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 24506 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Davis MP (2010) 21173850 182183 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24507 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Nyroenen T (2001) 11306720 175591 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24508 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Giovannoni MP (2009) 18680204 175590 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 9614 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Piletz JE (1996) 8930173 177889 687 Tizanidine Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin tizanidine hydrochloride|zanaf DRUGBANK DB00697 C9H8ClN5S small molecule M03BX02 51322-75-9 DRUGBANK 24393 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Dekeyne A (2006) 16814817 181951 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 24739 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Fukushima H (2008) 17852165 182048 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24740 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Piletz JE (1996) 8930173 177889 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 24741 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Ogidigben MJ (2001) 11180982 181768 5593 Naphazoline Nafazolin blue collyrium|odan-naphazolin DRUGBANK DB06711 C14H14N2 small molecule S01GA51|S01GA01|R01AA08|R01AB02 835-31-4 DRUGBANK 10590 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Song W (2002) 11938943 178428 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 9560 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Bylund DB (1992) 1346768 177681 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9561 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Giussani DA (1995) 7562640 177849 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9562 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Vonend O (2007) 17115069 177848 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9563 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Polak J (2005) 16273345 177843 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9564 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Blandizzi C (2003) 12770936 177847 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9565 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Molderings GJ (2000) 10988273 177846 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9566 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Trendelenburg AU (2003) 12721093 177845 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 9567 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Saeed M (1982) 6176798 177844 682 Phentolamine Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline rogitine 5mg/vial|phentolamine DRUGBANK DB00692 C17H19N3O small molecule V03AB36|C04AB01 50-60-2 DRUGBANK 11187 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11188 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 14806 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14807 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target de Leeuw van Weenen JE (2010) 20138024 180601 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14808 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 26865 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens unknown target Tarazi FI (2012) 22849428 182208 7585 Lurasidone Lurasidona|Lurasidonum latuda DRUGBANK DB08815 C28H36N4O2S small molecule N05AE05 367514-87-2 DRUGBANK 27513 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Ruffolo RR (1982) 6123592 188557 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 27514 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Horie K (1995) 8564227 188556 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 16772 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16773 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 9982 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9983 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 6658 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens partial agonist target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6659 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens partial agonist target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 7417 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Meana JJ (1992) 1373179 176422 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7418 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Wikberg-Matsson A (2001) 11481271 176420 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7419 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Rauly I (2000) 10799649 176421 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7420 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 9209 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9210 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Nash DT (1990) 1980236 175570 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9211 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Hieble JP (1998) 9836297 175588 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9212 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target MacLennan SJ (2000) 10742288 175589 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9213 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Nyroenen T (2001) 11306720 175591 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9214 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Giovannoni MP (2009) 18680204 175590 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 12826 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Millan MJ (1992) 1356794 179722 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 12827 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Avery RA (2000) 10942848 179723 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 12828 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Yuan R (2005) 15928018 179724 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 12829 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Stahl SM (2010) 20331927 179725 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 12830 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Sagvolden T (2006) 17173664 179726 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 12831 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Birnbaum SG (2000) 11164065 179727 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 27878 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 17076 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Jeng CH (1998) 9551769 181531 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17077 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17078 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Nishio M (2002) 12453616 181535 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 9607 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9608 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9609 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens partial agonist target Goernemann T (2008) 18066532 177880 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 12077 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12091 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Mitrani P (2007) 17164433 179197 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12092 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target MacKinnon AC (1992) 1327384 179196 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12093 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens agonist target Lepretre N (1994) 7892112 179198 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 7878 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7879 106659 150 - ADRA2A ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 15219 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8350 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 13275 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 16181 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 16182 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 4403 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Noshiro T (1989) 2545383 174457 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4404 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Noshiro T (1990) 1962798 174456 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 16141 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Kobayashi S (2003) 14570629 181168 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16142 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Rothman RB (2003) 12954796 174149 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16143 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 9748 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16340 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Freitag A (1996) 8872361 181255 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16341 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Alonso E (2007) 17123717 181254 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16342 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Cleary L (2002) 12110610 181253 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16343 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Takada K (2002) 12170055 181252 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16344 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16345 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Gyires K (2000) 10822066 181250 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 14060 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Koshimizu TA (2004) 15306222 180304 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 7069 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Uhlen S (1991) 1666366 176190 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 24016 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens unknown target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 8799 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Uhlen S (1991) 1666366 176190 619 Guanabenz Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo - DRUGBANK DB00629 C8H8Cl2N4 small molecule - 5051-62-7 DRUGBANK 4726 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 3929 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3930 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 10623 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10624 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10625 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Martin SW (1995) 7670737 178447 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 12333 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Liu JH (1991) 1676991 179370 954 Apraclonidine Apraclonidina|Apraclonidinum|4-Aminoclonidine apraclonidine ophthalmic|iopid DRUGBANK DB00964 C9H10Cl2N4 small molecule S01EA03 66711-21-5 DRUGBANK 27879 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 15553 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5649 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 9897 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens unknown target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 11959 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Frang H (2001) 11395517 179127 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 7881 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 5199 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Paris A (2003) 14508322 175001 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 5200 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Creagh O (2010) 20496522 175002 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 9187 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Rudling JE (2000) 11053214 175571 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9188 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9189 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Vizi ES (2001) 11728431 175568 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9190 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Gobbi M (1990) 1979424 175569 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9191 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Nash DT (1990) 1980236 175570 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 15034 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15035 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14265 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14600 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14601 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7338 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens unknown target Bylund DB (1988) 2835476 176342 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 16477 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16478 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16479 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Tsukamoto T (1984) 6149771 181308 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 14103 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 24446 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5970 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4962 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4813 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4814 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Newman-Tancredi A (2002) 12388667 174663 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4815 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4816 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24325 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Scheller D (2009) 18704368 182084 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 24481 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24482 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Davis MP (2010) 21173850 182183 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24483 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Giovannoni MP (2009) 18680204 175590 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 9613 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Piletz JE (1996) 8930173 177889 687 Tizanidine Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin tizanidine hydrochloride|zanaf DRUGBANK DB00697 C9H8ClN5S small molecule M03BX02 51322-75-9 DRUGBANK 10589 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Trendelenburg AU (1997) 9089664 178430 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 14789 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14790 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target de Leeuw van Weenen JE (2010) 20138024 180601 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14791 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 24648 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 27515 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Ruffolo RR (1982) 6123592 188557 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 27516 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Horie K (1995) 8564227 188556 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 9977 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9978 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9979 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9980 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 6654 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6655 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 7415 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Bohmann C (1993) 8097565 176419 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7416 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Trendelenburg AU (2003) 14610637 176418 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 6054 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Nash DT (1990) 1980236 175570 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6055 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6056 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6057 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Rudling JE (2000) 11053214 175571 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6058 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6059 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Vizi ES (2001) 11728431 175568 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6060 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Gobbi M (1990) 1979424 175569 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 12825 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Uhlen S (1991) 1666366 176190 1008 Guanfacine Estulic|Guanfacinum|Guanfacina guanfacine|intuniv xr|intuniv| DRUGBANK DB01018 C9H9Cl2N3O small molecule C02AC02 29110-47-2 DRUGBANK 17054 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Jeng CH (1998) 9551769 181531 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17055 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 9598 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9599 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9600 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9601 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 12078 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12080 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Uhlen S (1991) 1666366 176190 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 12081 106660 151 - ADRA2B ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR 9606 Homo sapiens binder target Gaulton A (2012) 21948594 174478 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 15226 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8336 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 13273 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 16179 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 16180 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 4399 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Noshiro T (1989) 2545383 174457 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4400 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Noshiro T (1990) 1962798 174456 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 16134 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Kobayashi S (2003) 14570629 181168 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16135 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Rothman RB (2003) 12954796 174149 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16136 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 9733 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16346 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Cleary L (2005) 16176444 181259 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16347 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Lalchandani SG (2002) 12438517 181258 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16348 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Rizzo CA (2001) 11226402 181257 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16349 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Kalkman HO (2003) 12591093 181256 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16350 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Cleary L (2002) 12110610 181253 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16351 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 14055 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Koshimizu TA (2004) 15306222 180304 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 24018 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens unknown target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 4736 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27917 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Oosterhof CA (2014) 25225185 196022 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 3927 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3928 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 10634 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10635 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10636 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Martin SW (1995) 7670737 178447 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 6638 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6639 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 27877 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 15514 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5667 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 11965 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Frang H (2001) 11395517 179127 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 7880 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6117 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6118 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 9215 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Bylund DB (1992) 1346768 177681 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 15043 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15044 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14263 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens binder target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14582 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14583 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7336 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens unknown target Bylund DB (1988) 2835476 176342 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 16454 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16455 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16456 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Tsukamoto T (1984) 6149771 181308 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 14110 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 24438 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5979 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4951 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4804 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4805 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Newman-Tancredi A (2002) 12388667 174663 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4806 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24489 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Rump LC (1995) 8590979 175575 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24490 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Davis MP (2010) 21173850 182183 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24491 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Giovannoni MP (2009) 18680204 175590 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 9616 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Piletz JE (1996) 8930173 177889 687 Tizanidine Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin tizanidine hydrochloride|zanaf DRUGBANK DB00697 C9H8ClN5S small molecule M03BX02 51322-75-9 DRUGBANK 27511 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Ruffolo RR (1982) 6123592 188557 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 27512 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Horie K (1995) 8564227 188556 7946 Cirazoline - - DRUGBANK DB09202 C13H16N2O small molecule - 59939-16-1 DRUGBANK 10588 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens binder target Trendelenburg AU (1997) 9089664 178430 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 14781 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14782 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target de Leeuw van Weenen JE (2010) 20138024 180601 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14783 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 24651 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 5576 Xylometazoline Balminil|Xylomethazoline otrivin cold and allergy relie DRUGBANK DB06694 C16H24N2 small molecule R01AA07|R01AB06|S01GA53|S01GA03 526-36-3 DRUGBANK 27703 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Li G (1994) 7906055 181690 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 9986 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9987 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 7421 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Orito K (2001) 11606316 176423 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7422 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Trendelenburg AU (2003) 14610637 176418 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7423 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Zhang W (2003) 12670699 176424 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 7424 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Prinster SC (2006) 16757535 176425 476 Brimonidine Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina pms-brimonidine|brimonidine|sa DRUGBANK DB00484 C11H10BrN5 small molecule S01EA05|D11AX21 59803-98-4 DRUGBANK 6066 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Nash DT (1990) 1980236 175570 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6067 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6068 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6069 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6070 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Rump LC (1995) 8590979 175575 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6071 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Shreve PE (1991) 1654268 175577 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6072 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Bruck H (2007) 17410123 175576 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 26861 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 7585 Lurasidone Lurasidona|Lurasidonum latuda DRUGBANK DB08815 C28H36N4O2S small molecule N05AE05 367514-87-2 DRUGBANK 17045 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Jeng CH (1998) 9551769 181531 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17046 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 12076 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12087 106661 152 - ADRA2C ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR 9606 Homo sapiens agonist target Haenisch B (2010) 20030735 179194 925 Oxymetazoline 6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol sunmark nasal|shopko extra moi DRUGBANK DB00935 C16H24N2O small molecule S01GA04|R01AB07|R01AA05 1491-59-4 DRUGBANK 16118 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Sanchez C (1993) 11224195 181163 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16119 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Frishman WH (1990) 2189902 181162 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16120 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Venter CP (1982) 6755764 181165 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16121 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Doze P (2002) 11738481 181164 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16122 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Sanchez C (1993) 11224195 181163 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16123 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Frishman WH (1990) 2189902 181162 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16124 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Venter CP (1982) 6755764 181165 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16125 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Doze P (2002) 11738481 181164 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 4413 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Horinouchi T (2007) 17628611 174482 214 Isoetarine Isoetharine|Isoetarinum|Isoetarina - DRUGBANK DB00221 C13H21NO3 small molecule R03CC06|R03AC07 79490-84-9 DRUGBANK 4414 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Muszkat M (2007) 17329986 174483 214 Isoetarine Isoetharine|Isoetarinum|Isoetarina - DRUGBANK DB00221 C13H21NO3 small molecule R03CC06|R03AC07 79490-84-9 DRUGBANK 4415 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Terra SG (2005) 15917856 174480 214 Isoetarine Isoetharine|Isoetarinum|Isoetarina - DRUGBANK DB00221 C13H21NO3 small molecule R03CC06|R03AC07 79490-84-9 DRUGBANK 4416 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Burniston JG (2006) 16973691 174481 214 Isoetarine Isoetharine|Isoetarinum|Isoetarina - DRUGBANK DB00221 C13H21NO3 small molecule R03CC06|R03AC07 79490-84-9 DRUGBANK 4417 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Rodrigues LL (2006) 17157779 174479 214 Isoetarine Isoetharine|Isoetarinum|Isoetarina - DRUGBANK DB00221 C13H21NO3 small molecule R03CC06|R03AC07 79490-84-9 DRUGBANK 16177 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 4391 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4392 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Hart GR (1981) 6114720 174453 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4393 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Bacaner MB (1982) 6812406 174452 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 8622 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Bruck H (2005) 16325050 177294 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8623 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Breed JG (1992) 1280737 177295 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8624 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Mauz AB (1990) 1691366 177292 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8625 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Lipworth BJ (1991) 1676675 177293 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8626 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Brouri F (2004) 14757145 177290 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8627 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 14079 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Nichols AJ (1989) 2577144 180320 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14080 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target de Mey C (1994) 7908256 180321 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14081 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Nichols AJ (1989) 2575762 180322 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14082 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Nichols AJ (1991) 1712335 180307 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 5553 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens binder target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24022 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Dale KM (2007) 17389667 181997 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 24790 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Zimmerman TJ (1979) 37605 181633 5606 Bufuralol Bufuralolum - DRUGBANK DB06726 C16H23NO2 small molecule - 54340-62-4 DRUGBANK 27904 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens ligand target Bang-Andersen B (2011) 21486038 196006 8112 Vortioxetine 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation brintellix|trintellix DRUGBANK DB09068 C18H23N2S small molecule N06AX26 508233-74-7 DRUGBANK 12663 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Baker JG (2005) 15655528 179611 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 3923 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3924 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 26392 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7132 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile - - DRUGBANK DB08347 C16H21N3O2 small molecule - - DRUGBANK 4923 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Staudt Y (2003) 12679135 174744 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 4924 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 4925 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Staudt A (2001) 11448474 174741 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 4926 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Johnson JA (2003) 12844134 174740 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 4927 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Liu J (2003) 14534524 174743 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 4928 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Schaefer M (2000) 10913016 174742 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 14880 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Sharif NA (2001) 11572462 180647 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14881 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Brooks AM (1992) 1351412 180645 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14882 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Gonzalez JP (1987) 2892662 180644 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14883 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Harris A (1994) 7928182 180643 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14884 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chidlow G (2000) 10864881 176628 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14885 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Lesar TS (1987) 2891463 174265 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 11251 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11252 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Surman AJ (1993) 7678677 178784 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11253 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Varma DR (1999) 10433496 175645 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11254 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target De Ponti F (1995) 7606348 178781 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11255 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Brahmadevara N (2003) 12522078 178783 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11256 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Im MJ (1988) 2828119 178782 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11004 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Raddatz A (2006) 16627864 178639 831 Dobutamine rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum dobutamine hydrochloride injec DRUGBANK DB00841 C18H23NO3 small molecule C01CA07 34368-04-2 DRUGBANK 11005 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target La Rosee K (2004) 15564877 178638 831 Dobutamine rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum dobutamine hydrochloride injec DRUGBANK DB00841 C18H23NO3 small molecule C01CA07 34368-04-2 DRUGBANK 11006 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 831 Dobutamine rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum dobutamine hydrochloride injec DRUGBANK DB00841 C18H23NO3 small molecule C01CA07 34368-04-2 DRUGBANK 11007 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Junker V (2002) 12098582 178640 831 Dobutamine rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum dobutamine hydrochloride injec DRUGBANK DB00841 C18H23NO3 small molecule C01CA07 34368-04-2 DRUGBANK 11008 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Bruck H (2005) 16325050 177294 831 Dobutamine rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum dobutamine hydrochloride injec DRUGBANK DB00841 C18H23NO3 small molecule C01CA07 34368-04-2 DRUGBANK 14828 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Koshiji M (1992) 1354084 180614 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14829 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Varma DR (1999) 10606440 180615 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14830 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14831 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Wheeldon NM (1994) 7981009 180612 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14832 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Wheeldon NM (1994) 7912539 180613 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14833 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Varma DR (1999) 10433496 175645 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 12306 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Watkins DJ (1996) 8884690 179354 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12307 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Joseph SS (2003) 14608456 179351 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12308 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Brodde OE (1988) 2907348 179353 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12309 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Doggrell SA (1991) 1687398 179347 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12310 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12311 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Berendsen HH (1990) 2148726 179352 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 16152 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Vansal SS (1999) 10449190 178696 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 4029 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Kirshenbaum JM (1989) 2568748 174208 180 Esmolol methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester brevibloc liq iv 10mg/ml|brevi DRUGBANK DB00187 C16H25NO4 small molecule C07AB09 81147-92-4 DRUGBANK 4030 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Jahn P (1995) 7612051 174209 180 Esmolol methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester brevibloc liq iv 10mg/ml|brevi DRUGBANK DB00187 C16H25NO4 small molecule C07AB09 81147-92-4 DRUGBANK 4031 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Jacobs JR (1988) 2894187 174212 180 Esmolol methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester brevibloc liq iv 10mg/ml|brevi DRUGBANK DB00187 C16H25NO4 small molecule C07AB09 81147-92-4 DRUGBANK 4034 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Howie MB (1990) 1975995 174211 180 Esmolol methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester brevibloc liq iv 10mg/ml|brevi DRUGBANK DB00187 C16H25NO4 small molecule C07AB09 81147-92-4 DRUGBANK 4033 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Volz-Zang C (1994) 7957532 174210 180 Esmolol methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester brevibloc liq iv 10mg/ml|brevi DRUGBANK DB00187 C16H25NO4 small molecule C07AB09 81147-92-4 DRUGBANK 4032 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 180 Esmolol methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester brevibloc liq iv 10mg/ml|brevi DRUGBANK DB00187 C16H25NO4 small molecule C07AB09 81147-92-4 DRUGBANK 5714 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5744 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Horinouchi T (2007) 17628611 174482 327 Atenolol 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum tenoretic|ftp-atenolol|dom-ate DRUGBANK DB00335 C14H22N2O3 small molecule C07AB03|C07DB01|C07FB03|C07CB53|C07BB03|C07CB03 29122-68-7 DRUGBANK 5745 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Alberti C (1997) 9300315 175329 327 Atenolol 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum tenoretic|ftp-atenolol|dom-ate DRUGBANK DB00335 C14H22N2O3 small molecule C07AB03|C07DB01|C07FB03|C07CB53|C07BB03|C07CB03 29122-68-7 DRUGBANK 5746 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 327 Atenolol 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum tenoretic|ftp-atenolol|dom-ate DRUGBANK DB00335 C14H22N2O3 small molecule C07AB03|C07DB01|C07FB03|C07CB53|C07BB03|C07CB03 29122-68-7 DRUGBANK 5747 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Brown RA (2002) 12065078 175330 327 Atenolol 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum tenoretic|ftp-atenolol|dom-ate DRUGBANK DB00335 C14H22N2O3 small molecule C07AB03|C07DB01|C07FB03|C07CB53|C07BB03|C07CB03 29122-68-7 DRUGBANK 5748 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Schaefer M (2000) 10913016 174742 327 Atenolol 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum tenoretic|ftp-atenolol|dom-ate DRUGBANK DB00335 C14H22N2O3 small molecule C07AB03|C07DB01|C07FB03|C07CB53|C07BB03|C07CB03 29122-68-7 DRUGBANK 8148 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Rezmann-Vitti LA (2004) 15236843 176968 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8149 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Lewis CJ (2004) 14757703 176967 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8150 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Yazawa K (2007) 17572694 176966 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8151 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8152 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Rouget C (2006) 16177222 176964 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8153 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Horinouchi T (2007) 17628611 174482 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 17099 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Lemmer B (1982) 6124492 181544 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17100 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Campbell CA (1984) 6202960 181543 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17101 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17102 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17103 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17104 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Abrahamsson T (1986) 2871880 178780 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 4128 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Rudoy CA (2007) 17513029 174266 188 Betaxolol 1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum betaxolol|novo-betaxolol|betop DRUGBANK DB00195 C18H29NO3 small molecule S01ED02|S01ED52|C07AB05 63659-18-7 DRUGBANK 4129 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target McLean AJ (2002) 12181453 174267 188 Betaxolol 1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum betaxolol|novo-betaxolol|betop DRUGBANK DB00195 C18H29NO3 small molecule S01ED02|S01ED52|C07AB05 63659-18-7 DRUGBANK 4130 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 188 Betaxolol 1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum betaxolol|novo-betaxolol|betop DRUGBANK DB00195 C18H29NO3 small molecule S01ED02|S01ED52|C07AB05 63659-18-7 DRUGBANK 4131 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Lesar TS (1987) 2891463 174265 188 Betaxolol 1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum betaxolol|novo-betaxolol|betop DRUGBANK DB00195 C18H29NO3 small molecule S01ED02|S01ED52|C07AB05 63659-18-7 DRUGBANK 4132 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Satoh N (1990) 2077180 174268 188 Betaxolol 1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum betaxolol|novo-betaxolol|betop DRUGBANK DB00195 C18H29NO3 small molecule S01ED02|S01ED52|C07AB05 63659-18-7 DRUGBANK 6207 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6208 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Varma DR (1999) 10433496 175645 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6209 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Bhattacharyya BJ (2002) 12221524 175644 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6210 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Hirooka K (2000) 10870519 175643 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6211 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Wang T (1996) 8864321 175642 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6212 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Nieminen T (2005) 16315032 175641 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6156 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens binder target Millan MJ (2000) 10762339 175610 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 9206 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Ozakca I (2007) 17622774 176145 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9207 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Leineweber K (2007) 17541557 177680 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9208 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 14911 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Bilcikova L (1987) 2885244 180658 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14912 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Drimal J (1987) 2895037 180659 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14913 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14914 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Arai K (2003) 12967722 180660 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14915 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 15790 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1279 Practolol N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum - DRUGBANK DB01297 C14H22N2O3 small molecule C07AB01 6673-35-4 DRUGBANK 15792 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Abrahamsson T (1986) 2871880 178780 1279 Practolol N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum - DRUGBANK DB01297 C14H22N2O3 small molecule C07AB01 6673-35-4 DRUGBANK 15791 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Saarnivaara L (1984) 6524278 181082 1279 Practolol N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum - DRUGBANK DB01297 C14H22N2O3 small molecule C07AB01 6673-35-4 DRUGBANK 15789 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Keyrilaeinen O (1978) 30388 181083 1279 Practolol N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum - DRUGBANK DB01297 C14H22N2O3 small molecule C07AB01 6673-35-4 DRUGBANK 15793 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Buxton IL (1985) 2857116 181081 1279 Practolol N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum - DRUGBANK DB01297 C14H22N2O3 small molecule C07AB01 6673-35-4 DRUGBANK 14250 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Samnick S (2004) 15093822 180382 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14251 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Matsumoto K (1994) 7816863 180368 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14252 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Sapena R (1996) 8741184 180369 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14253 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Mudunkotuwa NT (1996) 8730743 180380 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14254 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Buergi S (2003) 12393876 180381 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 13746 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1090 Arbutamine Arbutamina|Arbutaminum - DRUGBANK DB01102 C18H23NO4 small molecule C01CA22 128470-16-6 DRUGBANK 13747 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1090 Arbutamine Arbutamina|Arbutaminum - DRUGBANK DB01102 C18H23NO4 small molecule C01CA22 128470-16-6 DRUGBANK 13748 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Abou-Mohamed G (1996) 8723169 180137 1090 Arbutamine Arbutamina|Arbutaminum - DRUGBANK DB01102 C18H23NO4 small molecule C01CA22 128470-16-6 DRUGBANK 9885 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 15758 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Hoffmann C (2004) 14730417 181057 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 13374 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Kobayashi H (2005) 16038799 179948 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13375 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Sato M (2004) 14734046 179946 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13376 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Jurgens CW (2005) 15908512 179947 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13377 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13378 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 8446 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8447 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Nakagawa Y (1981) 7286847 177188 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8448 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Monopoli A (1984) 6151824 177186 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8449 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Riva E (1991) 1687367 177187 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8450 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target van Zwieten PA (1993) 7684671 177184 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8451 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Rosendorff C (1993) 8104240 177185 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8452 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Pujos E (2009) 19879818 177182 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8453 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Sassard J (1983) 6355664 177183 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 15765 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target van Zwieten PA (1988) 2901958 181061 1275 Pirbuterol Pirbuterol|Pirbuterolum|Maxair autohaler maxair aem 240mcg/aem DRUGBANK DB01291 C12H20N2O3 small molecule R03AC08|R03CC07 38677-81-5 DRUGBANK 15766 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Kenakin TP (1984) 6143816 181062 1275 Pirbuterol Pirbuterol|Pirbuterolum|Maxair autohaler maxair aem 240mcg/aem DRUGBANK DB01291 C12H20N2O3 small molecule R03AC08|R03CC07 38677-81-5 DRUGBANK 24458 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Fagiolini A (2013) 23356509 182227 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24459 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 4837 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens binder target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 6478 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Thomas SH (1991) 1722692 175805 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 6479 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Moya-Huff FA (1987) 2881994 175801 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 15769 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Loefdahl CG (1984) 6148733 181064 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 15770 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Horinouchi T (2007) 17628611 174482 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 15771 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Dukes ID (1985) 2858236 181066 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 15772 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Hino T (1989) 2568629 181065 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 15773 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Vaughan Williams EM (1987) 2888789 181063 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 7442 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Yalcin I (2009) 19259968 176450 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7443 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7444 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Doggrell SA (1993) 8095397 176448 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7445 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Lowe MD (2002) 11815381 176449 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7446 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Joseph SS (2004) 15060759 176446 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7447 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Juberg EN (1985) 2865685 176447 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 26600 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7336 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL - - DRUGBANK DB08558 C14H28O5S small molecule - - DRUGBANK 11185 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Vansal SS (1999) 10449190 178696 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11186 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Vansal SS (1999) 10449190 178696 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 6092 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target El-Armouche A (2009) 19110970 175562 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6093 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6094 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6095 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Mersmann HJ (1998) 9464897 175567 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 24031 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 4661 Nebivolol alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol nebivolol|bystolic DRUGBANK DB04861 C22H25F2NO4 small molecule C07FB12|C07BB12|C07AB12 118457-14-0 DRUGBANK 24032 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Gielen W (2006) 16961165 181965 4661 Nebivolol alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol nebivolol|bystolic DRUGBANK DB04861 C22H25F2NO4 small molecule C07FB12|C07BB12|C07AB12 118457-14-0 DRUGBANK 24033 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target de Boer RA (2007) 17661735 182033 4661 Nebivolol alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol nebivolol|bystolic DRUGBANK DB04861 C22H25F2NO4 small molecule C07FB12|C07BB12|C07AB12 118457-14-0 DRUGBANK 14683 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 14684 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Abrahamsson T (1989) 2568935 180550 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 14685 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Fraysse B (2005) 16268148 180548 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 14686 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target van den Meiracker AH (1988) 2453744 180551 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 13936 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Doggrell SA (2002) 12083991 180239 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 26828 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Zelaszczyk D (2009) 19439807 182105 7579 Bupranolol Bupranol - DRUGBANK DB08808 C14H22ClNO2 small molecule C07AA19 14556-46-8 DRUGBANK 27360 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Hayashi T (2007) 17141277 188508 7761 Celiprolol RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea - DRUGBANK DB04846 C20H33N3O4 small molecule C07AB08 56980-93-9 DRUGBANK 27361 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Yao EH (2008) 18636069 188509 7761 Celiprolol RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea - DRUGBANK DB04846 C20H33N3O4 small molecule C07AB08 56980-93-9 DRUGBANK 27362 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens antagonist target Chen X (2007) 17384462 188507 7761 Celiprolol RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea - DRUGBANK DB04846 C20H33N3O4 small molecule C07AB08 56980-93-9 DRUGBANK 16535 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Baker JG (2010) 20590599 181333 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 26814 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Watkins DJ (1996) 8884690 179354 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26815 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Joseph SS (2003) 14608456 179351 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26816 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Brodde OE (1988) 2907348 179353 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26817 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Doggrell SA (1991) 1687398 179347 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26818 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26819 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Berendsen HH (1990) 2148726 179352 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 7688 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Chidlow G (2000) 10864881 176628 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 7689 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Floreani M (2005) 16160085 176629 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 7690 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 7691 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens partial agonist target Bruck H (2004) 15526107 176627 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 24503 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target El-Armouche A (2009) 19110970 175562 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24504 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24505 106662 153 - ADRB1 ADRB1R|B1AR|BETA1AR|RHR 9606 Homo sapiens agonist target Mersmann HJ (1998) 9464897 175567 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 16106 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Kulkarni RD (1977) 16716 181161 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16107 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Hjorth S (1996) 8982649 181160 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16108 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Sanchez C (1993) 11224195 181163 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16109 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Frishman WH (1990) 2189902 181162 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16110 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Ijzerman AP (1987) 2446632 181158 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16111 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Hjorth S (1993) 8098761 181159 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16112 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Kulkarni RD (1977) 16716 181161 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16113 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Hjorth S (1996) 8982649 181160 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16114 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Sanchez C (1993) 11224195 181163 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16115 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Frishman WH (1990) 2189902 181162 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16116 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Ijzerman AP (1987) 2446632 181158 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16117 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Hjorth S (1993) 8098761 181159 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 4412 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Gaulton A (2012) 21948594 174478 214 Isoetarine Isoetharine|Isoetarinum|Isoetarina - DRUGBANK DB00221 C13H21NO3 small molecule R03CC06|R03AC07 79490-84-9 DRUGBANK 16176 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 4388 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4389 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Hart GR (1981) 6114720 174453 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4390 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Bacaner MB (1982) 6812406 174452 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 8617 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Bruck H (2004) 15526107 176627 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8618 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Motomura S (1990) 1968697 177289 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8619 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Brodde OE (1986) 2439795 177288 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8620 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Brouri F (2004) 14757145 177290 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 8621 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Daul A (1986) 2886573 177291 602 Bisoprolol (+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol monocor -(5mg)|bisoprolol fu DRUGBANK DB00612 C18H31NO4 small molecule C07BB07|C09BX02|C07FB07|C07AB07|C07AB57 66722-44-9 DRUGBANK 15630 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Cazzola M (2005) 16022567 180980 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15631 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Cazzola M (2010) 20406080 180978 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15632 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Matera MG (2007) 17352511 180977 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15633 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Unknown Authors (2004) 14725487 180976 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15634 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Op't Holt TB (2007) 17594727 179504 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15635 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Kharidia J (2008) 18501650 180979 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15636 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 15637 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Baumgartner RA (2007) 17472819 180981 1261 Arformoterol (R,R)-formoterol|(-)-Formoterol brovana DRUGBANK DB01274 C19H24N2O4 small molecule - 67346-49-0 DRUGBANK 14056 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Okajima K (2004) 14764656 180306 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14057 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Nichols AJ (1991) 1712335 180307 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14058 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Irodova NL (2002) 12360591 180305 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14059 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Maebara C (2002) 12398570 180308 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 5552 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens binder target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24789 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Zimmerman TJ (1979) 37605 181633 5606 Bufuralol Bufuralolum - DRUGBANK DB06726 C16H23NO2 small molecule - 54340-62-4 DRUGBANK 24285 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Cazzola M (2005) 16022567 180980 4826 Indacaterol QAB-149|5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one|QAB149|QAB 149 arcapta neohaler|ultibro breez DRUGBANK DB05039 C24H28N2O3 small molecule R03AL04|R03AC18 312753-06-3 DRUGBANK 12657 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chong LK (2003) 12569076 178802 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 12658 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Brouri F (2004) 14757145 177290 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 12659 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Choudhry S (2005) 15557128 179610 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 12660 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 12661 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Yamanishi T (2003) 12808710 179609 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 12662 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Brichetto L (2003) 12388338 179608 991 Salbutamol Albuterol|Proventil|Salbutamol|Levalbuterol ventolin nebules p.f. sol 2.5m DRUGBANK DB01001 C13H21NO3 small molecule R03AC02|R03AK04|R03CC02|R03AL02 18559-94-9 DRUGBANK 3921 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3922 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 4922 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Zebrack JS (2009) 19637941 174739 257 Metoprolol DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol betaloc durules tab 200 mg|bet DRUGBANK DB00264 C15H25NO3 small molecule C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02 51384-51-1 DRUGBANK 14873 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Sharif NA (2001) 11572462 180647 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14874 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Quast U (1984) 6147147 180646 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14875 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Brooks AM (1992) 1351412 180645 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14876 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Gonzalez JP (1987) 2892662 180644 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14877 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Harris A (1994) 7928182 180643 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14878 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 14879 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Lesar TS (1987) 2891463 174265 1198 Levobunolol Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone betagan oph soln 0.25%|probeta DRUGBANK DB01210 C17H25NO3 small molecule S01ED03 47141-42-4 DRUGBANK 11248 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Brodde OE (1985) 2859531 178778 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11249 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Brodde OE (1986) 2439825 178779 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11250 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Abrahamsson T (1986) 2871880 178780 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11003 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Tibayan FA (1997) 9279221 178637 831 Dobutamine rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum dobutamine hydrochloride injec DRUGBANK DB00841 C18H23NO3 small molecule C01CA07 34368-04-2 DRUGBANK 12478 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12479 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Op't Holt TB (2007) 17594727 179504 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12480 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Kompa AR (1995) 7675115 179498 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12481 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Faulds D (1991) 1718682 179499 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12482 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Cheer SM (2004) 14720051 179496 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12483 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Scola AM (2004) 14662724 179497 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12484 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Bartow RA (1998) 9506248 179495 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12485 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Ryall JG (2006) 16432501 179500 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12486 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Steiropoulos P (2008) 18686730 179501 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12487 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Handley DA (2002) 12090787 179502 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 12488 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Loefdahl CG (1989) 2544117 179503 973 Formoterol 2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide dulera|foradil|duaklir genuair DRUGBANK DB00983 C19H24N2O4 small molecule R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09 73573-87-2 DRUGBANK 26825 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Lenard NR (2003) 12606631 181811 7579 Bupranolol Bupranol - DRUGBANK DB08808 C14H22ClNO2 small molecule C07AA19 14556-46-8 DRUGBANK 12300 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Wheeldon NM (1991) 1678274 179346 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12301 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Doggrell SA (1991) 1687398 179347 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12302 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Dejgaard A (1991) 1666931 179350 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12303 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12304 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Rubenstein LA (2006) 16574446 179348 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12305 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Doggrell SA (1990) 1979630 179349 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 16128 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Vansal SS (1999) 10449190 178696 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 5713 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5743 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Nuttall SL (2003) 12795776 175328 327 Atenolol 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum tenoretic|ftp-atenolol|dom-ate DRUGBANK DB00335 C14H22N2O3 small molecule C07AB03|C07DB01|C07FB03|C07CB53|C07BB03|C07CB03 29122-68-7 DRUGBANK 8141 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Horinouchi T (2007) 17628611 174482 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8142 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8143 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Rouget C (2006) 16177222 176964 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8144 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Isaza C (2005) 16082424 176963 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8145 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Illingworth CJ (2006) 16706406 176962 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 11958 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Frang H (2001) 11395517 179127 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 17094 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17095 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17096 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Fujita H (1998) 9509999 181542 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17097 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Prinz M (2001) 11311890 181541 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 17098 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Sekut L (1995) 7882570 181540 1520 Oxprenolol Oxprenololum|Oxprenolol trasicor tab 80mg|slow trasico DRUGBANK DB01580 C15H23NO3 small molecule C07CA02|C07AA02|C07BA02 6452-71-7 DRUGBANK 4127 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Rait JL (1999) 10080340 174264 188 Betaxolol 1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum betaxolol|novo-betaxolol|betop DRUGBANK DB00195 C18H29NO3 small molecule S01ED02|S01ED52|C07AB05 63659-18-7 DRUGBANK 6200 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6201 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6202 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Fuchsjager-Mayrl G (2005) 16205624 175638 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6203 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Rotmensch HH (1993) 8103526 175639 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6204 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Van der Graaf PH (1995) 8719802 175636 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6205 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Borger P (1998) 9730867 175637 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6206 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Ferro A (1997) 9088585 175640 365 Timolol Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum teva-latanoprost/timolol|sando DRUGBANK DB00373 C13H24N4O3S small molecule C07DA06|S01ED51|C07BA06|S01ED01|C07AA06 26839-75-8 DRUGBANK 6119 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens binder target Millan MJ (2000) 10762339 175610 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 16191 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Kobayashi M (2002) 12428391 181178 1328 Procaterol - pro-air aerosol 10mcg/aem DRUGBANK DB01366 C16H22N2O3 small molecule R03AC16|R03CC08 72332-33-3 DRUGBANK 16192 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Aizawa H (1991) 1684063 181179 1328 Procaterol - pro-air aerosol 10mcg/aem DRUGBANK DB01366 C16H22N2O3 small molecule R03AC16|R03CC08 72332-33-3 DRUGBANK 16193 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Brodde OE (1990) 1968366 181182 1328 Procaterol - pro-air aerosol 10mcg/aem DRUGBANK DB01366 C16H22N2O3 small molecule R03AC16|R03CC08 72332-33-3 DRUGBANK 16194 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Noguchi K (1991) 1682484 181181 1328 Procaterol - pro-air aerosol 10mcg/aem DRUGBANK DB01366 C16H22N2O3 small molecule R03AC16|R03CC08 72332-33-3 DRUGBANK 16195 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Yamasaki Y (2004) 15069780 181180 1328 Procaterol - pro-air aerosol 10mcg/aem DRUGBANK DB01366 C16H22N2O3 small molecule R03AC16|R03CC08 72332-33-3 DRUGBANK 16196 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1328 Procaterol - pro-air aerosol 10mcg/aem DRUGBANK DB01366 C16H22N2O3 small molecule R03AC16|R03CC08 72332-33-3 DRUGBANK 9183 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Ozakca I (2007) 17622774 176145 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9184 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Lucin KM (2007) 17597612 176144 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9185 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 9186 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Prenner L (2007) 17417877 176146 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 14905 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14906 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14907 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Bilcikova L (1987) 2885244 180658 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14908 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Drimal J (1987) 2895037 180659 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14909 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Arai K (2003) 12967722 180660 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 14910 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Noack E (1986) 2876128 180657 1202 Metipranolol Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol metipranolol DRUGBANK DB01214 C17H27NO4 small molecule C07BA68|S01ED54|S01ED04 22664-55-7 DRUGBANK 11554 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 891 Bitolterol Bitolterol Mesylate|Bitolterolum - DRUGBANK DB00901 C28H31NO5 small molecule R03AC17 30392-40-6 DRUGBANK 11555 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 891 Bitolterol Bitolterol Mesylate|Bitolterolum - DRUGBANK DB00901 C28H31NO5 small molecule R03AC17 30392-40-6 DRUGBANK 11556 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Friedel HA (1988) 3278878 178955 891 Bitolterol Bitolterol Mesylate|Bitolterolum - DRUGBANK DB00901 C28H31NO5 small molecule R03AC17 30392-40-6 DRUGBANK 11557 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Wilson AJ (2000) 10796631 178956 891 Bitolterol Bitolterol Mesylate|Bitolterolum - DRUGBANK DB00901 C28H31NO5 small molecule R03AC17 30392-40-6 DRUGBANK 14227 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Prenner L (2007) 17417877 176146 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14224 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Osadchii OE (2007) 17558518 180367 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14225 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Matsumoto K (1994) 7816863 180368 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14223 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Abadie C (1996) 8988485 180370 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14226 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Sapena R (1996) 8741184 180369 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 13744 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Abou-Mohamed G (1996) 8723169 180137 1090 Arbutamine Arbutamina|Arbutaminum - DRUGBANK DB01102 C18H23NO4 small molecule C01CA22 128470-16-6 DRUGBANK 9884 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 7002 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Ozakca I (2007) 17622774 176145 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 7003 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Lucin KM (2007) 17597612 176144 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 7004 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 7005 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Prenner L (2007) 17417877 176146 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 15751 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 15752 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Boterman M (2006) 16324695 181052 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 15753 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Marone G (1984) 6203844 181055 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 15754 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Coqueret O (1996) 8777955 181054 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 15755 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Bouillon T (1996) 8911881 181056 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 15756 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target de Vries B (2001) 11730729 181053 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 16536 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Waldeck B (2002) 12065188 181345 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 16537 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Coleman RA (1996) 8885698 181344 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 16538 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chou YL (2010) 20012638 181347 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 16539 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Rosberg B (1993) 8223836 181346 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 16540 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Zhang D (2007) 18065099 181349 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 16541 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Svensson LA (1988) 3262993 181348 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 16542 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1357 Bambuterol Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate) - DRUGBANK DB01408 C18H29N3O5 small molecule R03CC12 81732-65-2 DRUGBANK 13344 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13345 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13346 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Jones SM (2003) 14656380 179930 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13347 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Abraham G (2003) 12963495 179933 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13348 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Teixeira CE (2004) 14752060 179932 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13349 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Odley A (2004) 15105445 179928 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13350 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Uezono Y (2004) 15151902 179929 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 8439 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8440 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target van Zwieten PA (1993) 7684671 177184 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8441 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Rosendorff C (1993) 8104240 177185 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8442 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Pujos E (2009) 19879818 177182 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8443 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Sassard J (1983) 6355664 177183 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8444 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Doggrell SA (1992) 1361547 177180 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 8445 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Doggrell SA (1988) 2907566 177181 588 Labetalol Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide labetalol hcl|labetalol hydroc DRUGBANK DB00598 C19H24N2O3 small molecule C07BG01|C07CG01|C07AG01 36894-69-6 DRUGBANK 15761 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Leier CV (1982) 7053311 181059 1275 Pirbuterol Pirbuterol|Pirbuterolum|Maxair autohaler maxair aem 240mcg/aem DRUGBANK DB01291 C12H20N2O3 small molecule R03AC08|R03CC07 38677-81-5 DRUGBANK 15762 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Hamdad N (1996) 8945911 181058 1275 Pirbuterol Pirbuterol|Pirbuterolum|Maxair autohaler maxair aem 240mcg/aem DRUGBANK DB01291 C12H20N2O3 small molecule R03AC08|R03CC07 38677-81-5 DRUGBANK 15763 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1275 Pirbuterol Pirbuterol|Pirbuterolum|Maxair autohaler maxair aem 240mcg/aem DRUGBANK DB01291 C12H20N2O3 small molecule R03AC08|R03CC07 38677-81-5 DRUGBANK 15764 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Carie AE (2007) 17260025 181060 1275 Pirbuterol Pirbuterol|Pirbuterolum|Maxair autohaler maxair aem 240mcg/aem DRUGBANK DB01291 C12H20N2O3 small molecule R03AC08|R03CC07 38677-81-5 DRUGBANK 24460 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Fagiolini A (2013) 23356509 182227 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24461 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 11257 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 857 Ritodrine Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium yutopar inj 50mg/5ml|yutopar t DRUGBANK DB00867 C17H21NO3 small molecule G02CA01 26652-09-5 DRUGBANK 11258 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Lenselink DR (1994) 8059831 178789 857 Ritodrine Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium yutopar inj 50mg/5ml|yutopar t DRUGBANK DB00867 C17H21NO3 small molecule G02CA01 26652-09-5 DRUGBANK 11259 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Bianchetti A (1990) 1976401 178788 857 Ritodrine Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium yutopar inj 50mg/5ml|yutopar t DRUGBANK DB00867 C17H21NO3 small molecule G02CA01 26652-09-5 DRUGBANK 11260 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Tanaka N (2001) 11311067 178785 857 Ritodrine Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium yutopar inj 50mg/5ml|yutopar t DRUGBANK DB00867 C17H21NO3 small molecule G02CA01 26652-09-5 DRUGBANK 11261 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Schwarz MK (2003) 12871140 178787 857 Ritodrine Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium yutopar inj 50mg/5ml|yutopar t DRUGBANK DB00867 C17H21NO3 small molecule G02CA01 26652-09-5 DRUGBANK 11262 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Lye SJ (1992) 1332478 178786 857 Ritodrine Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium yutopar inj 50mg/5ml|yutopar t DRUGBANK DB00867 C17H21NO3 small molecule G02CA01 26652-09-5 DRUGBANK 4794 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens binder target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 6468 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Moya-Huff FA (1987) 2881994 175801 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 15767 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Horinouchi T (2007) 17628611 174482 1277 Bevantolol Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol - DRUGBANK DB01295 C20H27NO4 small molecule C07BB06|C07AB06 59170-23-9 DRUGBANK 27506 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Bouyssou T (2010) 20371707 188555 7827 Olodaterol - inspiolto respimat|stiolto res DRUGBANK DB09080 C21H26N2O5 small molecule R03AL06|R03AC19 868049-49-4 DRUGBANK 7437 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Doggrell SA (1993) 8095397 176448 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7438 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Lowe MD (2002) 11815381 176449 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7439 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Yalcin I (2009) 19259968 176450 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7440 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Joseph SS (2004) 15060759 176446 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7441 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Juberg EN (1985) 2865685 176447 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 11160 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11161 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11162 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Vansal SS (1999) 10449190 178696 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 25560 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6353 (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol - - DRUGBANK DB07543 C18H22N2O2 small molecule - - DRUGBANK 6046 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6047 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6048 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target El-Armouche A (2009) 19110970 175562 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6049 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6050 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Weinshenker D (2001) 11504801 175566 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6051 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Mersmann HJ (1998) 9464897 175567 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6052 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Tarizzo VI (1994) 7969507 175564 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6053 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Sanders VM (1998) 9666280 175565 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 11284 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chong LK (2003) 12569076 178802 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11285 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Riether C (2011) 20674738 178803 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11286 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Ramer-Quinn DS (2000) 11120594 178806 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11287 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Schaefers RF (1999) 10226872 178807 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11288 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Haahtela T (1991) 2062329 178804 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11289 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Hochhaus G (1992) 1358833 178805 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11290 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Cooperberg BA (2008) 18782903 178808 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11291 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Zetterlund A (2001) 11256987 178809 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11292 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Nakamura A (2001) 11675405 178810 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 11293 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 861 Terbutaline Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin terbutaline sulfate|bricanyl t DRUGBANK DB00871 C12H19NO3 small molecule R03CC53|R03AC03|R03CC03 23031-25-6 DRUGBANK 24030 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Nuttall SL (2003) 12795776 175328 4661 Nebivolol alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol nebivolol|bystolic DRUGBANK DB04861 C22H25F2NO4 small molecule C07FB12|C07BB12|C07AB12 118457-14-0 DRUGBANK 14680 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Varma DR (1999) 10433496 175645 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 14681 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Fraysse B (2005) 16268148 180548 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 14682 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Lima JJ (1996) 8968966 180549 1181 Acebutolol Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol apo-acebutolol|monitan 400|ace DRUGBANK DB01193 C18H28N2O4 small molecule C07BB04|C07AB04 37517-30-9 DRUGBANK 12116 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 928 Salmeterol GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol advair diskus|advair 100 disku DRUGBANK DB00938 C25H37NO4 small molecule R03AC12|R03AK06|R03AK12 89365-50-4 DRUGBANK 12117 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Rong Y (1999) 10471277 179215 928 Salmeterol GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol advair diskus|advair 100 disku DRUGBANK DB00938 C25H37NO4 small molecule R03AC12|R03AK06|R03AK12 89365-50-4 DRUGBANK 12118 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Green SA (2001) 11516429 179216 928 Salmeterol GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol advair diskus|advair 100 disku DRUGBANK DB00938 C25H37NO4 small molecule R03AC12|R03AK06|R03AK12 89365-50-4 DRUGBANK 12119 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Finney PA (2001) 11250877 179217 928 Salmeterol GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol advair diskus|advair 100 disku DRUGBANK DB00938 C25H37NO4 small molecule R03AC12|R03AK06|R03AK12 89365-50-4 DRUGBANK 12120 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Brogden RN (1992) 1359777 179218 928 Salmeterol GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol advair diskus|advair 100 disku DRUGBANK DB00938 C25H37NO4 small molecule R03AC12|R03AK06|R03AK12 89365-50-4 DRUGBANK 12121 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Meliton AY (2003) 12897749 179219 928 Salmeterol GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol advair diskus|advair 100 disku DRUGBANK DB00938 C25H37NO4 small molecule R03AC12|R03AK06|R03AK12 89365-50-4 DRUGBANK 14822 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Ozakca I (2007) 17622774 176145 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14823 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14824 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Liu YL (1995) 8574280 180611 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14825 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Wheeldon NM (1994) 7981009 180612 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14826 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Varma DR (1999) 10433496 175645 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 14827 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Wheeldon NM (1992) 1349493 176626 1191 Nadolol Corgard teva-nadolol|nadolol-160 tab 1 DRUGBANK DB01203 C17H27NO4 small molecule C07AA12|C07BA12 42200-33-9 DRUGBANK 27679 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Hayashi T (2007) 17141277 188508 7761 Celiprolol RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea - DRUGBANK DB04846 C20H33N3O4 small molecule C07AB08 56980-93-9 DRUGBANK 16518 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16519 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Sillence MN (1991) 1685013 181329 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16520 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Mazzanti G (2007) 17449161 181328 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16521 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Zhu Y (2001) 11720783 181330 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16522 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Choo JJ (1992) 1322047 181331 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16523 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Ryall JG (2002) 12388476 181332 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 26807 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Wheeldon NM (1991) 1678274 179346 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26808 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Doggrell SA (1991) 1687398 179347 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26809 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Dejgaard A (1991) 1666931 179350 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26810 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26811 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Rubenstein LA (2006) 16574446 179348 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26812 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens partial agonist target Doggrell SA (1990) 1979630 179349 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 7685 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 7686 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Wheeldon NM (1992) 1349493 176626 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 7687 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens antagonist target Bruck H (2004) 15526107 176627 511 Carteolol Carteolol|Carteololum carteolol hydrochloride DRUGBANK DB00521 C16H24N2O3 small molecule C07AA15|S01ED55|S01ED05 51781-06-7 DRUGBANK 10781 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Kimura M (1999) 10490901 178519 806 Orciprenaline Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina metaproterenol sulfate|tanta o DRUGBANK DB00816 C11H17NO3 small molecule R03AB03|R03CB53|R03CB03 586-06-1 DRUGBANK 10782 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 806 Orciprenaline Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina metaproterenol sulfate|tanta o DRUGBANK DB00816 C11H17NO3 small molecule R03AB03|R03CB53|R03CB03 586-06-1 DRUGBANK 10783 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Fitch KD (1986) 2870555 178521 806 Orciprenaline Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina metaproterenol sulfate|tanta o DRUGBANK DB00816 C11H17NO3 small molecule R03AB03|R03CB53|R03CB03 586-06-1 DRUGBANK 10784 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Hu DN (2000) 10973730 178520 806 Orciprenaline Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina metaproterenol sulfate|tanta o DRUGBANK DB00816 C11H17NO3 small molecule R03AB03|R03CB53|R03CB03 586-06-1 DRUGBANK 10785 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Singh H (1996) 8760245 178523 806 Orciprenaline Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina metaproterenol sulfate|tanta o DRUGBANK DB00816 C11H17NO3 small molecule R03AB03|R03CB53|R03CB03 586-06-1 DRUGBANK 10786 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Gelmont DM (1988) 3168573 178522 806 Orciprenaline Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina metaproterenol sulfate|tanta o DRUGBANK DB00816 C11H17NO3 small molecule R03AB03|R03CB53|R03CB03 586-06-1 DRUGBANK 24476 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target El-Armouche A (2009) 19110970 175562 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24477 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24478 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Mersmann HJ (1998) 9464897 175567 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24479 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Tarizzo VI (1994) 7969507 175564 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24480 106663 154 - ADRB2 ADRB2R|ADRBR|B2AR|BAR|BETA2AR 9606 Homo sapiens agonist target Sanders VM (1998) 9666280 175565 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 13367 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Schiffelers SL (2000) 10824635 179945 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13368 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Ahlquist RP (1976) 10722 179931 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13745 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Abou-Mohamed G (1996) 8723169 180137 1090 Arbutamine Arbutamina|Arbutaminum - DRUGBANK DB01102 C18H23NO4 small molecule C01CA22 128470-16-6 DRUGBANK 16178 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Mohta M (2010) 21182601 181177 1327 Mephentermine Mephentermine wyamine sulfate injection liq DRUGBANK DB01365 C11H17N small molecule C01CA11 100-92-5 DRUGBANK 4394 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4395 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Hart GR (1981) 6114720 174453 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4396 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Bacaner MB (1982) 6812406 174452 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 16146 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Vansal SS (1999) 10449190 178696 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 26826 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Lenard NR (2003) 12606631 181811 7579 Bupranolol Bupranol - DRUGBANK DB08808 C14H22ClNO2 small molecule C07AA19 14556-46-8 DRUGBANK 26827 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Matsushita M (2003) 14660028 181839 7579 Bupranolol Bupranol - DRUGBANK DB08808 C14H22ClNO2 small molecule C07AA19 14556-46-8 DRUGBANK 26813 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 15757 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Hoffmann C (2004) 14730417 181057 1273 Fenoterol 3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane berotec forte metered aer|bero DRUGBANK DB01288 C17H21NO4 small molecule R03CC04|G02CA03|R03AL01|R03AC04 13392-18-2 DRUGBANK 16524 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Baker JG (2010) 20590599 181333 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 5554 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens binder target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 26962 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Kashyap M (2013) 23550899 182240 7637 Mirabegron Myrbetriq myrbetriq DRUGBANK DB08893 C21H24N4O2S small molecule G04BD12 223673-61-8 DRUGBANK 24791 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Zimmerman TJ (1979) 37605 181633 5606 Bufuralol Bufuralolum - DRUGBANK DB06726 C16H23NO2 small molecule - 54340-62-4 DRUGBANK 5715 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6086 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6087 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6088 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Tamaoki J (1993) 8105356 175585 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6089 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Galitzky J (1993) 8106131 175586 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6090 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Carpene C (1993) 8097243 175587 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6091 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Mersmann HJ (1998) 9464897 175567 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 9886 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 8146 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Berg T (2010) 20231523 176965 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8147 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 3925 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Leibowitz SF (1970) 4399738 174168 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3926 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Reisine TD (1980) 6245760 174167 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 24499 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target El-Armouche A (2009) 19110970 175562 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24500 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Gilsbach R (2007) 18064417 175563 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24501 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Coman OA (2009) 19434307 182104 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24502 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Mersmann HJ (1998) 9464897 175567 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 27828 106664 155 - ADRB3 BETA3AR 9606 Homo sapiens agonist target Grudell AB (2008) 18372395 195982 8067 Solabegron - - DRUGBANK DB06190 C23H23ClN2O3 small molecule - 252920-94-8 DRUGBANK 3682 106665 156 - ADRBK1 BARK1|BETA-ARK1|GRK2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3683 106665 156 - ADRBK1 BARK1|BETA-ARK1|GRK2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3728 106666 157 - ADRBK2 BARK2|GRK3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3729 106666 157 - ADRBK2 BARK2|GRK3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 2027 106668 159 RP11-518L10.4 ADSS ADEH|ADSS 2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2028 106668 159 RP11-518L10.4 ADSS ADEH|ADSS 2 9606 Homo sapiens unknown target Raman J (2004) 15500910 172948 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2029 106668 159 RP11-518L10.4 ADSS ADEH|ADSS 2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2030 106668 159 RP11-518L10.4 ADSS ADEH|ADSS 2 9606 Homo sapiens unknown target Mehrotra S (2007) 17929831 172947 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2031 106668 159 RP11-518L10.4 ADSS ADEH|ADSS 2 9606 Homo sapiens unknown target Datta SK (1994) 7825060 172946 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 18804 106684 176 - ACAN AGC1|AGCAN|CSPG1|CSPGCP|MSK16|SEDK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2164 GM6001 - - DRUGBANK DB02255 C20H28N4O4 small molecule - - DRUGBANK 10569 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Caballero-George C (2003) 12504781 178423 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10570 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Engelhorn T (2006) 16901636 178419 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10571 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Wada T (1996) 10968199 178418 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10572 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Vauquelin G (2006) 16601569 178415 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10573 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Meredith PA (2007) 17588300 178421 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10574 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Malmqvist K (2000) 10826401 178417 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10575 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Mendis B (2009) 19563275 178416 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10576 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Cervenka L (1999) 9892163 178424 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10577 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target McInnes GT (2000) 10805052 178420 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10578 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 10579 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Baguet JP (2009) 19436650 178422 786 Candesartan 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid auro-candesartan|atacand plus| DRUGBANK DB00796 C24H20N6O3 small molecule C09DB07|C09DA06|C09CA06 139481-59-7 DRUGBANK 15960 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1314 Tasosartan ANA-756|Tasosartan|WAY-ana-756 - DRUGBANK DB01349 C23H21N7O small molecule C09CA05 145733-36-4 DRUGBANK 15961 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Elokdah HM (2002) 12113820 181140 1314 Tasosartan ANA-756|Tasosartan|WAY-ana-756 - DRUGBANK DB01349 C23H21N7O small molecule C09CA05 145733-36-4 DRUGBANK 15962 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Unger T (2001) 11683476 181141 1314 Tasosartan ANA-756|Tasosartan|WAY-ana-756 - DRUGBANK DB01349 C23H21N7O small molecule C09CA05 145733-36-4 DRUGBANK 15963 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Maillard MP (2000) 11046101 181139 1314 Tasosartan ANA-756|Tasosartan|WAY-ana-756 - DRUGBANK DB01349 C23H21N7O small molecule C09CA05 145733-36-4 DRUGBANK 15953 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1312 Saprisartan - - DRUGBANK DB01347 C25H22BrF3N4O4S small molecule - 146623-69-0 DRUGBANK 15954 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Timmermans PB (1999) 10579749 181135 1312 Saprisartan - - DRUGBANK DB01347 C25H22BrF3N4O4S small molecule - 146623-69-0 DRUGBANK 9411 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 668 Losartan Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89 jamp-losartan hctz|losartan/hc DRUGBANK DB00678 C22H23ClN6O small molecule C09CA01|C09DA01|C09DB06 114798-26-4 DRUGBANK 9412 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Sardo MA (2004) 15026875 177762 668 Losartan Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89 jamp-losartan hctz|losartan/hc DRUGBANK DB00678 C22H23ClN6O small molecule C09CA01|C09DA01|C09DB06 114798-26-4 DRUGBANK 9413 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Anand-Srivastava MB (2003) 12710529 177763 668 Losartan Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89 jamp-losartan hctz|losartan/hc DRUGBANK DB00678 C22H23ClN6O small molecule C09CA01|C09DA01|C09DB06 114798-26-4 DRUGBANK 9414 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Rocha I (2003) 12719755 177760 668 Losartan Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89 jamp-losartan hctz|losartan/hc DRUGBANK DB00678 C22H23ClN6O small molecule C09CA01|C09DA01|C09DB06 114798-26-4 DRUGBANK 9415 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Dickstein K (1998) 15991937 177761 668 Losartan Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89 jamp-losartan hctz|losartan/hc DRUGBANK DB00678 C22H23ClN6O small molecule C09CA01|C09DA01|C09DB06 114798-26-4 DRUGBANK 9416 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Guan J (2004) 15573751 177764 668 Losartan Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89 jamp-losartan hctz|losartan/hc DRUGBANK DB00678 C22H23ClN6O small molecule C09CA01|C09DA01|C09DB06 114798-26-4 DRUGBANK 15922 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Hagmann M (1997) 9156352 181127 1308 Forasartan SC-52458|Forasartan - DRUGBANK DB01342 C23H28N8 small molecule - 145216-43-9 DRUGBANK 15923 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Usune S (1996) 8981065 181126 1308 Forasartan SC-52458|Forasartan - DRUGBANK DB01342 C23H28N8 small molecule - 145216-43-9 DRUGBANK 15924 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1308 Forasartan SC-52458|Forasartan - DRUGBANK DB01342 C23H28N8 small molecule - 145216-43-9 DRUGBANK 15925 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Tokunaga R (2001) 11569611 181128 1308 Forasartan SC-52458|Forasartan - DRUGBANK DB01342 C23H28N8 small molecule - 145216-43-9 DRUGBANK 11336 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target de la Sierra A (2007) 18093407 178839 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11337 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Ilson BE (1998) 9602957 178838 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11338 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11339 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Hedner T (2002) 12184062 178837 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11340 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Gremmler B (2000) 10856732 178846 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11341 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Heusser K (2003) 12927226 178844 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11342 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Puig JG (2002) 12766389 178845 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11343 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Murdoch DR (2001) 11320369 178842 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11344 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Nap A (2003) 12782193 178843 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11345 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Suzuki G (2003) 12540520 178840 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 11346 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Ruilope L (2003) 12517247 178841 866 Eprosartan (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan teveten|teveten tablets 300 mg DRUGBANK DB00876 C23H24N2O4S small molecule C09DA02|C09CA02 133040-01-4 DRUGBANK 12947 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12948 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Waeber B (2003) 15030294 179779 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12949 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Croom KF (2004) 15101793 179778 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12950 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Adams MA (2000) 10822210 179782 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12951 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Voigt JP (2007) 17408613 179780 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12952 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Dol F (2001) 11486244 179781 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12953 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target van den Meiracker AH (1995) 7843749 179773 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12954 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Mazzolai L (1999) 10082498 179772 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12955 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Carraway JW (1999) 10069682 179771 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12956 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Martin G (2004) 14716205 179777 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12957 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Croom KF (2008) 18627212 179776 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12958 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Morsing P (1999) 10373224 179775 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12959 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Hope S (1999) 10075381 179774 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 26889 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 7590 Azilsartan medoxomil Azilsartan medoxomilo|Azilsartan|Azilsartan kamedoxomil|Edarbi|Azilsartanum medoxomilum edarbi|edarbyclor DRUGBANK DB08822 C30H24N4O8 small molecule C09CA09|C09DA09 863031-21-4 DRUGBANK 26890 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Miura S (2014) 23563275 182242 7590 Azilsartan medoxomil Azilsartan medoxomilo|Azilsartan|Azilsartan kamedoxomil|Edarbi|Azilsartanum medoxomilum edarbi|edarbyclor DRUGBANK DB08822 C30H24N4O8 small molecule C09CA09|C09DA09 863031-21-4 DRUGBANK 5019 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 268 Olmesartan 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid benicar|azor|benicar hct|tribe DRUGBANK DB00275 C24H26N6O3 small molecule C09DA08|C09CA08|C09DX03|C09DB02 144689-24-7 DRUGBANK 5020 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Kreutz R (2006) 17163232 174806 268 Olmesartan 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid benicar|azor|benicar hct|tribe DRUGBANK DB00275 C24H26N6O3 small molecule C09DA08|C09CA08|C09DX03|C09DB02 144689-24-7 DRUGBANK 5021 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Koike H (2001) 11451212 174807 268 Olmesartan 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid benicar|azor|benicar hct|tribe DRUGBANK DB00275 C24H26N6O3 small molecule C09DA08|C09CA08|C09DX03|C09DB02 144689-24-7 DRUGBANK 5022 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Warner GT (2002) 12076183 174810 268 Olmesartan 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid benicar|azor|benicar hct|tribe DRUGBANK DB00275 C24H26N6O3 small molecule C09DA08|C09CA08|C09DX03|C09DB02 144689-24-7 DRUGBANK 5023 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Mire DE (2005) 16220064 174808 268 Olmesartan 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid benicar|azor|benicar hct|tribe DRUGBANK DB00275 C24H26N6O3 small molecule C09DA08|C09CA08|C09DX03|C09DB02 144689-24-7 DRUGBANK 5024 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Ochiai K (2006) 16775509 174809 268 Olmesartan 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid benicar|azor|benicar hct|tribe DRUGBANK DB00275 C24H26N6O3 small molecule C09DA08|C09CA08|C09DX03|C09DB02 144689-24-7 DRUGBANK 12359 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Yamagishi S (2004) 15617852 179382 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12360 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Strohmenger HU (1997) 9259062 179390 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12361 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Fujimoto M (2004) 15498586 179393 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12362 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Kurtz TW (2008) 18580862 179381 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12363 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Balt JC (2001) 11444497 179387 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12364 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Imayama I (2006) 16938288 179384 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12365 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Yamagishi S (2007) 17691961 179383 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12366 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Gohlke P (2001) 11408526 179388 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12367 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target McClellan KJ (1998) 9878991 179389 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12371 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Galzerano D (2010) 20448797 179394 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12368 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Karlberg BE (1999) 10067800 179391 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12369 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Sharpe M (2001) 11558835 179392 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12370 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 27586 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Tagami T (2009) 19147680 171006 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 3856 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Criscione L (1993) 8242249 174107 170 Valsartan Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine diovan|amlodipine, valsartan, DRUGBANK DB00177 C24H29N5O3 small molecule C09DX02|C09CA03|C09DA03|C09DB01|C09DX01|C09DB08|C09DX04|C10BX10 137862-53-4 DRUGBANK 3857 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target de Gasparo M (1995) 8577935 174106 170 Valsartan Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine diovan|amlodipine, valsartan, DRUGBANK DB00177 C24H29N5O3 small molecule C09DX02|C09CA03|C09DA03|C09DB01|C09DX01|C09DB08|C09DX04|C10BX10 137862-53-4 DRUGBANK 3858 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Azizi M (2004) 15579516 174105 170 Valsartan Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine diovan|amlodipine, valsartan, DRUGBANK DB00177 C24H29N5O3 small molecule C09DX02|C09CA03|C09DA03|C09DB01|C09DX01|C09DB08|C09DX04|C10BX10 137862-53-4 DRUGBANK 3859 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Shargorodsky M (2002) 12460705 174104 170 Valsartan Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine diovan|amlodipine, valsartan, DRUGBANK DB00177 C24H29N5O3 small molecule C09DX02|C09CA03|C09DA03|C09DB01|C09DX01|C09DB08|C09DX04|C10BX10 137862-53-4 DRUGBANK 3860 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 170 Valsartan Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine diovan|amlodipine, valsartan, DRUGBANK DB00177 C24H29N5O3 small molecule C09DX02|C09CA03|C09DA03|C09DB01|C09DX01|C09DB08|C09DX04|C10BX10 137862-53-4 DRUGBANK 3861 106691 185 - AGTR1 AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R 9606 Homo sapiens antagonist target Siragy HM (2002) 12023686 174108 170 Valsartan Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine diovan|amlodipine, valsartan, DRUGBANK DB00177 C24H29N5O3 small molecule C09DX02|C09CA03|C09DA03|C09DB01|C09DX01|C09DB08|C09DX04|C10BX10 137862-53-4 DRUGBANK 15964 106692 186 - AGTR2 AT2|ATGR2|MRX88 9606 Homo sapiens antagonist target Unger T (2001) 11683476 181141 1314 Tasosartan ANA-756|Tasosartan|WAY-ana-756 - DRUGBANK DB01349 C23H21N7O small molecule C09CA05 145733-36-4 DRUGBANK 22528 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22529 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 3485 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3486 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Amoroso A (2001) 11562405 173859 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3487 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3488 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Pirulli D (1999) 10453743 173861 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3489 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Salido EC (2006) 17110443 173860 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 26084 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6853 4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID - - DRUGBANK DB08060 C10H11NO3 small molecule - - DRUGBANK 18488 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1999 Aminooxyacetic acid (aminooxy)acetic acid|AOAA|Carboxymethoxylamine|aminoxyacetic acid|carboxymethoxyamine - DRUGBANK DB02079 C2H5NO3 small molecule - 645-88-5 DRUGBANK 18489 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1999 Aminooxyacetic acid (aminooxy)acetic acid|AOAA|Carboxymethoxylamine|aminoxyacetic acid|carboxymethoxyamine - DRUGBANK DB02079 C2H5NO3 small molecule - 645-88-5 DRUGBANK 1482 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Nishijima S (2002) 12383475 172510 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1466 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1465 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1481 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Danpure CJ (2003) 12686111 172508 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1483 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Gable K (2002) 11781309 17464 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1480 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Nishijima S (2006) 16847354 172509 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1484 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Nishijima S (2003) 12544342 172511 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1553 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens cofactor target Coulter-Mackie MB (2006) 16971151 172556 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2164 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Ikushiro H (2007) 17557831 173074 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2165 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Cowart LA (2007) 17322298 72498 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2166 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Son JH (2007) 17654249 173073 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2167 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Yard BA (2007) 17559874 72070 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2774 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Ricoult C (2006) 16899523 173461 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2775 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Han Q (2006) 16990263 173460 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2776 106694 189 - AGXT AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6 9606 Homo sapiens unknown target Lu TC (2007) 17616291 173459 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 10153 106695 190 - NR0B1 AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10154 106695 190 - NR0B1 AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 15167 106695 190 - NR0B1 AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2 9606 Homo sapiens stimulator target Gummow BM (2006) 16857744 180766 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15168 106695 190 - NR0B1 AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2 9606 Homo sapiens stimulator target Yu CC (2006) 17526944 180767 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 21899 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3610 D-Eritadenine Eritadenine|Lentysine|Lentinacin - DRUGBANK DB03769 C9H11N5O4 small molecule - 23918-98-1 DRUGBANK 21900 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3610 D-Eritadenine Eritadenine|Lentysine|Lentinacin - DRUGBANK DB03769 C9H11N5O4 small molecule - 23918-98-1 DRUGBANK 21901 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3610 D-Eritadenine Eritadenine|Lentysine|Lentinacin - DRUGBANK DB03769 C9H11N5O4 small molecule - 23918-98-1 DRUGBANK 20767 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3084 (1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine - - DRUGBANK DB03216 C10H11N5O2 small molecule - - DRUGBANK 20768 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3084 (1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine - - DRUGBANK DB03216 C10H11N5O2 small molecule - - DRUGBANK 20884 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3139 3'-Oxo-Adenosine - - DRUGBANK DB03273 C10H11N5O4 small molecule - - DRUGBANK 20885 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3139 3'-Oxo-Adenosine - - DRUGBANK DB03273 C10H11N5O4 small molecule - - DRUGBANK 20886 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3139 3'-Oxo-Adenosine - - DRUGBANK DB03273 C10H11N5O4 small molecule - - DRUGBANK 27635 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27636 106696 191 - AHCY SAHH|adoHcyase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 13701 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Hu W (2007) 17327465 175679 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13702 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target O'Donnell EF (2010) 20957046 180114 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 16491 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Wang Y (2008) 19022240 181311 1353 Ginseng - ginsana cap 100mg|siberian gin DRUGBANK DB01404 - small molecule - 50647-08-0 DRUGBANK 13529 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Chauvin B (2013) 23703578 180014 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 13530 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Hu W (2007) 17327465 175679 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 6434 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Hu W (2007) 17327465 175679 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6263 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Hu W (2007) 17327465 175679 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 7532 106699 196 - AHR bHLHe76 9606 Homo sapiens agonist target Hu W (2007) 17327465 175679 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 17656 106706 203 RP11-203J24.1 AK1 HTL-S-58j 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17657 106706 203 RP11-203J24.1 AK1 HTL-S-58j 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17648 106707 204 - AK2 ADK2|AK 2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17649 106707 204 - AK2 ADK2|AK 2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17650 106707 204 - AK2 ADK2|AK 2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 3727 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens unknown target Van Meter TE (2006) 17041888 174029 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 17958 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17959 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 14405 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens inducer target Tsou TC (2005) 16239170 180445 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14406 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens inducer target Fauconneau B (2002) 12472888 180444 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14407 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens inducer target Ivanov VN (2005) 15580309 180446 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14408 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens inducer target Wang ZX (2005) 15916724 180443 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14409 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens inducer target He Z (2003) 12529330 180442 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 25594 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6391 N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine - - DRUGBANK DB07584 C15H13N7 small molecule - - DRUGBANK 25596 106710 207 - AKT1 AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6392 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine - - DRUGBANK DB07585 C12H11ClN6 small molecule - - DRUGBANK 25894 106711 208 - AKT2 HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6656 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE - - DRUGBANK DB07859 C20H20ClN3 small molecule - - DRUGBANK 26101 106711 208 - AKT2 HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6866 (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE - - DRUGBANK DB08073 C24H23N5O small molecule - - DRUGBANK 25835 106711 208 - AKT2 HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6610 N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide - - DRUGBANK DB07812 C20H18N4OS small molecule - - DRUGBANK 25974 106711 208 - AKT2 HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6743 ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE - - DRUGBANK DB07947 C20H22ClN3O3S small molecule - - DRUGBANK 11193 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Sakai T (2000) 10812836 178705 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 11194 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Flora SJ (2002) 12107644 178704 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 11195 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Frere F (2002) 12079382 178707 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 11196 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Akagi R (1999) 10519994 178706 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 11197 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Chen X (2002) 11752352 171740 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 11198 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Tomas-Zapico C (2002) 11906825 178709 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 11199 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens inducer target Vajpayee P (2000) 10879826 178708 845 Aminolevulinic acid 5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA levulan kerastick DRUGBANK DB00855 C5H9NO3 small molecule L01XD04 106-60-5 DRUGBANK 18450 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1988 Delta-Amino Valeric Acid - - DRUGBANK DB02068 C5H12NO2 small molecule - - DRUGBANK 18451 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1988 Delta-Amino Valeric Acid - - DRUGBANK DB02068 C5H12NO2 small molecule - - DRUGBANK 18452 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1988 Delta-Amino Valeric Acid - - DRUGBANK DB02068 C5H12NO2 small molecule - - DRUGBANK 18856 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2181 Porphobilinogen 2-aminomethylpyrrol-3-acetic acid 4-propionic acid|5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid|PBG - DRUGBANK DB02272 C10H13N2O4 small molecule - 487-90-1 DRUGBANK 18857 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2181 Porphobilinogen 2-aminomethylpyrrol-3-acetic acid 4-propionic acid|5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid|PBG - DRUGBANK DB02272 C10H13N2O4 small molecule - 487-90-1 DRUGBANK 18858 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2181 Porphobilinogen 2-aminomethylpyrrol-3-acetic acid 4-propionic acid|5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid|PBG - DRUGBANK DB02272 C10H13N2O4 small molecule - 487-90-1 DRUGBANK 18786 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2150 Laevulinic Acid - - DRUGBANK DB02239 C5H8O3 small molecule - 123-76-2 DRUGBANK 18787 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2150 Laevulinic Acid - - DRUGBANK DB02239 C5H8O3 small molecule - 123-76-2 DRUGBANK 18788 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2150 Laevulinic Acid - - DRUGBANK DB02239 C5H8O3 small molecule - 123-76-2 DRUGBANK 18817 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2169 4-Oxosebacic Acid - - DRUGBANK DB02260 C10H16O5 small molecule - - DRUGBANK 23704 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4370 4,7-Dioxosebacic Acid - - DRUGBANK DB04560 C10H14O6 small molecule - - DRUGBANK 23881 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4583 5-hydroxyvaleric acid 5-hydroxy-pentanoic acid|delta-hydroxyvaleric acid|5-Hydroxyvalerate|5-Hydroxypentanoate|5-hydroxypentanoic acid|5-hydroxy valeric acid|delta-Hydroxypentanoic acid - DRUGBANK DB04781 C5H10O3 small molecule - 13392-69-3 DRUGBANK 23882 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Erskine PT (2005) 16131755 181908 4583 5-hydroxyvaleric acid 5-hydroxy-pentanoic acid|delta-hydroxyvaleric acid|5-Hydroxyvalerate|5-Hydroxypentanoate|5-hydroxypentanoic acid|5-hydroxy valeric acid|delta-Hydroxypentanoic acid - DRUGBANK DB04781 C5H10O3 small molecule - 13392-69-3 DRUGBANK 20067 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2759 3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid - - DRUGBANK DB02878 C10H20N2O4 small molecule - - DRUGBANK 20068 106712 210 RP11-10I9.1 ALAD ALADH|PBGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2759 3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid - - DRUGBANK DB02878 C10H20N2O4 small molecule - - DRUGBANK 2777 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens unknown target He XM (2007) 17578005 173462 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2778 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens unknown target Turbeville TD (2007) 17469798 172569 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 1579 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Zhang J (2002) 12191993 172567 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1506 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Shoolingin-Jordan PM (2003) 12686158 172529 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1509 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Nakamura I (1981) 7275938 172528 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1505 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1507 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1508 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Harigae H (1999) 10577279 172527 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1582 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Turbeville TD (2007) 17469798 172569 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1583 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Zhang J (2005) 15840827 172568 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1580 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Choi HP (2004) 15251194 172570 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1581 106713 211 OK/SW-cl.121 ALAS1 ALAS|ALAS3|ALASH|MIG4 9606 Homo sapiens cofactor target Ferreira GC (2002) 12699240 172571 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2754 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2755 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens unknown target Shoolingin-Jordan PM (2003) 12686158 172529 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2756 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2757 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens unknown target Munakata H (1993) 8407861 173447 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2758 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens unknown target Hungerer C (1995) 7883699 173448 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 27551 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens cofactor target Choi HP (2004) 15251194 172570 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27743 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens cofactor target Heller T (2004) 14724775 195959 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27552 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens cofactor target Shoolingin-Jordan PM (2003) 12686158 172529 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27744 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens cofactor target Clayton PT (2006) 16763894 195969 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27745 106714 212 RP5-884M20.1 ALAS2 ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA 9606 Homo sapiens cofactor target Astner I (2005) 16121195 195963 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27106 106715 213 GIG20 ALB ANALBA|FDAH|PRO0883|PRO0903|PRO1341 9606 Homo sapiens unknown target Baneres-Roquet F (2009) 19164148 188474 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27108 106715 213 GIG20 ALB ANALBA|FDAH|PRO0883|PRO0903|PRO1341 9606 Homo sapiens unknown target Baneres-Roquet F (2009) 19164148 188474 502 Vancomycin Vancomycine|Vancomycinum|Vancomycin|Vancocin|Vancomicina|(2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]|(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid vancomycin|sterile vancomycin DRUGBANK DB00512 C66H75Cl2N9O24 small molecule J01XA01|A07AA09 1404-90-6 DRUGBANK 27222 106715 213 GIG20 ALB ANALBA|FDAH|PRO0883|PRO0903|PRO1341 9606 Homo sapiens unknown target Baneres-Roquet F (2009) 19164148 188474 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 27070 106715 213 GIG20 ALB ANALBA|FDAH|PRO0883|PRO0903|PRO1341 9606 Homo sapiens unknown target Baneres-Roquet F (2009) 19164148 188474 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 3337 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3338 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Wroczynski P (2006) 16583981 173765 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3339 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3340 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Russo J (2002) 11872149 173679 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 23428 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 10136 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Mic FA (2004) 15366004 178209 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10137 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Gidlof AC (2006) 16837774 173874 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10138 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Matt N (2005) 16207763 119194 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10139 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Kim H (2005) 16166285 178211 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10140 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Everts HB (2004) 15245423 178212 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 3553 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Gyamfi MA (2006) 16829625 173902 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3554 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Huq MD (2006) 16763553 173903 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3555 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Maden M (2007) 17486539 173900 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3556 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Chambers D (2007) 17329364 173904 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3557 106718 216 RP11-151D14.2 ALDH1A1 ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1 9606 Homo sapiens unknown target Asson-Batres MA (2006) 16538685 173884 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3363 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Quintanilla ME (2007) 17488809 173775 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3364 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Quintanilla ME (2006) 16961761 173776 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 23238 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4203 Crotonaldehyde - - DRUGBANK DB04381 C4H6O small molecule - - DRUGBANK 23239 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4203 Crotonaldehyde - - DRUGBANK DB04381 C4H6O small molecule - - DRUGBANK 7793 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7794 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 10834 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens inhibitor target Mackenzie IS (2005) 16051882 178554 812 Disulfiram Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide antabuse tab 0.25gm|antabuse t DRUGBANK DB00822 C10H20N2S4 small molecule P03AA54|P03AA04|N07BB01 97-77-8 DRUGBANK 10835 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens inhibitor target Ho MP (2007) 17220694 178555 812 Disulfiram Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide antabuse tab 0.25gm|antabuse t DRUGBANK DB00822 C10H20N2S4 small molecule P03AA54|P03AA04|N07BB01 97-77-8 DRUGBANK 18565 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2035 Daidzin Daidzoside|7-O-B-D-GLUCOPYRANOSIDE|Daidzein-7-glucoside|Daidzein 7-glucoside|Daidzein 7-O-glucoside|7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-chromen-4-one|4',7-Dihydroxyisoflavone - DRUGBANK DB02115 C21H20O9 small molecule - 552-66-9 DRUGBANK 18566 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2035 Daidzin Daidzoside|7-O-B-D-GLUCOPYRANOSIDE|Daidzein-7-glucoside|Daidzein 7-glucoside|Daidzein 7-O-glucoside|7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-chromen-4-one|4',7-Dihydroxyisoflavone - DRUGBANK DB02115 C21H20O9 small molecule - 552-66-9 DRUGBANK 18567 106719 217 - ALDH2 ALDH-E2|ALDHI|ALDM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2035 Daidzin Daidzoside|7-O-B-D-GLUCOPYRANOSIDE|Daidzein-7-glucoside|Daidzein 7-glucoside|Daidzein 7-O-glucoside|7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-chromen-4-one|4',7-Dihydroxyisoflavone - DRUGBANK DB02115 C21H20O9 small molecule - 552-66-9 DRUGBANK 3394 106720 218 - ALDH3A1 ALDH3|ALDHIII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3395 106720 218 - ALDH3A1 ALDH3|ALDHIII 9606 Homo sapiens unknown target Wroczynski P (2006) 16583981 173765 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3396 106720 218 - ALDH3A1 ALDH3|ALDHIII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3031 106721 219 - ALDH1B1 ALDH5|ALDHX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3032 106721 219 - ALDH1B1 ALDH5|ALDHX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3135 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3136 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3137 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Graham CE (2006) 16241904 155769 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3549 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Nakazawa N (2007) 17270546 173882 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3550 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Maden M (2007) 17486539 173900 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3551 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Everts HB (2005) 15950969 173901 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3552 106722 220 RP11-66B24.1 ALDH1A3 ALDH1A6|ALDH6|MCOP8|RALDH3 9606 Homo sapiens unknown target Halilagic A (2007) 17184764 119197 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3159 106723 221 - ALDH3B1 ALDH4|ALDH7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3160 106723 221 - ALDH3B1 ALDH4|ALDH7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3161 106724 222 - ALDH3B2 ALDH8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3162 106724 222 - ALDH3B2 ALDH8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3232 106725 223 - ALDH9A1 ALDH4|ALDH7|ALDH9|E3|TMABADH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3233 106725 223 - ALDH9A1 ALDH4|ALDH7|ALDH9|E3|TMABADH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3234 106725 223 - ALDH9A1 ALDH4|ALDH7|ALDH9|E3|TMABADH 9606 Homo sapiens unknown target Prieto MI (1987) 3129020 173726 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3235 106725 223 - ALDH9A1 ALDH4|ALDH7|ALDH9|E3|TMABADH 9606 Homo sapiens unknown target Testore G (1995) 7584606 173727 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3219 106726 224 - ALDH3A2 ALDH10|FALDH|SLS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3220 106726 224 - ALDH3A2 ALDH10|FALDH|SLS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3218 106726 224 - ALDH3A2 ALDH10|FALDH|SLS 9606 Homo sapiens unknown target Bognar A (1983) 6603890 173718 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 26293 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7030 N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE - - DRUGBANK DB08240 C17H13ClNO5P small molecule - - DRUGBANK 23856 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4536 1,6-DI-O-PHOSPHONO-D-MANNITOL - - DRUGBANK DB04733 C6H16O12P2 small molecule - - DRUGBANK 23134 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23135 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23136 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 19371 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2409 1,6-Fructose Diphosphate (Linear Form) - - DRUGBANK DB02512 C6H14O12P2 small molecule - - DRUGBANK 19372 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2409 1,6-Fructose Diphosphate (Linear Form) - - DRUGBANK DB02512 C6H14O12P2 small molecule - - DRUGBANK 19373 106728 226 - ALDOA ALDA|GSD12|HEL-S-87p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2409 1,6-Fructose Diphosphate (Linear Form) - - DRUGBANK DB02512 C6H14O12P2 small molecule - - DRUGBANK 19374 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2409 1,6-Fructose Diphosphate (Linear Form) - - DRUGBANK DB02512 C6H14O12P2 small molecule - - DRUGBANK 19375 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2409 1,6-Fructose Diphosphate (Linear Form) - - DRUGBANK DB02512 C6H14O12P2 small molecule - - DRUGBANK 19376 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2409 1,6-Fructose Diphosphate (Linear Form) - - DRUGBANK DB02512 C6H14O12P2 small molecule - - DRUGBANK 19382 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19383 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19384 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 23139 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23140 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23141 106730 229 RP11-490D19.1 ALDOB ALDB|ALDO2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 3119 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Linster CL (2007) 17222174 173683 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3120 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Ido Y (2007) 17508915 173682 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 8543 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8544 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Jacobson M (1983) 6413448 177230 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8545 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Sharma YR (1989) 2632448 177231 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8546 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Chaudhry PS (1983) 6409111 177232 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8547 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Crabbe MJ (1985) 3920599 177233 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8548 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target van der Sloot P (1995) 8529171 177234 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 26126 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6891 [5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid - - DRUGBANK DB08098 C8H5N3O6S small molecule - - DRUGBANK 25067 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5881 {3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID - - DRUGBANK DB07063 C18H11F3N2O2S small molecule - - DRUGBANK 26114 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6877 IDD594 - - DRUGBANK DB08084 C16H12BrF2NO3S small molecule - - DRUGBANK 19990 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2716 IDD552 - - DRUGBANK DB02834 C17H10F4N2O4S small molecule - - DRUGBANK 19991 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2716 IDD552 - - DRUGBANK DB02834 C17H10F4N2O4S small molecule - - DRUGBANK 19992 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2716 IDD552 - - DRUGBANK DB02834 C17H10F4N2O4S small molecule - - DRUGBANK 18592 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2051 [3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid - - DRUGBANK DB02132 C17H11BrClFN2O4 small molecule - - DRUGBANK 18593 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2051 [3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid - - DRUGBANK DB02132 C17H11BrClFN2O4 small molecule - - DRUGBANK 18594 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2051 [3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid - - DRUGBANK DB02132 C17H11BrClFN2O4 small molecule - - DRUGBANK 25193 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6004 6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE - - DRUGBANK DB07187 C13H9ClN2O4S small molecule - - DRUGBANK 25468 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6261 2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE - - DRUGBANK DB07450 C19H11BrF2N2O4 small molecule - - DRUGBANK 18355 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1943 Alrestatin - - DRUGBANK DB02020 C14H9NO4 small molecule - 51411-04-2 DRUGBANK 18356 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1943 Alrestatin - - DRUGBANK DB02020 C14H9NO4 small molecule - 51411-04-2 DRUGBANK 18357 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1943 Alrestatin - - DRUGBANK DB02020 C14H9NO4 small molecule - 51411-04-2 DRUGBANK 18358 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1944 Fidarestat Aldos|(S,S)-fidarestat - DRUGBANK DB02021 C12H10FN3O4 small molecule - 136087-85-9 DRUGBANK 25041 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5846 (2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID - - DRUGBANK DB07028 C16H12BrClFNO4 small molecule - - DRUGBANK 25521 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6309 4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID - - DRUGBANK DB07498 C12H11N3O5 small molecule - - DRUGBANK 25043 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5848 (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID - - DRUGBANK DB07030 C16H13ClN2O6 small molecule - - DRUGBANK 19119 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2288 Tolrestat - - DRUGBANK DB02383 C16H14F3NO3S small molecule A10XA01 82964-04-3 DRUGBANK 19120 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2288 Tolrestat - - DRUGBANK DB02383 C16H14F3NO3S small molecule A10XA01 82964-04-3 DRUGBANK 20251 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 20252 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 19749 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2600 Sorbinil - - DRUGBANK DB02712 C11H9FN2O3 small molecule - 68367-52-2 DRUGBANK 19750 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2600 Sorbinil - - DRUGBANK DB02712 C11H9FN2O3 small molecule - 68367-52-2 DRUGBANK 22930 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22931 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 18301 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18302 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 26498 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7231 2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid - - DRUGBANK DB08449 C17H10F3N3O2S small molecule - - DRUGBANK 21277 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21278 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21279 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 26027 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6794 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE - - DRUGBANK DB08000 C14H9NO7S small molecule - - DRUGBANK 26026 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6793 {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID - - DRUGBANK DB07999 C16H11NO9S small molecule - - DRUGBANK 25150 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5957 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid - - DRUGBANK DB07139 C13H11NO4S small molecule - - DRUGBANK 17562 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1624 Inhibitor Idd 384 - - DRUGBANK DB01689 C19H22N2O5S small molecule - - DRUGBANK 17563 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1624 Inhibitor Idd 384 - - DRUGBANK DB01689 C19H22N2O5S small molecule - - DRUGBANK 17564 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1624 Inhibitor Idd 384 - - DRUGBANK DB01689 C19H22N2O5S small molecule - - DRUGBANK 25104 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5911 {3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID - - DRUGBANK DB07093 C14H10ClN3O4S small molecule - - DRUGBANK 19387 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2415 N-Acetylalanine L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine - DRUGBANK DB02518 C5H9NO3 small molecule - 97-69-8 DRUGBANK 19388 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2415 N-Acetylalanine L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine - DRUGBANK DB02518 C5H9NO3 small molecule - 97-69-8 DRUGBANK 19389 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2415 N-Acetylalanine L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine - DRUGBANK DB02518 C5H9NO3 small molecule - 97-69-8 DRUGBANK 18530 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2021 (S,R)-fidarestat (2S,4R)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione|Fidarestat(stereoisomer) - DRUGBANK DB02101 C12H10FN3O4 small molecule - - DRUGBANK 18531 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2021 (S,R)-fidarestat (2S,4R)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione|Fidarestat(stereoisomer) - DRUGBANK DB02101 C12H10FN3O4 small molecule - - DRUGBANK 26771 106732 231 - AKR1B1 ADR|ALDR1|ALR2|AR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7544 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID - - DRUGBANK DB08772 C19H12F3N3O3S small molecule - - DRUGBANK 3700 106739 238 - ALK CD246|NBLST3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3701 106739 238 - ALK CD246|NBLST3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 27472 106739 238 - ALK CD246|NBLST3 9606 Homo sapiens antagonist target Galkin AV (2007) 17185414 188545 7816 Ceritinib critinib|N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide zykadia DRUGBANK DB09063 C28H36ClN5O3S small molecule L01XE28 1032900-25-6 DRUGBANK 27473 106739 238 - ALK CD246|NBLST3 9606 Homo sapiens antagonist target Marsilje TH (2013) 23742252 188546 7816 Ceritinib critinib|N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide zykadia DRUGBANK DB09063 C28H36ClN5O3S small molecule L01XE28 1032900-25-6 DRUGBANK 26931 106739 238 - ALK CD246|NBLST3 9606 Homo sapiens inhibitor target Forde PM (2012) 22594847 182202 7610 Crizotinib MET Tyrosine Kinase Inhibitor PF-02341066|(R)-Crizotinib|PF-2341066|C-Met/Hepatocyte Growth Factor Receptor Tyrosine Kinase Inhibitor PF-02341066|C-Met/HGFR Tyrosine Kinase Inhibitor PF-02341066|PF 2341066|Crizotinibum xalkori DRUGBANK DB08865 C21H22Cl2FN5O small molecule L01XE16 877399-52-5 DRUGBANK 9707 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 9708 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Cernak I (1996) 8606397 177968 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 9709 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Bach MK (1986) 3004501 177969 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 9710 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Davidson D (1992) 1400062 177965 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 9711 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Gross NJ (1991) 1886988 177966 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 9712 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Zunic G (1999) 10518442 177967 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 10553 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Nielsen OH (1987) 2882965 174547 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10554 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Sircar JC (1983) 6131674 174549 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10555 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Allgayer H (1984) 6428914 174548 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 4697 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Nielsen OH (1987) 2882965 174547 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4698 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Sircar JC (1983) 6131674 174549 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4699 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Allgayer H (1984) 6428914 174548 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 23847 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens unknown target Vidal C (2007) 17015640 181969 4529 Licofelone LCF|ML3000 - DRUGBANK DB04725 C23H22ClNO2 small molecule - 156897-06-2 DRUGBANK 23848 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 4529 Licofelone LCF|ML3000 - DRUGBANK DB04725 C23H22ClNO2 small molecule - 156897-06-2 DRUGBANK 3584 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens unknown target Taccone-Gallucci M (2006) 16531984 173928 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 8306 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens potentiator target Whittle BJ (2004) 15525540 177094 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8307 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens potentiator target Charlier C (2003) 12932896 177095 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8308 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens potentiator target Kudo C (2003) 12826271 177096 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 7251 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens unknown target Ramires R (2004) 15474500 176302 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 18028 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1819 Hyperforin Hiperforina|Hyperforine - DRUGBANK DB01892 C35H52O4 small molecule - 11079-53-1 DRUGBANK 12129 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Boctor AM (1986) 3020588 179225 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12130 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Yu XY (1992) 1539679 179224 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 10023 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Berger W (2007) 17394438 178138 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10024 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Hardy DB (1999) 10377029 178139 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10025 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Qian C (2001) 11529688 178143 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10026 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10027 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Zouboulis CC (2009) 20436887 178144 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10028 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Zouboulis CC (2010) 19645854 178136 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10029 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Coffey MJ (2001) 11561080 178137 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10030 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Wenzel SE (1999) 10322101 178141 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10031 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Yamashita M (2000) 10694244 178140 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10032 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Wenzel SE (1996) 8826571 178142 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 10033 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Guidot DM (1994) 8058773 178145 734 Zileuton N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea zyflo cr|zyflo DRUGBANK DB00744 C11H12N2O2S small molecule - 111406-87-2 DRUGBANK 12811 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Song Y (2004) 15371729 179711 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12812 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Song Y (2006) 16574083 179710 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12813 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Chu LS (2007) 17506934 179709 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 4565 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Nielsen OH (1987) 2882965 174547 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4566 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Sircar JC (1983) 6131674 174549 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4567 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Allgayer H (1984) 6428914 174548 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 12743 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Wiggins JB (2009) 19743890 179656 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12744 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Rask-Madsen J (1992) 1359745 179659 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 3866 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 172 Masoprocol meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan - DRUGBANK DB00179 C18H22O4 small molecule L01XX10 27686-84-6 DRUGBANK 3867 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Lambert JD (2001) 11318430 174118 172 Masoprocol meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan - DRUGBANK DB00179 C18H22O4 small molecule L01XX10 27686-84-6 DRUGBANK 3868 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target West M (2004) 15379894 174119 172 Masoprocol meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan - DRUGBANK DB00179 C18H22O4 small molecule L01XX10 27686-84-6 DRUGBANK 3869 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Jeon SB (2005) 15694390 174121 172 Masoprocol meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan - DRUGBANK DB00179 C18H22O4 small molecule L01XX10 27686-84-6 DRUGBANK 3870 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Azadzoi KM (2004) 15098224 174120 172 Masoprocol meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan - DRUGBANK DB00179 C18H22O4 small molecule L01XX10 27686-84-6 DRUGBANK 3871 106741 240 RP11-67C2.3 ALOX5 5-LO|5-LOX|5LPG|LOG5 9606 Homo sapiens inhibitor target Audouin C (2001) 11277534 174117 172 Masoprocol meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan - DRUGBANK DB00179 C18H22O4 small molecule L01XX10 27686-84-6 DRUGBANK 26538 106747 246 - ALOX15 12-LOX|15-LOX-1|15LOX-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7272 (2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID - - DRUGBANK DB08492 C17H20O2 small molecule - - DRUGBANK 26462 106751 250 - ALPP ALP|PALP|PLAP|PLAP-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7197 METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER - - DRUGBANK DB08413 C7H8NO5P small molecule - - DRUGBANK 11097 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inhibitor target Mota A (2008) 18719742 178684 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11098 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inhibitor target Chang YL (2000) 10951365 178685 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11099 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inhibitor target Funk CJ (2001) 11304750 178686 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11100 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inhibitor target de Aguiar Matos JA (2001) 11403767 178681 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11101 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inhibitor target Soory M (2003) 12615144 178682 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11102 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inhibitor target McDougall K (2002) 11850443 178683 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 14161 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inducer target Plasswilm L (2000) 10628381 180343 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 14162 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inducer target Buschini A (2000) 10995012 137566 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 14163 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inducer target Santini V (1999) 10553165 180346 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 14164 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inducer target Capizzi RL (1999) 10348255 180344 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 14165 106752 251 - ALPPL2 ALPG|ALPPL|GCAP 9606 Homo sapiens inducer target Orditura M (1999) 10523712 180345 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 749 106757 259 - AMBP A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI 9606 Homo sapiens unknown target Sala A (2004) 15452109 172111 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 762 106757 259 - AMBP A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 763 106757 259 - AMBP A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 18071 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 18072 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 21868 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21869 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 1699 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens cofactor target Notari S (2004) 15051528 172673 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1700 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens cofactor target Ndjonka D (2003) 12974388 172672 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1701 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens cofactor target Dudkowska M (2003) 12545203 172671 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1702 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens cofactor target Yerlikaya A (2006) 16515461 172670 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 26186 106759 262 RP11-397G5.3 AMD1 ADOMETDC|AMD|SAMDC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6955 5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine - - DRUGBANK DB08163 C17H27N7O4 small molecule - - DRUGBANK 3751 106766 269 - AMHR2 AMHR|MISR2|MISRII|MRII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3752 106766 269 - AMHR2 AMHR|MISR2|MISRII|MRII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3386 106772 275 - AMT GCE|GCST|GCVT|NKH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3387 106772 275 - AMT GCE|GCST|GCVT|NKH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 1647 106772 275 - AMT GCE|GCST|GCVT|NKH 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1648 106772 275 - AMT GCE|GCST|GCVT|NKH 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1649 106772 275 - AMT GCE|GCST|GCVT|NKH 9606 Homo sapiens cofactor target Masai E (2004) 15090517 172628 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 21235 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3295 4,6-Dideoxy-4-Amino-Alpha-D-Glucose - - DRUGBANK DB03439 C6H13NO4 small molecule - - DRUGBANK 21236 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3295 4,6-Dideoxy-4-Amino-Alpha-D-Glucose - - DRUGBANK DB03439 C6H13NO4 small molecule - - DRUGBANK 19063 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19064 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 20464 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20465 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20473 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2963 5-Hydroxymethyl-Chonduritol - - DRUGBANK DB03092 C7H12O5 small molecule - - DRUGBANK 20474 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2963 5-Hydroxymethyl-Chonduritol - - DRUGBANK DB03092 C7H12O5 small molecule - - DRUGBANK 22876 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4065 Tris(Hydroxyethyl)Aminomethane - - DRUGBANK DB04237 C7H17NO3 small molecule - - DRUGBANK 22877 106773 276 - AMY1A AMY1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4065 Tris(Hydroxyethyl)Aminomethane - - DRUGBANK DB04237 C7H17NO3 small molecule - - DRUGBANK 5128 106776 279 - AMY2A AMY2|AMY2B|PA 9606 Homo sapiens inhibitor target Jonas L (2003) 12890998 174915 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 17980 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1798 1,4-Dithio-Alpha-D-Mannose - - DRUGBANK DB01870 C6H12O4S2 small molecule - - DRUGBANK 17981 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1798 1,4-Dithio-Alpha-D-Mannose - - DRUGBANK DB01870 C6H12O4S2 small molecule - - DRUGBANK 17982 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1798 1,4-Dithio-Alpha-D-Mannose - - DRUGBANK DB01870 C6H12O4S2 small molecule - - DRUGBANK 18750 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2130 N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside - - DRUGBANK DB02218 C13H23NO8 small molecule - - DRUGBANK 18751 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2130 N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside - - DRUGBANK DB02218 C13H23NO8 small molecule - - DRUGBANK 18752 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2130 N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside - - DRUGBANK DB02218 C13H23NO8 small molecule - - DRUGBANK 20470 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2963 5-Hydroxymethyl-Chonduritol - - DRUGBANK DB03092 C7H12O5 small molecule - - DRUGBANK 20471 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2963 5-Hydroxymethyl-Chonduritol - - DRUGBANK DB03092 C7H12O5 small molecule - - DRUGBANK 20472 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2963 5-Hydroxymethyl-Chonduritol - - DRUGBANK DB03092 C7H12O5 small molecule - - DRUGBANK 20971 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 20972 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 20973 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 19104 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19105 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19106 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19808 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2618 4-Methylthio-Alpha-D-Mannose - - DRUGBANK DB02730 C7H14O5S small molecule - - DRUGBANK 19809 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2618 4-Methylthio-Alpha-D-Mannose - - DRUGBANK DB02730 C7H14O5S small molecule - - DRUGBANK 19810 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2618 4-Methylthio-Alpha-D-Mannose - - DRUGBANK DB02730 C7H14O5S small molecule - - DRUGBANK 20892 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3143 Amylotriose - - DRUGBANK DB03277 C18H32O16 small molecule - 1109-28-0 DRUGBANK 20893 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3143 Amylotriose - - DRUGBANK DB03277 C18H32O16 small molecule - 1109-28-0 DRUGBANK 20894 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3143 Amylotriose - - DRUGBANK DB03277 C18H32O16 small molecule - 1109-28-0 DRUGBANK 20453 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20454 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20455 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 23367 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4233 P-Nitrophenol - - DRUGBANK DB04417 C6H5NO3 small molecule - 100-02-7 DRUGBANK 23368 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4233 P-Nitrophenol - - DRUGBANK DB04417 C6H5NO3 small molecule - 100-02-7 DRUGBANK 23369 106777 280 - AMY2B AMY2|AMY3|HXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4233 P-Nitrophenol - - DRUGBANK DB04417 C6H5NO3 small molecule - 100-02-7 DRUGBANK 22957 106780 283 - ANG ALS9|HEL168|RAA1|RNASE4|RNASE5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22958 106780 283 - ANG ALS9|HEL168|RAA1|RNASE4|RNASE5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 20462 106780 283 - ANG ALS9|HEL168|RAA1|RNASE4|RNASE5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20463 106780 283 - ANG ALS9|HEL168|RAA1|RNASE4|RNASE5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 24411 106787 290 - ANPEP APN|CD13|GP150|LAP1|P150|PEPN 9606 Homo sapiens inhibitor target Bawolak MT (2006) 17026984 181971 5524 Icatibant HOE 140 firazyr DRUGBANK DB06196 C59H89N19O13S small molecule B06AC02 130308-48-4 DRUGBANK 12418 106787 290 - ANPEP APN|CD13|GP150|LAP1|P150|PEPN 9606 Homo sapiens unknown target Kramer W (2005) 15494415 179435 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 22766 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4008 Di-Stearoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04178 C44H89NO8P small molecule - - DRUGBANK 22767 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4008 Di-Stearoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04178 C44H89NO8P small molecule - - DRUGBANK 22768 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4008 Di-Stearoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04178 C44H89NO8P small molecule - - DRUGBANK 19177 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2329 Carboxyatractyloside - - DRUGBANK DB02426 C31H46O19S2 small molecule - 33286-30-5 DRUGBANK 19178 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2329 Carboxyatractyloside - - DRUGBANK DB02426 C31H46O19S2 small molecule - 33286-30-5 DRUGBANK 19179 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2329 Carboxyatractyloside - - DRUGBANK DB02426 C31H46O19S2 small molecule - 33286-30-5 DRUGBANK 9806 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 710 Clodronate Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid bonefos|clasteon|ostac cap 400 DRUGBANK DB00720 CH4Cl2O6P2 small molecule - 10596-23-3 DRUGBANK 9807 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens inhibitor target Lehenkari PP (2002) 11961144 178023 710 Clodronate Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid bonefos|clasteon|ostac cap 400 DRUGBANK DB00720 CH4Cl2O6P2 small molecule - 10596-23-3 DRUGBANK 3744 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Walther T (2007) 17210842 174036 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 21192 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3286 Cardiolipin CDL|Diphosphatidyl Glycerol|Diphosphatidylglycerol - DRUGBANK DB03429 C81H158O17P2 small molecule - - DRUGBANK 21193 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3286 Cardiolipin CDL|Diphosphatidyl Glycerol|Diphosphatidylglycerol - DRUGBANK DB03429 C81H158O17P2 small molecule - - DRUGBANK 21194 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3286 Cardiolipin CDL|Diphosphatidyl Glycerol|Diphosphatidylglycerol - DRUGBANK DB03429 C81H158O17P2 small molecule - - DRUGBANK 17686 106788 291 - SLC25A4 1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1670 [3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium - - DRUGBANK DB01736 C17H36N2O2 small molecule - - DRUGBANK 9805 106789 292 - SLC25A5 2F1|AAC2|ANT2|T2|T3 9606 Homo sapiens inhibitor target Lehenkari PP (2002) 11961144 178023 710 Clodronate Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid bonefos|clasteon|ostac cap 400 DRUGBANK DB00720 CH4Cl2O6P2 small molecule - 10596-23-3 DRUGBANK 9804 106790 293 RP11-261P4.6 SLC25A6 2|3|AAC3|ANT|ANT 2|ANT 3|ANT3|ANT3Y 9606 Homo sapiens inhibitor target Lehenkari PP (2002) 11961144 178023 710 Clodronate Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid bonefos|clasteon|ostac cap 400 DRUGBANK DB00720 CH4Cl2O6P2 small molecule - 10596-23-3 DRUGBANK 5168 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5169 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Serres M (1994) 7981624 174978 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5170 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 10013 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10014 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Sato-Matsumura KC (2000) 11142771 178123 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10015 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10016 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Serres M (1994) 8060156 178125 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10017 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target White MV (1991) 1712816 178124 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 15163 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Morand EF (2006) 16883066 180762 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15164 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Davies E (2007) 17158208 180763 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15165 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target John CD (2006) 17076770 180764 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15166 106798 301 RP11-71A24.1 ANXA1 ANX1|LPC1 9606 Homo sapiens agonist target Wang C (2007) 17644190 180765 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 394 106799 302 - ANXA2 ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV 9606 Homo sapiens unknown target Kang HM (1999) 10578524 171908 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 395 106799 302 - ANXA2 ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV 9606 Homo sapiens unknown target MacLeod TJ (2003) 12730231 171909 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 396 106799 302 - ANXA2 ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV 9606 Homo sapiens unknown target Diaz VM (2004) 15194650 171907 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 22214 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3771 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03935 C6H10O8S small molecule - - DRUGBANK 22215 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3771 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03935 C6H10O8S small molecule - - DRUGBANK 22216 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3771 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03935 C6H10O8S small molecule - - DRUGBANK 22330 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 22331 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 22332 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 22270 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 22271 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 22272 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 20017 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2728 L-thioproline (4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid - DRUGBANK DB02846 C4H7NO2S small molecule - 2756-91-4 DRUGBANK 20018 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2728 L-thioproline (4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid - DRUGBANK DB02846 C4H7NO2S small molecule - 2756-91-4 DRUGBANK 20019 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2728 L-thioproline (4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid - DRUGBANK DB02846 C4H7NO2S small molecule - 2756-91-4 DRUGBANK 19340 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2394 L-Alpha-Glycerophosphorylserine - - DRUGBANK DB02497 C6H14NO8P small molecule - - DRUGBANK 19341 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2394 L-Alpha-Glycerophosphorylserine - - DRUGBANK DB02497 C6H14NO8P small molecule - - DRUGBANK 19342 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2394 L-Alpha-Glycerophosphorylserine - - DRUGBANK DB02497 C6H14NO8P small molecule - - DRUGBANK 21367 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3339 L-Alpha-Glycerophosphorylethanolamine - - DRUGBANK DB03484 C5H14NO6P small molecule - - DRUGBANK 21368 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3339 L-Alpha-Glycerophosphorylethanolamine - - DRUGBANK DB03484 C5H14NO6P small molecule - - DRUGBANK 21369 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3339 L-Alpha-Glycerophosphorylethanolamine - - DRUGBANK DB03484 C5H14NO6P small molecule - - DRUGBANK 20146 106805 308 - ANXA5 ANX5|ENX2|HEL-S-7|PP4|RPRGL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2807 K201 - - DRUGBANK DB02929 C25H32N2O2S small molecule - - DRUGBANK 21433 106813 316 - AOX1 AO|AOH1 9606 Homo sapiens unknown target Porter DJ (1994) 8161345 181694 3371 Eniluracil 5-Ethynyluracil|5-ethynyl-2,4(1H,3H)-Pyrimidinedione|Compound 776C - DRUGBANK DB03516 C6H4N2O2 small molecule - 59989-18-3 DRUGBANK 3702 106814 317 - APAF1 APAF-1|CED4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3703 106814 317 - APAF1 APAF-1|CED4 9606 Homo sapiens unknown target Chinnaiyan AM (1999) 10935465 174015 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3704 106814 317 - APAF1 APAF-1|CED4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 17506 106822 325 - APCS HEL-S-92n|PTX2|SAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1588 Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside - - DRUGBANK DB01651 C10H16O8 small molecule - - DRUGBANK 17507 106822 325 - APCS HEL-S-92n|PTX2|SAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1588 Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside - - DRUGBANK DB01651 C10H16O8 small molecule - - DRUGBANK 25589 106822 325 - APCS HEL-S-92n|PTX2|SAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6386 BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE - - DRUGBANK DB07579 C16H24N2O12 small molecule - - DRUGBANK 25590 106822 325 - APCS HEL-S-92n|PTX2|SAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6387 BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE - - DRUGBANK DB07580 C18H26N2O12 small molecule - - DRUGBANK 24252 106825 328 - APEX1 APE|APE1|APEN|APEX|APX|HAP1|REF1 9606 Homo sapiens inhibitor target Luo M (2004) 15330152 181860 4759 Lucanthone 1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona - DRUGBANK DB04967 C20H24N2OS small molecule - 479-50-5 DRUGBANK 19570 106828 331 RP1-315G1.5 XIAP API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2520 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide - - DRUGBANK DB02628 C25H38N4O3 small molecule - - DRUGBANK 19571 106828 331 RP1-315G1.5 XIAP API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2520 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide - - DRUGBANK DB02628 C25H38N4O3 small molecule - - DRUGBANK 19572 106828 331 RP1-315G1.5 XIAP API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2520 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide - - DRUGBANK DB02628 C25H38N4O3 small molecule - - DRUGBANK 750 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Mojzisova H (2007) 17141733 172116 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 751 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Michaelis K (2006) 16554356 172114 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 752 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Yuan Z (2003) 12860569 172115 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 753 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Yuan ZY (2003) 12887764 172112 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 754 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Yamashita T (2007) 17553935 172113 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 764 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Wang L (2006) 17378158 172130 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 765 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 766 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 767 106845 348 - APOE AD2|APO-E|LDLCQ5|LPG 9606 Homo sapiens unknown target Cano NJ (2006) 16441928 172131 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 27922 106848 351 - APP AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2 9606 Homo sapiens binder target Beach TG (2016) 27031469 196039 7896 Flutemetamol (18F) [18F]-Flutemetamol|2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|Flutemetamol F-18|flutemetamol (18F)|Flutemetamol F18|Flutemetamol F 18 - DRUGBANK DB09151 C14H11FN2OS small molecule V09AX04 765922-62-1 DRUGBANK 18779 106848 351 - APP AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2146 L-methionine (R)-S-oxide Methionine Sulfoxide - DRUGBANK DB02235 C5H11NO3S small molecule - 62697-73-8 DRUGBANK 27921 106848 351 - APP AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2 9606 Homo sapiens binder target Choi SR (2009) 19837759 195994 7894 Florbetapir (18F) florbetapir-fluorine-18|18F-AV-45|4-{(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline|Florbetapir F-18|Florbetapir F18 amyvid DRUGBANK DB09149 C20H25FN2O3 small molecule V09AX05 956103-76-7 DRUGBANK 17466 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 22963 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 3804 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Boitz JM (2006) 16597468 174046 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3805 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Di Pietro V (2007) 17126311 174047 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3806 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Katahira R (2006) 17064924 174044 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3807 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Katahira R (2006) 16845529 174045 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3808 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Barrett C (2006) 17199504 173062 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3809 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 21418 106849 353 - APRT AMP|APRTD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3361 9-Deazaadenine - - DRUGBANK DB03506 C6H5N4 small molecule - - DRUGBANK 10799 106854 358 - AQP1 AQP-CHIP|CHIP28|CO 9606 Homo sapiens inhibitor target Mu SM (2003) 12830709 178536 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10800 106854 358 - AQP1 AQP-CHIP|CHIP28|CO 9606 Homo sapiens inhibitor target Xiang Y (2002) 12147198 178537 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10801 106854 358 - AQP1 AQP-CHIP|CHIP28|CO 9606 Homo sapiens inhibitor target Xiang Y (2004) 15169637 178534 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10802 106854 358 - AQP1 AQP-CHIP|CHIP28|CO 9606 Homo sapiens inhibitor target Ma B (2004) 14704128 178535 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10803 106854 358 - AQP1 AQP-CHIP|CHIP28|CO 9606 Homo sapiens inhibitor target Oshio K (2004) 14753499 178538 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 27740 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Kloosterboer HJ (1988) 3139361 175069 8156 Norgestrel LD norgestrel|17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one|Methylnorethindrone low-ogestrel|ovrette tablets|e DRUGBANK DB09389 C21H28O2 small molecule G03FB01|G03FA10|G03AA06 6533-00-2 DRUGBANK 16396 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Krattenmacher R (2000) 11024226 181281 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 27855 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Davison SL (2006) 16633980 195967 8076 Oxymetholone Oximetolona|17-Hydroxy-2-hydroxymethylidene-17-methyl-3-androstanone|Oxymetholon|Oxymetholonum|Oxymtholone anapolon 50 tablets 50mg|anapo DRUGBANK DB06412 C21H32O3 small molecule A14AA05 434-07-1 DRUGBANK 27856 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens activator target Davison SL (2006) 16633980 195967 8076 Oxymetholone Oximetolona|17-Hydroxy-2-hydroxymethylidene-17-methyl-3-androstanone|Oxymetholon|Oxymetholonum|Oxymtholone anapolon 50 tablets 50mg|anapo DRUGBANK DB06412 C21H32O3 small molecule A14AA05 434-07-1 DRUGBANK 16888 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1481 Boldenone 1,4-androstadiene-3-one-17beta-ol|delta1-Testosterone|1-Dehydrotestosterone|17beta-Hydroxyandrosta-1,4-dien-3-one|dehydrotestosterone|17beta-Hydroxyandrosta-1,4-diene-3-one|1,2-Dehydrotestosterone|1,4-Androstadien-17beta-ol-3-one|Boldenona|1,2-Didehydrotestosterone|17beta-Boldenone|17-beta-Hydroxy-17-alpha-1,4-androstadien-3-one|Boldenonum|17-beta-Hydroxyandrosta-1,4-dien-3-one - DRUGBANK DB01541 C19H26O2 small molecule - 846-48-0 DRUGBANK 16889 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1481 Boldenone 1,4-androstadiene-3-one-17beta-ol|delta1-Testosterone|1-Dehydrotestosterone|17beta-Hydroxyandrosta-1,4-dien-3-one|dehydrotestosterone|17beta-Hydroxyandrosta-1,4-diene-3-one|1,2-Dehydrotestosterone|1,4-Androstadien-17beta-ol-3-one|Boldenona|1,2-Didehydrotestosterone|17beta-Boldenone|17-beta-Hydroxy-17-alpha-1,4-androstadien-3-one|Boldenonum|17-beta-Hydroxyandrosta-1,4-dien-3-one - DRUGBANK DB01541 C19H26O2 small molecule - 846-48-0 DRUGBANK 16890 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Merlanti R (2007) 17386710 181486 1481 Boldenone 1,4-androstadiene-3-one-17beta-ol|delta1-Testosterone|1-Dehydrotestosterone|17beta-Hydroxyandrosta-1,4-dien-3-one|dehydrotestosterone|17beta-Hydroxyandrosta-1,4-diene-3-one|1,2-Dehydrotestosterone|1,4-Androstadien-17beta-ol-3-one|Boldenona|1,2-Didehydrotestosterone|17beta-Boldenone|17-beta-Hydroxy-17-alpha-1,4-androstadien-3-one|Boldenonum|17-beta-Hydroxyandrosta-1,4-dien-3-one - DRUGBANK DB01541 C19H26O2 small molecule - 846-48-0 DRUGBANK 7525 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 7526 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Shilling AD (2000) 11162924 176512 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 7527 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Martelli A (2000) 10752671 176513 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 7528 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Montalvo L (2000) 10822172 176510 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 7529 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Pazos F (2000) 10879806 176511 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 7530 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Balk SP (2002) 12231070 176509 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 7531 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Chang HC (1999) 10500149 176508 491 Flutamide FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide flutamide-250|penta-flutamide| DRUGBANK DB00499 C11H11F3N2O3 small molecule L02BB01 13311-84-7 DRUGBANK 25786 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6570 S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE - - DRUGBANK DB07769 C17H14F4N2O5 small molecule - - DRUGBANK 12489 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Cen Y (2003) 14663936 179507 974 Nandrolone phenpropionate Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate - DRUGBANK DB00984 C27H34O3 small molecule - 434-22-0 DRUGBANK 12490 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 974 Nandrolone phenpropionate Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate - DRUGBANK DB00984 C27H34O3 small molecule - 434-22-0 DRUGBANK 12491 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Burger LL (2007) 17405825 179508 974 Nandrolone phenpropionate Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate - DRUGBANK DB00984 C27H34O3 small molecule - 434-22-0 DRUGBANK 12492 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Yan W (2003) 12760377 179509 974 Nandrolone phenpropionate Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate - DRUGBANK DB00984 C27H34O3 small molecule - 434-22-0 DRUGBANK 12493 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Li K (2003) 14619588 179511 974 Nandrolone phenpropionate Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate - DRUGBANK DB00984 C27H34O3 small molecule - 434-22-0 DRUGBANK 12494 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Fujii Y (2004) 14761877 179510 974 Nandrolone phenpropionate Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate - DRUGBANK DB00984 C27H34O3 small molecule - 434-22-0 DRUGBANK 20106 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2781 Dihydrotestosterone 17beta-Hydroxy-5alpha-androstane-3-one|Dihydrotestosteron|Dihydrotestostrone|Stanolone|17beta-Hydroxy-5alpha-androstan-3-one|4-Dihydrotestosterone|17-hydroxy-3-oxo-5-androstanone|5-DHT|17-hydroxy-5-androstan-3-one|17beta-Hydroxyandrostan-3-one|DHT|Androstanolone|5alpha-Dihydrotestosterone - DRUGBANK DB02901 C19H30O2 small molecule A14AA01|G03BB02 521-18-6 DRUGBANK 20107 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Askew EB (2007) 17591767 182022 2781 Dihydrotestosterone 17beta-Hydroxy-5alpha-androstane-3-one|Dihydrotestosteron|Dihydrotestostrone|Stanolone|17beta-Hydroxy-5alpha-androstan-3-one|4-Dihydrotestosterone|17-hydroxy-3-oxo-5-androstanone|5-DHT|17-hydroxy-5-androstan-3-one|17beta-Hydroxyandrostan-3-one|DHT|Androstanolone|5alpha-Dihydrotestosterone - DRUGBANK DB02901 C19H30O2 small molecule A14AA01|G03BB02 521-18-6 DRUGBANK 26512 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7242 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL - - DRUGBANK DB08461 C16H19N5O small molecule - - DRUGBANK 16781 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Friedel A (2006) 16621347 181446 1427 Delta1-dihydrotestosterone 1-testosterone|1-Testo|1-T|17beta-hydroxy-5alpha-androst-1-en-3-one - DRUGBANK DB01481 C19H28O2 small molecule - 65-06-5 DRUGBANK 16782 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1427 Delta1-dihydrotestosterone 1-testosterone|1-Testo|1-T|17beta-hydroxy-5alpha-androst-1-en-3-one - DRUGBANK DB01481 C19H28O2 small molecule - 65-06-5 DRUGBANK 16783 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1427 Delta1-dihydrotestosterone 1-testosterone|1-Testo|1-T|17beta-hydroxy-5alpha-androst-1-en-3-one - DRUGBANK DB01481 C19H28O2 small molecule - 65-06-5 DRUGBANK 23830 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4513 (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE - - DRUGBANK DB04709 C20H18N2O4 small molecule - - DRUGBANK 25298 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6102 2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE - - DRUGBANK DB07286 C14H12ClN3O3 small molecule - - DRUGBANK 9138 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9139 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Brawer MK (2006) 16986000 177645 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9140 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Schasfoort EM (2002) 12497048 177644 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9141 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Moguilewsky M (1987) 3320565 177647 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9142 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Kaisary AV (2002) 12497018 177646 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9143 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Raynaud JP (1984) 6374639 177643 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9144 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Raynaud JP (1988) 3071951 177642 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9145 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Labrie F (2010) 20541672 177649 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 9146 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Kolvenbag GJ (1998) 12496872 177648 655 Nilutamide Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida anandron - tab 100mg|anandron DRUGBANK DB00665 C12H10F3N3O4 small molecule L02BB02 63612-50-0 DRUGBANK 16977 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Small EJ (2006) 17084172 177399 1504 Calusterone Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS - DRUGBANK DB01564 C21H32O2 small molecule - 17021-26-0 DRUGBANK 16978 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Omwancha J (2006) 17086931 177398 1504 Calusterone Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS - DRUGBANK DB01564 C21H32O2 small molecule - 17021-26-0 DRUGBANK 16979 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1504 Calusterone Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS - DRUGBANK DB01564 C21H32O2 small molecule - 17021-26-0 DRUGBANK 16980 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Lapauw B (2007) 17322500 177397 1504 Calusterone Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS - DRUGBANK DB01564 C21H32O2 small molecule - 17021-26-0 DRUGBANK 16981 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target McPhaul MJ (2001) 11511858 181510 1504 Calusterone Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS - DRUGBANK DB01564 C21H32O2 small molecule - 17021-26-0 DRUGBANK 16982 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Brodkin RA (1978) 152592 181511 1504 Calusterone Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS - DRUGBANK DB01564 C21H32O2 small molecule - 17021-26-0 DRUGBANK 18837 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 12913 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens binder target Eil C (1992) 1526623 179758 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 27891 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Gemzell-Danielsson K (2013) 23437846 196017 8104 Ulipristal - ella|fibristal DRUGBANK DB08867 C28H35NO3 small molecule G03XB02|G03AD02 159811-51-5 DRUGBANK 9502 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Matias PM (2002) 11906285 177823 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 9503 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Krishnan AV (2002) 11956172 177822 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 14560 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Smallridge RC (1984) 6439037 180519 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14561 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14562 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Fernandez L (1994) 8119180 180522 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14563 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Kasperk CH (1989) 2521824 180523 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14564 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Kemppainen JA (1999) 10077001 180520 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14565 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Miner JN (2007) 17023534 180521 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 20156 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2810 (2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide - - DRUGBANK DB02932 C18H14F4N2O4S small molecule - - DRUGBANK 20257 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2874 Methyltrienolone Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one - DRUGBANK DB02998 C19H24O2 small molecule - 965-93-5 DRUGBANK 26056 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6828 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE - - DRUGBANK DB08035 C18H23N5 small molecule - - DRUGBANK 16620 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Yin D (2003) 12604714 181385 1368 Testosterone Propionate Testex malogen in oil liq 100mg/ml|te DRUGBANK DB01420 C22H32O3 small molecule - 57-85-2 DRUGBANK 16621 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Small EJ (2006) 17084172 177399 1368 Testosterone Propionate Testex malogen in oil liq 100mg/ml|te DRUGBANK DB01420 C22H32O3 small molecule - 57-85-2 DRUGBANK 16622 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Omwancha J (2006) 17086931 177398 1368 Testosterone Propionate Testex malogen in oil liq 100mg/ml|te DRUGBANK DB01420 C22H32O3 small molecule - 57-85-2 DRUGBANK 16623 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Petraki CD (2007) 17128417 177401 1368 Testosterone Propionate Testex malogen in oil liq 100mg/ml|te DRUGBANK DB01420 C22H32O3 small molecule - 57-85-2 DRUGBANK 16624 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Maudsley S (2007) 17202804 177400 1368 Testosterone Propionate Testex malogen in oil liq 100mg/ml|te DRUGBANK DB01420 C22H32O3 small molecule - 57-85-2 DRUGBANK 16625 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Lapauw B (2007) 17322500 177397 1368 Testosterone Propionate Testex malogen in oil liq 100mg/ml|te DRUGBANK DB01420 C22H32O3 small molecule - 57-85-2 DRUGBANK 8703 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Bi LX (2007) 17364004 177384 611 Oxandrolone Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar oxandrolone DRUGBANK DB00621 C19H30O3 small molecule A14AA08 53-39-4 DRUGBANK 8704 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Cadwallader AB (2010) 20230007 177385 611 Oxandrolone Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar oxandrolone DRUGBANK DB00621 C19H30O3 small molecule A14AA08 53-39-4 DRUGBANK 8705 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Juul A (2001) 11392377 177386 611 Oxandrolone Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar oxandrolone DRUGBANK DB00621 C19H30O3 small molecule A14AA08 53-39-4 DRUGBANK 8706 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 611 Oxandrolone Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar oxandrolone DRUGBANK DB00621 C19H30O3 small molecule A14AA08 53-39-4 DRUGBANK 8707 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Zhao J (2004) 15219414 177383 611 Oxandrolone Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar oxandrolone DRUGBANK DB00621 C19H30O3 small molecule A14AA08 53-39-4 DRUGBANK 8736 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Small EJ (2006) 17084172 177399 614 Testosterone Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F taro-testosterone|testosterone DRUGBANK DB00624 C19H28O2 small molecule G03BA03|G03EA02 58-22-0 DRUGBANK 8737 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Omwancha J (2006) 17086931 177398 614 Testosterone Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F taro-testosterone|testosterone DRUGBANK DB00624 C19H28O2 small molecule G03BA03|G03EA02 58-22-0 DRUGBANK 8738 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 614 Testosterone Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F taro-testosterone|testosterone DRUGBANK DB00624 C19H28O2 small molecule G03BA03|G03EA02 58-22-0 DRUGBANK 8739 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Maudsley S (2007) 17202804 177400 614 Testosterone Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F taro-testosterone|testosterone DRUGBANK DB00624 C19H28O2 small molecule G03BA03|G03EA02 58-22-0 DRUGBANK 8740 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Lapauw B (2007) 17322500 177397 614 Testosterone Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F taro-testosterone|testosterone DRUGBANK DB00624 C19H28O2 small molecule G03BA03|G03EA02 58-22-0 DRUGBANK 8741 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Petraki CD (2007) 17128417 177401 614 Testosterone Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F taro-testosterone|testosterone DRUGBANK DB00624 C19H28O2 small molecule G03BA03|G03EA02 58-22-0 DRUGBANK 25723 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6520 (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE - - DRUGBANK DB07717 C27H36F2O3 small molecule - - DRUGBANK 25470 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6265 (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE - - DRUGBANK DB07454 C11H10BrF3N2O4 small molecule - - DRUGBANK 26118 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6882 6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE - - DRUGBANK DB08089 C14H9F9N2O small molecule - - DRUGBANK 16513 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Gomez F (2000) 10882672 181327 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16514 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Roselli CE (1998) 9593936 181326 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16515 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Donaldson VH (1989) 2486535 181325 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16516 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Sasagawa S (2008) 18061638 181323 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16517 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Dmowski WP (1990) 2404115 181318 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 26116 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6880 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE - - DRUGBANK DB08087 C17H13N3O3 small molecule - - DRUGBANK 26117 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6881 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile - - DRUGBANK DB08088 C15H13ClF3N3O2 small molecule - - DRUGBANK 26798 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Birgner C (2008) 18809391 182085 7575 Nandrolone decanoate Deca-durabolin|19-nortestosterone decanoate|Nandrolone 17-decanoate deca durabolin inj 100mg/ml|na DRUGBANK DB08804 C28H44O3 small molecule - 360-70-3 DRUGBANK 24733 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Small EJ (2006) 17084172 177399 5592 Methyltestosterone 17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android methitest|eemt hs|esterified e DRUGBANK DB06710 C20H30O2 small molecule G03EA01|G03BA02|G03EK01 58-18-4 DRUGBANK 24734 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Omwancha J (2006) 17086931 177398 5592 Methyltestosterone 17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android methitest|eemt hs|esterified e DRUGBANK DB06710 C20H30O2 small molecule G03EA01|G03BA02|G03EK01 58-18-4 DRUGBANK 24735 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 5592 Methyltestosterone 17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android methitest|eemt hs|esterified e DRUGBANK DB06710 C20H30O2 small molecule G03EA01|G03BA02|G03EK01 58-18-4 DRUGBANK 24736 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Maudsley S (2007) 17202804 177400 5592 Methyltestosterone 17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android methitest|eemt hs|esterified e DRUGBANK DB06710 C20H30O2 small molecule G03EA01|G03BA02|G03EK01 58-18-4 DRUGBANK 24737 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Lapauw B (2007) 17322500 177397 5592 Methyltestosterone 17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android methitest|eemt hs|esterified e DRUGBANK DB06710 C20H30O2 small molecule G03EA01|G03BA02|G03EK01 58-18-4 DRUGBANK 24738 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Petraki CD (2007) 17128417 177401 5592 Methyltestosterone 17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android methitest|eemt hs|esterified e DRUGBANK DB06710 C20H30O2 small molecule G03EA01|G03BA02|G03EK01 58-18-4 DRUGBANK 23958 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 4641 Cyproterone acetate Cyproterone 17-O-acetate androcur|novo-cyproterone|novo DRUGBANK DB04839 C24H29ClO4 small molecule G03HB01|G03HA01 427-51-0 DRUGBANK 23960 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 4641 Cyproterone acetate Cyproterone 17-O-acetate androcur|novo-cyproterone|novo DRUGBANK DB04839 C24H29ClO4 small molecule G03HB01|G03HA01 427-51-0 DRUGBANK 23962 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Sonneveld E (2005) 15483189 181867 4641 Cyproterone acetate Cyproterone 17-O-acetate androcur|novo-cyproterone|novo DRUGBANK DB04839 C24H29ClO4 small molecule G03HB01|G03HA01 427-51-0 DRUGBANK 23959 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Cabeza M (2004) 15579329 181875 4641 Cyproterone acetate Cyproterone 17-O-acetate androcur|novo-cyproterone|novo DRUGBANK DB04839 C24H29ClO4 small molecule G03HB01|G03HA01 427-51-0 DRUGBANK 23961 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Agoulnik IU (2009) 19463689 182108 4641 Cyproterone acetate Cyproterone 17-O-acetate androcur|novo-cyproterone|novo DRUGBANK DB04839 C24H29ClO4 small molecule G03HB01|G03HA01 427-51-0 DRUGBANK 11208 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Takahashi M (2004) 15351799 178730 848 Drostanolone Drostanolonum|Medrotestron|Metholone|2alpha-Methyldihydrotestosterone|Dihydro-2alpha-methyltestosterone|Medrosteron|Drostanolona|Dromostanolone|Drostanolone|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one - DRUGBANK DB00858 C20H32O2 small molecule - 58-19-5 DRUGBANK 11209 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Zakar T (1986) 3758193 178731 848 Drostanolone Drostanolonum|Medrotestron|Metholone|2alpha-Methyldihydrotestosterone|Dihydro-2alpha-methyltestosterone|Medrosteron|Drostanolona|Dromostanolone|Drostanolone|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one - DRUGBANK DB00858 C20H32O2 small molecule - 58-19-5 DRUGBANK 11210 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 848 Drostanolone Drostanolonum|Medrotestron|Metholone|2alpha-Methyldihydrotestosterone|Dihydro-2alpha-methyltestosterone|Medrosteron|Drostanolona|Dromostanolone|Drostanolone|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one - DRUGBANK DB00858 C20H32O2 small molecule - 58-19-5 DRUGBANK 24899 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5690 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE - - DRUGBANK DB06870 C21H28O2 small molecule - - DRUGBANK 25051 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5857 (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide - - DRUGBANK DB07039 C18H14IN3O3 small molecule - - DRUGBANK 14018 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1116 Bicalutamide Casodex casodex tab 50mg|ag-bicalutami DRUGBANK DB01128 C18H14F4N2O4S small molecule L02BB03 90357-06-5 DRUGBANK 14019 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Wang LG (1998) 10076535 180290 1116 Bicalutamide Casodex casodex tab 50mg|ag-bicalutami DRUGBANK DB01128 C18H14F4N2O4S small molecule L02BB03 90357-06-5 DRUGBANK 14020 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Bouchal J (2002) 11931851 180291 1116 Bicalutamide Casodex casodex tab 50mg|ag-bicalutami DRUGBANK DB01128 C18H14F4N2O4S small molecule L02BB03 90357-06-5 DRUGBANK 14021 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Hara T (2003) 12517791 180292 1116 Bicalutamide Casodex casodex tab 50mg|ag-bicalutami DRUGBANK DB01128 C18H14F4N2O4S small molecule L02BB03 90357-06-5 DRUGBANK 14022 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Laufer M (1999) 10754148 180293 1116 Bicalutamide Casodex casodex tab 50mg|ag-bicalutami DRUGBANK DB01128 C18H14F4N2O4S small molecule L02BB03 90357-06-5 DRUGBANK 14023 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Chang HC (1999) 10500149 176508 1116 Bicalutamide Casodex casodex tab 50mg|ag-bicalutami DRUGBANK DB01128 C18H14F4N2O4S small molecule L02BB03 90357-06-5 DRUGBANK 6798 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens antagonist target Ye P (2009) 18819053 175957 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 25442 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6235 (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide - - DRUGBANK DB07422 C17H10F8N2O5 small molecule - - DRUGBANK 25441 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6234 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile - - DRUGBANK DB07421 C18H16F3N3O5 small molecule - - DRUGBANK 25443 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6236 (2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide - - DRUGBANK DB07423 C19H18F3N3O6 small molecule - - DRUGBANK 6029 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Kloosterboer HJ (1988) 3139361 175069 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6030 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Freyberger A (2010) 19833195 175550 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6031 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Freyberger A (2010) 19836445 175548 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6032 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens agonist target Shields-Botella J (2003) 14672731 175549 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 25440 106862 367 RP11-383C12.1 AR AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6232 (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide - - DRUGBANK DB07419 C18H13ClF4N2O3 small molecule - - DRUGBANK 3678 106864 369 RP1-230G1.1 ARAF A-RAF|ARAF1|PKS2|RAFA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3679 106864 369 RP1-230G1.1 ARAF A-RAF|ARAF1|PKS2|RAFA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 19897 106870 375 - ARF1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2658 1,3-Propandiol - - DRUGBANK DB02774 C3H8O2 small molecule - - DRUGBANK 19898 106870 375 - ARF1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2658 1,3-Propandiol - - DRUGBANK DB02774 C3H8O2 small molecule - - DRUGBANK 19899 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2658 1,3-Propandiol - - DRUGBANK DB02774 C3H8O2 small molecule - - DRUGBANK 22603 106870 375 - ARF1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3953 Guanosine-3'-Monophosphate-5'-Diphosphate - - DRUGBANK DB04121 C10H16N5O14P3 small molecule - - DRUGBANK 22604 106870 375 - ARF1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3953 Guanosine-3'-Monophosphate-5'-Diphosphate - - DRUGBANK DB04121 C10H16N5O14P3 small molecule - - DRUGBANK 22605 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3953 Guanosine-3'-Monophosphate-5'-Diphosphate - - DRUGBANK DB04121 C10H16N5O14P3 small molecule - - DRUGBANK 22480 106870 375 - ARF1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22481 106870 375 - ARF1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22482 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 23105 106870 375 - ARF1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23106 106870 375 - ARF1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23107 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 26249 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 25354 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6164 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE - - DRUGBANK DB07348 C16H24O4 small molecule - - DRUGBANK 22658 106870 375 - ARF1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22659 106870 375 - ARF1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22660 106870 375 - ARF1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 26256 106877 382 - ARF6 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 23047 106877 382 - ARF6 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23048 106877 382 - ARF6 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23049 106877 382 - ARF6 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 17968 106877 382 - ARF6 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 17969 106877 382 - ARF6 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 17970 106877 382 - ARF6 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 19346 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2396 Dinor-N(Omega)-Hydroxy-L-Arginine - - DRUGBANK DB02499 C4H10N4O3 small molecule - - DRUGBANK 19347 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2396 Dinor-N(Omega)-Hydroxy-L-Arginine - - DRUGBANK DB02499 C4H10N4O3 small molecule - - DRUGBANK 19348 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2396 Dinor-N(Omega)-Hydroxy-L-Arginine - - DRUGBANK DB02499 C4H10N4O3 small molecule - - DRUGBANK 2079 106878 383 - ARG1 - 9606 Homo sapiens unknown target El Alami M (2003) 12679340 96036 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2080 106878 383 - ARG1 - 9606 Homo sapiens unknown target Gobert AP (2002) 11971019 172970 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2081 106878 383 - ARG1 - 9606 Homo sapiens unknown target Bansal V (2003) 12589193 172971 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2082 106878 383 - ARG1 - 9606 Homo sapiens unknown target Stickings P (2002) 12446178 172972 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2083 106878 383 - ARG1 - 9606 Homo sapiens unknown target Iwata S (2002) 12135320 172973 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 19703 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2578 S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine - - DRUGBANK DB02689 C5H14N2O4S2 small molecule - - DRUGBANK 19704 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2578 S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine - - DRUGBANK DB02689 C5H14N2O4S2 small molecule - - DRUGBANK 19705 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2578 S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine - - DRUGBANK DB02689 C5H14N2O4S2 small molecule - - DRUGBANK 20578 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20579 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20580 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 21814 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3574 S-2-(Boronoethyl)-L-Cysteine - - DRUGBANK DB03731 C5H13BNO5S small molecule - - DRUGBANK 21815 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3574 S-2-(Boronoethyl)-L-Cysteine - - DRUGBANK DB03731 C5H13BNO5S small molecule - - DRUGBANK 21816 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3574 S-2-(Boronoethyl)-L-Cysteine - - DRUGBANK DB03731 C5H13BNO5S small molecule - - DRUGBANK 23754 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4395 DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID - - DRUGBANK DB04585 C6H13BNO5 small molecule - - DRUGBANK 19116 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2286 Nor-N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB02381 C5H12N4O3 small molecule - - DRUGBANK 19117 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2286 Nor-N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB02381 C5H12N4O3 small molecule - - DRUGBANK 19118 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2286 Nor-N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB02381 C5H12N4O3 small molecule - - DRUGBANK 22159 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 22160 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 22161 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 23795 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4453 S-propylamine-L-cysteine BPE - DRUGBANK DB04648 C6H16N2OS small molecule - - DRUGBANK 22793 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4025 Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine - - DRUGBANK DB04197 C4H13N4O small molecule - - DRUGBANK 22794 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4025 Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine - - DRUGBANK DB04197 C4H13N4O small molecule - - DRUGBANK 22795 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4025 Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine - - DRUGBANK DB04197 C4H13N4O small molecule - - DRUGBANK 18236 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1907 2(S)-Amino-6-Boronohexanoic Acid - - DRUGBANK DB01983 C6H15BNO5 small molecule - - DRUGBANK 18237 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1907 2(S)-Amino-6-Boronohexanoic Acid - - DRUGBANK DB01983 C6H15BNO5 small molecule - - DRUGBANK 18238 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1907 2(S)-Amino-6-Boronohexanoic Acid - - DRUGBANK DB01983 C6H15BNO5 small molecule - - DRUGBANK 23650 106878 383 - ARG1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23651 106878 383 - ARG1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23652 106878 383 - ARG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 21812 106879 384 - ARG2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3574 S-2-(Boronoethyl)-L-Cysteine - - DRUGBANK DB03731 C5H13BNO5S small molecule - - DRUGBANK 21813 106879 384 - ARG2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3574 S-2-(Boronoethyl)-L-Cysteine - - DRUGBANK DB03731 C5H13BNO5S small molecule - - DRUGBANK 2064 106879 384 - ARG2 - 9606 Homo sapiens unknown target Bussiere FI (2005) 15548540 172963 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2065 106879 384 - ARG2 - 9606 Homo sapiens unknown target Levillain O (2005) 15539552 172967 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2066 106879 384 - ARG2 - 9606 Homo sapiens unknown target Nissim I (2005) 15753084 172966 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2067 106879 384 - ARG2 - 9606 Homo sapiens unknown target Rodriguez PC (2003) 12874210 172965 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2068 106879 384 - ARG2 - 9606 Homo sapiens unknown target Levillain O (2004) 14871882 172964 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 1875 106879 384 - ARG2 - 9606 Homo sapiens unknown target Topal G (2006) 16801455 172849 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1876 106879 384 - ARG2 - 9606 Homo sapiens unknown target Hood HM (2007) 16979358 71274 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 23108 106880 387 - RHOA ARH12|ARHA|RHO12|RHOH12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23109 106880 387 - RHOA ARH12|ARHA|RHO12|RHOH12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23110 106880 387 - RHOA ARH12|ARHA|RHO12|RHOH12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 1067 106881 388 - RHOB ARH6|ARHB|MST081|MSTP081|RHOH6 9606 Homo sapiens unknown target Ishida H (2004) 15140914 172259 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 22628 106883 390 - RND3 ARHE|Rho8|RhoE|memB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22629 106883 390 - RND3 ARHE|Rho8|RhoE|memB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22630 106883 390 - RND3 ARHE|Rho8|RhoE|memB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 23059 106893 400 - ARL1 ARFL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23054 106896 403 RP11-47A8.3 ARL3 ARFL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 22022 106896 403 RP11-47A8.3 ARL3 ARFL3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 17804 106903 410 - ARSA MLD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1731 N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium - - DRUGBANK DB01800 C6H5NO7S small molecule - - DRUGBANK 19819 106905 412 - STS ARSC|ARSC1|ASC|ES|SSDD|XLI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2623 2-Amino-3-Oxo-4-Sulfo-Butyric Acid - - DRUGBANK DB02735 C3H5NO7S small molecule - - DRUGBANK 19820 106905 412 - STS ARSC|ARSC1|ASC|ES|SSDD|XLI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2623 2-Amino-3-Oxo-4-Sulfo-Butyric Acid - - DRUGBANK DB02735 C3H5NO7S small molecule - - DRUGBANK 17934 106910 417 - ART1 ART2|ARTC1|CD296|RT6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1784 5-Bromonicotinamide - - DRUGBANK DB01854 C6H5BrN2O small molecule - 28733-43-9 DRUGBANK 17935 106910 417 - ART1 ART2|ARTC1|CD296|RT6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1784 5-Bromonicotinamide - - DRUGBANK DB01854 C6H5BrN2O small molecule - 28733-43-9 DRUGBANK 17936 106910 417 - ART1 ART2|ARTC1|CD296|RT6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1784 5-Bromonicotinamide - - DRUGBANK DB01854 C6H5BrN2O small molecule - 28733-43-9 DRUGBANK 283 106925 433 - ASGR2 ASGP-R2|ASGPR2|CLEC4H2|HBXBP|HL-2 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 284 106925 433 - ASGR2 ASGP-R2|ASGPR2|CLEC4H2|HBXBP|HL-2 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 285 106925 433 - ASGR2 ASGP-R2|ASGPR2|CLEC4H2|HBXBP|HL-2 9606 Homo sapiens binder target Bovenschen N (2005) 15946216 171874 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 1882 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Bizzoco E (2007) 17198704 172857 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1883 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Mages W (2007) 17611150 172856 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1884 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Tischner R (2007) 17651442 172855 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1885 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Mori M (2007) 17513437 172854 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1886 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Moradi H (2006) 16809898 172852 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 18843 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2176 Argininosuccinate - - DRUGBANK DB02267 C10H18N4O6 small molecule - - DRUGBANK 18844 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2176 Argininosuccinate - - DRUGBANK DB02267 C10H18N4O6 small molecule - - DRUGBANK 18845 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2176 Argininosuccinate - - DRUGBANK DB02267 C10H18N4O6 small molecule - - DRUGBANK 22014 106927 435 - ASL ASAL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 13394 106930 438 RP13-297E16.2 ASMT ASMTY|HIOMT|HIOMTY 9606 Homo sapiens unknown target Minneman KP (1976) 180879 179961 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 3742 106931 439 - ASNA1 ARSA-I|ARSA1|ASNA-I|GET3|TRC40|hASNA-I 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3743 106931 439 - ASNA1 ARSA-I|ARSA1|ASNA-I|GET3|TRC40|hASNA-I 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3684 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3685 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 1974 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1975 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 3831 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Chaffei C (2004) 15574844 174064 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3833 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Fresquet V (2004) 14990305 174062 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3832 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Iwamoto S (2007) 17380207 174061 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3830 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Al Sarraj J (2005) 16164412 172990 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3834 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Tesson AR (2003) 12706338 174063 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 2342 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2343 106932 440 - ASNS ASNSD|TS11 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 1987 106935 443 - ASPA ACY2|ASP 9606 Homo sapiens unknown target Moffett JR (2007) 17275978 172927 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1988 106935 443 - ASPA ACY2|ASP 9606 Homo sapiens unknown target Srikanth SG (2007) 17219235 172926 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1989 106935 443 - ASPA ACY2|ASP 9606 Homo sapiens unknown target Wang J (2007) 17254025 172925 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1990 106935 443 - ASPA ACY2|ASP 9606 Homo sapiens unknown target Bitto E (2007) 17194761 172924 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1991 106935 443 - ASPA ACY2|ASP 9606 Homo sapiens unknown target Janson CG (2006) 17177147 172928 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2261 106936 444 - ASPH AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2262 106936 444 - ASPH AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2012 106936 444 - ASPH AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2013 106936 444 - ASPH AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin 9606 Homo sapiens unknown target Iijima T (1977) 403177 172939 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2014 106936 444 - ASPH AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2015 106936 444 - ASPH AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin 9606 Homo sapiens unknown target Whiteman P (1980) 6785382 172940 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 3753 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3754 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 2021 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2022 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Ben-Yoseph Y (1989) 2791302 172943 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2023 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2024 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Shen LJ (2005) 15588718 172945 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2025 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Flam BR (2007) 17869551 172944 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1878 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Cheng PN (2007) 17210712 172853 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1879 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Moradi H (2006) 16809898 172852 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1880 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Feun L (2006) 16787144 172851 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1881 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Szlosarek PW (2007) 17354225 172850 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 2968 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Braissant O (1999) 10407171 173612 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2955 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Takahashi H (2006) 16449956 173600 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2971 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Keilhoff G (2000) 10944418 173610 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2972 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Zhang B (2000) 11067741 173611 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2969 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Zhang WY (2000) 11072090 173609 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2970 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Braissant O (1999) 10353334 173608 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2952 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Hammermann R (1998) 9879717 173597 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2951 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Van Geldre LA (2002) 12445581 173601 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2953 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Husson A (2003) 12709047 173599 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2954 106937 445 RP11-618A20.2 ASS1 ASS|CTLN1 9606 Homo sapiens unknown target Zandvliet MM (2007) 17427379 173598 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 15081 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Peng K (2005) 16207425 180715 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 15082 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Lee S (2007) 17489664 180717 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 15083 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Bisio A (2009) 19888521 180716 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 13845 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Sun W (2007) 17600786 180206 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13846 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Pappalardo F (2006) 17201083 180205 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13847 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Petitou M (1999) 10201371 180204 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13848 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Schedin-Weiss S (2010) 20816747 180203 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13849 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Chuang YJ (2001) 11278930 180202 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13850 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Gettins PG (2009) 19818773 180201 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13851 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Mirow N (2007) 17537059 180200 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13852 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 8105 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Donat F (2002) 12383039 176937 559 Fondaparinux sodium Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt fondaparinux sodium injection| DRUGBANK DB00569 C31H45N3Na10O49S8 small molecule - 114870-03-0 DRUGBANK 8106 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Cheng JW (2002) 12501872 176938 559 Fondaparinux sodium Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt fondaparinux sodium injection| DRUGBANK DB00569 C31H45N3Na10O49S8 small molecule - 114870-03-0 DRUGBANK 8107 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Dager WE (2004) 15317404 176939 559 Fondaparinux sodium Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt fondaparinux sodium injection| DRUGBANK DB00569 C31H45N3Na10O49S8 small molecule - 114870-03-0 DRUGBANK 8108 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Paolucci F (2002) 12383040 176940 559 Fondaparinux sodium Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt fondaparinux sodium injection| DRUGBANK DB00569 C31H45N3Na10O49S8 small molecule - 114870-03-0 DRUGBANK 24828 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Rey E (2000) 11044537 181763 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 24829 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Frydman A (1996) 8707165 181705 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 24532 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Cosmi B (2003) 12818259 181821 5541 Sulodexide - - DRUGBANK DB06271 - biologic B01AB11 57821-29-1 DRUGBANK 24533 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 5541 Sulodexide - - DRUGBANK DB06271 - biologic B01AB11 57821-29-1 DRUGBANK 24534 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Harenberg J (1998) 9436179 181724 5541 Sulodexide - - DRUGBANK DB06271 - biologic B01AB11 57821-29-1 DRUGBANK 23494 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 26842 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Frydman A (1996) 8707165 181705 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 26843 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Davis R (1997) 9108990 181715 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 6593 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Mousa SA (2002) 12397367 175874 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 6594 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Shaughnessy SG (1995) 7632944 175872 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 6595 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Lin P (2001) 11287128 175873 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 24845 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Florian-Kujawski M (2004) 15767980 181886 5647 Tinzaparin Tinzaparin sodium innohep multi-dose vial- 10000 DRUGBANK DB06822 - small molecule B01AB10 9041-08-1 DRUGBANK 24846 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Morris TA (2004) 15567452 181874 5647 Tinzaparin Tinzaparin sodium innohep multi-dose vial- 10000 DRUGBANK DB06822 - small molecule B01AB10 9041-08-1 DRUGBANK 24847 106953 462 PRO0309 SERPINC1 AT3|AT3D|ATIII|THPH7 9606 Homo sapiens potentiator target Bisio A (2009) 19888521 180716 5647 Tinzaparin Tinzaparin sodium innohep multi-dose vial- 10000 DRUGBANK DB06822 - small molecule B01AB10 9041-08-1 DRUGBANK 11177 106956 466 - ATF1 EWS-ATF1|FUS/ATF-1|TREB36 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11170 106957 467 RP11-338C15.1 ATF3 - 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11172 106958 468 - ATF4 CREB-2|CREB2|TAXREB67|TXREB 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 8947 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens inhibitor target Racanelli AC (2009) 19549896 177531 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8948 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens inhibitor target Hanauske AR (2001) 11524555 177528 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8949 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens inhibitor target Kindler HL (2002) 12571811 177522 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 17591 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1635 Aicar - - DRUGBANK DB01700 C9H15N4O8P small molecule - 3031-94-5 DRUGBANK 17592 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1635 Aicar - - DRUGBANK DB01700 C9H15N4O8P small molecule - 3031-94-5 DRUGBANK 17593 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1635 Aicar - - DRUGBANK DB01700 C9H15N4O8P small molecule - 3031-94-5 DRUGBANK 22442 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3889 Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor - - DRUGBANK DB04057 C32H34N9O15P small molecule - - DRUGBANK 22443 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3889 Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor - - DRUGBANK DB04057 C32H34N9O15P small molecule - - DRUGBANK 22444 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3889 Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor - - DRUGBANK DB04057 C32H34N9O15P small molecule - - DRUGBANK 21238 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3298 2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid - - DRUGBANK DB03442 C18H16N4O9S2 small molecule - - DRUGBANK 21239 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3298 2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid - - DRUGBANK DB03442 C18H16N4O9S2 small molecule - - DRUGBANK 21240 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3298 2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid - - DRUGBANK DB03442 C18H16N4O9S2 small molecule - - DRUGBANK 1665 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens cofactor target Wolan DW (2003) 12974624 172642 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1666 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens cofactor target Bulock KG (2002) 11948179 172641 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 18217 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18218 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18219 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18907 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2216 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine - - DRUGBANK DB02309 C10H14N4O9P small molecule - - DRUGBANK 18908 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2216 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine - - DRUGBANK DB02309 C10H14N4O9P small molecule - - DRUGBANK 18909 106961 471 OK/SW-cl.86 ATIC AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2216 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine - - DRUGBANK DB02309 C10H14N4O9P small molecule - - DRUGBANK 4261 106962 472 - ATM AT1|ATA|ATC|ATD|ATDC|ATE|TEL1|TELO1 9606 Homo sapiens unknown target Blasina A (1999) 10531013 174349 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4262 106962 472 - ATM AT1|ATA|ATC|ATD|ATDC|ATE|TEL1|TELO1 9606 Homo sapiens unknown target Sarkaria JN (1999) 10485486 174348 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 20545 106965 475 - ATOX1 ATX1|HAH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20546 106965 475 - ATOX1 ATX1|HAH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20547 106965 475 - ATOX1 ATX1|HAH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 14613 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Niewerth M (2003) 12760852 60390 1176 Ciclopirox Ciclopiroxum|6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone ciclodan|taro-ciclopirox|lopro DRUGBANK DB01188 C12H17NO2 small molecule G01AX12|D01AE14 29342-05-0 DRUGBANK 11563 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Valdes RM (2003) 12680902 178959 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 11564 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Ronquist G (1975) 124205 178961 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 11565 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Schurek HJ (1975) 127690 178960 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 11566 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Kiil F (2003) 12713517 178963 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 11567 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Proverbio F (1975) 124600 178962 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 14313 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Helms JB (2004) 15121098 180403 1146 Bretylium 2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium bretylium tosylate 0.2% and de DRUGBANK DB01158 C11H17BrN small molecule - 59-41-6 DRUGBANK 14314 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Dzimiri N (1992) 1334399 180402 1146 Bretylium 2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium bretylium tosylate 0.2% and de DRUGBANK DB01158 C11H17BrN small molecule - 59-41-6 DRUGBANK 14315 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Dzimiri N (1991) 1662173 180405 1146 Bretylium 2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium bretylium tosylate 0.2% and de DRUGBANK DB01158 C11H17BrN small molecule - 59-41-6 DRUGBANK 14316 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Tiku PE (1991) 1667290 180404 1146 Bretylium 2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium bretylium tosylate 0.2% and de DRUGBANK DB01158 C11H17BrN small molecule - 59-41-6 DRUGBANK 15329 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Smith SJ (1990) 2207500 180817 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15330 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Kovacic H (1992) 1329768 180820 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15331 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Lamers JM (1985) 2933041 179746 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15332 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Raess BU (1990) 2148481 180818 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15333 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Fuchs J (1986) 2938592 180819 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 13672 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Almotrefi AA (1999) 10593659 180096 1080 Ouabain Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous - DRUGBANK DB01092 C29H44O12 small molecule C01AC01 630-60-4 DRUGBANK 13673 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Mentre P (1999) 10541475 180097 1080 Ouabain Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous - DRUGBANK DB01092 C29H44O12 small molecule C01AC01 630-60-4 DRUGBANK 13674 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Tao QF (1999) 10567200 180094 1080 Ouabain Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous - DRUGBANK DB01092 C29H44O12 small molecule C01AC01 630-60-4 DRUGBANK 13675 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Qazzaz HM (1999) 10564763 180095 1080 Ouabain Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous - DRUGBANK DB01092 C29H44O12 small molecule C01AC01 630-60-4 DRUGBANK 13676 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1080 Ouabain Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous - DRUGBANK DB01092 C29H44O12 small molecule C01AC01 630-60-4 DRUGBANK 13677 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Hawke TJ (1999) 10593655 180098 1080 Ouabain Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous - DRUGBANK DB01092 C29H44O12 small molecule C01AC01 630-60-4 DRUGBANK 16252 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Sirijovski N (2006) 16928192 181226 1335 Magnesium - mnps formula supplement|calciu DRUGBANK DB01378 Mg small molecule - 7439-95-4 DRUGBANK 16253 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Nogovitsina OR (2007) 17294093 181227 1335 Magnesium - mnps formula supplement|calciu DRUGBANK DB01378 Mg small molecule - 7439-95-4 DRUGBANK 16254 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Balasubramaniyan V (2006) 16990961 181224 1335 Magnesium - mnps formula supplement|calciu DRUGBANK DB01378 Mg small molecule - 7439-95-4 DRUGBANK 16255 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Buchachenko AL (2006) 16808357 181225 1335 Magnesium - mnps formula supplement|calciu DRUGBANK DB01378 Mg small molecule - 7439-95-4 DRUGBANK 15926 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Simon WA (2007) 17369284 181132 1310 Potassium K|UN2257|UN1420|Kalium|Potassium alloy complexed potassium tablets - DRUGBANK DB01345 - small molecule C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04 7440-09-7 DRUGBANK 15927 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Li C (2007) 17347782 181129 1310 Potassium K|UN2257|UN1420|Kalium|Potassium alloy complexed potassium tablets - DRUGBANK DB01345 - small molecule C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04 7440-09-7 DRUGBANK 15928 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Silva E (2007) 17334838 181133 1310 Potassium K|UN2257|UN1420|Kalium|Potassium alloy complexed potassium tablets - DRUGBANK DB01345 - small molecule C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04 7440-09-7 DRUGBANK 15929 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Iannello S (2007) 17444965 181130 1310 Potassium K|UN2257|UN1420|Kalium|Potassium alloy complexed potassium tablets - DRUGBANK DB01345 - small molecule C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04 7440-09-7 DRUGBANK 15930 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Stanely Mainzen Prince P (2007) 17366541 181131 1310 Potassium K|UN2257|UN1420|Kalium|Potassium alloy complexed potassium tablets - DRUGBANK DB01345 - small molecule C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04 7440-09-7 DRUGBANK 16211 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16212 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Kohila T (2004) 15254985 181198 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16213 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Kohila T (2004) 15651920 181199 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16214 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Amador FC (2001) 15111247 181195 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16215 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Silva VS (2003) 14507470 181196 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16216 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Menz RI (2001) 11509182 181197 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 10317 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10318 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 13535 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Zhao YN (2005) 16319518 180016 1066 Deslanoside (3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide|Desacetyllanatoside C|Deslanosido|Deacetyllanatoside C|Deslanosidum|3-[(O-beta-D-Glucopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3beta,5beta,12beta-card-20(22)-enolide|Glucodigoxin - DRUGBANK DB01078 C47H74O19 small molecule C01AA07 17598-65-1 DRUGBANK 13536 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1066 Deslanoside (3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide|Desacetyllanatoside C|Deslanosido|Deacetyllanatoside C|Deslanosidum|3-[(O-beta-D-Glucopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3beta,5beta,12beta-card-20(22)-enolide|Glucodigoxin - DRUGBANK DB01078 C47H74O19 small molecule C01AA07 17598-65-1 DRUGBANK 13949 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Lawrence CL (2002) 12086984 174490 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13950 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Comelli M (2007) 17287451 180251 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13951 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Guo W (2007) 17281115 180252 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 6386 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Ravikumar A (2000) 11272406 175739 382 Digoxin 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum novo-digoxin tab 0.25mg|apo-di DRUGBANK DB00390 C41H64O14 small molecule C01AA05 20830-75-5 DRUGBANK 6387 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Chen JJ (2001) 11309248 175738 382 Digoxin 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum novo-digoxin tab 0.25mg|apo-di DRUGBANK DB00390 C41H64O14 small molecule C01AA05 20830-75-5 DRUGBANK 6388 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Aizman O (2001) 11687608 175737 382 Digoxin 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum novo-digoxin tab 0.25mg|apo-di DRUGBANK DB00390 C41H64O14 small molecule C01AA05 20830-75-5 DRUGBANK 6389 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Kumar AR (2001) 11515751 175740 382 Digoxin 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum novo-digoxin tab 0.25mg|apo-di DRUGBANK DB00390 C41H64O14 small molecule C01AA05 20830-75-5 DRUGBANK 6390 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens unknown target Ke YS (2000) 11324464 175741 382 Digoxin 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum novo-digoxin tab 0.25mg|apo-di DRUGBANK DB00390 C41H64O14 small molecule C01AA05 20830-75-5 DRUGBANK 16408 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Fricke U (1976) 136410 181287 1346 Digitoxin Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin digitaline welcker tab 0.1mg DRUGBANK DB01396 C41H64O13 small molecule C01AA04 71-63-6 DRUGBANK 16404 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Prignitz R (1976) 131389 181288 1346 Digitoxin Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin digitaline welcker tab 0.1mg DRUGBANK DB01396 C41H64O13 small molecule C01AA04 71-63-6 DRUGBANK 16405 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Hauck C (2009) 19751721 181289 1346 Digitoxin Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin digitaline welcker tab 0.1mg DRUGBANK DB01396 C41H64O13 small molecule C01AA04 71-63-6 DRUGBANK 16406 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Marcus FI (1975) 123547 181286 1346 Digitoxin Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin digitaline welcker tab 0.1mg DRUGBANK DB01396 C41H64O13 small molecule C01AA04 71-63-6 DRUGBANK 16407 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Bluschke V (1976) 132355 181290 1346 Digitoxin Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin digitaline welcker tab 0.1mg DRUGBANK DB01396 C41H64O13 small molecule C01AA04 71-63-6 DRUGBANK 16403 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Chen JJ (2001) 11309248 175738 1346 Digitoxin Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin digitaline welcker tab 0.1mg DRUGBANK DB01396 C41H64O13 small molecule C01AA04 71-63-6 DRUGBANK 16651 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 1378 Almitrine 2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina - DRUGBANK DB01430 C26H29F2N7 small molecule R07AB07 27469-53-0 DRUGBANK 16652 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Rigoulet M (1990) 2144185 181409 1378 Almitrine 2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina - DRUGBANK DB01430 C26H29F2N7 small molecule R07AB07 27469-53-0 DRUGBANK 16653 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Rigoulet M (1990) 2165421 181406 1378 Almitrine 2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina - DRUGBANK DB01430 C26H29F2N7 small molecule R07AB07 27469-53-0 DRUGBANK 16654 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Benzi G (1993) 8099718 181407 1378 Almitrine 2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina - DRUGBANK DB01430 C26H29F2N7 small molecule R07AB07 27469-53-0 DRUGBANK 16655 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens binder target Rigoulet M (1989) 2527061 181408 1378 Almitrine 2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina - DRUGBANK DB01430 C26H29F2N7 small molecule R07AB07 27469-53-0 DRUGBANK 12839 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Takahashi N (1995) 7752578 179731 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 7614 106966 476 RP4-655J12.1 ATP1A1 - 9606 Homo sapiens inhibitor target Gonzalez-Garcia C (1987) 2826993 176566 501 Acetyldigitoxin Acetyl-digitoxin-alpha|alpha-Monoacetyldigitoxin|Acetildigitoxina|Desglucolanatoside A|Acetyldigitoxinum|Acetylgitaloxin|Acetylgitoxin|Digitoxin 3'''-acetate|Acetyldiginatin|alpha-Acetylgitaloxin|alpha-Acetyldigitoxin - DRUGBANK DB00511 C43H66O14 small molecule C01AA01 1111-39-3 DRUGBANK 8567 106976 486 - FXYD2 ATP1G1|HOMG2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8568 106976 486 - FXYD2 ATP1G1|HOMG2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 22183 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22184 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22185 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 23413 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23414 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23415 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23789 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4443 2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE - - DRUGBANK DB04638 C14H22O2 small molecule - - DRUGBANK 25611 106977 487 - ATP2A1 ATP2A|SERCA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6410 (6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE - - DRUGBANK DB07604 C20H20N2O3 small molecule - - DRUGBANK 9994 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 726 Esomeprazole (S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole esomeprazole magnesium|pms-eso DRUGBANK DB00736 C17H19N3O3S small molecule A02BC05|A02BD06|M01AE52 119141-88-7 DRUGBANK 9995 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Vachhani R (2009) 19210109 178106 726 Esomeprazole (S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole esomeprazole magnesium|pms-eso DRUGBANK DB00736 C17H19N3O3S small molecule A02BC05|A02BD06|M01AE52 119141-88-7 DRUGBANK 9996 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Saccar CL (2009) 19606942 178105 726 Esomeprazole (S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole esomeprazole magnesium|pms-eso DRUGBANK DB00736 C17H19N3O3S small molecule A02BC05|A02BD06|M01AE52 119141-88-7 DRUGBANK 9997 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target McKeage K (2008) 18627213 178104 726 Esomeprazole (S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole esomeprazole magnesium|pms-eso DRUGBANK DB00736 C17H19N3O3S small molecule A02BC05|A02BD06|M01AE52 119141-88-7 DRUGBANK 6998 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 440 Lansoprazole Ogastro|Lansoprazole|Lanzol|Prevacid|Lansoprazol|Lansoprazolum|Lanzul|Limpidex|Monolitum|AG 1749|Lanzopral|Bamalite|Opiren health mart lansoprazole|dg he DRUGBANK DB00448 C16H14F3N3O2S small molecule A02BD02|A02BD03|A02BD10|A02BD07|A02BD09|A02BC03|A02BC53 103577-45-3 DRUGBANK 6999 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Langtry HD (1997) 9279507 176141 440 Lansoprazole Ogastro|Lansoprazole|Lanzol|Prevacid|Lansoprazol|Lansoprazolum|Lanzul|Limpidex|Monolitum|AG 1749|Lanzopral|Bamalite|Opiren health mart lansoprazole|dg he DRUGBANK DB00448 C16H14F3N3O2S small molecule A02BD02|A02BD03|A02BD10|A02BD07|A02BD09|A02BC03|A02BC53 103577-45-3 DRUGBANK 7000 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Matheson AJ (2001) 11693467 176140 440 Lansoprazole Ogastro|Lansoprazole|Lanzol|Prevacid|Lansoprazol|Lansoprazolum|Lanzul|Limpidex|Monolitum|AG 1749|Lanzopral|Bamalite|Opiren health mart lansoprazole|dg he DRUGBANK DB00448 C16H14F3N3O2S small molecule A02BD02|A02BD03|A02BD10|A02BD07|A02BD09|A02BC03|A02BC53 103577-45-3 DRUGBANK 5760 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Kirchheiner J (2009) 18925391 175337 330 Omeprazole OMZ|OMEP|Prilosec|OMP dg health omeprazole|q-omepraz DRUGBANK DB00338 C17H19N3O3S small molecule A02BD01|A02BC01|A02BD05 73590-58-6 DRUGBANK 5761 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Tajima A (2008) 19120905 175336 330 Omeprazole OMZ|OMEP|Prilosec|OMP dg health omeprazole|q-omepraz DRUGBANK DB00338 C17H19N3O3S small molecule A02BD01|A02BC01|A02BD05 73590-58-6 DRUGBANK 5762 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 330 Omeprazole OMZ|OMEP|Prilosec|OMP dg health omeprazole|q-omepraz DRUGBANK DB00338 C17H19N3O3S small molecule A02BD01|A02BC01|A02BD05 73590-58-6 DRUGBANK 5763 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Shi S (2008) 18679668 175338 330 Omeprazole OMZ|OMEP|Prilosec|OMP dg health omeprazole|q-omepraz DRUGBANK DB00338 C17H19N3O3S small molecule A02BD01|A02BC01|A02BD05 73590-58-6 DRUGBANK 14024 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1117 Rabeprazole Rabeprazole|Clofezone rabeprazole|apo-rabeprazole|sa DRUGBANK DB01129 C18H21N3O3S small molecule A02BC04|A02BC54|M01AA05|M02AA03 117976-89-3 DRUGBANK 14025 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Carswell CI (2002) 11772142 180294 1117 Rabeprazole Rabeprazole|Clofezone rabeprazole|apo-rabeprazole|sa DRUGBANK DB01129 C18H21N3O3S small molecule A02BC04|A02BC54|M01AA05|M02AA03 117976-89-3 DRUGBANK 14026 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Langtry HD (1999) 10551440 180295 1117 Rabeprazole Rabeprazole|Clofezone rabeprazole|apo-rabeprazole|sa DRUGBANK DB01129 C18H21N3O3S small molecule A02BC04|A02BC54|M01AA05|M02AA03 117976-89-3 DRUGBANK 4346 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Moreira Dias L (2009) 19938880 174419 206 Pantoprazole Pantoprazolum|Pantoprazol pantoprazole sodium delayed-re DRUGBANK DB00213 C16H15F2N3O4S small molecule A02BD11|A02BD04|A02BC02 102625-70-7 DRUGBANK 4347 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Cheer SM (2002) 12487624 174418 206 Pantoprazole Pantoprazolum|Pantoprazol pantoprazole sodium delayed-re DRUGBANK DB00213 C16H15F2N3O4S small molecule A02BD11|A02BD04|A02BC02 102625-70-7 DRUGBANK 4348 106985 495 - ATP4A ATP6A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 206 Pantoprazole Pantoprazolum|Pantoprazol pantoprazole sodium delayed-re DRUGBANK DB00213 C16H15F2N3O4S small molecule A02BD11|A02BD04|A02BC02 102625-70-7 DRUGBANK 22826 106987 498 - ATP5A1 ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 26656 106987 498 - ATP5A1 ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7404 N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE - - DRUGBANK DB08629 C13H27N3 small molecule - - DRUGBANK 26445 106987 498 - ATP5A1 ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7183 PICEATANNOL - - DRUGBANK DB08399 C14H12O4 small molecule - - DRUGBANK 25402 106987 498 - ATP5A1 ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6200 1-ACETYL-2-CARBOXYPIPERIDINE - - DRUGBANK DB07384 C8H13NO3 small molecule - - DRUGBANK 25412 106987 498 - ATP5A1 ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6209 AUROVERTIN B - - DRUGBANK DB07394 C25H32O8 small molecule - - DRUGBANK 3365 106990 501 - ALDH7A1 ATQ1|EPD|PDE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3366 106990 501 - ALDH7A1 ATQ1|EPD|PDE 9606 Homo sapiens unknown target de La Fuente JL (1997) 9355735 173777 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3367 106990 501 - ALDH7A1 ATQ1|EPD|PDE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22825 106994 506 - ATP5B ATPMB|ATPSB|HEL-S-271 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 26655 106994 506 - ATP5B ATPMB|ATPSB|HEL-S-271 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7404 N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE - - DRUGBANK DB08629 C13H27N3 small molecule - - DRUGBANK 26444 106994 506 - ATP5B ATPMB|ATPSB|HEL-S-271 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7183 PICEATANNOL - - DRUGBANK DB08399 C14H12O4 small molecule - - DRUGBANK 25401 106994 506 - ATP5B ATPMB|ATPSB|HEL-S-271 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6200 1-ACETYL-2-CARBOXYPIPERIDINE - - DRUGBANK DB07384 C8H13NO3 small molecule - - DRUGBANK 25411 106994 506 - ATP5B ATPMB|ATPSB|HEL-S-271 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6209 AUROVERTIN B - - DRUGBANK DB07394 C25H32O8 small molecule - - DRUGBANK 22827 106997 509 RP11-401E9.1 ATP5C1 ATP5C|ATP5CL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 26657 106997 509 RP11-401E9.1 ATP5C1 ATP5C|ATP5CL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7404 N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE - - DRUGBANK DB08629 C13H27N3 small molecule - - DRUGBANK 26446 106997 509 RP11-401E9.1 ATP5C1 ATP5C|ATP5CL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7183 PICEATANNOL - - DRUGBANK DB08399 C14H12O4 small molecule - - DRUGBANK 25403 106997 509 RP11-401E9.1 ATP5C1 ATP5C|ATP5CL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6200 1-ACETYL-2-CARBOXYPIPERIDINE - - DRUGBANK DB07384 C8H13NO3 small molecule - - DRUGBANK 25413 106997 509 RP11-401E9.1 ATP5C1 ATP5C|ATP5CL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6209 AUROVERTIN B - - DRUGBANK DB07394 C25H32O8 small molecule - - DRUGBANK 14614 106998 513 - ATP5D - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14615 106998 513 - ATP5D - 9606 Homo sapiens unknown target Kosk-Kosicka D (1993) 8214757 174516 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14616 106998 513 - ATP5D - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 15198 106998 513 - ATP5D - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15199 106998 513 - ATP5D - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 14317 106998 513 - ATP5D - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14318 106998 513 - ATP5D - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 10105 106998 513 - ATP5D - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10106 106998 513 - ATP5D - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 12923 106998 513 - ATP5D - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12924 106998 513 - ATP5D - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 4448 106998 513 - ATP5D - 9606 Homo sapiens unknown target Kosk-Kosicka D (1993) 8214757 174516 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 14041 107007 523 - ATP6V1A ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1 9606 Homo sapiens inhibitor target David P (1996) 8889850 177442 1121 Tiludronate Tiludronic acid|Acide tiludronique|Tiludronate|Acido tiludronico|Acidum tiludronicum - DRUGBANK DB01133 C7H9ClO6P2S small molecule M05BA05 89987-06-4 DRUGBANK 8814 107007 523 - ATP6V1A ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1 9606 Homo sapiens inhibitor target David P (1996) 8889850 177442 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 13532 107007 523 - ATP6V1A ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1 9606 Homo sapiens inhibitor target David P (1996) 8889850 177442 1065 Etidronic acid Acetodiphosphonic acid|1,1,1-Ethanetriol diphosphonate|acidum etidronicum|acide tidronique|Etidronsure|cido etidrnico|(1-hydroxy-ethylidene)diphosphonic acid|Etidronate|1-Hydroxyethane-1,1-diphosphonic acid|1-Hydroxyethylidene-1,1-diphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonic acid|(1-Hydroxyethylidene)bis(phosphonic acid)|1-Hydroxyethane-1,1-bisphosphonic acid|Hydroxyethanediphosphonic acid|1-Hydroxyethylidene-1,1-bisphosphonate|1-hydroxyethane 1,1-diphosphonic acid|1-Hydroxyethanediphosphonic acid|Oxyethylidenediphosphonic acid|1-Hydroxyethane-1,1-diphosphonate|Ethane-1-hydroxy-1,1-bisphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonate|1-Hydroxy-1,1-diphosphonoethane|(1-Hydroxyethylidene)diphosphonic acid|EHDP|HEDP|(Hydroxyethylidene)diphosphonic acid|(1-Hydroxyethylidene)bisphosphonic acid|(1-Hydroxyethylene)diphosphonic acid act etidronate|didrocal|mylan- DRUGBANK DB01077 C2H8O7P2 small molecule M05BA01|M05BB01 2809-21-4 DRUGBANK 24794 107007 523 - ATP6V1A ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1 9606 Homo sapiens inhibitor target Schuhmann T (2004) 15638326 181877 5614 Bafilomycin B1 Setamycin - DRUGBANK DB06734 - small molecule - 88899-56-3 DRUGBANK 24793 107007 523 - ATP6V1A ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1 9606 Homo sapiens inhibitor target Takami M (2003) 12689676 181814 5613 Bafilomycin A1 - - DRUGBANK DB06733 C35H58O9 small molecule - 88899-55-2 DRUGBANK 25351 107009 526 - ATP6V1B2 ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6163 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE - - DRUGBANK DB07347 C8H10FNO2S small molecule - - DRUGBANK 24300 107009 526 - ATP6V1B2 ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2 9606 Homo sapiens inhibitor target Bockman R (2003) 12776254 181817 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 24301 107009 526 - ATP6V1B2 ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2 9606 Homo sapiens inhibitor target Jakupec MA (2004) 15206110 181852 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 24302 107009 526 - ATP6V1B2 ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2 9606 Homo sapiens inhibitor target Mattsson JP (1997) 9144341 181717 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 17578 107011 528 - ATP6V1C1 ATP6C|ATP6D|VATC|Vma5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 23316 107029 547 - KIF1A ATSV|C2orf20|HSN2C|MRD9|SPG30|UNC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 11306 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Ali F (2007) 17428103 178812 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11307 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Hoque MZ (2009) 19663609 178815 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11308 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Ali F (2007) 17919259 178817 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11309 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Ghali JK (2006) 16522696 178816 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11310 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Mao ZL (2009) 19695403 178819 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11311 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Annane D (2009) 19057376 178818 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11312 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11313 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Wada K (2007) 17202666 178820 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11314 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Walter KA (2007) 17592003 178821 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11315 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Ghali JK (2010) 20054444 178822 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 19602 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens stimulator target Hammock EA (2005) 16011575 172158 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19603 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens stimulator target Liedman R (2006) 16532916 172159 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19604 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens stimulator target Chen X (2002) 11752352 171740 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19605 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens stimulator target Aoyagi T (2007) 17303660 172156 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19606 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens stimulator target Adikesavan NV (2005) 16511036 172157 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19607 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens stimulator target Hiroyama M (2007) 17275806 172155 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 431 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Loichot C (2000) 10731046 171927 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 432 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Pequeux C (2004) 15613460 171925 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 433 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Mechaly I (1999) 10594321 171928 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 434 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Barthelmebs M (1996) 8957254 171929 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 24427 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens antagonist target Nemerovski C (2010) 20637957 182159 5531 Tolvaptan Samsca samsca|jinarc DRUGBANK DB06212 C26H25ClN2O3 small molecule C03XA01 150683-30-0 DRUGBANK 1156 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 89 Felypressin Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine - DRUGBANK DB00093 C46H65N13O11S2 small molecule - 56-59-7 DRUGBANK 1157 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 89 Felypressin Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine - DRUGBANK DB00093 C46H65N13O11S2 small molecule - 56-59-7 DRUGBANK 1158 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 89 Felypressin Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine - DRUGBANK DB00093 C46H65N13O11S2 small molecule - 56-59-7 DRUGBANK 1159 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens agonist target Manning M (2008) 18655903 172364 89 Felypressin Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine - DRUGBANK DB00093 C46H65N13O11S2 small molecule - 56-59-7 DRUGBANK 796 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Hammock EA (2005) 16011575 172158 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 797 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Liedman R (2006) 16532916 172159 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 798 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Aoyagi T (2007) 17303660 172156 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 799 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Adikesavan NV (2005) 16511036 172157 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 800 107033 552 - AVPR1A AVPR V1a|AVPR1|V1aR 9606 Homo sapiens unknown target Hiroyama M (2007) 17275806 172155 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 19597 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Young WS (2006) 17027167 172152 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19598 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Slusarz MJ (2006) 16114100 172153 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19599 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Jurkevich A (2005) 15993108 172150 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19600 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Volpi S (2006) 16720725 172151 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19601 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Wersinger SR (2007) 17284170 172154 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 428 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Dinan TG (2004) 14971638 171926 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 429 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Craighead M (2008) 18655906 171924 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 430 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Pequeux C (2004) 15613460 171925 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 791 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Young WS (2006) 17027167 172152 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 792 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Slusarz MJ (2006) 16114100 172153 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 793 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Jurkevich A (2005) 15993108 172150 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 794 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Volpi S (2006) 16720725 172151 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 795 107034 553 - AVPR1B AVPR3 9606 Homo sapiens unknown target Wersinger SR (2007) 17284170 172154 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 24425 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Aperis G (2011) 20868352 182167 5531 Tolvaptan Samsca samsca|jinarc DRUGBANK DB06212 C26H25ClN2O3 small molecule C03XA01 150683-30-0 DRUGBANK 24426 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Dixon MB (2008) 19337422 182101 5531 Tolvaptan Samsca samsca|jinarc DRUGBANK DB06212 C26H25ClN2O3 small molecule C03XA01 150683-30-0 DRUGBANK 11294 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Wada K (2005) 15659304 178813 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11295 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Ali F (2007) 17428103 178812 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11296 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Hoque MZ (2009) 19663609 178815 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11297 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Palm C (2006) 16843091 178814 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11298 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Ali F (2007) 17919259 178817 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11299 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Ghali JK (2006) 16522696 178816 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11300 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Mao ZL (2009) 19695403 178819 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11301 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Annane D (2009) 19057376 178818 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11302 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11303 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Wada K (2007) 17202666 178820 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11304 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Walter KA (2007) 17592003 178821 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 11305 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens antagonist target Ghali JK (2010) 20054444 178822 862 Conivaptan 4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan vaprisol dextrose in plastic c DRUGBANK DB00872 C32H26N4O2 small molecule C03XA02 210101-16-9 DRUGBANK 19593 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Yi X (2007) 17287200 71892 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19594 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Boson WL (2006) 17020465 172148 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19595 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Slusarz MJ (2006) 16333859 171922 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 19596 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Bouley R (2006) 16563128 172149 2529 Terlipressin Terlipressine|Terlipressina|Terlipressinum|Terlipressin - DRUGBANK DB02638 C52H74N16O15S2 small molecule H01BA04 14636-12-5 DRUGBANK 425 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 426 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Slusarz MJ (2006) 16333859 171922 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 427 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Del Tredici AL (2008) 18761325 171923 35 Desmopressin DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin ddavp rhinal tube|ddavp melt|d DRUGBANK DB00035 C46H64N14O12S2 small molecule H01BA02 16679-58-6 DRUGBANK 786 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Yi X (2007) 17287200 71892 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 787 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Boson WL (2006) 17020465 172148 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 788 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 789 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Slusarz MJ (2006) 16333859 171922 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 790 107035 554 - AVPR2 ADHR|DI1|DIR|DIR3|NDI|V2R 9606 Homo sapiens agonist target Bouley R (2006) 16563128 172149 66 Vasopressin Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH vasopressin injection usp|pitr DRUGBANK DB00067 C46H65N15O12S2 biologic H01BA06|H01BA01 11000-17-2 DRUGBANK 27074 107044 567 CDABP0092 B2M - 9606 Homo sapiens unknown target Giorgetti S (2011) 21068391 188478 247 Doxycycline Doxycyclin|6-deoxy-5-oxytetracycline|Supracyclin|Doxycycline (anhydrous)|(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide|Vibramycin|Jenacyclin|Doxiciclina|Doxycyclinum|5-Hydroxy-alpha-6-deoxytetracycline|6alpha-Deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline acticlate|doxycycline tablets| DRUGBANK DB00254 C22H24N2O8 small molecule J01AA02|A01AB22 564-25-0 DRUGBANK 23484 107044 567 CDABP0092 B2M - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19821 107044 567 CDABP0092 B2M - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2626 3-Indolebutyric Acid - - DRUGBANK DB02740 C12H13NO2 small molecule - 133-32-4 DRUGBANK 2801 107046 570 - BAAT BACAT|BAT 9606 Homo sapiens unknown target Pellicoro A (2007) 17256745 158237 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2802 107046 570 - BAAT BACAT|BAT 9606 Homo sapiens unknown target Styles NA (2007) 17379925 173482 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2803 107046 570 - BAAT BACAT|BAT 9606 Homo sapiens unknown target Nakamura K (2007) 16931649 173481 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2804 107046 570 - BAAT BACAT|BAT 9606 Homo sapiens unknown target Visser WF (2007) 17416343 173480 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 25053 107049 573 RP11-326F20.2 BAG1 BAG-1|HAP|RAP46 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5863 (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol - - DRUGBANK DB07045 C17H18Cl2N6O4 small molecule - - DRUGBANK 25561 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6354 N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE - - DRUGBANK DB07544 C16H10ClF3N2O4S small molecule - - DRUGBANK 3504 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Saito M (2007) 17077963 173514 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 3505 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Beck HC (2005) 15667998 173868 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 3506 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Chen CD (2007) 17554170 173513 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 2857 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Saito M (2007) 17077963 173514 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2858 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Chen CD (2007) 17554170 173513 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 1543 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1544 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2344 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Smirnov SV (2007) 17559390 173209 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 3612 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Madsen SM (2002) 12147502 173950 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3611 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Goto M (2003) 12667063 173951 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3610 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Beck HC (2005) 15667998 173868 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3613 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Chen CD (2007) 17554170 173513 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3614 107061 586 RP11-625L16.4 BCAT1 BCATC|BCT1|ECA39|MECA39|PNAS121|PP18 9606 Homo sapiens unknown target Thage BV (2004) 14962140 173949 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 22471 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3906 Alpha-ketoisovalerate 2-Oxoisovalerate|3-Methyl-2-oxobutanoic acid|2-Oxoisopentanoate|2-Ketovaline|3-Methyl-2-oxobutanoate|3-Methyl-2-oxobutyric acid|2-Oxo-3-methylbutanoate|2-Keto-3-methylbutyric acid|alpha-Ketovaline - DRUGBANK DB04074 C5H8O3 small molecule - 759-05-7 DRUGBANK 22472 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3906 Alpha-ketoisovalerate 2-Oxoisovalerate|3-Methyl-2-oxobutanoic acid|2-Oxoisopentanoate|2-Ketovaline|3-Methyl-2-oxobutanoate|3-Methyl-2-oxobutyric acid|2-Oxo-3-methylbutanoate|2-Keto-3-methylbutyric acid|alpha-Ketovaline - DRUGBANK DB04074 C5H8O3 small molecule - 759-05-7 DRUGBANK 19584 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2526 N-[O-Phosphono-Pyridoxyl]-Isoleucine - - DRUGBANK DB02635 C14H23N2O7P small molecule - - DRUGBANK 19585 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2526 N-[O-Phosphono-Pyridoxyl]-Isoleucine - - DRUGBANK DB02635 C14H23N2O7P small molecule - - DRUGBANK 2868 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2869 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2870 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Berger BJ (2003) 12670965 173519 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 1490 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1491 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2433 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2434 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 18601 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 18602 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 3609 107062 587 - BCAT2 BCAM|BCATM|BCT2|PP18 9606 Homo sapiens unknown target Berger BJ (2003) 12670965 173519 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 21688 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3518 9-N-Phenylmethylamino-Tacrine - - DRUGBANK DB03672 C20H20N2 small molecule - - DRUGBANK 21689 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3518 9-N-Phenylmethylamino-Tacrine - - DRUGBANK DB03672 C20H20N2 small molecule - - DRUGBANK 21690 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3518 9-N-Phenylmethylamino-Tacrine - - DRUGBANK DB03672 C20H20N2 small molecule - - DRUGBANK 15096 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Kao YJ (1996) 8922768 180725 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 13316 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1045 Echothiophate Ecothiopatum|Phospholine|Echothiophate|2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide phospholine iodide - pws 12.5m DRUGBANK DB01057 C9H23NO3PS small molecule - 6736-03-4 DRUGBANK 13317 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Henderson EG (1989) 2481033 179921 1045 Echothiophate Ecothiopatum|Phospholine|Echothiophate|2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide phospholine iodide - pws 12.5m DRUGBANK DB01057 C9H23NO3PS small molecule - 6736-03-4 DRUGBANK 9406 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Kelly SS (1990) 2361169 177758 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9407 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Acey RA (2002) 12459190 177757 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9408 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Pittel Z (1992) 1511344 177756 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9409 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Kamata R (2001) 11405252 177755 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 9410 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Miller RB (1991) 1776688 177754 667 Isoflurophate Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate - DRUGBANK DB00677 C6H14FO3P small molecule - 55-91-4 DRUGBANK 7006 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens potentiator target Nakamura M (1993) 8446367 176143 441 Dipivefrin Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine pms-dipivefrin|probeta - liq o DRUGBANK DB00449 C19H29NO5 small molecule S01EA02 52365-63-6 DRUGBANK 9304 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Giacobini E (2002) 11888344 177726 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9305 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Svoboda Z (2006) 17159811 177727 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9306 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Wilkinson DG (2001) 19811027 177728 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 1828 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens product of target Calaf GM (2007) 17390078 172774 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1829 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens product of target Amenta F (2006) 16297435 172766 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1830 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens product of target Hsieh BC (2007) 17329059 172772 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1831 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens product of target Stoytcheva M (2006) 16376069 172773 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1832 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens product of target Lurie S (2007) 17636231 172771 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 12541 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Greig NH (2003) 12636181 179548 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12542 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Bassil N (2009) 19374459 179549 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 27796 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Naik RS (2009) 19470293 195992 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12543 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Birks J (2009) 19370562 179541 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12544 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Lalli S (2008) 18671661 179542 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12548 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Smith DA (2009) 19420308 179550 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12545 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Gottwald MD (1999) 11139819 179544 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12546 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Onor ML (2007) 18044073 179545 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12547 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Farlow MR (2003) 14587496 179547 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 27795 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Birks J (2006) 16437532 195965 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12549 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Stahl SM (2000) 11078030 177717 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 12550 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 979 Rivastigmine (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base sandoz rivastigmine patch 5|ex DRUGBANK DB00989 C14H22N2O2 small molecule N06DA03 123441-03-2 DRUGBANK 6315 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Marco JL (2003) 12871155 175702 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6316 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Wang H (1998) 10375753 175703 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6317 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Krustev AD (2006) 17218977 175701 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 6318 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Ahmed M (2006) 16860785 175707 374 Tacrine Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine - DRUGBANK DB00382 C13H14N2 small molecule N06DA01 321-64-2 DRUGBANK 10297 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Ramos ZR (2006) 16782587 178319 762 Malathion O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester ovide|malathion lotion, 0.5%|m DRUGBANK DB00772 C10H19O6PS2 small molecule P03AX03 121-75-5 DRUGBANK 10298 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Ahmed M (2007) 17364237 178317 762 Malathion O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester ovide|malathion lotion, 0.5%|m DRUGBANK DB00772 C10H19O6PS2 small molecule P03AX03 121-75-5 DRUGBANK 10299 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 762 Malathion O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester ovide|malathion lotion, 0.5%|m DRUGBANK DB00772 C10H19O6PS2 small molecule P03AX03 121-75-5 DRUGBANK 10300 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target da Silva AP (2006) 16716398 178318 762 Malathion O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester ovide|malathion lotion, 0.5%|m DRUGBANK DB00772 C10H19O6PS2 small molecule P03AX03 121-75-5 DRUGBANK 10301 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 762 Malathion O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester ovide|malathion lotion, 0.5%|m DRUGBANK DB00772 C10H19O6PS2 small molecule P03AX03 121-75-5 DRUGBANK 10302 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 762 Malathion O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester ovide|malathion lotion, 0.5%|m DRUGBANK DB00772 C10H19O6PS2 small molecule P03AX03 121-75-5 DRUGBANK 7935 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens antagonist target Servatius RJ (2000) 10869589 176802 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7936 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens antagonist target Abou-Donia MB (1996) 8954750 176806 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 7937 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens antagonist target Somani SM (2000) 10942908 176807 535 Pyridostigmine Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina mestinon|mestinon tab 60mg usp DRUGBANK DB00545 C9H13N2O2 small molecule N07AA02 155-97-5 DRUGBANK 24094 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Janas AM (2005) 15620572 181876 4692 Phenserine (-)-eseroline phenylcarbamate|(-)-phenserine - DRUGBANK DB04892 C20H23N3O2 small molecule - 101246-66-6 DRUGBANK 9942 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens activator target Pohanka M (2009) 18825528 178088 723 Pralidoxime Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim duodote|protopam chloride - DRUGBANK DB00733 C7H9N2O small molecule V03AB04 6735-59-7 DRUGBANK 9943 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens activator target Khan S (2001) 11393267 178087 723 Pralidoxime Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim duodote|protopam chloride - DRUGBANK DB00733 C7H9N2O small molecule V03AB04 6735-59-7 DRUGBANK 25965 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6736 9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE - - DRUGBANK DB07940 C20H19IN2 small molecule - - DRUGBANK 12147 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Gum GG (1993) 8430939 179238 934 Demecarium Demecarium - DRUGBANK DB00944 C32H52N4O4 small molecule S01EB04 - DRUGBANK 12148 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Meiniel R (1981) 7196602 179237 934 Demecarium Demecarium - DRUGBANK DB00944 C32H52N4O4 small molecule S01EB04 - DRUGBANK 12139 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Schuh FR (1976) 948350 179230 931 Hexafluronium Hexafluorenium|Hexafluorenium ion|Hexamethylenebis(fluoren-9-yldimethylammonium)|Hexafluorenium cation - DRUGBANK DB00941 C36H42N2 small molecule M03AC05 4844-10-4 DRUGBANK 12140 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 931 Hexafluronium Hexafluorenium|Hexafluorenium ion|Hexamethylenebis(fluoren-9-yldimethylammonium)|Hexafluorenium cation - DRUGBANK DB00941 C36H42N2 small molecule M03AC05 4844-10-4 DRUGBANK 12716 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Harel M (1992) 1438284 179643 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 12717 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens inhibitor target Saxena A (1997) 9398183 179642 1000 Edrophonium N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium tensilon|enlon liq iv 10mg/ml| DRUGBANK DB01010 C10H16NO small molecule - - DRUGBANK 26225 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6992 (1S)-MENTHYL HEXYL PHOSPHONATE GROUP - - DRUGBANK DB08201 C16H33O3P small molecule - - DRUGBANK 25689 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6487 DODECANESULFONATE ION - - DRUGBANK DB07681 C12H25O3S small molecule - - DRUGBANK 26224 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6991 (1R)-MENTHYL HEXYL PHOSPHONATE GROUP - - DRUGBANK DB08200 C16H33O3P small molecule - - DRUGBANK 26673 107064 590 - BCHE CHE1|CHE2|E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7432 ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE - - DRUGBANK DB08658 C6H16NO3P small molecule - - DRUGBANK 14420 107067 595 - CCND1 BCL1|D11S287E|PRAD1|U21B31 9606 Homo sapiens antagonist target Hwang BJ (2006) 17005224 180456 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14421 107067 595 - CCND1 BCL1|D11S287E|PRAD1|U21B31 9606 Homo sapiens antagonist target Ouyang W (2007) 17370311 180454 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14422 107067 595 - CCND1 BCL1|D11S287E|PRAD1|U21B31 9606 Homo sapiens antagonist target Hyun Park W (2003) 12480548 180455 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14423 107067 595 - CCND1 BCL1|D11S287E|PRAD1|U21B31 9606 Homo sapiens antagonist target Ouyang W (2005) 16230390 180453 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14424 107067 595 - CCND1 BCL1|D11S287E|PRAD1|U21B31 9606 Homo sapiens antagonist target Ouyang W (2006) 16387740 180451 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 15366 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Inoue Y (2005) 15643508 180835 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15367 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Magi-Galluzzi C (2007) 17674353 180836 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15368 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Marshall J (2004) 15277270 180837 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15369 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Gligorov J (2004) 15161985 180838 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15370 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Petrylak DP (2005) 15685445 180839 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15371 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Miyoshi Y (2005) 15714982 180840 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 27935 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Souers AJ (2013) 23291630 196015 8250 Venetoclax 4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide venclexta DRUGBANK DB11581 C45H50ClN7O7S small molecule - 1257044-40-8 DRUGBANK 27936 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Davids MS (2013) 23410971 196016 8250 Venetoclax 4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide venclexta DRUGBANK DB11581 C45H50ClN7O7S small molecule - 1257044-40-8 DRUGBANK 24184 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens unknown target Kuznetsov G (2004) 15313917 181859 4735 E7389 - - DRUGBANK DB04940 - small molecule - - DRUGBANK 16197 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens activator target Bar-Am O (2005) 16148027 181187 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16198 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens activator target Youdim MB (2001) 12043833 181186 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16199 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens activator target Maruyama W (2002) 12200198 181185 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16200 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens activator target Youdim MB (2003) 14555244 181184 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16201 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens activator target Akao Y (2002) 12057839 181183 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 13283 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens modulator target Palayoor ST (2012) 22668799 179903 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 15113 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Matsuyoshi S (2006) 17119350 180733 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15114 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Thomadaki H (2006) 16895478 180737 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15115 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Yoshino T (2006) 17062688 180736 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15116 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Zhang X (2007) 17230521 180735 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15117 107068 596 - BCL2 Bcl-2|PPP1R50 9606 Homo sapiens inhibitor target Gan Y (2006) 16741658 180734 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 25118 107070 598 RP5-857M17.3 BCL2L1 BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5926 4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID - - DRUGBANK DB07108 C13H9FO2 small molecule - - DRUGBANK 18925 107081 610 - HCN2 BCNG-2|BCNG2|HAC-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 18926 107081 610 - HCN2 BCNG-2|BCNG2|HAC-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 18927 107081 610 - HCN2 BCNG-2|BCNG2|HAC-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 19398 107081 610 - HCN2 BCNG-2|BCNG2|HAC-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19399 107081 610 - HCN2 BCNG-2|BCNG2|HAC-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19400 107081 610 - HCN2 BCNG-2|BCNG2|HAC-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 26977 107083 613 - BCR ALL|BCR1|CML|D22S11|D22S662|PHL 9606 Homo sapiens inhibitor target Iqbal Z (2013) 23409026 182230 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 3138 107091 622 - BDH1 BDH|SDR9C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3139 107091 622 - BDH1 BDH|SDR9C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3140 107091 622 - BDH1 BDH|SDR9C1 9606 Homo sapiens unknown target Rudy B (1989) 2550053 173692 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3141 107091 622 - BDH1 BDH|SDR9C1 9606 Homo sapiens unknown target Tabata M (1995) 8533882 173690 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3142 107091 622 - BDH1 BDH|SDR9C1 9606 Homo sapiens unknown target Smith CM (1979) 38961 173691 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 27809 107093 624 - BDKRB2 B2R|BK-2|BK2|BKR2|BRB2 9606 Homo sapiens antagonist target Pruneau D (1999) 10596852 195948 4825 Anatibant - - DRUGBANK DB05038 C34H36Cl2N6O5S small molecule - 209733-45-9 DRUGBANK 24409 107093 624 - BDKRB2 B2R|BK-2|BK2|BKR2|BRB2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5524 Icatibant HOE 140 firazyr DRUGBANK DB06196 C59H89N19O13S small molecule B06AC02 130308-48-4 DRUGBANK 24410 107093 624 - BDKRB2 B2R|BK-2|BK2|BKR2|BRB2 9606 Homo sapiens antagonist target Privitera PJ (2003) 14514033 181835 5524 Icatibant HOE 140 firazyr DRUGBANK DB06196 C59H89N19O13S small molecule B06AC02 130308-48-4 DRUGBANK 19239 107098 629 DADB-122G4.5 CFB AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2359 4-Guanidinobenzoic Acid - - DRUGBANK DB02459 C8H9N3O2 small molecule - - DRUGBANK 19240 107098 629 DADB-122G4.5 CFB AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2359 4-Guanidinobenzoic Acid - - DRUGBANK DB02459 C8H9N3O2 small molecule - - DRUGBANK 23550 107098 629 DADB-122G4.5 CFB AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4304 Diisopropylphosphono Group - - DRUGBANK DB04491 C6H15O3P small molecule - - DRUGBANK 23551 107098 629 DADB-122G4.5 CFB AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4304 Diisopropylphosphono Group - - DRUGBANK DB04491 C6H15O3P small molecule - - DRUGBANK 3657 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens agonist target Price PA (1988) 3060178 173993 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 12853 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens agonist target Sato Y (1999) 10418836 179737 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12854 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens agonist target Kawana K (2001) 11678581 179736 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12855 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens agonist target Schurgers LJ (2001) 11374034 179735 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12856 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens agonist target Vermeer C (1998) 11541904 179739 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12857 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens agonist target Askim M (2001) 11668761 179738 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 24304 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens antagonist target Jenis LG (1993) 8366144 181697 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 24305 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens antagonist target Guidon PT (1993) 8381250 181698 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 22059 107101 632 RP11-54H19.5 BGLAP BGP|OC|OCN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3684 Gamma-Carboxy-Glutamic Acid - - DRUGBANK DB03847 C6H9NO6 small molecule - - DRUGBANK 1393 107103 634 - CEACAM1 BGP|BGP1|BGPI 9606 Homo sapiens unknown target Hughes K (1997) 9389396 172459 108 Arcitumomab IMMU-4|anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment - DRUGBANK DB00113 C6398H9900N1714O1995S54 biologic - 154361-48-5 DRUGBANK 1394 107103 634 - CEACAM1 BGP|BGP1|BGPI 9606 Homo sapiens unknown target Fuster D (2003) 12865871 172460 108 Arcitumomab IMMU-4|anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment - DRUGBANK DB00113 C6398H9900N1714O1995S54 biologic - 154361-48-5 DRUGBANK 2180 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens product of target Liu J (2007) 17350061 173083 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2181 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens product of target Slow S (2006) 16920841 172788 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2182 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens product of target Hazra A (2007) 17389618 173086 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2183 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens product of target Uthus EO (2007) 17513393 173085 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2184 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens product of target Sparks JD (2006) 16396637 173084 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 22948 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22949 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 18967 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2242 S-(D-Carboxybutyl)-L-Homocysteine - - DRUGBANK DB02337 C9H17NO4S small molecule - - DRUGBANK 18968 107104 635 - BHMT BHMT1|HEL-S-61p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2242 S-(D-Carboxybutyl)-L-Homocysteine - - DRUGBANK DB02337 C9H17NO4S small molecule - - DRUGBANK 3118 107113 644 - BLVRA BLVR|BVR|BVRA 9606 Homo sapiens unknown target Franklin E (2007) 17402939 173681 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3181 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Deng D (2007) 17559398 173705 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 18465 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 18466 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 20845 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20846 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 23208 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4185 Mesobiliverdin Iv Alpha - - DRUGBANK DB04363 C33H37N4O6 small molecule - - DRUGBANK 23209 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4185 Mesobiliverdin Iv Alpha - - DRUGBANK DB04363 C33H37N4O6 small molecule - - DRUGBANK 23170 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4169 7,8-dimethylalloxazine Riboflavin lumichrome|6,7-Dimethylalloxazine|7,8-dimethylisoalloxazine|lumichrome|7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione - DRUGBANK DB04345 C12H10N4O2 small molecule - 1086-80-2 DRUGBANK 23171 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4169 7,8-dimethylalloxazine Riboflavin lumichrome|6,7-Dimethylalloxazine|7,8-dimethylisoalloxazine|lumichrome|7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione - DRUGBANK DB04345 C12H10N4O2 small molecule - 1086-80-2 DRUGBANK 23172 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4169 7,8-dimethylalloxazine Riboflavin lumichrome|6,7-Dimethylalloxazine|7,8-dimethylisoalloxazine|lumichrome|7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione - DRUGBANK DB04345 C12H10N4O2 small molecule - 1086-80-2 DRUGBANK 2306 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens product of target Russell TR (2004) 14769034 173179 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2307 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens product of target van Pee KH (2006) 16544142 173178 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 21318 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21319 107114 645 - BLVRB BVRB|FLR|HEL-S-10|SDR43U1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21065 107138 670 - BPHL BPH-RP|MCNAA|VACVASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3239 L-Tyrosinamide L-Tyrosine amide|Tyrosinamide - DRUGBANK DB03380 C9H12N2O2 small molecule - 4985-46-0 DRUGBANK 22769 107139 671 RP13-218F6_A.1 BPI BPIFD1|rBPI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4008 Di-Stearoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04178 C44H89NO8P small molecule - - DRUGBANK 22770 107139 671 RP13-218F6_A.1 BPI BPIFD1|rBPI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4008 Di-Stearoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04178 C44H89NO8P small molecule - - DRUGBANK 25013 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5818 N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide - - DRUGBANK DB07000 C21H16F2N4O3S small molecule - - DRUGBANK 26596 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7331 (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime - - DRUGBANK DB08553 C22H23N5O small molecule - - DRUGBANK 26948 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Jordan EJ (2012) 23094782 182216 7625 Vemurafenib Zelboraf|PLX4032|BRAF(V600E) Kinase Inhibitor RO5185426 zelboraf DRUGBANK DB08881 C23H18ClF2N3O3S small molecule L01XE15 918504-65-1 DRUGBANK 6501 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Lu X (2010) 20812347 175817 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6502 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6503 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Kim S (2007) 17575107 175827 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6504 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Eisen T (2006) 16880785 175826 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6505 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Haluska FG (2006) 16901402 175825 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6506 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Flaherty KT (2006) 16609060 175828 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 26991 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens inhibitor target Gibney GT (2013) 23621583 182249 7656 Dabrafenib Dabrafenib|GSK2118436a tafinlar DRUGBANK DB08912 C23H20F3N5O2S2 small molecule L01XE23 - DRUGBANK 25012 107141 673 - BRAF B-RAF1|BRAF1|NS7|RAFB1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5817 N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide - - DRUGBANK DB06999 C17H14ClF2N3O3S small molecule - - DRUGBANK 19302 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2381 Etheno-Nad - - DRUGBANK DB02483 C17H23N5O14P2 small molecule - - DRUGBANK 19303 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2381 Etheno-Nad - - DRUGBANK DB02483 C17H23N5O14P2 small molecule - - DRUGBANK 21817 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3575 Etheno-Nadp - - DRUGBANK DB03732 C17H24N5O17P3 small molecule - - DRUGBANK 21818 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3575 Etheno-Nadp - - DRUGBANK DB03732 C17H24N5O17P3 small molecule - - DRUGBANK 17520 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 17521 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 19730 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 19731 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 20794 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3095 Nicotinamide Mononucleotide - - DRUGBANK DB03227 C11H16N2O8P small molecule - - DRUGBANK 20795 107148 683 - BST1 CD157 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3095 Nicotinamide Mononucleotide - - DRUGBANK DB03227 C11H16N2O8P small molecule - - DRUGBANK 17952 107160 695 RP1-164F3.2 BTK AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17953 107160 695 RP1-164F3.2 BTK AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 27471 107160 695 RP1-164F3.2 BTK AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA 9606 Homo sapiens inhibitor target Kim ES (2015) 25802231 188544 7814 Ibrutinib 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one imbruvica DRUGBANK DB09053 C25H24N6O2 small molecule L01XE27 936563-96-1 DRUGBANK 8798 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Park CH (1996) 8787774 174205 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 11490 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Park CH (1996) 8787774 174205 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 13441 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13442 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Awad M (1989) 2723642 179968 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13443 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Bono F (1999) 10558889 179969 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13444 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Carmel I (1999) 10423168 179970 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13445 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Marano G (1990) 2364987 179966 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13446 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Bolger GT (1990) 1691678 179967 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 14748 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14749 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 12320 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 12321 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 6544 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6545 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6546 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Becker PM (2009) 19744401 175860 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6547 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Jufe GS (2008) 18265473 175859 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 14502 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1166 Chlormezanone 2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide|Chlormezanonum|2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide|Chlormezanone|(+-)-Chlormezanone|Chlormezanona|Chlormethazanone|()-chlormezanone|Clormezanona - DRUGBANK DB01178 C11H12ClNO3S small molecule M03BB52|M03BB72|M03BB02 80-77-3 DRUGBANK 14503 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1166 Chlormezanone 2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide|Chlormezanonum|2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide|Chlormezanone|(+-)-Chlormezanone|Chlormezanona|Chlormethazanone|()-chlormezanone|Clormezanona - DRUGBANK DB01178 C11H12ClNO3S small molecule M03BB52|M03BB72|M03BB02 80-77-3 DRUGBANK 14504 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1166 Chlormezanone 2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide|Chlormezanonum|2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide|Chlormezanone|(+-)-Chlormezanone|Chlormezanona|Chlormethazanone|()-chlormezanone|Clormezanona - DRUGBANK DB01178 C11H12ClNO3S small molecule M03BB52|M03BB72|M03BB02 80-77-3 DRUGBANK 10899 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10900 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens potentiator target Falchi AM (2007) 17631921 178583 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 17144 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17145 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Falchi AM (2007) 17631921 178583 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17146 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Vega D (2001) 11443263 181549 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 4025 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Uusi-Oukari M (1991) 1647706 174204 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 4026 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Park CH (1996) 8787774 174205 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 4027 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Venneti S (2006) 17156911 174206 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 4028 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Miller EI (2006) 16959136 174203 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 16909 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Gandolfo P (1997) 9098698 181493 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16910 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Katz Y (1992) 1320691 181492 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16911 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Papadopoulos V (1991) 1847384 181495 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16912 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Poisnel G (2009) 19443999 181494 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16913 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Papadopoulos V (1991) 1651852 181496 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16914 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens agonist target Awad M (1989) 2723642 179968 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 4533 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Dobbin M (2003) 12850901 174535 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4534 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Mant A (1993) 7911332 174536 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4535 107168 706 RP3-526I14.4 TSPO BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18 9606 Homo sapiens unknown target Miller EI (2006) 16959136 174203 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 26870 107169 708 - C1QBP GC1QBP|HABP1|SF2p32|gC1Q-R|gC1qR|p32 9606 Homo sapiens binder target Yadav G (2009) 19004836 182090 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 722 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 723 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1349 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1350 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 607 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 608 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 648 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 649 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1019 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1020 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1145 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1146 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 23 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 24 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 63 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 64 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 927 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 928 107173 712 - C1QA - 9606 Homo sapiens unknown target Di Gaetano N (2003) 12874252 172217 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 929 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 896 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 897 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1301 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1302 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1179 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1180 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1091 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1092 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1046 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1047 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 954 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 955 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1381 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1382 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 988 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 989 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1326 107173 712 - C1QA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1327 107173 712 - C1QA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 720 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 721 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1347 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1348 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 605 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 606 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 641 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 642 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1017 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1018 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1143 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1144 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 21 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 22 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 58 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 59 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 925 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 926 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 894 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 895 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1299 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1300 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1177 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1178 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1089 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1090 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1044 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1045 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 952 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 953 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1379 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1380 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 986 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 987 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1324 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1325 107174 713 RP4-815O16.3 C1QB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 727 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 728 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1353 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1354 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 611 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 612 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 652 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 653 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1023 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1024 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1151 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1152 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 28 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 29 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 67 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 68 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 933 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 934 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 899 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 900 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1308 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1309 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1183 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1184 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1094 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1095 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1050 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1051 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 958 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 959 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1385 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1386 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 992 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 993 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1330 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1331 107175 714 - C1QC C1Q-C|C1QG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 911 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 912 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1042 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1043 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 718 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 719 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1345 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1346 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 603 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 604 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 643 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 644 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1015 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1016 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1141 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1142 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 33 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 34 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 60 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 61 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 923 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 924 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 27849 107176 715 - C1R - 9606 Homo sapiens inhibitor target Harpel PC (1975) 123251 195954 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 1297 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1298 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1175 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1176 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1087 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1088 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1322 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1323 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 950 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 951 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1377 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1378 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 984 107176 715 - C1R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 985 107176 715 - C1R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 27924 107176 715 - C1R - 9606 Homo sapiens inhibitor target Harpel PC (1975) 123251 195954 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 19039 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2276 2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid - - DRUGBANK DB02371 C6H15NO6S small molecule - 7365-44-8 DRUGBANK 19040 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2276 2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid - - DRUGBANK DB02371 C6H15NO6S small molecule - 7365-44-8 DRUGBANK 884 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 885 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 711 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 712 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 597 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 598 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 635 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 636 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1009 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1010 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 9 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 10 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 54 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 55 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 915 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 916 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 27848 107177 716 - C1S - 9606 Homo sapiens inhibitor target Harpel PC (1975) 123251 195954 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 946 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 947 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 978 107177 716 - C1S - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 979 107177 716 - C1S - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 27923 107177 716 - C1S - 9606 Homo sapiens inhibitor target Harpel PC (1975) 123251 195954 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 18062 107179 718 - C3 AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18063 107179 718 - C3 AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18064 107179 718 - C3 AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 324 107179 718 - C3 AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p 9606 Homo sapiens binder target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 325 107179 718 - C3 AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p 9606 Homo sapiens binder target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 326 107179 718 - C3 AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p 9606 Homo sapiens binder target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 336 107181 720 DAMC-258G8.6 C4A C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG 9606 Homo sapiens binder target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 337 107181 720 DAMC-258G8.6 C4A C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG 9606 Homo sapiens binder target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 338 107181 720 DAMC-258G8.6 C4A C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG 9606 Homo sapiens binder target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 330 107182 721 DADB-112B14.11-001 C4B C4B1|C4B12|C4B2|C4B3|C4B5|C4BD|C4B_2|C4F|CH|CO4|CPAMD3 9606 Homo sapiens binder target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 331 107182 721 DADB-112B14.11-001 C4B C4B1|C4B12|C4B2|C4B3|C4B5|C4BD|C4B_2|C4F|CH|CO4|CPAMD3 9606 Homo sapiens binder target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 332 107182 721 DADB-112B14.11-001 C4B C4B1|C4B12|C4B2|C4B3|C4B5|C4BD|C4B_2|C4F|CH|CO4|CPAMD3 9606 Homo sapiens binder target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 321 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens binder target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 322 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens binder target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 323 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens binder target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 15436 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Imming P (2006) 17016423 171742 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15437 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15438 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Overington JP (2006) 17139284 171741 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15439 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Rother RP (2007) 17989688 180880 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15440 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Hillmen P (2006) 16990386 180874 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15441 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Dmytrijuk A (2008) 18784156 180875 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15442 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Kelly R (2009) 20011245 180876 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15443 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Luzzatto L (2010) 20378572 180877 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15444 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Singer AL (2009) 19399743 180878 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 15445 107188 727 - C5 C5D|C5a|C5b|CPAMD4|ECLZB 9606 Homo sapiens antibody target Hillmen P (2007) 17702897 180879 1245 Eculizumab 5G1.1 soliris DRUGBANK DB01257 - biologic L04AA25 219685-50-4 DRUGBANK 27665 107194 733 RP11-229P13.14-003 C8G C8C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 12649 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12650 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Couloigner V (1998) 9546276 174541 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12651 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 8569 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Pirotte B (1998) 9685234 177252 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8570 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Rammes G (1996) 8882618 177253 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8571 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Fleck MW (1996) 8793745 177251 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8572 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Rammes G (1999) 9929558 177254 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8573 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Larson J (1994) 8003661 177255 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 10322 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10323 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10324 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 8061 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 8062 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 26179 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6949 ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE - - DRUGBANK DB08157 C11H15NO4S small molecule - - DRUGBANK 26177 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6948 3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID - - DRUGBANK DB08156 C9H11NO4S small molecule - - DRUGBANK 26175 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6947 N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE - - DRUGBANK DB08155 C10H14N2O3S small molecule - - DRUGBANK 9638 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Winum JY (2004) 14684332 177906 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 9639 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Ilies MA (2004) 15110853 177907 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 9640 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Scozzafava A (2000) 10649985 175094 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 9641 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Iyer GR (1999) 10533697 177905 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 9642 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Lindskog S (1997) 9336012 177908 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 13954 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Scuvee-Moreau J (1997) 9439778 180254 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13955 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Erdemli G (1995) 7585327 180255 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13956 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Erdemli G (1993) 8298083 180256 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13957 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Crepel V (1993) 7681475 180257 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13958 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Domoki F (2004) 15306243 180253 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 11265 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Hasegawa T (1994) 8070313 178792 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11266 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Maren TH (1997) 9029437 178793 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11267 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Sugrue MF (1996) 8875343 178791 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11361 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2000) 10954127 178858 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11362 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 6923 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 6924 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 14168 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Winum JY (2004) 14684332 177906 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 14169 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Cleland JC (2008) 19019313 180348 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 14170 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Nishimori I (2007) 17228881 180349 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 14171 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Giacomotto J (2009) 19648295 180347 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 14172 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Lindskog S (1997) 9336012 177908 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 15843 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2008) 18374572 181102 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15844 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2008) 18600270 181101 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15845 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Supuran CT (2008) 18336309 181100 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 12843 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12844 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12845 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 11723 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11724 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Masuda Y (1993) 8494570 179045 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11725 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target De Simone G (2005) 15837316 179044 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11726 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2008) 18162396 179047 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11727 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Shank RP (2008) 18343915 179046 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11728 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11729 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11730 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5371 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Koehling R (2000) 10995826 175096 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 5372 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Heck RW (1994) 7929150 175097 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 5373 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Scozzafava A (2000) 10649985 175094 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 5374 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Bertucci A (2009) 19520577 175095 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 5375 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Perez Velazquez JL (2003) 12956733 175092 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 5376 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Siffert W (1982) 6816217 175093 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 4552 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4553 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Couloigner V (1998) 9546276 174541 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4554 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 12970 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Parr JS (1992) 1460006 175971 1020 Ethinamate Ethinamate|Ethinamatum|1-Ethynylcyclohexanol carbamate|Etinamato|Aethinyl-cyclohexyl-carbamat - DRUGBANK DB01031 C9H13NO2 small molecule - 126-52-3 DRUGBANK 26919 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 14689 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Winum JY (2004) 14684332 177906 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14690 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Herkel U (2001) 11224713 180552 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 6818 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Parr JS (1992) 1460006 175971 415 Methocarbamol Robaxin|(RS)-2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate|Methocarbamol|Metocarbamol|Mthocarbamol|Delaxin|Metocarbamolo|Methocarbamolum aspirin backache|aspirin night DRUGBANK DB00423 C11H15NO5 small molecule M03BA73|M03BA03|M03BA53 532-03-6 DRUGBANK 10807 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Perez Velazquez JL (2003) 12956733 175092 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10808 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10809 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2001) 11430635 178542 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10810 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (1996) 8667211 178541 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10811 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Meierkord H (2000) 10651143 178540 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10812 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 6299 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas L (2000) 11101200 175695 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6300 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2001) 11392054 175696 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6301 107214 759 - CA1 CA-I|CAB|Car1|HEL-S-11 9606 Homo sapiens inhibitor target Puscas I (2000) 11061585 175697 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 22095 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3714 AL4623 - - DRUGBANK DB03877 C11H19N3O5S3 small molecule - - DRUGBANK 22096 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3714 AL4623 - - DRUGBANK DB03877 C11H19N3O5S3 small molecule - - DRUGBANK 22542 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3921 AL5300 - - DRUGBANK DB04089 C11H12N2O5S4 small molecule - - DRUGBANK 22543 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3921 AL5300 - - DRUGBANK DB04089 C11H12N2O5S4 small molecule - - DRUGBANK 22544 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3921 AL5300 - - DRUGBANK DB04089 C11H12N2O5S4 small molecule - - DRUGBANK 10325 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10326 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Schaeffer P (1990) 2226620 174542 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 26363 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7115 SULTHIAME - - DRUGBANK DB08329 C10H14N2O4S2 small molecule - - DRUGBANK 26113 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6876 2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide - - DRUGBANK DB08083 C10H8N4O2S2 small molecule - - DRUGBANK 9643 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 20868 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3129 Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide] - - DRUGBANK DB03262 C17H19N3O6S3 small molecule - - DRUGBANK 20869 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3129 Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide] - - DRUGBANK DB03262 C17H19N3O6S3 small molecule - - DRUGBANK 20870 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3129 Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide] - - DRUGBANK DB03262 C17H19N3O6S3 small molecule - - DRUGBANK 26464 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7199 (9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE - - DRUGBANK DB08416 C19H28N2O7S2 small molecule - - DRUGBANK 20364 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2911 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide - - DRUGBANK DB03039 C14H12F2N2O3S small molecule - - DRUGBANK 20365 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2911 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide - - DRUGBANK DB03039 C14H12F2N2O3S small molecule - - DRUGBANK 20366 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2911 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide - - DRUGBANK DB03039 C14H12F2N2O3S small molecule - - DRUGBANK 22366 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3836 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide - - DRUGBANK DB04002 C12H19N3O3S2 small molecule - - DRUGBANK 22367 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3836 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide - - DRUGBANK DB04002 C12H19N3O3S2 small molecule - - DRUGBANK 22368 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3836 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide - - DRUGBANK DB04002 C12H19N3O3S2 small molecule - - DRUGBANK 26226 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6993 4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE - - DRUGBANK DB08202 C12H19N5O2S2 small molecule - - DRUGBANK 22801 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4031 3-Mercuri-4-Aminobenzenesulfonamide - - DRUGBANK DB04203 C6H7HgN2O2S small molecule - - DRUGBANK 22802 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4031 3-Mercuri-4-Aminobenzenesulfonamide - - DRUGBANK DB04203 C6H7HgN2O2S small molecule - - DRUGBANK 20877 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3136 2,6-Difluorobenzenesulfonamide - - DRUGBANK DB03270 C6H5F2NO2S small molecule - - DRUGBANK 20878 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3136 2,6-Difluorobenzenesulfonamide - - DRUGBANK DB03270 C6H5F2NO2S small molecule - - DRUGBANK 5009 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Di Fiore A (2007) 17251017 174798 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5010 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Maryanoff BE (2005) 15771438 174799 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5011 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Ma L (2007) 17521680 174797 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5012 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Casini A (2003) 12617904 174800 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5013 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Winum JY (2005) 15478125 174801 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 15850 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2008) 18374572 181102 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15851 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2008) 18600270 181101 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15852 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Supuran CT (2008) 18336309 181100 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 23761 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4409 4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE - - DRUGBANK DB04600 C16H13BrN6O3S small molecule - - DRUGBANK 26915 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 19523 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2496 AL7182 - - DRUGBANK DB02602 C13H14N2O5S3 small molecule - - DRUGBANK 19524 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2496 AL7182 - - DRUGBANK DB02602 C13H14N2O5S3 small molecule - - DRUGBANK 19525 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2496 AL7182 - - DRUGBANK DB02602 C13H14N2O5S3 small molecule - - DRUGBANK 21561 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3444 N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide - - DRUGBANK DB03596 C19H21N3O3S small molecule - - DRUGBANK 21562 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3444 N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide - - DRUGBANK DB03596 C19H21N3O3S small molecule - - DRUGBANK 21563 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3444 N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide - - DRUGBANK DB03596 C19H21N3O3S small molecule - - DRUGBANK 12652 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12653 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12655 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Meyerson LR (1991) 1901209 174543 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12654 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12656 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Schaeffer P (1990) 2226620 174542 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 8574 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8575 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Liljequist S (1995) 8615854 177256 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 20086 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2774 Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester - - DRUGBANK DB02894 C9H15NO10S2 small molecule - - DRUGBANK 20087 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2774 Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester - - DRUGBANK DB02894 C9H15NO10S2 small molecule - - DRUGBANK 21087 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 21088 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 17783 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1716 4-Flourobenzenesulfonamide - - DRUGBANK DB01784 C6H6FNO2S small molecule - - DRUGBANK 17784 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1716 4-Flourobenzenesulfonamide - - DRUGBANK DB01784 C6H6FNO2S small molecule - - DRUGBANK 21440 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3380 AL5927 - - DRUGBANK DB03526 C12H14N2O5S3 small molecule - - DRUGBANK 21441 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3380 AL5927 - - DRUGBANK DB03526 C12H14N2O5S3 small molecule - - DRUGBANK 21442 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3380 AL5927 - - DRUGBANK DB03526 C12H14N2O5S3 small molecule - - DRUGBANK 25715 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6513 PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE - - DRUGBANK DB07710 C22H30N4O6S small molecule - - DRUGBANK 23762 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4410 4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE - - DRUGBANK DB04601 C16H14N6O3S small molecule - - DRUGBANK 6925 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 6926 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 26766 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7538 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE - - DRUGBANK DB08765 C7H6N2O3S2 small molecule - - DRUGBANK 26674 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7433 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide - - DRUGBANK DB08659 C15H14N4O3S small molecule - - DRUGBANK 12846 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12847 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12848 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 23259 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4215 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide - - DRUGBANK DB04394 C10H11N3O5S small molecule - - DRUGBANK 23260 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4215 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide - - DRUGBANK DB04394 C10H11N3O5S small molecule - - DRUGBANK 23261 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4215 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide - - DRUGBANK DB04394 C10H11N3O5S small molecule - - DRUGBANK 14173 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 5377 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 23226 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4193 AL6528 - - DRUGBANK DB04371 C13H12N2O5S3 small molecule - - DRUGBANK 23227 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4193 AL6528 - - DRUGBANK DB04371 C13H12N2O5S3 small molecule - - DRUGBANK 23228 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4193 AL6528 - - DRUGBANK DB04371 C13H12N2O5S3 small molecule - - DRUGBANK 22162 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 22163 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 23674 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4359 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB04549 C14H11F3N2O3S small molecule - - DRUGBANK 23675 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4359 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB04549 C14H11F3N2O3S small molecule - - DRUGBANK 23676 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4359 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB04549 C14H11F3N2O3S small molecule - - DRUGBANK 25370 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6179 THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE) - - DRUGBANK DB07363 C12H14N2O4S3 small molecule - - DRUGBANK 24976 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5773 2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate - - DRUGBANK DB06954 C16H21NO5S2 small molecule - - DRUGBANK 25480 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6278 4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide - - DRUGBANK DB07467 C16H16ClN3O3S small molecule - - DRUGBANK 19277 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2377 (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02479 C19H21N3O3S small molecule - - DRUGBANK 19278 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2377 (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02479 C19H21N3O3S small molecule - - DRUGBANK 19279 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2377 (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02479 C19H21N3O3S small molecule - - DRUGBANK 22310 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3809 Mercuribenzoic Acid - - DRUGBANK DB03975 C7H5HgO2 small molecule - - DRUGBANK 22311 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3809 Mercuribenzoic Acid - - DRUGBANK DB03975 C7H5HgO2 small molecule - - DRUGBANK 26066 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6839 2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide - - DRUGBANK DB08046 C14H11ClN2O4S small molecule - - DRUGBANK 18881 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2199 6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate - - DRUGBANK DB02292 C14H15NO5S small molecule - - DRUGBANK 18882 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2199 6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate - - DRUGBANK DB02292 C14H15NO5S small molecule - - DRUGBANK 18883 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2199 6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate - - DRUGBANK DB02292 C14H15NO5S small molecule - - DRUGBANK 25635 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6438 5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide - - DRUGBANK DB07632 C8H6ClN3O2S2 small molecule - - DRUGBANK 20915 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3159 1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide - - DRUGBANK DB03294 C8H8N2O3S2 small molecule - - DRUGBANK 20916 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3159 1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide - - DRUGBANK DB03294 C8H8N2O3S2 small molecule - - DRUGBANK 20917 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3159 1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide - - DRUGBANK DB03294 C8H8N2O3S2 small molecule - - DRUGBANK 19689 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2569 Cyanamide - - DRUGBANK DB02679 CH2N2 small molecule - 420-04-2 DRUGBANK 19690 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2569 Cyanamide - - DRUGBANK DB02679 CH2N2 small molecule - 420-04-2 DRUGBANK 25501 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6287 N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE - - DRUGBANK DB07476 C13H12N2O3S2 small molecule - - DRUGBANK 11268 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11269 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Lachmann C (1998) 10048009 178798 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11270 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Wong BK (1996) 8781782 178796 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11271 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Srinivas SP (2002) 12356834 178797 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11272 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Berg JT (2004) 15258186 178794 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11273 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Sugrue MF (2000) 10614682 178795 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11274 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Hasegawa T (1994) 8070313 178792 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11275 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Maren TH (1997) 9029437 178793 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 11276 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Sugrue MF (1996) 8875343 178791 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 18453 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1989 N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02069 C14H13FN2O3S small molecule - - DRUGBANK 18454 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1989 N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02069 C14H13FN2O3S small molecule - - DRUGBANK 18455 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1989 N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02069 C14H13FN2O3S small molecule - - DRUGBANK 20774 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3089 AL7099A - - DRUGBANK DB03221 C14H17N3O5S3 small molecule - - DRUGBANK 20775 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3089 AL7099A - - DRUGBANK DB03221 C14H17N3O5S3 small molecule - - DRUGBANK 20776 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3089 AL7099A - - DRUGBANK DB03221 C14H17N3O5S3 small molecule - - DRUGBANK 25057 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5868 5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide - - DRUGBANK DB07050 C8H8N4O4S3 small molecule - - DRUGBANK 25055 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5866 N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide - - DRUGBANK DB07048 C17H26N2O3S small molecule - - DRUGBANK 26783 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7554 4-(2-AMINOETHYL)BENZENESULFONAMIDE - - DRUGBANK DB08782 C8H12N2O2S small molecule - - DRUGBANK 18112 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18113 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 22247 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3786 (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB03950 C19H21N3O3S small molecule - - DRUGBANK 22248 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3786 (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB03950 C19H21N3O3S small molecule - - DRUGBANK 22249 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3786 (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB03950 C19H21N3O3S small molecule - - DRUGBANK 4555 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4556 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Meyerson LR (1991) 1901209 174543 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4557 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Schaeffer P (1990) 2226620 174542 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 26188 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6957 indane-5-sulfonamide - - DRUGBANK DB08165 C9H11NO2S small molecule - - DRUGBANK 25606 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6403 (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate - - DRUGBANK DB07596 C21H28N2O4S small molecule - - DRUGBANK 26666 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7419 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE - - DRUGBANK DB08645 C8H8Cl3N3O4S2 small molecule - - DRUGBANK 12971 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1020 Ethinamate Ethinamate|Ethinamatum|1-Ethynylcyclohexanol carbamate|Etinamato|Aethinyl-cyclohexyl-carbamat - DRUGBANK DB01031 C9H13NO2 small molecule - 126-52-3 DRUGBANK 12972 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Parr JS (1992) 1460006 175971 1020 Ethinamate Ethinamate|Ethinamatum|1-Ethynylcyclohexanol carbamate|Etinamato|Aethinyl-cyclohexyl-carbamat - DRUGBANK DB01031 C9H13NO2 small molecule - 126-52-3 DRUGBANK 26340 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7088 N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE - - DRUGBANK DB08301 C14H15N3O5S2 small molecule - - DRUGBANK 22051 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3681 N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB03844 C14H12F2N2O3S small molecule - - DRUGBANK 22052 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3681 N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB03844 C14H12F2N2O3S small molecule - - DRUGBANK 22053 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3681 N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB03844 C14H12F2N2O3S small molecule - - DRUGBANK 21569 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3446 Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide] - - DRUGBANK DB03598 C18H21N3O6S3 small molecule - - DRUGBANK 21570 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3446 Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide] - - DRUGBANK DB03598 C18H21N3O6S3 small molecule - - DRUGBANK 21571 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3446 Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide] - - DRUGBANK DB03598 C18H21N3O6S3 small molecule - - DRUGBANK 14691 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Boriack-Sjodin PA (1998) 9865942 180553 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14692 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Ilies M (2000) 11003159 180557 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14693 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Iester M (2008) 19668749 180556 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14694 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Stams T (1998) 9541386 180555 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14695 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target DeSantis L (2000) 10665514 180554 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14696 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Winum JY (2004) 14684332 177906 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 14697 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Vullo D (2004) 14971907 174791 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 24918 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5711 5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE - - DRUGBANK DB06891 C8H7ClFN5O4S3 small molecule - - DRUGBANK 21558 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3442 1,2,4-Triazole - - DRUGBANK DB03594 C2H2N3 small molecule - - DRUGBANK 21559 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3442 1,2,4-Triazole - - DRUGBANK DB03594 C2H2N3 small molecule - - DRUGBANK 13959 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Munoz A (2003) 12511769 180258 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13960 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Sekine N (1996) 8612523 180259 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 20236 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2863 N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide - - DRUGBANK DB02986 C9H10N2O4S4 small molecule - - DRUGBANK 20237 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2863 N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide - - DRUGBANK DB02986 C9H10N2O4S4 small molecule - - DRUGBANK 20238 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2863 N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide - - DRUGBANK DB02986 C9H10N2O4S4 small molecule - - DRUGBANK 19416 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2432 Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide - - DRUGBANK DB02535 C13H21N3O5S small molecule - - DRUGBANK 19417 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2432 Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide - - DRUGBANK DB02535 C13H21N3O5S small molecule - - DRUGBANK 8063 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 8064 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 8065 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 26180 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6949 ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE - - DRUGBANK DB08157 C11H15NO4S small molecule - - DRUGBANK 26178 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6948 3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID - - DRUGBANK DB08156 C9H11NO4S small molecule - - DRUGBANK 26176 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6947 N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE - - DRUGBANK DB08155 C10H14N2O3S small molecule - - DRUGBANK 18753 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2132 Al7089a - - DRUGBANK DB02220 C14H17N3O5S3 small molecule - 220402-83-5 DRUGBANK 18754 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2132 Al7089a - - DRUGBANK DB02220 C14H17N3O5S3 small molecule - 220402-83-5 DRUGBANK 18755 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2132 Al7089a - - DRUGBANK DB02220 C14H17N3O5S3 small molecule - 220402-83-5 DRUGBANK 18756 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2133 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02221 C14H11F3N2O3S small molecule - - DRUGBANK 18757 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2133 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02221 C14H11F3N2O3S small molecule - - DRUGBANK 18758 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2133 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02221 C14H11F3N2O3S small molecule - - DRUGBANK 26465 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7200 (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate - - DRUGBANK DB08418 C24H27N3O5S small molecule - - DRUGBANK 11363 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11364 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Weiner ID (2003) 14656370 178863 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11365 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Verlander JW (2003) 12388412 178864 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11366 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Puscas I (2000) 10954127 178858 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 20043 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2743 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02861 C14H11F3N2O3S small molecule - - DRUGBANK 20044 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2743 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02861 C14H11F3N2O3S small molecule - - DRUGBANK 20045 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2743 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02861 C14H11F3N2O3S small molecule - - DRUGBANK 20048 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2748 Dansylamide - - DRUGBANK DB02866 C12H14N2O2S small molecule - - DRUGBANK 20049 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2748 Dansylamide - - DRUGBANK DB02866 C12H14N2O2S small molecule - - DRUGBANK 20050 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2748 Dansylamide - - DRUGBANK DB02866 C12H14N2O2S small molecule - - DRUGBANK 19537 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2503 N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02610 C14H9F5N2O3S small molecule - - DRUGBANK 19538 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2503 N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02610 C14H9F5N2O3S small molecule - - DRUGBANK 19539 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2503 N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide - - DRUGBANK DB02610 C14H9F5N2O3S small molecule - - DRUGBANK 22522 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3913 (4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide - - DRUGBANK DB04081 C9H14N2O4S3 small molecule - - DRUGBANK 22523 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3913 (4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide - - DRUGBANK DB04081 C9H14N2O4S3 small molecule - - DRUGBANK 11844 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11845 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Masuda Y (1993) 8494570 179045 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11846 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target De Simone G (2005) 15837316 179044 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11847 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Temperini C (2008) 18162396 179047 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11848 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Shank RP (2008) 18343915 179046 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11849 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11850 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11851 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11852 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 18190 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1888 AL5424 - - DRUGBANK DB01964 C13H14N2O6S3 small molecule - - DRUGBANK 18191 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1888 AL5424 - - DRUGBANK DB01964 C13H14N2O6S3 small molecule - - DRUGBANK 18192 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1888 AL5424 - - DRUGBANK DB01964 C13H14N2O6S3 small molecule - - DRUGBANK 19181 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2332 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02429 C14H13FN2O3S small molecule - - DRUGBANK 19182 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2332 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02429 C14H13FN2O3S small molecule - - DRUGBANK 19183 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2332 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide - - DRUGBANK DB02429 C14H13FN2O3S small molecule - - DRUGBANK 25746 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6543 N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE - - DRUGBANK DB07742 C14H12F2N2O3S small molecule - - DRUGBANK 21751 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3541 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide - - DRUGBANK DB03697 C11H17N3O3S small molecule - - DRUGBANK 21752 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3541 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide - - DRUGBANK DB03697 C11H17N3O3S small molecule - - DRUGBANK 22771 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4010 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide - - DRUGBANK DB04180 C14H12F2N2O3S small molecule - - DRUGBANK 22772 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4010 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide - - DRUGBANK DB04180 C14H12F2N2O3S small molecule - - DRUGBANK 22773 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4010 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide - - DRUGBANK DB04180 C14H12F2N2O3S small molecule - - DRUGBANK 17537 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1607 4-(Hydroxymercury)Benzoic Acid - - DRUGBANK DB01671 C7H6HgO3 small molecule - - DRUGBANK 17538 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1607 4-(Hydroxymercury)Benzoic Acid - - DRUGBANK DB01671 C7H6HgO3 small molecule - - DRUGBANK 20994 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3197 (4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester - - DRUGBANK DB03333 C13H14N2O3S3 small molecule - - DRUGBANK 20995 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3197 (4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester - - DRUGBANK DB03333 C13H14N2O3S3 small molecule - - DRUGBANK 20996 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3197 (4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester - - DRUGBANK DB03333 C13H14N2O3S3 small molecule - - DRUGBANK 10815 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Avvaru BS (2010) 20605094 178539 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10816 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 17702 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1682 N-Benzyl-4-Sulfamoyl-Benzamide - - DRUGBANK DB01748 C14H14N2O3S small molecule - - DRUGBANK 17703 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1682 N-Benzyl-4-Sulfamoyl-Benzamide - - DRUGBANK DB01748 C14H14N2O3S small molecule - - DRUGBANK 17704 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1682 N-Benzyl-4-Sulfamoyl-Benzamide - - DRUGBANK DB01748 C14H14N2O3S small molecule - - DRUGBANK 18501 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2007 3,5-Difluorobenzenesulfonamide - - DRUGBANK DB02087 C6H5F2NO2S small molecule - - DRUGBANK 18502 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2007 3,5-Difluorobenzenesulfonamide - - DRUGBANK DB02087 C6H5F2NO2S small molecule - - DRUGBANK 9575 107215 760 - CA2 CA-II|CAC|CAII|Car2|HEL-76 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 685 Furosemide Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid lasix injection 10mg/ml|apo fu DRUGBANK DB00695 C12H11ClN2O5S small molecule C03EB01|C03CB01|C03CA01 54-31-9 DRUGBANK 11770 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11771 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Temperini C (2008) 18162396 179047 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11772 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11773 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11774 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11775 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 10813 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Avvaru BS (2010) 20605094 178539 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 26920 107216 761 - CA3 CAIII|Car3 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 9637 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 12647 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12648 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 5370 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 8565 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 8566 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 596 Cyclothiazide Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00606 C14H16ClN3O4S2 small molecule C03AA09|C03AB09 2259-96-3 DRUGBANK 11831 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11832 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11833 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11834 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11835 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26917 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 14687 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Vullo D (2004) 14971907 174791 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 11264 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Sugrue MF (1996) 8875343 178791 859 Dorzolamide Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide jamp-dorzolamide|dorzolamide h DRUGBANK DB00869 C10H16N2O4S3 small molecule S01EC03 120279-96-1 DRUGBANK 10319 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10320 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10321 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 8059 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 8060 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 6917 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 6918 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 10805 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Avvaru BS (2010) 20605094 178539 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 10806 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 5000 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Abbate F (2004) 14684331 174789 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5001 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Dodgson SJ (2000) 10768298 174788 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5002 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Masereel B (2002) 11784136 174790 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5003 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Vullo D (2004) 14971907 174791 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 14167 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 11354 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Puscas I (2000) 10954127 178858 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11355 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 4550 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4551 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Puscas I (2000) 10713865 174540 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 12840 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12841 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12842 107217 762 - CA4 CAIV|Car4|RP17 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 11789 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11790 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target De Simone G (2005) 15837316 179044 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11791 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11792 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11793 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11794 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26922 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 14688 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens inhibitor target Vullo D (2004) 14971907 174791 1182 Brinzolamide Azopt|Brinzolamide sandoz brinzolamide|simbrinza| DRUGBANK DB01194 C12H21N3O5S3 small molecule S01EC04|S01EC54 138890-62-7 DRUGBANK 21084 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 21085 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 21086 107218 763 - CA5A CA5|CA5AD|CAV|CAVA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 11751 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11752 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11753 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11754 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11755 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26914 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 24835 107220 765 RP3-477M7.7 CA6 CA-VI|GUSTIN 9606 Homo sapiens antagonist target Demirdag R (2013) 22974493 182211 5637 Mafenide Bensulfamide|Maphenidum|4-Homosufanilamide|4-(aminomethyl)benzenesulfonamide mafenide acetate|sulfamylon cr DRUGBANK DB06795 C7H10N2O2S small molecule D06BA03 138-39-6 DRUGBANK 9636 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 693 Methazolamide Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane neptazane tablets 25mg|methazo DRUGBANK DB00703 C5H8N4O3S2 small molecule S01EC05 554-57-4 DRUGBANK 11746 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11747 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11748 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11749 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11750 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26913 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 5369 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 304 Ethoxzolamide Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide - DRUGBANK DB00311 C9H10N2O3S2 small molecule - 452-35-7 DRUGBANK 10804 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 14166 107221 766 - CA7 CAVII 9606 Homo sapiens inhibitor target Mincione F (2008) 18336310 175091 1132 Diclofenamide 1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide daranide|keveyis DRUGBANK DB01144 C6H6Cl2N2O4S2 small molecule S01EC02 120-97-8 DRUGBANK 11675 107222 767 - CA8 CA-VIII|CALS|CAMRQ3|CARP 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11676 107222 767 - CA8 CA-VIII|CALS|CAMRQ3|CARP 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11677 107222 767 - CA8 CA-VIII|CALS|CAMRQ3|CARP 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11678 107222 767 - CA8 CA-VIII|CALS|CAMRQ3|CARP 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11679 107222 767 - CA8 CA-VIII|CALS|CAMRQ3|CARP 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11741 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11742 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11743 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11744 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11745 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26912 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 12639 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 10316 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 8056 107223 768 - CA9 CAIX|MN 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 11665 107224 770 UNQ211/PRO237 CA11 CARPX1 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11666 107224 770 UNQ211/PRO237 CA11 CARPX1 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11667 107224 770 UNQ211/PRO237 CA11 CARPX1 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11668 107224 770 UNQ211/PRO237 CA11 CARPX1 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11669 107224 770 UNQ211/PRO237 CA11 CARPX1 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11805 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11806 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11807 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11808 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11809 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26907 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 12637 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 10310 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 8055 107225 771 - CA12 CAXII|HsT18816 9606 Homo sapiens inhibitor target Temperini C (2009) 19119014 174539 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 6768 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6769 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 10985 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10986 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10987 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Church J (1994) 8183255 178626 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 4504 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Gazulla J (2006) 16899342 174529 223 Pregabalin S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008 pregabalin-150|ran-pregabalin| DRUGBANK DB00230 C8H17NO2 small molecule N03AX16 148553-50-8 DRUGBANK 4505 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Jacquy J (2006) 17144644 174528 223 Pregabalin S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008 pregabalin-150|ran-pregabalin| DRUGBANK DB00230 C8H17NO2 small molecule N03AX16 148553-50-8 DRUGBANK 4506 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Taylor CP (2007) 17126531 174530 223 Pregabalin S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008 pregabalin-150|ran-pregabalin| DRUGBANK DB00230 C8H17NO2 small molecule N03AX16 148553-50-8 DRUGBANK 4507 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Gazulla J (2007) 17489948 174531 223 Pregabalin S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008 pregabalin-150|ran-pregabalin| DRUGBANK DB00230 C8H17NO2 small molecule N03AX16 148553-50-8 DRUGBANK 4508 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Field MJ (2006) 17088553 174532 223 Pregabalin S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008 pregabalin-150|ran-pregabalin| DRUGBANK DB00230 C8H17NO2 small molecule N03AX16 148553-50-8 DRUGBANK 15346 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15347 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Bezprozvanny I (1995) 7565636 180816 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15348 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 9131 107227 773 - CACNA1A APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 14820 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Lukyanetz EA (2002) 11879381 180610 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14821 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target De Smedt T (2007) 17461889 180604 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 6780 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6781 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 12593 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Cheng JK (2006) 16368827 179584 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12594 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Hoffmann U (2010) 20588320 179582 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12595 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Hendrich J (2008) 18299583 179583 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 26898 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens antagonist target Weng XC (2003) 12904272 181828 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 9117 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 6280 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Miyashita Y (2010) 20097194 175689 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6281 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Ogihara T (2009) 19634509 175694 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6282 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Murakami M (2001) 11426839 175690 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6283 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Qu YL (1998) 10374627 175691 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6284 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6285 107228 774 - CACNA1B BIII|CACNL1A5|CACNN|Cav2.2 9606 Homo sapiens inhibitor target Furukawa T (1997) 9249249 175693 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 13298 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 8086 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8087 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8711 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 5338 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5339 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens activator target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5340 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens activator target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 27153 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens unknown target Hendricson AW (2003) 12970385 188490 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 24161 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens unknown target Nordlander M (2004) 15492770 181868 4718 Clevidipine Clevidipine butyrate cleviprex DRUGBANK DB04920 C21H23Cl2NO6 small molecule C08CA16 167221-71-8 DRUGBANK 12871 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12872 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12873 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Zahradnikova A (2007) 17475903 179745 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 16329 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Moosmang S (2006) 16306443 181248 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16330 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16331 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16332 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16222 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens ligand target Boda D (2011) 21303162 181205 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 6533 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 6534 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Hu H (1998) 9584217 175856 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 6535 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Morel N (1998) 9846638 175854 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 6536 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Wei X (1995) 7592963 175855 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 9108 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9109 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Morel N (1998) 9846638 175854 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9110 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Patel MK (2005) 15880143 177614 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9111 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Dilmac N (2004) 15286207 177615 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9034 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 9035 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 13911 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 13912 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Morel N (1998) 9846638 175854 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 24816 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Romics I (2003) 12823389 181822 5626 Drotaverine Drotaverin|Drotin - DRUGBANK DB06751 C24H31NO4 small molecule A03AD02 14009-24-6 DRUGBANK 24817 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Toemoeskoezi Z (2002) 12163106 181798 5626 Drotaverine Drotaverin|Drotin - DRUGBANK DB06751 C24H31NO4 small molecule A03AD02 14009-24-6 DRUGBANK 4977 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Zuehlke RD (1998) 9607315 174773 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4978 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Berjukow S (2000) 10766758 174774 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4979 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Hitzl M (2002) 12135765 174775 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 6279 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6782 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6783 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 24755 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Rosenthal J (1994) 7898101 181689 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24756 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Morel N (1998) 9846638 175854 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 6426 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6427 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Marchetti C (1996) 8731425 175776 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6428 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6429 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6430 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6431 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6432 107229 775 - CACNA1C CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 13300 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 8092 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8093 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8714 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Bell DC (2001) 11160515 177389 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 27158 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens unknown target Hendricson AW (2003) 12970385 188490 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 24162 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens unknown target Nordlander M (2004) 15492770 181868 4718 Clevidipine Clevidipine butyrate cleviprex DRUGBANK DB04920 C21H23Cl2NO6 small molecule C08CA16 167221-71-8 DRUGBANK 12879 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 6537 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 16323 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16324 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16325 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 13915 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Bell DC (2001) 11160515 177389 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 13916 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 9119 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 4981 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Koschak A (2001) 11285265 174776 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4982 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 6286 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6792 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6793 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 24757 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 6440 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Sinnegger-Brauns MJ (2009) 19029287 174777 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6441 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6442 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6443 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6444 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6445 107230 776 - CACNA1D CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 8080 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8081 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 16293 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16294 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16295 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 6790 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6791 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 24159 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens unknown target Nordlander M (2004) 15492770 181868 4718 Clevidipine Clevidipine butyrate cleviprex DRUGBANK DB04920 C21H23Cl2NO6 small molecule C08CA16 167221-71-8 DRUGBANK 6411 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6412 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6413 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6414 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 9105 107232 778 - CACNA1F AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 13296 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 8084 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8085 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 16304 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16305 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16306 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 27154 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens unknown target Hendricson AW (2003) 12970385 188490 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 24160 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens unknown target Nordlander M (2004) 15492770 181868 4718 Clevidipine Clevidipine butyrate cleviprex DRUGBANK DB04920 C21H23Cl2NO6 small molecule C08CA16 167221-71-8 DRUGBANK 12867 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 6531 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 9030 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 9031 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 13908 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 9107 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 4973 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 6277 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6788 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6789 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 24751 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 6420 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Peterson BZ (2006) 16675661 174772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6421 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6422 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6423 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6424 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6425 107233 779 - CACNA1S CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 8664 107234 780 DAAP-278B20.1 DDR1 CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE 9606 Homo sapiens antagonist target Gotlib J (2005) 15972446 177331 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8665 107234 780 DAAP-278B20.1 DDR1 CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE 9606 Homo sapiens antagonist target Neef M (2006) 16168515 177330 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8666 107234 780 DAAP-278B20.1 DDR1 CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE 9606 Homo sapiens antagonist target Jubert C (2006) 16298518 177328 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8667 107234 780 DAAP-278B20.1 DDR1 CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE 9606 Homo sapiens antagonist target Benjamin RS (2006) 16401709 177329 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8668 107234 780 DAAP-278B20.1 DDR1 CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE 9606 Homo sapiens antagonist target Xu L (2005) 15994946 177332 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 13297 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 24752 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24753 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Araie M (2011) 20933604 182170 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24754 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Li GR (2006) 16484345 180227 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 8710 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 5336 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens activator target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5337 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens activator target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 23957 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Pascual J (1999) 10659603 181745 4640 Cyclandelate 3,5,5-Trimethylcyclohexyl amygdalate|3,3,5-Trimethylcyclohexyl mandelate|Cyclandelatum|Ciclandelato cyclospasmol tablets 200mg DRUGBANK DB04838 C17H24O3 small molecule C04AX01 456-59-7 DRUGBANK 12596 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Gazulla J (2006) 16899342 174529 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12597 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Maneuf YP (2006) 17067834 179585 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12598 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Hota D (2007) 17982508 179581 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12599 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Hoffmann U (2010) 20588320 179582 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12600 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Hendrich J (2008) 18299583 179583 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 6532 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 9032 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 9033 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 13909 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 13910 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Li GR (2006) 16484345 180227 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 6776 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6777 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 4974 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4975 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4976 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 6278 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 12868 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12869 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12870 107235 781 H_DJ0560O14.1 CACNA2D1 CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3 9606 Homo sapiens inhibitor target Zahradnikova A (2007) 17475903 179745 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 16326 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16327 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16328 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 5347 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens activator target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5348 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens activator target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 27183 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens unknown target Hendricson AW (2003) 12970385 188490 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 9120 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9036 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 9037 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 6446 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6447 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6448 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6449 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6450 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6772 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6773 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6293 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Miyashita Y (2010) 20097194 175689 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6294 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Ogihara T (2009) 19634509 175694 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6295 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Murakami M (2001) 11426839 175690 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6296 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Qu YL (1998) 10374627 175691 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6297 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6298 107236 782 - CACNB1 CAB1|CACNLB1|CCHLB1 9606 Homo sapiens inhibitor target Furukawa T (1997) 9249249 175693 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 13295 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 24748 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Rosenthal J (1994) 7898101 181689 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24749 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Honerjaeger P (1992) 1283184 181636 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24750 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Araie M (2011) 20933604 182170 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 8709 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 6778 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6779 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6530 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 393 Nisoldipine isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular nisoldipine|sular DRUGBANK DB00401 C20H24N2O6 small molecule C08CA07 63675-72-9 DRUGBANK 16317 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16318 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16319 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 9028 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 9029 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 13907 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 9106 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 4980 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 6276 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 12876 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12877 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12878 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Zahradnikova A (2007) 17475903 179745 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 6415 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6417 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6416 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6419 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6418 107237 783 RP11-383B4.2 CACNB2 CACNLB2|CAVB2|MYSB 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 16320 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16321 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16322 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 6770 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6771 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6435 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6436 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6437 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6438 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6439 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 9118 107238 784 - CACNB3 CAB3|CACNLB3 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 16290 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Mocanu MM (1999) 10372226 181239 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16291 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Jimenez C (2000) 10665814 181238 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16292 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 6784 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6785 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6406 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Kim JH (2009) 19844625 175775 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6407 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Dong CJ (2010) 20335610 175774 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6408 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Kumar R (2010) 20661350 175773 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6409 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Weant KA (2010) 20334460 175772 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6410 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Keyrouz SG (2007) 17705883 175771 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 9104 107239 785 - CACNB4 CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 13302 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 13303 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 5795 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 335 Diltiazem Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one cardizem injectable liq 5mg/ml DRUGBANK DB00343 C22H26N2O4S small molecule C05AE03|C08DB01 42399-41-7 DRUGBANK 5796 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Romero M (2003) 15320693 175364 335 Diltiazem Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one cardizem injectable liq 5mg/ml DRUGBANK DB00343 C22H26N2O4S small molecule C05AE03|C08DB01 42399-41-7 DRUGBANK 5797 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 335 Diltiazem Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one cardizem injectable liq 5mg/ml DRUGBANK DB00343 C22H26N2O4S small molecule C05AE03|C08DB01 42399-41-7 DRUGBANK 5798 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Budriesi R (2009) 19929811 175363 335 Diltiazem Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one cardizem injectable liq 5mg/ml DRUGBANK DB00343 C22H26N2O4S small molecule C05AE03|C08DB01 42399-41-7 DRUGBANK 5353 107240 786 - CACNG1 CACNLG 9606 Homo sapiens activator target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5354 107240 786 - CACNG1 CACNLG 9606 Homo sapiens activator target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 27187 107240 786 - CACNG1 CACNLG 9606 Homo sapiens unknown target Hendricson AW (2003) 12970385 188490 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 23991 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Kenny BA (1990) 1696149 181641 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 23992 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Wang SJ (2002) 11842444 181787 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 7753 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 518 Lercanidipine Lercanidipine|Lercanil - DRUGBANK DB00528 C36H41N3O6 small molecule C08CA13|C09BB02|C09DB08 100427-26-7 DRUGBANK 7752 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Burnier M (2009) 19619074 176678 518 Lercanidipine Lercanidipine|Lercanil - DRUGBANK DB00528 C36H41N3O6 small molecule C08CA13|C09BB02|C09DB08 100427-26-7 DRUGBANK 7754 107240 786 - CACNG1 CACNLG 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 518 Lercanidipine Lercanidipine|Lercanil - DRUGBANK DB00528 C36H41N3O6 small molecule C08CA13|C09BB02|C09DB08 100427-26-7 DRUGBANK 9038 107240 786 - CACNG1 CACNLG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 9039 107240 786 - CACNG1 CACNLG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 643 Magnesium Sulfate Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate epsom salts natural|epsom salt DRUGBANK DB00653 MgO4S small molecule D11AX05|V04CC02|A06AD04|B05XA05|A12CC02 7487-88-9 DRUGBANK 6774 107240 786 - CACNG1 CACNLG 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6775 107240 786 - CACNG1 CACNLG 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 8268 107241 788 - SLC25A20 CAC|CACT 9606 Homo sapiens unknown target Sekoguchi E (2003) 12882971 177055 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8269 107241 788 - SLC25A20 CAC|CACT 9606 Homo sapiens unknown target Tonazzi A (2005) 15757911 177056 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8270 107241 788 - SLC25A20 CAC|CACT 9606 Homo sapiens unknown target Peluso G (2005) 15515015 177057 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 2037 107243 790 - CAD - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2038 107243 790 - CAD - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 21264 107243 790 - CAD - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3314 Sparfosic acid PALA|N-(phosphonacetyl)-L-aspartic acid|phosphonoacetyl-L-aspartic acid|N-phosphonacetyl-L-aspartic acid|N-(phosphonoacetyl)-L-aspartic acid - DRUGBANK DB03459 C6H10NO8P small molecule - 51321-79-0 DRUGBANK 21265 107243 790 - CAD - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3314 Sparfosic acid PALA|N-(phosphonacetyl)-L-aspartic acid|phosphonoacetyl-L-aspartic acid|N-phosphonacetyl-L-aspartic acid|N-(phosphonoacetyl)-L-aspartic acid - DRUGBANK DB03459 C6H10NO8P small molecule - 51321-79-0 DRUGBANK 21266 107243 790 - CAD - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3314 Sparfosic acid PALA|N-(phosphonacetyl)-L-aspartic acid|phosphonoacetyl-L-aspartic acid|N-phosphonacetyl-L-aspartic acid|N-(phosphonoacetyl)-L-aspartic acid - DRUGBANK DB03459 C6H10NO8P small molecule - 51321-79-0 DRUGBANK 23501 107246 795 - S100G CABP|CABP1|CABP9K|CALB3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 24048 107247 796 - CALCA CALC1|CGRP|CGRP-I|CGRP1|CT|KC 9606 Homo sapiens unknown target Recober A (2007) 17665333 182035 4669 Olcegepant - - DRUGBANK DB04869 C38H47Br2N9O5 small molecule - 204697-65-4 DRUGBANK 192 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 17 Salmon Calcitonin Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon caltine inj 100 unit/ml (1ml a DRUGBANK DB00017 C145H240N44O48S2 biologic H05BA01 47931-85-1 DRUGBANK 193 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Sarkar A (1997) 9231703 171830 17 Salmon Calcitonin Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon caltine inj 100 unit/ml (1ml a DRUGBANK DB00017 C145H240N44O48S2 biologic H05BA01 47931-85-1 DRUGBANK 194 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Stroop SD (1995) 7610922 171831 17 Salmon Calcitonin Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon caltine inj 100 unit/ml (1ml a DRUGBANK DB00017 C145H240N44O48S2 biologic H05BA01 47931-85-1 DRUGBANK 195 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Bouizar Z (1986) 3004987 171832 17 Salmon Calcitonin Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon caltine inj 100 unit/ml (1ml a DRUGBANK DB00017 C145H240N44O48S2 biologic H05BA01 47931-85-1 DRUGBANK 15679 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Roth JD (2009) 19273748 181015 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15680 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Qi T (2008) 18593822 181014 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15681 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Lutz TA (2010) 20357016 181011 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15682 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Qi T (2010) 20015292 181010 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15683 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Nyholm B (2001) 11772274 181013 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15684 107250 799 - CALCR CRT|CT-R|CTR|CTR1 9606 Homo sapiens agonist target Hay DL (2004) 15494035 181012 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 26059 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6832 (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE - - DRUGBANK DB08039 C19H21N3O3S small molecule - - DRUGBANK 10122 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Fan RS (2005) 15845548 178201 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10123 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Bickler PE (2005) 16129978 178202 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10124 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Sazonova OV (2007) 17229152 178203 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 23581 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4325 N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide - - DRUGBANK DB04513 C16H21ClN2O2S small molecule - - DRUGBANK 13728 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Wang XB (1990) 2120879 182269 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13729 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Mody I (1984) 6146939 182270 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13730 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Papadopoulos V (1990) 1965307 182271 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13731 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Strobl JS (1990) 2386945 182272 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13732 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Cimino M (1988) 3134891 179132 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 22146 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 22147 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 13401 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Radogna F (2009) 19463840 179949 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13402 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target del Rio B (2004) 15229223 179956 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13465 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Cohen ME (1986) 3022601 182263 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13466 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target DiPaola M (1984) 6319437 182262 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13467 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Lohr KM (1984) 6092486 182261 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13468 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Luchowski EM (1984) 6433001 182265 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13469 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Scott JA (1986) 3820316 182264 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 16648 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Levine SN (1983) 6186851 182289 1377 Aprindine Aprindine|Compound 99170|Aprindina|Aprindinum - DRUGBANK DB01429 C22H30N2 small molecule C01BB04 37640-71-4 DRUGBANK 11967 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Kuromi H (1997) 9100252 179135 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11968 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Lukas TJ (1985) 3994963 179134 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11969 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Suko J (1986) 3758070 179131 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11970 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Earl CQ (1984) 6146911 179133 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 11971 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Cimino M (1988) 3134891 179132 915 Phenoxybenzamine Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB phenoxybenzamine hydrochloride DRUGBANK DB00925 C18H22ClNO small molecule C04AX02 59-96-1 DRUGBANK 12880 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Johnson JD (1987) 2442519 182258 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12881 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Mills JS (1985) 4074665 182259 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12882 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Lamers JM (1987) 2964559 182257 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12883 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Walsh MP (1988) 2833901 182260 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12884 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Lamers JM (1985) 2933041 179746 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12885 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Bostroem SL (1988) 3178884 179747 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 22320 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3811 N-Trimethyllysine - - DRUGBANK DB03977 C9H21N2O2 small molecule - - DRUGBANK 22321 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3811 N-Trimethyllysine - - DRUGBANK DB03977 C9H21N2O2 small molecule - - DRUGBANK 22322 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3811 N-Trimethyllysine - - DRUGBANK DB03977 C9H21N2O2 small molecule - - DRUGBANK 7359 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Marshak DR (1985) 2986673 176354 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 15334 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens binder target Lamers JM (1985) 2933041 179746 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15335 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens binder target Lamers JM (1987) 2964559 182257 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 8716 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Thayer SA (1983) 6865927 177390 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 8727 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Edlind T (2002) 12366848 58606 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8728 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Kauss H (1981) 16661928 177393 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8729 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Kawai M (2001) 11409178 54890 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8730 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Mongin AA (1999) 10516112 177395 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8731 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Nakabayashi H (1992) 1515867 177394 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 16227 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Sosa V (2007) 17537429 182285 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16228 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Lo LW (2007) 17612522 182284 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16229 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Schallreuter KU (2007) 17592724 182287 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16230 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Caride AJ (2007) 17595168 182286 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16231 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Zhou Z (2007) 17550897 182288 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 26268 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 23933 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Lamers JM (1985) 2933041 179746 4627 Prenylamine N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-1-propanamine|Prenilamina|N-(3'-Phenyl-2-propyl)-1,1-diphenyl-3-propyloamine|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin|N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine|DL-prenylamine|1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane|Prenylaminum|N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine - DRUGBANK DB04825 C24H27N small molecule C01DX52|C01DX02 390-64-7 DRUGBANK 11149 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Edlind T (2002) 12366848 58606 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11150 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Natochin YuV (1987) 2885243 178692 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11151 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Kawai M (2001) 11409178 54890 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11152 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Mongin AA (1999) 10516112 177395 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 23976 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23977 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 13917 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Lamers JM (1985) 2933041 179746 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 20051 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2750 3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine - - DRUGBANK DB02868 C46H55ClN5O7 small molecule - - DRUGBANK 20052 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2750 3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine - - DRUGBANK DB02868 C46H55ClN5O7 small molecule - - DRUGBANK 20053 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2750 3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine - - DRUGBANK DB02868 C46H55ClN5O7 small molecule - - DRUGBANK 10980 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Diener M (1988) 2851449 178622 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10981 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Suzuki T (2000) 10991984 178623 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10982 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Mellstrand T (1987) 2820051 178621 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10983 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Daly JW (2000) 10949586 178624 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10984 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Stoll R (1988) 2836258 178625 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10937 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Torres-Piedra M (2011) 21129983 178592 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10938 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 7748 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Volpi M (1981) 6262771 176673 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7749 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Sambandam T (1993) 8382768 176676 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7750 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Liu SH (1993) 7680317 176675 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7751 107252 801 - CALM1 CALML2|CAMI|CPVT4|DD132|PHKD|caM 9606 Homo sapiens inhibitor target Muto Y (1983) 6140014 176674 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 278 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens chaperone target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 279 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens chaperone target Kaufman RJ (1997) 9607108 171871 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 280 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens chaperone target Pipe SW (1998) 9525969 1039 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 281 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens chaperone target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 282 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens chaperone target Srour MA (2008) 17899080 171873 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 383 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens unknown target Allen S (1997) 9359841 1042 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 13389 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens unknown target Hardeland R (2009) 19449447 179953 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13390 107262 811 - CALR CRT|HEL-S-99n|RO|SSA|cC1qR 9606 Homo sapiens unknown target Macias M (2003) 12603316 179957 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 25684 107264 814 - CAMK4 CaMK IV|CaMK-GR|IV|caMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6482 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one - - DRUGBANK DB07676 C20H19N3O4 small molecule - - DRUGBANK 25670 107264 814 - CAMK4 CaMK IV|CaMK-GR|IV|caMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6470 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE - - DRUGBANK DB07664 C15H13F2N7O2S2 small molecule - - DRUGBANK 23425 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23426 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23427 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 22600 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3951 Hexatantalum Dodecabromide - - DRUGBANK DB04119 Br12Ta6 small molecule - - DRUGBANK 22601 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3951 Hexatantalum Dodecabromide - - DRUGBANK DB04119 Br12Ta6 small molecule - - DRUGBANK 22602 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3951 Hexatantalum Dodecabromide - - DRUGBANK DB04119 Br12Ta6 small molecule - - DRUGBANK 25783 107265 815 - CAMK2A CAMKA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6567 (2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME} - - DRUGBANK DB07766 C20H19N3O4 small molecule - - DRUGBANK 25178 107266 816 - CAMK2B CAM2|CAMK2|CAMKB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5985 [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile - - DRUGBANK DB07168 C19H20N8 small molecule - - DRUGBANK 26060 107267 817 - CAMK2D CAMKD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6832 (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE - - DRUGBANK DB08039 C19H21N3O3S small molecule - - DRUGBANK 25880 107267 817 - CAMK2D CAMKD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6650 [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE - - DRUGBANK DB07853 C22H19N7 small molecule - - DRUGBANK 26727 107268 818 RP11-574K11.6 CAMK2G CAMK|CAMK-II|CAMKG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7473 1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine - - DRUGBANK DB08699 C17H21N5 small molecule - - DRUGBANK 24587 107268 818 RP11-574K11.6 CAMK2G CAMK|CAMK-II|CAMKG 9606 Homo sapiens inhibitor target Amsberg GK (2013) 23493838 182235 5562 Bosutinib SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate bosulif DRUGBANK DB06616 C26H29Cl2N5O3 small molecule L01XE14 380843-75-4 DRUGBANK 1120 107269 819 - CAMLG CAML 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1121 107269 819 - CAMLG CAML 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1122 107269 819 - CAMLG CAML 9606 Homo sapiens binder target Bernasconi R (2010) 20927389 172297 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1123 107269 819 - CAMLG CAML 9606 Homo sapiens binder target Lee J (2010) 20637127 172290 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1124 107269 819 - CAMLG CAML 9606 Homo sapiens binder target Yamashita H (2010) 20674565 172299 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1125 107269 819 - CAMLG CAML 9606 Homo sapiens binder target Galat A (2010) 20602248 172298 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 18999 107270 820 HSD26 CAMP CAP-18|CAP18|CRAMP|FALL-39|FALL39|LL37 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 19000 107270 820 HSD26 CAMP CAP-18|CAP18|CRAMP|FALL-39|FALL39|LL37 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 19001 107270 820 HSD26 CAMP CAP-18|CAP18|CRAMP|FALL-39|FALL39|LL37 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 272 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens chaperone target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 273 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens chaperone target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 274 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens chaperone target Pipe SW (1998) 9525969 1039 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 275 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens chaperone target Kaufman RJ (1997) 9607108 171871 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 276 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens chaperone target Becker S (2004) 15213841 171872 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 277 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens chaperone target Srour MA (2008) 17899080 171873 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 387 107271 821 - CANX CNX|IP90|P90 9606 Homo sapiens unknown target Allen S (1997) 9359841 1042 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 22984 107273 823 PIG30 CAPN1 CANP|CANP1|CANPL1|muCANP|muCL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4103 N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine - - DRUGBANK DB04276 C15H30N5O5 small molecule - - DRUGBANK 25631 107273 823 PIG30 CAPN1 CANP|CANP1|CANPL1|muCANP|muCL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6433 (2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE - - DRUGBANK DB07627 C17H25N3O3S small molecule - - DRUGBANK 19479 107276 826 - CAPNS1 CALPAIN4|CANP|CANPS|CAPN4|CDPS|CSS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2466 PD150606 - - DRUGBANK DB02570 C9H9IO2S small molecule - - DRUGBANK 16225 107281 831 - CAST BS-17 9606 Homo sapiens unknown target Hanna RA (2007) 17543955 181208 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16226 107281 831 - CAST BS-17 9606 Homo sapiens unknown target De Tullio R (2007) 17570336 181209 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 2905 107283 833 - CARS CARS1|CYSRS|MGC:11246 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2906 107283 833 - CARS CARS1|CYSRS|MGC:11246 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 12793 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens negative modulator target Sanchez Mejia RO (2001) 11383749 179694 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12794 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens negative modulator target Vincent JA (2007) 17192486 179695 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12795 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens negative modulator target Chen M (2000) 10888929 179696 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12796 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens negative modulator target Kim HS (2009) 18977395 179697 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 25747 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6545 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID - - DRUGBANK DB07744 C21H29N3O7 small molecule - - DRUGBANK 25937 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6712 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID - - DRUGBANK DB07916 C24H25N3O6S small molecule - - DRUGBANK 24054 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens unknown target Ross J (2007) 17845807 182047 4675 Pralnacasan HMR 3480 - DRUGBANK DB04875 C26H29N5O7 small molecule - 192755-52-5 DRUGBANK 25737 107284 834 - CASP1 ICE|IL1BC|P45 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6534 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE - - DRUGBANK DB07733 C10H10F3N3OS2 small molecule - - DRUGBANK 26541 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7276 (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate - - DRUGBANK DB08497 C19H14N2O6 small molecule - - DRUGBANK 26542 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7277 (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate - - DRUGBANK DB08498 C19H13ClN2O6 small molecule - - DRUGBANK 25703 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6501 methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate - - DRUGBANK DB07696 C11H19NO5 small molecule - - DRUGBANK 20525 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2993 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid - - DRUGBANK DB03124 C20H20N2O9S small molecule - - DRUGBANK 20526 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2993 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid - - DRUGBANK DB03124 C20H20N2O9S small molecule - - DRUGBANK 20527 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2993 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid - - DRUGBANK DB03124 C20H20N2O9S small molecule - - DRUGBANK 26230 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7004 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE - - DRUGBANK DB08213 C20H20N2O5S small molecule - - DRUGBANK 26304 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7040 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID - - DRUGBANK DB08251 C17H14N2O6 small molecule - - DRUGBANK 26246 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7019 [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID - - DRUGBANK DB08229 C20H23N3O5 small molecule - - DRUGBANK 12805 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens negative modulator target Baptiste DC (2004) 15304547 179708 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12806 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens negative modulator target Lee SM (2003) 14588118 179706 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12807 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens negative modulator target Arvin KL (2002) 12112047 179707 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12808 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens negative modulator target Dommergues MA (2003) 14568022 179705 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12809 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens negative modulator target Chen M (2000) 10888929 179696 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12810 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens negative modulator target Kim HS (2009) 18977395 179697 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 26543 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7278 N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide - - DRUGBANK DB08499 C21H18FN3O6 small molecule - - DRUGBANK 24892 107286 836 - CASP3 CPP32|CPP32B|SCA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5683 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID - - DRUGBANK DB06862 C9H11NO5S2 small molecule - - DRUGBANK 21078 107290 840 RP11-211N11.6 CASP7 CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3243 Fica - - DRUGBANK DB03384 C11H11FN2OS small molecule - - DRUGBANK 21079 107290 840 RP11-211N11.6 CASP7 CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3243 Fica - - DRUGBANK DB03384 C11H11FN2OS small molecule - - DRUGBANK 21080 107290 840 RP11-211N11.6 CASP7 CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3243 Fica - - DRUGBANK DB03384 C11H11FN2OS small molecule - - DRUGBANK 12722 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Drueeke TB (2009) 19056615 179647 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12723 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12724 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Eriguchi R (2008) 19461861 179649 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12725 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Belozeroff V (2009) 19261825 179648 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12726 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target de Francisco AL (2005) 15794735 179654 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12727 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Rothe HM (2005) 15864123 179655 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12728 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Cunningham J (2005) 16109140 179650 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12729 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Tasic V (2005) 15884662 179651 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12730 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Moe SM (2005) 16030053 179652 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 12731 107296 846 - CASR CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1 9606 Homo sapiens agonist target Meola M (2009) 19181759 179653 1002 Cinacalcet N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara sandoz cinacalcet|mylan-cinaca DRUGBANK DB01012 C22H22F3N small molecule H05BX01 226256-56-0 DRUGBANK 14886 107297 847 - CAT - 9606 Homo sapiens inhibitor target Bradford BU (1993) 8423764 38291 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14887 107297 847 - CAT - 9606 Homo sapiens inhibitor target Thurman RG (1975) 240743 180649 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 14888 107297 847 - CAT - 9606 Homo sapiens inhibitor target Handler JA (1988) 3416882 180648 1201 Fomepizole Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole antizol|fomepizole|fomepizole DRUGBANK DB01213 C4H6N2 small molecule V03AB34 7554-65-6 DRUGBANK 23477 107319 873 - CBR1 CBR|SDR21C1|hCBR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4277 3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol - - DRUGBANK DB04463 C15H17N5O small molecule - - DRUGBANK 2916 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Lowicka E (2007) 17377202 172462 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2917 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Oh GS (2006) 16781459 173565 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2918 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Zhang H (2006) 16428267 173548 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2919 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Bhatia M (2005) 15671155 173567 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2920 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Tamizhselvi R (2007) 17488480 173566 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 1714 107321 875 - CBS HIP4 9606 Homo sapiens activator target Janosik M (2001) 11524006 172682 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1715 107321 875 - CBS HIP4 9606 Homo sapiens activator target Evande R (2002) 12269827 172683 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1716 107321 875 - CBS HIP4 9606 Homo sapiens activator target Choumenkovitch SF (2002) 12163655 172684 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1717 107321 875 - CBS HIP4 9606 Homo sapiens activator target Jacobs RL (2001) 11559709 172685 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1609 107321 875 - CBS HIP4 9606 Homo sapiens cofactor target Taoka S (2002) 11948191 172592 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1610 107321 875 - CBS HIP4 9606 Homo sapiens cofactor target Evande R (2004) 15196993 172593 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1611 107321 875 - CBS HIP4 9606 Homo sapiens cofactor target Mino K (2003) 12644499 172591 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1612 107321 875 - CBS HIP4 9606 Homo sapiens cofactor target Linnebank M (2004) 15365998 172594 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1613 107321 875 - CBS HIP4 9606 Homo sapiens cofactor target Taoka S (2002) 12173932 172595 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2178 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Qu K (2008) 17629356 173082 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2179 107321 875 - CBS HIP4 9606 Homo sapiens unknown target Sen S (2007) 17352495 173081 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 25977 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6745 1H-INDOL-3-YLACETIC ACID - - DRUGBANK DB07950 C10H9NO2 small molecule - - DRUGBANK 18605 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 18606 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 22536 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22537 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 1594 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens cofactor target Mosca M (2003) 12850267 172581 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1595 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens cofactor target Cooper AJ (2006) 16463021 172583 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1596 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens cofactor target Zhang L (2006) 16846239 172582 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1597 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens cofactor target Cooper AJ (2002) 12167474 172517 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1598 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens cofactor target Venhorst J (2003) 12798391 172477 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 19456 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2453 D-Phenylalanine - - DRUGBANK DB02556 C9H11NO2 small molecule - 673-06-3 DRUGBANK 19457 107326 883 RP11-545E17.6 CCBL1 GTK|KAT1|KATI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2453 D-Phenylalanine - - DRUGBANK DB02556 C9H11NO2 small molecule - 673-06-3 DRUGBANK 24026 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens unknown target Persiani S (2006) 17112294 181975 4656 Dexloxiglumide CR 2017|CR-2017 - DRUGBANK DB04856 C21H30Cl2N2O5 small molecule - 119817-90-2 DRUGBANK 6550 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens inducer target Shinohara S (1992) 1356589 175863 395 Ceruletide Ceruletidum|Cerulein|Ceruletida|Caerulein - DRUGBANK DB00403 C58H73N13O21S2 small molecule V04CC04 17650-98-5 DRUGBANK 6551 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens inducer target Katsuura G (1992) 1620654 175862 395 Ceruletide Ceruletidum|Cerulein|Ceruletida|Caerulein - DRUGBANK DB00403 C58H73N13O21S2 small molecule V04CC04 17650-98-5 DRUGBANK 6552 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens inducer target Makovec F (1987) 3440035 175861 395 Ceruletide Ceruletidum|Cerulein|Ceruletida|Caerulein - DRUGBANK DB00403 C58H73N13O21S2 small molecule V04CC04 17650-98-5 DRUGBANK 6553 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens inducer target Maurice T (1994) 8182534 175866 395 Ceruletide Ceruletidum|Cerulein|Ceruletida|Caerulein - DRUGBANK DB00403 C58H73N13O21S2 small molecule V04CC04 17650-98-5 DRUGBANK 6554 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens inducer target Ibii N (1989) 2587420 175865 395 Ceruletide Ceruletidum|Cerulein|Ceruletida|Caerulein - DRUGBANK DB00403 C58H73N13O21S2 small molecule V04CC04 17650-98-5 DRUGBANK 6555 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens inducer target Ishikawa Y (1990) 2087492 175864 395 Ceruletide Ceruletidum|Cerulein|Ceruletida|Caerulein - DRUGBANK DB00403 C58H73N13O21S2 small molecule V04CC04 17650-98-5 DRUGBANK 24041 107328 886 - CCKAR CCK-A|CCK1-R|CCK1R|CCKRA 9606 Homo sapiens unknown target Kreiss C (1998) 9712175 181732 4667 Lintitript - - DRUGBANK DB04867 C20H14ClN3O3S small molecule - 136381-85-6 DRUGBANK 3940 107329 887 - CCKBR CCK-B|CCK2R|GASR 9606 Homo sapiens agonist target Radu D (2002) 12073167 174176 176 Pentagastrin - pentagastrin|peptavlon liq inj DRUGBANK DB00183 C37H49N7O9S small molecule V04CG04 5534-95-2 DRUGBANK 3941 107329 887 - CCKBR CCK-B|CCK2R|GASR 9606 Homo sapiens agonist target Singh P (1986) 3004700 174177 176 Pentagastrin - pentagastrin|peptavlon liq inj DRUGBANK DB00183 C37H49N7O9S small molecule V04CG04 5534-95-2 DRUGBANK 3942 107329 887 - CCKBR CCK-B|CCK2R|GASR 9606 Homo sapiens agonist target Makovec F (1992) 1732532 174174 176 Pentagastrin - pentagastrin|peptavlon liq inj DRUGBANK DB00183 C37H49N7O9S small molecule V04CG04 5534-95-2 DRUGBANK 3943 107329 887 - CCKBR CCK-B|CCK2R|GASR 9606 Homo sapiens agonist target Nishida A (1995) 7491961 174175 176 Pentagastrin - pentagastrin|peptavlon liq inj DRUGBANK DB00183 C37H49N7O9S small molecule V04CG04 5534-95-2 DRUGBANK 3944 107329 887 - CCKBR CCK-B|CCK2R|GASR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 176 Pentagastrin - pentagastrin|peptavlon liq inj DRUGBANK DB00183 C37H49N7O9S small molecule V04CG04 5534-95-2 DRUGBANK 3945 107329 887 - CCKBR CCK-B|CCK2R|GASR 9606 Homo sapiens agonist target Khan S (2004) 15157745 174178 176 Pentagastrin - pentagastrin|peptavlon liq inj DRUGBANK DB00183 C37H49N7O9S small molecule V04CG04 5534-95-2 DRUGBANK 25696 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6493 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE - - DRUGBANK DB07688 C17H20N6O3S small molecule - - DRUGBANK 19989 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2715 [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine - - DRUGBANK DB02833 C14H12N6O2S small molecule - - DRUGBANK 26295 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7031 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE - - DRUGBANK DB08241 C19H22N6O2 small molecule - - DRUGBANK 24871 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5665 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE - - DRUGBANK DB06844 C21H15N5O3S2 small molecule - - DRUGBANK 26301 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7037 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE - - DRUGBANK DB08248 C18H22N6O3S small molecule - - DRUGBANK 24972 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5767 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE - - DRUGBANK DB06948 C18H21N5O small molecule - - DRUGBANK 24968 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5763 N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide - - DRUGBANK DB06944 C18H17N3O small molecule - - DRUGBANK 26237 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7010 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE - - DRUGBANK DB08219 C18H20N6OS small molecule - - DRUGBANK 26614 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7349 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE - - DRUGBANK DB08572 C18H22N6O3 small molecule - - DRUGBANK 26347 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7096 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL - - DRUGBANK DB08309 C23H32N6O4S small molecule - - DRUGBANK 25135 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5944 O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE - - DRUGBANK DB07126 C18H22N6O3S small molecule - - DRUGBANK 26515 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7244 (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol - - DRUGBANK DB08463 C24H29N7O small molecule - - DRUGBANK 25550 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6344 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE - - DRUGBANK DB07534 C14H11N3O4S2 small molecule - - DRUGBANK 26576 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7305 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE - - DRUGBANK DB08527 C15H12N6O3S small molecule - - DRUGBANK 25175 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5982 N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine - - DRUGBANK DB07164 C13H12N6 small molecule - - DRUGBANK 25554 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6348 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE - - DRUGBANK DB07538 C15H10F3N3O4S2 small molecule - - DRUGBANK 25485 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6282 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE - - DRUGBANK DB07471 C22H20ClN3O4S small molecule - - DRUGBANK 26326 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7073 (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol - - DRUGBANK DB08285 C19H26N6O small molecule - - DRUGBANK 25206 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6020 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE - - DRUGBANK DB07203 C18H20ClN5O small molecule - - DRUGBANK 18513 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2011 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine - - DRUGBANK DB02091 C9H10N4S small molecule - - DRUGBANK 26209 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6974 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine - - DRUGBANK DB08182 C14H15N5O small molecule - - DRUGBANK 26204 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6970 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine - - DRUGBANK DB08178 C12H11N5O small molecule - - DRUGBANK 25548 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6343 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE - - DRUGBANK DB07533 C15H13N3O4S2 small molecule - - DRUGBANK 26235 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7009 HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM - - DRUGBANK DB08218 C19H15N7O2 small molecule - - DRUGBANK 25877 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6649 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID - - DRUGBANK DB07852 C10H7Cl2N3O2 small molecule - - DRUGBANK 26274 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7023 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE - - DRUGBANK DB08233 C18H21N5O2 small molecule - - DRUGBANK 25148 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5955 (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE - - DRUGBANK DB07137 C18H19N5O2 small molecule - - DRUGBANK 26403 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7140 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid - - DRUGBANK DB08355 C17H15N5O2 small molecule - - DRUGBANK 19157 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2310 6-O-Cyclohexylmethyl Guanine - - DRUGBANK DB02407 C12H17N5O small molecule - - DRUGBANK 25556 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6349 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID - - DRUGBANK DB07539 C15H10N2O4S small molecule - - DRUGBANK 26722 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7468 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol - - DRUGBANK DB08694 C14H11N7O small molecule - - DRUGBANK 25578 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6371 N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE - - DRUGBANK DB07562 C17H19N5S small molecule - - DRUGBANK 20130 107331 890 - CCNA2 CCN1|CCNA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2794 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine - - DRUGBANK DB02915 C16H13F3N4S small molecule - - DRUGBANK 1198 107347 909 - CD1A CD1|FCB6|HTA1|R4|T6 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 1199 107347 909 - CD1A CD1|FCB6|HTA1|R4|T6 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 1200 107347 909 - CD1A CD1|FCB6|HTA1|R4|T6 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 23803 107350 912 - CD1D CD1A|R3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4466 Cis-tetracosenoyl sulfatide (2S,3R,4E)-n-nervonic-1-[beta-d-(3-sulfate)-galactopyranosyl]-2-amino-octadecene-3-ol - DRUGBANK DB04661 C48H91NO11S small molecule - - DRUGBANK 1131 107352 914 RP4-655N15.2 CD2 LFA-2|SRBC|T11 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1132 107352 914 RP4-655N15.2 CD2 LFA-2|SRBC|T11 9606 Homo sapiens inhibitor target da Silva AJ (2002) 11970990 172361 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1133 107352 914 RP4-655N15.2 CD2 LFA-2|SRBC|T11 9606 Homo sapiens inhibitor target Ortonne JP (2003) 12795770 172360 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1134 107352 914 RP4-655N15.2 CD2 LFA-2|SRBC|T11 9606 Homo sapiens inhibitor target Larsen R (2007) 17403057 172362 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1135 107352 914 RP4-655N15.2 CD2 LFA-2|SRBC|T11 9606 Homo sapiens inhibitor target Chamian F (2007) 17555598 172358 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1136 107352 914 RP4-655N15.2 CD2 LFA-2|SRBC|T11 9606 Homo sapiens inhibitor target Goedkoop AY (2004) 14968366 172359 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 996 107353 915 - CD3D CD3-DELTA|IMD19|T3D 9606 Homo sapiens unknown target Wilde MI (1996) 8861551 172234 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 997 107353 915 - CD3D CD3-DELTA|IMD19|T3D 9606 Homo sapiens unknown target Todd PA (1989) 2503348 172233 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 27470 107353 915 - CD3D CD3-DELTA|IMD19|T3D 9606 Homo sapiens activator target Zugmaier G (2015) 25883042 188543 7813 Blinatumomab - blincyto DRUGBANK DB09052 C2367H3577N649O772S19 biologic L01XC19 853426-35-4 DRUGBANK 1004 107354 916 - CD3E IMD18|T3E|TCRE 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1005 107354 916 - CD3E IMD18|T3E|TCRE 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1006 107354 916 - CD3E IMD18|T3E|TCRE 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 998 107355 917 - CD3G CD3-GAMMA|IMD17|T3G 9606 Homo sapiens unknown target Wilde MI (1996) 8861551 172234 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 999 107355 917 - CD3G CD3-GAMMA|IMD17|T3G 9606 Homo sapiens unknown target Todd PA (1989) 2503348 172233 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1000 107357 919 RP11-104L21.1 CD247 CD3-ZETA|CD3H|CD3Q|CD3Z|IMD25|T3Z|TCRZ 9606 Homo sapiens unknown target Wilde MI (1996) 8861551 172234 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1001 107357 919 RP11-104L21.1 CD247 CD3-ZETA|CD3H|CD3Q|CD3Z|IMD25|T3Z|TCRZ 9606 Homo sapiens unknown target Todd PA (1989) 2503348 172233 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1201 107358 920 - CD4 CD4mut 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 27469 107368 930 - CD19 B4|CVID3 9606 Homo sapiens activator target Zugmaier G (2015) 25883042 188543 7813 Blinatumomab - blincyto DRUGBANK DB09052 C2367H3577N649O772S19 biologic L01XC19 853426-35-4 DRUGBANK 1027 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1028 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Dillman RO (2002) 11879282 172242 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1029 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Wiseman GA (1999) 10541376 172243 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1030 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Witzig TE (2002) 12011122 172240 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1031 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Goldenberg DM (2001) 11418316 172241 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1032 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Goldsmith SJ (2010) 20113680 172244 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1033 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Witzig TE (2004) 15045033 172239 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 27009 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Robak T (2009) 19513948 182112 7674 Obinutuzumab Afutuzumab gazyva DRUGBANK DB08935 C6512H10060N1712O2020S44 biologic L01XC15 949142-50-1 DRUGBANK 1054 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1055 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Dillman RO (2002) 11879282 172242 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1056 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Goldenberg DM (2001) 11418316 172241 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1057 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Unknown (2003) 12899647 172246 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1058 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Beeson C (2003) 13129395 172247 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1059 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Silverman DH (2004) 15023434 172245 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1060 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Friedberg JW (2004) 14748653 172248 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 27870 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens inhibitor target Du J (2009) 19427037 195989 8081 Ofatumumab Ofatumumabum|HuMax-CD20|Ofatumumab arzerra DRUGBANK DB06650 C6480H10022N1742O2020S44 biologic L01XC10 679818-59-8 DRUGBANK 27871 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens inhibitor target Doerner T (2008) 18388516 195983 8081 Ofatumumab Ofatumumabum|HuMax-CD20|Ofatumumab arzerra DRUGBANK DB06650 C6480H10022N1742O2020S44 biologic L01XC10 679818-59-8 DRUGBANK 27872 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens inhibitor target Glennie MJ (2007) 17768100 195981 8081 Ofatumumab Ofatumumabum|HuMax-CD20|Ofatumumab arzerra DRUGBANK DB06650 C6480H10022N1742O2020S44 biologic L01XC10 679818-59-8 DRUGBANK 937 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target van Meerten T (2010) 20350667 172220 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 938 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 939 107369 931 - MS4A1 B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7 9606 Homo sapiens antibody target Jaglowski SM (2010) 20350663 172219 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 24239 107371 933 - CD22 SIGLEC-2|SIGLEC2 9606 Homo sapiens unknown target Steinfeld SD (2006) 16918261 181961 4752 Epratuzumab anti-CD22 IgG|humanised anti-CD22 antibody - DRUGBANK DB04958 - biologic - 205923-57-5 DRUGBANK 24240 107371 933 - CD22 SIGLEC-2|SIGLEC2 9606 Homo sapiens unknown target Carnahan J (2007) 16814387 181950 4752 Epratuzumab anti-CD22 IgG|humanised anti-CD22 antibody - DRUGBANK DB04958 - biologic - 205923-57-5 DRUGBANK 24241 107371 933 - CD22 SIGLEC-2|SIGLEC2 9606 Homo sapiens unknown target Leonard JP (2007) 17530024 182016 4752 Epratuzumab anti-CD22 IgG|humanised anti-CD22 antibody - DRUGBANK DB04958 - biologic - 205923-57-5 DRUGBANK 15714 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Kremer JM (2005) 16357751 181021 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15715 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Weyand CM (2006) 16932686 181022 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15716 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Maxwell LJ (2010) 20080922 181023 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15717 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Hervey PS (2006) 16573350 181024 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15718 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Vincenti F (2006) 17020493 181025 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15719 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Nogid A (2006) 17212998 181026 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15720 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Reynolds J (2007) 18041889 181027 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15721 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Scheinfeld N (2006) 16971318 181028 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15722 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 24126 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens unknown target Czuczman MS (2005) 15994148 181897 4701 Galiximab N/A|IDEC-114 - DRUGBANK DB04901 - biologic - 357613-77-5 DRUGBANK 24127 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens unknown target Gottlieb AB (2004) 15093549 181846 4701 Galiximab N/A|IDEC-114 - DRUGBANK DB04901 - biologic - 357613-77-5 DRUGBANK 24128 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens unknown target Leonard JP (2007) 17470451 182005 4701 Galiximab N/A|IDEC-114 - DRUGBANK DB04901 - biologic - 357613-77-5 DRUGBANK 24626 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens unknown target Yabu JM (2007) 17616278 182026 5570 Belatacept BMS224818|BMS-224818|LEA29Y|CTLA4-Ig|LEA 29Y|CD152 antigen nulojix DRUGBANK DB06681 C3508H5440N922O1096S32 biologic L04AA28 706808-37-9 DRUGBANK 24627 107379 941 - CD80 B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7 9606 Homo sapiens unknown target Tedesco Silva H (2006) 16978033 181967 5570 Belatacept BMS224818|BMS-224818|LEA29Y|CTLA4-Ig|LEA 29Y|CD152 antigen nulojix DRUGBANK DB06681 C3508H5440N922O1096S32 biologic L04AA28 706808-37-9 DRUGBANK 15705 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Kremer JM (2005) 16357751 181021 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15706 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Weyand CM (2006) 16932686 181022 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15707 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Maxwell LJ (2010) 20080922 181023 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15708 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Hervey PS (2006) 16573350 181024 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15709 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Vincenti F (2006) 17020493 181025 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15710 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Nogid A (2006) 17212998 181026 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15711 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Reynolds J (2007) 18041889 181027 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15712 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Scheinfeld N (2006) 16971318 181028 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 15713 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1268 Abatacept CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig orencia DRUGBANK DB01281 C3498H5458N922O1090S32 biologic L04AA24 332348-12-6 DRUGBANK 1205 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 24625 107380 942 - CD86 B7-2|B7.2|B70|CD28LG2|LAB72 9606 Homo sapiens unknown target Vincenti F (2008) 18269922 182065 5570 Belatacept BMS224818|BMS-224818|LEA29Y|CTLA4-Ig|LEA 29Y|CD152 antigen nulojix DRUGBANK DB06681 C3508H5440N922O1096S32 biologic L04AA28 706808-37-9 DRUGBANK 26936 107381 943 - TNFRSF8 CD30|D1S166E|Ki-1 9606 Homo sapiens binder target Francisco JA (2003) 12714494 181815 7614 Brentuximab vedotin cAC10-vcMMAE adcetris DRUGBANK DB08870 C6476H9930N1690O2030S40 biologic L01XC12 914088-09-8 DRUGBANK 730 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target McHayleh W (2010) 20564405 172101 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 731 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target van Der Velden VH (2001) 11342449 172100 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 732 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target Naito K (2000) 10942240 172102 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 733 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target Niculescu-Duvaz I (2000) 11249747 172099 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 734 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target Sievers EL (2001) 11432892 172098 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 735 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target Bross PF (2001) 11410481 172097 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 736 107383 945 - CD33 SIGLEC-3|SIGLEC3|p67 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 2695 107387 949 - SCARB1 CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1 9606 Homo sapiens unknown target Osada Y (2006) 16530182 173407 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2696 107387 949 - SCARB1 CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1 9606 Homo sapiens unknown target Zhang J (2006) 16371234 173406 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2697 107387 949 - SCARB1 CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1 9606 Homo sapiens unknown target Yancey PG (2004) 14594995 173405 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2698 107387 949 - SCARB1 CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1 9606 Homo sapiens unknown target Nakagawa A (2005) 15791597 173404 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2699 107387 949 - SCARB1 CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1 9606 Homo sapiens unknown target Yan X (2004) 15541376 173408 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 27931 107390 952 - CD38 ADPRC 1|T10 9606 Homo sapiens antibody target de Weers M (2011) 21187443 196002 8130 Daratumumab HuMax-CD38 darzalex DRUGBANK DB09331 - biologic - 945721-28-8 DRUGBANK 18411 107420 983 - CDK1 CDC2|CDC28A|P34CDC2 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18573 107420 983 - CDK1 CDC2|CDC28A|P34CDC2 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 21391 107420 983 - CDK1 CDC2|CDC28A|P34CDC2 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 22390 107420 983 - CDK1 CDC2|CDC28A|P34CDC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3848 Alsterpaullone - - DRUGBANK DB04014 C16H11N3O3 small molecule - - DRUGBANK 21190 107420 983 - CDK1 CDC2|CDC28A|P34CDC2 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 3285 SU9516 - - DRUGBANK DB03428 C13H11N3O2 small molecule - - DRUGBANK 20189 107420 983 - CDK1 CDC2|CDC28A|P34CDC2 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 2827 Hymenialdisine - - DRUGBANK DB02950 C11H10BrN5O2 small molecule - - DRUGBANK 21666 107429 994 RP5-1009E24.3 CDC25B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 21667 107429 994 RP5-1009E24.3 CDC25B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 17747 107429 994 RP5-1009E24.3 CDC25B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17748 107429 994 RP5-1009E24.3 CDC25B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 19560 107433 998 RP1-224A6.5 CDC42 CDC42Hs|G25K 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2515 Aminophosphonic Acid-Guanylate Ester - - DRUGBANK DB02623 C10H16N6O10P2 small molecule - - DRUGBANK 19561 107433 998 RP1-224A6.5 CDC42 CDC42Hs|G25K 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2515 Aminophosphonic Acid-Guanylate Ester - - DRUGBANK DB02623 C10H16N6O10P2 small molecule - - DRUGBANK 19562 107433 998 RP1-224A6.5 CDC42 CDC42Hs|G25K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2515 Aminophosphonic Acid-Guanylate Ester - - DRUGBANK DB02623 C10H16N6O10P2 small molecule - - DRUGBANK 23050 107433 998 RP1-224A6.5 CDC42 CDC42Hs|G25K 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23051 107433 998 RP1-224A6.5 CDC42 CDC42Hs|G25K 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23052 107433 998 RP1-224A6.5 CDC42 CDC42Hs|G25K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 7367 107438 1003 - CDH5 7B4|CD144 9606 Homo sapiens antagonist target Lu L (2009) 18805433 176372 472 Lenalidomide 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501 revlimid DRUGBANK DB00480 C13H13N3O3 small molecule L04AX04 191732-72-6 DRUGBANK 24347 107438 1003 - CDH5 7B4|CD144 9606 Homo sapiens unknown target Atar D (2006) 17019083 181970 5289 FX06 - - DRUGBANK DB05685 - biologic - - DRUGBANK 19986 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2715 [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine - - DRUGBANK DB02833 C14H12N6O2S small molecule - - DRUGBANK 19987 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2715 [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine - - DRUGBANK DB02833 C14H12N6O2S small molecule - - DRUGBANK 19988 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2715 [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine - - DRUGBANK DB02833 C14H12N6O2S small molecule - - DRUGBANK 20200 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2840 (5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine - - DRUGBANK DB02963 C13H11ClN4O2S small molecule - - DRUGBANK 20201 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2840 (5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine - - DRUGBANK DB02963 C13H11ClN4O2S small molecule - - DRUGBANK 20202 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2840 (5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine - - DRUGBANK DB02963 C13H11ClN4O2S small molecule - - DRUGBANK 26492 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7223 6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE - - DRUGBANK DB08441 C13H14BrN5O2S small molecule - - DRUGBANK 23350 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4225 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol - - DRUGBANK DB04407 C15H15N5OS small molecule - - DRUGBANK 23351 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4225 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol - - DRUGBANK DB04407 C15H15N5OS small molecule - - DRUGBANK 23352 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4225 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol - - DRUGBANK DB04407 C15H15N5OS small molecule - - DRUGBANK 26325 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7073 (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol - - DRUGBANK DB08285 C19H26N6O small molecule - - DRUGBANK 23806 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4474 TRIAZOLOPYRIMIDINE - - DRUGBANK DB04669 C17H14BrN6 small molecule - - DRUGBANK 25876 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6649 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID - - DRUGBANK DB07852 C10H7Cl2N3O2 small molecule - - DRUGBANK 26575 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7305 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE - - DRUGBANK DB08527 C15H12N6O3S small molecule - - DRUGBANK 25174 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5982 N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine - - DRUGBANK DB07164 C13H12N6 small molecule - - DRUGBANK 25173 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5981 5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE - - DRUGBANK DB07163 C17H15FN4O small molecule - - DRUGBANK 26144 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6917 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE - - DRUGBANK DB08125 C18H14N4O3S2 small molecule - - DRUGBANK 18510 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2011 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine - - DRUGBANK DB02091 C9H10N4S small molecule - - DRUGBANK 18511 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2011 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine - - DRUGBANK DB02091 C9H10N4S small molecule - - DRUGBANK 18512 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2011 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine - - DRUGBANK DB02091 C9H10N4S small molecule - - DRUGBANK 26583 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7313 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08535 C18H14BrN5 small molecule - - DRUGBANK 20215 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2850 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide - - DRUGBANK DB02973 C14H9BrN4O3S small molecule - - DRUGBANK 20216 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2850 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide - - DRUGBANK DB02973 C14H9BrN4O3S small molecule - - DRUGBANK 20217 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2850 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide - - DRUGBANK DB02973 C14H9BrN4O3S small molecule - - DRUGBANK 22570 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3933 N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide - - DRUGBANK DB04101 C10H11N5OS small molecule - - DRUGBANK 22571 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3933 N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide - - DRUGBANK DB04101 C10H11N5OS small molecule - - DRUGBANK 22572 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3933 N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide - - DRUGBANK DB04101 C10H11N5OS small molecule - - DRUGBANK 26141 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6914 N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE - - DRUGBANK DB08122 C16H15N3O3S small molecule - - DRUGBANK 26142 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6915 N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE - - DRUGBANK DB08123 C17H15N5O3S2 small molecule - - DRUGBANK 26143 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6916 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE - - DRUGBANK DB08124 C20H15N3O4S small molecule - - DRUGBANK 25186 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5996 3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide - - DRUGBANK DB07179 C19H16BrN5O small molecule - - DRUGBANK 26582 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7312 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08534 C18H14FN5 small molecule - - DRUGBANK 26145 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6918 3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE - - DRUGBANK DB08126 C16H15N5O3S small molecule - - DRUGBANK 21979 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 21980 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 17758 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17759 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 26684 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7447 4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE - - DRUGBANK DB08673 C12H15N3O2S2 small molecule - - DRUGBANK 26585 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7315 3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine - - DRUGBANK DB08537 C18H14BrN5 small molecule - - DRUGBANK 26584 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7314 3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine - - DRUGBANK DB08536 C18H14BrN5 small molecule - - DRUGBANK 26587 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7317 3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08539 C21H19N5 small molecule - - DRUGBANK 26586 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7316 N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08538 C19H17F2N7 small molecule - - DRUGBANK 26581 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7311 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine - - DRUGBANK DB08533 C13H13N5 small molecule - - DRUGBANK 26580 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7310 6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine - - DRUGBANK DB08532 C18H14FN5 small molecule - - DRUGBANK 19154 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2310 6-O-Cyclohexylmethyl Guanine - - DRUGBANK DB02407 C12H17N5O small molecule - - DRUGBANK 19155 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2310 6-O-Cyclohexylmethyl Guanine - - DRUGBANK DB02407 C12H17N5O small molecule - - DRUGBANK 19156 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2310 6-O-Cyclohexylmethyl Guanine - - DRUGBANK DB02407 C12H17N5O small molecule - - DRUGBANK 25769 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6562 (2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL - - DRUGBANK DB07761 C21H23F2N5O2 small molecule - - DRUGBANK 25523 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6312 (2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL - - DRUGBANK DB07501 C21H24BrN5O2 small molecule - - DRUGBANK 22373 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3840 [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone - - DRUGBANK DB04006 C21H13F2N3O2 small molecule - - DRUGBANK 22374 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3840 [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone - - DRUGBANK DB04006 C21H13F2N3O2 small molecule - - DRUGBANK 22375 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3840 [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone - - DRUGBANK DB04006 C21H13F2N3O2 small molecule - - DRUGBANK 25526 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6315 (2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL - - DRUGBANK DB07504 C21H24BrN5O2 small molecule - - DRUGBANK 25736 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6532 4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL - - DRUGBANK DB07731 C9H10N6O small molecule - - DRUGBANK 20127 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2794 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine - - DRUGBANK DB02915 C16H13F3N4S small molecule - - DRUGBANK 20128 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2794 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine - - DRUGBANK DB02915 C16H13F3N4S small molecule - - DRUGBANK 20129 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2794 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine - - DRUGBANK DB02915 C16H13F3N4S small molecule - - DRUGBANK 26154 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6928 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide - - DRUGBANK DB08136 C12H11FN4O2 small molecule - - DRUGBANK 20095 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2778 5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone - - DRUGBANK DB02898 C10H11N6O2 small molecule - - DRUGBANK 20096 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2778 5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone - - DRUGBANK DB02898 C10H11N6O2 small molecule - - DRUGBANK 26092 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6859 N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE - - DRUGBANK DB08066 C17H13N5O small molecule - - DRUGBANK 26294 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7031 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE - - DRUGBANK DB08241 C19H22N6O2 small molecule - - DRUGBANK 19526 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2497 1-Amino-6-Cyclohex-3-Enylmethyloxypurine - - DRUGBANK DB02603 C13H18N4O small molecule - - DRUGBANK 19527 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2497 1-Amino-6-Cyclohex-3-Enylmethyloxypurine - - DRUGBANK DB02603 C13H18N4O small molecule - - DRUGBANK 19528 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2497 1-Amino-6-Cyclohex-3-Enylmethyloxypurine - - DRUGBANK DB02603 C13H18N4O small molecule - - DRUGBANK 26299 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7036 6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE - - DRUGBANK DB08247 C15H23N5O small molecule - - DRUGBANK 26300 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7037 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE - - DRUGBANK DB08248 C18H22N6O3S small molecule - - DRUGBANK 24971 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5767 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE - - DRUGBANK DB06948 C18H21N5O small molecule - - DRUGBANK 20185 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 2827 Hymenialdisine - - DRUGBANK DB02950 C11H10BrN5O2 small molecule - - DRUGBANK 20186 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2827 Hymenialdisine - - DRUGBANK DB02950 C11H10BrN5O2 small molecule - - DRUGBANK 20187 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 2827 Hymenialdisine - - DRUGBANK DB02950 C11H10BrN5O2 small molecule - - DRUGBANK 20188 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2827 Hymenialdisine - - DRUGBANK DB02950 C11H10BrN5O2 small molecule - - DRUGBANK 24967 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5763 N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide - - DRUGBANK DB06944 C18H17N3O small molecule - - DRUGBANK 26514 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7244 (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol - - DRUGBANK DB08463 C24H29N7O small molecule - - DRUGBANK 23767 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4416 PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE - - DRUGBANK DB04607 C20H14Cl2N4O3S small molecule - - DRUGBANK 24588 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Remsing Rix LL (2009) 19039322 182092 5562 Bosutinib SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate bosulif DRUGBANK DB06616 C26H29Cl2N5O3 small molecule L01XE14 380843-75-4 DRUGBANK 25037 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5842 2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE - - DRUGBANK DB07024 C19H17NO7S small molecule - - DRUGBANK 25516 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6304 (2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE - - DRUGBANK DB07493 C16H9BrN2O2 small molecule - - DRUGBANK 21826 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3580 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One - - DRUGBANK DB03737 C20H20FN3O4 small molecule - - DRUGBANK 21827 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3580 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One - - DRUGBANK DB03737 C20H20FN3O4 small molecule - - DRUGBANK 21828 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3580 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One - - DRUGBANK DB03737 C20H20FN3O4 small molecule - - DRUGBANK 25818 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6589 N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE - - DRUGBANK DB07790 C20H26N6O3S small molecule - - DRUGBANK 26273 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7023 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE - - DRUGBANK DB08233 C18H21N5O2 small molecule - - DRUGBANK 26159 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6933 4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide - - DRUGBANK DB08141 C16H17F2N5O2 small molecule - - DRUGBANK 26156 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6930 {[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide - - DRUGBANK DB08138 C17H11F3N4O2 small molecule - - DRUGBANK 26157 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6931 5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile - - DRUGBANK DB08139 C10H10ClN5 small molecule - - DRUGBANK 26160 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6934 4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide - - DRUGBANK DB08142 C16H17Cl2N5O2 small molecule - - DRUGBANK 18336 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18337 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18889 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2204 2-Amino-6-Chloropyrazine - - DRUGBANK DB02297 C4H4ClN3 small molecule - - DRUGBANK 18890 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2204 2-Amino-6-Chloropyrazine - - DRUGBANK DB02297 C4H4ClN3 small molecule - - DRUGBANK 25623 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6424 2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE - - DRUGBANK DB07618 C24H31N5O2 small molecule - - DRUGBANK 26158 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6932 5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE - - DRUGBANK DB08140 C16H23N7 small molecule - - DRUGBANK 26009 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6777 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol - - DRUGBANK DB07982 C23H29N7O2 small molecule - - DRUGBANK 25626 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6428 1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA - - DRUGBANK DB07622 C21H23N7O2S small molecule - - DRUGBANK 25060 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5872 (2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL - - DRUGBANK DB07054 C22H23F4N5O2 small molecule - - DRUGBANK 23004 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4115 2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine - - DRUGBANK DB04288 C23H31N7 small molecule - - DRUGBANK 23005 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4115 2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine - - DRUGBANK DB04288 C23H31N7 small molecule - - DRUGBANK 23006 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4115 2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine - - DRUGBANK DB04288 C23H31N7 small molecule - - DRUGBANK 25577 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6371 N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE - - DRUGBANK DB07562 C17H19N5S small molecule - - DRUGBANK 25819 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6590 4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE - - DRUGBANK DB07791 C18H20N6O2S small molecule - - DRUGBANK 26579 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7309 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08531 C18H13Cl2N5 small molecule - - DRUGBANK 26155 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6929 (4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide - - DRUGBANK DB08137 C17H13FN4O2 small molecule - - DRUGBANK 26348 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7098 6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB08312 C11H17N5O2 small molecule - - DRUGBANK 24870 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5665 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE - - DRUGBANK DB06844 C21H15N5O3S2 small molecule - - DRUGBANK 26151 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6925 N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide - - DRUGBANK DB08133 C14H12N4O3S small molecule - - DRUGBANK 26150 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6924 5-hydroxynaphthalene-1-sulfonamide - - DRUGBANK DB08132 C10H9NO3S small molecule - - DRUGBANK 26153 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6927 N-phenyl-1H-pyrazole-3-carboxamide - - DRUGBANK DB08135 C10H9N3O small molecule - - DRUGBANK 26152 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6926 4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide - - DRUGBANK DB08134 C10H9ClN4O2S small molecule - - DRUGBANK 26236 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7010 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE - - DRUGBANK DB08219 C18H20N6OS small molecule - - DRUGBANK 26613 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7349 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE - - DRUGBANK DB08572 C18H22N6O3 small molecule - - DRUGBANK 26346 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7096 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL - - DRUGBANK DB08309 C23H32N6O4S small molecule - - DRUGBANK 25134 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5944 O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE - - DRUGBANK DB07126 C18H22N6O3S small molecule - - DRUGBANK 24917 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5708 (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE - - DRUGBANK DB06888 C22H21N5O3 small molecule - - DRUGBANK 21674 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3510 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol - - DRUGBANK DB03663 C10H13N5O2 small molecule - - DRUGBANK 21675 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3510 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol - - DRUGBANK DB03663 C10H13N5O2 small molecule - - DRUGBANK 21676 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3510 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol - - DRUGBANK DB03663 C10H13N5O2 small molecule - - DRUGBANK 25484 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6282 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE - - DRUGBANK DB07471 C22H20ClN3O4S small molecule - - DRUGBANK 18713 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2113 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide - - DRUGBANK DB02197 C17H14N6O2S small molecule - - DRUGBANK 18714 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2113 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide - - DRUGBANK DB02197 C17H14N6O2S small molecule - - DRUGBANK 18715 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2113 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide - - DRUGBANK DB02197 C17H14N6O2S small molecule - - DRUGBANK 25919 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6686 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL - - DRUGBANK DB07889 C23H26N6O2 small molecule - - DRUGBANK 19815 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 19816 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 19817 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 26234 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7009 HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM - - DRUGBANK DB08218 C19H15N7O2 small molecule - - DRUGBANK 26122 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6887 (4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE - - DRUGBANK DB08094 C18H21F2N5O4S small molecule - - DRUGBANK 21186 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 3285 SU9516 - - DRUGBANK DB03428 C13H11N3O2 small molecule - - DRUGBANK 21187 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3285 SU9516 - - DRUGBANK DB03428 C13H11N3O2 small molecule - - DRUGBANK 21188 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 3285 SU9516 - - DRUGBANK DB03428 C13H11N3O2 small molecule - - DRUGBANK 21189 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 3285 SU9516 - - DRUGBANK DB03428 C13H11N3O2 small molecule - - DRUGBANK 20933 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3172 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide - - DRUGBANK DB03307 C10H11N5O2S small molecule - - DRUGBANK 20934 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3172 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide - - DRUGBANK DB03307 C10H11N5O2S small molecule - - DRUGBANK 20935 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3172 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide - - DRUGBANK DB03307 C10H11N5O2S small molecule - - DRUGBANK 25605 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6402 (5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE - - DRUGBANK DB07595 C18H15BrN5 small molecule - - DRUGBANK 25147 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5955 (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE - - DRUGBANK DB07137 C18H19N5O2 small molecule - - DRUGBANK 25557 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6350 4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE - - DRUGBANK DB07540 C15H13N3O4S2 small molecule - - DRUGBANK 25453 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6244 (3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one - - DRUGBANK DB07431 C13H15N3O2S small molecule - - DRUGBANK 20323 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2893 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine - - DRUGBANK DB03019 C8H5Cl2N3S small molecule - - DRUGBANK 20324 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2893 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine - - DRUGBANK DB03019 C8H5Cl2N3S small molecule - - DRUGBANK 24991 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5794 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA - - DRUGBANK DB06976 C19H22N6O2 small molecule - - DRUGBANK 25693 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6491 4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE - - DRUGBANK DB07686 C17H21N7O2S small molecule - - DRUGBANK 25692 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6490 4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE - - DRUGBANK DB07685 C18H22N6O3S small molecule - - DRUGBANK 25695 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6493 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE - - DRUGBANK DB07688 C17H20N6O3S small molecule - - DRUGBANK 25694 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6492 4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE - - DRUGBANK DB07687 C17H22N8O2S small molecule - - DRUGBANK 26402 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7140 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid - - DRUGBANK DB08355 C17H15N5O2 small molecule - - DRUGBANK 19418 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2435 N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide - - DRUGBANK DB02538 C14H13N5O small molecule - - DRUGBANK 19419 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2435 N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide - - DRUGBANK DB02538 C14H13N5O small molecule - - DRUGBANK 19420 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2435 N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide - - DRUGBANK DB02538 C14H13N5O small molecule - - DRUGBANK 25069 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5883 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB07065 C19H12Cl2N6S small molecule - - DRUGBANK 21384 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3345 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole - - DRUGBANK DB03490 C15H11N3 small molecule - - DRUGBANK 21385 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3345 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole - - DRUGBANK DB03490 C15H11N3 small molecule - - DRUGBANK 21386 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3345 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole - - DRUGBANK DB03490 C15H11N3 small molecule - - DRUGBANK 25546 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6341 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE - - DRUGBANK DB07531 C14H10N2O5S2 small molecule - - DRUGBANK 18017 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1815 4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide - - DRUGBANK DB01888 C23H33N7O2S small molecule - - DRUGBANK 18018 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1815 4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide - - DRUGBANK DB01888 C23H33N7O2S small molecule - - DRUGBANK 25763 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6556 (2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL - - DRUGBANK DB07755 C21H23Cl2N5O2 small molecule - - DRUGBANK 25751 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6551 (2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL - - DRUGBANK DB07750 C21H23Cl2N5O2 small molecule - - DRUGBANK 25752 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6552 (2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL - - DRUGBANK DB07751 C21H23F2N5O2 small molecule - - DRUGBANK 25555 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6349 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID - - DRUGBANK DB07539 C15H10N2O4S small molecule - - DRUGBANK 25553 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6348 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE - - DRUGBANK DB07538 C15H10F3N3O4S2 small molecule - - DRUGBANK 26690 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7451 N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE - - DRUGBANK DB08677 C13H15N3OS small molecule - - DRUGBANK 25613 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6412 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE - - DRUGBANK DB07606 C20H15Cl3N4O3 small molecule - - DRUGBANK 18569 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 18570 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 18571 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 18572 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 25205 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6020 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE - - DRUGBANK DB07203 C18H20ClN5O small molecule - - DRUGBANK 24997 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5801 (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol - - DRUGBANK DB06983 C19H17N5O small molecule - - DRUGBANK 25215 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6027 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB07210 C18H14BrN5 small molecule - - DRUGBANK 26208 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6974 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine - - DRUGBANK DB08182 C14H15N5O small molecule - - DRUGBANK 26203 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6970 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine - - DRUGBANK DB08178 C12H11N5O small molecule - - DRUGBANK 25617 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6418 6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE - - DRUGBANK DB07612 C19H19F3N4 small molecule - - DRUGBANK 25547 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6343 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE - - DRUGBANK DB07533 C15H13N3O4S2 small molecule - - DRUGBANK 25964 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6732 N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine - - DRUGBANK DB07936 C24H30FN7O small molecule - - DRUGBANK 21400 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 21401 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Zvelebil MJ (1998) 18465538 182075 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 23592 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4330 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol - - DRUGBANK DB04518 C15H14N4OS small molecule - - DRUGBANK 23593 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4330 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol - - DRUGBANK DB04518 C15H14N4OS small molecule - - DRUGBANK 23594 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4330 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol - - DRUGBANK DB04518 C15H14N4OS small molecule - - DRUGBANK 26768 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7541 N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE - - DRUGBANK DB08768 C10H13N5 small molecule - - DRUGBANK 23804 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4467 OLOMOUCINE II - - DRUGBANK DB04662 C19H26N6O2 small molecule - - DRUGBANK 25549 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6344 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE - - DRUGBANK DB07534 C14H11N3O4S2 small molecule - - DRUGBANK 21040 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3227 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline - - DRUGBANK DB03365 C16H15N3O3 small molecule - - DRUGBANK 21041 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3227 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline - - DRUGBANK DB03365 C16H15N3O3 small molecule - - DRUGBANK 21042 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3227 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline - - DRUGBANK DB03365 C16H15N3O3 small molecule - - DRUGBANK 18409 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18410 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 22781 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4015 N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea - - DRUGBANK DB04186 C17H16N4O2 small molecule - - DRUGBANK 22782 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4015 N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea - - DRUGBANK DB04186 C17H16N4O2 small molecule - - DRUGBANK 22783 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4015 N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea - - DRUGBANK DB04186 C17H16N4O2 small molecule - - DRUGBANK 25543 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6339 2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE - - DRUGBANK DB07529 C9H7N3OS small molecule - - DRUGBANK 19620 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2538 N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide - - DRUGBANK DB02647 C13H13N3O small molecule - - DRUGBANK 19621 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2538 N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide - - DRUGBANK DB02647 C13H13N3O small molecule - - DRUGBANK 19622 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2538 N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide - - DRUGBANK DB02647 C13H13N3O small molecule - - DRUGBANK 26721 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7468 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol - - DRUGBANK DB08694 C14H11N7O small molecule - - DRUGBANK 21535 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3431 (2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One - - DRUGBANK DB03583 C22H23N3O5S small molecule - - DRUGBANK 21536 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3431 (2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One - - DRUGBANK DB03583 C22H23N3O5S small molecule - - DRUGBANK 21537 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3431 (2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One - - DRUGBANK DB03583 C22H23N3O5S small molecule - - DRUGBANK 25228 107452 1017 - CDK2 CDKN2|p33(CDK2) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6036 N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE - - DRUGBANK DB07220 C23H27N5O3S small molecule - - DRUGBANK 19812 107454 1019 - CDK4 CMM3|PSK-J3 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 21393 107454 1019 - CDK4 CMM3|PSK-J3 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 27477 107454 1019 - CDK4 CMM3|PSK-J3 9606 Homo sapiens inhibitor target Fry DW (2004) 15542782 188549 7820 Palbociclib 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one ibrance DRUGBANK DB09073 C24H29N7O2 small molecule L01XE33 571190-30-2 DRUGBANK 18412 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18413 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18574 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 21403 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 25372 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6180 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE - - DRUGBANK DB07364 C16H17N3O small molecule - - DRUGBANK 22391 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3848 Alsterpaullone - - DRUGBANK DB04014 C16H11N3O3 small molecule - - DRUGBANK 21191 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3285 SU9516 - - DRUGBANK DB03428 C13H11N3O2 small molecule - - DRUGBANK 20190 107455 1020 - CDK5 PSSALRE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2827 Hymenialdisine - - DRUGBANK DB02950 C11H10BrN5O2 small molecule - - DRUGBANK 25397 107456 1021 - CDK6 MCPH12|PLSTIRE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6195 (2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol (2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol|Aminopurvalanol - DRUGBANK DB07379 C19H26ClN7O small molecule - - DRUGBANK 27478 107456 1021 - CDK6 MCPH12|PLSTIRE 9606 Homo sapiens inhibitor target Fry DW (2004) 15542782 188549 7820 Palbociclib 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one ibrance DRUGBANK DB09073 C24H29N7O2 small molecule L01XE33 571190-30-2 DRUGBANK 25823 107456 1021 - CDK6 MCPH12|PLSTIRE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6594 3,7,3',4'-TETRAHYDROXYFLAVONE - - DRUGBANK DB07795 C15H10O6 small molecule - - DRUGBANK 21398 107456 1021 - CDK6 MCPH12|PLSTIRE 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 19290 107457 1022 - CDK7 CAK1|CDKN7|HCAK|MO15|STK1|p39MO15 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19291 107457 1022 - CDK7 CAK1|CDKN7|HCAK|MO15|STK1|p39MO15 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 21402 107457 1022 - CDK7 CAK1|CDKN7|HCAK|MO15|STK1|p39MO15 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 21399 107458 1024 - CDK8 K35 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 21392 107459 1025 RP11-228B15.5 CDK9 C-2k|CDC2L4|CTK1|PITALRE|TAK 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 3121 107468 1036 - CDO1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3122 107468 1036 - CDO1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 2889 107468 1036 - CDO1 - 9606 Homo sapiens unknown target Jin HF (2007) 17657274 173551 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2890 107468 1036 - CDO1 - 9606 Homo sapiens unknown target McCoy JG (2006) 16492780 173550 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2891 107468 1036 - CDO1 - 9606 Homo sapiens unknown target Ye S (2007) 17135237 173553 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2892 107468 1036 - CDO1 - 9606 Homo sapiens unknown target Roopnarinesingh ES (2005) 16355974 173552 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2915 107468 1036 - CDO1 - 9606 Homo sapiens unknown target Pierce BS (2007) 17602574 173564 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 1098 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1099 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Hederer RA (2000) 10744652 172279 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1100 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Rawstron AC (1999) 10520035 172278 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1101 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Rebello PR (1999) 10573085 172282 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1102 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Geissinger E (2009) 19479612 172280 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1103 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Gilliland LK (1999) 10092828 172281 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1104 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target James LC (1999) 10366506 172277 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1105 107473 1043 - CD52 CDW52 9606 Homo sapiens antibody target Quintas-Cardama A (2009) 19343298 172276 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 26232 107478 1048 - CEACAM5 CD66e|CEA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7008 2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL - - DRUGBANK DB08217 C9H17NOS small molecule - - DRUGBANK 23173 107485 1056 - CEL BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4172 Taurocholic Acid - - DRUGBANK DB04348 C26H45NO7S small molecule - 81-24-3 DRUGBANK 23174 107485 1056 - CEL BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4172 Taurocholic Acid - - DRUGBANK DB04348 C26H45NO7S small molecule - 81-24-3 DRUGBANK 23175 107485 1056 - CEL BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4172 Taurocholic Acid - - DRUGBANK DB04348 C26H45NO7S small molecule - 81-24-3 DRUGBANK 19643 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 8267 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Bell FP (1984) 6509906 177054 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 23956 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Heffron F (1990) 2306268 181649 4640 Cyclandelate 3,5,5-Trimethylcyclohexyl amygdalate|3,3,5-Trimethylcyclohexyl mandelate|Cyclandelatum|Ciclandelato cyclospasmol tablets 200mg DRUGBANK DB04838 C17H24O3 small molecule C04AX01 456-59-7 DRUGBANK 4154 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Zhu HJ (2009) 19022936 174299 191 Oseltamivir Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir tamiflu oral suspension|tamifl DRUGBANK DB00198 C16H28N2O4 small molecule J05AH02 196618-13-0 DRUGBANK 4155 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Wattanagoon Y (2009) 19104028 174298 191 Oseltamivir Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir tamiflu oral suspension|tamifl DRUGBANK DB00198 C16H28N2O4 small molecule J05AH02 196618-13-0 DRUGBANK 4156 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Shi D (2006) 16966469 174297 191 Oseltamivir Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir tamiflu oral suspension|tamifl DRUGBANK DB00198 C16H28N2O4 small molecule J05AH02 196618-13-0 DRUGBANK 20394 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2927 4-Piperidino-Piperidine - - DRUGBANK DB03056 C10H20N2 small molecule - - DRUGBANK 17300 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Jeon SM (2005) 16292755 181576 1537 Probucol Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol lorelco DRUGBANK DB01599 C31H48O2S2 small molecule C10AX02 23288-49-5 DRUGBANK 23906 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Zhang JG (2002) 11992644 181793 4597 Thenoyltrifluoroacetone alpha-Thenoyltrifluoroacetone|.alpha.-Thenoyltrifluoroacetone|2-Thenoyltrifluoroacetone|Perfluoroacetyl(2-thenoyl)methane|1-Thenoyl-3,3,3-trifluoroacetone|1,1,1-Trifluoro-3-(2-thenoyl)acetone|TTFA - DRUGBANK DB04795 C8H5F3O2S small molecule - 326-91-0 DRUGBANK 23907 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4597 Thenoyltrifluoroacetone alpha-Thenoyltrifluoroacetone|.alpha.-Thenoyltrifluoroacetone|2-Thenoyltrifluoroacetone|Perfluoroacetyl(2-thenoyl)methane|1-Thenoyl-3,3,3-trifluoroacetone|1,1,1-Trifluoro-3-(2-thenoyl)acetone|TTFA - DRUGBANK DB04795 C8H5F3O2S small molecule - 326-91-0 DRUGBANK 25839 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6619 (1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE - - DRUGBANK DB07821 C7H17O2P small molecule - - DRUGBANK 26243 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7015 (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL - - DRUGBANK DB08224 C18H26O4 small molecule - - DRUGBANK 18645 107494 1066 - CES1 ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2077 Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester - - DRUGBANK DB02161 C16H21NO3 small molecule - - DRUGBANK 22699 107499 1072 - CFL1 CFL|HEL-S-15 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 23317 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 24186 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Tradtrantip L (2010) 19808995 182129 4736 Crofelemer SP-303|Provir fulyzaq DRUGBANK DB04941 - small molecule - 148465-45-6 DRUGBANK 26888 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens potentiator target Yu H (2012) 22293084 182198 7589 Ivacaftor Ivacaftorum|Kalydeco kalydeco|orkambi DRUGBANK DB08820 C24H28N2O3 small molecule R07AX30|R07AX02 873054-44-5 DRUGBANK 11410 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Reddy MM (1999) 9886939 178890 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 23617 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 13286 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens inhibitor target Devor DC (1998) 9710435 179905 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 12780 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Lee SY (2005) 15365090 179687 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12781 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Zhou Z (2002) 12407077 179686 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12782 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Reddy MM (2002) 12202948 179685 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12783 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Jiang J (2003) 12391048 179684 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12784 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens antagonist target Larsen EH (2003) 14729151 179683 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 27929 107506 1080 tcag7.78 CFTR ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1 9606 Homo sapiens modulator target Kuk K (2015) 26416827 196033 8024 Lumacaftor lumacaftor|3-(6-{[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropane-1-carbonyl]amino}-3-methylpyridin-2-yl)benzoic acid|VRT 826809 orkambi DRUGBANK DB09280 C24H18F2N2O5 small molecule R07AX30 936727-05-8 DRUGBANK 3961 107528 1103 - CHAT CHOACTASE|CMS1A|CMS1A2 9606 Homo sapiens unknown target FAHMY AR (1954) 13192619 174187 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 6991 107530 1105 - CHD1 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 437 Epirubicin Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine epirubicin hydrochloride for i DRUGBANK DB00445 C27H29NO11 small molecule L01DB03 56420-45-2 DRUGBANK 6992 107530 1105 - CHD1 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 437 Epirubicin Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine epirubicin hydrochloride for i DRUGBANK DB00445 C27H29NO11 small molecule L01DB03 56420-45-2 DRUGBANK 3203 107534 1109 - AKR1C4 3-alpha-HSD|C11|CDR|CHDR|DD-4|DD4|HAKRA 9606 Homo sapiens unknown target Atalla A (2000) 11037109 173713 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3204 107534 1109 - AKR1C4 3-alpha-HSD|C11|CDR|CHDR|DD-4|DD4|HAKRA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3205 107534 1109 - AKR1C4 3-alpha-HSD|C11|CDR|CHDR|DD-4|DD4|HAKRA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 26438 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7177 2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL - - DRUGBANK DB08393 C20H17N3O2 small molecule - - DRUGBANK 26437 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7176 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL - - DRUGBANK DB08392 C22H21N3O4 small molecule - - DRUGBANK 25654 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6454 (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL - - DRUGBANK DB07648 C21H20N4O2 small molecule - - DRUGBANK 25657 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6459 N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE - - DRUGBANK DB07653 C20H15N3O3 small molecule - - DRUGBANK 26692 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7457 REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE - - DRUGBANK DB08683 C24H15N3O3 small molecule - - DRUGBANK 25049 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5855 (2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL - - DRUGBANK DB07037 C12H14N4O3 small molecule - - DRUGBANK 25038 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5843 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE - - DRUGBANK DB07025 C24H26N4O small molecule - - DRUGBANK 25237 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6044 1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA - - DRUGBANK DB07228 C17H22ClN5O3 small molecule - - DRUGBANK 26782 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7553 1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE - - DRUGBANK DB08781 C11H14BrN5O small molecule - - DRUGBANK 26781 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7552 6-MORPHOLIN-4-YL-9H-PURINE - - DRUGBANK DB08780 C9H11N5O small molecule - - DRUGBANK 26780 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7551 2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol - - DRUGBANK DB08779 C9H10N2OS2 small molecule - - DRUGBANK 26779 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7550 [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone - - DRUGBANK DB08778 C14H17N3OS small molecule - - DRUGBANK 25253 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6059 (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE - - DRUGBANK DB07243 C16H19N3O2 small molecule - - DRUGBANK 25341 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6152 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL - - DRUGBANK DB07336 C21H16N4O2 small molecule - - DRUGBANK 24880 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5673 4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE - - DRUGBANK DB06852 C23H22ClN5O small molecule - - DRUGBANK 25653 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6453 (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL - - DRUGBANK DB07647 C21H20N4O small molecule - - DRUGBANK 25082 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5896 (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE - - DRUGBANK DB07078 C20H16N2O3 small molecule - - DRUGBANK 25658 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6460 (5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC - - DRUGBANK DB07654 C21H19N3O2 small molecule - - DRUGBANK 25659 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6461 3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE - - DRUGBANK DB07655 C20H18N4O small molecule - - DRUGBANK 25321 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6130 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA - - DRUGBANK DB07314 C14H12ClN5O3 small molecule - - DRUGBANK 25327 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6136 4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID - - DRUGBANK DB07320 C25H27N3O2 small molecule - - DRUGBANK 25318 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6127 18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE - - DRUGBANK DB07311 C16H17ClN4O3 small molecule - - DRUGBANK 25991 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6754 3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE - - DRUGBANK DB07959 C14H10N4 small molecule - - DRUGBANK 26777 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7548 N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE - - DRUGBANK DB08776 C9H11N3O2S small molecule - - DRUGBANK 26778 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7549 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE - - DRUGBANK DB08777 C10H10N2OS small molecule - - DRUGBANK 25050 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5856 2-(cyclohexylamino)benzoic acid - - DRUGBANK DB07038 C13H17NO2 small molecule - - DRUGBANK 25079 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5893 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE - - DRUGBANK DB07075 C23H24N6 small molecule - - DRUGBANK 24906 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5696 N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE - - DRUGBANK DB06876 C24H24N6O small molecule - - DRUGBANK 25047 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5852 2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID - - DRUGBANK DB07034 C17H13NO7 small molecule - - DRUGBANK 25219 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6030 (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL - - DRUGBANK DB07213 C24H25N7O small molecule - - DRUGBANK 25168 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5976 5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE - - DRUGBANK DB07158 C13H13N3O small molecule - - DRUGBANK 26775 107536 1111 - CHEK1 CHK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7546 1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine - - DRUGBANK DB08774 C17H19N5O small molecule - - DRUGBANK 23182 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4174 Argadin FO 7314 - DRUGBANK DB04350 C29H42N10O9 small molecule - 289665-92-5 DRUGBANK 23183 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4174 Argadin FO 7314 - DRUGBANK DB04350 C29H42N10O9 small molecule - 289665-92-5 DRUGBANK 21455 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3390 2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose - - DRUGBANK DB03539 C8H12N2O4 small molecule - - DRUGBANK 21456 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3390 2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose - - DRUGBANK DB03539 C8H12N2O4 small molecule - - DRUGBANK 20503 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2980 N-Acetyl-D-Allosamine - - DRUGBANK DB03109 C8H15NO6 small molecule - - DRUGBANK 20504 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2980 N-Acetyl-D-Allosamine - - DRUGBANK DB03109 C8H15NO6 small molecule - - DRUGBANK 21625 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3479 Argifin - - DRUGBANK DB03632 C29H41N9O10 small molecule - - DRUGBANK 21626 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3479 Argifin - - DRUGBANK DB03632 C29H41N9O10 small molecule - - DRUGBANK 27626 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27627 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 23346 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4222 Allosamizoline - - DRUGBANK DB04404 C9H16N2O4 small molecule - - DRUGBANK 23347 107542 1118 - CHIT1 CHI3|CHIT|CHITD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4222 Allosamizoline - - DRUGBANK DB04404 C9H16N2O4 small molecule - - DRUGBANK 15286 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 10436 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10437 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 4408 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 212 Oxyphenonium Oxyphenonium cation|Oxyphenonium ion - DRUGBANK DB00219 C21H34NO3 small molecule A03AB03|A03AB53 14214-84-7 DRUGBANK 4409 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 212 Oxyphenonium Oxyphenonium cation|Oxyphenonium ion - DRUGBANK DB00219 C21H34NO3 small molecule A03AB03|A03AB53 14214-84-7 DRUGBANK 4410 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 212 Oxyphenonium Oxyphenonium cation|Oxyphenonium ion - DRUGBANK DB00219 C21H34NO3 small molecule A03AB03|A03AB53 14214-84-7 DRUGBANK 4411 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Eglen RM (1987) 3580704 174466 212 Oxyphenonium Oxyphenonium cation|Oxyphenonium ion - DRUGBANK DB00219 C21H34NO3 small molecule A03AB03|A03AB53 14214-84-7 DRUGBANK 8097 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 15158 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Burger DM (2006) 16466463 180760 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15159 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Hammer D (2005) 15835479 180755 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15160 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15161 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 14492 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Bareggi SR (2007) 17916059 174434 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 4269 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 4270 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 4271 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Fisher DM (1999) 10437710 174357 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 5791 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens binder target Yasuda SU (1999) 10212017 175352 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 10294 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 761 Clidinium 3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|CLIDINIUM|3-Hydroxy-1-methylquinuclidinium benzilate ester|N-Methyl quinuclidinyl benzilate|Clidinium bromid|Clidinii Bromidum|Bromure de Clidinium corium cap|chlordiazepoxide hy DRUGBANK DB00771 C22H26NO3 small molecule A03CA02 7020-55-5 DRUGBANK 10295 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 761 Clidinium 3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|CLIDINIUM|3-Hydroxy-1-methylquinuclidinium benzilate ester|N-Methyl quinuclidinyl benzilate|Clidinium bromid|Clidinii Bromidum|Bromure de Clidinium corium cap|chlordiazepoxide hy DRUGBANK DB00771 C22H26NO3 small molecule A03CA02 7020-55-5 DRUGBANK 10296 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 761 Clidinium 3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|CLIDINIUM|3-Hydroxy-1-methylquinuclidinium benzilate ester|N-Methyl quinuclidinyl benzilate|Clidinium bromid|Clidinii Bromidum|Bromure de Clidinium corium cap|chlordiazepoxide hy DRUGBANK DB00771 C22H26NO3 small molecule A03CA02 7020-55-5 DRUGBANK 7163 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 7164 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 7165 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Figueroa KW (2010) 20590642 176251 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 10365 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10366 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 23210 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4187 Arecoline - - DRUGBANK DB04365 C8H13NO2 small molecule - 63-75-2 DRUGBANK 23211 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4187 Arecoline - - DRUGBANK DB04365 C8H13NO2 small molecule - 63-75-2 DRUGBANK 5548 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5075 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Yamamoto N (1999) 10413067 174865 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5076 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Ishida Y (1990) 1690310 174866 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 4713 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4714 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4715 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4750 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 6323 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6324 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Schjelderup L (1988) 3247303 175713 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6325 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6326 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 4006 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 4007 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Fisher A (1996) 8624083 174199 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 4008 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 6027 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 358 Doxylamine Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether tylenol cold and flu nighttime DRUGBANK DB00366 C17H22N2O small molecule R06AA09|R06AA59 469-21-6 DRUGBANK 6028 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 358 Doxylamine Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether tylenol cold and flu nighttime DRUGBANK DB00366 C17H22N2O small molecule R06AA09|R06AA59 469-21-6 DRUGBANK 7345 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens unknown target Davies MA (2005) 15765260 176347 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7582 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 497 Tridihexethyl - - DRUGBANK DB00505 C21H36NO small molecule A03AB08 60-49-1 DRUGBANK 7583 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 497 Tridihexethyl - - DRUGBANK DB00505 C21H36NO small molecule A03AB08 60-49-1 DRUGBANK 13328 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13329 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Sinha S (2010) 20590605 179924 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13327 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Oki T (2007) 17222678 179925 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13331 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Maruyama S (2006) 16406943 179827 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13330 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 7505 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Jha S (2007) 18046909 176497 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7506 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Moriya H (1999) 10374898 176500 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 10700 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Worms P (1989) 2586634 178469 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10701 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Duarte CD (2007) 18045214 178462 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10677 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 794 Dicyclomine DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin bentylol tablet 10mg|dicyclomi DRUGBANK DB00804 C19H35NO2 small molecule A03AA07 77-19-0 DRUGBANK 10678 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 794 Dicyclomine DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin bentylol tablet 10mg|dicyclomi DRUGBANK DB00804 C19H35NO2 small molecule A03AA07 77-19-0 DRUGBANK 10679 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 794 Dicyclomine DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin bentylol tablet 10mg|dicyclomi DRUGBANK DB00804 C19H35NO2 small molecule A03AA07 77-19-0 DRUGBANK 10680 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Jin CH (2009) 19533734 178460 794 Dicyclomine DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin bentylol tablet 10mg|dicyclomi DRUGBANK DB00804 C19H35NO2 small molecule A03AA07 77-19-0 DRUGBANK 14142 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Ehlert FJ (1990) 2329499 180337 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14143 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14144 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14145 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 13471 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Golembiewski JA (2002) 12476402 179971 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 10408 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Mokry J (2005) 16080359 178362 772 Propantheline Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de propantheline bromide|propanth DRUGBANK DB00782 C23H30NO3 small molecule A03CA34|A03AB05 298-50-0 DRUGBANK 10409 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Saitoh H (1986) 3572714 178361 772 Propantheline Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de propantheline bromide|propanth DRUGBANK DB00782 C23H30NO3 small molecule A03CA34|A03AB05 298-50-0 DRUGBANK 10410 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Lukacs VA (1989) 2656175 178360 772 Propantheline Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de propantheline bromide|propanth DRUGBANK DB00782 C23H30NO3 small molecule A03CA34|A03AB05 298-50-0 DRUGBANK 10411 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 772 Propantheline Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de propantheline bromide|propanth DRUGBANK DB00782 C23H30NO3 small molecule A03CA34|A03AB05 298-50-0 DRUGBANK 10412 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 772 Propantheline Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de propantheline bromide|propanth DRUGBANK DB00782 C23H30NO3 small molecule A03CA34|A03AB05 298-50-0 DRUGBANK 10413 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Trkulja V (2004) 15337834 178359 772 Propantheline Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de propantheline bromide|propanth DRUGBANK DB00782 C23H30NO3 small molecule A03CA34|A03AB05 298-50-0 DRUGBANK 13608 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 13609 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 13610 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Figueroa KW (2009) 18824613 180060 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 10725 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Betz AJ (2007) 17594079 178475 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 7120 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 5912 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 346 Buclizine 1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina - DRUGBANK DB00354 C28H33ClN2 small molecule R06AE01|R06AE51 82-95-1 DRUGBANK 5913 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 346 Buclizine 1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina - DRUGBANK DB00354 C28H33ClN2 small molecule R06AE01|R06AE51 82-95-1 DRUGBANK 12498 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 976 Glycopyrronium Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion robinul forte tab 2mg|ultibro DRUGBANK DB00986 C19H28NO3 small molecule R03BB06|R03AL04|A03AB02|A03CA05 740028-90-4 DRUGBANK 12499 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 976 Glycopyrronium Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion robinul forte tab 2mg|ultibro DRUGBANK DB00986 C19H28NO3 small molecule R03BB06|R03AL04|A03AB02|A03CA05 740028-90-4 DRUGBANK 12500 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 976 Glycopyrronium Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion robinul forte tab 2mg|ultibro DRUGBANK DB00986 C19H28NO3 small molecule R03BB06|R03AL04|A03AB02|A03CA05 740028-90-4 DRUGBANK 12501 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Ali-Melkkilae T (1993) 8249551 179514 976 Glycopyrronium Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion robinul forte tab 2mg|ultibro DRUGBANK DB00986 C19H28NO3 small molecule R03BB06|R03AL04|A03AB02|A03CA05 740028-90-4 DRUGBANK 6622 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens agonist target Weiner DM (2004) 15059034 175896 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6225 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6226 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6227 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6228 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Freedman SB (1988) 3208836 175651 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6229 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Doerje F (1991) 1994002 175652 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6230 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Prus AJ (2009) 18685832 175654 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6231 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Tanda G (2007) 17631384 175655 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6232 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Giachetti A (1986) 2432979 175656 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 9774 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 7668 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Bachrach WH (1972) 4555460 176615 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7669 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7670 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Pace F (2010) 20391952 176617 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7671 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7672 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Tittor W (1982) 6897316 176616 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 12137 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 930 Methantheline Methanthelinium|Methanthelinum|Methantheline - DRUGBANK DB00940 C21H26NO3 small molecule A03AB07 5818-17-7 DRUGBANK 12138 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 930 Methantheline Methanthelinium|Methanthelinum|Methantheline - DRUGBANK DB00940 C21H26NO3 small molecule A03AB07 5818-17-7 DRUGBANK 8162 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8163 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8164 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 6913 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Eltze M (1989) 2625138 176038 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 15063 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15064 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 7852 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 14260 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14261 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14262 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 4313 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 202 Trospium - trospium chloride|trospium chl DRUGBANK DB00209 C25H30NO3 small molecule G04BD09|A03DA06 47608-32-2 DRUGBANK 4314 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 202 Trospium - trospium chloride|trospium chl DRUGBANK DB00209 C25H30NO3 small molecule G04BD09|A03DA06 47608-32-2 DRUGBANK 10267 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10268 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 5628 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Wellington K (2005) 15987237 175290 324 Ipratropium bromide Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide atroventhfa|combivent udv|atro DRUGBANK DB00332 C20H30BrNO3 small molecule R01AX03|R03AL02|R03AL01|R03BB01 22254-24-6 DRUGBANK 11616 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Carrera MR (2004) 15351386 178995 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 8721 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 4365 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens binder target Bareggi SR (2007) 17916059 174434 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 9869 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Gil L (2000) 11124384 178060 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9870 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9871 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9872 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target George N (2010) 20085574 178061 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 15132 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15133 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Waelbroeck M (1991) 1863523 180744 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15134 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 7046 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens binder target Hustveit O (1994) 8164394 176164 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 14187 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 14188 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 14189 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Abbiati GA (1988) 3247311 180355 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 5992 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6400 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Katayama S (1990) 2236897 175768 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6401 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6402 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6403 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Burke RE (1986) 2904117 175767 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 16547 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Barnes PJ (2001) 11281822 181352 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 16548 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Barnes PJ (1995) 10188785 181350 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 16549 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Hansel TT (2002) 12582447 181351 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 9901 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens binder target Eikmeier G (1990) 1979173 178065 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 12142 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 932 Cycrimine (+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum - DRUGBANK DB00942 C19H29NO small molecule - 77-39-4 DRUGBANK 12143 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 932 Cycrimine (+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum - DRUGBANK DB00942 C19H29NO small molecule - 77-39-4 DRUGBANK 12141 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Vedasiromoni JR (1976) 1267542 179231 932 Cycrimine (+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum - DRUGBANK DB00942 C19H29NO small molecule - 77-39-4 DRUGBANK 12144 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 932 Cycrimine (+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum - DRUGBANK DB00942 C19H29NO small molecule - 77-39-4 DRUGBANK 27485 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Salmon M (2013) 23435542 188552 7823 Umeclidinium 1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane incruse ellipta|anoro ellipta DRUGBANK DB09076 C29H34NO2 small molecule R03BB07|R03AL03 869185-19-3 DRUGBANK 5768 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 5769 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 13044 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13045 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13046 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Schneider T (2004) 14769832 179826 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 10730 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10731 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10732 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10733 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Eltze M (1994) 8081071 178479 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10734 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Eltze M (1999) 10370904 178478 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10735 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Pehl C (1998) 9798802 178477 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10736 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Hosoi R (2000) 10907719 178476 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 17362 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens unknown target Neeper R (1991) 1678146 181594 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 9247 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Pedretti RF (2003) 12717096 177702 660 Pirenzepine Pirenzpine|Pirenzepinum|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|Pirenzepina|Pirenzepin gastrozepin tab 50mg DRUGBANK DB00670 C19H21N5O2 small molecule A02BX03 28797-61-7 DRUGBANK 9248 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 660 Pirenzepine Pirenzpine|Pirenzepinum|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|Pirenzepina|Pirenzepin gastrozepin tab 50mg DRUGBANK DB00670 C19H21N5O2 small molecule A02BX03 28797-61-7 DRUGBANK 12073 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Golds PR (1980) 7052344 178830 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12074 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target El-Fakahany E (1983) 6297650 179177 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12075 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Doggrell SA (1981) 6118411 179176 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 11335 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Golds PR (1980) 7052344 178830 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 12439 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 969 Cyclopentolate 2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate|Ciclopentolato|beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate|(+-)-Cyclopentolate|alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|()-cyclopentolate|Cyclopentolatum|-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate|Cyclopentolate|2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester|1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester cyclomydril|cyclogyl oph dps 1 DRUGBANK DB00979 C17H25NO3 small molecule S01FA54|S01FA04 512-15-2 DRUGBANK 12440 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 969 Cyclopentolate 2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate|Ciclopentolato|beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate|(+-)-Cyclopentolate|alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|()-cyclopentolate|Cyclopentolatum|-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate|Cyclopentolate|2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester|1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester cyclomydril|cyclogyl oph dps 1 DRUGBANK DB00979 C17H25NO3 small molecule S01FA54|S01FA04 512-15-2 DRUGBANK 23997 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Ochillo RF (1982) 7122991 181681 4645 Mepenzolate Mepenzolate|Mepenzolic acid cantil DRUGBANK DB04843 C21H26NO3 small molecule A03AB12 25990-43-6 DRUGBANK 23998 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Tsai CS (1989) 2791613 181660 4645 Mepenzolate Mepenzolate|Mepenzolic acid cantil DRUGBANK DB04843 C21H26NO3 small molecule A03AB12 25990-43-6 DRUGBANK 23999 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Tsai CS (1995) 7623487 181685 4645 Mepenzolate Mepenzolate|Mepenzolic acid cantil DRUGBANK DB04843 C21H26NO3 small molecule A03AB12 25990-43-6 DRUGBANK 6361 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Larson EW (1991) 2027917 175724 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6362 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Myhrer T (2010) 20624420 175721 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6363 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Waelbroeck M (1990) 2253700 175723 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6364 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6365 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6366 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6821 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 6822 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 6823 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Huang XP (1998) 9732369 175973 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 7891 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Richelson E (1983) 6130192 176784 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7892 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7889 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 24713 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Nilvebrant L (2002) 12076307 181796 5584 Fesoterodine FESO|Fesoterodine toviaz DRUGBANK DB06702 C26H37NO3 small molecule G04BD11 286930-02-7 DRUGBANK 10048 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Klinkenberg I (2010) 20398692 178163 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 10049 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Murasaki O (2003) 14534362 178162 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 17217 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17218 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Sinha S (2010) 20590605 179924 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17219 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17220 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 10964 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 15004 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 5693 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5694 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5695 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 15238 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 6743 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6744 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 16485 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16486 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 7588 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Snyder S (1974) 4152054 176563 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7589 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7590 107550 1128 - CHRM1 HM1|M1|M1R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 15285 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15236 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15001 107551 1129 - CHRM2 HM2 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 8094 107551 1129 - CHRM2 HM2 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 15892 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Son SL (1980) 7437219 181112 1302 Metocurine Dimethyltubocurarine - DRUGBANK DB01336 C40H48N2O6 small molecule M03AA04 5152-30-7 DRUGBANK 15898 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cembala TM (2007) 17588565 176410 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 15899 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Okanlami OA (1996) 8572329 181113 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 15900 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Milchert M (2009) 20400785 178072 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 4272 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Hou VY (1998) 9523819 174352 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 5788 107551 1129 - CHRM2 HM2 9606 Homo sapiens binder target Yasuda SU (1999) 10212017 175352 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5629 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Wellington K (2005) 15987237 175290 324 Ipratropium bromide Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide atroventhfa|combivent udv|atro DRUGBANK DB00332 C20H30BrNO3 small molecule R01AX03|R03AL02|R03AL01|R03BB01 22254-24-6 DRUGBANK 14052 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Hou VY (1998) 9523819 174352 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 14053 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 14054 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 7166 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 7167 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Soukup O (2009) 19565307 176252 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 10363 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10364 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5544 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5077 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Yamamoto N (1999) 10413067 174865 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5078 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Ishida Y (1990) 1690310 174866 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 4748 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 15907 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Zappi L (1999) 10598601 181118 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15908 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Karpati E (2002) 12426786 181115 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15909 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 7584 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 497 Tridihexethyl - - DRUGBANK DB00505 C21H36NO small molecule A03AB08 60-49-1 DRUGBANK 7585 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 497 Tridihexethyl - - DRUGBANK DB00505 C21H36NO small molecule A03AB08 60-49-1 DRUGBANK 13332 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Dmochowski R (2005) 15963006 179926 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13333 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nelson CP (2006) 16188951 176974 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13334 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Sinha S (2010) 20590605 179924 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13335 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Oki T (2007) 17222678 179925 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13336 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Ito Y (2009) 19446545 179922 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 12502 107551 1129 - CHRM2 HM2 9606 Homo sapiens binder target Haddad EB (1999) 10385241 179513 976 Glycopyrronium Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion robinul forte tab 2mg|ultibro DRUGBANK DB00986 C19H28NO3 small molecule R03BB06|R03AL04|A03AB02|A03CA05 740028-90-4 DRUGBANK 24712 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 5584 Fesoterodine FESO|Fesoterodine toviaz DRUGBANK DB06702 C26H37NO3 small molecule G04BD11 286930-02-7 DRUGBANK 10681 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Pavia J (1997) 9059856 178461 794 Dicyclomine DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin bentylol tablet 10mg|dicyclomi DRUGBANK DB00804 C19H35NO2 small molecule A03AA07 77-19-0 DRUGBANK 10440 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10441 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Jandhyala BS (1966) 5918523 178383 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10442 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10443 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Jandhyala ML (1968) 5674398 178384 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 13463 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Golembiewski JA (2002) 12476402 179971 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 9918 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9919 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9920 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Milchert M (2009) 20400785 178072 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 6824 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 6825 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 6826 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Lysikova M (2001) 11495349 175972 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 10727 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Betz AJ (2007) 17594079 178475 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 7117 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 6623 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Zuchner T (2005) 16181410 175897 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6624 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target May LT (2005) 15333678 175900 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6625 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Sterin-Borda L (2002) 12505062 175901 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6626 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Peter JC (2004) 15485827 175898 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6627 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Sawatzky DA (2003) 12948933 175899 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6235 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Freedman SB (1988) 3208836 175651 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6236 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Doerje F (1991) 1994002 175652 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6237 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Bognar IT (1992) 1635586 175653 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 9771 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 7673 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Bachrach WH (1972) 4555460 176615 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7674 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7675 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7405 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Redka DS (2008) 18552124 176413 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7406 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Ten Berge RE (1996) 9007524 176412 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7407 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Ehlert FJ (2008) 18305010 176411 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7408 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cembala TM (2007) 17588565 176410 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7409 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Huang XP (2005) 15937215 176417 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7410 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Spina D (1994) 7522861 176416 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7411 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Maier-Peuschel M (2010) 20083608 176415 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7412 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target De Vries B (2001) 11426849 176414 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7413 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Elsinghorst PW (2007) 17944454 176403 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7414 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 8169 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Roman S (2005) 16248990 176973 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8170 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nelson CP (2006) 16188951 176974 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8171 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Minaba M (2006) 17087737 176975 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8172 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cembala TM (2007) 17588565 176410 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8173 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8174 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target May LT (2005) 15333678 175900 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 13611 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Moreno-Vinasco L (2009) 19465517 180061 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 13612 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Figueroa KW (2009) 18824613 180060 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 13613 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 6911 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Eltze M (1989) 2625138 176038 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 15059 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15060 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 7851 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 14245 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14246 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14247 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 15135 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Pavia J (1997) 9059856 178461 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15136 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Jovanovic A (1994) 8050463 180748 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15137 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Lazartigues E (1998) 9851542 180746 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15138 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Kovacs I (1998) 9454790 180747 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15139 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Waelbroeck M (1991) 1863523 180744 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15140 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Pelat M (1999) 10497897 180745 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15141 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Varoli L (1999) 10530931 180742 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15142 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Braverman AS (2002) 12185001 180743 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 10261 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10262 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10043 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 10044 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Johnson DE (2005) 15627430 178160 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 15097 107551 1129 - CHRM2 HM2 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15098 107551 1129 - CHRM2 HM2 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15099 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15100 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 11626 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Carrera MR (2004) 15351386 178995 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11627 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Sharkey J (1988) 3047364 179005 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 8720 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 9898 107551 1129 - CHRM2 HM2 9606 Homo sapiens binder target Eikmeier G (1990) 1979173 178065 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9877 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Gil L (2000) 11124384 178060 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9878 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9879 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Manjeet S (1989) 2612581 178062 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9880 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9881 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target George N (2010) 20085574 178061 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 14139 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Ehlert FJ (1990) 2329499 180337 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14140 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14141 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 7043 107551 1129 - CHRM2 HM2 9606 Homo sapiens binder target Hustveit O (1994) 8164394 176164 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 14190 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 14191 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Greco KA (2008) 19002123 177129 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 14192 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 14193 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Abbiati GA (1988) 3247311 180355 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 14194 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Uckert S (2000) 10858873 180356 1136 Flavoxate Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate pms-flavoxate|flavoxate|urispa DRUGBANK DB01148 C24H25NO4 small molecule G04BD02 15301-69-6 DRUGBANK 26796 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Pfaff O (1995) 8608784 181703 7572 Dimetindene Dimethindene - DRUGBANK DB08801 C20H24N2 small molecule R06AB03|D04AA13 5636-83-9 DRUGBANK 6404 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Katayama S (1990) 2236897 175768 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6405 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Burke RE (1986) 2904117 175767 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 16550 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Barnes PJ (1995) 10188785 181350 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 16551 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Hansel TT (2002) 12582447 181351 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 7509 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Jha S (2007) 18046909 176497 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7510 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Moriya H (1999) 10374898 176500 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 27487 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Salmon M (2013) 23435542 188552 7823 Umeclidinium 1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane incruse ellipta|anoro ellipta DRUGBANK DB09076 C29H34NO2 small molecule R03BB07|R03AL03 869185-19-3 DRUGBANK 5766 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 5767 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 13047 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nelson CP (2006) 16188951 176974 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13048 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Schneider T (2004) 14769832 179826 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13049 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Sellers DJ (2000) 11193006 179825 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13050 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target McNamara A (2009) 19168050 179824 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 6327 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6328 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Schjelderup L (1988) 3247303 175713 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6329 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6330 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 27798 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Liu H (2006) 16453179 195966 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 6369 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Larson EW (1991) 2027917 175724 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6370 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Myhrer T (2010) 20624420 175721 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6371 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Waelbroeck M (1990) 2253700 175723 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6372 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6373 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6374 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 5991 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7886 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 12832 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Buranakarl C (2001) 11798291 179728 1009 Bethanechol (2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine myotonachol tablets 25mg|myoto DRUGBANK DB01019 C7H17N2O2 small molecule N07AB02 674-38-4 DRUGBANK 12833 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Agrawal A (2007) 17413603 179729 1009 Bethanechol (2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine myotonachol tablets 25mg|myoto DRUGBANK DB01019 C7H17N2O2 small molecule N07AB02 674-38-4 DRUGBANK 12834 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1009 Bethanechol (2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine myotonachol tablets 25mg|myoto DRUGBANK DB01019 C7H17N2O2 small molecule N07AB02 674-38-4 DRUGBANK 12835 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1009 Bethanechol (2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine myotonachol tablets 25mg|myoto DRUGBANK DB01019 C7H17N2O2 small molecule N07AB02 674-38-4 DRUGBANK 12836 107551 1129 - CHRM2 HM2 9606 Homo sapiens agonist target Cruzblanca H (2006) 16953191 179730 1009 Bethanechol (2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine myotonachol tablets 25mg|myoto DRUGBANK DB01019 C7H17N2O2 small molecule N07AB02 674-38-4 DRUGBANK 17222 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Sinha S (2010) 20590605 179924 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17223 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 10961 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 5687 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5688 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 12058 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Golds PR (1980) 7052344 178830 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12059 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target El-Fakahany E (1983) 6297650 179177 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12060 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Doggrell SA (1981) 6118411 179176 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 6735 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6736 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 16473 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16474 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 7593 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Snyder S (1974) 4152054 176563 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7594 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7595 107551 1129 - CHRM2 HM2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 15283 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15227 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15005 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 8098 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 15893 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Okanlami OA (1996) 8572329 181113 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 15894 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Milchert M (2009) 20400785 178072 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 4263 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Hou VY (1998) 9523819 174352 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 4264 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 5789 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5627 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Wellington K (2005) 15987237 175290 324 Ipratropium bromide Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide atroventhfa|combivent udv|atro DRUGBANK DB00332 C20H30BrNO3 small molecule R01AX03|R03AL02|R03AL01|R03BB01 22254-24-6 DRUGBANK 7160 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Saito M (2010) 20687226 176250 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 7161 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Sykes DA (2009) 19498041 176248 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 7162 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Voigtlaender U (2003) 12815157 176249 454 Methylscopolamine bromide Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide pamine forte|methscopolamine|p DRUGBANK DB00462 C18H24BrNO4 small molecule - 155-41-9 DRUGBANK 10357 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10358 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5559 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5079 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Yamamoto N (1999) 10413067 174865 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 4737 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 15901 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Karpati E (2002) 12426786 181115 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 4002 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Li X (2008) 18450949 174198 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 4003 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 4004 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 4005 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 178 Cevimeline Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum cevimeline hydrochloride|evoxa DRUGBANK DB00185 C10H17NOS small molecule N07AX03 107233-08-9 DRUGBANK 7358 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens unknown target Davies MA (2005) 15765260 176347 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7580 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 497 Tridihexethyl - - DRUGBANK DB00505 C21H36NO small molecule A03AB08 60-49-1 DRUGBANK 7581 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 497 Tridihexethyl - - DRUGBANK DB00505 C21H36NO small molecule A03AB08 60-49-1 DRUGBANK 13319 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Maruyama S (2006) 16406943 179827 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13320 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13321 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13322 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13323 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Sinha S (2010) 20590605 179924 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13324 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Oki T (2007) 17222678 179925 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13325 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Ito Y (2009) 19446545 179922 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 13326 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Baldwin CM (2009) 19275276 179923 1050 Oxybutynin 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat ditropan syrup 1mg/ml|oxybutyn DRUGBANK DB01062 C22H31NO3 small molecule G04BD04 5633-20-5 DRUGBANK 12497 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Haddad EB (1999) 10385241 179513 976 Glycopyrronium Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion robinul forte tab 2mg|ultibro DRUGBANK DB00986 C19H28NO3 small molecule R03BB06|R03AL04|A03AB02|A03CA05 740028-90-4 DRUGBANK 24709 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5584 Fesoterodine FESO|Fesoterodine toviaz DRUGBANK DB06702 C26H37NO3 small molecule G04BD11 286930-02-7 DRUGBANK 24710 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Nilvebrant L (2002) 12076307 181796 5584 Fesoterodine FESO|Fesoterodine toviaz DRUGBANK DB06702 C26H37NO3 small molecule G04BD11 286930-02-7 DRUGBANK 10432 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10433 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 9921 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 719 Diphemanil Methylsulfate Diphemanil methylsulfat|Mtilsulfate de Diphmanil|P-(alpha-Phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate|Diphemanili metilsulfas|Diphemanil metilsulfate|4-(Diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate|Metilsulfato de difemanilo|Diphemanil methosulfate|Vagophemanil|N,N-Dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate - DRUGBANK DB00729 C21H27NO4S small molecule - 62-97-5 DRUGBANK 9922 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 719 Diphemanil Methylsulfate Diphemanil methylsulfat|Mtilsulfate de Diphmanil|P-(alpha-Phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate|Diphemanili metilsulfas|Diphemanil metilsulfate|4-(Diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate|Metilsulfato de difemanilo|Diphemanil methosulfate|Vagophemanil|N,N-Dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate - DRUGBANK DB00729 C21H27NO4S small molecule - 62-97-5 DRUGBANK 9923 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 719 Diphemanil Methylsulfate Diphemanil methylsulfat|Mtilsulfate de Diphmanil|P-(alpha-Phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate|Diphemanili metilsulfas|Diphemanil metilsulfate|4-(Diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate|Metilsulfato de difemanilo|Diphemanil methosulfate|Vagophemanil|N,N-Dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate - DRUGBANK DB00729 C21H27NO4S small molecule - 62-97-5 DRUGBANK 13464 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Golembiewski JA (2002) 12476402 179971 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 7847 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 24163 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens unknown target Choung RS (2007) 17300287 181987 4721 Itopride N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide - DRUGBANK DB04924 C20H26N2O4 small molecule A03FA07 122898-67-3 DRUGBANK 6819 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Lysikova M (2001) 11495349 175972 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 10726 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Betz AJ (2007) 17594079 178475 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 7127 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 4119 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Shiga Y (2002) 12401609 174255 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4120 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Shiraishi M (2001) 11561087 174254 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 6220 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Freedman SB (1988) 3208836 175651 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6221 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Doerje F (1991) 1994002 175652 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6222 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Bognar IT (1992) 1635586 175653 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 9772 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 7665 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Bachrach WH (1972) 4555460 176615 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7666 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 7667 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 507 Anisotropine Methylbromide Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate - DRUGBANK DB00517 C17H32BrNO2 small molecule - 80-50-2 DRUGBANK 17426 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Eglen RM (1987) 3580704 174466 1562 Isopropamide Isopropamide stelabid no 1|stelabid forte|s DRUGBANK DB01625 C23H33N2O small molecule A03CA01|A03AB09 7492-32-2 DRUGBANK 17427 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Lane MA (1978) 29133 181610 1562 Isopropamide Isopropamide stelabid no 1|stelabid forte|s DRUGBANK DB01625 C23H33N2O small molecule A03CA01|A03AB09 7492-32-2 DRUGBANK 8156 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8157 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8158 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 6912 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Eltze M (1989) 2625138 176038 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 15045 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15046 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 13038 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13039 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Schneider T (2004) 14769832 179826 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13040 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Sellers DJ (2000) 11193006 179825 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 13041 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target McNamara A (2009) 19168050 179824 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 14249 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14154 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Ehlert FJ (1990) 2329499 180337 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14155 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14156 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 10263 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10264 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10045 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Reitz AB (2007) 18045203 178159 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 15089 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Habre W (2008) 19020136 180723 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 8715 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 9902 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens binder target Eikmeier G (1990) 1979173 178065 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9873 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Gil L (2000) 11124384 178060 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9874 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9875 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9876 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Li CK (1980) 6893558 178059 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 15127 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15128 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Waelbroeck M (1991) 1863523 180744 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15129 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15130 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Varoli L (1999) 10530931 180742 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 15131 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Braverman AS (2002) 12185001 180743 1219 Diphenidol Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol - DRUGBANK DB01231 C21H27NO small molecule - 972-02-1 DRUGBANK 7047 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens binder target Hustveit O (1994) 8164394 176164 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 16543 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Barnes PJ (2001) 11281822 181352 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 16544 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Barnes PJ (1995) 10188785 181350 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 16545 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Hansel TT (2002) 12582447 181351 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 16546 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1358 Tiotropium - inspiolto respimat|spiriva res DRUGBANK DB01409 C19H22NO4S2 small molecule R03BB54|R03BB04|R03AL06 186691-13-4 DRUGBANK 7499 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Bozkurt TE (2009) 19416629 176499 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7500 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Bharucha AE (2010) 20395537 176498 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7501 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Jha S (2007) 18046909 176497 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7502 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 27483 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Salmon M (2013) 23435542 188552 7823 Umeclidinium 1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane incruse ellipta|anoro ellipta DRUGBANK DB09076 C29H34NO2 small molecule R03BB07|R03AL03 869185-19-3 DRUGBANK 5770 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 5771 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 24729 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Liu T (2010) 19951374 182136 5591 Methacholine Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh methacholine omega|sterile pro DRUGBANK DB06709 C8H18NO2 small molecule - 55-92-5 DRUGBANK 24730 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Fernandez-Rodriguez S (2010) 20347047 182149 5591 Methacholine Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh methacholine omega|sterile pro DRUGBANK DB06709 C8H18NO2 small molecule - 55-92-5 DRUGBANK 24731 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Liu PS (2011) 20888332 182169 5591 Methacholine Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh methacholine omega|sterile pro DRUGBANK DB06709 C8H18NO2 small molecule - 55-92-5 DRUGBANK 24732 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Gosens R (2009) 19460789 182107 5591 Methacholine Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh methacholine omega|sterile pro DRUGBANK DB06709 C8H18NO2 small molecule - 55-92-5 DRUGBANK 6319 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6320 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Schjelderup L (1988) 3247303 175713 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6321 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 6322 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 375 Oxyphencyclimine Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine - DRUGBANK DB00383 C20H28N2O3 small molecule A03CA03|A03AA01 125-53-1 DRUGBANK 23994 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Ochillo RF (1982) 7122991 181681 4645 Mepenzolate Mepenzolate|Mepenzolic acid cantil DRUGBANK DB04843 C21H26NO3 small molecule A03AB12 25990-43-6 DRUGBANK 23995 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Tsai CS (1989) 2791613 181660 4645 Mepenzolate Mepenzolate|Mepenzolic acid cantil DRUGBANK DB04843 C21H26NO3 small molecule A03AB12 25990-43-6 DRUGBANK 23996 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Tsai CS (1995) 7623487 181685 4645 Mepenzolate Mepenzolate|Mepenzolic acid cantil DRUGBANK DB04843 C21H26NO3 small molecule A03AB12 25990-43-6 DRUGBANK 6367 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Myhrer T (2010) 20624420 175721 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6368 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 5980 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7890 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6737 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6738 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 17210 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17211 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17212 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17213 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Sinha S (2010) 20590605 179924 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17214 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Ito Y (2009) 19446545 179922 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 17215 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 10962 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 5668 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5669 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 12061 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Golds PR (1980) 7052344 178830 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12062 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target El-Fakahany E (1983) 6297650 179177 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12063 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Doggrell SA (1981) 6118411 179176 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 13606 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Figueroa KW (2009) 18824613 180060 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 13607 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens agonist target Sykes DA (2009) 19498041 176248 1073 Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine pms-pilocarpine 4%|pilocarpine DRUGBANK DB01085 C11H16N2O2 small molecule N07AX01|S01EB51|S01EB01 92-13-7 DRUGBANK 16475 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16476 107553 1131 - CHRM3 EGBRS|HM3 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 15284 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15231 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15002 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 8095 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 7112 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 9773 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 10359 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10360 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5764 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 5765 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 4741 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 24714 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 5584 Fesoterodine FESO|Fesoterodine toviaz DRUGBANK DB06702 C26H37NO3 small molecule G04BD11 286930-02-7 DRUGBANK 10434 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10435 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 13470 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Golembiewski JA (2002) 12476402 179971 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 7850 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 6820 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Lysikova M (2001) 11495349 175972 416 Hyoscyamine (S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine uro-mp|symax sr|hyophen|bellad DRUGBANK DB00424 C17H23NO3 small molecule A03BA03|A03CB31 101-31-5 DRUGBANK 10721 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 10722 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 10723 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 10724 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Betz AJ (2007) 17594079 178475 799 Tropicamide Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl diotrope 1% solution|minims tr DRUGBANK DB00809 C17H20N2O2 small molecule S01FA06|S01FA56 1508-75-4 DRUGBANK 5673 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5674 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 10046 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Reitz AB (2007) 18045203 178159 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 5790 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens binder target Yasuda SU (1999) 10212017 175352 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 17428 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Eglen RM (1987) 3580704 174466 1562 Isopropamide Isopropamide stelabid no 1|stelabid forte|s DRUGBANK DB01625 C23H33N2O small molecule A03CA01|A03AB09 7492-32-2 DRUGBANK 17429 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Lane MA (1978) 29133 181610 1562 Isopropamide Isopropamide stelabid no 1|stelabid forte|s DRUGBANK DB01625 C23H33N2O small molecule A03CA01|A03AB09 7492-32-2 DRUGBANK 8159 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8160 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8161 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 15049 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15050 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14255 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 10265 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10266 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 6223 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Doerje F (1991) 1994002 175652 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6224 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Bognar IT (1992) 1635586 175653 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 8719 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 9899 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens binder target Eikmeier G (1990) 1979173 178065 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9863 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9864 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9865 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Li CK (1980) 6893558 178059 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 14115 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Ehlert FJ (1990) 2329499 180337 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14116 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14117 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 7044 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens binder target Hustveit O (1994) 8164394 176164 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7503 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Jha S (2007) 18046909 176497 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7504 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Moriya H (1999) 10374898 176500 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 27484 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Salmon M (2013) 23435542 188552 7823 Umeclidinium 1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane incruse ellipta|anoro ellipta DRUGBANK DB09076 C29H34NO2 small molecule R03BB07|R03AL03 869185-19-3 DRUGBANK 5534 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 13043 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Maruyama S (2006) 16406943 179827 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 6355 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Myhrer T (2010) 20624420 175721 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6356 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Alberts P (1995) 7616431 175722 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6357 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Waelbroeck M (1990) 2253700 175723 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6358 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6359 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 6360 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Waelbroeck M (1992) 1426023 175714 379 Procyclidine 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin phl-procyclidine tablets|pendo DRUGBANK DB00387 C19H29NO small molecule N04AA04 77-37-2 DRUGBANK 5984 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7887 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6739 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6740 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 17216 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 10963 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 12070 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Golds PR (1980) 7052344 178830 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12071 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target El-Fakahany E (1983) 6297650 179177 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12072 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Doggrell SA (1981) 6118411 179176 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 16481 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16482 107554 1132 - CHRM4 HM4|M4R 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 15266 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15233 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15003 107555 1133 - CHRM5 HM5 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 8096 107555 1133 - CHRM5 HM5 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 7113 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 9758 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 10339 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10340 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5772 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 5773 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 5774 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 332 Metixene Methixene|Metisene|Metixenum|Methixen|Metixeno - DRUGBANK DB00340 C20H23NS small molecule N04AA03 4969-02-2 DRUGBANK 4743 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 24711 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 5584 Fesoterodine FESO|Fesoterodine toviaz DRUGBANK DB06702 C26H37NO3 small molecule G04BD11 286930-02-7 DRUGBANK 10438 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 10439 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 775 Cryptenamine - - DRUGBANK DB00785 - small molecule - 1356-18-9 DRUGBANK 13447 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Golembiewski JA (2002) 12476402 179971 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 7826 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 5677 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5678 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6233 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Doerje F (1991) 1994002 175652 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 6234 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Bognar IT (1992) 1635586 175653 368 Trihexyphenidyl Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex trihexyphen tab 2mg|nu-trihexy DRUGBANK DB00376 C20H31NO small molecule N04AA01 144-11-6 DRUGBANK 5781 107555 1133 - CHRM5 HM5 9606 Homo sapiens binder target Yasuda SU (1999) 10212017 175352 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 8165 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8166 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8167 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 8168 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 562 Atropine Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine belladonna alkaloids with phen DRUGBANK DB00572 C17H23NO3 small molecule A03CB03|A03BA01|S01FA01 51-55-8 DRUGBANK 15053 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15054 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14236 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 10255 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10256 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10042 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Reitz AB (2007) 18045203 178159 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 8708 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Thayer SA (1985) 2981533 177387 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 9900 107555 1133 - CHRM5 HM5 9606 Homo sapiens binder target Eikmeier G (1990) 1979173 178065 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9866 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9867 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 9868 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 715 Homatropine Methylbromide 3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum hydromet|tussigon|hydrocodone DRUGBANK DB00725 C17H24BrNO3 small molecule A03CB04 80-49-9 DRUGBANK 14121 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Ehlert FJ (1990) 2329499 180337 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14122 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14123 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 7045 107555 1133 - CHRM5 HM5 9606 Homo sapiens binder target Hustveit O (1994) 8164394 176164 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7507 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Jha S (2007) 18046909 176497 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 7508 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Moriya H (1999) 10374898 176500 488 Darifenacin Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine darifenacin hydrobromide exten DRUGBANK DB00496 C28H30N2O2 small molecule G04BD10 133099-04-4 DRUGBANK 27486 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Salmon M (2013) 23435542 188552 7823 Umeclidinium 1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane incruse ellipta|anoro ellipta DRUGBANK DB09076 C29H34NO2 small molecule R03BB07|R03AL03 869185-19-3 DRUGBANK 5538 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 13042 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Maruyama S (2006) 16406943 179827 1025 Tolterodine Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol mylan-tolterodine er|teva-tolt DRUGBANK DB01036 C22H31NO small molecule G04BD07 124937-51-5 DRUGBANK 5986 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7888 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6717 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6718 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6719 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 17221 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Mansfield KJ (2009) 19029429 181560 1530 Solifenacin - act solifenacin|mint-solifenac DRUGBANK DB01591 C23H26N2O2 small molecule G04BD08|G04CA53 242478-37-1 DRUGBANK 10954 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 12044 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Golds PR (1980) 7052344 178830 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12045 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target El-Fakahany E (1983) 6297650 179177 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12046 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Doggrell SA (1981) 6118411 179176 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 16457 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16458 107555 1133 - CHRM5 HM5 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 9313 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9314 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9315 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9316 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9317 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9318 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 26900 107556 1134 - CHRNA1 ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS 9606 Homo sapiens antagonist target Loring RH (1990) 2331571 181650 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 15902 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15903 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15904 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Karpati E (2002) 12426786 181115 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15905 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Kiss JP (1997) 9227834 181116 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15906 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Toeroecsik A (1991) 1748153 181117 1304 Pipecuronium Pipecuronium|Pipecurium - DRUGBANK DB01338 C35H62N4O4 small molecule M03AC06 68399-58-6 DRUGBANK 15910 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Paul M (2002) 12145052 181119 1305 Vecuronium Vecuronium vecuronium bromide for injecti DRUGBANK DB01339 C34H57N2O4 small molecule M03AC03 86029-43-8 DRUGBANK 15911 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2008) 18633030 175926 1305 Vecuronium Vecuronium vecuronium bromide for injecti DRUGBANK DB01339 C34H57N2O4 small molecule M03AC03 86029-43-8 DRUGBANK 15912 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson Fagerlund M (2009) 19417616 178070 1305 Vecuronium Vecuronium vecuronium bromide for injecti DRUGBANK DB01339 C34H57N2O4 small molecule M03AC03 86029-43-8 DRUGBANK 9343 107557 1135 - CHRNA2 - 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9344 107557 1135 - CHRNA2 - 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9345 107557 1135 - CHRNA2 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9346 107557 1135 - CHRNA2 - 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9347 107557 1135 - CHRNA2 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9348 107557 1135 - CHRNA2 - 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 15887 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Groebe DR (1994) 8132625 181110 1302 Metocurine Dimethyltubocurarine - DRUGBANK DB01336 C40H48N2O6 small molecule M03AA04 5152-30-7 DRUGBANK 15888 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2009) 18842832 181111 1302 Metocurine Dimethyltubocurarine - DRUGBANK DB01336 C40H48N2O6 small molecule M03AA04 5152-30-7 DRUGBANK 15889 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1302 Metocurine Dimethyltubocurarine - DRUGBANK DB01336 C40H48N2O6 small molecule M03AA04 5152-30-7 DRUGBANK 15890 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2008) 18633030 175926 1302 Metocurine Dimethyltubocurarine - DRUGBANK DB01336 C40H48N2O6 small molecule M03AA04 5152-30-7 DRUGBANK 15891 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Wang HL (2003) 12799358 181109 1302 Metocurine Dimethyltubocurarine - DRUGBANK DB01336 C40H48N2O6 small molecule M03AA04 5152-30-7 DRUGBANK 15090 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15091 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson M (2006) 16931985 178069 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15092 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15093 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15094 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson Fagerlund M (2009) 19417616 178070 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 15095 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Ihmsen H (2009) 19352159 180724 1214 Mivacurium Mivacurium mivacron DRUGBANK DB01226 C58H80N2O14 small molecule M03AC10 133814-19-4 DRUGBANK 9911 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9912 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson M (2006) 16931985 178069 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9913 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9914 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9915 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson Fagerlund M (2009) 19417616 178070 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9916 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2008) 18633030 175926 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 8077 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 555 Cisatracurium besylate (1R,1'R,2R,2'r)-atracurium besylate|(1R-cis,1'R-cis)-atracurium besylate|Besilate de cisatracurium|(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate|Cisatracurium-Kation|Cisatracurium dibenzenesulfonate|Cisatracurii besilas|Besilato de cisatracurio|Cisatracurium besilate aj-cisatracurium|cisatracurium DRUGBANK DB00565 C65H82N2O18S2 small molecule - 96946-42-8 DRUGBANK 8078 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Tuba Z (2002) 12171561 176921 555 Cisatracurium besylate (1R,1'R,2R,2'r)-atracurium besylate|(1R-cis,1'R-cis)-atracurium besylate|Besilate de cisatracurium|(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate|Cisatracurium-Kation|Cisatracurium dibenzenesulfonate|Cisatracurii besilas|Besilato de cisatracurio|Cisatracurium besilate aj-cisatracurium|cisatracurium DRUGBANK DB00565 C65H82N2O18S2 small molecule - 96946-42-8 DRUGBANK 8079 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 555 Cisatracurium besylate (1R,1'R,2R,2'r)-atracurium besylate|(1R-cis,1'R-cis)-atracurium besylate|Besilate de cisatracurium|(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate|Cisatracurium-Kation|Cisatracurium dibenzenesulfonate|Cisatracurii besilas|Besilato de cisatracurio|Cisatracurium besilate aj-cisatracurium|cisatracurium DRUGBANK DB00565 C65H82N2O18S2 small molecule - 96946-42-8 DRUGBANK 14760 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14761 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14762 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14763 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson Fagerlund M (2009) 19417616 178070 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14764 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Nishimura K (2010) 20338223 180591 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14765 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Wenningmann I (2001) 11562442 180590 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14766 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2008) 18633030 175926 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14048 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 14049 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 14050 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 14051 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2008) 18633030 175926 1123 Doxacurium chloride - nuromax DRUGBANK DB01135 C56H78Cl2N2O16 small molecule M03AC07 106819-53-8 DRUGBANK 27175 107557 1135 - CHRNA2 - 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27581 107557 1135 - CHRNA2 - 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 15895 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 15896 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Dilger JP (2007) 17525594 181114 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 15897 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Jonsson Fagerlund M (2009) 19417616 178070 1303 Pancuronium Bromuro de pancuronio|Bromure de pancuronium|Pancuronium pancuronium bromide|pancuroniu DRUGBANK DB01337 C35H60N2O4 small molecule M03AC01 - DRUGBANK 9826 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Wang H (2010) 20045405 178032 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 6618 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6619 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6620 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 6621 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target An MC (2010) 20498043 175895 403 Carbachol Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride isopto carbachol 1.5%|carbacho DRUGBANK DB00411 C6H15ClN2O2 small molecule N07AB01|S01EB02 51-83-2 DRUGBANK 9068 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 647 Mecamylamine Versamine mecamylamine hydrochloride|vec DRUGBANK DB00657 C11H21N small molecule C02BB01 60-40-2 DRUGBANK 9069 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Struthers AM (2009) 19778551 177602 647 Mecamylamine Versamine mecamylamine hydrochloride|vec DRUGBANK DB00657 C11H21N small molecule C02BB01 60-40-2 DRUGBANK 9070 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 647 Mecamylamine Versamine mecamylamine hydrochloride|vec DRUGBANK DB00657 C11H21N small molecule C02BB01 60-40-2 DRUGBANK 9071 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Shytle RD (2002) 12080428 177603 647 Mecamylamine Versamine mecamylamine hydrochloride|vec DRUGBANK DB00657 C11H21N small molecule C02BB01 60-40-2 DRUGBANK 9072 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 647 Mecamylamine Versamine mecamylamine hydrochloride|vec DRUGBANK DB00657 C11H21N small molecule C02BB01 60-40-2 DRUGBANK 7402 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7403 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 7404 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Aoshima H (1992) 1337082 176409 475 Gallamine Triethiodide Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil flaxedil inj 20mg/ml DRUGBANK DB00483 C30H60I3N3O3 small molecule - 65-29-2 DRUGBANK 3987 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Sullivan PF (2004) 15048644 174193 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3988 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3989 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3990 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3991 107557 1135 - CHRNA2 - 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 9935 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 722 Atracurium besylate Atracurium dibesylate|Atracurium besilate|1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium atracurium - (for single do DRUGBANK DB00732 C65H82N2O18S2 small molecule - 64228-81-5 DRUGBANK 9936 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 722 Atracurium besylate Atracurium dibesylate|Atracurium besilate|1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium atracurium - (for single do DRUGBANK DB00732 C65H82N2O18S2 small molecule - 64228-81-5 DRUGBANK 9937 107557 1135 - CHRNA2 - 9606 Homo sapiens inhibitor target Jonsson Fagerlund M (2009) 19417616 178070 722 Atracurium besylate Atracurium dibesylate|Atracurium besilate|1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium atracurium - (for single do DRUGBANK DB00732 C65H82N2O18S2 small molecule - 64228-81-5 DRUGBANK 7659 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7660 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7661 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Lee JH (2006) 16563374 176588 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7662 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Damaj MI (2005) 15356218 176579 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 10728 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 10729 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 800 Biperiden Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum akineton tab 2mg DRUGBANK DB00810 C21H29NO small molecule N04AA02 514-65-8 DRUGBANK 15354 107557 1135 - CHRNA2 - 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15355 107557 1135 - CHRNA2 - 9606 Homo sapiens partial agonist target Maneckjee R (1994) 7848904 180830 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15356 107557 1135 - CHRNA2 - 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15357 107557 1135 - CHRNA2 - 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 15358 107557 1135 - CHRNA2 - 9606 Homo sapiens partial agonist target Lee C (2002) 12067008 180829 1233 Decamethonium Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium - DRUGBANK DB01245 C16H38N2 small molecule - 156-74-1 DRUGBANK 6665 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 408 Metocurine Iodide (+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi metubine iodide inj 2mg/ml DRUGBANK DB00416 C40H48I2N2O6 small molecule - 7601-55-0 DRUGBANK 6666 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 408 Metocurine Iodide (+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi metubine iodide inj 2mg/ml DRUGBANK DB00416 C40H48I2N2O6 small molecule - 7601-55-0 DRUGBANK 6667 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 408 Metocurine Iodide (+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi metubine iodide inj 2mg/ml DRUGBANK DB00416 C40H48I2N2O6 small molecule - 7601-55-0 DRUGBANK 6668 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Liu M (2008) 18633030 175926 408 Metocurine Iodide (+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi metubine iodide inj 2mg/ml DRUGBANK DB00416 C40H48I2N2O6 small molecule - 7601-55-0 DRUGBANK 6669 107557 1135 - CHRNA2 - 9606 Homo sapiens antagonist target Iwatsuki N (1980) 6107062 175925 408 Metocurine Iodide (+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi metubine iodide inj 2mg/ml DRUGBANK DB00416 C40H48I2N2O6 small molecule - 7601-55-0 DRUGBANK 15622 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens partial agonist target Mihalak KB (2006) 16766716 180971 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 13661 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens antagonist target Cachelin AB (1995) 7761270 180088 1078 Pentolinium Pentolonum|Pentolonium|Pentolineum - DRUGBANK DB01090 C15H32N2 small molecule - 144-44-5 DRUGBANK 14292 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens antagonist target Slemmer JE (2000) 10991997 180394 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14293 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens antagonist target Fryer JD (1999) 9862757 180393 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 15102 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens antagonist target Xiao Y (2001) 11561100 180726 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 11103 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Parker S (2007) 17629760 108198 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11104 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Rayes D (2007) 17314321 178679 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11105 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11106 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11107 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11108 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Hu Y (2009) 19668355 178687 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 11109 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Culetto E (2004) 15280391 178680 838 Levamisole Levamisol|Levamisolum ergamisol tab 50mg|novo-levami DRUGBANK DB00848 C11H12N2S small molecule P02CE01 14769-73-4 DRUGBANK 9337 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9338 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9339 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9340 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9341 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9342 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 27149 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27576 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27030 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Walker N (2014) 25517706 182256 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 27031 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Houlihan LM (2001) 11553677 181776 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 3983 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3984 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3985 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3986 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 7658 107558 1136 - CHRNA3 LNCR2|NACHRA3|PAOD2 9606 Homo sapiens antagonist target Damaj MI (2005) 15356218 176579 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 14468 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14469 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14470 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 9361 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9362 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9363 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9364 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9365 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9366 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 7189 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7190 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7191 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 3970 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Espeseth T (2007) 17590520 174190 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3971 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target De Luca V (2006) 16636791 174191 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3972 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Ehringer MA (2007) 17226798 174192 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3973 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Klaassen A (2006) 17146052 174189 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3974 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Winterer G (2007) 17613539 174188 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3975 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3976 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3977 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3978 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 4654 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4655 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4656 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4622 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4623 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4624 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 16802 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16803 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16804 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11137 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11138 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11139 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 27036 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Walker N (2014) 25517706 182256 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 27037 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens agonist target Houlihan LM (2001) 11553677 181776 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 16832 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16833 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16834 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 7664 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Damaj MI (2005) 15356218 176579 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 16033 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16034 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16035 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16007 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16008 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16009 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15984 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15985 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15986 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 27171 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27580 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 5403 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5404 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5405 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16083 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16084 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16085 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16056 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16057 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16058 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 8496 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8497 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8498 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 10540 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10541 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10542 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 15625 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens partial agonist target Steensland P (2007) 17626178 180975 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 15626 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens partial agonist target Rollema H (2007) 17573127 180974 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 15627 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 15628 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens partial agonist target Nakamura M (2007) 17692720 180973 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 15629 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens partial agonist target McColl SL (2008) 18288085 180972 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 6695 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6696 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6697 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5302 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5303 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5304 107559 1137 - CHRNA4 BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 3998 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3999 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 4000 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 4001 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 9355 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9356 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9357 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9358 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9359 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9360 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 27152 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27578 107560 1138 - CHRNA5 LNCR2 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14456 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14457 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14458 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 27561 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Rogers KR (1992) 1621972 174356 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 27562 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Fiacchino F (1990) 2272786 174354 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 27563 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Marshall CG (1990) 2133043 174355 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 9274 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9275 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9276 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9277 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9278 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9279 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 7171 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7172 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7173 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 3950 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Olincy A (2006) 16754836 174185 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3951 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Mexal S (2007) 17360707 174184 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3952 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3953 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3954 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3955 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 4635 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4636 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4637 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4619 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4620 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4621 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 16787 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16788 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16789 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11114 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11115 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11116 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 27034 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Walker N (2014) 25517706 182256 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 27035 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Houlihan LM (2001) 11553677 181776 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 16817 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16818 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16819 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 27587 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Aracava Y (2005) 15522999 179864 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 27560 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Shiraishi M (2002) 12010769 174247 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 7630 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Damaj MI (2005) 15356218 176579 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 27621 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Pagan OR (2001) 11551210 181477 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 16015 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16016 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16017 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 15992 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15993 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15994 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15968 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15969 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15970 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15624 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens agonist target Mihalak KB (2006) 16766716 180971 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 5381 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5382 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5383 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16064 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16065 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16066 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16041 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16042 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16043 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 8480 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8481 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8482 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 10522 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10523 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10524 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 27527 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27582 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 6674 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6675 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6676 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5284 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5285 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5286 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens antagonist target Arias HR (2005) 16248797 174570 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 24348 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens unknown target Pavlov VA (2007) 17334244 181992 5295 GTS-21 Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine - DRUGBANK DB05708 C19H20N2O2 small molecule - 148372-04-7 DRUGBANK 24349 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens unknown target Kim SW (2007) 17591554 182021 5295 GTS-21 Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine - DRUGBANK DB05708 C19H20N2O2 small molecule - 148372-04-7 DRUGBANK 24350 107561 1139 - CHRNA7 CHRNA7-2|NACHRA7 9606 Homo sapiens unknown target Stokes C (2004) 15213292 181853 5295 GTS-21 Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine - DRUGBANK DB05708 C19H20N2O2 small molecule - 148372-04-7 DRUGBANK 9319 107562 1140 - CHRNB1 ACHRB|CHRNB|CMS1D|CMS2A|SCCMS 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9320 107562 1140 - CHRNB1 ACHRB|CHRNB|CMS1D|CMS2A|SCCMS 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9321 107562 1140 - CHRNB1 ACHRB|CHRNB|CMS1D|CMS2A|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9322 107562 1140 - CHRNB1 ACHRB|CHRNB|CMS1D|CMS2A|SCCMS 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9323 107562 1140 - CHRNB1 ACHRB|CHRNB|CMS1D|CMS2A|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9324 107562 1140 - CHRNB1 ACHRB|CHRNB|CMS1D|CMS2A|SCCMS 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 3992 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens agonist target De Luca V (2006) 16636791 174191 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3993 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens agonist target Ehringer MA (2007) 17226798 174192 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3994 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3995 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3996 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3997 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 24360 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens unknown target Li X (2002) 12170059 181799 5414 Rivanicline (3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine|(E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine|(E)-metanicotine|N-methyl-4-(3-pyridinyl)-(3E)-3-buten-1-amine|trans-metanicotine - DRUGBANK DB05855 C10H14N2 small molecule - 15585-43-0 DRUGBANK 7663 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens antagonist target Damaj MI (2005) 15356218 176579 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 9268 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9269 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9270 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9271 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9272 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9273 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 27151 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27577 107563 1141 RP11-61L14.4 CHRNB2 EFNL3|nAChRB2 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 3966 107564 1142 - CHRNB3 - 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3967 107564 1142 - CHRNB3 - 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3968 107564 1142 - CHRNB3 - 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3969 107564 1142 - CHRNB3 - 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 9307 107564 1142 - CHRNB3 - 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9308 107564 1142 - CHRNB3 - 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9309 107564 1142 - CHRNB3 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9310 107564 1142 - CHRNB3 - 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9311 107564 1142 - CHRNB3 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9312 107564 1142 - CHRNB3 - 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 27147 107564 1142 - CHRNB3 - 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27574 107564 1142 - CHRNB3 - 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27148 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27575 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 13660 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens antagonist target Cachelin AB (1995) 7761270 180088 1078 Pentolinium Pentolonum|Pentolonium|Pentolineum - DRUGBANK DB01090 C15H32N2 small molecule - 144-44-5 DRUGBANK 15101 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens unknown target Xiao Y (2001) 11561100 180726 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 9331 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9332 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9333 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9334 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9335 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9336 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 3979 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3980 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3981 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3982 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 7647 107565 1143 hCG_1731645 CHRNB4 - 9606 Homo sapiens antagonist target Damaj MI (2005) 15356218 176579 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 9325 107566 1144 - CHRND ACHRD|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9326 107566 1144 - CHRND ACHRD|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9327 107566 1144 - CHRND ACHRD|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9328 107566 1144 - CHRND ACHRD|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9329 107566 1144 - CHRND ACHRD|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9330 107566 1144 - CHRND ACHRD|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9292 107567 1145 - CHRNE ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9293 107567 1145 - CHRNE ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9294 107567 1145 - CHRNE ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9295 107567 1145 - CHRNE ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9296 107567 1145 - CHRNE ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9297 107567 1145 - CHRNE ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9286 107568 1146 - CHRNG ACHRG 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9287 107568 1146 - CHRNG ACHRG 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9288 107568 1146 - CHRNG ACHRG 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9289 107568 1146 - CHRNG ACHRG 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9290 107568 1146 - CHRNG ACHRG 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9291 107568 1146 - CHRNG ACHRG 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 24402 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Oka S (2000) 10788610 181749 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 4561 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Weber CK (2000) 11054378 174546 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4562 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Bantel H (2000) 11151876 174545 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4563 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4701 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Weber CK (2000) 11054378 174546 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4702 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Bantel H (2000) 11151876 174545 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4703 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 10560 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Weber CK (2000) 11054378 174546 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10561 107569 1147 - CHUK IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 2841 107572 1152 - CKB B-CK|BCK|CKBB|HEL-211|HEL-S-29 9606 Homo sapiens ligand target Buerklen TS (2007) 17036164 173506 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2842 107572 1152 - CKB B-CK|BCK|CKBB|HEL-211|HEL-S-29 9606 Homo sapiens ligand target Debrincat MA (2007) 17148442 140592 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2843 107572 1152 - CKB B-CK|BCK|CKBB|HEL-211|HEL-S-29 9606 Homo sapiens ligand target Wallimann T (1992) 1731757 173504 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2844 107572 1152 - CKB B-CK|BCK|CKBB|HEL-211|HEL-S-29 9606 Homo sapiens ligand target Tian XF (2006) 16875703 173505 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2838 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens ligand target Wallimann T (1992) 1731757 173504 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2839 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens ligand target Zhou DQ (2006) 17000714 173502 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2840 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens ligand target Zeng L (2007) 17389266 173503 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 19312 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2387 (Diaminomethyl-Methyl-Amino)-Acetic Acid - - DRUGBANK DB02490 C4H11N3O2 small molecule - - DRUGBANK 19313 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2387 (Diaminomethyl-Methyl-Amino)-Acetic Acid - - DRUGBANK DB02490 C4H11N3O2 small molecule - - DRUGBANK 19314 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2387 (Diaminomethyl-Methyl-Amino)-Acetic Acid - - DRUGBANK DB02490 C4H11N3O2 small molecule - - DRUGBANK 22411 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3859 D-Arginine - - DRUGBANK DB04027 C6H15N4O2 small molecule - 157-06-2 DRUGBANK 22412 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3859 D-Arginine - - DRUGBANK DB04027 C6H15N4O2 small molecule - 157-06-2 DRUGBANK 22413 107578 1158 - CKM CKMM|M-CK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3859 D-Arginine - - DRUGBANK DB04027 C6H15N4O2 small molecule - 157-06-2 DRUGBANK 2851 107580 1160 - CKMT2 SMTCK 9606 Homo sapiens ligand target Imming P (2006) 17016423 171742 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2852 107580 1160 - CKMT2 SMTCK 9606 Homo sapiens ligand target Wallimann T (1992) 1731757 173504 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2853 107580 1160 - CKMT2 SMTCK 9606 Homo sapiens ligand target Overington JP (2006) 17139284 171741 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2854 107580 1160 - CKMT2 SMTCK 9606 Homo sapiens ligand target Koufen P (1999) 10567223 173511 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2855 107580 1160 - CKMT2 SMTCK 9606 Homo sapiens ligand target Stachowiak O (1998) 9642223 173510 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2856 107580 1160 - CKMT2 SMTCK 9606 Homo sapiens ligand target Wyss M (1993) 8399219 173512 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 19691 107582 1163 RP11-307C12.6 CKS1B CKS1|PNAS-16|PNAS-18|ckshs1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2571 Meta Vanadate - - DRUGBANK DB02681 O19V7 small molecule - - DRUGBANK 19692 107582 1163 RP11-307C12.6 CKS1B CKS1|PNAS-16|PNAS-18|ckshs1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2571 Meta Vanadate - - DRUGBANK DB02681 O19V7 small molecule - - DRUGBANK 19693 107582 1163 RP11-307C12.6 CKS1B CKS1|PNAS-16|PNAS-18|ckshs1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2571 Meta Vanadate - - DRUGBANK DB02681 O19V7 small molecule - - DRUGBANK 20228 107592 1178 - CLC GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2860 Para-Mercury-Benzenesulfonic Acid - - DRUGBANK DB02983 C6H5HgO3S small molecule - - DRUGBANK 20229 107592 1178 - CLC GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2860 Para-Mercury-Benzenesulfonic Acid - - DRUGBANK DB02983 C6H5HgO3S small molecule - - DRUGBANK 20211 107592 1178 - CLC GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2844 N-Ethylmaleimide - - DRUGBANK DB02967 C6H7NO2 small molecule - 128-53-0 DRUGBANK 20212 107592 1178 - CLC GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2844 N-Ethylmaleimide - - DRUGBANK DB02967 C6H7NO2 small molecule - 128-53-0 DRUGBANK 13135 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Chen X (2002) 11752352 171740 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13136 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Lacy BE (2008) 18686757 179881 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13137 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Ambizas EM (2007) 17519292 179883 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13138 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Moeser AJ (2007) 17053162 179882 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13139 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Crowell MD (2007) 17263187 179885 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13140 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Lacy BE (2009) 19236188 179884 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13141 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Lacy BE (2007) 17413599 179887 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13142 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Johanson JF (2007) 17509103 179886 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13143 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Unknown Authors (2005) 15991886 179889 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 13144 107595 1181 - CLCN2 CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2 9606 Homo sapiens inducer target Kapoor S (2010) 20345211 179888 1035 Lubiprostone - amitiza DRUGBANK DB01046 C20H32F2O5 small molecule A06AX03 136790-76-6 DRUGBANK 23686 107601 1187 RP11-5P18.7 CLCNKA CLCK1|ClC-K1|hClC-Ka 9606 Homo sapiens inducer target Picollo A (2007) 17659402 182031 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 23217 107606 1195 - CLK1 CLK|CLK/STY|STY 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4189 Debromohymenialdisine - - DRUGBANK DB04367 C11H10N5O2 small molecule - - DRUGBANK 23218 107606 1195 - CLK1 CLK|CLK/STY|STY 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4189 Debromohymenialdisine - - DRUGBANK DB04367 C11H10N5O2 small molecule - - DRUGBANK 26718 107606 1195 - CLK1 CLK|CLK/STY|STY 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7465 ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate - - DRUGBANK DB08691 C15H13Cl2N3O2 small molecule - - DRUGBANK 25672 107609 1198 - CLK3 PHCLK3|PHCLK3/152 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6470 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE - - DRUGBANK DB07664 C15H13F2N7O2S2 small molecule - - DRUGBANK 26717 107609 1198 - CLK3 PHCLK3|PHCLK3/152 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7465 ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate - - DRUGBANK DB08691 C15H13Cl2N3O2 small molecule - - DRUGBANK 22854 107618 1208 - CLPS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 26241 107618 1208 - CLPS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7013 METHOXYUNDECYLPHOSPHINIC ACID - - DRUGBANK DB08222 C12H27O3P small molecule - - DRUGBANK 20924 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 20925 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 22005 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22006 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 25688 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6486 [(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID - - DRUGBANK DB07680 C20H15ClNO4PS small molecule - - DRUGBANK 20671 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3017 Phenylalanylmethane - - DRUGBANK DB03149 C10H13NO small molecule - 5440-27-7 DRUGBANK 22398 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3850 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid - - DRUGBANK DB04016 C40H35N2O6P small molecule - - DRUGBANK 22399 107624 1215 - CMA1 CYH|MCT1|chymase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3850 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid - - DRUGBANK DB04016 C40H35N2O6P small molecule - - DRUGBANK 23942 107639 1234 - CCR5 CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 4637 Maraviroc - selzentry|celsentri DRUGBANK DB04835 C29H41F2N5O small molecule J05AX09 376348-65-1 DRUGBANK 23943 107639 1234 - CCR5 CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 4637 Maraviroc - selzentry|celsentri DRUGBANK DB04835 C29H41F2N5O small molecule J05AX09 376348-65-1 DRUGBANK 23944 107639 1234 - CCR5 CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 4637 Maraviroc - selzentry|celsentri DRUGBANK DB04835 C29H41F2N5O small molecule J05AX09 376348-65-1 DRUGBANK 23945 107639 1234 - CCR5 CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22 9606 Homo sapiens antagonist target Agrawal-Gamse C (2009) 19692476 182123 4637 Maraviroc - selzentry|celsentri DRUGBANK DB04835 C29H41F2N5O small molecule J05AX09 376348-65-1 DRUGBANK 23946 107639 1234 - CCR5 CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22 9606 Homo sapiens antagonist target Napier C (2005) 16298345 181920 4637 Maraviroc - selzentry|celsentri DRUGBANK DB04835 C29H41F2N5O small molecule J05AX09 376348-65-1 DRUGBANK 23947 107639 1234 - CCR5 CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22 9606 Homo sapiens antagonist target Levy JA (2009) 19098484 182094 4637 Maraviroc - selzentry|celsentri DRUGBANK DB04835 C29H41F2N5O small molecule J05AX09 376348-65-1 DRUGBANK 3737 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens unknown target Li GX (2007) 17467962 174035 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3738 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens unknown target Rau T (2006) 17112803 174034 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3739 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens unknown target Materna V (2006) 16876126 174033 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 14097 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens inhibitor target Flanagan SD (2002) 11834888 176952 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14098 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens inhibitor target Evers R (2000) 10917554 173398 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14099 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens inhibitor target Bakos E (2000) 10727523 176911 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14100 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens inhibitor target Ito K (2001) 11500505 180333 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14101 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens inhibitor target Morrow CS (2000) 11108662 180332 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14102 107647 1244 RP11-114F7.2 ABCC2 ABC30|CMOAT|DJS|MRP2|cMRP 9606 Homo sapiens inhibitor target Hagos Y (2007) 17229912 180331 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 24405 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5520 Rimonabant - - DRUGBANK DB06155 C22H21Cl3N4O small molecule A08AX01 168273-06-1 DRUGBANK 24406 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens antagonist target Shire D (1996) 8636122 181704 5520 Rimonabant - - DRUGBANK DB06155 C22H21Cl3N4O small molecule A08AX01 168273-06-1 DRUGBANK 7430 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens partial agonist target Hirst RA (1996) 8981483 176433 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7431 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens partial agonist target Pertwee RG (1999) 10575283 176432 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7432 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens partial agonist target Pertwee RG (1996) 8864542 176434 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7433 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7434 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens partial agonist target Davis M (2007) 17139494 176294 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7435 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens partial agonist target Darmani NA (2001) 11698062 176428 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7240 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 7241 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 7242 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 7243 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens agonist target Pryce G (2003) 12686391 176295 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 7244 107668 1268 RP1-23D17.1 CNR1 CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR 9606 Homo sapiens agonist target Tsai SJ (2000) 11204352 176296 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 7425 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens partial agonist target Kraft B (2004) 15221424 176431 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7426 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens partial agonist target Conti S (2002) 11786493 176430 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7427 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens partial agonist target Darmani NA (2001) 11698062 176428 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7428 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens partial agonist target Mendizabal VE (2007) 17450170 176429 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7429 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens partial agonist target Davis M (2007) 17139494 176294 478 Nabilone Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum act nabilone|cesamet|pms-nabil DRUGBANK DB00486 C24H36O3 small molecule A04AD11 51022-71-0 DRUGBANK 7238 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens agonist target Pertwee RG (2009) 19226257 176293 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 7239 107669 1269 RP11-4M23.1 CNR2 CB-2|CB2|CX5 9606 Homo sapiens agonist target Davis M (2007) 17139494 176294 462 Dronabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC dronabinol|marinol|sativex|mar DRUGBANK DB00470 C21H30O2 small molecule A04AD10 1972-08-3 DRUGBANK 581 107674 1277 - COL1A1 OI4 9606 Homo sapiens unknown target Beare AH (2003) 12535212 172031 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 582 107674 1277 - COL1A1 OI4 9606 Homo sapiens unknown target Beare AH (2005) 15659034 172030 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 583 107674 1277 - COL1A1 OI4 9606 Homo sapiens unknown target Chiu CJ (2002) 12101112 172028 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 584 107674 1277 - COL1A1 OI4 9606 Homo sapiens unknown target Lindsey ML (2003) 12855673 172032 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 585 107674 1277 - COL1A1 OI4 9606 Homo sapiens unknown target Egeblad M (2007) 17440987 119407 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 24040 107674 1277 - COL1A1 OI4 9606 Homo sapiens unknown target Elkin M (2000) 11099465 181766 4666 Halofuginone Tempostatin (Collgard Biopharmaceuticals) - DRUGBANK DB04866 C16H17BrClN3O3 small molecule - 55837-20-2 DRUGBANK 577 107675 1278 - COL1A2 OI4 9606 Homo sapiens unknown target Chiu CJ (2002) 12101112 172028 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 572 107677 1280 - COL2A1 ANFH|AOM|COL11A3|SEDC|STL1 9606 Homo sapiens unknown target Imai K (2007) 17652426 172023 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 573 107677 1280 - COL2A1 ANFH|AOM|COL11A3|SEDC|STL1 9606 Homo sapiens unknown target Martin G (2004) 15299286 172026 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 574 107677 1280 - COL2A1 ANFH|AOM|COL11A3|SEDC|STL1 9606 Homo sapiens unknown target Pratta MA (2003) 12890681 172027 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 575 107677 1280 - COL2A1 ANFH|AOM|COL11A3|SEDC|STL1 9606 Homo sapiens unknown target Fraser A (2003) 14613270 172024 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 576 107677 1280 - COL2A1 ANFH|AOM|COL11A3|SEDC|STL1 9606 Homo sapiens unknown target Verstappen SM (2006) 16507130 172025 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 579 107678 1281 - COL3A1 EDS4A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 580 107678 1281 - COL3A1 EDS4A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 578 107678 1281 - COL3A1 EDS4A 9606 Homo sapiens unknown target Cole WG (1990) 2145268 172029 47 Collagenase clostridium histolyticum - collagenase santyl|xiaflex DRUGBANK DB00048 C5028H7666N1300O1564S21 biologic M09AB02 9001-12-1 DRUGBANK 16244 107706 1311 - COMP EDM1|EPD1|MED|PSACH|THBS5 9606 Homo sapiens unknown target Chen FH (2007) 17588949 181221 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 25478 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6273 (3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE - - DRUGBANK DB07462 C13H9NO5 small molecule - - DRUGBANK 22166 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3744 N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide - - DRUGBANK DB03907 C19H20N7O8 small molecule - - DRUGBANK 22167 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3744 N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide - - DRUGBANK DB03907 C19H20N7O8 small molecule - - DRUGBANK 22168 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3744 N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide - - DRUGBANK DB03907 C19H20N7O8 small molecule - - DRUGBANK 5568 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Ries V (2010) 20502133 175221 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5569 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5570 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Stocchi F (2007) 18046910 175222 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5571 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Kaakkola S (2000) 10882160 175220 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5572 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Guay DR (1999) 9917075 175218 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5573 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Truong DD (2009) 19503773 175219 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5574 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Apud JA (2007) 17063156 175213 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5575 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Tai CH (2002) 11873938 175214 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5576 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Ruottinen HM (1998) 9808337 175215 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5577 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Keating GM (2005) 15697329 175216 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 5578 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Forsberg M (2003) 12538800 175217 316 Tolcapone Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone tasmar|tolcapone DRUGBANK DB00323 C14H11NO5 small molecule N04BX01 134308-13-7 DRUGBANK 18536 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2025 3,5-Dinitrocatechol - - DRUGBANK DB02105 C6H4N2O6 small molecule - - DRUGBANK 18537 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2025 3,5-Dinitrocatechol - - DRUGBANK DB02105 C6H4N2O6 small molecule - - DRUGBANK 18538 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2025 3,5-Dinitrocatechol - - DRUGBANK DB02105 C6H4N2O6 small molecule - - DRUGBANK 23925 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Parvez S (1975) 1170911 181630 4622 Nialamide 2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum - DRUGBANK DB04820 C16H18N4O2 small molecule N06AF02 51-12-7 DRUGBANK 1703 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens cofactor target Lee BW (2010) 20196537 172675 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1704 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens cofactor target Rutherford K (2008) 18486144 172674 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 26071 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6842 7,8-dihydroxy-4-phenyl-2H-chromen-2-one - - DRUGBANK DB08049 C15H10O4 small molecule - - DRUGBANK 7488 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7489 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Kaakkola S (2000) 10882160 175220 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7490 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Holm KJ (1999) 10439935 176479 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7491 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Chong BS (2000) 10981253 176478 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7492 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Najib J (2001) 11440283 176475 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7493 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Poewe WH (2002) 11939936 176477 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7494 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Brooks DJ (2003) 12876237 176476 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7495 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Tai CH (2002) 11873938 175214 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7496 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Ruottinen HM (1998) 9808337 175215 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 7497 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens inhibitor target Forsberg M (2003) 12538800 175217 486 Entacapone Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide comtan|teva-entacapone|apo-ent DRUGBANK DB00494 C14H15N3O5 small molecule N04BX02 130929-57-6 DRUGBANK 18988 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Parvez S (1975) 1170911 181630 2247 2-Methoxyestradiol 2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta - DRUGBANK DB02342 C19H26O3 small molecule - 362-07-2 DRUGBANK 20997 107707 1312 - COMT HEL-S-98n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3199 BIA - - DRUGBANK DB03336 C20H20F3N3O5 small molecule - - DRUGBANK 19650 107720 1327 - COX4I1 COX4|COX4-1|COXIV 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23492 107720 1327 - COX4I1 COX4|COX4-1|COXIV 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19659 107722 1329 - COX5B COXVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23505 107722 1329 - COX5B COXVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19641 107732 1339 - COX6A2 COX6AH|COXVIAH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23487 107732 1339 - COX6A2 COX6AH|COXVIAH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19655 107733 1340 - COX6B1 COX6B|COXG|COXVIb1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23486 107733 1340 - COX6B1 COX6B|COXG|COXVIb1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19660 107738 1345 - COX6C - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23491 107738 1345 - COX6C - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19645 107739 1346 - COX7A1 COX7A|COX7AH|COX7AM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23485 107739 1346 - COX7A1 COX7A|COX7AH|COX7AM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19649 107742 1349 - COX7B APLCC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23490 107742 1349 - COX7B APLCC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19658 107743 1350 - COX7C - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23489 107743 1350 - COX7C - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19657 107744 1351 - COX8A COX|COX8|COX8-2|COX8L|VIII|VIII-L 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23488 107744 1351 - COX8A COX|COX8|COX8-2|COX8L|VIII|VIII-L 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 694 107748 1356 - CP CP-2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 695 107748 1356 - CP CP-2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 19631 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2543 L-[(N-Hydroxyamino)Carbonyl]Phenylalanine - - DRUGBANK DB02652 C10H12N2O4 small molecule - - DRUGBANK 26416 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7153 OCTANE-1,3,5,7-TETRACARBOXYLIC ACID - - DRUGBANK DB08368 C12H18O8 small molecule - - DRUGBANK 25506 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6295 (2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid - - DRUGBANK DB07484 C12H15NO6 small molecule - - DRUGBANK 23111 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4141 D-[(N-Hydroxyamino)Carbonyl]Phenylalanine - - DRUGBANK DB04316 C10H12N2O4 small molecule - - DRUGBANK 24947 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5743 (2R)-2-benzyl-3-nitropropanoic acid - - DRUGBANK DB06924 C10H11NO4 small molecule - - DRUGBANK 25527 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6317 L-BENZYLSUCCINIC ACID - - DRUGBANK DB07506 C11H12O4 small molecule - - DRUGBANK 22445 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3890 D-[(Amino)Carbonyl]Phenylalanine - - DRUGBANK DB04058 C10H12N2O3 small molecule - - DRUGBANK 19328 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 26762 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7535 O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID - - DRUGBANK DB08762 C22H27N2O8P small molecule - - DRUGBANK 20748 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3069 D-Cysteine D-Amino-3-mercaptopropionic acid|D-Cystein|(2S)-2-amino-3-mercaptopropanoic acid|(2S)-2-amino-3-sulfanylpropanoic acid|D-Zystein|(S)-2-amino-3-mercaptopropanoic acid - DRUGBANK DB03201 C3H7NO2S small molecule - 921-01-7 DRUGBANK 20749 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3069 D-Cysteine D-Amino-3-mercaptopropionic acid|D-Cystein|(2S)-2-amino-3-mercaptopropanoic acid|(2S)-2-amino-3-sulfanylpropanoic acid|D-Zystein|(S)-2-amino-3-mercaptopropanoic acid - DRUGBANK DB03201 C3H7NO2S small molecule - 921-01-7 DRUGBANK 20750 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3069 D-Cysteine D-Amino-3-mercaptopropionic acid|D-Cystein|(2S)-2-amino-3-mercaptopropanoic acid|(2S)-2-amino-3-sulfanylpropanoic acid|D-Zystein|(S)-2-amino-3-mercaptopropanoic acid - DRUGBANK DB03201 C3H7NO2S small molecule - 921-01-7 DRUGBANK 21237 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3297 2-Benzyl-3-Iodopropanoic Acid - - DRUGBANK DB03441 C10H11IO2 small molecule - - DRUGBANK 20310 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2888 Phenylalanine-N-Sulfonamide - - DRUGBANK DB03012 C9H12N2O4S small molecule - - DRUGBANK 25360 107749 1357 - CPA1 CPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6167 O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE - - DRUGBANK DB07351 C21H25N2O8P small molecule - - DRUGBANK 25146 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5954 (2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID - - DRUGBANK DB07136 C23H33N2O6PS small molecule - - DRUGBANK 23845 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4527 2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID - - DRUGBANK DB04723 C10H13N3O2S small molecule - - DRUGBANK 24944 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5740 (2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID - - DRUGBANK DB06921 C20H27N2O6PS small molecule - - DRUGBANK 24858 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5656 (2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID - - DRUGBANK DB06835 C22H31N2O6PS small molecule - - DRUGBANK 25281 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6085 (2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID - - DRUGBANK DB07269 C22H29N2O6P small molecule - - DRUGBANK 25189 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5999 (2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID - - DRUGBANK DB07182 C19H24N3O4P small molecule - - DRUGBANK 25167 107752 1360 - CPB1 CPB|PASP|PCPB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5975 (5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE - - DRUGBANK DB07157 C21H27N2O7P small molecule - - DRUGBANK 23547 107754 1362 - CPD GP180 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4302 Guanidinoethylmercaptosuccinic acid gemsa|Guanidinoethyl-Mercaptosuccinic Acid - DRUGBANK DB04489 C7H13N3O4S small molecule - 77482-44-1 DRUGBANK 23548 107754 1362 - CPD GP180 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4302 Guanidinoethylmercaptosuccinic acid gemsa|Guanidinoethyl-Mercaptosuccinic Acid - DRUGBANK DB04489 C7H13N3O4S small molecule - 77482-44-1 DRUGBANK 23549 107754 1362 - CPD GP180 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4302 Guanidinoethylmercaptosuccinic acid gemsa|Guanidinoethyl-Mercaptosuccinic Acid - DRUGBANK DB04489 C7H13N3O4S small molecule - 77482-44-1 DRUGBANK 370 107755 1363 - CPE - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 371 107755 1363 - CPE - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 862 107755 1363 - CPE - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 863 107755 1363 - CPE - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 864 107755 1363 - CPE - 9606 Homo sapiens unknown target Polastri L (2003) 12588113 172192 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 865 107755 1363 - CPE - 9606 Homo sapiens unknown target Guest PC (1989) 2481446 172190 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 866 107755 1363 - CPE - 9606 Homo sapiens unknown target Furuta M (1998) 9452465 172191 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 24819 107764 1373 - CPS1 CPSASE1|PHN 9606 Homo sapiens allosteric modulator target Hart EJ (2009) 19106093 94369 5632 Carglumic Acid Acide carglumique|Acidum carglumicum|Carbamylglutamic acid|L-N-Carbamoylglutamic acid|(2S)-2-(Carbamoylamino)pentanedioic acid|Acido carglumico|N-Carbamoyl-L-Glutamic Acid|Carbaglu|Ureidoglutaric acid|(S)-2-ureidopentanedioic acid|Carbamino-L-glutamic acid|N-Carbamyl-L-glutamate|N-Carbamylglutamate carbaglu DRUGBANK DB06775 C6H10N2O5 small molecule A16AA05 1188-38-1 DRUGBANK 24820 107764 1373 - CPS1 CPSASE1|PHN 9606 Homo sapiens allosteric modulator target Kasapkara CS (2011) 21207059 182184 5632 Carglumic Acid Acide carglumique|Acidum carglumicum|Carbamylglutamic acid|L-N-Carbamoylglutamic acid|(2S)-2-(Carbamoylamino)pentanedioic acid|Acido carglumico|N-Carbamoyl-L-Glutamic Acid|Carbaglu|Ureidoglutaric acid|(S)-2-ureidopentanedioic acid|Carbamino-L-glutamic acid|N-Carbamyl-L-glutamate|N-Carbamylglutamate carbaglu DRUGBANK DB06775 C6H10N2O5 small molecule A16AA05 1188-38-1 DRUGBANK 24821 107764 1373 - CPS1 CPSASE1|PHN 9606 Homo sapiens allosteric modulator target Unknown Authors (2008) 18516804 182080 5632 Carglumic Acid Acide carglumique|Acidum carglumicum|Carbamylglutamic acid|L-N-Carbamoylglutamic acid|(2S)-2-(Carbamoylamino)pentanedioic acid|Acido carglumico|N-Carbamoyl-L-Glutamic Acid|Carbaglu|Ureidoglutaric acid|(S)-2-ureidopentanedioic acid|Carbamino-L-glutamic acid|N-Carbamyl-L-glutamate|N-Carbamylglutamate carbaglu DRUGBANK DB06775 C6H10N2O5 small molecule A16AA05 1188-38-1 DRUGBANK 8273 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens activator target Waldner R (2006) 16283381 177061 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8274 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens activator target Tripodi G (2005) 15647998 177060 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8275 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens activator target Xu ZR (2003) 12705401 177063 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8276 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens activator target Morillas M (2004) 14711372 177062 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8277 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens activator target Shin ES (2006) 16362726 177059 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8278 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 12785 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens unknown target Patel TB (1986) 3090894 179689 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12786 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens unknown target Cook GA (1987) 3104327 179688 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 13506 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13507 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13508 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13509 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Ashrafian H (2007) 17445089 180001 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13510 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Unger SA (2005) 16306812 180000 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13511 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Kennedy JA (1996) 8694852 180003 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13512 107765 1374 - CPT1A CPT1|CPT1-L|L-CPT1 9606 Homo sapiens inhibitor target Kennedy JA (2000) 11117381 180002 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 8279 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens unknown target Lehtihet M (2003) 12684219 177068 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8280 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens unknown target Barrero MJ (2003) 12408750 177065 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8281 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens unknown target Rasmussen BB (2002) 12464674 177064 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8282 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens unknown target Kong JY (2002) 12445488 177067 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8283 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens unknown target Price NT (2003) 12662154 177066 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 13513 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens inhibitor target Unger SA (2005) 16306812 180000 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13514 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens inhibitor target Kennedy JA (1996) 8694852 180003 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 13515 107767 1376 - CPT2 CPT1|CPTASE|IIAE4 9606 Homo sapiens inhibitor target Kennedy JA (2000) 11117381 180002 1062 Perhexiline Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina - DRUGBANK DB01074 C19H35N small molecule C08EX02 6621-47-2 DRUGBANK 8257 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Vikramadithyan RK (2003) 12582227 177049 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8258 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Cordente AG (2004) 15155769 177040 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8259 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Jogl G (2003) 12526798 177047 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8260 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Wu D (2003) 12562770 177046 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8261 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Govindasamy L (2004) 15099582 177048 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 19626 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2539 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium - - DRUGBANK DB02648 C7H16NO3 small molecule - 461-06-3 DRUGBANK 19627 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2539 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium - - DRUGBANK DB02648 C7H16NO3 small molecule - 461-06-3 DRUGBANK 19628 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2539 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium - - DRUGBANK DB02648 C7H16NO3 small molecule - 461-06-3 DRUGBANK 18275 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18276 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18277 107774 1384 RP11-247A12.5 CRAT CAT1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 2121 107775 1385 - CREB1 CREB 9606 Homo sapiens activator target Brenhouse HC (2007) 17324065 173047 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2122 107775 1385 - CREB1 CREB 9606 Homo sapiens activator target Ulfhammer E (2006) 16879221 173050 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2123 107775 1385 - CREB1 CREB 9606 Homo sapiens activator target Saha B (2006) 17083486 173051 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2124 107775 1385 - CREB1 CREB 9606 Homo sapiens activator target Kozinn J (2006) 17122581 173049 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2125 107775 1385 - CREB1 CREB 9606 Homo sapiens activator target Perlis RH (2007) 17300755 173048 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 14538 107775 1385 - CREB1 CREB 9606 Homo sapiens unknown target Chartoff EH (2003) 12969258 180508 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14539 107775 1385 - CREB1 CREB 9606 Homo sapiens unknown target Li J (2003) 12956944 180509 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14540 107775 1385 - CREB1 CREB 9606 Homo sapiens unknown target Walters CL (2005) 15953421 180510 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14541 107775 1385 - CREB1 CREB 9606 Homo sapiens unknown target Gao C (2003) 14653953 180506 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14542 107775 1385 - CREB1 CREB 9606 Homo sapiens unknown target Hawes JJ (2006) 16417577 180507 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 11171 107776 1386 - ATF2 CRE-BP1|CREB-2|CREB2|HB16|TREB7 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 26672 107777 1387 - CREBBP CBP|KAT3A|RSTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7429 9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE - - DRUGBANK DB08655 C14H13NO2 small molecule - - DRUGBANK 15746 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens agonist target Hellman P (2006) 16467980 181051 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15747 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens agonist target Zhao LF (2006) 16503922 181050 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15748 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens agonist target Wagner U (2006) 16523405 181048 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15749 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens agonist target Matejec R (2006) 16534240 181049 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15750 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens agonist target Dinan TG (2006) 16472586 181047 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 20192 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2829 Alpha-Aminoisobutyric Acid - - DRUGBANK DB02952 C4H9NO2 small molecule - - DRUGBANK 19458 107782 1392 - CRH CRF|CRH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2453 D-Phenylalanine - - DRUGBANK DB02556 C9H11NO2 small molecule - 673-06-3 DRUGBANK 22238 107791 1401 RP11-419N10.4 CRP PTX1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3781 Phosphocholine - - DRUGBANK DB03945 C5H15NO4P small molecule - 107-73-3 DRUGBANK 22239 107791 1401 RP11-419N10.4 CRP PTX1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3781 Phosphocholine - - DRUGBANK DB03945 C5H15NO4P small molecule - 107-73-3 DRUGBANK 26874 107794 1404 - HAPLN1 CRTL1 9606 Homo sapiens binder target Arming S (1997) 9288901 181722 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26875 107794 1404 - HAPLN1 CRTL1 9606 Homo sapiens binder target Spicer AP (2003) 12663660 181813 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 4929 107816 1429 - CRYZ - 9606 Homo sapiens inhibitor target Maser E (1991) 1722672 174754 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4930 107816 1429 - CRYZ - 9606 Homo sapiens inhibitor target Hao H (2007) 17305492 174752 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4931 107816 1429 - CRYZ - 9606 Homo sapiens inhibitor target Audi SH (2003) 12882764 174753 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4932 107816 1429 - CRYZ - 9606 Homo sapiens inhibitor target Asher G (2006) 16700548 174750 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4933 107816 1429 - CRYZ - 9606 Homo sapiens inhibitor target Evans PJ (1999) 10561120 174751 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 21286 107816 1429 - CRYZ - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21287 107816 1429 - CRYZ - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 22934 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22935 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22936 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 19590 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2528 Oxaloacetate Ion - - DRUGBANK DB02637 C4H3O5 small molecule - - DRUGBANK 19591 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2528 Oxaloacetate Ion - - DRUGBANK DB02637 C4H3O5 small molecule - - DRUGBANK 19592 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2528 Oxaloacetate Ion - - DRUGBANK DB02637 C4H3O5 small molecule - - DRUGBANK 22846 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4058 Nitromethyldethia Coenzyme A - - DRUGBANK DB04230 C22H37N8O18P3 small molecule - - DRUGBANK 22847 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4058 Nitromethyldethia Coenzyme A - - DRUGBANK DB04230 C22H37N8O18P3 small molecule - - DRUGBANK 22848 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4058 Nitromethyldethia Coenzyme A - - DRUGBANK DB04230 C22H37N8O18P3 small molecule - - DRUGBANK 21408 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 21409 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 21410 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 18253 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18254 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18255 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 20718 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3050 Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex - - DRUGBANK DB03182 C23H37FN7O18P3 small molecule - - DRUGBANK 20719 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3050 Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex - - DRUGBANK DB03182 C23H37FN7O18P3 small molecule - - DRUGBANK 20720 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3050 Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex - - DRUGBANK DB03182 C23H37FN7O18P3 small molecule - - DRUGBANK 18198 107818 1431 - CS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1893 Trifluoroacetonyl Coenzyme A - - DRUGBANK DB01969 C24H37F3N7O17P3S small molecule - - DRUGBANK 18199 107818 1431 - CS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1893 Trifluoroacetonyl Coenzyme A - - DRUGBANK DB01969 C24H37F3N7O17P3S small molecule - - DRUGBANK 18200 107818 1431 - CS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1893 Trifluoroacetonyl Coenzyme A - - DRUGBANK DB01969 C24H37F3N7O17P3S small molecule - - DRUGBANK 20233 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2861 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline - - DRUGBANK DB02984 C17H17N3O2S small molecule - - DRUGBANK 20234 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2861 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline - - DRUGBANK DB02984 C17H17N3O2S small molecule - - DRUGBANK 20235 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2861 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline - - DRUGBANK DB02984 C17H17N3O2S small molecule - - DRUGBANK 26089 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6857 N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA - - DRUGBANK DB08064 C20H22ClN5O2 small molecule - - DRUGBANK 25614 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6413 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE - - DRUGBANK DB07607 C21H16IN3OS small molecule - - DRUGBANK 18147 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1877 Inhibitor of P38 Kinase - - DRUGBANK DB01953 C15H14N2 small molecule - - DRUGBANK 18148 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1877 Inhibitor of P38 Kinase - - DRUGBANK DB01953 C15H14N2 small molecule - - DRUGBANK 18149 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1877 Inhibitor of P38 Kinase - - DRUGBANK DB01953 C15H14N2 small molecule - - DRUGBANK 26296 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7032 N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide - - DRUGBANK DB08242 C20H18N6O small molecule - - DRUGBANK 18139 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1872 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One - - DRUGBANK DB01948 C26H22Cl2F2N2O small molecule - - DRUGBANK 18140 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1872 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One - - DRUGBANK DB01948 C26H22Cl2F2N2O small molecule - - DRUGBANK 17814 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1737 N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea - - DRUGBANK DB01807 C20H21ClN4O small molecule - - DRUGBANK 17815 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1737 N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea - - DRUGBANK DB01807 C20H21ClN4O small molecule - - DRUGBANK 17816 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1737 N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea - - DRUGBANK DB01807 C20H21ClN4O small molecule - - DRUGBANK 25314 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6123 N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide - - DRUGBANK DB07307 C26H23N3O small molecule - - DRUGBANK 25850 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6629 4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde - - DRUGBANK DB07832 C20H15N3O2S small molecule - - DRUGBANK 25847 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6626 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE - - DRUGBANK DB07829 C14H10FN3 small molecule - - DRUGBANK 25833 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6609 N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide - - DRUGBANK DB07811 C21H21N3O2 small molecule - - DRUGBANK 26440 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7179 2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE - - DRUGBANK DB08395 C22H18FN3O5 small molecule - - DRUGBANK 23786 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4438 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE - - DRUGBANK DB04632 C24H26FN3O4S small molecule - - DRUGBANK 26399 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7137 6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine - - DRUGBANK DB08352 C19H16FN3OS small molecule - - DRUGBANK 26398 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7136 N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide - - DRUGBANK DB08351 C25H29N5O2 small molecule - - DRUGBANK 26572 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7300 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE - - DRUGBANK DB08522 C18H16FN3 small molecule - - DRUGBANK 18241 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1912 6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine - - DRUGBANK DB01988 C30H27N5 small molecule - - DRUGBANK 18242 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1912 6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine - - DRUGBANK DB01988 C30H27N5 small molecule - - DRUGBANK 23161 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4163 SB220025 - - DRUGBANK DB04338 C18H19FN6 small molecule - - DRUGBANK 23162 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4163 SB220025 - - DRUGBANK DB04338 C18H19FN6 small molecule - - DRUGBANK 23163 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4163 SB220025 - - DRUGBANK DB04338 C18H19FN6 small molecule - - DRUGBANK 22329 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3814 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole - - DRUGBANK DB03980 C17H16FN5 small molecule - - DRUGBANK 20505 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2981 2-Chlorophenol - - DRUGBANK DB03110 C6H5ClO small molecule - - DRUGBANK 20506 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2981 2-Chlorophenol - - DRUGBANK DB03110 C6H5ClO small molecule - - DRUGBANK 26469 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7206 [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE - - DRUGBANK DB08424 C19H18FN3O4 small molecule - - DRUGBANK 26468 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7205 [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE - - DRUGBANK DB08423 C21H21FN4O2 small molecule - - DRUGBANK 26396 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7134 N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide - - DRUGBANK DB08349 C24H21F2N5O2 small molecule - - DRUGBANK 25004 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5809 N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide - - DRUGBANK DB06991 C17H22N4O2S small molecule - - DRUGBANK 24912 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5702 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea - - DRUGBANK DB06882 C24H25N5O small molecule - - DRUGBANK 18697 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2111 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine - - DRUGBANK DB02195 C18H12FN3O small molecule - - DRUGBANK 18698 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2111 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine - - DRUGBANK DB02195 C18H12FN3O small molecule - - DRUGBANK 18699 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2111 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine - - DRUGBANK DB02195 C18H12FN3O small molecule - - DRUGBANK 23910 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4599 Triazolopyridine - - DRUGBANK DB04797 C18H15FN4O small molecule - - DRUGBANK 25852 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6631 N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide - - DRUGBANK DB07834 C21H21N3O2 small molecule - - DRUGBANK 20375 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2916 1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea - - DRUGBANK DB03044 C31H37N5O3 small molecule - - DRUGBANK 20376 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2916 1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea - - DRUGBANK DB03044 C31H37N5O3 small molecule - - DRUGBANK 26570 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7299 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE - - DRUGBANK DB08521 C21H16FN3OS small molecule - - DRUGBANK 26121 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6886 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE - - DRUGBANK DB08093 C16H14N2O small molecule - - DRUGBANK 26119 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6884 3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE - - DRUGBANK DB08091 C26H25FN4O2 small molecule - - DRUGBANK 26120 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6885 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide - - DRUGBANK DB08092 C19H18FN3O2 small molecule - - DRUGBANK 18864 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2186 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea - - DRUGBANK DB02277 C15H19ClN4O small molecule - - DRUGBANK 18865 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2186 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea - - DRUGBANK DB02277 C15H19ClN4O small molecule - - DRUGBANK 18866 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2186 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea - - DRUGBANK DB02277 C15H19ClN4O small molecule - - DRUGBANK 25966 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6737 3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide - - DRUGBANK DB07941 C22H19BrF2N2O3 small molecule - - DRUGBANK 25967 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6738 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine - - DRUGBANK DB07942 C14H9F2N3 small molecule - - DRUGBANK 25851 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6630 N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide - - DRUGBANK DB07833 C24H18N4O2 small molecule - - DRUGBANK 24963 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5759 N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide - - DRUGBANK DB06940 C19H22N6O3 small molecule - - DRUGBANK 25853 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6632 N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide - - DRUGBANK DB07835 C22H24N2O2 small molecule - - DRUGBANK 26094 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6861 N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO- - - DRUGBANK DB08068 C23H25ClFN3O3 small molecule - - DRUGBANK 26123 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6888 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA - - DRUGBANK DB08095 C23H26ClN5O3 small molecule - - DRUGBANK 26124 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6889 8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM - - DRUGBANK DB08096 C19H15ClF2N6 small molecule - - DRUGBANK 25475 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6270 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE - - DRUGBANK DB07459 C19H16N2O2 small molecule - - DRUGBANK 25968 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6739 2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol - - DRUGBANK DB07943 C20H20ClN5O2 small molecule - - DRUGBANK 26125 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6890 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE - - DRUGBANK DB08097 C20H16F3N5O small molecule - - DRUGBANK 25149 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5956 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one - - DRUGBANK DB07138 C19H9Cl2F2N3OS small molecule - - DRUGBANK 17734 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1694 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine - - DRUGBANK DB01761 C28H29F3N6 small molecule - - DRUGBANK 17735 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1694 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine - - DRUGBANK DB01761 C28H29F3N6 small molecule - - DRUGBANK 20061 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2755 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One - - DRUGBANK DB02873 C24H20Cl2F2N4O small molecule - - DRUGBANK 20062 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2755 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One - - DRUGBANK DB02873 C24H20Cl2F2N4O small molecule - - DRUGBANK 20063 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2755 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One - - DRUGBANK DB02873 C24H20Cl2F2N4O small molecule - - DRUGBANK 26736 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7503 3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE - - DRUGBANK DB08730 C26H25FN4O2 small molecule - - DRUGBANK 19012 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2257 3-(Benzyloxy)Pyridin-2-Amine - - DRUGBANK DB02352 C12H12N2O small molecule - - DRUGBANK 19013 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2257 3-(Benzyloxy)Pyridin-2-Amine - - DRUGBANK DB02352 C12H12N2O small molecule - - DRUGBANK 19014 107819 1432 RP1-179N16.5 MAPK14 CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2257 3-(Benzyloxy)Pyridin-2-Amine - - DRUGBANK DB02352 C12H12N2O small molecule - - DRUGBANK 25204 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6019 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE - - DRUGBANK DB07202 C19H13ClN2O2 small molecule - - DRUGBANK 27612 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens inhibitor target Roskoski R (2007) 17367763 180930 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27613 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens inhibitor target Guo J (2006) 16648572 180942 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 8690 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens antagonist target Dewar AL (2006) 16449525 177348 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8691 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens antagonist target Ando W (2006) 16816921 177349 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8693 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens antagonist target Dewar AL (2005) 15917650 177323 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8692 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens antagonist target El Hajj Dib I (2006) 17049513 177351 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8694 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens antagonist target Taylor JR (2006) 16170366 177350 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 25177 107823 1436 - CSF1R C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5984 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE - - DRUGBANK DB07167 C19H21N3O3 small molecule - - DRUGBANK 228 107825 1438 - CSF2RA CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 229 107825 1438 - CSF2RA CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4 9606 Homo sapiens agonist target Wang Y (2007) 17090651 171852 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 230 107825 1438 - CSF2RA CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4 9606 Homo sapiens agonist target Lencz T (2007) 17522711 171848 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 231 107825 1438 - CSF2RA CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4 9606 Homo sapiens agonist target Chen J (2006) 16760463 171850 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 232 107825 1438 - CSF2RA CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4 9606 Homo sapiens agonist target Xiao R (2006) 16638185 171851 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 233 107826 1439 CITF22-45C1.4 CSF2RB CD131|CDw131|IL3RB|IL5RB|SMDP5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 234 107826 1439 CITF22-45C1.4 CSF2RB CD131|CDw131|IL3RB|IL5RB|SMDP5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 235 107826 1439 CITF22-45C1.4 CSF2RB CD131|CDw131|IL3RB|IL5RB|SMDP5 9606 Homo sapiens agonist target Shen Y (1992) 1424804 171853 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 24311 107826 1439 CITF22-45C1.4 CSF2RB CD131|CDw131|IL3RB|IL5RB|SMDP5 9606 Homo sapiens unknown target Bhol KC (2007) 17436088 182002 5041 NPI 32101 - - DRUGBANK DB05264 - small molecule - - DRUGBANK 212 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens agonist target Zhuang D (2005) 16033816 171838 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 213 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens agonist target Elsaesser A (2003) 12944913 171839 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 214 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens agonist target Erkeland SJ (2007) 17001306 99479 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 215 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens agonist target Cao YR (2005) 15949269 171841 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 216 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens agonist target Kotto-Kome AC (2004) 15082029 171840 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 217 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens agonist target Ward AC (2006) 17127322 171842 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 1213 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens stimulator target Ward AC (2006) 17127322 171842 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1214 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens stimulator target Zhuang D (2005) 16033816 171838 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1217 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens stimulator target Erkeland SJ (2007) 17001306 99479 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1216 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens stimulator target Cao YR (2005) 15949269 171841 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1215 107828 1441 - CSF3R CD114|GCSFR 9606 Homo sapiens stimulator target Link DC (2007) 17494858 172375 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 18332 107832 1445 - CSK - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18333 107832 1445 - CSK - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 20438 107839 1455 - CSNK1G2 CK1g2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2954 IC261 - - DRUGBANK DB03083 C18H17NO4 small molecule - - DRUGBANK 23765 107839 1455 - CSNK1G2 CK1g2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4413 5-iodotubercidin - - DRUGBANK DB04604 C11H13IN4O4 small molecule - 24386-93-4 DRUGBANK 21745 107839 1455 - CSNK1G2 CK1g2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3537 N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide - - DRUGBANK DB03693 C11H12ClN3O2S small molecule - - DRUGBANK 23865 107840 1456 - CSNK1G3 CKI-gamma 3|CSNK1G3L 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4554 Purvalanol A 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv - DRUGBANK DB04751 C19H25ClN6O small molecule - 212844-53-6 DRUGBANK 25671 107840 1456 - CSNK1G3 CKI-gamma 3|CSNK1G3L 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6470 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE - - DRUGBANK DB07664 C15H13F2N7O2S2 small molecule - - DRUGBANK 25510 107840 1456 - CSNK1G3 CKI-gamma 3|CSNK1G3L 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6300 {[4-AMINO-2-(3-CHLOROANILINO)-1,3-THIAZOL-5-YL](4-FLUOROPHENYL)METHANONE - - DRUGBANK DB07489 C16H12ClFN3OS small molecule - - DRUGBANK 25509 107840 1456 - CSNK1G3 CKI-gamma 3|CSNK1G3L 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6299 {(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE - - DRUGBANK DB07488 C18H17N3O3S small molecule - - DRUGBANK 19744 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 2597 Resveratrol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol co-veratrol DRUGBANK DB02709 C14H12O3 small molecule - 501-36-0 DRUGBANK 23841 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4523 DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE - - DRUGBANK DB04719 C9H7Br4N3 small molecule - - DRUGBANK 20361 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2908 1,8-Di-Hydroxy-4-Nitro-Anthraquinone - - DRUGBANK DB03035 C14H7NO6 small molecule - - DRUGBANK 25828 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6600 3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE - - DRUGBANK DB07802 C10H6Br2O3 small molecule - - DRUGBANK 26400 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7138 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE - - DRUGBANK DB08353 C19H21N7 small molecule - - DRUGBANK 26390 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7130 4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE - - DRUGBANK DB08345 C17H15N9 small molecule - - DRUGBANK 25721 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6518 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE - - DRUGBANK DB07715 C15H10O5 small molecule - - DRUGBANK 26675 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7434 1,2,5,8-tetrahydroxyanthracene-9,10-dione - - DRUGBANK DB08660 C14H8O6 small molecule - - DRUGBANK 23842 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4524 S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE - - DRUGBANK DB04720 C8H4Br4N2S small molecule - - DRUGBANK 17741 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1698 (5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid - - DRUGBANK DB01765 C17H12N2O3 small molecule - - DRUGBANK 22197 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3760 5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone - - DRUGBANK DB03924 C14H10N2O4 small molecule - - DRUGBANK 23269 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23270 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23271 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23474 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4276 Tetrabromo-2-Benzotriazole - - DRUGBANK DB04462 C6HBr4N3 small molecule - - DRUGBANK 23475 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4276 Tetrabromo-2-Benzotriazole - - DRUGBANK DB04462 C6HBr4N3 small molecule - - DRUGBANK 23476 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4276 Tetrabromo-2-Benzotriazole - - DRUGBANK DB04462 C6HBr4N3 small molecule - - DRUGBANK 26382 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7126 N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE - - DRUGBANK DB08340 C17H14N6 small molecule - - DRUGBANK 26380 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7124 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one - - DRUGBANK DB08338 C19H21N7O small molecule - - DRUGBANK 26522 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7254 5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole - - DRUGBANK DB08473 C12H12Cl2N2O4 small molecule - - DRUGBANK 26401 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7139 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE - - DRUGBANK DB08354 C19H14ClN7 small molecule - - DRUGBANK 26410 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7145 2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE - - DRUGBANK DB08360 C18H20N8 small molecule - - DRUGBANK 23843 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4525 N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE - - DRUGBANK DB04721 C10H7Br4N3 small molecule - - DRUGBANK 26412 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7147 N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE - - DRUGBANK DB08362 C20H16N8O small molecule - - DRUGBANK 18660 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2086 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One - - DRUGBANK DB02170 C13H7NO6 small molecule - - DRUGBANK 20540 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20541 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20542 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 26905 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens inhibitor target Cozza G (2006) 16610779 181936 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 26906 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens inhibitor target Sekiguchi Y (2009) 19414254 182103 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 27704 107841 1457 - CSNK2A1 CK2A1|CKII|CSNK2A3 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 25563 107842 1459 - CSNK2A2 CK2A2|CSNK2A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6356 [1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid - - DRUGBANK DB07546 C20H20N6O2 small molecule - - DRUGBANK 26866 107844 1462 - VCAN CSPG2|ERVR|GHAP|PG-M|WGN|WGN1 9606 Homo sapiens binder target Bignami A (1989) 2469524 181652 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26867 107844 1462 - VCAN CSPG2|ERVR|GHAP|PG-M|WGN|WGN1 9606 Homo sapiens binder target Perides G (1989) 2466833 181651 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 23320 107845 1463 - NCAN CSPG3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 23321 107845 1463 - NCAN CSPG3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 23322 107845 1463 - NCAN CSPG3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 26881 107845 1463 - NCAN CSPG3 9606 Homo sapiens binder target Prange CK (1998) 9795216 181733 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 19107 107845 1463 - NCAN CSPG3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19108 107845 1463 - NCAN CSPG3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19109 107845 1463 - NCAN CSPG3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 2287 107850 1468 - SLC25A10 DIC 9606 Homo sapiens unknown target Mizuarai S (2005) 16027120 173168 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2288 107850 1468 - SLC25A10 DIC 9606 Homo sapiens unknown target Ventura FV (2005) 16176879 173167 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 18116 107869 1487 - CTBP1 BARS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18117 107869 1487 - CTBP1 BARS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18118 107869 1487 - CTBP1 BARS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 22829 107873 1491 - CTH - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4045 L-2-amino-3-butynoic acid (S)-2-Amino-4-pentynoic acid|L-C-Propargylglycine|(S)-2-Amino-3-butynoic acid - DRUGBANK DB04217 C4H5NO2 small molecule - 73537-09-4 DRUGBANK 22830 107873 1491 - CTH - 9606 Homo sapiens unknown target Yu S (2000) 10954021 181760 4045 L-2-amino-3-butynoic acid (S)-2-Amino-4-pentynoic acid|L-C-Propargylglycine|(S)-2-Amino-3-butynoic acid - DRUGBANK DB04217 C4H5NO2 small molecule - 73537-09-4 DRUGBANK 1395 107873 1491 - CTH - 9606 Homo sapiens cofactor target Lowicka E (2007) 17377202 172462 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1396 107873 1491 - CTH - 9606 Homo sapiens cofactor target Yamagata S (2004) 15184188 172463 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1397 107873 1491 - CTH - 9606 Homo sapiens cofactor target Okuno T (2001) 11578145 172461 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1398 107873 1491 - CTH - 9606 Homo sapiens cofactor target Lima CP (2006) 16857832 172464 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1399 107873 1491 - CTH - 9606 Homo sapiens cofactor target Bertoldi M (2005) 15823094 172465 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 22203 107873 1491 - CTH - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3764 Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol - - DRUGBANK DB03928 C10H7ClN2O3S small molecule - - DRUGBANK 18953 107873 1491 - CTH - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2234 2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid - - DRUGBANK DB02328 C13H18N2O10P2 small molecule - - DRUGBANK 2886 107873 1491 - CTH - 9606 Homo sapiens unknown target Zhang H (2006) 16428267 173548 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2887 107873 1491 - CTH - 9606 Homo sapiens unknown target Wallace JL (2007) 17634391 173549 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2888 107873 1491 - CTH - 9606 Homo sapiens unknown target Fiorucci S (2005) 16108046 173547 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 24408 107875 1493 - CTLA4 ALPS5|CD|CD152|CELIAC3|CTLA-4|GRD4|GSE|IDDM12 9606 Homo sapiens unknown target Yang JC (2007) 18049334 182061 5522 Ipilimumab MDX-010|MDX-101|MOAB-CTLA-4|MDX-CTLA-4 yervoy DRUGBANK DB06186 C6572H10126N1734O2080S40 biologic L01XC11 477202-00-9 DRUGBANK 2224 107878 1497 - CTNS CTNS-LSB|PQLC4 9606 Homo sapiens unknown target Kalatzis V (2001) 11689434 55988 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 22156 107880 1499 OK/SW-cl.35 CTNNB1 CTNNB|MRD19|armadillo 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 22157 107880 1499 OK/SW-cl.35 CTNNB1 CTNNB|MRD19|armadillo 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 22158 107880 1499 OK/SW-cl.35 CTNNB1 CTNNB|MRD19|armadillo 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 2091 107883 1503 - CTPS1 CTPS|IMD24 9606 Homo sapiens antagonist target Taylor SD (2006) 17137369 172977 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2092 107883 1503 - CTPS1 CTPS|IMD24 9606 Homo sapiens antagonist target MacLeod TJ (2006) 16427816 172978 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2093 107883 1503 - CTPS1 CTPS|IMD24 9606 Homo sapiens antagonist target Fijolek A (2007) 17331943 172979 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 22314 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 22315 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 22316 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 25750 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6550 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE - - DRUGBANK DB07749 C17H24N2O3 small molecule - - DRUGBANK 26422 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7159 PHENYLALANYLMETHYLCHLORIDE - - DRUGBANK DB08374 C10H12ClNO small molecule - - DRUGBANK 17594 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1639 2,4-Dihydroxy-Trans Cinnamic Acid - - DRUGBANK DB01704 C9H8O4 small molecule - 614-86-8 DRUGBANK 24639 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Mahdy AM (2004) 15277296 181856 5574 Aprotinin Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine trasylol|trasylol inj 10000 ki DRUGBANK DB06692 C284H432N84O79S7 biologic B02AB01 9087-70-1 DRUGBANK 17527 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1598 Trans-O-Hydroxy-Alpha-Methyl Cinnamate - - DRUGBANK DB01662 C10H12O3 small molecule - - DRUGBANK 26719 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7466 D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID - - DRUGBANK DB08692 C10H14BClNO4 small molecule - - DRUGBANK 25398 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6196 1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) - - DRUGBANK DB07380 C12H12F3NO2 small molecule - - DRUGBANK 26607 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7342 L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID - - DRUGBANK DB08565 C14H17BNO4 small molecule - - DRUGBANK 26139 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6911 1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) - - DRUGBANK DB08119 C18H23F3N2O3 small molecule - - DRUGBANK 25400 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6199 N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE - - DRUGBANK DB07383 C12H14F3NO3 small molecule - - DRUGBANK 18187 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1887 Phenylethane Boronic Acid - - DRUGBANK DB01963 C8H11BO2 small molecule - 34420-17-2 DRUGBANK 18188 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1887 Phenylethane Boronic Acid - - DRUGBANK DB01963 C8H11BO2 small molecule - 34420-17-2 DRUGBANK 18189 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1887 Phenylethane Boronic Acid - - DRUGBANK DB01963 C8H11BO2 small molecule - 34420-17-2 DRUGBANK 25675 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6474 3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID - - DRUGBANK DB07668 C14H19NO3 small molecule - - DRUGBANK 26720 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7467 L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID - - DRUGBANK DB08693 C10H14BClNO4 small molecule - - DRUGBANK 25924 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6696 (2S) N-ACETYL-L-ALANYL-ALPHAL-PHENYLALANYL-CHLOROETHYLKETONE - - DRUGBANK DB07899 C16H21ClN2O3 small molecule - - DRUGBANK 26608 107884 1504 - CTRB1 CTRB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7343 D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID - - DRUGBANK DB08566 C14H17BNO4 small molecule - - DRUGBANK 23752 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4389 N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}- - - DRUGBANK DB04579 C16H28N2O8 small molecule - - DRUGBANK 20032 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2737 N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline - DRUGBANK DB02855 C18H31N3O6 small molecule - 134448-10-5 DRUGBANK 19701 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2575 3-Methylphenylalanine - - DRUGBANK DB02685 C10H13NO2 small molecule - - DRUGBANK 19702 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2575 3-Methylphenylalanine - - DRUGBANK DB02685 C10H13NO2 small molecule - - DRUGBANK 25230 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6039 METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE - - DRUGBANK DB07223 C19H31N3O6 small molecule - - DRUGBANK 21546 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3436 Diphenylacetic Acid - - DRUGBANK DB03588 C14H12O2 small molecule - - DRUGBANK 21547 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3436 Diphenylacetic Acid - - DRUGBANK DB03588 C14H12O2 small molecule - - DRUGBANK 21548 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3436 Diphenylacetic Acid - - DRUGBANK DB03588 C14H12O2 small molecule - - DRUGBANK 25231 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6040 N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE - - DRUGBANK DB07224 C15H24N2O7 small molecule - - DRUGBANK 25170 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5978 N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE - - DRUGBANK DB07160 C12H19NO6 small molecule - - DRUGBANK 20983 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3193 2-Pyridinethiol - - DRUGBANK DB03329 C5H5NS small molecule - - DRUGBANK 20984 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3193 2-Pyridinethiol - - DRUGBANK DB03329 C5H5NS small molecule - - DRUGBANK 20985 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3193 2-Pyridinethiol - - DRUGBANK DB03329 C5H5NS small molecule - - DRUGBANK 25241 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6047 N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE - - DRUGBANK DB07231 C22H29N3O6 small molecule - - DRUGBANK 22609 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3958 N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane - - DRUGBANK DB04126 C15H28N2O5 small molecule - - DRUGBANK 25232 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6041 N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE - - DRUGBANK DB07225 C18H30N2O7 small molecule - - DRUGBANK 18544 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2028 2-Aminoethanimidic Acid - - DRUGBANK DB02108 C2H6N2 small molecule - - DRUGBANK 18545 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2028 2-Aminoethanimidic Acid - - DRUGBANK DB02108 C2H6N2 small molecule - - DRUGBANK 25227 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6035 BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE - - DRUGBANK DB07219 C25H35N3O6 small molecule - - DRUGBANK 18614 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2067 3-Amino-4-Oxybenzyl-2-Butanone - - DRUGBANK DB02148 C11H15NO2 small molecule - - DRUGBANK 18615 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2067 3-Amino-4-Oxybenzyl-2-Butanone - - DRUGBANK DB02148 C11H15NO2 small molecule - - DRUGBANK 18616 107888 1508 - CTSB APPS|CPSB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2067 3-Amino-4-Oxybenzyl-2-Butanone - - DRUGBANK DB02148 C11H15NO2 small molecule - - DRUGBANK 20348 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2901 1h-Benoximidazole-2-Carboxylic Acid - - DRUGBANK DB03028 C8H5N2O2 small molecule - - DRUGBANK 20349 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2901 1h-Benoximidazole-2-Carboxylic Acid - - DRUGBANK DB03028 C8H5N2O2 small molecule - - DRUGBANK 20350 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2901 1h-Benoximidazole-2-Carboxylic Acid - - DRUGBANK DB03028 C8H5N2O2 small molecule - - DRUGBANK 25559 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6352 5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID - - DRUGBANK DB07542 C16H31NO3 small molecule - - DRUGBANK 18742 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2128 S-Methylcysteine - - DRUGBANK DB02216 C4H9NO2S small molecule - 1187-84-4 DRUGBANK 18743 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2128 S-Methylcysteine - - DRUGBANK DB02216 C4H9NO2S small molecule - 1187-84-4 DRUGBANK 18744 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2128 S-Methylcysteine - - DRUGBANK DB02216 C4H9NO2S small molecule - 1187-84-4 DRUGBANK 360 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 361 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 20478 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2967 N-Aminoethylmorpholine - - DRUGBANK DB03096 C6H14N2O small molecule - - DRUGBANK 20479 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2967 N-Aminoethylmorpholine - - DRUGBANK DB03096 C6H14N2O small molecule - - DRUGBANK 20480 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2967 N-Aminoethylmorpholine - - DRUGBANK DB03096 C6H14N2O small molecule - - DRUGBANK 26743 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7513 CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE - - DRUGBANK DB08740 C14H29NO2 small molecule - - DRUGBANK 834 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 836 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 835 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Authier F (2002) 11779865 172178 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 837 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Nunn SE (1997) 9130467 172177 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 838 107889 1509 - CTSD CLN10|CPSD|HEL-S-130P 9606 Homo sapiens unknown target Ogino S (1999) 10229502 172179 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 22396 107891 1511 - CTSG CATG|CG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3850 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid - - DRUGBANK DB04016 C40H35N2O6P small molecule - - DRUGBANK 22397 107891 1511 - CTSG CATG|CG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3850 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid - - DRUGBANK DB04016 C40H35N2O6P small molecule - - DRUGBANK 19024 107891 1511 - CTSG CATG|CG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2265 Bis-Napthyl Beta-Ketophosphonic Acid - - DRUGBANK DB02360 C22H17O4P small molecule - - DRUGBANK 19025 107891 1511 - CTSG CATG|CG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2265 Bis-Napthyl Beta-Ketophosphonic Acid - - DRUGBANK DB02360 C22H17O4P small molecule - - DRUGBANK 19026 107891 1511 - CTSG CATG|CG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2265 Bis-Napthyl Beta-Ketophosphonic Acid - - DRUGBANK DB02360 C22H17O4P small molecule - - DRUGBANK 18599 107892 1512 - CTSH ACC-4|ACC-5|CPSB|minichain 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2059 N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide - - DRUGBANK DB02140 C22H26N4O4 small molecule - - DRUGBANK 20519 107892 1512 - CTSH ACC-4|ACC-5|CPSB|minichain 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2991 Para-Toluene Sulfonate - - DRUGBANK DB03120 C7H8O3S small molecule - - DRUGBANK 20520 107892 1512 - CTSH ACC-4|ACC-5|CPSB|minichain 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2991 Para-Toluene Sulfonate - - DRUGBANK DB03120 C7H8O3S small molecule - - DRUGBANK 20521 107892 1512 - CTSH ACC-4|ACC-5|CPSB|minichain 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2991 Para-Toluene Sulfonate - - DRUGBANK DB03120 C7H8O3S small molecule - - DRUGBANK 22610 107892 1512 - CTSH ACC-4|ACC-5|CPSB|minichain 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3958 N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane - - DRUGBANK DB04126 C15H28N2O5 small molecule - - DRUGBANK 26574 107892 1512 - CTSH ACC-4|ACC-5|CPSB|minichain 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7304 CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE - - DRUGBANK DB08526 C22H36N2O5 small molecule - - DRUGBANK 17937 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1788 [1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate - - DRUGBANK DB01858 C23H29FN4O4 small molecule - - DRUGBANK 21643 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3489 Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide - - DRUGBANK DB03642 C26H30N4O6S small molecule - - DRUGBANK 21644 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3489 Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide - - DRUGBANK DB03642 C26H30N4O6S small molecule - - DRUGBANK 21645 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3489 Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide - - DRUGBANK DB03642 C26H30N4O6S small molecule - - DRUGBANK 25602 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6400 1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE - - DRUGBANK DB07593 C19H27NO3 small molecule - - DRUGBANK 25601 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6399 (1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE - - DRUGBANK DB07592 C18H27NO3 small molecule - - DRUGBANK 26327 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7075 (1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE - - DRUGBANK DB08287 C17H26N2O4S small molecule - - DRUGBANK 26625 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7371 TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE - - DRUGBANK DB08594 C7H13N3O2 small molecule - - DRUGBANK 23622 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4335 Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate - - DRUGBANK DB04523 C13H23NO3 small molecule - - DRUGBANK 25996 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6762 9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE - - DRUGBANK DB07967 C23H24N8O small molecule - - DRUGBANK 22885 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4072 1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone - - DRUGBANK DB04244 C26H31N3O4S small molecule - - DRUGBANK 22886 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4072 1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone - - DRUGBANK DB04244 C26H31N3O4S small molecule - - DRUGBANK 22887 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4072 1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone - - DRUGBANK DB04244 C26H31N3O4S small molecule - - DRUGBANK 21150 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3262 1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N - - DRUGBANK DB03405 C32H42N4O7 small molecule - - DRUGBANK 21151 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3262 1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N - - DRUGBANK DB03405 C32H42N4O7 small molecule - - DRUGBANK 21152 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3262 1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N - - DRUGBANK DB03405 C32H42N4O7 small molecule - - DRUGBANK 22124 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3728 1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide - - DRUGBANK DB03891 C29H40N6O7 small molecule - - DRUGBANK 22125 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3728 1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide - - DRUGBANK DB03891 C29H40N6O7 small molecule - - DRUGBANK 22126 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3728 1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide - - DRUGBANK DB03891 C29H40N6O7 small molecule - - DRUGBANK 20054 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2751 3-amino-5-phenylpentane - - DRUGBANK DB02869 C17H21NO2S small molecule - - DRUGBANK 26315 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7058 N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE - - DRUGBANK DB08270 C22H29F3N4O3S small molecule - - DRUGBANK 25579 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6372 1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine - - DRUGBANK DB07563 C25H34N6 small molecule - - DRUGBANK 21263 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3312 N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide - - DRUGBANK DB03456 C19H26N4O3 small molecule - - DRUGBANK 25994 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6760 6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile 6-(Cyclohexylamino)-9-[2-(4-methyl-1-piperazinyl)ethyl]-9H-purine-2-carbonitrile - DRUGBANK DB07965 C19H28N8 small molecule - - DRUGBANK 22872 107893 1513 RP11-363I22.4 CTSK CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4062 N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide - - DRUGBANK DB04234 C20H29BrN2O4 small molecule - - DRUGBANK 25502 107894 1514 RP11-65B23.1 CTSL CATL|CTSL1|MEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6288 BIPHENYL-4-YL-ACETALDEHYDE - - DRUGBANK DB07477 C14H12O2 small molecule - - DRUGBANK 23455 107895 1515 UNQ268/PRO305 CTSV CATL2|CTSL2|CTSU 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4265 4-Methylpiperazin-1-Yl Carbonyl Group - - DRUGBANK DB04451 C6H12N2O small molecule - - DRUGBANK 23456 107895 1515 UNQ268/PRO305 CTSV CATL2|CTSL2|CTSU 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4265 4-Methylpiperazin-1-Yl Carbonyl Group - - DRUGBANK DB04451 C6H12N2O small molecule - - DRUGBANK 20055 107895 1515 UNQ268/PRO305 CTSV CATL2|CTSL2|CTSU 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2751 3-amino-5-phenylpentane - - DRUGBANK DB02869 C17H21NO2S small molecule - - DRUGBANK 20056 107895 1515 UNQ268/PRO305 CTSV CATL2|CTSL2|CTSU 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2751 3-amino-5-phenylpentane - - DRUGBANK DB02869 C17H21NO2S small molecule - - DRUGBANK 20057 107895 1515 UNQ268/PRO305 CTSV CATL2|CTSL2|CTSU 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2751 3-amino-5-phenylpentane - - DRUGBANK DB02869 C17H21NO2S small molecule - - DRUGBANK 26221 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6986 (1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE - - DRUGBANK DB08195 C18H21F2N3O7S small molecule - - DRUGBANK 22343 107900 1520 - CTSS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3818 Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide - - DRUGBANK DB03984 C24H29N3O4S small molecule - - DRUGBANK 22344 107900 1520 - CTSS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3818 Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide - - DRUGBANK DB03984 C24H29N3O4S small molecule - - DRUGBANK 22345 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3818 Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide - - DRUGBANK DB03984 C24H29N3O4S small molecule - - DRUGBANK 21896 107900 1520 - CTSS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3608 Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide - - DRUGBANK DB03767 C21H30N4O4 small molecule - - DRUGBANK 21897 107900 1520 - CTSS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3608 Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide - - DRUGBANK DB03767 C21H30N4O4 small molecule - - DRUGBANK 21898 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3608 Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide - - DRUGBANK DB03767 C21H30N4O4 small molecule - - DRUGBANK 25599 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6396 N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE - - DRUGBANK DB07589 C22H26F3N3O4S small molecule - - DRUGBANK 25598 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6394 N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE - - DRUGBANK DB07587 C20H22F4N4O4S small molecule - - DRUGBANK 25912 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6675 N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE - - DRUGBANK DB07878 C21H28N4O2 small molecule - - DRUGBANK 26643 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7388 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL - - DRUGBANK DB08611 C14H11F3O2 small molecule - - DRUGBANK 25536 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6331 N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE - - DRUGBANK DB07520 C19H26F4N4O4S small molecule - - DRUGBANK 26753 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7525 N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide - - DRUGBANK DB08752 C21H35N5O3 small molecule - - DRUGBANK 26754 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7528 N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide - - DRUGBANK DB08755 C25H36N4O4 small molecule - - DRUGBANK 22048 107900 1520 - CTSS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3675 Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide - - DRUGBANK DB03837 C28H37N3O5S small molecule - - DRUGBANK 22049 107900 1520 - CTSS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3675 Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide - - DRUGBANK DB03837 C28H37N3O5S small molecule - - DRUGBANK 25857 107900 1520 - CTSS - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6636 N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE - - DRUGBANK DB07839 C25H32N4O3 small molecule - - DRUGBANK 22379 107908 1528 - CYB5A CYB5|MCB5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3843 Dimethyl Propionate Ester Heme - - DRUGBANK DB04009 C36H36FeN4O4 small molecule - - DRUGBANK 22380 107908 1528 - CYB5A CYB5|MCB5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3843 Dimethyl Propionate Ester Heme - - DRUGBANK DB04009 C36H36FeN4O4 small molecule - - DRUGBANK 22381 107908 1528 - CYB5A CYB5|MCB5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3843 Dimethyl Propionate Ester Heme - - DRUGBANK DB04009 C36H36FeN4O4 small molecule - - DRUGBANK 7632 107915 1535 - CYBA p22-PHOX 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7633 107916 1536 - CYBB AMCBX2|CGD|GP91-1|GP91-PHOX|GP91PHOX|IMD34|NOX2|p91-PHOX 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 25798 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25777 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25425 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26508 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22677 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 25638 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6442 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE - - DRUGBANK DB07636 C14H17NO3S small molecule - - DRUGBANK 26371 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23919 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26715 107917 1537 - CYC1 MC3DN6|UQCR4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 18989 107923 1543 - CYP1A1 AHH|AHRR|CP11|CYP1|P1-450|P450-C|P450DX 9606 Homo sapiens unknown target Dawling S (2003) 12810639 181629 2247 2-Methoxyestradiol 2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta - DRUGBANK DB02342 C19H26O3 small molecule - 362-07-2 DRUGBANK 25469 107924 1544 - CYP1A2 CP12|P3-450|P450(PA) 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6264 2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE - - DRUGBANK DB07453 C19H12O2 small molecule - - DRUGBANK 27190 107924 1544 - CYP1A2 CP12|P3-450|P450(PA) 9606 Homo sapiens unknown target Fontana E (2005) 16248836 188492 941 Isoniazid Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide isotamine syr pediatric 50mg/5 DRUGBANK DB00951 C6H7N3O small molecule J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04 54-85-3 DRUGBANK 18987 107925 1545 - CYP1B1 CP1B|CYPIB1|GLC3A|P4501B1 9606 Homo sapiens unknown target Dawling S (2003) 12810639 181629 2247 2-Methoxyestradiol 2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta - DRUGBANK DB02342 C19H26O3 small molecule - 362-07-2 DRUGBANK 25616 107927 1548 - CYP2A6 CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6415 N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE - - DRUGBANK DB07609 C12H14N2O small molecule - - DRUGBANK 25625 107927 1548 - CYP2A6 CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6427 (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE - - DRUGBANK DB07621 C10H10N2O small molecule - - DRUGBANK 25627 107927 1548 - CYP2A6 CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6429 4,4'-DIPYRIDYL DISULFIDE - - DRUGBANK DB07623 C10H8N2S2 small molecule - - DRUGBANK 25622 107927 1548 - CYP2A6 CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6423 N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE - - DRUGBANK DB07617 C11H12N2O small molecule - - DRUGBANK 20218 107933 1555 - CYP2B6 CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2851 4-(4-Chlorophenyl)Imidazole - - DRUGBANK DB02974 C9H6ClN2 small molecule - - DRUGBANK 20219 107933 1555 - CYP2B6 CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2851 4-(4-Chlorophenyl)Imidazole - - DRUGBANK DB02974 C9H6ClN2 small molecule - - DRUGBANK 20220 107933 1555 - CYP2B6 CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2851 4-(4-Chlorophenyl)Imidazole - - DRUGBANK DB02974 C9H6ClN2 small molecule - - DRUGBANK 26417 107933 1555 - CYP2B6 CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7154 1-(biphenyl-4-ylmethyl)-1H-imidazole - - DRUGBANK DB08369 C16H14N2 small molecule - - DRUGBANK 23901 107933 1555 - CYP2B6 CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4596 Bifonazole Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole - DRUGBANK DB04794 C22H18N2 small molecule D01AC60|D01AC10 60628-96-8 DRUGBANK 23805 107933 1555 - CYP2B6 CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4469 Cyclohexyl-pentyl-maltoside 5-CYCLOHEXYLPENTYL 4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE|5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE|CYMAL-5 - DRUGBANK DB04664 C23H42O11 small molecule - - DRUGBANK 27191 107935 1557 RP11-400G3.4 CYP2C19 CPCJ|CYP2C|CYPIIC17|CYPIIC19|P450C2C|P450IIC19 9606 Homo sapiens unknown target Fontana E (2005) 16248836 188492 941 Isoniazid Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide isotamine syr pediatric 50mg/5 DRUGBANK DB00951 C6H7N3O small molecule J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04 54-85-3 DRUGBANK 21956 107936 1558 - CYP2C8 CPC8|CYPIIC8|MP-12/MP-20 9606 Homo sapiens unknown target Schoch GA (2004) 14676196 181840 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 26639 107936 1558 - CYP2C8 CPC8|CYPIIC8|MP-12/MP-20 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7384 (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE - - DRUGBANK DB08607 C24H27NO5S small molecule - - DRUGBANK 27192 107936 1558 - CYP2C8 CPC8|CYPIIC8|MP-12/MP-20 9606 Homo sapiens unknown target Fontana E (2005) 16248836 188492 941 Isoniazid Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide isotamine syr pediatric 50mg/5 DRUGBANK DB00951 C6H7N3O small molecule J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04 54-85-3 DRUGBANK 19362 107937 1559 RP11-208C17.6 CYP2C9 CPC9|CYP2C|CYP2C10|CYPIIC9|P450IIC9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2404 4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One - - DRUGBANK DB02507 C19H16O4 small molecule - - DRUGBANK 25676 107938 1562 RP11-466J14.4 CYP2C18 CPCI|CYP2C|CYP2C17|P450-6B/29C|P450IIC17 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6476 4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE - - DRUGBANK DB07670 C17H17N3O2S small molecule - - DRUGBANK 15552 107940 1565 RP4-669P10.2 CYP2D6 CPD6|CYP2D|CYP2D7AP|CYP2D7BP|CYP2D7P2|CYP2D8P2|CYP2DL1|CYPIID6|P450-DB1|P450C2D|P450DB1 9606 Homo sapiens unknown target Boerth JM (2005) 15767244 180928 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 27245 107948 1576 - CYP3A4 CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1 9606 Homo sapiens unknown target Fontana E (2005) 16248836 188492 1199 Clarithromycin Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum mylan-clarithromycin|ran-clari DRUGBANK DB01211 C38H69NO13 small molecule J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09 81103-11-9 DRUGBANK 27073 107948 1576 - CYP3A4 CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1 9606 Homo sapiens unknown target Bosnar M (2012) 22697905 188477 200 Azithromycin Azithromycinum|Azitromicina|Azithromycine azithromycin for injection|riv DRUGBANK DB00207 C38H72N2O12 small molecule J01FA10|J01RA07|S01AA26 83905-01-5 DRUGBANK 15554 107948 1576 - CYP3A4 CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1 9606 Homo sapiens unknown target Gunes A (2008) 18708991 180929 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 27066 107948 1576 - CYP3A4 CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1 9606 Homo sapiens unknown target Schwab D (2003) 12699389 137014 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 27189 107948 1576 - CYP3A4 CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1 9606 Homo sapiens unknown target Fontana E (2005) 16248836 188492 941 Isoniazid Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide isotamine syr pediatric 50mg/5 DRUGBANK DB00951 C6H7N3O small molecule J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04 54-85-3 DRUGBANK 15556 107949 1577 - CYP3A5 CP35|CYPIIIA5|P450PCN3|PCN3 9606 Homo sapiens unknown target Yasui-Furukori N (2001) 11560868 178097 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 3350 107951 1579 - CYP4A11 CP4Y|CYP4A2|CYP4AII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3351 107951 1579 - CYP4A11 CP4Y|CYP4A2|CYP4AII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3352 107951 1579 - CYP4A11 CP4Y|CYP4A2|CYP4AII 9606 Homo sapiens unknown target Ngo S (2000) 11246504 173770 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 5929 107955 1583 - CYP11A1 CYP11A|CYPXIA1|P450SCC 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5930 107955 1583 - CYP11A1 CYP11A|CYPXIA1|P450SCC 9606 Homo sapiens inhibitor target Oka H (2000) 11161433 175464 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5931 107955 1583 - CYP11A1 CYP11A|CYPXIA1|P450SCC 9606 Homo sapiens inhibitor target Slominski A (2006) 16817851 175463 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 8987 107956 1584 - CYP11B1 CPN1|CYP11B|FHI|P450C11 9606 Homo sapiens inducer target Lindhe O (2002) 11889204 177554 638 Mitotane Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum lysodren DRUGBANK DB00648 C14H10Cl4 small molecule L01XX23 53-19-0 DRUGBANK 12718 107956 1584 - CYP11B1 CPN1|CYP11B|FHI|P450C11 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1001 Metyrapone Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona metopirone DRUGBANK DB01011 C14H14N2O small molecule V04CD01 54-36-4 DRUGBANK 12719 107956 1584 - CYP11B1 CPN1|CYP11B|FHI|P450C11 9606 Homo sapiens inhibitor target Young EA (2007) 17462829 179646 1001 Metyrapone Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona metopirone DRUGBANK DB01011 C14H14N2O small molecule V04CD01 54-36-4 DRUGBANK 12720 107956 1584 - CYP11B1 CPN1|CYP11B|FHI|P450C11 9606 Homo sapiens inhibitor target Johansson MK (2002) 11869873 179645 1001 Metyrapone Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona metopirone DRUGBANK DB01011 C14H14N2O small molecule V04CD01 54-36-4 DRUGBANK 12721 107956 1584 - CYP11B1 CPN1|CYP11B|FHI|P450C11 9606 Homo sapiens inhibitor target Hermansson V (2007) 17487473 179644 1001 Metyrapone Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona metopirone DRUGBANK DB01011 C14H14N2O small molecule V04CD01 54-36-4 DRUGBANK 6759 107957 1585 - CYP11B2 ALDOS|CPN2|CYP11B|CYP11BL|CYPXIB2|P-450C18|P450C18|P450aldo 9606 Homo sapiens antagonist target Cheng SC (1976) 976190 175953 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 3096 107958 1586 RP11-753C18.1 CYP17A1 CPT7|CYP17|P450C17|S17AH 9606 Homo sapiens unknown target Pandey AV (2007) 17595315 173677 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 6456 107958 1586 RP11-753C18.1 CYP17A1 CPT7|CYP17|P450C17|S17AH 9606 Homo sapiens inhibitor target Haidar S (2003) 12596217 175784 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 24356 107958 1586 RP11-753C18.1 CYP17A1 CPT7|CYP17|P450C17|S17AH 9606 Homo sapiens inhibitor target Vogiatzi P (2010) 20645691 182160 5374 Abiraterone 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol|(3beta)-17-(Pyridin-3-yl)androsta-5,16-dien-3-ol zytiga DRUGBANK DB05812 C24H31NO small molecule L02BX03 154229-19-3 DRUGBANK 12681 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens antagonist target Ebert AD (2003) 14505258 179624 996 Letrozole Letrozole|Femara|Letrozol letrozole|riva-letrozole|nat-l DRUGBANK DB01006 C17H11N5 small molecule L02BG04 112809-51-5 DRUGBANK 12682 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 996 Letrozole Letrozole|Femara|Letrozol letrozole|riva-letrozole|nat-l DRUGBANK DB01006 C17H11N5 small molecule L02BG04 112809-51-5 DRUGBANK 12683 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens antagonist target Murphy MJ (1999) 10388095 179623 996 Letrozole Letrozole|Femara|Letrozol letrozole|riva-letrozole|nat-l DRUGBANK DB01006 C17H11N5 small molecule L02BG04 112809-51-5 DRUGBANK 12684 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens antagonist target Long BJ (2004) 15026471 179622 996 Letrozole Letrozole|Femara|Letrozol letrozole|riva-letrozole|nat-l DRUGBANK DB01006 C17H11N5 small molecule L02BG04 112809-51-5 DRUGBANK 11452 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Raman JD (2002) 11792932 178932 884 Testolactone (4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone - DRUGBANK DB00894 C19H24O3 small molecule - 968-93-4 DRUGBANK 11453 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Dunkel L (2006) 16766117 178933 884 Testolactone (4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone - DRUGBANK DB00894 C19H24O3 small molecule - 968-93-4 DRUGBANK 11454 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Herzog AG (1998) 9521275 178930 884 Testolactone (4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone - DRUGBANK DB00894 C19H24O3 small molecule - 968-93-4 DRUGBANK 11455 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Cepa MM (2005) 16190763 178931 884 Testolactone (4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone - DRUGBANK DB00894 C19H24O3 small molecule - 968-93-4 DRUGBANK 11456 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 884 Testolactone (4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone - DRUGBANK DB00894 C19H24O3 small molecule - 968-93-4 DRUGBANK 14961 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14962 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Mauras N (2009) 19470631 180678 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14963 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Nabholtz JM (2006) 16439860 180676 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14964 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Gangadhara S (2009) 19753124 180677 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14965 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Santen RJ (2009) 19389994 180674 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14966 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Milani M (2009) 19794821 180675 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14967 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Rugo HS (2008) 17693420 180672 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14968 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Cuzick J (2005) 16034487 180673 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 14969 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Jakesz R (2007) 18073378 180671 1205 Anastrozole alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol sandoz anastrozole|taro-anastr DRUGBANK DB01217 C17H19N5 small molecule L02BG03 120511-73-1 DRUGBANK 12551 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12552 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Untch M (2008) 19337436 179557 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12553 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Koutras A (2009) 19930708 179556 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12554 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Abrial C (2009) 20360896 179555 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12555 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Nabholtz JM (2008) 18728707 179554 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12556 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Barnadas A (2009) 19156139 179553 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12557 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Brueggemeier RW (2006) 17020418 179552 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12558 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Robinson A (2009) 19436613 179551 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 12559 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Brueggemeier RW (2005) 15814851 179558 980 Exemestane Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano apo-exemestane|teva-exemestane DRUGBANK DB00990 C20H24O2 small molecule L02BG06 107868-30-4 DRUGBANK 3960 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens unknown target Barbieri RL (1986) 3711333 174186 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 12912 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens unknown target Weber MM (1991) 2004042 179757 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 18990 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens unknown target Purohit A (1999) 10405348 181631 2247 2-Methoxyestradiol 2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta - DRUGBANK DB02342 C19H26O3 small molecule - 362-07-2 DRUGBANK 5922 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Siraki AG (2007) 17602675 175459 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5923 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5924 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5925 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5926 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Greco F (2005) 16332571 175462 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5927 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Shirakawa H (2006) 16474421 175461 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 5928 107960 1588 - CYP19A1 ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM 9606 Homo sapiens inhibitor target Martinez-Campa C (2005) 16244789 175460 349 Aminoglutethimide alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida cytadren tab 250mg DRUGBANK DB00357 C13H16N2O2 small molecule L02BG01 125-84-8 DRUGBANK 12922 107961 1589 DADB-112B14.10-001 CYP21A2 CA21H|CAH1|CPS1|CYP21|CYP21B|P450c21B 9606 Homo sapiens unknown target Trachtenberg J (1988) 2966691 179762 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 16674 107966 1594 - CYP27B1 CP2B|CYP1|CYP1alpha|CYP27B|P450c1|PDDR|VDD1|VDDR|VDDRI|VDR 9606 Homo sapiens unknown target Uchida E (2004) 15369780 173973 1384 Alfacalcidol 1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol one alpha caps 1mcg|one alpha DRUGBANK DB01436 C27H44O2 small molecule A11CC03|M05BB06 41294-56-8 DRUGBANK 12685 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12686 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Fliri AF (2005) 15625110 179625 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12687 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12688 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 27188 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens unknown target Ekins S (2007) 17194716 188471 906 Metronidazole 1-(-oxyethyl)-2-methyl-5-nitroimidazole|2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole|Metronidazolum|1-(-hydroxyethyl)-2-methyl-5-nitroimidazole|1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole|2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole|1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole|1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole|2-methyl-5-nitroimidazole-1-ethanol|1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole|Metronidazol|1-(-ethylol)-2-methyl-5-nitro-3-azapyrrole|1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole flagyl 500 500mg|flagystatin c DRUGBANK DB00916 C6H9N3O3 small molecule J01RA03|J01XD01|G01AF01|J01RA04|J01RA10|P01AB01|A01AB17|P01AB51|A02BD02|A02BD03|D06BX01|A02BD01|A02BD11|A02BD08 443-48-1 DRUGBANK 14395 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Carrillo-Munoz AJ (2006) 16964330 174576 1155 Itraconazole Itrizole (tn)|Itraconazolum|Sporanox (tn)|Oriconazole|Itraconazole|Itraconazol sporanox oral solution 10mg/ml DRUGBANK DB01167 C35H38Cl2N8O4 small molecule J02AC02 84625-61-6 DRUGBANK 14396 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Cotrim PC (1999) 10608831 180436 1155 Itraconazole Itrizole (tn)|Itraconazolum|Sporanox (tn)|Oriconazole|Itraconazole|Itraconazol sporanox oral solution 10mg/ml DRUGBANK DB01167 C35H38Cl2N8O4 small molecule J02AC02 84625-61-6 DRUGBANK 14397 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1155 Itraconazole Itrizole (tn)|Itraconazolum|Sporanox (tn)|Oriconazole|Itraconazole|Itraconazol sporanox oral solution 10mg/ml DRUGBANK DB01167 C35H38Cl2N8O4 small molecule J02AC02 84625-61-6 DRUGBANK 25710 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6509 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE - - DRUGBANK DB07705 C18H15Cl3N2O small molecule - - DRUGBANK 27065 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens unknown target Ekins S (2007) 17194716 188471 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 27217 107967 1595 - CYP51A1 CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1 9606 Homo sapiens unknown target Ekins S (2007) 17194716 188471 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 6996 107974 1604 RP11-357P18.1 CD55 CR|CROM|DAF|TC 9606 Homo sapiens unknown target Korotkova N (2007) 17376081 176127 438 Chloramphenicol Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide ophtho-chloram liq 0.5%|pms-ch DRUGBANK DB00446 C11H12Cl2N2O5 small molecule S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01 56-75-7 DRUGBANK 6997 107974 1604 RP11-357P18.1 CD55 CR|CROM|DAF|TC 9606 Homo sapiens unknown target Pettigrew D (2004) 15331605 176126 438 Chloramphenicol Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide ophtho-chloram liq 0.5%|pms-ch DRUGBANK DB00446 C11H12Cl2N2O5 small molecule S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01 56-75-7 DRUGBANK 3582 107976 1606 - DGKA DAGK|DAGK1|DGK-alpha 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3583 107976 1606 - DGKA DAGK|DAGK1|DGK-alpha 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 2711 107978 1608 - DGKG DAGK3|DGK-GAMMA 9606 Homo sapiens unknown target Yamaguchi Y (2006) 16905533 173415 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 21447 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3383 Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone - - DRUGBANK DB03531 C31H39N9O16P2 small molecule - - DRUGBANK 21448 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3383 Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone - - DRUGBANK DB03531 C31H39N9O16P2 small molecule - - DRUGBANK 21449 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3383 Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone - - DRUGBANK DB03531 C31H39N9O16P2 small molecule - - DRUGBANK 20001 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2720 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate - - DRUGBANK DB02838 C5H7NO2 small molecule - - DRUGBANK 20002 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2720 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate - - DRUGBANK DB02838 C5H7NO2 small molecule - - DRUGBANK 20003 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2720 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate - - DRUGBANK DB02838 C5H7NO2 small molecule - - DRUGBANK 26006 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6774 (2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID - - DRUGBANK DB07979 C9H9NO4 small molecule - - DRUGBANK 21931 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21932 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21933 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 20625 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20626 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20627 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20783 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3093 D-Tryptophan - - DRUGBANK DB03225 C11H11N2O2 small molecule - 153-94-6 DRUGBANK 20784 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3093 D-Tryptophan - - DRUGBANK DB03225 C11H11N2O2 small molecule - 153-94-6 DRUGBANK 20785 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3093 D-Tryptophan - - DRUGBANK DB03225 C11H11N2O2 small molecule - 153-94-6 DRUGBANK 22753 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3996 2-Aminobenzoic Acid - - DRUGBANK DB04166 C7H7NO2 small molecule - - DRUGBANK 22754 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3996 2-Aminobenzoic Acid - - DRUGBANK DB04166 C7H7NO2 small molecule - - DRUGBANK 22755 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3996 2-Aminobenzoic Acid - - DRUGBANK DB04166 C7H7NO2 small molecule - - DRUGBANK 20243 107980 1610 - DAO DAAO|DAMOX|OXDA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2865 Imino-Tryptophan - - DRUGBANK DB02988 C11H10N2O2 small molecule - - DRUGBANK 23312 107982 1612 - DAPK1 DAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23313 107982 1612 - DAPK1 DAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 22462 107982 1612 - DAPK1 DAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3901 5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine - - DRUGBANK DB04069 C12H11N3 small molecule - - DRUGBANK 22463 107982 1612 - DAPK1 DAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3901 5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine - - DRUGBANK DB04069 C12H11N3 small molecule - - DRUGBANK 22464 107982 1612 - DAPK1 DAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3901 5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine - - DRUGBANK DB04069 C12H11N3 small molecule - - DRUGBANK 25463 107982 1612 - DAPK1 DAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6255 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE - - DRUGBANK DB07444 C19H19N3O2 small molecule - - DRUGBANK 23838 107983 1613 - DAPK3 DLK|ZIP|ZIPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4520 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE - - DRUGBANK DB04716 C18H16FN3O small molecule - - DRUGBANK 25251 107983 1613 - DAPK3 DLK|ZIP|ZIPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6058 (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile - - DRUGBANK DB07242 C18H18Cl2N4O small molecule - - DRUGBANK 25133 107983 1613 - DAPK3 DLK|ZIP|ZIPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5943 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid - - DRUGBANK DB07125 C17H18N4O3 small molecule - - DRUGBANK 2016 107984 1615 PIG40 DARS HBSL|aspRS 9606 Homo sapiens unknown target Eiler S (1999) 10562565 172941 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2017 107984 1615 PIG40 DARS HBSL|aspRS 9606 Homo sapiens unknown target Cavarelli J (1994) 8313877 37601 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2018 107984 1615 PIG40 DARS HBSL|aspRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2019 107984 1615 PIG40 DARS HBSL|aspRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2020 107984 1615 PIG40 DARS HBSL|aspRS 9606 Homo sapiens unknown target Fender A (2006) 16597625 172942 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1924 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1925 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens unknown target Feng J (2000) 10947967 172877 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1926 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1927 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens unknown target Pettingill TM (1991) 1894598 172879 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1928 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens unknown target Suzuki E (1997) 9505234 172878 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 10833 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens inhibitor target Gaval-Cruz M (2009) 19720750 178553 812 Disulfiram Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide antabuse tab 0.25gm|antabuse t DRUGBANK DB00822 C10H20N2S4 small molecule P03AA54|P03AA04|N07BB01 97-77-8 DRUGBANK 12518 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens ligand target Goldman JM (2007) 17258889 179530 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12519 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens ligand target Arboleda G (2007) 17561816 179528 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12520 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens ligand target Garland EM (2007) 17625104 179529 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12521 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens ligand target Pyatskowit JW (2007) 17287146 179526 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12522 107989 1621 RP11-317B10.1 DBH DBM 9606 Homo sapiens ligand target LeBlanc J (2007) 17433386 179527 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 21067 107990 1622 - DBI ACBD1|ACBP|CCK-RP|EP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3240 Hexadecanal Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde - DRUGBANK DB03381 C16H32O small molecule - 629-80-1 DRUGBANK 21068 107990 1622 - DBI ACBD1|ACBP|CCK-RP|EP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3240 Hexadecanal Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde - DRUGBANK DB03381 C16H32O small molecule - 629-80-1 DRUGBANK 21069 107990 1622 - DBI ACBD1|ACBP|CCK-RP|EP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3240 Hexadecanal Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde - DRUGBANK DB03381 C16H32O small molecule - 629-80-1 DRUGBANK 18256 107990 1622 - DBI ACBD1|ACBP|CCK-RP|EP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18257 107990 1622 - DBI ACBD1|ACBP|CCK-RP|EP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18258 107990 1622 - DBI ACBD1|ACBP|CCK-RP|EP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 20121 108000 1632 - ECI1 DCI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 20122 108000 1632 - ECI1 DCI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 20537 108000 1632 - ECI1 DCI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20538 108000 1632 - ECI1 DCI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20539 108000 1632 - ECI1 DCI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 13498 108001 1633 - DCK - 9606 Homo sapiens agonist target Jordheim LP (2005) 15820918 179997 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13499 108001 1633 - DCK - 9606 Homo sapiens agonist target Yao L (2010) 20137114 179996 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13500 108001 1633 - DCK - 9606 Homo sapiens agonist target Zhang Y (2006) 16421443 179998 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 21870 108002 1634 - DCN CSCD|DSPG2|PG40|PGII|PGS2|SLRR1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21871 108002 1634 - DCN CSCD|DSPG2|PG40|PGII|PGS2|SLRR1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21872 108002 1634 - DCN CSCD|DSPG2|PG40|PGII|PGS2|SLRR1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 18379 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1955 1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid - - DRUGBANK DB02032 C9H15NO3S small molecule - - DRUGBANK 18380 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1955 1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid - - DRUGBANK DB02032 C9H15NO3S small molecule - - DRUGBANK 18381 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1955 1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid - - DRUGBANK DB02032 C9H15NO3S small molecule - - DRUGBANK 15913 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Hannedouche T (1992) 1382161 181125 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 15914 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Yoshiyama M (1999) 10205231 181124 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 15915 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Kihara M (1999) 10398211 181121 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 15916 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Mervaala E (1999) 10446934 181120 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 15917 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Tylicki L (2008) 18423812 181123 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 15918 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Rosendorff C (1992) 1382157 181122 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 15919 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1306 Cilazapril Cilazapril|Cilazaprilum|Cilazapril anhydrous cilazapril|mylan-cilazapril|do DRUGBANK DB01340 C22H31N3O5 small molecule C09BA08|C09AA08 88768-40-5 DRUGBANK 8645 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Dumoulin MJ (2001) 11300648 177316 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 8646 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Kostova E (2006) 16642666 177315 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 10509 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Alfakih K (2006) 16370923 178404 780 Perindopril (2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum arcosyl plus|viacoram|coversyl DRUGBANK DB00790 C19H32N2O5 small molecule C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11 82834-16-0 DRUGBANK 10511 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 780 Perindopril (2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum arcosyl plus|viacoram|coversyl DRUGBANK DB00790 C19H32N2O5 small molecule C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11 82834-16-0 DRUGBANK 10510 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 780 Perindopril (2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum arcosyl plus|viacoram|coversyl DRUGBANK DB00790 C19H32N2O5 small molecule C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11 82834-16-0 DRUGBANK 10512 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Brugts JJ (2009) 19379059 178403 780 Perindopril (2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum arcosyl plus|viacoram|coversyl DRUGBANK DB00790 C19H32N2O5 small molecule C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11 82834-16-0 DRUGBANK 11400 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Neal B (2002) 12584671 178882 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11401 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Trippodo NC (1999) 10598120 178883 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11402 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Ferdinand KC (2001) 11588409 178881 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11403 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Azizi M (2000) 10856268 178884 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11404 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Heudi O (2002) 12487427 178885 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 14726 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Natesh R (2004) 15236580 177072 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14727 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Andujar-Sanchez M (2007) 17618628 177073 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14728 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Dalkas GA (2010) 20014331 180582 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14729 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Tzakos AG (2006) 16889963 180583 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14730 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Piepho RW (2000) 11030016 174112 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14731 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14732 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14518 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1168 Rescinnamine Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine - DRUGBANK DB01180 C35H42N2O9 small molecule C02AA01|C02LA52|C02LA02 24815-24-5 DRUGBANK 14519 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1168 Rescinnamine Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine - DRUGBANK DB01180 C35H42N2O9 small molecule C02AA01|C02LA52|C02LA02 24815-24-5 DRUGBANK 14520 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1168 Rescinnamine Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine - DRUGBANK DB01180 C35H42N2O9 small molecule C02AA01|C02LA52|C02LA02 24815-24-5 DRUGBANK 14521 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Azhar I (2005) 16431399 180495 1168 Rescinnamine Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine - DRUGBANK DB01180 C35H42N2O9 small molecule C02AA01|C02LA52|C02LA02 24815-24-5 DRUGBANK 9834 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Andujar-Sanchez M (2007) 17618628 177073 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9835 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Piepho RW (2000) 11030016 174112 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9836 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9837 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9838 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Tellez-Sanz R (1998) 9506845 178040 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 7480 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Piepho RW (2000) 11030016 174112 484 Fosinopril Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid ava-fosinopril|fosinopril-20|r DRUGBANK DB00492 C30H46NO7P small molecule C09AA09|C09BA09 98048-97-6 DRUGBANK 7479 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Ondetti MA (1988) 2836111 176471 484 Fosinopril Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid ava-fosinopril|fosinopril-20|r DRUGBANK DB00492 C30H46NO7P small molecule C09AA09|C09BA09 98048-97-6 DRUGBANK 7481 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 484 Fosinopril Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid ava-fosinopril|fosinopril-20|r DRUGBANK DB00492 C30H46NO7P small molecule C09AA09|C09BA09 98048-97-6 DRUGBANK 7482 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Sharma S (1999) 11329095 176470 484 Fosinopril Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid ava-fosinopril|fosinopril-20|r DRUGBANK DB00492 C30H46NO7P small molecule C09AA09|C09BA09 98048-97-6 DRUGBANK 26892 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Furuta S (1993) 8513851 181700 7600 Temocapril Temocaprilum - DRUGBANK DB08836 C23H28N2O5S2 small molecule C09AA14 111902-57-9 DRUGBANK 8284 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Natesh R (2004) 15236580 177072 574 Enalapril Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester riva-enalapril|apo-enalapril t DRUGBANK DB00584 C20H28N2O5 small molecule C09BA02|C09AA02|C09BB02|C09BB06 75847-73-3 DRUGBANK 8285 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Andujar-Sanchez M (2007) 17618628 177073 574 Enalapril Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester riva-enalapril|apo-enalapril t DRUGBANK DB00584 C20H28N2O5 small molecule C09BA02|C09AA02|C09BB02|C09BB06 75847-73-3 DRUGBANK 8286 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 574 Enalapril Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester riva-enalapril|apo-enalapril t DRUGBANK DB00584 C20H28N2O5 small molecule C09BA02|C09AA02|C09BB02|C09BB06 75847-73-3 DRUGBANK 8287 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Liu YH (2006) 16424790 177074 574 Enalapril Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester riva-enalapril|apo-enalapril t DRUGBANK DB00584 C20H28N2O5 small molecule C09BA02|C09AA02|C09BB02|C09BB06 75847-73-3 DRUGBANK 21835 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 21836 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 7861 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 532 Benazepril Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))- amlodipine and benazepril hydr DRUGBANK DB00542 C24H28N2O5 small molecule C09AA07|C09BA07 86541-75-5 DRUGBANK 7862 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 532 Benazepril Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))- amlodipine and benazepril hydr DRUGBANK DB00542 C24H28N2O5 small molecule C09AA07|C09BA07 86541-75-5 DRUGBANK 7682 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Piepho RW (2000) 11030016 174112 509 Trandolapril Trandolaprilum|Mavik tarka|mavik|trandolapril and v DRUGBANK DB00519 C24H34N2O5 small molecule C09AA10|C09BB10 87679-37-6 DRUGBANK 7683 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 509 Trandolapril Trandolaprilum|Mavik tarka|mavik|trandolapril and v DRUGBANK DB00519 C24H34N2O5 small molecule C09AA10|C09BB10 87679-37-6 DRUGBANK 7684 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 509 Trandolapril Trandolaprilum|Mavik tarka|mavik|trandolapril and v DRUGBANK DB00519 C24H34N2O5 small molecule C09AA10|C09BB10 87679-37-6 DRUGBANK 15955 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Hermida RC (2010) 20524801 181136 1313 Spirapril Spirapril|Renormax - DRUGBANK DB01348 C22H30N2O5S2 small molecule C09AA11 83647-97-6 DRUGBANK 15956 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Maul B (2005) 16126915 181137 1313 Spirapril Spirapril|Renormax - DRUGBANK DB01348 C22H30N2O5S2 small molecule C09AA11 83647-97-6 DRUGBANK 15957 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1313 Spirapril Spirapril|Renormax - DRUGBANK DB01348 C22H30N2O5S2 small molecule C09AA11 83647-97-6 DRUGBANK 15958 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 1313 Spirapril Spirapril|Renormax - DRUGBANK DB01348 C22H30N2O5S2 small molecule C09AA11 83647-97-6 DRUGBANK 15959 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Arend U (2002) 12613273 181138 1313 Spirapril Spirapril|Renormax - DRUGBANK DB01348 C22H30N2O5S2 small molecule C09AA11 83647-97-6 DRUGBANK 11367 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 871 Quinapril Quinaprilum|Quinapril gd-quinapril hctz|accuretic|ap DRUGBANK DB00881 C25H30N2O5 small molecule C09BA06|C09AA06 85441-61-8 DRUGBANK 11368 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 871 Quinapril Quinaprilum|Quinapril gd-quinapril hctz|accuretic|ap DRUGBANK DB00881 C25H30N2O5 small molecule C09BA06|C09AA06 85441-61-8 DRUGBANK 11369 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Klutchko S (1986) 3020249 178865 871 Quinapril Quinaprilum|Quinapril gd-quinapril hctz|accuretic|ap DRUGBANK DB00881 C25H30N2O5 small molecule C09BA06|C09AA06 85441-61-8 DRUGBANK 11370 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Culy CR (2002) 11817979 178866 871 Quinapril Quinaprilum|Quinapril gd-quinapril hctz|accuretic|ap DRUGBANK DB00881 C25H30N2O5 small molecule C09BA06|C09AA06 85441-61-8 DRUGBANK 9552 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chrysant SG (2004) 15286086 177842 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9553 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Edling O (1995) 7473177 177841 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9554 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9555 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 3862 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Piepho RW (2000) 11030016 174112 171 Ramipril Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace ava-ramipril|altace hct|ramipr DRUGBANK DB00178 C23H32N2O5 small molecule C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06 87333-19-5 DRUGBANK 3863 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Levitt DG (2006) 16398929 174113 171 Ramipril Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace ava-ramipril|altace hct|ramipr DRUGBANK DB00178 C23H32N2O5 small molecule C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06 87333-19-5 DRUGBANK 3864 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 171 Ramipril Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace ava-ramipril|altace hct|ramipr DRUGBANK DB00178 C23H32N2O5 small molecule C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06 87333-19-5 DRUGBANK 3865 108004 1636 - ACE ACE1|CD143|DCP|DCP1|ICH|MVCD3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 171 Ramipril Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace ava-ramipril|altace hct|ramipr DRUGBANK DB00178 C23H32N2O5 small molecule C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06 87333-19-5 DRUGBANK 4067 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Kaufmann H (2003) 12885750 174222 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 4068 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Durso R (2000) 10934669 174219 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 4069 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Orlefors H (2006) 16184369 174221 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 4070 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Yee RE (2001) 11709201 172562 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 4071 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 4072 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Gilbert JA (2000) 11106255 174220 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 4073 108011 1644 - DDC AADC 9606 Homo sapiens inhibitor target Calabrese V (2007) 17241115 174218 183 Carbidopa L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid sinemet 100/25|sinemet 250/25| DRUGBANK DB00190 C10H14N2O4 small molecule - 28860-95-9 DRUGBANK 1563 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Skoeldberg F (2003) 12679420 172563 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1564 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Yee RE (2001) 11709201 172562 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1565 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Tan EK (2005) 15965967 172561 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1434 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Rahman MK (1982) 6983619 172488 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1435 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Allen GF (2010) 20403077 172489 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1436 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1562 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Skoeldberg F (2004) 15070923 172526 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1437 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Rorsman F (1995) 7567987 172491 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1438 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Bertoldi M (2000) 11085948 172490 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1439 108011 1644 - DDC AADC 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 12380 108011 1644 - DDC AADC 9606 Homo sapiens unknown target SOURKES TL (1954) 13189588 179398 958 Methyldopa -methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine methyldopa 125 tab 125mg|novo- DRUGBANK DB00968 C10H13NO4 small molecule - 555-30-6 DRUGBANK 3197 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Fukuda T (1986) 3463506 173674 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3199 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3198 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3196 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Burczynski ME (2001) 11060293 173710 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3200 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Pineda JA (1989) 2615366 173675 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 25784 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6569 (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE - - DRUGBANK DB07768 C19H28O2 small molecule - - DRUGBANK 23808 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Dhagat U (2007) 18045204 179205 4478 2-HYDROXY-3,5-DIIODOBENZOIC ACID - - DRUGBANK DB04674 C7H4I2O3 small molecule - - DRUGBANK 25958 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6727 Hexestrol Hexoestrolum|4,4'-(1,2-diethylethylene)diphenol|Mesohexestrol|Hexanoestrol|Synoestrolum|Erythrohexestrol|Meso-3,4-di(p-hydroxyphenyl)-n-hexane|Meso-hexestrol - DRUGBANK DB07931 C18H22O2 small molecule - 84-16-2 DRUGBANK 12104 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens inhibitor target Dhagat U (2007) 18045204 179205 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12155 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens inhibitor target Dhagat U (2007) 18045204 179205 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 21269 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21270 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21271 108012 1645 RP11-69D4.1 AKR1C1 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3346 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3347 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3348 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Rizner TL (2003) 12810547 173768 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3349 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Trauger JW (2002) 12416991 173769 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 17131 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens inducer target Amaral JD (2009) 19747134 181547 1525 Ursodeoxycholic acid Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid actigall|urso 250|phl-ursodiol DRUGBANK DB01586 C24H40O4 small molecule A05AA02 128-13-2 DRUGBANK 17132 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1525 Ursodeoxycholic acid Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid actigall|urso 250|phl-ursodiol DRUGBANK DB01586 C24H40O4 small molecule A05AA02 128-13-2 DRUGBANK 17133 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1525 Ursodeoxycholic acid Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid actigall|urso 250|phl-ursodiol DRUGBANK DB01586 C24H40O4 small molecule A05AA02 128-13-2 DRUGBANK 25785 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6569 (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE - - DRUGBANK DB07768 C19H28O2 small molecule - - DRUGBANK 21280 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21281 108013 1646 - AKR1C2 AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 26637 108030 1666 - DECR1 DECR|NADPH|SDR18C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7382 6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL - - DRUGBANK DB08605 C9H13BN2O3S2 small molecule - - DRUGBANK 20395 108039 1675 - CFD ADIPSIN|ADN|DF|PFD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2929 2-Aminobenzyl alcohol o-(Hydroxymethyl)aniline|2-Aminobenzenemethanol|o-Aminobenzylic alcohol|2-Aminobenzyl alcohol|o-Aminobenzyl alcohol - DRUGBANK DB03058 C7H9NO small molecule - 5344-90-1 DRUGBANK 20396 108039 1675 - CFD ADIPSIN|ADN|DF|PFD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2929 2-Aminobenzyl alcohol o-(Hydroxymethyl)aniline|2-Aminobenzenemethanol|o-Aminobenzylic alcohol|2-Aminobenzyl alcohol|o-Aminobenzyl alcohol - DRUGBANK DB03058 C7H9NO small molecule - 5344-90-1 DRUGBANK 23468 108039 1675 - CFD ADIPSIN|ADN|DF|PFD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4273 3,4-Dichloroisocoumarin - - DRUGBANK DB04459 C9H4Cl2O2 small molecule - - DRUGBANK 23469 108039 1675 - CFD ADIPSIN|ADN|DF|PFD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4273 3,4-Dichloroisocoumarin - - DRUGBANK DB04459 C9H4Cl2O2 small molecule - - DRUGBANK 3318 108063 1717 - DHCR7 SLOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3319 108063 1717 - DHCR7 SLOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3368 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Vickers TJ (2006) 17032644 173779 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3369 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Argyrou A (2006) 17115689 173778 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 4296 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Rastelli G (2003) 12951104 174385 198 Pyrimethamine 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn pyrimethamine leucovorin|darap DRUGBANK DB00205 C12H13ClN4 small molecule P01BD01|P01BD51|P01BF04 58-14-0 DRUGBANK 4297 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Fidock DA (1997) 9380737 174384 198 Pyrimethamine 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn pyrimethamine leucovorin|darap DRUGBANK DB00205 C12H13ClN4 small molecule P01BD01|P01BD51|P01BF04 58-14-0 DRUGBANK 4298 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 198 Pyrimethamine 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn pyrimethamine leucovorin|darap DRUGBANK DB00205 C12H13ClN4 small molecule P01BD01|P01BD51|P01BF04 58-14-0 DRUGBANK 4299 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Wooden JM (1997) 9108546 42426 198 Pyrimethamine 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn pyrimethamine leucovorin|darap DRUGBANK DB00205 C12H13ClN4 small molecule P01BD01|P01BD51|P01BF04 58-14-0 DRUGBANK 22348 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3821 2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB03987 C17H20N6O2 small molecule - - DRUGBANK 14306 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Warlick CA (2002) 11752096 182278 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 14307 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 14308 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Graffner-Nordberg M (2001) 11448221 182280 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 14309 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Bertino JR (1999) 10386066 182281 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 14310 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Polshakov VI (1999) 10091649 182279 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 14311 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Zhu WY (2002) 12416030 182283 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 14312 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Sweeney CL (2003) 12649191 182282 1145 Trimetrexate Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin neutrexin pws iv 25mg/vial DRUGBANK DB01157 C19H23N5O3 small molecule P01AX07 52128-35-5 DRUGBANK 20528 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2994 2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium - - DRUGBANK DB03125 C14H19N4O3 small molecule - - DRUGBANK 19463 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2456 6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine - - DRUGBANK DB02559 C17H33N5 small molecule - - DRUGBANK 19464 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2456 6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine - - DRUGBANK DB02559 C17H33N5 small molecule - - DRUGBANK 19465 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2456 6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine - - DRUGBANK DB02559 C17H33N5 small molecule - - DRUGBANK 8066 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Bennett B (2006) 17130456 176879 553 Methotrexate Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid rheumatrex dose pack|apo-metho DRUGBANK DB00563 C20H22N8O5 small molecule L01BA01|L04AX03 59-05-2 DRUGBANK 8067 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 553 Methotrexate Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid rheumatrex dose pack|apo-metho DRUGBANK DB00563 C20H22N8O5 small molecule L01BA01|L04AX03 59-05-2 DRUGBANK 8068 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Assaraf YG (2007) 17333344 176880 553 Methotrexate Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid rheumatrex dose pack|apo-metho DRUGBANK DB00563 C20H22N8O5 small molecule L01BA01|L04AX03 59-05-2 DRUGBANK 8069 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Totani K (2006) 16647263 176881 553 Methotrexate Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid rheumatrex dose pack|apo-metho DRUGBANK DB00563 C20H22N8O5 small molecule L01BA01|L04AX03 59-05-2 DRUGBANK 8070 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Al-Rashood ST (2006) 16971132 176882 553 Methotrexate Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid rheumatrex dose pack|apo-metho DRUGBANK DB00563 C20H22N8O5 small molecule L01BA01|L04AX03 59-05-2 DRUGBANK 8071 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Uga H (2006) 16936229 176883 553 Methotrexate Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid rheumatrex dose pack|apo-metho DRUGBANK DB00563 C20H22N8O5 small molecule L01BA01|L04AX03 59-05-2 DRUGBANK 19487 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2478 N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine - - DRUGBANK DB02583 C17H20N6O2 small molecule - 175354-76-4 DRUGBANK 19488 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2478 N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine - - DRUGBANK DB02583 C17H20N6O2 small molecule - 175354-76-4 DRUGBANK 19489 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2478 N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine - - DRUGBANK DB02583 C17H20N6O2 small molecule - 175354-76-4 DRUGBANK 21746 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3539 6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine - - DRUGBANK DB03695 C17H19N5O2 small molecule - - DRUGBANK 21747 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3539 6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine - - DRUGBANK DB03695 C17H19N5O2 small molecule - - DRUGBANK 21748 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3539 6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine - - DRUGBANK DB03695 C17H19N5O2 small molecule - - DRUGBANK 24843 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Shimanovsky A (2013) 23409799 182231 5645 Pralatrexate N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid|PDX|10-Propargyl-10-deazaaminopterin|Pralatrexatum|Pralatrexato|Folotyn|(2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid|(2S)-2-((4-((1RS)-1-((2,4-diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid|HSDB 7786 folotyn DRUGBANK DB06813 C23H23N7O5 small molecule L01BA05 146464-95-1 DRUGBANK 21031 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3214 Sri-9439 - - DRUGBANK DB03351 C18H17N7 small molecule - - DRUGBANK 21032 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3214 Sri-9439 - - DRUGBANK DB03351 C18H17N7 small molecule - - DRUGBANK 21033 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3214 Sri-9439 - - DRUGBANK DB03351 C18H17N7 small molecule - - DRUGBANK 26664 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7416 (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine - - DRUGBANK DB08642 C19H29N5O3 small molecule - - DRUGBANK 25153 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5960 5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine - - DRUGBANK DB07142 C24H26N4O small molecule - - DRUGBANK 25155 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5962 5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine - - DRUGBANK DB07144 C24H26N4O small molecule - - DRUGBANK 22119 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3723 Biopterin - - DRUGBANK DB03886 C9H11N5O3 small molecule - - DRUGBANK 8935 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Adjei AA (2002) 12023793 177527 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8936 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Hanauske AR (2001) 11524555 177528 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8937 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Adjei AA (2001) 11742712 177529 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8938 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Schultz RM (2002) 11848474 177524 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8939 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Molina JR (2003) 14596699 177525 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8940 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8941 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Mauritz R (2002) 11841783 177530 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8942 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Pivot X (2001) 11531245 177521 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8943 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Kindler HL (2002) 12571811 177522 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8944 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Adjei AA (2001) 11252887 177523 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8945 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Giovannetti E (2005) 15795320 176083 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8946 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Norman P (2001) 11763166 177526 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 20405 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2931 Sri-9662 - - DRUGBANK DB03060 C18H19N5O2 small molecule - - DRUGBANK 20406 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2931 Sri-9662 - - DRUGBANK DB03060 C18H19N5O2 small molecule - - DRUGBANK 20407 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2931 Sri-9662 - - DRUGBANK DB03060 C18H19N5O2 small molecule - - DRUGBANK 14029 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1119 Proguanil N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide malarone pediatric|mylan-atova DRUGBANK DB01131 C11H16ClN5 small molecule P01BB51|P01BB01 500-92-5 DRUGBANK 14030 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Le Bras J (2003) 12667224 182274 1119 Proguanil N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide malarone pediatric|mylan-atova DRUGBANK DB01131 C11H16ClN5 small molecule P01BB51|P01BB01 500-92-5 DRUGBANK 14031 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Tahar R (2001) 11295178 182275 1119 Proguanil N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide malarone pediatric|mylan-atova DRUGBANK DB01131 C11H16ClN5 small molecule P01BB51|P01BB01 500-92-5 DRUGBANK 14032 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Kaneko A (1999) 10068594 182276 1119 Proguanil N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide malarone pediatric|mylan-atova DRUGBANK DB01131 C11H16ClN5 small molecule P01BB51|P01BB01 500-92-5 DRUGBANK 14033 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Vasconcelos KF (2000) 10998224 182277 1119 Proguanil N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide malarone pediatric|mylan-atova DRUGBANK DB01131 C11H16ClN5 small molecule P01BB51|P01BB01 500-92-5 DRUGBANK 14034 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Durand R (2001) 11740746 182273 1119 Proguanil N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide malarone pediatric|mylan-atova DRUGBANK DB01131 C11H16ClN5 small molecule P01BB51|P01BB01 500-92-5 DRUGBANK 26497 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7230 (4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol - - DRUGBANK DB08448 C21H19N7O small molecule - - DRUGBANK 26275 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7024 5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine - - DRUGBANK DB08234 C17H20N4O2 small molecule - - DRUGBANK 21291 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21292 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 19180 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2330 2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline - - DRUGBANK DB02427 C18H21N5O2 small molecule - - DRUGBANK 26455 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7190 [N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE - - DRUGBANK DB08406 C21H17N7 small molecule - - DRUGBANK 25152 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5959 5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine - - DRUGBANK DB07141 C23H24N4O small molecule - - DRUGBANK 25151 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5958 5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine - - DRUGBANK DB07140 C22H22N4O small molecule - - DRUGBANK 27139 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Al-Omary FA (2010) 20350811 188485 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 18533 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2024 2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB02104 C19H24N6O3 small molecule - - DRUGBANK 18534 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2024 2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB02104 C19H24N6O3 small molecule - - DRUGBANK 18535 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2024 2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB02104 C19H24N6O3 small molecule - - DRUGBANK 20135 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2798 2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB02919 C18H22N6O3 small molecule - - DRUGBANK 20136 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2798 2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB02919 C18H22N6O3 small molecule - - DRUGBANK 20137 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2798 2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine - - DRUGBANK DB02919 C18H22N6O3 small molecule - - DRUGBANK 6955 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6956 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Laskowska E (2003) 14629008 176073 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6957 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Rosowsky A (2004) 15115391 176072 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6958 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Nahimana A (2004) 15504856 176075 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6959 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Floris-Moore MA (2003) 14632594 176074 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6960 108065 1719 - DHFR DHFRP1|DYR 9606 Homo sapiens inhibitor target Barrow EW (2004) 15561838 176076 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 26194 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6961 (2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide - - DRUGBANK DB08169 C19H16N2O2 small molecule - - DRUGBANK 13686 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Fukushima R (2007) 17604599 180110 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13687 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13688 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Herrmann ML (2000) 10878294 180111 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13689 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Reitzik M (1975) 1060033 180104 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13690 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Goldenberg MM (1999) 10890256 180105 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13691 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Li EK (2004) 15189743 180106 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13692 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Breedveld FC (2000) 11053058 180107 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13693 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Wozel G (2002) 12063741 180101 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13694 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Fox RI (1998) 9666414 180102 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13695 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Schattenkirchner M (2000) 10878295 180103 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13696 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Prakash A (1999) 10651393 180108 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13697 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Sanders S (2002) 12003373 180109 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 26196 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6964 (2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide - - DRUGBANK DB08172 C18H15ClN2O3 small molecule - - DRUGBANK 25652 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6452 UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE - - DRUGBANK DB07646 C13H29NO small molecule - - DRUGBANK 22992 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4108 2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone - - DRUGBANK DB04281 C22H19ClO3 small molecule - - DRUGBANK 26302 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7038 3,6,9,12,15-PENTAOXATRICOSAN-1-OL - - DRUGBANK DB08249 C18H38O6 small molecule - - DRUGBANK 25575 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6368 (2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide - - DRUGBANK DB07559 C17H12Cl2N2O2 small molecule - - DRUGBANK 26032 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6799 N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08006 C20H15N5 small molecule - - DRUGBANK 18820 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 18821 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 18822 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 22690 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 19544 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 19545 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 19546 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 26034 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6801 5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine - - DRUGBANK DB08008 C13H10F3N5 small molecule - - DRUGBANK 26946 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Davis JP (1996) 8573583 181702 7624 Teriflunomide (Z)-2-Cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-P-crotonotoluidide|Teriflunomidum|Aubagio|a 77-1726|Teriflunomida|HMR1726|HMR 1726|a 771726 aubagio DRUGBANK DB08880 - small molecule L04AA31 163451-81-8 DRUGBANK 26947 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Palmer AM (2010) 21157651 182182 7624 Teriflunomide (Z)-2-Cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-P-crotonotoluidide|Teriflunomidum|Aubagio|a 77-1726|Teriflunomida|HMR1726|HMR 1726|a 771726 aubagio DRUGBANK DB08880 - small molecule L04AA31 163451-81-8 DRUGBANK 21363 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3335 Brequinar Analog - - DRUGBANK DB03480 C23H16FNO2 small molecule - - DRUGBANK 21364 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3335 Brequinar Analog - - DRUGBANK DB03480 C23H16FNO2 small molecule - - DRUGBANK 21987 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3644 Antiproliferative Agent A771726 - - DRUGBANK DB03805 C12H11F3N2O2 small molecule - - DRUGBANK 21988 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3644 Antiproliferative Agent A771726 - - DRUGBANK DB03805 C12H11F3N2O2 small molecule - - DRUGBANK 21989 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3644 Antiproliferative Agent A771726 - - DRUGBANK DB03805 C12H11F3N2O2 small molecule - - DRUGBANK 21436 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3377 6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid - - DRUGBANK DB03523 C23H15F2NO2 small molecule - - DRUGBANK 21437 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3377 6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid - - DRUGBANK DB03523 C23H15F2NO2 small molecule - - DRUGBANK 21438 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3377 6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid - - DRUGBANK DB03523 C23H15F2NO2 small molecule - - DRUGBANK 20820 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20821 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20822 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 23753 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4393 5-(AMINOCARBONYL)-1,1':4',1''-TERPHENYL-3-CARBOXYLICACID - - DRUGBANK DB04583 C20H15NO3 small molecule - - DRUGBANK 26002 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6770 2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID - - DRUGBANK DB07975 C20H14F5NO4 small molecule - - DRUGBANK 26003 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6771 3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB07976 C19H14FNO4S small molecule - - DRUGBANK 26004 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6772 3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB07977 C19H10F5NO4S small molecule - - DRUGBANK 26005 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6773 2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID - - DRUGBANK DB07978 C20H10F7NO4 small molecule - - DRUGBANK 13922 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Hansen M (2004) 15044733 180236 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13923 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Seymour KK (1994) 7909690 180234 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13924 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Ittarat I (1995) 7726490 180235 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13925 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Seymour KK (1997) 9425362 180232 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13926 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Knecht W (2000) 10658902 180233 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13927 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 25576 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6370 (2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide - - DRUGBANK DB07561 C19H18N2O3 small molecule - - DRUGBANK 25462 108068 1723 - DHODH DHOdehase|POADS|URA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6254 (2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide - - DRUGBANK DB07443 C17H14N2O2 small molecule - - DRUGBANK 21639 108070 1725 - DHPS DHS|DS|MIG13 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 3486 1-Guanidinium-7-Aminoheptane - - DRUGBANK DB03639 C8H22N4 small molecule - - DRUGBANK 21640 108070 1725 - DHPS DHS|DS|MIG13 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3486 1-Guanidinium-7-Aminoheptane - - DRUGBANK DB03639 C8H22N4 small molecule - - DRUGBANK 21641 108070 1725 - DHPS DHS|DS|MIG13 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 3486 1-Guanidinium-7-Aminoheptane - - DRUGBANK DB03639 C8H22N4 small molecule - - DRUGBANK 21642 108070 1725 - DHPS DHS|DS|MIG13 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 3486 1-Guanidinium-7-Aminoheptane - - DRUGBANK DB03639 C8H22N4 small molecule - - DRUGBANK 3080 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Ikegami T (2007) 17341833 173669 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3081 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Roma GW (2006) 16814740 173670 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3082 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Nussenzveig RH (2006) 17082011 173671 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3083 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Kim S (2007) 17401193 173672 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3084 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Kurian JR (2006) 17040106 173673 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 20661 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20662 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20663 108071 1727 - CYB5R3 B5R|DIA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 19579 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2525 Cibacron Blue - - DRUGBANK DB02633 C29H20ClN7O11S3 small molecule - 84166-13-2 DRUGBANK 19580 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2525 Cibacron Blue - - DRUGBANK DB02633 C29H20ClN7O11S3 small molecule - 84166-13-2 DRUGBANK 19581 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2525 Cibacron Blue - - DRUGBANK DB02633 C29H20ClN7O11S3 small molecule - 84166-13-2 DRUGBANK 22545 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3922 2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione - - DRUGBANK DB04090 C12H14N2O3 small molecule - - DRUGBANK 22546 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3922 2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione - - DRUGBANK DB04090 C12H14N2O3 small molecule - - DRUGBANK 19136 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2298 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol - - DRUGBANK DB02395 C15H18N2O4 small molecule - - DRUGBANK 19137 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2298 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol - - DRUGBANK DB02395 C15H18N2O4 small molecule - - DRUGBANK 23255 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4213 Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] - - DRUGBANK DB04392 C19H12O6 small molecule - - DRUGBANK 21617 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3473 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione - - DRUGBANK DB03626 C18H17NO4 small molecule - - DRUGBANK 21618 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3473 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione - - DRUGBANK DB03626 C18H17NO4 small molecule - - DRUGBANK 21619 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3473 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione - - DRUGBANK DB03626 C18H17NO4 small molecule - - DRUGBANK 18084 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1852 Duroquinone - - DRUGBANK DB01927 C10H12O2 small molecule - 527-17-3 DRUGBANK 18085 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1852 Duroquinone - - DRUGBANK DB01927 C10H12O2 small molecule - 527-17-3 DRUGBANK 18086 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1852 Duroquinone - - DRUGBANK DB01927 C10H12O2 small molecule - 527-17-3 DRUGBANK 20619 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20620 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20621 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 4934 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens inhibitor target Joseph P (2000) 10755406 174758 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4935 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens inhibitor target Floreani M (2000) 10874136 174759 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4936 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens inhibitor target Chen S (1999) 10419545 174756 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4937 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens inhibitor target Preusch PC (1990) 2113031 174757 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4938 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens inhibitor target Jaiswal AK (2000) 10683249 174755 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4939 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens inhibitor target Arriagada C (2000) 10949919 174760 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 25404 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6201 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE - - DRUGBANK DB07385 C19H18N2O3 small molecule - - DRUGBANK 19146 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2303 5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione - - DRUGBANK DB02400 C18H16N2O6 small molecule - - DRUGBANK 19147 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2303 5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione - - DRUGBANK DB02400 C18H16N2O6 small molecule - - DRUGBANK 19148 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2303 5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione - - DRUGBANK DB02400 C18H16N2O6 small molecule - - DRUGBANK 3660 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Kishi T (2002) 12069105 173999 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3661 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Ip SP (2000) 10939639 173998 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3662 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Munday R (1999) 10654840 174000 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3663 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Munday R (1999) 10190578 173997 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3664 108072 1728 - NQO1 DHQU|DIA4|DTD|NMOR1|NMORI|QR1 9606 Homo sapiens unknown target Chiou TJ (1999) 10614691 173996 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3193 108081 1737 - DLAT DLTA|PDC-E2|PDCE2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3194 108081 1737 - DLAT DLTA|PDC-E2|PDCE2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3195 108081 1737 - DLAT DLTA|PDC-E2|PDCE2 9606 Homo sapiens unknown target Shi S (2006) 16368957 173709 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21885 108081 1737 - DLAT DLTA|PDC-E2|PDCE2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3602 Dihydrolipoic Acid - - DRUGBANK DB03760 C8H16O2S2 small molecule - 462-20-4 DRUGBANK 21878 108081 1737 - DLAT DLTA|PDC-E2|PDCE2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3600 Radicicol - - DRUGBANK DB03758 C18H23ClO6 small molecule - - DRUGBANK 3155 108082 1738 tcag7.39 DLD DLDD|DLDH|E3|GCSL|LAD|PHE3 9606 Homo sapiens unknown target Gutierrez-Correa J (2006) 17017892 173700 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3156 108082 1738 tcag7.39 DLD DLDD|DLDH|E3|GCSL|LAD|PHE3 9606 Homo sapiens unknown target Yan LJ (2007) 17315258 173701 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3157 108082 1738 tcag7.39 DLD DLDD|DLDH|E3|GCSL|LAD|PHE3 9606 Homo sapiens unknown target Islam MM (2007) 17314104 173702 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 20609 108082 1738 tcag7.39 DLD DLDD|DLDH|E3|GCSL|LAD|PHE3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 7806 108086 1742 - DLG4 PSD95|SAP-90|SAP90 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7807 108086 1742 - DLG4 PSD95|SAP-90|SAP90 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7808 108086 1742 - DLG4 PSD95|SAP-90|SAP90 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 18224 108086 1742 - DLG4 PSD95|SAP-90|SAP90 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18225 108086 1742 - DLG4 PSD95|SAP-90|SAP90 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18226 108086 1742 - DLG4 PSD95|SAP-90|SAP90 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18134 108100 1760 - DMPK DM|DM1|DM1PK|DMK|MDPK|MT-PK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1870 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione - - DRUGBANK DB01946 C24H22N4O2 small molecule - - DRUGBANK 13716 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Wyszynski MW (1993) 8441637 180122 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13717 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13718 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13719 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Shieh FK (2007) 17897676 180123 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13034 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Lee BH (2005) 16230360 179823 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13035 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Oelke K (2004) 15188362 179822 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13036 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Januchowski R (2005) 15795105 179821 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13037 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens unknown target Scheinbart LS (1991) 2066944 179820 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 12003 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Cataldo VD (2009) 19589026 179158 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12004 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Fenaux P (2005) 16341239 179149 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12005 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Kaminskas E (2005) 15793220 179153 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12006 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target O'Dwyer K (2008) 18627335 179152 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12007 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Ghoshal K (2007) 17612710 179151 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12008 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Hollenbach PW (2010) 20126405 179150 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12009 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Leone G (2003) 14585280 179157 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12010 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Silverman LR (2002) 12011120 179156 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12011 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Glover AB (1987) 2443243 179155 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12012 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Silverman LR (2001) 11700387 179154 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 12013 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 918 Azacitidine Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine azacitidine|vidaza DRUGBANK DB00928 C8H12N4O5 small molecule L01BC07 320-67-2 DRUGBANK 15485 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Csankovszki G (2001) 11352938 131895 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15486 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15488 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Oki Y (2007) 17023173 180908 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15489 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Takebayashi S (2001) 11688997 91253 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15490 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Saba HI (2005) 16015501 180912 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15491 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Stresemann C (2008) 18425818 180905 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15492 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Jabbour E (2008) 18398832 180906 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15487 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Daskalakis M (2010) 20072836 180910 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15493 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Karpf AR (2001) 11259619 180907 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15494 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Saunthararajah Y (2003) 12907443 180911 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 15495 108123 1786 - DNMT1 ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT 9606 Homo sapiens inhibitor target Ando T (2000) 11069027 180909 1249 Decitabine Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine decitabine|dacogen DRUGBANK DB01262 C8H12N4O4 small molecule L01BC08 2353-33-5 DRUGBANK 10002 108124 1787 RP11-406H21.1 TRDMT1 DMNT2|DNMT2|MHSAIIP|PUMET|RNMT1 9606 Homo sapiens unknown target Sun T (2008) 18263620 178110 728 Pentamidine Pentamidin|Pentamidindiisetionat|Pentamidina|4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide|4,4'-Diamidinodiphenoxypentane|P,P'-(pentamethylenedioxy)dibenzamidine|4,4'-(Pentamethylenedioxy)dibenzamidine|Pentamidine|Pentamidinum|1,5-Bis(4-amidinophenoxy)pentane pentam 300|pentamidine isethio DRUGBANK DB00738 C19H24N4O2 small molecule P01CX01 100-33-4 DRUGBANK 18688 108127 1791 - DNTT TDT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2105 2',3'-Dideoxyadenosine-5'-Triphosphate - - DRUGBANK DB02189 C10H16N5O11P3 small molecule - - DRUGBANK 18689 108127 1791 - DNTT TDT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2105 2',3'-Dideoxyadenosine-5'-Triphosphate - - DRUGBANK DB02189 C10H16N5O11P3 small molecule - - DRUGBANK 18690 108127 1791 - DNTT TDT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2105 2',3'-Dideoxyadenosine-5'-Triphosphate - - DRUGBANK DB02189 C10H16N5O11P3 small molecule - - DRUGBANK 17282 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17283 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17284 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17285 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Farrell CA (1987) 3038022 181569 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17286 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Keynan S (1995) 7492120 181568 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17287 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Hirota T (1986) 3780719 181565 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17288 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Kumon H (1987) 3480361 181567 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17289 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Lin JH (1989) 2571484 181566 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17290 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Richerson MA (1998) 9573653 181570 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 17291 108134 1800 - DPEP1 MBD1|MDP|RDP 9606 Homo sapiens inhibitor target Hirota T (1987) 3474745 181571 1535 Cilastatin Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid primaxin iv|imipenem and cilas DRUGBANK DB01597 C16H26N2O5S small molecule - 82009-34-5 DRUGBANK 26546 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7283 6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM - - DRUGBANK DB08504 C22H25FN6O2 small molecule - - DRUGBANK 25505 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6293 (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE - - DRUGBANK DB07482 C9H17BN2O3 small molecule - - DRUGBANK 26064 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6837 (1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE - - DRUGBANK DB08044 C19H17F6N5O small molecule - - DRUGBANK 24281 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4789 PSN9301 - - DRUGBANK DB05001 - small molecule - - DRUGBANK 23552 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4304 Diisopropylphosphono Group - - DRUGBANK DB04491 C6H15O3P small molecule - - DRUGBANK 23553 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4304 Diisopropylphosphono Group - - DRUGBANK DB04491 C6H15O3P small molecule - - DRUGBANK 23750 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4387 1-(1-phenylcyclopentyl)methylamine C-(1-Phenyl-cyclopentyl)-methylamine|1-Phenylcyclopentanemethylamine|1-(1-PHENYLCYCLOPENTYL)METHANAMINE - DRUGBANK DB04577 C12H17N small molecule - 17511-89-6 DRUGBANK 26048 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6817 1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE - - DRUGBANK DB08024 C20H25N3O small molecule - - DRUGBANK 25071 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5885 (2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE - - DRUGBANK DB07067 C17H22N4O4S small molecule - - DRUGBANK 25334 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6144 METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE - - DRUGBANK DB07328 C20H29N5O4 small molecule - - DRUGBANK 18298 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1928 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine - - DRUGBANK DB02004 C19H18Cl2N4O2 small molecule - - DRUGBANK 18299 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1928 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine - - DRUGBANK DB02004 C19H18Cl2N4O2 small molecule - - DRUGBANK 18300 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1928 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine - - DRUGBANK DB02004 C19H18Cl2N4O2 small molecule - - DRUGBANK 25283 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6087 (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE - - DRUGBANK DB07271 C17H19F6N3O2 small molecule - - DRUGBANK 21663 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3507 4-Iodo-L-phenylalanine p-iodophenylalanine|p-Iodo-L-phenylalanine|4-iodophenylalanine - DRUGBANK DB03660 C9H10INO2 small molecule - 24250-85-9 DRUGBANK 23751 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4388 (S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide - - DRUGBANK DB04578 C20H22FN3O2 small molecule - - DRUGBANK 25875 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6648 (3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE - - DRUGBANK DB07851 C20H26N2O2 small molecule - - DRUGBANK 18012 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1812 2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One - - DRUGBANK DB01884 C9H18N2O small molecule - - DRUGBANK 18013 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1812 2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One - - DRUGBANK DB01884 C9H18N2O small molecule - - DRUGBANK 18014 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1812 2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One - - DRUGBANK DB01884 C9H18N2O small molecule - - DRUGBANK 24055 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Ahren B (2004) 15562200 181871 4676 Vildagliptin Galvus|Xiliarx|NVP-LAF-237|Jalra|EQUA|LAF237|Vildagliptin|NVP-LAF237|LAF-237|LAF 237 - DRUGBANK DB04876 C17H25N3O2 small molecule A10BD08|A10BH02 274901-16-5 DRUGBANK 24056 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Mentlein R (1993) 8100523 181692 4676 Vildagliptin Galvus|Xiliarx|NVP-LAF-237|Jalra|EQUA|LAF237|Vildagliptin|NVP-LAF237|LAF-237|LAF 237 - DRUGBANK DB04876 C17H25N3O2 small molecule A10BD08|A10BH02 274901-16-5 DRUGBANK 24057 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Gupta R (2009) 19149538 182095 4676 Vildagliptin Galvus|Xiliarx|NVP-LAF-237|Jalra|EQUA|LAF237|Vildagliptin|NVP-LAF237|LAF-237|LAF 237 - DRUGBANK DB04876 C17H25N3O2 small molecule A10BD08|A10BH02 274901-16-5 DRUGBANK 25801 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6578 N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE - - DRUGBANK DB07779 C22H26FN3O2 small molecule - - DRUGBANK 20858 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3121 (2s)-Pyrrolidin-2-Ylmethylamine - - DRUGBANK DB03253 C5H12N2 small molecule - - DRUGBANK 20859 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3121 (2s)-Pyrrolidin-2-Ylmethylamine - - DRUGBANK DB03253 C5H12N2 small molecule - - DRUGBANK 20860 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3121 (2s)-Pyrrolidin-2-Ylmethylamine - - DRUGBANK DB03253 C5H12N2 small molecule - - DRUGBANK 24910 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5700 (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE - - DRUGBANK DB06880 C15H25N3O small molecule - - DRUGBANK 26621 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7365 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE - - DRUGBANK DB08588 C21H21N5O small molecule - - DRUGBANK 25103 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5910 (2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE - - DRUGBANK DB07092 C22H30F2N6O2 small molecule - - DRUGBANK 26746 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7516 2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE - - DRUGBANK DB08743 C20H23N7O2 small molecule - - DRUGBANK 25437 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6226 1-biphenyl-2-ylmethanamine - - DRUGBANK DB07412 C13H13N small molecule - - DRUGBANK 26187 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6956 (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE - - DRUGBANK DB08164 C22H21F3N4O2S small molecule - - DRUGBANK 25196 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6010 (2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine - - DRUGBANK DB07193 C18H16F3N3O2S small molecule - - DRUGBANK 25848 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6627 (4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE - - DRUGBANK DB07830 C20H19F3N2O3 small molecule - - DRUGBANK 24561 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Augeri DJ (2005) 16033281 181900 5549 Saxagliptin BMS 477118|BMS-477118|(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile|Onglyza kombiglyze xr|komboglyze|ongly DRUGBANK DB06335 C18H25N3O2 small molecule A10BD10|A10BD21|A10BH03 361442-04-8 DRUGBANK 25006 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5811 (2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine - - DRUGBANK DB06993 C20H28F2N4O4S small molecule - - DRUGBANK 25090 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5899 (2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE - - DRUGBANK DB07081 C17H17F6N5O small molecule - - DRUGBANK 24962 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5758 N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE - - DRUGBANK DB06939 C17H30FN3O2 small molecule - - DRUGBANK 25363 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6172 (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE - - DRUGBANK DB07356 C14H23N3O small molecule - - DRUGBANK 25188 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5998 4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide - - DRUGBANK DB07181 C21H18F2N2O small molecule - - DRUGBANK 26072 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6844 (2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE - - DRUGBANK DB08051 C22H24F3N3O2 small molecule - - DRUGBANK 25076 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5890 (1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE - - DRUGBANK DB07072 C18H19F6N5 small molecule - - DRUGBANK 25145 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5953 (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE - - DRUGBANK DB07135 C22H31FN6O2 small molecule - - DRUGBANK 25029 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5833 (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine - - DRUGBANK DB07015 C18H21N5O2 small molecule - - DRUGBANK 25479 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6276 (1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile - - DRUGBANK DB07465 C18H25N3O2 small molecule - - DRUGBANK 26472 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7211 N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide - - DRUGBANK DB08429 C23H28ClN3O4S small molecule - - DRUGBANK 26495 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7227 (3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE - - DRUGBANK DB08445 C20H18F3N5O small molecule - - DRUGBANK 26683 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7446 4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE - - DRUGBANK DB08672 C19H21FN2O2 small molecule - - DRUGBANK 26428 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7166 2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine - - DRUGBANK DB08382 C17H24F2N6O small molecule - - DRUGBANK 13531 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Taldone T (2008) 18068977 180015 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 25034 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5839 (7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine - - DRUGBANK DB07021 C16H13F3N4 small molecule - - DRUGBANK 26949 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Forst T (2012) 22149370 182197 7626 Linagliptin (R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|BI 1356|Tradjenta|BI-1356|Trajenta glyxambi|tradjenta|jentadueto| DRUGBANK DB08882 C25H28N8O2 small molecule A10BD11|A10BH05|A10BD19 668270-12-0 DRUGBANK 25674 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6472 (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE - - DRUGBANK DB07666 C21H19F3N4O2S small molecule - - DRUGBANK 25250 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6055 7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile - - DRUGBANK DB07239 C16H13ClN4 small molecule - - DRUGBANK 25165 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5972 (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE - - DRUGBANK DB07154 C16H20F3N3O2 small molecule - - DRUGBANK 25007 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5812 (2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine - - DRUGBANK DB06994 C21H25ClFN3O3S small molecule - - DRUGBANK 15473 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15474 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Lyseng-Williamson KA (2007) 17352516 180904 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15475 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Pratley RE (2007) 17407649 180898 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15476 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Gallwitz B (2006) 16682937 180899 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15477 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Gallwitz B (2007) 17315049 180896 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15478 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Karasik A (2008) 18182122 180897 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15479 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Herman GA (2006) 16855072 180894 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15480 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Bergman AJ (2006) 16490580 180895 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15481 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Hermansen K (2007) 17593236 180900 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15482 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Herman GA (2005) 16338283 180901 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15483 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Miller S (2006) 16868220 180902 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 15484 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens inhibitor target Richter B (2008) 19065993 180903 1248 Sitagliptin Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum janumet|janumet xr|januvia DRUGBANK DB01261 C16H15F6N5O small molecule A10BH51|A10BD12|A10BD07|A10BH01 486460-32-6 DRUGBANK 26578 108137 1803 - DPP4 ADABP|ADCP2|CD26|DPPIV|TP103 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7308 7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE - - DRUGBANK DB08530 C18H23N6O2 small molecule - - DRUGBANK 18899 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2210 (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione - - DRUGBANK DB02303 C4H5IN2O2 small molecule - - DRUGBANK 18900 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2210 (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione - - DRUGBANK DB02303 C4H5IN2O2 small molecule - - DRUGBANK 18901 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2210 (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione - - DRUGBANK DB02303 C4H5IN2O2 small molecule - - DRUGBANK 20380 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2920 6-Carboxymethyluracil - - DRUGBANK DB03048 C6H6N2O4 small molecule - - DRUGBANK 20381 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2920 6-Carboxymethyluracil - - DRUGBANK DB03048 C6H6N2O4 small molecule - - DRUGBANK 20382 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2920 6-Carboxymethyluracil - - DRUGBANK DB03048 C6H6N2O4 small molecule - - DRUGBANK 20841 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20842 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20843 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 21432 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Czito BG (2006) 16466986 181929 3371 Eniluracil 5-Ethynyluracil|5-ethynyl-2,4(1H,3H)-Pyrimidinedione|Compound 776C - DRUGBANK DB03516 C6H4N2O2 small molecule - 59989-18-3 DRUGBANK 20642 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20643 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20644 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21178 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21179 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21180 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21484 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3403 5-Iodouracil - - DRUGBANK DB03554 C4H3IN2O2 small molecule - - DRUGBANK 21485 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3403 5-Iodouracil - - DRUGBANK DB03554 C4H3IN2O2 small molecule - - DRUGBANK 21486 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3403 5-Iodouracil - - DRUGBANK DB03554 C4H3IN2O2 small molecule - - DRUGBANK 18972 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 18973 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 18974 108140 1806 - DPYD DHP|DHPDHASE|DPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 15276 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15277 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15278 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Fux M (1991) 1830565 180792 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15215 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens partial agonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15216 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8353 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8354 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8355 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15182 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Koller WC (1998) 9633680 180775 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15183 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Deleu D (2002) 11978145 179837 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15184 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Onofrj M (2008) 18549347 180774 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 8102 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 9425 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Hammock RG (1995) 8720030 177776 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 7096 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens binder target Toll L (1998) 9686407 176206 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 10341 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10342 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 4735 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 6469 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens partial agonist target Cheng JT (2003) 12873745 175802 389 Phenylpropanolamine PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin trisulfaminic tab|tantacol dm DRUGBANK DB00397 C9H13NO small molecule R01BA51|R01BA01 14838-15-4 DRUGBANK 7567 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Cai G (1999) 10531405 176548 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7568 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 17320 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kanba S (1994) 7918347 176330 1546 Propericiazine 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina neuleptil 5mg capsules|neulept DRUGBANK DB01608 C21H23N3OS small molecule N05AC01 2622-26-6 DRUGBANK 13342 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 13343 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 10684 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10685 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10618 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10619 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Dhasmana KM (1993) 8103596 178446 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10620 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Zeng C (2009) 19293728 178445 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 24208 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Bobo WV (2013) 23272794 182224 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 6660 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 12513 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Dolzan V (2007) 17455212 178693 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12514 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Fu W (2007) 17468175 179523 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12528 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Huebner H (2000) 10691700 179533 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12515 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Ostadali MR (2004) 17301410 179521 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12516 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Hoenicka J (2007) 17449449 179524 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12517 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target da Silva Lobo DS (2007) 17394052 179525 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 5904 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 345 Methylergometrine 9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine methylergonovine maleate|methe DRUGBANK DB00353 C20H25N3O2 small molecule G02AB01|G02AC01 113-42-8 DRUGBANK 5905 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 345 Methylergometrine 9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine methylergonovine maleate|methe DRUGBANK DB00353 C20H25N3O2 small molecule G02AB01|G02AC01 113-42-8 DRUGBANK 5906 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 345 Methylergometrine 9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine methylergonovine maleate|methe DRUGBANK DB00353 C20H25N3O2 small molecule G02AB01|G02AC01 113-42-8 DRUGBANK 5907 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Reyes FD (2005) 15930499 175441 345 Methylergometrine 9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine methylergonovine maleate|methe DRUGBANK DB00353 C20H25N3O2 small molecule G02AB01|G02AC01 113-42-8 DRUGBANK 5908 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Nargeot R (1999) 10200235 175442 345 Methylergometrine 9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine methylergonovine maleate|methe DRUGBANK DB00353 C20H25N3O2 small molecule G02AB01|G02AC01 113-42-8 DRUGBANK 15558 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15559 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5664 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5665 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5662 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5663 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Fernandez J (2005) 15771415 175310 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5666 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6600 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 17409 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kanba S (1994) 7918347 176330 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17410 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Shultz PJ (1987) 3039860 181603 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17413 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Manzaneque JM (1999) 10222441 181604 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17414 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Lublin H (1991) 1822319 181605 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 6196 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 6197 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 6141 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens binder target de Boer T (1995) 8930006 175620 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6142 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6143 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 15030 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14607 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14608 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14609 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7318 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kanba S (1994) 7918347 176330 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7327 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens unknown target Seeman P (1993) 8104554 176336 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 8732 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8733 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Cai G (1999) 10531405 176548 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8734 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8735 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Van Kampen JM (2000) 11113312 177396 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 9753 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9754 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9755 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9756 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Guo H (2002) 12453049 177992 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 13147 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13148 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13149 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13150 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13151 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13152 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13153 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13154 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 24466 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24467 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5978 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4965 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4833 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4834 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2006) 16982285 174668 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4835 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Ichikawa K (2001) 11436517 174659 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4836 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4845 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 9895 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 24327 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 13073 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Bora G (1968) 4887393 179838 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13074 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Platz AR (1967) 4861216 179839 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13075 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Vinar O (1967) 4889058 179840 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 17346 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kanba S (1994) 7918347 176330 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 14802 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 11153 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Dolzan V (2007) 17455212 178693 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11154 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Farde L (1989) 2573104 178690 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 17397 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kanba S (1994) 7918347 176330 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17386 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Kanba S (1994) 7918347 176330 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 11330 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11331 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Cai G (1999) 10531405 176548 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11332 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11333 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Reimold M (2007) 17111172 178827 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 9984 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9985 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 7866 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Nasu R (2000) 11180191 176779 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6745 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6746 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 9611 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens agonist target Bigal ME (2003) 12525272 177883 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 16471 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 7586 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7587 108146 1812 - DRD1 DADR|DRD1A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 15267 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target von Coburg Y (2009) 19091563 180793 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15268 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Fux M (1991) 1830565 180792 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15269 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15270 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Froimowitz M (1993) 8101879 175877 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15240 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Kim E (2006) 16981227 180782 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15241 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Hirose T (2005) 16366516 180783 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15242 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15243 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Wood M (2007) 17501690 180786 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15244 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Inoue A (1997) 9083792 180784 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15245 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Wood MD (2006) 16925992 180785 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15246 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kim E (2006) 16981227 180782 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15247 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hirose T (2005) 16366516 180783 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15248 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15249 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wood M (2007) 17501690 180786 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15250 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Inoue A (1997) 9083792 180784 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15251 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wood MD (2006) 16925992 180785 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8334 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8335 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 13156 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13157 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 14993 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Seeman P (2009) 19391150 180698 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 14994 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Seeman P (2009) 19391150 180698 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 8099 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Kuzuhara S (1997) 9014432 176935 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8100 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Bruecke T (1995) 7714010 176936 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 9417 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (1990) 1978482 177771 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9418 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Barth VN (2006) 16434058 177773 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9419 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Assie MB (1993) 7689973 177772 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9420 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Carey GJ (1997) 9292626 177775 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9421 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Dimpfel W (1992) 1352051 177774 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 7124 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target Peddi S (2004) 15081025 176220 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 24164 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Choung RS (2007) 17300287 181987 4721 Itopride N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide - DRUGBANK DB04924 C20H26N2O4 small molecule A03FA07 122898-67-3 DRUGBANK 24165 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Holtmann G (2006) 16495395 181932 4721 Itopride N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide - DRUGBANK DB04924 C20H26N2O4 small molecule A03FA07 122898-67-3 DRUGBANK 16355 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 7591 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7592 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 10361 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10362 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 13720 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13721 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13722 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Silva MR (2003) 12828573 180126 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13723 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Murphy LL (1999) 10503726 180127 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13724 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Muscat R (1990) 2378927 180124 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13725 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Zarrindast MR (1994) 8082693 180125 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13726 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13727 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Freedman SB (1994) 8301582 176340 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 5994 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5995 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Stonehouse AH (2005) 15781964 175516 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5996 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Green AI (2002) 12769622 175515 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5997 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Young RM (2004) 15286066 175514 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5998 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Takano A (2006) 16040180 175513 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5999 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Weizman T (2003) 14575800 175315 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 24027 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Zhu M (2008) 17908924 182052 4657 Brasofensine - - DRUGBANK DB04857 C16H20Cl2N2O small molecule - 171655-91-7 DRUGBANK 4752 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kopecek M (2005) 15726024 174628 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4753 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4754 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeger TF (1995) 7562537 174627 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4755 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4756 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Stahl SM (2004) 14728084 174620 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4757 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27519 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Yoshikawa T (2001) 11350861 188558 7951 AS-8112 - - DRUGBANK DB09207 C17H27BrN4O2 small molecule - - DRUGBANK 27915 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Maeda K (2014) 24947465 196021 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 27916 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Maeda K (2014) 24947465 196021 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 7552 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7553 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7554 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2010) 20643630 176352 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7555 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Bustillo J (2006) 16132064 176540 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7556 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Osinski MA (2005) 15894081 176541 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7557 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Ishiwata K (2006) 17134027 176539 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7558 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Naiker DV (2006) 16730699 175316 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7559 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 15188 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Zappia M (2005) 15824260 180777 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15189 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kovoor A (2005) 15728856 180776 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15190 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Koller WC (1998) 9633680 180775 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15191 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Deleu D (2002) 11978145 179837 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15192 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Dupre KB (2007) 17553470 180779 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15193 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Mori A (2005) 15710490 180778 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15194 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Onofrj M (2008) 18549347 180774 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 3908 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target Innis RB (1992) 1532675 174155 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 16931 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Seeman P (2009) 19391150 180698 1489 Rolicyclidine Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine - DRUGBANK DB01549 C16H23N small molecule - 2201-39-0 DRUGBANK 27029 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Tonini M (2004) 14871277 181842 7751 Bromopride Bromopridum|4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide|Bromoprid|Bromoprida|Bromopride - DRUGBANK DB09018 C14H22BrN3O2 small molecule A03FA04 4093-35-0 DRUGBANK 13337 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 13338 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 13339 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 13340 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 13341 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Tam SW (1984) 6147851 179927 1051 Acetophenazine Acetophenazine - DRUGBANK DB01063 C23H29N3O2S small molecule N05AB07 2751-68-0 DRUGBANK 10689 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10690 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 15150 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15151 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kishibayashi N (1995) 7745844 180758 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15152 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hammer D (2005) 15835479 180755 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15153 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Dahloef CG (1998) 9876882 180754 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15154 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chemnitius JM (1996) 8981558 180757 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15155 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target See RE (1996) 8730709 180756 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 15156 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Harrold MW (1993) 8230103 180753 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 13457 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Golembiewski JA (2002) 12476402 179971 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 24202 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hesselink JM (2002) 12861482 181824 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 24203 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kongsamut S (1996) 8997630 181714 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 24552 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 24553 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Horacek J (2006) 16696579 181941 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 24554 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Rosenzweig P (2002) 12404702 181804 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 6635 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6636 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6637 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 12508 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12509 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Ostadali MR (2004) 17301410 179521 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 9736 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9737 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9738 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Berlin I (2000) 11343576 177987 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9739 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Yamada S (2000) 11215397 177991 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9740 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lucht MJ (2001) 11692072 177990 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9741 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9742 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Yamada S (1999) 10494453 177988 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9743 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kim HJ (2001) 11212866 177989 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 15538 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Remington G (2006) 16513859 178091 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15539 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15540 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15541 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15542 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Yamada Y (2002) 12211096 180926 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15543 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cohen LJ (1994) 7524043 180924 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15544 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Regenthal R (2005) 16119512 180925 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 6125 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6126 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target Wikstroem HV (2002) 12109911 175612 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6127 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 5697 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5698 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5699 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lencz T (2006) 16513877 175319 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5700 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Jordan S (2007) 17092971 175318 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5701 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Weizman T (2003) 14575800 175315 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5702 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Thacker SK (2006) 17067304 175317 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5703 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Naiker DV (2006) 16730699 175316 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5704 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Uchida S (2007) 17316700 175303 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5705 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5706 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5707 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lencz T (2006) 16513877 175319 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5708 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Jordan S (2007) 17092971 175318 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5709 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Weizman T (2003) 14575800 175315 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5710 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Thacker SK (2006) 17067304 175317 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5711 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Naiker DV (2006) 16730699 175316 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5712 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6612 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6613 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6614 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lang AE (1995) 8665533 175881 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6602 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 6603 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lang AE (1995) 8665533 175881 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 6604 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hjerde E (2005) 15694653 175879 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 6605 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Froimowitz M (1997) 9342550 175878 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 6606 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lee T (1984) 6239298 175876 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 6607 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Froimowitz M (1993) 8101879 175877 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 6608 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kalkman HO (1998) 9570468 175880 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 17402 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17403 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17404 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu S (2005) 15694263 176350 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17405 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Oades RD (2000) 11103886 176351 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17406 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2010) 20643630 176352 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17407 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Shultz PJ (1987) 3039860 181603 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17408 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu SN (2006) 16867246 176349 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17416 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nyberg S (1995) 8748043 181608 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17417 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17418 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lublin H (1991) 1822319 181605 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17419 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Gareri P (2007) 17535043 181607 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 6193 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 6194 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 6195 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Briani C (2004) 15469457 175635 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 6898 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hamik A (1989) 2527092 176028 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 6899 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Callan JE (2008) 18534808 176029 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 6900 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Roberge RJ (2006) 16677982 176027 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 6901 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 6902 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Narita M (2008) 18955042 176031 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 6903 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Golembiewski J (2006) 17169748 176030 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 6904 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Vinson DR (2006) 17044574 176032 425 Prochlorperazine 3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine prochlorperazine maleate|sando DRUGBANK DB00433 C20H24ClN3S small molecule N05AB04 58-38-8 DRUGBANK 15066 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15067 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15068 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15069 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kapur S (2000) 10839333 180714 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15070 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 7848 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Peroutka SJ (1982) 6121969 176755 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 14235 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14573 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Huettl P (1991) 1674528 178828 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14574 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14575 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14576 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Mehta MA (2006) 16842172 180531 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14577 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Fuller RW (1985) 2860228 180530 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14578 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14579 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Linazasoro G (1999) 10516878 180532 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14580 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Paturle L (1987) 3828803 180529 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7348 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7349 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7350 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu S (2005) 15694263 176350 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7351 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Oades RD (2000) 11103886 176351 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7352 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2010) 20643630 176352 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7353 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu SN (2006) 16867246 176349 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7354 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Roth BL (1995) 8524985 176332 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7355 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Roth BL (1994) 7908055 176335 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 14553 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Ali I (2006) 18970411 180517 1172 Domperidone 1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone ran-domperidone|motilium tab 1 DRUGBANK DB01184 C22H24ClN5O2 small molecule A03FA03 57808-66-9 DRUGBANK 14554 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Osinski MA (2005) 15894081 176541 1172 Domperidone 1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone ran-domperidone|motilium tab 1 DRUGBANK DB01184 C22H24ClN5O2 small molecule A03FA03 57808-66-9 DRUGBANK 14555 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1172 Domperidone 1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone ran-domperidone|motilium tab 1 DRUGBANK DB01184 C22H24ClN5O2 small molecule A03FA03 57808-66-9 DRUGBANK 14556 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cavallotti C (2002) 12010185 175759 1172 Domperidone 1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone ran-domperidone|motilium tab 1 DRUGBANK DB01184 C22H24ClN5O2 small molecule A03FA03 57808-66-9 DRUGBANK 14557 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target de Mey C (1991) 1683559 174763 1172 Domperidone 1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone ran-domperidone|motilium tab 1 DRUGBANK DB01184 C22H24ClN5O2 small molecule A03FA03 57808-66-9 DRUGBANK 8723 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8724 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hoyberg OJ (1993) 7508675 177392 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8725 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 8726 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Qin ZH (1994) 7828655 177391 613 Fluphenazine Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine apo fluphenazine tab 2.5mg|apo DRUGBANK DB00623 C22H26F3N3OS small molecule N05AB02 69-23-8 DRUGBANK 14147 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14148 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 24434 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24435 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Tadori Y (2011) 21658377 182191 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24436 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 13104 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Seeman P (2008) 18000814 179862 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 4945 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4946 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4947 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Iida M (1999) 10446316 174765 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4948 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Matsukawa N (2007) 17573046 174764 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4949 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target de Mey C (1991) 1683559 174763 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4950 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 6391 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Jaber M (1994) 7518029 175760 383 Sulpiride N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid - DRUGBANK DB00391 C15H23N3O4S small molecule N05AL01|N05AL07 15676-16-1 DRUGBANK 6392 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 383 Sulpiride N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid - DRUGBANK DB00391 C15H23N3O4S small molecule N05AL01|N05AL07 15676-16-1 DRUGBANK 6393 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cavallotti C (2002) 12010185 175759 383 Sulpiride N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid - DRUGBANK DB00391 C15H23N3O4S small molecule N05AL01|N05AL07 15676-16-1 DRUGBANK 4795 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kageyama K (2002) 12008749 174661 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4796 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4797 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Ichikawa K (2001) 11436517 174659 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4798 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Pastor P (2003) 12721865 174660 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4799 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Linazasoro G (2008) 18303487 174658 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4800 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Curran MP (2004) 15341508 174657 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4801 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Miyagi M (1996) 8951172 174656 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4802 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lombardi G (2002) 12464354 174655 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 9892 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 24322 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 7011 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Grip G (1992) 1549935 176149 442 Droperidol Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo inapsine|droperidol|innovar in DRUGBANK DB00450 C22H22FN3O2 small molecule N05AD08 548-73-2 DRUGBANK 7012 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Larson MD (2003) 14633536 176148 442 Droperidol Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo inapsine|droperidol|innovar in DRUGBANK DB00450 C22H22FN3O2 small molecule N05AD08 548-73-2 DRUGBANK 7013 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hamik A (1989) 2527092 176028 442 Droperidol Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo inapsine|droperidol|innovar in DRUGBANK DB00450 C22H22FN3O2 small molecule N05AD08 548-73-2 DRUGBANK 7014 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Gao HR (2010) 20358234 176150 442 Droperidol Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo inapsine|droperidol|innovar in DRUGBANK DB00450 C22H22FN3O2 small molecule N05AD08 548-73-2 DRUGBANK 24366 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cincotta SL (2010) 20856607 182166 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24367 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lindstroem E (2006) 16925508 181962 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24368 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Mork A (2009) 19506838 182111 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24369 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24370 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2008) 18293356 182066 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24392 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Terai M (1989) 2576228 181658 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 23986 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 23987 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Schotte A (1996) 8935801 181713 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 23988 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 23989 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 23990 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wang SJ (2002) 11842444 181787 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 13069 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13070 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Bora G (1968) 4887393 179838 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13071 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Platz AR (1967) 4861216 179839 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13072 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Vinar O (1967) 4889058 179840 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 17338 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17339 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17340 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu S (2005) 15694263 176350 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17341 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Oades RD (2000) 11103886 176351 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17342 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2010) 20643630 176352 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17343 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu SN (2006) 16867246 176349 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 23758 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Nakamura K (2001) 11412837 181773 4408 Aniracetam 1-P-ANISOYL-2-PYRROLIDINONE - DRUGBANK DB04599 C12H13NO3 small molecule N06BX11 72432-10-1 DRUGBANK 14772 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lahlou S (2000) 10626749 180597 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14773 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14774 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lahlou S (2000) 10721819 180600 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14775 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14776 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14777 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Cavallotti C (2002) 12010185 175759 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14778 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Lahlou S (2003) 12753422 180599 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14779 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Stefaneanu L (2001) 11444429 180598 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 11143 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Talvik M (2004) 15007534 178691 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11144 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Farde L (1989) 2573104 178690 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11145 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11146 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Hoyberg OJ (1993) 7508675 177392 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11148 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 11147 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Qin ZH (1994) 7828655 177391 840 Perphenazine Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum pms perphenazine tab 16mg|perp DRUGBANK DB00850 C21H26ClN3OS small molecule N05AB03 58-39-9 DRUGBANK 17389 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17390 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17391 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu S (2005) 15694263 176350 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17392 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Oades RD (2000) 11103886 176351 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17393 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2010) 20643630 176352 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17394 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu SN (2006) 16867246 176349 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17379 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17380 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17381 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2010) 20643630 176352 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17382 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu S (2005) 15694263 176350 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17383 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Oades RD (2000) 11103886 176351 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17384 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Boireau A (1986) 2875894 181602 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17385 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wu SN (2006) 16867246 176349 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 7460 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Malt EA (2003) 12781354 176464 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7461 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nader MA (1993) 11224194 176462 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7462 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Fernandez-Perez S (2005) 16214127 176463 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7463 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Pache DM (2003) 14522358 176460 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7464 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Boido A (2001) 11421254 176461 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 11875 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Tomitaka S (1995) 8566141 179067 905 Amantadine Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane symmetrel syrup 10mg/ml|gapeam DRUGBANK DB00915 C10H17N small molecule N04BB01 768-94-5 DRUGBANK 11876 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Cousins MS (1997) 9098680 179066 905 Amantadine Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane symmetrel syrup 10mg/ml|gapeam DRUGBANK DB00915 C10H17N small molecule N04BB01 768-94-5 DRUGBANK 11877 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Hesselink MB (1999) 10443547 179064 905 Amantadine Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane symmetrel syrup 10mg/ml|gapeam DRUGBANK DB00915 C10H17N small molecule N04BB01 768-94-5 DRUGBANK 11878 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Ameri A (1998) 9806328 179068 905 Amantadine Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane symmetrel syrup 10mg/ml|gapeam DRUGBANK DB00915 C10H17N small molecule N04BB01 768-94-5 DRUGBANK 11321 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Huettl P (1991) 1674528 178828 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11322 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nilsson CL (1996) 8797192 178829 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11323 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11326 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Arnt J (1995) 7498321 174624 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11325 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Reimold M (2007) 17111172 178827 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11324 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 11327 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Ogren SO (1984) 6149133 178826 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 24085 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Auclair AL (2007) 17393144 181998 4688 Bifeprunox Bifeprunoxum|Bifeprunox mesilate - DRUGBANK DB04888 C24H23N3O2 small molecule - 350992-10-8 DRUGBANK 24086 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Newman-Tancredi A (2007) 17659474 182032 4688 Bifeprunox Bifeprunoxum|Bifeprunox mesilate - DRUGBANK DB04888 C24H23N3O2 small molecule - 350992-10-8 DRUGBANK 24087 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens unknown target Basile AS (2007) 17325229 181989 4689 Bicifadine - - DRUGBANK DB04889 C12H15N small molecule - 71195-57-8 DRUGBANK 27371 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens partial agonist target Citrome L (2013) 23320989 188516 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 27372 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Citrome L (2013) 23320989 188516 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 17357 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 17358 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 17359 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Froimowitz M (1997) 9342550 175878 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 17360 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (1998) 9577836 181592 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 17361 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lidow MS (1997) 9353417 181593 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 9944 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Remington G (2006) 16513859 178091 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9945 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lane HY (2004) 15140279 178090 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9946 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9947 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9948 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Catafau AM (2006) 17059881 178089 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9949 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9950 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Naiker DV (2006) 16730699 175316 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 16627 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Kilpatrick GJ (1986) 2943980 181389 1373 Alizapride Alizaprida|Plitican|Alizapridum - DRUGBANK DB01425 C16H21N5O2 small molecule A03FA05 59338-93-1 DRUGBANK 16628 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Gomez F (1999) 10075867 181387 1373 Alizapride Alizaprida|Plitican|Alizapridum - DRUGBANK DB01425 C16H21N5O2 small molecule A03FA05 59338-93-1 DRUGBANK 16629 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Dhasmana KM (1993) 8103596 178446 1373 Alizapride Alizaprida|Plitican|Alizapridum - DRUGBANK DB01425 C16H21N5O2 small molecule A03FA05 59338-93-1 DRUGBANK 16630 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Szelenyi I (1994) 7865862 181388 1373 Alizapride Alizaprida|Plitican|Alizapridum - DRUGBANK DB01425 C16H21N5O2 small molecule A03FA05 59338-93-1 DRUGBANK 7894 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Nasu R (2000) 11180191 176779 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7895 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6729 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6730 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 26860 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 7585 Lurasidone Lurasidona|Lurasidonum latuda DRUGBANK DB08815 C28H36N4O2S small molecule N05AE05 367514-87-2 DRUGBANK 10924 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10925 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10926 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Schmidt MH (1991) 1676523 178589 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10927 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Seeman P (1976) 945467 178588 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10928 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Lahti RA (1993) 8102973 178587 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10929 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Cahir M (2005) 15695070 176331 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 12038 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 923 Mesoridazine 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina serentil tab 25mg|serentil tab DRUGBANK DB00933 C21H26N2OS2 small molecule N05AC03 5588-33-0 DRUGBANK 12039 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Burstein ES (2005) 16135699 176776 923 Mesoridazine 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina serentil tab 25mg|serentil tab DRUGBANK DB00933 C21H26N2OS2 small molecule N05AC03 5588-33-0 DRUGBANK 12040 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Choi S (2004) 15357957 179174 923 Mesoridazine 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina serentil tab 25mg|serentil tab DRUGBANK DB00933 C21H26N2OS2 small molecule N05AC03 5588-33-0 DRUGBANK 12052 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens binder target Richelson E (1984) 6086881 176781 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 16459 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Dahl SG (1986) 2870716 181307 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16460 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 16461 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 9580 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Larson BT (1995) 7665369 177878 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9581 108147 1813 - DRD2 D2DR|D2R 9606 Homo sapiens agonist target Verhoeff NP (1993) 8242725 177879 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 15273 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15274 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15275 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Fux M (1991) 1830565 180792 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15228 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens partial agonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15229 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8338 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15185 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Koller WC (1998) 9633680 180775 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15186 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Deleu D (2002) 11978145 179837 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15187 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Onofrj M (2008) 18549347 180774 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 9735 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16354 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 13733 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Freedman SB (1994) 8301582 176340 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 4738 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4739 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27520 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Yoshikawa T (2001) 11350861 188558 7951 AS-8112 - - DRUGBANK DB09207 C17H27BrN4O2 small molecule - - DRUGBANK 7547 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens inverse agonist target Tadori Y (2008) 18831971 176538 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7548 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens inverse agonist target Leysen JE (1994) 7520908 175510 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7549 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens inverse agonist target Malmberg (1998) 9536001 176535 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7550 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens inverse agonist target Tuppurainen H (2009) 19496999 176536 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7551 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens inverse agonist target Kessler RM (2005) 16123775 176537 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 24201 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 24555 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Seeman P (2002) 11873706 174626 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 24556 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Horacek J (2006) 16696579 181941 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 24557 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Rosenzweig P (2002) 12404702 181804 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 6642 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6643 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6644 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 12512 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Ostadali MR (2004) 17301410 179521 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 15536 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15537 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5670 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5671 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6615 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Christian AJ (2001) 11325388 175885 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6122 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens unknown target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6123 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens unknown target Wikstroem HV (2002) 12109911 175612 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6124 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens unknown target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 15047 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14587 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14588 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14589 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Wachtel H (1991) 1683537 180533 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7332 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens unknown target Freedman SB (1994) 8301582 176340 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 14558 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Freedman SB (1994) 8301582 176340 1172 Domperidone 1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone ran-domperidone|motilium tab 1 DRUGBANK DB01184 C22H24ClN5O2 small molecule A03FA03 57808-66-9 DRUGBANK 16470 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 24443 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24444 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Tadori Y (2011) 21658377 182191 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24445 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5981 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4953 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4954 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4955 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 6394 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Collo G (2008) 18973551 175761 383 Sulpiride N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid - DRUGBANK DB00391 C15H23N3O4S small molecule N05AL01|N05AL07 15676-16-1 DRUGBANK 6395 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Lipina TV (2009) 19795811 175762 383 Sulpiride N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid - DRUGBANK DB00391 C15H23N3O4S small molecule N05AL01|N05AL07 15676-16-1 DRUGBANK 4810 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4811 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4812 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24321 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 14787 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14788 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 27373 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens partial agonist target Citrome L (2013) 23320989 188516 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 27374 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Citrome L (2013) 23320989 188516 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 9968 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9969 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 7873 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens antagonist target Burstein ES (2005) 16135699 176776 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 27015 108148 1814 - DRD3 D3DR|ETM1|FET1 9606 Homo sapiens agonist target Ring RM (2013) 23863923 182253 7747 Captodiame Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine - DRUGBANK DB09014 C21H29NS2 small molecule N05BB02 486-17-9 DRUGBANK 15224 108149 1815 - DRD4 D4DR 9606 Homo sapiens partial agonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15225 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8339 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15195 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Koller WC (1998) 9633680 180775 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15196 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Deleu D (2002) 11978145 179837 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15197 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Onofrj M (2008) 18549347 180774 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 9727 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Melis MR (2006) 17067298 177986 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9728 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9729 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9730 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Mansbach RS (1998) 9497025 177984 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9731 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Boeckler F (2004) 15007532 177985 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9732 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Succu S (2007) 17164075 177983 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 27774 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Sanner MA (1998) 9871530 196049 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 10351 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10352 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 4722 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4723 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 12529 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Ostadali MR (2004) 17301410 179521 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 24198 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Bobo WV (2013) 23272794 182224 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 6645 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6646 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 27684 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Borsini F (2002) 12177684 181800 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 27685 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Invernizzi RW (2003) 12890707 181826 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 27807 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Deeks ED (2015) 26412054 196031 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 15515 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15516 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5642 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5643 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Hutchison KE (2006) 16237394 175302 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6616 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Seeman P (1997) 9015795 175886 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6198 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 6199 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 364 Thiethylperazine Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine - DRUGBANK DB00372 C22H29N3S2 small molecule R06AD03 1420-55-9 DRUGBANK 15042 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14590 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7320 108149 1815 - DRD4 D4DR 9606 Homo sapiens binder target Roth BL (1995) 8524985 176332 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 16487 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 24462 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24463 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24464 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5962 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5963 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Glatt SJ (2003) 13129658 175503 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5964 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Patel S (2003) 12763097 175504 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5965 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Zhao AL (2005) 16223700 175505 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5966 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Kuballa G (2005) 15886414 175506 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5967 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Nakane M (2005) 15992586 175502 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4956 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4957 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4846 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4847 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Newman-Tancredi A (2002) 12388667 174663 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24320 108149 1815 - DRD4 D4DR 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 14809 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 9970 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9971 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 7863 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Burstein ES (2005) 16135699 176776 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6720 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6721 108149 1815 - DRD4 D4DR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 15263 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens partial agonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15264 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8351 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15179 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Koller WC (1998) 9633680 180775 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15180 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Deleu D (2002) 11978145 179837 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 15181 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Onofrj M (2008) 18549347 180774 1223 Levodopa 3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa sinemet 100/25|sinemet 250/25| DRUGBANK DB01235 C9H11NO4 small molecule N04BA02|N04BA03|N04BA01 59-92-7 DRUGBANK 8101 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens binder target Nasu R (2000) 11180191 176779 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 7095 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens binder target Toll L (1998) 9686407 176206 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 4749 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 10627 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10628 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10629 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Dhasmana KM (1993) 8103596 178446 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 10630 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Zeng C (2009) 19293728 178445 790 Fenoldopam Fenoldopam|Fenoldopamum|Fnoldopam corlopam DRUGBANK DB00800 C16H16ClNO3 small molecule C01CA19 67227-56-9 DRUGBANK 12527 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Huebner H (2000) 10691700 179533 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12526 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Ostadali MR (2004) 17301410 179521 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 9750 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 9751 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 6653 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 5689 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5690 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5660 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5661 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Fernandez J (2005) 15771415 175310 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 9894 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 17423 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Manzaneque JM (1999) 10222441 181604 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17424 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Lublin H (1991) 1822319 181605 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 6138 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens binder target de Boer T (1995) 8930006 175620 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6139 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6140 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 15078 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14599 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7326 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens unknown target Seeman P (1993) 8104554 176336 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 16480 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 4961 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4829 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4830 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2006) 16982285 174668 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4831 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Ichikawa K (2001) 11436517 174659 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4844 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Millan MJ (2002) 12388666 174654 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 24326 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 13066 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Bora G (1968) 4887393 179838 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13067 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Platz AR (1967) 4861216 179839 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 13068 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens antagonist target Vinar O (1967) 4889058 179840 1027 Carphenazine Carphenazin|Carfenazine - DRUGBANK DB01038 C23H29N3O2S small molecule - 2622-30-2 DRUGBANK 14800 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 9610 108150 1816 - DRD5 DBDR|DRD1B|DRD1L2 9606 Homo sapiens agonist target Bigal ME (2003) 12525272 177883 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 20672 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3018 2',3'-Dideoxythymidine-5'-Monophosphate - - DRUGBANK DB03150 C10H15N2O7P small molecule - - DRUGBANK 20673 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3018 2',3'-Dideoxythymidine-5'-Monophosphate - - DRUGBANK DB03150 C10H15N2O7P small molecule - - DRUGBANK 23267 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23268 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 21680 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3512 3'-Azido-3'-Deoxythymidine-5'-Monophosphate - - DRUGBANK DB03666 C10H14N5O7P small molecule - - DRUGBANK 21681 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3512 3'-Azido-3'-Deoxythymidine-5'-Monophosphate - - DRUGBANK DB03666 C10H14N5O7P small molecule - - DRUGBANK 21682 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3512 3'-Azido-3'-Deoxythymidine-5'-Monophosphate - - DRUGBANK DB03666 C10H14N5O7P small molecule - - DRUGBANK 17478 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 17479 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 17480 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 20803 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3101 Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester - - DRUGBANK DB03233 C10H16N3O7P small molecule - - DRUGBANK 20804 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3101 Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester - - DRUGBANK DB03233 C10H16N3O7P small molecule - - DRUGBANK 20743 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3063 Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester - - DRUGBANK DB03195 C10H14FN2O7P small molecule - - DRUGBANK 20744 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3063 Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester - - DRUGBANK DB03195 C10H14FN2O7P small molecule - - DRUGBANK 20745 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3063 Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester - - DRUGBANK DB03195 C10H14FN2O7P small molecule - - DRUGBANK 20900 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3146 P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate - - DRUGBANK DB03280 C20H30N7O23P5 small molecule - - DRUGBANK 20901 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3146 P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate - - DRUGBANK DB03280 C20H30N7O23P5 small molecule - - DRUGBANK 20902 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3146 P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate - - DRUGBANK DB03280 C20H30N7O23P5 small molecule - - DRUGBANK 22054 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3682 P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate - - DRUGBANK DB03845 C20H24N10O22P5 small molecule - - DRUGBANK 22055 108174 1841 - DTYMK CDC8|PP3731|TMPK|TYMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3682 P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate - - DRUGBANK DB03845 C20H24N10O22P5 small molecule - - DRUGBANK 23815 108187 1854 - DUT dUTPase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4489 1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE - - DRUGBANK DB04685 C28H25FN2O4 small molecule - - DRUGBANK 21156 108187 1854 - DUT dUTPase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3270 Deoxyuridine-5'-Diphosphate - - DRUGBANK DB03413 C9H14N2O11P2 small molecule - - DRUGBANK 21157 108187 1854 - DUT dUTPase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3270 Deoxyuridine-5'-Diphosphate - - DRUGBANK DB03413 C9H14N2O11P2 small molecule - - DRUGBANK 25615 108192 1859 - DYRK1A DYRK|DYRK1|HP86|MNB|MNBH|MRD7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6414 N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide - - DRUGBANK DB07608 C24H22ClN5O2 small molecule - - DRUGBANK 25179 108218 1889 RP3-329E20.1 ECE1 ECE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5988 5-(2-hydroxyethyl)nonane-1,9-diol - - DRUGBANK DB07171 C11H24O3 small molecule - - DRUGBANK 22594 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3949 4-(N,N-Dimethylamino)Cinnamoyl-Coa - - DRUGBANK DB04117 C32H47N8O17P3S small molecule - - DRUGBANK 22595 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3949 4-(N,N-Dimethylamino)Cinnamoyl-Coa - - DRUGBANK DB04117 C32H47N8O17P3S small molecule - - DRUGBANK 22596 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3949 4-(N,N-Dimethylamino)Cinnamoyl-Coa - - DRUGBANK DB04117 C32H47N8O17P3S small molecule - - DRUGBANK 20118 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 20119 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 20120 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2790 Octanoyl-Coenzyme A - - DRUGBANK DB02910 C29H50N7O17P3S small molecule - - DRUGBANK 19468 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2460 Hexanoyl-Coenzyme A - - DRUGBANK DB02563 C27H46N7O17P3S small molecule - 5060-32-2 DRUGBANK 19469 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2460 Hexanoyl-Coenzyme A - - DRUGBANK DB02563 C27H46N7O17P3S small molecule - 5060-32-2 DRUGBANK 19470 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2460 Hexanoyl-Coenzyme A - - DRUGBANK DB02563 C27H46N7O17P3S small molecule - 5060-32-2 DRUGBANK 20402 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 20403 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 20404 108221 1892 - ECHS1 SCEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 27910 108225 1901 - S1PR1 CD363|CHEDG1|D1S3362|ECGF1|EDG-1|EDG1|S1P1 9606 Homo sapiens agonist target Bolli MH (2010) 20446681 195997 7850 Asfotase Alfa Asfotase alpha strensiq DRUGBANK DB09105 C7108H11008N1968O2206S56 biologic A16AB13 1174277-80-5 DRUGBANK 27911 108225 1901 - S1PR1 CD363|CHEDG1|D1S3362|ECGF1|EDG-1|EDG1|S1P1 9606 Homo sapiens agonist target Piali L (2011) 21345969 196003 7850 Asfotase Alfa Asfotase alpha strensiq DRUGBANK DB09105 C7108H11008N1968O2206S56 biologic A16AB13 1174277-80-5 DRUGBANK 24074 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens unknown target Xia QG (2006) 17049116 181972 4683 Darusentan - - DRUGBANK DB04883 C22H22N2O6 small molecule - 171714-84-4 DRUGBANK 24075 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens unknown target Orth SR (2007) 17890870 182050 4683 Darusentan - - DRUGBANK DB04883 C22H22N2O6 small molecule - 171714-84-4 DRUGBANK 24518 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Kramp R (2001) 11704565 176862 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24519 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Kiowski W (2001) 11447307 176863 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24520 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24521 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Sihvola RK (2002) 11849873 176861 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24522 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Martin C (2000) 10961375 176864 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24523 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Albertini M (2001) 11728166 176865 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24524 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Girgis RE (2007) 17472992 182007 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 27842 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Casserly B (2009) 19920913 195995 8074 Ambrisentan (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid letairis|volibris DRUGBANK DB06403 C22H22N2O4 small molecule C02KX02 177036-94-1 DRUGBANK 27843 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Spence R (2010) 20811346 195998 8074 Ambrisentan (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid letairis|volibris DRUGBANK DB06403 C22H22N2O4 small molecule C02KX02 177036-94-1 DRUGBANK 27844 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Kingman M (2009) 19601701 195993 8074 Ambrisentan (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid letairis|volibris DRUGBANK DB06403 C22H22N2O4 small molecule C02KX02 177036-94-1 DRUGBANK 27845 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Richards DB (2009) 19389876 195988 8074 Ambrisentan (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid letairis|volibris DRUGBANK DB06403 C22H22N2O4 small molecule C02KX02 177036-94-1 DRUGBANK 23809 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens unknown target Blandin V (2000) 11093786 181765 4478 2-HYDROXY-3,5-DIIODOBENZOIC ACID - - DRUGBANK DB04674 C7H4I2O3 small molecule - - DRUGBANK 8027 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Kramp R (2001) 11704565 176862 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8028 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Kiowski W (2001) 11447307 176863 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8029 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8030 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Sihvola RK (2002) 11849873 176861 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8031 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Martin C (2000) 10961375 176864 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8032 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Albertini M (2001) 11728166 176865 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 12175 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens unknown target Talbodec A (2000) 10727528 179250 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 27002 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Bolli MH (2012) 22862294 182209 7671 Macitentan Macitentanum opsumit DRUGBANK DB08932 C19H20Br2N6O4S small molecule C02KX04 441798-33-0 DRUGBANK 27003 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Bruderer S (2012) 22458347 182200 7671 Macitentan Macitentanum opsumit DRUGBANK DB08932 C19H20Br2N6O4S small molecule C02KX04 441798-33-0 DRUGBANK 27004 108231 1909 - EDNRA ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR 9606 Homo sapiens antagonist target Dingemanse J (2014) 24261583 182254 7671 Macitentan Macitentanum opsumit DRUGBANK DB08932 C19H20Br2N6O4S small molecule C02KX04 441798-33-0 DRUGBANK 24525 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Richard V (1994) 7858879 176868 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24526 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Marano G (1998) 9806221 176869 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24527 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Gardiner SM (1994) 7921608 176870 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24528 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24529 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Said SA (2005) 15629255 176866 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24530 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Gupta SK (2005) 16335785 176867 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 24531 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Girgis RE (2007) 17472992 182007 5540 Sitaxentan Sitaxsentan thelin DRUGBANK DB06268 C18H15ClN2O6S2 small molecule C02KX03 184036-34-8 DRUGBANK 8033 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Richard V (1994) 7858879 176868 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8034 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Marano G (1998) 9806221 176869 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8035 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Gardiner SM (1994) 7921608 176870 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8036 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8037 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Said SA (2005) 15629255 176866 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 8038 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Gupta SK (2005) 16335785 176867 549 Bosentan 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum ipg-bosentan|tracleer|mylan-bo DRUGBANK DB00559 C27H29N5O6S small molecule C02KX01 147536-97-8 DRUGBANK 27846 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Casserly B (2009) 19920913 195995 8074 Ambrisentan (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid letairis|volibris DRUGBANK DB06403 C22H22N2O4 small molecule C02KX02 177036-94-1 DRUGBANK 27847 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Kingman M (2009) 19601701 195993 8074 Ambrisentan (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid letairis|volibris DRUGBANK DB06403 C22H22N2O4 small molecule C02KX02 177036-94-1 DRUGBANK 27005 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Bolli MH (2012) 22862294 182209 7671 Macitentan Macitentanum opsumit DRUGBANK DB08932 C19H20Br2N6O4S small molecule C02KX04 441798-33-0 DRUGBANK 27006 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Bruderer S (2012) 22458347 182200 7671 Macitentan Macitentanum opsumit DRUGBANK DB08932 C19H20Br2N6O4S small molecule C02KX04 441798-33-0 DRUGBANK 27007 108232 1910 RP11-318G21.1 EDNRB ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A 9606 Homo sapiens antagonist target Dingemanse J (2014) 24261583 182254 7671 Macitentan Macitentanum opsumit DRUGBANK DB08932 C19H20Br2N6O4S small molecule C02KX04 441798-33-0 DRUGBANK 23053 108237 1915 RP11-505P4.2 EEF1A1 CCS-3|CCS3|EE1A1|EEF-1|EEF1A|EF-Tu|EF1A|GRAF-1EF|HNGC:16303|LENG7|PTI1|eEF1A-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 26395 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7133 N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE - - DRUGBANK DB08348 C17H17N3O2 small molecule - - DRUGBANK 20780 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3091 Diphthamide 2-(3-Carboxyamido-3-(Trimethylammonio)Propyl)Histidine - DRUGBANK DB03223 C13H23N5O3 small molecule - 75645-22-6 DRUGBANK 20781 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3091 Diphthamide 2-(3-Carboxyamido-3-(Trimethylammonio)Propyl)Histidine - DRUGBANK DB03223 C13H23N5O3 small molecule - 75645-22-6 DRUGBANK 20782 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3091 Diphthamide 2-(3-Carboxyamido-3-(Trimethylammonio)Propyl)Histidine - DRUGBANK DB03223 C13H23N5O3 small molecule - 75645-22-6 DRUGBANK 23061 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23062 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23063 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 18431 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18432 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18433 108258 1938 - EEF2 EEF-2|EF-2|EF2|SCA26 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 23461 108270 1950 - EGF HOMG4|URG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4268 Alpha-Aminobutyric Acid - - DRUGBANK DB04454 C4H9NO2 small molecule - - DRUGBANK 23462 108270 1950 - EGF HOMG4|URG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4268 Alpha-Aminobutyric Acid - - DRUGBANK DB04454 C4H9NO2 small molecule - - DRUGBANK 23463 108270 1950 - EGF HOMG4|URG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4268 Alpha-Aminobutyric Acid - - DRUGBANK DB04454 C4H9NO2 small molecule - - DRUGBANK 6021 108270 1950 - EGF HOMG4|URG 9606 Homo sapiens inducer target Konturek SJ (1990) 1970337 175531 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 6022 108270 1950 - EGF HOMG4|URG 9606 Homo sapiens inducer target Tarnawski A (1995) 8578218 175530 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 6023 108270 1950 - EGF HOMG4|URG 9606 Homo sapiens inducer target Szabo S (1991) 1957124 175528 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 25666 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6468 N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE - - DRUGBANK DB07662 C17H13BrN4O small molecule - - DRUGBANK 893 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 27933 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Kuenen B (2010) 20197484 195996 8209 Necitumumab - portrazza DRUGBANK DB09559 - biologic L01XC22 906805-06-9 DRUGBANK 25610 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6408 S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE - - DRUGBANK DB07602 C20H21N5O3S small molecule - - DRUGBANK 5481 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Nicholson RI (2001) 11566608 175152 310 Gefitinib N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa iressa DRUGBANK DB00317 C22H24ClFN4O3 small molecule L01XE02 184475-35-2 DRUGBANK 5482 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Albanell J (2001) 11522647 175151 310 Gefitinib N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa iressa DRUGBANK DB00317 C22H24ClFN4O3 small molecule L01XE02 184475-35-2 DRUGBANK 5483 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Arteaga CL (2001) 11673690 175150 310 Gefitinib N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa iressa DRUGBANK DB00317 C22H24ClFN4O3 small molecule L01XE02 184475-35-2 DRUGBANK 5484 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 310 Gefitinib N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa iressa DRUGBANK DB00317 C22H24ClFN4O3 small molecule L01XE02 184475-35-2 DRUGBANK 5485 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Ciardiello F (2000) 10815932 175148 310 Gefitinib N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa iressa DRUGBANK DB00317 C22H24ClFN4O3 small molecule L01XE02 184475-35-2 DRUGBANK 5486 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Moasser MM (2001) 11585753 175149 310 Gefitinib N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa iressa DRUGBANK DB00317 C22H24ClFN4O3 small molecule L01XE02 184475-35-2 DRUGBANK 15594 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Heymach JV (2006) 16857825 180948 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15595 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Cohen RB (2003) 12620146 180949 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15596 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Chen X (2002) 11752352 171740 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15597 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Foon KA (2004) 14967460 180947 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15598 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Keating GM (2010) 20481659 180957 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15599 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Yang XD (2001) 11255078 180956 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15600 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Segaert S (2005) 16012181 180955 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15601 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Lynch DH (2002) 11894013 180954 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15602 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Saadeh CE (2007) 17355997 180953 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15603 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Wu M (2008) 18343240 180952 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15604 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Jean GW (2008) 18503402 180951 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15605 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens suppressor target Keating GM (2010) 20623992 180950 1256 Panitumumab ABX-EGF vectibix DRUGBANK DB01269 - biologic L01XC08 339177-26-3 DRUGBANK 15 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Viloria-Petit A (2001) 11431346 171748 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 16 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 17 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Hosokawa N (1999) 10480573 171746 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 18 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Wakita H (1999) 10601294 171747 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 19 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Suwa T (2000) 10628369 171745 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 20 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Burke P (2001) 11408594 141935 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 7762 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Bulgaru AM (2003) 12820772 176686 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 7763 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Kim TE (2002) 12498017 176687 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 7764 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Akita RW (2003) 12840797 176684 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 7765 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Laird AD (2003) 12517254 176685 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 7766 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Delbaldo C (2003) 12814826 176683 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 7767 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 27930 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens inhibitor target Yosaatmadja Y (2015) 26522274 196035 8129 Osimertinib N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide|Mereletinib tagrisso DRUGBANK DB09330 C28H33N7O2 small molecule - 1421373-65-0 DRUGBANK 15446 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Zhou H (2004) 14751502 180891 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15455 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15447 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Burris HA (2004) 15163842 180890 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15448 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Xia W (2004) 14737100 180889 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15449 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Vazquez-Martin A (2011) 20658522 180888 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15450 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Grana TM (2003) 14633707 180885 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15451 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Wood ER (2004) 15374980 180884 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15452 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Johnston SR (2006) 16894399 180887 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15453 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Xia W (2002) 12214266 180886 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15454 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Langer CJ (2004) 14967461 180881 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15456 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Tevaarwerk AJ (2010) 20110044 180883 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15457 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Medina PJ (2008) 18803986 180882 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 5089 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens antagonist target Sakaguchi M (2006) 16551906 174881 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 21394 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 24279 108276 1956 - EGFR ERBB|ERBB1|HER1|NISBD2|PIG61|mENA 9606 Homo sapiens unknown target Farhan H (2006) 16963623 181966 4779 IGN311 - - DRUGBANK DB04988 - biologic - - DRUGBANK 3129 108282 1962 - EHHADH ECHD|FRTS3|L-PBE|LBFP|LBP|PBFE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3130 108282 1962 - EHHADH ECHD|FRTS3|L-PBE|LBFP|LBP|PBFE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 23039 108287 1968 - EIF2S3 EIF2|EIF2G|EIF2gamma|eIF-2gA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23040 108287 1968 - EIF2S3 EIF2|EIF2G|EIF2gamma|eIF-2gA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23041 108287 1968 - EIF2S3 EIF2|EIF2G|EIF2gamma|eIF-2gA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 15427 108288 1969 - EPHA2 ARCC2|CTPA|CTPP1|CTRCT6|ECK 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15428 108288 1969 - EPHA2 ARCC2|CTPA|CTPP1|CTRCT6|ECK 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15429 108288 1969 - EPHA2 ARCC2|CTPA|CTPP1|CTRCT6|ECK 9606 Homo sapiens antagonist target Lindauer M (2010) 20072833 180857 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 23306 108288 1969 - EPHA2 ARCC2|CTPA|CTPP1|CTRCT6|ECK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23307 108288 1969 - EPHA2 ARCC2|CTPA|CTPP1|CTRCT6|ECK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 19758 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2604 7-Methyl-Guanosine-5'-Triphosphate - - DRUGBANK DB02716 C11H19N5O14P3 small molecule - - DRUGBANK 19759 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2604 7-Methyl-Guanosine-5'-Triphosphate - - DRUGBANK DB02716 C11H19N5O14P3 small molecule - - DRUGBANK 19760 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2604 7-Methyl-Guanosine-5'-Triphosphate - - DRUGBANK DB02716 C11H19N5O14P3 small molecule - - DRUGBANK 26233 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7008 2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL - - DRUGBANK DB08217 C9H17NOS small molecule - - DRUGBANK 18175 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 18176 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 18177 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 17502 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1586 7-Methyl-Gpppa P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE - DRUGBANK DB01649 C21H30N10O17P3 small molecule - - DRUGBANK 17503 108292 1977 - EIF4E AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1586 7-Methyl-Gpppa P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE - DRUGBANK DB01649 C21H30N10O17P3 small molecule - - DRUGBANK 17924 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1774 Dimethylformamide - - DRUGBANK DB01844 C3H7NO small molecule - 68-12-2 DRUGBANK 17925 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1774 Dimethylformamide - - DRUGBANK DB01844 C3H7NO small molecule - 68-12-2 DRUGBANK 17926 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1774 Dimethylformamide - - DRUGBANK DB01844 C3H7NO small molecule - 68-12-2 DRUGBANK 21755 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3546 2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid - - DRUGBANK DB03702 C26H33F3N4O7 small molecule - - DRUGBANK 21756 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3546 2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid - - DRUGBANK DB03702 C26H33F3N4O7 small molecule - - DRUGBANK 21757 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3546 2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid - - DRUGBANK DB03702 C26H33F3N4O7 small molecule - - DRUGBANK 26645 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7391 3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE - - DRUGBANK DB08614 C20H23F3N4O5S small molecule - - DRUGBANK 22200 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3761 ONO-6818 CP-955 - DRUGBANK DB03925 C23H30N6O4 small molecule - 208848-19-5 DRUGBANK 22201 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3761 ONO-6818 CP-955 - DRUGBANK DB03925 C23H30N6O4 small molecule - 208848-19-5 DRUGBANK 22202 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3761 ONO-6818 CP-955 - DRUGBANK DB03925 C23H30N6O4 small molecule - 208848-19-5 DRUGBANK 25989 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6752 METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE - - DRUGBANK DB07957 C12H13NO6 small molecule - - DRUGBANK 21873 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3599 (Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine - - DRUGBANK DB03757 C11H21N3O4 small molecule - - DRUGBANK 21874 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3599 (Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine - - DRUGBANK DB03757 C11H21N3O4 small molecule - - DRUGBANK 21875 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3599 (Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine - - DRUGBANK DB03757 C11H21N3O4 small molecule - - DRUGBANK 25988 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6751 [1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER - - DRUGBANK DB07956 C17H23ClN2O4 small molecule - - DRUGBANK 26033 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6800 (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID - - DRUGBANK DB08007 C11H14N2O4 small molecule - - DRUGBANK 20751 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3070 2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide - - DRUGBANK DB03202 C19H22F3N5O5S small molecule - - DRUGBANK 18562 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2034 Para-Isopropylaniline - - DRUGBANK DB02114 C9H13N small molecule - - DRUGBANK 18563 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2034 Para-Isopropylaniline - - DRUGBANK DB02114 C9H13N small molecule - - DRUGBANK 18564 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2034 Para-Isopropylaniline - - DRUGBANK DB02114 C9H13N small molecule - - DRUGBANK 26662 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7414 (2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID - - DRUGBANK DB08640 C14H19NO5S small molecule - - DRUGBANK 26663 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7415 (2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID - - DRUGBANK DB08641 C13H16N2O7S small molecule - - DRUGBANK 24973 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5770 (3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid - - DRUGBANK DB06951 C13H17NO6S small molecule - - DRUGBANK 18982 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2246 Mdl 101,146 - - DRUGBANK DB02341 C29H37F5N4O6 small molecule - 149859-17-6 DRUGBANK 18983 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2246 Mdl 101,146 - - DRUGBANK DB02341 C29H37F5N4O6 small molecule - 149859-17-6 DRUGBANK 18984 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2246 Mdl 101,146 - - DRUGBANK DB02341 C29H37F5N4O6 small molecule - 149859-17-6 DRUGBANK 22123 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3727 N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide - - DRUGBANK DB03890 C19H33N3O4S small molecule - - DRUGBANK 25987 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6750 (2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE - - DRUGBANK DB07955 C11H12BrNO3 small molecule - - DRUGBANK 25454 108305 1990 - CELA1 ELA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6246 (TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE - - DRUGBANK DB07433 C11H21N3O4 small molecule - - DRUGBANK 207 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Druhan LJ (2005) 15353486 171834 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 208 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Pelus LM (2004) 12958067 171835 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 209 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Jian MY (2004) 16245075 171836 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 210 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Schepers H (2007) 17475913 171837 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 211 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Carter CR (2004) 14657210 171833 19 Pegfilgrastim Lenograstim|N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)|Granulocyte colony-stimulating factor precursor|Pluripoietin|G-CSF neulasta DRUGBANK DB00019 C845H1343N223O243S9 biologic L03AA10|L03AA13 208265-92-3 DRUGBANK 22198 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens inhibitor target Yoshimura Y (2003) 14530017 181836 3761 ONO-6818 CP-955 - DRUGBANK DB03925 C23H30N6O4 small molecule - 208848-19-5 DRUGBANK 22199 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3761 ONO-6818 CP-955 - DRUGBANK DB03925 C23H30N6O4 small molecule - 208848-19-5 DRUGBANK 739 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens inhibitor target Topic A (2011) 20521180 172104 57 Alpha-1-proteinase inhibitor Alpha-1-antiproteinase|alpha1-proteinase inhibitor human|Alpha-1 protease inhibitor|Alpha1-proteinase inhibitor (human)|Alpha1-proteinase Inhibitor|API|Alpha-1-proteinase inhibitor human|Alpha-1-antitrypsin|Alpha 1-antitrypsin|Alpha-1-proteinase Inhibitor, Human|Alpha 1-Proteinase Inhibitor|Alpha-1-proteinase Inhibitor (human) glassia|aralast np|zemaira|pro DRUGBANK DB00058 C2001H3130N514O601S10 biologic - 9041-92-3 DRUGBANK 740 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 57 Alpha-1-proteinase inhibitor Alpha-1-antiproteinase|alpha1-proteinase inhibitor human|Alpha-1 protease inhibitor|Alpha1-proteinase inhibitor (human)|Alpha1-proteinase Inhibitor|API|Alpha-1-proteinase inhibitor human|Alpha-1-antitrypsin|Alpha 1-antitrypsin|Alpha-1-proteinase Inhibitor, Human|Alpha 1-Proteinase Inhibitor|Alpha-1-proteinase Inhibitor (human) glassia|aralast np|zemaira|pro DRUGBANK DB00058 C2001H3130N514O601S10 biologic - 9041-92-3 DRUGBANK 741 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens inhibitor target Karnaukhova E (2006) 16773239 172103 57 Alpha-1-proteinase inhibitor Alpha-1-antiproteinase|alpha1-proteinase inhibitor human|Alpha-1 protease inhibitor|Alpha1-proteinase inhibitor (human)|Alpha1-proteinase Inhibitor|API|Alpha-1-proteinase inhibitor human|Alpha-1-antitrypsin|Alpha 1-antitrypsin|Alpha-1-proteinase Inhibitor, Human|Alpha 1-Proteinase Inhibitor|Alpha-1-proteinase Inhibitor (human) glassia|aralast np|zemaira|pro DRUGBANK DB00058 C2001H3130N514O601S10 biologic - 9041-92-3 DRUGBANK 1207 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Druhan LJ (2005) 15353486 171834 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1208 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Jian MY (2004) 16245075 171836 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1209 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Schepers H (2007) 17475913 171837 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1210 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Carter CR (2004) 14657210 171833 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1211 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target El Ouriaghli F (2003) 12393522 172373 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 1212 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Donini M (2007) 17311988 172374 95 Filgrastim Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF grastofil|granix|neupogen DRUGBANK DB00099 C845H1343N223O243S9 biologic L03AA02 121181-53-1 DRUGBANK 18980 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2246 Mdl 101,146 - - DRUGBANK DB02341 C29H37F5N4O6 small molecule - 149859-17-6 DRUGBANK 18981 108306 1991 - ELANE ELA2|GE|HLE|HNE|NE|PMN-E|SCN1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2246 Mdl 101,146 - - DRUGBANK DB02341 C29H37F5N4O6 small molecule - 149859-17-6 DRUGBANK 7771 108321 2006 - ELN SVAS|WBS|WS 9606 Homo sapiens unknown target Oitate M (2007) 17164475 176699 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7772 108321 2006 - ELN SVAS|WBS|WS 9606 Homo sapiens unknown target Oitate M (2007) 17620346 176701 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7773 108321 2006 - ELN SVAS|WBS|WS 9606 Homo sapiens unknown target Oitate M (2006) 16679386 176700 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 20938 108335 2020 tcag7.568 EN2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3174 N-Cyclohexyltaurine CHES - DRUGBANK DB03309 C8H17NO3S small molecule - - DRUGBANK 20939 108335 2020 tcag7.568 EN2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3174 N-Cyclohexyltaurine CHES - DRUGBANK DB03309 C8H17NO3S small molecule - - DRUGBANK 20940 108335 2020 tcag7.568 EN2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3174 N-Cyclohexyltaurine CHES - DRUGBANK DB03309 C8H17NO3S small molecule - - DRUGBANK 19791 108340 2026 - ENO2 HEL-S-279|NSE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19792 108340 2026 - ENO2 HEL-S-279|NSE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19793 108340 2026 - ENO2 HEL-S-279|NSE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 21342 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3320 2-Phospho-D-Glyceric Acid - - DRUGBANK DB03465 C3H7O7P small molecule - - DRUGBANK 21343 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3320 2-Phospho-D-Glyceric Acid - - DRUGBANK DB03465 C3H7O7P small molecule - - DRUGBANK 21344 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3320 2-Phospho-D-Glyceric Acid - - DRUGBANK DB03465 C3H7O7P small molecule - - DRUGBANK 19784 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19785 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19786 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 21648 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3492 Phosphonoacetohydroxamic Acid - - DRUGBANK DB03645 C2H6NO5P small molecule - - DRUGBANK 21649 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3492 Phosphonoacetohydroxamic Acid - - DRUGBANK DB03645 C2H6NO5P small molecule - - DRUGBANK 21650 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3492 Phosphonoacetohydroxamic Acid - - DRUGBANK DB03645 C2H6NO5P small molecule - - DRUGBANK 17863 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 17864 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 17865 108341 2027 - ENO3 GSD13|MSE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 2402 108342 2028 - ENPEP APA|CD249|gp160 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2403 108342 2028 - ENPEP APA|CD249|gp160 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2404 108342 2028 - ENPEP APA|CD249|gp160 9606 Homo sapiens unknown target Acartuerk F (2001) 11732752 173238 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2405 108342 2028 - ENPEP APA|CD249|gp160 9606 Homo sapiens unknown target Sasaki M (1995) 8568030 173239 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2406 108342 2028 - ENPEP APA|CD249|gp160 9606 Homo sapiens unknown target Tobe H (1980) 7448199 173240 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 27144 108344 2030 - SLC29A1 ENT1 9606 Homo sapiens unknown target Allen-Gipson DS (2009) 19298329 188486 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 4142 108344 2030 - SLC29A1 ENT1 9606 Homo sapiens inhibitor target Leung GP (2005) 15963471 174280 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 25999 108359 2045 - EPHA7 EHK-3|EHK3|EK11|HEK11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6765 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide - - DRUGBANK DB07970 C21H17F3N4O2 small molecule - - DRUGBANK 23305 108362 2048 - EPHB2 CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 25261 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6065 N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine - - DRUGBANK DB07249 C24H27ClN4O4 small molecule - - DRUGBANK 25262 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6066 N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB07250 C20H19ClN4O5 small molecule - - DRUGBANK 25263 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6067 N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE - - DRUGBANK DB07251 C19H20ClN5O4 small molecule - - DRUGBANK 25268 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6072 3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE - - DRUGBANK DB07256 C18H14ClN5O3 small molecule - - DRUGBANK 25267 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6071 N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB07255 C21H20ClN5O3 small molecule - - DRUGBANK 25266 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6070 N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE - - DRUGBANK DB07254 C18H16ClN5O4S small molecule - - DRUGBANK 25264 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6068 3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide - - DRUGBANK DB07252 C17H14ClN5O4S small molecule - - DRUGBANK 25265 108364 2050 - EPHB4 HTK|MYK1|TYRO11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6069 N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine - - DRUGBANK DB07253 C18H15ClN4O4S small molecule - - DRUGBANK 22813 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4041 N-Cyclohexyl-N'-(Propyl)Phenyl Urea - - DRUGBANK DB04213 C16H24N2O small molecule - - DRUGBANK 26307 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7045 N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE - - DRUGBANK DB08256 C9H16N2O3 small molecule - - DRUGBANK 26309 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7047 6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID - - DRUGBANK DB08258 C13H24N2O3 small molecule - - DRUGBANK 26308 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7046 4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID - - DRUGBANK DB08257 C11H20N2O3 small molecule - - DRUGBANK 21700 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3523 N-Cyclohexyl-N'-Decylurea - - DRUGBANK DB03677 C17H34N2O small molecule - - DRUGBANK 18372 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1952 N-Cyclohexyl-N'-(4-Iodophenyl)Urea - - DRUGBANK DB02029 C13H17IN2O small molecule - - DRUGBANK 18373 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1952 N-Cyclohexyl-N'-(4-Iodophenyl)Urea - - DRUGBANK DB02029 C13H17IN2O small molecule - - DRUGBANK 18374 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1952 N-Cyclohexyl-N'-(4-Iodophenyl)Urea - - DRUGBANK DB02029 C13H17IN2O small molecule - - DRUGBANK 26310 108367 2053 - EPHX2 CEH|SEH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7048 7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID - - DRUGBANK DB08259 C14H26N2O3 small molecule - - DRUGBANK 189 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 16 Erythropoietin Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human) eprex sterile solution 5000iu/ DRUGBANK DB00016 C815H1317N233O241S5 biologic B03XA01 11096-26-7 DRUGBANK 190 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target LaMontagne KR (2006) 16505108 171793 16 Erythropoietin Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human) eprex sterile solution 5000iu/ DRUGBANK DB00016 C815H1317N233O241S5 biologic B03XA01 11096-26-7 DRUGBANK 191 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target Kokhaei P (2007) 17575216 171792 16 Erythropoietin Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human) eprex sterile solution 5000iu/ DRUGBANK DB00016 C815H1317N233O241S5 biologic B03XA01 11096-26-7 DRUGBANK 26999 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target Wizemann V (2008) 18208642 182063 7663 Epoetin Zeta 1-165-Erythropoietin (human clone B03XA01) glycoform zeta|Epoetinum zeta|Epoetina dseta|Epoetin zeta|Epotine zta - DRUGBANK DB08923 C809H1301N229O240S5 biologic - 604802-70-2 DRUGBANK 27000 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target Barosi G (2011) 21719882 182192 7663 Epoetin Zeta 1-165-Erythropoietin (human clone B03XA01) glycoform zeta|Epoetinum zeta|Epoetina dseta|Epoetin zeta|Epotine zta - DRUGBANK DB08923 C809H1301N229O240S5 biologic - 604802-70-2 DRUGBANK 127 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 12 Darbepoetin alfa Darbepoetin|Darbepoetin alfa,recombinant aranesp|aranesp -(hsa-f DRUGBANK DB00012 C815H1317N233O241S5 biologic B03XA02 209810-58-2 DRUGBANK 128 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target LaMontagne KR (2006) 16505108 171793 12 Darbepoetin alfa Darbepoetin|Darbepoetin alfa,recombinant aranesp|aranesp -(hsa-f DRUGBANK DB00012 C815H1317N233O241S5 biologic B03XA02 209810-58-2 DRUGBANK 129 108371 2057 - EPOR EPO-R 9606 Homo sapiens agonist target Kokhaei P (2007) 17575216 171792 12 Darbepoetin alfa Darbepoetin|Darbepoetin alfa,recombinant aranesp|aranesp -(hsa-f DRUGBANK DB00012 C815H1317N233O241S5 biologic B03XA02 209810-58-2 DRUGBANK 26963 108371 2057 - EPOR EPO-R 9606 Homo sapiens stimulator target Woodburn KW (2013) 23318685 182225 7638 Peginesatide Erythropoiesis-Stimulating Agent (ESA)|Hematide - DRUGBANK DB08894 (C2H4O)n(C2H4O)nC229H344N62O58S6 small molecule B03XA04 913976-27-9 DRUGBANK 25642 108371 2057 - EPOR EPO-R 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6443 3,5 DIBROMOTYROSINE - - DRUGBANK DB07637 C9H9Br2NO3 small molecule - - DRUGBANK 3758 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3759 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 19698 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2574 5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine - - DRUGBANK DB02684 C13H19N7O7S2 small molecule - - DRUGBANK 19699 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2574 5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine - - DRUGBANK DB02684 C13H19N7O7S2 small molecule - - DRUGBANK 19700 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2574 5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine - - DRUGBANK DB02684 C13H19N7O7S2 small molecule - - DRUGBANK 21059 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3236 '5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine - - DRUGBANK DB03376 C13H19N7O7S small molecule - - DRUGBANK 21060 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3236 '5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine - - DRUGBANK DB03376 C13H19N7O7S small molecule - - DRUGBANK 21061 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3236 '5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine - - DRUGBANK DB03376 C13H19N7O7S small molecule - - DRUGBANK 2376 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2377 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Ting SM (1994) 8132637 173229 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2378 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2379 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Cerini C (1997) 9063462 173230 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 19368 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2407 '5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine - - DRUGBANK DB02510 C15H21N7O7S small molecule - - DRUGBANK 19369 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2407 '5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine - - DRUGBANK DB02510 C15H21N7O7S small molecule - - DRUGBANK 19370 108372 2058 PIG32 EPRS EARS|GLUPRORS|PARS|QARS|QPRS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2407 '5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine - - DRUGBANK DB02510 C15H21N7O7S small molecule - - DRUGBANK 24352 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Lewis Phillips GD (2008) 19010901 182091 5339 Trastuzumab emtansine T-DM1|Ado-trastuzumab emtansine|Trastuzumab-DM1|Ado-trastuzumab|Trastuzumab emtansine|Trastuzumab-MCC-DM1 kadcyla DRUGBANK DB05773 - biologic L01XC14 1018448-65-1 DRUGBANK 24353 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 5339 Trastuzumab emtansine T-DM1|Ado-trastuzumab emtansine|Trastuzumab-DM1|Ado-trastuzumab|Trastuzumab emtansine|Trastuzumab-MCC-DM1 kadcyla DRUGBANK DB05773 - biologic L01XC14 1018448-65-1 DRUGBANK 24354 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Barginear MF (2012) 23196784 182221 5339 Trastuzumab emtansine T-DM1|Ado-trastuzumab emtansine|Trastuzumab-DM1|Ado-trastuzumab|Trastuzumab emtansine|Trastuzumab-MCC-DM1 kadcyla DRUGBANK DB05773 - biologic L01XC14 1018448-65-1 DRUGBANK 15458 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Zhou H (2004) 14751502 180891 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15467 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15459 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Burris HA (2004) 15163842 180890 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15460 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Xia W (2004) 14737100 180889 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15461 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Vazquez-Martin A (2011) 20658522 180888 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15462 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Grana TM (2003) 14633707 180885 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15463 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Wood ER (2004) 15374980 180884 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15464 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Johnston SR (2006) 16894399 180887 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15465 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Xia W (2002) 12214266 180886 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15466 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Langer CJ (2004) 14967461 180881 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15468 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Tevaarwerk AJ (2010) 20110044 180883 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 15469 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antagonist target Medina PJ (2008) 18803986 180882 1246 Lapatinib GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb tykerb DRUGBANK DB01259 C29H26ClFN4O4S small molecule L01XE07 231277-92-2 DRUGBANK 24562 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Franklin MC (2004) 15093539 181845 5550 Pertuzumab 2C4 Antibody|MOAB 2C4|rhuMAb-2C4|Monoclonal Antibody 2C4|Omnitarg perjeta|perjeta-herceptin DRUGBANK DB06366 - biologic L01XC13 380610-27-5 DRUGBANK 886 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 887 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Lin A (2007) 17660958 172202 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 888 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Treish I (2000) 11098307 172203 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 889 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens antibody target Leveque D (2008) 18690878 172201 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 24280 108376 2064 - ERBB2 CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1 9606 Homo sapiens unknown target Farhan H (2006) 16963623 181966 4779 IGN311 - - DRUGBANK DB04988 - biologic - - DRUGBANK 25399 108391 2081 - ERN1 IRE1|IRE1P|IRE1a|hIRE1p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6198 N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine - - DRUGBANK DB07382 C17H16N8 small molecule - - DRUGBANK 2640 108402 2098 RP11-147L20.1 ESD FGH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2641 108402 2098 RP11-147L20.1 ESD FGH 9606 Homo sapiens unknown target Sabatier L (1989) 2554783 173363 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2642 108402 2098 RP11-147L20.1 ESD FGH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2643 108402 2098 RP11-147L20.1 ESD FGH 9606 Homo sapiens unknown target Neben I (1980) 7397203 173364 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2644 108402 2098 RP11-147L20.1 ESD FGH 9606 Homo sapiens unknown target Yurimoto H (2003) 12904537 173365 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 8509 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Jain JK (2007) 17094978 177204 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8510 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Ghebeh H (2007) 17415709 175788 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8511 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Lessey BA (2006) 17118173 175789 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8512 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Yuri T (2007) 17203775 175786 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8513 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kumar AS (2007) 17103262 175785 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 11433 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Grove RI (1987) 3622377 178918 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 11434 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Juriansz RL (1988) 3334987 178919 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 11435 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Bovee TF (2004) 15276617 178914 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 11436 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Maru BS (2009) 18976723 178915 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 11437 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chae K (1998) 9558716 178916 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 11438 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kuiper GG (1997) 9048584 178917 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 11439 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 880 Dienestrol Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol ortho dienestrol crm DRUGBANK DB00890 C18H18O2 small molecule G03CB01|G03CC02 13029-44-2 DRUGBANK 9383 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Fabian CJ (2002) 11906441 177735 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9384 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9385 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9386 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Cyrus K (2010) 20512796 177734 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9387 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Fabian CJ (2002) 11906441 177735 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9388 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Sasson S (1991) 2011412 177583 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9389 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9390 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Cyrus K (2010) 20512796 177734 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 16101 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Cleuren AC (2010) 20524981 181154 1321 Mestranol - ortho-novum 1/50 tablets (28 d DRUGBANK DB01357 C21H26O2 small molecule - 72-33-3 DRUGBANK 16102 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Dulos J (2010) 20497523 181155 1321 Mestranol - ortho-novum 1/50 tablets (28 d DRUGBANK DB01357 C21H26O2 small molecule - 72-33-3 DRUGBANK 16103 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1321 Mestranol - ortho-novum 1/50 tablets (28 d DRUGBANK DB01357 C21H26O2 small molecule - 72-33-3 DRUGBANK 24950 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5746 [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE - - DRUGBANK DB06927 C16H11NO3 small molecule - - DRUGBANK 27905 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Escande A (2009) 19464167 195991 8113 Tibolone 17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one|tibolona|tibolonum - DRUGBANK DB09070 C21H28O2 small molecule G03CX01 5630-53-5 DRUGBANK 5154 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Stroud FC (2006) 16884174 174936 279 Conjugated Equine Estrogens Estrogens, Conjugated|conjugated estrogens apo-conest tab 0.3mg|premphase DRUGBANK DB00286 C18H21NaO5S small molecule G03CA57|G03CC07 438-67-5 DRUGBANK 5155 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Smith MR (2006) 16985877 174937 279 Conjugated Equine Estrogens Estrogens, Conjugated|conjugated estrogens apo-conest tab 0.3mg|premphase DRUGBANK DB00286 C18H21NaO5S small molecule G03CA57|G03CC07 438-67-5 DRUGBANK 5156 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Hou NN (2006) 16955786 174940 279 Conjugated Equine Estrogens Estrogens, Conjugated|conjugated estrogens apo-conest tab 0.3mg|premphase DRUGBANK DB00286 C18H21NaO5S small molecule G03CA57|G03CC07 438-67-5 DRUGBANK 5157 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Gouva L (2006) 16982590 174938 279 Conjugated Equine Estrogens Estrogens, Conjugated|conjugated estrogens apo-conest tab 0.3mg|premphase DRUGBANK DB00286 C18H21NaO5S small molecule G03CA57|G03CC07 438-67-5 DRUGBANK 5158 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Ropero AB (2006) 16876190 174939 279 Conjugated Equine Estrogens Estrogens, Conjugated|conjugated estrogens apo-conest tab 0.3mg|premphase DRUGBANK DB00286 C18H21NaO5S small molecule G03CA57|G03CC07 438-67-5 DRUGBANK 25962 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6729 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL - - DRUGBANK DB07933 C18H18O3 small molecule - - DRUGBANK 25960 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6728 dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate - - DRUGBANK DB07932 C22H18O7 small molecule - - DRUGBANK 23522 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Reed CA (2005) 15846122 181889 4282 Afimoxifene 4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT - DRUGBANK DB04468 C26H29NO2 small molecule - 68392-35-8 DRUGBANK 13387 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target del Rio B (2004) 15229223 179956 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13388 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Yoo YM (2009) 19796047 179955 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 14530 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Farooqui M (2006) 16546975 180500 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 23526 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4285 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol - - DRUGBANK DB04471 C28H32N2O2 small molecule - - DRUGBANK 23527 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4285 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol - - DRUGBANK DB04471 C28H32N2O2 small molecule - - DRUGBANK 23731 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 4383 Estriol 16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol - DRUGBANK DB04573 C18H24O3 small molecule G03CA04|G03CC06 50-27-1 DRUGBANK 23732 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 4383 Estriol 16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol - DRUGBANK DB04573 C18H24O3 small molecule G03CA04|G03CC06 50-27-1 DRUGBANK 25712 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6511 (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL - - DRUGBANK DB07707 C20H28O3 small molecule - - DRUGBANK 25714 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6512 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL - - DRUGBANK DB07708 C13H9ClN2O2 small molecule - - DRUGBANK 11371 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Homburg R (2005) 15878925 178873 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11372 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Overbeek A (2009) 19761360 178872 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11373 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kurosawa T (2010) 20379036 178871 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11374 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Brown J (2009) 19821295 178870 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11375 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11376 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11377 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Hughes E (2010) 20091498 178868 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11378 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Unknown Authors (2006) 17055820 178869 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11379 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Homburg R (2008) 18320435 178867 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11380 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Homburg R (2005) 15878925 178873 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11381 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Overbeek A (2009) 19761360 178872 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11382 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Kurosawa T (2010) 20379036 178871 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11383 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Brown J (2009) 19821295 178870 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11384 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Sasson S (1991) 2011412 177583 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11385 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11386 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Hughes E (2010) 20091498 178868 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11387 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Unknown Authors (2006) 17055820 178869 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 11388 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Homburg R (2008) 18320435 178867 872 Clomifene Clomifeno|Clomifene|Clomiphene|Clomifenum clomid|serophene tab 50mg|clom DRUGBANK DB00882 C26H28ClNO small molecule G03GB02 911-45-5 DRUGBANK 25718 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6515 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL - - DRUGBANK DB07712 C15H14N2O2 small molecule - - DRUGBANK 23739 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Imming P (2006) 17016423 171742 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23740 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Chen X (2002) 11752352 171740 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23741 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Overington JP (2006) 17139284 171741 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23742 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Shyu C (2011) 21075131 182176 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23743 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23744 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23745 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23746 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Shyu C (2011) 21075131 182176 4385 Quinestrol Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis - DRUGBANK DB04575 C25H32O2 small molecule - 152-43-2 DRUGBANK 23735 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 4384 Estrone sulfate Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate ogen .625|estropipate|ogen 2.5 DRUGBANK DB04574 C18H22O5S small molecule - 481-97-0 DRUGBANK 23736 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Lehnes K (2007) 17138652 178365 4384 Estrone sulfate Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate ogen .625|estropipate|ogen 2.5 DRUGBANK DB04574 C18H22O5S small molecule - 481-97-0 DRUGBANK 23737 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 4384 Estrone sulfate Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate ogen .625|estropipate|ogen 2.5 DRUGBANK DB04574 C18H22O5S small molecule - 481-97-0 DRUGBANK 23738 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Brama M (2007) 17125913 178366 4384 Estrone sulfate Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate ogen .625|estropipate|ogen 2.5 DRUGBANK DB04574 C18H22O5S small molecule - 481-97-0 DRUGBANK 25580 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6375 (2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL - - DRUGBANK DB07567 C28H31NO4 small molecule - - DRUGBANK 21985 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3641 1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol - - DRUGBANK DB03802 C29H33N3O small molecule - - DRUGBANK 21986 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3641 1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol - - DRUGBANK DB03802 C29H33N3O small molecule - - DRUGBANK 25095 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5904 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB07086 C16H20O3 small molecule - - DRUGBANK 27840 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Gruber C (2004) 15535430 195962 7770 Bazedoxifene bazedoxifene/conjugated estrogens duavee|duavive DRUGBANK DB06401 C30H34N2O3 small molecule G03XC02|G03CC07 198481-32-2 DRUGBANK 27841 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Gruber C (2004) 15535430 195962 7770 Bazedoxifene bazedoxifene/conjugated estrogens duavee|duavive DRUGBANK DB06401 C30H34N2O3 small molecule G03XC02|G03CC07 198481-32-2 DRUGBANK 16656 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Csaba G (1996) 8820988 181410 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16657 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Yuri T (2007) 17203775 175786 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16658 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Montero Girard G (2007) 17341305 175787 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16659 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kumar AS (2007) 17103262 175785 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16660 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Ghebeh H (2007) 17415709 175788 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16661 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Lessey BA (2006) 17118173 175789 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 10836 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 813 Ethynodiol diacetate Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol kelnor 1/35|demulen 30 (28 day DRUGBANK DB00823 C24H32O4 small molecule G03AA01|G03DC06|G03FA06 297-76-7 DRUGBANK 10837 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kappus H (1973) 4123746 178556 813 Ethynodiol diacetate Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol kelnor 1/35|demulen 30 (28 day DRUGBANK DB00823 C24H32O4 small molecule G03AA01|G03DC06|G03FA06 297-76-7 DRUGBANK 10838 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 813 Ethynodiol diacetate Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol kelnor 1/35|demulen 30 (28 day DRUGBANK DB00823 C24H32O4 small molecule G03AA01|G03DC06|G03FA06 297-76-7 DRUGBANK 12189 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Curran M (2001) 11398912 179274 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12190 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Elkak AE (2002) 11922402 179275 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12191 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Morris C (2002) 12542403 179272 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12192 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Dow KH (2002) 12080538 179273 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12193 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Bundred N (2002) 12113237 179270 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12194 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Kabos P (2010) 20151846 179271 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12195 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12196 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target McKeage K (2004) 15018596 179269 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 12197 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Jones SE (2005) 15865850 179268 937 Fulvestrant ICI 182,780 faslodex DRUGBANK DB00947 C32H47F5O3S small molecule L02BA03 129453-61-8 DRUGBANK 26044 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6813 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL - - DRUGBANK DB08020 C20H22O4 small molecule - - DRUGBANK 5216 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 287 Etonogestrel Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel nexplanon|implanon|nuvaring DRUGBANK DB00294 C22H28O2 small molecule G03AC08 54048-10-1 DRUGBANK 5217 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 287 Etonogestrel Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel nexplanon|implanon|nuvaring DRUGBANK DB00294 C22H28O2 small molecule G03AC08 54048-10-1 DRUGBANK 13825 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens allosteric modulator target Barker S (2006) 16806905 180192 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13826 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens allosteric modulator target Puddefoot JR (2002) 12209583 180191 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13827 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens allosteric modulator target Puddefoot JR (2006) 17109615 180190 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 7376 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Moen MD (2008) 18778124 176379 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7377 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7378 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Matsumoto T (2006) 16951478 176385 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7379 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Khovidhunkit W (1999) 10068418 176383 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7380 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Figtree GA (1999) 10477535 176382 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7381 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Cummings SR (1999) 10376571 176381 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7382 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Scott JA (1999) 10507743 176380 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7383 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Bryant HU (1999) 10418979 176378 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7384 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Schafer JI (1999) 10485477 176384 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 14566 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Sledge GW (2000) 10637238 180526 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14567 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Perloff M (1996) 8622076 180527 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14568 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Swain SM (1988) 3058238 180524 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14569 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Pearson OH (1982) 7044524 180525 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14570 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Ingle JN (2006) 16538529 180528 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 21843 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3585 Compound 4-D - - DRUGBANK DB03742 C27H29NO4S small molecule - - DRUGBANK 21844 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3585 Compound 4-D - - DRUGBANK DB03742 C27H29NO4S small molecule - - DRUGBANK 10417 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 10418 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Lehnes K (2007) 17138652 178365 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 10419 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 10420 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Brama M (2007) 17125913 178366 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 19756 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2603 Compound 18 - - DRUGBANK DB02715 C27H29NO4S small molecule - 31112-66-0 DRUGBANK 19757 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2603 Compound 18 - - DRUGBANK DB02715 C27H29NO4S small molecule - 31112-66-0 DRUGBANK 25199 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6012 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB07195 C18H24O3 small molecule - - DRUGBANK 25097 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5905 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB07087 C17H24O3 small molecule - - DRUGBANK 16495 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Fujimoto J (1995) 7540578 181316 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16496 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Snyder BW (1990) 2326286 181314 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16497 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sanfilippo JS (1985) 4039467 181315 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16498 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 4967 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Jordan VC (1983) 6872937 174767 262 Chlorotrianisene Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen - DRUGBANK DB00269 C23H21ClO3 small molecule G03CA06 569-57-3 DRUGBANK 4968 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Wang JY (2006) 17236558 174766 262 Chlorotrianisene Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen - DRUGBANK DB00269 C23H21ClO3 small molecule G03CA06 569-57-3 DRUGBANK 4969 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 262 Chlorotrianisene Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen - DRUGBANK DB00269 C23H21ClO3 small molecule G03CA06 569-57-3 DRUGBANK 4970 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kupfer D (1990) 2307235 174768 262 Chlorotrianisene Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen - DRUGBANK DB00269 C23H21ClO3 small molecule G03CA06 569-57-3 DRUGBANK 25644 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6444 (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL - - DRUGBANK DB07638 C18H16F2O3 small molecule - - DRUGBANK 19548 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2507 Compound 19 - - DRUGBANK DB02615 C27H29NO4S small molecule - - DRUGBANK 19549 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2507 Compound 19 - - DRUGBANK DB02615 C27H29NO4S small molecule - - DRUGBANK 26356 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7106 DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE - - DRUGBANK DB08320 C24H24O7 small molecule - - DRUGBANK 5272 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Juchem M (1990) 2175153 175067 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5273 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Fuhrmann U (1995) 7750284 175066 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5274 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Rabe T (2000) 10836199 175065 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 6457 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Ghebeh H (2007) 17415709 175788 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6458 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Lessey BA (2006) 17118173 175789 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6459 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Yuri T (2007) 17203775 175786 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6460 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Montero Girard G (2007) 17341305 175787 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6461 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kumar AS (2007) 17103262 175785 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 26068 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6840 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol - - DRUGBANK DB08047 C17H13F3N2O2 small molecule - - DRUGBANK 26070 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6841 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL - - DRUGBANK DB08048 C13H10N2O3 small molecule - - DRUGBANK 4870 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4871 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Baron S (2007) 17317669 116189 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4872 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Hart SA (2007) 17314305 174699 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4873 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Kwok KC (2010) 20387803 174698 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4874 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Dixon A (2007) 17308373 174697 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4875 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Bains M (2007) 17320868 174696 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4876 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Munoz G (2007) 17306201 174695 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 25687 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6484 (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL - - DRUGBANK DB07678 C22H30O2 small molecule - - DRUGBANK 12430 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Brama M (2007) 17125913 178366 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12434 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Lehnes K (2007) 17138652 178365 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12432 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Notch EG (2009) 19237207 179459 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12433 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12431 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Micevych PE (2007) 17095591 179458 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12435 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Bennink HJ (2009) 19434891 179462 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12436 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Mukai H (2006) 17142999 179461 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 12437 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Garcia-Segura LM (2006) 17124377 179460 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 17631 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens binder target Chen F (2005) 15994348 181621 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 24180 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Wurz GT (2005) 16153821 181910 4734 Ospemifene 2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271 osphena DRUGBANK DB04938 C24H23ClO2 small molecule G03XC05 128607-22-7 DRUGBANK 24181 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Komi J (2004) 15255284 181854 4734 Ospemifene 2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271 osphena DRUGBANK DB04938 C24H23ClO2 small molecule G03XC05 128607-22-7 DRUGBANK 24182 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Wurz GT (2005) 16153821 181910 4734 Ospemifene 2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271 osphena DRUGBANK DB04938 C24H23ClO2 small molecule G03XC05 128607-22-7 DRUGBANK 24183 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens antagonist target Komi J (2004) 15255284 181854 4734 Ospemifene 2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271 osphena DRUGBANK DB04938 C24H23ClO2 small molecule G03XC05 128607-22-7 DRUGBANK 24924 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5717 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol - - DRUGBANK DB06898 C13H12N4O small molecule - - DRUGBANK 12281 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Pasqualini JR (2003) 14670645 179325 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 12282 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Juchem M (1990) 2175153 175067 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 12283 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Shields-Botella J (2003) 14672731 175549 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 14710 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Tew KD (1983) 6364362 180571 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14711 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target von Schoultz E (1994) 7703721 180570 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14712 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Yoshizumi N (1985) 3989343 180568 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14713 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Fernoe M (1987) 3314674 180569 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 26016 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6786 N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE - - DRUGBANK DB07991 C26H26N2O2 small molecule - - DRUGBANK 7814 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Lewis-Wambi JS (2006) 16917142 176743 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7815 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Liu X (2003) 12870885 176742 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7816 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Locci P (2001) 11747628 176741 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7817 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Gennari L (2007) 17503894 176740 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7818 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Shelly W (2008) 18279543 176738 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7819 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Jones KL (2004) 15369444 176739 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7820 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Ariazi EA (2006) 16515478 176736 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7821 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Goldstein LJ (2006) 16595024 176737 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7822 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Smith MR (2006) 17062721 176734 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7823 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Taneja SS (2006) 16503765 176735 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 7824 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens modulator target Chen X (2002) 11752352 171740 529 Toremifene Toremifenum|Toremifeno fareston DRUGBANK DB00539 C26H28ClNO small molecule L02BA02 89778-26-7 DRUGBANK 17494 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 24901 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5691 17-METHYL-17-ALPHA-DIHYDROEQUILENIN - - DRUGBANK DB06871 C19H22O2 small molecule - - DRUGBANK 9046 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 645 Estrone Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone oestrilin creme vaginale 1mg|e DRUGBANK DB00655 C18H22O2 small molecule G03CA07|G03CC04 53-16-7 DRUGBANK 9047 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 645 Estrone Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone oestrilin creme vaginale 1mg|e DRUGBANK DB00655 C18H22O2 small molecule G03CA07|G03CC04 53-16-7 DRUGBANK 9048 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens agonist target Margeat E (2003) 12547192 177584 645 Estrone Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone oestrilin creme vaginale 1mg|e DRUGBANK DB00655 C18H22O2 small molecule G03CA07|G03CC04 53-16-7 DRUGBANK 26627 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7372 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB08595 C17H22O2 small molecule - - DRUGBANK 26740 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7510 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL - - DRUGBANK DB08737 C18H18O3 small molecule - - DRUGBANK 26443 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7182 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE - - DRUGBANK DB08398 C13H12N4 small molecule - - DRUGBANK 26774 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7545 RALOXIFENE CORE - - DRUGBANK DB08773 C14H10O2S small molecule - - DRUGBANK 6033 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Vereide AB (2006) 16325240 175553 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6034 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Mirkin S (2005) 16084894 175552 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6035 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Vijayanathan V (2006) 16609013 175551 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6036 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Sun D (2007) 17634204 175555 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6037 108403 2099 RP1-130E4.1 ESR1 ER|ESR|ESRA|ESTRR|Era|NR3A1 9606 Homo sapiens unknown target Abdel-Aleem H (2005) 16307966 175554 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 20230 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2860 Para-Mercury-Benzenesulfonic Acid - - DRUGBANK DB02983 C6H5HgO3S small molecule - - DRUGBANK 20231 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2860 Para-Mercury-Benzenesulfonic Acid - - DRUGBANK DB02983 C6H5HgO3S small molecule - - DRUGBANK 20232 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2860 Para-Mercury-Benzenesulfonic Acid - - DRUGBANK DB02983 C6H5HgO3S small molecule - - DRUGBANK 4877 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Unknown Authors (2009) 19101832 174701 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4878 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Geistlinger TR (2004) 15123288 174700 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 9367 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Mc Ilroy M (2006) 17158759 131588 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9368 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9369 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9370 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Hayes DF (2010) 20827267 177731 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9371 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Gruvberger-Saal SK (2007) 17404078 177730 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9372 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Girault I (2006) 16822624 177733 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9373 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Horner-Glister E (2005) 16326830 177732 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9374 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Chen B (2005) 16010412 177729 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9375 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Mc Ilroy M (2006) 17158759 131588 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9376 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Sasson S (1991) 2011412 177583 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9377 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9378 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Hayes DF (2010) 20827267 177731 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9379 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Gruvberger-Saal SK (2007) 17404078 177730 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9380 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Girault I (2006) 16822624 177733 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9381 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Horner-Glister E (2005) 16326830 177732 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9382 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens antagonist target Chen B (2005) 16010412 177729 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 22113 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Norata GD (2010) 20557886 182158 3719 5-Alpha-Androstane-3-Beta,17beta-Diol - - DRUGBANK DB03882 C19H32O2 small molecule - 571-20-0 DRUGBANK 24951 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5746 [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE - - DRUGBANK DB06927 C16H11NO3 small molecule - - DRUGBANK 25961 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6729 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL - - DRUGBANK DB07933 C18H18O3 small molecule - - DRUGBANK 22078 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3697 N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide - - DRUGBANK DB03860 C34H55NO3 small molecule - - DRUGBANK 22079 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3697 N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide - - DRUGBANK DB03860 C34H55NO3 small molecule - - DRUGBANK 22080 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3697 N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide - - DRUGBANK DB03860 C34H55NO3 small molecule - - DRUGBANK 17490 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 17491 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 17492 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 23521 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Reed CA (2005) 15846122 181889 4282 Afimoxifene 4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT - DRUGBANK DB04468 C26H29NO2 small molecule - 68392-35-8 DRUGBANK 25048 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5854 (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol - - DRUGBANK DB07036 C20H20F2O4 small molecule - - DRUGBANK 25022 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5827 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL - - DRUGBANK DB07009 C17H11NO3 small molecule - - DRUGBANK 23730 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Mishra RG (2006) 16199482 181911 4383 Estriol 16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol - DRUGBANK DB04573 C18H24O3 small molecule G03CA04|G03CC06 50-27-1 DRUGBANK 25765 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6558 (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one - - DRUGBANK DB07757 C17H19BrO2 small molecule - - DRUGBANK 23733 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 4384 Estrone sulfate Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate ogen .625|estropipate|ogen 2.5 DRUGBANK DB04574 C18H22O5S small molecule - 481-97-0 DRUGBANK 23734 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Vijayanathan V (2007) 17464340 178364 4384 Estrone sulfate Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate ogen .625|estropipate|ogen 2.5 DRUGBANK DB04574 C18H22O5S small molecule - 481-97-0 DRUGBANK 25161 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5968 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME - - DRUGBANK DB07150 C17H13NO2 small molecule - - DRUGBANK 25239 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6046 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE - - DRUGBANK DB07230 C15H9BrO3 small molecule - - DRUGBANK 22404 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3853 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol - - DRUGBANK DB04020 C24H29ClN6OS small molecule - - DRUGBANK 22405 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3853 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol - - DRUGBANK DB04020 C24H29ClN6OS small molecule - - DRUGBANK 26043 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6813 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL - - DRUGBANK DB08020 C20H22O4 small molecule - - DRUGBANK 13835 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens allosteric modulator target Barker S (2006) 16806905 180192 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13836 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens allosteric modulator target Puddefoot JR (2002) 12209583 180191 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13837 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens allosteric modulator target Puddefoot JR (2006) 17109615 180190 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 10415 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Sasson S (1991) 2011412 177583 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 10416 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Vijayanathan V (2007) 17464340 178364 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 25643 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6444 (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL - - DRUGBANK DB07638 C18H16F2O3 small molecule - - DRUGBANK 24960 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5756 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL - - DRUGBANK DB06937 C13H9NO4 small molecule - - DRUGBANK 24854 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5653 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL - - DRUGBANK DB06832 C15H10FNO3 small molecule - - DRUGBANK 25202 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6015 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE - - DRUGBANK DB07198 C15H9NO3 small molecule - - DRUGBANK 17606 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens activator target Chen F (2005) 15994348 181621 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14709 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Ho SM (2004) 14755680 180567 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 25709 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6506 (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL - - DRUGBANK DB07702 C18H24O3 small molecule - - DRUGBANK 25127 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5937 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL - - DRUGBANK DB07119 C16H11ClO2 small molecule - - DRUGBANK 7370 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Sun J (2002) 11861516 176376 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7371 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7372 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Iannone MA (2001) 11500849 112774 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7373 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Zhou W (2002) 11810032 176377 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7374 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Kim IY (2002) 12097269 176375 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 7375 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens agonist target Bryant HU (1999) 10418979 176378 473 Raloxifene (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum pms-raloxifene|evista|act ralo DRUGBANK DB00481 C28H27NO4S small molecule G03XC01 84449-90-1 DRUGBANK 25045 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5850 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL - - DRUGBANK DB07032 C14H10O3 small molecule - - DRUGBANK 24904 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5695 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE - - DRUGBANK DB06875 C17H10FNO2 small molecule - - DRUGBANK 25247 108404 2100 - ESR2 ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6052 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL - - DRUGBANK DB07236 C17H11NO3 small molecule - - DRUGBANK 24856 108405 2101 - ESRRA ERR1|ERRa|ERRalpha|ESRL1|NR3B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5654 1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE - - DRUGBANK DB06833 C23H28N2 small molecule - - DRUGBANK 4150 108405 2101 - ESRRA ERR1|ERRa|ERRalpha|ESRL1|NR3B1 9606 Homo sapiens inverse agonist target Wang Y (2010) 20298676 174274 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 19640 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23523 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4282 Afimoxifene 4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT - DRUGBANK DB04468 C26H29NO2 small molecule - 68392-35-8 DRUGBANK 24915 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5704 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE - - DRUGBANK DB06884 C17H20N2O2 small molecule - - DRUGBANK 25507 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6296 4,4'-cyclohexane-1,1-diyldiphenol - - DRUGBANK DB07485 C18H20O2 small molecule - - DRUGBANK 24928 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5721 4-(1-methyl-1-phenylethyl)phenol - - DRUGBANK DB06902 C15H16O small molecule - - DRUGBANK 4136 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens inverse agonist target Wang Y (2010) 20298676 174274 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 24990 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5792 4,4'-PROPANE-2,2-DIYLDIPHENOL - - DRUGBANK DB06973 C15H16O2 small molecule - - DRUGBANK 4868 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens agonist target Greschik H (2004) 15161930 174694 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 4869 108407 2104 - ESRRG ERR3|ERRgamma|NR3B3 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 248 Diethylstilbestrol trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol stilbestrol 1.0mg tablet|stilb DRUGBANK DB00255 C18H20O2 small molecule G03CB02|G03CC05|L02AA01 56-53-1 DRUGBANK 22681 108411 2110 - ETFDH ETFQO|MADD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 18710 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18711 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18712 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 21109 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21110 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21111 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21220 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21221 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21222 108436 2135 - EXTL2 EXTR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 24959 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5755 N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide - - DRUGBANK DB06936 C19H28N4O2 small molecule - - DRUGBANK 24954 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5748 1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06929 C17H24N4O2 small molecule - - DRUGBANK 25195 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6007 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide - - DRUGBANK DB07190 C21H30ClN3O2 small molecule - - DRUGBANK 25018 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5823 D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide - - DRUGBANK DB07005 C22H28N5O2 small molecule - - DRUGBANK 25176 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5983 N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE - - DRUGBANK DB07165 C22H23Cl2N5O2S small molecule - - DRUGBANK 25673 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6471 N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide - - DRUGBANK DB07665 C19H20F3N7O2 small molecule - - DRUGBANK 25534 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6326 1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL - - DRUGBANK DB07515 C20H30ClF2N7O small molecule - - DRUGBANK 25092 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5901 beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide - - DRUGBANK DB07083 C23H29N3O2 small molecule - - DRUGBANK 25099 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5906 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07088 C20H28N4O3 small molecule - - DRUGBANK 1224 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Seitz R (1999) 10499905 172386 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1225 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Bauer KA (2000) 11019961 172385 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1226 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Butenas S (1999) 10498586 172384 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1227 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Koehler M (1999) 10499904 172383 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1228 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Samis JA (2000) 10648407 172382 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 25645 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6445 3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER - - DRUGBANK DB07639 C26H31N3O3 small molecule - - DRUGBANK 26306 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7043 2-NAPHTHALENESULFONIC ACID - - DRUGBANK DB08254 C10H8O3S small molecule - - DRUGBANK 25289 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6093 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE - - DRUGBANK DB07277 C17H24ClN3O5S2 small molecule - - DRUGBANK 25293 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6095 N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE - - DRUGBANK DB07279 C21H29N3O2 small molecule - - DRUGBANK 25291 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6094 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE - - DRUGBANK DB07278 C17H22ClN3O5S2 small molecule - - DRUGBANK 17746 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1700 Hemi-Babim - - DRUGBANK DB01767 C16H14N6 small molecule - - DRUGBANK 20570 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3004 4-Iodobenzo[B]Thiophene-2-Carboxamidine - - DRUGBANK DB03136 C9H8IN2S small molecule - - DRUGBANK 698 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Omar MN (1999) 10463819 172085 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 699 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Cvirn G (2002) 12062545 172064 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 700 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Conway EM (2002) 12208873 172087 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 701 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Gruber A (2002) 12070133 172088 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 702 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Levi M (2002) 12296618 172086 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 23756 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4400 N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE - - DRUGBANK DB04591 C22H23F2N7O small molecule - - DRUGBANK 19011 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2256 Hirulog - - DRUGBANK DB02351 C98H138N24O33 small molecule - 128270-60-0 DRUGBANK 24908 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5698 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide - - DRUGBANK DB06878 C16H22ClN3O2 small molecule - - DRUGBANK 25529 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6319 4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE - - DRUGBANK DB07508 C22H21N5O2S small molecule - - DRUGBANK 25107 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5913 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07095 C21H30N4O2 small molecule - - DRUGBANK 26086 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6855 3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE - - DRUGBANK DB08062 C9H8ClN3S small molecule - - DRUGBANK 26085 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6854 4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE - - DRUGBANK DB08061 C14H16ClN3 small molecule - - DRUGBANK 25824 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6595 (3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE - - DRUGBANK DB07796 C23H24FN4O2 small molecule - - DRUGBANK 5055 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 271 Argatroban - argatroban DRUGBANK DB00278 C23H36N6O5S small molecule B01AE03 74863-84-6 DRUGBANK 5056 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Kawada T (1999) 10226408 174842 271 Argatroban - argatroban DRUGBANK DB00278 C23H36N6O5S small molecule B01AE03 74863-84-6 DRUGBANK 5057 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Matsuo T (1995) 10608016 174843 271 Argatroban - argatroban DRUGBANK DB00278 C23H36N6O5S small molecule B01AE03 74863-84-6 DRUGBANK 5058 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Sakai M (1999) 10353669 174840 271 Argatroban - argatroban DRUGBANK DB00278 C23H36N6O5S small molecule B01AE03 74863-84-6 DRUGBANK 5059 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Serebruany VL (1999) 10608050 174841 271 Argatroban - argatroban DRUGBANK DB00278 C23H36N6O5S small molecule B01AE03 74863-84-6 DRUGBANK 5060 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Jang IK (1999) 10362188 174844 271 Argatroban - argatroban DRUGBANK DB00278 C23H36N6O5S small molecule B01AE03 74863-84-6 DRUGBANK 24970 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5766 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06947 C17H25N5O2 small molecule - - DRUGBANK 22056 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3684 Gamma-Carboxy-Glutamic Acid - - DRUGBANK DB03847 C6H9NO6 small molecule - - DRUGBANK 22057 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3684 Gamma-Carboxy-Glutamic Acid - - DRUGBANK DB03847 C6H9NO6 small molecule - - DRUGBANK 22058 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3684 Gamma-Carboxy-Glutamic Acid - - DRUGBANK DB03847 C6H9NO6 small molecule - - DRUGBANK 27739 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Cugno M (2001) 11460008 6756 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 20695 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3027 CRA_8696 - - DRUGBANK DB03159 C21H17N3O small molecule - - DRUGBANK 25040 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5845 D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide - - DRUGBANK DB07027 C21H24FN3O2 small molecule - - DRUGBANK 24898 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5689 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE - - DRUGBANK DB06869 C24H35ClN4O4 small molecule - - DRUGBANK 24897 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5688 N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide - - DRUGBANK DB06868 C18H25ClN2O2 small molecule - - DRUGBANK 24894 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5685 6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID - - DRUGBANK DB06865 C22H26N2O4 small molecule - - DRUGBANK 25154 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5961 D-phenylalanyl-N-benzyl-L-prolinamide - - DRUGBANK DB07143 C21H25N3O2 small molecule - - DRUGBANK 24895 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5686 6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID - - DRUGBANK DB06866 C23H28N2O4 small molecule - - DRUGBANK 24890 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5680 N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE - - DRUGBANK DB06859 C19H27ClN4O3 small molecule - - DRUGBANK 24891 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5682 6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE - - DRUGBANK DB06861 C12H22N2O2 small molecule - - DRUGBANK 24878 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5671 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB06850 C21H31N5O2 small molecule - - DRUGBANK 24882 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5674 N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06853 C22H33N5O2 small molecule - - DRUGBANK 24884 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5675 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE - - DRUGBANK DB06854 C20H16N4O small molecule - - DRUGBANK 25459 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6252 4-TERT-BUTYLBENZENESULFONIC ACID - - DRUGBANK DB07440 C10H14O3S small molecule - - DRUGBANK 24889 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5679 N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06858 C23H35N5O2 small molecule - - DRUGBANK 25477 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6272 3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE - - DRUGBANK DB07461 C15H19N3O2 small molecule - - DRUGBANK 24656 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Liesenfeld KH (2006) 17061960 181973 5577 Dabigatran etexilate Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran pradaxa DRUGBANK DB06695 C34H41N7O5 small molecule B01AE07 211915-06-9 DRUGBANK 24657 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Karthikeyan G (2010) 20424539 182153 5577 Dabigatran etexilate Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran pradaxa DRUGBANK DB06695 C34H41N7O5 small molecule B01AE07 211915-06-9 DRUGBANK 24658 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Squizzato A (2009) 19756950 182126 5577 Dabigatran etexilate Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran pradaxa DRUGBANK DB06695 C34H41N7O5 small molecule B01AE07 211915-06-9 DRUGBANK 19776 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2611 4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide - - DRUGBANK DB02723 C22H32N6O5S small molecule - - DRUGBANK 19777 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2611 4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide - - DRUGBANK DB02723 C22H32N6O5S small molecule - - DRUGBANK 25361 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6169 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL - - DRUGBANK DB07353 C11H18N2O2 small molecule - - DRUGBANK 24864 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5662 D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide - - DRUGBANK DB06841 C21H32ClN6O3 small molecule - - DRUGBANK 24873 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5666 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB06845 C20H29N5O2 small molecule - - DRUGBANK 25832 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6607 4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE - - DRUGBANK DB07809 C21H20N4O small molecule - - DRUGBANK 25137 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5946 N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE - - DRUGBANK DB07128 C17H21ClN6 small molecule - - DRUGBANK 13981 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Valeri AM (1980) 7407200 180272 1111 Proflavine 3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine triple dye|perineze triple dye DRUGBANK DB01123 C13H11N3 small molecule - 92-62-6 DRUGBANK 13982 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Koehler KA (1974) 4857231 180273 1111 Proflavine 3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine triple dye|perineze triple dye DRUGBANK DB01123 C13H11N3 small molecule - 92-62-6 DRUGBANK 13983 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target De Cristofaro R (1995) 7837275 180271 1111 Proflavine 3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine triple dye|perineze triple dye DRUGBANK DB01123 C13H11N3 small molecule - 92-62-6 DRUGBANK 13984 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1111 Proflavine 3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine triple dye|perineze triple dye DRUGBANK DB01123 C13H11N3 small molecule - 92-62-6 DRUGBANK 13985 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Sie P (1991) 1711542 180274 1111 Proflavine 3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine triple dye|perineze triple dye DRUGBANK DB01123 C13H11N3 small molecule - 92-62-6 DRUGBANK 13986 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Sonder SA (1984) 6722124 180275 1111 Proflavine 3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine triple dye|perineze triple dye DRUGBANK DB01123 C13H11N3 small molecule - 92-62-6 DRUGBANK 25141 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5949 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07131 C22H32N4O2 small molecule - - DRUGBANK 86 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 6 Bivalirudin - bivalirudin|bivalirudin for in DRUGBANK DB00006 C98H138N24O33 small molecule B01AE06 128270-60-0 DRUGBANK 87 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Gladwell TD (2002) 11833835 171773 6 Bivalirudin - bivalirudin|bivalirudin for in DRUGBANK DB00006 C98H138N24O33 small molecule B01AE06 128270-60-0 DRUGBANK 88 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Scatena R (2000) 11060732 171777 6 Bivalirudin - bivalirudin|bivalirudin for in DRUGBANK DB00006 C98H138N24O33 small molecule B01AE06 128270-60-0 DRUGBANK 89 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Kleiman NS (2002) 11923794 171776 6 Bivalirudin - bivalirudin|bivalirudin for in DRUGBANK DB00006 C98H138N24O33 small molecule B01AE06 128270-60-0 DRUGBANK 90 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Carswell CI (2002) 11929334 171775 6 Bivalirudin - bivalirudin|bivalirudin for in DRUGBANK DB00006 C98H138N24O33 small molecule B01AE06 128270-60-0 DRUGBANK 91 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Bates ER (2001) 11504570 171774 6 Bivalirudin - bivalirudin|bivalirudin for in DRUGBANK DB00006 C98H138N24O33 small molecule B01AE06 128270-60-0 DRUGBANK 25566 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6360 2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE - - DRUGBANK DB07550 C20H17ClF3N5O3 small molecule - - DRUGBANK 25725 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6521 3-(4-HYDROXY-PHENYL)PYRUVIC ACID - - DRUGBANK DB07718 C9H8O4 small molecule - - DRUGBANK 24862 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5659 methyl L-phenylalaninate - - DRUGBANK DB06838 C10H13NO2 small molecule - - DRUGBANK 3665 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens activator target Wang Z (1995) 7657295 174004 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3666 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens activator target McCarthy DJ (1989) 2922761 174005 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3667 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens activator target Szejtli J (1983) 6867080 174002 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3668 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens activator target Lee SK (1999) 10469489 174003 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3669 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens activator target Casper HH (1989) 2484931 174001 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 25143 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5951 D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide - - DRUGBANK DB07133 C22H27N3O2 small molecule - - DRUGBANK 25102 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5909 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07091 C21H30N4O3 small molecule - - DRUGBANK 23844 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4526 2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE - - DRUGBANK DB04722 C22H20Cl2F2N4O3 small molecule - - DRUGBANK 25564 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6358 2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE - - DRUGBANK DB07548 C20H19F3N6O2 small molecule - - DRUGBANK 25565 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6359 2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE - - DRUGBANK DB07549 C21H23F3N6O2 small molecule - - DRUGBANK 22625 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3967 Lysophosphotidylserine - - DRUGBANK DB04136 C21H44NO9P small molecule - - DRUGBANK 22626 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3967 Lysophosphotidylserine - - DRUGBANK DB04136 C21H44NO9P small molecule - - DRUGBANK 22627 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3967 Lysophosphotidylserine - - DRUGBANK DB04136 C21H44NO9P small molecule - - DRUGBANK 18696 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2109 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB02193 C14H13N4O small molecule - - DRUGBANK 25417 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6214 1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE - - DRUGBANK DB07400 C21H33N5O4 small molecule - - DRUGBANK 25393 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6192 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID) - - DRUGBANK DB07376 C12H13NO3S small molecule - - DRUGBANK 25009 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5814 D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06996 C19H29N5O2 small molecule - - DRUGBANK 26651 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7400 BENZOTHIAZOLE - - DRUGBANK DB08624 C13H17N5OS small molecule - - DRUGBANK 25923 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6694 1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE - - DRUGBANK DB07897 C9H21NO2 small molecule - - DRUGBANK 25969 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6740 N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE - - DRUGBANK DB07944 C20H22N3O3S small molecule - - DRUGBANK 25970 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6742 N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide - - DRUGBANK DB07946 C19H21ClF3N5O2 small molecule - - DRUGBANK 26173 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6944 {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate - - DRUGBANK DB08152 C20H27ClN2O5 small molecule - - DRUGBANK 26589 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7324 4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE - - DRUGBANK DB08546 C24H24N4O5 small molecule - - DRUGBANK 24120 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Ersdal E (2007) 17532684 182018 4698 Ximelagatran H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95 - DRUGBANK DB04898 C24H35N5O5 small molecule B01AE05 192939-46-1 DRUGBANK 24121 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Testa L (2007) 17688383 182037 4698 Ximelagatran H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95 - DRUGBANK DB04898 C24H35N5O5 small molecule B01AE05 192939-46-1 DRUGBANK 24122 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4698 Ximelagatran H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95 - DRUGBANK DB04898 C24H35N5O5 small molecule B01AE05 192939-46-1 DRUGBANK 24123 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Bergqvist D (2007) 17516699 182013 4698 Ximelagatran H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95 - DRUGBANK DB04898 C24H35N5O5 small molecule B01AE05 192939-46-1 DRUGBANK 24124 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Ho SJ (2007) 17319469 181988 4698 Ximelagatran H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95 - DRUGBANK DB04898 C24H35N5O5 small molecule B01AE05 192939-46-1 DRUGBANK 26467 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7204 [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE - - DRUGBANK DB08422 C21H27N5O2 small molecule - - DRUGBANK 25216 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6028 (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE - - DRUGBANK DB07211 C18H24ClN3O5S2 small molecule - - DRUGBANK 25541 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6337 N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE - - DRUGBANK DB07527 C20H28N2O4S small molecule - - DRUGBANK 25373 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6182 2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER - - DRUGBANK DB07366 C17H26N4O3 small molecule - - DRUGBANK 27691 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Cugno M (2001) 11460008 6756 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 25114 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5923 2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE - - DRUGBANK DB07105 C18H20ClN5O2S small molecule - - DRUGBANK 24965 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5761 N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide - - DRUGBANK DB06942 C22H26N4O2 small molecule - - DRUGBANK 17743 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1699 Beta-(2-Naphthyl)-Alanine - - DRUGBANK DB01766 C13H13NO2 small molecule - - DRUGBANK 26216 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6979 METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE - - DRUGBANK DB08187 C22H34N4O2 small molecule - - DRUGBANK 25963 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6730 [[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE - - DRUGBANK DB07934 C22H36N5O4S small molecule - - DRUGBANK 24936 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5730 D-leucyl-N-(3-chlorobenzyl)-L-prolinamide - - DRUGBANK DB06911 C18H26ClN3O2 small molecule - - DRUGBANK 22088 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3702 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine - - DRUGBANK DB03865 C21H17ClN3O small molecule - - DRUGBANK 24942 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5738 D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide - - DRUGBANK DB06919 C21H24ClN3O2 small molecule - - DRUGBANK 25030 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5834 (3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline - - DRUGBANK DB07016 C10H13NO2S small molecule - - DRUGBANK 25745 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6542 4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE - - DRUGBANK DB07741 C24H27F3N4O small molecule - - DRUGBANK 25662 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6464 AC-(D)PHE-PRO-BOROLYS-OH - - DRUGBANK DB07658 C21H33BN4O5 small molecule - - DRUGBANK 25663 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6465 AC-(D)PHE-PRO-BOROHOMOLYS-OH - - DRUGBANK DB07659 C22H35BN4O5 small molecule - - DRUGBANK 25664 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6466 AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH - - DRUGBANK DB07660 C20H31BN4O5 small molecule - - DRUGBANK 1 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Eriksson BI (2000) 11055889 171739 1 Lepirudin Lepirudin recombinant|Hirudin variant-1 refludan DRUGBANK DB00001 C287H440N80O110S6 biologic B01AE02 138068-37-8 DRUGBANK 2 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Warkentin TE (2000) 10912644 171738 1 Lepirudin Lepirudin recombinant|Hirudin variant-1 refludan DRUGBANK DB00001 C287H440N80O110S6 biologic B01AE02 138068-37-8 DRUGBANK 3 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Szaba FM (2002) 11807012 171737 1 Lepirudin Lepirudin recombinant|Hirudin variant-1 refludan DRUGBANK DB00001 C287H440N80O110S6 biologic B01AE02 138068-37-8 DRUGBANK 4 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Fabrizio MC (2001) 11467439 171736 1 Lepirudin Lepirudin recombinant|Hirudin variant-1 refludan DRUGBANK DB00001 C287H440N80O110S6 biologic B01AE02 138068-37-8 DRUGBANK 5 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Turpie AG (1999) 10505536 171735 1 Lepirudin Lepirudin recombinant|Hirudin variant-1 refludan DRUGBANK DB00001 C287H440N80O110S6 biologic B01AE02 138068-37-8 DRUGBANK 6 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1 Lepirudin Lepirudin recombinant|Hirudin variant-1 refludan DRUGBANK DB00001 C287H440N80O110S6 biologic B01AE02 138068-37-8 DRUGBANK 23895 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens inhibitor target Monteiro RQ (2004) 15203120 181850 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 25537 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6332 6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL - - DRUGBANK DB07521 C22H31Cl2N5OS small molecule - - DRUGBANK 25538 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6333 N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE - - DRUGBANK DB07522 C20H22N2O3S small molecule - - DRUGBANK 25129 108447 2147 - F2 PT|RPRGL2|THPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5938 N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE - - DRUGBANK DB07120 C14H15N5O small molecule - - DRUGBANK 1080 108448 2149 - F2R CF2R|HTR|PAR-1|PAR1|TR 9606 Homo sapiens cleavage target McRedmond JP (2000) 10666203 172270 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 27451 108448 2149 - F2R CF2R|HTR|PAR-1|PAR1|TR 9606 Homo sapiens antagonist target Bonaca MP (2009) 19715408 188530 7794 Vorapaxar Ethyl N-[(3R,3aS,4S,4aR,7R,8aR,9aR)-4-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f]isobenzofuran-7-yl]carbamate|Zontivity|Carbamic acid, N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester|[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-Fluorophnyl)-2-pyridinyl]vinyl}-1-mthyl-3-oxododcahydronaphto[2,3-c]furan-6-yl]carbamate d'thyle|Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2- pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester zontivity DRUGBANK DB09030 C29H33FN2O4 small molecule B01AC26 618385-01-6 DRUGBANK 26272 108451 2152 - F3 CD142|TF|TFA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7022 {5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID - - DRUGBANK DB08232 C21H16N4O5 small molecule - - DRUGBANK 25212 108451 2152 - F3 CD142|TF|TFA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6024 2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE - - DRUGBANK DB07207 C17H14N6O small molecule - - DRUGBANK 442 108451 2152 - F3 CD142|TF|TFA 9606 Homo sapiens unknown target Rogers KS (1992) 1586032 171935 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 443 108451 2152 - F3 CD142|TF|TFA 9606 Homo sapiens unknown target Christensen NJ (1983) 6658368 171936 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 444 108451 2152 - F3 CD142|TF|TFA 9606 Homo sapiens unknown target HERMANSKY F (1960) 13713641 171933 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 25259 108451 2152 - F3 CD142|TF|TFA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6063 [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA - - DRUGBANK DB07247 C21H18N4O2 small molecule - - DRUGBANK 683 108452 2153 - F5 FVL|PCCF|RPRGL1|THPH2 9606 Homo sapiens multitarget target Poe K (2002) 12030642 172079 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 684 108452 2153 - F5 FVL|PCCF|RPRGL1|THPH2 9606 Homo sapiens multitarget target Bernard GR (2001) 11236773 172078 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 685 108452 2153 - F5 FVL|PCCF|RPRGL1|THPH2 9606 Homo sapiens multitarget target Joyce DE (2002) 12004250 172075 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 686 108452 2153 - F5 FVL|PCCF|RPRGL1|THPH2 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 687 108452 2153 - F5 FVL|PCCF|RPRGL1|THPH2 9606 Homo sapiens multitarget target Kanji S (2001) 11714212 172076 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 688 108452 2153 - F5 FVL|PCCF|RPRGL1|THPH2 9606 Homo sapiens multitarget target Lyseng-Williamson KA (2002) 11893230 172077 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 450 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Rizoli SB (2006) 16370916 171944 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 451 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Perera L (1999) 10388743 171945 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 452 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Siddiqui MA (2005) 15907148 171946 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 453 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Shapiro A (2001) 11735107 171942 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 454 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Shapiro A (2003) 12525826 171943 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 26271 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7022 {5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID - - DRUGBANK DB08232 C21H16N4O5 small molecule - - DRUGBANK 25394 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6192 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID) - - DRUGBANK DB07376 C12H13NO3S small molecule - - DRUGBANK 25258 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6063 [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA - - DRUGBANK DB07247 C21H18N4O2 small molecule - - DRUGBANK 3670 108453 2155 - F7 SPCA 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3671 108453 2155 - F7 SPCA 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 25211 108453 2155 - F7 SPCA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6024 2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE - - DRUGBANK DB07207 C17H14N6O small molecule - - DRUGBANK 1242 108453 2155 - F7 SPCA 9606 Homo sapiens ligand target Shord SS (2000) 10938981 171862 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1243 108453 2155 - F7 SPCA 9606 Homo sapiens ligand target Baker DC (1999) 10192655 172393 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1244 108453 2155 - F7 SPCA 9606 Homo sapiens ligand target Celie PH (2000) 10617609 172394 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1245 108453 2155 - F7 SPCA 9606 Homo sapiens ligand target Hertzberg MS (1999) 10381508 172395 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1246 108453 2155 - F7 SPCA 9606 Homo sapiens ligand target Di Scipio RG (1978) 659613 172378 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1247 108453 2155 - F7 SPCA 9606 Homo sapiens ligand target Butenas S (1999) 10498586 172384 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 666 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 667 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens multitarget target Colin G (2008) 18954704 172062 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 668 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens multitarget target Geng JP (1997) 9184404 172063 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 1218 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens cofactor target Carr ME (2003) 12719776 172376 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1219 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens cofactor target Kalashnikova LA (2003) 14598591 172377 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1220 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens cofactor target Di Scipio RG (1978) 659613 172378 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1221 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens cofactor target Federici AB (2003) 12826528 172379 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1222 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens cofactor target Neels JG (2000) 11150722 172381 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1223 108455 2157 RP11-115M6.7 F8 AHF|DXS1253E|F8B|F8C|FVIII|HEMA 9606 Homo sapiens cofactor target Johansen RF (2006) 16476097 172380 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 254 108456 2158 RP6-88D7.1 F9 FIX|HEMB|P19|PTC|THPH8 9606 Homo sapiens cofactor target Prince AM (1984) 6422634 171856 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 255 108456 2158 RP6-88D7.1 F9 FIX|HEMB|P19|PTC|THPH8 9606 Homo sapiens cofactor target Hoofnagle JH (1976) 932529 171857 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 256 108456 2158 RP6-88D7.1 F9 FIX|HEMB|P19|PTC|THPH8 9606 Homo sapiens cofactor target Yoshitake S (1985) 2994716 171860 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 257 108456 2158 RP6-88D7.1 F9 FIX|HEMB|P19|PTC|THPH8 9606 Homo sapiens cofactor target Hule V (1975) 1119107 171858 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 258 108456 2158 RP6-88D7.1 F9 FIX|HEMB|P19|PTC|THPH8 9606 Homo sapiens cofactor target LUNDBLAD RL (1964) 14240634 171859 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 3644 108456 2158 RP6-88D7.1 F9 FIX|HEMB|P19|PTC|THPH8 9606 Homo sapiens activator target Berkessel A (2007) 17348045 173990 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 8109 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Grouzi E (2010) 19825921 176941 559 Fondaparinux sodium Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt fondaparinux sodium injection| DRUGBANK DB00569 C31H45N3Na10O49S8 small molecule - 114870-03-0 DRUGBANK 26198 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6966 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE - - DRUGBANK DB08174 C22H20ClN3O3S small molecule - - DRUGBANK 25826 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6598 N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE - - DRUGBANK DB07800 C23H17ClN4O4S small molecule - - DRUGBANK 25612 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6411 2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE - - DRUGBANK DB07605 C20H17ClN4O4S2 small molecule - - DRUGBANK 25906 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6672 5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide - - DRUGBANK DB07875 C22H20ClFN4O4S small molecule - - DRUGBANK 25830 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6602 5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE - - DRUGBANK DB07804 C17H21ClN6O5S2 small molecule - - DRUGBANK 26197 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6965 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE - - DRUGBANK DB08173 C19H16ClN3O3S small molecule - - DRUGBANK 264 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target BLATRIX C (1959) 13801371 171867 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 265 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Orthner CL (1984) 6436416 171866 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 266 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Radnoff OD (1975) 236567 171870 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 267 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Freedman J (2002) 11891806 171869 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 268 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target LUNDBLAD RL (1965) 14285227 171868 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 25633 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6435 N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE - - DRUGBANK DB07629 C23H26ClN5O2S small molecule - - DRUGBANK 25903 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6669 5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide - - DRUGBANK DB07872 C22H20ClFN4O3S small molecule - - DRUGBANK 26534 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7268 4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE - - DRUGBANK DB08488 C18H17ClN4O3S2 small molecule - - DRUGBANK 26001 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6769 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE - - DRUGBANK DB07974 C25H29ClN4O2 small molecule - - DRUGBANK 26000 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6768 N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE - - DRUGBANK DB07973 C25H31N3O2 small molecule - - DRUGBANK 25871 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6644 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE - - DRUGBANK DB07847 C21H24ClN3O5S small molecule - - DRUGBANK 25872 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6645 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE - - DRUGBANK DB07848 C19H23ClN4O5S small molecule - - DRUGBANK 26533 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7267 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE - - DRUGBANK DB08487 C20H19ClN4O3S2 small molecule - - DRUGBANK 25867 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6640 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE - - DRUGBANK DB07843 C19H22ClN3O5S2 small molecule - - DRUGBANK 25868 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6641 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE - - DRUGBANK DB07844 C19H22ClN3O5S2 small molecule - - DRUGBANK 25217 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6028 (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE - - DRUGBANK DB07211 C18H24ClN3O5S2 small molecule - - DRUGBANK 1229 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1230 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Jones KC (1994) 8083242 172390 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1231 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Ambrosini G (1997) 9079657 8349 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1232 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target London FS (2000) 10933803 172389 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1233 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Scandella DH (2000) 10919405 172388 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1234 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Worfolk LA (1992) 1391956 172387 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1235 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Di Scipio RG (1978) 659613 172378 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 26749 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7519 1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE - - DRUGBANK DB08746 C23H29ClN4O2S small molecule - - DRUGBANK 26748 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7518 4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE - - DRUGBANK DB08745 C23H27ClN4O3S small molecule - - DRUGBANK 15084 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Sanchez-Pena P (2005) 16187968 180719 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 15085 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Graff J (2007) 17474542 180718 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 15086 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Berges A (2007) 17509040 180720 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 15087 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Paige JT (2007) 17567541 180721 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 15088 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Dalmora SL (2005) 15675440 180722 1213 Enoxaparin Enoxaparin sodium lovenox|enoxaparin sodium|love DRUGBANK DB01225 C26H42N2O37S5 small molecule B01AB05 9005-49-6 DRUGBANK 13853 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Patey SJ (2006) 17004727 180207 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13854 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Rezaie AR (2000) 11369259 180210 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13855 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Ignjatovic V (2006) 17118432 180209 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13856 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Rosenberg RD (1985) 3155697 180208 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 25634 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6436 N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE - - DRUGBANK DB07630 C23H26ClN5O2S small molecule - - DRUGBANK 26470 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7208 THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE - - DRUGBANK DB08426 C19H17N5O3S2 small molecule - - DRUGBANK 24473 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens antagonist target Melillo SN (2010) 20424181 182152 5535 Rivaroxaban Xarelto|BAY 59-7939|BAY59-7939 xarelto DRUGBANK DB06228 C19H18ClN3O5S small molecule B01AF01 366789-02-8 DRUGBANK 24474 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens antagonist target Ufer M (2010) 20135071 182145 5535 Rivaroxaban Xarelto|BAY 59-7939|BAY59-7939 xarelto DRUGBANK DB06228 C19H18ClN3O5S small molecule B01AF01 366789-02-8 DRUGBANK 26161 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6935 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE - - DRUGBANK DB08143 C22H19ClF2N4O3S small molecule - - DRUGBANK 27482 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Turpie AG (2008) 18096568 188551 7822 Edoxaban - savaysa DRUGBANK DB09075 C24H30ClN7O4S small molecule - 480449-70-5 DRUGBANK 25290 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6093 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE - - DRUGBANK DB07277 C17H24ClN3O5S2 small molecule - - DRUGBANK 24943 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5739 (2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE - - DRUGBANK DB06920 C24H22ClFN4O4 small molecule - - DRUGBANK 25292 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6094 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE - - DRUGBANK DB07278 C17H22ClN3O5S2 small molecule - - DRUGBANK 3655 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3656 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 24585 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Harenberg J (2008) 18393142 182072 5560 Apixaban Apixabanum|BMS 562247-01|Eliquis|BMS-562247-01|BMS-562247 eliquis DRUGBANK DB06605 C25H25N5O4 small molecule B01AF02 503612-47-3 DRUGBANK 24586 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens inhibitor target Spyropoulos AC (2007) 17371192 181996 5560 Apixaban Apixabanum|BMS 562247-01|Eliquis|BMS-562247-01|BMS-562247 eliquis DRUGBANK DB06605 C25H25N5O4 small molecule B01AF02 503612-47-3 DRUGBANK 26540 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7275 4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE - - DRUGBANK DB08495 C20H19ClN4O3S2 small molecule - - DRUGBANK 26525 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7258 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide - - DRUGBANK DB08477 C19H18ClN3O5S small molecule - - DRUGBANK 437 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target BLATRIX C (1959) 13801371 171867 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 438 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Malinvaud G (1966) 5969560 171934 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 439 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target GAERTNER H (1964) 14227143 171931 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 440 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target HERMANSKY F (1960) 13713641 171933 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 441 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target DIDISHEIM P (1959) 13621053 171932 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 22060 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3684 Gamma-Carboxy-Glutamic Acid - - DRUGBANK DB03847 C6H9NO6 small molecule - - DRUGBANK 25273 108457 2159 RP11-98F14.9 F10 FX|FXA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6077 THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE - - DRUGBANK DB07261 C21H19N5O3S2 small molecule - - DRUGBANK 27852 108458 2160 - F11 FXI 9606 Homo sapiens inhibitor target Cicardi M (2005) 16267649 195964 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 25307 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6115 4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE - - DRUGBANK DB07299 C20H36N6O3S small molecule - - DRUGBANK 25218 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6029 N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE - - DRUGBANK DB07212 C19H17N3O2 small molecule - - DRUGBANK 25078 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5892 6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER - - DRUGBANK DB07074 C21H19N3O4 small molecule - - DRUGBANK 25081 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5895 (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE - - DRUGBANK DB07077 C10H14BN3O3 small molecule - - DRUGBANK 25036 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5841 (1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE - - DRUGBANK DB07023 C18H21BN4O5 small molecule - - DRUGBANK 25035 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5840 3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPHTHYL}AMINO)CARBONYL]BENZENESULFONATE - - DRUGBANK DB07022 C21H21N3O5S small molecule - - DRUGBANK 25075 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5889 (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE - - DRUGBANK DB07071 C12H18BN3O3 small molecule - - DRUGBANK 1236 108458 2160 - F11 FXI 9606 Homo sapiens ligand target Gailani D (2001) 11342438 172391 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1237 108458 2160 - F11 FXI 9606 Homo sapiens ligand target Di Scipio RG (1978) 659613 172378 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1238 108458 2160 - F11 FXI 9606 Homo sapiens ligand target Sun MF (1999) 10593931 172392 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 25917 108458 2160 - F11 FXI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6684 (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE - - DRUGBANK DB07887 C11H16BN3O3 small molecule - - DRUGBANK 27927 108458 2160 - F11 FXI 9606 Homo sapiens inhibitor target Cicardi M (2005) 16267649 195964 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 24630 108459 2161 - F12 HAE3|HAEX|HAF 9606 Homo sapiens activator target Takada K (1991) 1986546 181646 5572 Ethanolamine Oleate Ethanolamine oleate|Monoethanolamine oleate|Oldamin|Ethamolin|beta-Hydroxyethylammonium oleate ethanolamine oleate inj 50mg/m DRUGBANK DB06689 C20H41NO3 small molecule C05BB01 2272-11-9 DRUGBANK 24631 108459 2161 - F12 HAE3|HAEX|HAF 9606 Homo sapiens activator target Kang JH (1987) 3828735 181669 5572 Ethanolamine Oleate Ethanolamine oleate|Monoethanolamine oleate|Oldamin|Ethamolin|beta-Hydroxyethylammonium oleate ethanolamine oleate inj 50mg/m DRUGBANK DB06689 C20H41NO3 small molecule C05BB01 2272-11-9 DRUGBANK 27851 108459 2161 - F12 HAE3|HAEX|HAF 9606 Homo sapiens inhibitor target de Agostini A (1984) 6725552 196046 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 27926 108459 2161 - F12 HAE3|HAEX|HAF 9606 Homo sapiens inhibitor target de Agostini A (1984) 6725552 196046 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 18978 108460 2162 RP11-232H4.1 F13A1 F13A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2245 N-Acetyl-Serine - - DRUGBANK DB02340 C5H9NO4 small molecule - 16354-58-8 DRUGBANK 18979 108460 2162 RP11-232H4.1 F13A1 F13A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2245 N-Acetyl-Serine - - DRUGBANK DB02340 C5H9NO4 small molecule - 16354-58-8 DRUGBANK 17911 108460 2162 RP11-232H4.1 F13A1 F13A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1769 1,2-Propanediol - - DRUGBANK DB01839 C3H8O2 small molecule - 57-55-6 DRUGBANK 17912 108460 2162 RP11-232H4.1 F13A1 F13A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1769 1,2-Propanediol - - DRUGBANK DB01839 C3H8O2 small molecule - 57-55-6 DRUGBANK 19251 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2365 Methoxy arachidonyl fluorophosphonate MAFP - DRUGBANK DB02465 C21H36FO2P small molecule - - DRUGBANK 19252 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2365 Methoxy arachidonyl fluorophosphonate MAFP - DRUGBANK DB02465 C21H36FO2P small molecule - - DRUGBANK 19253 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2365 Methoxy arachidonyl fluorophosphonate MAFP - DRUGBANK DB02465 C21H36FO2P small molecule - - DRUGBANK 24920 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5714 1-DODECANOL - - DRUGBANK DB06894 C12H26O small molecule - - DRUGBANK 26447 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7184 4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid - - DRUGBANK DB08400 C19H19F3N2O3 small molecule - - DRUGBANK 26431 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7169 4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid - - DRUGBANK DB08385 C16H18N2O2 small molecule - - DRUGBANK 8475 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8476 108464 2166 - FAAH FAAH-1|PSAB 9606 Homo sapiens inhibitor target Patel S (2003) 12839875 177193 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 13288 108467 2169 - FABP2 FABPI|I-FABP 9606 Homo sapiens binder target Velkov T (2005) 15722357 179906 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 19647 108470 2172 - FABP6 I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23176 108470 2172 - FABP6 I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4172 Taurocholic Acid - - DRUGBANK DB04348 C26H45NO7S small molecule - 81-24-3 DRUGBANK 23177 108470 2172 - FABP6 I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4172 Taurocholic Acid - - DRUGBANK DB04348 C26H45NO7S small molecule - 81-24-3 DRUGBANK 19707 108470 2172 - FABP6 I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2580 N-Cholylglycine - - DRUGBANK DB02691 C26H43NO6 small molecule - 475-31-0 DRUGBANK 19708 108470 2172 - FABP6 I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2580 N-Cholylglycine - - DRUGBANK DB02691 C26H43NO6 small molecule - 475-31-0 DRUGBANK 19709 108470 2172 - FABP6 I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2580 N-Cholylglycine - - DRUGBANK DB02691 C26H43NO6 small molecule - 475-31-0 DRUGBANK 3745 108476 2180 - ACSL1 ACS1|FACL1|FACL2|LACS|LACS1|LACS2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3746 108476 2180 - ACSL1 ACS1|FACL1|FACL2|LACS|LACS1|LACS2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 2138 108476 2180 - ACSL1 ACS1|FACL1|FACL2|LACS|LACS1|LACS2 9606 Homo sapiens product of target Ingram-Smith C (2006) 16981708 69339 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2139 108476 2180 - ACSL1 ACS1|FACL1|FACL2|LACS|LACS1|LACS2 9606 Homo sapiens product of target Ingram-Smith C (2007) 17350930 173057 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 3451 108477 2181 - ACSL3 ACS3|FACL3|PRO2194 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3452 108477 2181 - ACSL3 ACS3|FACL3|PRO2194 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3442 108478 2182 - ACSL4 ACS4|FACL4|LACS4|MRX63|MRX68 9606 Homo sapiens inducer target Heimli H (2003) 12784866 173834 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3443 108478 2182 - ACSL4 ACS4|FACL4|LACS4|MRX63|MRX68 9606 Homo sapiens inducer target Covault J (2004) 15108178 173835 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 6628 108478 2182 - ACSL4 ACS4|FACL4|LACS4|MRX63|MRX68 9606 Homo sapiens inhibitor target Askari B (2007) 17259370 160377 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 4151 108478 2182 - ACSL4 ACS4|FACL4|LACS4|MRX63|MRX68 9606 Homo sapiens inhibitor target Lewin TM (2002) 12147264 174287 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4152 108478 2182 - ACSL4 ACS4|FACL4|LACS4|MRX63|MRX68 9606 Homo sapiens inhibitor target Kim JH (2001) 11319222 174288 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4153 108478 2182 - ACSL4 ACS4|FACL4|LACS4|MRX63|MRX68 9606 Homo sapiens inhibitor target Lewin TM (2001) 11319232 174289 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 17889 108479 2184 - FAH - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1762 4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid - - DRUGBANK DB01832 C5H9O5P small molecule - - DRUGBANK 17890 108479 2184 - FAH - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1762 4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid - - DRUGBANK DB01832 C5H9O5P small molecule - - DRUGBANK 17891 108479 2184 - FAH - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1762 4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid - - DRUGBANK DB01832 C5H9O5P small molecule - - DRUGBANK 17736 108479 2184 - FAH - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1695 Acetoacetic Acid - - DRUGBANK DB01762 C4H6O3 small molecule - 541-50-4 DRUGBANK 17737 108479 2184 - FAH - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1695 Acetoacetic Acid - - DRUGBANK DB01762 C4H6O3 small molecule - 541-50-4 DRUGBANK 17738 108479 2184 - FAH - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1695 Acetoacetic Acid - - DRUGBANK DB01762 C4H6O3 small molecule - 541-50-4 DRUGBANK 17547 108479 2184 - FAH - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1613 Fumarate - - DRUGBANK DB01677 C4H2O4 small molecule - 110-17-8 DRUGBANK 17548 108479 2184 - FAH - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1613 Fumarate - - DRUGBANK DB01677 C4H2O4 small molecule - 110-17-8 DRUGBANK 17549 108479 2184 - FAH - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1613 Fumarate - - DRUGBANK DB01677 C4H2O4 small molecule - 110-17-8 DRUGBANK 17495 108480 2185 - PTK2B CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 17496 108480 2185 - PTK2B CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 26383 108480 2185 - PTK2B CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7127 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide - - DRUGBANK DB08341 C19H25F3N6O2S small molecule - - DRUGBANK 13698 108480 2185 - PTK2B CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK 9606 Homo sapiens antagonist target Steeghs N (2007) 17103252 180113 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13699 108480 2185 - PTK2B CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK 9606 Homo sapiens antagonist target Pytel D (2009) 19149483 180112 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 13700 108480 2185 - PTK2B CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK 9606 Homo sapiens antagonist target Fukushima R (2007) 17604599 180110 1085 Leflunomide Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum arava 20 mg|arava 10mg|teva-le DRUGBANK DB01097 C12H9F3N2O2 small molecule L04AA13 75706-12-6 DRUGBANK 1770 108487 2193 - FARSA CML33|FARSL|FARSLA|FRSA|PheHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1771 108487 2193 - FARSA CML33|FARSL|FARSLA|FRSA|PheHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1772 108487 2193 - FARSA CML33|FARSL|FARSLA|FRSA|PheHA 9606 Homo sapiens unknown target Kodama K (2006) 16969782 172734 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1773 108487 2193 - FARSA CML33|FARSL|FARSLA|FRSA|PheHA 9606 Homo sapiens unknown target Kotik-Kogan O (2005) 16338408 172735 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 13021 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13022 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Oskouian B (1999) 10102370 47998 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13023 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Heiligtag SJ (2002) 12181752 179812 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13024 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Lupu R (2006) 17168665 179813 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13025 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Flavin R (2010) 20373869 179810 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13026 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Ronnett GV (2005) 15878185 179811 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13027 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Li JN (2001) 11245456 179814 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13593 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Purohit VC (2006) 16749788 180052 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13594 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Kremer L (2005) 16091048 180053 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13595 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Kridel SJ (2004) 15026345 180050 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13596 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Knowles LM (2004) 15138278 180051 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13597 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Menendez JA (2005) 15870086 180054 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13598 108488 2194 - FASN FAS|OA-519|SDR27X1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 20020 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2730 {4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol - - DRUGBANK DB02848 C22H22N4O3S small molecule - - DRUGBANK 23557 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23558 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23559 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 26530 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7264 4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE - - DRUGBANK DB08484 C9H13N3O3S2 small molecule - - DRUGBANK 25328 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6137 2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE - - DRUGBANK DB07321 C20H15Cl2N3O5S small molecule - - DRUGBANK 22765 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4005 Mdl-29951 - - DRUGBANK DB04175 C12H9Cl2NO4 small molecule - 101861-63-6 DRUGBANK 2112 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens antagonist target Xue Y (1994) 7809062 173044 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2113 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens antagonist target Hebeisen P (2008) 18650089 173043 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2114 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens inhibitory allosteric modulator target Xue Y (1994) 7809062 173044 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2115 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens inhibitory allosteric modulator target Hebeisen P (2008) 18650089 173043 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 19900 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2661 2,5-Anhydroglucitol-1,6-Biphosphate - - DRUGBANK DB02778 C6H14O11P2 small molecule - - DRUGBANK 19901 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2661 2,5-Anhydroglucitol-1,6-Biphosphate - - DRUGBANK DB02778 C6H14O11P2 small molecule - - DRUGBANK 19902 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2661 2,5-Anhydroglucitol-1,6-Biphosphate - - DRUGBANK DB02778 C6H14O11P2 small molecule - - DRUGBANK 25282 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6086 N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE - - DRUGBANK DB07270 C20H15Cl2N3O4S small molecule - - DRUGBANK 25319 108497 2203 RP11-342C23.1 FBP1 FBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6128 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE - - DRUGBANK DB07312 C13H7Cl3N2O3S small molecule - - DRUGBANK 552 108499 2205 RP11-550P17.3 FCER1A FCE1A|FcERI 9606 Homo sapiens unknown target Mirkina I (2007) 17368811 172013 42 Omalizumab Ig gamma-1 chain C region xolair DRUGBANK DB00043 C6450H9916N1714O2023S38 biologic R03DX05 242138-07-4 DRUGBANK 553 108499 2205 RP11-550P17.3 FCER1A FCE1A|FcERI 9606 Homo sapiens unknown target Beck LA (2004) 15356552 172012 42 Omalizumab Ig gamma-1 chain C region xolair DRUGBANK DB00043 C6450H9916N1714O2023S38 biologic R03DX05 242138-07-4 DRUGBANK 11457 108499 2205 RP11-550P17.3 FCER1A FCE1A|FcERI 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 11458 108499 2205 RP11-550P17.3 FCER1A FCE1A|FcERI 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 11459 108499 2205 RP11-550P17.3 FCER1A FCE1A|FcERI 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 11460 108499 2205 RP11-550P17.3 FCER1A FCE1A|FcERI 9606 Homo sapiens agonist target Chandra RK (1980) 7436456 178934 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 554 108500 2206 - MS4A2 APY|ATOPY|FCER1B|FCERI|IGEL|IGER|IGHER|MS4A1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 42 Omalizumab Ig gamma-1 chain C region xolair DRUGBANK DB00043 C6450H9916N1714O2023S38 biologic R03DX05 242138-07-4 DRUGBANK 555 108500 2206 - MS4A2 APY|ATOPY|FCER1B|FCERI|IGEL|IGER|IGHER|MS4A1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 42 Omalizumab Ig gamma-1 chain C region xolair DRUGBANK DB00043 C6450H9916N1714O2023S38 biologic R03DX05 242138-07-4 DRUGBANK 556 108500 2206 - MS4A2 APY|ATOPY|FCER1B|FCERI|IGEL|IGER|IGHER|MS4A1 9606 Homo sapiens antagonist target DuBuske LM (2006) 17073688 172014 42 Omalizumab Ig gamma-1 chain C region xolair DRUGBANK DB00043 C6450H9916N1714O2023S38 biologic R03DX05 242138-07-4 DRUGBANK 11461 108501 2207 - FCER1G FCRG 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 11462 108501 2207 - FCER1G FCRG 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 11463 108501 2207 - FCER1G FCRG 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 11464 108501 2207 - FCER1G FCRG 9606 Homo sapiens agonist target Chandra RK (1980) 7436456 178934 885 Benzylpenicilloyl Polylysine Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine pre-pen DRUGBANK DB00895 C28H46N6O8S small molecule - 31855-75-1 DRUGBANK 9686 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens antagonist target Krutmann J (1989) 2544592 177939 697 Porfimer Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium photofrin DRUGBANK DB00707 C68H74N8O11 small molecule L01XD01 87806-31-3 DRUGBANK 1025 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1026 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 729 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Ericson SG (1994) 7509291 172095 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1361 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Simms HH (1991) 1828823 172452 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 312 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 313 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 314 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 613 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 614 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 654 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 655 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 12571 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens antibody target Imming P (2006) 17016423 171742 982 Methyl aminolevulinate Methyl aminolevulinate|Aminolevulinic acid methyl ester|Methyl delta-aminolevulinate|5-Aminolevulinic acid methyl ester metvix DRUGBANK DB00992 C6H11NO3 small molecule L01XD03 33320-16-0 DRUGBANK 12572 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens antibody target Overington JP (2006) 17139284 171741 982 Methyl aminolevulinate Methyl aminolevulinate|Aminolevulinic acid methyl ester|Methyl delta-aminolevulinate|5-Aminolevulinic acid methyl ester metvix DRUGBANK DB00992 C6H11NO3 small molecule L01XD03 33320-16-0 DRUGBANK 1139 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1140 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 30 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Negri DR (1995) 7547242 171749 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 56 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 57 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 935 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 936 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 890 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 891 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Curnow RT (1998) 9435876 172204 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 892 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1310 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1311 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1185 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1186 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1096 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1097 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1052 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1053 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 948 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 949 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1389 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1390 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 994 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 995 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1332 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1333 108503 2209 RP11-196G18.2 FCGR1A CD64|CD64A|FCRI|IGFR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 333 108504 2210 RP11-439A17.1 FCGR1B CD64b|IGFRB 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 334 108504 2210 RP11-439A17.1 FCGR1B CD64b|IGFRB 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 335 108504 2210 RP11-439A17.1 FCGR1B CD64b|IGFRB 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 713 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 714 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1338 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1339 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 309 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 310 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 311 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 599 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 600 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 637 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 638 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1011 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1012 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1137 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1138 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 11 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 12 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Zhang W (2007) 17704420 171743 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 13 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 52 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Hughes LB (2004) 15526004 171758 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 53 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Criswell LA (2004) 15457442 171757 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 917 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Hatjiharissi E (2007) 17324336 172213 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 918 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Kim DH (2006) 16609067 172212 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 906 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 907 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Zhang W (2007) 17704420 171743 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 908 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1292 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1293 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1169 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1170 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1083 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Lin TS (2005) 15217834 172272 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1038 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1039 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 944 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 945 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1373 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1374 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 980 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 981 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1316 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1317 108506 2212 RP11-5K23.6 FCGR2A CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 709 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 710 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1336 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1337 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 306 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 307 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 308 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 595 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 596 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 633 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 634 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1197 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 1007 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1008 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1129 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1130 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 7 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 8 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 50 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 51 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 913 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 914 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 882 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 883 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1290 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1291 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1187 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1188 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1081 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1082 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1036 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1037 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 942 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 943 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1371 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1372 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 976 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 977 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1334 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1335 108507 2213 RP11-474I16.2 FCGR2B CD32|CD32B|FCG2|FCGR2|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 724 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 725 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 726 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Ericson SG (1994) 7509291 172095 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1351 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1352 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 315 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 316 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 317 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 609 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 610 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 650 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 651 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1021 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1022 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1147 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target da Silva AJ (2002) 11970990 172361 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1148 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1149 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Vaishnaw AK (2002) 12795239 172363 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1150 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 25 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 26 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Zhang W (2007) 17704420 171743 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 27 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 65 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Hughes LB (2004) 15526004 171758 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 66 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Criswell LA (2004) 15457442 171757 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 930 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Niwa R (2004) 15448014 172218 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 931 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Hatjiharissi E (2007) 17324336 172213 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 932 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Kim DH (2006) 16609067 172212 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 898 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Suzuki E (2007) 17363544 172205 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1312 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1313 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1181 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1182 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1093 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Lin TS (2005) 15217834 172272 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1048 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1049 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 956 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 957 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1383 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1384 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 990 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 991 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1328 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1329 108508 2214 RP11-5K23.1 FCGR3A CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 715 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Rogler G (1998) 9649182 172096 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 716 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Ericson SG (1994) 7509291 172095 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 717 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Caron PC (1995) 9815888 172094 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1340 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Martelletti P (1990) 2335478 172444 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1341 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Hoshino S (1991) 1835892 172445 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1342 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Galandrini R (1993) 8097750 172446 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1343 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Hayakawa K (1991) 1900882 172447 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1344 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Lanier LL (1985) 2415663 172443 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 318 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 319 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 320 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 601 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 602 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 639 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 640 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1013 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1014 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1153 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target da Silva AJ (2002) 11970990 172361 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 14 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Snyder LC (2005) 16336752 171744 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 74 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Hart SP (2000) 10800083 171764 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 75 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Ozgocmen S (2007) 17387033 171765 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 76 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Criswell LA (2004) 15457442 171757 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 77 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Hughes LB (2004) 15526004 171758 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 919 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Treon SP (2005) 15659493 172215 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 920 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Bowles JA (2006) 16825493 172214 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 921 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Hatjiharissi E (2007) 17475906 172216 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 922 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Bowles JA (2005) 16109421 172208 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 901 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Shahied LS (2004) 15471859 172206 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 902 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Kubo M (2003) 14666732 172207 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 903 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Xie Z (2005) 15680154 172210 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 904 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Bowles JA (2005) 16109421 172208 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 905 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Yamaguchi Y (2005) 15868915 172209 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1295 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1296 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1173 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1174 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1084 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Brett S (1996) 8707338 172273 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1085 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Nagler A (1997) 9337053 172275 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1086 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Osterborg A (1997) 9020367 172274 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1040 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1041 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 966 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 967 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1375 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1376 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 982 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Pellegrini P (1996) 10851527 172232 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 983 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Contasta I (1996) 10851498 172231 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1320 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1321 108509 2215 RP11-25K21.3 FCGR3B CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 23831 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4518 ISOPENTENYL PYROPHOSPHATE - - DRUGBANK DB04714 C5H12O7P2 small molecule - - DRUGBANK 8805 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 8806 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Bergstrom JD (2000) 10620343 174891 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 8807 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Guo RT (2007) 17535895 175844 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 8808 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Dunford JE (2001) 11160603 174892 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 17785 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1717 Dimethylallyl Diphosphate - - DRUGBANK DB01785 C5H12O7P2 small molecule - 358-72-5 DRUGBANK 11394 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Coxon FP (2005) 16006204 178877 874 Risedronate Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate pms-risedronate plus calcium|p DRUGBANK DB00884 C7H11NO7P2 small molecule M05BB02|M05BB04|M05BB07|M05BA07 105462-24-6 DRUGBANK 11395 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 874 Risedronate Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate pms-risedronate plus calcium|p DRUGBANK DB00884 C7H11NO7P2 small molecule M05BB02|M05BB04|M05BB07|M05BA07 105462-24-6 DRUGBANK 11396 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Bergstrom JD (2000) 10620343 174891 874 Risedronate Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate pms-risedronate plus calcium|p DRUGBANK DB00884 C7H11NO7P2 small molecule M05BB02|M05BB04|M05BB07|M05BA07 105462-24-6 DRUGBANK 11397 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Russell RG (2007) 18056045 178879 874 Risedronate Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate pms-risedronate plus calcium|p DRUGBANK DB00884 C7H11NO7P2 small molecule M05BB02|M05BB04|M05BB07|M05BA07 105462-24-6 DRUGBANK 11398 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Dunford JE (2001) 11160603 174892 874 Risedronate Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate pms-risedronate plus calcium|p DRUGBANK DB00884 C7H11NO7P2 small molecule M05BB02|M05BB04|M05BB07|M05BA07 105462-24-6 DRUGBANK 11399 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Ortiz-Gomez A (2006) 16835450 178878 874 Risedronate Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate pms-risedronate plus calcium|p DRUGBANK DB00884 C7H11NO7P2 small molecule M05BB02|M05BB04|M05BB07|M05BA07 105462-24-6 DRUGBANK 25805 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 9702 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 700 Ibandronate Bondronat|Ibandronic Acid bondronat|boniva|ibandronate s DRUGBANK DB00710 C9H23NO7P2 small molecule M05BA06 114084-78-5 DRUGBANK 9703 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Chapurlat RD (2006) 16932286 177963 700 Ibandronate Bondronat|Ibandronic Acid bondronat|boniva|ibandronate s DRUGBANK DB00710 C9H23NO7P2 small molecule M05BA06 114084-78-5 DRUGBANK 9704 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Rondeau JM (2006) 16892359 177962 700 Ibandronate Bondronat|Ibandronic Acid bondronat|boniva|ibandronate s DRUGBANK DB00710 C9H23NO7P2 small molecule M05BA06 114084-78-5 DRUGBANK 9705 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Dunford JE (2001) 11160603 174892 700 Ibandronate Bondronat|Ibandronic Acid bondronat|boniva|ibandronate s DRUGBANK DB00710 C9H23NO7P2 small molecule M05BA06 114084-78-5 DRUGBANK 25861 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 6524 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Glickman JF (2007) 17477829 175843 391 Zoledronic acid Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid reclast|act zoledronic acid co DRUGBANK DB00399 C5H10N2O7P2 small molecule M05BA08|M05BB08 118072-93-8 DRUGBANK 6526 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Dunford JE (2001) 11160603 174892 391 Zoledronic acid Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid reclast|act zoledronic acid co DRUGBANK DB00399 C5H10N2O7P2 small molecule M05BA08|M05BB08 118072-93-8 DRUGBANK 6525 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 391 Zoledronic acid Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid reclast|act zoledronic acid co DRUGBANK DB00399 C5H10N2O7P2 small molecule M05BA08|M05BB08 118072-93-8 DRUGBANK 6523 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Guo RT (2007) 17535895 175844 391 Zoledronic acid Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid reclast|act zoledronic acid co DRUGBANK DB00399 C5H10N2O7P2 small molecule M05BA08|M05BB08 118072-93-8 DRUGBANK 19363 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2405 Isopentyl Pyrophosphate - - DRUGBANK DB02508 C5H14O7P2 small molecule - - DRUGBANK 5099 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Zhang PL (2004) 15487700 174888 275 Pamidronate Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat aredia liq inj 3mg/ml|val-pami DRUGBANK DB00282 C3H11NO7P2 small molecule M05BA03 40391-99-9 DRUGBANK 5100 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Notarnicola M (2005) 15713990 174889 275 Pamidronate Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat aredia liq inj 3mg/ml|val-pami DRUGBANK DB00282 C3H11NO7P2 small molecule M05BA03 40391-99-9 DRUGBANK 5101 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 275 Pamidronate Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat aredia liq inj 3mg/ml|val-pami DRUGBANK DB00282 C3H11NO7P2 small molecule M05BA03 40391-99-9 DRUGBANK 5102 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Bergstrom JD (2000) 10620343 174891 275 Pamidronate Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat aredia liq inj 3mg/ml|val-pami DRUGBANK DB00282 C3H11NO7P2 small molecule M05BA03 40391-99-9 DRUGBANK 5103 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Riebeling C (2002) 12177810 174890 275 Pamidronate Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat aredia liq inj 3mg/ml|val-pami DRUGBANK DB00282 C3H11NO7P2 small molecule M05BA03 40391-99-9 DRUGBANK 5104 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens inhibitor target Dunford JE (2001) 11160603 174892 275 Pamidronate Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat aredia liq inj 3mg/ml|val-pami DRUGBANK DB00282 C3H11NO7P2 small molecule M05BA03 40391-99-9 DRUGBANK 19448 108517 2224 - FDPS FPPS|FPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2449 Geranyl Diphosphate - - DRUGBANK DB02552 C10H20O7P2 small molecule - - DRUGBANK 8988 108521 2230 - FDX1 ADX|FDX|LOH11CR1D 9606 Homo sapiens unknown target Cai W (1997) 9118466 177555 638 Mitotane Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum lysodren DRUGBANK DB00648 C14H10Cl4 small molecule L01XX23 53-19-0 DRUGBANK 8989 108521 2230 - FDX1 ADX|FDX|LOH11CR1D 9606 Homo sapiens unknown target Cabrini DA (2001) 11159707 177557 638 Mitotane Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum lysodren DRUGBANK DB00648 C14H10Cl4 small molecule L01XX23 53-19-0 DRUGBANK 8990 108521 2230 - FDX1 ADX|FDX|LOH11CR1D 9606 Homo sapiens unknown target Kandul SV (1986) 3770229 177556 638 Mitotane Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum lysodren DRUGBANK DB00648 C14H10Cl4 small molecule L01XX23 53-19-0 DRUGBANK 20618 108523 2232 - FDXR ADXR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21285 108523 2232 - FDXR ADXR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 19653 108526 2235 - FECH EPP|FCE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 19654 108526 2235 - FECH EPP|FCE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 19642 108526 2235 - FECH EPP|FCE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 24158 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Ahmed NK (1990) 1696922 181642 4717 Alfimeprase - - DRUGBANK DB04919 - biologic - 259074-76-5 DRUGBANK 183 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Melandri G (2009) 19436656 171787 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 184 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Longstaff C (2008) 18673235 171788 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 185 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 391 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Melandri G (2009) 19436656 171787 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 392 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Longstaff C (2008) 18673235 171788 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 393 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 343 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 344 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 24343 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Spuentrup E (2007) 17948194 182058 5287 EP-2104R EP 2104R - DRUGBANK DB05675 - biologic - - DRUGBANK 24344 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Spuentrup E (2007) 17620942 182028 5287 EP-2104R EP 2104R - DRUGBANK DB05675 - biologic - - DRUGBANK 6015 108534 2243 - FGA Fib2 9606 Homo sapiens antagonist target Terao N (1980) 6892775 175526 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 109 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Melandri G (2009) 19436656 171787 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 110 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Longstaff C (2008) 18673235 171788 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 111 108534 2243 - FGA Fib2 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 6013 108535 2244 - FGB HEL-S-78p 9606 Homo sapiens antagonist target Terao N (1980) 6892775 175526 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 24157 108535 2244 - FGB HEL-S-78p 9606 Homo sapiens unknown target Ahmed NK (1990) 1696922 181642 4717 Alfimeprase - - DRUGBANK DB04919 - biologic - 259074-76-5 DRUGBANK 23353 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4227 Naphthalene Trisulfonate - - DRUGBANK DB04409 C10H5O9S3 small molecule - - DRUGBANK 23354 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4227 Naphthalene Trisulfonate - - DRUGBANK DB04409 C10H5O9S3 small molecule - - DRUGBANK 23355 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4227 Naphthalene Trisulfonate - - DRUGBANK DB04409 C10H5O9S3 small molecule - - DRUGBANK 18037 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1828 Sucrosofate Sucrose octasulfate - DRUGBANK DB01901 C12H22O35S8 small molecule - 57680-56-5 DRUGBANK 18038 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1828 Sucrosofate Sucrose octasulfate - DRUGBANK DB01901 C12H22O35S8 small molecule - 57680-56-5 DRUGBANK 18039 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1828 Sucrosofate Sucrose octasulfate - DRUGBANK DB01901 C12H22O35S8 small molecule - 57680-56-5 DRUGBANK 22279 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 22280 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 9493 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens antagonist target Jerebtsova M (2007) 17071728 177814 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9494 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens antagonist target Pascu C (1996) 8867461 177815 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9495 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens antagonist target Zenjari C (1996) 8946244 177816 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 18834 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 18835 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 24581 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens inhibitor target Deeks ED (2012) 23072642 182214 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 18122 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18123 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 12911 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens inhibitor target Rajalingam D (2005) 16300395 179756 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 26291 108537 2246 - FGF1 AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7028 5-AMINO-NAPHTALENE-2-MONOSULFONATE - - DRUGBANK DB08238 C10H9NO3S small molecule - - DRUGBANK 22217 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3771 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03935 C6H10O8S small molecule - - DRUGBANK 22218 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3771 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03935 C6H10O8S small molecule - - DRUGBANK 22333 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 22334 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 22277 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 22278 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 9488 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens antagonist target Zugmaier G (2000) 10667230 177811 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9489 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens antagonist target Pluda JM (1993) 7692072 177812 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9490 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens antagonist target Mucha S (2002) 12375053 177813 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9491 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens antagonist target Jerebtsova M (2007) 17071728 177814 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9492 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens antagonist target McLeskey SW (1996) 8738610 177808 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 11349 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens unknown target Sehgal SN (2003) 12742462 178847 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 6016 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens agonist target Szabo S (1995) 8578198 175527 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 6017 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens agonist target Konturek SJ (1990) 1970337 175531 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 6018 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens agonist target Tarnawski A (1995) 8578218 175530 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 6019 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens agonist target Szabo S (1991) 1957124 175528 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 6020 108538 2247 - FGF2 BFGF|FGF-2|FGFB|HBGF-2 9606 Homo sapiens agonist target Korman MG (1994) 7948825 175529 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 9485 108540 2249 - FGF4 HBGF-4|HST|HST-1|HSTF1|K-FGF|KFGF 9606 Homo sapiens inhibitor target Zugmaier G (1992) 1279186 177810 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9486 108540 2249 - FGF4 HBGF-4|HST|HST-1|HSTF1|K-FGF|KFGF 9606 Homo sapiens inhibitor target Wellstein A (1991) 1708834 177809 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 9487 108540 2249 - FGF4 HBGF-4|HST|HST-1|HSTF1|K-FGF|KFGF 9606 Homo sapiens inhibitor target McLeskey SW (1996) 8738610 177808 676 Pentosan Polysulfate Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas elmiron DRUGBANK DB00686 C10H18O21S4 small molecule C05BA04|G04BX15 37300-21-3 DRUGBANK 470 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Sher I (2000) 10950949 3241 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 469 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Lu W (1999) 10212269 171961 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 472 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Matsubara A (1999) 11091737 171959 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 471 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Wang F (1999) 9890894 171958 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 473 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Ostrovsky O (2002) 11714710 171960 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 18423 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1979 SU4984 - - DRUGBANK DB02058 C20H21N3O2 small molecule - - DRUGBANK 25540 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6335 3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine - - DRUGBANK DB07525 C15H14N2O small molecule - - DRUGBANK 6515 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Carlomagno F (2006) 16507829 175814 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6516 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Wilhelm S (2006) 17016424 175812 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6517 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Wilhelm SM (2004) 15466206 175813 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 26618 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7354 3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE - - DRUGBANK DB08577 C17H16N2O3 small molecule - - DRUGBANK 26968 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Ren M (2013) 23563700 182243 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 26969 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Gozgit JM (2013) 23468082 182234 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 25858 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6637 (E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol - - DRUGBANK DB07840 C21H14F2N2O2 small molecule - - DRUGBANK 27499 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 27491 108551 2260 - FGFR1 BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 24573 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens inhibitor target Deeks ED (2012) 23072642 182214 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 464 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens unknown target Mummery CL (1993) 7680555 171953 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 465 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens unknown target Cancilla B (2001) 11422746 171957 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 466 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens unknown target Beer HD (2000) 10821861 171956 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 467 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens unknown target Yamanaka T (2000) 11149756 171955 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 468 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens unknown target Launay C (1994) 7890137 171954 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 26967 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens inhibitor target Gozgit JM (2013) 23468082 182234 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 27490 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 27498 108552 2261 - FGFR3 ACH|CD333|CEK2|HSFGFR3EX|JTK4 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 474 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Beaven AW (2007) 17728847 171962 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 475 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Cardoso WV (1997) 9056643 171963 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 476 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Berman B (1999) 10593896 171966 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 477 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Radtke ML (2005) 16390600 171967 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 478 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Patrie KM (1995) 7499435 171964 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 479 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Huang YW (2006) 16854582 171965 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 480 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Zhu X (2007) 17456767 171968 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 481 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 18422 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 1979 SU4984 - - DRUGBANK DB02058 C20H21N3O2 small molecule - - DRUGBANK 26971 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens inhibitor target Gozgit JM (2013) 23468082 182234 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 19315 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2388 4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine - - DRUGBANK DB02491 C25H30ClN5O small molecule - - DRUGBANK 19316 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2388 4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine - - DRUGBANK DB02491 C25H30ClN5O small molecule - - DRUGBANK 13087 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens antagonist target Eichholz A (2010) 20616958 179850 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 27497 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 27489 108554 2263 - FGFR2 BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 485 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens unknown target Imagawa W (1994) 7526860 171971 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 486 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens unknown target Luo Y (1998) 9843417 171970 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 487 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens unknown target Sher I (2000) 10950949 3241 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 488 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens unknown target Sannes PL (1998) 9755102 171972 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 489 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens unknown target Yamanaka T (2000) 11149756 171955 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 26973 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens inhibitor target Gozgit JM (2013) 23468082 182234 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 27495 108555 2264 - FGFR4 CD334|JTK2|TKF 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 6014 108557 2266 PRO2061 FGG - 9606 Homo sapiens antagonist target Terao N (1980) 6892775 175526 356 Sucralfate Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat sulcrate suspension plus|caraf DRUGBANK DB00364 C11H28Al8O51S8 small molecule A02BX02 54182-58-0 DRUGBANK 22763 108563 2272 - FHIT AP3Aase|FRA3B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4003 Fructose - good neighbor pharmacy anti na DRUGBANK DB04173 C6H12O6 small molecule V06DC02 - DRUGBANK 22764 108563 2272 - FHIT AP3Aase|FRA3B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4003 Fructose - good neighbor pharmacy anti na DRUGBANK DB04173 C6H12O6 small molecule V06DC02 - DRUGBANK 23249 108563 2272 - FHIT AP3Aase|FRA3B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4211 Ado-P-Ch2-P-Ps-Ado - - DRUGBANK DB04389 C21H29N10O14P3S small molecule - - DRUGBANK 23250 108563 2272 - FHIT AP3Aase|FRA3B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4211 Ado-P-Ch2-P-Ps-Ado - - DRUGBANK DB04389 C21H29N10O14P3S small molecule - - DRUGBANK 19041 108563 2272 - FHIT AP3Aase|FRA3B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2278 Adenosine Monotungstate - - DRUGBANK DB02373 C10H14N5O7W small molecule - - DRUGBANK 19042 108563 2272 - FHIT AP3Aase|FRA3B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2278 Adenosine Monotungstate - - DRUGBANK DB02373 C10H14N5O7W small molecule - - DRUGBANK 11235 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens inhibitor target Masri M (2007) 17524933 178762 854 Tacrolimus Tacrolimus anhydrous|Anhydrous tacrolimus|Tacrolimus, anhydrous envarsus xr|advagraf|sandoz ta DRUGBANK DB00864 C44H69NO12 small molecule L04AD02|D11AH01 104987-11-3 DRUGBANK 11236 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens inhibitor target Labrande C (2005) 16289353 178761 854 Tacrolimus Tacrolimus anhydrous|Anhydrous tacrolimus|Tacrolimus, anhydrous envarsus xr|advagraf|sandoz ta DRUGBANK DB00864 C44H69NO12 small molecule L04AD02|D11AH01 104987-11-3 DRUGBANK 17643 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1647 (3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester - - DRUGBANK DB01712 C23H28N2O5S2 small molecule - - DRUGBANK 20076 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2768 FKB-001 - - DRUGBANK DB02888 C35H42F2N2O6 small molecule - - DRUGBANK 20077 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2768 FKB-001 - - DRUGBANK DB02888 C35H42F2N2O6 small molecule - - DRUGBANK 20078 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2768 FKB-001 - - DRUGBANK DB02888 C35H42F2N2O6 small molecule - - DRUGBANK 22552 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3926 4-Hydroxy-2-Butanone - - DRUGBANK DB04094 C4H8O2 small molecule - - DRUGBANK 22553 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3926 4-Hydroxy-2-Butanone - - DRUGBANK DB04094 C4H8O2 small molecule - - DRUGBANK 22554 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3926 4-Hydroxy-2-Butanone - - DRUGBANK DB04094 C4H8O2 small molecule - - DRUGBANK 21002 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3201 Heptyl-Beta-D-Glucopyranoside - - DRUGBANK DB03338 C13H26O6 small molecule - - DRUGBANK 26569 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7298 (21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE - - DRUGBANK DB08520 C24H39NO6 small molecule - - DRUGBANK 18915 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2218 Methyl Methylsulfinylmethyl Sulfide - - DRUGBANK DB02311 C3H8OS2 small molecule - 33577-16-1 DRUGBANK 18916 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2218 Methyl Methylsulfinylmethyl Sulfide - - DRUGBANK DB02311 C3H8OS2 small molecule - 33577-16-1 DRUGBANK 18917 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2218 Methyl Methylsulfinylmethyl Sulfide - - DRUGBANK DB02311 C3H8OS2 small molecule - 33577-16-1 DRUGBANK 17658 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1658 {3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid - - DRUGBANK DB01723 C38H47NO11 small molecule - - DRUGBANK 17659 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1658 {3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid - - DRUGBANK DB01723 C38H47NO11 small molecule - - DRUGBANK 17660 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1658 {3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid - - DRUGBANK DB01723 C38H47NO11 small molecule - - DRUGBANK 11347 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Sehgal SN (2003) 12742462 178847 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 11348 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 21604 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3468 L-709,587 - - DRUGBANK DB03621 C52H76N2O13 small molecule - - DRUGBANK 21605 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3468 L-709,587 - - DRUGBANK DB03621 C52H76N2O13 small molecule - - DRUGBANK 21606 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3468 L-709,587 - - DRUGBANK DB03621 C52H76N2O13 small molecule - - DRUGBANK 26248 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 18146 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1875 Gpi-1046 - - DRUGBANK DB01951 C20H28N2O4 small molecule - - DRUGBANK 22383 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3846 (3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine - - DRUGBANK DB04012 C18H26N2O5S2 small molecule - - DRUGBANK 5758 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens potentiator target Reitamo S (2002) 12113647 175334 329 Pimecrolimus Pimecrolimusum|Pimecrolimus|33-Epi-chloro-33-desoxyascomycin elidel DRUGBANK DB00337 C43H68ClNO11 small molecule D11AH02 137071-32-0 DRUGBANK 26630 108570 2280 RP11-314N13.2 FKBP1A FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7374 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine - - DRUGBANK DB08597 C24H25N5O small molecule - - DRUGBANK 24068 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens unknown target Yamamoto A (2007) 17584317 182020 4679 Vatalanib PTK 787|PTK/ZK|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate - DRUGBANK DB04879 C20H15ClN4 small molecule - 212141-54-3 DRUGBANK 24595 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Cohen EE (2008) 18541897 182081 5564 Axitinib - inlyta DRUGBANK DB06626 - small molecule L01XE17 319460-85-0 DRUGBANK 25299 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6104 N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide - - DRUGBANK DB07288 C19H16ClN3O small molecule - - DRUGBANK 24576 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Sonpavde G (2007) 17288876 181986 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 6485 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Carlomagno F (2006) 16507829 175814 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6486 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Wilhelm S (2006) 17016424 175812 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6487 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Wilhelm SM (2004) 15466206 175813 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 27599 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Roskoski R (2007) 17367763 180930 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27600 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target O'Farrell AM (2003) 14654525 180938 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27501 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 27493 108609 2321 - FLT1 FLT|FLT-1|VEGFR-1|VEGFR1 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 6521 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens antagonist target Lierman E (2007) 17229632 175832 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6522 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens antagonist target Auclair D (2007) 17205056 175835 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 27503 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 26976 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target Smith CC (2013) 23430109 182232 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 27615 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27616 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target O'Farrell AM (2003) 12531805 180944 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27617 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target Schmidt-Arras D (2004) 15180525 180945 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27618 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target Yee KW (2004) 15304385 180946 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27619 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target Baratte S (2004) 14753710 180935 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27620 108610 2322 RP11-153M24.3 FLT3 CD135|FLK-2|FLK2|STK1 9606 Homo sapiens inhibitor target O'Farrell AM (2003) 14654525 180938 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 24067 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens unknown target Yamamoto A (2007) 17584317 182020 4679 Vatalanib PTK 787|PTK/ZK|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate - DRUGBANK DB04879 C20H15ClN4 small molecule - 212141-54-3 DRUGBANK 24594 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Cohen EE (2008) 18541897 182081 5564 Axitinib - inlyta DRUGBANK DB06626 - small molecule L01XE17 319460-85-0 DRUGBANK 24572 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens unknown target Sonpavde G (2007) 17288876 181986 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 6480 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens antagonist target Adnane L (2006) 16757355 175807 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6481 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens antagonist target Reddy GK (2006) 16729906 175809 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6482 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens antagonist target Strumberg D (2005) 16474853 175808 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6483 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens antagonist target Lathia C (2006) 16133532 175810 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6484 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens antagonist target Gridelli C (2007) 17296815 175811 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 27588 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Katoh Y (2006) 16685460 180931 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27589 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Roskoski R (2007) 17367763 180930 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27590 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Deprimo SE (2007) 17605814 180933 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27591 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Ahmed SI (2004) 15688612 180932 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27592 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Gridelli C (2007) 17296815 175811 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27496 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 27488 108612 2324 - FLT4 FLT41|LMPH1A|PCL|VEGFR3 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 26954 108621 2335 - FN1 CIG|ED-B|FINC|FN|FNZ|GFND|GFND2|LETS|MSF 9606 Homo sapiens cleavage target Tsui I (2012) 23193358 182220 7632 Ocriplasmin - jetrea DRUGBANK DB08888 C1214H1890N338O348S14 biologic S01XA22 1048016-09-6 DRUGBANK 25789 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6572 [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID - - DRUGBANK DB07771 C17H30NO5P small molecule - - DRUGBANK 24096 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Wakeling AE (2005) 16113095 181904 4693 AZD3409 - - DRUGBANK DB04893 - small molecule - - DRUGBANK 26207 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6972 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE - - DRUGBANK DB08180 C19H37NO7P2 small molecule - - DRUGBANK 26689 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7450 (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE - - DRUGBANK DB08676 C27H27N5O2 small molecule - - DRUGBANK 25236 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6043 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE - - DRUGBANK DB07227 C22H20ClN5O small molecule - - DRUGBANK 26686 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7448 (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE - - DRUGBANK DB08674 C26H21N5O2 small molecule - - DRUGBANK 25809 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 25865 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 25223 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6032 (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE - - DRUGBANK DB07216 C24H29ClN4O2S small molecule - - DRUGBANK 25922 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6692 ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID - - DRUGBANK DB07895 C15H33O4P small molecule - - DRUGBANK 24975 108625 2339 - FNTA FPTA|PGGT1A|PTAR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5772 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE - - DRUGBANK DB06953 C25H17Cl2N5O small molecule - - DRUGBANK 25788 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6572 [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID - - DRUGBANK DB07771 C17H30NO5P small molecule - - DRUGBANK 24095 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Wakeling AE (2005) 16113095 181904 4693 AZD3409 - - DRUGBANK DB04893 - small molecule - - DRUGBANK 26688 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7450 (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE - - DRUGBANK DB08676 C27H27N5O2 small molecule - - DRUGBANK 25235 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6043 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE - - DRUGBANK DB07227 C22H20ClN5O small molecule - - DRUGBANK 26685 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7448 (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE - - DRUGBANK DB08674 C26H21N5O2 small molecule - - DRUGBANK 25808 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 24244 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Venkatasubbarao K (2005) 15805288 181887 4754 Tipifarnib Zarnestra - DRUGBANK DB04960 C27H22Cl2N4O small molecule - 192185-72-1 DRUGBANK 25864 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 25222 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6032 (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE - - DRUGBANK DB07216 C24H29ClN4O2S small molecule - - DRUGBANK 25921 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6692 ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID - - DRUGBANK DB07895 C15H33O4P small molecule - - DRUGBANK 24974 108627 2342 - FNTB FPTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5772 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE - - DRUGBANK DB06953 C25H17Cl2N5O small molecule - - DRUGBANK 25762 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6555 N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid - - DRUGBANK DB07754 C16H19FN2O7S small molecule - - DRUGBANK 1108 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Smith-Jones PM (2000) 11016653 172286 85 Capromab - prostascint kit for the prepar DRUGBANK DB00089 - biologic - 151763-64-3 DRUGBANK 1109 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Gregorakis AK (1998) 9508077 172284 85 Capromab - prostascint kit for the prepar DRUGBANK DB00089 - biologic - 151763-64-3 DRUGBANK 1110 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Sodee DB (1998) 9792131 172285 85 Capromab - prostascint kit for the prepar DRUGBANK DB00089 - biologic - 151763-64-3 DRUGBANK 1111 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 85 Capromab - prostascint kit for the prepar DRUGBANK DB00089 - biologic - 151763-64-3 DRUGBANK 1112 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Sodee DB (2005) 15882479 172283 85 Capromab - prostascint kit for the prepar DRUGBANK DB00089 - biologic - 151763-64-3 DRUGBANK 2421 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2422 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2423 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Maung J (2004) 15336276 173249 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2424 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Rodriguez CE (2001) 11916141 173248 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2425 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Davis MI (2005) 15837926 173250 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 24953 108630 2346 GIG27 FOLH1 FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5747 (2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID - - DRUGBANK DB06928 C13H16IO6P small molecule - - DRUGBANK 27368 108631 2348 - FOLR1 FBP|FOLR 9606 Homo sapiens antibody target Kalli KR (2007) 18058577 188514 7763 Farletuzumab Fareletuzumab - DRUGBANK DB05595 - biologic - 896723-44-7 DRUGBANK 3414 108633 2350 - FOLR2 BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3 9606 Homo sapiens binder target Wlodarczyk BJ (2006) 16620997 173803 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3415 108633 2350 - FOLR2 BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3 9606 Homo sapiens binder target Boyles AL (2006) 17035141 173802 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3416 108633 2350 - FOLR2 BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3417 108633 2350 - FOLR2 BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3 9606 Homo sapiens binder target Dixit V (2006) 16704197 173804 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3418 108635 2352 - FOLR3 FR-G|FR-gamma|gamma-hFR 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3419 108635 2352 - FOLR3 FR-G|FR-gamma|gamma-hFR 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3420 108635 2352 - FOLR3 FR-G|FR-gamma|gamma-hFR 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3421 108635 2352 - FOLR3 FR-G|FR-gamma|gamma-hFR 9606 Homo sapiens binder target Shen F (1995) 7727426 173807 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3422 108635 2352 - FOLR3 FR-G|FR-gamma|gamma-hFR 9606 Homo sapiens binder target Shen F (1994) 8110752 173806 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 3423 108635 2352 - FOLR3 FR-G|FR-gamma|gamma-hFR 9606 Homo sapiens binder target Prasad PD (1994) 8061055 173805 152 Folic Acid Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M vitamin b complex 100 tab|foli DRUGBANK DB00158 C19H19N7O6 small molecule B03BB51|B03AE01|B03AE02|B03BB01 59-30-3 DRUGBANK 11173 108636 2353 - FOS AP-1|C-FOS|p55 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 26846 108636 2353 - FOS AP-1|C-FOS|p55 9606 Homo sapiens inhibitor target Sustar V (2009) 19261492 182099 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 26847 108636 2353 - FOS AP-1|C-FOS|p55 9606 Homo sapiens inhibitor target Nagy Z (2009) 19757196 182127 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 2445 108639 2356 RP11-228B15.1 FPGS - 9606 Homo sapiens unknown target DeMartino JK (2006) 16686541 173256 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2446 108639 2356 RP11-228B15.1 FPGS - 9606 Homo sapiens unknown target Gangjee A (2006) 16990006 173257 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 5215 108639 2356 RP11-228B15.1 FPGS - 9606 Homo sapiens antagonist target Innocenti F (2002) 11916544 175013 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 9790 108640 2357 - FPR1 FMLP|FPR 9606 Homo sapiens antagonist target Carolan EJ (1992) 1329582 178011 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9791 108640 2357 - FPR1 FMLP|FPR 9606 Homo sapiens antagonist target Warringa RA (1993) 8384226 178010 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9792 108640 2357 - FPR1 FMLP|FPR 9606 Homo sapiens antagonist target Peroni DG (1992) 1326878 178009 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 5759 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens potentiator target Reitamo S (2002) 12113647 175334 329 Pimecrolimus Pimecrolimusum|Pimecrolimus|33-Epi-chloro-33-desoxyascomycin elidel DRUGBANK DB00337 C43H68ClNO11 small molecule D11AH02 137071-32-0 DRUGBANK 17203 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 17204 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Rostaing L (2010) 20155724 181558 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 17205 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target George S (2009) 19774211 181559 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 17206 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Ettenger R (2008) 18466433 181554 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 17207 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Coppin C (2010) 20531964 181555 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 17208 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Albert S (2010) 20569080 181556 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 17209 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Teachey DT (2009) 19344392 181557 1529 Everolimus 40-O-(2-hydroxyethyl)-rapamycin afinitor|afinitor disperz|zort DRUGBANK DB01590 C53H83NO14 small molecule L04AA18|L01XE10 159351-69-6 DRUGBANK 11350 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Sehgal SN (2003) 12742462 178847 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 11351 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 11352 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Dowling RJ (2010) 20005306 178848 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 11353 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Shuuin T (2009) 19620795 178849 867 Sirolimus (-)-Rapamycin|Rapamycin rapamune oral solution|sirolim DRUGBANK DB00877 C51H79NO13 small molecule L04AA10|S01XA23 53123-88-9 DRUGBANK 24548 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 5545 Temsirolimus 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel gd-temsirolimus|torisel DRUGBANK DB06287 C56H87NO16 small molecule L01XE09 162635-04-3 DRUGBANK 24549 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Radulovic S (2007) 17935273 182057 5545 Temsirolimus 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel gd-temsirolimus|torisel DRUGBANK DB06287 C56H87NO16 small molecule L01XE09 162635-04-3 DRUGBANK 24550 108757 2475 - MTOR FRAP|FRAP1|FRAP2|RAFT1|RAPT1 9606 Homo sapiens inhibitor target Patard JJ (2008) 18265991 182064 5545 Temsirolimus 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel gd-temsirolimus|torisel DRUGBANK DB06287 C56H87NO16 small molecule L01XE09 162635-04-3 DRUGBANK 410 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 411 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Olive DL (1995) 7872378 171916 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 412 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 413 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 414 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target van de Weijer BH (2003) 14680547 171917 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 1189 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Jameson JL (1996) 9027352 172369 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 1190 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Tao YX (2009) 20374735 172368 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 1191 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 1192 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens binder target Lin W (2007) 17059863 172367 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 23887 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens antagonist target Bose CK (2007) 17552360 182019 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 23888 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens antagonist target McGeary RP (2008) 18991754 182088 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 1160 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Dattatreyamurty B (1993) 8319832 172143 90 Urofollitropin FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit humegon inj 75 i.u.|pergonal 7 DRUGBANK DB00094 C42H65N11O12S2 biologic G03GA04 146479-72-3 DRUGBANK 1161 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Lindau-Shepard B (1994) 8070368 172142 90 Urofollitropin FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit humegon inj 75 i.u.|pergonal 7 DRUGBANK DB00094 C42H65N11O12S2 biologic G03GA04 146479-72-3 DRUGBANK 1162 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Layman LC (2001) 11299519 172145 90 Urofollitropin FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit humegon inj 75 i.u.|pergonal 7 DRUGBANK DB00094 C42H65N11O12S2 biologic G03GA04 146479-72-3 DRUGBANK 1163 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Santa Coloma TA (1990) 2108722 172147 90 Urofollitropin FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit humegon inj 75 i.u.|pergonal 7 DRUGBANK DB00094 C42H65N11O12S2 biologic G03GA04 146479-72-3 DRUGBANK 1164 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Leng N (1995) 7755615 172146 90 Urofollitropin FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit humegon inj 75 i.u.|pergonal 7 DRUGBANK DB00094 C42H65N11O12S2 biologic G03GA04 146479-72-3 DRUGBANK 1165 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 90 Urofollitropin FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit humegon inj 75 i.u.|pergonal 7 DRUGBANK DB00094 C42H65N11O12S2 biologic G03GA04 146479-72-3 DRUGBANK 779 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Dattatreyamurty B (1993) 8319832 172143 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 780 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Lindau-Shepard B (1994) 8070368 172142 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 781 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Layman LC (2001) 11299519 172145 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 782 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Goa KL (1998) 18020563 172144 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 783 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Santa Coloma TA (1990) 2108722 172147 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 784 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Leng N (1995) 7755615 172146 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 785 108770 2492 - FSHR FSHRO|LGR1|ODG1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 65 Follitropin beta FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit puregon 50 i.u.|puregon 100 i. DRUGBANK DB00066 C975H1513N267O304S26 biologic G03GA06 9002-68-0 DRUGBANK 11450 108773 2495 OK/SW-cl.84 FTH1 FHC|FTH|FTHL6|HFE5|PIG15|PLIF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 11451 108773 2495 OK/SW-cl.84 FTH1 FHC|FTH|FTHL6|HFE5|PIG15|PLIF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 11446 108789 2512 - FTL LFTD|NBIA3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 11447 108789 2512 - FTL LFTD|NBIA3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 18876 108789 2512 - FTL LFTD|NBIA3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2193 Protoporphyrin Ix - - DRUGBANK DB02285 C34H33N4O4 small molecule - 553-12-8 DRUGBANK 18877 108789 2512 - FTL LFTD|NBIA3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2193 Protoporphyrin Ix - - DRUGBANK DB02285 C34H33N4O4 small molecule - 553-12-8 DRUGBANK 18878 108789 2512 - FTL LFTD|NBIA3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2193 Protoporphyrin Ix - - DRUGBANK DB02285 C34H33N4O4 small molecule - 553-12-8 DRUGBANK 23814 108792 2516 RP11-101K10.1 NR5A1 AD4BP|ELP|FTZ1|FTZF1|POF7|SF-1|SF1|SPGF8|SRXY3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4487 (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE - - DRUGBANK DB04683 C40H75O10P small molecule - - DRUGBANK 18484 108810 2534 RP1-66H14.1 FYN SLK|SYN|p59-FYN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1998 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane - - DRUGBANK DB02078 C8H18O4 small molecule - - DRUGBANK 15418 108810 2534 RP1-66H14.1 FYN SLK|SYN|p59-FYN 9606 Homo sapiens multitarget target Imming P (2006) 17016423 171742 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15419 108810 2534 RP1-66H14.1 FYN SLK|SYN|p59-FYN 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15420 108810 2534 RP1-66H14.1 FYN SLK|SYN|p59-FYN 9606 Homo sapiens multitarget target Overington JP (2006) 17139284 171741 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15421 108810 2534 RP1-66H14.1 FYN SLK|SYN|p59-FYN 9606 Homo sapiens multitarget target Lindauer M (2010) 20072833 180857 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 20443 108814 2539 - G6PD G6PD1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2956 Hydroxyacetic Acid Hydroxyethanoic Acid - DRUGBANK DB03085 C2H4O3 small molecule - 79-14-1 DRUGBANK 20444 108814 2539 - G6PD G6PD1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2956 Hydroxyacetic Acid Hydroxyethanoic Acid - DRUGBANK DB03085 C2H4O3 small molecule - 79-14-1 DRUGBANK 21298 108814 2539 - G6PD G6PD1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21299 108814 2539 - G6PD G6PD1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 7469 108823 2548 - GAA LYAG 9606 Homo sapiens antagonist target Fukaya N (2009) 19818342 176466 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7470 108823 2548 - GAA LYAG 9606 Homo sapiens antagonist target Hirata A (2009) 19085811 176467 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 5120 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5121 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Bourbon JR (1987) 3539207 174910 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5122 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Li Y (2004) 15292070 174911 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5123 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Lundquist I (1992) 1594557 174912 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5124 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Gelb MH (2006) 16763908 174913 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5125 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Zhang H (2006) 16702880 174914 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5126 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Salehi A (2001) 11404235 174909 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5127 108823 2548 - GAA LYAG 9606 Homo sapiens inhibitor target Luellmann-Rauch R (1987) 3467980 174908 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 13560 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Tyacke RJ (2010) 20655489 180029 1068 Vigabatrin gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA sabril pwr 1g/sachet|sabril pw DRUGBANK DB01080 C6H11NO2 small molecule N03AG04 68506-86-5 DRUGBANK 10993 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Fadda F (1985) 2985405 178630 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 10994 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 10995 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Agmo A (1998) 9443561 178632 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 3887 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3888 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Stringer JL (1999) 10094428 174140 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3889 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Bowery NG (1993) 8388192 174129 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3890 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Motalli R (1999) 10444662 174138 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3891 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Ogasawara T (1999) 10494996 174139 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3892 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Mott DD (1999) 10482760 174136 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3893 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Garcia-Gil L (1999) 10386831 174137 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3894 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Lehmann A (2009) 19303900 174134 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3895 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Pittman QJ (1999) 10545129 174133 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 27730 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27731 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Stringer JL (1999) 10094428 174140 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27732 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Bowery NG (1993) 8388192 174129 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27733 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Motalli R (1999) 10444662 174138 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27734 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Ogasawara T (1999) 10494996 174139 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27735 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Mott DD (1999) 10482760 174136 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27736 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Garcia-Gil L (1999) 10386831 174137 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27737 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Lehmann A (2009) 19303900 174134 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27738 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Pittman QJ (1999) 10545129 174133 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27713 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27714 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Stringer JL (1999) 10094428 174140 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27715 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Bowery NG (1993) 8388192 174129 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27716 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Motalli R (1999) 10444662 174138 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27717 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Ogasawara T (1999) 10494996 174139 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27718 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Mott DD (1999) 10482760 174136 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27719 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Garcia-Gil L (1999) 10386831 174137 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27720 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Lehmann A (2009) 19303900 174134 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27721 108825 2550 DAAP-188P13.3 GABBR1 GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2 9606 Homo sapiens agonist target Pittman QJ (1999) 10545129 174133 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 7211 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7212 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7213 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7214 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Richter D (2010) 20491873 176266 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7215 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Law RJ (2008) 18446586 176267 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 14281 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14282 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14283 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Krasowski MD (1999) 10487207 174567 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14284 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Grasshoff C (2008) 18619475 177194 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14285 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Sugimura M (2002) 11900777 180392 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14286 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Mehta AK (1999) 10209232 174569 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14287 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Yamakura T (2001) 11264449 174568 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14288 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Whiting PJ (2003) 14579514 174584 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 10110 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target McCracken ML (2010) 20826568 178200 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10111 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10112 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10113 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Seo K (2010) 20097266 178199 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 11472 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11473 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 14347 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14348 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14459 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14460 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14461 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14462 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Macdonald RL (1986) 2871724 180469 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14463 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14464 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14465 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 13814 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1095 Methyprylon Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon - DRUGBANK DB01107 C10H17NO2 small molecule N05CE02 125-64-4 DRUGBANK 13815 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1095 Methyprylon Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon - DRUGBANK DB01107 C10H17NO2 small molecule N05CE02 125-64-4 DRUGBANK 13816 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1095 Methyprylon Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon - DRUGBANK DB01107 C10H17NO2 small molecule N05CE02 125-64-4 DRUGBANK 13817 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target de Fiebre CM (1992) 1352660 180182 1095 Methyprylon Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon - DRUGBANK DB01107 C10H17NO2 small molecule N05CE02 125-64-4 DRUGBANK 11508 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Earl DE (2011) 21262851 178936 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11509 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11505 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27776 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11506 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11507 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 7174 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7175 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7176 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7177 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7178 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7179 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7180 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 14922 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14923 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 15202 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15203 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 14650 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14651 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 6576 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6577 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4019 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 6538 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Hanson SM (2008) 18973287 175858 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6539 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Nutt DJ (2010) 19942638 175857 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 4638 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4639 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4640 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4641 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4642 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Cutrer FM (2001) 11279945 174583 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4643 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4644 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4645 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 27957 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27958 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4607 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4608 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11015 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11016 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 4515 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4516 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 10643 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10645 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10644 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10647 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10646 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 16790 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16791 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16792 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16793 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 14845 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 14846 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Whitwam JG (1995) 8693922 180623 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 14847 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Wingrove PB (2002) 11864636 180625 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 11117 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11118 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11119 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11120 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Olsen RW (2011) 21194017 178688 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11121 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Roden WH (2010) 20692323 178689 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11122 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11123 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11124 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11125 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 13188 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13189 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13190 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 4061 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10882 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10883 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10884 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Derry JM (2004) 15009644 178582 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 17139 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17138 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Derry JM (2004) 15009644 178582 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17140 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17141 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Blaschke G (1986) 2874815 181548 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17154 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 17155 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Amin J (1997) 9145922 181551 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 17156 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 17157 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5728 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5867 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5868 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 16820 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16821 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16822 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16823 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 17227 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Amin J (1997) 9145922 181551 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 12928 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12929 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12930 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12931 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Moody EJ (1988) 2459308 179764 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12932 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Krasowski MD (2000) 10683198 179765 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12933 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Moody EJ (1988) 2845216 179766 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 5201 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 5202 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Desai R (2009) 19741491 175004 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 5203 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 5204 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 5205 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Martin LJ (2009) 19809285 175003 285 Etomidate Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester amidate|etomidate DRUGBANK DB00292 C14H16N2O2 small molecule N01AX07 33125-97-2 DRUGBANK 6182 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Gonzalez LA (2009) 19244096 175633 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6183 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6184 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Rho JM (1997) 9067327 175634 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 17002 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 16018 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16019 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16020 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16021 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16022 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16023 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16024 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 15995 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15996 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15997 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15998 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 8786 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8787 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 6831 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Pritchett DB (1990) 2157817 175975 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 6832 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Smith AJ (2001) 11306694 175974 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 6833 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 6834 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Vlainic J (2009) 19345234 175976 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 6835 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 15939 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Stobbs SH (2004) 15169831 181134 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15940 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15941 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15942 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15943 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15944 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 16270 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens negative modulator target Hanrahan JR (2003) 12824018 181231 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 7264 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 466 Methohexital (+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital brietal sodium ampoule 660|bre DRUGBANK DB00474 C14H18N2O3 small molecule N01AF01|N05CA15 151-83-7 DRUGBANK 7265 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 466 Methohexital (+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital brietal sodium ampoule 660|bre DRUGBANK DB00474 C14H18N2O3 small molecule N01AF01|N05CA15 151-83-7 DRUGBANK 7266 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 466 Methohexital (+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital brietal sodium ampoule 660|bre DRUGBANK DB00474 C14H18N2O3 small molecule N01AF01|N05CA15 151-83-7 DRUGBANK 7267 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Koltchine VV (1996) 9014160 176312 466 Methohexital (+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital brietal sodium ampoule 660|bre DRUGBANK DB00474 C14H18N2O3 small molecule N01AF01|N05CA15 151-83-7 DRUGBANK 9448 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9449 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 12322 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Patat A (2001) 12404558 179361 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 12323 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Sanger DJ (1999) 10515302 179362 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 12324 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Barbera J (2005) 15783240 179363 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 12325 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Terzano MG (2003) 12608888 179364 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 12326 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 12327 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 952 Zaleplon 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide starnoc|zaleplon|sonata DRUGBANK DB00962 C17H15N5O small molecule N05CF03 151319-34-5 DRUGBANK 16067 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16068 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16069 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16070 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Tomlin SL (1999) 10360871 181142 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16071 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16072 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16073 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16074 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 5384 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Steinbach JH (2001) 11744750 175099 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5385 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5386 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5387 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5388 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Rahman M (2006) 16866778 175100 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5389 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Feigenspan A (2004) 15240758 175101 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5390 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Davies DL (2001) 11605100 175102 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5391 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5392 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5393 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5394 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 7864 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Buckley NA (1998) 9589848 176777 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7908 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 4996 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4997 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Braga MF (2009) 19417176 174783 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4998 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4999 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Nowakowska E (2009) 19998575 174787 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 16937 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16957 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Baburin I (2008) 18604239 181509 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 16958 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 8483 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Grasshoff C (2008) 18619475 177194 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8484 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8485 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8486 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8487 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 4483 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4484 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4485 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10525 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10526 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10527 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10528 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10529 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10530 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10531 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 7278 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 15972 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15974 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15971 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15973 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15975 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 13429 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13430 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17624 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14750 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Hanson SM (2008) 18973287 175858 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14751 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Skerritt JH (1983) 6135616 176313 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14754 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Nutt DJ (2010) 19942638 175857 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14753 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Sanger DJ (2004) 15291009 180586 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14752 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Ramerstorfer J (2010) 20303942 180585 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 17174 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17175 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17176 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17177 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17178 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 16044 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16045 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16046 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16047 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 15920 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1307 Dihydroquinidine barbiturate - - DRUGBANK DB01341 - small molecule - - DRUGBANK 15921 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1307 Dihydroquinidine barbiturate - - DRUGBANK DB01341 - small molecule - - DRUGBANK 7944 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7945 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17249 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Tanaka M (2008) 18603831 181563 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17246 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17248 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17247 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17250 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Podhorna J (2000) 10877119 181562 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 6677 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6678 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6679 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6680 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Peters JA (1988) 2850060 175928 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6681 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6682 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6683 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Miller LG (1988) 2906155 175929 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6684 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6685 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Kirkness EF (1986) 3006661 175927 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6686 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5287 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5288 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5289 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5290 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Krasowski MD (1999) 10487207 174567 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5291 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5292 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5293 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Whiting PJ (2003) 14579514 174584 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 9083 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 16678 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Skerritt JH (1983) 6318143 181416 1385 Glutethimide Doriden|2-Ethyl-2-phenylglutarimide - DRUGBANK DB01437 C13H15NO2 small molecule N05CE01 77-21-4 DRUGBANK 10988 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Grech DM (1993) 7831422 178631 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 10989 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Fadda F (1985) 2985405 178630 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 10990 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Agmo A (1998) 9443561 178632 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 10991 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 10992 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 827 Progabide Progabida|Progabidum|Progabide|Halogabide - DRUGBANK DB00837 C17H16ClFN2O2 small molecule N03AG05 62666-20-0 DRUGBANK 9520 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9521 108828 2554 - GABRA1 ECA4|EIEE19|EJM|EJM5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 14654 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14655 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 11480 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11481 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 16903 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Oblak AL (2011) 20858465 181488 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16904 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target You H (2010) 20638393 181489 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16905 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16906 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16907 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Skilbeck KJ (2008) 17976880 181487 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16908 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Oelschlaeger H (1989) 2570451 181491 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 7185 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7186 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 14926 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14927 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6580 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6581 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4021 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 6542 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Hanson SM (2008) 18973287 175858 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6543 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Nutt DJ (2010) 19942638 175857 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 4650 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4651 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 27961 108829 2555 - GABRA2 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27962 108829 2555 - GABRA2 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4611 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4612 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11023 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11024 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 6829 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Pritchett DB (1990) 2157817 175975 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 6830 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Smith AJ (2001) 11306694 175974 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 24132 108829 2555 - GABRA2 - 9606 Homo sapiens unknown target Atack JR (2006) 16430927 181927 4703 Pagoclone - - DRUGBANK DB04903 C23H22ClN3O2 small molecule - 133737-32-3 DRUGBANK 10650 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10651 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 16798 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16799 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11132 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11133 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Olsen RW (2011) 21194017 178688 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11134 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 4063 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10888 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10889 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10890 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Derry JM (2004) 15009644 178582 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13194 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13195 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13196 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17159 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5730 108829 2555 - GABRA2 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5871 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5872 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 16828 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16829 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 17229 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 17181 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17182 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 6189 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Gonzalez LA (2009) 19244096 175633 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6190 108829 2555 - GABRA2 - 9606 Homo sapiens agonist target Rho JM (1997) 9067327 175634 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 17004 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 16029 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16030 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16003 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16004 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 8790 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8791 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 27778 108829 2555 - GABRA2 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27145 108829 2555 - GABRA2 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 15934 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Stobbs SH (2004) 15169831 181134 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15935 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15936 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 7280 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 5399 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5400 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16079 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16080 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 8492 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8493 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 7910 108829 2555 - GABRA2 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 16941 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16960 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4523 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4524 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4489 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4490 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4491 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10536 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10537 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 15980 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15981 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 13433 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13434 108829 2555 - GABRA2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17626 108829 2555 - GABRA2 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14745 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Hanson SM (2008) 18973287 175858 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14746 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Ramerstorfer J (2010) 20303942 180585 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14747 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Nutt DJ (2010) 19942638 175857 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 16052 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16053 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 7948 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7949 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17257 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17258 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 6691 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6692 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5298 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5299 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 9085 108829 2555 - GABRA2 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9456 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9457 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9528 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9529 108829 2555 - GABRA2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 14656 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14657 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 11493 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11494 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 16915 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16916 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target You H (2010) 20638393 181489 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16917 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 7192 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7193 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 14938 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14939 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6582 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6583 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4022 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 6548 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Hanson SM (2008) 18973287 175858 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6549 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Nutt DJ (2010) 19942638 175857 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 4657 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4658 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 27963 108830 2556 - GABRA3 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27964 108830 2556 - GABRA3 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4613 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4614 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11035 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11036 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 6827 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Pritchett DB (1990) 2157817 175975 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 6828 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Smith AJ (2001) 11306694 175974 417 Zolpidem Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide zolpidem tartrate|zolpidem tar DRUGBANK DB00425 C19H21N3O small molecule N05CF02 82626-48-0 DRUGBANK 24131 108830 2556 - GABRA3 - 9606 Homo sapiens unknown target Atack JR (2006) 16430927 181927 4703 Pagoclone - - DRUGBANK DB04903 C23H22ClN3O2 small molecule - 133737-32-3 DRUGBANK 10662 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10663 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 16805 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16806 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11140 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11141 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Olsen RW (2011) 21194017 178688 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11142 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 4064 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10903 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10904 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10905 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Derry JM (2004) 15009644 178582 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13197 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13198 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13199 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17165 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5731 108830 2556 - GABRA3 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5873 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5874 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 16835 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16836 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 17235 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 17193 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17194 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 6191 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Gonzalez LA (2009) 19244096 175633 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6192 108830 2556 - GABRA3 - 9606 Homo sapiens agonist target Rho JM (1997) 9067327 175634 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 17010 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 16036 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16037 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16010 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16011 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 8792 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8793 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 27782 108830 2556 - GABRA3 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27163 108830 2556 - GABRA3 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 7281 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 5406 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5407 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16086 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16087 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 8499 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8500 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 7911 108830 2556 - GABRA3 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 16948 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16967 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4538 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4539 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4492 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4493 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4494 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10543 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10544 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 15987 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15988 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 13435 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13436 108830 2556 - GABRA3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17627 108830 2556 - GABRA3 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14738 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Hanson SM (2008) 18973287 175858 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14739 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Ramerstorfer J (2010) 20303942 180585 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14740 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Nutt DJ (2010) 19942638 175857 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 16059 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16060 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 7960 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7961 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17270 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17271 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 6698 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6699 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5305 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5306 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 9086 108830 2556 - GABRA3 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9468 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9469 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9540 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9541 108830 2556 - GABRA3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 14642 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14643 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 11468 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11469 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 27775 108831 2557 - GABRA4 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27142 108831 2557 - GABRA4 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 7168 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 6568 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6569 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4015 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 16891 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16893 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Oblak AL (2011) 20858465 181488 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16892 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target You H (2010) 20638393 181489 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16895 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Skilbeck KJ (2008) 17976880 181487 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16894 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 4632 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 27949 108831 2557 - GABRA4 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27950 108831 2557 - GABRA4 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4599 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4600 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11011 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11012 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13421 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13422 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 16784 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11110 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11111 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Olsen RW (2011) 21194017 178688 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 4057 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 13176 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13177 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13178 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5724 108831 2557 - GABRA4 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5859 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5860 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 16814 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 7904 108831 2557 - GABRA4 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6180 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Gonzalez LA (2009) 19244096 175633 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6181 108831 2557 - GABRA4 - 9606 Homo sapiens agonist target Rho JM (1997) 9067327 175634 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 16012 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 15989 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 8778 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8779 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7274 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 5378 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16061 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 8477 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 16935 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 4511 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4512 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4471 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4472 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4473 108831 2557 - GABRA4 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10519 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 15965 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 17620 108831 2557 - GABRA4 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 16038 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 17242 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17243 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 6671 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5281 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 9079 108831 2557 - GABRA4 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9444 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9445 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9516 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9517 108831 2557 - GABRA4 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 14648 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14649 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 11476 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11477 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 16896 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Imming P (2006) 17016423 171742 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16898 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Oblak AL (2011) 20858465 181488 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16897 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target You H (2010) 20638393 181489 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16899 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Overington JP (2006) 17139284 171741 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 7181 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7182 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 14924 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14925 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6574 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6575 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4018 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 6540 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Hanson SM (2008) 18973287 175858 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 6541 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Nutt DJ (2010) 19942638 175857 394 Eszopiclone Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate eszopiclone|lunesta DRUGBANK DB00402 C17H17ClN6O3 small molecule N05CF04 138729-47-2 DRUGBANK 4646 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4647 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 27955 108832 2558 - GABRA5 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27956 108832 2558 - GABRA5 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4605 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4606 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11019 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11020 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 10648 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10649 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 16794 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16795 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 14841 108832 2558 - GABRA5 - 9606 Homo sapiens antagonist target Clement Y (2009) 19907641 180622 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 11126 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11127 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Olsen RW (2011) 21194017 178688 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11128 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 4060 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10885 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10886 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10887 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Derry JM (2004) 15009644 178582 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13185 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13186 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13187 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17158 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5727 108832 2558 - GABRA5 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5865 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5866 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 16824 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16825 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 17228 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 17179 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17180 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 6185 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Gonzalez LA (2009) 19244096 175633 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6186 108832 2558 - GABRA5 - 9606 Homo sapiens agonist target Rho JM (1997) 9067327 175634 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 17003 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 16025 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16026 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 15999 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16000 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 8784 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8785 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 27777 108832 2558 - GABRA5 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27143 108832 2558 - GABRA5 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 7277 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 5395 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5396 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16075 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16076 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 8488 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8489 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 7907 108832 2558 - GABRA5 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 16939 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16959 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4519 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4520 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4480 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4481 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4482 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10532 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10533 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 15976 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15977 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 13427 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13428 108832 2558 - GABRA5 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17623 108832 2558 - GABRA5 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14741 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Hanson SM (2008) 18973287 175858 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14742 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Skerritt JH (1983) 6135616 176313 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14744 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Nutt DJ (2010) 19942638 175857 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 14743 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Ramerstorfer J (2010) 20303942 180585 1186 Zopiclone 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone pro-zopiclone|nu-zopiclone tab DRUGBANK DB01198 C17H17ClN6O3 small molecule N05CF01 43200-80-2 DRUGBANK 16048 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16049 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 7946 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7947 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17253 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17254 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 6687 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6688 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5294 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5295 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 9082 108832 2558 - GABRA5 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9452 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9453 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9524 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9525 108832 2558 - GABRA5 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 14632 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14633 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 11478 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11479 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 27781 108833 2559 - GABRA6 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27157 108833 2559 - GABRA6 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 7183 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7184 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 6558 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6559 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4010 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 16900 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Santhakumar V (2006) 16554486 181490 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16901 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target You H (2010) 20638393 181489 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 16902 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Skilbeck KJ (2008) 17976880 181487 1484 Flunitrazepam Flunitrazepamum|Rohypnol - DRUGBANK DB01544 C16H12FN3O3 small molecule N05CD03 1622-62-4 DRUGBANK 4648 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4649 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 27939 108833 2559 - GABRA6 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27940 108833 2559 - GABRA6 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4589 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4590 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11021 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11022 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13411 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13412 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 16796 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16797 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11129 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11130 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Olsen RW (2011) 21194017 178688 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11131 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 4052 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 13161 108833 2559 - GABRA6 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13162 108833 2559 - GABRA6 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13163 108833 2559 - GABRA6 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5719 108833 2559 - GABRA6 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5849 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5850 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 16826 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16827 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 7899 108833 2559 - GABRA6 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6187 108833 2559 - GABRA6 - 9606 Homo sapiens agonist target Gonzalez LA (2009) 19244096 175633 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 6188 108833 2559 - GABRA6 - 9606 Homo sapiens agonist target Rho JM (1997) 9067327 175634 363 Meprobamate Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid 282 mep tab|apo meprobamate ta DRUGBANK DB00371 C9H18N2O4 small molecule N05CX01|N05BC01|N05BC51 57-53-4 DRUGBANK 16027 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16028 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16001 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16002 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 8768 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8769 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7269 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 5397 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5398 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16077 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16078 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 8490 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8491 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 16940 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 4521 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4522 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4456 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4457 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4458 108833 2559 - GABRA6 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10534 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10535 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 15978 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15979 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 17615 108833 2559 - GABRA6 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 16050 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16051 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 17255 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17256 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 6689 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6690 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 5296 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Mehta AK (1999) 10209232 174569 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5297 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 9074 108833 2559 - GABRA6 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9454 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9455 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9526 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9527 108833 2559 - GABRA6 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27943 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27944 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27792 108834 2560 - GABRB1 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27179 108834 2560 - GABRB1 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14918 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14919 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6562 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6563 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4012 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11474 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11475 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4593 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4594 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11017 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11018 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13415 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13416 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17135 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17134 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Derry JM (2004) 15009644 178582 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17136 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17137 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Blaschke G (1986) 2874815 181548 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 4054 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10878 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10879 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13167 108834 2560 - GABRB1 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13168 108834 2560 - GABRB1 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13169 108834 2560 - GABRB1 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17152 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5721 108834 2560 - GABRB1 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17000 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 17225 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 6864 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Joy RM (1995) 7566682 176008 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6865 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Heusinkveld HJ (2010) 20600211 176009 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6866 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Cole LM (1995) 7885191 176003 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6867 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6868 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6869 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Sauviat MP (2003) 12645305 176004 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6870 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6871 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Narahashi T (1996) 8841090 176006 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6872 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Vale C (2003) 12614680 176005 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6873 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Bloomquist JR (2003) 14635176 176010 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6874 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Anand M (1998) 9530529 176007 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 17172 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17173 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5853 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5854 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14636 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14637 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8772 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8773 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7271 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9450 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9451 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 7901 108834 2560 - GABRB1 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 16938 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16955 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4517 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4518 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4462 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4463 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4464 108834 2560 - GABRB1 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10639 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10640 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17617 108834 2560 - GABRB1 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7940 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7941 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17251 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17252 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 16697 108834 2560 - GABRB1 - 9606 Homo sapiens agonist target Maitre M (2005) 15745703 181421 1388 Gamma Hydroxybutyric Acid 3-carboxypropoxy acid|4-hydroxy-butyric acid|gamma-Hydroxybutyrate|4-hydroxybutanoic acid|-Hydroxybutyric acid|GHB|4-hydroxybutanoate|oxy-n-butyric acid|4-Hydroxybutyric acid|gamma-Hydroxybutyric acid - DRUGBANK DB01440 C4H7O3 small molecule - 591-81-1 DRUGBANK 9076 108834 2560 - GABRB1 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9522 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9523 108834 2560 - GABRB1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27951 108835 2561 - GABRB2 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27952 108835 2561 - GABRB2 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27785 108835 2561 - GABRB2 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27170 108835 2561 - GABRB2 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14920 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14921 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6570 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6571 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4016 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11470 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11471 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4601 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4602 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11013 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11014 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13423 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13424 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 10797 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Franks NP (2006) 16402123 174522 808 Propofol Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan pms-propofol|propofol-ii injec DRUGBANK DB00818 C12H18O small molecule N01AX10 2078-54-8 DRUGBANK 4058 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10880 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10881 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13179 108835 2561 - GABRB2 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13180 108835 2561 - GABRB2 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13181 108835 2561 - GABRB2 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17153 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5725 108835 2561 - GABRB2 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17001 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7905 108835 2561 - GABRB2 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7275 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 5861 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5862 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14644 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14645 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8780 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8781 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 16264 108835 2561 - GABRB2 - 9606 Homo sapiens negative modulator target Hanrahan JR (2003) 12824018 181231 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 9446 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9447 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16936 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16956 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Baburin I (2008) 18604239 181509 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4513 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4514 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4474 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4475 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4476 108835 2561 - GABRB2 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10641 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10642 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17621 108835 2561 - GABRB2 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 24777 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Franks NP (2006) 16402123 174522 5598 Fospropofol Fospropofol lusedra DRUGBANK DB06716 C13H21O5P small molecule - 258516-89-1 DRUGBANK 7942 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7943 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17244 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17245 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17226 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9080 108835 2561 - GABRB2 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9518 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9519 108835 2561 - GABRB2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 8502 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 8503 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Feng XP (2002) 12421359 177198 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 8504 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 11466 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11467 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 27791 108836 2562 - GABRB3 ECA5 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27178 108836 2562 - GABRB3 ECA5 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14916 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14917 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6578 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6579 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4020 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 27959 108836 2562 - GABRB3 ECA5 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27960 108836 2562 - GABRB3 ECA5 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 4609 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4610 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11009 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11010 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 10637 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10638 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10795 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Franks NP (2006) 16402123 174522 808 Propofol Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan pms-propofol|propofol-ii injec DRUGBANK DB00818 C12H18O small molecule N01AX10 2078-54-8 DRUGBANK 4062 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10876 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10877 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13191 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13192 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13193 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17151 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5729 108836 2562 - GABRB3 ECA5 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 16999 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7909 108836 2562 - GABRB3 ECA5 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17170 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17171 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5869 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5870 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14652 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14653 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8788 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8789 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8379 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 582 Piperazine Diethylenediamine|Piperazidine|Piperazin veriga 125|formule c34|vermire DRUGBANK DB00592 C4H10N2 small molecule P02CB01 110-85-0 DRUGBANK 8380 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Maskell PD (2001) 11156579 177135 582 Piperazine Diethylenediamine|Piperazidine|Piperazin veriga 125|formule c34|vermire DRUGBANK DB00592 C4H10N2 small molecule P02CB01 110-85-0 DRUGBANK 8381 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 582 Piperazine Diethylenediamine|Piperazidine|Piperazin veriga 125|formule c34|vermire DRUGBANK DB00592 C4H10N2 small molecule P02CB01 110-85-0 DRUGBANK 8382 108836 2562 - GABRB3 ECA5 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 582 Piperazine Diethylenediamine|Piperazidine|Piperazin veriga 125|formule c34|vermire DRUGBANK DB00592 C4H10N2 small molecule P02CB01 110-85-0 DRUGBANK 7279 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9442 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9443 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16934 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16954 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4509 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4510 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4486 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4487 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4488 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 13431 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13432 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17625 108836 2562 - GABRB3 ECA5 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 24776 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Franks NP (2006) 16402123 174522 5598 Fospropofol Fospropofol lusedra DRUGBANK DB06716 C13H21O5P small molecule - 258516-89-1 DRUGBANK 7938 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7939 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17240 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17241 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17224 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9084 108836 2562 - GABRB3 ECA5 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9514 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9515 108836 2562 - GABRB3 ECA5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27947 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27948 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27784 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27169 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14932 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14933 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6566 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6567 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4014 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11486 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11487 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4597 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4598 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11029 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11030 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13419 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13420 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17142 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17143 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 4056 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10895 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10896 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13173 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13174 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13175 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17162 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5723 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17007 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7903 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17187 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17188 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5857 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5858 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14640 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14641 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8776 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8777 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7273 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9462 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9463 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16944 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16964 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4529 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4530 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4468 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4469 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4470 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10656 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10657 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17619 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7954 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7955 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17264 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17265 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17232 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9078 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9534 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9535 108837 2563 - GABRD EIG10|EJM7|GEFSP5 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27967 108838 2564 - GABRE - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27968 108838 2564 - GABRE - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27789 108838 2564 - GABRE - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27176 108838 2564 - GABRE - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14944 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14945 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6586 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6587 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4024 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11501 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11502 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4617 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4618 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11043 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11044 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13439 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13440 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17149 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17150 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 4066 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10912 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10913 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13203 108838 2564 - GABRE - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13204 108838 2564 - GABRE - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13205 108838 2564 - GABRE - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17168 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5733 108838 2564 - GABRE - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17013 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7913 108838 2564 - GABRE - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17199 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17200 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5877 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5878 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14660 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14661 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8796 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8797 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7283 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9476 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9477 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16952 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16972 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4546 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4547 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4498 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4499 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4500 108838 2564 - GABRE - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10668 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10669 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17629 108838 2564 - GABRE - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7966 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7967 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17278 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17279 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17238 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9088 108838 2564 - GABRE - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9548 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9549 108838 2564 - GABRE - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27953 108839 2565 - GABRG1 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27954 108839 2565 - GABRG1 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27786 108839 2565 - GABRG1 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27172 108839 2565 - GABRG1 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14930 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14931 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6572 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6573 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4017 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11484 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11485 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4603 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4604 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11027 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11028 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13425 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13426 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 17147 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 17148 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1526 Ketazolam U-28774|Ketazolam loftran cap 30mg DRUGBANK DB01587 C20H17ClN2O3 small molecule N05BA10 27223-35-4 DRUGBANK 4059 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10893 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10894 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13182 108839 2565 - GABRG1 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13183 108839 2565 - GABRG1 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13184 108839 2565 - GABRG1 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17161 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5726 108839 2565 - GABRG1 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17006 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7906 108839 2565 - GABRG1 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17185 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17186 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5863 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5864 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14646 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14647 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8782 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8783 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7276 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9460 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9461 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16943 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16962 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Baburin I (2008) 18604239 181509 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 16963 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4527 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4528 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4477 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4478 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4479 108839 2565 - GABRG1 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10654 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10655 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17622 108839 2565 - GABRG1 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7952 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7953 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17262 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17263 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17231 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9081 108839 2565 - GABRG1 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9532 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9533 108839 2565 - GABRG1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27941 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27942 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 14940 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14941 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6560 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6561 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4011 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11495 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11496 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4591 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4592 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11037 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11038 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13413 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13414 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 14842 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens antagonist target Whitwam JG (1995) 8693922 180623 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 14843 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens antagonist target Wingrove PB (2002) 11864636 180625 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 14844 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens antagonist target Padgett CL (2008) 17974564 180624 1193 Flumazenil Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo flumazenil injection|flumazeni DRUGBANK DB01205 C15H14FN3O3 small molecule V03AB25 78755-81-4 DRUGBANK 4053 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10906 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10907 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13164 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13165 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13166 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17166 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5720 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17011 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7900 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17195 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17196 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 16269 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens negative modulator target Hanrahan JR (2003) 12824018 181231 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 5851 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5852 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14634 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14635 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8770 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8771 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7270 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9470 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9471 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16949 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16968 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Baburin I (2008) 18604239 181509 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 16969 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 16970 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Berman HM (2000) 10592235 172122 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4540 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4541 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4459 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4460 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4461 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10664 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10665 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17616 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7962 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7963 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17272 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17273 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17236 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9075 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9542 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9543 108840 2566 - GABRG2 CAE2|ECA2|GEFSP3 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27965 108841 2567 - GABRG3 - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27966 108841 2567 - GABRG3 - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27790 108841 2567 - GABRG3 - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27177 108841 2567 - GABRG3 - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14946 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14947 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6584 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6585 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4023 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11503 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11504 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4615 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4616 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11045 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11046 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13437 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13438 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 4065 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10914 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10915 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13200 108841 2567 - GABRG3 - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13201 108841 2567 - GABRG3 - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13202 108841 2567 - GABRG3 - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17169 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5732 108841 2567 - GABRG3 - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17014 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7912 108841 2567 - GABRG3 - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17201 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17202 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5875 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5876 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14658 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14659 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8794 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8795 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7282 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9478 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9479 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16953 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16973 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4548 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4549 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4495 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4496 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4497 108841 2567 - GABRG3 - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10670 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10671 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17628 108841 2567 - GABRG3 - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7968 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7969 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17280 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17281 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17239 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9087 108841 2567 - GABRG3 - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9550 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9551 108841 2567 - GABRG3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 27945 108842 2568 - GABRP - 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27946 108842 2568 - GABRP - 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27793 108842 2568 - GABRP - 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27184 108842 2568 - GABRP - 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14942 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14943 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 6564 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6565 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4013 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11499 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11500 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4595 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4596 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11041 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11042 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13417 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13418 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 4055 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10910 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10911 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13170 108842 2568 - GABRP - 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13171 108842 2568 - GABRP - 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13172 108842 2568 - GABRP - 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 17167 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 5722 108842 2568 - GABRP - 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 17012 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 7902 108842 2568 - GABRP - 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 17197 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17198 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 5855 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5856 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14638 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14639 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8774 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8775 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7272 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9474 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9475 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16951 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16971 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4544 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4545 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4465 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4466 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4467 108842 2568 - GABRP - 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 10666 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10667 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 17618 108842 2568 - GABRP - 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 7964 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7965 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 17276 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17277 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17237 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 9077 108842 2568 - GABRP - 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9546 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9547 108842 2568 - GABRP - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 7216 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7217 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7218 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens antagonist target Richter D (2010) 20491873 176266 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7219 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens antagonist target Law RJ (2008) 18446586 176267 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 11025 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11026 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11482 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11483 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 10652 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10653 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 7950 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7951 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 14928 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14929 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 9458 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9459 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 10891 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10892 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 17260 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17261 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17230 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 17160 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 16942 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16961 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4525 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4526 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 17183 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17184 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 9530 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9531 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 17005 108843 2569 RP11-63L7.1 GABRR1 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 11031 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11032 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11488 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11489 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 10658 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10659 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 7956 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7957 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 14934 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14935 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 9464 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9465 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 10897 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10898 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 17266 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17267 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17233 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 17163 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 16945 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16965 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4531 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4532 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 17189 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17190 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 9536 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9537 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 17008 108844 2570 RP1-131H7.1 GABRR2 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 1443 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Bennett CL (2005) 16075246 172494 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1442 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1444 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1445 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Cormier-Daire V (2000) 10978228 172493 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1446 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Vassort C (1993) 8499653 172492 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1539 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Chen CH (2003) 12535612 172549 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1540 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Rust E (2001) 11488610 172548 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1538 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Hwang IK (2004) 15381280 172547 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1541 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Jin H (2005) 15686475 172550 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1542 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens cofactor target Tong JC (2002) 12067524 172551 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2449 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens unknown target Tueting P (2006) 16769115 173261 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2447 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens unknown target Tronci E (2007) 17445798 173260 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2448 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens unknown target Manto MU (2007) 17600364 173262 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2450 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens unknown target Akama K (2007) 17562689 173258 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2451 108845 2571 - GAD1 CPSQ1|GAD|SCP 9606 Homo sapiens unknown target Wang FY (2006) 16643338 173259 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 1404 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Gospe SM (2006) 16538088 172471 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1405 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Hwang IK (2007) 17531224 172470 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1407 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Tong JC (2002) 12021103 172469 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1408 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Myers MA (2000) 11034389 172472 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1460 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1406 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Burd L (2000) 11108513 172468 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1461 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Bennett CL (2005) 16075246 172494 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1463 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Cormier-Daire V (2000) 10978228 172493 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1464 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Vassort C (1993) 8499653 172492 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1462 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2536 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens unknown target Castelli MP (2007) 17507169 173298 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2538 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens unknown target Pop SM (2007) 17317763 173296 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2537 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens unknown target Manto MU (2007) 17600364 173262 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2539 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens unknown target Wei J (2006) 16879709 173297 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2540 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens unknown target Wang FY (2006) 16643338 173259 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 10386 108846 2572 RP11-420F12.2 GAD2 GAD65 9606 Homo sapiens inhibitor target McKenna KF (1994) 7931216 178351 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 20476 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2966 Tetramethylammonium Ion - - DRUGBANK DB03095 C4H12N small molecule - - DRUGBANK 20477 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2966 Tetramethylammonium Ion - - DRUGBANK DB03095 C4H12N small molecule - - DRUGBANK 17941 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1791 Glucose-Uridine-C1,5'-Diphosphate - - DRUGBANK DB01861 C15H24N2O17P2 small molecule - - DRUGBANK 17942 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1791 Glucose-Uridine-C1,5'-Diphosphate - - DRUGBANK DB01861 C15H24N2O17P2 small molecule - - DRUGBANK 17943 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1791 Glucose-Uridine-C1,5'-Diphosphate - - DRUGBANK DB01861 C15H24N2O17P2 small molecule - - DRUGBANK 23193 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 23194 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 21101 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21102 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21413 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Thoden JB (2001) 11279193 54231 3356 Uridine Diphosphate Galactose UDP-D-Galactopyranose|UDP-galactose|GDU|UPG|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-d-galactose|UDP-galactopyranose|UDP-gal|Uridine pyrophosphogalactose|UDP-d-galactose|Uridine diphosphate-d-galactose|GALACTOSE-URIDINE-5'-DIPHOSPHATE|Uridine 5'-diphosphate galactose|Uridine 5'-diphosphogalactose|Uridinediphosphate galactose|UDP galactose - DRUGBANK DB03501 C15H24N2O17P2 small molecule - 2956-16-3 DRUGBANK 18702 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18703 108855 2582 RP5-886K2.6 GALE SDR1E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 7795 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7796 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Komoto J (2004) 15533043 176719 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7797 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7798 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7799 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Karelin AA (1976) 179611 176720 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 19845 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2636 N-[Amino(Imino)Methyl]Glycine - - DRUGBANK DB02751 C3H7N3O2 small molecule - - DRUGBANK 19846 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2636 N-[Amino(Imino)Methyl]Glycine - - DRUGBANK DB02751 C3H7N3O2 small molecule - - DRUGBANK 19847 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2636 N-[Amino(Imino)Methyl]Glycine - - DRUGBANK DB02751 C3H7N3O2 small molecule - - DRUGBANK 2835 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens product of target Kan HE (2007) 17347380 173501 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2836 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens product of target Almeida LS (2007) 17336114 173500 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2837 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens product of target Wang L (2007) 17486546 173431 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 17713 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17714 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17715 108865 2593 - GAMT CCDS2|HEL-S-20|PIG2|TP53I2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 7465 108866 2595 - GANC - 9606 Homo sapiens antagonist target Fukaya N (2009) 19818342 176466 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7466 108866 2595 - GANC - 9606 Homo sapiens antagonist target Hirata A (2009) 19085811 176467 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 3284 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Trost P (2006) 17031544 173750 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3285 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Markova EV (2006) 16898590 173735 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3286 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Swearengin TA (2006) 17194030 173751 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3287 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Ido Y (2007) 17508915 173682 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 25352 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6163 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE - - DRUGBANK DB07347 C8H10FNO2S small molecule - - DRUGBANK 18424 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18425 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18426 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 22130 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3730 Thionicotinamide-Adenine-Dinucleotide - - DRUGBANK DB03893 C21H27N7O13P2S small molecule - - DRUGBANK 22131 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3730 Thionicotinamide-Adenine-Dinucleotide - - DRUGBANK DB03893 C21H27N7O13P2S small molecule - - DRUGBANK 22132 108868 2597 CDABP0047 GAPDH G3PD|GAPD|HEL-S-162eP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3730 Thionicotinamide-Adenine-Dinucleotide - - DRUGBANK DB03893 C21H27N7O13P2S small molecule - - DRUGBANK 2744 108887 2617 - GARS CMT2D|DSMAV|GlyRS|HMN5|SMAD1 9606 Homo sapiens unknown target Cader MZ (2007) 17544401 173443 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2745 108887 2617 - GARS CMT2D|DSMAV|GlyRS|HMN5|SMAD1 9606 Homo sapiens unknown target Okamoto K (2006) 17150752 173442 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2746 108887 2617 - GARS CMT2D|DSMAV|GlyRS|HMN5|SMAD1 9606 Homo sapiens unknown target Antonellis A (2006) 17035524 173441 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2747 108887 2617 - GARS CMT2D|DSMAV|GlyRS|HMN5|SMAD1 9606 Homo sapiens unknown target Scherer SS (2006) 16982409 173440 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2748 108887 2617 - GARS CMT2D|DSMAV|GlyRS|HMN5|SMAD1 9606 Homo sapiens unknown target Tsang SW (2008) 17433503 173439 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 18782 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2147 Glycinamide Ribonucleotide - - DRUGBANK DB02236 C7H13N2O8P small molecule - - DRUGBANK 18783 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2147 Glycinamide Ribonucleotide - - DRUGBANK DB02236 C7H13N2O8P small molecule - - DRUGBANK 8925 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Hanauske AR (2001) 11524555 177528 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8926 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Adjei AA (2001) 11742712 177529 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8927 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Schultz RM (2002) 11848474 177524 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8928 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Molina JR (2003) 14596699 177525 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8929 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Adjei AA (2002) 12023793 177527 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8930 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8931 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Kindler HL (2002) 12571811 177522 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8932 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Adjei AA (2001) 11252887 177523 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8933 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Giovannetti E (2005) 15795320 176083 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8934 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens inhibitor target Pivot X (2001) 11531245 177521 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 21471 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3396 10-CF3C(OH)2-DDACTHF Hydrolyzed Form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid - DRUGBANK DB03546 C22H30F3N5O8 small molecule - - DRUGBANK 21472 108888 2618 - GART AIRS|GARS|GARTF|PAIS|PGFT|PRGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3396 10-CF3C(OH)2-DDACTHF Hydrolyzed Form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid - DRUGBANK DB03546 C22H30F3N5O8 small molecule - - DRUGBANK 23459 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4268 Alpha-Aminobutyric Acid - - DRUGBANK DB04454 C4H9NO2 small molecule - - DRUGBANK 23460 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4268 Alpha-Aminobutyric Acid - - DRUGBANK DB04454 C4H9NO2 small molecule - - DRUGBANK 18448 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1988 Delta-Amino Valeric Acid - - DRUGBANK DB02068 C5H12NO2 small molecule - - DRUGBANK 18449 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1988 Delta-Amino Valeric Acid - - DRUGBANK DB02068 C5H12NO2 small molecule - - DRUGBANK 19409 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2427 Gamma(Amino)-Butyric Acid - - DRUGBANK DB02530 C4H9NO2 small molecule - - DRUGBANK 19410 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2427 Gamma(Amino)-Butyric Acid - - DRUGBANK DB02530 C4H9NO2 small molecule - - DRUGBANK 2046 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Mitruka BM (1967) 5335895 172952 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2047 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Natesan S (2001) 11691635 172953 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2048 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2049 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Thomasset N (1982) 7173402 172954 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2050 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2730 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Dutta U (2007) 16970975 173430 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2731 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Wang L (2007) 17486546 173431 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 22776 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4014 Norvaline - - DRUGBANK DB04185 C5H11NO2 small molecule - - DRUGBANK 22777 108898 2628 - GATM AGAT|AT|CCDS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4014 Norvaline - - DRUGBANK DB04185 C5H11NO2 small molecule - - DRUGBANK 21839 108899 2629 - GBA GBA1|GCB|GLUC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 21840 108899 2629 - GBA GBA1|GCB|GLUC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 24780 108899 2629 - GBA GBA1|GCB|GLUC 9606 Homo sapiens unknown target Pastores GM (2010) 20336596 182148 5602 Velaglucerase alfa VPRIV|Imiglucerase vpriv DRUGBANK DB06720 C2532H3850N672O711S16 biologic A16AB10 884604-91-5 DRUGBANK 26324 108899 2629 - GBA GBA1|GCB|GLUC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7071 (2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL - - DRUGBANK DB08283 C15H31NO4 small molecule - - DRUGBANK 20500 108899 2629 - GBA GBA1|GCB|GLUC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2977 Myo-Inositol - - DRUGBANK DB03106 C6H12O6 small molecule - - DRUGBANK 20501 108899 2629 - GBA GBA1|GCB|GLUC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2977 Myo-Inositol - - DRUGBANK DB03106 C6H12O6 small molecule - - DRUGBANK 20815 108909 2639 - GCDH ACAD5|GCD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3113 S-4-Nitrobutyryl-Coa - - DRUGBANK DB03245 C25H42N8O19P3S small molecule - - DRUGBANK 20816 108909 2639 - GCDH ACAD5|GCD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3113 S-4-Nitrobutyryl-Coa - - DRUGBANK DB03245 C25H42N8O19P3S small molecule - - DRUGBANK 20656 108909 2639 - GCDH ACAD5|GCD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20657 108909 2639 - GCDH ACAD5|GCD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 504 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Lok S (1994) 8144028 171983 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 505 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Li XC (2007) 17623014 171984 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 506 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Katayama T (2007) 17462598 171985 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 507 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Menzel S (1994) 8020989 171986 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 508 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Fischer AJ (2007) 17534934 171976 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 509 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Winzell MS (2007) 17479245 171988 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 510 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 511 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Li P (2007) 17620721 171987 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 512 108912 2642 - GCGR GGR|GL-R 9606 Homo sapiens agonist target Brubaker PL (2003) 12529935 171977 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 19047 108913 2643 - GCH1 DYT14|DYT5|DYT5a|GCH|GTP-CH-1|GTPCH1|HPABH4B 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 27628 108913 2643 - GCH1 DYT14|DYT5|DYT5a|GCH|GTP-CH-1|GTPCH1|HPABH4B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27629 108913 2643 - GCH1 DYT14|DYT5|DYT5a|GCH|GTP-CH-1|GTPCH1|HPABH4B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 26229 108915 2645 - GCK FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7001 2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE - - DRUGBANK DB08210 C14H12FN5OS2 small molecule - - DRUGBANK 19070 108915 2645 - GCK FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19071 108915 2645 - GCK FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 25365 108915 2645 - GCK FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6174 2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide - - DRUGBANK DB07358 C14H14N6OS2 small molecule - - DRUGBANK 25366 108915 2645 - GCK FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6175 3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide - - DRUGBANK DB07359 C19H15FN6OS3 small molecule - - DRUGBANK 26138 108915 2645 - GCK FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6910 2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide - - DRUGBANK DB08118 C15H16N6OS2 small molecule - - DRUGBANK 18268 108918 2648 - KAT2A GCN5|GCN5L2|PCAF-b|hGCN5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 21884 108923 2653 - GCSH GCE|NKH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3602 Dihydrolipoic Acid - - DRUGBANK DB03760 C8H16O2S2 small molecule - 462-20-4 DRUGBANK 2805 108923 2653 - GCSH GCE|NKH 9606 Homo sapiens unknown target Kanno J (2007) 17361008 173477 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 20725 108923 2653 - GCSH GCE|NKH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3055 6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid - - DRUGBANK DB03187 C11H23NO3S3 small molecule - - DRUGBANK 20726 108923 2653 - GCSH GCE|NKH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3055 6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid - - DRUGBANK DB03187 C11H23NO3S3 small molecule - - DRUGBANK 20727 108923 2653 - GCSH GCE|NKH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3055 6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid - - DRUGBANK DB03187 C11H23NO3S3 small molecule - - DRUGBANK 20628 108939 2671 - GFER ALR|ERV1|HERV1|HPO|HPO1|HPO2|HSS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 696 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 697 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 455 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 456 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 457 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Bouwman CA (1999) 10901669 171947 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 13991 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1113 Anisindione 2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione|2-P-Anisyl-1,3-indandione|Anisin indandione|2-(4-Methoxyphenyl)indan-1,3-dione|Anisindionum|Anisindiona|2-(P-Methoxyphenyl)-1,3-indandione|2-(P-Methoxyphenyl)indane-1,3-dione|2-Para-anisyl-1,3-indandione - DRUGBANK DB01125 C16H12O3 small molecule - 117-37-3 DRUGBANK 13992 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1113 Anisindione 2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione|2-P-Anisyl-1,3-indandione|Anisin indandione|2-(4-Methoxyphenyl)indan-1,3-dione|Anisindionum|Anisindiona|2-(P-Methoxyphenyl)-1,3-indandione|2-(P-Methoxyphenyl)indane-1,3-dione|2-Para-anisyl-1,3-indandione - DRUGBANK DB01125 C16H12O3 small molecule - 117-37-3 DRUGBANK 13993 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1113 Anisindione 2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione|2-P-Anisyl-1,3-indandione|Anisin indandione|2-(4-Methoxyphenyl)indan-1,3-dione|Anisindionum|Anisindiona|2-(P-Methoxyphenyl)-1,3-indandione|2-(P-Methoxyphenyl)indane-1,3-dione|2-Para-anisyl-1,3-indandione - DRUGBANK DB01125 C16H12O3 small molecule - 117-37-3 DRUGBANK 2457 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Lal S (2006) 17112295 173267 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2458 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Zhu A (2007) 17327402 173266 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 3672 108945 2677 - GGCX VKCFD1 9606 Homo sapiens cofactor target Presnell SR (2002) 12083499 174006 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3673 108945 2677 - GGCX VKCFD1 9606 Homo sapiens cofactor target Stafford DW (2005) 16102054 173991 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3674 108945 2677 - GGCX VKCFD1 9606 Homo sapiens cofactor target Wang Z (1995) 7657295 174004 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 12858 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inducer target Chen X (2002) 11752352 171740 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12859 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inducer target Tasatargil A (2006) 16929463 179742 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12860 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inducer target Morris DP (1993) 8473318 179743 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12861 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inducer target Tuan RS (1979) 105006 179740 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12862 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inducer target Reedstrom CK (1995) 7638250 179741 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 12863 108945 2677 - GGCX VKCFD1 9606 Homo sapiens inducer target Olson RE (1984) 6380538 179744 1012 Phylloquinone Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone vitamin k1 inj 10mg/ml usp|mep DRUGBANK DB01022 C31H46O2 small molecule B02BA01 84-80-0 DRUGBANK 1248 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Rehemtulla A (1993) 8506307 172398 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1249 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Lin PJ (2004) 14660587 172399 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1250 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Wu SM (1997) 9115224 172400 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1251 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Stanley TB (1997) 9141486 172396 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1252 108945 2677 - GGCX VKCFD1 9606 Homo sapiens unknown target Stanley TB (1998) 9748333 172397 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 2624 108946 2678 - GGT1 CD224|D22S672|D22S732|GGT|GGT 1|GTG 9606 Homo sapiens unknown target Ohkama-Ohtsu N (2007) 17316176 173353 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2625 108946 2678 - GGT1 CD224|D22S672|D22S732|GGT|GGT 1|GTG 9606 Homo sapiens unknown target Adamis PD (2007) 17644279 73689 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2626 108946 2678 - GGT1 CD224|D22S672|D22S732|GGT|GGT 1|GTG 9606 Homo sapiens unknown target Anilakumar KR (2007) 17569287 173356 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2627 108946 2678 - GGT1 CD224|D22S672|D22S732|GGT|GGT 1|GTG 9606 Homo sapiens unknown target Zhu Y (2007) 17291629 173355 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2628 108946 2678 - GGT1 CD224|D22S672|D22S732|GGT|GGT 1|GTG 9606 Homo sapiens unknown target Martin MN (2007) 17545509 173354 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 19720 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2585 6-Aminohexyl-Uridine-C1,5'-Diphosphate - - DRUGBANK DB02696 C15H27N3O12P2 small molecule - - DRUGBANK 19721 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2585 6-Aminohexyl-Uridine-C1,5'-Diphosphate - - DRUGBANK DB02696 C15H27N3O12P2 small molecule - - DRUGBANK 19722 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2585 6-Aminohexyl-Uridine-C1,5'-Diphosphate - - DRUGBANK DB02696 C15H27N3O12P2 small molecule - - DRUGBANK 20314 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2889 Di(N-Acetyl-D-Glucosamine) - - DRUGBANK DB03013 C16H28N2O11 small molecule - - DRUGBANK 20315 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2889 Di(N-Acetyl-D-Glucosamine) - - DRUGBANK DB03013 C16H28N2O11 small molecule - - DRUGBANK 20316 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2889 Di(N-Acetyl-D-Glucosamine) - - DRUGBANK DB03013 C16H28N2O11 small molecule - - DRUGBANK 21718 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21719 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21720 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21414 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3356 Uridine Diphosphate Galactose UDP-D-Galactopyranose|UDP-galactose|GDU|UPG|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-d-galactose|UDP-galactopyranose|UDP-gal|Uridine pyrophosphogalactose|UDP-d-galactose|Uridine diphosphate-d-galactose|GALACTOSE-URIDINE-5'-DIPHOSPHATE|Uridine 5'-diphosphate galactose|Uridine 5'-diphosphogalactose|Uridinediphosphate galactose|UDP galactose - DRUGBANK DB03501 C15H24N2O17P2 small molecule - 2956-16-3 DRUGBANK 21415 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Ramakrishnan B (2002) 12051854 181794 3356 Uridine Diphosphate Galactose UDP-D-Galactopyranose|UDP-galactose|GDU|UPG|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-d-galactose|UDP-galactopyranose|UDP-gal|Uridine pyrophosphogalactose|UDP-d-galactose|Uridine diphosphate-d-galactose|GALACTOSE-URIDINE-5'-DIPHOSPHATE|Uridine 5'-diphosphate galactose|Uridine 5'-diphosphogalactose|Uridinediphosphate galactose|UDP galactose - DRUGBANK DB03501 C15H24N2O17P2 small molecule - 2956-16-3 DRUGBANK 2331 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Hidalgo A (2006) 17203585 173199 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2332 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Ramakrishnan B (2005) 15736931 173200 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2333 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Ramakrishnan B (2004) 15449940 173201 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2334 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Ramasamy V (2005) 16157350 173202 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2335 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Boeggeman E (2007) 17370997 173203 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 22002 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22003 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22004 108950 2683 - B4GALT1 B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 623 108957 2690 - GHR GHBP 9606 Homo sapiens binder target Bernstein RM (2007) 17133434 172048 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 624 108957 2690 - GHR GHBP 9606 Homo sapiens binder target Wu XY (2006) 16965663 172049 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 625 108957 2690 - GHR GHBP 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 626 108957 2690 - GHR GHBP 9606 Homo sapiens binder target Choi JH (2006) 17128263 172047 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 627 108957 2690 - GHR GHBP 9606 Homo sapiens binder target Adriani M (2006) 17082603 172051 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 628 108957 2690 - GHR GHBP 9606 Homo sapiens binder target Walenkamp MJ (2006) 16917171 172050 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 1063 108957 2690 - GHR GHBP 9606 Homo sapiens antagonist target Paisley AN (2007) 17322491 172251 79 Pegvisomant GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH somavert DRUGBANK DB00082 C990H1532N262O300S7 biologic H01AX01 218620-50-9 DRUGBANK 1064 108957 2690 - GHR GHBP 9606 Homo sapiens antagonist target De Martino MC (2010) 20595800 172250 79 Pegvisomant GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH somavert DRUGBANK DB00082 C990H1532N262O300S7 biologic H01AX01 218620-50-9 DRUGBANK 1065 108957 2690 - GHR GHBP 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 79 Pegvisomant GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH somavert DRUGBANK DB00082 C990H1532N262O300S7 biologic H01AX01 218620-50-9 DRUGBANK 1066 108957 2690 - GHR GHBP 9606 Homo sapiens antagonist target Moller L (2009) 19820031 172249 79 Pegvisomant GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH somavert DRUGBANK DB00082 C990H1532N262O300S7 biologic H01AX01 218620-50-9 DRUGBANK 115 108959 2692 - GHRHR GHRFR|GRFR|IGHD1B 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 10 Sermorelin - - DRUGBANK DB00010 C149H246N44O42S biologic H01AC04|V04CD03 86168-78-7 DRUGBANK 116 108959 2692 - GHRHR GHRFR|GRFR|IGHD1B 9606 Homo sapiens agonist target Esposito P (2003) 14499707 171790 10 Sermorelin - - DRUGBANK DB00010 C149H246N44O42S biologic H01AC04|V04CD03 86168-78-7 DRUGBANK 26935 108959 2692 - GHRHR GHRFR|GRFR|IGHD1B 9606 Homo sapiens binder target Spooner LM (2012) 22298602 182199 7613 Tesamorelin N-[(3E)-1-oxo-3-hexenyl]Somatoliberin (human pancreatic islet)|GHRH(1-44) egrifta DRUGBANK DB08869 C216H360N72O63S small molecule H01AC06 218949-48-5 DRUGBANK 24342 108960 2693 - GHSR - 9606 Homo sapiens unknown target Venkova K (2007) 17436082 182001 5281 TZP-101 - - DRUGBANK DB05657 - small molecule - - DRUGBANK 14086 108964 2697 - GJA1 AVSD3|CMDR|CX43|GJAL|HLHS1|HSS|ODDD 9606 Homo sapiens unknown target Fan SY (2005) 16563290 180324 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14087 108964 2697 - GJA1 AVSD3|CMDR|CX43|GJAL|HLHS1|HSS|ODDD 9606 Homo sapiens unknown target Yeh HI (2006) 16448880 180325 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 2903 108991 2729 - GCLC GCL|GCS|GLCL|GLCLC 9606 Homo sapiens unknown target Srivastava S (2008) 17615559 173558 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2904 108991 2729 - GCLC GCL|GCS|GLCL|GLCLC 9606 Homo sapiens unknown target Ashida H (2005) 15695431 173554 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2534 108991 2729 - GCLC GCL|GCS|GLCL|GLCLC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2535 108991 2729 - GCLC GCL|GCS|GLCL|GLCLC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2893 108992 2730 RP4-561L24.2 GCLM GLCLR 9606 Homo sapiens unknown target Ashida H (2005) 15695431 173554 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2414 108992 2730 RP4-561L24.2 GCLM GLCLR 9606 Homo sapiens unknown target Giordano G (2006) 17000861 173244 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2798 108993 2731 RP11-472F14.1 GLDC GCE|GCSP|HYGN1 9606 Homo sapiens unknown target Mukherjee M (2006) 17158739 173478 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2799 108993 2731 RP11-472F14.1 GLDC GCE|GCSP|HYGN1 9606 Homo sapiens unknown target Engel N (2007) 17496108 173479 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2800 108993 2731 RP11-472F14.1 GLDC GCE|GCSP|HYGN1 9606 Homo sapiens unknown target Kanno J (2007) 17361008 173477 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 1554 108993 2731 RP11-472F14.1 GLDC GCE|GCSP|HYGN1 9606 Homo sapiens cofactor target Igamberdiev AU (2005) 16228305 172557 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1555 108993 2731 RP11-472F14.1 GLDC GCE|GCSP|HYGN1 9606 Homo sapiens cofactor target Nakai T (2005) 15791207 172558 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 20559 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2999 S-P-Nitrobenzyloxycarbonylglutathione - - DRUGBANK DB03130 C18H24N4O10S small molecule - - DRUGBANK 20560 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2999 S-P-Nitrobenzyloxycarbonylglutathione - - DRUGBANK DB03130 C18H24N4O10S small molecule - - DRUGBANK 21577 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3450 S-Benzyl-Glutathione - - DRUGBANK DB03602 C17H23N3O6S small molecule - - DRUGBANK 21578 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3450 S-Benzyl-Glutathione - - DRUGBANK DB03602 C17H23N3O6S small molecule - - DRUGBANK 26205 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6971 methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate - - DRUGBANK DB08179 C16H16O6 small molecule - - DRUGBANK 21015 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 21016 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 22621 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 22622 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 5612 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens inhibitor target Sato S (2007) 17243824 175246 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 2670 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Deponte M (2007) 17664277 173379 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2671 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Barati MT (2007) 17609286 173380 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 20986 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3194 S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione - - DRUGBANK DB03330 C17H23IN4O8S small molecule - - DRUGBANK 20987 109001 2739 - GLO1 GLOD1|GLYI|HEL-S-74 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3194 S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione - - DRUGBANK DB03330 C17H23IN4O8S small molecule - - DRUGBANK 15653 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Lebovitz HE (2006) 16627399 181004 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15654 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Kolterman OG (2005) 15700891 181005 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15655 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Degn KB (2004) 15331551 180997 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15656 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Briones M (2006) 16722815 180996 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15657 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Barnett AH (2005) 16341288 180995 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15658 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Diamant M (2004) 15495988 181001 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15659 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Wajchenberg BL (2007) 17353295 180999 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15660 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Mack CM (2006) 16534527 180998 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15661 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Hargrove DM (2007) 17292977 181000 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15662 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Mann RJ (2010) 20649595 181002 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15663 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 15664 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Geelhoed-Duijvestijn PH (2007) 17379930 181003 1263 Exenatide Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic bydureon|byetta DRUGBANK DB01276 C184H282N50O60S biologic A10BX04 141758-74-9 DRUGBANK 494 109002 2740 - GLP1R - 9606 Homo sapiens unknown target Koerner M (2007) 17475961 171979 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 495 109002 2740 - GLP1R - 9606 Homo sapiens unknown target Baggio LL (2007) 17498508 171978 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 496 109002 2740 - GLP1R - 9606 Homo sapiens unknown target Brubaker PL (2003) 12529935 171977 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 497 109002 2740 - GLP1R - 9606 Homo sapiens unknown target Fischer AJ (2007) 17534934 171976 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 24614 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Larsen PJ (2008) 18333889 182069 5567 Liraglutide NN-2211|Liraglutidum|N-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide|Victoza|NN2211|N-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide|NN 2211|Liraglutide recombinant|Arg34Lys26-(N--(-Glu(N--hexadecanoyl)))-GLP-1[7-37]|NNC 90-1170|Liraglutida saxenda|victoza DRUGBANK DB06655 C172H265N43O51 biologic A10BX07|A10AE56 204656-20-2 DRUGBANK 24615 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Bock T (2003) 14678021 181841 5567 Liraglutide NN-2211|Liraglutidum|N-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide|Victoza|NN2211|N-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide|NN 2211|Liraglutide recombinant|Arg34Lys26-(N--(-Glu(N--hexadecanoyl)))-GLP-1[7-37]|NNC 90-1170|Liraglutida saxenda|victoza DRUGBANK DB06655 C172H265N43O51 biologic A10BX07|A10AE56 204656-20-2 DRUGBANK 27465 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Sanford M (2014) 25367716 188539 7807 Dulaglutide - trulicity DRUGBANK DB09045 C2646H4044N704O836S18 biologic A10BX14 923950-08-7 DRUGBANK 27464 109002 2740 - GLP1R - 9606 Homo sapiens agonist target Trujillo JM (2014) 25136065 188538 7806 Albiglutide - eperzan|tanzeum DRUGBANK DB09043 C3232H5032N864O979S41 biologic A10BX13 782500-75-8 DRUGBANK 14621 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Grasshoff C (2006) 16973644 174521 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14622 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14623 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 10114 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Grasshoff C (2006) 16973644 174521 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10115 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10116 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 27970 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 14324 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens allosteric modulator target Imming P (2006) 17016423 171742 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14325 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens allosteric modulator target Overington JP (2006) 17139284 171741 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14326 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens allosteric modulator target Schofield CM (2004) 15287733 180406 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 16268 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens antagonist target Heads JA (2008) 18221374 181235 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 11510 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11511 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Ye Q (1998) 9452448 178938 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11512 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11513 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Fuentealba J (2010) 21044637 178939 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11514 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Baenziger JE (2011) 20713066 178937 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 15204 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15205 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 2736 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens unknown target Eulenburg V (2006) 16884688 173434 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2737 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens unknown target Heinze L (2007) 17154252 173433 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 12934 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12935 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Krasowski MD (2000) 10683198 179765 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12936 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 6879 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens antagonist target Heusinkveld HJ (2010) 20600211 176009 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6880 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens antagonist target Vale C (2003) 12614680 176005 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 4502 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens agonist target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 22208 109003 2741 - GLRA1 HKPX1|STHE 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3765 D-Serine - - DRUGBANK DB03929 C3H7NO3 small molecule - 312-84-5 DRUGBANK 7220 109004 2742 - GLRA2 GLR 9606 Homo sapiens antagonist target Wang DS (2007) 17405877 176268 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 7221 109004 2742 - GLRA2 GLR 9606 Homo sapiens antagonist target Yang Z (2007) 17714449 176265 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 2764 109004 2742 - GLRA2 GLR 9606 Homo sapiens unknown target Qi Z (2006) 17012403 173451 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2765 109004 2742 - GLRA2 GLR 9606 Homo sapiens unknown target Majumdar S (2007) 17550639 173452 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2766 109004 2742 - GLRA2 GLR 9606 Homo sapiens unknown target Young-Pearse TL (2006) 16847326 173453 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 11533 109004 2742 - GLRA2 GLR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11534 109004 2742 - GLRA2 GLR 9606 Homo sapiens agonist target Ye Q (1998) 9452448 178938 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11535 109004 2742 - GLRA2 GLR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11536 109004 2742 - GLRA2 GLR 9606 Homo sapiens agonist target Baenziger JE (2011) 20713066 178937 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 6877 109004 2742 - GLRA2 GLR 9606 Homo sapiens antagonist target Heusinkveld HJ (2010) 20600211 176009 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6878 109004 2742 - GLRA2 GLR 9606 Homo sapiens antagonist target Vale C (2003) 12614680 176005 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 2779 109005 2743 - GLRB HKPX2 9606 Homo sapiens unknown target Eulenburg V (2006) 16884688 173434 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 6875 109005 2743 - GLRB HKPX2 9606 Homo sapiens antagonist target Heusinkveld HJ (2010) 20600211 176009 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6876 109005 2743 - GLRB HKPX2 9606 Homo sapiens antagonist target Vale C (2003) 12614680 176005 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 4501 109005 2743 - GLRB HKPX2 9606 Homo sapiens agonist target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 2523 109006 2744 - GLS AAD20|GAC|GAM|GLS1|KGA 9606 Homo sapiens unknown target Ashiuchi M (2006) 16952838 173292 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2524 109006 2744 - GLS AAD20|GAC|GAM|GLS1|KGA 9606 Homo sapiens unknown target Ashiuchi M (2006) 16861819 173293 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2525 109006 2744 - GLS AAD20|GAC|GAM|GLS1|KGA 9606 Homo sapiens unknown target Karmaker S (2006) 16824605 173291 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2526 109006 2744 - GLS AAD20|GAC|GAM|GLS1|KGA 9606 Homo sapiens unknown target Yang XX (2006) 16815871 173294 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2527 109006 2744 - GLS AAD20|GAC|GAM|GLS1|KGA 9606 Homo sapiens unknown target Shi F (2006) 16720907 173295 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2645 109007 2745 - GLRX GRX|GRX1 9606 Homo sapiens unknown target Hakansson KO (2007) 17327665 173370 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2646 109007 2745 - GLRX GRX|GRX1 9606 Homo sapiens unknown target Rouhier N (2007) 17460036 173368 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2647 109007 2745 - GLRX GRX|GRX1 9606 Homo sapiens unknown target Diwakar L (2007) 17512091 173369 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2648 109007 2745 - GLRX GRX|GRX1 9606 Homo sapiens unknown target Wang J (2007) 17431186 173366 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2649 109007 2745 - GLRX GRX|GRX1 9606 Homo sapiens unknown target Lu J (2007) 17640917 173367 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 3110 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3111 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 2390 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2391 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Anagnou NP (1993) 8288265 173236 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2392 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 10166 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens inhibitor target Wang JL (1978) 570044 178227 746 Hexachlorophene Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm sapoderm|phisohex DRUGBANK DB00756 C13H6Cl6O2 small molecule D08AE01 70-30-4 DRUGBANK 10167 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens inhibitor target Li M (2009) 19531491 178228 746 Hexachlorophene Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm sapoderm|phisohex DRUGBANK DB00756 C13H6Cl6O2 small molecule D08AE01 70-30-4 DRUGBANK 22655 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22656 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22657 109008 2746 - GLUD1 GDH|GDH1|GLUD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 3175 109009 2747 - GLUD2 GDH2|GLUDP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3176 109009 2747 - GLUD2 GDH2|GLUDP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 2466 109009 2747 - GLUD2 GDH2|GLUDP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2467 109009 2747 - GLUD2 GDH2|GLUDP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2094 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens product of target Tan S (2006) 16547651 172984 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2095 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens product of target Mong JA (2005) 16326016 172981 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2096 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens product of target Rose C (2005) 16382338 172980 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2097 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens product of target Miguel-Hidalgo JJ (2006) 16484281 172983 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2098 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens product of target Chatauret N (2006) 16530878 172982 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2492 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens unknown target Yamamoto S (2007) 17284842 173278 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2493 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens unknown target Scaraffia PY (2006) 16876704 173279 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2494 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens unknown target Singh U (2006) 16973920 173281 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2495 109014 2752 - GLUL GLNS|GS|PIG43|PIG59 9606 Homo sapiens unknown target Re DB (2006) 16673373 173280 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 21630 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3480 Lpc-Ether - - DRUGBANK DB03633 C26H57NO6P small molecule - - DRUGBANK 21631 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3480 Lpc-Ether - - DRUGBANK DB03633 C26H57NO6P small molecule - - DRUGBANK 18818 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2170 Platelet Activating Factor - - DRUGBANK DB02261 C26H54NO7P small molecule - 74389-68-7 DRUGBANK 18819 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2170 Platelet Activating Factor - - DRUGBANK DB02261 C26H54NO7P small molecule - 74389-68-7 DRUGBANK 27656 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27657 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27658 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 26266 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 27648 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27649 109022 2760 - GM2A GM2-AP|SAP-3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 23102 109024 2762 RP1-118B18.1 GMDS GMD|SDR3E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 19438 109024 2762 RP1-118B18.1 GMDS GMD|SDR3E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2444 Guanosine-5'-Diphosphate-Rhamnose - - DRUGBANK DB02547 C16H25N5O15P2 small molecule - - DRUGBANK 19439 109024 2762 RP1-118B18.1 GMDS GMD|SDR3E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2444 Guanosine-5'-Diphosphate-Rhamnose - - DRUGBANK DB02547 C16H25N5O15P2 small molecule - - DRUGBANK 19440 109024 2762 RP1-118B18.1 GMDS GMD|SDR3E1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2444 Guanosine-5'-Diphosphate-Rhamnose - - DRUGBANK DB02547 C16H25N5O15P2 small molecule - - DRUGBANK 18222 109028 2766 RP3-467D16.2 GMPR GMPR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18223 109028 2766 RP3-467D16.2 GMPR GMPR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 23404 109032 2770 - GNAI1 Gi 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23405 109032 2770 - GNAI1 Gi 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23406 109032 2770 - GNAI1 Gi 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23044 109032 2770 - GNAI1 Gi 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23045 109032 2770 - GNAI1 Gi 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23046 109032 2770 - GNAI1 Gi 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 19495 109040 2778 RP4-543J19.4 GNAS AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PHP1A|PHP1B|PHP1C|POH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2481 Colforsin Forskolin - DRUGBANK DB02587 C22H34O7 small molecule - 66575-29-9 DRUGBANK 24869 109040 2778 RP4-543J19.4 GNAS AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PHP1A|PHP1B|PHP1C|POH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5664 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE - - DRUGBANK DB06843 C10H14N5O5P small molecule - - DRUGBANK 23410 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23411 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23412 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 20248 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 20249 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 20250 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 23082 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23083 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23084 109041 2779 - GNAT1 CSNBAD3|GBT1|GNATR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 8962 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Moles G (2007) 16962597 177539 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8963 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Lee PA (2006) 17002488 177538 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8964 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8965 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Bliss SP (2007) 17068198 177542 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8966 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Mamputha S (2007) 16973761 177540 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8967 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Lu ZL (2005) 15967801 177541 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 175 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Kirby RS (2009) 20053189 171829 14 Goserelin Zoladex|ICI-118630|Goserelin|Goserelin acetate zoladex|zoladex la inj depot 1 DRUGBANK DB00014 C59H84N18O14 small molecule L02AE03 65807-02-5 DRUGBANK 24668 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Anderson J (2009) 19450172 182106 5581 Degarelix - firmagon DRUGBANK DB06699 C82H103ClN18O16 small molecule L02BX02 214766-78-6 DRUGBANK 24669 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Steinberg M (2010) 20110043 182143 5581 Degarelix - firmagon DRUGBANK DB06699 C82H103ClN18O16 small molecule L02BX02 214766-78-6 DRUGBANK 24670 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Samant MP (2005) 15705170 181884 5581 Degarelix - firmagon DRUGBANK DB06699 C82H103ClN18O16 small molecule L02BX02 214766-78-6 DRUGBANK 24671 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Kirby RS (2009) 20053189 171829 5581 Degarelix - firmagon DRUGBANK DB06699 C82H103ClN18O16 small molecule L02BX02 214766-78-6 DRUGBANK 586 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Roth C (2004) 14605254 172040 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 587 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 588 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Zapatero-Caballero H (2003) 12606421 172037 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 589 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Voelker P (2002) 11854630 172039 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 590 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Zapatero-Caballero H (2004) 14561652 172038 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 591 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Castellon E (2006) 16809153 171783 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 16499 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens negative modulator target Roth C (2004) 14605254 172040 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16500 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens negative modulator target Menon M (1986) 3004220 181317 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16501 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens negative modulator target Dmowski WP (1990) 2404115 181318 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16502 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens negative modulator target Tian ZZ (2003) 14571621 181319 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 9147 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9148 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Valle RF (2003) 14644830 177656 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9149 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Hugues JN (1998) 9622415 177657 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9150 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Suh J (2004) 14687742 177654 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9151 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Batzer FR (2006) 17097577 177655 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9152 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Saltiel E (1991) 1830521 177652 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9153 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Barbieri RL (1990) 2137975 177653 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9154 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Garner C (1994) 7996307 177651 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9155 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Chrisp P (1990) 2140979 177658 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9156 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Letassy NA (1990) 2151003 177659 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 24778 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens unknown target Kirby RS (2009) 20053189 171829 5601 Buserelin Tiloryth|D-Ser(Tbu)6EA10LHRH|Etilamide|(Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH suprefact inj 1mg/ml|suprefact DRUGBANK DB06719 C62H90N16O15 biologic L02AE01 57982-77-1 DRUGBANK 92 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Imai A (1998) 9625809 171779 7 Leuprolide Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet eligard 45 mg|lupaneta pack|le DRUGBANK DB00007 C59H84N16O12 biologic L02AE02 53714-56-0 DRUGBANK 93 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Borroni R (2000) 10687850 171782 7 Leuprolide Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet eligard 45 mg|lupaneta pack|le DRUGBANK DB00007 C59H84N16O12 biologic L02AE02 53714-56-0 DRUGBANK 94 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Castellon E (2006) 16809153 171783 7 Leuprolide Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet eligard 45 mg|lupaneta pack|le DRUGBANK DB00007 C59H84N16O12 biologic L02AE02 53714-56-0 DRUGBANK 95 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Murase M (2005) 15758569 171780 7 Leuprolide Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet eligard 45 mg|lupaneta pack|le DRUGBANK DB00007 C59H84N16O12 biologic L02AE02 53714-56-0 DRUGBANK 96 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens agonist target Khurana KK (1999) 10394541 171781 7 Leuprolide Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet eligard 45 mg|lupaneta pack|le DRUGBANK DB00007 C59H84N16O12 biologic L02AE02 53714-56-0 DRUGBANK 1281 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Debruyne FM (2006) 16985933 172421 101 Abarelix - - DRUGBANK DB00106 C72H95ClN14O14 biologic L02BX01 183552-38-7 DRUGBANK 27885 109060 2798 - GNRHR GNRHR1|GRHR|HH7|LHRHR|LRHR 9606 Homo sapiens antagonist target Oberye J (2000) 10655292 195949 7780 Ganirelix - ganirelix acetate|orgalutran DRUGBANK DB06785 C80H113ClN18O13 small molecule H01CC01 124904-93-4 DRUGBANK 1992 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1993 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2007 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Tordjman J (2007) 17545671 172938 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2008 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Zappacosta B (2007) 17328883 172934 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2009 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Girgin S (2006) 17168267 172935 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2010 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Guidetti P (2007) 17442055 172936 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2011 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Wu ZM (2007) 17244260 172937 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1440 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1441 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1492 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens activator target Eliot AC (2002) 11888303 172518 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1493 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens activator target Waldmann A (2006) 16925884 172519 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1494 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1496 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens activator target Hansen CM (2001) 11340119 172520 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1495 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens activator target Cooper AJ (2002) 12167474 172517 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2398 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2439 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Yudkoff M (2007) 17444813 173254 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2399 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2896 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2897 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 23020 109067 2805 - GOT1 ASTQTL1|GIG18|cAspAT|cCAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4126 Maleic Acid - - DRUGBANK DB04299 C4H4O4 small molecule - 110-16-7 DRUGBANK 1976 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1977 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1978 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1979 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Grell EH (1976) 823072 172918 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1980 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Recasens M (1979) 261660 172919 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1981 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Collier RH (1972) 4404056 172917 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 19906 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2665 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate - - DRUGBANK DB02783 C10H15N2O8P small molecule - - DRUGBANK 19907 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2665 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate - - DRUGBANK DB02783 C10H15N2O8P small molecule - - DRUGBANK 19908 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2665 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate - - DRUGBANK DB02783 C10H15N2O8P small molecule - - DRUGBANK 2357 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2358 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2359 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2360 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens unknown target Recasens M (1979) 261660 172919 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 1420 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1421 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens cofactor target Mavrides C (1975) 236311 172482 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1422 109068 2806 - GOT2 KAT4|KATIV|mitAAT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 7225 109077 2815 - GP9 CD42a|GPIX 9606 Homo sapiens unknown target Asvadi P (2003) 12738668 176280 460 Quinine (-)-Quinine|(8S,9R)-Quinine|Chinin|Chininum|(R)-(-)-Quinine|Chinine|Quinina|6'-Methoxycinchonidine|Quinine|(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol quinine sulfate|quinine - odan DRUGBANK DB00468 C20H24N2O2 small molecule M09AA72|P01BC01 130-95-0 DRUGBANK 3158 109080 2819 - GPD1 GPD-C|GPDH-C|HTGTI 9606 Homo sapiens unknown target Fonvielle M (2007) 17088060 173703 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22219 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3773 Erythose-4-Phosphate - - DRUGBANK DB03937 C4H9O7P small molecule - - DRUGBANK 22220 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3773 Erythose-4-Phosphate - - DRUGBANK DB03937 C4H9O7P small molecule - - DRUGBANK 22221 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3773 Erythose-4-Phosphate - - DRUGBANK DB03937 C4H9O7P small molecule - - DRUGBANK 21528 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3429 Glucose-6-Phosphate - - DRUGBANK DB03581 C6H13O9P small molecule - 56-73-5 DRUGBANK 21529 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3429 Glucose-6-Phosphate - - DRUGBANK DB03581 C6H13O9P small molecule - 56-73-5 DRUGBANK 21530 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3429 Glucose-6-Phosphate - - DRUGBANK DB03581 C6H13O9P small molecule - 56-73-5 DRUGBANK 20372 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2914 5-Phosphoarabinonic Acid - - DRUGBANK DB03042 C5H11O9P small molecule - - DRUGBANK 20373 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2914 5-Phosphoarabinonic Acid - - DRUGBANK DB03042 C5H11O9P small molecule - - DRUGBANK 20374 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2914 5-Phosphoarabinonic Acid - - DRUGBANK DB03042 C5H11O9P small molecule - - DRUGBANK 23560 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 18472 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 18473 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 18474 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 19441 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2445 Sorbitol 6-phosphate D-glucitol-6-phosphate|1-O-phosphono-D-glucitol - DRUGBANK DB02548 C6H15O9P small molecule - 20479-58-7 DRUGBANK 19442 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2445 Sorbitol 6-phosphate D-glucitol-6-phosphate|1-O-phosphono-D-glucitol - DRUGBANK DB02548 C6H15O9P small molecule - 20479-58-7 DRUGBANK 19443 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2445 Sorbitol 6-phosphate D-glucitol-6-phosphate|1-O-phosphono-D-glucitol - DRUGBANK DB02548 C6H15O9P small molecule - 20479-58-7 DRUGBANK 18312 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18313 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18314 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18514 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2013 5-Phospho-D-Arabinohydroxamic Acid - - DRUGBANK DB02093 C5H12NO9P small molecule - - DRUGBANK 18515 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2013 5-Phospho-D-Arabinohydroxamic Acid - - DRUGBANK DB02093 C5H12NO9P small molecule - - DRUGBANK 18516 109082 2821 - GPI AMF|GNPI|NLK|PGI|PHI|SA-36|SA36 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2013 5-Phospho-D-Arabinohydroxamic Acid - - DRUGBANK DB02093 C5H12NO9P small molecule - - DRUGBANK 2808 109100 2841 RP11-461N23.8 GPR18 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2809 109100 2841 RP11-461N23.8 GPR18 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 27068 109120 2862 - MLNR GPR38|MTLR1 9606 Homo sapiens unknown target Li JJ (2004) 15027861 188473 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 3441 109122 2864 - FFAR1 FFA1R|GPCR40|GPR40 9606 Homo sapiens agonist target Itoh Y (2005) 16214394 173833 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3498 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens unknown target Miyashita Y (2007) 17319845 173865 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3499 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens unknown target Chen CH (2007) 17353078 173864 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3500 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens unknown target Gray S (2007) 17403374 173866 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3501 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens unknown target Taracha E (2006) 17163821 173863 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 1485 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens cofactor target Beranek M (2001) 11330835 172512 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1486 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens cofactor target Baines CJ (2004) 15347780 172513 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1487 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens cofactor target Cheung PY (2003) 14688239 172516 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1488 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens cofactor target Halfon P (2002) 12537583 172514 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1489 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens cofactor target Inubushi T (2005) 16179747 172515 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 10399 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens inhibitor target Todd KG (2009) 19203467 178349 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10400 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens inhibitor target McKenna KF (1991) 1881457 178348 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10401 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens inhibitor target Tanay VA (2001) 11775064 178350 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 2432 109133 2875 - GPT AAT1|ALT1|GPT1 9606 Homo sapiens unknown target Ohgami N (2007) 16854580 173251 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2659 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens unknown target Walshe J (2007) 17510403 173331 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2660 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens unknown target Chattopadhyay S (2007) 17561443 173375 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2661 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens unknown target Du X (2007) 17387467 71461 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2662 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens unknown target Sordillo LM (2007) 17297093 173377 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2663 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens unknown target Sheridan PA (2007) 17513408 173376 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2591 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2592 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens cofactor target Liddell JR (2006) 16721761 173334 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2593 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2594 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens cofactor target Destro-Bisol G (1989) 2742004 173333 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2595 109134 2876 - GPX1 GPXD|GSHPX1 9606 Homo sapiens cofactor target Ursini F (2005) 15679624 173332 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2590 109135 2877 - GPX2 GI-GPx|GPRP|GPRP-2|GPx-2|GPx-GI|GSHPX-GI|GSHPx-2 9606 Homo sapiens cofactor target Walshe J (2007) 17510403 173331 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2688 109136 2878 - GPX3 GPx-P|GSHPx-3|GSHPx-P 9606 Homo sapiens cofactor target Carmeli E (2007) 17578749 173388 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2689 109136 2878 - GPX3 GPx-P|GSHPx-3|GSHPx-P 9606 Homo sapiens cofactor target Jacobson GA (2007) 17558897 173389 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2559 109137 2879 - GPX4 GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2560 109137 2879 - GPX4 GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx 9606 Homo sapiens cofactor target Baek IJ (2007) 17503194 173309 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2561 109137 2879 - GPX4 GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2562 109137 2879 - GPX4 GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx 9606 Homo sapiens cofactor target Nam SY (2003) 14967915 173311 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2563 109137 2879 - GPX4 GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx 9606 Homo sapiens cofactor target Moreno SG (2003) 12751792 173310 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2687 109138 2880 - GPX5 HEL-S-75p 9606 Homo sapiens cofactor target Koh CS (2007) 17531267 173387 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2553 109139 2882 UNQ469/PRO828 GPX7 CL683|GPX6|GPx-7|GSHPx-7|NPGPx 9606 Homo sapiens cofactor target Giovannini C (2008) 17588737 173305 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 748 109142 2885 - GRB2 ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2 9606 Homo sapiens binder target Ramos-Morales F (1997) 9299436 283 60 Pegademase bovine Adenosine deaminase|Adenosine aminohydrolase adagen DRUGBANK DB00061 C1821H2834N484O552S14 biologic - 9026-93-1 DRUGBANK 20889 109142 2885 - GRB2 ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3142 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid - - DRUGBANK DB03276 C37H45N4O7P small molecule - - DRUGBANK 20890 109142 2885 - GRB2 ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3142 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid - - DRUGBANK DB03276 C37H45N4O7P small molecule - - DRUGBANK 20891 109142 2885 - GRB2 ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3142 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid - - DRUGBANK DB03276 C37H45N4O7P small molecule - - DRUGBANK 14627 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14628 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14629 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Dildy-Mayfield JE (1996) 8786535 174519 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 10120 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Dildy-Mayfield JE (1996) 8786535 174519 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10121 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Guo L (2007) 17207582 139486 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 27159 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 24265 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Denes L (2006) 16861112 181955 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24266 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Langan YM (2003) 12581229 181810 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24267 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Howes JF (2007) 17199027 181981 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 26950 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Hanada T (2011) 21635236 182189 7627 Perampanel prampanel|Perampanelum|3-(2-Cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one|perampanel fycompa DRUGBANK DB08883 C23H15N3O small molecule N03AX22 380917-97-5 DRUGBANK 15208 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15209 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 2504 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2505 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Henley JM (1993) 7679210 173247 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2506 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2507 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Stein E (1992) 1279377 173276 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2508 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens unknown target Li F (1995) 7838123 173277 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 12940 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12941 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12942 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Martin DC (1995) 7702639 179768 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 4452 109147 2890 - GRIA1 GLUH1|GLUR1|GLURA|GluA1|HBGR1 9606 Homo sapiens antagonist target Dildy-Mayfield JE (1996) 8786535 174519 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 16013 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16014 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 14453 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14454 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14455 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Jin LJ (2010) 20051697 180468 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 27180 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 7169 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7170 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 2485 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2486 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Henley JM (1993) 7679210 173247 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2487 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2488 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Stein E (1992) 1279377 173276 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2489 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Li F (1995) 7838123 173277 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 4633 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4634 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4625 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4626 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 8478 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8479 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 25471 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6266 N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide - - DRUGBANK DB07455 C20H28N2O4S2 small molecule - - DRUGBANK 20807 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3108 (S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid - - DRUGBANK DB03240 C10H13N3O4 small molecule - - DRUGBANK 20808 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3108 (S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid - - DRUGBANK DB03240 C10H13N3O4 small molecule - - DRUGBANK 20809 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3108 (S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid - - DRUGBANK DB03240 C10H13N3O4 small molecule - - DRUGBANK 15931 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15932 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Stobbs SH (2004) 15169831 181134 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15933 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 26342 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7090 (3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide - - DRUGBANK DB08303 C18H28N4O4S2 small molecule - - DRUGBANK 26343 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7091 (3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide - - DRUGBANK DB08304 C18H27N3O4S2 small molecule - - DRUGBANK 16785 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16786 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 11112 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11113 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 20966 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3184 (S)-ATPA (S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid - DRUGBANK DB03319 C10H15N2O4 small molecule - - DRUGBANK 20967 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3184 (S)-ATPA (S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid - DRUGBANK DB03319 C10H15N2O4 small molecule - - DRUGBANK 20968 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3184 (S)-ATPA (S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid - DRUGBANK DB03319 C10H15N2O4 small molecule - - DRUGBANK 16815 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16816 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 22360 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3834 Bromo-Willardiine - - DRUGBANK DB04000 C7H8BrN3O4 small molecule - - DRUGBANK 22361 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3834 Bromo-Willardiine - - DRUGBANK DB04000 C7H8BrN3O4 small molecule - - DRUGBANK 22362 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3834 Bromo-Willardiine - - DRUGBANK DB04000 C7H8BrN3O4 small molecule - - DRUGBANK 15990 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15991 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15966 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15967 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 20262 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2875 Quisqualate - - DRUGBANK DB02999 C5H7N3O5 small molecule - - DRUGBANK 20263 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2875 Quisqualate - - DRUGBANK DB02999 C5H7N3O5 small molecule - - DRUGBANK 20264 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2875 Quisqualate - - DRUGBANK DB02999 C5H7N3O5 small molecule - - DRUGBANK 5282 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5283 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5379 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5380 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16062 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16063 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 20208 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2843 Fluoro-Willardiine - - DRUGBANK DB02966 C7H8FN3O4 small molecule - - DRUGBANK 20209 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2843 Fluoro-Willardiine - - DRUGBANK DB02966 C7H8FN3O4 small molecule - - DRUGBANK 20210 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2843 Fluoro-Willardiine - - DRUGBANK DB02966 C7H8FN3O4 small molecule - - DRUGBANK 24268 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Denes L (2006) 16861112 181955 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24269 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Langan YM (2003) 12581229 181810 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24270 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Howes JF (2007) 17199027 181981 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 26344 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7092 (3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide - - DRUGBANK DB08305 C19H29N3O4S2 small molecule - - DRUGBANK 16039 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16040 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 23911 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4600 THIO-ATPA - - DRUGBANK DB04798 C10H16N2O3S small molecule - - DRUGBANK 10520 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10521 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 23759 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4408 Aniracetam 1-P-ANISOYL-2-PYRROLIDINONE - DRUGBANK DB04599 C12H13NO3 small molecule N06BX11 72432-10-1 DRUGBANK 18419 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1978 (S)-AMPA (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid - DRUGBANK DB02057 C7H10N2O4 small molecule - 83643-88-3 DRUGBANK 18420 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1978 (S)-AMPA (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid - DRUGBANK DB02057 C7H10N2O4 small molecule - 83643-88-3 DRUGBANK 18421 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1978 (S)-AMPA (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid - DRUGBANK DB02057 C7H10N2O4 small molecule - 83643-88-3 DRUGBANK 17528 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1600 (S)-Des-Me-Ampa (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID - DRUGBANK DB01664 C6H8N2O4 small molecule - - DRUGBANK 17529 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1600 (S)-Des-Me-Ampa (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID - DRUGBANK DB01664 C6H8N2O4 small molecule - - DRUGBANK 17530 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1600 (S)-Des-Me-Ampa (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID - DRUGBANK DB01664 C6H8N2O4 small molecule - - DRUGBANK 25608 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6405 2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE - - DRUGBANK DB07598 C13H13NO4 small molecule - - DRUGBANK 19954 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2700 Iodo-Willardiine - - DRUGBANK DB02818 C7H8IN3O4 small molecule - - DRUGBANK 19955 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2700 Iodo-Willardiine - - DRUGBANK DB02818 C7H8IN3O4 small molecule - - DRUGBANK 19956 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2700 Iodo-Willardiine - - DRUGBANK DB02818 C7H8IN3O4 small molecule - - DRUGBANK 6672 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6673 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 22611 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3961 Willardiine - - DRUGBANK DB04129 C7H9N3O4 small molecule - - DRUGBANK 22612 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3961 Willardiine - - DRUGBANK DB04129 C7H9N3O4 small molecule - - DRUGBANK 22613 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3961 Willardiine - - DRUGBANK DB04129 C7H9N3O4 small molecule - - DRUGBANK 21880 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3601 FG-9041 6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX - DRUGBANK DB03759 C8H4N4O6 small molecule - 2379-57-9 DRUGBANK 21881 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3601 FG-9041 6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX - DRUGBANK DB03759 C8H4N4O6 small molecule - 2379-57-9 DRUGBANK 21882 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3601 FG-9041 6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX - DRUGBANK DB03759 C8H4N4O6 small molecule - 2379-57-9 DRUGBANK 19002 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2252 2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid - - DRUGBANK DB02347 C11H19N2O7P small molecule - - DRUGBANK 19003 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2252 2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid - - DRUGBANK DB02347 C11H19N2O7P small molecule - - DRUGBANK 19004 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2252 2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid - - DRUGBANK DB02347 C11H19N2O7P small molecule - - DRUGBANK 22725 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3982 2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid - - DRUGBANK DB04152 C11H14N2O4 small molecule - - DRUGBANK 22726 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3982 2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid - - DRUGBANK DB04152 C11H14N2O4 small molecule - - DRUGBANK 22727 109148 2891 - GRIA2 GLUR2|GLURB|GluA2|GluR-K2|HBGR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3982 2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid - - DRUGBANK DB04152 C11H14N2O4 small molecule - - DRUGBANK 16091 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens potentiator target Karkanias NB (1999) 10626836 181146 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 27156 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 23757 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4408 Aniracetam 1-P-ANISOYL-2-PYRROLIDINONE - DRUGBANK DB04599 C12H13NO3 small molecule N06BX11 72432-10-1 DRUGBANK 2528 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2529 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Henley JM (1993) 7679210 173247 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2530 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 24259 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Denes L (2006) 16861112 181955 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24260 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Langan YM (2003) 12581229 181810 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24261 109149 2892 RP11-349N19.3 GRIA3 GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94 9606 Homo sapiens unknown target Howes JF (2007) 17199027 181981 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24262 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Denes L (2006) 16861112 181955 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24263 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Langan YM (2003) 12581229 181810 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 24264 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Howes JF (2007) 17199027 181981 4774 Talampanel - - DRUGBANK DB04982 C19H19N3O3 small molecule - 161832-65-1 DRUGBANK 27185 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 2415 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Linden AM (2001) 11406192 173245 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2416 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2417 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Henley JM (1993) 7679210 173247 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2418 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2419 109150 2893 - GRIA4 GLUR4|GLUR4C|GLURD|GluA4 9606 Homo sapiens unknown target Cristovao AJ (2002) 12008069 173246 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2551 109151 2894 RP11-93H12.1 GRID1 GluD1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2552 109151 2894 RP11-93H12.1 GRID1 GluD1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2393 109152 2895 - GRID2 GluD2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2394 109152 2895 - GRID2 GluD2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2468 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens unknown target Valgeirsson J (2003) 13129570 173270 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2469 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens unknown target Sahara Y (1997) 9254673 173271 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2470 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens unknown target Stensbol TB (1999) 10513575 173272 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2471 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2472 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 4991 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4994 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens antagonist target Rogawski MA (2003) 12724156 174784 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4993 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens antagonist target Gryder DS (2003) 12904467 174785 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4992 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens antagonist target Braga MF (2009) 19417176 174783 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 4995 109154 2897 - GRIK1 EAA3|EEA3|GLR5|GLUR5|GluK1 9606 Homo sapiens antagonist target Kaminski RM (2004) 15111016 174786 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 10538 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 10539 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 784 Primidone Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione mysoline|primidone|sertan tab DRUGBANK DB00794 C12H14N2O2 small molecule N03AA03 125-33-7 DRUGBANK 16005 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 16006 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1316 Aprobarbital 5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione - DRUGBANK DB01352 C10H14N2O3 small molecule N05CA05 77-02-1 DRUGBANK 15982 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 15983 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1315 Amobarbital 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil amytal sodium pulvule 222 0.2g DRUGBANK DB01351 C11H18N2O3 small molecule N05CA02 57-43-2 DRUGBANK 7187 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 7188 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 455 Metharbital Metharbital|Metharbitalum|Metarbital - DRUGBANK DB00463 C9H14N2O3 small molecule N03AA30 50-11-3 DRUGBANK 20265 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2875 Quisqualate - - DRUGBANK DB02999 C5H7N3O5 small molecule - - DRUGBANK 20266 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2875 Quisqualate - - DRUGBANK DB02999 C5H7N3O5 small molecule - - DRUGBANK 20267 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2875 Quisqualate - - DRUGBANK DB02999 C5H7N3O5 small molecule - - DRUGBANK 14466 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 14467 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 16031 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 16032 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1317 Butethal Butobarbitone|Butobarbital|Butethal|Neonal - DRUGBANK DB01353 C10H16N2O3 small molecule N05CA03 77-28-1 DRUGBANK 11135 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 11136 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 839 Methylphenobarbital Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum - DRUGBANK DB00849 C13H14N2O3 small molecule N03AA01 115-38-8 DRUGBANK 5401 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 5402 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 16081 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16082 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1319 Hexobarbital 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl - DRUGBANK DB01355 C12H16N2O3 small molecule N05CA16|N01AF02 56-29-1 DRUGBANK 16054 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16055 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1318 Heptabarbital Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm - DRUGBANK DB01354 C13H18N2O3 small molecule N05CA11 509-86-4 DRUGBANK 16800 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 16801 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1429 Barbital - - DRUGBANK DB01483 C8H12N2O3 small molecule N05CA04 57-44-3 DRUGBANK 20024 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2734 Domoic Acid L-domoic acid|(-)-domoic acid - DRUGBANK DB02852 C15H21NO6 small molecule - 14277-97-5 DRUGBANK 20025 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2734 Domoic Acid L-domoic acid|(-)-domoic acid - DRUGBANK DB02852 C15H21NO6 small molecule - 14277-97-5 DRUGBANK 20026 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2734 Domoic Acid L-domoic acid|(-)-domoic acid - DRUGBANK DB02852 C15H21NO6 small molecule - 14277-97-5 DRUGBANK 6693 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 6694 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2516 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Wong AY (2007) 17581967 173287 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 16830 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 16831 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 1441 Barbituric acid derivative - - DRUGBANK DB01496 C16H11F3N2O3S small molecule - - DRUGBANK 5300 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 5301 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 299 Talbutal (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate - DRUGBANK DB00306 C11H16N2O3 small molecule N05CA07 115-44-6 DRUGBANK 4652 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 4653 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 234 Butalbital allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid allzital|ratio-tecnal c 1/4|ra DRUGBANK DB00241 C11H16N2O3 small molecule - 77-26-9 DRUGBANK 8494 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 8495 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 589 Thiopental Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal pentothal inj 25mg/ml|pentotha DRUGBANK DB00599 C11H18N2O2S small molecule N05CA19|N01AF03 76-75-5 DRUGBANK 4585 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Krasowski MD (1999) 10487207 174567 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4586 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens antagonist target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 21183 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3282 2s,4r-4-Methylglutamate - - DRUGBANK DB03425 C6H12NO4 small molecule - - DRUGBANK 21184 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3282 2s,4r-4-Methylglutamate - - DRUGBANK DB03425 C6H12NO4 small molecule - - DRUGBANK 21185 109155 2898 - GRIK2 EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3282 2s,4r-4-Methylglutamate - - DRUGBANK DB03425 C6H12NO4 small molecule - - DRUGBANK 2345 109156 2899 - GRIK3 EAA5|GLR7|GLUR7|GluK3|GluR7a 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2346 109156 2899 - GRIK3 EAA5|GLR7|GLUR7|GluK3|GluR7a 9606 Homo sapiens unknown target Bettler B (1992) 1371217 173212 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2347 109156 2899 - GRIK3 EAA5|GLR7|GLUR7|GluK3|GluR7a 9606 Homo sapiens unknown target Stuehmer T (1996) 8622118 173210 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2348 109156 2899 - GRIK3 EAA5|GLR7|GLUR7|GluK3|GluR7a 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2349 109156 2899 - GRIK3 EAA5|GLR7|GLUR7|GluK3|GluR7a 9606 Homo sapiens unknown target Takeda M (2000) 11058796 173211 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2517 109157 2900 - GRIK4 EAA1|GRIK|GluK4|KA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2518 109157 2900 - GRIK4 EAA1|GRIK|GluK4|KA1 9606 Homo sapiens unknown target Korczak B (1995) 8589992 173288 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2519 109157 2900 - GRIK4 EAA1|GRIK|GluK4|KA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2500 109158 2901 - GRIK5 EAA2|GRIK2|GluK5|KA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2501 109158 2901 - GRIK5 EAA2|GRIK2|GluK5|KA2 9606 Homo sapiens unknown target Takeda M (2000) 11058796 173211 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2502 109158 2901 - GRIK5 EAA2|GRIK2|GluK5|KA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2503 109158 2901 - GRIK5 EAA2|GRIK2|GluK5|KA2 9606 Homo sapiens unknown target Murphy DE (1988) 2850065 173284 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 5408 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 17599 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 23774 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Snell LD (1988) 2843389 181662 4428 Cycloleucine 1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate - DRUGBANK DB04620 C6H11NO2 small molecule - 52-52-8 DRUGBANK 23775 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Hershkowitz N (1989) 2556198 181657 4428 Cycloleucine 1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate - DRUGBANK DB04620 C6H11NO2 small molecule - 52-52-8 DRUGBANK 23776 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Herberg LJ (1990) 2170997 181648 4428 Cycloleucine 1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate - DRUGBANK DB04620 C6H11NO2 small molecule - 52-52-8 DRUGBANK 23777 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4428 Cycloleucine 1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate - DRUGBANK DB04620 C6H11NO2 small molecule - 52-52-8 DRUGBANK 14439 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14440 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Kornhuber J (1995) 8788072 180466 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14441 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14471 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 24104 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24105 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 12601 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 24806 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 7038 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Yamakura T (2000) 10735801 176162 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 18089 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1856 Dcka, 5,7-Dichlorokynurenic Acid - - DRUGBANK DB01931 C10H5Cl2NO3 small molecule - - DRUGBANK 24796 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 24396 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens activator target Lipton SA (2002) 12183209 181801 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 9089 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9090 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 6700 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2350 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Miglio G (2007) 17662248 173213 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 13105 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens binder target Kotermanski SE (2009) 19687120 179863 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 27012 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Seppaelae T (1988) 3365283 181667 7690 Ifenprodil - - DRUGBANK DB08954 C21H27NO2 small molecule C04AX28 23210-56-2 DRUGBANK 22204 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3765 D-Serine - - DRUGBANK DB03929 C3H7NO3 small molecule - 312-84-5 DRUGBANK 22205 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3765 D-Serine - - DRUGBANK DB03929 C3H7NO3 small molecule - 312-84-5 DRUGBANK 22206 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3765 D-Serine - - DRUGBANK DB03929 C3H7NO3 small molecule - 312-84-5 DRUGBANK 5188 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 26897 109159 2902 RP11-350O14.1 GRIN1 GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1 9606 Homo sapiens antagonist target Yang XC (1999) 9918557 181735 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 17603 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 5412 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 14337 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Perouansky M (1996) 8968191 180413 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14475 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 24112 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24113 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 12605 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 24810 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 7041 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Yamakura T (2000) 10735801 176162 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 24800 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 24400 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens activator target Lipton SA (2002) 12183209 181801 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 9097 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9098 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 12206 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 6704 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2368 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens unknown target Rutter AR (2000) 11080203 173223 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2369 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2370 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2371 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens unknown target Rutter AR (2002) 12068077 173225 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2372 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens unknown target Bresink I (1996) 8886398 173224 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 13107 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Blanpied TA (1997) 9120573 179867 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13108 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Chen HS (2005) 15901795 179866 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13109 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Maler JM (2005) 16009352 179865 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13110 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Rogawski MA (2003) 14530799 179868 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13111 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Bresink I (1996) 8886398 173224 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 2768 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2769 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Milutinovic PS (2007) 17646495 173458 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2770 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Gabra BH (2007) 17405869 173454 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2771 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Brosnan RJ (2007) 17513636 173455 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2772 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Liu Y (2007) 17360906 173456 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2773 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Domingues A (2007) 17403555 173457 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 5192 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 16867 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Stirling JM (1989) 2538766 181476 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 16868 109160 2903 RP11-297M9.2 GRIN2A EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A 9606 Homo sapiens antagonist target Geldenhuys WJ (2007) 17157509 181478 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 5411 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 17602 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14474 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 24110 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24111 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24809 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 12604 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 7051 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Yamakura T (2000) 10735801 176162 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 24799 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 24399 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens activator target Lipton SA (2002) 12183209 181801 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 7560 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7561 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Gallagher MJ (1998) 9572299 176543 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7562 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Hattori K (2006) 16407246 176542 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7563 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Zhuravliova E (2007) 17092607 176545 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7564 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Gu WH (2007) 17588330 176544 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7565 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Sinor JD (2000) 11102491 176547 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7566 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Steinmetz RD (2002) 11741727 176546 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 12201 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Harty TP (2000) 10690753 179282 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 12202 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Luszczki JJ (2008) 18253065 179281 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 12203 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Chang HR (2008) 18311896 179280 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 12204 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 12205 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Kleckner NW (1999) 10215667 179279 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 6703 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2512 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens unknown target Miglio G (2007) 17662248 173213 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2513 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens unknown target Verkhratsky A (2007) 17229973 173286 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 9095 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9096 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 27011 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Seppaelae T (1988) 3365283 181667 7690 Ifenprodil - - DRUGBANK DB08954 C21H27NO2 small molecule C04AX28 23210-56-2 DRUGBANK 5191 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 16873 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Stirling JM (1989) 2538766 181476 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 13118 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Blanpied TA (1997) 9120573 179867 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13119 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Maler JM (2005) 16009352 179865 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13120 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Nakazato E (2005) 15452358 179873 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13121 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Kashiwagi K (2002) 11854433 179872 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13122 109161 2904 - GRIN2B GluN2B|MRD6|NMDAR2B|NR2B|hNR3 9606 Homo sapiens antagonist target Rogawski MA (2003) 14530799 179868 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 5414 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 17605 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14477 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 24116 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24117 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24812 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 12607 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 7040 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Yamakura T (2000) 10735801 176162 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 24802 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 6706 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2363 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Olmos G (1999) 10455281 173220 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2364 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Kuner T (1993) 7905294 173222 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2365 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Sundstroem E (1997) 9417820 173221 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2366 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2367 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 9101 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9102 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 2738 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Widdowson PS (1996) 8955518 173436 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2739 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2740 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2741 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Malayev A (2002) 11861317 173435 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2742 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens unknown target Al-Ghoul WM (1997) 9073168 173437 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 5194 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 16865 109162 2905 - GRIN2C GluN2C|NMDAR2C|NR2C 9606 Homo sapiens antagonist target Stirling JM (1989) 2538766 181476 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 17600 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 5409 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 14442 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14443 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Kornhuber J (1995) 8788072 180466 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14444 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14472 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 24106 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24107 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 12602 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 24807 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 7039 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Yamakura T (2000) 10735801 176162 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 24797 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 24398 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens activator target Lipton SA (2002) 12183209 181801 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 6701 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2473 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2474 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens unknown target Sundstroem E (1997) 9417820 173221 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2475 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2476 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens unknown target Pliss L (2002) 11755246 173273 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2477 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens unknown target Bresink I (1996) 8886398 173224 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 9091 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9092 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 5189 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 16864 109163 2906 - GRIN2D EB11|GluN2D|NMDAR2D|NR2D 9606 Homo sapiens antagonist target Stirling JM (1989) 2538766 181476 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 4428 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Pearce DJ (2004) 15764038 174491 216 Diflorasone (6,11,16)-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Diflorasonum|(6alpha,11beta,16beta)-6,9-Difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Diflorasona diflorasone diacetate|apexicon DRUGBANK DB00223 C22H28F2O5 small molecule D07AC10 2557-49-5 DRUGBANK 8324 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hoegger P (1994) 7878687 177114 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8325 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Lumry WR (1999) 10518812 177111 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8326 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Johnson M (1996) 8646863 177110 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8327 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Andersson O (1999) 10200007 177113 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8328 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Zhang X (2001) 11730731 177112 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8329 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 11465 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hochhaus G (1990) 2386110 174125 886 Rimexolone Rimexolon vexol|vexol ophthalmic suspens DRUGBANK DB00896 C24H34O3 small molecule H02AB12|S01BA13 49697-38-3 DRUGBANK 8849 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 8850 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Friel PN (2006) 16597193 177469 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 8851 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Diez JJ (2007) 17504182 177468 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 8852 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Yano A (2006) 17062674 177465 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 8853 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Liu BG (2006) 17121036 177467 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 8854 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Yano A (2006) 16707595 177466 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 5579 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Rautanen A (2006) 16895953 174979 317 Fluorometholone 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one fml forte sus 0.25%|fml forte| DRUGBANK DB00324 C22H29FO4 small molecule S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05 426-13-1 DRUGBANK 5580 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 317 Fluorometholone 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one fml forte sus 0.25%|fml forte| DRUGBANK DB00324 C22H29FO4 small molecule S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05 426-13-1 DRUGBANK 5581 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hammer F (2006) 16980198 174982 317 Fluorometholone 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one fml forte sus 0.25%|fml forte| DRUGBANK DB00324 C22H29FO4 small molecule S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05 426-13-1 DRUGBANK 5582 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 317 Fluorometholone 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one fml forte sus 0.25%|fml forte| DRUGBANK DB00324 C22H29FO4 small molecule S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05 426-13-1 DRUGBANK 5583 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Sher L (2006) 17086345 174980 317 Fluorometholone 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one fml forte sus 0.25%|fml forte| DRUGBANK DB00324 C22H29FO4 small molecule S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05 426-13-1 DRUGBANK 5584 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Samudre SS (2004) 15684812 175223 317 Fluorometholone 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one fml forte sus 0.25%|fml forte| DRUGBANK DB00324 C22H29FO4 small molecule S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05 426-13-1 DRUGBANK 15018 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Kunz S (2003) 12920235 180706 1210 Budesonide (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione pulmicort nebuamp 0.25 mg/ml|u DRUGBANK DB01222 C25H34O6 small molecule R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05 51333-22-3 DRUGBANK 15019 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Henriksson G (2001) 11258648 180707 1210 Budesonide (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione pulmicort nebuamp 0.25 mg/ml|u DRUGBANK DB01222 C25H34O6 small molecule R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05 51333-22-3 DRUGBANK 15020 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Zhang X (2000) 11040338 180705 1210 Budesonide (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione pulmicort nebuamp 0.25 mg/ml|u DRUGBANK DB01222 C25H34O6 small molecule R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05 51333-22-3 DRUGBANK 15021 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1210 Budesonide (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione pulmicort nebuamp 0.25 mg/ml|u DRUGBANK DB01222 C25H34O6 small molecule R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05 51333-22-3 DRUGBANK 15022 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Zhang X (2001) 11730731 177112 1210 Budesonide (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione pulmicort nebuamp 0.25 mg/ml|u DRUGBANK DB01222 C25H34O6 small molecule R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05 51333-22-3 DRUGBANK 15023 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Kompella UB (2003) 12601049 180708 1210 Budesonide (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione pulmicort nebuamp 0.25 mg/ml|u DRUGBANK DB01222 C25H34O6 small molecule R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05 51333-22-3 DRUGBANK 14559 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Mayer M (1975) 173192 180518 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 3872 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 3873 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hochhaus G (1990) 2386110 174125 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 3874 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hoegger P (1998) 9523318 174124 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 3875 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Philibert D (1993) 8466638 174127 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 3876 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Valotis A (2004) 15285788 174126 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 3877 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Johnson M (1998) 9563368 174123 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 3878 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Badia L (2001) 11368283 174122 173 Flunisolide Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum flunisolide|pms-flunisolide|no DRUGBANK DB00180 C24H31FO6 small molecule R03BA03|R01AD04 3385-03-3 DRUGBANK 4630 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Labeur M (2010) 20920967 174580 233 Alclometasone 7-Chloro-16-methylprednisolone|(7alpha,11beta,16alpha)-7-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione aclovate|alclometasone dipropi DRUGBANK DB00240 C22H29ClO5 small molecule D07AB10|S01BA10 67452-97-5 DRUGBANK 4631 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hofmann TG (1998) 9891987 174579 233 Alclometasone 7-Chloro-16-methylprednisolone|(7alpha,11beta,16alpha)-7-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione aclovate|alclometasone dipropi DRUGBANK DB00240 C22H29ClO5 small molecule D07AB10|S01BA10 67452-97-5 DRUGBANK 11080 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Baschant U (2010) 20346397 178666 836 Flurandrenolide Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide cordran|flurandrenolide cream| DRUGBANK DB00846 C24H33FO6 small molecule D07CC03|D07AC07 1524-88-5 DRUGBANK 11081 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Fitzgerald P (2006) 16255837 178667 836 Flurandrenolide Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide cordran|flurandrenolide cream| DRUGBANK DB00846 C24H33FO6 small molecule D07CC03|D07AC07 1524-88-5 DRUGBANK 11082 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Issar M (2006) 16507850 175778 836 Flurandrenolide Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide cordran|flurandrenolide cream| DRUGBANK DB00846 C24H33FO6 small molecule D07CC03|D07AC07 1524-88-5 DRUGBANK 8378 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Nehme A (2009) 19744340 105018 581 Fluocinolone Acetonide Flucort|Fluocinolon acetonid|Flucinar|Flupollon|Synotic|Radiocin|Fluocinolonacetonid|Fluocet|Fluonid|Retisert|Iluvien|Fluzon|Sinalar|Synandone|Coriphate|Derma-smoothe/fs|Fluocinoloni acetonidum|Cortiplastol|Acetnida de fluocinolona|Omniderm|Synsac|Percutina|Localyn|6alpha-Fluorotriamcinolone acetonide|Actonide de fluocinolone|Synemol|Synalar|Acetonido de fluocinolona|Tefunote|Synandrone|Prodermin|Fluocinolone 16,17-acetonide|Jellin|Dermalar|Fluotrex|6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide|Fluovitif|Synamol synalar ont regular 0.025%|syn DRUGBANK DB00591 C24H30F2O6 small molecule D07CC02|S01CA10|D07AC04|S02CA05|C05AA10|S02BA08|D07BC02|S01BA15 67-73-2 DRUGBANK 10018 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Rautanen A (2006) 16895953 174979 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10019 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10020 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hammer F (2006) 16980198 174982 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10021 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 10022 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Sher L (2006) 17086345 174980 731 Hydrocortisone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone kaiser permanente hydrocortiso DRUGBANK DB00741 C21H30O5 small molecule S01BA02|S01BB01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07XA01|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60 50-23-7 DRUGBANK 9134 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 653 Flumethasone Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum locacorten vioform|locasalen|l DRUGBANK DB00663 C22H28F2O5 small molecule D07CB05|S02CA02|D07BB01|D07AB03|D07XB01 2135-17-3 DRUGBANK 9135 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Labeur M (2010) 20920967 174580 653 Flumethasone Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum locacorten vioform|locasalen|l DRUGBANK DB00663 C22H28F2O5 small molecule D07CB05|S02CA02|D07BB01|D07AB03|D07XB01 2135-17-3 DRUGBANK 9136 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 653 Flumethasone Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum locacorten vioform|locasalen|l DRUGBANK DB00663 C22H28F2O5 small molecule D07CB05|S02CA02|D07BB01|D07AB03|D07XB01 2135-17-3 DRUGBANK 9137 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Maier C (2005) 16079279 177640 653 Flumethasone Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum locacorten vioform|locasalen|l DRUGBANK DB00663 C22H28F2O5 small molecule D07CB05|S02CA02|D07BB01|D07AB03|D07XB01 2135-17-3 DRUGBANK 5889 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Gonzalez Villarroel P (2008) 18411198 175429 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5890 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Lamberts SW (1985) 2982481 175428 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5891 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Wiedemann K (1998) 9744490 175427 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5892 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chao Y (1997) 9195366 175426 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5893 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Kontula K (1983) 6222739 175425 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5894 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Wermers RA (2004) 15595341 175424 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5171 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5172 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5173 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Rautanen A (2006) 16895953 174979 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5174 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5175 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hammer F (2006) 16980198 174982 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5176 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 5177 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Sher L (2006) 17086345 174980 281 Amcinonide Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida cyclocort ont 0.1%|taro-amcino DRUGBANK DB00288 C28H35FO7 small molecule D07AC11 51022-69-6 DRUGBANK 14027 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Ikonomidis I (2009) 19482847 178735 1118 Prednicarbate - dermatop|dermatop emollient cr DRUGBANK DB01130 C27H36O8 small molecule D07AC18 73771-04-7 DRUGBANK 14028 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Boudinot FD (1986) 2879901 178736 1118 Prednicarbate - dermatop|dermatop emollient cr DRUGBANK DB01130 C27H36O8 small molecule D07AC18 73771-04-7 DRUGBANK 13146 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Jessop S (2001) 11279785 179891 1036 Fluocinonide Lidex|Fluocinonide|Fluocinonido|Vanos|Fluocinonidum fluocinonide|lidex ont 0.05%|l DRUGBANK DB01047 C26H32F2O7 small molecule D07AC08|C05AA11|D07CC05 356-12-7 DRUGBANK 8700 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shahin V (2005) 15976447 177375 610 Triamcinolone 9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona triaderm ont 0.1%|theraderm cr DRUGBANK DB00620 C21H27FO6 small molecule D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|D07BB03|D07XB02|S01BA05 124-94-7 DRUGBANK 8701 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Nehme A (2009) 19744340 105018 610 Triamcinolone 9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona triaderm ont 0.1%|theraderm cr DRUGBANK DB00620 C21H27FO6 small molecule D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|D07BB03|D07XB02|S01BA05 124-94-7 DRUGBANK 8702 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Issar M (2006) 16507850 175778 610 Triamcinolone 9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona triaderm ont 0.1%|theraderm cr DRUGBANK DB00620 C21H27FO6 small molecule D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|D07BB03|D07XB02|S01BA05 124-94-7 DRUGBANK 8437 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Mohandas S (2009) 19293512 177179 586 Ulobetasol Ulobtasol|Halobetasol|21-chloro diflorasone|Ulobetasolum|Ulobetasol ultravate cream|ultravate oint DRUGBANK DB00596 C22H27ClF2O4 small molecule D07AC21 98651-66-2 DRUGBANK 8438 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hofmann TG (1998) 9891987 174579 586 Ulobetasol Ulobtasol|Halobetasol|21-chloro diflorasone|Ulobetasolum|Ulobetasol ultravate cream|ultravate oint DRUGBANK DB00596 C22H27ClF2O4 small molecule D07AC21 98651-66-2 DRUGBANK 27892 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Gemzell-Danielsson K (2013) 23437846 196017 8104 Ulipristal - ella|fibristal DRUGBANK DB08867 C28H35NO3 small molecule G03XB02|G03AD02 159811-51-5 DRUGBANK 16552 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Barnes NC (2007) 17530144 181353 1359 Ciclesonide - apo-ciclesonide|alvesco|omnari DRUGBANK DB01410 C32H44O7 small molecule R01AD13|R03BA08 126544-47-6 DRUGBANK 9504 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Trune DR (2010) 20800906 177824 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 16284 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Fitzgerald P (2006) 16255837 178667 1339 Paramethasone Dillar - DRUGBANK DB01384 C22H29FO5 small molecule H02AB05 53-33-8 DRUGBANK 16285 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Rautanen A (2006) 16895953 174979 1339 Paramethasone Dillar - DRUGBANK DB01384 C22H29FO5 small molecule H02AB05 53-33-8 DRUGBANK 16286 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 1339 Paramethasone Dillar - DRUGBANK DB01384 C22H29FO5 small molecule H02AB05 53-33-8 DRUGBANK 16287 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hammer F (2006) 16980198 174982 1339 Paramethasone Dillar - DRUGBANK DB01384 C22H29FO5 small molecule H02AB05 53-33-8 DRUGBANK 16288 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 1339 Paramethasone Dillar - DRUGBANK DB01384 C22H29FO5 small molecule H02AB05 53-33-8 DRUGBANK 16289 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Sher L (2006) 17086345 174980 1339 Paramethasone Dillar - DRUGBANK DB01384 C22H29FO5 small molecule H02AB05 53-33-8 DRUGBANK 10245 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Zhang X (2002) 12127907 178288 754 Mometasone Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate nasal allergy and congestion r DRUGBANK DB00764 C22H28Cl2O4 small molecule D07AC13|R03BA07|R03AK09|D07XC03|R01AD09 105102-22-5 DRUGBANK 10246 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 754 Mometasone Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate nasal allergy and congestion r DRUGBANK DB00764 C22H28Cl2O4 small molecule D07AC13|R03BA07|R03AK09|D07XC03|R01AD09 105102-22-5 DRUGBANK 10247 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Lumry WR (1999) 10518812 177111 754 Mometasone Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate nasal allergy and congestion r DRUGBANK DB00764 C22H28Cl2O4 small molecule D07AC13|R03BA07|R03AK09|D07XC03|R01AD09 105102-22-5 DRUGBANK 10248 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Isogai M (1993) 8439518 178286 754 Mometasone Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate nasal allergy and congestion r DRUGBANK DB00764 C22H28Cl2O4 small molecule D07AC13|R03BA07|R03AK09|D07XC03|R01AD09 105102-22-5 DRUGBANK 10249 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Smith CL (1998) 9793625 178287 754 Mometasone Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate nasal allergy and congestion r DRUGBANK DB00764 C22H28Cl2O4 small molecule D07AC13|R03BA07|R03AK09|D07XC03|R01AD09 105102-22-5 DRUGBANK 10284 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 759 Hydrocortamate 17-Hydroxycorticosterone, 21-(diethylamino)acetate|Hydrocortamatum|Hidrocortamato - DRUGBANK DB00769 C27H41NO6 small molecule - 76-47-1 DRUGBANK 10285 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 759 Hydrocortamate 17-Hydroxycorticosterone, 21-(diethylamino)acetate|Hydrocortamatum|Hidrocortamato - DRUGBANK DB00769 C27H41NO6 small molecule - 76-47-1 DRUGBANK 16256 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Schlechte JA (1982) 7062741 181228 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 16257 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Schlechte JA (1982) 7054210 181229 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 16258 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Rautanen A (2006) 16895953 174979 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 16259 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 16260 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hammer F (2006) 16980198 174982 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 16261 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 16262 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Sher L (2006) 17086345 174980 1336 Cortisone acetate Cortisyl|Cortone acetate cortisone acetate|cortisone ac DRUGBANK DB01380 C23H30O6 small molecule S01BA03|H02AB10 50-04-4 DRUGBANK 4860 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 246 Medrysone HMS|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione hms DRUGBANK DB00253 C22H32O3 small molecule S01BA08 2668-66-8 DRUGBANK 4861 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Southren AL (1983) 6336597 174690 246 Medrysone HMS|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione hms DRUGBANK DB00253 C22H32O3 small molecule S01BA08 2668-66-8 DRUGBANK 6451 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Usmani OS (2005) 15860753 175780 386 Beclomethasone dipropionate 9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate beclovent rotacaps - inh 200 DRUGBANK DB00394 C28H37ClO7 small molecule D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01 5534-09-8 DRUGBANK 6452 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Saklatvala J (2002) 12010562 175779 386 Beclomethasone dipropionate 9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate beclovent rotacaps - inh 200 DRUGBANK DB00394 C28H37ClO7 small molecule D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01 5534-09-8 DRUGBANK 6453 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Issar M (2006) 16507850 175778 386 Beclomethasone dipropionate 9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate beclovent rotacaps - inh 200 DRUGBANK DB00394 C28H37ClO7 small molecule D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01 5534-09-8 DRUGBANK 11211 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Ikonomidis I (2009) 19482847 178735 850 Prednisolone Prednisolona|delta-dehydrocortisol|delta-hydrocortisone|Prednisolonum|PRDL|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Metacortandralone|Hydroretrocortine|3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene|delta(1)-Hydrocortisone|delta(1)-Dehydrohydrocortisone|delta(1)-Dehydrocortisol|delta-dehydrohydrocortisone|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione pms-prednisolone sod phos oph DRUGBANK DB00860 C21H28O5 small molecule S01BB02|S03BA02|S01CA02|S01BA04|D07AA03|D07BA01|D07XA02|V03AB05|D07CA03|A01AC54|C05AA04|R01AD52|S02CA01|S01CB02|R01AD02|H02AB06|A07EA01|S02BA03|S03CA02 50-24-8 DRUGBANK 11212 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Boudinot FD (1986) 2879901 178736 850 Prednisolone Prednisolona|delta-dehydrocortisol|delta-hydrocortisone|Prednisolonum|PRDL|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Metacortandralone|Hydroretrocortine|3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene|delta(1)-Hydrocortisone|delta(1)-Dehydrohydrocortisone|delta(1)-Dehydrocortisol|delta-dehydrohydrocortisone|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione pms-prednisolone sod phos oph DRUGBANK DB00860 C21H28O5 small molecule S01BB02|S03BA02|S01CA02|S01BA04|D07AA03|D07BA01|D07XA02|V03AB05|D07CA03|A01AC54|C05AA04|R01AD52|S02CA01|S01CB02|R01AD02|H02AB06|A07EA01|S02BA03|S03CA02 50-24-8 DRUGBANK 18732 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 18733 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 12289 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Juruena MF (2006) 17016711 179339 949 Methylprednisolone Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum methylprednisolone acetate inj DRUGBANK DB00959 C22H30O5 small molecule D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04 83-43-2 DRUGBANK 12291 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Quesnell RR (2007) 17251323 179338 949 Methylprednisolone Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum methylprednisolone acetate inj DRUGBANK DB00959 C22H30O5 small molecule D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04 83-43-2 DRUGBANK 12292 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Owen HC (2007) 17182172 179337 949 Methylprednisolone Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum methylprednisolone acetate inj DRUGBANK DB00959 C22H30O5 small molecule D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04 83-43-2 DRUGBANK 12290 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 949 Methylprednisolone Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum methylprednisolone acetate inj DRUGBANK DB00959 C22H30O5 small molecule D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04 83-43-2 DRUGBANK 12293 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Boivin MA (2007) 17068119 179336 949 Methylprednisolone Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum methylprednisolone acetate inj DRUGBANK DB00959 C22H30O5 small molecule D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04 83-43-2 DRUGBANK 24833 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Jamal KN (2009) 19668594 182122 5635 Difluprednate DFBA|Durezol|Difluoroprednisolone butyrate acetate durezol DRUGBANK DB06781 C27H34F2O7 small molecule D07AC19 23674-86-4 DRUGBANK 24834 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Tajika T (2010) 20509750 182155 5635 Difluprednate DFBA|Durezol|Difluoroprednisolone butyrate acetate durezol DRUGBANK DB06781 C27H34F2O7 small molecule D07AC19 23674-86-4 DRUGBANK 11316 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Druzgala P (1991) 2004037 178824 863 Loteprednol Loteprednol|Loteprednolum zylet|lotemax ointment|lotemax DRUGBANK DB00873 C21H27ClO5 small molecule S01BA14 129260-79-3 DRUGBANK 11317 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Bodor N (2006) 17020532 178825 863 Loteprednol Loteprednol|Loteprednolum zylet|lotemax ointment|lotemax DRUGBANK DB00873 C21H27ClO5 small molecule S01BA14 129260-79-3 DRUGBANK 11318 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 863 Loteprednol Loteprednol|Loteprednolum zylet|lotemax ointment|lotemax DRUGBANK DB00873 C21H27ClO5 small molecule S01BA14 129260-79-3 DRUGBANK 11319 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Samudre SS (2004) 15684812 175223 863 Loteprednol Loteprednol|Loteprednolum zylet|lotemax ointment|lotemax DRUGBANK DB00873 C21H27ClO5 small molecule S01BA14 129260-79-3 DRUGBANK 11320 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Szelenyi I (2000) 12861354 178823 863 Loteprednol Loteprednol|Loteprednolum zylet|lotemax ointment|lotemax DRUGBANK DB00873 C21H27ClO5 small molecule S01BA14 129260-79-3 DRUGBANK 7970 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Lange K (2000) 10754457 176811 537 Desoximetasone Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason topicort gel 0.05%|topicort mi DRUGBANK DB00547 C22H29FO4 small molecule D07XC02|D07AC03 382-67-2 DRUGBANK 7971 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Rautanen A (2006) 16895953 174979 537 Desoximetasone Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason topicort gel 0.05%|topicort mi DRUGBANK DB00547 C22H29FO4 small molecule D07XC02|D07AC03 382-67-2 DRUGBANK 7972 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 537 Desoximetasone Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason topicort gel 0.05%|topicort mi DRUGBANK DB00547 C22H29FO4 small molecule D07XC02|D07AC03 382-67-2 DRUGBANK 7973 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hammer F (2006) 16980198 174982 537 Desoximetasone Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason topicort gel 0.05%|topicort mi DRUGBANK DB00547 C22H29FO4 small molecule D07XC02|D07AC03 382-67-2 DRUGBANK 7974 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 537 Desoximetasone Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason topicort gel 0.05%|topicort mi DRUGBANK DB00547 C22H29FO4 small molecule D07XC02|D07AC03 382-67-2 DRUGBANK 7975 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Sher L (2006) 17086345 174980 537 Desoximetasone Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason topicort gel 0.05%|topicort mi DRUGBANK DB00547 C22H29FO4 small molecule D07XC02|D07AC03 382-67-2 DRUGBANK 15169 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Vaitkuviene A (2006) 16963802 180771 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15170 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Wang D (2007) 16971495 180770 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15171 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15172 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Warne JP (2006) 16835395 180768 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15173 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Funato H (2006) 16956592 180769 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15174 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Grossman R (2006) 16891588 174981 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 10996 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Buchwald P (2008) 18022656 178633 828 Clocortolone 9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona cloderm|clocortolone pivalate DRUGBANK DB00838 C22H28ClFO4 small molecule D07AB21 4828-27-7 DRUGBANK 10997 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Tanigawa K (2002) 12188035 176104 828 Clocortolone 9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona cloderm|clocortolone pivalate DRUGBANK DB00838 C22H28ClFO4 small molecule D07AB21 4828-27-7 DRUGBANK 10998 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Ali A (2008) 18691892 178634 828 Clocortolone 9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona cloderm|clocortolone pivalate DRUGBANK DB00838 C22H28ClFO4 small molecule D07AB21 4828-27-7 DRUGBANK 15470 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Shaw JR (2007) 17038445 174983 1247 Desonide 11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide tridesilon crm 0.05%|tridesilo DRUGBANK DB01260 C24H32O6 small molecule S01BA11|D07AB08|D07BB02 638-94-8 DRUGBANK 15471 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Otte C (2010) 20371666 180892 1247 Desonide 11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide tridesilon crm 0.05%|tridesilo DRUGBANK DB01260 C24H32O6 small molecule S01BA11|D07AB08|D07BB02 638-94-8 DRUGBANK 15472 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Russell GM (2010) 20427668 180893 1247 Desonide 11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide tridesilon crm 0.05%|tridesilo DRUGBANK DB01260 C24H32O6 small molecule S01BA11|D07AB08|D07BB02 638-94-8 DRUGBANK 6758 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Fagart J (2010) 20650892 175952 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 10943 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Gu G (2005) 15909120 178604 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10944 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Aida K (2004) 15336699 176103 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10945 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target LeVan TD (1999) 10796070 178601 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10946 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target de Pablos RM (2006) 16723527 178602 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10947 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens antagonist target Attardi BJ (2004) 15120421 178603 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 6978 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 435 Betamethasone Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron betnesol retention enema 5mg/1 DRUGBANK DB00443 C22H29FO5 small molecule S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04 378-44-9 DRUGBANK 6979 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Johnstone JF (2005) 15866114 176102 435 Betamethasone Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron betnesol retention enema 5mg/1 DRUGBANK DB00443 C22H29FO5 small molecule S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04 378-44-9 DRUGBANK 6980 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Aida K (2004) 15336699 176103 435 Betamethasone Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron betnesol retention enema 5mg/1 DRUGBANK DB00443 C22H29FO5 small molecule S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04 378-44-9 DRUGBANK 6981 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Tanigawa K (2002) 12188035 176104 435 Betamethasone Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron betnesol retention enema 5mg/1 DRUGBANK DB00443 C22H29FO5 small molecule S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04 378-44-9 DRUGBANK 12732 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Fitzgerald P (2006) 16255837 178667 1003 Clobetasol propionate clobetasol 17-propionate|21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-propionate|clobetasol 17-propanoate|Clobetasol propionate E taro-clobetasol topical soluti DRUGBANK DB01013 C25H32ClFO5 small molecule - 25122-46-7 DRUGBANK 12733 109165 2908 - NR3C1 GCCR|GCR|GCRST|GR|GRL 9606 Homo sapiens agonist target Hofmann TG (1998) 9891987 174579 1003 Clobetasol propionate clobetasol 17-propionate|21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-propionate|clobetasol 17-propanoate|Clobetasol propionate E taro-clobetasol topical soluti DRUGBANK DB01013 C25H32ClFO5 small molecule - 25122-46-7 DRUGBANK 22903 109168 2911 - GRM1 GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4083 4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid - - DRUGBANK DB04256 C10H11NO4 small molecule - - DRUGBANK 22904 109168 2911 - GRM1 GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4083 4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid - - DRUGBANK DB04256 C10H11NO4 small molecule - - DRUGBANK 22905 109168 2911 - GRM1 GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4083 4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid - - DRUGBANK DB04256 C10H11NO4 small molecule - - DRUGBANK 2520 109168 2911 - GRM1 GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13 9606 Homo sapiens unknown target San Gabriel AM (2007) 17331504 173289 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2521 109168 2911 - GRM1 GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13 9606 Homo sapiens unknown target Suzuki G (2007) 17360958 173218 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2522 109168 2911 - GRM1 GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13 9606 Homo sapiens unknown target Chiocchetti A (2006) 16751798 173290 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2420 109171 2914 - GRM4 GPRC1D|MGLUR4|mGlu4 9606 Homo sapiens unknown target Suzuki G (2007) 17360958 173218 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 9103 109172 2915 - GRM5 GPRC1E|MGLUR5|PPP1R86|mGlu5 9606 Homo sapiens antagonist target De Witte P (2005) 15963001 177611 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 24413 109172 2915 - GRM5 GPRC1E|MGLUR5|PPP1R86|mGlu5 9606 Homo sapiens inhibitor target Wier HA (2011) 21351809 182185 5525 Rufinamide RUF 331|Xilep|Banzel banzel DRUGBANK DB06201 C10H8F2N4O small molecule N03AF03 106308-44-5 DRUGBANK 2429 109174 2917 - GRM7 GLUR7|GPRC1G|MGLU7|MGLUR7|PPP1R87 9606 Homo sapiens unknown target Suzuki G (2007) 17360958 173218 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2361 109175 2918 - GRM8 GLUR8|GPRC1H|MGLUR8|mGlu8 9606 Homo sapiens unknown target Suzuki G (2007) 17360958 173218 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2362 109175 2918 - GRM8 GLUR8|GPRC1H|MGLUR8|mGlu8 9606 Homo sapiens unknown target Morimoto R (2006) 16957773 173219 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 16088 109187 2932 - GSK3B - 9606 Homo sapiens inhibitor target Borsotto M (2007) 16733521 181143 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16089 109187 2932 - GSK3B - 9606 Homo sapiens inhibitor target Adli M (2007) 17628506 181145 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16090 109187 2932 - GSK3B - 9606 Homo sapiens inhibitor target O'Brien WT (2009) 19754466 181144 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 23302 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23303 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 25028 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5832 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole - - DRUGBANK DB07014 C17H13FN2O4S small molecule - - DRUGBANK 17761 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1705 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione - - DRUGBANK DB01772 C22H20FN3O4 small molecule - - DRUGBANK 17762 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1705 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione - - DRUGBANK DB01772 C22H20FN3O4 small molecule - - DRUGBANK 17763 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1705 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione - - DRUGBANK DB01772 C22H20FN3O4 small molecule - - DRUGBANK 25595 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6392 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine - - DRUGBANK DB07585 C12H11ClN6 small molecule - - DRUGBANK 25891 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6656 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE - - DRUGBANK DB07859 C20H20ClN3 small molecule - - DRUGBANK 17799 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1724 I-5 - - DRUGBANK DB01793 C17H10Cl2N2O4 small molecule - - DRUGBANK 17800 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1724 I-5 - - DRUGBANK DB01793 C17H10Cl2N2O4 small molecule - - DRUGBANK 17801 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1724 I-5 - - DRUGBANK DB01793 C17H10Cl2N2O4 small molecule - - DRUGBANK 25593 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6391 N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine - - DRUGBANK DB07584 C15H13N7 small molecule - - DRUGBANK 18405 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18406 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18407 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 18143 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1874 N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea - - DRUGBANK DB01950 C12H12N4O4S small molecule - - DRUGBANK 18144 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1874 N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea - - DRUGBANK DB01950 C12H12N4O4S small molecule - - DRUGBANK 18145 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1874 N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea - - DRUGBANK DB01950 C12H12N4O4S small molecule - - DRUGBANK 25834 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6610 N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide - - DRUGBANK DB07812 C20H18N4OS small molecule - - DRUGBANK 25063 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5876 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione - - DRUGBANK DB07058 C16H12N4O2S small molecule - - DRUGBANK 25971 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6743 ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE - - DRUGBANK DB07947 C20H22ClN3O3S small molecule - - DRUGBANK 18330 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18331 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 25683 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6482 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one - - DRUGBANK DB07676 C20H19N3O4 small molecule - - DRUGBANK 22387 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3848 Alsterpaullone - - DRUGBANK DB04014 C16H11N3O3 small molecule - - DRUGBANK 22388 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3848 Alsterpaullone - - DRUGBANK DB04014 C16H11N3O3 small molecule - - DRUGBANK 22389 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3848 Alsterpaullone - - DRUGBANK DB04014 C16H11N3O3 small molecule - - DRUGBANK 26098 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6866 (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE - - DRUGBANK DB08073 C24H23N5O small molecule - - DRUGBANK 21244 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3300 (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime - - DRUGBANK DB03444 C16H10BrN3O2 small molecule - - DRUGBANK 25160 109187 2932 - GSK3B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5967 (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one - - DRUGBANK DB07149 C13H14FN5O small molecule - - DRUGBANK 19556 109189 2934 RP11-477J21.1 GSN ADF|AGEL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2513 Latrunculin A LAT-A|LatA|(+)-latrunculin A|(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one - DRUGBANK DB02621 C22H31NO5S small molecule - 76343-93-6 DRUGBANK 23091 109190 2935 - GSPT1 551G9.2|ETF3A|GST1|eRF3a 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 3047 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Cheng Z (2007) 17550271 173652 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3048 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Gazaryan IG (2007) 17565998 173653 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3049 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Aon MA (2007) 17540766 173656 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3050 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Wan C (2007) 17053903 173654 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3051 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Knapp KG (2007) 17502280 173655 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 18631 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 18632 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 20941 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3175 Oxidized Glutathione Disulfide - - DRUGBANK DB03310 C20H32N6O12S2 small molecule - - DRUGBANK 20942 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3175 Oxidized Glutathione Disulfide - - DRUGBANK DB03310 C20H32N6O12S2 small molecule - - DRUGBANK 17485 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1581 3,6-Dihydroxy-Xanthene-9-Propionic Acid - - DRUGBANK DB01644 C16H14O5 small molecule - - DRUGBANK 17486 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1581 3,6-Dihydroxy-Xanthene-9-Propionic Acid - - DRUGBANK DB01644 C16H14O5 small molecule - - DRUGBANK 17487 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1581 3,6-Dihydroxy-Xanthene-9-Propionic Acid - - DRUGBANK DB01644 C16H14O5 small molecule - - DRUGBANK 20088 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2775 3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol - - DRUGBANK DB02895 C6H10OS2 small molecule - - DRUGBANK 20089 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2775 3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol - - DRUGBANK DB02895 C6H10OS2 small molecule - - DRUGBANK 19451 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2450 Glutathionylspermidine Disulfide - - DRUGBANK DB02553 C34H66N12O10S2 small molecule - - DRUGBANK 19452 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2450 Glutathionylspermidine Disulfide - - DRUGBANK DB02553 C34H66N12O10S2 small molecule - - DRUGBANK 2615 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Maity S (2008) 17512104 173346 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2616 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Markaryan AA (2006) 17369902 173347 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2617 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Guruvayoorappan C (2007) 17338281 173348 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2618 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Brocardo PS (2007) 17327255 173349 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2619 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Messarah M (2007) 17303537 173350 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 20645 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20646 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 25410 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6208 2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE - - DRUGBANK DB07393 C24H21N2P small molecule - - DRUGBANK 25720 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6517 6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID - - DRUGBANK DB07714 C17H18O4 small molecule - - DRUGBANK 22091 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3704 Meta-Nitro-Tyrosine - - DRUGBANK DB03867 C9H10N2O5 small molecule - - DRUGBANK 22092 109191 2936 - GSR HEL-75 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3704 Meta-Nitro-Tyrosine - - DRUGBANK DB03867 C9H10N2O5 small molecule - - DRUGBANK 4910 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Jopperi-Davis KS (2004) 15104113 174729 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4911 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Akella SS (1999) 10378469 174728 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4912 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Vallyathan V (1992) 1312851 174734 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4913 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Kirsch JD (2002) 12477282 174735 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4914 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Brodie AE (1992) 1394620 174730 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4915 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Powell SR (1987) 3806383 174731 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4916 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Doroshenko N (2004) 15321730 174732 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 4917 109191 2936 - GSR HEL-75 9606 Homo sapiens inhibitor target Puglia CD (1984) 6094175 174733 255 Carmustine Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea gliadel wafer|gliadel|bicnu DRUGBANK DB00262 C5H9Cl2N3O2 small molecule L01AD01 154-93-8 DRUGBANK 2914 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Tanaka T (2006) 16940754 173563 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 24403 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens stimulator target Martensson J (1989) 2502672 181653 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 23288 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23289 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23290 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 2575 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Mohanpuria P (2007) 17607728 173321 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2576 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Janaky R (2007) 17401648 173322 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2577 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Herrera K (2007) 17452339 173320 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2578 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Bridges CC (2007) 17467761 173319 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2579 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Forcella M (2007) 17630655 173318 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 21153 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3265 gamma-Glutamylcysteine gamma-L-Glutamyl-L-cysteine|5-L-Glutamyl-L-cysteine|L-gamma-Glutamylcysteine|GluCys|L-gamma-glutamyl-L-cysteine|Glu(-Cys)|gamma-Glu-Cys - DRUGBANK DB03408 C8H14N2O5S small molecule - 636-58-8 DRUGBANK 21154 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3265 gamma-Glutamylcysteine gamma-L-Glutamyl-L-cysteine|5-L-Glutamyl-L-cysteine|L-gamma-Glutamylcysteine|GluCys|L-gamma-glutamyl-L-cysteine|Glu(-Cys)|gamma-Glu-Cys - DRUGBANK DB03408 C8H14N2O5S small molecule - 636-58-8 DRUGBANK 21155 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3265 gamma-Glutamylcysteine gamma-L-Glutamyl-L-cysteine|5-L-Glutamyl-L-cysteine|L-gamma-Glutamylcysteine|GluCys|L-gamma-glutamyl-L-cysteine|Glu(-Cys)|gamma-Glu-Cys - DRUGBANK DB03408 C8H14N2O5S small molecule - 636-58-8 DRUGBANK 2752 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Ristoff E (2007) 17397529 173445 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2750 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Janaky R (2007) 17401648 173322 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2749 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Pai CH (2006) 17124497 173446 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2751 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Herrera K (2007) 17452339 173320 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2753 109192 2937 - GSS GSHS|HEL-S-64p|HEL-S-88n 9606 Homo sapiens unknown target Ducruix C (2006) 16996193 173444 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 18057 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18058 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18059 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 2631 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Kim I (2007) 17425746 173358 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2632 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Soederdahl T (2007) 17346923 173357 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2633 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2634 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Joensson LS (2007) 17333241 173328 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 20268 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20269 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20270 109193 2938 RP11-392A23.1 GSTA1 GST2|GSTA1-1|GTH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 8576 109194 2939 - GSTA2 GST2|GSTA2-2|GTA2|GTH2 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 2635 109194 2939 - GSTA2 GST2|GSTA2-2|GTA2|GTH2 9606 Homo sapiens unknown target Sharma P (2007) 17317527 173362 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2636 109194 2939 - GSTA2 GST2|GSTA2-2|GTA2|GTH2 9606 Homo sapiens unknown target Gupta S (2007) 17401685 173359 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2637 109194 2939 - GSTA2 GST2|GSTA2-2|GTA2|GTH2 9606 Homo sapiens unknown target Ozkilic AC (2007) 17338280 173361 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2638 109194 2939 - GSTA2 GST2|GSTA2-2|GTA2|GTH2 9606 Homo sapiens unknown target Guruvayoorappan C (2007) 17338281 173348 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2639 109194 2939 - GSTA2 GST2|GSTA2-2|GTA2|GTH2 9606 Homo sapiens unknown target Skamarauskas J (2007) 17321661 173360 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2681 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Board PG (1998) 9480897 173385 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2682 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target McHugh TE (1996) 8910329 173386 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2683 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2684 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2685 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2686 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target McDonagh PD (1999) 10085232 173308 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 23595 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4333 GSHNA - - DRUGBANK DB04521 C19H33N3O8S small molecule - - DRUGBANK 23596 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4333 GSHNA - - DRUGBANK DB04521 C19H33N3O8S small molecule - - DRUGBANK 23597 109195 2940 RP1-214M20.2 GSTA3 GSTA3-3|GTA3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4333 GSHNA - - DRUGBANK DB04521 C19H33N3O8S small molecule - - DRUGBANK 2607 109196 2941 RP1-214M20.1 GSTA4 GSTA4-4|GTA4 9606 Homo sapiens unknown target Gallagher EP (2007) 17553661 173341 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 18652 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2081 Zinc Trihydroxide - - DRUGBANK DB02165 H3O3Zn small molecule - - DRUGBANK 18653 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2081 Zinc Trihydroxide - - DRUGBANK DB02165 H3O3Zn small molecule - - DRUGBANK 22784 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4016 (9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB04187 C24H27N3O7S small molecule - - DRUGBANK 22785 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4016 (9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB04187 C24H27N3O7S small molecule - - DRUGBANK 22786 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4016 (9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB04187 C24H27N3O7S small molecule - - DRUGBANK 20950 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3179 Fluorotryptophane 5-Fluoro-L-tryptophan - DRUGBANK DB03314 C11H11FN2O2 small molecule - 16626-02-1 DRUGBANK 20951 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3179 Fluorotryptophane 5-Fluoro-L-tryptophan - DRUGBANK DB03314 C11H11FN2O2 small molecule - 16626-02-1 DRUGBANK 20952 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3179 Fluorotryptophane 5-Fluoro-L-tryptophan - DRUGBANK DB03314 C11H11FN2O2 small molecule - 16626-02-1 DRUGBANK 19237 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2358 Glutathione S-(2,4 Dinitrobenzene) - - DRUGBANK DB02458 C16H19N5O10S small molecule - 26289-39-4 DRUGBANK 19238 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2358 Glutathione S-(2,4 Dinitrobenzene) - - DRUGBANK DB02458 C16H19N5O10S small molecule - 26289-39-4 DRUGBANK 2672 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Ouerhani S (2007) 17381051 173326 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2673 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Contreras-Vergara CA (2007) 17427177 173381 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2674 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Sakoda LC (2008) 17624589 173382 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2675 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Moore LE (2007) 17311259 173383 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2676 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Schwartzbaum JA (2007) 17372252 173330 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 17897 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1764 (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB01834 C24H27N3O7S small molecule - - DRUGBANK 17898 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1764 (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB01834 C24H27N3O7S small molecule - - DRUGBANK 17899 109199 2944 - GSTM1 GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1764 (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB01834 C24H27N3O7S small molecule - - DRUGBANK 2610 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Kurtovic S (2007) 17490601 173344 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2611 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Yalcinkaya S (2007) 17498936 173345 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2612 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Gallagher EP (2007) 17553661 173341 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2613 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Roh JY (2007) 17604895 173342 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2614 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Vararattanavech A (2007) 17523921 173343 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 19235 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2358 Glutathione S-(2,4 Dinitrobenzene) - - DRUGBANK DB02458 C16H19N5O10S small molecule - 26289-39-4 DRUGBANK 19236 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2358 Glutathione S-(2,4 Dinitrobenzene) - - DRUGBANK DB02458 C16H19N5O10S small molecule - 26289-39-4 DRUGBANK 20943 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3175 Oxidized Glutathione Disulfide - - DRUGBANK DB03310 C20H32N6O12S2 small molecule - - DRUGBANK 20944 109201 2946 - GSTM2 GST4|GSTM|GSTM2-2|GTHMUS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3175 Oxidized Glutathione Disulfide - - DRUGBANK DB03310 C20H32N6O12S2 small molecule - - DRUGBANK 2608 109202 2947 RP4-735C1.2 GSTM3 GST5|GSTB|GSTM3-3|GTM3 9606 Homo sapiens unknown target Moore LE (2007) 17617661 173327 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2609 109202 2947 RP4-735C1.2 GSTM3 GST5|GSTB|GSTM3-3|GTM3 9606 Homo sapiens unknown target Schwartzbaum JA (2007) 17372252 173330 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 20354 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2905 S-Octylglutathione - - DRUGBANK DB03032 C18H33N3O6S small molecule - - DRUGBANK 20355 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2905 S-Octylglutathione - - DRUGBANK DB03032 C18H33N3O6S small molecule - - DRUGBANK 20356 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2905 S-Octylglutathione - - DRUGBANK DB03032 C18H33N3O6S small molecule - - DRUGBANK 21763 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3550 1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane - - DRUGBANK DB03706 C19H26N4O10S small molecule - - DRUGBANK 21764 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3550 1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane - - DRUGBANK DB03706 C19H26N4O10S small molecule - - DRUGBANK 21765 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3550 1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane - - DRUGBANK DB03706 C19H26N4O10S small molecule - - DRUGBANK 21566 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3445 Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine - - DRUGBANK DB03597 C17H22IN3O6S small molecule - - DRUGBANK 21567 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3445 Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine - - DRUGBANK DB03597 C17H22IN3O6S small molecule - - DRUGBANK 21568 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3445 Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine - - DRUGBANK DB03597 C17H22IN3O6S small molecule - - DRUGBANK 20274 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20275 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20276 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 22617 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 22618 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 22619 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 2601 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2602 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2603 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Cantlay AM (1994) 7974294 173340 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2604 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Beuckmann CT (2000) 10905636 3668 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2605 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2606 109203 2948 - GSTM4 GSTM4-4|GTM4 9606 Homo sapiens unknown target Efferth T (2005) 15796179 173339 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2650 109204 2949 RP4-735C1.1 GSTM5 GSTM5-5|GTM5 9606 Homo sapiens unknown target Schnakenberg E (2001) 11173863 173371 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2651 109204 2949 RP4-735C1.1 GSTM5 GSTM5-5|GTM5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2652 109204 2949 RP4-735C1.1 GSTM5 GSTM5-5|GTM5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2653 109204 2949 RP4-735C1.1 GSTM5 GSTM5-5|GTM5 9606 Homo sapiens unknown target Rao AV (2001) 11684093 173372 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 19582 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2525 Cibacron Blue - - DRUGBANK DB02633 C29H20ClN7O11S3 small molecule - 84166-13-2 DRUGBANK 19583 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2525 Cibacron Blue - - DRUGBANK DB02633 C29H20ClN7O11S3 small molecule - 84166-13-2 DRUGBANK 23165 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4164 Carbocisteine S-carboxymethylcysteine - DRUGBANK DB04339 C5H9NO4S small molecule R05CB03 638-23-3 DRUGBANK 23166 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4164 Carbocisteine S-carboxymethylcysteine - DRUGBANK DB04339 C5H9NO4S small molecule R05CB03 638-23-3 DRUGBANK 23167 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4164 Carbocisteine S-carboxymethylcysteine - DRUGBANK DB04339 C5H9NO4S small molecule R05CB03 638-23-3 DRUGBANK 15312 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15313 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens inhibitor target Baranczyk-Kuzma A (2001) 11899840 180810 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15314 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens inhibitor target Baranczyk-Kuzma A (2004) 15094841 180811 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 24331 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5222 TLK-199 - - DRUGBANK DB05460 C27H35N3O6S small molecule - - DRUGBANK 18060 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18061 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 22493 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22494 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 21731 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3531 S-(P-Nitrobenzyl)Glutathione - - DRUGBANK DB03686 C17H22N4O8S small molecule - - DRUGBANK 21732 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3531 S-(P-Nitrobenzyl)Glutathione - - DRUGBANK DB03686 C17H22N4O8S small molecule - - DRUGBANK 21733 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3531 S-(P-Nitrobenzyl)Glutathione - - DRUGBANK DB03686 C17H22N4O8S small molecule - - DRUGBANK 22614 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 22615 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 22616 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 2598 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Kadokawa Y (2007) 17517071 173337 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2599 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Ramachandran K (2007) 17465221 173338 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 17895 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1764 (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB01834 C24H27N3O7S small molecule - - DRUGBANK 17896 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1764 (9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene - - DRUGBANK DB01834 C24H27N3O7S small molecule - - DRUGBANK 20271 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20272 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20273 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 25873 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6646 S-NONYL-CYSTEINE - - DRUGBANK DB07849 C12H25NO2S small molecule - - DRUGBANK 26418 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7155 S-(4-BROMOBENZYL)CYSTEINE - - DRUGBANK DB08370 C10H12BrNO2S small molecule - - DRUGBANK 22011 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22012 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 24255 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Rosen LS (2003) 12738715 181816 4764 Canfosfamide - - DRUGBANK DB04972 C26H40Cl4N5O10PS small molecule - 158382-37-7 DRUGBANK 24256 109205 2950 - GSTP1 DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI 9606 Homo sapiens unknown target Kavanagh JJ (2005) 16014111 181898 4764 Canfosfamide - - DRUGBANK DB04972 C26H40Cl4N5O10PS small molecule - 158382-37-7 DRUGBANK 2585 109207 2952 - GSTT1 - 9606 Homo sapiens unknown target Ouerhani S (2007) 17381051 173326 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2586 109207 2952 - GSTT1 - 9606 Homo sapiens unknown target Moore LE (2007) 17617661 173327 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2587 109207 2952 - GSTT1 - 9606 Homo sapiens unknown target Schwartzbaum JA (2007) 17372252 173330 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2588 109207 2952 - GSTT1 - 9606 Homo sapiens unknown target Joensson LS (2007) 17333241 173328 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2589 109207 2952 - GSTT1 - 9606 Homo sapiens unknown target Gawecki W (2007) 17653748 173329 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 22620 109208 2953 hCG_41095 GSTT2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3964 S-Hexylglutathione - - DRUGBANK DB04132 C16H30N3O6S small molecule - - DRUGBANK 23431 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23432 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 2580 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2581 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Fernandez-Canon JM (2002) 12052898 173324 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2582 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2583 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Hagedorn SR (1985) 4019417 173325 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2584 109209 2954 - GSTZ1 GSTZ1-1|MAAI|MAI 9606 Homo sapiens unknown target Lim CE (2004) 15277241 173323 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 27894 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens stimulator target Humbert M (2016) 26219978 196028 8105 Riociguat Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate adempas DRUGBANK DB08931 C20H19FN8O2 small molecule C02KX05 625115-55-1 DRUGBANK 27895 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens stimulator target Soeiro-Pereira PV (2012) 22044316 196012 8105 Riociguat Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate adempas DRUGBANK DB08931 C20H19FN8O2 small molecule C02KX05 625115-55-1 DRUGBANK 27896 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens agonist target Humbert M (2016) 26219978 196028 8105 Riociguat Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate adempas DRUGBANK DB08931 C20H19FN8O2 small molecule C02KX05 625115-55-1 DRUGBANK 27897 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens agonist target Soeiro-Pereira PV (2012) 22044316 196012 8105 Riociguat Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate adempas DRUGBANK DB08931 C20H19FN8O2 small molecule C02KX05 625115-55-1 DRUGBANK 12837 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens inducer target Moncada S (1991) 1852778 176040 1010 Isosorbide Mononitrate Vasdilat|Imdur|Ismexin|Ismox|Promocard|Monodur durules|Monosorbitrate|Imtrate|Monomax|Mononitrato de Isosorbida|Duride|Monopront|Monoket|Nitramin|Isosorbidi Mononitras|Monocord|Elantan|Turimonit|Orasorbil|Monicor|Ismo|Pertil|Mononitrate d'Isosorbide|Corangin|Mononit|Medocor|Isosorbide mononitrate|Monolong|Mono corax|Uniket|Monosorb xl 60|Monocedocard|Olicard|Sigacora|Monosordil|Sorbimon monoket|isosorbide mononitrate DRUGBANK DB01020 C6H9NO6 small molecule C01DA14 16051-77-7 DRUGBANK 12838 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens inducer target Mancuso C (2010) 20089135 176039 1010 Isosorbide Mononitrate Vasdilat|Imdur|Ismexin|Ismox|Promocard|Monodur durules|Monosorbitrate|Imtrate|Monomax|Mononitrato de Isosorbida|Duride|Monopront|Monoket|Nitramin|Isosorbidi Mononitras|Monocord|Elantan|Turimonit|Orasorbil|Monicor|Ismo|Pertil|Mononitrate d'Isosorbide|Corangin|Mononit|Medocor|Isosorbide mononitrate|Monolong|Mono corax|Uniket|Monosorb xl 60|Monocedocard|Olicard|Sigacora|Monosordil|Sorbimon monoket|isosorbide mononitrate DRUGBANK DB01020 C6H9NO6 small molecule C01DA14 16051-77-7 DRUGBANK 6915 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens inducer target Moncada S (1991) 1852778 176040 427 Nitric Oxide Mononitrogen monoxide|Nitrogen monoxide|Oxyde azotique|Nitrosyl|Stickstoffmonoxid|(.)NO|endothelium-derived relaxing factor|NO|nitrogen monooxide|Monoxyde d'azote|[NO]|Monoxido de nitrogeno|Oxyde nitrique|(NO)(.)|Stickstoff(ii)-oxid|Oxido nitrico|Nitric oxide|EDRF|NO(.)|Oxido de nitrogeno(ii) noxivent|kinox|inomax|nitric o DRUGBANK DB00435 NO small molecule R07AX01 10102-43-9 DRUGBANK 6916 109232 2977 - GUCY1A2 GC-SA2|GUC1A2 9606 Homo sapiens inducer target Mancuso C (2010) 20089135 176039 427 Nitric Oxide Mononitrogen monoxide|Nitrogen monoxide|Oxyde azotique|Nitrosyl|Stickstoffmonoxid|(.)NO|endothelium-derived relaxing factor|NO|nitrogen monooxide|Monoxyde d'azote|[NO]|Monoxido de nitrogeno|Oxyde nitrique|(NO)(.)|Stickstoff(ii)-oxid|Oxido nitrico|Nitric oxide|EDRF|NO(.)|Oxido de nitrogeno(ii) noxivent|kinox|inomax|nitric o DRUGBANK DB00435 NO small molecule R07AX01 10102-43-9 DRUGBANK 26253 109233 2978 RP1-139D8.2 GUCA1A C6orf131|COD3|CORD14|GCAP|GCAP1|GUCA|GUCA1|dJ139D8.6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 26961 109239 2984 - GUCY2C DIAR6|GUC2C|MECIL|MUCIL|STAR 9606 Homo sapiens agonist target Busby RW (2013) 23090647 182215 7634 Linaclotide L-Cysteinyl-L-cysteinyl-L-alpha-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-L-tyrosine cyclic (1->6),(2->10),(5->13)-tris(disulfide)|Linzess|Cys cys glu tyr cys cys asn pro ala cys thr gly cys tyr (disulfide bridge: 1-6; 2-10; 5-13) constella|linzess DRUGBANK DB08890 C59H79N15O21S6 small molecule A06AX04 851199-59-2 DRUGBANK 18205 109242 2987 RP11-520H14.2 GUK1 GMK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18206 109242 2987 RP11-520H14.2 GUK1 GMK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18207 109242 2987 RP11-520H14.2 GUK1 GMK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 23202 109247 2992 - GYG1 GSD15|GYG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 21209 109247 2992 - GYG1 GSD15|GYG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 26882 109276 3026 - HABP2 FSAP|HABP|HGFAL|PHBP 9606 Homo sapiens binder target Choi-Miura NH (1996) 8827452 181709 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26883 109276 3026 - HABP2 FSAP|HABP|HGFAL|PHBP 9606 Homo sapiens binder target Choi-Miura NH (2001) 11217080 181769 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 3038 109278 3028 RP3-339A18.2 HSD17B10 17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3039 109278 3028 RP3-339A18.2 HSD17B10 17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 19957 109278 3028 RP3-339A18.2 HSD17B10 17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2702 1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct - - DRUGBANK DB02820 C40H44N12O15P2S small molecule - - DRUGBANK 19958 109278 3028 RP3-339A18.2 HSD17B10 17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2702 1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct - - DRUGBANK DB02820 C40H44N12O15P2S small molecule - - DRUGBANK 22121 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3726 S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione - - DRUGBANK DB03889 C17H23BrN4O8S small molecule - - DRUGBANK 22122 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3726 S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione - - DRUGBANK DB03889 C17H23BrN4O8S small molecule - - DRUGBANK 2690 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2691 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2692 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Al-Timari A (1986) 3955057 173392 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2693 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Ridderstroem M (2000) 11018726 173391 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2694 109279 3029 - HAGH GLO2|GLX2|GLXII|HAGH1 9606 Homo sapiens unknown target Chyan MK (1994) 8589803 173390 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 3150 109280 3030 - HADHA ECHA|GBP|HADH|LCEH|LCHAD|MTPA|TP-ALPHA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3151 109280 3030 - HADHA ECHA|GBP|HADH|LCEH|LCHAD|MTPA|TP-ALPHA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3057 109283 3033 - HADH HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD 9606 Homo sapiens unknown target Norman JP (2007) 17202348 173657 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 20397 109283 3033 - HADH HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 20398 109283 3033 - HADH HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2930 Acetoacetyl-Coenzyme A - - DRUGBANK DB03059 C25H40N7O18P3S small molecule - 1420-36-6 DRUGBANK 21596 109283 3033 - HADH HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3460 3-Hydroxybutyryl-Coenzyme A - - DRUGBANK DB03612 C25H42N7O18P3S small molecule - - DRUGBANK 21597 109283 3033 - HADH HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3460 3-Hydroxybutyryl-Coenzyme A - - DRUGBANK DB03612 C25H42N7O18P3S small molecule - - DRUGBANK 1687 109284 3034 - HAL HIS|HSTD 9606 Homo sapiens unknown target Katona A (2006) 17193285 172660 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1688 109284 3034 - HAL HIS|HSTD 9606 Homo sapiens unknown target Viergutz S (2004) 17191848 172661 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1689 109284 3034 - HAL HIS|HSTD 9606 Homo sapiens unknown target Lambrecht NW (2007) 17536021 172662 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1690 109284 3034 - HAL HIS|HSTD 9606 Homo sapiens unknown target Watts KT (2006) 17185227 172659 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1685 109285 3035 - HARS HRS|USH3B 9606 Homo sapiens unknown target Nagatoyo Y (2006) 17150756 172657 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1686 109285 3035 - HARS HRS|USH3B 9606 Homo sapiens unknown target Rosen AE (2006) 16741232 172658 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 11443 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 11444 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 11445 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 18584 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2045 4-Carboxycinnamic Acid - - DRUGBANK DB02126 C10H8O4 small molecule - - DRUGBANK 25449 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6241 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine - - DRUGBANK DB07428 C14H15NO2 small molecule - - DRUGBANK 26311 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7051 2,6-dicarboxynaphthalene - - DRUGBANK DB08262 C12H8O4 small molecule - 1141-38-4 DRUGBANK 25650 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6451 SEBACIC ACID - - DRUGBANK DB07645 C10H18O4 small molecule - - DRUGBANK 5932 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 350 Mefloquine [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina mefloquine|lariam tab 250mg|me DRUGBANK DB00358 C17H16F6N2O small molecule P01BF02|P01BC02 53230-10-7 DRUGBANK 5933 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 350 Mefloquine [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina mefloquine|lariam tab 250mg|me DRUGBANK DB00358 C17H16F6N2O small molecule P01BF02|P01BC02 53230-10-7 DRUGBANK 25447 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6240 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine - - DRUGBANK DB07427 C14H15NO2 small molecule - - DRUGBANK 26531 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7266 2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID - - DRUGBANK DB08486 C20H23NO4 small molecule - - DRUGBANK 26659 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7406 1,3,5-BENZENETRICARBOXYLIC ACID - - DRUGBANK DB08632 C9H6O6 small molecule - - DRUGBANK 26105 109289 3039 - HBA1 HBA-T3|HBH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6870 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID - - DRUGBANK DB08077 C17H16Cl2N2O4 small molecule - - DRUGBANK 11448 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 11449 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens activator target Zaric J (1998) 9629498 178924 883 Iron Dextran Dextran iron|Iron dextran complex|Dexferrum se-tan plus|preferaob plus dha DRUGBANK DB00893 - small molecule - 9004-66-4 DRUGBANK 18585 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2045 4-Carboxycinnamic Acid - - DRUGBANK DB02126 C10H8O4 small molecule - - DRUGBANK 26312 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7051 2,6-dicarboxynaphthalene - - DRUGBANK DB08262 C12H8O4 small molecule - 1141-38-4 DRUGBANK 25651 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6451 SEBACIC ACID - - DRUGBANK DB07645 C10H18O4 small molecule - - DRUGBANK 25450 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6241 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine - - DRUGBANK DB07428 C14H15NO2 small molecule - - DRUGBANK 25448 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6240 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine - - DRUGBANK DB07427 C14H15NO2 small molecule - - DRUGBANK 26532 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7266 2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID - - DRUGBANK DB08486 C20H23NO4 small molecule - - DRUGBANK 26660 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7406 1,3,5-BENZENETRICARBOXYLIC ACID - - DRUGBANK DB08632 C9H6O6 small molecule - - DRUGBANK 26106 109293 3043 - HBB CD113t-C|beta-globin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6870 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID - - DRUGBANK DB08077 C17H16Cl2N2O4 small molecule - - DRUGBANK 6596 109303 3053 - SERPIND1 D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10 9606 Homo sapiens agonist target Mousa SA (2002) 12397367 175874 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 6597 109303 3053 - SERPIND1 D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 6598 109303 3053 - SERPIND1 D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 6599 109303 3053 - SERPIND1 D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 399 Ardeparin Ardeparin sodium - DRUGBANK DB00407 - small molecule - 9041-08-1 DRUGBANK 24535 109303 3053 - SERPIND1 D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10 9606 Homo sapiens agonist target Cosmi B (2003) 12818259 181821 5541 Sulodexide - - DRUGBANK DB06271 - biologic B01AB11 57821-29-1 DRUGBANK 17817 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1739 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB01809 C16H19N5 small molecule - - DRUGBANK 17818 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1739 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB01809 C16H19N5 small molecule - - DRUGBANK 17819 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1739 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB01809 C16H19N5 small molecule - - DRUGBANK 18181 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1886 Phosphonotyrosine - - DRUGBANK DB01962 C9H12NO6P small molecule - 21820-51-9 DRUGBANK 18182 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1886 Phosphonotyrosine - - DRUGBANK DB01962 C9H12NO6P small molecule - 21820-51-9 DRUGBANK 22817 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 22818 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 22819 109305 3055 RP5-836N17.3 HCK JTK9|p59Hck|p61Hck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 20451 109310 3060 - HCRT NRCLP1|OX|PPOX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 27455 109311 3061 - HCRTR1 OX1R 9606 Homo sapiens antagonist target Palasz A (2014) 23702225 188532 7797 Suvorexant [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone|[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-mthyl-1,4-diazpan-1-yl][5-mthyl-2-(2H-1,2,3-triazol-2-yl)phnyl]mthanone|[(7R)-4-(5-Chlor-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanon|[(7R)-4-(5-chlorobenzoxazol-2-yl)-7-methylhexahydro-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone belsomra DRUGBANK DB09034 C23H23ClN6O2 small molecule - 1030377-33-3 DRUGBANK 27454 109312 3062 - HCRTR2 OX2R 9606 Homo sapiens antagonist target Palasz A (2014) 23702225 188532 7797 Suvorexant [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone|[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-mthyl-1,4-diazpan-1-yl][5-mthyl-2-(2H-1,2,3-triazol-2-yl)phnyl]mthanone|[(7R)-4-(5-Chlor-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanon|[(7R)-4-(5-chlorobenzoxazol-2-yl)-7-methylhexahydro-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone belsomra DRUGBANK DB09034 C23H23ClN6O2 small molecule - 1030377-33-3 DRUGBANK 27869 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27701 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 19436 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2443 Vorinostat Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH zolinza DRUGBANK DB02546 C14H20N2O3 small molecule L01XX38 149647-78-9 DRUGBANK 19437 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens inhibitor target Xu WS (2007) 17694093 181632 2443 Vorinostat Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH zolinza DRUGBANK DB02546 C14H20N2O3 small molecule L01XX38 149647-78-9 DRUGBANK 24340 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens unknown target Khan N (2008) 17868033 182049 5277 MGCD-0103 MGCD0103 - DRUGBANK DB05651 - small molecule - - DRUGBANK 24341 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens unknown target Beckers T (2007) 17455259 182004 5277 MGCD-0103 MGCD0103 - DRUGBANK DB05651 - small molecule - - DRUGBANK 27825 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens inhibitor target VanderMolen KM (2011) 21587264 196007 8066 Romidepsin chromodax|istodax istodax DRUGBANK DB06176 C24H36N4O6S2 small molecule L01XX39 128517-07-7 DRUGBANK 27826 109315 3065 RP4-811H24.2 HDAC1 GON-10|HD1|RPD3|RPD3L1 9606 Homo sapiens antagonist target VanderMolen KM (2011) 21587264 196007 8066 Romidepsin chromodax|istodax istodax DRUGBANK DB06176 C24H36N4O6S2 small molecule L01XX39 128517-07-7 DRUGBANK 27868 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27700 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 19435 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens inhibitor target Xu WS (2007) 17694093 181632 2443 Vorinostat Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH zolinza DRUGBANK DB02546 C14H20N2O3 small molecule L01XX38 149647-78-9 DRUGBANK 15029 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens activator target Ito K (2002) 12070353 174833 1211 Aminophylline Somophyllin|Theophylline ethylenediamine|Aminophyllin aminophylline tab 100mg|aminop DRUGBANK DB01223 C16H24N10O4 small molecule R03DA55|R03DB05|R03DA05 317-34-0 DRUGBANK 15809 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens activator target Cosio BG (2004) 15337792 174834 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15810 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens activator target Ito K (2002) 12070353 174833 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 27823 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens inhibitor target VanderMolen KM (2011) 21587264 196007 8066 Romidepsin chromodax|istodax istodax DRUGBANK DB06176 C24H36N4O6S2 small molecule L01XX39 128517-07-7 DRUGBANK 27824 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens antagonist target VanderMolen KM (2011) 21587264 196007 8066 Romidepsin chromodax|istodax istodax DRUGBANK DB06176 C24H36N4O6S2 small molecule L01XX39 128517-07-7 DRUGBANK 5447 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens unknown target Kraemer OH (2003) 12840003 110006 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5448 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens unknown target Goettlicher M (2004) 15124690 175118 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5053 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens activator target Cosio BG (2004) 15337792 174834 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5054 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens activator target Ito K (2002) 12070353 174833 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 24339 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens unknown target Khan N (2008) 17868033 182049 5277 MGCD-0103 MGCD0103 - DRUGBANK DB05651 - small molecule - - DRUGBANK 4447 109316 3066 - HDAC2 HD2|RPD3|YAF1 9606 Homo sapiens unknown target Lin YC (2008) 18381445 112336 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 1599 109317 3067 - HDC - 9606 Homo sapiens cofactor target Graham DE (2002) 11980912 172545 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1600 109317 3067 - HDC - 9606 Homo sapiens cofactor target Landete JM (2006) 16790022 172585 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1601 109317 3067 - HDC - 9606 Homo sapiens cofactor target Skoeldberg F (2003) 12679420 172563 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1602 109317 3067 - HDC - 9606 Homo sapiens cofactor target Moya-Garcia AA (2006) 16547811 172584 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1603 109317 3067 - HDC - 9606 Homo sapiens cofactor target Skoeldberg F (2004) 15070923 172526 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1680 109317 3067 - HDC - 9606 Homo sapiens unknown target Castellani ML (2006) 17191019 172655 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1681 109317 3067 - HDC - 9606 Homo sapiens unknown target Kitamura Y (2006) 17075268 172654 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1682 109317 3067 - HDC - 9606 Homo sapiens unknown target Nitta Y (2007) 17227057 172656 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1683 109317 3067 - HDC - 9606 Homo sapiens unknown target Landete JM (2006) 16790022 172585 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1684 109317 3067 - HDC - 9606 Homo sapiens unknown target Fernandez M (2006) 16960050 172653 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 22081 109323 3074 HCC7 HEXB ENC-1AS|HEL-248 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3698 (2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium - - DRUGBANK DB03861 C8H16N2O4 small molecule - - DRUGBANK 22082 109323 3074 HCC7 HEXB ENC-1AS|HEL-248 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3698 (2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium - - DRUGBANK DB03861 C8H16N2O4 small molecule - - DRUGBANK 21848 109323 3074 HCC7 HEXB ENC-1AS|HEL-248 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3589 3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol - - DRUGBANK DB03747 C8H13NO4S small molecule - - DRUGBANK 21849 109323 3074 HCC7 HEXB ENC-1AS|HEL-248 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3589 3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol - - DRUGBANK DB03747 C8H13NO4S small molecule - - DRUGBANK 19952 109323 3074 HCC7 HEXB ENC-1AS|HEL-248 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2695 2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone - - DRUGBANK DB02813 C8H13NO6 small molecule - 19026-22-3 DRUGBANK 19953 109323 3074 HCC7 HEXB ENC-1AS|HEL-248 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2695 2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone - - DRUGBANK DB02813 C8H13NO6 small molecule - 19026-22-3 DRUGBANK 18832 109330 3082 - HGF DFNB39|F-TCF|HGFB|HPTA|SF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 18833 109330 3082 - HGF DFNB39|F-TCF|HGFB|HPTA|SF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 22273 109330 3082 - HGF DFNB39|F-TCF|HGFB|HPTA|SF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 22274 109330 3082 - HGF DFNB39|F-TCF|HGFB|HPTA|SF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 26694 109338 3091 - HIF1A HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7461 N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE - - DRUGBANK DB08687 C12H9ClN2O4 small molecule - - DRUGBANK 18985 109338 3091 - HIF1A HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78 9606 Homo sapiens unknown target Dai Y (2007) 17498737 181627 2247 2-Methoxyestradiol 2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta - DRUGBANK DB02342 C19H26O3 small molecule - 362-07-2 DRUGBANK 18986 109338 3091 - HIF1A HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78 9606 Homo sapiens unknown target Zhou D (2008) 17716391 181628 2247 2-Methoxyestradiol 2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta - DRUGBANK DB02342 C19H26O3 small molecule - 362-07-2 DRUGBANK 14084 109338 3091 - HIF1A HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78 9606 Homo sapiens modulator target Shyu KG (2005) 15732037 180310 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 18208 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18209 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18210 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18646 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2078 5'-O-(N-Ethyl-Sulfamoyl)Adenosine - - DRUGBANK DB02162 C12H18N6O6S small molecule - - DRUGBANK 18647 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2078 5'-O-(N-Ethyl-Sulfamoyl)Adenosine - - DRUGBANK DB02162 C12H18N6O6S small molecule - - DRUGBANK 18648 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2078 5'-O-(N-Ethyl-Sulfamoyl)Adenosine - - DRUGBANK DB02162 C12H18N6O6S small molecule - - DRUGBANK 18680 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2099 Adenosine-5'-Ditungstate - - DRUGBANK DB02183 C10H15N5O10W2 small molecule - - DRUGBANK 18681 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2099 Adenosine-5'-Ditungstate - - DRUGBANK DB02183 C10H15N5O10W2 small molecule - - DRUGBANK 2116 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens product of target Chou TF (2007) 17217311 173046 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2117 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens product of target Chou TF (2007) 17337452 173045 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2118 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens product of target Chou TF (2007) 17158446 172832 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 21024 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3212 8-Bromo-Adenosine-5'-Monophosphate - - DRUGBANK DB03349 C10H13BrN5O7P small molecule - - DRUGBANK 21025 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3212 8-Bromo-Adenosine-5'-Monophosphate - - DRUGBANK DB03349 C10H13BrN5O7P small molecule - - DRUGBANK 21026 109341 3094 - HINT1 HINT|NMAN|PKCI-1|PRKCNH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3212 8-Bromo-Adenosine-5'-Monophosphate - - DRUGBANK DB03349 C10H13BrN5O7P small molecule - - DRUGBANK 18315 109345 3098 - HK1 HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18316 109345 3098 - HK1 HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 23308 109345 3098 - HK1 HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23309 109345 3098 - HK1 HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 19078 109345 3098 - HK1 HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19079 109345 3098 - HK1 HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19822 109350 3105 DAQB-90C11.16-002 HLA-A HLAA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2626 3-Indolebutyric Acid - - DRUGBANK DB02740 C12H13NO2 small molecule - 133-32-4 DRUGBANK 23500 109351 3106 CDABP0067 HLA-B AS|HLAB|SPDA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 842 109363 3118 DAAP-381D23.2 HLA-DQA2 DX-ALPHA|HLA-DXA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 843 109363 3118 DAAP-381D23.2 HLA-DQA2 DX-ALPHA|HLA-DXA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 844 109363 3118 DAAP-381D23.2 HLA-DQA2 DX-ALPHA|HLA-DXA 9606 Homo sapiens unknown target Pugliese A (1994) 8200980 172181 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 845 109363 3118 DAAP-381D23.2 HLA-DQA2 DX-ALPHA|HLA-DXA 9606 Homo sapiens unknown target Donner H (1997) 9458118 172183 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 846 109363 3118 DAAP-381D23.2 HLA-DQA2 DX-ALPHA|HLA-DXA 9606 Homo sapiens unknown target Hermann R (2000) 11006709 172182 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 867 109364 3119 DADB-249P12.2 HLA-DQB1 CELIAC1|HLA-DQB|IDDM1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 868 109364 3119 DADB-249P12.2 HLA-DQB1 CELIAC1|HLA-DQB|IDDM1 9606 Homo sapiens unknown target Levy-Marchal C (1992) 1612232 172194 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 869 109364 3119 DADB-249P12.2 HLA-DQB1 CELIAC1|HLA-DQB|IDDM1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 870 109364 3119 DADB-249P12.2 HLA-DQB1 CELIAC1|HLA-DQB|IDDM1 9606 Homo sapiens unknown target Mahran MZ (1992) 1728861 172193 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 871 109364 3119 DADB-249P12.2 HLA-DQB1 CELIAC1|HLA-DQB|IDDM1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 24298 109368 3123 XXbac-BPG161M6.1 HLA-DRB1 DRB1|DRw10|HLA-DR1B|HLA-DRB|SS1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 5037 Glatiramer Acetate Copoylmer 1|COP-1|Copolymer-1 teva-glatiramer acetate|glatop DRUGBANK DB05259 C254H422N70O72 biologic L03AX13 147245-92-9 DRUGBANK 24299 109368 3123 XXbac-BPG161M6.1 HLA-DRB1 DRB1|DRw10|HLA-DR1B|HLA-DRB|SS1 9606 Homo sapiens binder target Arnon R (2004) 15371592 181863 5037 Glatiramer Acetate Copoylmer 1|COP-1|Copolymer-1 teva-glatiramer acetate|glatop DRUGBANK DB05259 C254H422N70O72 biologic L03AX13 147245-92-9 DRUGBANK 1202 109385 3140 RP11-309G3.1 MR1 HLALS 9606 Homo sapiens antagonist target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 1811 109386 3141 - HLCS HCS 9606 Homo sapiens unknown target Hassan YI (2006) 16772434 172758 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1812 109386 3141 - HLCS HCS 9606 Homo sapiens unknown target Velazquez-Arellano A (2006) 16359899 172756 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1813 109386 3141 - HLCS HCS 9606 Homo sapiens unknown target Camporeale G (2006) 17056793 172757 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 3007 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Li S (2003) 14511985 173638 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3008 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Hedl M (2004) 15152097 173639 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3009 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3010 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3011 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Huber R (2005) 15755483 173640 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 8908 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Kocarek TA (2002) 12433810 177513 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8909 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Liu L (2003) 12852453 177512 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8910 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Pappu AS (2003) 12677170 177515 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8911 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Stoebner PE (2003) 12671581 177514 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8912 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Cenedella RJ (2003) 12518039 177516 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8913 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 4439 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Farina HG (2002) 12405293 174503 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4440 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Buxbaum JD (2001) 12214063 174502 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4441 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Abe Y (2002) 12172803 174501 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4442 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Podar K (2009) 19249983 174500 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4443 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Baranova NA (2002) 12369143 174506 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4444 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Miyazaki A (2002) 12204108 174505 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4445 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Dimitroulakos J (2002) 12082550 174504 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 4446 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 13684 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1083 Fluvastatin - fluvastatin|fluvastatin sodium DRUGBANK DB01095 C24H26FNO4 small molecule C10AA04 93957-54-1 DRUGBANK 13685 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Podar K (2009) 19249983 174500 1083 Fluvastatin - fluvastatin|fluvastatin sodium DRUGBANK DB01095 C24H26FNO4 small molecule C10AA04 93957-54-1 DRUGBANK 13703 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target McTaggart F (2001) 11256847 180120 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13704 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Hanefeld M (2001) 11501230 180121 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13705 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Olsson AG (2002) 12481202 180117 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13706 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Carbonell T (2005) 16128575 180116 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13707 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Davidson MH (2002) 11772327 180115 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13708 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Holdgate GA (2003) 12773150 180119 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13709 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chapman MJ (2003) 12539816 180118 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 13710 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1086 Rosuvastatin (3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid priva-rosuvastatin|crestor - 2 DRUGBANK DB01098 C22H28FN3O6S small molecule C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10 287714-41-4 DRUGBANK 24641 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Kocarek TA (2002) 12433810 177513 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 24642 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Liu L (2003) 12852453 177512 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 24643 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Pappu AS (2003) 12677170 177515 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 24644 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Stoebner PE (2003) 12671581 177514 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 24645 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Cenedella RJ (2003) 12518039 177516 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 24646 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 24647 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 5575 Mevastatin Compactin - DRUGBANK DB06693 C23H34O5 small molecule - 73573-88-3 DRUGBANK 20700 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3037 (S)-Hmg-Coa - - DRUGBANK DB03169 - small molecule - - DRUGBANK 20701 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3037 (S)-Hmg-Coa - - DRUGBANK DB03169 - small molecule - - DRUGBANK 13523 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 13524 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Davidson MH (2002) 12769127 180009 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 13525 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Boesel J (2005) 15748157 180012 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 13526 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Jafari M (2003) 12808485 180013 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 13527 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Baxter JD (2004) 15109613 180010 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 13528 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Maejima T (2004) 15474503 180011 1064 Atorvastatin Lipovastatinklonal caduet|ran-atorvastatin|mar-at DRUGBANK DB01076 C33H34FN2O5 small molecule C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11 134523-00-5 DRUGBANK 6942 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 431 Cerivastatin - baycol (0.2mg)|baycol (0.3mg)| DRUGBANK DB00439 C26H34FNO5 small molecule C10AA06 145599-86-6 DRUGBANK 6943 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Shiomi M (1999) 10193776 176062 431 Cerivastatin - baycol (0.2mg)|baycol (0.3mg)| DRUGBANK DB00439 C26H34FNO5 small molecule C10AA06 145599-86-6 DRUGBANK 6944 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Wong WW (2001) 11448925 176063 431 Cerivastatin - baycol (0.2mg)|baycol (0.3mg)| DRUGBANK DB00439 C26H34FNO5 small molecule C10AA06 145599-86-6 DRUGBANK 6945 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Denoyelle C (2001) 11470741 176061 431 Cerivastatin - baycol (0.2mg)|baycol (0.3mg)| DRUGBANK DB00439 C26H34FNO5 small molecule C10AA06 145599-86-6 DRUGBANK 6946 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Ganne F (2000) 11057870 176064 431 Cerivastatin - baycol (0.2mg)|baycol (0.3mg)| DRUGBANK DB00439 C26H34FNO5 small molecule C10AA06 145599-86-6 DRUGBANK 6947 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Blumenthal RS (2000) 10740137 176065 431 Cerivastatin - baycol (0.2mg)|baycol (0.3mg)| DRUGBANK DB00439 C26H34FNO5 small molecule C10AA06 145599-86-6 DRUGBANK 3845 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 168 Pravastatin Pravastatina|Pravastatinum|Pravastatin acid|(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid|Pravastatine pravachol - tab 20mg|ach-prava DRUGBANK DB00175 C23H36O7 small molecule C10BA03|C10BX02|C10AA03 81093-37-0 DRUGBANK 26929 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens inhibitor target Morgan RE (2012) 22472908 182201 7608 Pitavastatin Pitavastatinum|Pitavastatine|Pitavastatia livalo DRUGBANK DB08860 C25H24FNO4 small molecule C10AA08 147511-69-1 DRUGBANK 24874 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5667 7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID - - DRUGBANK DB06846 C24H28FNO4 small molecule - - DRUGBANK 21267 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21268 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 23429 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23430 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23233 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4199 3-Hydroxy-3-Methyl-Glutaric Acid - - DRUGBANK DB04377 C6H10O5 small molecule - - DRUGBANK 23234 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4199 3-Hydroxy-3-Methyl-Glutaric Acid - - DRUGBANK DB04377 C6H10O5 small molecule - - DRUGBANK 18251 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18252 109399 3156 - HMGCR LDLCQ3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 25744 109400 3157 - HMGCS1 HMGCS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6541 (3R,5S,7R,12S,13R)-13-FORMYL-12,14-DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID - - DRUGBANK DB07740 C18H34O5 small molecule - - DRUGBANK 26868 109404 3161 - HMMR CD168|IHABP|RHAMM 9606 Homo sapiens unknown target Turley EA (1982) 6185115 181674 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 3312 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3314 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3315 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Calo LA (2003) 12897089 173760 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3313 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Auclair K (2003) 12699699 60080 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 18467 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 18468 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 18469 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 24938 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5733 1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE - - DRUGBANK DB06914 C15H17ClN2O2 small molecule - - DRUGBANK 24148 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Drummond GS (2004) 15686268 181882 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24149 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Cannon JB (1993) 8321837 181696 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24150 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Boeni RE (1993) 8265722 181695 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24151 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Nalos M (2003) 12785007 181819 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24152 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Wagner KR (2000) 10872746 181754 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 22164 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3743 2-Phenylheme - - DRUGBANK DB03906 C40H36FeN4O4 small molecule - - DRUGBANK 22165 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3743 2-Phenylheme - - DRUGBANK DB03906 C40H36FeN4O4 small molecule - - DRUGBANK 18126 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18127 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18128 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 19260 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2368 12-Phenylheme - - DRUGBANK DB02468 C40H38FeN4O4 small molecule - - DRUGBANK 19261 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2368 12-Phenylheme - - DRUGBANK DB02468 C40H38FeN4O4 small molecule - - DRUGBANK 25347 109405 3162 CTA-286B10.6 HMOX1 HMOX1D|HO-1|HSP32|bK286B10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6158 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone - - DRUGBANK DB07342 C15H20N2O small molecule - - DRUGBANK 3201 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Tanaka M (2006) 16986858 173712 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3202 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Goldstone AB (2006) 17157188 173711 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 24143 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Drummond GS (2004) 15686268 181882 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24144 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Cannon JB (1993) 8321837 181696 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24145 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Boeni RE (1993) 8265722 181695 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24146 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Nalos M (2003) 12785007 181819 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 24147 109406 3163 - HMOX2 HO-2 9606 Homo sapiens unknown target Wagner KR (2000) 10872746 181754 4712 Stannsoporfin tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP - DRUGBANK DB04912 - small molecule - 106344-20-1 DRUGBANK 26269 109414 3172 RP5-1013A22.1 HNF4A FRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 27671 109414 3172 RP5-1013A22.1 HNF4A FRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 24329 109414 3172 RP5-1013A22.1 HNF4A FRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5210 AVI-4557 - - DRUGBANK DB05447 - small molecule - - DRUGBANK 25115 109418 3176 - HNMT HMT|HNMT-S1|HNMT-S2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5924 4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE - - DRUGBANK DB07106 C7H17N3S small molecule - - DRUGBANK 8628 109418 3176 - HNMT HMT|HNMT-S1|HNMT-S2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 603 Amodiaquine Amodiaquina|Amodiaquinum|Amodiaquine - DRUGBANK DB00613 C20H22ClN3O small molecule P01BF03|P01BA06 86-42-0 DRUGBANK 8629 109418 3176 - HNMT HMT|HNMT-S1|HNMT-S2 9606 Homo sapiens inhibitor target Nowak JZ (1980) 6789797 177300 603 Amodiaquine Amodiaquina|Amodiaquinum|Amodiaquine - DRUGBANK DB00613 C20H22ClN3O small molecule P01BF03|P01BA06 86-42-0 DRUGBANK 8630 109418 3176 - HNMT HMT|HNMT-S1|HNMT-S2 9606 Homo sapiens inhibitor target Barth H (1975) 1203620 177301 603 Amodiaquine Amodiaquina|Amodiaquinum|Amodiaquine - DRUGBANK DB00613 C20H22ClN3O small molecule P01BF03|P01BA06 86-42-0 DRUGBANK 8631 109418 3176 - HNMT HMT|HNMT-S1|HNMT-S2 9606 Homo sapiens inhibitor target Yokoyama A (2007) 17222819 177299 603 Amodiaquine Amodiaquina|Amodiaquinum|Amodiaquine - DRUGBANK DB00613 C20H22ClN3O small molecule P01BF03|P01BA06 86-42-0 DRUGBANK 23800 109418 3176 - HNMT HMT|HNMT-S1|HNMT-S2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4460 METOPRINE, METHODICHLOROPHEN - - DRUGBANK DB04655 C11H10Cl2N4 small molecule - - DRUGBANK 27167 109419 3177 - SLC29A2 DER12|ENT2|HNP36 9606 Homo sapiens unknown target Allen-Gipson DS (2009) 19298329 188486 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27770 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens inhibitor target Santra S (2008) 18422479 195984 340 Nitisinone Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin orfadin DRUGBANK DB00348 C14H10F3NO5 small molecule A16AX04 104206-65-7 DRUGBANK 5844 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 340 Nitisinone Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin orfadin DRUGBANK DB00348 C14H10F3NO5 small molecule A16AX04 104206-65-7 DRUGBANK 5842 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens inhibitor target Hanauske-Abel HM (2002) 12142814 175412 340 Nitisinone Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin orfadin DRUGBANK DB00348 C14H10F3NO5 small molecule A16AX04 104206-65-7 DRUGBANK 5843 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens inhibitor target Fisher AA (2004) 15931360 175413 340 Nitisinone Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin orfadin DRUGBANK DB00348 C14H10F3NO5 small molecule A16AX04 104206-65-7 DRUGBANK 5845 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens inhibitor target Yang DY (2003) 14668946 175411 340 Nitisinone Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin orfadin DRUGBANK DB00348 C14H10F3NO5 small molecule A16AX04 104206-65-7 DRUGBANK 5846 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens inhibitor target Suwannarat P (2005) 15931605 175414 340 Nitisinone Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin orfadin DRUGBANK DB00348 C14H10F3NO5 small molecule A16AX04 104206-65-7 DRUGBANK 20021 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2732 (1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone - - DRUGBANK DB02850 C23H28N2O5S small molecule - - DRUGBANK 20022 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2732 (1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone - - DRUGBANK DB02850 C23H28N2O5S small molecule - - DRUGBANK 20023 109482 3242 - HPD 4-HPPD|4HPPD|GLOD3|HPPDASE|PPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2732 (1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone - - DRUGBANK DB02850 C23H28N2O5S small molecule - - DRUGBANK 3329 109485 3248 - HPGD 15-PGDH|PGDH|PGDH1|PHOAR1|SDR36C1 9606 Homo sapiens unknown target Gao L (2007) 17463062 173761 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22089 109486 3249 - HPN TMPRSS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3702 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine - - DRUGBANK DB03865 C21H17ClN3O small molecule - - DRUGBANK 7692 109486 3249 - HPN TMPRSS1 9606 Homo sapiens ligand target Toskes PP (1984) 6371722 176633 512 Bentiromide Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide - DRUGBANK DB00522 C23H20N2O5 small molecule V04CK03 37106-97-1 DRUGBANK 7693 109486 3249 - HPN TMPRSS1 9606 Homo sapiens ligand target Chowdhury RS (2003) 12641496 176632 512 Bentiromide Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide - DRUGBANK DB00522 C23H20N2O5 small molecule V04CK03 37106-97-1 DRUGBANK 7694 109486 3249 - HPN TMPRSS1 9606 Homo sapiens ligand target Bujanover Y (1988) 3258344 176631 512 Bentiromide Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide - DRUGBANK DB00522 C23H20N2O5 small molecule V04CK03 37106-97-1 DRUGBANK 7695 109486 3249 - HPN TMPRSS1 9606 Homo sapiens ligand target Berman HM (2000) 10592235 172122 512 Bentiromide Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide - DRUGBANK DB00522 C23H20N2O5 small molecule V04CK03 37106-97-1 DRUGBANK 20923 109486 3249 - HPN TMPRSS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 435 109486 3249 - HPN TMPRSS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 436 109486 3249 - HPN TMPRSS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 21647 109486 3249 - HPN TMPRSS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3490 CRA_1144 - - DRUGBANK DB03643 C14H12N4O small molecule - - DRUGBANK 18910 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2216 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine - - DRUGBANK DB02309 C10H14N4O9P small molecule - - DRUGBANK 18911 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2216 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine - - DRUGBANK DB02309 C10H14N4O9P small molecule - - DRUGBANK 18912 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2216 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine - - DRUGBANK DB02309 C10H14N4O9P small molecule - - DRUGBANK 12997 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens inhibitor target Dubinsky MC (2004) 15354273 179565 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 12573 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens inhibitor target Anstey A (1998) 18020555 179566 983 Azathioprine Imuran (tn)|6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine|6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine azathioprine sodium for inject DRUGBANK DB00993 C9H7N7O2S small molecule L04AX01 446-86-6 DRUGBANK 12574 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens inhibitor target Dubinsky MC (2004) 15354273 179565 983 Azathioprine Imuran (tn)|6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine|6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine azathioprine sodium for inject DRUGBANK DB00993 C9H7N7O2S small molecule L04AX01 446-86-6 DRUGBANK 23203 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4179 9-Deazaguanine - - DRUGBANK DB04356 C6H5N4O small molecule - - DRUGBANK 23204 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4179 9-Deazaguanine - - DRUGBANK DB04356 C6H5N4O small molecule - - DRUGBANK 23205 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4179 9-Deazaguanine - - DRUGBANK DB04356 C6H5N4O small molecule - - DRUGBANK 20679 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3021 3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol - - DRUGBANK DB03153 C5H4N4O small molecule - - DRUGBANK 20680 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3021 3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol - - DRUGBANK DB03153 C5H4N4O small molecule - - DRUGBANK 20681 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3021 3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol - - DRUGBANK DB03153 C5H4N4O small molecule - - DRUGBANK 17467 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 17468 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 17469 109488 3251 - HPRT1 HGPRT|HPRT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 20786 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3094 Trifluoroethanol - - DRUGBANK DB03226 C2H3F3O small molecule - - DRUGBANK 20787 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3094 Trifluoroethanol - - DRUGBANK DB03226 C2H3F3O small molecule - - DRUGBANK 20788 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3094 Trifluoroethanol - - DRUGBANK DB03226 C2H3F3O small molecule - - DRUGBANK 18734 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 18735 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 18736 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 22644 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22645 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22646 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 26752 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7524 N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE - - DRUGBANK DB08751 C12H15N5O4 small molecule - - DRUGBANK 23055 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23056 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23057 109501 3265 - HRAS C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 27971 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wang XY (2016) 27110120 196040 8254 Bilastine - blexten DRUGBANK DB11591 C28H37N3O3 small molecule R06AX29 202189-78-4 DRUGBANK 10347 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10348 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10349 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10350 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target KRAKOWSKI AJ (1962) 14035428 178336 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 24135 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Brandes LJ (1987) 2886214 181664 4705 Tesmilifene N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|DPPE|Depmpe - DRUGBANK DB04905 C19H25NO small molecule - 98774-23-3 DRUGBANK 24663 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Lacour M (2001) 11700150 181781 5580 Betahistine 2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine pms-betahistine|serc 8 mg|teva DRUGBANK DB06698 C8H12N2 small molecule N07CA01 5638-76-6 DRUGBANK 24664 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Barak N (2008) 18447604 182074 5580 Betahistine 2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine pms-betahistine|serc 8 mg|teva DRUGBANK DB06698 C8H12N2 small molecule N07CA01 5638-76-6 DRUGBANK 24818 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Simons FE (2011) 22035879 182195 5627 Alcaftadine 6,11-Dihydro-11-(1-Methyl-4-piperidinylidene)-5H-iMidazo[2,1-b][3]benzazepine-3-carboxaldehyde|Lastacaft|Alcaftadina|Alcaftadinum|Vilasta lastacaft DRUGBANK DB06766 C19H21N3O small molecule S01GX11 147084-10-4 DRUGBANK 13599 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Murota H (2009) 19558341 180056 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 13600 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Corrado ME (2004) 15553105 180057 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 13601 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sharif NA (1994) 7714409 180055 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 13602 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Inagaki N (1998) 9747899 180058 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 13603 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Murota H (2008) 18714531 180059 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 13604 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yanni JM (1994) 7714410 175868 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 13605 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1072 Emedastine Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina emadine DRUGBANK DB01084 C17H26N4O small molecule S01GX06 87233-61-2 DRUGBANK 5909 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 346 Buclizine 1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina - DRUGBANK DB00354 C28H33ClN2 small molecule R06AE01|R06AE51 82-95-1 DRUGBANK 5910 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 346 Buclizine 1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina - DRUGBANK DB00354 C28H33ClN2 small molecule R06AE01|R06AE51 82-95-1 DRUGBANK 5911 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 346 Buclizine 1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina - DRUGBANK DB00354 C28H33ClN2 small molecule R06AE01|R06AE51 82-95-1 DRUGBANK 8021 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sakaguchi T (2008) 19057127 176853 547 Hydroxyzine Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine atarax cap 25mg|hydroxyzine hy DRUGBANK DB00557 C21H27ClN2O2 small molecule N05BB51|N05BB01 68-88-2 DRUGBANK 8022 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Snowman AM (1990) 1979798 176852 547 Hydroxyzine Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine atarax cap 25mg|hydroxyzine hy DRUGBANK DB00557 C21H27ClN2O2 small molecule N05BB51|N05BB01 68-88-2 DRUGBANK 8023 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen C (2008) 18781943 176851 547 Hydroxyzine Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine atarax cap 25mg|hydroxyzine hy DRUGBANK DB00557 C21H27ClN2O2 small molecule N05BB51|N05BB01 68-88-2 DRUGBANK 8024 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 547 Hydroxyzine Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine atarax cap 25mg|hydroxyzine hy DRUGBANK DB00557 C21H27ClN2O2 small molecule N05BB51|N05BB01 68-88-2 DRUGBANK 8025 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Spahr L (2007) 17222324 176854 547 Hydroxyzine Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine atarax cap 25mg|hydroxyzine hy DRUGBANK DB00557 C21H27ClN2O2 small molecule N05BB51|N05BB01 68-88-2 DRUGBANK 13805 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sugimoto Y (1999) 10631382 180175 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13806 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chalon P (1996) 8647296 180177 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13807 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yamada M (1998) 9627096 180176 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13808 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13809 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Betancur C (1998) 9551716 180179 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13810 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Akiyoshi M (2002) 11915520 180178 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 9889 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 24384 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Grinshpoon A (2000) 11004734 181762 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 24385 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nowak JZ (1983) 6302549 181677 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 24386 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Csaba G (2003) 12967590 181830 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 17351 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1553 Aceprometazine Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone - DRUGBANK DB01615 C19H22N2OS small molecule - 13461-01-3 DRUGBANK 17352 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1553 Aceprometazine Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone - DRUGBANK DB01615 C19H22N2OS small molecule - 13461-01-3 DRUGBANK 17353 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1553 Aceprometazine Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone - DRUGBANK DB01615 C19H22N2OS small molecule - 13461-01-3 DRUGBANK 17354 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Mercier J (1974) 4406367 181589 1553 Aceprometazine Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone - DRUGBANK DB01615 C19H22N2OS small molecule - 13461-01-3 DRUGBANK 17369 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17370 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17371 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yanni JM (1994) 7714410 175868 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17372 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Leurs R (1989) 2567596 181600 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17373 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nosal R (2009) 20027159 181601 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17374 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Gepdiremen A (2003) 14506317 181597 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17375 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Karadag CH (1996) 8835636 181598 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17376 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nath C (2001) 11526976 181599 1557 Pheniramine Feniramina|Pheniraminum|Pheniramine extra strength pharmacitron|ca DRUGBANK DB01620 C16H20N2 small molecule D04AA16|R06AB05 86-21-5 DRUGBANK 17364 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1556 Phenindamine Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin - DRUGBANK DB01619 C19H19N small molecule R06AX04 82-88-2 DRUGBANK 17365 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Witek TJ (1992) 1360991 181595 1556 Phenindamine Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin - DRUGBANK DB01619 C19H19N small molecule R06AX04 82-88-2 DRUGBANK 17366 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1556 Phenindamine Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin - DRUGBANK DB01619 C19H19N small molecule R06AX04 82-88-2 DRUGBANK 17367 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target van Drooge MJ (1991) 1686618 181596 1556 Phenindamine Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin - DRUGBANK DB01619 C19H19N small molecule R06AX04 82-88-2 DRUGBANK 17368 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target ter Laak AM (1995) 7650688 179985 1556 Phenindamine Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin - DRUGBANK DB01619 C19H19N small molecule R06AX04 82-88-2 DRUGBANK 23968 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23969 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23970 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Taylor JE (1986) 20493137 182154 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 13516 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kesiova M (2006) 16702624 179145 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 13517 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 13518 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wang Z (2007) 17196194 180008 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 13519 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hasala H (2007) 17390763 180005 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 13520 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Havas TE (1986) 2878016 180004 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 13521 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Piao H (2007) 17169617 180007 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 13522 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ishikawa T (2007) 17329841 180006 1063 Diphenhydramine O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine cvs cough and severe cold nigh DRUGBANK DB01075 C17H21NO small molecule R06AA52|D04AA32|R06AA02 58-73-1 DRUGBANK 7882 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6726 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6727 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6728 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 7827 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sadava D (1984) 6096660 176746 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7828 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 10955 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yasuda SU (1999) 10212017 175352 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 10956 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 10957 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yanni JM (1994) 7714410 175868 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 10958 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 10959 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Boekesoy TA (1991) 1680053 175870 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 10960 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Onaran HO (1990) 1970615 175871 825 Brompheniramine 2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum lohist peb dm|brompheniramine DRUGBANK DB00835 C16H19BrN2 small molecule R06AB51|R06AB01 86-22-6 DRUGBANK 12054 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cavero I (1981) 6115693 179183 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12055 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kanba S (1984) 6146381 179184 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12056 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Noguchi S (1992) 1353628 177589 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 6838 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6839 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Peroutka SJ (1981) 7214150 175988 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6840 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Paton DM (1985) 2866055 175984 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6841 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Simons FE (1994) 7913608 175985 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6842 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hiroi T (1995) 7853212 175986 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6843 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Estelle F (1999) 10582735 175987 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6844 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Claro E (1986) 3011460 175980 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6845 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kuzmin AI (1999) 10493107 175981 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6846 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Mann KV (1989) 2568212 175982 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 6847 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ziganshina LE (1996) 8907591 175983 419 Triprolidine Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine actifed plus caplets|histex-pe DRUGBANK DB00427 C19H22N2 small molecule R06AX07 486-12-4 DRUGBANK 9800 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 709 Azatadine Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin trinalin repetabs|optimine tab DRUGBANK DB00719 C20H22N2 small molecule R06AX09 3964-81-6 DRUGBANK 9801 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Clissold SP (1989) 2523301 178020 709 Azatadine Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin trinalin repetabs|optimine tab DRUGBANK DB00719 C20H22N2 small molecule R06AX09 3964-81-6 DRUGBANK 9802 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Haria M (1994) 7528133 178021 709 Azatadine Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin trinalin repetabs|optimine tab DRUGBANK DB00719 C20H22N2 small molecule R06AX09 3964-81-6 DRUGBANK 9799 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Singh N (1998) 9638277 178022 709 Azatadine Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin trinalin repetabs|optimine tab DRUGBANK DB00719 C20H22N2 small molecule R06AX09 3964-81-6 DRUGBANK 9803 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Mann KV (1989) 2568212 175982 709 Azatadine Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin trinalin repetabs|optimine tab DRUGBANK DB00719 C20H22N2 small molecule R06AX09 3964-81-6 DRUGBANK 5539 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 27772 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sadofsky LR (2008) 19085565 195985 397 Dexbrompheniramine (+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine m-end max d|bionatuss dxp|pana DRUGBANK DB00405 C16H19BrN2 small molecule R06AB06|R06AB56 132-21-8 DRUGBANK 6591 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 397 Dexbrompheniramine (+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine m-end max d|bionatuss dxp|pana DRUGBANK DB00405 C16H19BrN2 small molecule R06AB06|R06AB56 132-21-8 DRUGBANK 6588 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target McLeod RL (1998) 9691225 175869 397 Dexbrompheniramine (+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine m-end max d|bionatuss dxp|pana DRUGBANK DB00405 C16H19BrN2 small molecule R06AB06|R06AB56 132-21-8 DRUGBANK 6589 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yanni JM (1994) 7714410 175868 397 Dexbrompheniramine (+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine m-end max d|bionatuss dxp|pana DRUGBANK DB00405 C16H19BrN2 small molecule R06AB06|R06AB56 132-21-8 DRUGBANK 6590 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Boekesoy TA (1991) 1680053 175870 397 Dexbrompheniramine (+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine m-end max d|bionatuss dxp|pana DRUGBANK DB00405 C16H19BrN2 small molecule R06AB06|R06AB56 132-21-8 DRUGBANK 6592 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Onaran HO (1990) 1970615 175871 397 Dexbrompheniramine (+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine m-end max d|bionatuss dxp|pana DRUGBANK DB00405 C16H19BrN2 small molecule R06AB06|R06AB56 132-21-8 DRUGBANK 5105 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hallberg T (1984) 6701456 174899 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5106 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Dorsch W (1984) 6387510 174898 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5107 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Taniguchi K (1987) 2890562 174895 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5108 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hayashi H (1976) 1266718 174894 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5109 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Taniguchi K (1991) 1678430 174897 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5110 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Oishi R (1994) 7513381 174896 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5111 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5112 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Thomson NC (1980) 6449094 174902 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5113 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Thomas RH (1985) 4074605 174901 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 5114 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Schran HF (1996) 8930778 174900 276 Clemastine (+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum dayhist allergy 12 hour relief DRUGBANK DB00283 C21H26ClNO small molecule R06AA54|R06AA04|D04AA14 15686-51-8 DRUGBANK 15533 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15534 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Cohen LJ (1994) 7524043 180924 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15535 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 6113 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 11913 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Okabe S (1992) 1434122 179098 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11914 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Mita H (1995) 7893266 179099 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11915 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11916 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ito K (1996) 8836617 179097 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11917 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Werner-Klein M (2008) 18490184 179100 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11918 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hashimoto T (2006) 16404130 179101 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11919 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yokoyama H (1993) 8101246 179102 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 6905 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 15359 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Santos DE (1995) 7713167 180831 1234 Alimemazine Trimeprazine|Alimemazine|Methylpromazine|Repeltin panectyl tab 2.5mg|panectyl ta DRUGBANK DB01246 C18H22N2S small molecule R06AD01 84-96-8 DRUGBANK 15360 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1234 Alimemazine Trimeprazine|Alimemazine|Methylpromazine|Repeltin panectyl tab 2.5mg|panectyl ta DRUGBANK DB01246 C18H22N2S small molecule R06AD01 84-96-8 DRUGBANK 14242 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sawynok J (1999) 10467920 180379 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14243 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14124 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tashiro M (2004) 15286093 175350 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14125 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Singh H (2007) 17685877 180341 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14126 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tran VT (1981) 7238574 180339 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14127 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14128 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kano M (2004) 15255990 180340 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14129 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14130 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14131 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14132 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Claro E (1986) 3011460 175980 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14133 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 7054 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cavero I (1999) 10597865 175351 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7055 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tamura T (2005) 15942272 175347 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7056 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Menardo JL (1998) 9444440 176170 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7057 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Baroody FM (2001) 11291777 176171 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7058 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cieslewicz G (1992) 1303772 176172 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7059 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Grzelewska-Rzymowska I (1992) 1303773 176173 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7060 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Howarth PH (1990) 1977506 176174 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7061 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7062 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Letari O (1994) 8174605 176169 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 7063 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cieslewicz G (1995) 7581058 176168 447 Loratadine Loratadina|Claritin|Loratadinum family dollar allergy relief|l DRUGBANK DB00455 C22H23ClN2O2 small molecule R06AX13 79794-75-5 DRUGBANK 14174 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Lapa GB (2005) 15627433 180352 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 14175 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 14176 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nakai T (1991) 1912125 180350 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 14177 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Taniguchi K (1991) 1678430 174897 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 14178 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 14179 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Weis R (2008) 18977145 180351 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 14180 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 10583 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Roll C (1993) 8487790 178427 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 10513 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ohta Y (1999) 10208755 178408 782 Tripelennamine Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine vagin-x|vaginex w tripelennami DRUGBANK DB00792 C16H21N3 small molecule D04AA04|R06AC04 91-81-6 DRUGBANK 10514 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Sansone M (1988) 3253717 178409 782 Tripelennamine Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine vagin-x|vaginex w tripelennami DRUGBANK DB00792 C16H21N3 small molecule D04AA04|R06AC04 91-81-6 DRUGBANK 10515 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chiba S (1976) 996853 178406 782 Tripelennamine Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine vagin-x|vaginex w tripelennami DRUGBANK DB00792 C16H21N3 small molecule D04AA04|R06AC04 91-81-6 DRUGBANK 10516 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Shimizu K (1982) 6759742 178407 782 Tripelennamine Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine vagin-x|vaginex w tripelennami DRUGBANK DB00792 C16H21N3 small molecule D04AA04|R06AC04 91-81-6 DRUGBANK 10517 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 782 Tripelennamine Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine vagin-x|vaginex w tripelennami DRUGBANK DB00792 C16H21N3 small molecule D04AA04|R06AC04 91-81-6 DRUGBANK 10518 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Suzuki T (1997) 9226736 178410 782 Tripelennamine Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine vagin-x|vaginex w tripelennami DRUGBANK DB00792 C16H21N3 small molecule D04AA04|R06AC04 91-81-6 DRUGBANK 24632 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Mojtahedin A (2009) 19552055 182115 5573 Mepyramine Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine caldomine dh enfant|midol pms DRUGBANK DB06691 C17H23N3O small molecule R06AC01|D04AA02 91-84-9 DRUGBANK 24633 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Snowman AM (1990) 1979798 176852 5573 Mepyramine Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine caldomine dh enfant|midol pms DRUGBANK DB06691 C17H23N3O small molecule R06AC01|D04AA02 91-84-9 DRUGBANK 24634 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Parsons ME (2006) 16402096 181925 5573 Mepyramine Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine caldomine dh enfant|midol pms DRUGBANK DB06691 C17H23N3O small molecule R06AC01|D04AA02 91-84-9 DRUGBANK 24635 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chhabria MT (2009) 19537525 182113 5573 Mepyramine Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine caldomine dh enfant|midol pms DRUGBANK DB06691 C17H23N3O small molecule R06AC01|D04AA02 91-84-9 DRUGBANK 24636 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Moriyama K (2009) 19544046 182114 5573 Mepyramine Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine caldomine dh enfant|midol pms DRUGBANK DB06691 C17H23N3O small molecule R06AC01|D04AA02 91-84-9 DRUGBANK 9049 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9050 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Noguchi S (1992) 1353628 177589 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9051 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 15271 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15272 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15234 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15212 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1225 Bromodiphenhydramine Bromazine|2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine|Bromazina|Bromazinum|beta-(P-Bromobenzhydryloxy)ethyldimethylamine|Bromodiphenhydramine|beta-Dimethylaminoethyl P-bromobenzhydryl ether - DRUGBANK DB01237 C17H20BrNO small molecule R06AA01 118-23-0 DRUGBANK 15213 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1225 Bromodiphenhydramine Bromazine|2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine|Bromazina|Bromazinum|beta-(P-Bromobenzhydryloxy)ethyldimethylamine|Bromodiphenhydramine|beta-Dimethylaminoethyl P-bromobenzhydryl ether - DRUGBANK DB01237 C17H20BrNO small molecule R06AA01 118-23-0 DRUGBANK 15214 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1225 Bromodiphenhydramine Bromazine|2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine|Bromazina|Bromazinum|beta-(P-Bromobenzhydryloxy)ethyldimethylamine|Bromodiphenhydramine|beta-Dimethylaminoethyl P-bromobenzhydryl ether - DRUGBANK DB01237 C17H20BrNO small molecule R06AA01 118-23-0 DRUGBANK 8862 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cavero I (1999) 10597865 175351 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8863 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Salata JJ (1995) 8001268 175353 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8864 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8865 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Krstenansky PM (1987) 2892659 177483 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8866 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Howarth PH (1984) 6146346 177482 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8867 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kaliner MA (1988) 3147222 177481 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8868 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Llenas J (1999) 10597866 177485 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8869 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richards DM (1984) 6204835 177484 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 7114 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 5782 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Salata JJ (1995) 8001268 175353 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5783 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wood-Baker R (1995) 7654486 175355 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5784 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Phillips GD (1989) 2569356 175354 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5785 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kishimoto W (1997) 9485522 175357 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5786 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Rafferty P (1987) 2879489 175356 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5787 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5775 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cavero I (1999) 10597865 175351 333 Cetirizine Cetirizin|Cetirizina|Cetirizinum target childrens all day aller DRUGBANK DB00341 C21H25ClN2O3 small molecule R06AE07 83881-51-0 DRUGBANK 5776 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tashiro M (2004) 15286093 175350 333 Cetirizine Cetirizin|Cetirizina|Cetirizinum target childrens all day aller DRUGBANK DB00341 C21H25ClN2O3 small molecule R06AE07 83881-51-0 DRUGBANK 5777 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tamura T (2005) 15942272 175347 333 Cetirizine Cetirizin|Cetirizina|Cetirizinum target childrens all day aller DRUGBANK DB00341 C21H25ClN2O3 small molecule R06AE07 83881-51-0 DRUGBANK 5778 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Christophe B (2003) 12787835 175348 333 Cetirizine Cetirizin|Cetirizina|Cetirizinum target childrens all day aller DRUGBANK DB00341 C21H25ClN2O3 small molecule R06AE07 83881-51-0 DRUGBANK 5779 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tillement JP (2003) 14505791 175349 333 Cetirizine Cetirizin|Cetirizina|Cetirizinum target childrens all day aller DRUGBANK DB00341 C21H25ClN2O3 small molecule R06AE07 83881-51-0 DRUGBANK 5780 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 333 Cetirizine Cetirizin|Cetirizina|Cetirizinum target childrens all day aller DRUGBANK DB00341 C21H25ClN2O3 small molecule R06AE07 83881-51-0 DRUGBANK 23952 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 4639 Clofedanol Clofedianolo|Clofedanolum|Antitussin|Chlophedianol chlo tuss|abanatuss ped drops| DRUGBANK DB04837 C17H20ClNO small molecule R05DB10 791-35-5 DRUGBANK 23953 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 4639 Clofedanol Clofedianolo|Clofedanolum|Antitussin|Chlophedianol chlo tuss|abanatuss ped drops| DRUGBANK DB04837 C17H20ClNO small molecule R05DB10 791-35-5 DRUGBANK 23954 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 4639 Clofedanol Clofedianolo|Clofedanolum|Antitussin|Chlophedianol chlo tuss|abanatuss ped drops| DRUGBANK DB04837 C17H20ClNO small molecule R05DB10 791-35-5 DRUGBANK 23955 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Maurer H (1988) 2905706 178298 4639 Clofedanol Clofedianolo|Clofedanolum|Antitussin|Chlophedianol chlo tuss|abanatuss ped drops| DRUGBANK DB04837 C17H20ClNO small molecule R05DB10 791-35-5 DRUGBANK 14436 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14437 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Rumore MM (1985) 2578597 180465 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14438 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 12495 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Halpert AG (2002) 11835984 179512 975 Dimenhydrinate Diphenhydrinate|Dimenhidrinato|Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline|Diphenhydramine theoclate|(O-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophylline|8-chloro-1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)|O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophyllinate|N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate|Dimenhydrinatum|beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine travamine tab 50mg|travamine s DRUGBANK DB00985 C24H28ClN5O3 small molecule - 523-87-5 DRUGBANK 12496 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 975 Dimenhydrinate Diphenhydrinate|Dimenhidrinato|Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline|Diphenhydramine theoclate|(O-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophylline|8-chloro-1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)|O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophyllinate|N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate|Dimenhydrinatum|beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine travamine tab 50mg|travamine s DRUGBANK DB00985 C24H28ClN5O3 small molecule - 523-87-5 DRUGBANK 24200 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Bobo WV (2013) 23272794 182224 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 9171 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Miyoshi K (2006) 16648669 177664 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9172 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Tanimoto A (2007) 17478759 177663 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9173 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Han SK (2006) 17114052 177662 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9174 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Suzuki K (2007) 17336292 177661 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9175 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens agonist target Spahr L (2007) 17222324 176854 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 10050 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yang J (2009) 19761204 178165 738 Carbinoxamine {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina karbinal er|carbinoxamine male DRUGBANK DB00748 C16H19ClN2O small molecule R06AA08 486-16-8 DRUGBANK 10051 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Darby WJ (1975) 1143714 178164 738 Carbinoxamine {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina karbinal er|carbinoxamine male DRUGBANK DB00748 C16H19ClN2O small molecule R06AA08 486-16-8 DRUGBANK 10054 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 738 Carbinoxamine {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina karbinal er|carbinoxamine male DRUGBANK DB00748 C16H19ClN2O small molecule R06AA08 486-16-8 DRUGBANK 10052 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Oishi R (1994) 7513381 174896 738 Carbinoxamine {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina karbinal er|carbinoxamine male DRUGBANK DB00748 C16H19ClN2O small molecule R06AA08 486-16-8 DRUGBANK 10053 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ramadan AA (2006) 16574052 178166 738 Carbinoxamine {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina karbinal er|carbinoxamine male DRUGBANK DB00748 C16H19ClN2O small molecule R06AA08 486-16-8 DRUGBANK 15055 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15056 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 7339 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ruffolo RR (1978) 25190 176346 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7340 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Johnson HG (1979) 91313 176345 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7341 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Church MK (1983) 6189542 176344 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7342 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Palmer GC (1978) 687395 176343 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7343 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 16469 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hals PA (1988) 2899826 175941 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 10269 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Roland PS (2010) 20402382 178301 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10270 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ohmori K (2002) 12046981 178300 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10271 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yanni JM (1996) 8951675 178303 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10272 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ohmori K (2001) 11496828 178302 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10273 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kaliner MA (2010) 20406593 178305 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10274 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tamura T (2005) 15942272 175347 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10275 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ohmori K (2005) 15646365 178306 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10276 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10277 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Roland PS (2010) 20482305 178304 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 12402 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Conde Hernandez DJ (1995) 8829888 179425 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 12403 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Bernstein JA (2007) 17723160 179424 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 12404 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Horak F (2008) 19209282 179423 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 12405 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Golden SJ (1999) 10478514 179422 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 12406 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Casale TB (1989) 2540229 179421 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 12407 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Antepara I (1998) 9585822 179420 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 12408 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 962 Azelastine Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone azelastine hydrochloride|dymis DRUGBANK DB00972 C22H24ClN3O small molecule R06AX19|S01GX07|R01AC03 58581-89-8 DRUGBANK 27817 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target McCormack PL (2015) 26510944 196034 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 9999 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Taniguchi K (1991) 1678430 174897 727 Meclizine Meclozine|Meclizine|Nevidoxine rugbymeclizine hcl, 12.5 mg ea DRUGBANK DB00737 C25H27ClN2 small molecule R06AE05|R06AE55 569-65-3 DRUGBANK 9998 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Oishi R (1994) 7513381 174896 727 Meclizine Meclozine|Meclizine|Nevidoxine rugbymeclizine hcl, 12.5 mg ea DRUGBANK DB00737 C25H27ClN2 small molecule R06AE05|R06AE55 569-65-3 DRUGBANK 10001 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Martins MA (1992) 1350745 178109 727 Meclizine Meclozine|Meclizine|Nevidoxine rugbymeclizine hcl, 12.5 mg ea DRUGBANK DB00737 C25H27ClN2 small molecule R06AE05|R06AE55 569-65-3 DRUGBANK 10000 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Pasquale CP (1992) 1362160 178108 727 Meclizine Meclozine|Meclizine|Nevidoxine rugbymeclizine hcl, 12.5 mg ea DRUGBANK DB00737 C25H27ClN2 small molecule R06AE05|R06AE55 569-65-3 DRUGBANK 9965 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Schreiber S (1997) 9197279 178095 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9966 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9967 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 13898 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Hasenoehrl RU (2001) 11640974 180225 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 13899 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nicholson AN (1991) 1686208 180224 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 13900 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Salata JJ (1995) 8001268 175353 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 13901 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yasuda SU (1995) 7648771 180226 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 13902 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tagawa M (2001) 11736858 180223 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 13903 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 14493 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1164 Cyclizine 1-(Diphenylmethyl)-4-methylpiperazine|Cyclizine|()-1-diphenylmethyl-4-methylpiperazine|(N-Benzhydryl)(n'-methyl)diethylenediamine|Cyclizinum|1-Benzhydryl-4-methylpiperazin|N-methyl-N'-benzhydrylpiperazine|(+-)-1-Diphenylmethyl-4-methylpiperazine|N-Benzhydryl-N'-methylpiperazine|Ciclizina megral tabs|marzine inj 50mg/m DRUGBANK DB01176 C18H22N2 small molecule R06AE53|R06AE03 82-92-8 DRUGBANK 14494 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Leza JC (1990) 1983158 180476 1164 Cyclizine 1-(Diphenylmethyl)-4-methylpiperazine|Cyclizine|()-1-diphenylmethyl-4-methylpiperazine|(N-Benzhydryl)(n'-methyl)diethylenediamine|Cyclizinum|1-Benzhydryl-4-methylpiperazin|N-methyl-N'-benzhydrylpiperazine|(+-)-1-Diphenylmethyl-4-methylpiperazine|N-Benzhydryl-N'-methylpiperazine|Ciclizina megral tabs|marzine inj 50mg/m DRUGBANK DB01176 C18H22N2 small molecule R06AE53|R06AE03 82-92-8 DRUGBANK 10071 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tsujii T (2007) 17534605 178182 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 10072 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Walther G (1990) 1972625 178181 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 10073 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 8082 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Paton DM (1985) 2866055 175984 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8083 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 14478 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Fabre V (2003) 12876551 180470 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14479 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Bareggi SR (2007) 17916059 174434 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 27689 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens inhibitor target Devillier P (2008) 18336052 179288 8072 Levocetirizine 2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid levocetirizine dihydrochloride DRUGBANK DB06282 C21H25ClN2O3 small molecule R06AE09 130018-77-8 DRUGBANK 27837 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens inhibitor target Ferrer M (2011) 21639816 196009 8072 Levocetirizine 2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid levocetirizine dihydrochloride DRUGBANK DB06282 C21H25ClN2O3 small molecule R06AE09 130018-77-8 DRUGBANK 27690 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Devillier P (2008) 18336052 179288 8072 Levocetirizine 2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid levocetirizine dihydrochloride DRUGBANK DB06282 C21H25ClN2O3 small molecule R06AE09 130018-77-8 DRUGBANK 27838 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ferrer M (2011) 21639816 196009 8072 Levocetirizine 2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid levocetirizine dihydrochloride DRUGBANK DB06282 C21H25ClN2O3 small molecule R06AE09 130018-77-8 DRUGBANK 4712 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kulkarni SS (2006) 16460947 174610 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4744 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Arnt J (1995) 7498321 174624 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4745 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 10257 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10258 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10259 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Niemegeers CJ (1982) 6130555 178299 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 10260 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Maurer H (1988) 2905706 178298 757 Benzquinamide BZQ - DRUGBANK DB00767 C22H32N2O5 small molecule - 63-12-7 DRUGBANK 27010 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Enright BP (2010) 21058326 182175 7675 Chlorcyclizine Chlorcyclizine|Chlorcyclizinum|Chlorcyclizin|Clorciclizina dallergy|notuss-nx|bonine kids DRUGBANK DB08936 C18H21ClN2 small molecule R06AE04 82-93-9 DRUGBANK 26793 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Kurenova EV (2009) 19610651 182119 7571 Chloropyramine Chloropyramine|Halopyramine|Chlorpyramine - DRUGBANK DB08800 C16H20ClN3 small molecule R06AC03|D04AA09|R06AC53 59-32-5 DRUGBANK 24090 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Andoh T (2006) 16914135 181960 4690 Bepotastine TAU-284DS bepreve DRUGBANK DB04890 C21H25ClN2O3 small molecule - 125602-71-3 DRUGBANK 24091 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 4690 Bepotastine TAU-284DS bepreve DRUGBANK DB04890 C21H25ClN2O3 small molecule - 125602-71-3 DRUGBANK 26797 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Moreau A (1995) 8546983 181701 7573 Isothipendyl Actapront - DRUGBANK DB08802 C16H19N3S small molecule D04AA22|R06AD09 482-15-5 DRUGBANK 26794 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Moree WJ (2010) 20800486 182164 7572 Dimetindene Dimethindene - DRUGBANK DB08801 C20H24N2 small molecule R06AB03|D04AA13 5636-83-9 DRUGBANK 26795 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Pfaff O (1995) 8608784 181703 7572 Dimetindene Dimethindene - DRUGBANK DB08801 C20H24N2 small molecule R06AB03|D04AA13 5636-83-9 DRUGBANK 13448 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Suzuki A (2003) 12657913 179975 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13449 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13450 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Paton DM (1985) 2866055 175984 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13451 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Ikeda H (1997) 9442829 179973 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13452 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Miller RA (1989) 2576052 179972 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13453 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Claro E (1986) 3011460 175980 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13454 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Smith BN (1993) 8098142 179974 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13478 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wiseman LR (1996) 8808167 179982 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 13479 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Yakuo I (1994) 7511558 179983 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 13480 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wang YJ (2002) 12244568 179984 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 13481 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target ter Laak AM (1995) 7650688 179985 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 13482 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nicholson AN (1983) 6418550 179986 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 13483 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Nakamura K (1998) 9454781 179987 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 13484 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1059 Mequitazine Mequitazinum|Mequitazina|Kitazemin - DRUGBANK DB01071 C20H22N2S small molecule R06AD07 29216-28-2 DRUGBANK 12372 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Devillier P (2008) 18336052 179288 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12373 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target DuBuske L (2007) 17902729 179395 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12374 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wu RL (2004) 15564772 179397 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12375 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Simons FE (2003) 12642846 179396 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12376 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12377 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Dhanya NB (2008) 18797058 179285 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12378 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Letari O (1994) 8174605 176169 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 12379 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cieslewicz G (1995) 7581058 176168 957 Desloratadine Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine allergy control desloratadine| DRUGBANK DB00967 C19H19ClN2 small molecule R06AX27 100643-71-8 DRUGBANK 27873 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens inverse agonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 5679 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5680 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Poyurovsky M (2005) 15729086 175314 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5681 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5682 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5683 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Altschuler EL (2005) 15893120 175313 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5684 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Rasmussen K (2005) 16141369 175312 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 11558 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 892 Methdilazine Tacaryl|Metodilazina|Methdilazinum - DRUGBANK DB00902 C18H20N2S small molecule R06AD04 1982-37-2 DRUGBANK 11559 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chattopadhyay D (1998) 9700532 178958 892 Methdilazine Tacaryl|Metodilazina|Methdilazinum - DRUGBANK DB00902 C18H20N2S small molecule R06AD04 1982-37-2 DRUGBANK 11560 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 892 Methdilazine Tacaryl|Metodilazina|Methdilazinum - DRUGBANK DB00902 C18H20N2S small molecule R06AD04 1982-37-2 DRUGBANK 11561 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 892 Methdilazine Tacaryl|Metodilazina|Methdilazinum - DRUGBANK DB00902 C18H20N2S small molecule R06AD04 1982-37-2 DRUGBANK 11562 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Dasgupta A (2010) 20012879 178957 892 Methdilazine Tacaryl|Metodilazina|Methdilazinum - DRUGBANK DB00902 C18H20N2S small molecule R06AD04 1982-37-2 DRUGBANK 26792 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Swiader MJ (2005) 16129921 181907 7570 Antazoline Antazoline|Vasocon-a cooper a.r.|vasocon a eye drop DRUGBANK DB08799 C17H19N3 small molecule R01AC04|R06AX05 91-75-8 DRUGBANK 4364 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens binder target Bareggi SR (2007) 17916059 174434 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 24441 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24442 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 12207 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Cavero I (1999) 10597865 175351 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12208 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tashiro M (2004) 15286093 175350 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12209 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Amon U (2000) 10864400 179289 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12210 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Devillier P (2008) 18336052 179288 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12211 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Smith SM (2009) 19545214 179283 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12212 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12213 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Abbas MN (2004) 15352500 179287 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12214 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Markham A (1998) 9506246 179286 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12215 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Dhanya NB (2008) 18797058 179285 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 12216 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Grzelewska-Rzymowska I (2003) 12712828 179284 940 Fexofenadine Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate allegra|dg health aller ease|f DRUGBANK DB00950 C32H39NO4 small molecule R06AX26 83799-24-0 DRUGBANK 5987 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5988 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Roegge CS (2007) 17382376 175512 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5989 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 27023 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Wander TJ (1986) 3816971 181668 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27024 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Tatsumi M (1997) 9537821 174430 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27025 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 6024 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 358 Doxylamine Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether tylenol cold and flu nighttime DRUGBANK DB00366 C17H22N2O small molecule R06AA09|R06AA59 469-21-6 DRUGBANK 6025 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 358 Doxylamine Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether tylenol cold and flu nighttime DRUGBANK DB00366 C17H22N2O small molecule R06AA09|R06AA59 469-21-6 DRUGBANK 6026 109505 3269 - HRH1 H1-R|hisH1 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 358 Doxylamine Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether tylenol cold and flu nighttime DRUGBANK DB00366 C17H22N2O small molecule R06AA09|R06AA59 469-21-6 DRUGBANK 10070 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Bielory L (2005) 16131920 178180 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 10580 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Gaulton A (2012) 21948594 174478 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 10581 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Ward RM (1984) 6386273 178426 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 10582 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Roll C (1993) 8487790 178427 787 Tolazoline 2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole - DRUGBANK DB00797 C10H12N2 small molecule M02AX02|C04AB02 59-98-3 DRUGBANK 26799 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Black JW (1994) 7725982 181688 7576 Metiamide Metiamidum|Methiamide|Metiamida - DRUGBANK DB08805 C9H16N4S2 small molecule - 34839-70-8 DRUGBANK 26800 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Agrawal SS (2010) 20718616 182163 7577 Roxatidine acetate Roxatidine acetate|Roxatidina|Roxatidine|Aceroxatidine - DRUGBANK DB08806 C19H28N2O4 small molecule A02BA06 78628-28-1 DRUGBANK 11233 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 853 Ranitidine RAN|Ranitidina|Ranitidinum mylan-ranitidine|zantac maximu DRUGBANK DB00863 C13H22N4O3S small molecule A02BA07|A02BA02 66357-35-5 DRUGBANK 11234 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Pattichis K (1995) 7554999 178760 853 Ranitidine RAN|Ranitidina|Ranitidinum mylan-ranitidine|zantac maximu DRUGBANK DB00863 C13H22N4O3S small molecule A02BA07|A02BA02 66357-35-5 DRUGBANK 14119 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Figueiredo A (1990) 2141000 180336 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14120 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Beil W (1988) 2897127 180338 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 8288 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Lin TM (1986) 2877081 177078 575 Nizatidine Nizatidina|Nizatidinum|Nizatidine apo-nizatidine|novo-nizatidine DRUGBANK DB00585 C12H21N5O2S2 small molecule A02BA04 76963-41-2 DRUGBANK 8289 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Meredith CG (1985) 2858133 177079 575 Nizatidine Nizatidina|Nizatidinum|Nizatidine apo-nizatidine|novo-nizatidine DRUGBANK DB00585 C12H21N5O2S2 small molecule A02BA04 76963-41-2 DRUGBANK 8290 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Enriz RD (1991) 1843561 177081 575 Nizatidine Nizatidina|Nizatidinum|Nizatidine apo-nizatidine|novo-nizatidine DRUGBANK DB00585 C12H21N5O2S2 small molecule A02BA04 76963-41-2 DRUGBANK 8291 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Kounenis G (1987) 2895808 177080 575 Nizatidine Nizatidina|Nizatidinum|Nizatidine apo-nizatidine|novo-nizatidine DRUGBANK DB00585 C12H21N5O2S2 small molecule A02BA04 76963-41-2 DRUGBANK 8292 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 575 Nizatidine Nizatidina|Nizatidinum|Nizatidine apo-nizatidine|novo-nizatidine DRUGBANK DB00585 C12H21N5O2S2 small molecule A02BA04 76963-41-2 DRUGBANK 8293 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Okabe S (1989) 2567267 177077 575 Nizatidine Nizatidina|Nizatidinum|Nizatidine apo-nizatidine|novo-nizatidine DRUGBANK DB00585 C12H21N5O2S2 small molecule A02BA04 76963-41-2 DRUGBANK 5537 109510 3274 - HRH2 H2R 9606 Homo sapiens blocker target Angus JA (1980) 6103762 175192 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24432 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24433 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 9168 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Francis H (2007) 17334413 117236 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9169 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9170 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Soga F (2007) 17359382 177660 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 5676 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 4985 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Ribeiro TC (1980) 7213132 174778 265 Betazole Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine - DRUGBANK DB00272 C5H9N3 small molecule V04CG02 105-20-4 DRUGBANK 4986 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Leth R (1987) 3661710 174779 265 Betazole Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine - DRUGBANK DB00272 C5H9N3 small molecule V04CG02 105-20-4 DRUGBANK 4987 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 265 Betazole Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine - DRUGBANK DB00272 C5H9N3 small molecule V04CG02 105-20-4 DRUGBANK 4988 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Katz LB (1987) 2886642 174781 265 Betazole Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine - DRUGBANK DB00272 C5H9N3 small molecule V04CG02 105-20-4 DRUGBANK 4989 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Katz LB (1986) 2874214 174780 265 Betazole Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine - DRUGBANK DB00272 C5H9N3 small molecule V04CG02 105-20-4 DRUGBANK 4990 109510 3274 - HRH2 H2R 9606 Homo sapiens agonist target Hammond JB (1988) 2892392 174782 265 Betazole Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine - DRUGBANK DB00272 C5H9N3 small molecule V04CG02 105-20-4 DRUGBANK 11992 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Leurs R (1991) 1646056 179148 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11993 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Amagase K (2003) 12832840 179144 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11994 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Kesiova M (2006) 16702624 179145 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11995 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Ojiako K (2008) 18310651 179146 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11996 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Lesclous P (2006) 16513821 179147 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11997 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Weydert JA (2003) 12509588 179140 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11998 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Inan A (2009) 19578661 179141 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 11999 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Fukuda M (2007) 17273750 179142 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 12000 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Miyata K (1991) 2067140 179143 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 12001 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Takahashi HK (2006) 16723495 176525 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 12002 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 917 Famotidine Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina equate acid controller origina DRUGBANK DB00927 C8H15N7O2S3 small molecule A02BA53|A02BA03 76824-35-6 DRUGBANK 12136 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Hough LB (1981) 6116801 179229 930 Methantheline Methanthelinium|Methanthelinum|Methantheline - DRUGBANK DB00940 C21H26NO3 small molecule A03AB07 5818-17-7 DRUGBANK 7543 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 493 Cimetidine Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200 cimetidine tab 300mg|gaviscon DRUGBANK DB00501 C10H16N6S small molecule A02BA51|A02BA01 51481-61-9 DRUGBANK 7544 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Kuint J (1996) 8863950 176524 493 Cimetidine Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200 cimetidine tab 300mg|gaviscon DRUGBANK DB00501 C10H16N6S small molecule A02BA51|A02BA01 51481-61-9 DRUGBANK 7545 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Hernandez-Munoz R (2000) 10950107 176523 493 Cimetidine Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200 cimetidine tab 300mg|gaviscon DRUGBANK DB00501 C10H16N6S small molecule A02BA51|A02BA01 51481-61-9 DRUGBANK 7546 109510 3274 - HRH2 H2R 9606 Homo sapiens antagonist target Takahashi HK (2006) 16723495 176525 493 Cimetidine Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200 cimetidine tab 300mg|gaviscon DRUGBANK DB00501 C10H16N6S small molecule A02BA51|A02BA01 51481-61-9 DRUGBANK 17706 109512 3276 - PRMT1 ANM1|HCP1|HRMT1L2|IR1B4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 3226 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens unknown target Ishii-Ohba H (1987) 2961942 173722 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3227 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens unknown target Widenius TV (1987) 3476810 173723 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3228 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3229 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3230 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens unknown target Thomas JL (1990) 2362440 173724 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 13818 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Naville D (1991) 1944305 180188 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13819 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Suzuki S (1984) 6362415 180189 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13820 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Duffy DM (1994) 7989460 180184 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13821 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Igaz P (2008) 18991633 180185 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13822 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Takahashi M (1990) 2268554 180186 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13823 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Cooke GM (1996) 8809191 180187 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13824 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens inhibitor target Mensah-Nyagan AG (1994) 7996177 180183 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 16883 109516 3283 RP5-920G3.4 HSD3B1 3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1 9606 Homo sapiens positive allosteric modulator target Ishii-Ohba H (1986) 2945972 181485 1476 4-Androstenedione 4-Androstene-3,17-dione - DRUGBANK DB01536 C19H26O2 small molecule - 63-05-8 DRUGBANK 3245 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3246 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens unknown target Thomas JL (1991) 1911436 173730 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3247 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens unknown target Fan DF (1975) 239964 173731 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3248 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3249 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens unknown target Widenius TV (1987) 3476810 173723 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 13828 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Naville D (1991) 1944305 180188 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13829 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Suzuki S (1984) 6362415 180189 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13830 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Duffy DM (1994) 7989460 180184 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13831 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Igaz P (2008) 18991633 180185 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13832 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Takahashi M (1990) 2268554 180186 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13833 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Cooke GM (1996) 8809191 180187 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 13834 109517 3284 RP5-871G17.2 HSD3B2 HSD3B|HSDB|SDR11E2 9606 Homo sapiens inhibitor target Mensah-Nyagan AG (1994) 7996177 180183 1096 Trilostane Trilostano|Trilostanum - DRUGBANK DB01108 C20H27NO3 small molecule H02CA01 13647-35-3 DRUGBANK 3306 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Diederich S (1997) 9141556 173757 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3308 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3307 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3305 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Hermans JJ (1995) 8585102 173660 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 25624 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6425 N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide - - DRUGBANK DB07619 C24H27F3N2O2 small molecule - - DRUGBANK 25031 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5835 (5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one - - DRUGBANK DB07017 C15H19FN2O2S small molecule - - DRUGBANK 8848 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens ligand target Raza K (2010) 20634231 177464 625 Prednisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione winpred tab 1mg|deltasone 5mg| DRUGBANK DB00635 C21H26O5 small molecule A07EA03|H02AB07 53-03-2 DRUGBANK 25628 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6430 1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide - - DRUGBANK DB07624 C19H26F3N3O4S small molecule - - DRUGBANK 25323 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6132 N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide - - DRUGBANK DB07316 C23H30F3N3O3 small molecule - - DRUGBANK 25901 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6663 (5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one - - DRUGBANK DB07866 C15H26N2OS small molecule - - DRUGBANK 26322 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7065 2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE - - DRUGBANK DB08277 C21H27ClFNO4S small molecule - - DRUGBANK 26323 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7068 (1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE - - DRUGBANK DB08280 C22H30N2O4 small molecule - - DRUGBANK 18954 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2235 Carbenoxolone - - DRUGBANK DB02329 C34H50O7 small molecule A02BX71|A02BX51|A02BX01 5697-56-3 DRUGBANK 25317 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6126 (5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one - - DRUGBANK DB07310 C13H12F4N2OS small molecule - - DRUGBANK 23798 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4457 (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE - - DRUGBANK DB04652 C21H30O4 small molecule - - DRUGBANK 25061 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5874 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide - - DRUGBANK DB07056 C18H22ClN3O3S small molecule - - DRUGBANK 25005 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5810 (3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone - - DRUGBANK DB06992 C20H23FN2O small molecule - - DRUGBANK 25056 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5867 (2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine - - DRUGBANK DB07049 C21H27N3O4S small molecule - - DRUGBANK 26770 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7543 (5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one - - DRUGBANK DB08771 C12H13FN2OS small molecule - - DRUGBANK 22027 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22028 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 21332 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21333 109523 3290 - HSD11B1 11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3065 109524 3291 - HSD11B2 AME|AME1|HSD11K|HSD2|SDR9C3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3066 109524 3291 - HSD11B2 AME|AME1|HSD11K|HSD2|SDR9C3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3067 109524 3291 - HSD11B2 AME|AME1|HSD11K|HSD2|SDR9C3 9606 Homo sapiens unknown target Mercer WR (1992) 1727721 173659 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3064 109524 3291 - HSD11B2 AME|AME1|HSD11K|HSD2|SDR9C3 9606 Homo sapiens unknown target Hermans JJ (1995) 8585102 173660 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3168 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Rimsay RL (1988) 3164265 173704 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3169 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Fukuda T (1986) 3463506 173674 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3170 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3171 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3172 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Pineda JA (1989) 2615366 173675 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 17634 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17635 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17636 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 18948 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2230 EM-1745 - - DRUGBANK DB02323 C37H51N5O7 small molecule - - DRUGBANK 18949 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2230 EM-1745 - - DRUGBANK DB02323 C37H51N5O7 small molecule - - DRUGBANK 16974 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1501 Androstanedione 5alpha-Androstan-3,17-dione - DRUGBANK DB01561 C19H28O2 small molecule - 846-46-8 DRUGBANK 16975 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1501 Androstanedione 5alpha-Androstan-3,17-dione - DRUGBANK DB01561 C19H28O2 small molecule - 846-46-8 DRUGBANK 16976 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1501 Androstanedione 5alpha-Androstan-3,17-dione - DRUGBANK DB01561 C19H28O2 small molecule - 846-46-8 DRUGBANK 16886 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1476 4-Androstenedione 4-Androstene-3,17-dione - DRUGBANK DB01536 C19H26O2 small molecule - 63-05-8 DRUGBANK 16887 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1476 4-Androstenedione 4-Androstene-3,17-dione - DRUGBANK DB01536 C19H26O2 small molecule - 63-05-8 DRUGBANK 18683 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2103 Equilin 7-Dehydroestrone|Equilin|Dihydroequilenin|1,3,5,7-Estratetraen-3-ol-17-one - DRUGBANK DB02187 C18H20O2 small molecule - 474-86-2 DRUGBANK 18684 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2103 Equilin 7-Dehydroestrone|Equilin|Dihydroequilenin|1,3,5,7-Estratetraen-3-ol-17-one - DRUGBANK DB02187 C18H20O2 small molecule - 474-86-2 DRUGBANK 18685 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2103 Equilin 7-Dehydroestrone|Equilin|Dihydroequilenin|1,3,5,7-Estratetraen-3-ol-17-one - DRUGBANK DB02187 C18H20O2 small molecule - 474-86-2 DRUGBANK 21304 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21305 109525 3292 - HSD17B1 EDH17B2|EDHB17|HSD17|SDR28C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3355 109526 3293 RP11-240L7.3 HSD17B3 EDH17B3|SDR12C2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3356 109526 3293 RP11-240L7.3 HSD17B3 EDH17B3|SDR12C2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3357 109526 3293 RP11-240L7.3 HSD17B3 EDH17B3|SDR12C2 9606 Homo sapiens unknown target Inano H (1975) 237755 173771 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3089 109527 3294 - HSD17B2 EDH17B2|HSD17|SDR9C2 9606 Homo sapiens unknown target Fukuda T (1986) 3463506 173674 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3090 109527 3294 - HSD17B2 EDH17B2|HSD17|SDR9C2 9606 Homo sapiens unknown target Pineda JA (1989) 2615366 173675 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3091 109527 3294 - HSD17B2 EDH17B2|HSD17|SDR9C2 9606 Homo sapiens unknown target Wintergalen N (1995) 8529651 173676 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3092 109527 3294 - HSD17B2 EDH17B2|HSD17|SDR9C2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3093 109527 3294 - HSD17B2 EDH17B2|HSD17|SDR9C2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3040 109528 3295 - HSD17B4 DBP|MFE-2|MPF-2|PRLTS1|SDR8C1 9606 Homo sapiens unknown target Haapalainen AM (2003) 12517343 173649 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3041 109528 3295 - HSD17B4 DBP|MFE-2|MPF-2|PRLTS1|SDR8C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3042 109528 3295 - HSD17B4 DBP|MFE-2|MPF-2|PRLTS1|SDR8C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 20734 109528 3295 - HSD17B4 DBP|MFE-2|MPF-2|PRLTS1|SDR8C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3060 3r-Hydroxydecanoyl-Coa - - DRUGBANK DB03192 C31H54N7O18P3S small molecule - - DRUGBANK 20735 109528 3295 - HSD17B4 DBP|MFE-2|MPF-2|PRLTS1|SDR8C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3060 3r-Hydroxydecanoyl-Coa - - DRUGBANK DB03192 C31H54N7O18P3S small molecule - - DRUGBANK 20736 109528 3295 - HSD17B4 DBP|MFE-2|MPF-2|PRLTS1|SDR8C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3060 3r-Hydroxydecanoyl-Coa - - DRUGBANK DB03192 C31H54N7O18P3S small molecule - - DRUGBANK 269 109541 3309 - HSPA5 BIP|GRP78|HEL-S-89n|MIF2 9606 Homo sapiens chaperone target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 270 109541 3309 - HSPA5 BIP|GRP78|HEL-S-89n|MIF2 9606 Homo sapiens chaperone target Kaufman RJ (1997) 9607108 171871 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 271 109541 3309 - HSPA5 BIP|GRP78|HEL-S-89n|MIF2 9606 Homo sapiens chaperone target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 12157 109541 3309 - HSPA5 BIP|GRP78|HEL-S-89n|MIF2 9606 Homo sapiens binding target Deng WG (2001) 11689471 179245 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 25052 109544 3312 - HSPA8 HEL-33|HEL-S-72p|HSC54|HSC70|HSC71|HSP71|HSP73|HSPA10|LAP-1|LAP1|NIP71 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5863 (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol - - DRUGBANK DB07045 C17H18Cl2N6O4 small molecule - - DRUGBANK 8637 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Srethapakdi M (2000) 10919672 177312 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8638 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Yang J (2001) 11358819 177311 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8639 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Neckers L (2000) 10759403 177310 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8640 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Schnaider T (2000) 10701840 177308 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8641 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Muenster PN (2001) 11306472 177309 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 20475 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2964 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine - - DRUGBANK DB03093 C14H14FN5O2 small molecule - - DRUGBANK 21850 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3591 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole - - DRUGBANK DB03749 C14H14N4O2 small molecule - - DRUGBANK 21851 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3591 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole - - DRUGBANK DB03749 C14H14N4O2 small molecule - - DRUGBANK 21852 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3591 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole - - DRUGBANK DB03749 C14H14N4O2 small molecule - - DRUGBANK 19854 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2639 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine - - DRUGBANK DB02754 C19H25N5O3 small molecule - - DRUGBANK 22902 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4081 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine - - DRUGBANK DB04254 C17H18FN5O2 small molecule - - DRUGBANK 9784 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Okada M (2003) 12803546 178008 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9785 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Nishikawa M (2008) 17980980 178007 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 20571 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3005 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine - - DRUGBANK DB03137 C19H20FN5O2 small molecule - - DRUGBANK 25332 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6141 N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE - - DRUGBANK DB07325 C17H19N5O4S small molecule - - DRUGBANK 25331 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6140 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE - - DRUGBANK DB07324 C17H15N5O2 small molecule - - DRUGBANK 26494 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7225 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol - - DRUGBANK DB08443 C11H9NO4 small molecule - - DRUGBANK 26493 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7224 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol - - DRUGBANK DB08442 C18H19NO3 small molecule - - DRUGBANK 22137 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3736 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine - - DRUGBANK DB03899 C17H21N5O small molecule - - DRUGBANK 19444 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2447 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine - - DRUGBANK DB02550 C20H21ClFN5O3 small molecule - - DRUGBANK 19175 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2327 Geldanamycin - - DRUGBANK DB02424 C29H40N2O9 small molecule - 30562-34-6 DRUGBANK 19176 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2327 Geldanamycin - - DRUGBANK DB02424 C29H40N2O9 small molecule - 30562-34-6 DRUGBANK 24977 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5775 N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE - - DRUGBANK DB06956 C18H14ClN3O4 small molecule - - DRUGBANK 26222 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6988 (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime - - DRUGBANK DB08197 C20H18FN5O small molecule - - DRUGBANK 26787 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7559 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine - - DRUGBANK DB08787 C16H11Cl2N5 small molecule - - DRUGBANK 26786 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7558 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine - - DRUGBANK DB08786 C8H13N3O2 small molecule - - DRUGBANK 24982 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5780 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide - - DRUGBANK DB06961 C23H24ClN3O5 small molecule - - DRUGBANK 24985 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5783 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE - - DRUGBANK DB06964 C19H17ClN2O5 small molecule - - DRUGBANK 25518 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6306 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE - - DRUGBANK DB07495 C19H18ClN3O4 small molecule - - DRUGBANK 24987 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5788 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide - - DRUGBANK DB06969 C21H23Cl2N5O2S small molecule - - DRUGBANK 26220 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6985 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine - - DRUGBANK DB08194 C8H11N3S small molecule - - DRUGBANK 19023 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2264 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine - - DRUGBANK DB02359 C18H23N5O2 small molecule - - DRUGBANK 23755 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4398 N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE - - DRUGBANK DB04588 C17H15ClN4O5S small molecule - - DRUGBANK 20004 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2722 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid - - DRUGBANK DB02840 C19H16N2O6 small molecule - - DRUGBANK 20005 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2722 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid - - DRUGBANK DB02840 C19H16N2O6 small molecule - - DRUGBANK 20006 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2722 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid - - DRUGBANK DB02840 C19H16N2O6 small molecule - - DRUGBANK 23570 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4318 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine - - DRUGBANK DB04505 C20H22ClN5O3 small molecule - - DRUGBANK 25911 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6674 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE - - DRUGBANK DB07877 C18H21BrN6O2S small molecule - - DRUGBANK 22438 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3886 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine - - DRUGBANK DB04054 C18H22FN5O2 small molecule - - DRUGBANK 21993 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3647 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine - - DRUGBANK DB03809 C17H21N5O small molecule - - DRUGBANK 21417 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3359 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine - - DRUGBANK DB03504 C19H24ClN5O3 small molecule - - DRUGBANK 20430 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2951 17-Dmag - - DRUGBANK DB03080 C32H48N4O8 small molecule - - DRUGBANK 20431 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2951 17-Dmag - - DRUGBANK DB03080 C32H48N4O8 small molecule - - DRUGBANK 20432 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2951 17-Dmag - - DRUGBANK DB03080 C32H48N4O8 small molecule - - DRUGBANK 24979 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5777 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE - - DRUGBANK DB06958 C16H20ClN5O3 small molecule - - DRUGBANK 24978 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5776 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL - - DRUGBANK DB06957 C21H23ClN4O4S small molecule - - DRUGBANK 26476 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7218 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- - - DRUGBANK DB08436 C17H19N5O2 small molecule - - DRUGBANK 26598 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7335 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide - - DRUGBANK DB08557 C22H23N3O3 small molecule - - DRUGBANK 25604 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6401 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL - - DRUGBANK DB07594 C20H20N2O4 small molecule - - DRUGBANK 25609 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6407 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol - - DRUGBANK DB07601 C19H20ClN3O4 small molecule - - DRUGBANK 26788 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7560 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE - - DRUGBANK DB08788 C17H15N5O2S small molecule - - DRUGBANK 26789 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7561 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE - - DRUGBANK DB08789 C15H12Cl2N4OS small molecule - - DRUGBANK 25324 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6133 (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one - - DRUGBANK DB07317 C11H11NO2 small molecule - - DRUGBANK 25326 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6135 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE - - DRUGBANK DB07319 C13H10BrN5 small molecule - - DRUGBANK 25524 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6313 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol - - DRUGBANK DB07502 C13H8BrNO4 small molecule - - DRUGBANK 25110 109552 3320 - HSP90AA1 EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5918 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL - - DRUGBANK DB07100 C13H15ClN4O2 small molecule - - DRUGBANK 26331 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7080 (5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE - - DRUGBANK DB08293 C16H17ClO5 small molecule - - DRUGBANK 26516 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7245 METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE - - DRUGBANK DB08464 C18H18ClNO8 small molecule - - DRUGBANK 25603 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6401 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL - - DRUGBANK DB07594 C20H20N2O4 small molecule - - DRUGBANK 19851 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2639 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine - - DRUGBANK DB02754 C19H25N5O3 small molecule - - DRUGBANK 19852 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2639 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine - - DRUGBANK DB02754 C19H25N5O3 small molecule - - DRUGBANK 19853 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2639 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine - - DRUGBANK DB02754 C19H25N5O3 small molecule - - DRUGBANK 26330 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7079 (5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE - - DRUGBANK DB08292 C16H17ClO5 small molecule - - DRUGBANK 26518 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7246 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE - - DRUGBANK DB08465 C18H20ClNO7 small molecule - - DRUGBANK 26065 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6838 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL - - DRUGBANK DB08045 C18H18ClN3O3 small molecule - - DRUGBANK 25910 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6674 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE - - DRUGBANK DB07877 C18H21BrN6O2S small molecule - - DRUGBANK 21876 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3600 Radicicol - - DRUGBANK DB03758 C18H23ClO6 small molecule - - DRUGBANK 26391 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7131 (5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE - - DRUGBANK DB08346 C17H19ClO5 small molecule - - DRUGBANK 19172 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2327 Geldanamycin - - DRUGBANK DB02424 C29H40N2O9 small molecule - 30562-34-6 DRUGBANK 19173 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2327 Geldanamycin - - DRUGBANK DB02424 C29H40N2O9 small molecule - 30562-34-6 DRUGBANK 19174 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2327 Geldanamycin - - DRUGBANK DB02424 C29H40N2O9 small molecule - 30562-34-6 DRUGBANK 26174 109558 3326 RP1-302G2.1 HSP90AB1 D6S182|HSP84|HSP90B|HSPC2|HSPCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6945 (5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE - - DRUGBANK DB08153 C18H21ClO5 small molecule - - DRUGBANK 490 109571 3339 RP11-132G19.2 HSPG2 HSPG|PLC|PRCAN|SJA|SJS|SJS1 9606 Homo sapiens unknown target Iwabuchi T (2006) 16989989 171975 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 491 109571 3339 RP11-132G19.2 HSPG2 HSPG|PLC|PRCAN|SJA|SJS|SJS1 9606 Homo sapiens unknown target Sharma B (1998) 9788974 171973 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 492 109571 3339 RP11-132G19.2 HSPG2 HSPG|PLC|PRCAN|SJA|SJS|SJS1 9606 Homo sapiens unknown target Berman B (1999) 10593896 171966 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 493 109571 3339 RP11-132G19.2 HSPG2 HSPG|PLC|PRCAN|SJA|SJS|SJS1 9606 Homo sapiens unknown target Asada N (2004) 14753849 171974 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 16104 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Rabiner EA (2000) 10942852 181156 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 16105 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Hjorth S (1992) 1468487 181157 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 15252 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Jordan S (2002) 12063084 180791 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15253 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Cosi C (2005) 15862515 180790 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15254 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Jordan S (2004) 14709325 180788 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15255 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Marona-Lewicka D (2004) 14647959 180789 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15256 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Swainston Harrison T (2004) 15257633 180787 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15257 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Jordan S (2002) 12063084 180791 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15258 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cosi C (2005) 15862515 180790 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15259 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Jordan S (2004) 14709325 180788 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15260 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Marona-Lewicka D (2004) 14647959 180789 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15261 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Swainston Harrison T (2004) 15257633 180787 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8343 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Miyazawa T (1991) 1783326 177120 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8344 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Akai T (1991) 1678728 177121 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8345 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Cunningham KA (1987) 2887435 177122 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8346 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Marona-Lewicka D (2002) 12373423 177123 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8347 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kimura K (1991) 11224054 177124 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8348 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15014 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 17377 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cosi C (2001) 11755134 176338 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17378 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Newman-Tancredi A (1998) 9760039 176339 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 9746 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16360 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16361 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Kaumann AJ (1983) 6136920 181260 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 5558 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens inhibitor target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 23936 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target AGHAJANIAN GK (1964) 14209776 181833 4631 Lysergic Acid Diethylamide N,n-diethyllysergamide|Dextrolysergic acid diethylamide|Lysergaure diethylamid|Lysergidum|Lysergide|D-LSD|LSD|Lysergamide|Lysergic acid amide|D-LSD-25|(+)-lysergic acid diethylamide|N,N-Diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide|n,n-diethyl-(+)-lysergamide|(+)-LSD|D-lysergic acid dethylamide|Lysergamid|Diethylamid kyseliny lysergove|N,n-diethyl-d-lysergamide|9,10-Didehydro-N,N-diethyl-6-methylergoline-8b-carboxamide|D-lysergic acid diethylamide|Lysergic acid diethylamide-25|LSD-25|D-lysergic acid n,n-diethylamide - DRUGBANK DB04829 C20H25N3O small molecule - 50-37-3 DRUGBANK 24253 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Micheli F (2001) 16032484 181899 4762 Lesopitron Lesopitran - DRUGBANK DB04970 C15H21ClN6 small molecule - 132449-46-8 DRUGBANK 24254 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Fisas MA (2004) 15331910 181861 4762 Lesopitron Lesopitran - DRUGBANK DB04970 C15H21ClN6 small molecule - 132449-46-8 DRUGBANK 24082 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Auclair AL (2007) 17393144 181998 4688 Bifeprunox Bifeprunoxum|Bifeprunox mesilate - DRUGBANK DB04888 C24H23N3O2 small molecule - 350992-10-8 DRUGBANK 24083 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Newman-Tancredi A (2007) 17659474 182032 4688 Bifeprunox Bifeprunoxum|Bifeprunox mesilate - DRUGBANK DB04888 C24H23N3O2 small molecule - 350992-10-8 DRUGBANK 24084 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Bardin L (2006) 16237379 181914 4688 Bifeprunox Bifeprunoxum|Bifeprunox mesilate - DRUGBANK DB04888 C24H23N3O2 small molecule - 350992-10-8 DRUGBANK 27913 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Maeda K (2014) 24947465 196021 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 27914 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Maeda K (2014) 24947465 196021 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 27901 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Bang-Andersen B (2011) 21486038 196006 8112 Vortioxetine 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation brintellix|trintellix DRUGBANK DB09068 C18H23N2S small molecule N06AX26 508233-74-7 DRUGBANK 7329 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cosi C (2001) 11755134 176338 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7330 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Newman-Tancredi A (1998) 9760039 176339 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 27682 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Borsini F (2002) 12177684 181800 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 27683 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Invernizzi RW (2003) 12890707 181826 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 27806 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Deeks ED (2015) 26412054 196031 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 9976 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 11244 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Kuipers W (1997) 9145928 178774 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11245 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Darmani NA (1993) 8392199 178775 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11246 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Millan MJ (1992) 1323650 178776 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 11247 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Misane I (1998) 9806333 178777 856 Alprenolol (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo - DRUGBANK DB00866 C15H23NO2 small molecule C07AA01 13655-52-2 DRUGBANK 12294 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Haddjeri N (1999) 10331108 179344 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12295 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Andree B (1999) 10435400 179345 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12296 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Fornal CA (1999) 10490909 179342 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12297 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Smeraldi E (1999) 10088139 179343 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12298 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Gobert A (1999) 10432475 179341 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12299 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 24206 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Bobo WV (2013) 23272794 182224 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 13266 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13267 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13268 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13269 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 12506 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens binder target Weber JT (1997) 9185324 179520 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12507 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens binder target Toll L (1998) 9686407 176206 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 7126 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens activator target Haddjeri N (1998) 9822768 176221 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 15551 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5716 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 8140 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Smejkal-Jagar L (1995) 7759768 176961 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 5459 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 9060 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Odagaki Y (2005) 15888508 177596 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9061 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Subhash MN (2002) 12127910 177595 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9062 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Cusack B (1994) 7855217 175183 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9227 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 15072 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Ichikawa J (2002) 12445705 174617 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15073 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15074 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target McIntyre RS (2007) 17563257 180713 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15075 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Wood MD (2006) 16918396 174636 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15076 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 7846 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 14248 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens binder target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14597 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14598 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 11570 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target van Wijngaarden I (1990) 2164935 178972 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 4377 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 9896 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 14152 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Maj J (1977) 309138 180335 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14153 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14218 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 24452 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24453 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 4960 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4826 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4827 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4828 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4785 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Skyba DA (2003) 14581123 174652 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4786 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Scrogin KE (2000) 11049861 174651 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4787 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Sugimoto Y (2003) 14501155 174650 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4788 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Sugimoto Y (2003) 14517765 174648 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4789 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Pranzatelli MR (1991) 1838579 174649 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 24323 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 24324 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Scheller D (2009) 18704368 182084 5046 Rotigotine (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol neupro DRUGBANK DB05271 C19H25NOS small molecule N04BC09 99755-59-6 DRUGBANK 7453 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Osei-Owusu P (2004) 14769835 176457 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7454 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Rehman J (1999) 10064829 176456 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7455 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target de Boer SF (1999) 10027850 176455 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7456 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Becker C (1999) 10221756 176454 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7457 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7458 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Liang KC (1999) 10215901 176459 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 7459 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target Dupuis DS (1999) 10428422 176458 482 Buspirone Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione ftp-buspirone|pms-buspirone|ri DRUGBANK DB00490 C21H31N5O2 small molecule N05BE01 36505-84-7 DRUGBANK 17349 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cosi C (2001) 11755134 176338 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17350 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Newman-Tancredi A (1998) 9760039 176339 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17356 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Nguyen TV (1989) 2586632 181591 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 17355 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Coelho AM (2001) 11697552 181590 1554 Alverine N-Ethyl-N-(3-phenylpropyl)benzenepropanamine|N-Ethyl-3,3'-diphenyldipropylamine|N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine|Bis(gamma-phenylpropyl)ethylamine|N,N-Bis(3-phenylpropyl)ethylamine|Di(phenylpropyl)ethylamine|Alverinum|Phenopropamine|Alverina|Phenpropamine - DRUGBANK DB01616 C20H27N small molecule A03AX58|A03AX08 150-59-4 DRUGBANK 14798 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14799 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 17400 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Cosi C (2001) 11755134 176338 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17401 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Newman-Tancredi A (1998) 9760039 176339 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 26863 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 7585 Lurasidone Lurasidona|Lurasidonum latuda DRUGBANK DB08815 C28H36N4O2S small molecule N05AE05 367514-87-2 DRUGBANK 12229 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Boers PM (2004) 14728705 179304 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12230 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 26830 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Alarcon-de-la-Lastra Romero C (1997) 9211565 181721 7581 Cinitapride Paxapride - DRUGBANK DB08810 C21H30N4O4 small molecule - 66564-14-5 DRUGBANK 26831 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Alarcon de la Lastra C (1998) 9562338 181726 7581 Cinitapride Paxapride - DRUGBANK DB08810 C21H30N4O4 small molecule - 66564-14-5 DRUGBANK 24628 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Page ME (2002) 12183683 181802 5571 Vilazodone Vilazodona|Vilazodonum viibryd DRUGBANK DB06684 C26H27N5O2 small molecule N06AX24 163521-12-8 DRUGBANK 24629 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Adamec R (2004) 15507223 181869 5571 Vilazodone Vilazodona|Vilazodonum viibryd DRUGBANK DB06684 C26H27N5O2 small molecule N06AX24 163521-12-8 DRUGBANK 27820 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens partial agonist target McCormack PL (2015) 26510944 196034 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 27821 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target McCormack PL (2015) 26510944 196034 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 6000 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Tomic M (2004) 15261283 175517 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6004 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Hagino Y (2002) 12564641 175518 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6002 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Newman-Tancredi A (2003) 12923612 174630 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6003 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Chou YH (2003) 12589516 175519 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6001 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Zahorodna A (2004) 15213359 175520 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6651 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6652 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 7896 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens antagonist target Gozlan H (1991) 1666997 176778 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 26801 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Haddjeri N (1999) 10331108 179344 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26802 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Andree B (1999) 10435400 179345 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26803 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Fornal CA (1999) 10490909 179342 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26804 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Smeraldi E (1999) 10088139 179343 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26805 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Gobert A (1999) 10432475 179341 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26806 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 9597 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Bigal ME (2003) 12525272 177883 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 27769 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Schmidt AW (2001) 11513838 195953 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27565 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Wilner KD (2002) 11910268 174629 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27566 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Sprouse JS (1999) 10516958 174631 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27567 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Newman-Tancredi A (2003) 12923612 174630 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27568 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Stahl SM (2004) 14728084 174620 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27564 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Richelson E (2000) 11132243 174623 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27569 109582 3350 - HTR1A 5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD 9606 Homo sapiens agonist target Rollema H (2000) 10924666 174632 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 16126 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Hjorth S (1993) 8098761 181159 1322 Penbutolol Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol - DRUGBANK DB01359 C18H29NO2 small molecule C07AA23|C07CA23 38363-40-5 DRUGBANK 15218 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8337 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15012 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 9734 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16352 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16353 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Kaumann AJ (1983) 6136920 181260 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 12625 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Easthope SE (2001) 11735616 179593 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12626 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Deleu D (2000) 10883409 179597 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12627 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Parsons AA (1998) 9700983 179596 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12628 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Elkind AH (2004) 15342617 179595 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12629 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Balbisi EA (2004) 15311727 179594 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12630 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12631 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Buchan P (2002) 12028322 179598 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12632 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Dodick DW (2006) 17190530 179602 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12633 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Markus F (2007) 18001261 179601 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12634 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Balbisi EA (2006) 18360605 179600 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12635 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Comer MB (2002) 12028320 179599 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12636 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 5517 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens binder target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 4725 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27899 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens partial agonist target Bang-Andersen B (2011) 21486038 196006 8112 Vortioxetine 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation brintellix|trintellix DRUGBANK DB09068 C18H23N2S small molecule N06AX26 508233-74-7 DRUGBANK 12312 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Dawson LA (2000) 10727715 179355 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12313 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Herrick-Davis K (1988) 3141589 179357 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12314 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Leonhardt S (1989) 2664084 179356 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12315 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Ariani K (1989) 2512511 179359 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 12316 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Terron JA (1994) 7944828 179358 950 Pindolol Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol apo-pindol tab 5mg|teva-pindol DRUGBANK DB00960 C14H20N2O2 small molecule C07CA03|C07AA03 13523-86-9 DRUGBANK 6640 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6641 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 5512 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Villalon CM (2004) 14744615 175174 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5513 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Yu XJ (1996) 8622623 175177 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5511 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Buzzi MG (1991) 1660351 175180 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5515 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Pauwels PJ (1998) 9650800 175178 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5514 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Willems EW (1999) 10455274 175179 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 13234 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13235 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13236 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13237 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5648 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5466 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target de Almeida RM (2001) 11594437 175130 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5468 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Reuter U (2004) 15096229 175126 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5469 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Le Grand B (2000) 10844127 175127 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5470 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Whale R (1999) 10463324 175124 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5473 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Hargreaves RJ (1999) 10563228 175125 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5472 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Gowin JL (2010) 20407761 175128 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5467 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Pascual J (1998) 9859690 175129 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5474 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5471 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Martin GR (1997) 9399012 175123 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5475 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 9236 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Mitsikostas DD (2002) 12110114 177691 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9237 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9238 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Nikai T (2008) 18723285 177683 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9239 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Cohen ML (1999) 10454495 177682 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9240 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Granaes C (1999) 10513577 177696 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9241 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Cohen Z (1999) 10458598 177697 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9242 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Razzaque Z (2002) 11874390 177687 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9243 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Akin D (2002) 12010765 177686 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9244 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Roy A (2000) 10772044 177685 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9245 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Mitsikostas DD (1999) 10225363 177688 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9246 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Dupuis DS (1999) 10101238 177698 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 15033 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14584 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14585 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 11586 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target van Wijngaarden I (1990) 2164935 178972 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 4366 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4367 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4368 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Lambert GA (2002) 12384251 174445 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4369 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Napier C (1999) 10193663 174442 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4370 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Knyihar-Csillik E (2000) 11069595 174443 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4371 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target van den Broek RW (2000) 11050304 174441 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 8154 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Bailey SR (1998) 9760032 176970 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 8155 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Choppin A (1995) 7881730 176969 561 Propranolol Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol nu-propranolol tab 120mg|heman DRUGBANK DB00571 C16H21NO2 small molecule C07BA05|C07AA05|C07FA05 525-66-6 DRUGBANK 24439 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24440 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 4952 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4807 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4808 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4777 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens binder target Matsumoto I (1992) 1738111 174640 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 14784 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14785 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 11901 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Fleishaker JC (2000) 10824628 179089 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11902 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11903 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Bou J (2000) 11134654 179087 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11904 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Napier C (1999) 10193663 174442 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11905 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Knyihar-Csillik E (2000) 11069595 174443 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11906 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target van den Broek RW (2000) 11050304 174441 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 12238 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Hoskin KL (2004) 14725972 179299 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12239 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Akin D (2002) 12010764 179302 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12240 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Dulli DA (1999) 10410185 179300 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12241 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Johnston MM (2010) 20687618 179301 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12242 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Lambert GA (2006) 16389295 179306 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12243 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Boers PM (2004) 14728705 179304 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12244 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Massiou H (2002) 12463278 179305 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12245 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Pauwels PJ (1998) 9650800 175178 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12246 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12247 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12262 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Wellington K (2002) 12269863 179311 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12263 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Ikemoto F (2004) 15056946 179310 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12264 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12265 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Williamson DJ (2001) 11487512 179315 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12266 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Wellington K (2002) 12093318 179314 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12267 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Pauwels PJ (1998) 9650800 175178 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12268 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Wackenfors A (2005) 15821444 174449 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 5969 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7865 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens antagonist target Gozlan H (1991) 1666997 176778 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 26820 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Dawson LA (2000) 10727715 179355 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26821 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Herrick-Davis K (1988) 3141589 179357 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26822 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Leonhardt S (1989) 2664084 179356 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26823 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Ariani K (1989) 2512511 179359 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 26824 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens unknown target Terron JA (1994) 7944828 179358 7578 Bopindolol Sandonorm - DRUGBANK DB08807 C23H28N2O3 small molecule C07AA17|C07CA17 62658-63-3 DRUGBANK 9588 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Willems EW (1999) 10455274 175179 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9589 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Villalon CM (1999) 10188968 177882 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9590 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Valdivia LF (2004) 15224175 177881 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9591 109583 3351 - HTR1B 5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12 9606 Homo sapiens agonist target Cohen ML (2000) 11015308 177695 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 15237 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8349 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15011 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 9747 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16362 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Millan MJ (2000) 10611634 181251 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 12614 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Easthope SE (2001) 11735616 179593 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12615 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Deleu D (2000) 10883409 179597 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12616 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Parsons AA (1998) 9700983 179596 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12617 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Elkind AH (2004) 15342617 179595 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12618 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Balbisi EA (2004) 15311727 179594 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12619 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Comer MB (2002) 12028320 179599 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12620 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Buchan P (2002) 12028322 179598 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12621 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Jaehnichen S (2004) 15185063 174447 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12622 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Balbisi EA (2006) 18360605 179600 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12623 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 12624 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 988 Frovatriptan Frovatriptan succinate|Allergo filmtabletten teva-frovatriptan|frovatriptan DRUGBANK DB00998 C14H17N3O small molecule N02CC07 158747-02-5 DRUGBANK 5560 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens binder target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 4767 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Seeger TF (1995) 7562537 174627 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4768 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Sprouse JS (1999) 10516958 174631 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4769 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4770 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Stahl SM (2004) 14728084 174620 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4771 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Wilner KD (2002) 11910268 174629 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 15555 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5501 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5502 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Buzzi MG (1992) 1379707 175175 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5503 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Villalon CM (2004) 14744615 175174 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5504 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Silberstein SD (2003) 12558771 175176 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5505 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Buzzi MG (1992) 1324091 175171 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5506 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Lesage AS (1998) 9605573 175173 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5507 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Hoyer D (1992) 1407010 175172 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 13230 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13231 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13232 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13233 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5734 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5449 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Martin GR (1997) 9399012 175123 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5450 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Reuter U (2004) 15096229 175126 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5451 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Le Grand B (2000) 10844127 175127 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5452 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Whale R (1999) 10463324 175124 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5453 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Hargreaves RJ (1999) 10563228 175125 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5454 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5455 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Pascual J (1998) 9859690 175129 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5456 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target de Almeida RM (2001) 11594437 175130 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5457 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5458 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Gowin JL (2010) 20407761 175128 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 9216 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Mitsikostas DD (2002) 12110114 177691 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9217 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9218 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Zohar J (2004) 15554784 177690 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9219 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Nikai T (2008) 18723285 177683 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9220 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Cohen ML (1999) 10454495 177682 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9221 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Roy A (2000) 10772044 177685 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9222 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Baxter LR (2001) 11641558 177684 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9223 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Razzaque Z (2002) 11874390 177687 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9224 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Akin D (2002) 12010765 177686 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9225 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Koran LM (2001) 11313163 177689 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9226 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Mitsikostas DD (1999) 10225363 177688 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 15061 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens unknown target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15062 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens unknown target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14602 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14603 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 4380 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4381 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Johnson DE (2001) 11513839 174444 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4382 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Napier C (1999) 10193663 174442 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4383 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Strijbos PJ (2002) 12498013 174450 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4384 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4385 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Wackenfors A (2005) 15821444 174449 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 9905 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 6006 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4963 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4838 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4839 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 14803 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14804 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 11897 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Gras J (2001) 11642004 179088 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11898 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11899 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Napier C (1999) 10193663 174442 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 11900 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Bou J (2000) 11134654 179087 908 Almotriptan 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine axert 12.5mg|sandoz almotripta DRUGBANK DB00918 C17H25N3O2S small molecule N02CC05 154323-57-6 DRUGBANK 12217 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Pauwels PJ (1996) 8741180 179298 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12218 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Hoskin KL (2004) 14725972 179299 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12219 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Hargreaves RJ (1999) 10563228 175125 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12220 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Akin D (2002) 12010764 179302 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12221 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Donaldson C (2002) 11897116 179303 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12222 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Dulli DA (1999) 10410185 179300 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12223 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Johnston MM (2010) 20687618 179301 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12224 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Lambert GA (2006) 16389295 179306 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12225 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Boers PM (2004) 14728705 179304 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12226 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Massiou H (2002) 12463278 179305 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12227 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12228 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12248 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Longmore J (1996) 8904614 179309 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12249 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Wellington K (2002) 12269863 179311 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12250 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Ikemoto F (2004) 15056946 179310 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12251 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Sciberras DG (1997) 9056052 179313 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12252 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Longmore J (1997) 9127118 179312 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12253 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Williamson DJ (2001) 11487512 179315 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12254 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Wellington K (2002) 12093318 179314 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12255 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12256 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Wackenfors A (2005) 15821444 174449 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 9981 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 6656 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6657 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 9602 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Sanchez-Lopez A (2003) 14504136 177887 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9603 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Lovenberg TW (1993) 8384716 177886 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9604 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Silberstein SD (2003) 12558771 175176 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9605 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Deliganis AV (1991) 1646776 177888 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9606 109584 3352 - HTR1D 5-HT1D|HT1DA|HTR1DA|HTRL|RDC4 9606 Homo sapiens agonist target Hoyer D (1992) 1407010 175172 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 15041 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens unknown target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15223 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15013 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 4375 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4376 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 5977 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 13210 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13211 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13212 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13213 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5659 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 4734 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4791 109586 3354 - HTR1E 5-HT1E 9606 Homo sapiens binder target Adham N (1993) 8380639 174641 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 5460 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Wainscott DB (1998) 9718276 175131 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5461 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Villalon CM (2002) 12434581 175133 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5462 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Villalon CM (2003) 15320857 175132 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5463 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Reuter U (2004) 15096229 175126 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5464 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 5465 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Bhalla P (2002) 11834243 174446 308 Zolmitriptan Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90 sandoz zolmitriptan odt|mar-zo DRUGBANK DB00315 C16H21N3O2 small molecule N02CC03 139264-17-8 DRUGBANK 15010 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 4372 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Bhalla P (2002) 11834243 174446 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4373 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Jaehnichen S (2004) 15185063 174447 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4374 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Napier C (1999) 10193663 174442 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 12231 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Villalon CM (2002) 12434581 175133 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12232 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Villalon CM (2003) 15320857 175132 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12233 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Hoskin KL (2004) 14725972 179299 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12234 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12235 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Goadsby PJ (2003) 14614913 179307 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12236 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Massiou H (2002) 12463278 179305 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12237 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Tfelt-Hansen P (2000) 11152011 174448 942 Naratriptan N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum teva-naratriptan|naratriptan|s DRUGBANK DB00952 C17H25N3O2S small molecule N02CC02 121679-13-8 DRUGBANK 12257 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Wainscott DB (1998) 9718276 175131 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12258 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Villalon CM (2002) 12434581 175133 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12259 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Villalon CM (2003) 15320857 175132 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12260 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 12261 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Goadsby PJ (2003) 14614913 179307 943 Rizatriptan Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn maxalt|ipg-rizatriptan|jamp-ri DRUGBANK DB00953 C15H19N5 small molecule N02CC04 144034-80-0 DRUGBANK 13250 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13251 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13252 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13253 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 4778 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens binder target Adham N (1993) 8380639 174641 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 9592 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Bigal ME (2003) 12525272 177883 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9228 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9229 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Janssen P (2004) 15178373 177692 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9230 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Pauwels PJ (1999) 10367177 177693 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9231 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Nikai T (2008) 18723285 177683 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9232 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Mitsikostas DD (2002) 12110114 177691 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9233 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Razzaque Z (1999) 10073743 177694 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9234 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Cohen ML (2000) 11015308 177695 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 9235 109587 3355 - HTR1F 5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77 9606 Homo sapiens agonist target Mitsikostas DD (1999) 10225363 177688 659 Sumatriptan Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan phl-sumatriptan|sumavel dosepr DRUGBANK DB00669 C14H21N3O2S small molecule N02CC01 103628-46-2 DRUGBANK 15279 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Antkiewicz-Michaluk L (1986) 3774629 180795 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15280 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Wander TJ (1987) 2891550 180794 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 10075 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Dupont LJ (1996) 8836655 178183 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 10076 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Dupont LJ (1999) 10596692 178184 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 8340 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8341 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Egan CT (1998) 9600588 177119 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15016 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 8530 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Cushing DJ (1993) 8423526 177216 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8531 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Beubler E (1990) 1969947 177217 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8532 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Nieto JE (2000) 11131599 177218 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 9426 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Morisset S (1999) 9918563 177779 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9427 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Andree TH (1986) 2866233 177778 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9428 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Burki HR (1986) 2423886 177780 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9429 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Canton H (1994) 7898773 177777 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 9430 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Costall B (1995) 8680734 177781 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 15220 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Stark AD (2007) 17242925 174634 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15221 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Meltzer HY (2003) 14642974 180780 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 15222 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Bortolozzi A (2007) 17265076 180781 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 7093 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Zanoveli JM (2005) 16170231 176205 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7094 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 9769 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Bixo M (2001) 11403977 178000 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9770 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Meyer JH (2001) 11136637 177999 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 16356 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kaumann AJ (1983) 6136920 181260 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16357 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Baxter GS (1994) 8032658 181261 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 10353 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10354 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5518 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 4727 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Mamo D (2004) 15121646 174622 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4728 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Stahl SM (2004) 14728084 174620 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4729 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Mansbach RS (2001) 11509214 174621 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4730 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Ichikawa J (2002) 12445705 174617 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4731 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4732 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Lu BY (2002) 12530423 174619 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4733 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kast RE (2007) 17450180 174618 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27918 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Maeda K (2014) 24947465 196021 7873 Brexpiprazole - rexulti DRUGBANK DB09128 C25H27N3O2S small molecule N05AX16 913611-97-9 DRUGBANK 7569 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Leysen JE (1994) 7520908 175510 494 Haloperidol 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol apo-haloperidol tab 2mg|halope DRUGBANK DB00502 C21H23ClFNO2 small molecule N05AD01 52-86-8 DRUGBANK 7321 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yamada J (1995) 8593484 176333 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7322 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kusumi I (2000) 10821438 176334 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7324 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens binder target Roth BL (1994) 7908055 176335 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 11056 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Hayslett RL (2003) 14643839 178651 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 11057 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Hayslett RL (2005) 16045972 178650 833 Donepezil Donepezilo|Domepezil|Donepezilum|Donepezil donepezil hydrochloride 10mg|b DRUGBANK DB00843 C24H29NO3 small molecule N06DA02|N06DA53|N06DA52 120014-06-4 DRUGBANK 10691 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Biziere K (1985) 3836113 178465 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10692 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Muramatsu M (1988) 2975224 178466 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10693 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kodama K (1992) 1361012 178467 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10694 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nabeshima T (1989) 2530096 178468 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 13458 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kelley BM (1997) 9258998 179979 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13459 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Fiorella D (1995) 8584617 179978 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13460 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Hoenicke EM (1992) 1403790 176036 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13461 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Martinez F (1990) 2329012 179977 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 13462 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Bileviciute I (1998) 9863661 179976 1057 Promethazine Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine promethazine hcl, phenylephrin DRUGBANK DB01069 C17H20N2S small molecule R06AD52|V03AB05|D04AA10|R06AD02 60-87-7 DRUGBANK 26834 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Alarcon-de-la-Lastra Romero C (1997) 9211565 181721 7581 Cinitapride Paxapride - DRUGBANK DB08810 C21H30N4O4 small molecule - 66564-14-5 DRUGBANK 26835 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Alarcon de la Lastra C (1998) 9562338 181726 7581 Cinitapride Paxapride - DRUGBANK DB08810 C21H30N4O4 small molecule - 66564-14-5 DRUGBANK 24204 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Hesselink JM (2002) 12861482 181824 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 24205 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kongsamut S (1996) 8997630 181714 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 24558 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Tyson PJ (2004) 15204055 181851 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 13238 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13239 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13240 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13241 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13550 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Beattie DT (2004) 15466450 180017 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 27686 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Borsini F (2002) 12177684 181800 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 27687 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Invernizzi RW (2003) 12890707 181826 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 27808 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Deeks ED (2015) 26412054 196031 4708 Flibanserin BIMT-17-BS|BIMT-17 addyi DRUGBANK DB04908 C20H21F3N4O small molecule G02CX02 167933-07-5 DRUGBANK 9744 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 15545 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Megens AA (1994) 7531353 178096 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15546 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15547 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yamada Y (2002) 12211096 180926 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15548 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target He H (1995) 7542676 180927 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15549 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cohen LJ (1994) 7524043 180924 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 15550 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 5650 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5651 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5652 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yatham LN (2005) 16038601 175308 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5653 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target McDonald LM (2003) 14530903 175309 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5654 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Padin JF (2006) 16905159 175306 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5655 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Moresco RM (2004) 15358979 175307 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5656 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5657 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Sharpley AL (2005) 15816787 175305 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5658 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6617 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Seeman P (1997) 9015795 175886 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6601 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Li Z (2003) 12664192 175875 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 17411 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yamada J (1995) 8593484 176333 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 17412 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kusumi I (2000) 10821438 176334 1560 Thiothixene Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum navane capsules 10mg|thiothixe DRUGBANK DB01623 C23H29N3O2S2 small molecule N05AF04 3313-26-6 DRUGBANK 11956 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Honda M (2003) 12498911 176034 914 Cyclobenzaprine Cyclobenzaprinum|N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-5,-propylamine|(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine|Cyclobenzaprine|Ciclobenzaprina|N,N-Dimethyl-5H-dibenzo(a,D)cycloheptene-delta(5,gamma)-propylamine flexeril -(10mg)|jamp-cyclob DRUGBANK DB00924 C20H21N small molecule M03BX08 303-53-7 DRUGBANK 11957 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kobayashi H (1996) 8884233 179125 914 Cyclobenzaprine Cyclobenzaprinum|N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-5,-propylamine|(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine|Cyclobenzaprine|Ciclobenzaprina|N,N-Dimethyl-5H-dibenzo(a,D)cycloheptene-delta(5,gamma)-propylamine flexeril -(10mg)|jamp-cyclob DRUGBANK DB00924 C20H21N small molecule M03BX08 303-53-7 DRUGBANK 16743 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Nash JF (1994) 7824160 181437 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16744 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Lyon RA (1986) 2871581 181436 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 6128 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Laakmann G (1999) 10451911 175614 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6129 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nutt DJ (1999) 10446738 175615 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6130 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Gorman JM (1999) 10446735 175616 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6131 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Westenberg HG (1999) 10446734 175617 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6132 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Waldinger MD (2000) 11063897 175613 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6133 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Anttila SA (2001) 11607047 175618 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 9054 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Pazzagli M (1999) 10594316 177591 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9055 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Marcoli M (2001) 11714900 177590 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9056 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Conn PJ (1987) 3039120 177593 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9057 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Marek GJ (1992) 1365657 177592 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9058 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Luparini MR (2004) 15610924 177594 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9059 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 16704 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Fleckenstein AE (2007) 17209801 174169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16705 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16706 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16707 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Haughey HM (2000) 10987842 177998 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16708 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kokoshka JM (1998) 9666084 181422 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 15036 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15037 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target McIntyre RS (2007) 17563257 180713 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15038 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15039 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yatham LN (2005) 16038601 175308 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15040 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Goldstein JM (1999) 12973385 175507 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14244 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14591 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14592 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Cussac D (2008) 18703043 159118 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14593 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 15315 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Hentall ID (2000) 10682715 180815 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15316 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Sargent PA (1998) 9862411 180814 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15317 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Sugimoto Y (2003) 14501155 174650 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15318 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Contreras CM (1992) 1296670 180812 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15319 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Trifunovic RD (1996) 8558452 180813 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 9893 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 14107 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Maj J (1977) 309138 180335 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14108 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14109 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14210 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14211 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Davis R (1997) 9098663 180357 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14212 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Meyer JH (1999) 10435395 180364 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14213 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Avila A (2003) 14520130 180365 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14214 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Eckler JR (2003) 12873632 180366 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14215 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Taylor DP (1995) 7649970 180360 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14216 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Hidalgo R (1999) 10220119 180362 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14217 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Horton JC (1999) 10577608 180363 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 24447 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24448 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24449 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5971 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Heiser P (2004) 14751426 175508 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5972 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Broderick PA (2004) 14687870 175509 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5973 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target McDonald LM (2003) 14530903 175309 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5974 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Goldstein JM (1999) 12973385 175507 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5975 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Reist C (2004) 15037867 175511 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5976 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Leysen JE (1994) 7520908 175510 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4958 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 12041 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Rauser L (2001) 11561066 179175 923 Mesoridazine 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina serentil tab 25mg|serentil tab DRUGBANK DB00933 C21H26N2OS2 small molecule N05AC03 5588-33-0 DRUGBANK 12042 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Choi S (2004) 15357957 179174 923 Mesoridazine 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina serentil tab 25mg|serentil tab DRUGBANK DB00933 C21H26N2OS2 small molecule N05AC03 5588-33-0 DRUGBANK 12043 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Herrick-Davis K (2000) 10991983 175882 923 Mesoridazine 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina serentil tab 25mg|serentil tab DRUGBANK DB00933 C21H26N2OS2 small molecule N05AC03 5588-33-0 DRUGBANK 4817 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4818 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Sharif NA (2010) 20426763 174666 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4819 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4820 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4779 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Shaw AM (2000) 11061982 174644 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4780 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Prins NH (2001) 11704657 174645 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4781 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Connor JD (2001) 11720080 174646 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4782 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Geerts IS (1999) 10455282 174642 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4783 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Castilho VM (1999) 10080233 174643 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 17420 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nyberg S (1995) 8748043 181608 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17421 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Gjerden P (2009) 19644682 181609 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17422 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Khalifa AE (2003) 12957216 181606 1561 Zuclopenthixol Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol clopixol tablets 25mg|clopixol DRUGBANK DB01624 C22H25ClN2OS small molecule N05AF05 53772-83-1 DRUGBANK 17363 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Nguyen TV (1989) 2586632 181591 1555 Molindone Molindona|Molindonum|Molindone|(+-)-molindone|Moban molindone hydrochloride DRUGBANK DB01618 C16H24N2O2 small molecule N05AE02 7416-34-4 DRUGBANK 24375 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Hietala J (2001) 11594443 181778 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24376 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Lindstroem E (2006) 16925508 181962 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24377 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Schreiber R (1994) 7530204 181683 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 27001 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Svartengren J (1990) 2154737 181647 7667 Amperozide - - DRUGBANK DB08927 C23H29F2N3O small molecule - 75558-90-6 DRUGBANK 24389 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Grinshpoon A (2000) 11004734 181762 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 16812 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Su TP (2009) 19278957 181451 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 16813 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Pierce PA (1989) 2540505 181452 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 17347 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yamada J (1995) 8593484 176333 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 17348 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kusumi I (2000) 10821438 176334 1552 Acepromazine Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone - DRUGBANK DB01614 C19H22N2OS small molecule N05AA04 61-00-7 DRUGBANK 23760 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Nakamura K (2001) 11412837 181773 4408 Aniracetam 1-P-ANISOYL-2-PYRROLIDINONE - DRUGBANK DB04599 C12H13NO3 small molecule N06BX11 72432-10-1 DRUGBANK 14792 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14793 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Cussac D (2008) 18703043 159118 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14794 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 17398 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yamada J (1995) 8593484 176333 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17399 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kusumi I (2000) 10821438 176334 1559 Thioproperazine Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina majeptil tab 10mg DRUGBANK DB01622 C22H30N4O2S2 small molecule N05AB08 316-81-4 DRUGBANK 17387 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Yamada J (1995) 8593484 176333 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 17388 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Kusumi I (2000) 10821438 176334 1558 Pipotiazine Pipotiazina|Piportil|Pipothiazine|Pipotiazinum piportil l4 DRUGBANK DB01621 C24H33N3O3S2 small molecule N05AC04 39860-99-6 DRUGBANK 26862 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 7585 Lurasidone Lurasidona|Lurasidonum latuda DRUGBANK DB08815 C28H36N4O2S small molecule N05AE05 367514-87-2 DRUGBANK 11334 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Reimold M (2007) 17111172 178827 865 Flupentixol Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo fluanxol depot inj 20mg/ml|flu DRUGBANK DB00875 C23H27F3N2OS small molecule N05AF01 2709-56-0 DRUGBANK 27366 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens inverse agonist target Friedman JH (2013) 24016069 188512 5086 Pimavanserin - - DRUGBANK DB05316 C25H34FN3O2 small molecule - 706779-91-1 DRUGBANK 23993 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Schotte A (1996) 8935801 181713 4644 Fluspirilene Fluspirileno|Fluspirilenum|Imap imap forte inj 10mg/ml|imap in DRUGBANK DB04842 C29H31F2N3O small molecule N05AG01 1841-19-6 DRUGBANK 27026 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Wander TJ (1986) 3816971 181668 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27027 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Tatsumi M (1997) 9537821 174430 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27028 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27818 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target McCormack PL (2015) 26510944 196034 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 9974 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Keks NA (1999) 15992090 178094 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9973 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Fenton C (2005) 15907153 178092 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9975 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Uchida S (2007) 17316700 175303 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9972 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 6647 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6648 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 7867 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Paelvimaeki EP (1996) 8876023 176222 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 6731 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6732 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Govitrapong P (2002) 12106771 175942 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6733 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6734 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Govitrapong P (2000) 10980325 175943 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 7844 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 27875 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens inverse agonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 6906 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Calka O (2006) 16418149 176035 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 6907 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Honda M (2003) 12498911 176034 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 6908 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Rashid M (2002) 12233819 176037 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 6909 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Hoenicke EM (1992) 1403790 176036 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 6910 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Callaway CW (1992) 1358088 176033 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 12057 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens binder target Peroutka SJ (1981) 7221567 179185 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 16472 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 9594 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Bom AH (1989) 2758221 177885 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9595 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Panconesi A (1994) 8014033 177884 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9596 109588 3356 RP11-147L20.2 HTR2A 5-HT2A|HTR2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 15281 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15282 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 8342 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15017 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 9745 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16358 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Bonhaus DW (1997) 9225287 181262 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16359 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Baxter GS (1994) 8032658 181261 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 7596 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7597 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7598 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 7599 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Cooper M (1979) 497523 176564 499 Triflupromazine Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine - DRUGBANK DB00508 C18H19F3N2S small molecule N05AA05 146-54-3 DRUGBANK 15320 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Sargent PA (1998) 9862411 180814 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15321 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Sugimoto Y (2003) 14501155 174650 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15322 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Contreras CM (1992) 1296670 180812 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 5509 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Schaerlinger B (2003) 12970106 157246 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 5510 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 313 Dihydroergotamine Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman migranal nasal spray 4mg/ml|di DRUGBANK DB00320 C33H37N5O5 small molecule N02CA01|N02CA51 511-12-6 DRUGBANK 10695 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10697 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Muramatsu M (1988) 2975224 178466 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10696 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Kodama K (1992) 1361012 178467 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10699 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10698 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 6649 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6650 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 27876 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens inverse agonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 13242 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13243 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13244 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13245 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5692 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 16745 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Lyon RA (1986) 2871581 181436 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 6134 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens binder target Millan MJ (2000) 10762339 175610 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6135 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6136 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens binder target de Boer T (1996) 8636062 175619 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6137 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens binder target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 14594 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14595 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Cussac D (2008) 18703043 159118 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14596 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 7325 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens binder target Roth BL (1994) 7908055 176335 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 4386 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4387 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 14137 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Maj J (1977) 309138 180335 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14138 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 8187 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Rothman RB (2000) 11104741 176990 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8188 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Fitzgerald LW (2000) 10617681 176985 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8189 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Blanpain C (2003) 14659797 176987 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8190 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Setola V (2003) 12761331 176986 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8191 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Roth BL (2007) 17202450 176989 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8192 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Kaumann AJ (2006) 16960982 176988 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 24450 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24451 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 4959 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4821 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4822 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Sharif NA (2010) 20426763 174666 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4823 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Huang XP (2009) 19570945 174667 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4824 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4825 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4784 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Schmuck K (1996) 8743744 174647 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 14795 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14796 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Cussac D (2008) 18703043 159118 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14797 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 13551 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Beattie DT (2004) 15466450 180017 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13552 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Greenwood-Van Meerveld B (2006) 16629860 180023 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13553 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target McCullough JL (2006) 16495076 180022 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 27819 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target McCormack PL (2015) 26510944 196034 7764 Cariprazine trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride vraylar DRUGBANK DB06016 C21H32Cl2N4O small molecule N05AX15 839712-12-8 DRUGBANK 7885 109589 3357 - HTR2B 5-HT(2B)|5-HT2B 9606 Homo sapiens antagonist target Glusa E (2000) 10821800 176783 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 15287 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15288 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1227 Chlorprothixene Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine - DRUGBANK DB01239 C18H18ClNS small molecule N05AF03 113-59-7 DRUGBANK 15265 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8356 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 8357 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Egan CT (1998) 9600588 177119 579 Lisuride N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida - DRUGBANK DB00589 C20H26N4O small molecule G02CB02|N02CA07 18016-80-3 DRUGBANK 15015 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Martin LL (1982) 6460944 180704 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 9757 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 16369 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Kaumann AJ (1983) 6136920 181260 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16370 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Baxter GS (1994) 8032658 181261 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 10367 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 10368 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 767 Propiomazine 10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum - DRUGBANK DB00777 C20H24N2OS small molecule N05CM06 362-29-8 DRUGBANK 5562 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens binder target Di Matteo V (2001) 11339973 175199 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 4772 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Seeger TF (1995) 7562537 174627 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4773 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Sanchez C (2000) 11103883 174637 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4774 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Wood MD (2006) 16918396 174636 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4775 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4776 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Stahl SM (2004) 14728084 174620 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 15560 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1254 Paliperidone Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone invega|mylan-paliperidone|pali DRUGBANK DB01267 C23H27FN4O3 small molecule N05AX13 144598-75-4 DRUGBANK 7323 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens binder target Roth BL (1994) 7908055 176335 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 10702 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10704 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Muramatsu M (1988) 2975224 178466 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10703 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Kodama K (1992) 1361012 178467 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10705 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 27874 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens inverse agonist target Ivgy-May N (2015) 26047892 196027 7776 Esmirtazapine (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine - DRUGBANK DB06678 C17H19N3 small molecule - 61337-87-9 DRUGBANK 6661 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens unknown target Kvernmo T (2008) 18691132 174662 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 6662 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens unknown target Lam YW (2000) 10641988 174664 405 Pramipexole (S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum auro-pramipexole|mylan-pramipe DRUGBANK DB00413 C10H17N3S small molecule N04BC05 104632-26-0 DRUGBANK 24049 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens unknown target Halford JC (2006) 16625817 181937 4671 Lorcaserin Lorqess belviq DRUGBANK DB04871 C11H14ClN small molecule A08AA11 616202-92-7 DRUGBANK 24050 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens unknown target Jandacek RJ (2005) 16259227 181916 4671 Lorcaserin Lorqess belviq DRUGBANK DB04871 C11H14ClN small molecule A08AA11 616202-92-7 DRUGBANK 7128 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Roth BL (1994) 7804391 176211 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7129 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Paelvimaeki EP (1996) 8876023 176222 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7130 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens binder target Roth BL (1994) 7804391 176211 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7131 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens binder target Paelvimaeki EP (1996) 8876023 176222 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 13214 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13215 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13216 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13217 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 4122 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Horishita T (2006) 16679816 174257 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4123 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Ogata J (2004) 15105221 174258 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 6609 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Herrick-Davis K (2000) 10991983 175882 400 Loxapine Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina loxapine succinate tablets 50m DRUGBANK DB00408 C18H18ClN3O small molecule N05AH01 1977-10-2 DRUGBANK 5736 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5737 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Wood MD (2006) 16918396 174636 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5738 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Hertel P (2006) 16952163 175321 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5739 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Overstreet DH (2007) 17624999 175322 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5740 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Theisen FM (2007) 16983399 175323 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5741 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Zhang JY (2006) 16336943 175324 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5742 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Bymaster FP (1999) 10227113 175304 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 16751 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Nash JF (1994) 7824160 181437 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16752 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Lyon RA (1986) 2871581 181436 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 6174 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Millan MJ (2000) 10762339 175610 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6175 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6176 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Dekeyne A (2001) 11271412 175629 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6177 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Millan MJ (2006) 16433010 175628 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6178 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Benelli A (2004) 14615872 175630 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6179 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Meert TF (1997) 9832994 175631 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 9066 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Conn PJ (1987) 3039120 177593 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 9067 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Fiorella D (1995) 7659770 177597 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 6914 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Honda M (2003) 12498911 176034 426 Cyproheptadine 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina pms-cyproheptadine hcl tab 4mg DRUGBANK DB00434 C21H21N small molecule R06AX02 129-03-3 DRUGBANK 15079 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15080 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14259 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens binder target Paelvimaeki EP (1996) 8876023 176222 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14610 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14611 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Cussac D (2008) 18703043 159118 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 14612 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1174 Pergolide Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida permax tab 0.25mg|permax tab 0 DRUGBANK DB01186 C19H26N2S small molecule N04BC02 66104-22-1 DRUGBANK 15323 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Sargent PA (1998) 9862411 180814 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15324 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Sugimoto Y (2003) 14501155 174650 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15325 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Contreras CM (1992) 1296670 180812 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 27571 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9908 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 14157 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Maj J (1977) 309138 180335 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14158 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Cusack B (1994) 7855217 175183 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14221 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Millan MJ (2006) 16433010 175628 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14222 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14667 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Wilson AW (2001) 11198050 180540 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14668 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Vickers SP (2001) 11489456 180537 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14669 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Vickers SP (1999) 10353435 180539 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14670 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Bickerdike MJ (2003) 12678838 180538 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14671 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Tomkins DM (2002) 11888565 180541 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 24468 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24469 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24470 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 6011 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Navailles S (2006) 16182256 175524 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6012 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Sodhi MS (2005) 15917433 175523 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 4966 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 261 Ropinirole Ropinirolum|Ropinirole|Ropinirol apo-ropinirole|phl-ropinirole| DRUGBANK DB00268 C16H24N2O small molecule N04BC04 91374-21-9 DRUGBANK 4848 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4849 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Sharif NA (2010) 20426763 174666 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4850 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4851 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4792 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Johnson MP (2003) 12555241 174653 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 4793 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 24584 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Millan MJ (2005) 15289999 181857 5559 Agomelatine Valdoxan - DRUGBANK DB06594 C15H17NO2 small molecule N06AX22 138112-76-2 DRUGBANK 24378 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Hietala J (2001) 11594443 181778 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24379 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Lindstroem E (2006) 16925508 181962 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24394 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Grinshpoon A (2000) 11004734 181762 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 24076 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens unknown target Wang WF (2007) 17624269 182029 4684 Dapoxetine Dapoxetinum|Dapoxetina - DRUGBANK DB04884 C21H23NO small molecule G04BX14 119356-77-3 DRUGBANK 14810 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Kvernmo T (2008) 18691132 174662 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14811 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Cussac D (2008) 18703043 159118 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 14812 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Lam YW (2000) 10641988 174664 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 8182 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Nonogaki K (2006) 16973729 176981 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8183 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Miller KJ (2005) 16249524 176983 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8184 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target McCreary AC (2003) 12708517 176982 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8185 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Fitzgerald LW (2000) 10617681 176985 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8186 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Schuhler S (2005) 15869562 176984 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 13537 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Beattie DT (2004) 15466450 180017 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 9951 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Richelson E (2000) 11132243 174623 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 9952 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Canton H (1994) 7898773 177777 724 Risperidone Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone risperdal m-tab|risperidone - DRUGBANK DB00734 C23H27FN4O2 small molecule N05AX08 106266-06-2 DRUGBANK 7915 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Glusa E (2000) 10821800 176783 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 27016 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Ring RM (2013) 23863923 182253 7747 Captodiame Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine - DRUGBANK DB09014 C21H29NS2 small molecule N05BB02 486-17-9 DRUGBANK 6747 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 6748 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 412 Promazine 10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine promazine hcl inj 50mg/ml DRUGBANK DB00420 C17H20N2S small molecule N05AA03 58-40-2 DRUGBANK 7853 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Paelvimaeki EP (1996) 8876023 176222 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 9612 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens agonist target Bigal ME (2003) 12525272 177883 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 12079 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens binder target Peroutka SJ (1981) 7221567 179185 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 16488 109590 3358 RP11-810O3.1 HTR2C 5-HT2C|5-HTR2C|5HTR2C|HTR1C 9606 Homo sapiens antagonist target Green B (2004) 15701205 181306 1352 Methotrimeprazine (-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum riva-meprazine 5mg tablets|riv DRUGBANK DB01403 C19H24N2OS small molecule N05AA02 60-99-1 DRUGBANK 15230 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 8526 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens agonist target Haga N (1998) 9697104 177214 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8527 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens agonist target de Ridder WJ (1993) 8093733 177215 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8528 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens agonist target Nagakura Y (1999) 10328995 177212 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8529 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens agonist target Talley NJ (1992) 1600046 177213 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 15162 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens agonist target Costall B (1987) 2955843 180761 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 10168 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10169 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gan TJ (2005) 15740177 178235 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10170 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Balfour JA (1997) 9257083 178229 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10171 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Eisenberg P (2003) 14635083 175658 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10172 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Conroy T (1994) 8141114 178234 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10173 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Boeijinga PH (1992) 1397053 178236 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10174 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gregory RE (1998) 9506240 178231 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10175 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Monaca-Charley C (2003) 14586600 178230 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10176 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Reith MK (1995) 7493546 178233 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 10177 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Hui YF (1997) 9341357 178232 747 Dolasetron Dolasetron|Dolastron|Dolasetronum anzemet injection 20 mg/ml|anz DRUGBANK DB00757 C19H20N2O3 small molecule A04AA04 115956-12-2 DRUGBANK 27160 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 4740 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 24419 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5527 Tapentadol CG-5503|BN-200|Nucynta|Tapentadol nucynta ir|nucynta extended-re DRUGBANK DB06204 C14H23NO small molecule N02AX06 175591-23-8 DRUGBANK 27903 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Bang-Andersen B (2011) 21486038 196006 8112 Vortioxetine 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation brintellix|trintellix DRUGBANK DB09068 C18H23N2S small molecule N06AX26 508233-74-7 DRUGBANK 12389 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Camilleri M (2000) 11060667 179416 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12390 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Houghton LA (2000) 10848662 179414 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12392 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gunput MD (1999) 10429744 179415 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12393 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Lewis JH (2010) 20136586 179412 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12394 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Coldwell JR (2007) 17138606 179413 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12395 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Andresen V (2004) 15061683 179410 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12396 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Clayton NM (1999) 10354345 179411 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12397 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12398 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Balfour JA (2000) 10776833 179409 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12391 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Rahimi R (2008) 18555935 179407 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 12399 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Mayer EA (2003) 14596662 179408 959 Alosetron 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one lotronex|alosetron hydrochlori DRUGBANK DB00969 C17H18N4O small molecule A03AE01 122852-42-0 DRUGBANK 11424 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Turvill JL (2000) 10882387 178909 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11425 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Hillsley K (1999) 10412832 178908 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11426 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Ho KY (2006) 17093363 178907 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11427 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11428 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Tan M (2003) 12943486 178910 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11429 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Feyer P (2005) 16044252 178906 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11430 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Cappelli A (2002) 11814868 178912 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11431 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Abdelsayed GG (2007) 17379085 178911 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 11432 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gan TJ (2005) 15740177 178235 879 Granisetron granisetronum|granistron|granisetrn granisetron hydrochloride inje DRUGBANK DB00889 C18H24N4O small molecule A04AA02 109889-09-0 DRUGBANK 13206 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13207 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13208 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13209 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5672 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5641 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Deeb TZ (2009) 19131665 175298 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 13117 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Rammes G (2001) 11403963 179871 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 6150 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gorman JM (1999) 10446735 175616 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6151 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Westenberg HG (1999) 10446734 175617 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6152 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6153 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Anttila SA (2001) 11607047 175618 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6154 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target de Boer T (1995) 8930006 175620 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6155 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Kast RE (2007) 17587360 175622 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 15048 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens unknown target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 14367 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14368 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 11573 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11572 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Mohan KC (1995) 8588861 178982 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11575 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Llacer JM (2001) 11763467 178981 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11576 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Arcioni R (2002) 12032025 178980 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11577 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Artaiz I (1998) 10065930 178978 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11578 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Fortuno A (1999) 10517265 178979 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11579 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gallardo Lara V (2009) 19320280 178976 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11580 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Carvalho F (2002) 11972287 178977 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11581 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Szajewska H (2007) 17269994 178974 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11582 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Dimitrov DH (2010) 20098535 178975 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11583 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gregory RE (1998) 9506240 178231 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11584 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Ramsook C (2002) 11919526 178973 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 11574 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gan TJ (2005) 15740177 178235 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 9917 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Min KT (2000) 10648343 178071 718 Rocuronium Rocuronium rocuronium bromide injection|r DRUGBANK DB00728 C32H53N2O4 small molecule M03AC09 143558-00-3 DRUGBANK 9907 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 6238 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6239 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Yang LP (2009) 19852528 175657 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 27771 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Siddiqui MA (2004) 15139789 195960 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6240 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gralla R (2003) 14504060 175665 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6241 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Rubenstein EB (2004) 16163194 175664 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6242 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target De Leon A (2006) 17106506 175667 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6243 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Eisenberg P (2004) 14760130 175666 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6244 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Navari RM (2006) 17026451 175661 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6245 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Hesketh PJ (2004) 15232725 175660 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6246 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Grunberg SM (2003) 14640928 175663 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6247 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Stoltz R (2004) 15102873 175662 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6248 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Eisenberg P (2003) 14635083 175658 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 6249 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Stoltz R (2004) 15378559 175659 369 Palonosetron Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one aloxi|akynzeo DRUGBANK DB00377 C19H24N2O small molecule A04AA05|A04AA55 135729-56-5 DRUGBANK 9832 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9833 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Fan P (1994) 7539114 178037 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 24155 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens unknown target Tack J (2006) 16696817 181942 4715 Renzapride - - DRUGBANK DB04917 C16H22ClN3O2 small molecule - 112727-80-7 DRUGBANK 24077 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens unknown target Chey WD (2005) 15757394 181885 4685 Cilansetron - - DRUGBANK DB04885 C20H21N3O small molecule A03AE03 120635-74-7 DRUGBANK 24078 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens unknown target Komoto S (2006) 16898618 181958 4685 Cilansetron - - DRUGBANK DB04885 C20H21N3O small molecule A03AE03 120635-74-7 DRUGBANK 14767 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Yan D (2006) 16723497 180596 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14768 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Yan D (2002) 12243766 180595 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14769 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Peters JA (1990) 1691468 180594 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14770 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Emerit MB (1993) 7684066 180593 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 14771 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Hefft S (1999) 10066903 180592 1187 Tubocurarine 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin tubocurarine chloride inj 3mg/ DRUGBANK DB01199 C37H41N2O6 small molecule M03AA02 57-95-4 DRUGBANK 5983 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7874 109591 3359 - HTR3A 5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3 9606 Homo sapiens antagonist target Gozlan H (1991) 1666997 176778 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 24154 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens unknown target Craig DA (1991) 1364818 181639 4715 Renzapride - - DRUGBANK DB04917 C16H22ClN3O2 small molecule - 112727-80-7 DRUGBANK 11571 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target van Wijngaarden I (1990) 2164935 178972 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 8520 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8521 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Bach T (2001) 11218067 177209 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8522 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Crema F (1999) 10027842 177208 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8523 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Nagakura Y (1999) 10328995 177212 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8524 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Rahme MM (1999) 10556228 177210 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8525 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Bharucha AE (2000) 11034583 177211 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 15157 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Guillemot J (2009) 18948374 180759 1221 Metoclopramide Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide metoclopramide omega|reglan|me DRUGBANK DB01233 C14H22ClN3O2 small molecule A03FA01 364-62-5 DRUGBANK 24052 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens unknown target McCullough JL (2006) 16495076 180022 4673 Piboserod - - DRUGBANK DB04873 C22H31N3O2 small molecule - 152811-62-6 DRUGBANK 24053 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens unknown target Darblade B (2005) 15902472 181892 4673 Piboserod - - DRUGBANK DB04873 C22H31N3O2 small molecule - 152811-62-6 DRUGBANK 26832 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Alarcon-de-la-Lastra Romero C (1997) 9211565 181721 7581 Cinitapride Paxapride - DRUGBANK DB08810 C21H30N4O4 small molecule - 66564-14-5 DRUGBANK 26833 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Alarcon de la Lastra C (1998) 9562338 181726 7581 Cinitapride Paxapride - DRUGBANK DB08810 C21H30N4O4 small molecule - 66564-14-5 DRUGBANK 13538 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens partial agonist target Kamm MA (2002) 11876686 180021 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13539 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens partial agonist target Corsetti M (2002) 12150698 180020 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13540 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13541 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens partial agonist target Camilleri M (2001) 11207504 180018 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13542 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens partial agonist target Cole P (2004) 15645012 180019 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13543 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens partial agonist target Beattie DT (2004) 15466450 180017 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13544 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Kamm MA (2002) 11876686 180021 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13545 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Corsetti M (2002) 12150698 180020 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13546 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13547 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Camilleri M (2001) 11207504 180018 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13548 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Cole P (2004) 15645012 180019 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13549 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Beattie DT (2004) 15466450 180017 1067 Tegaserod tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum - DRUGBANK DB01079 C16H23N5O small molecule A06AX06 145158-71-0 DRUGBANK 13218 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13219 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13220 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13221 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 27381 109592 3360 - HTR4 5-HT4|5-HT4R 9606 Homo sapiens agonist target Briejer MR (2001) 11438309 188518 7774 Prucalopride - resotran DRUGBANK DB06480 C18H26ClN3O3 small molecule A06AX05 179474-81-8 DRUGBANK 24456 109593 3361 - HTR5A 5-HT5A 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24457 109593 3361 - HTR5A 5-HT5A 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 5691 109593 3361 - HTR5A 5-HT5A 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 15065 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens unknown target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 15239 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 16807 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens unknown target Glennon RA (1978) 278843 181447 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 16808 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens unknown target Glennon RA (2000) 10715164 181450 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 16809 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens unknown target Glennon RA (1977) 270770 181448 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 16810 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens unknown target Nyandege A (2007) 17239595 181449 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 7347 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens binder target Roth BL (1994) 7908055 176335 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7122 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens binder target Grimaldi B (1998) 9606024 176219 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7123 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens binder target Roth BL (1994) 7804391 176211 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 24197 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Bobo WV (2013) 23272794 182224 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 5993 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 5549 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Sebben M (1994) 7696602 175195 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5550 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Kohen R (1996) 8522988 175194 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24429 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24430 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24431 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 13254 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13255 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13256 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13257 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5696 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 4751 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 7825 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens binder target Monsma FJ (1993) 7680751 176745 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7893 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Roth BL (1994) 7908055 176335 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 24364 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Pouzet B (2002) 11888555 181790 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24365 109594 3362 - HTR6 5-HT6|5-HT6R 9606 Homo sapiens antagonist target Mork A (2009) 19506838 182111 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 10077 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Dupont LJ (1999) 10596692 178184 741 Epinastine Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine epinastine hydrochloride|elest DRUGBANK DB00751 C16H15N3 small molecule R06AX24|S01GX10 80012-43-7 DRUGBANK 15262 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1226 Aripiprazole OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum aristada|aripiprazole oral sol DRUGBANK DB01238 C23H27Cl2N3O2 small molecule N05AX12 129722-12-9 DRUGBANK 7102 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Roth BL (1994) 7804391 176211 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7103 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Lucchelli A (2000) 10997731 175186 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 5524 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Lucchelli A (2000) 10997731 175186 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 4764 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Meltzer HY (1999) 10432496 174635 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4765 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Stark AD (2007) 17242925 174634 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 4766 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Meltzer HY (1995) 7583621 174633 239 Ziprasidone Ziprasidone|Ziprasidona|Ziprasidonum zeldox|ziprasidone hydrochlori DRUGBANK DB00246 C21H21ClN4OS small molecule N05AE04 146939-27-7 DRUGBANK 27902 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Bang-Andersen B (2011) 21486038 196006 8112 Vortioxetine 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation brintellix|trintellix DRUGBANK DB09068 C18H23N2S small molecule N06AX26 508233-74-7 DRUGBANK 24207 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Bobo WV (2013) 23272794 182224 4740 Iloperidone HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone fanapt DRUGBANK DB04946 C24H27FN2O4 small molecule N05AX14 133454-47-4 DRUGBANK 24551 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Abbas AI (2009) 19337725 182102 5546 Amisulpride 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride - DRUGBANK DB06288 C17H27N3O4S small molecule N05AL05 71675-85-9 DRUGBANK 12523 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens binder target Shen Y (1993) 8394362 179531 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 12524 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens binder target Lovenberg TW (1993) 8398139 179532 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 13246 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13247 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13248 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13249 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5717 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 6144 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens binding target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6145 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens binding target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 15077 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 1212 Quetiapine Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate sandoz quetiapine|quetiapine t DRUGBANK DB01224 C21H25N3O2S small molecule N05AH04 111974-69-7 DRUGBANK 7331 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens binder target Roth BL (1994) 7908055 176335 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 4378 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 4379 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 209 Eletriptan Eletriptanum gd-eletriptan|relpax|apo-eletr DRUGBANK DB00216 C22H26N2O2S small molecule N02CC06 143322-58-1 DRUGBANK 24454 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 24455 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Citrome L (2011) 21655346 182190 5533 Asenapine Saphris saphris DRUGBANK DB06216 C21H20ClNO5 small molecule N05AH05 65576-45-6 DRUGBANK 4832 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Sharif NA (2009) 18992242 174665 241 Cabergoline (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide apo-cabergoline|cabergoline|ac DRUGBANK DB00248 C26H37N5O2 small molecule G02CB03|N04BC06 81409-90-7 DRUGBANK 4790 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Sugimoto Y (2003) 14501155 174650 240 Methysergide 1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide sansert DRUGBANK DB00247 C21H27N3O2 small molecule N02CA04 361-37-5 DRUGBANK 24390 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Lucchelli A (2000) 10997731 175186 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 14801 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Knight JA (2009) 18996971 180602 1188 Bromocriptine 2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine syn-bromocriptine cap 5mg|co b DRUGBANK DB01200 C32H40BrN5O5 small molecule G02CB01|N04BC01 25614-03-3 DRUGBANK 26864 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target George M (2013) 23545936 182239 7585 Lurasidone Lurasidona|Lurasidonum latuda DRUGBANK DB08815 C28H36N4O2S small molecule N05AE05 367514-87-2 DRUGBANK 6005 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Nasrallah HA (2008) 17848919 174616 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7897 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Roth BL (1994) 7908055 176335 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 12053 109595 3363 RP11-103A2.1 HTR7 5-HT7 9606 Homo sapiens antagonist target Lucchelli A (2000) 10997731 175186 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 3615 109605 3376 RP11-62C3.1 IARS IARS1|ILERS|ILRS|IRS|PRO0785 9606 Homo sapiens unknown target Wang P (2003) 12783542 173955 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3616 109605 3376 RP11-62C3.1 IARS IARS1|ILERS|ILRS|IRS|PRO0785 9606 Homo sapiens unknown target Fukunaga R (2004) 14672940 173954 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3617 109605 3376 RP11-62C3.1 IARS IARS1|ILERS|ILRS|IRS|PRO0785 9606 Homo sapiens unknown target Mock ML (2006) 16397872 173956 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3618 109605 3376 RP11-62C3.1 IARS IARS1|ILERS|ILRS|IRS|PRO0785 9606 Homo sapiens unknown target Pezo V (2004) 15163798 173953 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3619 109605 3376 RP11-62C3.1 IARS IARS1|ILERS|ILRS|IRS|PRO0785 9606 Homo sapiens unknown target Crasto CF (2003) 12788342 173952 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 1294 109610 3383 - ICAM1 BB2|CD54|P3.58 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 374 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 375 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 8747 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 8748 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens inhibitor target Medina V (1993) 8484964 177417 616 Bacitracin Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a bacitin|walgreenstriple antibi DRUGBANK DB00626 C66H103N17O16S small molecule R02AB04|J01XX10|D06AX05 1405-87-4 DRUGBANK 877 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 878 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 879 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target Harada S (1993) 8504733 172200 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 880 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target MARIGO S (1958) 13560210 172198 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 881 109642 3416 RP11-366I13.1 IDE INSULYSIN 9606 Homo sapiens unknown target Hsu MC (1998) 9643444 172199 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 17667 109643 3417 - IDH1 HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17668 109643 3417 - IDH1 HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 21301 109643 3417 - IDH1 HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21302 109643 3417 - IDH1 HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 17664 109644 3418 - IDH2 D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17665 109644 3418 - IDH2 D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17666 109644 3418 - IDH2 D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 3381 109645 3419 - IDH3A - 9606 Homo sapiens unknown target PLAUT GW (1954) 13152105 173784 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3382 109645 3419 - IDH3A - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3383 109645 3419 - IDH3A - 9606 Homo sapiens unknown target Stein AM (1967) 4292141 173661 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3384 109645 3419 - IDH3A - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3385 109645 3419 - IDH3A - 9606 Homo sapiens unknown target Rose ZB (1966) 4380379 173663 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3320 109646 3420 RP4-686C3.2 IDH3B H-IDHB|RP46 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3321 109646 3420 RP4-686C3.2 IDH3B H-IDHB|RP46 9606 Homo sapiens unknown target SANWAL BD (1964) 14189899 173662 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3322 109646 3420 RP4-686C3.2 IDH3B H-IDHB|RP46 9606 Homo sapiens unknown target Stein AM (1967) 4292141 173661 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3323 109646 3420 RP4-686C3.2 IDH3B H-IDHB|RP46 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3324 109646 3420 RP4-686C3.2 IDH3B H-IDHB|RP46 9606 Homo sapiens unknown target Rose ZB (1966) 4380379 173663 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3068 109647 3421 hCG_2004980 IDH3G H-IDHG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3069 109647 3421 hCG_2004980 IDH3G H-IDHG 9606 Homo sapiens unknown target SANWAL BD (1964) 14189899 173662 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3070 109647 3421 hCG_2004980 IDH3G H-IDHG 9606 Homo sapiens unknown target Stein AM (1967) 4292141 173661 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3071 109647 3421 hCG_2004980 IDH3G H-IDHG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3072 109647 3421 hCG_2004980 IDH3G H-IDHG 9606 Homo sapiens unknown target Rose ZB (1966) 4380379 173663 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 17786 109648 3422 - IDI1 IPP1|IPPI1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1717 Dimethylallyl Diphosphate - - DRUGBANK DB01785 C5H12O7P2 small molecule - 358-72-5 DRUGBANK 117 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 118 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 119 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 120 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Krown SE (1987) 10822464 171791 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 121 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 742 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Dupont SA (2002) 12034032 172105 59 Interferon beta-1a IFN-beta|Interferon beta precursor|Fibroblast interferon avonex pen|avonex|rebif|rebif DRUGBANK DB00060 C908H1408N246O252S7 biologic L03AB07 145258-61-3 DRUGBANK 743 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Russell-Harde D (1999) 10049744 172107 59 Interferon beta-1a IFN-beta|Interferon beta precursor|Fibroblast interferon avonex pen|avonex|rebif|rebif DRUGBANK DB00060 C908H1408N246O252S7 biologic L03AB07 145258-61-3 DRUGBANK 744 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Runkel L (2001) 11747625 172106 59 Interferon beta-1a IFN-beta|Interferon beta precursor|Fibroblast interferon avonex pen|avonex|rebif|rebif DRUGBANK DB00060 C908H1408N246O252S7 biologic L03AB07 145258-61-3 DRUGBANK 745 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target van Koetsveld PM (2006) 16912135 172108 59 Interferon beta-1a IFN-beta|Interferon beta precursor|Fibroblast interferon avonex pen|avonex|rebif|rebif DRUGBANK DB00060 C908H1408N246O252S7 biologic L03AB07 145258-61-3 DRUGBANK 239 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 240 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 241 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 242 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Dhalluin C (2005) 15898717 171786 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 243 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Yano H (2006) 16953837 171784 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 244 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 196 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Dhalluin C (2005) 15898717 171786 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 197 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 198 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 199 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 200 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 421 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens unknown target Dhalluin C (2005) 15898717 171786 34 Interferon Alfa-2a, Recombinant SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a roferon-a sol inj 3million iu/ DRUGBANK DB00034 C860H1353N227O255S9 biologic L03AB04 76543-88-9 DRUGBANK 422 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens unknown target Cironi P (2008) 18230610 171921 34 Interferon Alfa-2a, Recombinant SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a roferon-a sol inj 3million iu/ DRUGBANK DB00034 C860H1353N227O255S9 biologic L03AB04 76543-88-9 DRUGBANK 801 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Russell-Harde D (1999) 10049744 172107 67 Interferon beta-1b IFN-beta|Interferon beta precursor|Fibroblast interferon betaseron|extavia DRUGBANK DB00068 C908H1408N246O253S6 biologic L03AB08 145155-23-3 DRUGBANK 802 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 67 Interferon beta-1b IFN-beta|Interferon beta precursor|Fibroblast interferon betaseron|extavia DRUGBANK DB00068 C908H1408N246O253S6 biologic L03AB08 145155-23-3 DRUGBANK 805 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 806 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Yasuda S (2002) 12528473 172161 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 807 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 808 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 97 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Dhalluin C (2005) 15898717 171786 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 98 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Yano H (2006) 16953837 171784 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 99 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 100 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 1273 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 1274 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 1275 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 1276 109676 3454 - IFNAR1 AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC 9606 Homo sapiens binder target Khine AA (2000) 10567921 172419 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 122 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 123 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 124 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 125 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Krown SE (1987) 10822464 171791 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 126 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 11 Interferon alfa-n1 Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A wellferon inj 3000000unit/ml|w DRUGBANK DB00011 C860H1353N227O255S9 biologic L03AB06 74899-72-2 DRUGBANK 746 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens unknown target Runkel L (2001) 11747625 172106 59 Interferon beta-1a IFN-beta|Interferon beta precursor|Fibroblast interferon avonex pen|avonex|rebif|rebif DRUGBANK DB00060 C908H1408N246O252S7 biologic L03AB07 145258-61-3 DRUGBANK 747 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens unknown target van Koetsveld PM (2006) 16912135 172108 59 Interferon beta-1a IFN-beta|Interferon beta precursor|Fibroblast interferon avonex pen|avonex|rebif|rebif DRUGBANK DB00060 C908H1408N246O252S7 biologic L03AB07 145258-61-3 DRUGBANK 245 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 246 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 247 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 248 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Dhalluin C (2005) 15898717 171786 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 249 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Yano H (2006) 16953837 171784 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 250 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 22 Peginterferon alfa-2b - sylatron|pegetron|pegintron|un DRUGBANK DB00022 - biologic L03AB60|L03AB10 215647-85-1 DRUGBANK 201 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 202 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 203 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 204 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Dhalluin C (2005) 15898717 171786 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 205 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Yano H (2006) 16953837 171784 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 206 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 18 Interferon alfa-n3 - alferon DRUGBANK DB00018 - biologic - - DRUGBANK 423 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens unknown target Dhalluin C (2005) 15898717 171786 34 Interferon Alfa-2a, Recombinant SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a roferon-a sol inj 3million iu/ DRUGBANK DB00034 C860H1353N227O255S9 biologic L03AB04 76543-88-9 DRUGBANK 424 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens unknown target Cironi P (2008) 18230610 171921 34 Interferon Alfa-2a, Recombinant SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a roferon-a sol inj 3million iu/ DRUGBANK DB00034 C860H1353N227O255S9 biologic L03AB04 76543-88-9 DRUGBANK 803 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Russell-Harde D (1999) 10049744 172107 67 Interferon beta-1b IFN-beta|Interferon beta precursor|Fibroblast interferon betaseron|extavia DRUGBANK DB00068 C908H1408N246O253S6 biologic L03AB08 145155-23-3 DRUGBANK 804 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 67 Interferon beta-1b IFN-beta|Interferon beta precursor|Fibroblast interferon betaseron|extavia DRUGBANK DB00068 C908H1408N246O253S6 biologic L03AB08 145155-23-3 DRUGBANK 809 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Blatt LM (1996) 8836913 172162 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 810 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Yasuda S (2002) 12528473 172161 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 811 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 68 Interferon alfacon-1 rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1 infergen DRUGBANK DB00069 C860H1353N227O255S9 biologic L03AB09 118390-30-0 DRUGBANK 101 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Dhalluin C (2005) 15898717 171786 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 102 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Yano H (2006) 16953837 171784 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 103 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Ishii K (2009) 19955815 171785 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 104 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 8 Peginterferon alfa-2a - pegasys rbv|pegasys DRUGBANK DB00008 - biologic L03AB61|L03AB11 198153-51-4 DRUGBANK 1277 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 1278 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 1279 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 1280 109677 3455 - IFNAR2 IFN-R|IFN-alpha-REC|IFNABR|IFNARB 9606 Homo sapiens binder target Eid P (1995) 7584665 172420 100 Interferon Alfa-2b, Recombinant Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b) intron a inj 3000000unit/vial| DRUGBANK DB00105 C860H1353N229O255S9 biologic L03AB05 98530-12-2 DRUGBANK 19097 109678 3456 RP11-113D19.1 IFNB1 IFB|IFF|IFNB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19098 109678 3456 RP11-113D19.1 IFNB1 IFB|IFF|IFNB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 15774 109680 3458 - IFNG IFG|IFI 9606 Homo sapiens unknown target Chen JT (2006) 16431966 181067 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15775 109680 3458 - IFNG IFG|IFI 9606 Homo sapiens unknown target Sarrazin S (2005) 16155294 181068 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15776 109680 3458 - IFNG IFG|IFI 9606 Homo sapiens unknown target Lortat-Jacob H (2006) 16709188 181069 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15777 109680 3458 - IFNG IFG|IFI 9606 Homo sapiens unknown target Chen JT (2006) 17238806 181070 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15380 109680 3458 - IFNG IFG|IFI 9606 Homo sapiens unknown target Ito R (2006) 17034586 180845 1238 Olsalazine Dipentum dipentum DRUGBANK DB01250 C14H10N2O6 small molecule A07EC03 15722-48-2 DRUGBANK 15381 109680 3458 - IFNG IFG|IFI 9606 Homo sapiens unknown target Egan LJ (1998) 9797390 180846 1238 Olsalazine Dipentum dipentum DRUGBANK DB01250 C14H10N2O6 small molecule A07EC03 15722-48-2 DRUGBANK 415 109681 3459 RP3-503F13.3 IFNGR1 CD119|IFNGR|IMD27A|IMD27B 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 33 Interferon gamma-1b Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b actimmune DRUGBANK DB00033 C761H1206N214O225S6 biologic - 98059-61-1 DRUGBANK 416 109681 3459 RP3-503F13.3 IFNGR1 CD119|IFNGR|IMD27A|IMD27B 9606 Homo sapiens binder target Matsuda A (2007) 17251453 171919 33 Interferon gamma-1b Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b actimmune DRUGBANK DB00033 C761H1206N214O225S6 biologic - 98059-61-1 DRUGBANK 417 109681 3459 RP3-503F13.3 IFNGR1 CD119|IFNGR|IMD27A|IMD27B 9606 Homo sapiens binder target Yao X (2007) 17618444 171918 33 Interferon gamma-1b Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b actimmune DRUGBANK DB00033 C761H1206N214O225S6 biologic - 98059-61-1 DRUGBANK 418 109682 3460 - IFNGR2 AF-1|IFGR2|IFNGT1|IMD28 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 33 Interferon gamma-1b Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b actimmune DRUGBANK DB00033 C761H1206N214O225S6 biologic - 98059-61-1 DRUGBANK 419 109682 3460 - IFNGR2 AF-1|IFGR2|IFNGT1|IMD28 9606 Homo sapiens binder target Park-Min KH (2007) 17239631 171920 33 Interferon gamma-1b Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b actimmune DRUGBANK DB00033 C761H1206N214O225S6 biologic - 98059-61-1 DRUGBANK 420 109682 3460 - IFNGR2 AF-1|IFGR2|IFNGT1|IMD28 9606 Homo sapiens binder target Yao X (2007) 17618444 171918 33 Interferon gamma-1b Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b actimmune DRUGBANK DB00033 C761H1206N214O225S6 biologic - 98059-61-1 DRUGBANK 18022 109700 3479 - IGF1 IGF-I|IGF1A|IGFI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1817 N,N-bis(3-(D-gluconamido)propyl)deoxycholamide Deoxy-bigchap - DRUGBANK DB01890 C42H75N3O15 small molecule - 86303-23-3 DRUGBANK 18023 109700 3479 - IGF1 IGF-I|IGF1A|IGFI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1817 N,N-bis(3-(D-gluconamido)propyl)deoxycholamide Deoxy-bigchap - DRUGBANK DB01890 C42H75N3O15 small molecule - 86303-23-3 DRUGBANK 18024 109700 3479 - IGF1 IGF-I|IGF1A|IGFI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1817 N,N-bis(3-(D-gluconamido)propyl)deoxycholamide Deoxy-bigchap - DRUGBANK DB01890 C42H75N3O15 small molecule - 86303-23-3 DRUGBANK 19610 109700 3479 - IGF1 IGF-I|IGF1A|IGFI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2534 N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate - - DRUGBANK DB02643 C17H38NO3S small molecule - - DRUGBANK 23276 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23277 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 571 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens agonist target Smith TJ (2010) 20392809 172020 46 Insulin Glargine Insulin Glargine (rDNA origin)|Insulin glargine recombinant toujeo solostar|basaglar|touje DRUGBANK DB00047 C267H404N72O78S6 biologic A10AE04 160337-95-1 DRUGBANK 25486 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6285 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE - - DRUGBANK DB07474 C22H19N7O small molecule - - DRUGBANK 566 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Smith TJ (2010) 20392809 172020 45 Insulin Lispro Insulin Lispro Recombinant|Insulin lispro protamine recombinant humalog mix50/50|humalog (kwi DRUGBANK DB00046 C257H387N65O76S6 biologic A10AB04|A10AC04|A10AD04 133107-64-9 DRUGBANK 15666 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens agonist target Rosenbloom AL (2009) 19198769 181006 1264 Mecasermin IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant increlex DRUGBANK DB01277 C331H518N94O101S7 biologic H01AC03|H01AC05 68562-41-4 DRUGBANK 872 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Fottner C (1998) 9846170 172196 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 873 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Zhang Q (1998) 9582514 172197 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 874 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 875 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Sowers JR (1995) 7476290 172195 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 876 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 372 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 373 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 25166 109701 3480 - IGF1R CD221|IGFIR|IGFR|JTK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5974 (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione - - DRUGBANK DB07156 C21H20BrN3O2 small molecule - - DRUGBANK 20100 109703 3482 - IGF2R CD222|CIMPR|M6P-R|MPR1|MPRI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2780 Alpha-D-Mannose-6-Phosphate - - DRUGBANK DB02900 C6H13O9P small molecule - - DRUGBANK 20101 109703 3482 - IGF2R CD222|CIMPR|M6P-R|MPR1|MPRI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2780 Alpha-D-Mannose-6-Phosphate - - DRUGBANK DB02900 C6H13O9P small molecule - - DRUGBANK 20102 109703 3482 - IGF2R CD222|CIMPR|M6P-R|MPR1|MPRI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2780 Alpha-D-Mannose-6-Phosphate - - DRUGBANK DB02900 C6H13O9P small molecule - - DRUGBANK 15670 109703 3482 - IGF2R CD222|CIMPR|M6P-R|MPR1|MPRI 9606 Homo sapiens unknown target Rosenbloom AL (2009) 19198769 181006 1264 Mecasermin IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant increlex DRUGBANK DB01277 C331H518N94O101S7 biologic H01AC03|H01AC05 68562-41-4 DRUGBANK 15667 109707 3486 tcag7.703 IGFBP3 BP-53|IBP3 9606 Homo sapiens unknown target Unknown Authors (2005) 15777106 181007 1264 Mecasermin IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant increlex DRUGBANK DB01277 C331H518N94O101S7 biologic H01AC03|H01AC05 68562-41-4 DRUGBANK 15668 109707 3486 tcag7.703 IGFBP3 BP-53|IBP3 9606 Homo sapiens unknown target Williams RM (2008) 18363546 181008 1264 Mecasermin IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant increlex DRUGBANK DB01277 C331H518N94O101S7 biologic H01AC03|H01AC05 68562-41-4 DRUGBANK 15669 109707 3486 tcag7.703 IGFBP3 BP-53|IBP3 9606 Homo sapiens unknown target Kemp SF (2009) 19627167 181009 1264 Mecasermin IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant increlex DRUGBANK DB01277 C331H518N94O101S7 biologic H01AC03|H01AC05 68562-41-4 DRUGBANK 358 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 359 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 829 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Radulescu RT (2007) 17475416 172174 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 830 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Degeorges A (1999) 10383131 172175 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 831 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Lopez-Bermejo A (2000) 11089538 172176 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 832 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 833 109711 3490 - IGFBP7 AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 23810 109715 3494 - IGHA2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4480 Dansyllysine DNS-lysine|Nepsilon-Dansyl-L-lysine|DNS|N(epsilon)-Dansyl-L-lysine - DRUGBANK DB04676 C18H25N3O4S small molecule - 1101-84-4 DRUGBANK 26332 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7081 2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID - - DRUGBANK DB08294 C8H7NO5 small molecule - - DRUGBANK 17462 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1568 Methyl Nonanoate (Ester) - - DRUGBANK DB01631 C10H20O2 small molecule - - DRUGBANK 26334 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7083 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID - - DRUGBANK DB08296 C11H13NO7P small molecule - - DRUGBANK 25681 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6478 TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE - - DRUGBANK DB07672 C14H23NOSi small molecule - - DRUGBANK 25780 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6565 FLUORESCIN - - DRUGBANK DB07764 C20H14O5 small molecule - - DRUGBANK 26424 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7162 PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE - - DRUGBANK DB08377 C13H17N2O8P small molecule - - DRUGBANK 26439 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7178 PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE - - DRUGBANK DB08394 C12H15N2O8P small molecule - - DRUGBANK 25376 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6187 3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID - - DRUGBANK DB07371 C18H16O2 small molecule - - DRUGBANK 25916 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6680 (2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE - - DRUGBANK DB07883 C20H21NO small molecule - - DRUGBANK 25914 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6678 N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE - - DRUGBANK DB07881 C23H29N2O7P small molecule - - DRUGBANK 23790 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4444 Biphenylalanine - - DRUGBANK DB04639 C15H15NO2 small molecule - - DRUGBANK 25390 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6191 5-BETA-ANDROSTANE-3,17-DIONE - - DRUGBANK DB07375 C19H28O2 small molecule - - DRUGBANK 26604 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7340 4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID - - DRUGBANK DB08562 C19H19NO3 small molecule - - DRUGBANK 25838 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6614 N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID - - DRUGBANK DB07816 C23H20N4O2 small molecule - - DRUGBANK 26458 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7193 4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE - - DRUGBANK DB08409 C13H17N2O8P small molecule - - DRUGBANK 25460 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6253 3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID - - DRUGBANK DB07441 C19H17N3O3 small molecule - - DRUGBANK 26374 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7118 [2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE - - DRUGBANK DB08332 C18H16O4 small molecule - - DRUGBANK 25933 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6705 (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL - - DRUGBANK DB07909 C23H27NO4 small molecule - - DRUGBANK 26461 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7196 6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID - - DRUGBANK DB08412 C16H23N2O8P small molecule - - DRUGBANK 26460 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7195 PARA-NITROPHENYL PHOSPHONOBUTANOYL L-ALANINE - - DRUGBANK DB08411 C13H17N2O8P small molecule - - DRUGBANK 26459 109721 3500 - IGHG1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7194 PARA-NITROBENZYL GLUTARYL GLYCINIC ACID - - DRUGBANK DB08410 C14H17N3O6 small molecule - - DRUGBANK 26590 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7325 PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE - - DRUGBANK DB08547 C25H34O6 small molecule - - DRUGBANK 20027 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2736 Aetiocholanolone - - DRUGBANK DB02854 C19H30O2 small molecule - 53-42-9 DRUGBANK 26648 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7394 3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER - - DRUGBANK DB08618 C16H22NO5P small molecule - - DRUGBANK 26549 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7289 5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE - - DRUGBANK DB08510 C25H38O5 small molecule - - DRUGBANK 23816 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4492 ECGONINE METHYL ESTER - - DRUGBANK DB04688 C10H17NO3 small molecule - - DRUGBANK 25335 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6145 1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID - - DRUGBANK DB07329 C13H19N2O7P small molecule - - DRUGBANK 26457 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7193 4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE - - DRUGBANK DB08409 C13H17N2O8P small molecule - - DRUGBANK 26359 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7109 3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE - - DRUGBANK DB08323 C16H28N2O3 small molecule - - DRUGBANK 25391 109722 3501 - IGHG2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6191 5-BETA-ANDROSTANE-3,17-DIONE - - DRUGBANK DB07375 C19H28O2 small molecule - - DRUGBANK 26588 109727 3507 - IGHM AGM1|MU|VH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7323 (1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE - - DRUGBANK DB08545 C17H19NO4P small molecule - - DRUGBANK 25812 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6583 [4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID - - DRUGBANK DB07784 C21H23N3O7 small molecule - - DRUGBANK 25722 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6519 (4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL - - DRUGBANK DB07716 C22H30O8 small molecule - - DRUGBANK 26605 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7340 4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID - - DRUGBANK DB08562 C19H19NO3 small molecule - - DRUGBANK 17932 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1781 Tetrabutylammonium Ion - - DRUGBANK DB01851 C16H36N small molecule - 2052-49-5 DRUGBANK 26328 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7077 N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE - - DRUGBANK DB08289 C18H26N2O4 small molecule - - DRUGBANK 25934 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6705 (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL - - DRUGBANK DB07909 C23H27NO4 small molecule - - DRUGBANK 25915 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6679 4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID - - DRUGBANK DB07882 C24H33N3O6 small molecule - - DRUGBANK 23817 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4492 ECGONINE METHYL ESTER - - DRUGBANK DB04688 C10H17NO3 small molecule - - DRUGBANK 26667 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7421 TRAZEOLIDE - - DRUGBANK DB08647 C20H28O3 small molecule - - DRUGBANK 25461 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6253 3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID - - DRUGBANK DB07441 C19H17N3O3 small molecule - - DRUGBANK 25920 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6690 PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE - - DRUGBANK DB07893 C15H22NO6P small molecule - - DRUGBANK 26463 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7197 METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER - - DRUGBANK DB08413 C7H8NO5P small molecule - - DRUGBANK 25439 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6230 (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE - - DRUGBANK DB07416 C16H30O5 small molecule - - DRUGBANK 25392 109734 3514 - IGKC HCAK1|IGKCD|Km 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6191 5-BETA-ANDROSTANE-3,17-DIONE - - DRUGBANK DB07375 C19H28O2 small molecule - - DRUGBANK 20460 109753 3537 - IGLC1 IGLC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 10562 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Weber CK (2000) 11054378 174546 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10563 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 14416 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inducer target Chen X (2002) 11752352 171740 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14417 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inducer target Ouyang W (2007) 17450217 180452 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14418 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inducer target Ouyang W (2005) 16230390 180453 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14419 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inducer target Ouyang W (2006) 16387740 180451 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 12579 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Jeon KI (2003) 12754408 179568 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 12580 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Youn HS (2006) 17034761 179569 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 24404 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Oka S (2000) 10788610 181749 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 4704 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Weber CK (2000) 11054378 174546 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4705 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Bantel H (2000) 11151876 174545 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4706 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 12176 109767 3551 - IKBKB IKK-beta|IKK2|IKKB|IMD15|NFKBIKB 9606 Homo sapiens unknown target Yin MJ (1998) 9817203 179251 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 24563 109768 3552 - IL1A IL-1A|IL1|IL1-ALPHA|IL1F1 9606 Homo sapiens binder target Tran TH (2013) 23553601 182241 5551 Rilonacept Arcalyst|interleukin-1 (IL-1) trap arcalyst DRUGBANK DB06372 C9030H13932N2400O2670S74 biologic L04AC04 501081-76-1 DRUGBANK 24564 109768 3552 - IL1A IL-1A|IL1|IL1-ALPHA|IL1F1 9606 Homo sapiens binder target Cronstein BN (2013) 23319019 182226 5551 Rilonacept Arcalyst|interleukin-1 (IL-1) trap arcalyst DRUGBANK DB06372 C9030H13932N2400O2670S74 biologic L04AC04 501081-76-1 DRUGBANK 12797 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens modulator target Steinmeyer J (1998) 9413935 179698 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12798 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens modulator target Sadowski T (2001) 11246672 179699 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12799 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens modulator target Amin AR (1996) 8943052 179700 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12800 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens modulator target Oringer RJ (2002) 12211491 179701 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 24407 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens binder target Church LD (2009) 19169963 182096 5521 Canakinumab ACZ-885|ACZ885 ilaris DRUGBANK DB06168 C6452H9958N1722O2010S42 biologic L04AC08 914613-48-2 DRUGBANK 24567 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens binder target Tran TH (2013) 23553601 182241 5551 Rilonacept Arcalyst|interleukin-1 (IL-1) trap arcalyst DRUGBANK DB06372 C9030H13932N2400O2670S74 biologic L04AC04 501081-76-1 DRUGBANK 24568 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens binder target Cronstein BN (2013) 23319019 182226 5551 Rilonacept Arcalyst|interleukin-1 (IL-1) trap arcalyst DRUGBANK DB06372 C9030H13932N2400O2670S74 biologic L04AC04 501081-76-1 DRUGBANK 24303 109769 3553 - IL1B IL-1|IL1-BETA|IL1F2 9606 Homo sapiens antagonist target Eby G (2005) 16122880 181906 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 299 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target Do H (2006) 17083033 171889 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 300 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target Vannier E (1999) 10210771 171888 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 301 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 302 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target Vamvakopoulos J (2002) 12355453 171885 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 303 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target Dayer JM (2003) 12817089 171884 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 304 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target So A (2007) 17352828 171887 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 305 109770 3554 - IL1R1 CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80 9606 Homo sapiens antagonist target Tang YH (2007) 17498496 171886 26 Anakinra IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra kineret DRUGBANK DB00026 C759H1186N208O232S10 biologic L04AC03 143090-92-0 DRUGBANK 24565 109772 3557 - IL1RN DIRA|ICIL-1RA|IL-1RN|IL-1ra|IL-1ra3|IL1F3|IL1RA|IRAP|MVCD4 9606 Homo sapiens binder target Hawkins PN (2003) 12815153 181820 5551 Rilonacept Arcalyst|interleukin-1 (IL-1) trap arcalyst DRUGBANK DB06372 C9030H13932N2400O2670S74 biologic L04AC04 501081-76-1 DRUGBANK 24566 109772 3557 - IL1RN DIRA|ICIL-1RA|IL-1RN|IL-1ra|IL-1ra3|IL1F3|IL1RA|IRAP|MVCD4 9606 Homo sapiens binder target Cronstein BN (2013) 23319019 182226 5551 Rilonacept Arcalyst|interleukin-1 (IL-1) trap arcalyst DRUGBANK DB06372 C9030H13932N2400O2670S74 biologic L04AC04 501081-76-1 DRUGBANK 19484 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2476 5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid - - DRUGBANK DB02581 C30H37Cl2N7O6 small molecule - - DRUGBANK 19485 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2476 5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid - - DRUGBANK DB02581 C30H37Cl2N7O6 small molecule - - DRUGBANK 19486 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2476 5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid - - DRUGBANK DB02581 C30H37Cl2N7O6 small molecule - - DRUGBANK 11179 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 21050 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3233 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One - - DRUGBANK DB03372 C14H16N2OS small molecule - - DRUGBANK 19453 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2452 SP4160 - - DRUGBANK DB02555 C33H42Cl2N8O4 small molecule - - DRUGBANK 19454 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2452 SP4160 - - DRUGBANK DB02555 C33H42Cl2N8O4 small molecule - - DRUGBANK 19455 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2452 SP4160 - - DRUGBANK DB02555 C33H42Cl2N8O4 small molecule - - DRUGBANK 22987 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4105 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide - - DRUGBANK DB04278 C17H32N6O3S small molecule - - DRUGBANK 22988 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4105 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide - - DRUGBANK DB04278 C17H32N6O3S small molecule - - DRUGBANK 22989 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4105 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide - - DRUGBANK DB04278 C17H32N6O3S small molecule - - DRUGBANK 21259 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3309 (R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester - - DRUGBANK DB03453 C26H30N4O3 small molecule - - DRUGBANK 21260 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3309 (R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester - - DRUGBANK DB03453 C26H30N4O3 small molecule - - DRUGBANK 21261 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3309 (R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester - - DRUGBANK DB03453 C26H30N4O3 small molecule - - DRUGBANK 21262 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3311 (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid - - DRUGBANK DB03455 C12H14N2O3S small molecule - - DRUGBANK 22265 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3792 SP2456 - - DRUGBANK DB03957 C25H32Cl2N7O2 small molecule - - DRUGBANK 22266 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3792 SP2456 - - DRUGBANK DB03957 C25H32Cl2N7O2 small molecule - - DRUGBANK 22267 109773 3558 - IL2 IL-2|TCGF|lymphokine 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3792 SP2456 - - DRUGBANK DB03957 C25H32Cl2N7O2 small molecule - - DRUGBANK 968 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Garcia CD (2006) 16908318 172228 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 969 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Choy BY (2003) 12591363 172229 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 970 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 971 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Kovarik J (1998) 9695721 172226 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 972 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Berard JL (1999) 10512062 172227 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 973 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Mentre F (1999) 10567956 172230 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1362 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Garcia CD (2006) 16908318 172228 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1363 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Przepiorka D (2000) 10607689 172453 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1364 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1365 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Monti P (2009) 19788505 172457 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1366 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Patlolla V (2007) 17564638 172456 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1367 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Krouwels FH (1996) 8600944 172455 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1368 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens antibody target Shamsi TS (2005) 16304857 172454 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 40 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Duvic M (2008) 18684057 171751 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 41 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Turturro F (2007) 17187516 171750 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 42 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 43 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 44 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Murphy JR (1988) 3124610 171755 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 45 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Kiyokawa T (1989) 2786749 171754 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 46 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 525 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Ouyang Y (1999) 10207608 171999 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 526 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Waldmann TA (2007) 17530023 171998 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 527 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Vlad G (2007) 17584597 171997 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 528 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Waldmann TA (2007) 17216565 171996 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 529 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Liu BY (2006) 16864089 171995 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 530 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Recchia F (2003) 16767920 171994 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 531 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens modulator target Chen X (2002) 11752352 171740 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 532 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Ouyang Y (1999) 10207608 171999 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 533 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Waldmann TA (2007) 17530023 171998 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 534 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Vlad G (2007) 17584597 171997 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 535 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Waldmann TA (2007) 17216565 171996 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 536 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Liu BY (2006) 16864089 171995 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 537 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Recchia F (2003) 16767920 171994 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 538 109774 3559 RP11-536K7.1 IL2RA CD25|IDDM10|IL2R|TCGFR|p55 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 960 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Schmitz K (2002) 11840795 172221 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 961 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Onrust SV (1999) 10188761 172222 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 962 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Emparan C (2003) 12826150 172223 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 963 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Hausen B (2000) 10708100 172224 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 964 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Warle MC (2003) 12667677 172225 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 965 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1355 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Forrest K (2005) 15814281 172448 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1356 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Light JA (2002) 12372041 172449 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1357 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1358 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Ramos EL (1989) 2571203 172450 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1359 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Burkhardt K (1989) 2647626 172451 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1360 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens antibody target Aguillon JC (2003) 15022409 172042 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 35 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Duvic M (2008) 18684057 171751 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 36 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Turturro F (2007) 17187516 171750 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 37 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 38 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Foss F (2006) 16516670 171752 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 39 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Foss F (2005) 15811959 171753 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 513 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens modulator target Maclennan C (2006) 16617454 171989 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 514 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens modulator target Chen X (2002) 11752352 171740 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 515 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens modulator target Stauber DJ (2006) 16477002 171993 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 516 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens modulator target Cornish GH (2006) 16569767 171992 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 517 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens modulator target Lee KD (2006) 16596189 171991 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 518 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens modulator target Steppan S (2006) 16542139 171990 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 519 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Maclennan C (2006) 16617454 171989 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 520 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 521 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Stauber DJ (2006) 16477002 171993 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 522 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Cornish GH (2006) 16569767 171992 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 523 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Lee KD (2006) 16596189 171991 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 524 109775 3560 RP5-1170K4.6 IL2RB CD122|IL15RB|P70-75 9606 Homo sapiens agonist target Steppan S (2006) 16542139 171990 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 47 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens unknown target Foss F (2005) 15811959 171753 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 48 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens unknown target Foss F (2006) 16516670 171752 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 49 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens unknown target Foss FM (2000) 11707860 171756 4 Denileukin diftitox Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase) ontak DRUGBANK DB00004 C2560H4042N678O799S17 biologic L01XX29 173146-27-5 DRUGBANK 539 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens agonist target Stauber DJ (2006) 16477002 171993 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 540 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens agonist target Blank RB (2006) 17083048 172000 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 541 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens agonist target Smyth CM (2007) 17363735 172001 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 542 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens agonist target Fonseca SG (2007) 17635814 172002 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 543 109776 3561 - IL2RG CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1 9606 Homo sapiens agonist target Shibata F (2007) 17598841 172003 40 Aldesleukin Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin proleukin DRUGBANK DB00041 C690H1115N177O202S6 biologic L03AC01 110942-02-4 DRUGBANK 12901 109777 3562 - IL3 IL-3|MCGF|MULTI-CSF 9606 Homo sapiens antagonist target Urisu A (1990) 1701989 179751 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12902 109777 3562 - IL3 IL-3|MCGF|MULTI-CSF 9606 Homo sapiens antagonist target Nagai H (1992) 1378042 179752 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 221 109778 3563 RP11-261P4.2 IL3RA CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra 9606 Homo sapiens agonist target Sakhno LV (2007) 17500228 171847 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 222 109778 3563 RP11-261P4.2 IL3RA CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra 9606 Homo sapiens agonist target Ward KA (2006) 16698686 171846 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 223 109778 3563 RP11-261P4.2 IL3RA CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra 9606 Homo sapiens agonist target Eksioglu EA (2007) 17562355 171849 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 224 109778 3563 RP11-261P4.2 IL3RA CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra 9606 Homo sapiens agonist target Lencz T (2007) 17522711 171848 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 27383 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Basavaraju KP (2008) 18564273 188520 7775 Mepolizumab - nucala DRUGBANK DB06612 - biologic L04AC06 196078-29-2 DRUGBANK 27384 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Garrett JK (2004) 14699394 188521 7775 Mepolizumab - nucala DRUGBANK DB06612 - biologic L04AC06 196078-29-2 DRUGBANK 16557 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Hojo M (2000) 10773010 181362 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16558 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Fukushima C (2005) 15650315 181358 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16559 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Matsuse H (2006) 16892782 181359 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16560 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Nogimura M (2002) 12692940 181360 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16561 109781 3567 - IL5 EDF|IL-5|TRF 9606 Homo sapiens antagonist target Nabe T (2002) 11972613 181361 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16489 109783 3569 - IL6 BSF2|HGF|HSF|IFNB2|IL-6 9606 Homo sapiens antagonist target Kim SJ (2007) 17436372 181309 1353 Ginseng - ginsana cap 100mg|siberian gin DRUGBANK DB01404 - small molecule - 50647-08-0 DRUGBANK 16490 109783 3569 - IL6 BSF2|HGF|HSF|IFNB2|IL-6 9606 Homo sapiens antagonist target Kim DH (2003) 14642426 181310 1353 Ginseng - ginsana cap 100mg|siberian gin DRUGBANK DB01404 - small molecule - 50647-08-0 DRUGBANK 27457 109783 3569 - IL6 BSF2|HGF|HSF|IFNB2|IL-6 9606 Homo sapiens antagonist target van Zaanen HC (1996) 8823310 188534 7799 Siltuximab - sylvant DRUGBANK DB09036 C6450H9932N1688O2016S50 biologic L04AC11 541502-14-1 DRUGBANK 27458 109783 3569 - IL6 BSF2|HGF|HSF|IFNB2|IL-6 9606 Homo sapiens antibody target van Zaanen HC (1996) 8823310 188534 7799 Siltuximab - sylvant DRUGBANK DB09036 C6450H9932N1688O2016S50 biologic L04AC11 541502-14-1 DRUGBANK 24536 109784 3570 - IL6R CD126|IL-6R-1|IL-6RA|IL6Q|IL6RA|IL6RQ|gp80 9606 Homo sapiens antibody target Smolen JS (2006) 16899109 181959 5542 Tocilizumab Atlizumab|MRA|RoActemra actemra DRUGBANK DB06273 C6428H9976N1720O2018S42 biologic L04AC07 375823-41-9 DRUGBANK 24359 109790 3576 - CXCL8 GCP-1|GCP1|IL8|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1 9606 Homo sapiens antagonist target Spoettl T (2007) 16715250 181946 5414 Rivanicline (3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine|(E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine|(E)-metanicotine|N-methyl-4-(3-pyridinyl)-(3E)-3-buten-1-amine|trans-metanicotine - DRUGBANK DB05855 C10H14N2 small molecule - 15585-43-0 DRUGBANK 12700 109791 3577 - CXCR1 C-C|C-C-CKR-1|CD128|CD181|CDw128a|CKR-1|CMKAR1|IL8R1|IL8RA|IL8RBA 9606 Homo sapiens unknown target Wang LM (1997) 9093816 179632 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12701 109791 3577 - CXCR1 C-C|C-C-CKR-1|CD128|CD181|CDw128a|CKR-1|CMKAR1|IL8R1|IL8RA|IL8RBA 9606 Homo sapiens unknown target Bizzarri C (2001) 11331079 179633 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12702 109791 3577 - CXCR1 C-C|C-C-CKR-1|CD128|CD181|CDw128a|CKR-1|CMKAR1|IL8R1|IL8RA|IL8RBA 9606 Homo sapiens unknown target Allegretti M (2005) 15974585 179631 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 458 109804 3590 hCG_2011440 IL11RA CRSDA 9606 Homo sapiens agonist target Romas E (1996) 8676079 171948 37 Oprelvekin IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF neumega DRUGBANK DB00038 C854H1411N253O235S2 biologic L03AC02 145941-26-0 DRUGBANK 459 109804 3590 hCG_2011440 IL11RA CRSDA 9606 Homo sapiens agonist target Li R (2001) 11570967 171949 37 Oprelvekin IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF neumega DRUGBANK DB00038 C854H1411N253O235S2 biologic L03AC02 145941-26-0 DRUGBANK 460 109804 3590 hCG_2011440 IL11RA CRSDA 9606 Homo sapiens agonist target Nandurkar HH (1997) 9310465 171952 37 Oprelvekin IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF neumega DRUGBANK DB00038 C854H1411N253O235S2 biologic L03AC02 145941-26-0 DRUGBANK 461 109804 3590 hCG_2011440 IL11RA CRSDA 9606 Homo sapiens agonist target Nandurkar HH (2000) 11012177 171951 37 Oprelvekin IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF neumega DRUGBANK DB00038 C854H1411N253O235S2 biologic L03AC02 145941-26-0 DRUGBANK 462 109804 3590 hCG_2011440 IL11RA CRSDA 9606 Homo sapiens agonist target Nandurkar HH (1996) 8637716 171950 37 Oprelvekin IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF neumega DRUGBANK DB00038 C854H1411N253O235S2 biologic L03AC02 145941-26-0 DRUGBANK 463 109804 3590 hCG_2011440 IL11RA CRSDA 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 37 Oprelvekin IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF neumega DRUGBANK DB00038 C854H1411N253O235S2 biologic L03AC02 145941-26-0 DRUGBANK 19872 109807 3593 - IL12B CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2648 5-Mercapto-2-Nitro-Benzoic Acid - - DRUGBANK DB02763 C7H5NO4S small molecule - 15139-21-6 DRUGBANK 19873 109807 3593 - IL12B CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2648 5-Mercapto-2-Nitro-Benzoic Acid - - DRUGBANK DB02763 C7H5NO4S small molecule - 15139-21-6 DRUGBANK 24345 109807 3593 - IL12B CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2 9606 Homo sapiens unknown target Wittig BM (2007) 17979029 182059 5288 Ustekinumab Stelara|CNTO-1275|Ustekinumab stelara DRUGBANK DB05679 - biologic L04AC05 815610-63-0 DRUGBANK 24346 109807 3593 - IL12B CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2 9606 Homo sapiens unknown target Reddy M (2007) 17761156 182044 5288 Ustekinumab Stelara|CNTO-1275|Ustekinumab stelara DRUGBANK DB05679 - biologic L04AC05 815610-63-0 DRUGBANK 27038 109818 3605 - IL17A CTLA8|IL-17|IL-17A|IL17 9606 Homo sapiens antagonist target Ohtsuki M (2014) 25354738 182255 7760 Secukinumab - cosentyx DRUGBANK DB09029 C6584H10134N1754O2042S44 biologic L04AC10 1229022-83-6 DRUGBANK 16095 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens inhibitor target Ohnishi T (2007) 17251911 181147 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16096 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens inhibitor target Trinquet E (2006) 16965760 181151 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16097 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens inhibitor target Sarkar S (2006) 16874097 181152 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16098 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens inhibitor target Li Z (2010) 20027624 181153 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16099 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens inhibitor target Tanizawa Y (2006) 17158747 181150 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16100 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens inhibitor target Ohnishi T (2007) 17068342 181149 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 21463 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3393 L-Myo-Inositol-1-Phosphate - - DRUGBANK DB03542 C6H11O9P small molecule - - DRUGBANK 21464 109825 3612 - IMPA1 IMP|IMPA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3393 L-Myo-Inositol-1-Phosphate - - DRUGBANK DB03542 C6H11O9P small molecule - - DRUGBANK 16092 109826 3613 - IMPA2 - 9606 Homo sapiens inhibitor target Ohnishi T (2007) 17068342 181149 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16093 109826 3613 - IMPA2 - 9606 Homo sapiens inhibitor target Cryns K (2007) 16841073 181148 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 16094 109826 3613 - IMPA2 - 9606 Homo sapiens inhibitor target Ohnishi T (2007) 17251911 181147 1320 Lithium Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+) lithium carbonate|carbolith ca DRUGBANK DB01356 Li small molecule N05AN01 7439-93-2 DRUGBANK 3033 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3034 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens unknown target Bowne SJ (2006) 16384941 173648 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3035 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 9508 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Wang J (2008) 17851563 177828 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9509 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Bremer S (2007) 17463174 177825 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9510 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Sanquer S (2008) 17713475 177827 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9511 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9512 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9513 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 22245 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3784 6-Chloropurine Riboside, 5'-Monophosphate - - DRUGBANK DB03948 C10H13ClN4O7P small molecule - - DRUGBANK 22246 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3784 6-Chloropurine Riboside, 5'-Monophosphate - - DRUGBANK DB03948 C10H13ClN4O7P small molecule - - DRUGBANK 12993 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Sahasranaman S (2008) 18506437 179567 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 12994 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 12900 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Dzidic A (2006) 16629948 179750 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 10739 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 10740 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Leyssen P (2006) 16421290 178482 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 10741 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target McHutchison JG (2005) 16152757 178483 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 10742 109827 3614 - IMPDH1 IMPD|IMPD1|LCA11|RP10|sWSS2608 9606 Homo sapiens inhibitor target Gish RG (2006) 16293677 178484 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 3231 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Wang J (2007) 17496727 173725 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 9505 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Bremer S (2007) 17463174 177825 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9506 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 9507 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Vannozzi F (2004) 15621150 177826 678 Mycophenolate mofetil Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443 accel-mycophenolate mofetil ta DRUGBANK DB00688 C23H31NO7 small molecule - 128794-94-5 DRUGBANK 22243 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3784 6-Chloropurine Riboside, 5'-Monophosphate - - DRUGBANK DB03948 C10H13ClN4O7P small molecule - - DRUGBANK 22244 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3784 6-Chloropurine Riboside, 5'-Monophosphate - - DRUGBANK DB03948 C10H13ClN4O7P small molecule - - DRUGBANK 12995 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Sahasranaman S (2008) 18506437 179567 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 12996 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 12893 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 12894 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Vannozzi F (2004) 15621150 177826 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 12895 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 12896 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Dzidic A (2006) 16629948 179750 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 12897 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Wang J (2007) 17496727 173725 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 12898 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Yam P (2006) 16647299 179748 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 12899 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens inhibitor target Penuelas S (2005) 15614187 179749 1014 Mycophenolic acid Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum myfortic|mycophenolic acid|apo DRUGBANK DB01024 C17H20O6 small molecule L04AA06 24280-93-1 DRUGBANK 27572 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 27573 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 23722 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23723 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23724 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 20421 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2941 Selenazole-4-Carboxyamide-Adenine Dinucleotide - - DRUGBANK DB03070 C19H25N7O14P2Se small molecule - - DRUGBANK 20422 109828 3615 hCG_2002013 IMPDH2 IMPD2|IMPDH-II 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2941 Selenazole-4-Carboxyamide-Adenine Dinucleotide - - DRUGBANK DB03070 C19H25N7O14P2Se small molecule - - DRUGBANK 25344 109831 3619 - INCENP - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6156 N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine - - DRUGBANK DB07340 C21H27N7O small molecule - - DRUGBANK 23545 109839 3627 - CXCL10 C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4300 N-Methylleucine - - DRUGBANK DB04487 C7H15NO2 small molecule - - DRUGBANK 23546 109839 3627 - CXCL10 C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4300 N-Methylleucine - - DRUGBANK DB04487 C7H15NO2 small molecule - - DRUGBANK 17766 109842 3630 - INS IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1709 M-Cresol - - DRUGBANK DB01776 C7H8O small molecule - 108-39-4 DRUGBANK 17767 109842 3630 - INS IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1709 M-Cresol - - DRUGBANK DB01776 C7H8O small molecule - 108-39-4 DRUGBANK 17768 109842 3630 - INS IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1709 M-Cresol - - DRUGBANK DB01776 C7H8O small molecule - 108-39-4 DRUGBANK 26267 109842 3630 - INS IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 20690 109845 3633 RP11-109P14.7 INPP5B 5PTase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3026 D-Myo-Inositol-1,4-Bisphosphate - - DRUGBANK DB03158 C6H14O12P2 small molecule - 47055-78-7 DRUGBANK 20691 109845 3633 RP11-109P14.7 INPP5B 5PTase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3026 D-Myo-Inositol-1,4-Bisphosphate - - DRUGBANK DB03158 C6H14O12P2 small molecule - 47055-78-7 DRUGBANK 20692 109845 3633 RP11-109P14.7 INPP5B 5PTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3026 D-Myo-Inositol-1,4-Bisphosphate - - DRUGBANK DB03158 C6H14O12P2 small molecule - 47055-78-7 DRUGBANK 15815 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Wada T (2008) 18585815 172022 1285 Insulin Detemir Levemir innolet|Levemir penfill|Levemir flexpen|Insulin detemir|NN-304|Levemir|Insulin detemir recombinant levemir flextouch|levemir|leve DRUGBANK DB01307 C267H402N64O76S6 biologic A10AE05 169148-63-4 DRUGBANK 15816 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Hennige AM (2006) 16570163 181087 1285 Insulin Detemir Levemir innolet|Levemir penfill|Levemir flexpen|Insulin detemir|NN-304|Levemir|Insulin detemir recombinant levemir flextouch|levemir|leve DRUGBANK DB01307 C267H402N64O76S6 biologic A10AE05 169148-63-4 DRUGBANK 15817 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1285 Insulin Detemir Levemir innolet|Levemir penfill|Levemir flexpen|Insulin detemir|NN-304|Levemir|Insulin detemir recombinant levemir flextouch|levemir|leve DRUGBANK DB01307 C267H402N64O76S6 biologic A10AE05 169148-63-4 DRUGBANK 15818 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Sorensen AR (2010) 20590743 181088 1285 Insulin Detemir Levemir innolet|Levemir penfill|Levemir flexpen|Insulin detemir|NN-304|Levemir|Insulin detemir recombinant levemir flextouch|levemir|leve DRUGBANK DB01307 C267H402N64O76S6 biologic A10AE05 169148-63-4 DRUGBANK 15819 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Kurtzhals P (2000) 10866053 181089 1285 Insulin Detemir Levemir innolet|Levemir penfill|Levemir flexpen|Insulin detemir|NN-304|Levemir|Insulin detemir recombinant levemir flextouch|levemir|leve DRUGBANK DB01307 C267H402N64O76S6 biologic A10AE05 169148-63-4 DRUGBANK 15813 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Zib I (2006) 17026485 181086 1284 Insulin Aspart Aspart|Insulin X14|Insulin, Asp(B28)|INA-X14|Insulin aspart recombinant|B28-Aspart-Insulin|Aspart Insulin|Insulin aspart protamine recombinant novorapid|novolog mix 70/30|no DRUGBANK DB01306 C256H381N65O79S6 biologic A10AB05|A10AD06|A10AD05 116094-23-6 DRUGBANK 15814 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1284 Insulin Aspart Aspart|Insulin X14|Insulin, Asp(B28)|INA-X14|Insulin aspart recombinant|B28-Aspart-Insulin|Aspart Insulin|Insulin aspart protamine recombinant novorapid|novolog mix 70/30|no DRUGBANK DB01306 C256H381N65O79S6 biologic A10AB05|A10AD06|A10AD05 116094-23-6 DRUGBANK 26550 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7292 [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID - - DRUGBANK DB08513 C20H19N5O3 small molecule - - DRUGBANK 352 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Bell DS (2007) 17722952 171898 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 353 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 354 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Desbuquois B (2003) 12970169 171896 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 355 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chiu SL (2010) 20230616 171897 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 356 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Tanti JF (2009) 19683471 171894 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 357 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen LM (2002) 12038982 171895 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 567 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Wada T (2008) 18585815 172022 46 Insulin Glargine Insulin Glargine (rDNA origin)|Insulin glargine recombinant toujeo solostar|basaglar|touje DRUGBANK DB00047 C267H404N72O78S6 biologic A10AE04 160337-95-1 DRUGBANK 568 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Sciacca L (2010) 20424816 172019 46 Insulin Glargine Insulin Glargine (rDNA origin)|Insulin glargine recombinant toujeo solostar|basaglar|touje DRUGBANK DB00047 C267H404N72O78S6 biologic A10AE04 160337-95-1 DRUGBANK 569 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Le Roith D (2007) 17922476 172021 46 Insulin Glargine Insulin Glargine (rDNA origin)|Insulin glargine recombinant toujeo solostar|basaglar|touje DRUGBANK DB00047 C267H404N72O78S6 biologic A10AE04 160337-95-1 DRUGBANK 570 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 46 Insulin Glargine Insulin Glargine (rDNA origin)|Insulin glargine recombinant toujeo solostar|basaglar|touje DRUGBANK DB00047 C267H404N72O78S6 biologic A10AE04 160337-95-1 DRUGBANK 562 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 45 Insulin Lispro Insulin Lispro Recombinant|Insulin lispro protamine recombinant humalog mix50/50|humalog (kwi DRUGBANK DB00046 C257H387N65O76S6 biologic A10AB04|A10AC04|A10AD04 133107-64-9 DRUGBANK 563 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Jehle PM (1996) 8964871 172018 45 Insulin Lispro Insulin Lispro Recombinant|Insulin lispro protamine recombinant humalog mix50/50|humalog (kwi DRUGBANK DB00046 C257H387N65O76S6 biologic A10AB04|A10AC04|A10AD04 133107-64-9 DRUGBANK 564 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Jehle PM (1996) 8937933 172017 45 Insulin Lispro Insulin Lispro Recombinant|Insulin lispro protamine recombinant humalog mix50/50|humalog (kwi DRUGBANK DB00046 C257H387N65O76S6 biologic A10AB04|A10AC04|A10AD04 133107-64-9 DRUGBANK 565 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Sciacca L (2010) 20424816 172019 45 Insulin Lispro Insulin Lispro Recombinant|Insulin lispro protamine recombinant humalog mix50/50|humalog (kwi DRUGBANK DB00046 C257H387N65O76S6 biologic A10AB04|A10AC04|A10AD04 133107-64-9 DRUGBANK 15665 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens unknown target Rosenbloom AL (2009) 19198769 181006 1264 Mecasermin IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant increlex DRUGBANK DB01277 C331H518N94O101S7 biologic H01AC03|H01AC05 68562-41-4 DRUGBANK 22171 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22172 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 15820 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Sciacca L (2010) 20424816 172019 1286 Insulin Glulisine Insulin Glulisine (recombinant DNA origin)|Insulin glulisine recombinant apidra (10ml vial)|apidra DRUGBANK DB01309 C258H384N64O78S6 biologic A10AB06 207748-29-6 DRUGBANK 15821 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1286 Insulin Glulisine Insulin Glulisine (recombinant DNA origin)|Insulin glulisine recombinant apidra (10ml vial)|apidra DRUGBANK DB01309 C258H384N64O78S6 biologic A10AB06 207748-29-6 DRUGBANK 826 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 827 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens binder target Desbuquois B (2003) 12970169 171896 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 828 109854 3643 - INSR CD220|HHF5 9606 Homo sapiens binder target Chen LM (2002) 12038982 171895 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 26551 109874 3667 - IRS1 HIRS-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7292 [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID - - DRUGBANK DB08513 C20H19N5O3 small molecule - - DRUGBANK 21716 109876 3669 - ISG20 CD25|HEM45 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21717 109876 3669 - ISG20 CD25|HEM45 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 10330 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Juwana YB (2010) 20210689 178329 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10331 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target von Segesser LK (2001) 11565896 178334 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10332 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Kondo K (2002) 11929319 178330 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10333 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Dickfeld T (2001) 11342206 178331 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10334 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Roffi M (2002) 12057986 178332 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10335 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Theroux P (2000) 11076818 178333 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 645 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Gibbs NM (2009) 19499855 172057 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 646 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Ibbotson T (2003) 12749745 172056 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 647 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens antagonist target Mazzaferri EL (2008) 18510478 172055 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 24035 109881 3674 - ITGA2B BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93 9606 Homo sapiens unknown target Akkerhuis KM (2001) 11250974 181770 4663 Lefradafiban - - DRUGBANK DB04863 C23H25N3O6 small molecule - 149503-79-7 DRUGBANK 1303 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens antibody target Stueve O (2007) 17461891 172435 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1304 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens antibody target Sheremata WA (2005) 16268663 172434 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1305 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1306 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens antibody target Craddock CF (1997) 9389694 172433 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1307 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens antibody target Niino M (2006) 16634035 172432 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 24848 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens inhibitor target Schlesinger M (2009) 19888514 182133 5647 Tinzaparin Tinzaparin sodium innohep multi-dose vial- 10000 DRUGBANK DB06822 - small molecule B01AB10 9041-08-1 DRUGBANK 27453 109883 3676 - ITGA4 CD49D|IA4 9606 Homo sapiens antibody target Soler D (2009) 19509315 188531 7796 Vedolizumab Entyvio entyvio DRUGBANK DB09033 C6528H10072N1732O2042S42 biologic L04AA33 943609-66-3 DRUGBANK 18668 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2093 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine - - DRUGBANK DB02177 C25H27N4O4S small molecule - - DRUGBANK 18669 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2093 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine - - DRUGBANK DB02177 C25H27N4O4S small molecule - - DRUGBANK 22209 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3768 LFA703 - - DRUGBANK DB03932 C37H49NO6 small molecule - - DRUGBANK 22210 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3768 LFA703 - - DRUGBANK DB03932 C37H49NO6 small molecule - - DRUGBANK 25508 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6297 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline - - DRUGBANK DB07486 C21H18F6N2O2S small molecule - - DRUGBANK 24989 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5791 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile - - DRUGBANK DB06972 C22H15Cl2N3O small molecule - - DRUGBANK 1166 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1167 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens antibody target Frampton JE (2009) 19170413 172365 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1168 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens antibody target Descamps V (2006) 17053736 172366 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1196 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 4438 109889 3683 - ITGAL CD11A|LFA-1|LFA1A 9606 Homo sapiens unknown target Kallen J (1999) 10493852 4708 220 Lovastatin Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine dom-lovastatin|phl-lovastatin| DRUGBANK DB00227 C24H36O5 small molecule C10BA01|C10AA02 75330-75-5 DRUGBANK 1204 109891 3685 - ITGAV CD51|MSK8|VNRA|VTNR 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 1203 109894 3688 RP11-479G22.2 ITGB1 CD29|FNRB|GPIIA|MDF2|MSK12|VLA-BETA|VLAB 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 8904 109895 3689 - ITGB2 CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7 9606 Homo sapiens unknown target Fujii T (2007) 17289088 177511 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8905 109895 3689 - ITGB2 CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7 9606 Homo sapiens unknown target Fujii T (2006) 16828882 177510 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8906 109895 3689 - ITGB2 CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7 9606 Homo sapiens unknown target Takahashi HK (2005) 15936988 177508 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 8907 109895 3689 - ITGB2 CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7 9606 Homo sapiens unknown target Katano H (2004) 15041742 177509 631 Simvastatin 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin septa-simvastatin|riva-simvast DRUGBANK DB00641 C25H38O5 small molecule A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04 79902-63-9 DRUGBANK 755 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Schroer K (2003) 14618072 172126 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 756 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Schwarz M (2004) 14617694 172125 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 757 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Fischer TH (2005) 15860200 172124 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 758 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Auer J (2003) 12928738 172123 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 759 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 760 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Weber AA (2002) 12360110 172121 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 761 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Amoroso G (2001) 11588534 172059 62 Eptifibatide Intrifiban|Integrelin eptifibatide|eptifibatide inje DRUGBANK DB00063 C35H49N11O9S2 biologic B01AC16 188627-80-7 DRUGBANK 10327 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Juwana YB (2010) 20210689 178329 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10328 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 10329 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 765 Tirofiban Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid aggrastat DRUGBANK DB00775 C22H36N2O5S small molecule B01AC17 144494-65-5 DRUGBANK 1206 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Monti P (2003) 12586600 172372 94 Anti-thymocyte Globulin (Rabbit) rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit) thymoglobulin DRUGBANK DB00098 - biologic - - DRUGBANK 658 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 659 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Hall PR (2007) 17441904 172060 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 660 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Ibbotson T (2003) 12749745 172056 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 661 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Mazzaferri EL (2008) 18510478 172055 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 662 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Amoroso G (2001) 11588534 172059 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 663 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens antagonist target Weber AA (2002) 12165285 172058 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 24034 109896 3690 - ITGB3 BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT 9606 Homo sapiens unknown target Akkerhuis KM (2001) 11250974 181770 4663 Lefradafiban - - DRUGBANK DB04863 C23H25N3O6 small molecule - 149503-79-7 DRUGBANK 27452 109901 3695 - ITGB7 - 9606 Homo sapiens antibody target Soler D (2009) 19509315 188531 7796 Vedolizumab Entyvio entyvio DRUGBANK DB09033 C6528H10072N1732O2042S42 biologic L04AA33 943609-66-3 DRUGBANK 24575 109907 3702 - ITK EMT|LPFS1|LYK|PSCTK2 9606 Homo sapiens inhibitor target Deeks ED (2012) 23072642 182214 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 18326 109907 3702 - ITK EMT|LPFS1|LYK|PSCTK2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18327 109907 3702 - ITK EMT|LPFS1|LYK|PSCTK2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 22975 109909 3704 My049 ITPA C20orf37|HLC14-06-P|dJ794I6.3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 17956 109911 3706 - ITPKA IP3-3KA|IP3KA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17957 109911 3706 - ITPKA IP3-3KA|IP3KA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 21124 109911 3706 - ITPKA IP3-3KA|IP3KA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21125 109911 3706 - ITPKA IP3-3KA|IP3KA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 23286 109911 3706 - ITPKA IP3-3KA|IP3KA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23287 109911 3706 - ITPKA IP3-3KA|IP3KA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 21135 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21136 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21137 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 4255 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Parker I (1991) 1844813 174347 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 22508 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22509 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22510 109913 3708 - ITPR1 ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 4256 109914 3709 - ITPR2 CFAP48|IP3R2 9606 Homo sapiens unknown target Parker I (1991) 1844813 174347 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4257 109915 3710 - ITPR3 IP3R|IP3R3 9606 Homo sapiens unknown target Parker I (1991) 1844813 174347 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 22422 109916 3712 - IVD ACAD2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3868 Coenzyme a Persulfide - - DRUGBANK DB04036 C21H36N7O16P3S2 small molecule - - DRUGBANK 22423 109916 3712 - IVD ACAD2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3868 Coenzyme a Persulfide - - DRUGBANK DB04036 C21H36N7O16P3S2 small molecule - - DRUGBANK 20633 109916 3712 - IVD ACAD2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20634 109916 3712 - IVD ACAD2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 26210 109919 3716 - JAK1 JAK1A|JAK1B|JTK3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6975 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile - - DRUGBANK DB08183 C16H20N6O small molecule - - DRUGBANK 26942 109919 3716 - JAK1 JAK1A|JAK1B|JTK3 9606 Homo sapiens inhibitor target Yang LP (2012) 23061804 182213 7621 Ruxolitinib INCB424|INCB018424 jakafi|jakavi DRUGBANK DB08877 C17H18N6 small molecule L01XE18 941678-49-5 DRUGBANK 26943 109919 3716 - JAK1 JAK1A|JAK1B|JTK3 9606 Homo sapiens inhibitor target Cervantes F (2013) 23514013 182236 7621 Ruxolitinib INCB424|INCB018424 jakafi|jakavi DRUGBANK DB08877 C17H18N6 small molecule L01XE18 941678-49-5 DRUGBANK 23837 109919 3716 - JAK1 JAK1A|JAK1B|JTK3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4520 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE - - DRUGBANK DB04716 C18H16FN3O small molecule - - DRUGBANK 26212 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6975 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile - - DRUGBANK DB08183 C16H20N6O small molecule - - DRUGBANK 25172 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5980 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide - - DRUGBANK DB07162 C17H20N4O2S small molecule - - DRUGBANK 23839 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4520 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE - - DRUGBANK DB04716 C18H16FN3O small molecule - - DRUGBANK 25171 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5979 5-phenyl-1H-indazol-3-amine - - DRUGBANK DB07161 C13H11N3 small molecule - - DRUGBANK 26944 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens inhibitor target Yang LP (2012) 23061804 182213 7621 Ruxolitinib INCB424|INCB018424 jakafi|jakavi DRUGBANK DB08877 C17H18N6 small molecule L01XE18 941678-49-5 DRUGBANK 26945 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens inhibitor target Cervantes F (2013) 23514013 182236 7621 Ruxolitinib INCB424|INCB018424 jakafi|jakavi DRUGBANK DB08877 C17H18N6 small molecule L01XE18 941678-49-5 DRUGBANK 26093 109920 3717 - JAK2 JTK10|THCYT3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6860 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM - - DRUGBANK DB08067 C19H24N7O2 small molecule - - DRUGBANK 26211 109921 3718 - JAK3 JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6975 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile - - DRUGBANK DB08183 C16H20N6O small molecule - - DRUGBANK 23840 109921 3718 - JAK3 JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4520 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE - - DRUGBANK DB04716 C18H16FN3O small molecule - - DRUGBANK 8115 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Martinez-Campa C (2006) 16555127 176947 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8116 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Duan L (2007) 17126817 176949 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8117 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Obey TB (2005) 16111654 176948 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8118 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Brantley-Finley C (2003) 12907245 176950 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8119 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Bene A (2004) 15498923 176951 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 14398 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens inducer target Kietzmann T (2003) 12637567 180441 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14399 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens inducer target Li J (2003) 12547826 180437 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14400 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens inducer target Dong Z (2002) 12426127 180438 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14401 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens inducer target Drobna Z (2003) 12475910 180439 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14402 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens inducer target Muscarella DE (2002) 12075113 180440 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 12945 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Zhu ZS (2004) 15133856 179770 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 12946 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Cheng SM (2004) 15210574 179769 1018 Irbesartan 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295 ipg-irbesartan|dom-irbesartan| DRUGBANK DB01029 C25H28N6O small molecule C09DA04|C09CA04|C09DB05 138402-11-6 DRUGBANK 11174 109928 3725 - JUN AP-1|AP1|c-Jun 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 1848 109938 3735 - KARS CMTRIB|DFNB89|KARS1|KARS2|KRS 9606 Homo sapiens unknown target Wu XR (2007) 17425721 172831 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1849 109938 3735 - KARS CMTRIB|DFNB89|KARS1|KARS2|KRS 9606 Homo sapiens unknown target Kamenski P (2007) 17560369 72256 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1850 109938 3735 - KARS CMTRIB|DFNB89|KARS1|KARS2|KRS 9606 Homo sapiens unknown target Kwon I (2006) 16953616 172833 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1851 109938 3735 - KARS CMTRIB|DFNB89|KARS1|KARS2|KRS 9606 Homo sapiens unknown target Chou TF (2007) 17158446 172832 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 14624 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14625 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14626 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Matchett GA (2009) 19298752 174518 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 10117 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10118 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10119 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Matchett GA (2009) 19298752 174518 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 24602 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 5543 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inhibitor target Punke MA (2007) 17456683 175184 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 15206 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15207 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 13914 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inhibitor target Bett GC (2008) 18096604 180229 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 12937 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12938 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12939 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Elliott JR (1992) 1336744 179767 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 4451 109939 3736 - KCNA1 AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1 9606 Homo sapiens inducer target Matchett GA (2009) 19298752 174518 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 24599 109940 3737 RP11-284N8.1 KCNA2 HBK5|HK4|HUKIV|KV1.2|MK2|NGK1|RBK2 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24600 109941 3738 RP11-284N8.3 KCNA3 HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24610 109942 3739 - KCNA4 HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 18891 109942 3739 - KCNA4 HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2206 Arginineamide - - DRUGBANK DB02299 C6H16N5O small molecule - - DRUGBANK 18892 109942 3739 - KCNA4 HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2206 Arginineamide - - DRUGBANK DB02299 C6H16N5O small molecule - - DRUGBANK 18893 109942 3739 - KCNA4 HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2206 Arginineamide - - DRUGBANK DB02299 C6H16N5O small molecule - - DRUGBANK 24601 109943 3741 - KCNA5 ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24597 109944 3742 - KCNA6 HBK2|KV1.6|PPP1R96 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24598 109945 3743 - KCNA7 HAK6|KV1.7 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24607 109946 3744 - KCNA10 Kcn1|Kv1.8 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24606 109947 3745 - KCNB1 DRK1|EIEE26|KV2.1|h-DRK1 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24608 109948 3746 - KCNC1 KV3.1|KV4|NGK2 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24604 109949 3747 - KCNC2 KV3.2 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24603 109950 3748 - KCNC3 KSHIIID|KV3.3|SCA13 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 24605 109952 3750 - KCND1 KV4.1 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 7119 109953 3751 - KCND2 KV4.2|RK5 9606 Homo sapiens inhibitor target Casis O (1998) 9781919 174867 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 24611 109953 3751 - KCND2 KV4.2|RK5 9606 Homo sapiens antagonist target Goodman AD (2013) 23184313 182218 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 5081 109953 3751 - KCND2 KV4.2|RK5 9606 Homo sapiens inhibitor target Casis O (1998) 9781919 174867 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5547 109953 3751 - KCND2 KV4.2|RK5 9606 Homo sapiens inhibitor target Casis O (1998) 9781919 174867 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 7118 109954 3752 RP4-773A18.7 KCND3 KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22 9606 Homo sapiens inhibitor target Casis O (1998) 9781919 174867 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 24596 109954 3752 RP4-773A18.7 KCND3 KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 5080 109954 3752 RP4-773A18.7 KCND3 KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22 9606 Homo sapiens inhibitor target Casis O (1998) 9781919 174867 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5546 109954 3752 RP4-773A18.7 KCND3 KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22 9606 Homo sapiens inhibitor target Casis O (1998) 9781919 174867 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24235 109955 3753 - KCNE1 ISK|JLNS|JLNS2|LQT2/5|LQT5|MinK 9606 Homo sapiens unknown target Abrol R (2000) 11060832 181764 4751 Azimilide - - DRUGBANK DB04957 C23H28ClN5O3 small molecule - 149908-53-2 DRUGBANK 24236 109955 3753 - KCNE1 ISK|JLNS|JLNS2|LQT2/5|LQT5|MinK 9606 Homo sapiens unknown target Schmitt H (2001) 11573692 181777 4751 Azimilide - - DRUGBANK DB04957 C23H28ClN5O3 small molecule - 149908-53-2 DRUGBANK 10720 109955 3753 - KCNE1 ISK|JLNS|JLNS2|LQT2/5|LQT5|MinK 9606 Homo sapiens inhibitor target Ohya S (2002) 11804849 178472 798 Indapamide Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide dom-indapamide tablets 1.25mg| DRUGBANK DB00808 C16H16ClN3O3S small molecule C03BA11|C09BX01 26807-65-8 DRUGBANK 8870 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Taglialatela M (1999) 10444235 177490 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8871 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chiu PJ (2004) 15272206 177489 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8872 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Grzelewska-Rzymowska I (2001) 11575008 177488 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8873 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chachin M (1999) 10422790 177487 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8874 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Zhou Z (1999) 10376921 177486 627 Astemizole Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol hismanal tab 10mg|hismanal sus DRUGBANK DB00637 C28H31FN4O small molecule R06AX11 68844-77-9 DRUGBANK 8533 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Lin J (2005) 15967876 177220 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8534 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Walker BD (1999) 10510456 177223 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8535 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chen J (2002) 12209010 177222 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8536 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Mohammad S (1997) 9374794 177221 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 8537 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Perrio M (2007) 17408310 177219 594 Cisapride 4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride prepulsid sus 1mg/ml|prepulsid DRUGBANK DB00604 C23H29ClFN3O4 small molecule A03FA02 81098-60-4 DRUGBANK 9431 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Milnes JT (2006) 17056009 177782 669 Thioridazine Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril thioridazine tab 50mg|novo-rid DRUGBANK DB00679 C21H26N2S2 small molecule N05AC02 50-52-2 DRUGBANK 7121 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Teschemacher AG (1999) 10510461 176218 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 5792 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Gessner G (2004) 15102940 175359 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5793 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Testai L (2010) 20636881 175358 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 5794 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 334 Terfenadine Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol seldane 120mg once-a-day caple DRUGBANK DB00342 C32H41NO2 small molecule R06AX12 50679-08-8 DRUGBANK 4288 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Finlayson K (2001) 11698075 174374 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4289 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Ficker E (2001) 11723241 174375 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4290 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Kang J (2005) 15548764 174376 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4291 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Ficker E (1998) 9486667 174377 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4292 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Overholt JL (2000) 10712445 174373 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4293 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4294 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Finlayson K (2001) 11166283 174378 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4295 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Lees-Miller JP (2000) 10648647 174379 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 14970 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Mbai M (2002) 12176129 180680 1206 Halofantrine Halfan|Halofantrine|Halofantrinum|Halofantrina halfan - tab 250mg DRUGBANK DB01218 C26H30Cl2F3NO small molecule P01BX01 69756-53-2 DRUGBANK 14971 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Tie H (2000) 10952689 180679 1206 Halofantrine Halfan|Halofantrine|Halofantrinum|Halofantrina halfan - tab 250mg DRUGBANK DB01218 C26H30Cl2F3NO small molecule P01BX01 69756-53-2 DRUGBANK 14088 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Kawakami K (2006) 16314852 180326 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14089 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Karle CA (2001) 11164846 180327 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 13734 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Kang J (2001) 11511086 180131 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13735 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Osypenko VM (2001) 11296551 180130 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13736 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Kang J (2000) 10762666 180128 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 13737 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Shuba YM (2001) 11377395 180129 1088 Pimozide Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole orap|pms-pimozide|orap tab 10m DRUGBANK DB01100 C28H29F2N3O small molecule N05AG02 2062-78-4 DRUGBANK 24019 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Iwamoto T (2007) 17896959 182051 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 27242 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Keserue GM (2003) 12873512 188483 1199 Clarithromycin Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum mylan-clarithromycin|ran-clari DRUGBANK DB01211 C38H69NO13 small molecule J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09 81103-11-9 DRUGBANK 27111 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Keserue GM (2003) 12873512 188483 527 Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum riva-ciprofloxacin|cipro tab 2 DRUGBANK DB00537 C17H18FN3O3 small molecule S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03 85721-33-1 DRUGBANK 9124 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Duan JJ (2007) 17588331 177623 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9125 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Cheng HC (2006) 16507347 177622 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9126 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Shimizu W (2005) 15892662 177621 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9127 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Schneider J (2005) 15814090 177620 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9128 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Ridley JM (2004) 15135665 177624 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9129 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 7091 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 7346 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Thomas D (2003) 12788816 176348 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 8377 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 14524 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1170 Propafenone 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone propafenone|apo-propafenone|pr DRUGBANK DB01182 C21H27NO3 small molecule C01BC03 54063-53-5 DRUGBANK 14525 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Mergenthaler J (2001) 11330342 180496 1170 Propafenone 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone propafenone|apo-propafenone|pr DRUGBANK DB01182 C21H27NO3 small molecule C01BC03 54063-53-5 DRUGBANK 14526 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Arias C (2003) 12618228 180497 1170 Propafenone 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone propafenone|apo-propafenone|pr DRUGBANK DB01182 C21H27NO3 small molecule C01BC03 54063-53-5 DRUGBANK 11643 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Po SS (1999) 10028924 179020 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11644 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Wolpert C (2005) 15673388 176453 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11645 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Guerard NC (2008) 18582585 179017 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11646 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Dong DL (2004) 15125690 179022 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11647 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Lin C (2005) 15821840 179021 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11648 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Lin C (2005) 16041196 179019 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 5355 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Yang T (2001) 11602820 175085 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5356 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Perry M (2004) 15266014 175084 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5357 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Perry M (2006) 16291873 175087 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5358 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Wolpert C (2007) 17497253 175086 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5359 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5360 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Wolpert C (2005) 16076272 175083 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 14146 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Duncan RS (2007) 17560554 180342 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 13857 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13858 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Kikuchi K (2005) 15778703 180212 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 14386 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 5032 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Thomas D (2004) 15148258 174817 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 27071 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Du LP (2004) 15324906 188475 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 24380 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Kang J (2001) 11511086 180131 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24381 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Tang W (2001) 11689132 181779 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 24382 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Rampe D (1998) 9694935 181731 5514 Sertindole SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum - DRUGBANK DB06144 C24H26ClFN4O small molecule N05AE03 106516-24-9 DRUGBANK 7452 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Numaguchi H (2000) 11090546 176452 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7449 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Wolpert C (2005) 15673388 176453 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7448 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Fedida D (2006) 16686685 174883 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7451 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Shimizu W (2000) 10931813 176451 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 7450 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Wolpert C (2005) 16076272 175083 481 Sotalol Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum pro-sotalol|sotalol hydrochlor DRUGBANK DB00489 C12H20N2O3S small molecule C07BA07|C07AA57|C07AA07 3930-20-9 DRUGBANK 24233 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Abrol R (2000) 11060832 181764 4751 Azimilide - - DRUGBANK DB04957 C23H28ClN5O3 small molecule - 149908-53-2 DRUGBANK 24234 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens unknown target Schmitt H (2001) 11573692 181777 4751 Azimilide - - DRUGBANK DB04957 C23H28ClN5O3 small molecule - 149908-53-2 DRUGBANK 13937 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Wang SP (2008) 18505444 180242 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 13938 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Varro A (2004) 14754422 180241 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 13939 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Waldhauser KM (2008) 18604229 180240 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 13940 109959 3757 - KCNH2 ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 4421 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4422 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Bataille D (2002) 12703060 174488 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4423 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4424 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Proks P (2002) 12475777 174487 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 16277 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16278 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16279 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Greeley SA (2010) 20434356 181237 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16280 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Guirgis FK (1976) 134717 181236 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16281 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Serrano-Martin X (2006) 17015627 179676 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16282 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Lu M (2006) 16470247 179682 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16283 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Pondugula SR (2006) 16263802 179681 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 4397 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Bkaily G (1988) 3167688 174455 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 4398 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Bkaily G (1990) 2157221 174454 210 Bethanidine Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine - DRUGBANK DB00217 C10H15N3 small molecule C02CC01 55-73-2 DRUGBANK 16337 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 26901 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens antagonist target Shepherd RM (1996) 8922740 181712 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 6663 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 406 Acetohexamide 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea|Acetohexamidum|1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide|Actohexamide|Acetohexamid|Acetohexamida|Acetohexamide|N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea dimelor tablet 1843 500mg DRUGBANK DB00414 C15H20N2O4S small molecule A10BB31 968-81-0 DRUGBANK 6664 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 406 Acetohexamide 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea|Acetohexamidum|1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide|Actohexamide|Acetohexamid|Acetohexamida|Acetohexamide|N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea dimelor tablet 1843 500mg DRUGBANK DB00414 C15H20N2O4S small molecule A10BB31 968-81-0 DRUGBANK 13988 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Liu X (1999) 10455193 180278 1112 Tolbutamide 3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea orinase 1gm|novo-butamide 500m DRUGBANK DB01124 C12H18N2O3S small molecule V04CA01|A10BB03 64-77-7 DRUGBANK 13989 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Proks P (2001) 11226127 180276 1112 Tolbutamide 3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea orinase 1gm|novo-butamide 500m DRUGBANK DB01124 C12H18N2O3S small molecule V04CA01|A10BB03 64-77-7 DRUGBANK 13990 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Smith PA (1998) 9647478 180277 1112 Tolbutamide 3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea orinase 1gm|novo-butamide 500m DRUGBANK DB01124 C12H18N2O3S small molecule V04CA01|A10BB03 64-77-7 DRUGBANK 10999 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 829 Tolazamide 1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea tolazamide DRUGBANK DB00839 C14H21N3O3S small molecule A10BB05 1156-19-0 DRUGBANK 11000 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 829 Tolazamide 1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea tolazamide DRUGBANK DB00839 C14H21N3O3S small molecule A10BB05 1156-19-0 DRUGBANK 11001 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Szabo C (1996) 8799949 178635 829 Tolazamide 1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea tolazamide DRUGBANK DB00839 C14H21N3O3S small molecule A10BB05 1156-19-0 DRUGBANK 11002 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Asano K (1999) 10354277 178636 829 Tolazamide 1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea tolazamide DRUGBANK DB00839 C14H21N3O3S small molecule A10BB05 1156-19-0 DRUGBANK 5882 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Evans JM (2005) 16169954 175419 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5883 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5884 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5885 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Black KL (2008) 18602898 175423 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5886 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Kirsten R (1998) 9646008 175422 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5887 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Bray KM (1992) 1601843 175421 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5888 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inducer target Loeffler-Walz C (1998) 9579735 175420 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 12778 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Lu M (2006) 16470247 179682 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12779 109960 3758 - KCNJ1 KIR1.1|ROMK|ROMK1 9606 Homo sapiens inhibitor target Pondugula SR (2006) 16263802 179681 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 27168 109962 3760 - KCNJ3 GIRK1|KGA|KIR3.1 9606 Homo sapiens unknown target Spanagel R (2009) 19342616 188489 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27783 109962 3760 - KCNJ3 GIRK1|KGA|KIR3.1 9606 Homo sapiens unknown target Bodhinathan K (2013) 24145411 196019 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14340 109962 3760 - KCNJ3 GIRK1|KGA|KIR3.1 9606 Homo sapiens inhibitor target Milovic S (2004) 15175324 180409 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14341 109962 3760 - KCNJ3 GIRK1|KGA|KIR3.1 9606 Homo sapiens inhibitor target Yamakura T (2001) 11465552 180416 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14342 109962 3760 - KCNJ3 GIRK1|KGA|KIR3.1 9606 Homo sapiens inhibitor target Weigl LG (2001) 11455015 180415 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 12759 109964 3762 - KCNJ5 CIR|GIRK4|KATP1|KIR3.4|LQT13 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 27155 109964 3762 - KCNJ5 CIR|GIRK4|KATP1|KIR3.4|LQT13 9606 Homo sapiens unknown target Spanagel R (2009) 19342616 188489 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27780 109964 3762 - KCNJ5 CIR|GIRK4|KATP1|KIR3.4|LQT13 9606 Homo sapiens unknown target Bodhinathan K (2013) 24145411 196019 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27150 109965 3763 - KCNJ6 BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2 9606 Homo sapiens unknown target Spanagel R (2009) 19342616 188489 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27779 109965 3763 - KCNJ6 BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2 9606 Homo sapiens unknown target Bodhinathan K (2013) 24145411 196019 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14350 109965 3763 - KCNJ6 BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2 9606 Homo sapiens inhibitor target Milovic S (2004) 15175324 180409 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14351 109965 3763 - KCNJ6 BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2 9606 Homo sapiens inhibitor target Hara K (2005) 16243998 180417 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14278 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Eguchi S (2005) 15852621 180391 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14279 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Kawano T (2004) 14739809 180390 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14280 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Tsutsumi Y (2000) 10754636 180389 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 11872 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Aziz Q (2010) 20188727 179063 904 Phenformin DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum - DRUGBANK DB00914 C10H15N5 small molecule A10BD01|A10BA01 114-86-3 DRUGBANK 16334 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 15759 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Szewczyk A (1997) 9015372 180852 1274 Glisoxepide RP-22410|BAY-b-4231|FBB-4231|Glisoxepide - DRUGBANK DB01289 C20H27N5O5S small molecule A10BB11 25046-79-1 DRUGBANK 15760 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Sato T (2006) 16174795 180851 1274 Glisoxepide RP-22410|BAY-b-4231|FBB-4231|Glisoxepide - DRUGBANK DB01289 C20H27N5O5S small molecule A10BB11 25046-79-1 DRUGBANK 15386 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Szewczyk A (1997) 9015372 180852 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 15387 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Hill RA (2003) 12670661 180853 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 15388 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inhibitor target Sato T (2006) 16174795 180851 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 12760 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens unknown target Jaburek M (1998) 9593694 179666 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 11948 109966 3764 - KCNJ8 KIR6.1|uKATP-1 9606 Homo sapiens inducer target Yildiz O (2007) 17452812 179117 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 27173 109967 3765 RP11-536C5.1 KCNJ9 GIRK3|KIR3.3 9606 Homo sapiens unknown target Spanagel R (2009) 19342616 188489 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27787 109967 3765 RP11-536C5.1 KCNJ9 GIRK3|KIR3.3 9606 Homo sapiens unknown target Bodhinathan K (2013) 24145411 196019 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 16335 109968 3766 - KCNJ10 BIRK-10|KCNJ13-PEN|KIR1.2|KIR4.1|SESAME 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 14289 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Eguchi S (2005) 15852621 180391 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14290 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Kawano T (2004) 14739809 180390 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 14291 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Tsutsumi Y (2000) 10754636 180389 1142 Thiamylal 5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal - DRUGBANK DB01154 C12H18N2O2S small molecule - 77-27-0 DRUGBANK 4425 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Lawrence CL (2002) 12086984 174490 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4426 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Bataille D (2002) 12703060 174488 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4427 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Song DK (2001) 11325810 174489 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 5351 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5352 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 16336 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 13941 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inducer target D'hahan N (1999) 10518593 180243 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13942 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inducer target de Lonlay P (2002) 11808879 180247 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13943 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inducer target Russ U (2003) 12770942 180246 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13944 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inducer target Sakura H (1999) 10581306 180245 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13945 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inducer target Shindo T (2000) 10604939 180244 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 9121 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Shigeto M (2007) 17409272 177618 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9122 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Yamada S (2006) 17038430 177619 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9123 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 12787 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens modulator target Lim JG (2004) 15294453 179690 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12788 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens modulator target Ball AJ (2004) 15082027 179691 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12789 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens modulator target Nielsen FE (2002) 12213059 179678 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12790 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens modulator target Hambrock A (2002) 12145099 179665 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12791 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens modulator target Gojkovic-Bukarica L (2002) 12359624 179692 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12761 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens unknown target Jaburek M (1998) 9593694 179666 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 11955 109969 3767 - KCNJ11 BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3 9606 Homo sapiens inducer target Yildiz O (2007) 17452812 179117 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 4287 109970 3768 - KCNJ12 IRK-2|IRK2|KCNJN1|Kir2.2|Kir2.2v|hIRK|hIRK1|hkir2.2x|kcnj12x 9606 Homo sapiens inhibitor target Kiehn J (1996) 8700146 174372 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 16339 109970 3768 - KCNJ12 IRK-2|IRK2|KCNJN1|Kir2.2|Kir2.2v|hIRK|hIRK1|hkir2.2x|kcnj12x 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16333 109972 3770 - KCNJ14 IRK4|KIR2.4 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 16338 109974 3772 - KCNJ15 IRKK|KIR1.3|KIR4.2 9606 Homo sapiens unknown target Plant TD (1990) 2282453 181249 1342 Yohimbine (+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester yohimbine hydrochloride tablet DRUGBANK DB01392 C21H26N2O3 small molecule G04BE04 146-48-5 DRUGBANK 11631 109976 3775 RP4-550F15.1 KCNK1 DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1 9606 Homo sapiens inhibitor target Lesage F (1996) 8605869 179010 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11632 109976 3775 RP4-550F15.1 KCNK1 DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1 9606 Homo sapiens inhibitor target Fink M (1996) 9003761 179011 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 5349 109976 3775 RP4-550F15.1 KCNK1 DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1 9606 Homo sapiens inhibitor target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5350 109976 3775 RP4-550F15.1 KCNK1 DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1 9606 Homo sapiens inhibitor target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 15937 109976 3775 RP4-550F15.1 KCNK1 DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1 9606 Homo sapiens inhibitor target Lesage F (1996) 8605869 179010 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15938 109976 3775 RP4-550F15.1 KCNK1 DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1 9606 Homo sapiens inhibitor target Fink M (1996) 9003761 179011 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 24020 109977 3776 - KCNK2 K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e 9606 Homo sapiens inhibitor target Schmidt C (2012) 22790794 182206 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 4284 109977 3776 - KCNK2 K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4285 109977 3776 - KCNK2 K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 4286 109977 3776 - KCNK2 K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e 9606 Homo sapiens inhibitor target Roukoz H (2007) 17187453 174371 197 Dofetilide Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida tikosyn DRUGBANK DB00204 C19H27N3O5S2 small molecule C01BD04 115256-11-6 DRUGBANK 8049 109978 3777 - KCNK3 K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1 9606 Homo sapiens inhibitor target Anderson-Beck R (1995) 7617294 176878 551 Doxapram Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram dopram|dopram inj 20mg/ml|dopr DRUGBANK DB00561 C24H30N2O2 small molecule R07AB01 309-29-5 DRUGBANK 8050 109978 3777 - KCNK3 K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1 9606 Homo sapiens inhibitor target Yost CS (2007) 17227289 176877 551 Doxapram Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram dopram|dopram inj 20mg/ml|dopr DRUGBANK DB00561 C24H30N2O2 small molecule R07AB01 309-29-5 DRUGBANK 8051 109978 3777 - KCNK3 K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1 9606 Homo sapiens inhibitor target Peers C (1991) 1667613 176876 551 Doxapram Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram dopram|dopram inj 20mg/ml|dopr DRUGBANK DB00561 C24H30N2O2 small molecule R07AB01 309-29-5 DRUGBANK 14352 109978 3777 - KCNK3 K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1 9606 Homo sapiens binder target Lazarenko RM (2010) 20519544 180418 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14353 109978 3777 - KCNK3 K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1 9606 Homo sapiens binder target Pandit JJ (2010) 20217349 180419 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 12638 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Tricarico D (2004) 14766795 176046 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 14332 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inhibitor target Namba T (2000) 10794813 174523 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14333 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 12669 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 993 Cromoglicic acid Acide Cromoglicique|Cromoglicate|Acido Cromoglicico|5-[3-(2-Carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid|Cromolyn|Acidum Cromoglicicum|Cromoglycate|Cromoglicic Acid anti-allergy eye drops|vistacr DRUGBANK DB01003 C23H16O11 small molecule A07EB01|R03BC01|S01GX01|S01GX51|R01AC01|R03AK04|R03AK05|R01AC51|D11AH03 16110-51-3 DRUGBANK 12670 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 993 Cromoglicic acid Acide Cromoglicique|Cromoglicate|Acido Cromoglicico|5-[3-(2-Carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid|Cromolyn|Acidum Cromoglicicum|Cromoglycate|Cromoglicic Acid anti-allergy eye drops|vistacr DRUGBANK DB01003 C23H16O11 small molecule A07EB01|R03BC01|S01GX01|S01GX51|R01AC01|R03AK04|R03AK05|R01AC51|D11AH03 16110-51-3 DRUGBANK 6919 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inducer target Tricarico D (2004) 14766795 176046 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 13861 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13862 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 10314 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10315 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 13946 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Kloeckner U (1989) 2541731 180249 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13947 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target O'Malley D (2003) 12726817 180248 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13948 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Zhang L (2006) 16446048 180250 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 9816 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 5919 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Dong DL (2006) 16859676 175452 348 Chlorzoxazone 5-chloro-2-Benzoxazolone|Chlorzoxazone|2-hydroxy-5-chlorobenzoxazole|5-chloro-2-Benzoxazolol|Clorzoxazona|Chlorzoxane|Chlorzoxazonum|5-chlorobenzoxazolin-2-one|5-chloro-2-Benzoxazolinone|Chlorzoxazona|5-chloro-3H-benzooxazol-2-one|5-Chlorobenzoxazolidone|Clorzoxazone|Chlorzoxazon|5-chloro-2-Hydroxybenzoxazole|5-chloro-2(3H)-benzoxazolone parafon forte dsc|acetazone fo DRUGBANK DB00356 C7H4ClNO2 small molecule M03BB53|M03BB03|M03BB73 95-25-0 DRUGBANK 5920 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Alvina K (2010) 20505091 175450 348 Chlorzoxazone 5-chloro-2-Benzoxazolone|Chlorzoxazone|2-hydroxy-5-chlorobenzoxazole|5-chloro-2-Benzoxazolol|Clorzoxazona|Chlorzoxane|Chlorzoxazonum|5-chlorobenzoxazolin-2-one|5-chloro-2-Benzoxazolinone|Chlorzoxazona|5-chloro-3H-benzooxazol-2-one|5-Chlorobenzoxazolidone|Clorzoxazone|Chlorzoxazon|5-chloro-2-Hydroxybenzoxazole|5-chloro-2(3H)-benzoxazolone parafon forte dsc|acetazone fo DRUGBANK DB00356 C7H4ClNO2 small molecule M03BB53|M03BB03|M03BB73 95-25-0 DRUGBANK 5921 109979 3778 RP11-443A13.1 KCNMA1 BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1 9606 Homo sapiens unknown target Syme CA (2000) 10712246 175451 348 Chlorzoxazone 5-chloro-2-Benzoxazolone|Chlorzoxazone|2-hydroxy-5-chlorobenzoxazole|5-chloro-2-Benzoxazolol|Clorzoxazona|Chlorzoxane|Chlorzoxazonum|5-chlorobenzoxazolin-2-one|5-chloro-2-Benzoxazolinone|Chlorzoxazona|5-chloro-3H-benzooxazol-2-one|5-Chlorobenzoxazolidone|Clorzoxazone|Chlorzoxazon|5-chloro-2-Hydroxybenzoxazole|5-chloro-2(3H)-benzoxazolone parafon forte dsc|acetazone fo DRUGBANK DB00356 C7H4ClNO2 small molecule M03BB53|M03BB03|M03BB73 95-25-0 DRUGBANK 13875 109980 3779 - KCNMB1 BKbeta1|K(VCA)beta|SLO-BETA|hbeta1|hslo-beta|k(VCA)beta-1|slo-beta-1 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13876 109980 3779 - KCNMB1 BKbeta1|K(VCA)beta|SLO-BETA|hbeta1|hslo-beta|k(VCA)beta-1|slo-beta-1 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9811 109980 3779 - KCNMB1 BKbeta1|K(VCA)beta|SLO-BETA|hbeta1|hslo-beta|k(VCA)beta-1|slo-beta-1 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 13879 109981 3780 - KCNN1 KCa2.1|SK1|SKCA1|hSK1 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13880 109981 3780 - KCNN1 KCa2.1|SK1|SKCA1|hSK1 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9812 109981 3780 - KCNN1 KCa2.1|SK1|SKCA1|hSK1 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 13881 109982 3781 - KCNN2 KCa2.2|SK2|SKCA2|SKCa 2|hSK2 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13882 109982 3781 - KCNN2 KCa2.2|SK2|SKCA2|SKCa 2|hSK2 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9815 109982 3781 - KCNN2 KCa2.2|SK2|SKCA2|SKCa 2|hSK2 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 13867 109983 3782 RP11-274N19.1 KCNN3 KCa2.3|SK3|SKCA3|hSK3 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13868 109983 3782 RP11-274N19.1 KCNN3 KCa2.3|SK3|SKCA3|hSK3 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9808 109983 3782 RP11-274N19.1 KCNN3 KCa2.3|SK3|SKCA3|hSK3 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 14344 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14345 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Namba T (2000) 10794813 174523 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14346 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 13873 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13874 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 7226 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 460 Quinine (-)-Quinine|(8S,9R)-Quinine|Chinin|Chininum|(R)-(-)-Quinine|Chinine|Quinina|6'-Methoxycinchonidine|Quinine|(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol quinine sulfate|quinine - odan DRUGBANK DB00468 C20H24N2O2 small molecule M09AA72|P01BC01 130-95-0 DRUGBANK 9810 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 4895 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Brugnara C (1996) 8636434 174708 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4896 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4503 109984 3783 - KCNN4 IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4 9606 Homo sapiens inhibitor target Namba T (2000) 10794813 174523 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 24237 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens unknown target Abrol R (2000) 11060832 181764 4751 Azimilide - - DRUGBANK DB04957 C23H28ClN5O3 small molecule - 149908-53-2 DRUGBANK 24238 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens unknown target Schmitt H (2001) 11573692 181777 4751 Azimilide - - DRUGBANK DB04957 C23H28ClN5O3 small molecule - 149908-53-2 DRUGBANK 15338 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens inhibitor target Chouabe C (2000) 10860024 180823 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15339 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens inhibitor target Chouabe C (1998) 9765513 180822 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15340 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens inhibitor target Yumoto Y (2004) 14716203 180821 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 10717 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens inhibitor target Li RA (2001) 11351021 178473 798 Indapamide Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide dom-indapamide tablets 1.25mg| DRUGBANK DB00808 C16H16ClN3O3S small molecule C03BA11|C09BX01 26807-65-8 DRUGBANK 10718 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens inhibitor target Ohya S (2002) 11804849 178472 798 Indapamide Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide dom-indapamide tablets 1.25mg| DRUGBANK DB00808 C16H16ClN3O3S small molecule C03BA11|C09BX01 26807-65-8 DRUGBANK 10719 109985 3784 - KCNQ1 ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 798 Indapamide Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide dom-indapamide tablets 1.25mg| DRUGBANK DB00808 C16H16ClN3O3S small molecule C03BA11|C09BX01 26807-65-8 DRUGBANK 12127 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Peretz A (2005) 15598972 177097 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 24214 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Punke MA (2007) 17456683 175184 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24215 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Wuttke TV (2005) 15662042 181879 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24216 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Hirano K (2007) 17184917 181979 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24217 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Main MJ (2000) 10908292 181758 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24218 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Wickenden AD (2000) 10953053 181759 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 8309 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Xiong Q (2008) 18206251 177098 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8310 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens unknown target Peretz A (2005) 15598972 177097 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 5519 109986 3785 RP11-261N11.2 KCNQ2 BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1 9606 Homo sapiens inhibitor target Punke MA (2007) 17456683 175184 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 12128 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Peretz A (2005) 15598972 177097 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 24219 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Punke MA (2007) 17456683 175184 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24220 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Hirano K (2007) 17184917 181979 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24221 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Main MJ (2000) 10908292 181758 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24222 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Wickenden AD (2000) 10953053 181759 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 8311 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Xiong Q (2008) 18206251 177098 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8312 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Peretz A (2005) 15598972 177097 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 5521 109987 3786 - KCNQ3 BFNC2|EBN2|KV7.3 9606 Homo sapiens unknown target Punke MA (2007) 17456683 175184 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 26062 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6835 N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine - - DRUGBANK DB08042 C22H24N6O3 small molecule - - DRUGBANK 25333 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6142 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide - - DRUGBANK DB07326 C19H11ClF3N5O2 small molecule - - DRUGBANK 6496 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Adnane L (2006) 16757355 175807 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6497 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Rini BI (2006) 16503817 175824 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6498 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Veronese ML (2006) 16446323 175823 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6499 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Lacouture ME (2006) 16824050 175822 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6500 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Schoeffski P (2006) 16418310 175821 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 24009 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Wedge SR (2005) 15899831 181891 4650 AZD2171 - - DRUGBANK DB04849 C25H27FN4O3 small molecule - - DRUGBANK 25337 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6149 N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE - - DRUGBANK DB07333 C25H24N4O4S small molecule - - DRUGBANK 26937 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Yakes FM (2011) 21926191 182194 7619 Cabozantinib - cometriq DRUGBANK DB08875 C28H24FN3O5 small molecule L01XE26 849217-68-1 DRUGBANK 26938 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Kurzrock R (2011) 21606412 182188 7619 Cabozantinib - cometriq DRUGBANK DB08875 C28H24FN3O5 small molecule L01XE26 849217-68-1 DRUGBANK 24066 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Yamamoto A (2007) 17584317 182020 4679 Vatalanib PTK 787|PTK/ZK|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate - DRUGBANK DB04879 C20H15ClN4 small molecule - 212141-54-3 DRUGBANK 24593 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Cohen EE (2008) 18541897 182081 5564 Axitinib - inlyta DRUGBANK DB06626 - small molecule L01XE17 319460-85-0 DRUGBANK 25533 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6325 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one - - DRUGBANK DB07514 C24H23N5O small molecule - - DRUGBANK 27597 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Schoeffski P (2006) 16418310 175821 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27594 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27595 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Baratte S (2004) 14753710 180935 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27596 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Amino N (2006) 16533791 180934 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27593 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Schueneman AJ (2003) 12873999 180937 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27598 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Mendel DB (2003) 12538485 180936 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 26568 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7297 N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine - - DRUGBANK DB08519 C21H22N6O3 small molecule - - DRUGBANK 25338 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6150 N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE - - DRUGBANK DB07334 C23H21N3O4S small molecule - - DRUGBANK 24574 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Sonpavde G (2007) 17288876 181986 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 24961 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5757 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide - - DRUGBANK DB06938 C21H15ClF3N5O2 small molecule - - DRUGBANK 26970 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target O'Hare T (2009) 19878872 182132 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 25286 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6090 N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide - - DRUGBANK DB07274 C25H22N2O4 small molecule - - DRUGBANK 25190 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6000 N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide - - DRUGBANK DB07183 C24H20N4O2 small molecule - - DRUGBANK 27500 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 27492 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 25552 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6347 N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide - - DRUGBANK DB07537 C21H26N4O2 small molecule - - DRUGBANK 27367 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens antagonist target Goodkin R (1990) 2182794 188513 7762 Ramucirumab - cyramza DRUGBANK DB05578 C6374H9864N1692O1996S46 biologic L01XC21 947687-13-0 DRUGBANK 25542 109992 3791 - KDR CD309|FLK1|VEGFR|VEGFR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6338 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one - - DRUGBANK DB07528 C21H15F3N4O small molecule - - DRUGBANK 24047 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Guo T (2007) 17699867 182039 4668 Nilotinib Nilotinibum tasigna DRUGBANK DB04868 C28H22F3N7O small molecule L01XE08 641571-10-0 DRUGBANK 8669 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Posadas EM (2007) 17559139 177333 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8670 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Lee JL (2006) 16865565 177335 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8671 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Rutkowski P (2007) 17458563 177334 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8672 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target De Giorgi U (2007) 17369583 177337 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8673 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Dy GK (2005) 16087693 177336 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8674 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens multitarget target Posadas EM (2007) 17559139 177333 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8675 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens multitarget target Lee JL (2006) 16865565 177335 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8676 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens multitarget target Rutkowski P (2007) 17458563 177334 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8677 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens multitarget target De Giorgi U (2007) 17369583 177337 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8678 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens multitarget target Dy GK (2005) 16087693 177336 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 24288 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens unknown target Mahadevan D (2007) 17325667 181990 4997 MP470 - - DRUGBANK DB05216 - small molecule - - DRUGBANK 24577 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Sonpavde G (2007) 17288876 181986 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 15412 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Schittenhelm MM (2006) 16397263 180858 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15413 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Dizdar O (2008) 17351742 180865 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15414 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Shah NP (2006) 16434489 180864 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 6507 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Liu L (2006) 17178882 175830 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6508 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Guida T (2007) 17545544 175831 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6509 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Lierman E (2007) 17229632 175832 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6510 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Cascone T (2007) 17272980 175818 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6511 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens antagonist target Koch CA (2006) 17102120 175829 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 27601 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Joensuu H (2007) 17545799 180940 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27602 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27603 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Roskoski R (2007) 17367763 180930 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27604 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Baratte S (2004) 14753710 180935 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27605 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Schueneman AJ (2003) 12873999 180937 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27606 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Abrams TJ (2003) 12748309 180939 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 26972 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Gleixner KV (2013) 23539538 182238 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 18183 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1886 Phosphonotyrosine - - DRUGBANK DB01962 C9H12NO6P small molecule - 21820-51-9 DRUGBANK 18184 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1886 Phosphonotyrosine - - DRUGBANK DB01962 C9H12NO6P small molecule - 21820-51-9 DRUGBANK 27494 110015 3815 - KIT C-Kit|CD117|PBT|SCFR 9606 Homo sapiens inhibitor target Matsui J (2008) 17943726 188553 7825 Lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate lenvima DRUGBANK DB09078 C21H19ClN4O4 small molecule L01XE29 417716-92-8 DRUGBANK 24640 110016 3816 - KLK1 KLKR|Klk6|hK1 9606 Homo sapiens unknown target Mahdy AM (2004) 15277296 181856 5574 Aprotinin Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine trasylol|trasylol inj 10000 ki DRUGBANK DB06692 C284H432N84O79S7 biologic B02AB01 9087-70-1 DRUGBANK 27365 110018 3818 - KLKB1 KLK3|PPK 9606 Homo sapiens inhibitor target Lehmann A (2008) 18613770 188511 5081 Ecallantide - kalbitor DRUGBANK DB05311 - small molecule B06AC03 460738-38-9 DRUGBANK 27853 110018 3818 - KLKB1 KLK3|PPK 9606 Homo sapiens inhibitor target van der Graaf F (1983) 6184384 196044 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 27928 110018 3818 - KLKB1 KLK3|PPK 9606 Homo sapiens inhibitor target van der Graaf F (1983) 6184384 196044 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 26057 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6830 (2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide - - DRUGBANK DB08037 C25H28F3N3O2 small molecule - - DRUGBANK 23146 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4156 Monastrol - - DRUGBANK DB04331 C14H16N2O3S small molecule - - DRUGBANK 23147 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4156 Monastrol - - DRUGBANK DB04331 C14H16N2O3S small molecule - - DRUGBANK 23148 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4156 Monastrol - - DRUGBANK DB04331 C14H16N2O3S small molecule - - DRUGBANK 26054 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6825 N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE - - DRUGBANK DB08032 C18H22N2O2S2 small molecule - - DRUGBANK 26055 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6826 (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE - - DRUGBANK DB08033 C19H24N2O2S2 small molecule - - DRUGBANK 22355 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3830 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol - - DRUGBANK DB03996 C17H15ClN2O2 small molecule - - DRUGBANK 22356 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3830 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol - - DRUGBANK DB03996 C17H15ClN2O2 small molecule - - DRUGBANK 22357 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3830 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol - - DRUGBANK DB03996 C17H15ClN2O2 small molecule - - DRUGBANK 25068 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5882 (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE - - DRUGBANK DB07064 C20H24N2O2 small molecule - - DRUGBANK 26297 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7033 (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE - - DRUGBANK DB08244 C21H20F2N2O small molecule - - DRUGBANK 26298 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7035 (2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE - - DRUGBANK DB08246 C19H18F2N2O small molecule - - DRUGBANK 26303 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7039 (5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE - - DRUGBANK DB08250 C21H24F2N4O small molecule - - DRUGBANK 26292 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7029 (2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE - - DRUGBANK DB08239 C23H25F2N3O small molecule - - DRUGBANK 26223 110030 3832 - KIF11 EG5|HKSP|KNSL1|MCLMR|TRIP5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6989 [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE - - DRUGBANK DB08198 C19H18N2O2S small molecule - - DRUGBANK 25787 110043 3845 - KRAS C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6572 [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID - - DRUGBANK DB07771 C17H30NO5P small molecule - - DRUGBANK 25802 110043 3845 - KRAS C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 13619 110053 3855 - KRT7 CK7|K2C7|K7|SCL 9606 Homo sapiens unknown target Heard CM (2003) 12711178 180065 1075 Primaquine Primachinum|8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline|Neo-quipenyl|Primaquin|8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline|Primachin|6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline|Primaquina|Primaquinum primaquine|primaquine phosphat DRUGBANK DB01087 C15H21N3O small molecule P01BA03 90-34-6 DRUGBANK 13620 110053 3855 - KRT7 CK7|K2C7|K7|SCL 9606 Homo sapiens unknown target Basso LG (2011) 20713019 180064 1075 Primaquine Primachinum|8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline|Neo-quipenyl|Primaquin|8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline|Primachin|6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline|Primaquina|Primaquinum primaquine|primaquine phosphat DRUGBANK DB01087 C15H21N3O small molecule P01BA03 90-34-6 DRUGBANK 24242 110053 3855 - KRT7 CK7|K2C7|K7|SCL 9606 Homo sapiens unknown target Kanduc D (2002) 12072504 181795 4753 HspE7 HPV E7 Peptide Epitope Vaccine|HPV 16 E7/HSP65 Vaccine - DRUGBANK DB04959 - biologic - - DRUGBANK 400 110054 3856 - KRT8 CARD2|CK-8|CK8|CYK8|K2C8|K8|KO 9606 Homo sapiens unknown target Kralovich KR (1998) 9988531 4732 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 401 110054 3856 - KRT8 CARD2|CK-8|CK8|CYK8|K2C8|K8|KO 9606 Homo sapiens unknown target Hembrough TA (1996) 8810346 171913 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 402 110054 3856 - KRT8 CARD2|CK-8|CK8|CYK8|K2C8|K8|KO 9606 Homo sapiens unknown target Hembrough TA (1996) 8760360 171912 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 6528 110057 3859 - KRT12 K12 9606 Homo sapiens unknown target Sobue S (2004) 14693542 175850 392 Griseofulvin Fulvicin|Grifulvin|(+)-griseofulvin|Griseofulvin|Griseofulvine|Griseofulvin, ultramicrosize|Griseofulvina|Likuden|Griseofulvinum|Grysio|Lamoryl|Spirofulvin|Grisactin|Amudane|Poncyl|Sporostatin|Curling factor|Fulcin|Griseofulvin, microcrystalline|Grisovin grisovin-fp 250mg tab|griseofu DRUGBANK DB00400 C17H17ClO6 small molecule D01BA01|D01AA08 126-07-8 DRUGBANK 6529 110057 3859 - KRT12 K12 9606 Homo sapiens unknown target Nakamichi I (2002) 12388748 175851 392 Griseofulvin Fulvicin|Grifulvin|(+)-griseofulvin|Griseofulvin|Griseofulvine|Griseofulvin, ultramicrosize|Griseofulvina|Likuden|Griseofulvinum|Grysio|Lamoryl|Spirofulvin|Grisactin|Amudane|Poncyl|Sporostatin|Curling factor|Fulcin|Griseofulvin, microcrystalline|Grisovin grisovin-fp 250mg tab|griseofu DRUGBANK DB00400 C17H17ClO6 small molecule D01BA01|D01AA08 126-07-8 DRUGBANK 21963 110101 3906 - LALBA - 9606 Homo sapiens unknown target Barbana C (2008) 18620538 182082 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 24278 110115 3921 - RPSA 37LRP|67LR|ICAS|LAMBR|LAMR1|LBP|LBP/p40|LRP|LRP/LR|NEM/1CHD4|SA|lamR|p40 9606 Homo sapiens unknown target Annabi B (2006) 16759641 181949 4776 PCK3145 - - DRUGBANK DB04985 - biologic - - DRUGBANK 22369 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3837 (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid - - DRUGBANK DB04003 C29H38N3O10P small molecule - - DRUGBANK 22370 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3837 (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid - - DRUGBANK DB04003 C29H38N3O10P small molecule - - DRUGBANK 26078 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6850 N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine - - DRUGBANK DB08057 C22H23ClN6 small molecule - - DRUGBANK 23291 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23292 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 15430 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15431 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens multitarget target Lindauer M (2010) 20072833 180857 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15432 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens multitarget target Das J (2006) 17154512 180872 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 20333 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2897 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB03023 C15H17ClN5 small molecule - - DRUGBANK 20334 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2897 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB03023 C15H17ClN5 small molecule - - DRUGBANK 20335 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2897 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB03023 C15H17ClN5 small molecule - - DRUGBANK 25305 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6113 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE - - DRUGBANK DB07297 C24H25N5O small molecule - - DRUGBANK 26076 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6848 N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine - - DRUGBANK DB08055 C18H13ClN4 small molecule - - DRUGBANK 26077 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6849 N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine - - DRUGBANK DB08056 C20H18N4 small molecule - - DRUGBANK 24948 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5744 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE - - DRUGBANK DB06925 C23H17F3N4O small molecule - - DRUGBANK 26978 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens inhibitor target Gushwa NN (2012) 23190395 182219 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 18342 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18343 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 17885 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1760 {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid - - DRUGBANK DB01830 C30H41N3O10P2 small molecule - - DRUGBANK 17886 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1760 {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid - - DRUGBANK DB01830 C30H41N3O10P2 small molecule - - DRUGBANK 25157 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5964 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE - - DRUGBANK DB07146 C25H26N4O small molecule - - DRUGBANK 27504 110124 3932 RP4-675E8.4 LCK IMD22|LSK|YT16|p56lck|pp58lck 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 17539 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1608 2,3-Dihydroxy-Benzoic Acid - - DRUGBANK DB01672 C7H6O4 small molecule - 303-38-8 DRUGBANK 17540 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1608 2,3-Dihydroxy-Benzoic Acid - - DRUGBANK DB01672 C7H6O4 small molecule - 303-38-8 DRUGBANK 18082 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1851 Carboxymycobactin S - - DRUGBANK DB01926 C36H51FeN5O12 small molecule - - DRUGBANK 18083 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1851 Carboxymycobactin S - - DRUGBANK DB01926 C36H51FeN5O12 small molecule - - DRUGBANK 23530 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4289 Trencam-3,2-Hopo - - DRUGBANK DB04476 C7H7NO3 small molecule - - DRUGBANK 23531 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4289 Trencam-3,2-Hopo - - DRUGBANK DB04476 C7H7NO3 small molecule - - DRUGBANK 19746 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2598 2,3,-Dihydroxybenzoylserine - - DRUGBANK DB02710 C10H11NO6 small molecule - 127658-43-9 DRUGBANK 19747 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2598 2,3,-Dihydroxybenzoylserine - - DRUGBANK DB02710 C10H11NO6 small molecule - 127658-43-9 DRUGBANK 19748 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2598 2,3,-Dihydroxybenzoylserine - - DRUGBANK DB02710 C10H11NO6 small molecule - 127658-43-9 DRUGBANK 22428 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3875 Carboxymycobactin T - - DRUGBANK DB04043 C35H49FeN5O12 small molecule - - DRUGBANK 22429 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3875 Carboxymycobactin T - - DRUGBANK DB04043 C35H49FeN5O12 small molecule - - DRUGBANK 17459 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1568 Methyl Nonanoate (Ester) - - DRUGBANK DB01631 C10H20O2 small molecule - - DRUGBANK 17460 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1568 Methyl Nonanoate (Ester) - - DRUGBANK DB01631 C10H20O2 small molecule - - DRUGBANK 17461 110126 3934 RP11-395P17.6 LCN2 24p3|MSFI|NGAL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1568 Methyl Nonanoate (Ester) - - DRUGBANK DB01631 C10H20O2 small molecule - - DRUGBANK 26599 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7336 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL - - DRUGBANK DB08558 C14H28O5S small molecule - - DRUGBANK 21089 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3248 alpha-D-Xylopyranose - - DRUGBANK DB03389 C5H10O5 small molecule - - DRUGBANK 19046 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2281 D-Gluconhydroximo-1,5-Lactam - - DRUGBANK DB02376 C6H12N2O5 small molecule - - DRUGBANK 1929 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 23802 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4464 (1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE - - DRUGBANK DB04659 C15H21NO8S2 small molecule - - DRUGBANK 23880 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4581 ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE - - DRUGBANK DB04779 C10H13NO4S2 small molecule - - DRUGBANK 19262 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 23711 110130 3938 - LCT LAC|LPH|LPH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4374 Gluconolactone - renacidin DRUGBANK DB04564 C6H10O6 small molecule - 90-80-2 DRUGBANK 3261 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target O'Brien J (2006) 17006762 173739 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3262 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Draghia AC (2007) 17308685 173740 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3263 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Semenza GL (2007) 17555402 73182 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 19304 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2381 Etheno-Nad - - DRUGBANK DB02483 C17H23N5O14P2 small molecule - - DRUGBANK 19305 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2381 Etheno-Nad - - DRUGBANK DB02483 C17H23N5O14P2 small molecule - - DRUGBANK 19306 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2381 Etheno-Nad - - DRUGBANK DB02483 C17H23N5O14P2 small molecule - - DRUGBANK 19732 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 19733 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 19734 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 22224 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 22225 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 22226 110131 3939 PIG19 LDHA GSD11|HEL-S-133P|LDH1|LDHM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 3376 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3377 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3378 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Razeto A (2002) 12054772 173781 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3379 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Mdluli K (2005) 16198644 173782 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3380 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Clausen J (1969) 4303363 173783 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 19149 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2304 4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid - - DRUGBANK DB02401 C3H2N2O4 small molecule - - DRUGBANK 19150 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2304 4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid - - DRUGBANK DB02401 C3H2N2O4 small molecule - - DRUGBANK 22227 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 22228 110137 3945 - LDHB HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 3409 110140 3948 - LDHC CT32|LDH3|LDHX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3410 110140 3948 - LDHC CT32|LDH3|LDHX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3411 110140 3948 - LDHC CT32|LDH3|LDHX 9606 Homo sapiens unknown target Spielmann H (1976) 182529 173796 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3412 110140 3948 - LDHC CT32|LDH3|LDHX 9606 Homo sapiens unknown target Morris ID (1986) 3735252 173795 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3413 110140 3948 - LDHC CT32|LDH3|LDHX 9606 Homo sapiens unknown target Gu Y (1989) 2751392 173794 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 9687 110141 3949 - LDLR FH|FHC|LDLCQ2 9606 Homo sapiens unknown target Korbelik M (1992) 1531856 177942 697 Porfimer Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium photofrin DRUGBANK DB00707 C68H74N8O11 small molecule L01XD01 87806-31-3 DRUGBANK 9688 110141 3949 - LDLR FH|FHC|LDLCQ2 9606 Homo sapiens unknown target Maziere JC (1992) 1450993 177943 697 Porfimer Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium photofrin DRUGBANK DB00707 C68H74N8O11 small molecule L01XD01 87806-31-3 DRUGBANK 9689 110141 3949 - LDLR FH|FHC|LDLCQ2 9606 Homo sapiens unknown target Candide C (1986) 2945739 177940 697 Porfimer Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium photofrin DRUGBANK DB00707 C68H74N8O11 small molecule L01XD01 87806-31-3 DRUGBANK 9690 110141 3949 - LDLR FH|FHC|LDLCQ2 9606 Homo sapiens unknown target Maziere JC (1994) 7994588 177941 697 Porfimer Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium photofrin DRUGBANK DB00707 C68H74N8O11 small molecule L01XD01 87806-31-3 DRUGBANK 9691 110141 3949 - LDLR FH|FHC|LDLCQ2 9606 Homo sapiens unknown target Tsukagoshi S (1995) 7661580 177944 697 Porfimer Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium photofrin DRUGBANK DB00707 C68H74N8O11 small molecule L01XD01 87806-31-3 DRUGBANK 27898 110144 3953 - LEPR CD295|LEP-R|LEPRD|OB-R|OBR 9606 Homo sapiens agonist target Moon HS (2015) 25249580 196023 8107 Metreleptin Metreleptinum|r-metHuLeptin|Metreleptin|Mtrleptine|Metreleptina|N-Methionylleptin myalept DRUGBANK DB09046 C714H1167N191O221S6 biologic - 186018-45-1 DRUGBANK 23422 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23423 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23424 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23325 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 23326 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 23327 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 21012 110147 3956 - LGALS1 GAL1|GBP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 19060 110148 3957 - LGALS2 HL14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 17880 110149 3958 - LGALS3 CBP35|GAL3|GALBP|GALIG|L31|LGALS2|MAC2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1757 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide - - DRUGBANK DB01827 C8H5F4NO2 small molecule - - DRUGBANK 17881 110149 3958 - LGALS3 CBP35|GAL3|GALBP|GALIG|L31|LGALS2|MAC2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1757 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide - - DRUGBANK DB01827 C8H5F4NO2 small molecule - - DRUGBANK 17882 110149 3958 - LGALS3 CBP35|GAL3|GALBP|GALIG|L31|LGALS2|MAC2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1757 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide - - DRUGBANK DB01827 C8H5F4NO2 small molecule - - DRUGBANK 19687 110154 3963 - LGALS7 GAL7|LGALS7A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2568 2-Deoxy-2-Aminogalactose - - DRUGBANK DB02678 C6H13NO5 small molecule - - DRUGBANK 19688 110154 3963 - LGALS7 GAL7|LGALS7A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2568 2-Deoxy-2-Aminogalactose - - DRUGBANK DB02678 C6H13NO5 small molecule - - DRUGBANK 19092 110154 3963 - LGALS7 GAL7|LGALS7A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19093 110154 3963 - LGALS7 GAL7|LGALS7A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 23528 110156 3965 - LGALS9 HUAT|LGALS9A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4286 (R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol - - DRUGBANK DB04472 C8H8N4O3 small molecule - - DRUGBANK 176 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 14 Goserelin Zoladex|ICI-118630|Goserelin|Goserelin acetate zoladex|zoladex la inj depot 1 DRUGBANK DB00014 C59H84N18O14 small molecule L02AE03 65807-02-5 DRUGBANK 177 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Kirby RS (2009) 20053189 171829 14 Goserelin Zoladex|ICI-118630|Goserelin|Goserelin acetate zoladex|zoladex la inj depot 1 DRUGBANK DB00014 C59H84N18O14 small molecule L02AE03 65807-02-5 DRUGBANK 178 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 14 Goserelin Zoladex|ICI-118630|Goserelin|Goserelin acetate zoladex|zoladex la inj depot 1 DRUGBANK DB00014 C59H84N18O14 small molecule L02AE03 65807-02-5 DRUGBANK 592 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 593 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Ascoli M (2002) 11943741 172041 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 594 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 49 Cetrorelix Cetrorelixum cetrotide DRUGBANK DB00050 C70H92ClN17O14 small molecule H01CC02 120287-85-6 DRUGBANK 406 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 407 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Olive DL (1995) 7872378 171916 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 408 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 409 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target van de Weijer BH (2003) 14680547 171917 32 Menotropins Menotropins (FSH;LH) repronex|menopur DRUGBANK DB00032 C1014H1609N287O294S27 biologic - 61489-71-2 DRUGBANK 557 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 43 Lutropin alfa Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH pergoveris|pergonal 75 i.u.|hu DRUGBANK DB00044 C1014H1609N287O294S27 biologic G03GA07 152923-57-4 DRUGBANK 558 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 43 Lutropin alfa Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH pergoveris|pergonal 75 i.u.|hu DRUGBANK DB00044 C1014H1609N287O294S27 biologic G03GA07 152923-57-4 DRUGBANK 559 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 43 Lutropin alfa Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH pergoveris|pergonal 75 i.u.|hu DRUGBANK DB00044 C1014H1609N287O294S27 biologic G03GA07 152923-57-4 DRUGBANK 560 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens agonist target Gibreel A (2010) 20161981 172015 43 Lutropin alfa Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH pergoveris|pergonal 75 i.u.|hu DRUGBANK DB00044 C1014H1609N287O294S27 biologic G03GA07 152923-57-4 DRUGBANK 24779 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Kirby RS (2009) 20053189 171829 5601 Buserelin Tiloryth|D-Ser(Tbu)6EA10LHRH|Etilamide|(Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH suprefact inj 1mg/ml|suprefact DRUGBANK DB06719 C62H90N16O15 biologic L02AE01 57982-77-1 DRUGBANK 1193 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Gromoll J (2003) 12606382 172370 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 1194 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Bodek G (2005) 15967102 172371 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 1195 110161 3973 - LHCGR HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5 9606 Homo sapiens unknown target Lin W (2007) 17059863 172367 93 Chorionic Gonadotropin (Recombinant) Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG ovidrel DRUGBANK DB00097 C1105H1770N318O336S26 biologic - 177073-44-8 DRUGBANK 5197 110166 3978 - LIG1 - 9606 Homo sapiens inhibitor target Rose JL (2007) 17202402 174995 283 Bleomycin Bleomicina|Bleomycinum|Bleomycin A2|BLM|Bleomycine|Bleomicin|Bleocin bleomycin sulphate for injecti DRUGBANK DB00290 C55H84N17O21S3 small molecule L01DC01 11056-06-7 DRUGBANK 5198 110168 3980 - LIG3 LIG2 9606 Homo sapiens inhibitor target Rose JL (2007) 17202402 174995 283 Bleomycin Bleomicina|Bleomycinum|Bleomycin A2|BLM|Bleomycine|Bleomicin|Bleocin bleomycin sulphate for injecti DRUGBANK DB00290 C55H84N17O21S3 small molecule L01DC01 11056-06-7 DRUGBANK 3431 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens agonist target Engler MM (2000) 11026622 173823 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3432 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens agonist target Watts JL (1999) 9917342 173825 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3433 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens agonist target Navarro E (2000) 10685788 173824 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3434 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens agonist target Barham JB (2000) 10917903 173827 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3435 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens agonist target Chavali SR (1998) 9610840 173826 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 2142 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens ligand target Mohan IK (2000) 10765977 173065 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2143 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens ligand target Maniongui C (1993) 8487621 173064 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2144 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens ligand target Xiang M (2006) 16988497 173067 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2145 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens ligand target Descomps B (1995) 8673626 173066 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2146 110180 3992 - FADS1 D5D|FADS6|FADSD5|LLCDL1|TU12 9606 Homo sapiens ligand target Hoffman DR (2001) 11518758 173063 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 286 110185 3998 - LMAN1 ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58 9606 Homo sapiens chaperone target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 287 110185 3998 - LMAN1 ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58 9606 Homo sapiens chaperone target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 288 110185 3998 - LMAN1 ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58 9606 Homo sapiens chaperone target Cunningham MA (2003) 14629470 8787 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 289 110185 3998 - LMAN1 ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58 9606 Homo sapiens chaperone target Miao HZ (2004) 14726380 171875 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 7621 110202 4018 - LPA AK38|APOA|LP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7622 110202 4018 - LPA AK38|APOA|LP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7623 110202 4018 - LPA AK38|APOA|LP 9606 Homo sapiens unknown target Becker L (2004) 15287725 176572 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 24569 110205 4023 - LPL HDLCQ11|LIPD 9606 Homo sapiens inhibitor target Sato K (1997) 9406449 181723 5554 Tyloxapol - - DRUGBANK DB06439 - small molecule R05CA01 25301-02-4 DRUGBANK 24570 110205 4023 - LPL HDLCQ11|LIPD 9606 Homo sapiens inhibitor target Rodrigues B (1992) 1493594 181640 5554 Tyloxapol - - DRUGBANK DB06439 - small molecule R05CA01 25301-02-4 DRUGBANK 24571 110205 4023 - LPL HDLCQ11|LIPD 9606 Homo sapiens inhibitor target Levine S (2006) 16839786 181953 5554 Tyloxapol - - DRUGBANK DB06439 - small molecule R05CA01 25301-02-4 DRUGBANK 293 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens modulator target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 294 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens modulator target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 295 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens modulator target Franchini M (2011) 21391865 171876 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 397 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens unknown target Moestrup SK (1993) 8344937 6349 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 398 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens unknown target Nykjaer A (1992) 1378833 171911 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 399 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens unknown target Hu K (2006) 16303771 171910 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 1239 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1240 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 1241 110215 4035 - LRP1 A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5 9606 Homo sapiens unknown target Rohlena J (2003) 12522212 744 96 Coagulation Factor IX (Recombinant) nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant) benefix - (250iu)|idelvion|ix DRUGBANK DB00100 C2041H3136N558O641S25 biologic B02BD09 181054-95-5 DRUGBANK 137 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Korenberg JR (1994) 7959795 171801 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 138 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 139 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Kanalas JJ (1992) 1280065 171803 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 140 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 141 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Kanalas JJ (1993) 8241286 171802 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 364 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 365 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 10597 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Nagai J (2006) 16488503 178436 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 10598 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Watanabe A (2004) 15023454 178435 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 10599 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Takamoto K (2005) 15777622 178434 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 852 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 853 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Fuster DG (2007) 17018843 172186 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 854 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 855 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Christensen EI (1997) 9051350 172187 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 856 110216 4036 - LRP2 DBS|GP330 9606 Homo sapiens unknown target Orlando RA (1998) 9773776 6505 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 18351 110225 4047 - LSS OSC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1939 R048-8071 - - DRUGBANK DB02016 C23H27BrFNO2 small molecule - 161582-11-2 DRUGBANK 18352 110225 4047 - LSS OSC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1939 R048-8071 - - DRUGBANK DB02016 C23H27BrFNO2 small molecule - 161582-11-2 DRUGBANK 21749 110225 4047 - LSS OSC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3540 Lanosterol - - DRUGBANK DB03696 C30H50O small molecule - 79-63-0 DRUGBANK 21750 110225 4047 - LSS OSC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3540 Lanosterol - - DRUGBANK DB03696 C30H50O small molecule - 79-63-0 DRUGBANK 26061 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6833 N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine - - DRUGBANK DB08040 C14H18N2O5 small molecule - - DRUGBANK 26520 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7247 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol - - DRUGBANK DB08466 C14H14O3 small molecule - - DRUGBANK 25200 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6013 N-methyl-1-(2-thiophen-2-ylphenyl)methanamine - - DRUGBANK DB07196 C12H13NS small molecule - - DRUGBANK 21181 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3281 Ubenimex Bestatin - DRUGBANK DB03424 C16H24N2O4 small molecule - 58970-76-6 DRUGBANK 21182 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3281 Ubenimex Bestatin - DRUGBANK DB03424 C16H24N2O4 small molecule - 58970-76-6 DRUGBANK 18436 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1983 N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine - - DRUGBANK DB02062 C21H27N2O5P small molecule - - DRUGBANK 25301 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6108 4-(2-amino-1,3-thiazol-4-yl)phenol - - DRUGBANK DB07292 C9H8N2OS small molecule - - DRUGBANK 14737 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Thunnissen MM (2002) 12207002 152292 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 24879 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5672 N-(pyridin-3-ylmethyl)aniline - - DRUGBANK DB06851 C12H12N2 small molecule - - DRUGBANK 24849 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5649 5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole - - DRUGBANK DB06828 C14H14N2O small molecule - - DRUGBANK 25272 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6076 N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline - - DRUGBANK DB07260 C18H22N2O small molecule - - DRUGBANK 25271 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6075 1-(4-thiophen-2-ylphenyl)methanamine - - DRUGBANK DB07259 C11H11NS small molecule - - DRUGBANK 25270 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6074 (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol - - DRUGBANK DB07258 C18H22N2O2 small molecule - - DRUGBANK 25112 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5920 (2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid - - DRUGBANK DB07102 C18H20N2O4 small molecule - - DRUGBANK 25249 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6053 {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone - - DRUGBANK DB07237 C22H21NO2S small molecule - - DRUGBANK 25113 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5922 4-amino-N-[4-(benzyloxy)phenyl]butanamide - - DRUGBANK DB07104 C17H20N2O2 small molecule - - DRUGBANK 19015 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2257 3-(Benzyloxy)Pyridin-2-Amine - - DRUGBANK DB02352 C12H12N2O small molecule - - DRUGBANK 25109 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5917 N-[4-(benzyloxy)phenyl]glycinamide - - DRUGBANK DB07099 C15H16N2O2 small molecule - - DRUGBANK 24940 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5736 (4-fluorophenyl)(pyridin-4-yl)methanone - - DRUGBANK DB06917 C12H8FNO small molecule - - DRUGBANK 25105 110226 4048 - LTA4H - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5912 1-(2,2'-bithiophen-5-yl)methanamine - - DRUGBANK DB07094 C9H9NS2 small molecule - - DRUGBANK 69 110227 4049 DAMA-25N12.13-004 LTA LT|TNFB|TNFSF1 9606 Homo sapiens unknown target Kang CP (2005) 15695296 171759 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 70 110227 4049 DAMA-25N12.13-004 LTA LT|TNFB|TNFSF1 9606 Homo sapiens unknown target Gudbrandsdottir S (2004) 15005015 171760 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 71 110227 4049 DAMA-25N12.13-004 LTA LT|TNFB|TNFSF1 9606 Homo sapiens unknown target Buch MH (2004) 15033655 171761 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 72 110227 4049 DAMA-25N12.13-004 LTA LT|TNFB|TNFSF1 9606 Homo sapiens unknown target Pennica D (1992) 1328224 171762 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 73 110227 4049 DAMA-25N12.13-004 LTA LT|TNFB|TNFSF1 9606 Homo sapiens unknown target Johnson CJ (2001) 11302411 171763 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 2564 110234 4056 - LTC4S - 9606 Homo sapiens unknown target Ago H (2007) 17632548 160488 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2565 110234 4056 - LTC4S - 9606 Homo sapiens unknown target Martinez Molina D (2007) 17632546 160398 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 20367 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2912 Nitrilotriacetic Acid - - DRUGBANK DB03040 C6H9NO6 small molecule - - DRUGBANK 20368 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2912 Nitrilotriacetic Acid - - DRUGBANK DB03040 C6H9NO6 small molecule - - DRUGBANK 20369 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2912 Nitrilotriacetic Acid - - DRUGBANK DB03040 C6H9NO6 small molecule - - DRUGBANK 21372 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3340 Alpha-D-Fucose - - DRUGBANK DB03485 C6H12O5 small molecule - - DRUGBANK 21373 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3340 Alpha-D-Fucose - - DRUGBANK DB03485 C6H12O5 small molecule - - DRUGBANK 21374 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3340 Alpha-D-Fucose - - DRUGBANK DB03485 C6H12O5 small molecule - - DRUGBANK 27669 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 26491 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7221 Parecoxib - - DRUGBANK DB08439 C19H18N2O4S small molecule M01AH04 198470-84-7 DRUGBANK 17822 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1741 3h-Indole-5,6-Diol - - DRUGBANK DB01811 C8H6NO2 small molecule - 3131-52-0 DRUGBANK 17823 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1741 3h-Indole-5,6-Diol - - DRUGBANK DB01811 C8H6NO2 small molecule - 3131-52-0 DRUGBANK 17824 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1741 3h-Indole-5,6-Diol - - DRUGBANK DB01811 C8H6NO2 small molecule - 3131-52-0 DRUGBANK 25001 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5805 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE - - DRUGBANK DB06987 C14H22N2O3 small molecule - - DRUGBANK 23861 110235 4057 - LTF GIG12|HEL110|HLF2|LF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4546 Nimesulide - - DRUGBANK DB04743 C13H12N2O5S small molecule M01AX17|M02AA26 51803-78-2 DRUGBANK 20332 110245 4067 - LYN JTK8|p53Lyn|p56Lyn 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2897 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB03023 C15H17ClN5 small molecule - - DRUGBANK 27505 110245 4067 - LYN JTK8|p53Lyn|p56Lyn 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 26979 110245 4067 - LYN JTK8|p53Lyn|p56Lyn 9606 Homo sapiens inhibitor target O'Hare T (2009) 19878872 182132 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 20282 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2882 Arsanilic acid 4-Aminophenylarsonsure|4-arsanilic acid|p-arsanilic acid|4-aminobenzenearsonic acid|4-Aminophenylarsonic acid|(p-aminophenyl)arsonic acid|atoxylic acid|Arsanilsure - DRUGBANK DB03006 C6H8AsNO3 small molecule - 98-50-0 DRUGBANK 20283 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2882 Arsanilic acid 4-Aminophenylarsonsure|4-arsanilic acid|p-arsanilic acid|4-aminobenzenearsonic acid|4-Aminophenylarsonic acid|(p-aminophenyl)arsonic acid|atoxylic acid|Arsanilsure - DRUGBANK DB03006 C6H8AsNO3 small molecule - 98-50-0 DRUGBANK 20284 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2882 Arsanilic acid 4-Aminophenylarsonsure|4-arsanilic acid|p-arsanilic acid|4-aminobenzenearsonic acid|4-Aminophenylarsonic acid|(p-aminophenyl)arsonic acid|atoxylic acid|Arsanilsure - DRUGBANK DB03006 C6H8AsNO3 small molecule - 98-50-0 DRUGBANK 22920 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4095 Methylumbelliferyl Chitotriose - - DRUGBANK DB04268 C34H47N3O18 small molecule - - DRUGBANK 22921 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4095 Methylumbelliferyl Chitotriose - - DRUGBANK DB04268 C34H47N3O18 small molecule - - DRUGBANK 22922 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4095 Methylumbelliferyl Chitotriose - - DRUGBANK DB04268 C34H47N3O18 small molecule - - DRUGBANK 21377 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3342 3-Aminosuccinimide - - DRUGBANK DB03487 C4H6N2O2 small molecule - - DRUGBANK 21378 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3342 3-Aminosuccinimide - - DRUGBANK DB03487 C4H6N2O2 small molecule - - DRUGBANK 21379 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3342 3-Aminosuccinimide - - DRUGBANK DB03487 C4H6N2O2 small molecule - - DRUGBANK 20516 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2991 Para-Toluene Sulfonate - - DRUGBANK DB03120 C7H8O3S small molecule - - DRUGBANK 20517 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2991 Para-Toluene Sulfonate - - DRUGBANK DB03120 C7H8O3S small molecule - - DRUGBANK 20518 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2991 Para-Toluene Sulfonate - - DRUGBANK DB03120 C7H8O3S small molecule - - DRUGBANK 20311 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2889 Di(N-Acetyl-D-Glucosamine) - - DRUGBANK DB03013 C16H28N2O11 small molecule - - DRUGBANK 20312 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2889 Di(N-Acetyl-D-Glucosamine) - - DRUGBANK DB03013 C16H28N2O11 small molecule - - DRUGBANK 20313 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2889 Di(N-Acetyl-D-Glucosamine) - - DRUGBANK DB03013 C16H28N2O11 small molecule - - DRUGBANK 19865 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2644 4-Methylumbelliferyl Chitobiose - - DRUGBANK DB02759 C26H34N2O13 small molecule - - DRUGBANK 19866 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2644 4-Methylumbelliferyl Chitobiose - - DRUGBANK DB02759 C26H34N2O13 small molecule - - DRUGBANK 19867 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2644 4-Methylumbelliferyl Chitobiose - - DRUGBANK DB02759 C26H34N2O13 small molecule - - DRUGBANK 19888 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19889 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19890 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 1986 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 22787 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4022 Chitotriose - - DRUGBANK DB04194 C24H41N3O16 small molecule - - DRUGBANK 22788 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4022 Chitotriose - - DRUGBANK DB04194 C24H41N3O16 small molecule - - DRUGBANK 22789 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4022 Chitotriose - - DRUGBANK DB04194 C24H41N3O16 small molecule - - DRUGBANK 22298 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3801 Dodecyl Sulfate - - DRUGBANK DB03967 C12H26O4S small molecule - - DRUGBANK 20728 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3057 Cu-Cyclam - - DRUGBANK DB03189 C10H20CuN4 small molecule - - DRUGBANK 20729 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3057 Cu-Cyclam - - DRUGBANK DB03189 C10H20CuN4 small molecule - - DRUGBANK 20730 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3057 Cu-Cyclam - - DRUGBANK DB03189 C10H20CuN4 small molecule - - DRUGBANK 20705 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3043 1-Proponol - - DRUGBANK DB03175 C3H8O small molecule - 71-23-8 DRUGBANK 20706 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3043 1-Proponol - - DRUGBANK DB03175 C3H8O small molecule - 71-23-8 DRUGBANK 20707 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3043 1-Proponol - - DRUGBANK DB03175 C3H8O small molecule - 71-23-8 DRUGBANK 24937 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5731 UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE - - DRUGBANK DB06912 C15H20O4 small molecule - - DRUGBANK 18797 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2159 Cu-Bicyclam - - DRUGBANK DB02250 C28H48Cu2N8 small molecule - - DRUGBANK 18798 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2159 Cu-Bicyclam - - DRUGBANK DB02250 C28H48Cu2N8 small molecule - - DRUGBANK 18799 110247 4069 - LYZ LZM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2159 Cu-Bicyclam - - DRUGBANK DB02250 C28H48Cu2N8 small molecule - - DRUGBANK 19855 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2640 1-3 Sugar Ring of Pentamannosyl 6-Phosphate - - DRUGBANK DB02755 C18H33O19P small molecule - - DRUGBANK 19856 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2640 1-3 Sugar Ring of Pentamannosyl 6-Phosphate - - DRUGBANK DB02755 C18H33O19P small molecule - - DRUGBANK 19857 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2640 1-3 Sugar Ring of Pentamannosyl 6-Phosphate - - DRUGBANK DB02755 C18H33O19P small molecule - - DRUGBANK 20103 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2780 Alpha-D-Mannose-6-Phosphate - - DRUGBANK DB02900 C6H13O9P small molecule - - DRUGBANK 20104 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2780 Alpha-D-Mannose-6-Phosphate - - DRUGBANK DB02900 C6H13O9P small molecule - - DRUGBANK 20105 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2780 Alpha-D-Mannose-6-Phosphate - - DRUGBANK DB02900 C6H13O9P small molecule - - DRUGBANK 15621 110251 4074 - M6PR CD-MPR|MPR 46|MPR-46|MPR46|SMPR 9606 Homo sapiens binder target Chavez CA (2007) 17927214 173188 1259 Alglucosidase alfa Aglucosidase alfa|Aglucosidase alpha|Acid-alpha glucosidase|alpha-1,4-glucosidase|Acid maltase|Lysosomal Alpha-Glucosidase|Alpha-glucosidase lumizyme|myozyme DRUGBANK DB01272 C4435H6739N1175O1279S32 biologic A16AB07 420784-05-0 DRUGBANK 23602 110262 4087 - SMAD2 JV18|JV18-1|MADH2|MADR2|hMAD-2|hSMAD2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 20285 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2884 5-Fluoro-Beta-L-Gulosyl Fluoride - - DRUGBANK DB03008 C6H10F2O5 small molecule - - DRUGBANK 20286 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2884 5-Fluoro-Beta-L-Gulosyl Fluoride - - DRUGBANK DB03008 C6H10F2O5 small molecule - - DRUGBANK 20287 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2884 5-Fluoro-Beta-L-Gulosyl Fluoride - - DRUGBANK DB03008 C6H10F2O5 small molecule - - DRUGBANK 19830 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2628 Kifunensine - - DRUGBANK DB02742 C8H12N2O6 small molecule - 109944-15-2 DRUGBANK 19831 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2628 Kifunensine - - DRUGBANK DB02742 C8H12N2O6 small molecule - 109944-15-2 DRUGBANK 19832 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2628 Kifunensine - - DRUGBANK DB02742 C8H12N2O6 small molecule - 109944-15-2 DRUGBANK 18934 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2225 2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride - - DRUGBANK DB02318 C6H10F2O4 small molecule - - DRUGBANK 18935 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2225 2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride - - DRUGBANK DB02318 C6H10F2O4 small molecule - - DRUGBANK 18936 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2225 2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride - - DRUGBANK DB02318 C6H10F2O4 small molecule - - DRUGBANK 22259 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3790 1-deoxymannojirimycin D-manno-Deoxynojirimycin - DRUGBANK DB03955 C6H13NO4 small molecule - 84444-90-6 DRUGBANK 22260 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3790 1-deoxymannojirimycin D-manno-Deoxynojirimycin - DRUGBANK DB03955 C6H13NO4 small molecule - 84444-90-6 DRUGBANK 22261 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3790 1-deoxymannojirimycin D-manno-Deoxynojirimycin - DRUGBANK DB03955 C6H13NO4 small molecule - 84444-90-6 DRUGBANK 18382 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1957 Swainsonine (1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol|Tridolgosir - DRUGBANK DB02034 C8H15NO3 small molecule - 72741-87-8 DRUGBANK 18383 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1957 Swainsonine (1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol|Tridolgosir - DRUGBANK DB02034 C8H15NO3 small molecule - 72741-87-8 DRUGBANK 18384 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1957 Swainsonine (1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol|Tridolgosir - DRUGBANK DB02034 C8H15NO3 small molecule - 72741-87-8 DRUGBANK 26357 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7107 (1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol - - DRUGBANK DB08321 C15H29NO4 small molecule - - DRUGBANK 19317 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2389 Ghavamiol - - DRUGBANK DB02492 C9H18NO9S small molecule - - DRUGBANK 19318 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2389 Ghavamiol - - DRUGBANK DB02492 C9H18NO9S small molecule - - DRUGBANK 19319 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2389 Ghavamiol - - DRUGBANK DB02492 C9H18NO9S small molecule - - DRUGBANK 24998 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5802 (1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL - - DRUGBANK DB06984 C13H19NO3S small molecule - - DRUGBANK 21160 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3271 5-Thio-a/B-D-Mannopyranosylamine - - DRUGBANK DB03414 C6H13NO4S small molecule - - DRUGBANK 21161 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3271 5-Thio-a/B-D-Mannopyranosylamine - - DRUGBANK DB03414 C6H13NO4S small molecule - - DRUGBANK 21162 110297 4124 - MAN2A1 AMan II|GOLIM7|MANA2|MANII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3271 5-Thio-a/B-D-Mannopyranosylamine - - DRUGBANK DB03414 C6H13NO4S small molecule - - DRUGBANK 10092 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Shioda K (2010) 20655983 178189 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10093 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Wiest SA (1999) 10494892 178188 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10094 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Salsali M (2004) 15049511 178194 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10095 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Todd KG (1995) 8749840 178187 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10096 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Finberg JP (2002) 12504917 178196 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10097 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Gatch MB (2006) 16495723 178197 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10098 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Nolen WA (2003) 14574774 178190 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10099 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Volz HP (1998) 9829163 178186 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10100 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Lang W (2004) 15351283 178192 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10101 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Shioda K (2004) 15276688 178191 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10102 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Cohen C (1999) 10548268 178195 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10103 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Loescher W (1999) 10027835 178193 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10104 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 16139 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Ulus IH (2000) 10799660 174228 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16140 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 23940 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Egashira T (1996) 8842678 181710 4634 Zimelidine (z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine - DRUGBANK DB04832 C16H17BrN2 small molecule N06AB02 56775-88-3 DRUGBANK 27767 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Heal DJ (2013) 23539642 196018 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 10688 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Kan JP (1986) 3954800 178464 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 4079 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Ulus IH (2000) 10799660 174228 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4080 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Kilpatrick IC (2001) 11673765 174229 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4081 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Rothman RB (1999) 10231134 174226 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4082 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Nandigama RK (2002) 11911838 174227 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 22400 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3851 N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine - - DRUGBANK DB04017 C13H15Cl2NO small molecule - - DRUGBANK 17443 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Patkar AA (2006) 16641841 179836 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17444 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Baker GB (2007) 17823646 179831 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17445 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Lee KC (2007) 19300583 179829 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17446 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Azzaro AJ (2007) 17715422 179828 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17447 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Murphy DL (1998) 9564606 181613 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17448 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Fuentes JA (1979) 477738 181612 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 16702 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 15363 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Kettler R (1990) 2248058 180832 1235 Isocarboxazid Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida marplan DRUGBANK DB01247 C12H13N3O2 small molecule N06AF01 59-63-2 DRUGBANK 15364 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Thase ME (1995) 7612154 180834 1235 Isocarboxazid Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida marplan DRUGBANK DB01247 C12H13N3O2 small molecule N06AF01 59-63-2 DRUGBANK 15365 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1235 Isocarboxazid Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida marplan DRUGBANK DB01247 C12H13N3O2 small molecule N06AF01 59-63-2 DRUGBANK 14428 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1159 Moclobemide p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid manerix|nu-moclobemide|manerix DRUGBANK DB01171 C13H17ClN2O2 small molecule N06AG02 71320-77-9 DRUGBANK 14429 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Berlin I (1990) 1705137 180461 1159 Moclobemide p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid manerix|nu-moclobemide|manerix DRUGBANK DB01171 C13H17ClN2O2 small molecule N06AG02 71320-77-9 DRUGBANK 14430 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Fulton B (1996) 8875133 180460 1159 Moclobemide p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid manerix|nu-moclobemide|manerix DRUGBANK DB01171 C13H17ClN2O2 small molecule N06AG02 71320-77-9 DRUGBANK 10387 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10388 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Nolen WA (2003) 14574774 178190 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10389 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Volz HP (1998) 9829163 178186 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10390 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target McIntyre RS (2006) 16370964 178345 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10391 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Wooters TE (2007) 17912044 178344 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10392 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Pickar D (1982) 7092487 178347 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10393 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Chiche F (2009) 19201819 178346 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10394 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target MacKenzie EM (2008) 17768678 178353 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10395 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens antagonist target Chenu F (2009) 18700056 178343 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 11656 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Murata M (2010) 20502722 179028 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11657 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Okada M (1995) 8991786 179032 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 9827 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target MacFarlane MD (1975) 1109354 178033 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 25646 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6447 DECYL(DIMETHYL)PHOSPHINE OXIDE - - DRUGBANK DB07641 C12H27OP small molecule - - DRUGBANK 23926 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Hovevey-Sion D (1989) 2506486 181654 4622 Nialamide 2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum - DRUGBANK DB04820 C16H18N4O2 small molecule N06AF02 51-12-7 DRUGBANK 23929 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Egashira T (1999) 10580379 181743 4623 Nomifensine (+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine - DRUGBANK DB04821 C16H18N2 small molecule N06AX04 24526-64-5 DRUGBANK 25946 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6715 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE - - DRUGBANK DB07919 C13H12N2O small molecule - - DRUGBANK 13062 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Patkar AA (2006) 16641841 179836 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13063 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Azzaro AJ (2007) 17715422 179828 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13064 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Baker GB (2007) 17823646 179831 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13065 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Lee KC (2007) 19300583 179829 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 20601 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20602 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20603 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 16766 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Green AL (1980) 6103055 181444 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16767 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Ask AL (1983) 6646243 181443 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 17052 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Ulus IH (2000) 10799660 174228 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17053 110301 4128 RP1-201D17__B.2 MAOA MAO-A 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 10079 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Shioda K (2010) 20655983 178189 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10080 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Wiest SA (1999) 10494892 178188 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10081 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Salsali M (2004) 15049511 178194 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10082 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Todd KG (1995) 8749840 178187 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10083 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Finberg JP (2002) 12504917 178196 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10084 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Gatch MB (2006) 16495723 178197 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10085 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Nolen WA (2003) 14574774 178190 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10086 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Volz HP (1998) 9829163 178186 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10087 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Lang W (2004) 15351283 178192 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10088 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Shioda K (2004) 15276688 178191 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10089 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Cohen C (1999) 10548268 178195 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10090 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Loescher W (1999) 10027835 178193 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 10091 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 742 Tranylcypromine Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum parnate|tranylcypromine sulfat DRUGBANK DB00752 C9H11N small molecule N06AF04 155-09-9 DRUGBANK 16144 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Ulus IH (2000) 10799660 174228 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16145 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 26202 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6968 (1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE - - DRUGBANK DB08176 C11H12FN small molecule - - DRUGBANK 16202 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Youdim MB (2001) 12043833 181186 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16203 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16204 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chen JJ (2007) 18035186 181189 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16205 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Naoi M (2009) 19673610 181188 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16206 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Youdim MB (2004) 15573406 181190 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16207 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Weinreb O (2010) 20600573 181191 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16208 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chau KY (2010) 20624440 181192 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16209 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Leegwater-Kim J (2010) 20517484 181193 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 16210 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Uzun M (2009) 19499843 181194 1329 Rasagiline (R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine apo-rasagiline|teva-rasagiline DRUGBANK DB01367 C12H13N small molecule N04BD02 136236-51-6 DRUGBANK 23941 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Egashira T (1999) 10580379 181743 4634 Zimelidine (z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine - DRUGBANK DB04832 C16H17BrN2 small molecule N06AB02 56775-88-3 DRUGBANK 27768 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Heal DJ (2013) 23539642 196018 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3909 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Clarke DE (1982) 7059347 174156 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 26112 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6875 N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE - - DRUGBANK DB08082 C9H10ClNO2 small molecule - - DRUGBANK 22133 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3731 N-Propargyl-1(S)-Aminoindan - - DRUGBANK DB03894 C12H13N small molecule - - DRUGBANK 10371 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10372 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Nolen WA (2003) 14574774 178190 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10373 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Volz HP (1998) 9829163 178186 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10374 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target McIntyre RS (2006) 16370964 178345 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10375 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Wooters TE (2007) 17912044 178344 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10376 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Pickar D (1982) 7092487 178347 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10377 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Chiche F (2009) 19201819 178346 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10378 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Chenu F (2009) 18700056 178343 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 26528 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7261 4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN - - DRUGBANK DB08480 C12H13NO small molecule - - DRUGBANK 19367 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2406 Farnesol - - DRUGBANK DB02509 C15H26O small molecule - 4602-84-0 DRUGBANK 25532 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6324 7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE - - DRUGBANK DB07513 C18H16ClNO3 small molecule - - DRUGBANK 25531 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6323 7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE - - DRUGBANK DB07512 C17H11ClO4 small molecule - - DRUGBANK 4088 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Rothman RB (1999) 10218558 174235 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4089 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Ulus IH (2000) 10799660 174228 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4090 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Kilpatrick IC (2001) 11673765 174229 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4091 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Rothman RB (1999) 10231134 174226 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4092 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens antagonist target Nandigama RK (2002) 11911838 174227 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 22688 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 17430 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chrisp P (1991) 1794016 179834 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17431 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Heinonen EH (1994) 7995016 179835 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17432 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Patkar AA (2006) 16641841 179836 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17433 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Deleu D (2002) 11978145 179837 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17434 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Macleod AD (2005) 16034956 179830 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17435 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Baker GB (2007) 17823646 179831 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17436 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Unknown Authors (2002) 12199263 179832 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17437 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Heinonen EH (1998) 9673855 179833 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17438 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Lee KC (2007) 19300583 179829 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17439 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Azzaro AJ (2007) 17715422 179828 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 27800 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Magyar K (1984) 6441926 196045 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17440 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Murphy DL (1998) 9564606 181613 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17441 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Fuentes JA (1979) 477738 181612 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 17442 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Villeneuve C (2009) 19542488 181611 1563 Pargyline Eutonyl|Pargyline|Eutron - DRUGBANK DB01626 C11H13N small molecule C02KC01|C02LL01 555-57-7 DRUGBANK 16703 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 15361 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Kettler R (1990) 2248058 180832 1235 Isocarboxazid Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida marplan DRUGBANK DB01247 C12H13N3O2 small molecule N06AF01 59-63-2 DRUGBANK 15362 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Mason ST (1985) 4070383 180833 1235 Isocarboxazid Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida marplan DRUGBANK DB01247 C12H13N3O2 small molecule N06AF01 59-63-2 DRUGBANK 26567 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7295 (S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE] - - DRUGBANK DB08516 C17H17FN2O2 small molecule - - DRUGBANK 11649 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11650 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Murata M (2010) 20502722 179028 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11651 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Murata M (2001) 11755227 179027 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11652 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Murata M (2004) 14965331 179030 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11653 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11654 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Okada M (1995) 8991786 179032 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11655 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Okada M (1994) 7856330 179033 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 9828 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target MacFarlane MD (1975) 1109354 178033 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 23924 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Hovevey-Sion D (1989) 2506486 181654 4622 Nialamide 2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum - DRUGBANK DB04820 C16H18N4O2 small molecule N06AF02 51-12-7 DRUGBANK 23931 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Egashira T (1999) 10580379 181743 4623 Nomifensine (+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine - DRUGBANK DB04821 C16H18N2 small molecule N06AX04 24526-64-5 DRUGBANK 13051 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chrisp P (1991) 1794016 179834 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13052 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Heinonen EH (1994) 7995016 179835 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13053 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Patkar AA (2006) 16641841 179836 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13054 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Deleu D (2002) 11978145 179837 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13055 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Macleod AD (2005) 16034956 179830 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13056 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Baker GB (2007) 17823646 179831 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13057 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Unknown Authors (2002) 12199263 179832 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13058 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Heinonen EH (1998) 9673855 179833 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13059 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Lee KC (2007) 19300583 179829 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13060 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Azzaro AJ (2007) 17715422 179828 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 27797 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Magyar K (1984) 6441926 196045 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 13061 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1026 Selegiline L-Deprenalin|Selegilinum|()-selegiline|Selegilina dom-selegiline|mylan-selegilin DRUGBANK DB01037 C13H17N small molecule N04BD01 14611-51-9 DRUGBANK 18740 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2124 N-Methyl-N-Propargyl-1(R)-Aminoindan - - DRUGBANK DB02211 C13H15N small molecule - - DRUGBANK 23028 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4133 5-Hydroxy-N-Propargyl-1(R)-Aminoindan - - DRUGBANK DB04307 C12H13NO small molecule - - DRUGBANK 16760 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Green AL (1980) 6103055 181444 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16761 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Ask AL (1983) 6646243 181443 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 23811 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4481 N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE - - DRUGBANK DB04677 C13H19N small molecule - - DRUGBANK 17056 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Ulus IH (2000) 10799660 174228 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17057 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 19609 110302 4129 RP1-201D17__B.1 MAOB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2534 N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate - - DRUGBANK DB02643 C17H38NO3S small molecule - - DRUGBANK 14708 110303 4130 - MAP1A MAP1L|MTAP1A 9606 Homo sapiens antagonist target Stearns ME (1991) 1647395 180566 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 15379 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens unknown target McGrogan BT (2008) 18068131 180741 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 14714 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens antagonist target Friden B (1991) 1908244 180575 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14715 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens antagonist target Tew KD (1983) 6364362 180571 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14716 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens antagonist target Falconer MM (1989) 2679799 180573 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14717 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens antagonist target Moraga D (1992) 1599956 180572 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14718 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens antagonist target Stearns ME (1991) 1647395 180566 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 14719 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens antagonist target Burns RG (1990) 2125244 180574 1184 Estramustine Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine emcyt cap 140mg|emcyt DRUGBANK DB01196 C23H31Cl2NO3 small molecule L01XX11 2998-57-4 DRUGBANK 15126 110305 4133 - MAP2 MAP2A|MAP2B|MAP2C 9606 Homo sapiens unknown target McGrogan BT (2008) 18068131 180741 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15378 110306 4134 - MAP4 - 9606 Homo sapiens unknown target McGrogan BT (2008) 18068131 180741 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15125 110306 4134 - MAP4 - 9606 Homo sapiens unknown target McGrogan BT (2008) 18068131 180741 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15377 110308 4137 - MAPT DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU 9606 Homo sapiens unknown target McGrogan BT (2008) 18068131 180741 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15124 110308 4137 - MAPT DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU 9606 Homo sapiens unknown target McGrogan BT (2008) 18068131 180741 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 21593 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3459 L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid - - DRUGBANK DB03611 C5H9NO3 small molecule - - DRUGBANK 21594 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3459 L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid - - DRUGBANK DB03611 C5H9NO3 small molecule - - DRUGBANK 21595 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3459 L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid - - DRUGBANK DB03611 C5H9NO3 small molecule - - DRUGBANK 1709 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens cofactor target Santamaria E (2003) 12631701 172680 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1710 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens cofactor target Carretero MV (2001) 11301045 172681 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1711 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens cofactor target Martinez-Chantar ML (2003) 12671891 10442 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1712 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens cofactor target Martinez-Chantar ML (2002) 12060674 172679 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1713 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens cofactor target Martinez-Chantar ML (2003) 12660248 172678 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 20731 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3059 3-Oxiran-2ylalanine - - DRUGBANK DB03191 C5H9NO3 small molecule - - DRUGBANK 20732 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3059 3-Oxiran-2ylalanine - - DRUGBANK DB03191 C5H9NO3 small molecule - - DRUGBANK 20733 110313 4143 RP11-36D19.2 MAT1A MAT|MATA1|SAMS|SAMS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3059 3-Oxiran-2ylalanine - - DRUGBANK DB03191 C5H9NO3 small molecule - - DRUGBANK 1705 110314 4144 - MAT2A MATA2|MATII|SAMS2 9606 Homo sapiens cofactor target Farrar C (2002) 12023972 172677 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1706 110314 4144 - MAT2A MATA2|MATII|SAMS2 9606 Homo sapiens cofactor target Mudd SH (2001) 11596649 172676 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1707 110314 4144 - MAT2A MATA2|MATII|SAMS2 9606 Homo sapiens cofactor target Martinez-Chantar ML (2003) 12671891 10442 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1708 110314 4144 - MAT2A MATA2|MATII|SAMS2 9606 Homo sapiens cofactor target Martinez-Chantar ML (2003) 12660248 172678 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 17637 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1645 Porphyrin Fe(Iii) - - DRUGBANK DB01710 C20H12FeN4 small molecule - - DRUGBANK 17638 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1645 Porphyrin Fe(Iii) - - DRUGBANK DB01710 C20H12FeN4 small molecule - - DRUGBANK 17639 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1645 Porphyrin Fe(Iii) - - DRUGBANK DB01710 C20H12FeN4 small molecule - - DRUGBANK 18462 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 18463 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 18464 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1993 Biliverdine Ix Alpha - - DRUGBANK DB02073 C33H33N4O6 small molecule - 114-25-0 DRUGBANK 23158 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4162 Methyl Isocyanide - - DRUGBANK DB04337 C2H3N small molecule - - DRUGBANK 23159 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4162 Methyl Isocyanide - - DRUGBANK DB04337 C2H3N small molecule - - DRUGBANK 23160 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4162 Methyl Isocyanide - - DRUGBANK DB04337 C2H3N small molecule - - DRUGBANK 22435 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3882 N-Propyl Isocyanide - - DRUGBANK DB04050 C4H7N small molecule - - DRUGBANK 22436 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3882 N-Propyl Isocyanide - - DRUGBANK DB04050 C4H7N small molecule - - DRUGBANK 22437 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3882 N-Propyl Isocyanide - - DRUGBANK DB04050 C4H7N small molecule - - DRUGBANK 19678 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2562 1-Methylimidazole - - DRUGBANK DB02671 C4H7N2 small molecule - 616-47-7 DRUGBANK 19679 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2562 1-Methylimidazole - - DRUGBANK DB02671 C4H7N2 small molecule - 616-47-7 DRUGBANK 19680 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2562 1-Methylimidazole - - DRUGBANK DB02671 C4H7N2 small molecule - 616-47-7 DRUGBANK 19089 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19090 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19091 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19138 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2299 Methylethylamine - - DRUGBANK DB02396 C3H9N small molecule - 624-78-2 DRUGBANK 19139 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2299 Methylethylamine - - DRUGBANK DB02396 C3H9N small molecule - 624-78-2 DRUGBANK 19140 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2299 Methylethylamine - - DRUGBANK DB02396 C3H9N small molecule - 624-78-2 DRUGBANK 21115 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3256 Ethyl Isocyanide - - DRUGBANK DB03399 C3H6N small molecule - - DRUGBANK 21116 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3256 Ethyl Isocyanide - - DRUGBANK DB03399 C3H6N small molecule - - DRUGBANK 21117 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3256 Ethyl Isocyanide - - DRUGBANK DB03399 C3H6N small molecule - - DRUGBANK 19406 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2425 Tetrazolyl Histidine - - DRUGBANK DB02528 C7H8N7O small molecule - - DRUGBANK 19407 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2425 Tetrazolyl Histidine - - DRUGBANK DB02528 C7H8N7O small molecule - - DRUGBANK 19408 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2425 Tetrazolyl Histidine - - DRUGBANK DB02528 C7H8N7O small molecule - - DRUGBANK 17877 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1756 N-Butyl Isocyanide - - DRUGBANK DB01826 C5H9N small molecule - 2769-64-4 DRUGBANK 17878 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1756 N-Butyl Isocyanide - - DRUGBANK DB01826 C5H9N small molecule - 2769-64-4 DRUGBANK 17879 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1756 N-Butyl Isocyanide - - DRUGBANK DB01826 C5H9N small molecule - 2769-64-4 DRUGBANK 21081 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 21082 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 21083 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3244 4-Methylimidazole - - DRUGBANK DB03385 C4H5N2 small molecule - - DRUGBANK 19617 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2537 Nitrosoethane - - DRUGBANK DB02646 C2H5NO small molecule - 925-91-7 DRUGBANK 19618 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2537 Nitrosoethane - - DRUGBANK DB02646 C2H5NO small molecule - 925-91-7 DRUGBANK 19619 110321 4151 RP4-569D19.7 MB PVALB|myoglobgin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2537 Nitrosoethane - - DRUGBANK DB02646 C2H5NO small molecule - 925-91-7 DRUGBANK 22547 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3923 Alpha-L-1-Methyl-Fucose - - DRUGBANK DB04091 C7H14O5 small molecule - - DRUGBANK 22548 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3923 Alpha-L-1-Methyl-Fucose - - DRUGBANK DB04091 C7H14O5 small molecule - - DRUGBANK 22549 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3923 Alpha-L-1-Methyl-Fucose - - DRUGBANK DB04091 C7H14O5 small molecule - - DRUGBANK 22098 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3716 Alpha-L-Methyl-Fucose - - DRUGBANK DB03879 C7H14O5 small molecule - - DRUGBANK 22099 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3716 Alpha-L-Methyl-Fucose - - DRUGBANK DB03879 C7H14O5 small molecule - - DRUGBANK 22100 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3716 Alpha-L-Methyl-Fucose - - DRUGBANK DB03879 C7H14O5 small molecule - - DRUGBANK 21797 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 21798 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 21799 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 19998 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2719 O4-Sulfonylgalactose - - DRUGBANK DB02837 C6H12O9S small molecule - - DRUGBANK 19999 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2719 O4-Sulfonylgalactose - - DRUGBANK DB02837 C6H12O9S small molecule - - DRUGBANK 20000 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2719 O4-Sulfonylgalactose - - DRUGBANK DB02837 C6H12O9S small molecule - - DRUGBANK 23381 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4241 Alpha-Methyl-N-Acetyl-D-Glucosamine - - DRUGBANK DB04426 C9H17NO6 small molecule - - DRUGBANK 23382 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4241 Alpha-Methyl-N-Acetyl-D-Glucosamine - - DRUGBANK DB04426 C9H17NO6 small molecule - - DRUGBANK 23383 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4241 Alpha-Methyl-N-Acetyl-D-Glucosamine - - DRUGBANK DB04426 C9H17NO6 small molecule - - DRUGBANK 20740 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3062 Beta-L-Methyl-Fucose - - DRUGBANK DB03194 C7H14O5 small molecule - - DRUGBANK 20741 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3062 Beta-L-Methyl-Fucose - - DRUGBANK DB03194 C7H14O5 small molecule - - DRUGBANK 20742 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3062 Beta-L-Methyl-Fucose - - DRUGBANK DB03194 C7H14O5 small molecule - - DRUGBANK 17856 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1748 O3-Sulfonylgalactose - - DRUGBANK DB01818 C6H12O9S small molecule - - DRUGBANK 17857 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1748 O3-Sulfonylgalactose - - DRUGBANK DB01818 C6H12O9S small molecule - - DRUGBANK 17858 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1748 O3-Sulfonylgalactose - - DRUGBANK DB01818 C6H12O9S small molecule - - DRUGBANK 18233 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1903 Methyl alpha-D-mannoside - - DRUGBANK DB01979 C7H14O6 small molecule - 25281-48-5 DRUGBANK 18234 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1903 Methyl alpha-D-mannoside - - DRUGBANK DB01979 C7H14O6 small molecule - 25281-48-5 DRUGBANK 18235 110323 4153 RP11-94H3.1 MBL2 COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1903 Methyl alpha-D-mannoside - - DRUGBANK DB01979 C7H14O6 small molecule - 25281-48-5 DRUGBANK 24172 110327 4157 - MC1R CMM5|MSH-R|SHEP2 9606 Homo sapiens unknown target Fitzgerald LM (2006) 16293341 181919 4728 Afamelanotide MT-I|Melanotan 1|Melanotan I - DRUGBANK DB04931 C78H111N21O19 small molecule D02BB02 75921-69-6 DRUGBANK 15737 110328 4158 - MC2R ACTHR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1271 Cosyntropin Adrenocorticotropic hormone 1-24|Corticotropin-(1-24) tetracosapeptide|Corticotropin-(1-24)|alpha(1-24)-Corticotrophin|Tetracosactide|beta(1-24)-Corticotrophin|SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro|SYSMEHFRWGKPVGKKRRPVKVYP|Cosyntropin|ATCH (1-24) cortrosyn|cosyntropin|cortrosy DRUGBANK DB01284 C136H210N40O31S biologic H01AA02 16960-16-0 DRUGBANK 15738 110328 4158 - MC2R ACTHR 9606 Homo sapiens antagonist target Moraes RB (2010) 20562554 181041 1271 Cosyntropin Adrenocorticotropic hormone 1-24|Corticotropin-(1-24) tetracosapeptide|Corticotropin-(1-24)|alpha(1-24)-Corticotrophin|Tetracosactide|beta(1-24)-Corticotrophin|SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro|SYSMEHFRWGKPVGKKRRPVKVYP|Cosyntropin|ATCH (1-24) cortrosyn|cosyntropin|cortrosy DRUGBANK DB01284 C136H210N40O31S biologic H01AA02 16960-16-0 DRUGBANK 15739 110328 4158 - MC2R ACTHR 9606 Homo sapiens antagonist target Mehrabani PA (1990) 2156274 181040 1271 Cosyntropin Adrenocorticotropic hormone 1-24|Corticotropin-(1-24) tetracosapeptide|Corticotropin-(1-24)|alpha(1-24)-Corticotrophin|Tetracosactide|beta(1-24)-Corticotrophin|SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro|SYSMEHFRWGKPVGKKRRPVKVYP|Cosyntropin|ATCH (1-24) cortrosyn|cosyntropin|cortrosy DRUGBANK DB01284 C136H210N40O31S biologic H01AA02 16960-16-0 DRUGBANK 15740 110328 4158 - MC2R ACTHR 9606 Homo sapiens antagonist target Schwerin M (2005) 15710205 181039 1271 Cosyntropin Adrenocorticotropic hormone 1-24|Corticotropin-(1-24) tetracosapeptide|Corticotropin-(1-24)|alpha(1-24)-Corticotrophin|Tetracosactide|beta(1-24)-Corticotrophin|SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro|SYSMEHFRWGKPVGKKRRPVKVYP|Cosyntropin|ATCH (1-24) cortrosyn|cosyntropin|cortrosy DRUGBANK DB01284 C136H210N40O31S biologic H01AA02 16960-16-0 DRUGBANK 15741 110328 4158 - MC2R ACTHR 9606 Homo sapiens agonist target Carey LC (2006) 16478774 181042 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15742 110328 4158 - MC2R ACTHR 9606 Homo sapiens agonist target Johnston H (2007) 17636172 181043 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15743 110328 4158 - MC2R ACTHR 9606 Homo sapiens agonist target Suri D (2006) 17185906 181046 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15744 110328 4158 - MC2R ACTHR 9606 Homo sapiens agonist target Lin L (2007) 17223989 181044 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 15745 110328 4158 - MC2R ACTHR 9606 Homo sapiens agonist target Hruby VJ (2007) 17584128 181045 1272 Corticotropin Acthar|Corticotropin in gelatin matrix|H.P. acthar gel|ACTH|Repository corticotropin|Cortigel|Adrenocorticotrophin|Purified cortrophin gel|Corticotrophin injection, repository|Corticotropin, repository|Corticotrophin|Adrenocorticotropic hormone acthar gel hp inj 40unit/ml|ac DRUGBANK DB01285 C207H308N56O58S biologic H01AA01 12427-33-7 DRUGBANK 3391 110355 4190 - MDH1 HEL-S-32|MDH-s|MDHA|MGC:1375|MOR2 9606 Homo sapiens unknown target Drew DP (2007) 16983536 173786 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21303 110355 4190 - MDH1 HEL-S-32|MDH-s|MDHA|MGC:1375|MOR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3290 110356 4191 - MDH2 M-MDH|MDH|MGC:3559|MOR1 9606 Homo sapiens unknown target Baeumchen C (2007) 17619232 173685 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3291 110356 4191 - MDH2 M-MDH|MDH|MGC:3559|MOR1 9606 Homo sapiens unknown target Markova EV (2006) 16898590 173735 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3292 110356 4191 - MDH2 M-MDH|MDH|MGC:3559|MOR1 9606 Homo sapiens unknown target Gallarta F (2007) 17203264 173754 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3293 110356 4191 - MDH2 M-MDH|MDH|MGC:3559|MOR1 9606 Homo sapiens unknown target Yennaco LJ (2007) 17487443 173753 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3294 110356 4191 - MDH2 M-MDH|MDH|MGC:3559|MOR1 9606 Homo sapiens unknown target Rzem R (2007) 17603759 173752 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22969 110356 4191 - MDH2 M-MDH|MDH|MGC:3559|MOR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 20059 110358 4193 - MDM2 ACTFS|HDMX|hdm2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2754 Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone - - DRUGBANK DB02872 C31H34Br2N4O4 small molecule - - DRUGBANK 20060 110358 4193 - MDM2 ACTFS|HDMX|hdm2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2754 Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone - - DRUGBANK DB02872 C31H34Br2N4O4 small molecule - - DRUGBANK 22685 110358 4193 - MDM2 ACTFS|HDMX|hdm2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3975 Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone - - DRUGBANK DB04144 C30H32Cl2N4O3 small molecule - - DRUGBANK 22686 110358 4193 - MDM2 ACTFS|HDMX|hdm2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3975 Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone - - DRUGBANK DB04144 C30H32Cl2N4O3 small molecule - - DRUGBANK 22687 110358 4193 - MDM2 ACTFS|HDMX|hdm2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3975 Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone - - DRUGBANK DB04144 C30H32Cl2N4O3 small molecule - - DRUGBANK 3215 110363 4199 - ME1 HUMNDME|MES 9606 Homo sapiens unknown target McKinlay JB (2007) 17197218 173715 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21282 110363 4199 - ME1 HUMNDME|MES 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21283 110363 4199 - ME1 HUMNDME|MES 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21284 110363 4199 - ME1 HUMNDME|MES 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3402 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3403 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21411 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 21412 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 21701 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3526 Tartronate - - DRUGBANK DB03680 C3H2O5 small molecule - - DRUGBANK 21702 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3526 Tartronate - - DRUGBANK DB03680 C3H2O5 small molecule - - DRUGBANK 17550 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1613 Fumarate - - DRUGBANK DB01677 C4H2O4 small molecule - 110-17-8 DRUGBANK 17551 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1613 Fumarate - - DRUGBANK DB01677 C4H2O4 small molecule - 110-17-8 DRUGBANK 21549 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3437 Alpha-Ketomalonic Acid - - DRUGBANK DB03589 C3H2O5 small molecule - - DRUGBANK 21550 110364 4200 - ME2 ODS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3437 Alpha-Ketomalonic Acid - - DRUGBANK DB03589 C3H2O5 small molecule - - DRUGBANK 26791 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7563 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE - - DRUGBANK DB08791 C14H10N4O5S small molecule - - DRUGBANK 26620 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7361 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline - - DRUGBANK DB08584 C18H13N7S small molecule - - DRUGBANK 24921 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5715 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide - - DRUGBANK DB06896 C25H16F2N4O3 small molecule - - DRUGBANK 25998 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6764 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol - - DRUGBANK DB07969 C20H19F3N4O small molecule - - DRUGBANK 26932 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens inhibitor target Forde PM (2012) 22594847 182202 7610 Crizotinib MET Tyrosine Kinase Inhibitor PF-02341066|(R)-Crizotinib|PF-2341066|C-Met/Hepatocyte Growth Factor Receptor Tyrosine Kinase Inhibitor PF-02341066|C-Met/HGFR Tyrosine Kinase Inhibitor PF-02341066|PF 2341066|Crizotinibum xalkori DRUGBANK DB08865 C21H22Cl2FN5O small molecule L01XE16 877399-52-5 DRUGBANK 25010 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5815 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide - - DRUGBANK DB06997 C22H16F2N4O3 small molecule - - DRUGBANK 18622 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2069 K-252a - - DRUGBANK DB02152 C27H21N3O5 small molecule - 97161-97-2 DRUGBANK 18623 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2069 K-252a - - DRUGBANK DB02152 C27H21N3O5 small molecule - 97161-97-2 DRUGBANK 18624 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2069 K-252a - - DRUGBANK DB02152 C27H21N3O5 small molecule - 97161-97-2 DRUGBANK 25375 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6185 N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide - - DRUGBANK DB07369 C23H22ClN3O3S small molecule - - DRUGBANK 26132 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6904 4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol - - DRUGBANK DB08111 C18H14N4O small molecule - - DRUGBANK 25008 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5813 N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide - - DRUGBANK DB06995 C20H16F2N4O3 small molecule - - DRUGBANK 26728 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7474 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine - - DRUGBANK DB08700 C21H22Cl2FN5O small molecule - - DRUGBANK 26108 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6872 7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline - - DRUGBANK DB08079 C22H17N5O2 small molecule - - DRUGBANK 26940 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens antagonist target Yakes FM (2011) 21926191 182194 7619 Cabozantinib - cometriq DRUGBANK DB08875 C28H24FN3O5 small molecule L01XE26 849217-68-1 DRUGBANK 26941 110391 4233 - MET AUTS9|HGFR|RCCP2|c-Met 9606 Homo sapiens antagonist target Kurzrock R (2011) 21606412 182188 7619 Cabozantinib - cometriq DRUGBANK DB08875 C28H24FN3O5 small molecule L01XE26 849217-68-1 DRUGBANK 21112 110401 4245 - MGAT1 GLCNAC-TI|GLCT1|GLYT1|GNT-1|GNT-I|MGAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21113 110401 4245 - MGAT1 GLCNAC-TI|GLCT1|GLYT1|GNT-1|GNT-I|MGAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21114 110401 4245 - MGAT1 GLCNAC-TI|GLCT1|GLYT1|GNT-1|GNT-I|MGAT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 18745 110411 4255 RP11-109A6.1 MGMT - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2128 S-Methylcysteine - - DRUGBANK DB02216 C4H9NO2S small molecule - 1187-84-4 DRUGBANK 18746 110411 4255 RP11-109A6.1 MGMT - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2128 S-Methylcysteine - - DRUGBANK DB02216 C4H9NO2S small molecule - 1187-84-4 DRUGBANK 2921 110411 4255 RP11-109A6.1 MGMT - 9606 Homo sapiens unknown target Niture SK (2007) 16950796 173568 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 23655 110411 4255 RP11-109A6.1 MGMT - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4343 Benzylcysteine - - DRUGBANK DB04531 C10H13NO2S small molecule - - DRUGBANK 23656 110411 4255 RP11-109A6.1 MGMT - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4343 Benzylcysteine - - DRUGBANK DB04531 C10H13NO2S small molecule - - DRUGBANK 2620 110413 4257 - MGST1 GST12|MGST|MGST-I 9606 Homo sapiens unknown target Busenlehner LS (2007) 17297922 173352 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2621 110413 4257 - MGST1 GST12|MGST|MGST-I 9606 Homo sapiens unknown target Siritantikorn A (2007) 17306223 173351 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2574 110414 4258 - MGST2 GST2|MGST-II 9606 Homo sapiens unknown target Ago H (2007) 17632548 160488 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2600 110415 4259 RP11-466F5.1 MGST3 GST-III 9606 Homo sapiens unknown target Ago H (2007) 17632548 160488 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 19805 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2616 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester - - DRUGBANK DB02728 C12H10O5 small molecule - - DRUGBANK 19806 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2616 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester - - DRUGBANK DB02728 C12H10O5 small molecule - - DRUGBANK 19807 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2616 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester - - DRUGBANK DB02728 C12H10O5 small molecule - - DRUGBANK 22950 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22951 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 18011 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1808 3,4-Dihydroxycinnamic Acid - - DRUGBANK DB01880 C9H8O4 small molecule - 331-39-5 DRUGBANK 25724 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6521 3-(4-HYDROXY-PHENYL)PYRUVIC ACID - - DRUGBANK DB07718 C9H8O4 small molecule - - DRUGBANK 26765 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7538 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE - - DRUGBANK DB08765 C7H6N2O3S2 small molecule - - DRUGBANK 26375 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7119 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME - - DRUGBANK DB08333 C14H17NO3 small molecule - - DRUGBANK 25918 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6685 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER - - DRUGBANK DB07888 C12H13NO4 small molecule - - DRUGBANK 26376 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7120 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME - - DRUGBANK DB08334 C14H16FNO3 small molecule - - DRUGBANK 26377 110428 4282 - MIF GIF|GLIF|MMIF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7121 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME - - DRUGBANK DB08335 C13H17NO3 small molecule - - DRUGBANK 26729 110439 4293 - MAP3K9 MEKK9|MLK1|PRKE1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7477 12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one - - DRUGBANK DB08703 C27H24N2O3 small molecule - - DRUGBANK 26616 110447 4301 - MLLT4 AF6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7351 (5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE - - DRUGBANK DB08574 C11H8F3NOS2 small molecule - - DRUGBANK 9628 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Fraccarollo D (2003) 14607457 177899 690 Eplerenone Epoxymexrenone|Inspra eplerenone|inspra DRUGBANK DB00700 C24H30O6 small molecule C03DA04 107724-20-9 DRUGBANK 9629 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 690 Eplerenone Epoxymexrenone|Inspra eplerenone|inspra DRUGBANK DB00700 C24H30O6 small molecule C03DA04 107724-20-9 DRUGBANK 9630 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Rogerson FM (2004) 15554912 175945 690 Eplerenone Epoxymexrenone|Inspra eplerenone|inspra DRUGBANK DB00700 C24H30O6 small molecule C03DA04 107724-20-9 DRUGBANK 9631 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Moore TD (2003) 14503934 177900 690 Eplerenone Epoxymexrenone|Inspra eplerenone|inspra DRUGBANK DB00700 C24H30O6 small molecule C03DA04 107724-20-9 DRUGBANK 8322 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Austin RJ (2002) 12503693 177109 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8323 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Issar M (2006) 16507850 175778 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 14043 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1122 Desoxycorticosterone Pivalate DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate - DRUGBANK DB01134 C26H38O4 small molecule - 808-48-0 DRUGBANK 14044 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1122 Desoxycorticosterone Pivalate DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate - DRUGBANK DB01134 C26H38O4 small molecule - 808-48-0 DRUGBANK 14045 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1122 Desoxycorticosterone Pivalate DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate - DRUGBANK DB01134 C26H38O4 small molecule - 808-48-0 DRUGBANK 14046 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Sekihara H (1978) 744157 180302 1122 Desoxycorticosterone Pivalate DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate - DRUGBANK DB01134 C26H38O4 small molecule - 808-48-0 DRUGBANK 14047 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Beaumont K (1983) 6227474 180303 1122 Desoxycorticosterone Pivalate DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate - DRUGBANK DB01134 C26H38O4 small molecule - 808-48-0 DRUGBANK 9496 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Oelkers W (1994) 8157723 177818 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 9497 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Young MJ (1996) 8733007 177819 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 9498 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 9499 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Otte C (2003) 12888122 177821 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 9500 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Buckley TM (2007) 17666187 177820 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 9501 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens agonist target Kingsley-Kallesen M (2002) 12198239 177817 677 Fludrocortisone 9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison florinef acetate 0.1mg|fludroc DRUGBANK DB00687 C21H29FO5 small molecule H02AA02|S02CA07|S03CA05|S01CA06 127-31-1 DRUGBANK 16391 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Fuhrmann U (1996) 8922878 181280 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16392 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16393 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Oelkers WK (1996) 8732994 181279 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16394 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Krattenmacher R (2000) 11024226 181281 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16395 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Muhn P (1995) 7625729 181282 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 23779 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens unknown target Bunda S (2007) 17724138 182043 4436 Aldosterone 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|Aldocorten|Aldocortin|Electrocortin|18-Oxocorticosterone|Aldosteronum|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|Elektrocortin|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|18-Aldocorticosterone|Aldocortene|(+)-aldosterone|11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al|Aldosterona|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|D-aldosterone - DRUGBANK DB04630 C21H28O5 small molecule H02AA01 52-39-1 DRUGBANK 23780 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens unknown target Bruner KL (1997) 9392437 3987 4436 Aldosterone 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|Aldocorten|Aldocortin|Electrocortin|18-Oxocorticosterone|Aldosteronum|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|Elektrocortin|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|18-Aldocorticosterone|Aldocortene|(+)-aldosterone|11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al|Aldosterona|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|D-aldosterone - DRUGBANK DB04630 C21H28O5 small molecule H02AA01 52-39-1 DRUGBANK 23781 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4436 Aldosterone 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|Aldocorten|Aldocortin|Electrocortin|18-Oxocorticosterone|Aldosteronum|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|Elektrocortin|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|18-Aldocorticosterone|Aldocortene|(+)-aldosterone|11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al|Aldosterona|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|D-aldosterone - DRUGBANK DB04630 C21H28O5 small molecule H02AA01 52-39-1 DRUGBANK 23796 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4457 (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE - - DRUGBANK DB04652 C21H30O4 small molecule - - DRUGBANK 6433 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Dietz JD (2008) 18250364 175777 385 Nimodipine Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop nymalize|nimotop iv 0.2mg/ml|n DRUGBANK DB00393 C21H26N2O7 small molecule C08CA06 66085-59-4 DRUGBANK 6749 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6750 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Rogerson FM (2003) 14664717 175944 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6751 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Rogerson FM (2004) 15554912 175945 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6752 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Rossi G (2005) 15808807 175946 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6753 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Sitruk-Ware R (2002) 11791081 175947 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6754 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Gertner RA (2004) 14978157 175948 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6755 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Frishman WH (2004) 15128471 175949 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6756 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Sica DA (2005) 15947888 175950 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6454 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Rupprecht R (1993) 8282004 175782 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 12864 110451 4306 - NR3C2 MCR|MLR|MR|NR3C2VIT 9606 Homo sapiens antagonist target Dietz JD (2008) 18250364 175777 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 8647 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Elsner D (1992) 1386491 177320 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 8648 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Hirata Y (1994) 7511759 177321 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 8649 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Plamboeck A (2005) 16025254 177317 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 8650 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target O'Connell JE (1992) 1315825 177319 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 8651 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Sansoe G (2006) 16449355 177318 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 8652 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 606 Candoxatril 4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid - DRUGBANK DB00616 C29H41NO7 small molecule - 123122-55-4 DRUGBANK 18437 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1983 N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine - - DRUGBANK DB02062 C21H27N2O5P small molecule - - DRUGBANK 18438 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1983 N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine - - DRUGBANK DB02062 C21H27N2O5P small molecule - - DRUGBANK 18439 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1983 N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine - - DRUGBANK DB02062 C21H27N2O5P small molecule - - DRUGBANK 11405 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Intengan HD (2000) 10856267 178888 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11406 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Troughton RW (2000) 11040230 178889 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11407 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Burrell LM (2000) 11041166 178886 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11408 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target McClean DR (2000) 10933361 178887 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 11409 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Azizi M (2000) 10856268 178884 876 Omapatrilat Omapatrilate - DRUGBANK DB00886 C19H24N2O4S2 small molecule - 167305-00-2 DRUGBANK 19459 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2454 Phosphoramidon - - DRUGBANK DB02557 C23H34N3O10P small molecule - 36357-77-4 DRUGBANK 19460 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2455 N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine - - DRUGBANK DB02558 C21H24N2O4S small molecule - - DRUGBANK 19461 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2455 N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine - - DRUGBANK DB02558 C21H24N2O4S small molecule - - DRUGBANK 19462 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2455 N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine - - DRUGBANK DB02558 C21H24N2O4S small molecule - - DRUGBANK 19517 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2491 [2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala - - DRUGBANK DB02597 C19H28N2O4S small molecule - - DRUGBANK 19518 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2491 [2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala - - DRUGBANK DB02597 C19H28N2O4S small molecule - - DRUGBANK 19519 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2491 [2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala - - DRUGBANK DB02597 C19H28N2O4S small molecule - - DRUGBANK 26617 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7352 2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM - - DRUGBANK DB08575 C15H16N3S small molecule - - DRUGBANK 26652 110455 4311 - MME CALLA|CD10|NEP|SFE 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 7401 Thiorphan - - DRUGBANK DB08626 C12H15NO3S small molecule - 76721-89-6 DRUGBANK 10470 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10471 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10472 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 26529 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7263 [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER - - DRUGBANK DB08482 C19H35N3O6 small molecule - - DRUGBANK 25952 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6722 N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE - - DRUGBANK DB07926 C19H29N3O5 small molecule - - DRUGBANK 26537 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7271 N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE - - DRUGBANK DB08491 C19H21NO6S small molecule - - DRUGBANK 25569 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6365 N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE - - DRUGBANK DB07556 C18H23N3O5S small molecule - - DRUGBANK 26452 110456 4312 - MMP1 CLG|CLGN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7187 METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID - - DRUGBANK DB08403 C18H27N3O4 small molecule - - DRUGBANK 24039 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens unknown target Elkin M (2000) 11099465 181766 4666 Halofuginone Tempostatin (Collgard Biopharmaceuticals) - DRUGBANK DB04866 C16H17BrClN3O3 small molecule - 55837-20-2 DRUGBANK 10445 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Shinoda K (2003) 12527923 178389 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10446 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Bernardo MM (2002) 11790786 178388 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10447 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10448 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Bourd-Boittin K (2005) 15748894 178385 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10449 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Fanchon S (2004) 15056115 178387 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10450 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Treharne GD (1999) 10460642 178386 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 14720 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Williams RN (2005) 15993560 180580 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14721 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Brower GL (2007) 17308006 180581 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14722 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Reinhardt D (2002) 12381651 180579 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14723 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Okada M (2008) 19057128 180578 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14724 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Prontera C (1999) 10328230 180577 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14725 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens inhibitor target Yamamoto D (2010) 20184869 180576 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 17457 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1567 SC-74020 - - DRUGBANK DB01630 C29H42N4O6S small molecule - - DRUGBANK 17458 110457 4313 - MMP2 CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1567 SC-74020 - - DRUGBANK DB01630 C29H42N4O6S small molecule - - DRUGBANK 20357 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2906 1-Methyloxy-4-Sulfone-Benzene - - DRUGBANK DB03033 C7H8O3S small molecule - - DRUGBANK 20358 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2906 1-Methyloxy-4-Sulfone-Benzene - - DRUGBANK DB03033 C7H8O3S small molecule - - DRUGBANK 18282 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1920 3-Methylpyridine - - DRUGBANK DB01996 C6H7N small molecule - 108-99-6 DRUGBANK 18283 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1920 3-Methylpyridine - - DRUGBANK DB01996 C6H7N small molecule - 108-99-6 DRUGBANK 10444 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 26548 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7286 N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID - - DRUGBANK DB08507 C20H27N2O3P small molecule - - DRUGBANK 26013 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6781 [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID - - DRUGBANK DB07986 C19H22N2O4S small molecule - - DRUGBANK 26015 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6783 2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE - - DRUGBANK DB07988 C13H10F5N5O2S2 small molecule - - DRUGBANK 26317 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7059 N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID - - DRUGBANK DB08271 C13H20N2O5S small molecule - - DRUGBANK 22663 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3971 1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide - - DRUGBANK DB04140 C19H21N3O6S small molecule - - DRUGBANK 22664 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3971 1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide - - DRUGBANK DB04140 C19H21N3O6S small molecule - - DRUGBANK 22665 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3971 1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide - - DRUGBANK DB04140 C19H21N3O6S small molecule - - DRUGBANK 25409 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6205 2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE - - DRUGBANK DB07390 C13H15N5O2S2 small molecule - - DRUGBANK 26665 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7417 2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER - - DRUGBANK DB08643 C24H31N3O4S small molecule - - DRUGBANK 18507 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2010 A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor - - DRUGBANK DB02090 C20H37N3O6 small molecule - - DRUGBANK 18508 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2010 A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor - - DRUGBANK DB02090 C20H37N3O6 small molecule - - DRUGBANK 18509 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2010 A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor - - DRUGBANK DB02090 C20H37N3O6 small molecule - - DRUGBANK 19723 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2586 Hydroxyaminovaline - - DRUGBANK DB02697 C5H12N2O2 small molecule - - DRUGBANK 19724 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2586 Hydroxyaminovaline - - DRUGBANK DB02697 C5H12N2O2 small molecule - - DRUGBANK 26052 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6822 N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide - - DRUGBANK DB08029 C16H18N2O5S small molecule - - DRUGBANK 26053 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6823 3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide - - DRUGBANK DB08030 C16H14N2O3 small molecule - - DRUGBANK 19008 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2255 N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide - - DRUGBANK DB02350 C15H22N2O5S2 small molecule - - DRUGBANK 19009 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2255 N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide - - DRUGBANK DB02350 C15H22N2O5S2 small molecule - - DRUGBANK 19010 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2255 N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide - - DRUGBANK DB02350 C15H22N2O5S2 small molecule - - DRUGBANK 22849 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4060 N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide - - DRUGBANK DB04232 C20H23N3O7S small molecule - - DRUGBANK 22850 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4060 N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide - - DRUGBANK DB04232 C20H23N3O7S small molecule - - DRUGBANK 22851 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4060 N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide - - DRUGBANK DB04232 C20H23N3O7S small molecule - - DRUGBANK 26014 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6782 [2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER - - DRUGBANK DB07987 C19H18N4O3S2 small molecule - - DRUGBANK 23362 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4232 R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid - - DRUGBANK DB04416 C20H21NO6S small molecule - - DRUGBANK 23363 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4232 R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid - - DRUGBANK DB04416 C20H21NO6S small molecule - - DRUGBANK 23364 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4232 R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid - - DRUGBANK DB04416 C20H21NO6S small molecule - - DRUGBANK 18009 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1805 N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide - - DRUGBANK DB01877 C13H19N3O6S small molecule - - DRUGBANK 18010 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1805 N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide - - DRUGBANK DB01877 C13H19N3O6S small molecule - - DRUGBANK 21046 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3229 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione - - DRUGBANK DB03368 C17H14N2O4 small molecule - - DRUGBANK 21047 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3229 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione - - DRUGBANK DB03368 C17H14N2O4 small molecule - - DRUGBANK 21048 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3229 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione - - DRUGBANK DB03368 C17H14N2O4 small molecule - - DRUGBANK 19037 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2272 (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine - - DRUGBANK DB02367 C16H25N3O7S2 small molecule - - DRUGBANK 19038 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2272 (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine - - DRUGBANK DB02367 C16H25N3O7S2 small molecule - - DRUGBANK 19225 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2350 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid - - DRUGBANK DB02449 C28H28N3O4S small molecule - - DRUGBANK 19226 110458 4314 - MMP3 CHDS6|MMP-3|SL-1|STMY|STMY1|STR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2350 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid - - DRUGBANK DB02449 C28H28N3O4S small molecule - - DRUGBANK 26539 110459 4316 - MMP7 MMP-7|MPSL1|PUMP-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7273 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID - - DRUGBANK DB08493 C25H35N3O4 small molecule - - DRUGBANK 26195 110459 4316 - MMP7 MMP-7|MPSL1|PUMP-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6962 (1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE - - DRUGBANK DB08170 C18H20N2O7S small molecule - - DRUGBANK 26535 110459 4316 - MMP7 MMP-7|MPSL1|PUMP-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7269 N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE - - DRUGBANK DB08489 C25H36N4O4 small molecule - - DRUGBANK 10479 110459 4316 - MMP7 MMP-7|MPSL1|PUMP-1 9606 Homo sapiens antagonist target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10480 110459 4316 - MMP7 MMP-7|MPSL1|PUMP-1 9606 Homo sapiens antagonist target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 25790 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6573 (1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID - - DRUGBANK DB07772 C17H22NO6PS small molecule - - DRUGBANK 22102 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 22103 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 22104 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 10454 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10455 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 26051 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6821 BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE - - DRUGBANK DB08028 C13H14ClN3S small molecule - - DRUGBANK 21634 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3483 Glycinamid - - DRUGBANK DB03636 C2H6N2O small molecule - - DRUGBANK 21635 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3483 Glycinamid - - DRUGBANK DB03636 C2H6N2O small molecule - - DRUGBANK 18950 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2232 1-Hydroxyamine-2-Isobutylmalonic Acid - - DRUGBANK DB02326 C7H13NO4 small molecule - - DRUGBANK 18951 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2232 1-Hydroxyamine-2-Isobutylmalonic Acid - - DRUGBANK DB02326 C7H13NO4 small molecule - - DRUGBANK 18952 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2232 1-Hydroxyamine-2-Isobutylmalonic Acid - - DRUGBANK DB02326 C7H13NO4 small molecule - - DRUGBANK 25719 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6516 (1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID - - DRUGBANK DB07713 C17H22NO6PS small molecule - - DRUGBANK 26524 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7257 3-AMINO-AZACYCLOTRIDECAN-2-ONE - - DRUGBANK DB08476 C12H24N2O small molecule - - DRUGBANK 21607 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3469 2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione - - DRUGBANK DB03622 C17H21N3O4 small molecule - - DRUGBANK 21608 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3469 2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione - - DRUGBANK DB03622 C17H21N3O4 small molecule - - DRUGBANK 21609 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3469 2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione - - DRUGBANK DB03622 C17H21N3O4 small molecule - - DRUGBANK 20757 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3075 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid - - DRUGBANK DB03207 C22H19NO4S small molecule - - DRUGBANK 20758 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3075 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid - - DRUGBANK DB03207 C22H19NO4S small molecule - - DRUGBANK 20759 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3075 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid - - DRUGBANK DB03207 C22H19NO4S small molecule - - DRUGBANK 24988 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5790 N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA - - DRUGBANK DB06971 C17H17N3O3 small molecule - - DRUGBANK 26451 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7187 METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID - - DRUGBANK DB08403 C18H27N3O4 small molecule - - DRUGBANK 25925 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6697 3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE - - DRUGBANK DB07900 C8H15NO4 small molecule - - DRUGBANK 20193 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2830 2-Thiomethyl-3-Phenylpropanoic Acid - - DRUGBANK DB02953 C10H12O2S small molecule - - DRUGBANK 20194 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2830 2-Thiomethyl-3-Phenylpropanoic Acid - - DRUGBANK DB02953 C10H12O2S small molecule - - DRUGBANK 20195 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2830 2-Thiomethyl-3-Phenylpropanoic Acid - - DRUGBANK DB02953 C10H12O2S small molecule - - DRUGBANK 25416 110460 4317 - MMP8 CLG1|HNC|MMP-8|PMNL-CL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6212 (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide - - DRUGBANK DB07397 C22H21N5O5S small molecule - - DRUGBANK 15778 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens antagonist target Fenton JI (2002) 12405690 181073 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15779 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens antagonist target Dodge GR (2003) 12801482 181072 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15780 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens antagonist target Chu SC (2006) 16756968 181071 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15781 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens antagonist target Mendis E (2006) 16616490 181075 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15782 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens antagonist target Rajapakse N (2007) 17498959 181074 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 10451 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Nenan S (2007) 17234180 178390 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10452 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Underwood CK (2003) 12763661 178391 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10453 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 14733 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Williams RN (2005) 15993560 180580 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14734 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Okada M (2008) 19057128 180578 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14735 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Yamamoto D (2008) 18501888 180584 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 14736 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Reinhardt D (2002) 12381651 180579 1185 Captopril (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin capoten tab 100mg|med captopri DRUGBANK DB01197 C9H15NO3S small molecule C09AA01|C09BA01 62571-86-2 DRUGBANK 25297 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6101 (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID - - DRUGBANK DB07285 C11H12F2O5S small molecule - - DRUGBANK 25126 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5935 5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE - - DRUGBANK DB07117 C24H22N6O4 small molecule - - DRUGBANK 18141 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1873 2-Amino-N,3,3-Trimethylbutanamide - - DRUGBANK DB01949 C7H16N2O small molecule - - DRUGBANK 18142 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1873 2-Amino-N,3,3-Trimethylbutanamide - - DRUGBANK DB01949 C7H16N2O small molecule - - DRUGBANK 25257 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6062 (2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE - - DRUGBANK DB07246 C16H15F3N2O5S small molecule - - DRUGBANK 12820 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Koistinaho M (2005) 15674236 179720 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12821 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Sutton TA (2005) 15353401 179721 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12822 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Brundula V (2002) 12023318 179717 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12823 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Lee CZ (2006) 16395286 179719 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12824 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens inhibitor target Machado LS (2006) 16846501 179718 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 21706 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3529 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid - - DRUGBANK DB03683 C8H15NO4 small molecule - - DRUGBANK 21707 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3529 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid - - DRUGBANK DB03683 C8H15NO4 small molecule - - DRUGBANK 21708 110461 4318 - MMP9 CLG4B|GELB|MANDP2|MMP-9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3529 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid - - DRUGBANK DB03683 C8H15NO4 small molecule - - DRUGBANK 26319 110462 4319 - MMP10 SL-2|STMY2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7059 N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID - - DRUGBANK DB08271 C13H20N2O5S small molecule - - DRUGBANK 10456 110462 4319 - MMP10 SL-2|STMY2 9606 Homo sapiens antagonist target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10457 110462 4319 - MMP10 SL-2|STMY2 9606 Homo sapiens antagonist target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10481 110463 4320 - MMP11 SL-3|ST3|STMY3 9606 Homo sapiens antagonist target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10482 110463 4320 - MMP11 SL-3|ST3|STMY3 9606 Homo sapiens antagonist target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 23114 110463 4320 - MMP11 SL-3|ST3|STMY3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4143 1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid - - DRUGBANK DB04318 C39H42N4O6P small molecule - - DRUGBANK 23115 110463 4320 - MMP11 SL-3|ST3|STMY3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4143 1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid - - DRUGBANK DB04318 C39H42N4O6P small molecule - - DRUGBANK 23116 110463 4320 - MMP11 SL-3|ST3|STMY3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4143 1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid - - DRUGBANK DB04318 C39H42N4O6P small molecule - - DRUGBANK 7999 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens inhibitor target Fukuda M (2006) 16959356 176837 541 Acetohydroxamic Acid Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide lithostat DRUGBANK DB00551 C2H5NO2 small molecule G04BX03 546-88-3 DRUGBANK 8000 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens inhibitor target Bertini I (2007) 17269766 176836 541 Acetohydroxamic Acid Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide lithostat DRUGBANK DB00551 C2H5NO2 small molecule G04BX03 546-88-3 DRUGBANK 8001 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens inhibitor target Mannino C (2006) 16899369 176839 541 Acetohydroxamic Acid Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide lithostat DRUGBANK DB00551 C2H5NO2 small molecule G04BX03 546-88-3 DRUGBANK 8002 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens inhibitor target Bertini I (2005) 15809432 176838 541 Acetohydroxamic Acid Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide lithostat DRUGBANK DB00551 C2H5NO2 small molecule G04BX03 546-88-3 DRUGBANK 22105 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 22106 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 22107 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 26318 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7059 N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID - - DRUGBANK DB08271 C13H20N2O5S small molecule - - DRUGBANK 21043 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3228 PF-00356231 3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid - DRUGBANK DB03367 C25H20N2O3S small molecule - - DRUGBANK 21044 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3228 PF-00356231 3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid - DRUGBANK DB03367 C25H20N2O3S small molecule - - DRUGBANK 21045 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3228 PF-00356231 3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid - DRUGBANK DB03367 C25H20N2O3S small molecule - - DRUGBANK 26631 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7376 N-[(4-methoxyphenyl)sulfonyl]-D-alanine - - DRUGBANK DB08599 C10H13NO5S small molecule - - DRUGBANK 18575 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2037 CP-271485 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) ethyl-4-(4'-ethoxy [1,1'-biphenyl]-4-yl)-4-oxobutanoic acid|(6R)-4-BENZYL-6-(1-METHYL-2,2-DIOXIDO-1,3-DIHYDRO-2,1-BENZISOTHIAZOL-5-YL)MORPHOLIN-3-ONE - DRUGBANK DB02118 C19H20N2O4S small molecule - - DRUGBANK 18576 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2037 CP-271485 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) ethyl-4-(4'-ethoxy [1,1'-biphenyl]-4-yl)-4-oxobutanoic acid|(6R)-4-BENZYL-6-(1-METHYL-2,2-DIOXIDO-1,3-DIHYDRO-2,1-BENZISOTHIAZOL-5-YL)MORPHOLIN-3-ONE - DRUGBANK DB02118 C19H20N2O4S small molecule - - DRUGBANK 18577 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2037 CP-271485 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) ethyl-4-(4'-ethoxy [1,1'-biphenyl]-4-yl)-4-oxobutanoic acid|(6R)-4-BENZYL-6-(1-METHYL-2,2-DIOXIDO-1,3-DIHYDRO-2,1-BENZISOTHIAZOL-5-YL)MORPHOLIN-3-ONE - DRUGBANK DB02118 C19H20N2O4S small molecule - - DRUGBANK 25690 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6488 N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine - - DRUGBANK DB07683 C17H17NO4S2 small molecule - - DRUGBANK 10477 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10478 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 25039 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5844 (1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE - - DRUGBANK DB07026 C20H21N3O5 small molecule - - DRUGBANK 25949 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6718 N-oxo-2-(phenylsulfonylamino)ethanamide - - DRUGBANK DB07922 C8H8N2O4S small molecule - - DRUGBANK 25947 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6716 N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide - - DRUGBANK DB07920 C14H12N2O4S small molecule - - DRUGBANK 25948 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6717 2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide - - DRUGBANK DB07921 C8H7FN2O4S small molecule - - DRUGBANK 25464 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6257 N-(biphenyl-4-ylsulfonyl)-D-leucine - - DRUGBANK DB07446 C18H21NO4S small molecule - - DRUGBANK 25568 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6365 N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE - - DRUGBANK DB07556 C18H23N3O5S small molecule - - DRUGBANK 23348 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4223 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid - - DRUGBANK DB04405 C28H25NO6 small molecule - - DRUGBANK 23349 110464 4321 - MMP12 HME|ME|MME|MMP-12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4223 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid - - DRUGBANK DB04405 C28H25NO6 small molecule - - DRUGBANK 18456 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1991 WAY-151693 n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide - DRUGBANK DB02071 C21H21N3O5S small molecule - - DRUGBANK 18457 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1991 WAY-151693 n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide - DRUGBANK DB02071 C21H21N3O5S small molecule - - DRUGBANK 18458 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1991 WAY-151693 n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide - DRUGBANK DB02071 C21H21N3O5S small molecule - - DRUGBANK 19725 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2586 Hydroxyaminovaline - - DRUGBANK DB02697 C5H12N2O2 small molecule - - DRUGBANK 19726 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2586 Hydroxyaminovaline - - DRUGBANK DB02697 C5H12N2O2 small molecule - - DRUGBANK 26536 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7270 4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE - - DRUGBANK DB08490 C19H20ClNO6S small molecule - - DRUGBANK 10466 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10467 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 20359 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2906 1-Methyloxy-4-Sulfone-Benzene - - DRUGBANK DB03033 C7H8O3S small molecule - - DRUGBANK 20360 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2906 1-Methyloxy-4-Sulfone-Benzene - - DRUGBANK DB03033 C7H8O3S small molecule - - DRUGBANK 25027 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5831 TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE - - DRUGBANK DB07013 C22H31N3O6S small molecule - - DRUGBANK 23872 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4564 PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE] - - DRUGBANK DB04761 C18H16N6O2 small molecule - - DRUGBANK 18404 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1971 2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide - - DRUGBANK DB02049 C19H20ClNO6S small molecule - - DRUGBANK 18284 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1920 3-Methylpyridine - - DRUGBANK DB01996 C6H7N small molecule - 108-99-6 DRUGBANK 18285 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1920 3-Methylpyridine - - DRUGBANK DB01996 C6H7N small molecule - 108-99-6 DRUGBANK 23870 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4562 PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE) - - DRUGBANK DB04759 C22H22N4O2 small molecule - - DRUGBANK 26602 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7339 BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE - - DRUGBANK DB08561 C21H16N2O4S small molecule - - DRUGBANK 26434 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7172 5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE - - DRUGBANK DB08388 C20H19FN2O6 small molecule - - DRUGBANK 23871 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4563 PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE) - - DRUGBANK DB04760 C22H20F2N4O2 small molecule - - DRUGBANK 25846 110465 4322 - MMP13 CLG3|MANDP1|MMP-13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6625 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID - - DRUGBANK DB07827 C26H20N2O4 small molecule - - DRUGBANK 10483 110466 4323 - MMP14 MMP-14|MMP-X1|MT-MMP|MT-MMP 1|MT1-MMP|MT1MMP|MTMMP1|WNCHRS 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10484 110466 4323 - MMP14 MMP-14|MMP-X1|MT-MMP|MT-MMP 1|MT1-MMP|MT1MMP|MTMMP1|WNCHRS 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10485 110467 4324 - MMP15 MT2-MMP|MTMMP2|SMCP-2 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10486 110467 4324 - MMP15 MT2-MMP|MTMMP2|SMCP-2 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 22109 110468 4325 - MMP16 C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 22110 110468 4325 - MMP16 C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 22111 110468 4325 - MMP16 C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 10468 110468 4325 - MMP16 C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10469 110468 4325 - MMP16 C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10487 110469 4326 - MMP17 MT4-MMP 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10488 110469 4326 - MMP17 MT4-MMP 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10489 110470 4327 - MMP19 MMP18|RASI-1 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10490 110470 4327 - MMP19 MMP18|RASI-1 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 3206 110472 4329 - ALDH6A1 MMSADHA|MMSDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3207 110472 4329 - ALDH6A1 MMSADHA|MMSDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3208 110472 4329 - ALDH6A1 MMSADHA|MMSDH 9606 Homo sapiens unknown target Kedishvili NY (1991) 1898092 173714 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 27810 110492 4352 RP1-92O14.1 MPL C-MPL|CD110|MPLV|THCYT2|TPOR 9606 Homo sapiens agonist target Krzyzanski W (2013) 23250851 196014 5101 Romiplostim SU-5416|Semaxinib|Semaxanib nplate DRUGBANK DB05332 C2634H4086N722O790S18 biologic B02BX04 267639-76-9 DRUGBANK 24424 110492 4352 RP1-92O14.1 MPL C-MPL|CD110|MPLV|THCYT2|TPOR 9606 Homo sapiens agonist target Kuter DJ (2009) 19642221 182120 5530 Eltrombopag Promacta|Eltrombopagum|Eltrombopag revolade|promacta DRUGBANK DB06210 C25H22N4O4 small molecule B02BX05 496775-61-2 DRUGBANK 8271 110493 4353 - MPO - 9606 Homo sapiens unknown target Derin N (2005) 16130180 177058 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 7792 110493 4353 - MPO - 9606 Homo sapiens inhibitor target Labro MT (1994) 8133056 176716 525 Cefdinir (6R,7R)-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|(6R,7R,Z)-7-(2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefdinir|Cefdinirum|CFDN cefdinir DRUGBANK DB00535 C14H13N5O5S2 small molecule J01DD15 91832-40-5 DRUGBANK 4700 110493 4353 - MPO - 9606 Homo sapiens unknown target Nandi J (2008) 17503181 174609 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 13393 110493 4353 - MPO - 9606 Homo sapiens inhibitor target Galijasevic S (2008) 18237195 179960 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 23928 110493 4353 - MPO - 9606 Homo sapiens unknown target Obach RS (2006) 16679384 181940 4623 Nomifensine (+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine - DRUGBANK DB04821 C16H18N2 small molecule N06AX04 24526-64-5 DRUGBANK 14091 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens inhibitor target Evers R (2000) 10917554 173398 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14092 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens inhibitor target Raggers RJ (1999) 9885294 180328 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14093 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens inhibitor target Depeille P (2004) 15044619 180329 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14094 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14095 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens inhibitor target Bakos E (2000) 10727523 176911 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 14096 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens inhibitor target Morrow CS (1998) 9685354 180330 1126 Sulfinpyrazone Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione sulfinpyrazone tablets 200mg|s DRUGBANK DB01138 C23H20N2O3S small molecule M04AB02 57-96-5 DRUGBANK 24012 110503 4363 - ABCC1 ABC29|ABCC|GS-X|MRP|MRP1 9606 Homo sapiens unknown target Minderman H (2004) 15014037 181844 4652 Biricodar dicitrate biricodar - DRUGBANK DB04851 C46H57N3O21 small molecule - 174254-13-8 DRUGBANK 23433 110588 4482 - MSRA PMSR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 18870 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2190 Formycin - - DRUGBANK DB02281 C10H12N5O4 small molecule - 6742-12-7 DRUGBANK 18871 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2190 Formycin - - DRUGBANK DB02281 C10H12N5O4 small molecule - 6742-12-7 DRUGBANK 18874 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2191 5'-Deoxy-5'-Methylthioadenosine - - DRUGBANK DB02282 C11H15N5O3S small molecule - - DRUGBANK 18875 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2191 5'-Deoxy-5'-Methylthioadenosine - - DRUGBANK DB02282 C11H15N5O3S small molecule - - DRUGBANK 3822 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Singh V (2006) 17090056 174051 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3823 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Chow WA (2006) 16631464 174053 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3824 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Chattopadhyay S (2006) 17041099 174052 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 20157 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2811 5'-Deoxy-5'-(Methylthio)-Tubercidin - - DRUGBANK DB02933 C12H16N4O3S small molecule - - DRUGBANK 20158 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2811 5'-Deoxy-5'-(Methylthio)-Tubercidin - - DRUGBANK DB02933 C12H16N4O3S small molecule - - DRUGBANK 20159 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2811 5'-Deoxy-5'-(Methylthio)-Tubercidin - - DRUGBANK DB02933 C12H16N4O3S small molecule - - DRUGBANK 18639 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2074 (1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol - - DRUGBANK DB02158 C12H19N5O2S small molecule - - DRUGBANK 18640 110611 4507 - MTAP BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2074 (1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol - - DRUGBANK DB02158 C12H19N5O2S small molecule - - DRUGBANK 19656 110615 4512 - COX1 COI|MTCO1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23495 110615 4512 - COX1 COI|MTCO1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19646 110616 4513 - COX2 COII|MTCO2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23493 110616 4513 - COX2 COII|MTCO2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19651 110617 4514 - COX3 COIII|MTCO3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23503 110617 4514 - COX3 COIII|MTCO3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25791 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25770 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25418 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26501 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22666 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 25637 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6442 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE - - DRUGBANK DB07636 C14H17NO3S small molecule - - DRUGBANK 26364 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23912 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26703 110619 4519 - CYTB MTCYB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 3179 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3180 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 19021 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2263 LY374571 - - DRUGBANK DB02358 C17H19N7O7 small molecule - - DRUGBANK 19022 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2263 LY374571 - - DRUGBANK DB02358 C17H19N7O7 small molecule - - DRUGBANK 23117 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4147 LY249543 - - DRUGBANK DB04322 C21H25N5O6 small molecule - - DRUGBANK 23118 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4147 LY249543 - - DRUGBANK DB04322 C21H25N5O6 small molecule - - DRUGBANK 1654 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens cofactor target Akar N (2001) 11323021 172633 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1655 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens cofactor target Prasannan P (2003) 12937168 172637 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1656 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens cofactor target Salmassi TM (2003) 12949177 172636 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1657 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens cofactor target Walkup AS (2005) 16171773 172635 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1658 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens cofactor target Matakidou A (2007) 17533396 172634 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 21316 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21317 110622 4522 - MTHFD1 MTHFC|MTHFD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 27752 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Larsson J (2000) 10893069 195951 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27753 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Ubbink JB (1999) 10024094 195943 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27754 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Holmes ZR (1999) 10233370 195946 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27755 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Heijmans BT (1999) 10196703 195944 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1663 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Ott K (2006) 16929515 172640 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27756 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Tsai MY (1999) 10208491 195945 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1662 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Leopardi P (2006) 16950805 172639 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1661 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Siva A (2007) 17636160 172638 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1622 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Erdogan MO (2010) 20589617 172600 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1623 110624 4524 RP11-56N19.4 MTHFR - 9606 Homo sapiens cofactor target Nakamura T (2002) 11979347 172601 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 3058 110631 4535 - ND1 MTND1 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3059 110631 4535 - ND1 MTND1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3060 110631 4535 - ND1 MTND1 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 14619 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14620 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 15210 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15211 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 14321 110631 4535 - ND1 MTND1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14322 110631 4535 - ND1 MTND1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14323 110631 4535 - ND1 MTND1 9606 Homo sapiens inhibitor target Hanley PJ (2002) 12411515 178204 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 23497 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 12943 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12944 110631 4535 - ND1 MTND1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 3397 110632 4536 - ND2 MTND2 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3398 110632 4536 - ND2 MTND2 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3399 110632 4536 - ND2 MTND2 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3400 110632 4536 - ND2 MTND2 9606 Homo sapiens binder target Nikonova EV (2005) 15700717 173788 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3401 110632 4536 - ND2 MTND2 9606 Homo sapiens binder target Zhang HB (2003) 12882707 173787 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3165 110633 4537 - ND3 MTND3 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3166 110633 4537 - ND3 MTND3 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3167 110633 4537 - ND3 MTND3 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3332 110634 4538 - ND4 MTND4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3333 110634 4538 - ND4 MTND4 9606 Homo sapiens unknown target Carper DA (1999) 9950599 173764 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3334 110634 4538 - ND4 MTND4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3335 110634 4538 - ND4 MTND4 9606 Homo sapiens unknown target Dzelzkalns VA (1994) 7846157 173762 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3336 110634 4538 - ND4 MTND4 9606 Homo sapiens unknown target Shen XY (2004) 15560738 173763 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3085 110635 4539 - ND4L MTND4L 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3086 110635 4539 - ND4L MTND4L 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3131 110636 4540 - ND5 MTND5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3132 110636 4540 - ND5 MTND5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3133 110636 4540 - ND5 MTND5 9606 Homo sapiens unknown target Johnson WE (1997) 9071018 173689 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3134 110636 4540 - ND5 MTND5 9606 Homo sapiens unknown target Bao HG (2007) 17614984 173688 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 24328 110636 4540 - ND5 MTND5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5147 molecular iodine - - DRUGBANK DB05382 I2 small molecule - - DRUGBANK 3108 110637 4541 - ND6 MTND6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3109 110637 4541 - ND6 MTND6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 12454 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Miyamoto M (2009) 19768947 179481 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12455 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12456 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Miyamoto M (2006) 16730121 179480 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12457 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Greenblatt DJ (2007) 17389558 179474 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12458 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Johnson MW (2006) 17015817 179475 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12459 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Karim A (2006) 16432265 179476 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12460 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Pandi-Perumal SR (2009) 19568703 179477 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12461 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Kato K (2005) 15695169 179473 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12462 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Unknown Authors (2005) 15869323 179484 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12463 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Miyamoto M (2009) 19228178 179478 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12464 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Zammit G (2007) 17803013 179479 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12465 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Borja NL (2006) 17157111 179483 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12466 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens multitarget target Roth T (2005) 16173650 179482 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 13380 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Hardeland R (2009) 19449447 179953 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13381 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Srinivasan V (2010) 20827520 179952 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13382 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Carocci A (2010) 20674373 179951 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13383 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Prendergast BJ (2010) 19966183 179950 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13384 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Boutin JA (2005) 15992934 179954 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13385 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13386 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Radogna F (2009) 19463840 179949 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 24583 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Millan MJ (2005) 15289999 181857 5559 Agomelatine Valdoxan - DRUGBANK DB06594 C15H17NO2 small molecule N06AX22 138112-76-2 DRUGBANK 27476 110639 4543 - MTNR1A MEL-1A-R|MT1 9606 Homo sapiens agonist target Lavedan C (2015) 25534555 188548 7819 Tasimelteon tasimelton|N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide hetlioz DRUGBANK DB09071 C15H19NO2 small molecule N05CH03 609799-22-6 DRUGBANK 12441 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Miyamoto M (2009) 19768947 179481 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12442 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12443 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Miyamoto M (2006) 16730121 179480 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12444 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Greenblatt DJ (2007) 17389558 179474 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12445 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Johnson MW (2006) 17015817 179475 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12446 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Karim A (2006) 16432265 179476 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12447 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Pandi-Perumal SR (2009) 19568703 179477 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12448 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Kato K (2005) 15695169 179473 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12449 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Unknown Authors (2005) 15869323 179484 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12450 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Miyamoto M (2009) 19228178 179478 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12451 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Zammit G (2007) 17803013 179479 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12452 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Borja NL (2006) 17157111 179483 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 12453 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens multitarget target Roth T (2005) 16173650 179482 970 Ramelteon Rozerem rozerem DRUGBANK DB00980 C16H21NO2 small molecule N05CH02 196597-26-9 DRUGBANK 13395 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Hardeland R (2009) 19449447 179953 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13396 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Srinivasan V (2010) 20827520 179952 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13397 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Carocci A (2010) 20674373 179951 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13398 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Prendergast BJ (2010) 19966183 179950 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13399 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Boutin JA (2005) 15992934 179954 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13400 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Radogna F (2009) 19463840 179949 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 24582 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Millan MJ (2005) 15289999 181857 5559 Agomelatine Valdoxan - DRUGBANK DB06594 C15H17NO2 small molecule N06AX22 138112-76-2 DRUGBANK 27475 110640 4544 - MTNR1B FGQTL2|MEL-1B-R|MT2 9606 Homo sapiens agonist target Lavedan C (2015) 25534555 188548 7819 Tasimelteon tasimelton|N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide hetlioz DRUGBANK DB09071 C15H19NO2 small molecule N05CH03 609799-22-6 DRUGBANK 13683 110641 4547 - MTTP ABL|MTP 9606 Homo sapiens antagonist target Wilcox LJ (2001) 11352979 180099 1082 Hesperetin Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin - DRUGBANK DB01094 C16H14O6 small molecule - 520-33-2 DRUGBANK 24013 110641 4547 - MTTP ABL|MTP 9606 Homo sapiens unknown target Ueshima K (2005) 15684478 181881 4653 Implitapide AEGR427 - DRUGBANK DB04852 C35H37N3O2 small molecule - 177469-96-4 DRUGBANK 2190 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens product of target Taurog RE (2006) 16618098 173094 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2191 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens product of target Banks EC (2007) 17222188 173095 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2192 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens product of target Reynolds E (2006) 17052662 173091 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2193 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens product of target Yamada K (2007) 17615995 173092 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2194 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens product of target Hughes JA (2006) 16788729 173093 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 1673 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Hall DA (2000) 10978155 172647 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1674 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Jarrett JT (1998) 9730838 172651 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1675 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Fowler B (2001) 11169015 172650 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1676 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Fu TF (2001) 11237340 172648 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1677 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Jarrett JT (1997) 9398303 172649 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1633 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Allen LH (2008) 18709879 172610 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1634 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Stover PJ (2010) 19904199 172599 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 4178 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Tkachuck RD (1977) 18565 174327 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4179 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Quadros EV (1995) 7599160 135811 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4180 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Kolhouse JF (1991) 1744096 144013 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4181 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Rosenblatt DS (1987) 3812589 174329 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4182 110642 4548 - MTR HMAG|MS|cblG 9606 Homo sapiens cofactor target Ogier de Baulny H (1998) 9587031 174328 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 2195 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens product of target Kim DJ (2006) 17079868 173096 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2196 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens product of target Elmore CL (2007) 17369066 173097 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2197 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens product of target Tvedegaard KC (2006) 17101561 173098 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 1624 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens cofactor target van der Linden IJ (2006) 17024475 172602 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1625 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens cofactor target Berkun Y (2007) 17611986 172603 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1626 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens cofactor target Gueant-Rodriguez RM (2005) 16268464 172606 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1627 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens cofactor target O'Leary VB (2005) 15979034 172604 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1628 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens cofactor target Miriuka SG (2005) 15612980 172605 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 4173 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4174 110645 4552 - MTRR MSR|cblE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 16573 110670 4583 - MUC2 MLP|MUC-2|SMUC 9606 Homo sapiens unknown target Bai CH (2007) 17223000 181371 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16574 110670 4583 - MUC2 MLP|MUC-2|SMUC 9606 Homo sapiens unknown target Ishinaga H (2005) 15475658 181365 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 1617 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Moras E (2007) 17011224 141921 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1618 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Brooks AJ (2005) 16305240 141598 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1619 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Kozlowski PM (2006) 16813422 172598 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1620 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Stover PJ (2010) 19904199 172599 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1621 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Worgan LC (2006) 16281286 172597 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 4164 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Quadros EV (1995) 7599160 135811 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4165 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Chen X (2002) 11752352 171740 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4166 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Tkachuck RD (1977) 18565 174327 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4167 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Mayatepek E (1996) 8741039 174326 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4168 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Dayem LC (2002) 11955068 174325 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4169 110680 4594 - MUT MCM 9606 Homo sapiens cofactor target Willard HF (1979) 36882 174324 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 23824 110683 4598 - MVK LRBP|MK|MVLK|POROK3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4499 FARNESYL THIOPYROPHOSPHATE - - DRUGBANK DB04695 C15H28O6P2S small molecule - - DRUGBANK 26844 110694 4609 - MYC MRTL|MYCC|bHLHe39|c-Myc 9606 Homo sapiens inhibitor target Sustar V (2009) 19261492 182099 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 26845 110694 4609 - MYC MRTL|MYCC|bHLHe39|c-Myc 9606 Homo sapiens inhibitor target Nagy Z (2009) 19757196 182127 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 26425 110710 4625 - MYH7 CMD1S|CMH1|MPD1|MYHCB|SPMD|SPMM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7163 4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID - - DRUGBANK DB08378 C14H16N2O5 small molecule - - DRUGBANK 23407 110714 4629 - MYH11 AAT4|FAA4|SMHC|SMMHC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23408 110714 4629 - MYH11 AAT4|FAA4|SMHC|SMMHC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23409 110714 4629 - MYH11 AAT4|FAA4|SMHC|SMMHC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 22486 110749 4668 - NAGA D22S674|GALB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22487 110749 4668 - NAGA D22S674|GALB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22488 110749 4668 - NAGA D22S674|GALB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 2336 110750 4669 - NAGLU MPS-IIIB|MPS3B|NAG|UFHSD 9606 Homo sapiens activator target Vishu Kumar AB (2005) 15932346 173205 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2337 110750 4669 - NAGLU MPS-IIIB|MPS3B|NAG|UFHSD 9606 Homo sapiens activator target Zou L (2007) 17414423 173204 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2338 110750 4669 - NAGLU MPS-IIIB|MPS3B|NAG|UFHSD 9606 Homo sapiens activator target Spiro RG (2004) 15112051 173207 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2339 110750 4669 - NAGLU MPS-IIIB|MPS3B|NAG|UFHSD 9606 Homo sapiens activator target Nogawa M (1998) 16349528 173206 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2340 110750 4669 - NAGLU MPS-IIIB|MPS3B|NAG|UFHSD 9606 Homo sapiens activator target Shirazi F (2007) 17576230 173208 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2341 110750 4669 - NAGLU MPS-IIIB|MPS3B|NAG|UFHSD 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 3843 110758 4677 - NARS ASNRS|NARS1 9606 Homo sapiens unknown target Iwasaki W (2006) 16753178 174065 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3844 110758 4677 - NARS ASNRS|NARS1 9606 Homo sapiens unknown target Iwamoto S (2007) 17380207 174061 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 7635 110768 4688 RP1-127C7.5 NCF2 NCF-2|NOXA2|P67-PHOX|P67PHOX 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7638 110769 4689 CTA-833B7.1 NCF4 NCF|P40PHOX|SH3PXD4 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 3264 110774 4694 - NDUFA1 CI-MWFE|MWFE|ZNF183 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3265 110774 4694 - NDUFA1 CI-MWFE|MWFE|ZNF183 9606 Homo sapiens unknown target Au HC (1999) 10200266 173741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3266 110774 4694 - NDUFA1 CI-MWFE|MWFE|ZNF183 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3267 110774 4694 - NDUFA1 CI-MWFE|MWFE|ZNF183 9606 Homo sapiens unknown target Raha S (2002) 11864782 173678 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3330 110775 4695 - NDUFA2 B8|CD14|CIB8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3331 110775 4695 - NDUFA2 B8|CD14|CIB8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3106 110776 4696 - NDUFA3 B9|CI-B9 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3107 110776 4696 - NDUFA3 B9|CI-B9 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3087 110777 4697 - NDUFA4 CI-9k|CI-MLRQ|MLRQ 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3088 110777 4697 - NDUFA4 CI-9k|CI-MLRQ|MLRQ 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3019 110778 4698 - NDUFA5 B13|CI-13KD-B|CI-13kB|NUFM|UQOR13 9606 Homo sapiens unknown target Chen CL (2007) 17444656 173643 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3020 110778 4698 - NDUFA5 B13|CI-13KD-B|CI-13kB|NUFM|UQOR13 9606 Homo sapiens unknown target Belevich G (2007) 17209562 173642 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3104 110780 4700 - NDUFA6 B14|CI-B14|LYRM6|NADHB14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3105 110780 4700 - NDUFA6 B14|CI-B14|LYRM6|NADHB14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3053 110781 4701 - NDUFA7 B14.5a 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3054 110781 4701 - NDUFA7 B14.5a 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3012 110782 4702 - NDUFA8 CI-19KD|CI-PGIV|PGIV 9606 Homo sapiens unknown target Triepels R (1998) 9860297 173641 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3013 110782 4702 - NDUFA8 CI-19KD|CI-PGIV|PGIV 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3014 110782 4702 - NDUFA8 CI-19KD|CI-PGIV|PGIV 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3404 110784 4704 - NDUFA9 CC6|CI-39k|CI39k|NDUFS2L|SDR22E1 9606 Homo sapiens unknown target Matsuzaki S (2007) 17260964 173793 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3405 110784 4704 - NDUFA9 CC6|CI-39k|CI39k|NDUFS2L|SDR22E1 9606 Homo sapiens unknown target Balaban RS (2006) 17132781 173792 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3406 110784 4704 - NDUFA9 CC6|CI-39k|CI39k|NDUFS2L|SDR22E1 9606 Homo sapiens unknown target Barker CD (2007) 17323923 173791 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3407 110784 4704 - NDUFA9 CC6|CI-39k|CI39k|NDUFS2L|SDR22E1 9606 Homo sapiens unknown target Fisher N (2007) 17499024 173790 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3408 110784 4704 - NDUFA9 CC6|CI-39k|CI39k|NDUFS2L|SDR22E1 9606 Homo sapiens unknown target Liu Y (2008) 17530440 173789 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3021 110785 4705 - NDUFA10 CI-42KD|CI-42k 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3022 110785 4705 - NDUFA10 CI-42KD|CI-42k 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3288 110786 4706 - NDUFAB1 ACP|FASN2A|SDAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3289 110786 4706 - NDUFAB1 ACP|FASN2A|SDAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3353 110787 4707 - NDUFB1 CI-MNLL|CI-SGDH|MNLL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3354 110787 4707 - NDUFB1 CI-MNLL|CI-SGDH|MNLL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3327 110788 4708 - NDUFB2 AGGG|CI-AGGG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3328 110788 4708 - NDUFB2 AGGG|CI-AGGG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3236 110789 4709 - NDUFB3 B12|CI-B12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3237 110789 4709 - NDUFB3 B12|CI-B12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3187 110790 4710 - NDUFB4 B15|CI-B15 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3188 110790 4710 - NDUFB4 B15|CI-B15 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3116 110791 4711 - NDUFB5 CISGDH|SGDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3117 110791 4711 - NDUFB5 CISGDH|SGDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3055 110792 4712 RP11-205M20.6 NDUFB6 B17|CI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3056 110792 4712 RP11-205M20.6 NDUFB6 B17|CI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3097 110793 4713 - NDUFB7 B18|CI-B18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3098 110793 4713 - NDUFB7 B18|CI-B18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3099 110793 4713 - NDUFB7 B18|CI-B18 9606 Homo sapiens unknown target Raha S (2002) 11864782 173678 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3112 110794 4714 RP11-411B6.5 NDUFB8 ASHI|CI-ASHI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3113 110794 4714 RP11-411B6.5 NDUFB8 ASHI|CI-ASHI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3177 110795 4715 - NDUFB9 B22|CI-B22|LYRM3|UQOR22 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3178 110795 4715 - NDUFB9 B22|CI-B22|LYRM3|UQOR22 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3374 110796 4716 - NDUFB10 PDSW 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3375 110796 4716 - NDUFB10 PDSW 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3316 110797 4717 - NDUFC1 KFYI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3317 110797 4717 - NDUFC1 KFYI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3145 110798 4718 HLC1 NDUFC2 B14.5b|CI-B14.5b|HLC-1|NADHDH2 9606 Homo sapiens unknown target Quiles MJ (2006) 16898010 173696 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3146 110798 4718 HLC1 NDUFC2 B14.5b|CI-B14.5b|HLC-1|NADHDH2 9606 Homo sapiens unknown target Brooijmans RJ (2007) 17496098 173694 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3147 110798 4718 HLC1 NDUFC2 B14.5b|CI-B14.5b|HLC-1|NADHDH2 9606 Homo sapiens unknown target Zhu X (2007) 17513495 173695 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3148 110798 4718 HLC1 NDUFC2 B14.5b|CI-B14.5b|HLC-1|NADHDH2 9606 Homo sapiens unknown target Gyan S (2006) 17015645 173693 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3149 110798 4718 HLC1 NDUFC2 B14.5b|CI-B14.5b|HLC-1|NADHDH2 9606 Homo sapiens unknown target Bao HG (2007) 17614984 173688 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 14083 110798 4718 HLC1 NDUFC2 B14.5b|CI-B14.5b|HLC-1|NADHDH2 9606 Homo sapiens inhibitor target Oliveira PJ (2000) 10666308 180323 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 3259 110799 4719 - NDUFS1 CI-75Kd|CI-75k|PRO1304 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3260 110799 4719 - NDUFS1 CI-75Kd|CI-75k|PRO1304 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3238 110800 4720 - NDUFS2 CI-49 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3239 110800 4720 - NDUFS2 CI-49 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3163 110801 4722 - NDUFS3 CI-30 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3164 110801 4722 - NDUFS3 CI-30 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3026 110802 4723 - NDUFV1 CI-51K|CI51KD|UQOR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3027 110802 4723 - NDUFV1 CI-51K|CI51KD|UQOR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3028 110802 4723 - NDUFV1 CI-51K|CI51KD|UQOR1 9606 Homo sapiens unknown target Grad LI (2004) 14662656 173645 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3029 110802 4723 - NDUFV1 CI-51K|CI51KD|UQOR1 9606 Homo sapiens unknown target Ali ST (1993) 8288251 173647 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3030 110802 4723 - NDUFV1 CI-51K|CI51KD|UQOR1 9606 Homo sapiens unknown target Schuelke M (1998) 9571201 173646 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3341 110803 4724 - NDUFS4 AQDQ|CI-18 9606 Homo sapiens unknown target Papa S (2002) 11860175 173766 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3342 110803 4724 - NDUFS4 AQDQ|CI-18 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3343 110803 4724 - NDUFS4 AQDQ|CI-18 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3344 110803 4724 - NDUFS4 AQDQ|CI-18 9606 Homo sapiens unknown target Raha S (2002) 11864782 173678 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3345 110803 4724 - NDUFS4 AQDQ|CI-18 9606 Homo sapiens unknown target Petruzzella V (2001) 11181577 173767 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3023 110804 4725 RP11-781D11.3 NDUFS5 CI-15k|CI15K 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3024 110804 4725 RP11-781D11.3 NDUFS5 CI-15k|CI15K 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3025 110804 4725 RP11-781D11.3 NDUFS5 CI-15k|CI15K 9606 Homo sapiens unknown target Loeffen J (1999) 10070614 173644 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3392 110805 4726 - NDUFS6 CI-13kA|CI-13kD-A|CI13KDA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3393 110805 4726 - NDUFS6 CI-13kA|CI-13kD-A|CI13KDA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3270 110806 4728 - NDUFS8 CI-23k|CI23KD|TYKY 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3271 110806 4728 - NDUFS8 CI-23k|CI23KD|TYKY 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3272 110806 4728 - NDUFS8 CI-23k|CI23KD|TYKY 9606 Homo sapiens unknown target Jose Quiles M (1998) 9576793 173744 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3273 110806 4728 - NDUFS8 CI-23k|CI23KD|TYKY 9606 Homo sapiens unknown target Loeffen J (1998) 9837812 173745 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3274 110806 4728 - NDUFS8 CI-23k|CI23KD|TYKY 9606 Homo sapiens unknown target Albracht SP (2000) 11086155 173746 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3370 110807 4729 - NDUFV2 CI-24k 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3371 110807 4729 - NDUFV2 CI-24k 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3372 110807 4729 - NDUFV2 CI-24k 9606 Homo sapiens unknown target Paunesku T (2000) 10716640 50870 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3325 110809 4731 - NDUFV3 CI-10k|CI-9KD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3326 110809 4731 - NDUFV3 CI-10k|CI-9KD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 25187 110826 4751 - NEK2 HsPK21|NEK2A|NLK1|PPP1R111|RP67 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5997 5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE - - DRUGBANK DB07180 C17H16ClN3O2 small molecule - - DRUGBANK 4158 110831 4758 DAAP-222I20.1 NEU1 NANH|NEU|SIAL1 9606 Homo sapiens inhibitor target Chavas LM (2010) 20222714 174303 191 Oseltamivir Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir tamiflu oral suspension|tamifl DRUGBANK DB00198 C16H28N2O4 small molecule J05AH02 196618-13-0 DRUGBANK 8026 110832 4759 - NEU2 SIAL2 9606 Homo sapiens inhibitor target Chavas LM (2010) 20222714 174303 548 Zanamivir ZMR|4-Guanidino-neu5ac2en|ZANAMIVIR|Relenza|GNA|(2R,3R,4S)-3-(acetylamino)-4-Carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid|GANA|4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid|5-(acetylamino)-2,6-Anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid|5-acetamido-2,6-Anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid|Zanamavir|Modified sialic acid relenza DRUGBANK DB00558 C12H20N4O7 small molecule J05AH01 139110-80-8 DRUGBANK 4157 110832 4759 - NEU2 SIAL2 9606 Homo sapiens inhibitor target Chavas LM (2010) 20222714 174303 191 Oseltamivir Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir tamiflu oral suspension|tamifl DRUGBANK DB00198 C16H28N2O4 small molecule J05AH02 196618-13-0 DRUGBANK 25992 110832 4759 - NEU2 SIAL2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6755 5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID - - DRUGBANK DB07960 C12H19NO6 small molecule - - DRUGBANK 11180 110845 4772 - NFATC1 NF-ATC|NFAT2|NFATc 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 22700 110851 4779 - NFE2L1 LCR-F1|NRF1|TCF11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 26850 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Anninos H (2009) 19465361 182109 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26851 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Zhang W (2005) 15678110 181880 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26852 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Gomez-Isla T (2008) 18317243 182067 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26853 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Whitehead SN (2007) 17194886 181980 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 13085 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13086 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Yasui K (2005) 15723633 179849 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 12174 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens antagonist target Kopp E (1994) 8052854 179249 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 16562 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens unknown target Ichiyama T (2003) 12801316 181363 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16563 110857 4790 - NFKB1 EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50 9606 Homo sapiens unknown target Tomari S (2003) 12801315 181364 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 15788 110858 4791 - NFKB2 CVID10|H2TF1|LYT-10|LYT10|NF-kB2|p100|p52 9606 Homo sapiens antagonist target Largo R (2003) 12681956 181080 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 12173 110858 4791 - NFKB2 CVID10|H2TF1|LYT-10|LYT10|NF-kB2|p100|p52 9606 Homo sapiens antagonist target Kopp E (1994) 8052854 179249 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12172 110859 4792 - NFKBIA IKBA|MAD-3|NFKBI 9606 Homo sapiens unknown target Stevenson MA (1999) 10553090 179248 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 16530 110869 4803 - NGF Beta-NGF|HSAN5|NGFB 9606 Homo sapiens stimulator target Riaz SS (1999) 11221812 181341 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16531 110869 4803 - NGF Beta-NGF|HSAN5|NGFB 9606 Homo sapiens stimulator target Samina Riaz S (2000) 11146120 181339 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16532 110869 4803 - NGF Beta-NGF|HSAN5|NGFB 9606 Homo sapiens stimulator target Puls I (1999) 10637819 181343 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16533 110869 4803 - NGF Beta-NGF|HSAN5|NGFB 9606 Homo sapiens stimulator target Semkova I (1999) 10525174 181342 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16534 110869 4803 - NGF Beta-NGF|HSAN5|NGFB 9606 Homo sapiens stimulator target Culmsee C (1999) 10403429 181340 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 25389 110874 4809 CTA-216E10.8 NHP2L1 15.5K|FA-1|FA1|NHPX|OTK27|SNRNP15-5|SNU13|SPAG12|SSFA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19335 110874 4809 CTA-216E10.8 NHP2L1 15.5K|FA-1|FA1|NHPX|OTK27|SNRNP15-5|SNU13|SPAG12|SSFA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 172 110876 4811 - NID1 NID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 173 110876 4811 - NID1 NID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 174 110876 4811 - NID1 NID 9606 Homo sapiens unknown target Stephens RW (1992) 1499567 2893 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 19476 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2465 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate - - DRUGBANK DB02569 C10H14N2O10P2 small molecule - - DRUGBANK 19477 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2465 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate - - DRUGBANK DB02569 C10H14N2O10P2 small molecule - - DRUGBANK 19478 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2465 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate - - DRUGBANK DB02569 C10H14N2O10P2 small molecule - - DRUGBANK 22459 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3900 Fudp - - DRUGBANK DB04068 C9H13FN2O10P2 small molecule - - DRUGBANK 22460 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3900 Fudp - - DRUGBANK DB04068 C9H13FN2O10P2 small molecule - - DRUGBANK 22461 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3900 Fudp - - DRUGBANK DB04068 C9H13FN2O10P2 small molecule - - DRUGBANK 23212 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4188 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate - - DRUGBANK DB04366 C10H16N6O9P2 small molecule - - DRUGBANK 23213 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4188 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate - - DRUGBANK DB04366 C10H16N6O9P2 small molecule - - DRUGBANK 23214 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4188 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate - - DRUGBANK DB04366 C10H16N6O9P2 small molecule - - DRUGBANK 20073 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2767 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate - - DRUGBANK DB02887 C10H15N2O13P3 small molecule - - DRUGBANK 20074 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2767 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate - - DRUGBANK DB02887 C10H15N2O13P3 small molecule - - DRUGBANK 20075 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2767 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate - - DRUGBANK DB02887 C10H15N2O13P3 small molecule - - DRUGBANK 21387 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3346 2'-Deoxyguanosine-5'-Diphosphate - - DRUGBANK DB03491 C10H15N5O10P2 small molecule - - DRUGBANK 21388 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3346 2'-Deoxyguanosine-5'-Diphosphate - - DRUGBANK DB03491 C10H15N5O10P2 small molecule - - DRUGBANK 21389 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3346 2'-Deoxyguanosine-5'-Diphosphate - - DRUGBANK DB03491 C10H15N5O10P2 small molecule - - DRUGBANK 23074 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23075 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23076 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 18677 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2097 2'-Deoxyguanosine-5'-Triphosphate - - DRUGBANK DB02181 C10H16N5O13P3 small molecule - 2564-35-4 DRUGBANK 18678 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2097 2'-Deoxyguanosine-5'-Triphosphate - - DRUGBANK DB02181 C10H16N5O13P3 small molecule - 2564-35-4 DRUGBANK 18679 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2097 2'-Deoxyguanosine-5'-Triphosphate - - DRUGBANK DB02181 C10H16N5O13P3 small molecule - 2564-35-4 DRUGBANK 20494 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2974 Thymidine-5'- Diphosphate - - DRUGBANK DB03103 C10H16N2O11P2 small molecule - - DRUGBANK 20495 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2974 Thymidine-5'- Diphosphate - - DRUGBANK DB03103 C10H16N2O11P2 small molecule - - DRUGBANK 20496 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2974 Thymidine-5'- Diphosphate - - DRUGBANK DB03103 C10H16N2O11P2 small molecule - - DRUGBANK 19532 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2500 Adenosine Phosphonoacetic Acid - - DRUGBANK DB02607 C12H16N5O8P small molecule - - DRUGBANK 19533 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2500 Adenosine Phosphonoacetic Acid - - DRUGBANK DB02607 C12H16N5O8P small molecule - - DRUGBANK 19534 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2500 Adenosine Phosphonoacetic Acid - - DRUGBANK DB02607 C12H16N5O8P small molecule - - DRUGBANK 23668 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4352 3'-Azido-3'-Deoxythymidine-5'-Diphosphate - - DRUGBANK DB04542 C10H15N5O10P2 small molecule - - DRUGBANK 23669 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4352 3'-Azido-3'-Deoxythymidine-5'-Diphosphate - - DRUGBANK DB04542 C10H15N5O10P2 small molecule - - DRUGBANK 23670 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4352 3'-Azido-3'-Deoxythymidine-5'-Diphosphate - - DRUGBANK DB04542 C10H15N5O10P2 small molecule - - DRUGBANK 18996 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 18997 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 18998 110894 4830 - NME1 AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 3257 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Iskander K (2006) 16905546 173738 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3258 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Jamieson D (2006) 17031400 173737 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22898 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4080 CB1954 - - DRUGBANK DB04253 C9H8N4O5 small molecule - - DRUGBANK 13379 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Radogna F (2009) 19463840 179949 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13621 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens inhibitor target Graves PR (2002) 12435804 180066 1075 Primaquine Primachinum|8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline|Neo-quipenyl|Primaquin|8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline|Primachin|6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline|Primaquina|Primaquinum primaquine|primaquine phosphat DRUGBANK DB01087 C15H21N3O small molecule P01BA03 90-34-6 DRUGBANK 26217 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6981 N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide - - DRUGBANK DB08190 C13H15IN2O2 small molecule - - DRUGBANK 20638 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20639 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 26747 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7517 6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one - - DRUGBANK DB08744 C12H11NO4 small molecule - - DRUGBANK 19741 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Wang Z (2004) 15381063 181864 2597 Resveratrol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol co-veratrol DRUGBANK DB02709 C14H12O3 small molecule - 501-36-0 DRUGBANK 19742 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Buryanovskyy L (2004) 15350128 181862 2597 Resveratrol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol co-veratrol DRUGBANK DB02709 C14H12O3 small molecule - 501-36-0 DRUGBANK 25343 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6155 (3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione - - DRUGBANK DB07339 C9H9NO3 small molecule - - DRUGBANK 26245 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7018 5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one - - DRUGBANK DB08228 C13H15NO3 small molecule - - DRUGBANK 21457 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3392 10-Propargyl-5,8-Dideazafolic Acid - - DRUGBANK DB03541 C24H23N5O6 small molecule - - DRUGBANK 3636 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Foster CE (1999) 10433694 173988 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3637 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Boutin JA (2005) 15733542 173989 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3638 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Celli CM (2006) 16765324 173986 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3639 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Long DJ (2002) 12351651 173987 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3640 110898 4835 RP1-90J20.3 NQO2 DHQV|DIA6|NMOR2|QR2 9606 Homo sapiens unknown target Kwiek JJ (2004) 15078100 173985 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 20413 110899 4836 - NMT1 NMT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2933 (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone - - DRUGBANK DB03062 C23H24N4O3 small molecule - - DRUGBANK 8749 110900 4837 - NNMT - 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8750 110900 4837 - NNMT - 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8751 110900 4837 - NNMT - 9606 Homo sapiens binder target Riederer M (2009) 18996527 177419 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 19802 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2615 N-Butyl-N'-Hydroxyguanidine - - DRUGBANK DB02727 C5H13N3O small molecule - - DRUGBANK 19803 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2615 N-Butyl-N'-Hydroxyguanidine - - DRUGBANK DB02727 C5H13N3O small molecule - - DRUGBANK 19804 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2615 N-Butyl-N'-Hydroxyguanidine - - DRUGBANK DB02727 C5H13N3O small molecule - - DRUGBANK 26039 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6811 N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE - - DRUGBANK DB08018 C20H28ClN5 small molecule - - DRUGBANK 26041 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6812 N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine - - DRUGBANK DB08019 C20H28ClN5 small molecule - - DRUGBANK 18286 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 18287 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 18288 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 21253 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3305 N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine - - DRUGBANK DB03449 C20H20ClN3S small molecule - - DRUGBANK 21775 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3554 N5-(1-Imino-3-Butenyl)-L-Ornithine - - DRUGBANK DB03710 C9H20N3O2 small molecule - - DRUGBANK 21776 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3554 N5-(1-Imino-3-Butenyl)-L-Ornithine - - DRUGBANK DB03710 C9H20N3O2 small molecule - - DRUGBANK 21777 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3554 N5-(1-Imino-3-Butenyl)-L-Ornithine - - DRUGBANK DB03710 C9H20N3O2 small molecule - - DRUGBANK 21766 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3551 S-Ethyl-N-Phenyl-Isothiourea - - DRUGBANK DB03707 C9H12N2S small molecule - - DRUGBANK 18393 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1966 N-(3-(Aminomethyl)Benzyl)Acetamidine - - DRUGBANK DB02044 C10H15N3 small molecule - - DRUGBANK 20247 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2868 S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea - - DRUGBANK DB02991 C10H11F3N2S small molecule - - DRUGBANK 17868 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1751 L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide - - DRUGBANK DB01821 C10H22N8O4 small molecule - - DRUGBANK 17869 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1751 L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide - - DRUGBANK DB01821 C10H22N8O4 small molecule - - DRUGBANK 17870 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1751 L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide - - DRUGBANK DB01821 C10H22N8O4 small molecule - - DRUGBANK 19710 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 19711 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 19712 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 2973 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Giraldi-Guimaraes A (1999) 10681601 173616 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2974 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Perry JM (2000) 10799481 173617 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2975 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Yu W (2000) 10962148 173614 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2976 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Adak S (2000) 10945985 173615 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2977 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Kominami S (1999) 10502685 173613 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 18365 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1950 N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine - - DRUGBANK DB02027 C8H21N7O2 small molecule - - DRUGBANK 18366 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1950 N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine - - DRUGBANK DB02027 C8H21N7O2 small molecule - - DRUGBANK 18367 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1950 N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine - - DRUGBANK DB02027 C8H21N7O2 small molecule - - DRUGBANK 18129 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 22127 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3729 5-N-Allyl-Arginine - - DRUGBANK DB03892 C9H19N4O2 small molecule - - DRUGBANK 22128 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3729 5-N-Allyl-Arginine - - DRUGBANK DB03892 C9H19N4O2 small molecule - - DRUGBANK 22129 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3729 5-N-Allyl-Arginine - - DRUGBANK DB03892 C9H19N4O2 small molecule - - DRUGBANK 21335 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21336 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21337 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 22836 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4051 Nitroarginine Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg - DRUGBANK DB04223 C6H13N5O4 small molecule - 2149-70-4 DRUGBANK 18478 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1997 L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide - - DRUGBANK DB02077 C11H22N8O4 small molecule - - DRUGBANK 18479 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1997 L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide - - DRUGBANK DB02077 C11H22N8O4 small molecule - - DRUGBANK 18480 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1997 L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide - - DRUGBANK DB02077 C11H22N8O4 small molecule - - DRUGBANK 20581 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20582 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20583 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20851 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20852 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20853 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20666 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20667 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20668 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 18609 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2062 N-Isopropyl-N'-Hydroxyguanidine - - DRUGBANK DB02143 C4H11N3O small molecule - - DRUGBANK 18610 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2062 N-Isopropyl-N'-Hydroxyguanidine - - DRUGBANK DB02143 C4H11N3O small molecule - - DRUGBANK 18611 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2062 N-Isopropyl-N'-Hydroxyguanidine - - DRUGBANK DB02143 C4H11N3O small molecule - - DRUGBANK 19611 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2535 N-Omega-Propyl-L-Arginine - - DRUGBANK DB02644 C9H21N4O2 small molecule - - DRUGBANK 19612 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2535 N-Omega-Propyl-L-Arginine - - DRUGBANK DB02644 C9H21N4O2 small molecule - - DRUGBANK 19613 110905 4842 - NOS1 IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2535 N-Omega-Propyl-L-Arginine - - DRUGBANK DB02644 C9H21N4O2 small molecule - - DRUGBANK 15175 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens negative modulator target Nandi J (2008) 17503181 174609 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15176 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens negative modulator target Chen X (2002) 11752352 171740 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15177 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens negative modulator target Huang H (2007) 17494951 180773 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 15178 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens negative modulator target Soederberg M (2007) 17379310 180772 1222 Dexamethasone Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone maxidex ont 0.1%|999 itch reli DRUGBANK DB01234 C22H29FO5 small molecule S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04 50-02-2 DRUGBANK 19412 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 2430 Aminoguanidine - - DRUGBANK DB02533 CH6N4 small molecule - 79-17-4 DRUGBANK 19413 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2430 Aminoguanidine - - DRUGBANK DB02533 CH6N4 small molecule - 79-17-4 DRUGBANK 19414 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 2430 Aminoguanidine - - DRUGBANK DB02533 CH6N4 small molecule - 79-17-4 DRUGBANK 19415 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2430 Aminoguanidine - - DRUGBANK DB02533 CH6N4 small molecule - 79-17-4 DRUGBANK 19421 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2436 S-Ethylisothiourea - - DRUGBANK DB02539 C3H8N2S small molecule - 2986-20-1 DRUGBANK 19422 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2436 S-Ethylisothiourea - - DRUGBANK DB02539 C3H8N2S small molecule - 2986-20-1 DRUGBANK 18289 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 18290 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 18291 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 25313 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6122 ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE - - DRUGBANK DB07306 C13H18ClN3O2 small molecule - - DRUGBANK 23657 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4346 5-Nitroindazole - - DRUGBANK DB04534 C7H4N3O2 small molecule - - DRUGBANK 23658 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4346 5-Nitroindazole - - DRUGBANK DB04534 C7H4N3O2 small molecule - - DRUGBANK 23659 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4346 5-Nitroindazole - - DRUGBANK DB04534 C7H4N3O2 small molecule - - DRUGBANK 21254 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3305 N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine - - DRUGBANK DB03449 C20H20ClN3S small molecule - - DRUGBANK 1887 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Rotoli BM (2007) 17363779 172848 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1888 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Devan BD (2007) 17362916 172861 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1889 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Cui YY (2006) 16778961 172860 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1890 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Kagemann G (2007) 17340133 172859 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1891 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Popovic PJ (2007) 17513447 172858 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 25016 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5821 (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine - - DRUGBANK DB07003 C8H10N2OS small molecule - - DRUGBANK 25015 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5820 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile - - DRUGBANK DB07002 C19H20N4O2 small molecule - - DRUGBANK 25020 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5825 (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine - - DRUGBANK DB07007 C17H19N3O2S small molecule - - DRUGBANK 25021 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5826 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE - - DRUGBANK DB07008 C20H14N4O4 small molecule - - DRUGBANK 25026 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5829 (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE - - DRUGBANK DB07011 C22H23N3O3 small molecule - - DRUGBANK 23341 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23342 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23343 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 18394 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1966 N-(3-(Aminomethyl)Benzyl)Acetamidine - - DRUGBANK DB02044 C10H15N3 small molecule - - DRUGBANK 25408 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6204 N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE - - DRUGBANK DB07389 C16H16N4O small molecule - - DRUGBANK 25406 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6203 ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE - - DRUGBANK DB07388 C14H21N3O2 small molecule - - DRUGBANK 25042 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5847 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE - - DRUGBANK DB07029 C21H16N4O4 small molecule - - DRUGBANK 19243 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2362 Thiocoumarin - - DRUGBANK DB02462 C14H17NO2S small molecule - - DRUGBANK 19716 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 19717 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 13883 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Bogle RG (1994) 7518297 180218 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13884 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Sennequier N (1999) 9873034 180219 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13885 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Dudek RR (1995) 7536941 180220 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13886 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens inhibitor target Wolff DJ (1993) 7683652 180217 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 2983 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Yi GB (2003) 12745988 173625 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2984 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Cunningham JM (2000) 10906995 173624 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2985 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Conrad KP (2002) 11742852 173623 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2986 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Knowles RG (2000) 10906994 173622 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2987 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Keilhoff G (2000) 10944418 173610 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 24939 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5735 N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE - - DRUGBANK DB06916 C22H24N6O3 small molecule - - DRUGBANK 26751 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7523 1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE - - DRUGBANK DB08750 C20H22FN5O small molecule - - DRUGBANK 20481 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2971 6-Nitroindazole - - DRUGBANK DB03100 C7H4N3O2 small molecule - - DRUGBANK 20482 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2971 6-Nitroindazole - - DRUGBANK DB03100 C7H4N3O2 small molecule - - DRUGBANK 20483 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2971 6-Nitroindazole - - DRUGBANK DB03100 C7H4N3O2 small molecule - - DRUGBANK 26231 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7005 4-(1H-IMIDAZOL-1-YL)PHENOL - - DRUGBANK DB08214 C9H8N2O small molecule - - DRUGBANK 18721 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2121 7-Nitroindazole - - DRUGBANK DB02207 C7H4N3O2 small molecule - 2942-42-9 DRUGBANK 18722 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2121 7-Nitroindazole - - DRUGBANK DB02207 C7H4N3O2 small molecule - 2942-42-9 DRUGBANK 18723 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2121 7-Nitroindazole - - DRUGBANK DB02207 C7H4N3O2 small molecule - 2942-42-9 DRUGBANK 17560 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target van Guldener C (2007) 17937610 181618 1621 N,N-dimethylarginine dimethyl-L-arginine|L-NG,NG-dimethylarginine|N(g)-dimethylarginine|N(omega),N(omega)-dimethyl-l-arginine|Guanidino-n,n-dimethylarginine|ADMA|NG,NG-dimethyl-l-arginine|N(5)-[(dimethylamino)(imino)methyl]-L-ornithine|N(G1),N(G1)-Dimethylarginine|Asymmetric dimethylarginine|N(g),N(g)-dimethylarginine|N(g),N(g)-dimethyl-l-arginine|N(5)-((Dimethylamino)iminomethyl)-L-ornithine - DRUGBANK DB01686 C8H18N4O2 small molecule - 30315-93-6 DRUGBANK 26856 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens agonist target Gonzalez-Correa JA (2006) 16939630 181963 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26857 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens agonist target De Miguel LS (2000) 10998082 181761 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26858 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens agonist target Sanchez de Miguel L (1998) 9551715 181725 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26859 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens agonist target Anninos H (2009) 19465361 182109 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 22256 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3789 L-Thiocitrulline - - DRUGBANK DB03953 C6H13N3O2S small molecule - - DRUGBANK 22257 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3789 L-Thiocitrulline - - DRUGBANK DB03953 C6H13N3O2S small molecule - - DRUGBANK 22258 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3789 L-Thiocitrulline - - DRUGBANK DB03953 C6H13N3O2S small molecule - - DRUGBANK 25325 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6134 N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE - - DRUGBANK DB07318 C15H14F2N4O2 small molecule - - DRUGBANK 20584 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20585 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20586 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 18773 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2145 Ethylisothiourea - - DRUGBANK DB02234 C3H8N2S small molecule - 1071-37-0 DRUGBANK 18774 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2145 Ethylisothiourea - - DRUGBANK DB02234 C3H8N2S small molecule - 1071-37-0 DRUGBANK 18775 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2145 Ethylisothiourea - - DRUGBANK DB02234 C3H8N2S small molecule - 1071-37-0 DRUGBANK 19614 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2535 N-Omega-Propyl-L-Arginine - - DRUGBANK DB02644 C9H21N4O2 small molecule - - DRUGBANK 19615 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2535 N-Omega-Propyl-L-Arginine - - DRUGBANK DB02644 C9H21N4O2 small molecule - - DRUGBANK 19616 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2535 N-Omega-Propyl-L-Arginine - - DRUGBANK DB02644 C9H21N4O2 small molecule - - DRUGBANK 24909 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5699 5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE - - DRUGBANK DB06879 C21H22F2N6O small molecule - - DRUGBANK 25430 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6219 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE - - DRUGBANK DB07405 C19H16F2N6O small molecule - - DRUGBANK 17900 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1765 4r-Fluoro-N6-Ethanimidoyl-L-Lysine - - DRUGBANK DB01835 C8H16FN3O2 small molecule - - DRUGBANK 17901 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1765 4r-Fluoro-N6-Ethanimidoyl-L-Lysine - - DRUGBANK DB01835 C8H16FN3O2 small molecule - - DRUGBANK 17902 110906 4843 - NOS2 HEP-NOS|INOS|NOS|NOS2A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1765 4r-Fluoro-N6-Ethanimidoyl-L-Lysine - - DRUGBANK DB01835 C8H16FN3O2 small molecule - - DRUGBANK 22305 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3808 L-Homoarginine - - DRUGBANK DB03974 C7H17N4O2 small molecule - - DRUGBANK 22306 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3808 L-Homoarginine - - DRUGBANK DB03974 C7H17N4O2 small molecule - - DRUGBANK 22307 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3808 L-Homoarginine - - DRUGBANK DB03974 C7H17N4O2 small molecule - - DRUGBANK 26040 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6811 N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE - - DRUGBANK DB08018 C20H28ClN5 small molecule - - DRUGBANK 26042 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6812 N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine - - DRUGBANK DB08019 C20H28ClN5 small molecule - - DRUGBANK 22190 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3755 6s-5,6,7,8-Tetrahydrobiopterin - - DRUGBANK DB03918 C9H15N5O3 small molecule - - DRUGBANK 22191 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3755 6s-5,6,7,8-Tetrahydrobiopterin - - DRUGBANK DB03918 C9H15N5O3 small molecule - - DRUGBANK 22192 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3755 6s-5,6,7,8-Tetrahydrobiopterin - - DRUGBANK DB03918 C9H15N5O3 small molecule - - DRUGBANK 18292 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 18293 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 18294 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1921 3-Bromo-7-Nitroindazole - - DRUGBANK DB01997 C7H3BrN3O2 small molecule - - DRUGBANK 2988 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Trovati M (1999) 10440125 173627 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2989 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Hayakawa H (1999) 10403604 173626 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2990 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Tan E (1999) 10690351 173630 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2991 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Abu-Soud HM (2000) 10749853 173629 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2992 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target McDuffie JE (1999) 10460702 173628 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 23660 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4346 5-Nitroindazole - - DRUGBANK DB04534 C7H4N3O2 small molecule - - DRUGBANK 23661 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4346 5-Nitroindazole - - DRUGBANK DB04534 C7H4N3O2 small molecule - - DRUGBANK 1894 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Haruna Y (2006) 16729278 172866 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1895 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Ishikawa T (2006) 16720041 172867 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1896 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Yang J (2006) 16717106 172864 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1897 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Gautier C (2006) 16690332 172865 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1898 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Akamine EH (2006) 16682803 172863 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 22290 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 22291 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 22292 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 21767 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3551 S-Ethyl-N-Phenyl-Isothiourea - - DRUGBANK DB03707 C9H12N2S small molecule - - DRUGBANK 20991 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3196 5,6-Cyclic-Tetrahydropteridine - - DRUGBANK DB03332 C8H9N5O3 small molecule - - DRUGBANK 20992 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3196 5,6-Cyclic-Tetrahydropteridine - - DRUGBANK DB03332 C8H9N5O3 small molecule - - DRUGBANK 20993 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3196 5,6-Cyclic-Tetrahydropteridine - - DRUGBANK DB03332 C8H9N5O3 small molecule - - DRUGBANK 18395 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1966 N-(3-(Aminomethyl)Benzyl)Acetamidine - - DRUGBANK DB02044 C10H15N3 small molecule - - DRUGBANK 19499 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2483 Se-Ethyl-Isoselenourea - - DRUGBANK DB02589 C3H8N2Se small molecule - - DRUGBANK 19500 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2483 Se-Ethyl-Isoselenourea - - DRUGBANK DB02589 C3H8N2Se small molecule - - DRUGBANK 19501 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2483 Se-Ethyl-Isoselenourea - - DRUGBANK DB02589 C3H8N2Se small molecule - - DRUGBANK 25255 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6060 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB07244 C19H19F2N5 small molecule - - DRUGBANK 25407 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6203 ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE - - DRUGBANK DB07388 C14H21N3O2 small molecule - - DRUGBANK 22401 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3852 S-Isopropyl-Isothiourea - - DRUGBANK DB04018 C4H10N2S small molecule - - DRUGBANK 22402 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3852 S-Isopropyl-Isothiourea - - DRUGBANK DB04018 C4H10N2S small molecule - - DRUGBANK 22403 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3852 S-Isopropyl-Isothiourea - - DRUGBANK DB04018 C4H10N2S small molecule - - DRUGBANK 18961 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2240 2-Aminothiazoline - - DRUGBANK DB02335 C3H6N2S small molecule - 1779-81-3 DRUGBANK 18962 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2240 2-Aminothiazoline - - DRUGBANK DB02335 C3H6N2S small molecule - 1779-81-3 DRUGBANK 18963 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2240 2-Aminothiazoline - - DRUGBANK DB02335 C3H6N2S small molecule - 1779-81-3 DRUGBANK 17871 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1751 L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide - - DRUGBANK DB01821 C10H22N8O4 small molecule - - DRUGBANK 17872 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1751 L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide - - DRUGBANK DB01821 C10H22N8O4 small molecule - - DRUGBANK 17873 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1751 L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide - - DRUGBANK DB01821 C10H22N8O4 small molecule - - DRUGBANK 20253 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 20254 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 20255 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2871 Hydroxydimethylarsine Oxide - - DRUGBANK DB02994 C2H7AsO2 small molecule - - DRUGBANK 19713 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 19714 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 19715 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 20415 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2936 7-Nitroindazole-2-Carboxamidine - - DRUGBANK DB03065 C8H7N5O2 small molecule - - DRUGBANK 22186 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3747 S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea - - DRUGBANK DB03910 C12H18N4S2 small molecule - - DRUGBANK 13889 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens inhibitor target Bogle RG (1994) 7518297 180218 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13890 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens inhibitor target Sennequier N (1999) 9873034 180219 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13891 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens inhibitor target Dudek RR (1995) 7536941 180220 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13892 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens inhibitor target Wolff DJ (1993) 7683652 180217 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 20223 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2856 N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane - - DRUGBANK DB02979 C18H38N4S2 small molecule - - DRUGBANK 20224 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2856 N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane - - DRUGBANK DB02979 C18H38N4S2 small molecule - - DRUGBANK 20225 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2856 N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane - - DRUGBANK DB02979 C18H38N4S2 small molecule - - DRUGBANK 18368 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1950 N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine - - DRUGBANK DB02027 C8H21N7O2 small molecule - - DRUGBANK 18369 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1950 N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine - - DRUGBANK DB02027 C8H21N7O2 small molecule - - DRUGBANK 18370 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1950 N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine - - DRUGBANK DB02027 C8H21N7O2 small molecule - - DRUGBANK 20929 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3170 N5-Iminoethyl-L-Ornithine - - DRUGBANK DB03305 C7H15N3O2 small molecule - - DRUGBANK 20930 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3170 N5-Iminoethyl-L-Ornithine - - DRUGBANK DB03305 C7H15N3O2 small molecule - - DRUGBANK 20931 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3170 N5-Iminoethyl-L-Ornithine - - DRUGBANK DB03305 C7H15N3O2 small molecule - - DRUGBANK 20484 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2971 6-Nitroindazole - - DRUGBANK DB03100 C7H4N3O2 small molecule - - DRUGBANK 20485 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2971 6-Nitroindazole - - DRUGBANK DB03100 C7H4N3O2 small molecule - - DRUGBANK 18724 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2121 7-Nitroindazole - - DRUGBANK DB02207 C7H4N3O2 small molecule - 2942-42-9 DRUGBANK 18725 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2121 7-Nitroindazole - - DRUGBANK DB02207 C7H4N3O2 small molecule - 2942-42-9 DRUGBANK 18726 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2121 7-Nitroindazole - - DRUGBANK DB02207 C7H4N3O2 small molecule - 2942-42-9 DRUGBANK 17561 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1621 N,N-dimethylarginine dimethyl-L-arginine|L-NG,NG-dimethylarginine|N(g)-dimethylarginine|N(omega),N(omega)-dimethyl-l-arginine|Guanidino-n,n-dimethylarginine|ADMA|NG,NG-dimethyl-l-arginine|N(5)-[(dimethylamino)(imino)methyl]-L-ornithine|N(G1),N(G1)-Dimethylarginine|Asymmetric dimethylarginine|N(g),N(g)-dimethylarginine|N(g),N(g)-dimethyl-l-arginine|N(5)-((Dimethylamino)iminomethyl)-L-ornithine - DRUGBANK DB01686 C8H18N4O2 small molecule - 30315-93-6 DRUGBANK 18481 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1997 L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide - - DRUGBANK DB02077 C11H22N8O4 small molecule - - DRUGBANK 18482 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1997 L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide - - DRUGBANK DB02077 C11H22N8O4 small molecule - - DRUGBANK 18483 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1997 L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide - - DRUGBANK DB02077 C11H22N8O4 small molecule - - DRUGBANK 22837 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Raman CS (2001) 11695891 181780 4051 Nitroarginine Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg - DRUGBANK DB04223 C6H13N5O4 small molecule - 2149-70-4 DRUGBANK 22838 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4051 Nitroarginine Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg - DRUGBANK DB04223 C6H13N5O4 small molecule - 2149-70-4 DRUGBANK 20589 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20590 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20591 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 23700 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4369 N-(Chlorophenyl)-N'-Hydroxyguanidine - - DRUGBANK DB04559 C7H8ClN3O small molecule - - DRUGBANK 18401 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1970 1,2,4-Triazole-Carboxamidine - - DRUGBANK DB02048 C3H6N5 small molecule - - DRUGBANK 18402 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1970 1,2,4-Triazole-Carboxamidine - - DRUGBANK DB02048 C3H6N5 small molecule - - DRUGBANK 18403 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1970 1,2,4-Triazole-Carboxamidine - - DRUGBANK DB02048 C3H6N5 small molecule - - DRUGBANK 25014 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5819 (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine - - DRUGBANK DB07001 C10H14N2OS small molecule - - DRUGBANK 18776 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2145 Ethylisothiourea - - DRUGBANK DB02234 C3H8N2S small molecule - 1071-37-0 DRUGBANK 18777 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2145 Ethylisothiourea - - DRUGBANK DB02234 C3H8N2S small molecule - 1071-37-0 DRUGBANK 18778 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2145 Ethylisothiourea - - DRUGBANK DB02234 C3H8N2S small molecule - 1071-37-0 DRUGBANK 5951 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens cofactor target Huang A (2000) 10749876 175489 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5952 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens cofactor target Gorren AC (2002) 12003347 175488 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5953 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens cofactor target Gorren AC (2000) 10995244 175492 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5954 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens cofactor target Heller R (1999) 10075731 175493 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5955 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens cofactor target Shinozaki K (2000) 11009561 175490 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5956 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens cofactor target Berka V (2000) 10924132 175491 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 18600 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2060 S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea - - DRUGBANK DB02141 C12H18N4S2 small molecule - - DRUGBANK 17892 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1763 L-2-Amino-4-(Guanidinooxy)Butyric Acid - - DRUGBANK DB01833 C5H12N4O3 small molecule - - DRUGBANK 17893 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1763 L-2-Amino-4-(Guanidinooxy)Butyric Acid - - DRUGBANK DB01833 C5H12N4O3 small molecule - - DRUGBANK 17894 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1763 L-2-Amino-4-(Guanidinooxy)Butyric Acid - - DRUGBANK DB01833 C5H12N4O3 small molecule - - DRUGBANK 20126 110909 4846 - NOS3 ECNOS|eNOS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2791 2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine - - DRUGBANK DB02911 C12H14N6 small molecule - - DRUGBANK 21066 110914 4852 - NPY PYY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3239 L-Tyrosinamide L-Tyrosine amide|Tyrosinamide - DRUGBANK DB03380 C9H12N2O2 small molecule - 4985-46-0 DRUGBANK 20191 110914 4852 - NPY PYY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2829 Alpha-Aminoisobutyric Acid - - DRUGBANK DB02952 C4H9NO2 small molecule - - DRUGBANK 366 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 367 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 847 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 848 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Burren CP (1999) 10084601 4485 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 849 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Lafont J (2002) 12149257 172185 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 850 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 851 110918 4856 - NOV CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh 9606 Homo sapiens unknown target Martinerie C (1996) 8622864 172184 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 11552 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 890 Didanosine Didanosina|9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one|Didanosine|9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one|9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one|9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol|DDI|Dideoxyinosine|2,3-Dideoxyinosine|Didanosinum|DdIno videx|didanosine|videx chewabl DRUGBANK DB00900 C10H12N4O3 small molecule J05AF02 69655-05-6 DRUGBANK 11553 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 890 Didanosine Didanosina|9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one|Didanosine|9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one|9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one|9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol|DDI|Dideoxyinosine|2,3-Dideoxyinosine|Didanosinum|DdIno videx|didanosine|videx chewabl DRUGBANK DB00900 C10H12N4O3 small molecule J05AF02 69655-05-6 DRUGBANK 19474 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2464 Peldesine Peldesine|2-Amino-3,5-dihydro-7-(3-pyridylmethyl)-4H-pyrrolo(3,2-d)pyrimidin-4-one|4H-Pyrrolo(3,2-d)pyrimidin-4-one, 2-amino-3,5-dihydro-7-(3-pyridinylmethyl)- - DRUGBANK DB02568 C12H11N5O small molecule - - DRUGBANK 19475 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2464 Peldesine Peldesine|2-Amino-3,5-dihydro-7-(3-pyridylmethyl)-4H-pyrrolo(3,2-d)pyrimidin-4-one|4H-Pyrrolo(3,2-d)pyrimidin-4-one, 2-amino-3,5-dihydro-7-(3-pyridinylmethyl)- - DRUGBANK DB02568 C12H11N5O small molecule - - DRUGBANK 18759 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2134 2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine - - DRUGBANK DB02222 C9H13N6O4P small molecule - - DRUGBANK 18760 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2134 2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine - - DRUGBANK DB02222 C9H13N6O4P small molecule - - DRUGBANK 18761 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2134 2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine - - DRUGBANK DB02222 C9H13N6O4P small molecule - - DRUGBANK 4659 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens inducer target Takimoto T (1988) 3260648 174589 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4660 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens inducer target Dumontet C (1999) 10500836 174588 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4661 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens inducer target Bzowska A (1995) 8521855 174587 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4662 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens inducer target Dumontet C (1999) 10444166 174586 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4663 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens inducer target Carson DA (1982) 6808516 174585 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 21591 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3457 3-Deoxyguanosine - - DRUGBANK DB03609 C10H13N5O4 small molecule - - DRUGBANK 21592 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3457 3-Deoxyguanosine - - DRUGBANK DB03609 C10H13N5O4 small molecule - - DRUGBANK 22910 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4087 9-(5,5-Difluoro-5-Phosphonopentyl)Guanine - - DRUGBANK DB04260 C10H14F2N5O4P small molecule - - DRUGBANK 22911 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4087 9-(5,5-Difluoro-5-Phosphonopentyl)Guanine - - DRUGBANK DB04260 C10H14F2N5O4P small molecule - - DRUGBANK 22912 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4087 9-(5,5-Difluoro-5-Phosphonopentyl)Guanine - - DRUGBANK DB04260 C10H14F2N5O4P small molecule - - DRUGBANK 17535 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1603 8-azaguanine Azaguanine-8|Azaguanine|Pathocidin|Pathocidine|Guanazol - DRUGBANK DB01667 C4H4N6O small molecule - 134-58-7 DRUGBANK 17536 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1603 8-azaguanine Azaguanine-8|Azaguanine|Pathocidin|Pathocidine|Guanazol - DRUGBANK DB01667 C4H4N6O small molecule - 134-58-7 DRUGBANK 23154 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4160 Inosine Oxiamin|Inosina|Ribonosine|INO|Inosinum|beta-Inosine|Hypoxanthosine rejuvesol DRUGBANK DB04335 C10H12N4O5 small molecule D06BB05|G01AX02|S01XA10 58-63-9 DRUGBANK 23155 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4160 Inosine Oxiamin|Inosina|Ribonosine|INO|Inosinum|beta-Inosine|Hypoxanthosine rejuvesol DRUGBANK DB04335 C10H12N4O5 small molecule D06BB05|G01AX02|S01XA10 58-63-9 DRUGBANK 23156 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4160 Inosine Oxiamin|Inosina|Ribonosine|INO|Inosinum|beta-Inosine|Hypoxanthosine rejuvesol DRUGBANK DB04335 C10H12N4O5 small molecule D06BB05|G01AX02|S01XA10 58-63-9 DRUGBANK 22475 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3908 Hypoxanthine - - DRUGBANK DB04076 C5H3N4O small molecule - 68-94-0 DRUGBANK 22476 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3908 Hypoxanthine - - DRUGBANK DB04076 C5H3N4O small molecule - 68-94-0 DRUGBANK 22477 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3908 Hypoxanthine - - DRUGBANK DB04076 C5H3N4O small molecule - 68-94-0 DRUGBANK 20033 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2739 Guanosine Guanine riboside|G|9--D-ribofuranosyl-guanine|Guo|2-amino-1,9-dihydro-9--D-ribofuranosyl-6H-purin-6-one|Guanine-9--D-ribofuranoside|2(3H)-imino-9--D-ribofuranosyl-9H-purin-6(1H)-one|Guanosin - DRUGBANK DB02857 C10H13N5O5 small molecule - 118-00-3 DRUGBANK 20034 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2739 Guanosine Guanine riboside|G|9--D-ribofuranosyl-guanine|Guo|2-amino-1,9-dihydro-9--D-ribofuranosyl-6H-purin-6-one|Guanine-9--D-ribofuranoside|2(3H)-imino-9--D-ribofuranosyl-9H-purin-6(1H)-one|Guanosin - DRUGBANK DB02857 C10H13N5O5 small molecule - 118-00-3 DRUGBANK 19130 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2295 2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One - - DRUGBANK DB02391 C10H16N6O3 small molecule - - DRUGBANK 19131 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2295 2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One - - DRUGBANK DB02391 C10H16N6O3 small molecule - - DRUGBANK 19132 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2295 2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One - - DRUGBANK DB02391 C10H16N6O3 small molecule - - DRUGBANK 22112 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Shi W (2004) 14982926 181843 3718 MT-Immucillin-H (1s)-1-(0-Deazahypoxanthin-9-Yl)-1,4-Dideoxy-1,4-Imino-5-Methylthio-D-Ribitol|MT-ImmH|5'-Methylthio-Immucillin-H - DRUGBANK DB03881 C12H16N4O3S small molecule - - DRUGBANK 21475 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3400 4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol - - DRUGBANK DB03551 C12H18N4O3 small molecule - - DRUGBANK 21476 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3400 4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol - - DRUGBANK DB03551 C12H18N4O3 small molecule - - DRUGBANK 23869 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4560 GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE - - DRUGBANK DB04757 C11H14N5O8P small molecule - - DRUGBANK 18771 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 2142 Immucillin-G - - DRUGBANK DB02230 C11H14N5O4 small molecule - - DRUGBANK 18772 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2142 Immucillin-G - - DRUGBANK DB02230 C11H14N5O4 small molecule - - DRUGBANK 19928 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2678 9-Deazainosine - - DRUGBANK DB02796 C11H12N3O5 small molecule - 89458-19-5 DRUGBANK 19929 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2678 9-Deazainosine - - DRUGBANK DB02796 C11H12N3O5 small molecule - 89458-19-5 DRUGBANK 19930 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2678 9-Deazainosine - - DRUGBANK DB02796 C11H12N3O5 small molecule - 89458-19-5 DRUGBANK 20486 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2972 Ribose-1-Phosphate - - DRUGBANK DB03101 C5H11O8P small molecule - - DRUGBANK 20487 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2972 Ribose-1-Phosphate - - DRUGBANK DB03101 C5H11O8P small molecule - - DRUGBANK 20488 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2972 Ribose-1-Phosphate - - DRUGBANK DB03101 C5H11O8P small molecule - - DRUGBANK 23868 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4557 GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE - - DRUGBANK DB04754 C12H16N5O8P small molecule - - DRUGBANK 23867 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4556 9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE - - DRUGBANK DB04753 C13H16N3O8P small molecule - - DRUGBANK 19050 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 19051 110921 4860 - PNP NP|PRO1837|PUNP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 14074 110939 4879 - NPPB BNP 9606 Homo sapiens unknown target Richards AM (2001) 11401111 180315 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14075 110939 4879 - NPPB BNP 9606 Homo sapiens unknown target Takeda Y (2004) 15325927 180317 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14076 110939 4879 - NPPB BNP 9606 Homo sapiens unknown target Ohta Y (2001) 11206715 180316 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14077 110939 4879 - NPPB BNP 9606 Homo sapiens unknown target Frantz RP (2005) 15864245 180319 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14078 110939 4879 - NPPB BNP 9606 Homo sapiens unknown target Konishi H (2003) 14692707 180318 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 17332 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1551 Erythrityl Tetranitrate Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate - DRUGBANK DB01613 C4H6N4O12 small molecule C01DA13|C01DA63 7297-25-8 DRUGBANK 17333 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1551 Erythrityl Tetranitrate Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate - DRUGBANK DB01613 C4H6N4O12 small molecule C01DA13|C01DA63 7297-25-8 DRUGBANK 17334 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Schroeder H (1987) 2895614 181587 1551 Erythrityl Tetranitrate Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate - DRUGBANK DB01613 C4H6N4O12 small molecule C01DA13|C01DA63 7297-25-8 DRUGBANK 17330 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Bauersachs J (2009) 19732062 178066 1550 Amyl Nitrite n-pentyl nitrite|Nitramyl|1-nitropentane|pentyl nitrite|n-Amyl nitrite amylnitrite glass cap 5min|amy DRUGBANK DB01612 C5H11NO2 small molecule V03AB22 8017-89-8 DRUGBANK 17331 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Madhani M (2003) 12890708 178067 1550 Amyl Nitrite n-pentyl nitrite|Nitramyl|1-nitropentane|pentyl nitrite|n-Amyl nitrite amylnitrite glass cap 5min|amy DRUGBANK DB01612 C5H11NO2 small molecule V03AB22 8017-89-8 DRUGBANK 5585 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Madhani M (2006) 17016498 175225 318 Nitroprusside [Fe(CN)5(NO)](2-)|Nitroferricyanide sodium nitroprusside for injec DRUGBANK DB00325 C5FeN6O small molecule C02DD01 15078-28-1 DRUGBANK 5586 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Steinmetz M (2004) 15093694 175224 318 Nitroprusside [Fe(CN)5(NO)](2-)|Nitroferricyanide sodium nitroprusside for injec DRUGBANK DB00325 C5FeN6O small molecule C02DD01 15078-28-1 DRUGBANK 5587 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Fortin Y (2006) 16902599 175226 318 Nitroprusside [Fe(CN)5(NO)](2-)|Nitroferricyanide sodium nitroprusside for injec DRUGBANK DB00325 C5FeN6O small molecule C02DD01 15078-28-1 DRUGBANK 24125 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 4699 Nesiritide Natriuretic peptides B|BNP|Nesiritide recombinant|Brain natriuretic peptide 32 natrecor DRUGBANK DB04899 - biologic C01DX19 124584-08-3 DRUGBANK 11389 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 873 Isosorbide Dinitrate Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida isosorbide tab 30mg|isordil su DRUGBANK DB00883 C6H8N2O8 small molecule C01DA08|C05AE02|C01DA58 87-33-2 DRUGBANK 11390 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Villarroya M (2005) 16007231 178876 873 Isosorbide Dinitrate Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida isosorbide tab 30mg|isordil su DRUGBANK DB00883 C6H8N2O8 small molecule C01DA08|C05AE02|C01DA58 87-33-2 DRUGBANK 11391 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 873 Isosorbide Dinitrate Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida isosorbide tab 30mg|isordil su DRUGBANK DB00883 C6H8N2O8 small molecule C01DA08|C05AE02|C01DA58 87-33-2 DRUGBANK 11392 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Beauregard C (2002) 12419094 178874 873 Isosorbide Dinitrate Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida isosorbide tab 30mg|isordil su DRUGBANK DB00883 C6H8N2O8 small molecule C01DA08|C05AE02|C01DA58 87-33-2 DRUGBANK 11393 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Takabuchi S (2004) 15465035 178875 873 Isosorbide Dinitrate Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida isosorbide tab 30mg|isordil su DRUGBANK DB00883 C6H8N2O8 small molecule C01DA08|C05AE02|C01DA58 87-33-2 DRUGBANK 9909 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Bauersachs J (2009) 19732062 178066 717 Nitroglycerin Nitrolingual|Glyceroltrinitrat|Nitro-dur|Glyceryl trinitrate|Glycerol trinitrate|NG|Glycerin trinitrate|Trinitroglycerol|Nitromist|Propane-1,2,3-triyl trinitrate|Glycerol, nitric acid triester|1,2,3-Propanetrioltrinitrate|Nitroglycerine|Trinitrine|Transderm nitro|Nitroglicerina|Glyceroli trinitratis|Rectogesic|Natispray|Trinitroglycerin|Nitromed|Nitrostat|Nitroglycerol|Nitroglycerin|1,2,3-Propanetriyl nitrate|Minitran nitrolingual pumpspray|transde DRUGBANK DB00727 C3H5N3O9 small molecule C01DA02|C05AE01|C01DA52 55-63-0 DRUGBANK 9910 110941 4881 RP11-354A16.3 NPR1 ANPRA|ANPa|GUC2A|GUCY2A|NPRA 9606 Homo sapiens agonist target Madhani M (2003) 12890708 178067 717 Nitroglycerin Nitrolingual|Glyceroltrinitrat|Nitro-dur|Glyceryl trinitrate|Glycerol trinitrate|NG|Glycerin trinitrate|Trinitroglycerol|Nitromist|Propane-1,2,3-triyl trinitrate|Glycerol, nitric acid triester|1,2,3-Propanetrioltrinitrate|Nitroglycerine|Trinitrine|Transderm nitro|Nitroglicerina|Glyceroli trinitratis|Rectogesic|Natispray|Trinitroglycerin|Nitromed|Nitrostat|Nitroglycerol|Nitroglycerin|1,2,3-Propanetriyl nitrate|Minitran nitrolingual pumpspray|transde DRUGBANK DB00727 C3H5N3O9 small molecule C01DA02|C05AE01|C01DA52 55-63-0 DRUGBANK 17335 110942 4882 - NPR2 AMDM|ANPRB|ANPb|ECDM|GUC2B|GUCY2B|NPRB|NPRBi 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1551 Erythrityl Tetranitrate Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate - DRUGBANK DB01613 C4H6N4O12 small molecule C01DA13|C01DA63 7297-25-8 DRUGBANK 17336 110942 4882 - NPR2 AMDM|ANPRB|ANPb|ECDM|GUC2B|GUCY2B|NPRB|NPRBi 9606 Homo sapiens agonist target Lange K (2009) 19406636 181588 1551 Erythrityl Tetranitrate Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate - DRUGBANK DB01613 C4H6N4O12 small molecule C01DA13|C01DA63 7297-25-8 DRUGBANK 17337 110942 4882 - NPR2 AMDM|ANPRB|ANPb|ECDM|GUC2B|GUCY2B|NPRB|NPRBi 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1551 Erythrityl Tetranitrate Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate - DRUGBANK DB01613 C4H6N4O12 small molecule C01DA13|C01DA63 7297-25-8 DRUGBANK 11083 110947 4887 - NPY2R NPY2-R 9606 Homo sapiens unknown target Li W (1992) 1314592 178671 837 Cysteamine Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol cystaran|cystagon|procysbi del DRUGBANK DB00847 C2H7NS small molecule A16AA04|S01XA21 60-23-1 DRUGBANK 18043 110960 4905 - NSF SKD2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1829 1-Ethyl-Pyrrolidine-2,5-Dione - - DRUGBANK DB01902 C6H9NO2 small molecule - - DRUGBANK 18044 110960 4905 - NSF SKD2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1829 1-Ethyl-Pyrrolidine-2,5-Dione - - DRUGBANK DB01902 C6H9NO2 small molecule - - DRUGBANK 18045 110960 4905 - NSF SKD2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1829 1-Ethyl-Pyrrolidine-2,5-Dione - - DRUGBANK DB01902 C6H9NO2 small molecule - - DRUGBANK 10712 110962 4907 RP11-321N4.1 NT5E CALJA|CD73|E5NT|NT|NT5|NTE|eN|eNT 9606 Homo sapiens inhibitor target Ustunsoy H (2006) 16426349 178471 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 10713 110962 4907 RP11-321N4.1 NT5E CALJA|CD73|E5NT|NT|NT5|NTE|eN|eNT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 8685 110969 4914 - NTRK1 MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA 9606 Homo sapiens antagonist target de Groot JW (2006) 16782438 177343 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8686 110969 4914 - NTRK1 MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA 9606 Homo sapiens antagonist target Kovacs M (2005) 16052979 177344 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8687 110969 4914 - NTRK1 MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA 9606 Homo sapiens antagonist target Delbaldo C (2007) 17582306 177345 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8688 110969 4914 - NTRK1 MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA 9606 Homo sapiens antagonist target de Groot JW (2007) 17579194 177346 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8689 110969 4914 - NTRK1 MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA 9606 Homo sapiens antagonist target Catani M (2005) 15832750 177347 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 5520 110969 4914 - NTRK1 MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA 9606 Homo sapiens agonist target Jang SW (2009) 19549602 175185 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5545 110970 4915 RP11-263K15.1 NTRK2 GP145-TrkB|TRKB|trk-B 9606 Homo sapiens agonist target Jang SW (2009) 19549602 175185 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 20239 110992 4938 - OAS1 IFI-4|OIAS|OIASI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2864 Cysteine-S-Acetamide - - DRUGBANK DB02987 C5H10N2O3S small molecule - - DRUGBANK 18414 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1975 Gabaculine - - DRUGBANK DB02054 C7H7NO2 small molecule - 87980-11-8 DRUGBANK 18415 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1975 Gabaculine - - DRUGBANK DB02054 C7H7NO2 small molecule - 87980-11-8 DRUGBANK 2051 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens unknown target Inubushi T (2005) 16179747 172515 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2052 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens unknown target Kaneko S (2007) 17197567 172956 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2053 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens unknown target Levillain O (2005) 15616821 172955 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 19959 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 2703 Canaline - - DRUGBANK DB02821 C4H10N2O3 small molecule - 496-93-5 DRUGBANK 19960 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2703 Canaline - - DRUGBANK DB02821 C4H10N2O3 small molecule - 496-93-5 DRUGBANK 19961 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 2703 Canaline - - DRUGBANK DB02821 C4H10N2O3 small molecule - 496-93-5 DRUGBANK 1453 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1454 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1529 110996 4942 - OAT GACR|HOGA|OATASE|OKT 9606 Homo sapiens cofactor target Berman HM (2000) 10592235 172122 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2054 111000 4946 - OAZ1 AZI|OAZ 9606 Homo sapiens unknown target Lopez-Contreras AJ (2006) 16916800 119168 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2055 111000 4946 - OAZ1 AZI|OAZ 9606 Homo sapiens unknown target Yamaguchi Y (2006) 16354653 172958 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2056 111000 4946 - OAZ1 AZI|OAZ 9606 Homo sapiens unknown target Jaenne J (2004) 15009201 172957 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2059 111001 4947 - OAZ2 AZ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2060 111001 4947 - OAZ2 AZ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 22530 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22531 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 18727 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2122 Pyridoxine-5'-Phosphate - - DRUGBANK DB02209 C8H12NO6P small molecule - 447-05-2 DRUGBANK 18728 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2122 Pyridoxine-5'-Phosphate - - DRUGBANK DB02209 C8H12NO6P small molecule - 447-05-2 DRUGBANK 18729 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2122 Pyridoxine-5'-Phosphate - - DRUGBANK DB02209 C8H12NO6P small molecule - 447-05-2 DRUGBANK 18068 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 18069 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 18070 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 19967 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2706 N-Pyridoxyl-Glycine-5-Monophosphate - - DRUGBANK DB02824 C10H15N2O7P small molecule - - DRUGBANK 19968 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2706 N-Pyridoxyl-Glycine-5-Monophosphate - - DRUGBANK DB02824 C10H15N2O7P small molecule - - DRUGBANK 19969 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2706 N-Pyridoxyl-Glycine-5-Monophosphate - - DRUGBANK DB02824 C10H15N2O7P small molecule - - DRUGBANK 1958 111007 4953 - ODC1 ODC 9606 Homo sapiens product of target Korhonen VP (2001) 11160858 172890 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1954 111007 4953 - ODC1 ODC 9606 Homo sapiens product of target Roehn G (2001) 11408092 172889 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1955 111007 4953 - ODC1 ODC 9606 Homo sapiens product of target Ernestus RI (2001) 11413269 172893 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1956 111007 4953 - ODC1 ODC 9606 Homo sapiens product of target Nilsson J (2000) 10698696 172892 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1957 111007 4953 - ODC1 ODC 9606 Homo sapiens product of target Ray RM (2000) 10712236 172891 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 27763 111007 4953 - ODC1 ODC 9606 Homo sapiens product of target Lee NK (2011) 21413019 196005 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 22913 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4090 Geneticin - - DRUGBANK DB04263 C20H40N4O10 small molecule - 49863-47-0 DRUGBANK 22914 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4090 Geneticin - - DRUGBANK DB04263 C20H40N4O10 small molecule - 49863-47-0 DRUGBANK 22915 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4090 Geneticin - - DRUGBANK DB04263 C20H40N4O10 small molecule - 49863-47-0 DRUGBANK 1512 111007 4953 - ODC1 ODC 9606 Homo sapiens cofactor target Myers DP (2001) 11683631 172534 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1513 111007 4953 - ODC1 ODC 9606 Homo sapiens cofactor target Khomutov AR (2002) 12460114 172535 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1514 111007 4953 - ODC1 ODC 9606 Homo sapiens cofactor target Jackson LK (2004) 15476392 172536 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1515 111007 4953 - ODC1 ODC 9606 Homo sapiens cofactor target Jackson LK (2003) 12672797 172532 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1516 111007 4953 - ODC1 ODC 9606 Homo sapiens cofactor target Jackson LK (2003) 12627959 172533 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27379 111007 4953 - ODC1 ODC 9606 Homo sapiens antagonist target Poulin R (1992) 1730582 188517 7768 Eflornithine -difluoromethylornithine|DFMO|(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid vaniqa DRUGBANK DB06243 C6H12F2N2O2 small molecule P01CX03|D11AX16 70052-12-9 DRUGBANK 27380 111007 4953 - ODC1 ODC 9606 Homo sapiens blocker target Poulin R (1992) 1730582 188517 7768 Eflornithine -difluoromethylornithine|DFMO|(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid vaniqa DRUGBANK DB06243 C6H12F2N2O2 small molecule P01CX03|D11AX16 70052-12-9 DRUGBANK 22075 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3693 Alpha-Difluoromethylornithine - - DRUGBANK DB03856 C6H12F2N2O2 small molecule - - DRUGBANK 22076 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3693 Alpha-Difluoromethylornithine - - DRUGBANK DB03856 C6H12F2N2O2 small molecule - - DRUGBANK 22077 111007 4953 - ODC1 ODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3693 Alpha-Difluoromethylornithine - - DRUGBANK DB03856 C6H12F2N2O2 small molecule - - DRUGBANK 3074 111017 4967 - OGDH AKGDH|E1k|OGDC 9606 Homo sapiens unknown target Mailloux RJ (2007) 17668068 173665 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 5431 111017 4967 - OGDH AKGDH|E1k|OGDC 9606 Homo sapiens inhibitor target Johannessen CU (2003) 12847559 175116 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 14995 111030 4985 - OPRD1 OPRD 9606 Homo sapiens binder target Smith DJ (1980) 6246318 180696 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 14996 111030 4985 - OPRD1 OPRD 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 5491 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5492 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Loghin F (2002) 12067475 175164 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5493 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Ortiz MI (2005) 16386786 175162 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5494 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Karlsson JA (1990) 2156065 175163 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5495 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Mignat C (1995) 7885194 175160 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5496 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Advenier C (1993) 8119316 175161 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5542 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Onali P (2010) 19828880 175193 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24416 111030 4985 - OPRD1 OPRD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5527 Tapentadol CG-5503|BN-200|Nucynta|Tapentadol nucynta ir|nucynta extended-re DRUGBANK DB06204 C14H23NO small molecule N02AX06 175591-23-8 DRUGBANK 8609 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Wakabayashi H (1995) 8746803 177285 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8610 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Narita M (1994) 7705457 177284 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8611 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Commiskey S (2005) 15942128 177278 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8612 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Fan LW (2002) 12470863 177279 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8613 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Fan LW (2002) 12127012 177283 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8614 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8615 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Picker MJ (1996) 8968334 176556 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8616 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Walsh SL (2008) 17909753 177280 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 16924 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Webster JM (2003) 12909189 181503 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16925 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Jones AK (1999) 10413036 181502 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16926 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Cvejic S (1996) 20641600 181501 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16927 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Willoch F (1999) 10319982 181505 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16928 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Kampa M (2001) 11526449 181504 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16929 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Marie N (2003) 12672796 181462 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 11067 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11068 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Chen JC (1993) 8093631 178660 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11069 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target De Souza EB (1988) 2826773 178659 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 24539 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Beattie DT (2007) 17340127 181993 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24540 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Neary P (2005) 15882122 181890 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 9694 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Zhu J (1996) 8612823 177946 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9695 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Freye E (1992) 1330549 177947 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 5227 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5228 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Koch T (2006) 16539674 175025 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5229 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Dortch-Carnes J (2006) 16534251 175024 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5230 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Galeotti N (2006) 16650582 175023 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5231 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Kieffer BL (2002) 12015197 175022 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5232 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Yamada H (2006) 16530171 175021 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5233 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Asensio VJ (2006) 16678156 175020 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5591 111030 4985 - OPRD1 OPRD 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5592 111030 4985 - OPRD1 OPRD 9606 Homo sapiens partial agonist target Guay DR (2007) 17658959 175229 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5593 111030 4985 - OPRD1 OPRD 9606 Homo sapiens partial agonist target Hartvig P (1989) 2478994 175228 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5594 111030 4985 - OPRD1 OPRD 9606 Homo sapiens partial agonist target Fang X (1997) 9301669 175232 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5595 111030 4985 - OPRD1 OPRD 9606 Homo sapiens partial agonist target Jiang Q (1994) 7511163 175230 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5596 111030 4985 - OPRD1 OPRD 9606 Homo sapiens partial agonist target Hennies HH (1988) 2849950 175231 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 4106 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Wentland MP (2009) 19027293 174244 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 16845 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16846 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Li JG (2000) 10999950 181460 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16847 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Tao PL (1991) 1665782 181461 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16848 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Marie N (2003) 12672796 181462 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16849 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Li JG (2003) 12606694 181463 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16850 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Sumner BE (1992) 1316589 181464 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16851 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Niwa M (1995) 7739347 181453 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16726 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Klein G (2008) 18343363 181425 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16727 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16728 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Kieffer BL (2002) 12015197 175022 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 5635 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Gross ER (2009) 19843777 175294 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 7631 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Codd EE (1995) 7562497 176578 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 11938 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Lester PA (2006) 16443205 179108 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11939 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Induru RR (2009) 19666890 179109 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11940 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Megarbane B (2006) 16169027 179107 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11539 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Stucke AG (2008) 18815346 178949 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11540 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Poonawala T (2005) 15828941 178497 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11541 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Rodrigues AR (2005) 15665994 178502 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11542 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Darwish M (2006) 16861092 178501 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11543 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Sahin AS (2005) 15868528 178500 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11544 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Darwish M (2005) 16372825 178498 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 10971 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10972 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Giagnoni G (1983) 6319884 178618 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10973 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target di Bosco AM (2008) 18284554 178617 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 14531 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Helm S (2008) 18354714 177912 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14532 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Kakinohana M (2003) 12657847 180501 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14533 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Chudapongse N (2003) 14646257 180502 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14534 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Moncada A (2003) 12650833 180503 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14535 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Breljak D (2003) 12749773 180504 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14536 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Osman AM (2003) 14708857 180505 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14537 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target van Dorp E (2007) 17367258 180499 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 8979 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Neil A (1984) 6151117 177549 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 16993 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Crooks PA (2006) 16777416 181516 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16994 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Dietis N (2009) 19474215 176506 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16995 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Gilbert AK (2004) 15178355 181517 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 7516 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Ordonez Gallego A (2007) 17525040 176505 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 7517 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 13561 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Coupar IM (1995) 8583364 180030 1069 Diphenoxylate Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate diphenoxylate hcl and atropine DRUGBANK DB01081 C30H32N2O2 small molecule A07DA01 915-30-0 DRUGBANK 16719 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1392 Dimethylthiambutene Ohton|Dimethibutin - DRUGBANK DB01444 C14H17NS2 small molecule - 524-84-5 DRUGBANK 16720 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1392 Dimethylthiambutene Ohton|Dimethibutin - DRUGBANK DB01444 C14H17NS2 small molecule - 524-84-5 DRUGBANK 11190 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Prommer E (2007) 17039381 178702 844 Levorphanol Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum levorphanol tartrate DRUGBANK DB00854 C17H23NO small molecule - 77-07-6 DRUGBANK 9656 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Barrios de Tomasi E (2007) 17661275 177909 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9657 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Roy S (2005) 15788780 177917 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9658 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Herz A (1998) 9673788 177916 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9659 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Herz A (1997) 9040115 177911 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9660 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Weerts EM (2008) 17487229 177913 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9661 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 12271 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Peckham EM (2006) 16291875 179319 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12272 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12273 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Thompson CM (2004) 14600248 179320 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 14672 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Ananthan S (2004) 14998329 180542 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 14673 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Chamberlin KW (2007) 17595308 180543 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 24803 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Christensen CB (1993) 8153059 181693 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 27523 111030 4985 - OPRD1 OPRD 9606 Homo sapiens antagonist target Fujita W (2014) 25261794 188561 8016 Eluxadoline 5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid viberzi DRUGBANK DB09272 C32H35N5O5 small molecule - 864821-90-9 DRUGBANK 16876 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Mayberg HS (1991) 1656846 181480 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 16877 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Barry U (2005) 15853689 181479 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 10760 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Poonawala T (2005) 15828941 178497 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10761 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Rodrigues AR (2005) 15665994 178502 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10762 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Darwish M (2006) 16861092 178501 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10763 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Sahin AS (2005) 15868528 178500 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10764 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Hajiha M (2009) 19403616 178499 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10765 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Darwish M (2005) 16372825 178498 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 16682 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Poonawala T (2005) 15828941 178497 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16683 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Rodrigues AR (2005) 15665994 178502 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16684 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Darwish M (2006) 16861092 178501 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16685 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Sahin AS (2005) 15868528 178500 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16686 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Hajiha M (2009) 19403616 178499 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16687 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Darwish M (2005) 16372825 178498 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 17018 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Wang ZX (1993) 8030414 181521 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17019 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Jin WQ (1981) 6264594 181523 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17020 111030 4985 - OPRD1 OPRD 9606 Homo sapiens agonist target Zhu J (1996) 8576134 181522 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 14991 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Smith DJ (1980) 6246318 180696 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 14992 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 5487 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5488 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5489 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens partial agonist target Mignat C (1995) 7885194 175160 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5490 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens partial agonist target Takahama K (2007) 17620111 175159 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5551 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Onali P (2010) 19828880 175193 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24414 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5527 Tapentadol CG-5503|BN-200|Nucynta|Tapentadol nucynta ir|nucynta extended-re DRUGBANK DB06204 C14H23NO small molecule N02AX06 175591-23-8 DRUGBANK 8590 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Wakabayashi H (1995) 8746803 177285 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8591 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Narita M (1994) 7705457 177284 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8592 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Ohta S (1989) 2555580 177286 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8593 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Park Y (2000) 10779697 177281 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8594 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Fan LW (2002) 12470863 177279 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8595 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Fan LW (2002) 12127012 177283 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8596 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Vivian JA (1999) 10381785 177282 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8597 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Commiskey S (2005) 15942128 177278 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8598 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Picker MJ (1996) 8968334 176556 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8599 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Walsh SL (2008) 17909753 177280 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 16923 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Cvejic S (1996) 20641600 181501 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 9644 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9645 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Helm S (2008) 18354714 177912 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9646 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Herz A (1997) 9040115 177911 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9647 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Wee S (2009) 19484223 177910 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9648 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Barrios de Tomasi E (2007) 17661275 177909 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 24537 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Beattie DT (2007) 17340127 181993 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24538 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Neary P (2005) 15882122 181890 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 9692 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens unknown target Zhu J (1996) 8612823 177946 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9693 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens unknown target Chang HM (1989) 2467589 177945 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 14863 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14864 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14865 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14866 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Gharagozlou P (2006) 16433932 175227 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 5222 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5223 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Kozak CA (1994) 7959748 175017 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5224 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5225 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Teodorov E (2006) 16753266 175018 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5226 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Leventhal L (1998) 9808678 175019 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5588 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5589 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Gharagozlou P (2006) 16433932 175227 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5590 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 4101 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Sun HL (2003) 12570923 174240 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 16837 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Wannemacher KM (2007) 17720886 181454 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16838 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Gharagozlou P (2006) 16433932 175227 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16839 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Niwa M (1995) 7739347 181453 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16724 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Wee S (2010) 20352414 181424 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16725 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Klein G (2008) 18343363 181425 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16988 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Crooks PA (2006) 16777416 181516 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16989 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Dietis N (2009) 19474215 176506 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16990 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Gilbert AK (2004) 15178355 181517 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 7628 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Codd EE (1995) 7562497 176578 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 11936 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Boothby LA (2007) 17244875 179105 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11937 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Robinson SE (2006) 16953647 179106 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 10867 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Taniguchi Y (1994) 7851817 178573 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10868 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Galeotti N (2002) 11897159 178574 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10965 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target DeHaven-Hudkins DL (1999) 10087042 178611 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 14527 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Peng X (2007) 17305578 180498 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14528 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target van Dorp E (2007) 17367258 180499 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14529 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Helm S (2008) 18354714 177912 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 8977 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8978 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Neil A (1984) 6151117 177549 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 7034 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7035 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 11537 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Pascoe JE (2008) 18325678 178496 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11538 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Wong GT (2010) 19878098 178948 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 7513 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Ordonez Gallego A (2007) 17525040 176505 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 7514 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Nielsen CK (2007) 17467904 176504 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 7515 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Riley J (2008) 18039433 176503 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 6455 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens activator target Dawson-Basoa ME (1996) 8867260 175783 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 24383 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Olianas MC (2012) 22708686 182204 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 11189 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Prommer E (2007) 17039381 178702 844 Levorphanol Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum levorphanol tartrate DRUGBANK DB00854 C17H23NO small molecule - 77-07-6 DRUGBANK 24836 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens antagonist target Yuan CS (2007) 17504835 182010 5638 Methylnaltrexone MNTX relistor DRUGBANK DB06800 C21H26NO4 small molecule A06AH01 916055-93-1 DRUGBANK 11058 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11059 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11060 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Hoehe M (1993) 8388112 178657 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11061 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Mello NK (2005) 15602503 178656 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11062 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Gear RW (1999) 10534607 178655 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11063 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Peng X (2007) 17407276 178654 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11064 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Chen SL (2005) 15655510 178653 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11065 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Tao PL (2006) 16517095 178652 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11066 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Smith MA (2009) 19403853 178658 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 6112 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Schreiber S (2002) 12372565 175609 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 24795 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Christensen CB (1993) 8153059 181693 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 9022 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Chien CC (1995) 8788445 177572 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 16874 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Mayberg HS (1991) 1656846 181480 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 16875 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Barry U (2005) 15853689 181479 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 10759 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Pascoe JE (2008) 18325678 178496 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 16681 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Pascoe JE (2008) 18325678 178496 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 17015 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Wang ZX (1993) 8030414 181521 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17016 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Jin WQ (1981) 6264594 181523 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17017 111031 4986 - OPRK1 K-OR-1|KOR|KOR-1|OPRK 9606 Homo sapiens agonist target Zhu J (1996) 8576134 181522 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 16858 111032 4987 - OPRL1 KOR-3|NOCIR|OOR|ORL1 9606 Homo sapiens agonist target Hawkinson JE (2000) 10688973 181470 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 8600 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Wakabayashi H (1995) 8746803 177285 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8601 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Narita M (1994) 7705457 177284 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8602 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Picker MJ (1997) 9399970 177287 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8603 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Commiskey S (2005) 15942128 177278 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8604 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Fan LW (2002) 12470863 177279 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8605 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Fan LW (2002) 12127012 177283 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8606 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Vivian JA (1999) 10381785 177282 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8607 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Picker MJ (1996) 8968334 176556 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 8608 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial antagonist target Walsh SL (2008) 17909753 177280 601 Butorphanol (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol stadol ns - 10mg/ml aem-liq|pm DRUGBANK DB00611 C21H29NO2 small molecule N02AF01 42408-82-2 DRUGBANK 27468 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Leonard J (2015) 25471070 188542 7810 Naloxegol (5,6)-17-Allyl-6-[(20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy]-4,5-epoxymorphinan-3,14-diol movantik DRUGBANK DB09049 C34H53NO11 small molecule A06AH03 854601-70-0 DRUGBANK 5497 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5498 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Freissmuth M (1993) 8306082 175165 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5499 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Grond S (2004) 15509185 174252 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5500 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Takahama K (2007) 17620111 175159 311 Codeine Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether acetaminophen 500 mg with 15 m DRUGBANK DB00318 C18H21NO3 small molecule N02AA79|N02AA59|R05DA04 76-57-3 DRUGBANK 5556 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens binder target Hamon M (1987) 3037421 175197 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5557 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens binder target Wahlstroem A (1994) 7971731 175196 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24418 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 5527 Tapentadol CG-5503|BN-200|Nucynta|Tapentadol nucynta ir|nucynta extended-re DRUGBANK DB06204 C14H23NO small molecule N02AX06 175591-23-8 DRUGBANK 14998 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens binder target Smith DJ (1980) 6246318 180696 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 14999 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens binder target Hustveit O (1995) 8835358 180697 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 7576 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Emmerson PJ (1996) 8819494 176558 496 Levallorphan Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan - DRUGBANK DB00504 C19H25NO small molecule - 152-02-3 DRUGBANK 7575 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Traynor JR (1995) 7723747 176560 496 Levallorphan Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan - DRUGBANK DB00504 C19H25NO small molecule - 152-02-3 DRUGBANK 7578 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Picker MJ (1996) 8968334 176556 496 Levallorphan Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan - DRUGBANK DB00504 C19H25NO small molecule - 152-02-3 DRUGBANK 7577 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Selley DE (1997) 9016350 176559 496 Levallorphan Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan - DRUGBANK DB00504 C19H25NO small molecule - 152-02-3 DRUGBANK 7579 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Morgan D (1998) 9862398 176557 496 Levallorphan Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan - DRUGBANK DB00504 C19H25NO small molecule - 152-02-3 DRUGBANK 16930 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Cvejic S (1996) 20641600 181501 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 10672 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Oertel BG (2006) 16906017 178451 792 Alfentanil Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl alfenta inj 500mcg/ml|alfentan DRUGBANK DB00802 C21H32N6O3 small molecule N01AH02 71195-58-9 DRUGBANK 10673 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Leung A (2001) 11240090 178450 792 Alfentanil Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl alfenta inj 500mcg/ml|alfentan DRUGBANK DB00802 C21H32N6O3 small molecule N01AH02 71195-58-9 DRUGBANK 10674 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 792 Alfentanil Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl alfenta inj 500mcg/ml|alfentan DRUGBANK DB00802 C21H32N6O3 small molecule N01AH02 71195-58-9 DRUGBANK 10675 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Garrido M (2000) 10955836 178452 792 Alfentanil Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl alfenta inj 500mcg/ml|alfentan DRUGBANK DB00802 C21H32N6O3 small molecule N01AH02 71195-58-9 DRUGBANK 10676 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Loetsch J (2005) 15694871 178453 792 Alfentanil Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl alfenta inj 500mcg/ml|alfentan DRUGBANK DB00802 C21H32N6O3 small molecule N01AH02 71195-58-9 DRUGBANK 9649 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Barrios de Tomasi E (2007) 17661275 177909 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9650 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Kato H (2008) 19068776 177915 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9651 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Goodman AJ (2007) 17918759 177914 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9652 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9653 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Herz A (1998) 9673788 177916 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9654 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Weerts EM (2008) 17487229 177913 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9655 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Helm S (2008) 18354714 177912 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 27836 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Buechler MW (2008) 19086236 195986 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24541 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24542 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Saufl NM (2006) 16597533 181935 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24543 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Schmidt WK (2001) 11755894 181783 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24545 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Neary P (2005) 15882122 181890 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 24546 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Kraft MD (2007) 17909271 182053 5543 Alvimopan Anhydrous alvimopan|Alvimopan anhydrous entereg DRUGBANK DB06274 C25H32N2O4 small molecule A06AH02 156053-89-3 DRUGBANK 9696 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9697 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Ilien B (1988) 2847746 177951 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9698 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Leysen JE (1982) 6131653 177950 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9699 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Hurle MA (2001) 11299311 177952 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9700 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Levron JC (1991) 1688220 177948 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 9701 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Colpaert FC (1986) 3014923 177949 698 Sufentanil Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide sufentanil citrate injection u DRUGBANK DB00708 C22H30N2O2S small molecule N01AH03 56030-54-7 DRUGBANK 8980 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Picker MJ (1997) 9399970 177287 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8981 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8982 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Codd EE (1995) 7562497 176578 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8983 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Bannwarth B (2009) 19604717 177551 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8984 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Tyers MB (1980) 6249436 177550 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8985 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Ulens C (1999) 10690289 177553 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 8986 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Walker EA (1999) 10379623 177552 637 Dextropropoxyphene Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene 692 tab|642 tab|692 tablet|pro DRUGBANK DB00647 C22H29NO2 small molecule N02AC54|N02AC74|N02AC04 469-62-5 DRUGBANK 14867 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Picker MJ (1997) 9399970 177287 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14868 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Morgan D (1999) 9972766 180642 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14869 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Gharagozlou P (2003) 12513698 180641 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14870 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Jacobs AM (1992) 1361946 180640 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14871 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Barrett AC (2001) 11702089 180638 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 14872 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Cook CD (2000) 10958085 180639 1197 Dezocine Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol - DRUGBANK DB01209 C16H23NO small molecule N02AX03 53648-55-8 DRUGBANK 5234 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Castro RR (2006) 16580848 175027 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5235 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Choi HS (2006) 16580639 175026 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5236 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5237 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Yamada H (2006) 16530171 175021 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5238 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Johnson EA (2006) 16682505 175028 288 Morphine Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol ms contin srt 15mg|doloral 1|s DRUGBANK DB00295 C17H19NO3 small molecule N02AA01|A07DA52|N02AA51|N02AG01 57-27-2 DRUGBANK 5597 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Kumar P (2008) 18789923 175236 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5598 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Sarhill N (2001) 11305075 175234 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5599 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Quigley C (2002) 11869661 175235 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 5600 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Inturrisi CE (2002) 12479250 175233 320 Hydromorphone Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one hydromorphone hydrochloride su DRUGBANK DB00327 C17H19NO3 small molecule N02AA03|N02AG04 466-99-9 DRUGBANK 4111 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Potschka H (2000) 10991912 174253 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4112 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Grond S (2004) 15509185 174252 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4113 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Gillen C (2000) 10961373 174251 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4114 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Raffa RB (1992) 1309873 174250 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4115 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4116 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Minami K (2007) 17380034 174248 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4117 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Ide S (2006) 16793069 174249 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4118 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Frink MC (1996) 8955860 174243 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 16852 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16853 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Gomes BA (2002) 11900797 181468 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16854 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Melone M (2000) 11098106 181469 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16855 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Duttaroy A (2000) 10881033 181465 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16856 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Stafford K (2001) 11420091 181466 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16857 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Patel MB (2002) 12435815 181467 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16729 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Choi HS (2006) 16580639 175026 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16730 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Becker J (2004) 15013161 181426 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16731 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Greenwald MK (2003) 12902992 181427 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16732 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Yao L (2005) 15937104 181428 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 16733 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Antonilli L (2005) 15986196 181429 1399 Heroin (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|O,O'-diacetylmorphine|diamorphine|diacetylmorphine|Heroin|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|morphine diacetate|3,6-Diacetylmorphine - DRUGBANK DB01452 C21H23NO5 small molecule N07BC06 561-27-3 DRUGBANK 5636 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5637 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5638 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Kvam TM (2004) 14991152 175295 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5639 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Kakko J (2008) 17850768 175296 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5640 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Shi J (2002) 11933204 175297 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 7643 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Codd EE (1995) 7562497 176578 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 11941 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Ide S (2004) 15100703 179114 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11942 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Mizoguchi H (2002) 12435410 179113 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11943 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Kishioka S (2000) 10729371 179112 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11944 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Zubieta J (2000) 10942856 179111 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11945 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Sanchez-Blazquez P (2001) 11275413 179110 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11946 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens partial agonist target Chen X (2002) 11752352 171740 911 Buprenorphine 2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine act buprenorphine/naloxone|bup DRUGBANK DB00921 C29H41NO4 small molecule N07BC51|N02AE01|N07BC01 52485-79-7 DRUGBANK 11545 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11546 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Scott LJ (2005) 16332149 178507 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11547 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Scott LJ (2005) 16114980 178504 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11548 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Warner DS (1996) 8694317 178950 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11549 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Guy J (1997) 9066316 178951 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11550 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Patel SS (1996) 8875131 178952 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 11551 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Hoke JF (1997) 9103501 178953 889 Remifentanil REMIFENTANIL|Remifentanyl remifentanil hydrochloride for DRUGBANK DB00899 C20H28N2O5 small molecule N01AH06 132875-61-7 DRUGBANK 10974 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10975 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Tan-No K (2003) 14592702 178620 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10976 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Roge J (1993) 8488368 178619 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10977 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Giagnoni G (1983) 6319884 178618 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10978 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target DeHaven-Hudkins DL (1999) 10087042 178611 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10979 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target di Bosco AM (2008) 18284554 178617 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 11585 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens unknown target van Wijngaarden I (1990) 2164935 178972 894 Ondansetron Zofran odt riva-ondansetron|septa-ondanse DRUGBANK DB00904 C18H19N3O small molecule A04AA01 99614-02-5 DRUGBANK 14543 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target van Dorp E (2007) 17367258 180499 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14544 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Goodman AJ (2007) 17918759 177914 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14545 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14546 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Helm S (2008) 18354714 177912 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14547 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Spetea M (2003) 12887410 180515 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14548 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Neal CR (2003) 12842269 180514 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14549 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Freye E (1998) 12799988 180513 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14550 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Narita M (2003) 12566163 180512 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 14551 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Marek GJ (2003) 12909198 180511 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 15103 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 15104 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Skoulis NP (1989) 2471291 180727 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 15105 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Yu Y (1997) 9360954 180728 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 15106 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Xiao Y (2001) 11561100 180726 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 15107 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Kreek MJ (2000) 10911931 180729 1215 Levomethadyl Acetate Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol - DRUGBANK DB01227 C23H31NO2 small molecule N07BC03 1477-40-3 DRUGBANK 16996 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Crooks PA (2006) 16777416 181516 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16997 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dietis N (2009) 19474215 176506 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16998 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Gilbert AK (2004) 15178355 181517 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 7042 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Poulain R (2001) 11585443 176163 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7518 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Ordonez Gallego A (2007) 17525040 176505 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 7519 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dietis N (2009) 19474215 176506 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 7520 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Riley J (2008) 18039433 176503 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 13562 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Coupar IM (1995) 8583364 180030 1069 Diphenoxylate Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate diphenoxylate hcl and atropine DRUGBANK DB01081 C30H32N2O2 small molecule A07DA01 915-30-0 DRUGBANK 13563 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target De Luca A (1993) 8386327 180031 1069 Diphenoxylate Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate diphenoxylate hcl and atropine DRUGBANK DB01081 C30H32N2O2 small molecule A07DA01 915-30-0 DRUGBANK 13564 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Baker DE (2008) 18192961 178628 1069 Diphenoxylate Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate diphenoxylate hcl and atropine DRUGBANK DB01081 C30H32N2O2 small molecule A07DA01 915-30-0 DRUGBANK 13565 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1069 Diphenoxylate Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate diphenoxylate hcl and atropine DRUGBANK DB01081 C30H32N2O2 small molecule A07DA01 915-30-0 DRUGBANK 13566 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Corazziari E (1999) 10202212 180032 1069 Diphenoxylate Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate diphenoxylate hcl and atropine DRUGBANK DB01081 C30H32N2O2 small molecule A07DA01 915-30-0 DRUGBANK 11866 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 903 Anileridine N--(p-aminophenyl)ethylnormeperidine|1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester|ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate|N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine|N-beta-(P-Aminophenyl)ethylnormeperidine|Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate|Anileridina|Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate|Anileridinum leritine tablets 25mg|leritine DRUGBANK DB00913 C22H28N2O2 small molecule N01AH05 144-14-9 DRUGBANK 11867 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 903 Anileridine N--(p-aminophenyl)ethylnormeperidine|1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester|ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate|N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine|N-beta-(P-Aminophenyl)ethylnormeperidine|Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate|Anileridina|Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate|Anileridinum leritine tablets 25mg|leritine DRUGBANK DB00913 C22H28N2O2 small molecule N01AH05 144-14-9 DRUGBANK 11868 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 903 Anileridine N--(p-aminophenyl)ethylnormeperidine|1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester|ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate|N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine|N-beta-(P-Aminophenyl)ethylnormeperidine|Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate|Anileridina|Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate|Anileridinum leritine tablets 25mg|leritine DRUGBANK DB00913 C22H28N2O2 small molecule N01AH05 144-14-9 DRUGBANK 11191 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Allen RM (2003) 12975489 178703 844 Levorphanol Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum levorphanol tartrate DRUGBANK DB00854 C17H23NO small molecule - 77-07-6 DRUGBANK 11192 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Prommer E (2007) 17039381 178702 844 Levorphanol Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum levorphanol tartrate DRUGBANK DB00854 C17H23NO small molecule - 77-07-6 DRUGBANK 24837 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Yuan CS (2007) 17504835 182010 5638 Methylnaltrexone MNTX relistor DRUGBANK DB06800 C21H26NO4 small molecule A06AH01 916055-93-1 DRUGBANK 11070 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Picker MJ (1997) 9399970 177287 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11071 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Zernig G (1997) 9084061 178664 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11072 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Meerpohl JJ (2008) 18810678 178662 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11073 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target McNicol ED (2008) 18425947 178663 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11074 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Kishioka S (2000) 10844102 178661 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11075 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Hoehe M (1993) 8388112 178657 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11076 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Mello NK (2005) 15602503 178656 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11077 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Peng X (2007) 17407276 178654 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11078 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Tao PL (2006) 16517095 178652 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 11079 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Smith MA (2009) 19403853 178658 834 Nalbuphine Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina nubain injection 10mg/ml|nubai DRUGBANK DB00844 C21H27NO4 small molecule N02AF02 20594-83-6 DRUGBANK 12274 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Peckham EM (2006) 16291875 179319 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12275 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12276 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Thompson CM (2004) 14600248 179320 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12277 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Walsh SL (2008) 18606504 179321 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12278 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Kotzer CJ (2000) 10640321 179322 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12279 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Stoops WW (2010) 20665209 179323 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 12280 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Hennies HH (1988) 2849950 175231 946 Hydrocodone 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone vasofrinic dh|theracodophen-65 DRUGBANK DB00956 C18H21NO3 small molecule R05DA03 125-29-1 DRUGBANK 14674 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Gardell LR (2006) 16343768 180544 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 14675 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Lemberg KK (2006) 17006080 180545 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 14676 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Spetea M (1998) 9712193 180546 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 14677 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Halimi G (2000) 10854833 180547 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 14678 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chamberlin KW (2007) 17595308 180543 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 14679 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1180 Oxymorphone Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine opana|opana er|numorphan injec DRUGBANK DB01192 C17H19NO4 small molecule - 76-41-5 DRUGBANK 16721 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1392 Dimethylthiambutene Ohton|Dimethibutin - DRUGBANK DB01444 C14H17NS2 small molecule - 524-84-5 DRUGBANK 16722 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1392 Dimethylthiambutene Ohton|Dimethibutin - DRUGBANK DB01444 C14H17NS2 small molecule - 524-84-5 DRUGBANK 16723 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target GREEN AF (1959) 13651575 181423 1392 Dimethylthiambutene Ohton|Dimethibutin - DRUGBANK DB01444 C14H17NS2 small molecule - 524-84-5 DRUGBANK 9023 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Picker MJ (1996) 8968334 176556 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9024 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Saha N (1990) 2286420 177575 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9025 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Martin BR (1984) 6094791 177574 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9026 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Levine JD (1988) 3419842 177573 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9027 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens antagonist target Kamei J (1994) 8042002 177576 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 27524 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dove LS (2013) 23583433 188562 8016 Eluxadoline 5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid viberzi DRUGBANK DB09272 C32H35N5O5 small molecule - 864821-90-9 DRUGBANK 27525 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Fujita W (2014) 25261794 188561 8016 Eluxadoline 5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid viberzi DRUGBANK DB09272 C32H35N5O5 small molecule - 864821-90-9 DRUGBANK 16878 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Jewett DM (2004) 15028244 181482 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 16879 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Bencherif B (2004) 14744466 181483 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 16880 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Mayberg HS (1991) 1656846 181480 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 16881 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Bartenstein PA (1994) 7957034 181481 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 16882 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Bencherif B (2004) 15001679 181484 1475 Carfentanil Carfentanyl - DRUGBANK DB01535 C24H30N2O3 small molecule - 59708-52-0 DRUGBANK 10766 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10767 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Scott LJ (2005) 16332149 178507 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10768 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dardonville C (2006) 16797997 178506 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10769 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dosen-Micovic L (2006) 16376082 178505 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10770 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Scott LJ (2005) 16114980 178504 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10771 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target You HJ (2005) 15589524 178503 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 10772 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Hajiha M (2009) 19403616 178499 803 Fentanyl 1-Phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-Phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|1-Phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|N-Phenethyl-4-(N-propionylanilino)piperidine|Fentanylum|Fentanil|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo ran-fentanyl transdermal syste DRUGBANK DB00813 C22H28N2O small molecule N02AB03|N01AH01|N01AH51 437-38-7 DRUGBANK 24804 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Kristensen K (1996) 8878254 181711 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 24805 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Christensen CB (1993) 8153059 181693 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 16755 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Castro RR (2006) 16580848 175027 1412 Ethylmorphine Ethyl morphine|Ethylmorphine|Dionine - DRUGBANK DB01466 C19H23NO3 small molecule S01XA06|R05DA01 76-58-4 DRUGBANK 16756 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Choi HS (2006) 16580639 175026 1412 Ethylmorphine Ethyl morphine|Ethylmorphine|Dionine - DRUGBANK DB01466 C19H23NO3 small molecule S01XA06|R05DA01 76-58-4 DRUGBANK 16757 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1412 Ethylmorphine Ethyl morphine|Ethylmorphine|Dionine - DRUGBANK DB01466 C19H23NO3 small molecule S01XA06|R05DA01 76-58-4 DRUGBANK 16758 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Yamada H (2006) 16530171 175021 1412 Ethylmorphine Ethyl morphine|Ethylmorphine|Dionine - DRUGBANK DB01466 C19H23NO3 small molecule S01XA06|R05DA01 76-58-4 DRUGBANK 16759 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Johnson EA (2006) 16682505 175028 1412 Ethylmorphine Ethyl morphine|Ethylmorphine|Dionine - DRUGBANK DB01466 C19H23NO3 small molecule S01XA06|R05DA01 76-58-4 DRUGBANK 16688 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16689 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Scott LJ (2005) 16332149 178507 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16690 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dardonville C (2006) 16797997 178506 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16691 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Dosen-Micovic L (2006) 16376082 178505 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16692 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Scott LJ (2005) 16114980 178504 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16693 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target You HJ (2005) 15589524 178503 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 16694 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Hajiha M (2009) 19403616 178499 1387 3-Methylthiofentanyl 3-Methyl-thiofentanyl - DRUGBANK DB01439 C21H28N2OS small molecule - 86052-04-2 DRUGBANK 17021 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Wang ZX (1993) 8030414 181521 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17022 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Jin WQ (1981) 6264594 181523 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17023 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Zhu J (1996) 8576134 181522 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 17024 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Subramanian G (2000) 10669565 181524 1511 3-Methylfentanyl 3-MF|mefentanyl - DRUGBANK DB01571 C23H30N2O small molecule - 42045-86-3 DRUGBANK 16668 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Walczak SA (1981) 6268422 181413 1381 Methadyl Acetate Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol - DRUGBANK DB01433 C23H31NO2 small molecule - 509-74-0 DRUGBANK 16669 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Mancino MJ (2010) 20163389 181412 1381 Methadyl Acetate Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol - DRUGBANK DB01433 C23H31NO2 small molecule - 509-74-0 DRUGBANK 16670 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1381 Methadyl Acetate Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol - DRUGBANK DB01433 C23H31NO2 small molecule - 509-74-0 DRUGBANK 16671 111033 4988 - OPRM1 LMOR|M-OR-1|MOP|MOR|MOR1|OPRM 9606 Homo sapiens agonist target Wolstein J (2009) 19153939 181414 1381 Methadyl Acetate Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol - DRUGBANK DB01433 C23H31NO2 small molecule - 509-74-0 DRUGBANK 13088 111046 5004 RP11-82I1.3 ORM1 AGP-A|AGP1|HEL-S-153w|ORM 9606 Homo sapiens binder target Turk BE (1996) 8755512 179851 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 7356 111046 5004 RP11-82I1.3 ORM1 AGP-A|AGP1|HEL-S-153w|ORM 9606 Homo sapiens binder target Herve F (1996) 8946472 176353 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7511 111046 5004 RP11-82I1.3 ORM1 AGP-A|AGP1|HEL-S-153w|ORM 9606 Homo sapiens binder target Leow KP (1993) 8249052 176502 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 13089 111047 5005 RP11-82I1.2 ORM2 AGP-B|AGP-B|AGP2 9606 Homo sapiens binder target Turk BE (1996) 8755512 179851 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 7357 111047 5005 RP11-82I1.2 ORM2 AGP-B|AGP-B|AGP2 9606 Homo sapiens binder target Herve F (1996) 8946472 176353 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 7512 111047 5005 RP11-82I1.2 ORM2 AGP-B|AGP-B|AGP2 9606 Homo sapiens binder target Leow KP (1993) 8249052 176502 489 Oxycodone Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one sandoz oxycodone cr|oxy.ir|rox DRUGBANK DB00497 C18H21NO4 small molecule N02AA05|N02AA55 76-42-6 DRUGBANK 2966 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Morizono H (2006) 16585758 172976 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2967 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Quintero MJ (2000) 10648527 173607 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2084 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Templeton MD (2005) 15766270 172974 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2085 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target El Alami M (2003) 12679340 96036 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2086 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Morizono H (2006) 16585758 172976 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2087 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Barcelona-Andres B (2002) 12399499 172975 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 21434 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3374 2-Amino-Pentanoic Acid - - DRUGBANK DB03519 C5H11NO2 small molecule - - DRUGBANK 21435 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3374 2-Amino-Pentanoic Acid - - DRUGBANK DB03519 C5H11NO2 small molecule - - DRUGBANK 18344 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1935 N-(Phosphonoacetyl)-L-Ornithine - - DRUGBANK DB02011 C7H15N2O6P small molecule - 63446-55-9 DRUGBANK 18345 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1935 N-(Phosphonoacetyl)-L-Ornithine - - DRUGBANK DB02011 C7H15N2O6P small molecule - 63446-55-9 DRUGBANK 22778 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4014 Norvaline - - DRUGBANK DB04185 C5H11NO2 small molecule - - DRUGBANK 22779 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4014 Norvaline - - DRUGBANK DB04185 C5H11NO2 small molecule - - DRUGBANK 22780 111050 5009 - OTC OCTD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4014 Norvaline - - DRUGBANK DB04185 C5H11NO2 small molecule - - DRUGBANK 2249 111059 5019 - OXCT1 OXCT|SCOT 9606 Homo sapiens unknown target Coros AM (2004) 15388917 173150 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 19811 111059 5019 - OXCT1 OXCT|SCOT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2619 Ethylmercurithiosalicylic acid 2-(ethylmercuri-thio)-benzoic acid|2-(ethylmercuriothio)benzoic acid|[(o-carboxyphenyl)thio]ethylmercury - DRUGBANK DB02731 C9H10HgO2S small molecule - 148-61-8 DRUGBANK 1287 111060 5020 - OXT OT|OT-NPI|OXT-NPI 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1288 111060 5020 - OXT OT|OT-NPI|OXT-NPI 9606 Homo sapiens binder target Land H (1983) 6687626 172427 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1289 111060 5020 - OXT OT|OT-NPI|OXT-NPI 9606 Homo sapiens binder target Rao VV (1992) 1486803 172428 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1282 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Furman DJ (2011) 21208749 172426 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1283 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Gimpl G (2008) 18655883 172424 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1284 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Frantz MC (2010) 20104850 172425 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1285 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Spyranti Z (2010) 20108008 172422 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 1286 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Ahn TG (2005) 15646817 172423 102 Oxytocin Syntocinon|Pitocin oxytocin injection|oxytocin|pi DRUGBANK DB00107 C43H66N12O12S2 biologic H01BB02|G02AC01 50-56-6 DRUGBANK 15723 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Engstrom T (1998) 9760035 181029 1269 Carbetocin Carbetocino|Carbetocinum|Deamino-2-O-methyltyrosine-1-carbaoxytocin|1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin|1-Butyric acid-2-(3-(P-methoxyphenyl)-L-alanine)oxytocin duratocin injection DRUGBANK DB01282 C45H69N11O12S small molecule H01BB03 37025-55-1 DRUGBANK 15724 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1269 Carbetocin Carbetocino|Carbetocinum|Deamino-2-O-methyltyrosine-1-carbaoxytocin|1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin|1-Butyric acid-2-(3-(P-methoxyphenyl)-L-alanine)oxytocin duratocin injection DRUGBANK DB01282 C45H69N11O12S small molecule H01BB03 37025-55-1 DRUGBANK 15725 111061 5021 - OXTR OT-R 9606 Homo sapiens agonist target Gimpl G (2005) 15740719 181030 1269 Carbetocin Carbetocino|Carbetocinum|Deamino-2-O-methyltyrosine-1-carbaoxytocin|1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin|1-Butyric acid-2-(3-(P-methoxyphenyl)-L-alanine)oxytocin duratocin injection DRUGBANK DB01282 C45H69N11O12S small molecule H01BB03 37025-55-1 DRUGBANK 27912 111064 5025 - P2RX4 P2X4|P2X4R 9606 Homo sapiens antagonist target Tian M (2014) 24411477 196020 7864 Eslicarbazepine acetate (10S)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide|(10S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate|ESL|Stedesa aptiom DRUGBANK DB09119 C17H16N2O3 small molecule N03AF04 236395-14-5 DRUGBANK 24271 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Kellerman D (2002) 12458155 181808 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 24272 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Meyer CH (2002) 12407169 181806 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 24273 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Maminishkis A (2002) 12407168 181805 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 24274 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Brunschweiger A (2006) 16475938 181931 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 24275 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Nour M (2003) 14507899 181834 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 24276 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Deterding RR (2007) 17446337 182003 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 24277 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens unknown target Deterding R (2005) 15704203 181883 4775 Denufosol - - DRUGBANK DB04983 C18H27N5O21P4 small molecule - 211448-85-0 DRUGBANK 23889 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens antagonist target Homma R (2000) 11132624 181767 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 23890 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens antagonist target Trujillo CA (2006) 16388598 181924 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 23891 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens antagonist target Bogdanov YD (1998) 9647463 181729 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 23892 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens antagonist target Churchill GC (1997) 9112981 181716 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 23893 111068 5029 RP11-800A3.4 P2RY2 HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R 9606 Homo sapiens antagonist target Charlton SJ (1996) 8762097 181707 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 1952 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1953 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2298 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2299 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3801 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3802 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 15649 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens inhibitor target Chen KH (1977) 856725 180993 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15650 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens inhibitor target Murad S (1985) 2994564 180992 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15651 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15652 111072 5033 RP11-344N10.1 P4HA1 P4HA 9606 Homo sapiens inhibitor target Knowles HJ (2004) 15192023 180994 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 21600 111073 5034 - P4HB DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PHDB|PO4DB|PO4HB|PROHB 9606 Homo sapiens unknown target Horibe T (2001) 11741285 181782 3463 Ribostamycin Xylostasin|Vistamycin|RIO|Xylostacin|5-Amino-2-Aminomethyl-6-[4,6-Diamino-2-(3,4-Dihydroxy-5-Hydroxymethyl-Tetrahydro-Furan-2-Yloxy)-3-Hydroxy-Cyclohexyloxy]-Tetrahydro-Pyran-3,4-Diol|Ribastamin - DRUGBANK DB03615 C17H34N4O10 small molecule J01GB10 25546-65-0 DRUGBANK 21576 111082 5045 - FURIN FUR|PACE|PCSK3|SPC1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3448 Decanoic Acid Capric acid - DRUGBANK DB03600 C10H20O2 small molecule - 334-48-5 DRUGBANK 24213 111082 5045 - FURIN FUR|PACE|PCSK3|SPC1 9606 Homo sapiens unknown target Burghardt I (2007) 17234158 181983 4745 Pirfenidone - esbriet DRUGBANK DB04951 C12H11NO small molecule L04AX05 53179-13-8 DRUGBANK 19153 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2308 12-Bromododecanoic Acid - - DRUGBANK DB02405 C12H23BrO2 small molecule - 73367-80-3 DRUGBANK 21953 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21954 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21955 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 22513 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22514 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22515 111084 5047 RP11-98L5.3 PAEP GD|GdA|GdF|GdS|PAEG|PEP|PP14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 25840 111087 5050 - PAFAH1B3 PAFAHG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6619 (1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE - - DRUGBANK DB07821 C7H17O2P small molecule - - DRUGBANK 21691 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3519 Beta(2-Thienyl)Alanine - - DRUGBANK DB03673 C7H9NO2S small molecule - - DRUGBANK 21692 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3519 Beta(2-Thienyl)Alanine - - DRUGBANK DB03673 C7H9NO2S small molecule - - DRUGBANK 9200 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens antagonist target Erlandsen H (1998) 9843368 177678 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 19466 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2459 Quinonoid 7,8-Tetrahydrobiopterin - - DRUGBANK DB02562 C9H13N5O3 small molecule - 79647-29-3 DRUGBANK 19467 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2459 Quinonoid 7,8-Tetrahydrobiopterin - - DRUGBANK DB02562 C9H13N5O3 small molecule - 79647-29-3 DRUGBANK 19718 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 19719 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2581 (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin - - DRUGBANK DB02692 C9H15N5O3 small molecule - - DRUGBANK 1765 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Pueschel SM (1988) 2975336 172732 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1766 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Thorolfsson M (2002) 12056888 172733 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1767 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Nagasaki Y (1999) 10203136 172730 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1768 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Fusetti F (1998) 9642259 12571 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1769 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Stokka AJ (2003) 12379147 172731 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 5941 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens cofactor target Fitzpatrick PF (2000) 10872454 175478 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5942 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens cofactor target Werner ER (2000) 10839989 175479 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5943 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens cofactor target Zekanowski C (1998) 10089284 175481 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5944 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens cofactor target Jennings IG (2001) 11163771 175482 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5945 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens cofactor target Ayling JE (2000) 10924272 175480 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 23374 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4235 Norleucine - - DRUGBANK DB04419 C6H13NO2 small molecule - - DRUGBANK 23375 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4235 Norleucine - - DRUGBANK DB04419 C6H13NO2 small molecule - - DRUGBANK 24492 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Martinez A (1991) 1646718 175579 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24493 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Molinoff PB (1974) 4156788 175578 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 24494 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Martinez A (1990) 2226440 175580 5538 Droxidopa L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS northera DRUGBANK DB06262 C9H11NO5 small molecule C01CA27 23651-95-8 DRUGBANK 23333 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23334 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 6073 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Martinez A (1991) 1646718 175579 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6074 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Molinoff PB (1974) 4156788 175578 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6075 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6076 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 6077 111090 5053 - PAH PH|PKU|PKU1 9606 Homo sapiens inhibitor target Martinez A (1990) 2226440 175580 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 132 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Gerstein ES (2003) 12785198 171800 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 133 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Hellgren M (2003) 12709915 171797 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 134 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Chang H (2003) 12745435 171796 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 135 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Gamberi G (2003) 12579271 171799 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 136 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Shetty S (2003) 12642587 171798 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 186 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 672 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Cerchiara E (2007) 17566522 172067 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 673 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Dhainaut JF (2003) 14515185 172070 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 674 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Carr ME (2001) 11259926 172068 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 675 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Idell S (2002) 12004248 172069 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 376 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Lindberg P (2001) 11163592 171900 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 377 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Hattori M (2001) 14564902 171899 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 378 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 4137 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens antagonist target Kruszynska YT (2000) 10871202 174275 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4138 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens antagonist target Nordt TK (2000) 10770198 174277 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4139 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens antagonist target Kato K (2000) 10831180 174276 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4140 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens antagonist target Gottschling-Zeller H (2000) 10768100 174279 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4141 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens antagonist target Sobel BE (1999) 10418858 174278 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 345 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 112 111091 5054 - SERPINE1 PAI|PAI-1|PAI1|PLANH1 9606 Homo sapiens unknown target Hilleman DE (2007) 17963464 171789 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 148 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Wygrecka M (2004) 15351849 171809 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 149 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Grebenchtchikov N (2005) 15944795 171808 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 150 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Swartz JM (2004) 15277569 171810 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 151 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Iglesias D (2005) 15640330 171811 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 152 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Fernandez-Soria V (2006) 16327990 171812 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 388 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Verkleij-Hagoort AC (2007) 17141398 171904 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 389 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Bremer HA (1994) 7958159 171905 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 390 111092 5055 - SERPINB2 HsT1201|PAI|PAI-2|PAI2|PLANH2 9606 Homo sapiens unknown target Stump DC (1986) 3091604 171906 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 1930 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Floryszak-Wieczorek J (2006) 16773376 172880 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1931 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Crespo A (2006) 17002377 172881 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1932 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Romero I (2007) 17570561 172882 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 19520 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2492 N-Alpha-Acetyl-3,5-Diiodotyrosylglycine - - DRUGBANK DB02598 C13H14I2N2O5 small molecule - - DRUGBANK 19521 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2492 N-Alpha-Acetyl-3,5-Diiodotyrosylglycine - - DRUGBANK DB02598 C13H14I2N2O5 small molecule - - DRUGBANK 19522 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2492 N-Alpha-Acetyl-3,5-Diiodotyrosylglycine - - DRUGBANK DB02598 C13H14I2N2O5 small molecule - - DRUGBANK 22719 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3980 Threonine Derivative - - DRUGBANK DB04150 C15H18I2N2O6 small molecule - - DRUGBANK 22720 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3980 Threonine Derivative - - DRUGBANK DB04150 C15H18I2N2O6 small molecule - - DRUGBANK 22721 111101 5066 - PAM PAL|PHM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3980 Threonine Derivative - - DRUGBANK DB04150 C15H18I2N2O6 small molecule - - DRUGBANK 1737 111124 5091 - PC PCB 9606 Homo sapiens unknown target Ikeda K (2007) 16765071 172708 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1738 111124 5091 - PC PCB 9606 Homo sapiens unknown target Liu L (2007) 17008113 172707 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1739 111124 5091 - PC PCB 9606 Homo sapiens unknown target Jitrapakdee S (2006) 16505973 172706 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1740 111124 5091 - PC PCB 9606 Homo sapiens unknown target Simpson NE (2006) 16575559 172705 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1741 111124 5091 - PC PCB 9606 Homo sapiens unknown target Jensen MV (2006) 16740637 172704 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1805 111124 5091 - PC PCB 9606 Homo sapiens unknown target Ferreira G (2007) 17297119 172754 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1806 111124 5091 - PC PCB 9606 Homo sapiens unknown target Liu L (2007) 17008113 172707 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1807 111124 5091 - PC PCB 9606 Homo sapiens unknown target Jitrapakdee S (2007) 17478118 72451 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1808 111124 5091 - PC PCB 9606 Homo sapiens unknown target Jitrapakdee S (2007) 17659996 73562 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1809 111124 5091 - PC PCB 9606 Homo sapiens unknown target Ozimek PZ (2007) 17316367 72375 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 25520 111124 5091 - PC PCB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6308 5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL - - DRUGBANK DB07497 C10H16N2O2S small molecule - - DRUGBANK 23338 111125 5092 - PCBD1 DCOH|PCBD|PCD|PHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23339 111125 5092 - PCBD1 DCOH|PCBD|PCD|PHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23340 111125 5092 - PCBD1 DCOH|PCBD|PCD|PHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 1789 111128 5095 RP11-151A6.1 PCCA - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1790 111128 5095 RP11-151A6.1 PCCA - 9606 Homo sapiens unknown target Vlasova TI (2005) 15623830 172746 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1791 111128 5095 RP11-151A6.1 PCCA - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1792 111128 5095 RP11-151A6.1 PCCA - 9606 Homo sapiens unknown target Clavero S (2002) 12385775 172744 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1793 111128 5095 RP11-151A6.1 PCCA - 9606 Homo sapiens unknown target Cherbonnel-Lasserre CL (1997) 9311592 172745 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1800 111129 5096 - PCCB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1804 111129 5096 - PCCB - 9606 Homo sapiens unknown target Vlasova TI (2005) 15623830 172746 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1802 111129 5096 - PCCB - 9606 Homo sapiens unknown target Cherbonnel-Lasserre CL (1997) 9311592 172745 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1801 111129 5096 - PCCB - 9606 Homo sapiens unknown target Ishii M (2004) 14997352 172753 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1803 111129 5096 - PCCB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 3509 111129 5096 - PCCB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 3510 111129 5096 - PCCB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 3511 111129 5096 - PCCB - 9606 Homo sapiens unknown target Kim SN (2002) 12409268 173870 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 703 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Kobayashi H (1998) 9620917 172093 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 704 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Hayashi T (1993) 8391599 172092 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 705 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Shen L (1999) 10456457 172091 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 706 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target He X (1995) 7769227 172090 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 707 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Berg DT (2003) 12671072 172089 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 169 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Odet F (2004) 14645112 171828 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 170 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Uhrin P (2007) 17434507 171827 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 171 111135 5104 - SERPINA5 PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI 9606 Homo sapiens unknown target Espana F (2007) 17253188 171826 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 18317 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1932 1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine - - DRUGBANK DB02008 C25H26FN5O3 small molecule - - DRUGBANK 18318 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1932 1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine - - DRUGBANK DB02008 C25H26FN5O3 small molecule - - DRUGBANK 18319 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1932 1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine - - DRUGBANK DB02008 C25H26FN5O3 small molecule - - DRUGBANK 21803 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3568 Phosphomethylphosphonic Acid-Guanylate Ester - - DRUGBANK DB03725 C11H18N5O13P3 small molecule - - DRUGBANK 21804 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3568 Phosphomethylphosphonic Acid-Guanylate Ester - - DRUGBANK DB03725 C11H18N5O13P3 small molecule - - DRUGBANK 17861 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 17862 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 20871 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3133 1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine - - DRUGBANK DB03267 C21H25N5O3 small molecule - - DRUGBANK 20872 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3133 1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine - - DRUGBANK DB03267 C21H25N5O3 small molecule - - DRUGBANK 20873 111136 5105 - PCK1 PEPCK-C|PEPCK1|PEPCKC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3133 1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine - - DRUGBANK DB03267 C21H25N5O3 small molecule - - DRUGBANK 17718 111141 5110 - PCMT1 PIMT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17719 111141 5110 - PCMT1 PIMT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17720 111141 5110 - PCMT1 PIMT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 348 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 349 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 816 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 817 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Zhu X (2002) 12136131 172169 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 818 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 819 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Kuwahata M (2007) 17097861 172170 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 820 111151 5122 - PCSK1 BMIQ12|NEC1|PC1|PC3|SPC3 9606 Homo sapiens unknown target Marriott D (1992) 1435788 23625 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 350 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 351 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 821 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 822 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 823 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Utsunomiya N (1998) 9662053 172171 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 824 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Ohagi S (1996) 8666140 172172 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 825 111153 5126 - PCSK2 NEC 2|NEC-2|NEC2|PC2|SPC2 9606 Homo sapiens unknown target Zertal-Zidani S (2007) 17221210 172173 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 25782 111154 5127 - CDK16 PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6567 (2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME} - - DRUGBANK DB07766 C20H19N3O4 small molecule - - DRUGBANK 1838 111157 5130 - PCYT1A CCTA|CT|CTA|CTPCT|PCYT1|SMDCRD 9606 Homo sapiens product of target Enaw JO (2006) 17184542 172776 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1839 111157 5130 - PCYT1A CCTA|CT|CTA|CTPCT|PCYT1|SMDCRD 9606 Homo sapiens product of target Li L (2007) 17218027 172777 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 27456 111160 5133 - PDCD1 CD279|PD-1|PD1|SLEB2|hPD-1|hPD-l|hSLE1 9606 Homo sapiens antibody target Taneja SS (2012) 23289116 188533 7798 Nivolumab - opdivo DRUGBANK DB09035 C6362H9862N1712O1995S42 biologic L01XC17 946414-94-4 DRUGBANK 27459 111160 5133 - PDCD1 CD279|PD-1|PD1|SLEB2|hPD-1|hPD-l|hSLE1 9606 Homo sapiens antagonist target McDermott J (2015) 25685857 188535 7800 Pembrolizumab - keytruda DRUGBANK DB09037 C6504H10004N1716O2036S46 biologic L01XC18 1374853-91-4 DRUGBANK 27460 111160 5133 - PDCD1 CD279|PD-1|PD1|SLEB2|hPD-1|hPD-l|hSLE1 9606 Homo sapiens antibody target McDermott J (2015) 25685857 188535 7800 Pembrolizumab - keytruda DRUGBANK DB09037 C6504H10004N1716O2036S46 biologic L01XC18 1374853-91-4 DRUGBANK 8717 111162 5136 - PDE1A CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A 9606 Homo sapiens inhibitor target Sharma RK (1997) 9231746 177388 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 4209 111162 5136 - PDE1A CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4210 111162 5136 - PDE1A CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 15341 111162 5136 - PDE1A CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A 9606 Homo sapiens inhibitor target Lamers JM (1985) 2933041 179746 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 12888 111162 5136 - PDE1A CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A 9606 Homo sapiens inhibitor target Sharma RK (1997) 9231746 177388 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12889 111162 5136 - PDE1A CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A 9606 Homo sapiens inhibitor target Lamers JM (1985) 2933041 179746 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 4203 111163 5137 - PDE1C Hcam3|cam-PDE 1C|hCam-3 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4204 111163 5137 - PDE1C Hcam3|cam-PDE 1C|hCam-3 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4223 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4224 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 18928 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 18929 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 18930 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 25983 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 26839 111164 5138 - PDE2A CGS-PDE|PDE2A1|PED2A4|cGSPDE 9606 Homo sapiens inhibitor target Rundfeldt C (2010) 20967473 182172 7582 Tofisopam Tofizopam|Emandaxin - DRUGBANK DB08811 C22H26N2O4 small molecule N05BA23 22345-47-7 DRUGBANK 14390 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Hong KW (2006) 16472148 180434 1154 Cilostazol Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole cilostazol|pletal DRUGBANK DB01166 C20H27N5O2 small molecule B01AC23 73963-72-1 DRUGBANK 14391 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Schroer K (2002) 12180353 180435 1154 Cilostazol Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole cilostazol|pletal DRUGBANK DB01166 C20H27N5O2 small molecule B01AC23 73963-72-1 DRUGBANK 14392 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1154 Cilostazol Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole cilostazol|pletal DRUGBANK DB01166 C20H27N5O2 small molecule B01AC23 73963-72-1 DRUGBANK 14393 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Mokry J (2008) 19218671 180432 1154 Cilostazol Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole cilostazol|pletal DRUGBANK DB01166 C20H27N5O2 small molecule B01AC23 73963-72-1 DRUGBANK 14394 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Parkkonen J (2008) 18282775 180433 1154 Cilostazol Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole cilostazol|pletal DRUGBANK DB01166 C20H27N5O2 small molecule B01AC23 73963-72-1 DRUGBANK 15025 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Hirota K (2002) 11939921 180710 1211 Aminophylline Somophyllin|Theophylline ethylenediamine|Aminophyllin aminophylline tab 100mg|aminop DRUGBANK DB01223 C16H24N10O4 small molecule R03DA55|R03DB05|R03DA05 317-34-0 DRUGBANK 15026 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1211 Aminophylline Somophyllin|Theophylline ethylenediamine|Aminophyllin aminophylline tab 100mg|aminop DRUGBANK DB01223 C16H24N10O4 small molecule R03DA55|R03DB05|R03DA05 317-34-0 DRUGBANK 24069 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Sandroni C (2006) 16987374 181968 4680 Enoximone Perfan - DRUGBANK DB04880 C12H12N2O2S small molecule C01CE03 77671-31-9 DRUGBANK 24070 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Boldt J (2007) 17714066 182040 4680 Enoximone Perfan - DRUGBANK DB04880 C12H12N2O2S small molecule C01CE03 77671-31-9 DRUGBANK 15804 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Rickards KJ (2003) 12887610 174829 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15805 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Kajikawa S (2006) 16651698 174832 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15806 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Wu BN (2004) 15237094 174831 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 4225 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4226 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 26838 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Rundfeldt C (2010) 20967473 182172 7582 Tofisopam Tofizopam|Emandaxin - DRUGBANK DB08811 C22H26N2O4 small molecule N05BA23 22345-47-7 DRUGBANK 5049 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Rickards KJ (2003) 12887610 174829 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5050 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Kajikawa S (2006) 16651698 174832 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5051 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Wu BN (2004) 15237094 174831 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 16639 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Kobayashi T (2002) 12076859 181396 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16640 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Kucuk C (2009) 18468627 181397 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16641 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16642 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Ko Y (2009) 19901885 181398 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 4579 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 228 Milrinone 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone milrinone lactate|milrinone la DRUGBANK DB00235 C12H9N3O small molecule C01CE02 78415-72-2 DRUGBANK 4580 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Zhang W (2002) 12181427 174565 228 Milrinone 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone milrinone lactate|milrinone la DRUGBANK DB00235 C12H9N3O small molecule C01CE02 78415-72-2 DRUGBANK 4581 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Kuethe A (2000) 10859452 174564 228 Milrinone 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone milrinone lactate|milrinone la DRUGBANK DB00235 C12H9N3O small molecule C01CE02 78415-72-2 DRUGBANK 4582 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Shakur Y (2002) 12652111 174566 228 Milrinone 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone milrinone lactate|milrinone la DRUGBANK DB00235 C12H9N3O small molecule C01CE02 78415-72-2 DRUGBANK 4583 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Cone J (1999) 10511123 174563 228 Milrinone 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone milrinone lactate|milrinone la DRUGBANK DB00235 C12H9N3O small molecule C01CE02 78415-72-2 DRUGBANK 4584 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Lefievre L (2002) 12135876 1411 228 Milrinone 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone milrinone lactate|milrinone la DRUGBANK DB00235 C12H9N3O small molecule C01CE02 78415-72-2 DRUGBANK 24319 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Yamazaki T (2011) 21036126 182173 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 4906 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 254 Anagrelide Anagrelida|Anagrelidum pms-anagrelide|dom-anagrelide| DRUGBANK DB00261 C10H7Cl2N3O small molecule L01XX35 68475-42-3 DRUGBANK 4907 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 254 Anagrelide Anagrelida|Anagrelidum pms-anagrelide|dom-anagrelide| DRUGBANK DB00261 C10H7Cl2N3O small molecule L01XX35 68475-42-3 DRUGBANK 4908 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 254 Anagrelide Anagrelida|Anagrelidum pms-anagrelide|dom-anagrelide| DRUGBANK DB00261 C10H7Cl2N3O small molecule L01XX35 68475-42-3 DRUGBANK 4909 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Venuti MC (1988) 2846839 174727 254 Anagrelide Anagrelida|Anagrelidum pms-anagrelide|dom-anagrelide| DRUGBANK DB00261 C10H7Cl2N3O small molecule L01XX35 68475-42-3 DRUGBANK 11947 111165 5139 - PDE3A CGI-PDE|CGI-PDE A|CGI-PDE-A 9606 Homo sapiens inhibitor target Szilagyi S (2005) 16116344 179116 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 18201 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1894 Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide - - DRUGBANK DB01970 C17H35NO7 small molecule - - DRUGBANK 18202 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1894 Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide - - DRUGBANK DB01970 C17H35NO7 small molecule - - DRUGBANK 4227 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4228 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 25979 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 17476 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1577 (5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One - - DRUGBANK DB01640 C24H24IN3O2 small molecule - - DRUGBANK 17477 111166 5140 - PDE3B HcGIP1|cGIPDE1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1577 (5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One - - DRUGBANK DB01640 C24H24IN3O2 small molecule - - DRUGBANK 10709 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 15799 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Wang K (2002) 12421478 174828 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15800 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Rickards KJ (2003) 12887610 174829 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15801 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Haider S (2003) 12547256 174825 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15802 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Usta C (2004) 15253881 174826 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 15803 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Lee JM (2004) 15351234 174827 1283 Oxtriphylline Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate apo oxtriphylline tab 100mg|no DRUGBANK DB01303 C12H21N5O3 small molecule R03DA02|R03DB02 4499-40-5 DRUGBANK 26336 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7086 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid - - DRUGBANK DB08299 C21H13N3O4 small molecule - - DRUGBANK 13634 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inducer target Schermuly RT (2003) 12952271 180070 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13635 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inducer target Wilkens H (2001) 11551870 180069 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13636 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inducer target Ghofrani HA (2002) 12441759 180068 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13637 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inducer target Grant PG (1988) 2461561 180067 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 24813 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Romics I (2003) 12823389 181822 5626 Drotaverine Drotaverin|Drotin - DRUGBANK DB06751 C24H31NO4 small molecule A03AD02 14009-24-6 DRUGBANK 24814 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Pareek A (2010) 20554370 182157 5626 Drotaverine Drotaverin|Drotin - DRUGBANK DB06751 C24H31NO4 small molecule A03AD02 14009-24-6 DRUGBANK 24815 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Muravyov AV (2007) 17502703 182009 5626 Drotaverine Drotaverin|Drotin - DRUGBANK DB06751 C24H31NO4 small molecule A03AD02 14009-24-6 DRUGBANK 27815 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens antagonist target Baeumer W (2007) 17352685 195977 8064 Apremilast Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast otezla DRUGBANK DB05676 C22H24N2O7S small molecule L04AA32 608141-41-9 DRUGBANK 27816 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens antagonist target Abdulrahim H (2015) 25864487 196025 8064 Apremilast Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast otezla DRUGBANK DB05676 C22H24N2O7S small molecule L04AA32 608141-41-9 DRUGBANK 17510 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Barone FC (2007) 17726343 181617 1592 Roflumilast ROF|Daliresp|Roflumilastum daxas|daliresp DRUGBANK DB01656 C17H14Cl2F2N2O3 small molecule R03DX07 162401-32-3 DRUGBANK 17793 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens unknown target Beeh KM (2005) 15765929 181625 1722 Piclamilast RP 73-401 - DRUGBANK DB01791 C18H18Cl2N2O3 small molecule - 144035-83-6 DRUGBANK 26836 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Rundfeldt C (2010) 20967473 182172 7582 Tofisopam Tofizopam|Emandaxin - DRUGBANK DB08811 C22H26N2O4 small molecule N05BA23 22345-47-7 DRUGBANK 12419 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 9007 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9008 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9009 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9010 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Hariton C (1994) 7925603 177565 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9011 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Iancu L (1979) 225216 177566 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 10847 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10848 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Ukena D (1985) 3002801 178561 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10849 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Dar MS (1990) 2262902 178560 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10850 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Dulloo AG (1991) 1885257 178563 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10851 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Featherstone RL (2004) 17670210 178562 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10852 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Berg G (1987) 3446047 178564 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 5042 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Wang K (2002) 12421478 174828 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5043 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Rickards KJ (2003) 12887610 174829 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5044 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Haider S (2003) 12547256 174825 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5045 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Usta C (2004) 15253881 174826 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 5046 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Lee JM (2004) 15351234 174827 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 4235 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4236 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 24313 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Yamazaki T (2011) 21036126 182173 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 24314 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 24315 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Yagi K (2010) 20124930 182144 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 11924 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11925 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens inhibitor target Castillo JG (1990) 1702263 179104 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 24865 111167 5141 - PDE4A DPDE2|PDE4|PDE46 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5663 (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one - - DRUGBANK DB06842 C15H22N2O3 small molecule - - DRUGBANK 4188 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4189 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4190 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Daly JW (2007) 17514358 174335 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4239 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4240 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 5033 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Lipworth BJ (2005) 15639300 174818 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 23632 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23633 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 18153 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1878 Rolipram 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram - DRUGBANK DB01954 C16H21NO3 small molecule - 61413-54-5 DRUGBANK 18154 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1878 Rolipram 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram - DRUGBANK DB01954 C16H21NO3 small molecule - 61413-54-5 DRUGBANK 18155 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1878 Rolipram 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram - DRUGBANK DB01954 C16H21NO3 small molecule - 61413-54-5 DRUGBANK 10706 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 10707 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 24935 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5728 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide - - DRUGBANK DB06909 C21H25N5O2 small molecule - - DRUGBANK 21027 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3212 8-Bromo-Adenosine-5'-Monophosphate - - DRUGBANK DB03349 C10H13BrN5O7P small molecule - - DRUGBANK 21028 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3212 8-Bromo-Adenosine-5'-Monophosphate - - DRUGBANK DB03349 C10H13BrN5O7P small molecule - - DRUGBANK 13626 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inducer target Schermuly RT (2003) 12952271 180070 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13627 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inducer target Wilkens H (2001) 11551870 180069 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13628 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inducer target Ghofrani HA (2002) 12441759 180068 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13629 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inducer target Grant PG (1988) 2461561 180067 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 24317 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 17499 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1584 (R)-Mesopram - - DRUGBANK DB01647 C14H19NO4 small molecule - - DRUGBANK 17500 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1584 (R)-Mesopram - - DRUGBANK DB01647 C14H19NO4 small molecule - - DRUGBANK 17501 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1584 (R)-Mesopram - - DRUGBANK DB01647 C14H19NO4 small molecule - - DRUGBANK 16637 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16638 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 22716 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 3979 (R)-Rolipram R-rolipram|(-)-rolipram|(R)-(-)-rolipram - DRUGBANK DB04149 C16H21NO3 small molecule - 85416-75-7 DRUGBANK 22717 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3979 (R)-Rolipram R-rolipram|(-)-rolipram|(R)-(-)-rolipram - DRUGBANK DB04149 C16H21NO3 small molecule - 85416-75-7 DRUGBANK 22718 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 3979 (R)-Rolipram R-rolipram|(-)-rolipram|(R)-(-)-rolipram - DRUGBANK DB04149 C16H21NO3 small molecule - 85416-75-7 DRUGBANK 10842 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 10843 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 814 Enprofylline 3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum - DRUGBANK DB00824 C8H10N4O2 small molecule - 41078-02-8 DRUGBANK 11920 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11921 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Castillo JG (1990) 1702263 179104 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 27813 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens antagonist target Baeumer W (2007) 17352685 195977 8064 Apremilast Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast otezla DRUGBANK DB05676 C22H24N2O7S small molecule L04AA32 608141-41-9 DRUGBANK 27814 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens antagonist target Abdulrahim H (2015) 25864487 196025 8064 Apremilast Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast otezla DRUGBANK DB05676 C22H24N2O7S small molecule L04AA32 608141-41-9 DRUGBANK 16575 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Essayan DM (2001) 11692087 174342 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16576 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Daly JW (2007) 17514358 174335 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16577 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Fisone G (2004) 15095008 181372 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 16578 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Deree J (2008) 18568240 181373 1361 Theobromine Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione - DRUGBANK DB01412 C7H8N4O2 small molecule C03BD01|R03DA57|R03DA07 83-67-0 DRUGBANK 2107 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens product of target Porteous DJ (2006) 16843095 173042 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2108 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens product of target Siuciak JA (2007) 17333137 173041 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2109 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens product of target Terrin A (2006) 17088426 173040 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 17513 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Barone FC (2007) 17726343 181617 1592 Roflumilast ROF|Daliresp|Roflumilastum daxas|daliresp DRUGBANK DB01656 C17H14Cl2F2N2O3 small molecule R03DX07 162401-32-3 DRUGBANK 21990 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3645 1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB03807 C14H15ClN2O2 small molecule - - DRUGBANK 21991 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3645 1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB03807 C14H15ClN2O2 small molecule - - DRUGBANK 21992 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3645 1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB03807 C14H15ClN2O2 small molecule - - DRUGBANK 18170 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1883 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB01959 C14H15N3O4 small molecule - - DRUGBANK 18171 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1883 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB01959 C14H15N3O4 small molecule - - DRUGBANK 18172 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1883 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB01959 C14H15N3O4 small molecule - - DRUGBANK 19661 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2551 Filaminast - - DRUGBANK DB02660 C15H20N2O4 small molecule - 141184-34-1 DRUGBANK 19662 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2551 Filaminast - - DRUGBANK DB02660 C15H20N2O4 small molecule - 141184-34-1 DRUGBANK 19663 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2551 Filaminast - - DRUGBANK DB02660 C15H20N2O4 small molecule - 141184-34-1 DRUGBANK 21583 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 3454 (S)-Rolipram (S)-(+)-rolipram|S-rolipram|(+)-rolipram - DRUGBANK DB03606 C16H21NO3 small molecule - 85416-73-5 DRUGBANK 21584 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3454 (S)-Rolipram (S)-(+)-rolipram|S-rolipram|(+)-rolipram - DRUGBANK DB03606 C16H21NO3 small molecule - 85416-73-5 DRUGBANK 21585 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 3454 (S)-Rolipram (S)-(+)-rolipram|S-rolipram|(+)-rolipram - DRUGBANK DB03606 C16H21NO3 small molecule - 85416-73-5 DRUGBANK 21586 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 3454 (S)-Rolipram (S)-(+)-rolipram|S-rolipram|(+)-rolipram - DRUGBANK DB03606 C16H21NO3 small molecule - 85416-73-5 DRUGBANK 26338 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7086 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid - - DRUGBANK DB08299 C21H13N3O4 small molecule - - DRUGBANK 17796 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Beeh KM (2005) 15765929 181625 1722 Piclamilast RP 73-401 - DRUGBANK DB01791 C18H18Cl2N2O3 small molecule - 144035-83-6 DRUGBANK 17797 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1722 Piclamilast RP 73-401 - DRUGBANK DB01791 C18H18Cl2N2O3 small molecule - 144035-83-6 DRUGBANK 27804 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Kroegel C (2007) 17155857 195974 3686 Cilomilast Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid - DRUGBANK DB03849 C20H25NO4 small molecule - 153259-65-5 DRUGBANK 8998 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 8999 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9000 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Hariton C (1994) 7925603 177565 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9001 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Iancu L (1979) 225216 177566 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 13894 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1101 Papaverine Mesotina papaverine hydrochloride injec DRUGBANK DB01113 C20H21NO4 small molecule G04BE02|G04BE52|A03AD01 58-74-2 DRUGBANK 13895 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1101 Papaverine Mesotina papaverine hydrochloride injec DRUGBANK DB01113 C20H21NO4 small molecule G04BE02|G04BE52|A03AD01 58-74-2 DRUGBANK 13896 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Xin ZC (2003) 12646997 180221 1101 Papaverine Mesotina papaverine hydrochloride injec DRUGBANK DB01113 C20H21NO4 small molecule G04BE02|G04BE52|A03AD01 58-74-2 DRUGBANK 13897 111168 5142 RP5-876C12.1 PDE4B DPDE4|PDEIVB 9606 Homo sapiens inhibitor target Zhu S (2009) 19231363 180222 1101 Papaverine Mesotina papaverine hydrochloride injec DRUGBANK DB01113 C20H21NO4 small molecule G04BE02|G04BE52|A03AD01 58-74-2 DRUGBANK 13630 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inducer target Schermuly RT (2003) 12952271 180070 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13631 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inducer target Wilkens H (2001) 11551870 180069 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13632 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inducer target Ghofrani HA (2002) 12441759 180068 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13633 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inducer target Grant PG (1988) 2461561 180067 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 4231 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4232 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 17798 111169 5143 - PDE4C DPDE1 9606 Homo sapiens unknown target Beeh KM (2005) 15765929 181625 1722 Piclamilast RP 73-401 - DRUGBANK DB01791 C18H18Cl2N2O3 small molecule - 144035-83-6 DRUGBANK 9003 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9004 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9005 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Hariton C (1994) 7925603 177565 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9006 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Iancu L (1979) 225216 177566 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 17514 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Barone FC (2007) 17726343 181617 1592 Roflumilast ROF|Daliresp|Roflumilastum daxas|daliresp DRUGBANK DB01656 C17H14Cl2F2N2O3 small molecule R03DX07 162401-32-3 DRUGBANK 24318 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 11922 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11923 111169 5143 - PDE4C DPDE1 9606 Homo sapiens inhibitor target Castillo JG (1990) 1702263 179104 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 23524 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4283 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB04469 C15H18N2O3 small molecule - - DRUGBANK 18150 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1878 Rolipram 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram - DRUGBANK DB01954 C16H21NO3 small molecule - 61413-54-5 DRUGBANK 18151 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1878 Rolipram 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram - DRUGBANK DB01954 C16H21NO3 small molecule - 61413-54-5 DRUGBANK 18152 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1878 Rolipram 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram - DRUGBANK DB01954 C16H21NO3 small molecule - 61413-54-5 DRUGBANK 18169 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1883 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB01959 C14H15N3O4 small molecule - - DRUGBANK 26337 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7086 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid - - DRUGBANK DB08299 C21H13N3O4 small molecule - - DRUGBANK 13622 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inducer target Schermuly RT (2003) 12952271 180070 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13623 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inducer target Wilkens H (2001) 11551870 180069 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13624 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inducer target Ghofrani HA (2002) 12441759 180068 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13625 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inducer target Grant PG (1988) 2461561 180067 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 4243 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4244 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 27811 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens antagonist target Baeumer W (2007) 17352685 195977 8064 Apremilast Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast otezla DRUGBANK DB05676 C22H24N2O7S small molecule L04AA32 608141-41-9 DRUGBANK 27812 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens antagonist target Abdulrahim H (2015) 25864487 196025 8064 Apremilast Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast otezla DRUGBANK DB05676 C22H24N2O7S small molecule L04AA32 608141-41-9 DRUGBANK 22927 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4098 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB04271 C8H12N2O2 small molecule - - DRUGBANK 17794 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Beeh KM (2005) 15765929 181625 1722 Piclamilast RP 73-401 - DRUGBANK DB01791 C18H18Cl2N2O3 small molecule - 144035-83-6 DRUGBANK 17795 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1722 Piclamilast RP 73-401 - DRUGBANK DB01791 C18H18Cl2N2O3 small molecule - 144035-83-6 DRUGBANK 27678 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 3686 Cilomilast Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid - DRUGBANK DB03849 C20H25NO4 small molecule - 153259-65-5 DRUGBANK 27803 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Kroegel C (2007) 17155857 195974 3686 Cilomilast Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid - DRUGBANK DB03849 C20H25NO4 small molecule - 153259-65-5 DRUGBANK 24316 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 5043 Ibudilast Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal - DRUGBANK DB05266 C14H18N2O small molecule R03DC04 50847-11-5 DRUGBANK 19684 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2566 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol - - DRUGBANK DB02676 C11H26N2O6 small molecule - - DRUGBANK 19685 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2566 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol - - DRUGBANK DB02676 C11H26N2O6 small molecule - - DRUGBANK 19686 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2566 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol - - DRUGBANK DB02676 C11H26N2O6 small molecule - - DRUGBANK 8995 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 8996 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 8997 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Hariton C (1994) 7925603 177565 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 25058 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5869 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER - - DRUGBANK DB07051 C14H17N2O2 small molecule - - DRUGBANK 2106 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens product of target Terrin A (2006) 17088426 173040 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 17511 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Barone FC (2007) 17726343 181617 1592 Roflumilast ROF|Daliresp|Roflumilastum daxas|daliresp DRUGBANK DB01656 C17H14Cl2F2N2O3 small molecule R03DX07 162401-32-3 DRUGBANK 17512 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1592 Roflumilast ROF|Daliresp|Roflumilastum daxas|daliresp DRUGBANK DB01656 C17H14Cl2F2N2O3 small molecule R03DX07 162401-32-3 DRUGBANK 11926 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Huang Z (2006) 16313925 179103 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11927 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens inhibitor target Castillo JG (1990) 1702263 179104 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 25980 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 20134 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2797 6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One - - DRUGBANK DB02918 C12H10F2N2O3 small molecule - - DRUGBANK 24866 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5663 (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one - - DRUGBANK DB06842 C15H22N2O3 small molecule - - DRUGBANK 20721 111170 5144 - PDE4D ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3051 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester - - DRUGBANK DB03183 C14H17N3O2 small molecule - - DRUGBANK 4211 111171 5145 - PDE6A CGPR-A|PDEA|RP43 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4212 111171 5145 - PDE6A CGPR-A|PDEA|RP43 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4237 111172 5146 - PDE6C ACHM5|COD4|PDEA2 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4238 111172 5146 - PDE6C ACHM5|COD4|PDEA2 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4274 111174 5148 - PDE6G PDEG|RP57 9606 Homo sapiens inhibitor target Uckert S (2006) 16815627 174359 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 25981 111174 5148 - PDE6G PDEG|RP57 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 11223 111174 5148 - PDE6G PDEG|RP57 9606 Homo sapiens allosteric modulator target Zhang XJ (2008) 18779324 178753 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 4273 111175 5149 - PDE6H ACHM6|RCD3 9606 Homo sapiens inhibitor target Uckert S (2006) 16815627 174359 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 11222 111175 5149 - PDE6H ACHM6|RCD3 9606 Homo sapiens allosteric modulator target Zhang XJ (2008) 18779324 178753 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 9013 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9014 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 4207 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4208 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 26634 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7379 3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one - - DRUGBANK DB08602 C15H10F2N2OS small molecule - - DRUGBANK 25984 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 11928 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11929 111176 5150 RP11-707M3.3 PDE7A HCP1|PDE7 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 4205 111177 5151 - PDE8A HsT19550 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4206 111177 5151 - PDE8A HsT19550 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 25985 111177 5151 - PDE8A HsT19550 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 11930 111177 5151 - PDE8A HsT19550 9606 Homo sapiens inhibitor target Castillo JG (1990) 1702263 179104 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 4213 111178 5152 - PDE9A HSPDE9A2 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4214 111178 5152 - PDE9A HSPDE9A2 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 25982 111178 5152 - PDE9A HSPDE9A2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 8712 111179 5153 - PDE1B PDE1B1|PDES1B 9606 Homo sapiens inhibitor target Sharma RK (1997) 9231746 177388 612 Nicardipine Nicardipino|Nicardipinum|Cardene nicardipine hydrochloride|card DRUGBANK DB00622 C26H29N3O6 small molecule C08CA04 55985-32-5 DRUGBANK 4219 111179 5153 - PDE1B PDE1B1|PDES1B 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4220 111179 5153 - PDE1B PDE1B1|PDES1B 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 15328 111179 5153 - PDE1B PDE1B1|PDES1B 9606 Homo sapiens inhibitor target Lamers JM (1985) 2933041 179746 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 12874 111179 5153 - PDE1B PDE1B1|PDES1B 9606 Homo sapiens inhibitor target Sharma RK (1997) 9231746 177388 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12875 111179 5153 - PDE1B PDE1B1|PDES1B 9606 Homo sapiens inhibitor target Lamers JM (1985) 2933041 179746 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 24580 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens inhibitor target Sonpavde G (2007) 17288876 181986 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 27614 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens inhibitor target Prenen H (2006) 16638875 180943 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 8695 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens antagonist target Borbenyi Z (2005) 15921304 177356 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8696 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens antagonist target Tefferi A (2005) 15995325 177355 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8697 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens antagonist target Yi ES (2005) 15894928 177354 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8698 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens antagonist target Chen LL (2005) 15946589 177353 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8699 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens antagonist target Corless CL (2005) 15928335 177352 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 1253 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens unknown target Ebert M (1995) 7665222 172401 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 1254 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens unknown target Heidaran MA (1991) 1702511 172402 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 1255 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens unknown target Abdiu A (1998) 10070317 172403 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 1256 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens unknown target Miller-Kasprzak E (2003) 12632922 172404 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 1257 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens unknown target Yu J (2003) 14506245 172405 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 26975 111182 5156 - PDGFRA CD140A|PDGFR-2|PDGFR2|RHEPDGFRA 9606 Homo sapiens inhibitor target O'Hare T (2009) 19878872 182132 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 4241 111184 5158 - PDE6B CSNB3|CSNBAD2|PDEB|RP40|rd1 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4242 111184 5158 - PDE6B CSNB3|CSNBAD2|PDEB|RP40|rd1 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 8679 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Modi S (2005) 15803362 177339 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8680 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Jones RL (2005) 15794712 177338 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8681 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Chen J (2006) 15893416 177342 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8682 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Basciani S (2005) 15753388 177340 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 8683 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Johnson FM (2005) 15887238 177341 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 24578 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens inhibitor target Sonpavde G (2007) 17288876 181986 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 15415 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Zhang Z (2006) 16497876 180867 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15416 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Chen Z (2006) 16436588 180866 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15417 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Lindauer M (2010) 20072833 180857 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 6512 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Guida T (2007) 17545544 175831 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6513 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Gollob JA (2005) 16425993 175833 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6514 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens antagonist target Unnithan J (2007) 17619763 175834 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 27607 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens inhibitor target Abrams TJ (2003) 12748309 180939 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27608 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens inhibitor target Pietras K (2005) 15557593 180941 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27609 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens inhibitor target Gollob JA (2005) 16425993 175833 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27610 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens inhibitor target Baratte S (2004) 14753710 180935 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 27611 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens inhibitor target Mendel DB (2003) 12538485 180936 1255 Sunitinib Sunitinibum sutent DRUGBANK DB01268 C22H27FN4O2 small molecule L01XE04 557795-19-4 DRUGBANK 1260 111185 5159 - PDGFRB CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1 9606 Homo sapiens unknown target Papanas N (2008) 18686746 172408 97 Becaplermin PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor regranex (becaplermin) 0.01%|r DRUGBANK DB00102 C532H892N162O153S9 biologic A01AD08|D03AX06 165101-51-9 DRUGBANK 3015 111186 5160 RP11-723P2.1 PDHA1 PDHA|PDHAD|PDHCE1A|PHE1A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3016 111186 5160 RP11-723P2.1 PDHA1 PDHA|PDHAD|PDHCE1A|PHE1A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3213 111187 5161 hCG_1643458 PDHA2 PDHAL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3214 111187 5161 hCG_1643458 PDHA2 PDHAL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3388 111188 5162 - PDHB PDHBD|PDHE1-B|PHE1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3389 111188 5162 - PDHB PDHBD|PDHE1-B|PHE1B 9606 Homo sapiens unknown target Taylor SI (1975) 1116996 173785 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3390 111188 5162 - PDHB PDHBD|PDHE1-B|PHE1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 1748 111188 5162 - PDHB PDHBD|PDHE1-B|PHE1B 9606 Homo sapiens unknown target Kumar V (2006) 16855207 172714 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 25428 111189 5163 - PDK1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6217 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE - - DRUGBANK DB07403 C19H18ClF3N2O5S small molecule - - DRUGBANK 26829 111189 5163 - PDK1 - 9606 Homo sapiens inhibitor target Stacpoole PW (1989) 2554095 181656 7580 Dichloroacetic Acid dichloracetic acid|dichloroacetate|DCA bichloracetic acid 100% DRUGBANK DB08809 C2H2Cl2O2 small molecule - 79-43-6 DRUGBANK 26641 111190 5164 - PDK2 PDHK2|PDKII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7386 (N-{4-[(ETHYLANILINO)SULFONYL]-2-METHYLPHENYL}-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANAMIDE - - DRUGBANK DB08609 C19H21F3N2O4S small molecule - - DRUGBANK 26642 111190 5164 - PDK2 PDHK2|PDKII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7387 N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE - - DRUGBANK DB08610 C20H25ClN2O2 small molecule - - DRUGBANK 26640 111190 5164 - PDK2 PDHK2|PDKII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7385 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE - - DRUGBANK DB08608 C18H20F3N3O3 small molecule - - DRUGBANK 21883 111191 5165 - PDK3 CMTX6|GS1-358P8.4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3602 Dihydrolipoic Acid - - DRUGBANK DB03760 C8H16O2S2 small molecule - 462-20-4 DRUGBANK 21877 111191 5165 - PDK3 CMTX6|GS1-358P8.4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3600 Radicicol - - DRUGBANK DB03758 C18H23ClO6 small molecule - - DRUGBANK 26404 111192 5166 - PDK4 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7141 4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol - - DRUGBANK DB08356 C17H16N2O3 small molecule - - DRUGBANK 10743 111193 5167 - ENPP1 ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 10744 111193 5167 - ENPP1 ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 14159 111193 5167 - ENPP1 ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 14160 111193 5167 - ENPP1 ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1131 Amifostine Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065 amifostine|ethyol - pws iv 500 DRUGBANK DB01143 C5H15N2O3PS small molecule V03AF05 20537-88-6 DRUGBANK 18090 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1858 7-Hydroxystaurosporine - - DRUGBANK DB01933 C28H26N4O4 small molecule - 112953-11-4 DRUGBANK 18091 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1858 7-Hydroxystaurosporine - - DRUGBANK DB01933 C28H26N4O4 small molecule - 112953-11-4 DRUGBANK 25142 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5950 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA - - DRUGBANK DB07132 C15H14N4O2 small molecule - - DRUGBANK 18135 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1870 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione - - DRUGBANK DB01946 C24H22N4O2 small molecule - - DRUGBANK 18136 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1870 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione - - DRUGBANK DB01946 C24H22N4O2 small molecule - - DRUGBANK 18137 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1870 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione - - DRUGBANK DB01946 C24H22N4O2 small molecule - - DRUGBANK 25472 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6267 3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE - - DRUGBANK DB07456 C27H26N4O2 small molecule - - DRUGBANK 17966 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17967 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 23618 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23619 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 25473 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6268 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE - - DRUGBANK DB07457 C23H20N4O2 small molecule - - DRUGBANK 21912 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3618 Rbt205 Inhibitor - - DRUGBANK DB03777 C25H24N4O2 small molecule - - DRUGBANK 24957 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5751 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine - - DRUGBANK DB06932 C19H18N4O2 small molecule - - DRUGBANK 25046 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5851 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE - - DRUGBANK DB07033 C14H12N2O2 small molecule - - DRUGBANK 7385 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens inhibitor target Kulp SK (2004) 14973075 176389 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7386 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens inhibitor target Tong Z (2005) 16060857 176390 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7387 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens inhibitor target Li J (2006) 16455452 176391 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7388 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens inhibitor target Zhu J (2004) 15205346 176392 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7389 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens inhibitor target Tseng PH (2006) 16887935 176393 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 18338 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18339 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 25308 111196 5170 - PDPK1 PDK1|PDPK2|PDPK2P|PRO0461 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6116 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine - - DRUGBANK DB07300 C19H19N5O3 small molecule - - DRUGBANK 2430 111211 5188 HSPC199 GATB PET112|PET112L 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2431 111211 5188 HSPC199 GATB PET112|PET112L 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 708 111219 5196 - PF4 CXCL4|PF-4|SCYB4 9606 Homo sapiens unknown target Carr ME (2001) 11259926 172068 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 2426 111221 5198 - PFAS FGAMS|FGAR-AT|FGARAT|PURL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2427 111221 5198 - PFAS FGAMS|FGAR-AT|FGARAT|PURL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2428 111221 5198 - PFAS FGAMS|FGAR-AT|FGARAT|PURL 9606 Homo sapiens unknown target Jayaram HN (1990) 2347042 172999 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 20151 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2808 Phosphothiophosphoric Acid-Adenylate Ester - - DRUGBANK DB02930 C10H16N5O12P3S small molecule - - DRUGBANK 20152 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2808 Phosphothiophosphoric Acid-Adenylate Ester - - DRUGBANK DB02930 C10H16N5O12P3S small molecule - - DRUGBANK 19379 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19380 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19381 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19133 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2296 D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate - - DRUGBANK DB02393 C6H14O10P2 small molecule - - DRUGBANK 19134 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2296 D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate - - DRUGBANK DB02393 C6H14O10P2 small molecule - - DRUGBANK 19135 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2296 D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate - - DRUGBANK DB02393 C6H14O10P2 small molecule - - DRUGBANK 22650 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22651 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22652 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 23561 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23562 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23563 111228 5207 - PFKFB1 F6PK|HL2K|PFRX 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23262 111231 5210 - PFKFB4 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23263 111231 5210 - PFKFB4 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23264 111231 5210 - PFKFB4 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23554 111231 5210 - PFKFB4 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23555 111231 5210 - PFKFB4 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 23556 111231 5210 - PFKFB4 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4306 Fructose-6-Phosphate - - DRUGBANK DB04493 C6H13O9P small molecule - - DRUGBANK 25932 111237 5216 - PFN1 ALS18 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6704 7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN - - DRUGBANK DB07908 C12H12O4 small molecule - - DRUGBANK 18485 111238 5217 - PFN2 D3S1319E|PFL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1998 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane - - DRUGBANK DB02078 C8H18O4 small molecule - - DRUGBANK 19483 111238 5217 - PFN2 D3S1319E|PFL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2475 1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane - - DRUGBANK DB02580 C12H26O6 small molecule - 1191-87-3 DRUGBANK 17553 111245 5224 - PGAM2 GSD10|PGAM-M|PGAMM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1616 Benzene Hexacarboxylic Acid - - DRUGBANK DB01681 C12H6O12 small molecule - 517-60-2 DRUGBANK 17554 111245 5224 - PGAM2 GSD10|PGAM-M|PGAMM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1616 Benzene Hexacarboxylic Acid - - DRUGBANK DB01681 C12H6O12 small molecule - 517-60-2 DRUGBANK 17555 111245 5224 - PGAM2 GSD10|PGAM-M|PGAMM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1616 Benzene Hexacarboxylic Acid - - DRUGBANK DB01681 C12H6O12 small molecule - 517-60-2 DRUGBANK 23574 111245 5224 - PGAM2 GSD10|PGAM-M|PGAMM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 23575 111245 5224 - PGAM2 GSD10|PGAM-M|PGAMM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 23576 111245 5224 - PGAM2 GSD10|PGAM-M|PGAMM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 22281 111247 5226 - PGD 6PGD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3797 Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate - - DRUGBANK DB03962 C21H27BrN7O17P3 small molecule - - DRUGBANK 22282 111247 5226 - PGD 6PGD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3797 Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate - - DRUGBANK DB03962 C21H27BrN7O17P3 small molecule - - DRUGBANK 22283 111247 5226 - PGD 6PGD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3797 Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate - - DRUGBANK DB03962 C21H27BrN7O17P3 small molecule - - DRUGBANK 10507 111247 5226 - PGD 6PGD 9606 Homo sapiens inhibitor target Akkemik E (2010) 20235752 176889 779 Gadopentetate dimeglumine Meglumine gadopentetate|Gd-DTPA|Diethylenetriaminepentaacetic acid dimeglumine salt gadolinium chelate|Gadopentetic acid dimeglumine salt|Magnevist|Dimeglumine-gadolinium-dtpa magnevist|gadopentetate dimegl DRUGBANK DB00789 C28H54GdN5O20 small molecule - 86050-77-3 DRUGBANK 10508 111247 5226 - PGD 6PGD 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 779 Gadopentetate dimeglumine Meglumine gadopentetate|Gd-DTPA|Diethylenetriaminepentaacetic acid dimeglumine salt gadolinium chelate|Gadopentetic acid dimeglumine salt|Magnevist|Dimeglumine-gadolinium-dtpa magnevist|gadopentetate dimegl DRUGBANK DB00789 C28H54GdN5O20 small molecule - 86050-77-3 DRUGBANK 11934 111247 5226 - PGD 6PGD 9606 Homo sapiens inhibitor target Akkemik E (2010) 20235752 176889 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11935 111247 5226 - PGD 6PGD 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11155 111247 5226 - PGD 6PGD 9606 Homo sapiens inhibitor target Akkemik E (2010) 20235752 176889 841 Dacarbazine DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide dacarbazine|dacarbazine for in DRUGBANK DB00851 C6H10N6O small molecule L01AX04 4342-03-4 DRUGBANK 11156 111247 5226 - PGD 6PGD 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 841 Dacarbazine DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide dacarbazine|dacarbazine for in DRUGBANK DB00851 C6H10N6O small molecule L01AX04 4342-03-4 DRUGBANK 18475 111247 5226 - PGD 6PGD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 18476 111247 5226 - PGD 6PGD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 18477 111247 5226 - PGD 6PGD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 26953 111249 5228 - PGF D12S1900|PGFL|PLGF|PlGF-2|SHGC-10760 9606 Homo sapiens binder target Browning DJ (2012) 22813448 182207 7629 Aflibercept VEGF Trap|Ziv-Aflibercept|VEGF Trap-Eye eylea|zaltrap DRUGBANK DB08885 C4318H6788N1164O1304S32 biologic L01XX44|S01LA05 862111-32-8 DRUGBANK 25234 111250 5229 - PGGT1B BGGI|GGTI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6043 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE - - DRUGBANK DB07227 C22H20ClN5O small molecule - - DRUGBANK 26206 111250 5229 - PGGT1B BGGI|GGTI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6972 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE - - DRUGBANK DB08180 C19H37NO7P2 small molecule - - DRUGBANK 25863 111250 5229 - PGGT1B BGGI|GGTI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 22180 111251 5230 RP4-570L12.1 PGK1 HEL-S-68p|MIG10|PGKA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22181 111251 5230 RP4-570L12.1 PGK1 HEL-S-68p|MIG10|PGKA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22182 111251 5230 RP4-570L12.1 PGK1 HEL-S-68p|MIG10|PGKA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 23571 111251 5230 RP4-570L12.1 PGK1 HEL-S-68p|MIG10|PGKA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 23572 111251 5230 RP4-570L12.1 PGK1 HEL-S-68p|MIG10|PGKA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 23573 111251 5230 RP4-570L12.1 PGK1 HEL-S-68p|MIG10|PGKA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 19993 111256 5236 - PGM1 CDG1T|GSD14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2717 Alpha-D-Glucose 1,6-Bisphosphate - - DRUGBANK DB02835 C6H13O12P2 small molecule - 10139-18-1 DRUGBANK 19994 111256 5236 - PGM1 CDG1T|GSD14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2717 Alpha-D-Glucose 1,6-Bisphosphate - - DRUGBANK DB02835 C6H13O12P2 small molecule - 10139-18-1 DRUGBANK 19995 111256 5236 - PGM1 CDG1T|GSD14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2717 Alpha-D-Glucose 1,6-Bisphosphate - - DRUGBANK DB02835 C6H13O12P2 small molecule - 10139-18-1 DRUGBANK 23328 111256 5236 - PGM1 CDG1T|GSD14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4218 Alpha-D-Glucose-1-Phosphate-6-Vanadate - - DRUGBANK DB04397 C6H13O12PV small molecule - - DRUGBANK 23329 111256 5236 - PGM1 CDG1T|GSD14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4218 Alpha-D-Glucose-1-Phosphate-6-Vanadate - - DRUGBANK DB04397 C6H13O12PV small molecule - - DRUGBANK 23330 111256 5236 - PGM1 CDG1T|GSD14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4218 Alpha-D-Glucose-1-Phosphate-6-Vanadate - - DRUGBANK DB04397 C6H13O12PV small molecule - - DRUGBANK 8514 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8515 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Boonyaratanakornkit V (2007) 17138644 175790 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8516 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Wu HB (2006) 17109827 175793 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8517 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Madauss KP (2007) 17013809 175792 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8518 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Gizard F (2006) 17015480 175794 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8519 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Risch HA (2006) 16985038 177205 593 Medroxyprogesterone acetate 6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone provera 2.5mg tablets|medroxy- DRUGBANK DB00603 C24H34O4 small molecule G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02 71-58-9 DRUGBANK 8330 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Austin RJ (2002) 12503693 177109 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8331 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Issar M (2006) 16507850 175778 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 27741 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Hammond GL (2001) 11521119 175561 8156 Norgestrel LD norgestrel|17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one|Methylnorethindrone low-ogestrel|ovrette tablets|e DRUGBANK DB09389 C21H28O2 small molecule G03FB01|G03FA10|G03AA06 6533-00-2 DRUGBANK 9793 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Madauss KP (2004) 15189034 178013 707 Norethisterone 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one microgestin|norethindrone and DRUGBANK DB00717 C20H26O2 small molecule G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01 68-22-4 DRUGBANK 9794 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Mendoza-Rodriguez CA (1999) 10494488 178012 707 Norethisterone 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one microgestin|norethindrone and DRUGBANK DB00717 C20H26O2 small molecule G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01 68-22-4 DRUGBANK 9795 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Pasapera AM (1995) 7711211 178015 707 Norethisterone 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one microgestin|norethindrone and DRUGBANK DB00717 C20H26O2 small molecule G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01 68-22-4 DRUGBANK 9796 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Garcia-Becerra R (2004) 15261304 178014 707 Norethisterone 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one microgestin|norethindrone and DRUGBANK DB00717 C20H26O2 small molecule G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01 68-22-4 DRUGBANK 9797 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Mirkin S (2005) 16084894 175552 707 Norethisterone 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one microgestin|norethindrone and DRUGBANK DB00717 C20H26O2 small molecule G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01 68-22-4 DRUGBANK 9798 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 707 Norethisterone 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one microgestin|norethindrone and DRUGBANK DB00717 C20H26O2 small molecule G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01 68-22-4 DRUGBANK 16397 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Sitruk-Ware R (2004) 15493951 181284 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16398 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Sitruk-Ware R (2005) 16291771 181285 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16399 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Fuhrmann U (1996) 8922878 181280 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16400 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Krattenmacher R (2000) 11024226 181281 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16401 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Arias-Loza PA (2006) 17000933 181283 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 16402 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Bray JD (2005) 16157482 175558 1345 Drospirenone 6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone drospirenone and ethinyl estra DRUGBANK DB01395 C24H30O3 small molecule G03AC10|G03AA12|G03FA17 67392-87-4 DRUGBANK 5895 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Schindler AE (2009) 19434889 175430 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5896 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5897 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Lamberts SW (1985) 2982481 175428 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5898 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Vadivelu S (2010) 19731987 175434 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5899 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Gruber T (2004) 15086241 175433 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5900 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Wiedemann K (1998) 9744490 175427 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5901 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Mokbel K (2003) 14687437 175431 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5902 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Wentling GK (2005) 16343217 175432 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 5903 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Wermers RA (2004) 15595341 175424 343 Megestrol acetate 6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate apo-megestrol|megace os|megace DRUGBANK DB00351 C23H30O4 small molecule G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05 595-33-5 DRUGBANK 16662 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Bergink EW (1985) 3928974 181411 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16663 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Tranguch S (2006) 17169175 175791 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16664 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Boonyaratanakornkit V (2007) 17138644 175790 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16665 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Wu HB (2006) 17109827 175793 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16666 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Madauss KP (2007) 17013809 175792 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 16667 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Gizard F (2006) 17015480 175794 1379 Allylestrenol Perselin|Allyloestrenol|Allyl estrenol - DRUGBANK DB01431 C21H32O small molecule G03DC01 432-60-0 DRUGBANK 10839 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 813 Ethynodiol diacetate Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol kelnor 1/35|demulen 30 (28 day DRUGBANK DB00823 C24H32O4 small molecule G03AA01|G03DC06|G03FA06 297-76-7 DRUGBANK 10840 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Tamaya T (1977) 858280 178557 813 Ethynodiol diacetate Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol kelnor 1/35|demulen 30 (28 day DRUGBANK DB00823 C24H32O4 small molecule G03AA01|G03DC06|G03FA06 297-76-7 DRUGBANK 10841 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Briggs MH (1975) 166800 178558 813 Ethynodiol diacetate Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol kelnor 1/35|demulen 30 (28 day DRUGBANK DB00823 C24H32O4 small molecule G03AA01|G03DC06|G03FA06 297-76-7 DRUGBANK 5218 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Sitruk-Ware R (2004) 15063480 175016 287 Etonogestrel Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel nexplanon|implanon|nuvaring DRUGBANK DB00294 C22H28O2 small molecule G03AC08 54048-10-1 DRUGBANK 5219 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Macpherson AM (1999) 10601100 175014 287 Etonogestrel Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel nexplanon|implanon|nuvaring DRUGBANK DB00294 C22H28O2 small molecule G03AC08 54048-10-1 DRUGBANK 5220 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Charnock-Jones DS (2000) 11041225 175015 287 Etonogestrel Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel nexplanon|implanon|nuvaring DRUGBANK DB00294 C22H28O2 small molecule G03AC08 54048-10-1 DRUGBANK 5221 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 287 Etonogestrel Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel nexplanon|implanon|nuvaring DRUGBANK DB00294 C22H28O2 small molecule G03AC08 54048-10-1 DRUGBANK 27893 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens modulator target Gemzell-Danielsson K (2013) 23437846 196017 8104 Ulipristal - ella|fibristal DRUGBANK DB08867 C28H35NO3 small molecule G03XB02|G03AD02 159811-51-5 DRUGBANK 20259 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2874 Methyltrienolone Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one - DRUGBANK DB02998 C19H24O2 small molecule - 965-93-5 DRUGBANK 20260 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2874 Methyltrienolone Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one - DRUGBANK DB02998 C19H24O2 small molecule - 965-93-5 DRUGBANK 20261 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2874 Methyltrienolone Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one - DRUGBANK DB02998 C19H24O2 small molecule - 965-93-5 DRUGBANK 16509 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Huang HF (1994) 8000225 181324 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16510 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Sasagawa S (2008) 18061638 181323 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16511 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Beaumont H (2007) 17636649 181322 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16512 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Dmowski WP (1990) 2404115 181318 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 6250 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 370 Dydrogesterone Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone - DRUGBANK DB00378 C21H28O2 small molecule G03FB08|G03DB01|G03FA14 152-62-5 DRUGBANK 6251 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Tamaya T (1979) 436795 175672 370 Dydrogesterone Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone - DRUGBANK DB00378 C21H28O2 small molecule G03FB08|G03DB01|G03FA14 152-62-5 DRUGBANK 6252 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Blois SM (2004) 15128769 175673 370 Dydrogesterone Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone - DRUGBANK DB00378 C21H28O2 small molecule G03FB08|G03DB01|G03FA14 152-62-5 DRUGBANK 6253 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Tamaya T (1983) 6827166 175670 370 Dydrogesterone Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone - DRUGBANK DB00378 C21H28O2 small molecule G03FB08|G03DB01|G03FA14 152-62-5 DRUGBANK 6254 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Raghupathy R (2005) 16045524 175671 370 Dydrogesterone Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone - DRUGBANK DB00378 C21H28O2 small molecule G03FB08|G03DB01|G03FA14 152-62-5 DRUGBANK 6255 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Okada H (1993) 8486204 175669 370 Dydrogesterone Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone - DRUGBANK DB00378 C21H28O2 small molecule G03FB08|G03DB01|G03FA14 152-62-5 DRUGBANK 6462 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Tranguch S (2006) 17169175 175791 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6463 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Boonyaratanakornkit V (2007) 17138644 175790 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6464 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Wu HB (2006) 17109827 175793 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6465 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Madauss KP (2007) 17013809 175792 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6466 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Luconi M (1998) 9506743 175795 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 6467 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Gizard F (2006) 17015480 175794 388 Progesterone Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione gesterol in oil-liq im 50mg/ml DRUGBANK DB00396 C21H30O2 small molecule G03DA04|G03FA04 57-83-0 DRUGBANK 27888 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target O'Brien JM (2016) 26558340 196036 7781 Hydroxyprogesterone caproate Oxiprogesterone Caproate|Makena|Primolut depot|17alpha-Caproyloxypregn-4-ene-3,20-dione|Delalutin|Hydroxyprogesterone makena DRUGBANK DB06789 C27H40O4 small molecule G03FA02|G03DA03 630-56-8 DRUGBANK 24764 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Kuhnz W (1995) 7750291 179326 5595 Norelgestromin 17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime evra -(6/0.60)|evra -(6/0. DRUGBANK DB06713 C21H29NO2 small molecule G03AA13 53016-31-2 DRUGBANK 24765 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Juchem M (1993) 8384965 179327 5595 Norelgestromin 17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime evra -(6/0.60)|evra -(6/0. DRUGBANK DB06713 C21H29NO2 small molecule G03AA13 53016-31-2 DRUGBANK 24766 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Graziottin A (2006) 17107221 179328 5595 Norelgestromin 17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime evra -(6/0.60)|evra -(6/0. DRUGBANK DB06713 C21H29NO2 small molecule G03AA13 53016-31-2 DRUGBANK 24767 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target London RS (1992) 1324557 179329 5595 Norelgestromin 17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime evra -(6/0.60)|evra -(6/0. DRUGBANK DB06713 C21H29NO2 small molecule G03AA13 53016-31-2 DRUGBANK 24768 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Pasqualini JR (2009) 19962254 182138 5595 Norelgestromin 17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime evra -(6/0.60)|evra -(6/0. DRUGBANK DB06713 C21H29NO2 small molecule G03AA13 53016-31-2 DRUGBANK 12284 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 12286 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Juchem M (1993) 8384965 179327 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 12287 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Graziottin A (2006) 17107221 179328 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 12285 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Kuhnz W (1995) 7750291 179326 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 12288 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target London RS (1992) 1324557 179329 947 Norgestimate (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime tri-cyclen tablets - 21-day|tr DRUGBANK DB00957 C23H31NO3 small molecule G03FA13|G03AA11 35189-28-7 DRUGBANK 27358 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Zhang Z (2005) 15937332 153560 4589 Tanaproget - - DRUGBANK DB04787 C16H15N3OS small molecule - 304853-42-7 DRUGBANK 27359 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 4589 Tanaproget - - DRUGBANK DB04787 C16H15N3OS small molecule - 304853-42-7 DRUGBANK 6760 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Fagart J (2010) 20650892 175952 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 10948 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10949 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens antagonist target Greb RR (1999) 10374120 178608 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10950 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens antagonist target Gao Y (1998) 10806733 178609 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10951 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens antagonist target Sun M (1998) 10682471 178605 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10952 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens antagonist target Hazra BG (2000) 10699595 178606 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 10953 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens antagonist target Jiang J (2001) 11783365 178607 824 Mifepristone RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne korlym|mifegymiso DRUGBANK DB00834 C29H35NO2 small molecule G03XB01|G03XB51 84371-65-3 DRUGBANK 5275 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Fuhrmann U (1995) 7750284 175066 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5276 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5277 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Bergink EW (1983) 6645495 175068 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5278 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Macpherson AM (1999) 10601100 175014 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5279 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Charnock-Jones DS (2000) 11041225 175015 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 5280 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens agonist target Kloosterboer HJ (1988) 3139361 175069 297 Desogestrel Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol freya 21|linessa 28|apri|lines DRUGBANK DB00304 C22H30O small molecule G03AA09|G03FB10|G03AC09|G03AB05 54024-22-5 DRUGBANK 6038 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6039 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Hompes PG (2007) 17484506 175559 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6040 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Bray JD (2005) 16157482 175558 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6041 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Mirkin S (2005) 16084894 175552 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6042 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Maruo T (2007) 17531625 175557 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6043 111260 5241 - PGR NR3C3|PR 9606 Homo sapiens binder target Creinin MD (2006) 17077229 175556 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 27243 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Wang EJ (2001) 11716514 172321 1199 Clarithromycin Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum mylan-clarithromycin|ran-clari DRUGBANK DB01211 C38H69NO13 small molecule J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09 81103-11-9 DRUGBANK 10369 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Beltinger J (2006) 16595573 178341 768 Roxithromycin Roxitromicina|Roxithromycin|(9e)-Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime)|Roxithromycinum|Roxithromycine - DRUGBANK DB00778 C41H76N2O15 small molecule J01FA06 80214-83-1 DRUGBANK 10370 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Kaufmann P (2006) 17164692 178340 768 Roxithromycin Roxitromicina|Roxithromycin|(9e)-Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime)|Roxithromycinum|Roxithromycine - DRUGBANK DB00778 C41H76N2O15 small molecule J01FA06 80214-83-1 DRUGBANK 27140 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Wang EJ (2001) 11716514 172321 835 Clofazimine Clofazimine|Clofazimina|Clofaziminum|Clofazimin|Riminophenazine|Lamprene - DRUGBANK DB00845 C27H22Cl2N4 small molecule J04BA01 2030-63-9 DRUGBANK 24058 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens inhibitor, competitive target Meschini S (2003) 14612920 181837 4677 Voacamine Voacanginine|Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate|Vocamine - DRUGBANK DB04877 C43H52N4O5 small molecule - 3371-85-5 DRUGBANK 24059 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens inhibitor, competitive target Meschini S (2005) 16273216 181917 4677 Voacamine Voacanginine|Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate|Vocamine - DRUGBANK DB04877 C43H52N4O5 small molecule - 3371-85-5 DRUGBANK 24071 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Hubensack M (2008) 17932689 182056 4681 Elacridar - - DRUGBANK DB04881 C34H33N3O5 small molecule - 143664-11-3 DRUGBANK 24133 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens inducer target Vincent M (2006) 16413681 181926 4705 Tesmilifene N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|DPPE|Depmpe - DRUGBANK DB04905 C19H25NO small molecule - 98774-23-3 DRUGBANK 24134 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens inducer target Brandes LJ (2001) 10755318 181748 4705 Tesmilifene N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|DPPE|Depmpe - DRUGBANK DB04905 C19H25NO small molecule - 98774-23-3 DRUGBANK 27069 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Ekins S (2002) 11961113 172332 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 3689 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Blume H (2006) 16944963 174014 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3690 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Fukui N (2007) 17417072 174011 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3691 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Gardner ER (2006) 16890580 174010 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3692 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Lage H (2006) 16842213 174013 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3693 111262 5243 - ABCB1 ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1 9606 Homo sapiens unknown target Gervasini G (2006) 17120199 174012 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 1908 111282 5264 RP11-24J20.1 PHYH LN1|LNAP1|PAHX|PHYH1|RD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1909 111282 5264 RP11-24J20.1 PHYH LN1|LNAP1|PAHX|PHYH1|RD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 290 111282 5264 RP11-24J20.1 PHYH LN1|LNAP1|PAHX|PHYH1|RD 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 291 111282 5264 RP11-24J20.1 PHYH LN1|LNAP1|PAHX|PHYH1|RD 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 292 111282 5264 RP11-24J20.1 PHYH LN1|LNAP1|PAHX|PHYH1|RD 9606 Homo sapiens antagonist target Chen C (2001) 11574539 8784 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 18295 111283 5265 PRO0684 SERPINA1 A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1922 2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol - - DRUGBANK DB01998 C20H38O11 small molecule - - DRUGBANK 18296 111283 5265 PRO0684 SERPINA1 A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1922 2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol - - DRUGBANK DB01998 C20H38O11 small molecule - - DRUGBANK 21013 111283 5265 PRO0684 SERPINA1 A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 21014 111283 5265 PRO0684 SERPINA1 A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 23637 111286 5268 - SERPINB5 PI5|maspin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23638 111286 5268 - SERPINB5 PI5|maspin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 676 111287 5269 RP1-90J20.6 SERPINB6 CAP|DFNB91|MSTP057|PI-6|PI6|PTI|SPI3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 677 111287 5269 RP1-90J20.6 SERPINB6 CAP|DFNB91|MSTP057|PI-6|PI6|PTI|SPI3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 24859 111307 5289 - PIK3C3 VPS34|hVps34 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5657 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE - - DRUGBANK DB06836 C14H16ClN3O4S2 small molecule - - DRUGBANK 4259 111308 5290 - PIK3CA CLOVE|CWS5|MCAP|MCM|MCMTC|PI3K|p110-alpha 9606 Homo sapiens unknown target Foukas LC (2002) 12145276 174346 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 26081 111308 5290 - PIK3CA CLOVE|CWS5|MCAP|MCM|MCMTC|PI3K|p110-alpha 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6852 (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE - - DRUGBANK DB08059 C23H24O8 small molecule - - DRUGBANK 4254 111309 5291 - PIK3CB P110BETA|PI3K|PI3KBETA|PIK3C1 9606 Homo sapiens unknown target Foukas LC (2002) 12145276 174346 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 22824 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 25539 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6334 N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine - - DRUGBANK DB07524 C13H11N3 small molecule - - DRUGBANK 23300 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23301 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 19633 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2547 2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One - - DRUGBANK DB02656 C19H17NO3 small molecule - 154447-36-6 DRUGBANK 19634 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2547 2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One - - DRUGBANK DB02656 C19H17NO3 small molecule - 154447-36-6 DRUGBANK 19635 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2547 2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One - - DRUGBANK DB02656 C19H17NO3 small molecule - 154447-36-6 DRUGBANK 25163 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5969 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one - - DRUGBANK DB07151 C17H14N2O2 small molecule - - DRUGBANK 21913 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3618 Rbt205 Inhibitor - - DRUGBANK DB03777 C25H24N4O2 small molecule - - DRUGBANK 21914 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3618 Rbt205 Inhibitor - - DRUGBANK DB03777 C25H24N4O2 small molecule - - DRUGBANK 21915 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3618 Rbt205 Inhibitor - - DRUGBANK DB03777 C25H24N4O2 small molecule - - DRUGBANK 21653 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3497 (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One - - DRUGBANK DB03650 C14H10N2O2 small molecule - - DRUGBANK 21654 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3497 (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One - - DRUGBANK DB03650 C14H10N2O2 small molecule - - DRUGBANK 21655 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3497 (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One - - DRUGBANK DB03650 C14H10N2O2 small molecule - - DRUGBANK 23606 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23607 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 18328 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18329 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 26046 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6815 (2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile - - DRUGBANK DB08022 C20H16N6S small molecule - - DRUGBANK 23643 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23644 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 26189 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6958 (4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile - - DRUGBANK DB08166 C17H17ClN4O small molecule - - DRUGBANK 26730 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7479 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE - - DRUGBANK DB08705 C18H11BrN2O2 small molecule - - DRUGBANK 26247 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7020 5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE - - DRUGBANK DB08230 C15H10O7 small molecule - - DRUGBANK 26731 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7481 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine - - DRUGBANK DB08707 C17H11ClN4O small molecule - - DRUGBANK 2126 111310 5292 - PIM1 PIM 9606 Homo sapiens product of target Imming P (2006) 17016423 171742 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2127 111310 5292 - PIM1 PIM 9606 Homo sapiens product of target Overington JP (2006) 17139284 171741 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 26733 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7483 2,3-diphenyl-1H-indole-7-carboxylic acid - - DRUGBANK DB08709 C21H15NO2 small molecule - - DRUGBANK 26732 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7482 N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine - - DRUGBANK DB08708 C18H18F3N5 small molecule - - DRUGBANK 17723 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1688 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One - - DRUGBANK DB01754 C10H9NO3 small molecule - - DRUGBANK 17724 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1688 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One - - DRUGBANK DB01754 C10H9NO3 small molecule - - DRUGBANK 17725 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1688 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One - - DRUGBANK DB01754 C10H9NO3 small molecule - - DRUGBANK 23835 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4519 IMIDAZOPYRIDAZIN 1 - - DRUGBANK DB04715 C18H18N4O small molecule - - DRUGBANK 25252 111310 5292 - PIM1 PIM 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6058 (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile - - DRUGBANK DB07242 C18H18Cl2N4O small molecule - - DRUGBANK 4253 111311 5293 RP11-558F24.3 PIK3CD APDS|IMD14|P110DELTA|PI3K|p110D 9606 Homo sapiens unknown target Foukas LC (2002) 12145276 174346 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 24852 111311 5293 RP11-558F24.3 PIK3CD APDS|IMD14|P110DELTA|PI3K|p110D 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5652 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE - - DRUGBANK DB06831 C21H15ClN6O2S small molecule - - DRUGBANK 22821 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 19632 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2547 2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One - - DRUGBANK DB02656 C19H17NO3 small molecule - 154447-36-6 DRUGBANK 26339 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7087 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine - - DRUGBANK DB08300 C16H13N5 small molecule - - DRUGBANK 25077 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5891 5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one - - DRUGBANK DB07073 C13H18N2O2S small molecule - - DRUGBANK 19043 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2280 Myricetin 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|Cannabiscetin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|Myricetol|3,5,7,3',4',5'-Hexahydroxyflavone|MYC|Myricitin|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one - DRUGBANK DB02375 C15H10O8 small molecule - 529-44-2 DRUGBANK 19044 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2280 Myricetin 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|Cannabiscetin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|Myricetol|3,5,7,3',4',5'-Hexahydroxyflavone|MYC|Myricitin|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one - DRUGBANK DB02375 C15H10O8 small molecule - 529-44-2 DRUGBANK 19045 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2280 Myricetin 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|Cannabiscetin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|Myricetol|3,5,7,3',4',5'-Hexahydroxyflavone|MYC|Myricitin|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one - DRUGBANK DB02375 C15H10O8 small molecule - 529-44-2 DRUGBANK 24853 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5652 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE - - DRUGBANK DB06831 C21H15ClN6O2S small molecule - - DRUGBANK 26082 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6852 (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE - - DRUGBANK DB08059 C23H24O8 small molecule - - DRUGBANK 25340 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6151 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL - - DRUGBANK DB07335 C14H15N5O small molecule - - DRUGBANK 25525 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6314 (5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE - - DRUGBANK DB07503 C11H5F2NO4S small molecule - - DRUGBANK 18324 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18325 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 24860 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5657 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE - - DRUGBANK DB06836 C14H16ClN3O4S2 small molecule - - DRUGBANK 23875 111312 5294 - PIK3CG PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4571 5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE - - DRUGBANK DB04769 C12H7N3O2S small molecule - - DRUGBANK 13351 111313 5295 - PIK3R1 AGM7|GRB1|IMD36|p85|p85-ALPHA 9606 Homo sapiens agonist target Slomiany BL (2004) 15381832 179935 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13352 111313 5295 - PIK3R1 AGM7|GRB1|IMD36|p85|p85-ALPHA 9606 Homo sapiens agonist target Slomiany BL (2005) 15985706 179934 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13353 111313 5295 - PIK3R1 AGM7|GRB1|IMD36|p85|p85-ALPHA 9606 Homo sapiens agonist target Slomiany BL (2004) 15527548 179937 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13354 111313 5295 - PIK3R1 AGM7|GRB1|IMD36|p85|p85-ALPHA 9606 Homo sapiens agonist target Machida K (2005) 15618457 179936 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13355 111313 5295 - PIK3R1 AGM7|GRB1|IMD36|p85|p85-ALPHA 9606 Homo sapiens agonist target Slomiany BL (2004) 15110780 179938 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 26080 111313 5295 - PIK3R1 AGM7|GRB1|IMD36|p85|p85-ALPHA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6852 (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE - - DRUGBANK DB08059 C23H24O8 small molecule - - DRUGBANK 13362 111314 5296 - PIK3R2 MPPH|MPPH1|P85B|p85|p85-BETA 9606 Homo sapiens agonist target Slomiany BL (2004) 15381832 179935 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13363 111314 5296 - PIK3R2 MPPH|MPPH1|P85B|p85|p85-BETA 9606 Homo sapiens agonist target Slomiany BL (2005) 15985706 179934 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13364 111314 5296 - PIK3R2 MPPH|MPPH1|P85B|p85|p85-BETA 9606 Homo sapiens agonist target Slomiany BL (2004) 15527548 179937 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13365 111314 5296 - PIK3R2 MPPH|MPPH1|P85B|p85|p85-BETA 9606 Homo sapiens agonist target Machida K (2005) 15618457 179936 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13366 111314 5296 - PIK3R2 MPPH|MPPH1|P85B|p85|p85-BETA 9606 Homo sapiens agonist target Slomiany BL (2004) 15110780 179938 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 24896 111317 5300 - PIN1 DOD|UBL5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5687 3,6,9,12,15,18-HEXAOXAICOSANE - - DRUGBANK DB06867 C14H30O6 small molecule - - DRUGBANK 17742 111317 5300 - PIN1 DOD|UBL5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1699 Beta-(2-Naphthyl)-Alanine - - DRUGBANK DB01766 C13H13NO2 small molecule - - DRUGBANK 18612 111323 5306 - PITPNA HEL-S-36|PI-TPalpha|PITPN|VIB1A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2063 1,2-Diacyl-Sn-Glycero-3-Phosphoinositol - - DRUGBANK DB02144 C43H80O13P small molecule - - DRUGBANK 18613 111323 5306 - PITPNA HEL-S-36|PI-TPalpha|PITPN|VIB1A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2063 1,2-Diacyl-Sn-Glycero-3-Phosphoinositol - - DRUGBANK DB02144 C43H80O13P small molecule - - DRUGBANK 21738 111323 5306 - PITPNA HEL-S-36|PI-TPalpha|PITPN|VIB1A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3534 (Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide - - DRUGBANK DB03690 C44H85NO8P small molecule - - DRUGBANK 21739 111323 5306 - PITPNA HEL-S-36|PI-TPalpha|PITPN|VIB1A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3534 (Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide - - DRUGBANK DB03690 C44H85NO8P small molecule - - DRUGBANK 21740 111323 5306 - PITPNA HEL-S-36|PI-TPalpha|PITPN|VIB1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3534 (Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide - - DRUGBANK DB03690 C44H85NO8P small molecule - - DRUGBANK 1743 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Suzuki T (2006) 16365052 172709 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1744 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Percy MJ (2007) 17574881 172710 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1745 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Rajaseger G (2006) 16720364 172711 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1746 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Xu J (2006) 16644726 172712 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1747 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Meza NW (2007) 17547515 172713 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 19789 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19790 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 23679 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4361 beta-D-fructofuranose 1,6-bisphosphate 1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate - DRUGBANK DB04551 C6H14O12P2 small molecule - 488-69-7 DRUGBANK 23680 111330 5313 - PKLR PK1|PKL|PKR|PKRL|RPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4361 beta-D-fructofuranose 1,6-bisphosphate 1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate - DRUGBANK DB04551 C6H14O12P2 small molecule - 488-69-7 DRUGBANK 25702 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6497 1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine - - DRUGBANK DB07692 C18H18F2N2O6S2 small molecule - - DRUGBANK 25632 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6434 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one - - DRUGBANK DB07628 C17H14FN3OS small molecule - - DRUGBANK 25704 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6502 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine - - DRUGBANK DB07697 C19H22N2O7S2 small molecule - - DRUGBANK 1749 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Li Y (2005) 16132722 172715 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1750 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Staib P (2005) 16375581 172716 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1751 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Stetak A (2007) 17308100 172717 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1752 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Weinberger R (2007) 17587357 172718 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1753 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Vlaeminck-Guillem V (2006) 16741870 172719 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 19797 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19798 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19799 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 17680 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1667 L-Phospholactate - - DRUGBANK DB01733 C3H7O6P small molecule - - DRUGBANK 17681 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1667 L-Phospholactate - - DRUGBANK DB01733 C3H7O6P small molecule - - DRUGBANK 17682 111332 5315 - PKM CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1667 L-Phospholactate - - DRUGBANK DB01733 C3H7O6P small molecule - - DRUGBANK 19648 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 10556 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens antagonist target Pruzanski W (1997) 9256165 174553 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 18737 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 18738 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 18739 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2123 Hexane-1,6-Diol - - DRUGBANK DB02210 C6H14O2 small molecule - 629-11-8 DRUGBANK 20175 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2816 Heptanoic Acid - - DRUGBANK DB02938 C7H14O2 small molecule - - DRUGBANK 23684 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens inhibitor target Jabeen T (2005) 16301791 181921 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 23685 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 21627 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3480 Lpc-Ether - - DRUGBANK DB03633 C26H57NO6P small molecule - - DRUGBANK 21628 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3480 Lpc-Ether - - DRUGBANK DB03633 C26H57NO6P small molecule - - DRUGBANK 21629 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3480 Lpc-Ether - - DRUGBANK DB03633 C26H57NO6P small molecule - - DRUGBANK 25661 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6463 PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER - - DRUGBANK DB07657 C20H42NO6P small molecule - - DRUGBANK 19222 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2349 N-Tridecanoic Acid - - DRUGBANK DB02448 C13H26O2 small molecule - 638-53-9 DRUGBANK 21543 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3435 Pyruvoyl Group - - DRUGBANK DB03587 C3H4O2 small molecule - - DRUGBANK 21544 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3435 Pyruvoyl Group - - DRUGBANK DB03587 C3H4O2 small molecule - - DRUGBANK 21545 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3435 Pyruvoyl Group - - DRUGBANK DB03587 C3H4O2 small molecule - - DRUGBANK 21507 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3414 1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine - - DRUGBANK DB03565 C20H45NO8P2 small molecule - - DRUGBANK 21508 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3414 1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine - - DRUGBANK DB03565 C20H45NO8P2 small molecule - - DRUGBANK 21509 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3414 1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine - - DRUGBANK DB03565 C20H45NO8P2 small molecule - - DRUGBANK 19922 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2677 P-Anisic Acid - - DRUGBANK DB02795 C8H8O3 small molecule - 100-09-4 DRUGBANK 19923 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2677 P-Anisic Acid - - DRUGBANK DB02795 C8H8O3 small molecule - 100-09-4 DRUGBANK 19924 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2677 P-Anisic Acid - - DRUGBANK DB02795 C8H8O3 small molecule - 100-09-4 DRUGBANK 25854 111336 5319 - PLA2G1B PLA2|PLA2A|PPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6633 1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL - - DRUGBANK DB07836 C16H32F3O6P small molecule - - DRUGBANK 20168 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2814 4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid - - DRUGBANK DB02936 C22H24N2O4 small molecule - - DRUGBANK 20169 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2814 4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid - - DRUGBANK DB02936 C22H24N2O4 small molecule - - DRUGBANK 20170 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2814 4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid - - DRUGBANK DB02936 C22H24N2O4 small molecule - - DRUGBANK 19224 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2349 N-Tridecanoic Acid - - DRUGBANK DB02448 C13H26O2 small molecule - 638-53-9 DRUGBANK 16265 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Lim H (2006) 16651744 181233 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 16266 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Kim HK (1999) 10418340 181232 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 16267 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Weichel O (1999) 10619176 181234 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 23002 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4114 (S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid - - DRUGBANK DB04287 C31H37NO4 small molecule - - DRUGBANK 23003 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4114 (S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid - - DRUGBANK DB04287 C31H37NO4 small molecule - - DRUGBANK 22586 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3944 1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide - - DRUGBANK DB04112 C26H54NO6PS small molecule - - DRUGBANK 22587 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3944 1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide - - DRUGBANK DB04112 C26H54NO6PS small molecule - - DRUGBANK 8300 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Singh N (2006) 16552142 177090 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8301 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Maekelae A (1997) 9279965 177089 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8302 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Madanick RD (2005) 15906762 177088 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 21921 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3624 Elaidoylamide - - DRUGBANK DB03784 C18H35NO small molecule - - DRUGBANK 21922 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3624 Elaidoylamide - - DRUGBANK DB03784 C18H35NO small molecule - - DRUGBANK 21923 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3624 Elaidoylamide - - DRUGBANK DB03784 C18H35NO small molecule - - DRUGBANK 18491 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2000 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene - - DRUGBANK DB02080 C21H36O4 small molecule - - DRUGBANK 23884 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Murakami MT (2005) 15961104 181896 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 23885 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 21351 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3326 6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid - - DRUGBANK DB03471 C25H33NO3 small molecule - - DRUGBANK 21352 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3326 6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid - - DRUGBANK DB03471 C25H33NO3 small molecule - - DRUGBANK 19354 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2401 [3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid - - DRUGBANK DB02504 C21H25N2O5P small molecule - - DRUGBANK 19355 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2401 [3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid - - DRUGBANK DB02504 C21H25N2O5P small molecule - - DRUGBANK 19356 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2401 [3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid - - DRUGBANK DB02504 C21H25N2O5P small molecule - - DRUGBANK 27659 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27637 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 20522 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2992 1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid - - DRUGBANK DB03121 C19H19NO3 small molecule - - DRUGBANK 20523 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2992 1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid - - DRUGBANK DB03121 C19H19NO3 small molecule - - DRUGBANK 20524 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2992 1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid - - DRUGBANK DB03121 C19H19NO3 small molecule - - DRUGBANK 18161 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 18162 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 18163 111337 5320 - PLA2G2A MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 8332 111338 5321 - PLA2G4A PLA2G4|cPLA2-alpha 9606 Homo sapiens inhibitor target Sano A (1999) 10351938 177115 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 8333 111338 5321 - PLA2G4A PLA2G4|cPLA2-alpha 9606 Homo sapiens inhibitor target Myo S (2004) 15083746 177116 578 Fluticasone Propionate Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate apo-fluticasone|ratio-fluticas DRUGBANK DB00588 C25H31F3O5S small molecule D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58 80474-14-2 DRUGBANK 13759 111338 5321 - PLA2G4A PLA2G4|cPLA2-alpha 9606 Homo sapiens inhibitor target Ong WY (2003) 12582837 180148 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13760 111338 5321 - PLA2G4A PLA2G4|cPLA2-alpha 9606 Homo sapiens inhibitor target Hellstrand M (2002) 12110374 180149 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13761 111338 5321 - PLA2G4A PLA2G4|cPLA2-alpha 9606 Homo sapiens inhibitor target Kim BC (1998) 9480923 180150 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 23683 111338 5321 - PLA2G4A PLA2G4|cPLA2-alpha 9606 Homo sapiens unknown target Jabeen T (2005) 16301791 181921 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 153 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Stief TW (2003) 14507109 171813 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 154 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Chang H (2003) 12745435 171796 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 155 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Lindholt JS (2003) 12787697 171816 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 156 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Wells RG (2003) 12893898 171814 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 157 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Aleman C (2003) 12826021 171815 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 13647 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Nichols WW (1991) 1717784 180082 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13648 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Kerins DM (1992) 1370924 180081 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13651 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Nizankowski R (1991) 1726988 180080 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13650 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Nicolini FA (1990) 1689620 180083 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13649 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Herczenik E (2007) 17510465 180079 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 25691 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6489 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID - - DRUGBANK DB07684 C12H13NO3S small molecule - - DRUGBANK 13285 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens negative modulator target Palayoor ST (2012) 22668799 179903 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 27850 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens inhibitor target Cicardi M (2005) 16267649 195964 7771 C1 Esterase Inhibitor (Human) C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor berinert 1500|berinert|beriner DRUGBANK DB06404 - biologic - - DRUGBANK 7624 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens antagonist target Tran-Thang C (1994) 7962113 176574 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7625 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens antagonist target Urano T (1988) 3146348 176575 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7626 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens antagonist target Husain SS (1989) 2502209 176576 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7627 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens antagonist target Krishnamurti C (1994) 8073394 176573 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 27925 111343 5327 - PLAT T-PA|TPA 9606 Homo sapiens inhibitor target Cicardi M (2005) 16267649 195964 7972 C1 Esterase Inhibitor (Recombinant) C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH ruconest DRUGBANK DB09228 - biologic B06AC04 80295-38-1 DRUGBANK 19738 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2594 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02705 C24H26N4O small molecule - - DRUGBANK 19739 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2594 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02705 C24H26N4O small molecule - - DRUGBANK 19740 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2594 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02705 C24H26N4O small molecule - - DRUGBANK 22094 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3713 Thieno[2,3-B]Pyridine-2-Carboxamidine - - DRUGBANK DB03876 C8H8N3S small molecule - - DRUGBANK 20569 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3004 4-Iodobenzo[B]Thiophene-2-Carboxamidine - - DRUGBANK DB03136 C9H8IN2S small molecule - - DRUGBANK 18230 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1901 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine - - DRUGBANK DB01977 C18H15N3O small molecule - - DRUGBANK 18231 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1901 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine - - DRUGBANK DB01977 C18H15N3O small molecule - - DRUGBANK 18232 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1901 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine - - DRUGBANK DB01977 C18H15N3O small molecule - - DRUGBANK 18047 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1832 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB01905 C15H15N4O2 small molecule - - DRUGBANK 25138 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5947 (2R)-1-(2,6-dimethylphenoxy)propan-2-amine - - DRUGBANK DB07129 C11H17NO small molecule - - DRUGBANK 22087 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3702 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine - - DRUGBANK DB03865 C21H17ClN3O small molecule - - DRUGBANK 25630 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6432 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide - - DRUGBANK DB07626 C24H32ClN3O3 small molecule - - DRUGBANK 25131 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5940 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine - - DRUGBANK DB07122 C15H15N3O small molecule - - DRUGBANK 19141 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2301 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02398 C19H18N4O small molecule - - DRUGBANK 19142 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2301 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02398 C19H18N4O small molecule - - DRUGBANK 19143 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2301 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02398 C19H18N4O small molecule - - DRUGBANK 22761 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4002 [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine - - DRUGBANK DB04172 C32H48N6O4S small molecule - - DRUGBANK 22762 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4002 [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine - - DRUGBANK DB04172 C32H48N6O4S small molecule - - DRUGBANK 21810 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3572 2-Amino-5-Hydroxy-Benzimidazole - - DRUGBANK DB03729 C7H6N3O small molecule - - DRUGBANK 21811 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3572 2-Amino-5-Hydroxy-Benzimidazole - - DRUGBANK DB03729 C7H6N3O small molecule - - DRUGBANK 26726 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7471 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide - - DRUGBANK DB08697 C22H28ClN3O2 small molecule - - DRUGBANK 22446 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3891 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide - - DRUGBANK DB04059 C15H13N5 small molecule - - DRUGBANK 22447 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3891 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide - - DRUGBANK DB04059 C15H13N5 small molecule - - DRUGBANK 22448 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3891 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide - - DRUGBANK DB04059 C15H13N5 small molecule - - DRUGBANK 8407 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens inhibitor target Cejkova J (2005) 15866288 177159 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8408 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens inhibitor target Jankun J (2001) 11562773 177158 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8409 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8410 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens inhibitor target Luikart S (2002) 12183060 177160 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8411 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens inhibitor target Chen YX (2003) 12897821 177161 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8412 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens inhibitor target Vakili J (2001) 11544332 177162 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 19394 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2423 CRA_10655 - - DRUGBANK DB02526 C19H20N4O2 small molecule - - DRUGBANK 20377 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2918 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide - - DRUGBANK DB03046 C16H16N4O3S small molecule - - DRUGBANK 20378 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2918 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide - - DRUGBANK DB03046 C16H16N4O3S small molecule - - DRUGBANK 20379 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2918 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide - - DRUGBANK DB03046 C16H16N4O3S small molecule - - DRUGBANK 19445 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2448 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02551 C23H24N4O small molecule - - DRUGBANK 19446 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2448 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02551 C23H24N4O small molecule - - DRUGBANK 19447 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2448 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02551 C23H24N4O small molecule - - DRUGBANK 21917 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3622 N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea - - DRUGBANK DB03782 C19H27N5O small molecule - - DRUGBANK 21918 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3622 N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea - - DRUGBANK DB03782 C19H27N5O small molecule - - DRUGBANK 21919 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3622 N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea - - DRUGBANK DB03782 C19H27N5O small molecule - - DRUGBANK 21353 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3331 Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine - - DRUGBANK DB03476 C20H18N2 small molecule - - DRUGBANK 21354 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3331 Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine - - DRUGBANK DB03476 C20H18N2 small molecule - - DRUGBANK 21355 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3331 Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine - - DRUGBANK DB03476 C20H18N2 small molecule - - DRUGBANK 25080 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5894 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE - - DRUGBANK DB07076 C23H23N3O2 small molecule - - DRUGBANK 24883 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5675 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE - - DRUGBANK DB06854 C20H16N4O small molecule - - DRUGBANK 24885 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5676 6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE - - DRUGBANK DB06855 C18H19FN4O2 small molecule - - DRUGBANK 24886 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5677 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE - - DRUGBANK DB06856 C22H24FN3O2 small molecule - - DRUGBANK 24887 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5678 N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE - - DRUGBANK DB06857 C15H13ClIN3O2 small molecule - - DRUGBANK 26097 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6865 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE - - DRUGBANK DB08072 C18H20Cl2N2O3 small molecule - - DRUGBANK 20436 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2953 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide - - DRUGBANK DB03082 C23H21N7O small molecule - - DRUGBANK 20437 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2953 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide - - DRUGBANK DB03082 C23H21N7O small molecule - - DRUGBANK 158 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Bell WR (2003) 12556741 171818 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 159 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Chang H (2003) 12745435 171796 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 160 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Gamberi G (2003) 12579271 171799 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 161 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Zhang G (2003) 12707394 171817 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 162 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Wielockx B (2003) 12824001 171819 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 25629 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6431 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide - - DRUGBANK DB07625 C21H28N2O4 small molecule - - DRUGBANK 20548 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20549 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20694 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3027 CRA_8696 - - DRUGBANK DB03159 C21H17N3O small molecule - - DRUGBANK 18695 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2109 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB02193 C14H13N4O small molecule - - DRUGBANK 19272 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2373 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02473 C24H24N4O small molecule - - DRUGBANK 19273 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2373 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02473 C24H24N4O small molecule - - DRUGBANK 19274 111344 5328 RP11-417O11.1 PLAU ATF|BDPLT5|QPD|UPA|URK|u-PA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2373 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine - - DRUGBANK DB02473 C24H24N4O small molecule - - DRUGBANK 113 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 114 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 384 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Ferrier CM (2002) 12210068 171901 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 385 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Maupas-Schwalm F (2004) 15231724 171902 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 386 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Bankl HC (2001) 11447759 171903 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 187 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 188 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 163 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Fuchs T (2003) 12817472 171823 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 164 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Gutova M (2007) 17327908 171822 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 165 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Czekay RP (2003) 12615913 171821 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 166 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Kanse SM (2004) 14679304 171820 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 167 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Beaufort N (2004) 14688365 171825 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 168 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Guerrero J (2004) 14720519 171824 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 346 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 347 111345 5329 - PLAUR CD87|U-PAR|UPAR|URKR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 21121 111349 5333 - PLCD1 NDNC3|PLC-III 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21122 111349 5333 - PLCD1 NDNC3|PLC-III 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21123 111349 5333 - PLCD1 NDNC3|PLC-III 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 22262 111349 5333 - PLCD1 NDNC3|PLC-III 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3791 D-Myo-Inositol-2,4,5-Trisphosphate - - DRUGBANK DB03956 C6H15O15P3 small molecule - - DRUGBANK 22263 111349 5333 - PLCD1 NDNC3|PLC-III 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3791 D-Myo-Inositol-2,4,5-Trisphosphate - - DRUGBANK DB03956 C6H15O15P3 small molecule - - DRUGBANK 22264 111349 5333 - PLCD1 NDNC3|PLC-III 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3791 D-Myo-Inositol-2,4,5-Trisphosphate - - DRUGBANK DB03956 C6H15O15P3 small molecule - - DRUGBANK 13754 111350 5334 - PLCL1 PLCE|PLCL|PLDL1|PPP1R127|PRIP 9606 Homo sapiens inhibitor target Bjoro T (1993) 8469910 180143 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13755 111350 5334 - PLCL1 PLCE|PLCL|PLDL1|PPP1R127|PRIP 9606 Homo sapiens inhibitor target Biondi C (2001) 11207202 180144 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13756 111350 5334 - PLCL1 PLCE|PLCL|PLDL1|PPP1R127|PRIP 9606 Homo sapiens inhibitor target Otamiri T (1989) 2551803 180145 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13757 111350 5334 - PLCL1 PLCE|PLCL|PLDL1|PPP1R127|PRIP 9606 Homo sapiens inhibitor target Noveral JP (1995) 7573467 180146 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13758 111350 5334 - PLCL1 PLCE|PLCL|PLDL1|PPP1R127|PRIP 9606 Homo sapiens inhibitor target Takuwa N (1991) 1860838 180147 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 1827 111353 5337 - PLD1 - 9606 Homo sapiens product of target Lee JS (2005) 16179605 172770 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1840 111354 5338 - PLD2 - 9606 Homo sapiens product of target Szumilo M (2006) 16921342 71101 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1841 111354 5338 - PLD2 - 9606 Homo sapiens product of target Singh AT (2005) 16459925 172780 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1842 111354 5338 - PLD2 - 9606 Homo sapiens product of target Lee JS (2005) 16179605 172770 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1843 111354 5338 - PLD2 - 9606 Homo sapiens product of target Paruch S (2007) 17627030 172778 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1844 111354 5338 - PLD2 - 9606 Homo sapiens product of target Fensome-Green A (2006) 16878701 172779 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 142 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Lopez-Alemany R (2003) 12666133 171805 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 143 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Hashimoto M (2003) 12719778 171804 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 144 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Zhang X (2003) 12658774 171807 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 145 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Guda K (2003) 12720300 171806 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 146 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 147 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chang H (2003) 12745435 171796 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 179 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Melandri G (2009) 19436656 171787 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 180 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 181 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Longstaff C (2008) 18673235 171788 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 182 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Hilleman DE (2007) 17963464 171789 15 Reteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA retavase DRUGBANK DB00015 C1736H2671N499O522S22 biologic B01AD07 133652-38-7 DRUGBANK 379 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Melandri G (2009) 19436656 171787 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 380 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 381 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Longstaff C (2008) 18673235 171788 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 382 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Hilleman DE (2007) 17963464 171789 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 24638 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens unknown target Mahdy AM (2004) 15277296 181856 5574 Aprotinin Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine trasylol|trasylol inj 10000 ki DRUGBANK DB06692 C284H432N84O79S7 biologic B02AB01 9087-70-1 DRUGBANK 339 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Melandri G (2009) 19436656 171787 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 340 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 341 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Longstaff C (2008) 18673235 171788 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 342 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Hilleman DE (2007) 17963464 171789 29 Anistreplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA eminase 30 units DRUGBANK DB00029 C2569H3928N746O781S40 biologic B01AD03 81669-57-0 DRUGBANK 24166 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens unknown target Dafer RM (2007) 17425487 182000 4722 Desmoteplase DSPA|Desmodus rotundus salivary plasminogen activator - DRUGBANK DB04925 - biologic - 145137-38-8 DRUGBANK 105 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Melandri G (2009) 19436656 171787 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 106 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 107 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Longstaff C (2008) 18673235 171788 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 108 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Hilleman DE (2007) 17963464 171789 9 Alteplase t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor activase rt-pa|lysatec rt - pa DRUGBANK DB00009 C2569H3928N746O781S40 biologic B01AD02|S01XA13 105857-23-6 DRUGBANK 1074 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 1075 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Chaudhary A (1999) 10631997 172268 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 1076 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Alessi MC (1999) 10581996 172269 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 1077 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Caballero AR (1999) 10569766 172265 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 1078 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Parry MA (2000) 10664583 172266 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 1079 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens activator target Korol'chuk VI (2000) 10726310 172267 82 Streptokinase Streptokinase C precursor kabikinase - pws 250000 unit/v DRUGBANK DB00086 C2100H3278N566O669S4 biologic B01AD01|B06AA55 9002-01-1 DRUGBANK 21771 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3553 Bicine - - DRUGBANK DB03709 C6H13NO4 small molecule - - DRUGBANK 21772 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3553 Bicine - - DRUGBANK DB03709 C6H13NO4 small molecule - - DRUGBANK 5260 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Hanson AJ (2002) 12115473 175061 295 Tranexamic Acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid cyklokapron 500 mg|tranexamic DRUGBANK DB00302 C8H15NO2 small molecule B02AA02 1197-18-8 DRUGBANK 5261 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Dunn CJ (1999) 10400410 175060 295 Tranexamic Acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid cyklokapron 500 mg|tranexamic DRUGBANK DB00302 C8H15NO2 small molecule B02AA02 1197-18-8 DRUGBANK 5262 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 295 Tranexamic Acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid cyklokapron 500 mg|tranexamic DRUGBANK DB00302 C8H15NO2 small molecule B02AA02 1197-18-8 DRUGBANK 5263 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Bangert K (2000) 10959704 175058 295 Tranexamic Acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid cyklokapron 500 mg|tranexamic DRUGBANK DB00302 C8H15NO2 small molecule B02AA02 1197-18-8 DRUGBANK 5264 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Marti DN (1999) 10625440 175059 295 Tranexamic Acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid cyklokapron 500 mg|tranexamic DRUGBANK DB00302 C8H15NO2 small molecule B02AA02 1197-18-8 DRUGBANK 5265 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Jansen AJ (1999) 10673876 175057 295 Tranexamic Acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid cyklokapron 500 mg|tranexamic DRUGBANK DB00302 C8H15NO2 small molecule B02AA02 1197-18-8 DRUGBANK 7615 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Kanalas JJ (1992) 1280065 171803 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7616 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Mochalkin I (1999) 10026282 176570 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7617 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Prandota J (2001) 11304653 176571 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7618 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7619 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Sun Z (2002) 12007600 176568 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 7620 111356 5340 RP1-81D8.1 PLG - 9606 Homo sapiens inhibitor target Lee KN (2002) 11927133 176569 503 Aminocaproic Acid Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC exoden white tooth|amicar|amin DRUGBANK DB00513 C6H13NO2 small molecule B02AA01 60-32-2 DRUGBANK 24922 111362 5347 - PLK1 PLK|STPK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5716 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol - - DRUGBANK DB06897 C23H22ClN3O2 small molecule - - DRUGBANK 25817 111362 5347 - PLK1 PLK|STPK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6588 1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea - - DRUGBANK DB07789 C18H17F3N10O2S small molecule - - DRUGBANK 25192 111362 5347 - PLK1 PLK|STPK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6003 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE - - DRUGBANK DB07186 C23H24N6O2S small molecule - - DRUGBANK 24984 111362 5347 - PLK1 PLK|STPK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5782 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide - - DRUGBANK DB06963 C24H25N5O small molecule - - DRUGBANK 26083 111362 5347 - PLK1 PLK|STPK13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6852 (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE - - DRUGBANK DB08059 C23H24O8 small molecule - - DRUGBANK 1906 111366 5351 RP5-1077B9.2 PLOD1 EDS6|LH|LH1|LLH|PLOD 9606 Homo sapiens activator target Salavoura K (2006) 17100196 172875 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1907 111366 5351 RP5-1077B9.2 PLOD1 EDS6|LH|LH1|LLH|PLOD 9606 Homo sapiens activator target Chen X (2002) 11752352 171740 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2236 111366 5351 RP5-1077B9.2 PLOD1 EDS6|LH|LH1|LLH|PLOD 9606 Homo sapiens unknown target Cudic M (2007) 17610258 173143 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 1910 111367 5352 - PLOD2 LH2|TLH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1911 111367 5352 - PLOD2 LH2|TLH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 22713 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 18065 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18066 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 18067 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1841 S-Hydroxycysteine - - DRUGBANK DB01915 C3H7NO3S small molecule - - DRUGBANK 21960 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21961 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21962 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 22841 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4052 Oleic Acid - sha-lem DRUGBANK DB04224 C18H34O2 small molecule - 112-80-1 DRUGBANK 22842 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4052 Oleic Acid - sha-lem DRUGBANK DB04224 C18H34O2 small molecule - 112-80-1 DRUGBANK 22843 111388 5375 - PMP2 FABP8|M-FABP|MP2|P2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4052 Oleic Acid - sha-lem DRUGBANK DB04224 C18H34O2 small molecule - 112-80-1 DRUGBANK 22858 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 26242 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7013 METHOXYUNDECYLPHOSPHINIC ACID - - DRUGBANK DB08222 C12H27O3P small molecule - - DRUGBANK 13580 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Henness S (2006) 16956313 180040 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13581 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Nelson RH (2005) 16259579 180042 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13582 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Uusitupa M (1999) 10095983 180045 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13583 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Leonhardt M (1999) 10338682 180044 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13584 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target McNeely W (1998) 9711448 180047 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13585 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Bray GA (2000) 11054601 180046 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13586 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Gomis Barbara R (2004) 15382615 180049 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13587 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Bray GA (1999) 10932681 180048 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13588 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13589 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Heck AM (2000) 10730683 180038 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13590 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Ballinger A (2002) 12007529 180039 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13591 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Wong NN (2001) 11728255 180036 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13592 111407 5406 RP11-33D13.1 PNLIP PL|PNLIPD|PTL 9606 Homo sapiens inhibitor target Drew BS (2008) 18200802 180037 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 19547 111409 5408 - PNLIPRP2 PLRP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 25607 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6404 CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL - - DRUGBANK DB07597 C10H13NO small molecule - - DRUGBANK 22034 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3662 7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline - - DRUGBANK DB03824 C9H10IN small molecule - - DRUGBANK 22035 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3662 7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline - - DRUGBANK DB03824 C9H10IN small molecule - - DRUGBANK 22036 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3662 7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline - - DRUGBANK DB03824 C9H10IN small molecule - - DRUGBANK 25743 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6540 (3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE - - DRUGBANK DB07739 C14H19FN2O2S2 small molecule - - DRUGBANK 26593 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7328 7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE - - DRUGBANK DB08550 C9H9Cl2N small molecule - - DRUGBANK 25749 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6548 (3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE - - DRUGBANK DB07747 C16H17ClN2O3S small molecule - - DRUGBANK 22980 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4100 8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine - - DRUGBANK DB04273 C10H11Cl2N small molecule - - DRUGBANK 22981 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4100 8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine - - DRUGBANK DB04273 C10H11Cl2N small molecule - - DRUGBANK 22982 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4100 8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine - - DRUGBANK DB04273 C10H11Cl2N small molecule - - DRUGBANK 21348 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3323 1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide - - DRUGBANK DB03468 C9H12N2O2S small molecule - - DRUGBANK 21349 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3323 1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide - - DRUGBANK DB03468 C9H12N2O2S small molecule - - DRUGBANK 21350 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3323 1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide - - DRUGBANK DB03468 C9H12N2O2S small molecule - - DRUGBANK 25825 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6597 (3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE - - DRUGBANK DB07798 C13H16F4N2O2S small molecule - - DRUGBANK 17721 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17722 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 26658 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7405 N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE - - DRUGBANK DB08631 C15H15ClN2O2S small molecule - - DRUGBANK 25930 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6702 [(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL - - DRUGBANK DB07906 C10H12N2O3 small molecule - - DRUGBANK 26147 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6921 (1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol - - DRUGBANK DB08129 C9H10F3NO small molecule - - DRUGBANK 26146 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6920 (1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine - - DRUGBANK DB08128 C12H12F3N small molecule - - DRUGBANK 26671 111410 5409 - PNMT PENT|PNMTase 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7428 TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL - - DRUGBANK DB08654 C10H13NO small molecule - - DRUGBANK 13501 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Lech-Maranda E (2009) 19519505 177447 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13502 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13503 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Robak T (2009) 19325518 179995 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13504 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13505 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Robak T (2006) 17168705 179999 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 4664 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Kline JP (2005) 16316309 174590 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4665 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Hartman WR (2004) 14722255 174591 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4666 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4667 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Takahashi T (1999) 9923554 174593 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 8824 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Lech-Maranda E (2009) 19519505 177447 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8825 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Pession A (2010) 20631817 177446 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8826 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Harned TM (2008) 18728851 177445 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8827 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Musto P (2008) 18780321 177444 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8828 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Unknown Authors (2004) 15230627 177443 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8829 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8830 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8831 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Kantarjian HM (2007) 17852710 174594 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8832 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 15701 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Buie LW (2007) 18035189 181020 1267 Nelarabine 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine arranon|atriance DRUGBANK DB01280 C11H15N5O5 small molecule L01BB07 121032-29-9 DRUGBANK 15702 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Rodriguez CO (2003) 12750168 181017 1267 Nelarabine 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine arranon|atriance DRUGBANK DB01280 C11H15N5O5 small molecule L01BB07 121032-29-9 DRUGBANK 15703 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Ono K (1979) 91427 181019 1267 Nelarabine 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine arranon|atriance DRUGBANK DB01280 C11H15N5O5 small molecule L01BB07 121032-29-9 DRUGBANK 15704 111418 5422 - POLA1 NSX|POLA|p180 9606 Homo sapiens inhibitor target Curbo S (2006) 18473971 181018 1267 Nelarabine 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine arranon|atriance DRUGBANK DB01280 C11H15N5O5 small molecule L01BB07 121032-29-9 DRUGBANK 12503 111419 5423 - POLB - 9606 Homo sapiens inhibitor target Krynetskaia NF (2009) 19372559 179517 977 Cytarabine 1-beta-D-Arabinofuranosylcytosine|Cytarabine|Arabinofuranosyl Cytidine|Cytosine arabinoside|4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone|Cytarabinum|Ara-C|Cytosine-1-beta-D-arabinofuranoside|Citarabina|cytosine--D-arabinofuranoside|Cytosine-beta-D-arabinofuranoside aj-cytarabine|cytarabine injec DRUGBANK DB00987 C9H13N3O5 small molecule L01BC01 147-94-4 DRUGBANK 12504 111419 5423 - POLB - 9606 Homo sapiens inhibitor target Angeli JP (2006) 16866189 179516 977 Cytarabine 1-beta-D-Arabinofuranosylcytosine|Cytarabine|Arabinofuranosyl Cytidine|Cytosine arabinoside|4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone|Cytarabinum|Ara-C|Cytosine-1-beta-D-arabinofuranoside|Citarabina|cytosine--D-arabinofuranoside|Cytosine-beta-D-arabinofuranoside aj-cytarabine|cytarabine injec DRUGBANK DB00987 C9H13N3O5 small molecule L01BC01 147-94-4 DRUGBANK 12505 111419 5423 - POLB - 9606 Homo sapiens inhibitor target Miura S (2004) 15011952 179515 977 Cytarabine 1-beta-D-Arabinofuranosylcytosine|Cytarabine|Arabinofuranosyl Cytidine|Cytosine arabinoside|4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone|Cytarabinum|Ara-C|Cytosine-1-beta-D-arabinofuranoside|Citarabina|cytosine--D-arabinofuranoside|Cytosine-beta-D-arabinofuranoside aj-cytarabine|cytarabine injec DRUGBANK DB00987 C9H13N3O5 small molecule L01BC01 147-94-4 DRUGBANK 20777 111419 5423 - POLB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3090 2'-Deoxyadenosine 5'-Triphosphate - - DRUGBANK DB03222 C10H16N5O12P3 small molecule - 1927-31-7 DRUGBANK 20778 111419 5423 - POLB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3090 2'-Deoxyadenosine 5'-Triphosphate - - DRUGBANK DB03222 C10H16N5O12P3 small molecule - 1927-31-7 DRUGBANK 20779 111419 5423 - POLB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3090 2'-Deoxyadenosine 5'-Triphosphate - - DRUGBANK DB03222 C10H16N5O12P3 small molecule - 1927-31-7 DRUGBANK 25503 111419 5423 - POLB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6290 (1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL - - DRUGBANK DB07479 C18H16O3 small molecule - - DRUGBANK 4673 111422 5426 - POLE CRCS12|FILS|POLE1 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4674 111423 5427 - POLE2 DPE2 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 10966 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens modulator target Nomura A (2001) 11474216 178613 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10967 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens modulator target Auernhammer CJ (1992) 1322429 178612 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10968 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens modulator target Ambrosi B (1989) 2545766 178616 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10969 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens modulator target Ambrosi B (1987) 2832297 178615 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 10970 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens modulator target Bochicchio D (1988) 2855105 178614 826 Loperamide Lopramide|Loperamida|Loperamid|Loperamidum dg health loperamide hydrochlo DRUGBANK DB00836 C29H33ClN2O2 small molecule A07DA53|A07DA05|A07DA03 53179-11-6 DRUGBANK 16840 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens unknown target Dum J (1983) 6132412 181455 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16841 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens unknown target Nicolas P (1985) 2987913 181457 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16842 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens unknown target Xu JY (1992) 1328609 181456 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16843 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens unknown target Lemaire S (1981) 6259293 181459 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16844 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens unknown target Sanchez-Blazquez P (1992) 1318989 181458 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16991 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens agonist target Johnson N (1982) 6292632 181518 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16992 111439 5443 - POMC ACTH|CLIP|LPH|MSH|NPP|POC 9606 Homo sapiens agonist target Somoza E (1978) 29252 181519 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 15853 111440 5444 - PON1 ESA|MVCD5|PON 9606 Homo sapiens inhibitor target Sinan S (2006) 16600468 181103 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 20844 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20650 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20651 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20652 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21306 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21307 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21308 111443 5447 - POR CPR|CYPOR|P450R 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 18020 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1817 N,N-bis(3-(D-gluconamido)propyl)deoxycholamide Deoxy-bigchap - DRUGBANK DB01890 C42H75N3O15 small molecule - 86303-23-3 DRUGBANK 18021 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1817 N,N-bis(3-(D-gluconamido)propyl)deoxycholamide Deoxy-bigchap - DRUGBANK DB01890 C42H75N3O15 small molecule - 86303-23-3 DRUGBANK 8855 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Palkar PS (2010) 20637823 177478 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 8856 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Hunt MC (2000) 10787442 177476 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 8857 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Koemueves LG (2000) 10951268 177477 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 8858 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Barclay TB (1999) 10454501 177474 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 8859 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Casas F (2000) 10922459 177475 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 8860 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Murata M (2000) 10753628 177472 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 8861 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Gelosa P (2010) 20671072 177473 626 Clofibrate Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate novo-fibrate cap 500mg|atromid DRUGBANK DB00636 C12H15ClO3 small molecule C10AB01 637-07-0 DRUGBANK 17632 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens activator target Tamasi V (2008) 18079279 181624 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17633 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens activator target Kohalmy K (2007) 17591676 181619 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 16373 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Goldenberg I (2008) 18629356 181274 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16374 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Cabrero A (2000) 10933891 181271 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16375 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Guan Y (2001) 11422732 181270 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16376 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Pedraza N (2000) 10909982 181273 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16377 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Fruchart JC (2006) 16511610 181272 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16378 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16379 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Bonilla S (2001) 11519881 181268 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 16380 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Inoue I (2001) 11172467 181269 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 13078 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 13079 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Clavey V (1999) 10494028 179845 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 13080 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Casas F (2000) 11018525 179844 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 13081 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Bouly M (2001) 11342537 179847 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 13082 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Chaput E (2000) 10799317 179846 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 13083 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Guerre-Millo M (2000) 10828060 179843 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 13084 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Dana SL (2001) 11474486 179848 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 15298 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Clavey V (1999) 10494028 179845 1229 Gemfibrozil Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil scheinpharm gemfibrozil|penta- DRUGBANK DB01241 C15H22O3 small molecule C10AB04 25812-30-0 DRUGBANK 15299 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Bosse Y (2002) 12172398 180804 1229 Gemfibrozil Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil scheinpharm gemfibrozil|penta- DRUGBANK DB01241 C15H22O3 small molecule C10AB04 25812-30-0 DRUGBANK 15300 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Pahan K (2002) 12244038 180805 1229 Gemfibrozil Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil scheinpharm gemfibrozil|penta- DRUGBANK DB01241 C15H22O3 small molecule C10AB04 25812-30-0 DRUGBANK 15301 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Rizvi F (2003) 12935323 180803 1229 Gemfibrozil Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil scheinpharm gemfibrozil|penta- DRUGBANK DB01241 C15H22O3 small molecule C10AB04 25812-30-0 DRUGBANK 15302 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Shoji Y (2003) 12834305 180802 1229 Gemfibrozil Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil scheinpharm gemfibrozil|penta- DRUGBANK DB01241 C15H22O3 small molecule C10AB04 25812-30-0 DRUGBANK 5613 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Lehmann JM (1997) 9013583 175242 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 25730 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6527 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid - - DRUGBANK DB07724 C19H19NO6S small molecule - - DRUGBANK 26997 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 7659 Aleglitazar - - DRUGBANK DB08915 C24H23NO5S small molecule - 475479-34-6 DRUGBANK 26998 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens agonist target Cavender MA (2010) 20653327 182161 7659 Aleglitazar - - DRUGBANK DB08915 C24H23NO5S small molecule - 475479-34-6 DRUGBANK 25220 111461 5465 SC22CB-5E3.5 PPARA NR1C1|PPAR|PPARalpha|hPPAR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6031 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID - - DRUGBANK DB07215 C23H21F3N2O4S small molecule - - DRUGBANK 3445 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Iwata Y (2001) 11552681 173832 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3446 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Inoue I (1998) 9610365 173838 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3447 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Caldari-Torres C (2006) 16507691 173839 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3448 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Xu HE (1999) 10198642 173837 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3449 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Kondo H (2007) 17632107 173840 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 25701 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6496 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid - - DRUGBANK DB07691 C23H20N2O5S small molecule - - DRUGBANK 8555 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens negative modulator target Liou JY (2007) 17409426 177241 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8556 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens negative modulator target Kim DJ (2006) 16418176 177240 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8557 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens negative modulator target Jarvis MC (2005) 16091736 177243 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8558 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens negative modulator target He TC (1999) 10555149 177242 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8559 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens negative modulator target Babbar N (2003) 14506281 170907 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 20999 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3201 Heptyl-Beta-D-Glucopyranoside - - DRUGBANK DB03338 C13H26O6 small molecule - - DRUGBANK 21000 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3201 Heptyl-Beta-D-Glucopyranoside - - DRUGBANK DB03338 C13H26O6 small molecule - - DRUGBANK 21001 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3201 Heptyl-Beta-D-Glucopyranoside - - DRUGBANK DB03338 C13H26O6 small molecule - - DRUGBANK 16371 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Tenenbaum A (2005) 16168052 181267 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 25729 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6527 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid - - DRUGBANK DB07724 C19H19NO6S small molecule - - DRUGBANK 6213 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens agonist target Ali FY (2006) 16239641 175647 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 25074 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5888 (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid - - DRUGBANK DB07070 C21H21F4NO4 small molecule - - DRUGBANK 26107 111463 5467 - PPARD FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6871 {4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid - - DRUGBANK DB08078 C22H26O7 small molecule - - DRUGBANK 3436 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Horia E (2007) 17052999 173829 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3437 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Ramakers JD (2007) 17610002 173828 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3438 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Selvaraj RK (2006) 16702329 173830 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3439 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Chambrier C (2002) 12055328 173831 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3440 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Iwata Y (2001) 11552681 173832 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 14035 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Miyazaki Y (2004) 15356026 180300 1120 Pioglitazone Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone phl-pioglitazone|pms-pioglitaz DRUGBANK DB01132 C19H20N2O3S small molecule A10BD12|A10BG03|A10BD09|A10BD05|A10BD06 111025-46-8 DRUGBANK 14036 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1120 Pioglitazone Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone phl-pioglitazone|pms-pioglitaz DRUGBANK DB01132 C19H20N2O3S small molecule A10BD12|A10BG03|A10BD09|A10BD05|A10BD06 111025-46-8 DRUGBANK 14037 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Lehmann JM (1995) 7768881 180298 1120 Pioglitazone Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone phl-pioglitazone|pms-pioglitaz DRUGBANK DB01132 C19H20N2O3S small molecule A10BD12|A10BG03|A10BD09|A10BD05|A10BD06 111025-46-8 DRUGBANK 14038 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Willson TM (1996) 8576907 180299 1120 Pioglitazone Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone phl-pioglitazone|pms-pioglitaz DRUGBANK DB01132 C19H20N2O3S small molecule A10BD12|A10BG03|A10BD09|A10BD05|A10BD06 111025-46-8 DRUGBANK 14039 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Sugii S (2009) 20018750 180296 1120 Pioglitazone Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone phl-pioglitazone|pms-pioglitaz DRUGBANK DB01132 C19H20N2O3S small molecule A10BD12|A10BG03|A10BD09|A10BD05|A10BD06 111025-46-8 DRUGBANK 14040 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Spiegelman BM (1998) 9568680 180297 1120 Pioglitazone Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone phl-pioglitazone|pms-pioglitaz DRUGBANK DB01132 C19H20N2O3S small molecule A10BD12|A10BG03|A10BD09|A10BD05|A10BD06 111025-46-8 DRUGBANK 16372 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Tenenbaum A (2005) 16168052 181267 1343 Bezafibrate 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip pms-bezafibrate|bezalip tab 20 DRUGBANK DB01393 C19H20ClNO4 small molecule C10AB02 41859-67-0 DRUGBANK 4143 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4144 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Demetri GD (1999) 10097144 174284 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4145 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Petrova TV (1999) 10200320 174285 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4146 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Kitamura S (1999) 10076568 174286 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4147 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Baek SJ (2003) 12475986 174281 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4148 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Camp HS (1999) 10214942 174282 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 4149 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Satoh T (1999) 10222233 174283 190 Troglitazone - - DRUGBANK DB00197 C24H27NO5S small molecule A10BG01 97322-87-7 DRUGBANK 6629 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Johnson BA (2000) 10764590 175913 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 6630 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Camp HS (2000) 10871190 175912 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 6631 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Rieusset J (1999) 10548525 175911 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 6632 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Kameda N (2000) 10707565 175910 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 6633 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 6634 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Su JL (1999) 10475242 175909 404 Rosiglitazone (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona phl-rosiglitazone|avandaryl|av DRUGBANK DB00412 C18H19N3O3S small molecule A10BD03|A10BG02|A10BD04 122320-73-4 DRUGBANK 24949 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5745 (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid - - DRUGBANK DB06926 C18H32O3 small molecule - - DRUGBANK 26995 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 7659 Aleglitazar - - DRUGBANK DB08915 C24H23NO5S small molecule - 475479-34-6 DRUGBANK 26996 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Cavender MA (2010) 20653327 182161 7659 Aleglitazar - - DRUGBANK DB08915 C24H23NO5S small molecule - 475479-34-6 DRUGBANK 4693 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Desreumaux P (2006) 16939423 174608 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4694 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Schwab M (2008) 18544567 174605 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4695 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Linard C (2008) 18077625 174606 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4696 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Rousseaux C (2005) 15824083 174607 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 25180 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5989 (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid - - DRUGBANK DB07172 C20H30O3 small molecule - - DRUGBANK 13403 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Scarsi M (2007) 17082235 178076 1055 Glipizide Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024 glucotrol|glipizide|glipizidee DRUGBANK DB01067 C21H27N5O4S small molecule A10BB07 29094-61-9 DRUGBANK 25900 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6660 2-chloro-5-nitro-N-phenylbenzamide - - DRUGBANK DB07863 C13H9ClN2O3 small molecule - - DRUGBANK 24933 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5727 (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID - - DRUGBANK DB06908 C24H23ClN2O4 small molecule - - DRUGBANK 12352 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Yamagishi S (2004) 15617852 179382 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12353 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Yamagishi S (2007) 17691961 179383 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12354 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Kurtz TW (2008) 18580862 179381 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12355 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Kurtz TW (2005) 15868121 179386 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12356 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Imayama I (2006) 16938288 179384 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12357 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Yamagishi S (2005) 16154710 179385 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 12358 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens partial agonist target Tagami T (2009) 19147680 171006 956 Telmisartan 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid telmisartan/hctz|telmisartan|t DRUGBANK DB00966 C33H30N4O2 small molecule C09DA07|C09CA07|C09DB04 144701-48-4 DRUGBANK 13284 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens activator target Dill J (2010) 20089905 179904 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 25530 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6320 difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron - - DRUGBANK DB07509 C22H31BF2N2O2 small molecule - - DRUGBANK 25213 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6025 (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid - - DRUGBANK DB07208 C18H30O4 small molecule - - DRUGBANK 25214 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6026 (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid - - DRUGBANK DB07209 C18H30O4 small molecule - - DRUGBANK 22926 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4097 (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid - - DRUGBANK DB04270 C25H25NO4 small molecule - - DRUGBANK 25866 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6639 (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid - - DRUGBANK DB07842 C17H18O3 small molecule - - DRUGBANK 25731 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6527 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid - - DRUGBANK DB07724 C19H19NO6S small molecule - - DRUGBANK 25728 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6526 3-(5-methoxy-1H-indol-3-yl)propanoic acid - - DRUGBANK DB07723 C12H13NO3 small molecule - - DRUGBANK 26140 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6913 (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid - - DRUGBANK DB08121 C21H18O3 small molecule - - DRUGBANK 25682 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6481 (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID - - DRUGBANK DB07675 C25H25NO5 small molecule - - DRUGBANK 5606 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens activator target Cho MC (2003) 12689521 175243 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5607 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens activator target Lehmann JM (1997) 9013583 175242 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 11859 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Scarsi M (2007) 17082235 178076 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 10549 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Desreumaux P (2006) 16939423 174608 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10550 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Schwab M (2008) 18544567 174605 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10551 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Linard C (2008) 18077625 174606 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10552 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Rousseaux C (2005) 15824083 174607 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 25309 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6118 (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid - - DRUGBANK DB07302 C18H32O3 small molecule - - DRUGBANK 26341 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7089 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid - - DRUGBANK DB08302 C16H15NO5 small molecule - - DRUGBANK 26601 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7338 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE - - DRUGBANK DB08560 C19H13F2N3O2S2 small molecule - - DRUGBANK 26475 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7217 (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid - - DRUGBANK DB08435 C20H28O3 small molecule - - DRUGBANK 15394 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Scarsi M (2007) 17082235 178076 1240 Mitiglinide - - DRUGBANK DB01252 C19H25NO3 small molecule A10BX08 145375-43-5 DRUGBANK 25059 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5871 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID - - DRUGBANK DB07053 C24H23F3N2O5 small molecule - - DRUGBANK 26761 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7533 (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid - - DRUGBANK DB08760 C15H13ClO3 small molecule - - DRUGBANK 9928 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Scarsi M (2007) 17082235 178076 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 25120 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5929 (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid - - DRUGBANK DB07111 C22H32O3 small molecule - - DRUGBANK 12739 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Desreumaux P (2006) 16939423 174608 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12740 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Iacucci M (2010) 20151072 179657 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12741 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Tursi A (2009) 19708827 179658 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12742 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens agonist target Linard C (2008) 18077625 174606 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 26450 111464 5468 - PPARG CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7186 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID - - DRUGBANK DB08402 C18H11Cl2N3O4 small molecule - - DRUGBANK 26724 111465 5469 - MED1 CRSP1|CRSP200|DRIP205|DRIP230|PBP|PPARBP|PPARGBP|RB18A|TRAP220|TRIP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7470 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL - - DRUGBANK DB08696 C23H36O2 small molecule - - DRUGBANK 2099 111467 5471 - PPAT ATASE|GPAT|PRAT 9606 Homo sapiens product of target Jiang P (2007) 17355124 172985 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 2100 111467 5471 - PPAT ATASE|GPAT|PRAT 9606 Homo sapiens product of target Jiang P (2007) 17355125 172986 124 L-Glutamine L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid nutrestore DRUGBANK DB00130 C5H10N2O3 small molecule A16AA03 56-85-9 DRUGBANK 12998 111467 5471 - PPAT ATASE|GPAT|PRAT 9606 Homo sapiens unknown target Sahasranaman S (2008) 18506437 179567 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 12999 111467 5471 - PPAT ATASE|GPAT|PRAT 9606 Homo sapiens unknown target Gaulton A (2012) 21948594 174478 1022 Mercaptopurine Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine mercaptopurine|purixan|purinet DRUGBANK DB01033 C5H4N4S small molecule L01BB02 50-44-2 DRUGBANK 21632 111469 5473 - PPBP B-TG1|Beta-TG|CTAP-III|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|PBP|SCYB7|TC1|TC2|TGB|TGB1|THBGB|THBGB1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3482 Ethanesulfonic Acid - - DRUGBANK DB03635 C2H6O3S small molecule - - DRUGBANK 21633 111469 5473 - PPBP B-TG1|Beta-TG|CTAP-III|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|PBP|SCYB7|TC1|TC2|TGB|TGB1|THBGB|THBGB1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3482 Ethanesulfonic Acid - - DRUGBANK DB03635 C2H6O3S small molecule - - DRUGBANK 3760 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3761 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3762 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 17694 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1676 (3r)-1-Acetyl-3-Methylpiperidine - - DRUGBANK DB01742 C8H15NO small molecule - - DRUGBANK 17695 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1676 (3r)-1-Acetyl-3-Methylpiperidine - - DRUGBANK DB01742 C8H15NO small molecule - - DRUGBANK 17696 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1676 (3r)-1-Acetyl-3-Methylpiperidine - - DRUGBANK DB01742 C8H15NO small molecule - - DRUGBANK 19165 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2322 Ethyl Oxo(Piperidin-1-Yl)Acetate - - DRUGBANK DB02419 C9H15NO3 small molecule - 53074-96-7 DRUGBANK 21095 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3252 (3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl- - - DRUGBANK DB03393 C60H91N5O13 small molecule - - DRUGBANK 21096 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3252 (3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl- - - DRUGBANK DB03393 C60H91N5O13 small molecule - - DRUGBANK 21097 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3252 (3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl- - - DRUGBANK DB03393 C60H91N5O13 small molecule - - DRUGBANK 1113 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Keckesova Z (2006) 16641261 172295 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1114 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Stegmann CM (2010) 20368803 172294 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1115 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Schaller T (2007) 17609268 172291 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1116 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Lee J (2010) 20637127 172290 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1117 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Patwardhan AM (2006) 16849427 172293 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1118 111474 5478 - PPIA CYPA|CYPH|HEL-S-69p 9606 Homo sapiens unknown target Redell JB (2007) 17461417 172292 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 3773 111475 5479 - PPIB CYP-S1|CYPB|HEL-S-39|OI9|SCYLP 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3774 111475 5479 - PPIB CYP-S1|CYPB|HEL-S-39|OI9|SCYLP 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3775 111475 5479 - PPIB CYP-S1|CYPB|HEL-S-39|OI9|SCYLP 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 23438 111475 5479 - PPIB CYP-S1|CYPB|HEL-S-39|OI9|SCYLP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 3776 111476 5480 - PPIC CYPC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3777 111476 5480 - PPIC CYPC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 19359 111493 5499 - PPP1CA PP-1A|PP1A|PP1alpha|PPP1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2403 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid - - DRUGBANK DB02506 C20H33NO3 small molecule - - DRUGBANK 23858 111495 5501 - PPP1CC PP-1G|PP1C|PPP1G 9606 Homo sapiens unknown target Maynes JT (2006) 16343532 181923 4541 Motuporin nodularin-V - DRUGBANK DB04738 C40H63N5O10 small molecule - - DRUGBANK 20041 111495 5501 - PPP1CC PP-1G|PP1C|PPP1G 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2742 Calyculin A (-)-calyculin A - DRUGBANK DB02860 C50H81N4O15P small molecule - 101932-71-2 DRUGBANK 20042 111495 5501 - PPP1CC PP-1G|PP1C|PPP1G 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2742 Calyculin A (-)-calyculin A - DRUGBANK DB02860 C50H81N4O15P small molecule - 101932-71-2 DRUGBANK 18657 111495 5501 - PPP1CC PP-1G|PP1C|PPP1G 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2085 9,10-Deepithio-9,10-Didehydroacanthifolicin - - DRUGBANK DB02169 C44H68O13 small molecule - 78111-17-8 DRUGBANK 18658 111495 5501 - PPP1CC PP-1G|PP1C|PPP1G 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2085 9,10-Deepithio-9,10-Didehydroacanthifolicin - - DRUGBANK DB02169 C44H68O13 small molecule - 78111-17-8 DRUGBANK 18659 111495 5501 - PPP1CC PP-1G|PP1C|PPP1G 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2085 9,10-Deepithio-9,10-Didehydroacanthifolicin - - DRUGBANK DB02169 C44H68O13 small molecule - 78111-17-8 DRUGBANK 19361 111507 5515 - PPP2CA PP2Ac|PP2CA|PP2Calpha|RP-C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2403 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid - - DRUGBANK DB02506 C20H33NO3 small molecule - - DRUGBANK 3588 111507 5515 - PPP2CA PP2Ac|PP2CA|PP2Calpha|RP-C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3589 111507 5515 - PPP2CA PP2Ac|PP2CA|PP2Calpha|RP-C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 24930 111507 5515 - PPP2CA PP2Ac|PP2CA|PP2Calpha|RP-C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5724 (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid - - DRUGBANK DB06905 C20H29NO3 small molecule - - DRUGBANK 3580 111508 5516 - PPP2CB PP2Abeta|PP2CB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3581 111508 5516 - PPP2CB PP2Abeta|PP2CB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 19358 111510 5518 - PPP2R1A PP2A-Aalpha|PP2AAALPHA|PR65A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2403 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid - - DRUGBANK DB02506 C20H33NO3 small molecule - - DRUGBANK 24932 111510 5518 - PPP2R1A PP2A-Aalpha|PP2AAALPHA|PR65A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5724 (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid - - DRUGBANK DB06905 C20H29NO3 small molecule - - DRUGBANK 19357 111512 5520 - PPP2R2A B55A|B55ALPHA|PR52A|PR55A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2403 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid - - DRUGBANK DB02506 C20H33NO3 small molecule - - DRUGBANK 19360 111519 5527 - PPP2R5C B56G|PR61G 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2403 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid - - DRUGBANK DB02506 C20H33NO3 small molecule - - DRUGBANK 24931 111519 5527 - PPP2R5C B56G|PR61G 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5724 (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid - - DRUGBANK DB06905 C20H29NO3 small molecule - - DRUGBANK 26257 111522 5530 - PPP3CA CALN|CALNA|CALNA1|CCN1|CNA1|PPP2B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 26255 111526 5534 - PPP3R1 CALNB1|CNB|CNB1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 1126 111527 5535 RP11-102M4.2 PPP3R2 PPP3RL 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1127 111527 5535 RP11-102M4.2 PPP3R2 PPP3RL 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 1128 111527 5535 RP11-102M4.2 PPP3R2 PPP3RL 9606 Homo sapiens inhibitor target Yamashita H (2010) 20674565 172299 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 21957 111530 5538 RP11-115D7.2 PPT1 CLN1|INCL|PPT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21958 111530 5538 RP11-115D7.2 PPT1 CLN1|INCL|PPT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21959 111530 5538 RP11-115D7.2 PPT1 CLN1|INCL|PPT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 18385 111530 5538 RP11-115D7.2 PPT1 CLN1|INCL|PPT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1958 1-Hexadecylsulfonyl Fluoride - - DRUGBANK DB02035 C16H33FO2S small molecule - - DRUGBANK 18386 111530 5538 RP11-115D7.2 PPT1 CLN1|INCL|PPT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1958 1-Hexadecylsulfonyl Fluoride - - DRUGBANK DB02035 C16H33FO2S small molecule - - DRUGBANK 18387 111530 5538 RP11-115D7.2 PPT1 CLN1|INCL|PPT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1958 1-Hexadecylsulfonyl Fluoride - - DRUGBANK DB02035 C16H33FO2S small molecule - - DRUGBANK 21453 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3387 Z-Pro-Prolinal - - DRUGBANK DB03535 C18H22N2O4 small molecule - - DRUGBANK 17749 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17750 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17751 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17556 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1619 1-Hydroxy-1-Thio-Glycerol - - DRUGBANK DB01684 C3H8O3S small molecule - - DRUGBANK 17557 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1619 1-Hydroxy-1-Thio-Glycerol - - DRUGBANK DB01684 C3H8O3S small molecule - - DRUGBANK 17558 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1619 1-Hydroxy-1-Thio-Glycerol - - DRUGBANK DB01684 C3H8O3S small molecule - - DRUGBANK 21073 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3241 S-Oxy Cysteine - - DRUGBANK DB03382 C3H6NO3S small molecule - - DRUGBANK 21074 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3241 S-Oxy Cysteine - - DRUGBANK DB03382 C3H6NO3S small molecule - - DRUGBANK 21075 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3241 S-Oxy Cysteine - - DRUGBANK DB03382 C3H6NO3S small molecule - - DRUGBANK 26742 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7512 2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione - - DRUGBANK DB08739 C20H21F2N3O4 small molecule - - DRUGBANK 26741 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7511 1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one - - DRUGBANK DB08738 C26H28N4O3 small molecule - - DRUGBANK 22083 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3701 Monothioglycerol - - DRUGBANK DB03864 C3H8O2S small molecule - - DRUGBANK 22084 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3701 Monothioglycerol - - DRUGBANK DB03864 C3H8O2S small molecule - - DRUGBANK 22085 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3701 Monothioglycerol - - DRUGBANK DB03864 C3H8O2S small molecule - - DRUGBANK 25159 111541 5550 RP3-355L5.1 PREP PE|PEP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5966 (6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one - - DRUGBANK DB07148 C19H17ClFN3O3 small molecule - - DRUGBANK 218 111544 5553 - PRG2 BMPG|MBP|MBP1 9606 Homo sapiens unknown target Letuve S (2006) 16522458 171845 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 219 111544 5553 - PRG2 BMPG|MBP|MBP1 9606 Homo sapiens unknown target Kang JH (2007) 17600316 171844 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 220 111544 5553 - PRG2 BMPG|MBP|MBP1 9606 Homo sapiens unknown target Menon K (2007) 17383764 171843 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 3749 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3750 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 11869 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens activator target Zhang L (2007) 17369473 179062 904 Phenformin DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum - DRUGBANK DB00914 C10H15N5 small molecule A10BD01|A10BA01 114-86-3 DRUGBANK 11870 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens activator target Chen S (2008) 17995453 179061 904 Phenformin DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum - DRUGBANK DB00914 C10H15N5 small molecule A10BD01|A10BA01 114-86-3 DRUGBANK 11871 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens activator target Woollhead AM (2007) 17603555 179060 904 Phenformin DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum - DRUGBANK DB00914 C10H15N5 small molecule A10BD01|A10BA01 114-86-3 DRUGBANK 2128 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens activator target Mayes MA (2007) 17167165 173052 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 12168 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12169 111549 5562 - PRKAA1 AMPK|AMPKa1 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12164 111550 5563 - PRKAA2 AMPK|AMPK2|AMPKa2|PRKAA 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12165 111550 5563 - PRKAA2 AMPK|AMPK2|AMPKa2|PRKAA 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 5619 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Ruderman NB (2003) 14500570 175273 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5620 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Kovacic S (2003) 12890675 175276 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5621 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Vucicevic L (2009) 19428322 175277 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5622 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Leverve XM (2003) 14502105 175274 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5623 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Leclerc I (2004) 14871885 175275 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5624 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Hardie DG (2003) 12960015 175278 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5625 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Towler MC (2007) 17307971 175279 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 5626 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens inducer target Musi N (2002) 12086935 175280 323 Metformin Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid apo-metformin 850 mg tablets|g DRUGBANK DB00331 C4H11N5 small molecule A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20 657-24-9 DRUGBANK 2101 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target Whitehead JP (2006) 16634986 173038 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2102 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target Ruderman NB (2006) 16642960 173039 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2103 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target McGee SL (2006) 16620308 173036 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2104 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target Neurath KM (2006) 16518831 173037 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2105 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target Richter EA (2006) 16513051 173035 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 12158 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12159 111551 5564 - PRKAB1 AMPK|HAMPKb 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 2119 111552 5565 - PRKAB2 - 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2120 111552 5565 - PRKAB2 - 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 12160 111552 5565 - PRKAB2 - 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12161 111552 5565 - PRKAB2 - 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 26136 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6907 5-benzyl-1,3-thiazol-2-amine - - DRUGBANK DB08114 C10H10N2S small molecule - - DRUGBANK 26134 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6906 3-pyridin-4-yl-1H-indazole - - DRUGBANK DB08113 C12H9N3 small molecule - - DRUGBANK 26609 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7345 (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE - - DRUGBANK DB08568 C22H22N4O small molecule - - DRUGBANK 25972 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6743 ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE - - DRUGBANK DB07947 C20H22ClN3O3S small molecule - - DRUGBANK 26170 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6942 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium - - DRUGBANK DB08150 C18H21ClN5 small molecule - - DRUGBANK 26168 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6941 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine - - DRUGBANK DB08149 C19H22ClN5 small molecule - - DRUGBANK 26166 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6940 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine - - DRUGBANK DB08148 C18H20ClN5 small molecule - - DRUGBANK 23647 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23648 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23649 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 25132 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5942 (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE - - DRUGBANK DB07124 C22H20N6O small molecule - - DRUGBANK 21057 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3235 3,5-Diiodotyrosine - - DRUGBANK DB03374 C9H9I2NO3 small molecule - 300-39-0 DRUGBANK 23826 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4511 HYDROXYFASUDIL - - DRUGBANK DB04707 C14H17N3O3S small molecule - - DRUGBANK 25474 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6269 3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE - - DRUGBANK DB07458 C27H26N4O2 small molecule - - DRUGBANK 25116 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5925 (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE - - DRUGBANK DB07107 C23H22N4O small molecule - - DRUGBANK 19295 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19296 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19297 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 25207 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6021 (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE - - DRUGBANK DB07204 C24H21N5O small molecule - - DRUGBANK 19540 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2504 Balanol Analog 1 - - DRUGBANK DB02611 C20H22N2O5 small molecule - - DRUGBANK 23608 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23609 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23610 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 22557 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3930 Balanol - - DRUGBANK DB04098 C28H26N2O10 small molecule - - DRUGBANK 22558 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3930 Balanol - - DRUGBANK DB04098 C28H26N2O10 small molecule - - DRUGBANK 22559 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3930 Balanol - - DRUGBANK DB04098 C28H26N2O10 small molecule - - DRUGBANK 24980 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5778 (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE - - DRUGBANK DB06959 C25H22N4O small molecule - - DRUGBANK 26264 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 18100 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1865 Balanol Analog 2 - - DRUGBANK DB01940 C27H26N2O6 small molecule - - DRUGBANK 18101 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1865 Balanol Analog 2 - - DRUGBANK DB01940 C27H26N2O6 small molecule - - DRUGBANK 18102 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1865 Balanol Analog 2 - - DRUGBANK DB01940 C27H26N2O6 small molecule - - DRUGBANK 25907 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6673 (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE - - DRUGBANK DB07876 C16H21N3O2S small molecule - - DRUGBANK 18636 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2072 Balanol Analog 8 - - DRUGBANK DB02155 C32H36N2O7 small molecule - - DRUGBANK 18637 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2072 Balanol Analog 8 - - DRUGBANK DB02155 C32H36N2O7 small molecule - - DRUGBANK 18638 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2072 Balanol Analog 8 - - DRUGBANK DB02155 C32H36N2O7 small molecule - - DRUGBANK 26099 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6866 (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE - - DRUGBANK DB08073 C24H23N5O small molecule - - DRUGBANK 26182 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6954 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE - - DRUGBANK DB08162 C14H17N3O2S small molecule - - DRUGBANK 26095 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6863 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE - - DRUGBANK DB08070 C12H15N3 small molecule - - DRUGBANK 26611 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7346 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE - - DRUGBANK DB08569 C22H21BrN4O small molecule - - DRUGBANK 26024 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6792 N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE - - DRUGBANK DB07997 C12H15N3O2S small molecule - - DRUGBANK 26019 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6790 N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE - - DRUGBANK DB07995 C20H20BrN3O2S small molecule - - DRUGBANK 26022 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6791 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE - - DRUGBANK DB07996 C14H17N3O2S small molecule - - DRUGBANK 25895 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6657 (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE - - DRUGBANK DB07860 C14H14ClN small molecule - - DRUGBANK 25892 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6656 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE - - DRUGBANK DB07859 C20H20ClN3 small molecule - - DRUGBANK 26908 111553 5566 - PRKACA PKACA 9606 Homo sapiens inhibitor, competitive target Wang BH (1998) 9581512 181727 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 25887 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6654 (2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE - - DRUGBANK DB07857 C17H16ClN3 small molecule - - DRUGBANK 25885 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6653 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE - - DRUGBANK DB07856 C22H20ClN5 small molecule - - DRUGBANK 25883 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6652 (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE - - DRUGBANK DB07855 C18H15N5 small molecule - - DRUGBANK 25881 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6651 N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE - - DRUGBANK DB07854 C13H13N5 small molecule - - DRUGBANK 18075 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1844 Pentanal - - DRUGBANK DB01919 C5H10O small molecule - 110-62-3 DRUGBANK 18076 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1844 Pentanal - - DRUGBANK DB01919 C5H10O small molecule - 110-62-3 DRUGBANK 18077 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1844 Pentanal - - DRUGBANK DB01919 C5H10O small molecule - 110-62-3 DRUGBANK 24992 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5795 (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE - - DRUGBANK DB06977 C23H21N5O small molecule - - DRUGBANK 25889 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6655 (2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE - - DRUGBANK DB07858 C17H16ClN3 small molecule - - DRUGBANK 26755 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7529 (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE - - DRUGBANK DB08756 C14H21N3O small molecule - - DRUGBANK 25246 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6051 N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE - - DRUGBANK DB07235 C19H19Cl2N5OS small molecule - - DRUGBANK 25591 111553 5566 - PRKACA PKACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6390 (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE - - DRUGBANK DB07583 C21H22ClN3O3S small molecule - - DRUGBANK 19292 111554 5567 RP11-82H13.1 PRKACB PKA C-beta|PKACB 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19293 111554 5567 RP11-82H13.1 PRKACB PKA C-beta|PKACB 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19294 111554 5567 RP11-82H13.1 PRKACB PKA C-beta|PKACB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 26612 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7346 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE - - DRUGBANK DB08569 C22H21BrN4O small molecule - - DRUGBANK 26135 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6906 3-pyridin-4-yl-1H-indazole - - DRUGBANK DB08113 C12H9N3 small molecule - - DRUGBANK 26610 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7345 (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE - - DRUGBANK DB08568 C22H22N4O small molecule - - DRUGBANK 25973 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6743 ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE - - DRUGBANK DB07947 C20H22ClN3O3S small molecule - - DRUGBANK 26171 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6942 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium - - DRUGBANK DB08150 C18H21ClN5 small molecule - - DRUGBANK 26169 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6941 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine - - DRUGBANK DB08149 C19H22ClN5 small molecule - - DRUGBANK 26167 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6940 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine - - DRUGBANK DB08148 C18H20ClN5 small molecule - - DRUGBANK 21058 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3235 3,5-Diiodotyrosine - - DRUGBANK DB03374 C9H9I2NO3 small molecule - 300-39-0 DRUGBANK 23827 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4511 HYDROXYFASUDIL - - DRUGBANK DB04707 C14H17N3O3S small molecule - - DRUGBANK 25117 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5925 (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE - - DRUGBANK DB07107 C23H22N4O small molecule - - DRUGBANK 25208 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6021 (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE - - DRUGBANK DB07204 C24H21N5O small molecule - - DRUGBANK 24981 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5778 (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE - - DRUGBANK DB06959 C25H22N4O small molecule - - DRUGBANK 26265 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 25908 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6673 (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE - - DRUGBANK DB07876 C16H21N3O2S small molecule - - DRUGBANK 26100 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6866 (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE - - DRUGBANK DB08073 C24H23N5O small molecule - - DRUGBANK 26183 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6954 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE - - DRUGBANK DB08162 C14H17N3O2S small molecule - - DRUGBANK 26096 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6863 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE - - DRUGBANK DB08070 C12H15N3 small molecule - - DRUGBANK 26137 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6907 5-benzyl-1,3-thiazol-2-amine - - DRUGBANK DB08114 C10H10N2S small molecule - - DRUGBANK 26025 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6792 N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE - - DRUGBANK DB07997 C12H15N3O2S small molecule - - DRUGBANK 26020 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6790 N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE - - DRUGBANK DB07995 C20H20BrN3O2S small molecule - - DRUGBANK 26023 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6791 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE - - DRUGBANK DB07996 C14H17N3O2S small molecule - - DRUGBANK 25896 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6657 (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE - - DRUGBANK DB07860 C14H14ClN small molecule - - DRUGBANK 25893 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6656 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE - - DRUGBANK DB07859 C20H20ClN3 small molecule - - DRUGBANK 25592 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6390 (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE - - DRUGBANK DB07583 C21H22ClN3O3S small molecule - - DRUGBANK 25888 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6654 (2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE - - DRUGBANK DB07857 C17H16ClN3 small molecule - - DRUGBANK 25886 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6653 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE - - DRUGBANK DB07856 C22H20ClN5 small molecule - - DRUGBANK 25884 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6652 (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE - - DRUGBANK DB07855 C18H15N5 small molecule - - DRUGBANK 25882 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6651 N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE - - DRUGBANK DB07854 C13H13N5 small molecule - - DRUGBANK 26756 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7529 (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE - - DRUGBANK DB08756 C14H21N3O small molecule - - DRUGBANK 25890 111556 5569 - PKIA PRKACN1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6655 (2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE - - DRUGBANK DB07858 C17H16ClN3 small molecule - - DRUGBANK 12166 111558 5571 - PRKAG1 AMPKG 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12167 111558 5571 - PRKAG1 AMPKG 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 18922 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 18923 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 18924 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2222 Cyclic Guanosine Monophosphate Guanosine-3',5'-monophosphate - DRUGBANK DB02315 C10H12N5O7P small molecule - 7665-99-8 DRUGBANK 19401 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19402 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19403 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 17790 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1721 Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate - - DRUGBANK DB01790 C10H12N5O5PS small molecule - - DRUGBANK 17791 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1721 Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate - - DRUGBANK DB01790 C10H12N5O5PS small molecule - - DRUGBANK 17792 111559 5573 - PRKAR1A ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1721 Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate - - DRUGBANK DB01790 C10H12N5O5PS small molecule - - DRUGBANK 19395 111563 5577 - PRKAR2B PRKAR2|RII-BETA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19396 111563 5577 - PRKAR2B PRKAR2|RII-BETA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19397 111563 5577 - PRKAR2B PRKAR2|RII-BETA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 24282 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens ligand target Kedei N (2004) 15126366 181848 4800 Ingenol Mebutate 3-Ingenyl Angelate|Picato|ingenol mebutate|PEP005|Ingenol 3-angelate picato DRUGBANK DB05013 C25H34O6 small molecule D06BX02 75567-37-2 DRUGBANK 9397 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 2722 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Yu D (2002) 12269833 173425 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2723 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Lopez-Andreo MJ (2005) 16114872 173424 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2724 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Rodriguez-Alfaro JA (2004) 14698304 173426 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2725 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Corbin JA (2007) 17367165 173423 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 26910 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens inhibitor, competitive target Wang BH (1998) 9581512 181727 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 3575 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3576 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Sylvester PW (2001) 11736999 173926 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3577 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3578 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Azzi A (1997) 9430404 173927 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3579 111564 5578 - PRKCA AAG6|PKC-alpha|PKCA|PRKACA 9606 Homo sapiens unknown target Huang Y (2002) 11850093 173923 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 9398 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 3570 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Ganz MB (2000) 10644549 173924 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3571 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3572 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3573 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Wigg SJ (2004) 15184978 173925 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3574 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Huang Y (2002) 11850093 173923 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 17688 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1672 O-Phosphoethanolamine Colamine phosphoric acid|Phosphorylethanolamine - DRUGBANK DB01738 C3H10NO4P small molecule - 1071-23-4 DRUGBANK 17689 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1672 O-Phosphoethanolamine Colamine phosphoric acid|Phosphorylethanolamine - DRUGBANK DB01738 C3H10NO4P small molecule - 1071-23-4 DRUGBANK 17690 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1672 O-Phosphoethanolamine Colamine phosphoric acid|Phosphorylethanolamine - DRUGBANK DB01738 C3H10NO4P small molecule - 1071-23-4 DRUGBANK 26911 111565 5579 - PRKCB PKC-beta|PKCB|PRKCB1|PRKCB2 9606 Homo sapiens inhibitor, competitive target Wang BH (1998) 9581512 181727 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 24283 111566 5580 - PRKCD ALPS3|CVID9|MAY1|PKCD|nPKC-delta 9606 Homo sapiens ligand target Kedei N (2004) 15126366 181848 4800 Ingenol Mebutate 3-Ingenyl Angelate|Picato|ingenol mebutate|PEP005|Ingenol 3-angelate picato DRUGBANK DB05013 C25H34O6 small molecule D06BX02 75567-37-2 DRUGBANK 9394 111566 5580 - PRKCD ALPS3|CVID9|MAY1|PKCD|nPKC-delta 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 23232 111566 5580 - PRKCD ALPS3|CVID9|MAY1|PKCD|nPKC-delta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4198 13-Acetylphorbol - - DRUGBANK DB04376 C22H30O7 small molecule - - DRUGBANK 9396 111567 5581 - PRKCE PKCE|nPKC-epsilon 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 9395 111568 5582 - PRKCG PKC-gamma|PKCC|PKCG|SCA14 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 21911 111570 5584 - PRKCI DXS1179E|PKCI|nPKC-iota 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3618 Rbt205 Inhibitor - - DRUGBANK DB03777 C25H24N4O2 small molecule - - DRUGBANK 9393 111570 5584 - PRKCI DXS1179E|PKCI|nPKC-iota 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 19300 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19301 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 9391 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 23615 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23616 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 18340 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18341 111574 5588 RP11-563J2.1 PRKCQ PRKCT|nPKC-theta 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 9392 111576 5590 RP11-181G12.1 PRKCZ PKC-ZETA|PKC2 9606 Homo sapiens unknown target O'Brian CA (1985) 3157445 177736 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 4258 111577 5591 - PRKDC DNA-PKcs|DNAPK|DNPK1|HYRC|HYRC1|IMD26|XRCC7|p350 9606 Homo sapiens unknown target Foukas LC (2002) 12145276 174346 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 13356 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Dubey RK (2004) 15292328 179944 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13357 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Oudit GY (2003) 12963636 179940 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13358 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Vaniotis G (2011) 20732414 179941 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13359 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Azzi M (2003) 13679574 179942 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13360 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Yeh CK (2005) 15689414 179943 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13361 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Adissu HA (2004) 15138589 179939 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 19814 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 23164 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4163 SB220025 - - DRUGBANK DB04338 C18H19FN6 small molecule - - DRUGBANK 18568 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2036 Olomoucine - - DRUGBANK DB02116 C15H18N6O small molecule - 101622-51-9 DRUGBANK 25024 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5828 N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE - - DRUGBANK DB07010 C21H17ClN4O small molecule - - DRUGBANK 14403 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target Dong Z (2002) 12426127 180438 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14404 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens inducer target He Z (2003) 12529330 180442 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 26552 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7292 [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID - - DRUGBANK DB08513 C20H19N5O3 small molecule - - DRUGBANK 19284 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19285 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19286 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 25822 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6593 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE - - DRUGBANK DB07794 C18H13N7 small molecule - - DRUGBANK 24907 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5697 N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE - - DRUGBANK DB06877 C16H16N4O small molecule - - DRUGBANK 26571 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7299 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE - - DRUGBANK DB08521 C21H16FN3OS small molecule - - DRUGBANK 25929 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6701 (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione - - DRUGBANK DB07905 C19H22O8 small molecule - - DRUGBANK 25816 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6587 (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE - - DRUGBANK DB07788 C19H22O7 small molecule - - DRUGBANK 25276 111580 5594 - MAPK1 ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6080 (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE - - DRUGBANK DB07264 C22H17Cl2FN4O2 small molecule - - DRUGBANK 8550 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inhibitor target Rice PL (2001) 11245463 177238 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8551 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inhibitor target Rice PL (2004) 15548677 177239 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8552 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inhibitor target Rice PL (2003) 12566304 177235 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8553 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inhibitor target Pangburn HA (2005) 16138927 177236 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8554 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inhibitor target Rice PL (2006) 16546990 177237 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 14411 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inducer target Fauconneau B (2002) 12472888 180444 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14412 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inducer target Tanaka-Kagawa T (2003) 14674888 180447 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14413 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inducer target Jung DK (2003) 14516795 180449 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14414 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inducer target Mousa SA (2007) 17158527 180448 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 14415 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inducer target Felix K (2005) 15849723 180450 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 19818 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 23766 111581 5595 - MAPK3 ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4413 5-iodotubercidin - - DRUGBANK DB04604 C11H13IN4O4 small molecule - 24386-93-4 DRUGBANK 17777 111585 5599 - MAPK8 JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1714 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One - - DRUGBANK DB01782 C14H8N2O small molecule - - DRUGBANK 25869 111585 5599 - MAPK8 JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6642 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide - - DRUGBANK DB07845 C22H21FN6O4S small molecule - - DRUGBANK 25284 111585 5599 - MAPK8 JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6088 N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE - - DRUGBANK DB07272 C18H19BrN4O4 small molecule - - DRUGBANK 25280 111585 5599 - MAPK8 JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6084 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE - - DRUGBANK DB07268 C17H15N5O2 small molecule - - DRUGBANK 25287 111585 5599 - MAPK8 JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6092 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE - - DRUGBANK DB07276 C18H19N3O4 small molecule - - DRUGBANK 25225 111585 5599 - MAPK8 JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6034 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE - - DRUGBANK DB07218 C12H10ClN3O2 small molecule - - DRUGBANK 25033 111587 5601 - MAPK9 JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5838 N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide - - DRUGBANK DB07020 C20H14N6O2 small molecule - - DRUGBANK 26050 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6819 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide - - DRUGBANK DB08026 C19H23N7O small molecule - - DRUGBANK 26049 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6818 N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE - - DRUGBANK DB08025 C24H25FN4O2 small molecule - - DRUGBANK 23318 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23319 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 21610 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3470 9-(4-Hydroxyphenyl)-2,7-Phenanthroline - - DRUGBANK DB03623 C18H12N2O small molecule - - DRUGBANK 21611 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3470 9-(4-Hydroxyphenyl)-2,7-Phenanthroline - - DRUGBANK DB03623 C18H12N2O small molecule - - DRUGBANK 21612 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3470 9-(4-Hydroxyphenyl)-2,7-Phenanthroline - - DRUGBANK DB03623 C18H12N2O small molecule - - DRUGBANK 26038 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6808 (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime - - DRUGBANK DB08015 C23H17FN2O4 small molecule - - DRUGBANK 17778 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1714 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One - - DRUGBANK DB01782 C14H8N2O small molecule - - DRUGBANK 17779 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1714 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One - - DRUGBANK DB01782 C14H8N2O small molecule - - DRUGBANK 17780 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1714 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One - - DRUGBANK DB01782 C14H8N2O small molecule - - DRUGBANK 19128 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2293 Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine - - DRUGBANK DB02388 C27H34Cl2N6 small molecule - - DRUGBANK 19129 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2293 Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine - - DRUGBANK DB02388 C27H34Cl2N6 small molecule - - DRUGBANK 25025 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5828 N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE - - DRUGBANK DB07010 C21H17ClN4O small molecule - - DRUGBANK 26037 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6804 (3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime - - DRUGBANK DB08011 C17H12F2N2O4 small molecule - - DRUGBANK 26036 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6803 (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime - - DRUGBANK DB08010 C25H19FN2O4 small molecule - - DRUGBANK 26031 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6798 4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide - - DRUGBANK DB08005 C20H23ClN6O small molecule - - DRUGBANK 26045 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6814 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide - - DRUGBANK DB08021 C18H17BrClN3O2 small molecule - - DRUGBANK 24958 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5752 N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide - - DRUGBANK DB06933 C24H24N4O2S small molecule - - DRUGBANK 20439 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2955 Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine - - DRUGBANK DB03084 C25H30Cl2N6 small molecule - - DRUGBANK 20440 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2955 Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine - - DRUGBANK DB03084 C25H30Cl2N6 small molecule - - DRUGBANK 25224 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6033 N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide - - DRUGBANK DB07217 C16H13FN2OS small molecule - - DRUGBANK 26597 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7333 1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline - - DRUGBANK DB08555 C16H13BrClNO small molecule - - DRUGBANK 26047 111588 5602 RP13-514E23.1 MAPK10 JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6816 N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine - - DRUGBANK DB08023 C18H21N5 small molecule - - DRUGBANK 26228 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6999 2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE - - DRUGBANK DB08208 C17H13F3N2O3 small molecule - - DRUGBANK 27364 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens inhibitor target Singh A (2015) 26384788 188510 5018 Cobimetinib - cotellic DRUGBANK DB05239 C21H21F3IN3O2 small molecule - 934660-93-2 DRUGBANK 24919 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5712 (5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide - - DRUGBANK DB06892 C15H12F3IN2O3 small molecule - - DRUGBANK 24591 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens inhibitor target Remsing Rix LL (2009) 19039322 182092 5562 Bosutinib SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate bosulif DRUGBANK DB06616 C26H29Cl2N5O3 small molecule L01XE14 380843-75-4 DRUGBANK 20510 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2986 5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide - - DRUGBANK DB03115 C16H13BrF3IN2O4 small molecule - - DRUGBANK 20511 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2986 5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide - - DRUGBANK DB03115 C16H13BrF3IN2O4 small molecule - - DRUGBANK 18621 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2069 K-252a - - DRUGBANK DB02152 C27H21N3O5 small molecule - 97161-97-2 DRUGBANK 25111 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5919 N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide - - DRUGBANK DB07101 C16H14F3IN2O4 small molecule - - DRUGBANK 26990 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens inhibitor target Salama AK (2013) 23432625 182233 7655 Trametinib JTP 74057|GSK 1120212|Trametinib Dimethyl Sulfoxide|Trametinibum mekinist DRUGBANK DB08911 C26H23FIN5O4 small molecule L01XE25 871700-17-3 DRUGBANK 25054 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5864 2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide - - DRUGBANK DB07046 C16H14ClF2IN2O4 small molecule - - DRUGBANK 26148 111590 5604 - MAP2K1 CFC3|MAPKK1|MEK1|MKK1|PRKMK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6922 N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine - - DRUGBANK DB08130 C16H13F3IN5O small molecule - - DRUGBANK 26989 111591 5605 - MAP2K2 CFC4|MAPKK2|MEK2|MKK2|PRKMK2 9606 Homo sapiens inhibitor target Salama AK (2013) 23432625 182233 7655 Trametinib JTP 74057|GSK 1120212|Trametinib Dimethyl Sulfoxide|Trametinibum mekinist DRUGBANK DB08911 C26H23FIN5O4 small molecule L01XE25 871700-17-3 DRUGBANK 24590 111591 5605 - MAP2K2 CFC4|MAPKK2|MEK2|MKK2|PRKMK2 9606 Homo sapiens inhibitor target Remsing Rix LL (2009) 19039322 182092 5562 Bosutinib SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate bosulif DRUGBANK DB06616 C26H29Cl2N5O3 small molecule L01XE14 380843-75-4 DRUGBANK 629 111603 5618 - PRLR HPRL|MFAB|hPRLrI 9606 Homo sapiens unknown target Moederscheim TA (2007) 17317019 172054 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 630 111603 5618 - PRLR HPRL|MFAB|hPRLrI 9606 Homo sapiens unknown target Cunningham BC (1990) 2270485 172053 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 631 111603 5618 - PRLR HPRL|MFAB|hPRLrI 9606 Homo sapiens unknown target Keeler C (2007) 17279774 172052 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 632 111603 5618 - PRLR HPRL|MFAB|hPRLrI 9606 Homo sapiens unknown target Ahmed TA (2007) 17395896 131528 51 Somatropin recombinant Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH nutropin - kit pws(5mg) & liq DRUGBANK DB00052 C990H1532N262O300S7 biologic H01AC01 12629-01-5 DRUGBANK 14571 111603 5618 - PRLR HPRL|MFAB|hPRLrI 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 14572 111603 5618 - PRLR HPRL|MFAB|hPRLrI 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1173 Fluoxymesterone 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone androxy|halotestin DRUGBANK DB01185 C20H29FO3 small molecule G03BA01 76-43-7 DRUGBANK 10188 111606 5621 RP5-1068H6.2 PRNP ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 10189 111606 5621 RP5-1068H6.2 PRNP ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30 9606 Homo sapiens inhibitor target De Luigi A (2008) 18365024 178255 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 7194 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 456 Sodium Tetradecyl Sulfate Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt tromboject 3% inj 30mg/ml|trom DRUGBANK DB00464 C14H29NaO4S small molecule C05BB04 139-88-8 DRUGBANK 7195 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens inhibitor target Parsi K (2009) 19442540 176254 456 Sodium Tetradecyl Sulfate Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt tromboject 3% inj 30mg/ml|trom DRUGBANK DB00464 C14H29NaO4S small molecule C05BB04 139-88-8 DRUGBANK 7196 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 456 Sodium Tetradecyl Sulfate Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt tromboject 3% inj 30mg/ml|trom DRUGBANK DB00464 C14H29NaO4S small molecule C05BB04 139-88-8 DRUGBANK 7197 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens inhibitor target Jacobson BF (1992) 1344580 176253 456 Sodium Tetradecyl Sulfate Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt tromboject 3% inj 30mg/ml|trom DRUGBANK DB00464 C14H29NaO4S small molecule C05BB04 139-88-8 DRUGBANK 3641 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3642 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens activator target Milgrom E (2007) 17215245 72606 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3643 111608 5624 - PROC APC|PC|PROC1|THPH3|THPH4 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3768 111609 5625 - PRODH HSPOX2|PIG6|POX|PRODH1|PRODH2|TP53I6 9606 Homo sapiens unknown target White TA (2005) 16511143 174040 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3769 111609 5625 - PRODH HSPOX2|PIG6|POX|PRODH1|PRODH2|TP53I6 9606 Homo sapiens unknown target White TA (2007) 17344208 174041 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3770 111609 5625 - PRODH HSPOX2|PIG6|POX|PRODH1|PRODH2|TP53I6 9606 Homo sapiens unknown target Huang TC (2007) 17536821 174039 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 669 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens unknown target Hesselvik JF (1991) 1828915 172066 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 670 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens unknown target Cvirn G (2002) 12062545 172064 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 671 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens unknown target Cosio FG (1985) 3160800 172065 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 7198 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens inhibitor target Parsi K (2009) 19442540 176254 456 Sodium Tetradecyl Sulfate Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt tromboject 3% inj 30mg/ml|trom DRUGBANK DB00464 C14H29NaO4S small molecule C05BB04 139-88-8 DRUGBANK 7199 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens inhibitor target Jacobson BF (1992) 1344580 176253 456 Sodium Tetradecyl Sulfate Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt tromboject 3% inj 30mg/ml|trom DRUGBANK DB00464 C14H29NaO4S small molecule C05BB04 139-88-8 DRUGBANK 3658 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens activator target Chai YC (1994) 8161215 173995 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3659 111611 5627 - PROS1 PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6 9606 Homo sapiens activator target Mallis RJ (2002) 12033454 173994 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 23378 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4239 RPR128515 - - DRUGBANK DB04424 C27H30N4O3 small molecule - - DRUGBANK 23379 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4239 RPR128515 - - DRUGBANK DB04424 C27H30N4O3 small molecule - - DRUGBANK 23380 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4239 RPR128515 - - DRUGBANK DB04424 C27H30N4O3 small molecule - - DRUGBANK 22093 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3713 Thieno[2,3-B]Pyridine-2-Carboxamidine - - DRUGBANK DB03876 C8H8N3S small molecule - - DRUGBANK 21646 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3490 CRA_1144 - - DRUGBANK DB03643 C14H12N4O small molecule - - DRUGBANK 24946 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5742 2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE - - DRUGBANK DB06923 C16H15N3 small molecule - - DRUGBANK 23356 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4228 3-Phenylpropylamine 3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane - DRUGBANK DB04410 C9H13N small molecule - 2038-57-5 DRUGBANK 23357 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4228 3-Phenylpropylamine 3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane - DRUGBANK DB04410 C9H13N small molecule - 2038-57-5 DRUGBANK 23358 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4228 3-Phenylpropylamine 3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane - DRUGBANK DB04410 C9H13N small molecule - 2038-57-5 DRUGBANK 20704 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3041 CRA_10433 - - DRUGBANK DB03173 C20H21N3O2 small molecule - - DRUGBANK 18046 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1832 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB01905 C15H15N4O2 small molecule - - DRUGBANK 25098 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5906 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07088 C20H28N4O3 small molecule - - DRUGBANK 17697 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1679 N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester - - DRUGBANK DB01745 C27H30N4O5S small molecule - - DRUGBANK 17698 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1679 N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester - - DRUGBANK DB01745 C27H30N4O5S small molecule - - DRUGBANK 17699 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1679 N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester - - DRUGBANK DB01745 C27H30N4O5S small molecule - - DRUGBANK 17691 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1675 CRA_17693 - - DRUGBANK DB01741 C24H17FN4O5 small molecule - - DRUGBANK 17692 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1675 CRA_17693 - - DRUGBANK DB01741 C24H17FN4O5 small molecule - - DRUGBANK 17693 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1675 CRA_17693 - - DRUGBANK DB01741 C24H17FN4O5 small molecule - - DRUGBANK 25101 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5909 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07091 C21H30N4O3 small molecule - - DRUGBANK 17687 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1671 Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester - - DRUGBANK DB01737 C20H24N4O5S small molecule - 133397-81-6 DRUGBANK 22579 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3939 [(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester - - DRUGBANK DB04107 C29H31N7O3 small molecule - - DRUGBANK 22580 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3939 [(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester - - DRUGBANK DB04107 C29H31N7O3 small molecule - - DRUGBANK 22581 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3939 [(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester - - DRUGBANK DB04107 C29H31N7O3 small molecule - - DRUGBANK 21487 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3404 CRA_11092 - - DRUGBANK DB03555 C21H22FN4O2 small molecule - - DRUGBANK 21488 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3404 CRA_11092 - - DRUGBANK DB03555 C21H22FN4O2 small molecule - - DRUGBANK 21489 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3404 CRA_11092 - - DRUGBANK DB03555 C21H22FN4O2 small molecule - - DRUGBANK 26305 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7043 2-NAPHTHALENESULFONIC ACID - - DRUGBANK DB08254 C10H8O3S small molecule - - DRUGBANK 17745 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1700 Hemi-Babim - - DRUGBANK DB01767 C16H14N6 small molecule - - DRUGBANK 17760 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1704 CRA_10991 - - DRUGBANK DB01771 C20H20ClN3O2 small molecule - - DRUGBANK 19670 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2556 Trans-2-Phenylcyclopropylamine - - DRUGBANK DB02665 C9H12N small molecule - - DRUGBANK 19671 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2556 Trans-2-Phenylcyclopropylamine - - DRUGBANK DB02665 C9H12N small molecule - - DRUGBANK 19672 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2556 Trans-2-Phenylcyclopropylamine - - DRUGBANK DB02665 C9H12N small molecule - - DRUGBANK 20534 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20535 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20536 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 22376 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3842 Bis(5-Amidino-Benzimidazolyl)Methane Zinc - - DRUGBANK DB04008 C17H14N8Zn small molecule - - DRUGBANK 22377 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3842 Bis(5-Amidino-Benzimidazolyl)Methane Zinc - - DRUGBANK DB04008 C17H14N8Zn small molecule - - DRUGBANK 22378 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3842 Bis(5-Amidino-Benzimidazolyl)Methane Zinc - - DRUGBANK DB04008 C17H14N8Zn small molecule - - DRUGBANK 19018 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2259 4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine - - DRUGBANK DB02354 C25H25N7 small molecule - - DRUGBANK 19019 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2259 4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine - - DRUGBANK DB02354 C25H25N7 small molecule - - DRUGBANK 19020 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2259 4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine - - DRUGBANK DB02354 C25H25N7 small molecule - - DRUGBANK 22888 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4074 CRA_23653 - - DRUGBANK DB04246 C22H20N5O small molecule - - DRUGBANK 22889 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4074 CRA_23653 - - DRUGBANK DB04246 C22H20N5O small molecule - - DRUGBANK 22890 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4074 CRA_23653 - - DRUGBANK DB04246 C22H20N5O small molecule - - DRUGBANK 25106 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5913 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07095 C21H30N4O2 small molecule - - DRUGBANK 18879 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2195 2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB02287 C14H13N4O small molecule - - DRUGBANK 24872 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5666 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB06845 C20H29N5O2 small molecule - - DRUGBANK 21168 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3274 1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid - - DRUGBANK DB03417 C18H33N7O5 small molecule - - DRUGBANK 21169 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3274 1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid - - DRUGBANK DB03417 C18H33N7O5 small molecule - - DRUGBANK 21170 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3274 1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid - - DRUGBANK DB03417 C18H33N7O5 small molecule - - DRUGBANK 23033 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4136 4-Phenylbutylamine - - DRUGBANK DB04311 C10H15N small molecule - - DRUGBANK 23034 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4136 4-Phenylbutylamine - - DRUGBANK DB04311 C10H15N small molecule - - DRUGBANK 23035 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4136 4-Phenylbutylamine - - DRUGBANK DB04311 C10H15N small molecule - - DRUGBANK 26012 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6780 +/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE - - DRUGBANK DB07985 C20H24N4O2 small molecule - - DRUGBANK 23021 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4128 Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate - - DRUGBANK DB04301 C17H16N8O2 small molecule - - DRUGBANK 23022 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4128 Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate - - DRUGBANK DB04301 C17H16N8O2 small molecule - - DRUGBANK 23023 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4128 Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate - - DRUGBANK DB04301 C17H16N8O2 small molecule - - DRUGBANK 23525 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4284 CRA_10656 - - DRUGBANK DB04470 C18H20N4O2 small molecule - - DRUGBANK 22816 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4043 CRA_9076 - - DRUGBANK DB04215 C16H14BrN3O small molecule - - DRUGBANK 20693 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3027 CRA_8696 - - DRUGBANK DB03159 C21H17N3O small molecule - - DRUGBANK 18846 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2178 [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium - - DRUGBANK DB02269 C34H36N5O2 small molecule - - DRUGBANK 18847 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2178 [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium - - DRUGBANK DB02269 C34H36N5O2 small molecule - - DRUGBANK 18848 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2178 [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium - - DRUGBANK DB02269 C34H36N5O2 small molecule - - DRUGBANK 26763 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7536 [N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE - - DRUGBANK DB08763 C16H18N3O5P small molecule - - DRUGBANK 25515 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6302 5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid - - DRUGBANK DB07491 C8H4Br3NO4 small molecule - - DRUGBANK 22312 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 22313 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 23251 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4212 Aeruginosin 98-B - - DRUGBANK DB04391 C29H46N6O9S small molecule - - DRUGBANK 23252 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4212 Aeruginosin 98-B - - DRUGBANK DB04391 C29H46N6O9S small molecule - - DRUGBANK 23253 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4212 Aeruginosin 98-B - - DRUGBANK DB04391 C29H46N6O9S small molecule - - DRUGBANK 22606 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3957 N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine - - DRUGBANK DB04125 C26H29N5O4S small molecule - - DRUGBANK 22607 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3957 N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine - - DRUGBANK DB04125 C26H29N5O4S small molecule - - DRUGBANK 22608 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3957 N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine - - DRUGBANK DB04125 C26H29N5O4S small molecule - - DRUGBANK 24877 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5671 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB06850 C21H31N5O2 small molecule - - DRUGBANK 24881 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5674 N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06853 C22H33N5O2 small molecule - - DRUGBANK 24888 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5679 N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide - - DRUGBANK DB06858 C23H35N5O2 small molecule - - DRUGBANK 19034 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2271 CRA_10762 - - DRUGBANK DB02366 C20H14ClN4O small molecule - - DRUGBANK 19035 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2271 CRA_10762 - - DRUGBANK DB02366 C20H14ClN4O small molecule - - DRUGBANK 19036 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2271 CRA_10762 - - DRUGBANK DB02366 C20H14ClN4O small molecule - - DRUGBANK 17595 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1640 Bis(5-Amidino-Benzimidazolyl)Methane - - DRUGBANK DB01705 C17H16N8 small molecule - - DRUGBANK 17596 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1640 Bis(5-Amidino-Benzimidazolyl)Methane - - DRUGBANK DB01705 C17H16N8 small molecule - - DRUGBANK 17597 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1640 Bis(5-Amidino-Benzimidazolyl)Methane - - DRUGBANK DB01705 C17H16N8 small molecule - - DRUGBANK 21587 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3456 Diminazene Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate - DRUGBANK DB03608 C14H15N7 small molecule - 536-71-0 DRUGBANK 24637 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Mahdy AM (2004) 15277296 181856 5574 Aprotinin Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine trasylol|trasylol inj 10000 ki DRUGBANK DB06692 C284H432N84O79S7 biologic B02AB01 9087-70-1 DRUGBANK 17661 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1660 CRA_7806 - - DRUGBANK DB01725 C20H15N4O small molecule - - DRUGBANK 17662 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1660 CRA_7806 - - DRUGBANK DB01725 C20H15N4O small molecule - - DRUGBANK 17663 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1660 CRA_7806 - - DRUGBANK DB01725 C20H15N4O small molecule - - DRUGBANK 23421 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4260 Benzo[B]Thiophene-2-Carboxamidine - - DRUGBANK DB04446 C9H9N2S small molecule - - DRUGBANK 20568 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3004 4-Iodobenzo[B]Thiophene-2-Carboxamidine - - DRUGBANK DB03136 C9H8IN2S small molecule - - DRUGBANK 24863 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5661 diethyl [(1R)-1,5-diaminopentyl]boronate - - DRUGBANK DB06840 C9H23BN2O2 small molecule - - DRUGBANK 21241 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3299 Bis(5-Amidino-Benzimidazolyl)Methanone Zinc - - DRUGBANK DB03443 C17H16N8OZn small molecule - - DRUGBANK 21242 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3299 Bis(5-Amidino-Benzimidazolyl)Methanone Zinc - - DRUGBANK DB03443 C17H16N8OZn small molecule - - DRUGBANK 21243 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3299 Bis(5-Amidino-Benzimidazolyl)Methanone Zinc - - DRUGBANK DB03443 C17H16N8OZn small molecule - - DRUGBANK 18880 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2196 CRA_9334 - - DRUGBANK DB02288 C15H13BrN4O small molecule - - DRUGBANK 18440 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1984 CRA_16847 2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE - DRUGBANK DB02063 C18H12BrN4O5 small molecule - - DRUGBANK 18441 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1984 CRA_16847 2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE - DRUGBANK DB02063 C18H12BrN4O5 small molecule - - DRUGBANK 18442 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1984 CRA_16847 2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE - DRUGBANK DB02063 C18H12BrN4O5 small molecule - - DRUGBANK 22878 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4066 N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid - - DRUGBANK DB04238 C26H28N4O5S small molecule - - DRUGBANK 22879 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4066 N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid - - DRUGBANK DB04238 C26H28N4O5S small molecule - - DRUGBANK 22880 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4066 N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid - - DRUGBANK DB04238 C26H28N4O5S small molecule - - DRUGBANK 17805 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 17806 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 17807 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 25140 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5949 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide - - DRUGBANK DB07131 C22H32N4O2 small molecule - - DRUGBANK 25238 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6045 3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE - - DRUGBANK DB07229 C22H19N3O2 small molecule - - DRUGBANK 19245 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2364 Benzylamine - - DRUGBANK DB02464 C7H9N small molecule - 100-46-9 DRUGBANK 19246 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2364 Benzylamine - - DRUGBANK DB02464 C7H9N small molecule - 100-46-9 DRUGBANK 19247 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2364 Benzylamine - - DRUGBANK DB02464 C7H9N small molecule - 100-46-9 DRUGBANK 20762 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3081 Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone - - DRUGBANK DB03213 C17H14N8O small molecule - - DRUGBANK 20763 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3081 Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone - - DRUGBANK DB03213 C17H14N8O small molecule - - DRUGBANK 20764 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3081 Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone - - DRUGBANK DB03213 C17H14N8O small molecule - - DRUGBANK 19393 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2423 CRA_10655 - - DRUGBANK DB02526 C19H20N4O2 small molecule - - DRUGBANK 18099 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1864 5-Amidino-Benzimidazole - - DRUGBANK DB01939 C8H9N4 small molecule - - DRUGBANK 23708 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4373 CRA_9678 - - DRUGBANK DB04563 C17H12BrN3O3 small molecule - - DRUGBANK 23709 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4373 CRA_9678 - - DRUGBANK DB04563 C17H12BrN3O3 small molecule - - DRUGBANK 23710 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4373 CRA_9678 - - DRUGBANK DB04563 C17H12BrN3O3 small molecule - - DRUGBANK 20433 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2952 Crc200 (Chiron-Behring) - - DRUGBANK DB03081 C29H39N5O7S small molecule - - DRUGBANK 20434 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2952 Crc200 (Chiron-Behring) - - DRUGBANK DB03081 C29H39N5O7S small molecule - - DRUGBANK 20435 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2952 Crc200 (Chiron-Behring) - - DRUGBANK DB03081 C29H39N5O7S small molecule - - DRUGBANK 20998 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3200 1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea - - DRUGBANK DB03337 C20H18N4O2 small molecule - - DRUGBANK 19244 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2363 2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine - - DRUGBANK DB02463 C15H14N3O small molecule - - DRUGBANK 20320 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2891 CRA_1801 - - DRUGBANK DB03016 C13H10N5O small molecule - - DRUGBANK 20321 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2891 CRA_1801 - - DRUGBANK DB03016 C13H10N5O small molecule - - DRUGBANK 20322 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2891 CRA_1801 - - DRUGBANK DB03016 C13H10N5O small molecule - - DRUGBANK 21560 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3443 CRA_9785 - - DRUGBANK DB03595 C15H11F3N4O2 small molecule - - DRUGBANK 20064 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2756 CRA_1802 - - DRUGBANK DB02875 C14H11FN4O small molecule - - DRUGBANK 17531 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1601 ZK-800270 2H-BENZOIMIDAZOL-2-YLAMINE - DRUGBANK DB01665 C7H7N3 small molecule - - DRUGBANK 17532 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1601 ZK-800270 2H-BENZOIMIDAZOL-2-YLAMINE - DRUGBANK DB01665 C7H7N3 small molecule - - DRUGBANK 17533 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1601 ZK-800270 2H-BENZOIMIDAZOL-2-YLAMINE - DRUGBANK DB01665 C7H7N3 small molecule - - DRUGBANK 18694 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2109 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB02193 C14H13N4O small molecule - - DRUGBANK 19949 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2694 (2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide - - DRUGBANK DB02812 C20H26N6O4S small molecule - - DRUGBANK 19950 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2694 (2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide - - DRUGBANK DB02812 C20H26N6O4S small molecule - - DRUGBANK 19951 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2694 (2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide - - DRUGBANK DB02812 C20H26N6O4S small molecule - - DRUGBANK 20244 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2866 CRA_10972 - - DRUGBANK DB02989 C18H18ClN4O2 small molecule - - DRUGBANK 20245 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2866 CRA_10972 - - DRUGBANK DB02989 C18H18ClN4O2 small molecule - - DRUGBANK 20246 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2866 CRA_10972 - - DRUGBANK DB02989 C18H18ClN4O2 small molecule - - DRUGBANK 23384 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4247 ZK-805623 - - DRUGBANK DB04432 C20H18F2N5O2 small molecule - - DRUGBANK 19833 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2630 RPR131247 - - DRUGBANK DB02744 C19H19N5O4S2 small molecule - - DRUGBANK 19834 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2630 RPR131247 - - DRUGBANK DB02744 C19H19N5O4S2 small molecule - - DRUGBANK 19835 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2630 RPR131247 - - DRUGBANK DB02744 C19H19N5O4S2 small molecule - - DRUGBANK 23799 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4459 4-PIPERIDIN-4-YLBUTANAL - - DRUGBANK DB04654 C9H17NO small molecule - - DRUGBANK 21390 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3349 CRA_10950 - - DRUGBANK DB03494 C18H19FN4O2 small molecule - - DRUGBANK 21051 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3234 ZK-806711 - - DRUGBANK DB03373 C27H30N6O small molecule - - DRUGBANK 21052 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3234 ZK-806711 - - DRUGBANK DB03373 C27H30N6O small molecule - - DRUGBANK 21053 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3234 ZK-806711 - - DRUGBANK DB03373 C27H30N6O small molecule - - DRUGBANK 21054 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3235 3,5-Diiodotyrosine - - DRUGBANK DB03374 C9H9I2NO3 small molecule - 300-39-0 DRUGBANK 26466 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7202 1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID - - DRUGBANK DB08420 C23H27BN4O4 small molecule - - DRUGBANK 18396 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1967 Amylamine - - DRUGBANK DB02045 C5H13N small molecule - 110-58-7 DRUGBANK 18397 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1967 Amylamine - - DRUGBANK DB02045 C5H13N small molecule - 110-58-7 DRUGBANK 18398 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1967 Amylamine - - DRUGBANK DB02045 C5H13N small molecule - 110-58-7 DRUGBANK 23897 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4592 2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol 2,5-O,O-BIS-(3',3"-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL - DRUGBANK DB04790 C20H22N4O4 small molecule - - DRUGBANK 23898 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4593 2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL - - DRUGBANK DB04791 C20H22N4O4 small molecule - - DRUGBANK 25374 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6184 4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE - - DRUGBANK DB07368 C8H10N2O2S small molecule - - DRUGBANK 18557 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2032 Zk-806450 - - DRUGBANK DB02112 C31H31N5O small molecule - - DRUGBANK 18558 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2032 Zk-806450 - - DRUGBANK DB02112 C31H31N5O small molecule - - DRUGBANK 18559 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2032 Zk-806450 - - DRUGBANK DB02112 C31H31N5O small molecule - - DRUGBANK 23899 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4594 2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL - - DRUGBANK DB04792 C20H22N4O4 small molecule - - DRUGBANK 23900 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4595 2-O-(3'-AMIDINOPHENYL)-5-O-(4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL - - DRUGBANK DB04793 C20H22N4O4 small molecule - - DRUGBANK 26214 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6976 2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE - - DRUGBANK DB08184 C16H15N3 small molecule - - DRUGBANK 22923 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4096 Cyclotheonamide A - - DRUGBANK DB04269 C36H45N9O8 small molecule - 129033-04-1 DRUGBANK 22924 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4096 Cyclotheonamide A - - DRUGBANK DB04269 C36H45N9O8 small molecule - 129033-04-1 DRUGBANK 22925 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4096 Cyclotheonamide A - - DRUGBANK DB04269 C36H45N9O8 small molecule - 129033-04-1 DRUGBANK 23394 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4257 2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB04442 C13H11N5O small molecule - - DRUGBANK 23395 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4257 2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB04442 C13H11N5O small molecule - - DRUGBANK 23396 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4257 2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine - - DRUGBANK DB04442 C13H11N5O small molecule - - DRUGBANK 24941 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5737 2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE - - DRUGBANK DB06918 C16H15N3 small molecule - - DRUGBANK 22086 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3702 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine - - DRUGBANK DB03865 C21H17ClN3O small molecule - - DRUGBANK 23123 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 23124 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 23125 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 18006 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1804 Bis(5-Amidino-2-Benzimidazolyl)Methanone - - DRUGBANK DB01876 C17H12N8O small molecule - - DRUGBANK 18007 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1804 Bis(5-Amidino-2-Benzimidazolyl)Methanone - - DRUGBANK DB01876 C17H12N8O small molecule - - DRUGBANK 18008 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1804 Bis(5-Amidino-2-Benzimidazolyl)Methanone - - DRUGBANK DB01876 C17H12N8O small molecule - - DRUGBANK 23157 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4161 1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea - - DRUGBANK DB04336 C14H13ClN4O small molecule - - DRUGBANK 20855 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3119 RWJ-51084 - - DRUGBANK DB03251 C19H25N5O2S small molecule - - DRUGBANK 19197 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2338 Aminomethylcyclohexane - - DRUGBANK DB02435 C7H16N small molecule - 3218-02-8 DRUGBANK 19198 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2338 Aminomethylcyclohexane - - DRUGBANK DB02435 C7H16N small molecule - 3218-02-8 DRUGBANK 19199 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2338 Aminomethylcyclohexane - - DRUGBANK DB02435 C7H16N small molecule - 3218-02-8 DRUGBANK 20812 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3111 4-Fluorobenzylamine - - DRUGBANK DB03243 C7H9FN small molecule - - DRUGBANK 20813 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3111 4-Fluorobenzylamine - - DRUGBANK DB03243 C7H9FN small molecule - - DRUGBANK 20814 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3111 4-Fluorobenzylamine - - DRUGBANK DB03243 C7H9FN small molecule - - DRUGBANK 18492 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2001 Bis-Benzamidine - - DRUGBANK DB02081 C23H28N4O small molecule - - DRUGBANK 18493 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2001 Bis-Benzamidine - - DRUGBANK DB02081 C23H28N4O small molecule - - DRUGBANK 18494 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2001 Bis-Benzamidine - - DRUGBANK DB02081 C23H28N4O small molecule - - DRUGBANK 18498 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2004 CRA_17312 - - DRUGBANK DB02084 C25H19N4O6 small molecule - - DRUGBANK 18499 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2004 CRA_17312 - - DRUGBANK DB02084 C25H19N4O6 small molecule - - DRUGBANK 18500 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2004 CRA_17312 - - DRUGBANK DB02084 C25H19N4O6 small molecule - - DRUGBANK 17903 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1766 [4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone - - DRUGBANK DB01836 C25H27ClN4O3S small molecule - - DRUGBANK 17904 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1766 [4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone - - DRUGBANK DB01836 C25H27ClN4O3S small molecule - - DRUGBANK 17905 111626 5644 - PRSS1 TRP1|TRY1|TRY4|TRYP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1766 [4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone - - DRUGBANK DB01836 C25H27ClN4O3S small molecule - - DRUGBANK 22317 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 22318 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 22319 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3810 Phosphorylisopropane - - DRUGBANK DB03976 C3H9O4P small molecule - - DRUGBANK 19248 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2364 Benzylamine - - DRUGBANK DB02464 C7H9N small molecule - 100-46-9 DRUGBANK 19249 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2364 Benzylamine - - DRUGBANK DB02464 C7H9N small molecule - 100-46-9 DRUGBANK 19250 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2364 Benzylamine - - DRUGBANK DB02464 C7H9N small molecule - 100-46-9 DRUGBANK 17811 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 17812 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 17813 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1735 Monoisopropylphosphorylserine - - DRUGBANK DB01805 C6H14NO6P small molecule - - DRUGBANK 23128 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 23129 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 23130 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 20550 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20551 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20552 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 27645 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27646 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27647 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 23359 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4228 3-Phenylpropylamine 3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane - DRUGBANK DB04410 C9H13N small molecule - 2038-57-5 DRUGBANK 23360 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4228 3-Phenylpropylamine 3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane - DRUGBANK DB04410 C9H13N small molecule - 2038-57-5 DRUGBANK 23361 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4228 3-Phenylpropylamine 3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane - DRUGBANK DB04410 C9H13N small molecule - 2038-57-5 DRUGBANK 18227 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1897 O-Benzylsulfonyl-Serine - - DRUGBANK DB01973 C10H13NO5S small molecule - - DRUGBANK 18228 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1897 O-Benzylsulfonyl-Serine - - DRUGBANK DB01973 C10H13NO5S small molecule - - DRUGBANK 18229 111627 5645 - PRSS2 TRY2|TRY8|TRYP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1897 O-Benzylsulfonyl-Serine - - DRUGBANK DB01973 C10H13NO5S small molecule - - DRUGBANK 20558 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2998 [3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine - - DRUGBANK DB03129 C6H15BN3O3 small molecule - - DRUGBANK 19425 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2438 4-Hydroxybutan-1-Aminium - - DRUGBANK DB02541 C4H12NO small molecule - - DRUGBANK 19426 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2438 4-Hydroxybutan-1-Aminium - - DRUGBANK DB02541 C4H12NO small molecule - - DRUGBANK 19427 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2438 4-Hydroxybutan-1-Aminium - - DRUGBANK DB02541 C4H12NO small molecule - - DRUGBANK 18904 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2215 4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium - - DRUGBANK DB02308 C6H15BNO3 small molecule - - DRUGBANK 18905 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2215 4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium - - DRUGBANK DB02308 C6H15BNO3 small molecule - - DRUGBANK 18906 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2215 4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium - - DRUGBANK DB02308 C6H15BNO3 small molecule - - DRUGBANK 22585 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3941 [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine - - DRUGBANK DB04109 C10H14BN2O3 small molecule - - DRUGBANK 21636 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3484 Guanidine-3-Propanol - - DRUGBANK DB03637 C4H12N3O small molecule - - DRUGBANK 21637 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3484 Guanidine-3-Propanol - - DRUGBANK DB03637 C4H12N3O small molecule - - DRUGBANK 21638 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3484 Guanidine-3-Propanol - - DRUGBANK DB03637 C4H12N3O small molecule - - DRUGBANK 20543 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20544 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 23223 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4191 1,3,2-Dioxaborolan-2-Ol - - DRUGBANK DB04369 C2H5BO3 small molecule - - DRUGBANK 23224 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4191 1,3,2-Dioxaborolan-2-Ol - - DRUGBANK DB04369 C2H5BO3 small molecule - - DRUGBANK 23225 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4191 1,3,2-Dioxaborolan-2-Ol - - DRUGBANK DB04369 C2H5BO3 small molecule - - DRUGBANK 19490 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2479 4-(Hydroxymethyl)Benzamidine - - DRUGBANK DB02585 C8H10N2O small molecule - - DRUGBANK 19491 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2479 4-(Hydroxymethyl)Benzamidine - - DRUGBANK DB02585 C8H10N2O small molecule - - DRUGBANK 19492 111628 5646 RP11-176F3.3 PRSS3 MTG|PRSS4|T9|TRY3|TRY4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2479 4-(Hydroxymethyl)Benzamidine - - DRUGBANK DB02585 C8H10N2O small molecule - - DRUGBANK 26058 111631 5650 - KLK7 PRSS6|SCCE|hK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6831 L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide - - DRUGBANK DB08038 C16H25N3O3 small molecule - - DRUGBANK 24926 111633 5652 - PRSS8 CAP1|PROSTASIN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5719 1-[4-(hydroxymethyl)phenyl]guanidine - - DRUGBANK DB06900 C8H11N3O small molecule - - DRUGBANK 20553 111634 5653 - KLK6 Bssp|Klk7|PRSS18|PRSS9|SP59|hK6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20554 111634 5653 - KLK6 Bssp|Klk7|PRSS18|PRSS9|SP59|hK6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 18195 111639 5660 - PSAP GLBA|SAP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1890 Di-Stearoyl-3-Sn-Phosphatidylethanolamine - - DRUGBANK DB01966 C41H82NO8P small molecule - - DRUGBANK 18196 111639 5660 - PSAP GLBA|SAP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1890 Di-Stearoyl-3-Sn-Phosphatidylethanolamine - - DRUGBANK DB01966 C41H82NO8P small molecule - - DRUGBANK 26560 111655 5682 - PSMA1 HC2|HEL-S-275|NU|PROS30 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26559 111656 5683 - PSMA2 HC3|MU|PMSA2|PSC2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26558 111657 5684 - PSMA3 HC8|PSC3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26557 111658 5685 - PSMA4 HC9|HsT17706|PSC9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26556 111659 5686 - PSMA5 PSC5|ZETA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26555 111660 5687 - PSMA6 IOTA|PROS27|p27K 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 25574 111661 5688 RP5-1005F21.4 PSMA7 C6|HSPC|RC6-1|XAPC7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6367 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE - - DRUGBANK DB07558 C20H37N3O4 small molecule - - DRUGBANK 26554 111661 5688 RP5-1005F21.4 PSMA7 C6|HSPC|RC6-1|XAPC7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26955 111662 5689 - PSMB1 HC5|PMSB1|PSC5 9606 Homo sapiens inhibitor target Kuhn DJ (2007) 17591945 182023 7633 Carfilzomib PR-171|Kyprolis kyprolis DRUGBANK DB08889 C40H57N5O7 small molecule L01XX45 868540-17-4 DRUGBANK 26562 111662 5689 - PSMB1 HC5|PMSB1|PSC5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26956 111663 5690 RP5-983H21.1 PSMB2 HC7-I 9606 Homo sapiens inhibitor target Kuhn DJ (2007) 17591945 182023 7633 Carfilzomib PR-171|Kyprolis kyprolis DRUGBANK DB08889 C40H57N5O7 small molecule L01XX45 868540-17-4 DRUGBANK 26561 111663 5690 RP5-983H21.1 PSMB2 HC7-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26553 111664 5691 - PSMB3 HC10-II 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26564 111665 5692 - PSMB4 HN3|HsN3|PROS-26|PROS26 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26957 111666 5693 - PSMB5 LMPX|MB1|X 9606 Homo sapiens inhibitor target Kortuem KM (2013) 23393020 182229 7633 Carfilzomib PR-171|Kyprolis kyprolis DRUGBANK DB08889 C40H57N5O7 small molecule L01XX45 868540-17-4 DRUGBANK 26566 111666 5693 - PSMB5 LMPX|MB1|X 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26563 111667 5694 - PSMB6 DELTA|LMPY|Y 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26565 111668 5695 RP11-101K10.7 PSMB7 Z 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7294 (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE - - DRUGBANK DB08515 C15H21NO4 small molecule - - DRUGBANK 26960 111669 5696 DAAP-57C1.3 PSMB8 ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10 9606 Homo sapiens inhibitor target Kuhn DJ (2007) 17591945 182023 7633 Carfilzomib PR-171|Kyprolis kyprolis DRUGBANK DB08889 C40H57N5O7 small molecule L01XX45 868540-17-4 DRUGBANK 26958 111671 5698 DADB-223G19.3 PSMB9 LMP2|PSMB6i|RING12|beta1i 9606 Homo sapiens inhibitor target Kuhn DJ (2007) 17591945 182023 7633 Carfilzomib PR-171|Kyprolis kyprolis DRUGBANK DB08889 C40H57N5O7 small molecule L01XX45 868540-17-4 DRUGBANK 26959 111672 5699 - PSMB10 LMP10|MECL1|beta2i 9606 Homo sapiens inhibitor target Kuhn DJ (2007) 17591945 182023 7633 Carfilzomib PR-171|Kyprolis kyprolis DRUGBANK DB08889 C40H57N5O7 small molecule L01XX45 868540-17-4 DRUGBANK 20912 111695 5723 - PSPH PSP|PSPHD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3157 D-2-Amino-3-Phosphono-Propionic Acid - - DRUGBANK DB03292 C3H8NO5P small molecule - - DRUGBANK 20913 111695 5723 - PSPH PSP|PSPHD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3157 D-2-Amino-3-Phosphono-Propionic Acid - - DRUGBANK DB03292 C3H8NO5P small molecule - - DRUGBANK 20914 111695 5723 - PSPH PSP|PSPHD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3157 D-2-Amino-3-Phosphono-Propionic Acid - - DRUGBANK DB03292 C3H8NO5P small molecule - - DRUGBANK 9780 111701 5729 - PTGDR AS1|ASRT1|DP|DP1|PTGDR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9781 111701 5729 - PTGDR AS1|ASRT1|DP|DP1|PTGDR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9782 111701 5729 - PTGDR AS1|ASRT1|DP|DP1|PTGDR1 9606 Homo sapiens unknown target Lane SJ (1996) 8939179 178006 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9783 111701 5729 - PTGDR AS1|ASRT1|DP|DP1|PTGDR1 9606 Homo sapiens unknown target Ahluwalia P (2001) 11544467 178005 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 11590 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Ota T (2006) 16877408 178985 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11591 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Sharif NA (2003) 14733708 178984 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 13652 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Walch L (2001) 11739243 180085 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13653 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Sharif NA (2002) 11999132 180084 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 10289 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Ito Y (2000) 10670413 178312 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 10290 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Norel X (2004) 15560119 178313 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 10291 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Takahashi HK (2003) 14561849 178311 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 10292 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Matlhagela K (2006) 16516814 178314 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 10293 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Tokuda H (2001) 11524243 178315 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 6850 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 421 Carboprost Tromethamine 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt hemabate DRUGBANK DB00429 C25H47NO8 small molecule G02AD04 58551-69-2 DRUGBANK 6851 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Carrasco MP (1997) 9462300 175997 421 Carboprost Tromethamine 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt hemabate DRUGBANK DB00429 C25H47NO8 small molecule G02AD04 58551-69-2 DRUGBANK 6852 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Hay A (2010) 20519365 175996 421 Carboprost Tromethamine 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt hemabate DRUGBANK DB00429 C25H47NO8 small molecule G02AD04 58551-69-2 DRUGBANK 6853 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Tsuboi K (2001) 11338376 175995 421 Carboprost Tromethamine 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt hemabate DRUGBANK DB00429 C25H47NO8 small molecule G02AD04 58551-69-2 DRUGBANK 5242 111703 5731 - PTGER1 EP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 290 Bupivacaine 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina bupivacaine hydrochloride inje DRUGBANK DB00297 C18H28N2O small molecule N01BB01|N01BB51 38396-39-3 DRUGBANK 5243 111703 5731 - PTGER1 EP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 290 Bupivacaine 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina bupivacaine hydrochloride inje DRUGBANK DB00297 C18H28N2O small molecule N01BB01|N01BB51 38396-39-3 DRUGBANK 5244 111703 5731 - PTGER1 EP1 9606 Homo sapiens unknown target Beloeil H (2009) 19690271 175037 290 Bupivacaine 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina bupivacaine hydrochloride inje DRUGBANK DB00297 C18H28N2O small molecule N01BB01|N01BB51 38396-39-3 DRUGBANK 11884 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Sugimoto Y (2007) 17329241 179083 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11885 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Tamiji J (2010) 20599704 179082 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11886 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Legler DF (2010) 19788928 179085 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11887 111703 5731 - PTGER1 EP1 9606 Homo sapiens agonist target Baryawno N (2008) 18715952 179084 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 10286 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Dijkstra BG (1999) 10509658 178309 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 10287 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 10288 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Takahashi HK (2005) 15840408 178310 760 Alprostadil (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid prostin vr sterile solution|ca DRUGBANK DB00770 C20H34O5 small molecule G04BE01|C01EA01 745-65-3 DRUGBANK 12025 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Li J (2008) 18472336 179162 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12026 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Guan Y (2002) 12097143 179163 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12027 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Nataraj C (2001) 11602631 179160 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12028 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Nakae K (2005) 16039053 179161 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12029 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Kiriyama M (1997) 9313928 179164 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 11880 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Sugimoto Y (2007) 17329241 179083 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11881 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Tamiji J (2010) 20599704 179082 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11879 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Legler DF (2010) 19788928 179085 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11882 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11883 111704 5732 - PTGER2 EP2 9606 Homo sapiens agonist target Baryawno N (2008) 18715952 179084 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 12014 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Li J (2008) 18472336 179162 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12015 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Guan Y (2002) 12097143 179163 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12016 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Nataraj C (2001) 11602631 179160 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12017 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Nakae K (2005) 16039053 179161 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12018 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Kiriyama M (1997) 9313928 179164 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 11587 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Gabelt BT (2009) 19232013 178983 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11588 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Ota T (2006) 16877408 178985 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11589 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Sharif NA (2003) 14733708 178984 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11893 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Sugimoto Y (2007) 17329241 179083 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11894 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Tamiji J (2010) 20599704 179082 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11895 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Legler DF (2010) 19788928 179085 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11896 111705 5733 RP5-952N6.2 PTGER3 EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R 9606 Homo sapiens agonist target Baryawno N (2008) 18715952 179084 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 12019 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Li J (2008) 18472336 179162 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12020 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Guan Y (2002) 12097143 179163 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12021 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Nataraj C (2001) 11602631 179160 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12022 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Nakae K (2005) 16039053 179161 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12023 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Crider JY (2002) 11993717 160612 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 12024 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Kiriyama M (1997) 9313928 179164 919 Misoprostol Cytotec|Misoprostolum pms-misoprostol (0.2mg)|arthro DRUGBANK DB00929 C22H38O5 small molecule M01AE56|A02BB01|G02AD06 59122-46-2 DRUGBANK 11888 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Sugimoto Y (2007) 17329241 179083 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11889 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Tamiji J (2010) 20599704 179082 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11890 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Legler DF (2010) 19788928 179085 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11891 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Baryawno N (2008) 18715952 179084 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 11892 111706 5734 - PTGER4 EP4|EP4R 9606 Homo sapiens agonist target Wise H (2006) 16545798 179086 907 Dinoprostone Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate dinoprostone|prostin e2 tablet DRUGBANK DB00917 C20H32O5 small molecule G02AD02 363-24-6 DRUGBANK 5159 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Thieme H (2006) 16505027 161229 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5160 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5161 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Toris CB (2008) 19038618 174972 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5162 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Costagliola C (2009) 19929706 174973 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5163 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Ota T (2005) 16249494 174971 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5164 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Lim KS (2008) 18452763 174976 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5165 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Arranz-Marquez E (2008) 18983226 174977 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5166 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Neacsu AM (2009) 19697832 174974 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 5167 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Ferrari G (1996) 9038626 174975 280 Travoprost Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z mylan-travoprost z|apo-travopr DRUGBANK DB00287 C26H35F3O6 small molecule S01EE04 157283-68-6 DRUGBANK 14359 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Sakamoto K (1995) 8777582 180420 1148 Dinoprost Tromethamine PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol prostin f2 alpha DRUGBANK DB01160 C24H45NO8 small molecule - 38562-01-5 DRUGBANK 26887 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Pantcheva MB (2011) 21858491 182193 7588 Tafluprost AFP-168|Zioptan saflutan|zioptan DRUGBANK DB08819 C25H34F2O5 small molecule S01EE05 209860-87-7 DRUGBANK 9040 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Takagi Y (2004) 15037111 177577 644 Latanoprost Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan teva-latanoprost/timolol|apo-l DRUGBANK DB00654 C26H40O5 small molecule S01EE01 130209-82-4 DRUGBANK 9041 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 644 Latanoprost Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan teva-latanoprost/timolol|apo-l DRUGBANK DB00654 C26H40O5 small molecule S01EE01 130209-82-4 DRUGBANK 9042 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Nakajima T (2003) 14646172 177579 644 Latanoprost Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan teva-latanoprost/timolol|apo-l DRUGBANK DB00654 C26H40O5 small molecule S01EE01 130209-82-4 DRUGBANK 9043 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Ocklind A (1998) 9733584 177578 644 Latanoprost Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan teva-latanoprost/timolol|apo-l DRUGBANK DB00654 C26H40O5 small molecule S01EE01 130209-82-4 DRUGBANK 9044 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Ota T (2005) 16249494 174971 644 Latanoprost Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan teva-latanoprost/timolol|apo-l DRUGBANK DB00654 C26H40O5 small molecule S01EE01 130209-82-4 DRUGBANK 9045 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Maxey KM (2002) 12204699 177580 644 Latanoprost Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan teva-latanoprost/timolol|apo-l DRUGBANK DB00654 C26H40O5 small molecule S01EE01 130209-82-4 DRUGBANK 11593 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11594 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Sharif NA (2002) 12222762 178987 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11595 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Mintz EE (1978) 689791 178986 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11596 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Sharif NA (2003) 14733708 178984 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11597 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Wan Z (2007) 17724194 178989 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11598 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Sharif NA (2001) 11740958 178988 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11599 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Lim KS (2008) 18452763 174976 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 11600 111709 5737 RP5-944H6.1 PTGFR FP 9606 Homo sapiens agonist target Neacsu AM (2009) 19697832 174974 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 27934 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Kaufmann P (2015) 25850750 196024 8235 Selexipag - uptravi titration pack|uptravi DRUGBANK DB11362 C26H32N4O4S small molecule B01AC27 475086-01-2 DRUGBANK 13638 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Anderson JR (2010) 20395700 180078 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13639 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Krug S (2009) 19475782 180074 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13640 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Schermuly RT (2007) 17257398 180075 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13641 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Tsai AL (1988) 2456096 180076 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13642 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Idzko M (2007) 17273558 180077 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13643 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Takamatsu H (2002) 11792366 180071 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13644 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Mubarak KK (2010) 19683911 180072 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13645 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Crutchley DJ (1992) 1375507 180073 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 13646 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Olschewski H (2004) 15163595 175648 1076 Iloprost - ventavis DRUGBANK DB01088 C22H32O4 small molecule B01AC11 78919-13-8 DRUGBANK 14356 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1148 Dinoprost Tromethamine PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol prostin f2 alpha DRUGBANK DB01160 C24H45NO8 small molecule - 38562-01-5 DRUGBANK 14357 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1148 Dinoprost Tromethamine PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol prostin f2 alpha DRUGBANK DB01160 C24H45NO8 small molecule - 38562-01-5 DRUGBANK 14358 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1148 Dinoprost Tromethamine PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol prostin f2 alpha DRUGBANK DB01160 C24H45NO8 small molecule - 38562-01-5 DRUGBANK 15292 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Kasza Z (2009) 19302827 180799 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 15293 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Yang J (2002) 12297509 180798 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 15294 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Ibrahim S (2010) 20522800 160395 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 15295 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 6216 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Falcetti E (2010) 20622039 152865 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 6217 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 6218 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Sprague RS (2008) 18574748 175649 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 6219 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens agonist target Olschewski H (2004) 15163595 175648 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 24289 111711 5739 - PTGIR IP|PRIPR 9606 Homo sapiens unknown target Melian EB (2002) 11790158 181785 5009 Beraprost - - DRUGBANK DB05229 C24H29NaO5 small molecule B01AC19 88430-50-6 DRUGBANK 26687 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7449 (6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID - - DRUGBANK DB08675 C20H32N2O2 small molecule - - DRUGBANK 10750 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10751 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10752 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inhibitor target Marnett LJ (1984) 6434940 178491 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10753 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inhibitor target Reed GA (1985) 3917545 178493 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10754 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inhibitor target Tobin T (1986) 3517382 178492 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 15296 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inducer target Ruan KH (2008) 18081314 180801 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 15297 111712 5740 - PTGIS CYP8|CYP8A1|PGIS|PTGI 9606 Homo sapiens inducer target Nakayama T (2010) 20357747 180800 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 16431 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Stevenson DD (2004) 15242723 181293 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 16432 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Schmidt A (1991) 1680855 181292 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 16433 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 16434 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Josephs MD (1999) 10452868 181294 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 3424 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Yang P (2004) 14993240 173821 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3425 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Machida T (2005) 16141635 173820 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3426 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Lee JY (2003) 12562875 173822 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3427 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Vecchio AJ (2010) 20463020 173819 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3428 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Das UN (2005) 15990700 173594 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3429 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Das UN (2005) 16190133 173591 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3430 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Malkowski MG (2001) 11477109 173593 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 19743 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2597 Resveratrol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol co-veratrol DRUGBANK DB02709 C14H12O3 small molecule - 501-36-0 DRUGBANK 8538 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Cheng ZJ (2003) 12586211 177227 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8539 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Lim JT (1999) 10484067 177226 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8540 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Cheng ZJ (2002) 12512695 177225 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8541 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Giuliano F (1999) 10372826 177229 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8542 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Soriano AF (1999) 10626810 177228 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 21856 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3595 Flurbiprofen Methyl Ester - - DRUGBANK DB03753 C16H15FO2 small molecule - - DRUGBANK 21857 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3595 Flurbiprofen Methyl Ester - - DRUGBANK DB03753 C16H15FO2 small molecule - - DRUGBANK 21858 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3595 Flurbiprofen Methyl Ester - - DRUGBANK DB03753 C16H15FO2 small molecule - - DRUGBANK 21855 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3594 P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid - - DRUGBANK DB03752 C14H11IO3S small molecule - - DRUGBANK 7150 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Bensen W (1998) 9481468 176239 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7151 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Takeuchi K (2006) 16469680 176238 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7152 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Cipollone F (1995) 7554708 176237 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7153 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Giuliano F (2001) 11525777 176240 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 19896 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2657 (3-Chloro-4-Propoxy-Phenyl)-Acetic Acid - - DRUGBANK DB02773 C11H13ClO3 small molecule - - DRUGBANK 9706 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target McGarry HF (2005) 15932636 177964 701 Diethylcarbamazine N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum hetrazan tab 50mg DRUGBANK DB00711 C10H21N3O small molecule P02CB02 90-89-1 DRUGBANK 9713 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Nivsarkar M (2008) 19066416 177973 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9714 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kurahashi K (2001) 11811354 177972 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9715 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Hewett SJ (2000) 10773011 177971 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9716 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Basselin M (2007) 17562170 177977 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9717 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Rieke CJ (1999) 10358065 177976 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9718 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Droege MJ (2003) 12711844 177975 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9719 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Klegeris A (2002) 12392782 177974 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 7200 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Dionne RA (2001) 11695255 176255 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7201 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Uzan A (2005) 16262557 176257 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7202 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Blais V (2005) 16277613 176256 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7203 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Bosch-Marce M (1999) 10220509 176259 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7204 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Lashbrook JM (1999) 10422661 176258 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 23923 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 4619 Metamizole Dipyrone - DRUGBANK DB04817 C13H16N3NaO4S small molecule N02BB72|N02BB52|N02BB02 50567-35-6 DRUGBANK 10773 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Blanco FJ (1999) 10381057 176844 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 10774 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Panara MR (1999) 10381787 178508 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 4691 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4692 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 7533 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kennedy JH (2003) 14613550 176516 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7534 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Burdan F (2005) 16182428 176517 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7535 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Capasso A (1997) 9253954 176515 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7536 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Capasso A (1999) 10465690 176518 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 11213 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Cappon GD (2003) 12852483 178741 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11214 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen QH (2005) 15755648 178740 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11215 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Young JM (1996) 8737748 178742 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 12122 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Shiels IA (2000) 11094641 179221 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12123 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Meade EA (1993) 8454631 179220 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12124 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kalgutkar AS (2000) 10639181 179223 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12125 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Perez-Vizcaino F (2002) 12225961 179222 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12126 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Wilson JE (2004) 15198222 178171 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 21683 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3513 Acetic Acid Salicyloyl-Amino-Ester - - DRUGBANK DB03667 C9H9NO4 small molecule - - DRUGBANK 12328 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 953 Bromfenac Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum prolensa|bromday|bromfenac|bro DRUGBANK DB00963 C15H12BrNO3 small molecule S01BC11 91714-94-2 DRUGBANK 12329 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Waterbury LD (2006) 16846546 179366 953 Bromfenac Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum prolensa|bromday|bromfenac|bro DRUGBANK DB00963 C15H12BrNO3 small molecule S01BC11 91714-94-2 DRUGBANK 23681 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Talbot S (2011) 21600945 182187 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 18025 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1819 Hyperforin Hiperforina|Hyperforine - DRUGBANK DB01892 C35H52O4 small molecule - 11079-53-1 DRUGBANK 13276 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Chavez ML (2003) 12852704 177085 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13277 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13278 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Martic M (2004) 14987823 179630 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13279 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Gupta K (2004) 14741265 179900 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13280 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Yu L (2013) 23536207 179901 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13281 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Patrignani P (2003) 14592549 179902 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13282 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Hillarp A (2004) 15575422 179899 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 8007 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Blanco FJ (1999) 10381057 176844 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8008 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Bugajski J (2001) 11785774 176845 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8009 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Raju J (2002) 11952155 176846 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8010 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Veiga AP (2004) 15464832 176843 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8011 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Fackovcova D (2001) 11153163 176241 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 18551 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2030 Protoporphyrin Ix Containing Co - - DRUGBANK DB02110 C34H32CoN4O4 small molecule - - DRUGBANK 18552 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2030 Protoporphyrin Ix Containing Co - - DRUGBANK DB02110 C34H32CoN4O4 small molecule - - DRUGBANK 18553 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2030 Protoporphyrin Ix Containing Co - - DRUGBANK DB02110 C34H32CoN4O4 small molecule - - DRUGBANK 10055 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Glaser K (1995) 8566109 178167 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10056 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Riendeau D (1997) 9146894 178169 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10057 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Hirate K (2006) 16473424 178168 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10058 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Campbell NB (2002) 12358053 178170 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10059 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Wilson JE (2004) 15198222 178171 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10826 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Beretta C (2005) 15939622 178489 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 18716 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2114 2-Bromoacetyl Group - - DRUGBANK DB02198 C2H3BrO2 small molecule - 79-08-3 DRUGBANK 18717 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2114 2-Bromoacetyl Group - - DRUGBANK DB02198 C2H3BrO2 small molecule - 79-08-3 DRUGBANK 18718 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2114 2-Bromoacetyl Group - - DRUGBANK DB02198 C2H3BrO2 small molecule - 79-08-3 DRUGBANK 16446 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Simon RA (2004) 14680616 181305 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 16447 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Nizankowska E (1990) 2083404 181304 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 16448 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Schwartz KA (2006) 17131625 179240 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 12149 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Birnbaum Y (2007) 17259075 179239 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12150 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12151 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Flipo RM (2006) 17078596 179243 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12152 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Guthikonda S (2007) 17319904 179242 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12153 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Stevenson DD (2006) 17030227 179241 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12154 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Schwartz KA (2006) 17131625 179240 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 10421 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Cryer B (1998) 9626023 178378 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10422 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Joo Y (2006) 16223958 178379 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10423 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Gierse JK (1995) 7832763 178380 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10424 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Sinniah R (2001) 11316248 178376 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10425 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Laudanno OM (1998) 9773153 178377 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 12562 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Yood MU (2006) 17024689 179560 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12561 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kawai S (1998) 9831331 179562 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12560 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Ottonello L (2009) 19338579 179563 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12563 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kean WF (2004) 15324530 179559 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12564 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Zhou XP (2009) 19952416 179561 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 5879 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inducer target Gaffar A (1995) 7560228 175418 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5880 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inducer target Kurbel S (1999) 10616041 175416 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 5881 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inducer target Michelet JF (1997) 9008235 175417 342 Minoxidil Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain mens rogaine extra strength|mi DRUGBANK DB00350 C9H15N5O small molecule C02DC01|D11AX01 38304-91-5 DRUGBANK 10545 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 15726 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Esser R (2005) 15655513 181035 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15727 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Warner TD (2006) 16403783 181034 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15728 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Capone ML (2003) 14552704 181033 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15729 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Blobaum AL (2007) 17434872 181032 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15730 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Jermany J (2005) 16172182 181031 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 12695 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kurahashi K (2001) 11811354 177972 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12696 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Zuniga J (2003) 14513718 179627 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12697 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Parsadaniantz SM (2000) 10929089 179629 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12698 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Levoin N (2004) 15476667 179628 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12699 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Martic M (2004) 14987823 179630 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 21920 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 3623 Phenacetin Acetophenetin|Acetphenetidin|Acetophenetidine|Acetophenetidin - DRUGBANK DB03783 C10H13NO2 small molecule N02BE73|N02BE03|N02BE53 62-44-2 DRUGBANK 8175 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Poggi JC (2006) 17050798 176976 563 Fenoprofen 2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid nalfon tab 600mg|nalfon|fenopr DRUGBANK DB00573 C15H14O3 small molecule M01AE04 29679-58-1 DRUGBANK 19110 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19111 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19112 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 10500 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target James MJ (2007) 17541796 178397 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 2939 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2940 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Das UN (2005) 15990700 173594 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2941 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Das UN (2005) 16190133 173591 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2942 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Thuresson ED (2001) 11121413 173590 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2943 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Malkowski MG (2001) 11477109 173593 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2944 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Levin G (2002) 11939906 173592 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 8294 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Calkin AC (2002) 12414874 177087 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8295 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kaempfer H (2003) 12713596 177086 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8296 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chavez ML (2003) 12852704 177085 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8297 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Hinz B (2003) 12966366 177084 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8298 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kirchheiner J (2003) 12534640 177083 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8299 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 23693 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4367 Arachidonic Acid - - DRUGBANK DB04557 C20H32O2 small molecule - 506-32-1 DRUGBANK 23694 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4367 Arachidonic Acid - - DRUGBANK DB04557 C20H32O2 small molecule - 506-32-1 DRUGBANK 23695 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4367 Arachidonic Acid - - DRUGBANK DB04557 C20H32O2 small molecule - 506-32-1 DRUGBANK 7227 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Yamada M (1997) 9152412 176290 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7228 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kothekar V (2001) 11563332 176288 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7229 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Ozgocmen S (2005) 15943176 176289 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7230 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Lucio M (2006) 17017983 176286 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7231 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Lora M (1997) 9175172 176287 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 5476 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 309 Acetaminophen p-hydroxyphenolacetamide|Acetaminophene|p-acetamidophenol|Panadol|Acetaminofen|p-hydroxyacetanilide|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|p-Acetylaminophenol|Acetaminophen|Tylenol|Paracetamol|4-acetamidophenol|APAP tylenol cold and flu nighttime DRUGBANK DB00316 C8H9NO2 small molecule N02BE71|N02BE01|N02BE51 103-90-2 DRUGBANK 16409 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Sun R (2005) 15840771 179203 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16410 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Liu X (2006) 16368818 179202 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16411 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Graham GG (2004) 15035793 179201 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16412 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Moon C (2004) 14746879 179200 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16413 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Celik G (2005) 15871445 179199 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 5601 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Fornai M (2005) 15831902 175237 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5602 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Bobadilla L RA (2005) 15743404 175241 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5603 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Higuchi K (2005) 15700751 175240 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5604 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Kundu N (2005) 15891886 175238 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5605 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Moth CW (2005) 15887968 175239 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 18400 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1969 2-(1,1'-Biphenyl-4-Yl)Propanoic Acid - - DRUGBANK DB02047 C15H14O2 small molecule - - DRUGBANK 24781 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Renner RM (2010) 20399943 182151 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 24782 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Rose P (2007) 17516707 182014 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 24783 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Berg J (1999) 10450786 181738 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 24784 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Bianchi M (2002) 11846620 181788 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 12734 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12735 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12736 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12737 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Wiggins JB (2009) 19743890 179656 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12738 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 26010 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6778 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID - - DRUGBANK DB07983 C19H16INO4 small molecule - - DRUGBANK 26011 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6779 2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE - - DRUGBANK DB07984 C23H25ClN2O4 small molecule - - DRUGBANK 26848 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens antagonist target Dominguez MJ (1985) 3838919 181670 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26849 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens antagonist target Anninos H (2009) 19465361 182109 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 11277 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 11278 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Loll PJ (1996) 8652509 178801 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 11279 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Llorens O (2002) 11885959 178800 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 11280 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Bender A (2007) 17477341 178799 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 26008 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6776 2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE - - DRUGBANK DB07981 C23H25ClN2O4 small molecule - - DRUGBANK 18836 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Ouellet M (1995) 7864817 181626 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 16611 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Berry H (1983) 6342700 181384 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16612 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target James MJ (2007) 17541796 178397 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16613 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Hassan SM (1982) 7088753 181383 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 12097 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Celik G (2005) 15871445 179199 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12098 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12099 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Sun R (2005) 15840771 179203 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12100 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Liu X (2006) 16368818 179202 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12101 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Graham GG (2004) 15035793 179201 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12102 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Moon C (2004) 14746879 179200 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12103 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Vane JR (1971) 5284360 179204 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 10747 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Morton AJ (2005) 15563928 178490 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10748 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Zitova A (2010) 19849999 178488 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10749 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Beretta C (2005) 15939622 178489 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 16672 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Brune K (2001) 11695253 181415 1383 Antipyrine 1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon auralgan eardrops|antipyrine a DRUGBANK DB01435 C11H12N2O small molecule S02DA03|N02BB51|N02BB71|N02BB01 60-80-0 DRUGBANK 17906 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1767 O-acetyl-L-serine L-Serine, acetate (ester)|O3-acetyl-L-serine - DRUGBANK DB01837 C5H9NO4 small molecule - 5147-00-2 DRUGBANK 17907 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1767 O-acetyl-L-serine L-Serine, acetate (ester)|O3-acetyl-L-serine - DRUGBANK DB01837 C5H9NO4 small molecule - 5147-00-2 DRUGBANK 17908 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1767 O-acetyl-L-serine L-Serine, acetate (ester)|O3-acetyl-L-serine - DRUGBANK DB01837 C5H9NO4 small molecule - 5147-00-2 DRUGBANK 24838 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Gamache DA (2000) 10850857 181753 5639 Nepafenac AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac ilevro|nevanac DRUGBANK DB06802 C15H14N2O2 small molecule S01BC10 78281-72-8 DRUGBANK 17307 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Gupta K (2004) 14741265 179900 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 17308 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Patrignani P (2003) 14592549 179902 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 17309 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Hillarp A (2004) 15575422 179899 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 17310 111714 5742 RP11-542K23.6 PTGS1 COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS 9606 Homo sapiens inhibitor target Martic M (2004) 14987823 179630 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 16435 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Schaefer MG (2003) 12901032 181297 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 16436 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Motsko SP (2006) 16808554 181296 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 16437 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Stichtenoth DO (1998) 9711054 181295 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 16438 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Josephs MD (1999) 10452868 181294 1349 Salsalate Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid salsalate|disalcid tab 750mg|d DRUGBANK DB01399 C14H10O5 small molecule N02BA06 552-94-3 DRUGBANK 3453 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Machida T (2005) 16141635 173820 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3454 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Lee JY (2003) 12562875 173822 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3455 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chene G (2007) 17459764 173843 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3456 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Vecchio AJ (2010) 20463020 173819 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3457 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Das UN (2005) 16190133 173591 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 3458 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ait-Said F (2003) 12573452 173842 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 19745 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2597 Resveratrol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol co-veratrol DRUGBANK DB02709 C14H12O3 small molecule - 501-36-0 DRUGBANK 8563 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Molina MA (1999) 10485483 177247 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8561 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yip-Schneider MT (2000) 10657949 177245 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8562 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Fosslien E (2000) 11078056 177244 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8560 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Giuliano F (1999) 10372826 177229 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 8564 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Taylor MT (2000) 11118042 177246 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 10775 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Tegeder I (1999) 10340919 178510 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 10776 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Poulsen Nautrup B (1999) 10220944 178511 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 10777 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 10778 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Blanco FJ (1999) 10381057 176844 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 10779 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Gross JM (1999) 10567199 178509 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 10780 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Panara MR (1999) 10381787 178508 804 Meloxicam Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam ava-meloxicam|auro-meloxicam|a DRUGBANK DB00814 C14H13N3O4S2 small molecule M01AC56|M01AC06 71125-38-7 DRUGBANK 23687 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Alpert E (2007) 17098211 138173 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 23688 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Jabeen T (2005) 16301791 181921 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 23689 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Diao HL (2007) 17485303 182008 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 7154 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7155 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Elliott SN (1995) 7615202 176244 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7156 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Roy HK (2001) 11304699 176245 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7157 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hedner T (2004) 15456329 176242 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7158 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target van Kraaij DJ (2002) 12047490 176243 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 7159 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Fackovcova D (2001) 11153163 176241 453 Nabumetone Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone apo-nabumetone|relafen tablets DRUGBANK DB00461 C15H16O2 small molecule M01AX01 42924-53-8 DRUGBANK 8314 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kirchheiner J (2003) 12534640 177083 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8315 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chavez ML (2003) 12852704 177085 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8316 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Rowlinson SW (2003) 12925531 177102 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8317 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Beubler E (2003) 12705061 177100 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8318 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Blomme EA (2003) 12588370 177101 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 9720 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Bayly CI (1999) 10091674 177979 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9721 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hinz B (2001) 11405284 177978 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9722 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target van Haeringen NJ (2000) 10977131 177980 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9723 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Nivsarkar M (2008) 19066416 177973 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9724 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Smith T (2000) 11006278 160486 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9725 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hewett SJ (2000) 10773011 177971 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 9726 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Basselin M (2007) 17562170 177977 702 Flurbiprofen Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene nu-flurbiprofen tab 50mg|ratio DRUGBANK DB00712 C15H13FO2 small molecule M01AE09|S01BC04|M02AA19|R02AX01 5104-49-4 DRUGBANK 7205 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Blais V (2002) 12446609 176260 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7206 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ma W (2003) 14568028 176261 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7207 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Padi SS (2004) 15102535 176262 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7208 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hoecherl K (2002) 12110513 176263 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 7209 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ma W (2003) 14568029 176264 457 Ketorolac Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac toradol|acular ls|toradol tab DRUGBANK DB00465 C15H13NO3 small molecule M01AB15|S01BC05 74103-06-3 DRUGBANK 24785 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Renner RM (2010) 20399943 182151 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 24786 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Rose P (2007) 17516707 182014 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 24787 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Berg J (1999) 10450786 181738 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 24788 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Bianchi M (2002) 11846620 181788 5605 Lornoxicam Chlortenoxicam|Lornoxicamum - DRUGBANK DB06725 C13H10ClN3O4S2 small molecule M01AC05 70374-39-9 DRUGBANK 18842 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Ouellet M (1995) 7864817 181626 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 26988 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ferguson GD (2007) 17308870 159982 7654 Pomalidomide - pomalyst DRUGBANK DB08910 C13H11N3O4 small molecule L04AX06 19171-19-8 DRUGBANK 4568 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Cipolla G (2002) 12208114 174550 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4569 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Generini S (2002) 12463455 174551 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4570 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Mifflin RC (2004) 14742690 174552 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4571 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Pruzanski W (1997) 9256165 174553 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4572 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Distrutti E (2006) 16855178 174554 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 4707 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Cipolla G (2002) 12208114 174550 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4708 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Generini S (2002) 12463455 174551 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4709 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Mifflin RC (2004) 14742690 174552 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4710 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Pruzanski W (1997) 9256165 174553 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 4711 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Distrutti E (2006) 16855178 174554 237 Mesalazine Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol asacol 800|pentasa|pentasa sup DRUGBANK DB00244 C7H7NO3 small molecule A07EC02 89-57-6 DRUGBANK 7537 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7538 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kennedy JH (2003) 14613550 176516 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7539 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Capasso A (1997) 9253954 176515 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7540 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Burdan F (2004) 15458776 176519 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7541 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Capasso A (1999) 10465690 176518 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 7542 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kirkova M (2007) 17391279 176520 492 Tolmetin Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum tolectin 400 cap 400mg|tolmeti DRUGBANK DB00500 C15H15NO3 small molecule M01AB03|M02AA21 26171-23-3 DRUGBANK 11216 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Cappon GD (2003) 12852483 178741 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11217 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11218 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Young JM (1996) 8737748 178742 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11219 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Jeske AH (1999) 10825891 178745 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11220 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Mao H (2001) 11673972 178744 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 11221 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Moore PA (2001) 11315375 178743 851 Diflunisal 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal diflunisal-500 - tab 500mg|nu- DRUGBANK DB00861 C13H8F2O3 small molecule N02BA11 22494-42-4 DRUGBANK 12131 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Narsinghani T (2006) 16290292 179228 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12132 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kalgutkar AS (2000) 10639181 179223 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12133 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wilson JE (2004) 15198222 178171 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12134 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Traupe T (2002) 12409963 179227 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12135 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Smith WL (1994) 7825862 179226 929 Meclofenamic acid N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico meclofenamate sodium DRUGBANK DB00939 C14H11Cl2NO2 small molecule M01AG04|M02AA18 644-62-2 DRUGBANK 12330 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Sanchez-Matienzo D (2006) 16982289 179368 953 Bromfenac Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum prolensa|bromday|bromfenac|bro DRUGBANK DB00963 C15H12BrNO3 small molecule S01BC11 91714-94-2 DRUGBANK 12331 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Waterbury LD (2006) 16846546 179366 953 Bromfenac Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum prolensa|bromday|bromfenac|bro DRUGBANK DB00963 C15H12BrNO3 small molecule S01BC11 91714-94-2 DRUGBANK 12332 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chitturi S (2002) 12016548 179367 953 Bromfenac Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum prolensa|bromday|bromfenac|bro DRUGBANK DB00963 C15H12BrNO3 small molecule S01BC11 91714-94-2 DRUGBANK 15731 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kalbag J (2004) 15177307 181038 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15732 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Tacconelli S (2004) 14965322 181037 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15733 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Atherton C (2004) 15017615 181036 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15734 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Esser R (2005) 15655513 181035 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15735 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Capone ML (2003) 14552704 181033 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 15736 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1270 Lumiracoxib COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189 - DRUGBANK DB01283 C15H13ClFNO2 small molecule M01AH06 220991-20-8 DRUGBANK 13289 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chavez ML (2003) 12852704 177085 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13290 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13291 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Gallego-Sandin S (2004) 15481334 179907 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13292 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Murphey LJ (2004) 15494133 179908 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13293 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ouellet M (2004) 14510637 179909 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 13294 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Sanchez-Fidalgo S (2004) 15556152 179910 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 8012 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8013 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Fackovcova D (2001) 11153163 176241 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8014 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Blanco FJ (1999) 10381057 176844 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8015 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Bugajski J (2001) 11785774 176845 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8016 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Raju J (2002) 11952155 176846 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 8017 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Veiga AP (2004) 15464832 176843 544 Piroxicam 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum feldene cap 20mg|nu-pirox cap DRUGBANK DB00554 C15H13N3O4S small molecule M01AC01|M02AA07|S01BC06 36322-90-4 DRUGBANK 7774 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Malmstrom K (1999) 10566562 176707 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7775 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Matheson AJ (2001) 11398914 176706 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7776 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Langman MJ (1999) 10580458 176705 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7777 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chakraborti AK (2010) 20166930 176704 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7778 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ashok V (2011) 20724158 176703 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7779 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Baron JA (2008) 18922570 176702 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7780 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7781 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Pascucci RA (1999) 10643177 176709 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7782 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hawkey C (2000) 10693877 176708 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 7783 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ehrich EW (1999) 10555907 176710 523 Rofecoxib - vioxx tab 25mg|vioxx suspensio DRUGBANK DB00533 C17H14O4S small molecule M01AH02 162011-90-7 DRUGBANK 10061 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen WS (2001) 11275997 178176 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10062 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Svendsen KB (2000) 11009046 178174 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10063 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kusuhara H (1999) 10594327 178175 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10064 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen WS (2003) 12824918 178173 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10065 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wilson JE (2004) 15198222 178171 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10066 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 10827 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wilson JE (2004) 15198222 178171 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 10828 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 10829 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Brideau C (2001) 11703020 178550 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 10830 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Narlawar R (2006) 17181139 178551 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 10831 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kay-Mugford P (2000) 10895904 178552 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 10832 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Beretta C (2005) 15939622 178489 811 Carprofen (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid - DRUGBANK DB00821 C15H12ClNO2 small molecule - 53716-49-7 DRUGBANK 13098 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens antagonist target Kim JH (2011) 21507989 179857 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13099 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens antagonist target Payvandi F (2004) 15598423 176374 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13100 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens antagonist target Hada M (2004) 15446566 179858 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13101 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens antagonist target Horrobin DF (2003) 12710892 179859 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13102 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens antagonist target Wiedmann MW (2005) 15892618 179861 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13103 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens antagonist target Du GJ (2005) 15982930 179860 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 17449 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1565 Etoricoxib 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB - DRUGBANK DB01628 C18H15ClN2O2S small molecule M01AH05 202409-33-4 DRUGBANK 17450 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1565 Etoricoxib 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB - DRUGBANK DB01628 C18H15ClN2O2S small molecule M01AH05 202409-33-4 DRUGBANK 17451 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1565 Etoricoxib 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB - DRUGBANK DB01628 C18H15ClN2O2S small molecule M01AH05 202409-33-4 DRUGBANK 17452 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yuan Y (2007) 17691997 181616 1565 Etoricoxib 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB - DRUGBANK DB01628 C18H15ClN2O2S small molecule M01AH05 202409-33-4 DRUGBANK 17453 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Capone ML (2007) 17164136 181615 1565 Etoricoxib 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB - DRUGBANK DB01628 C18H15ClN2O2S small molecule M01AH05 202409-33-4 DRUGBANK 17454 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target FitzGerald GA (2007) 17573128 181614 1565 Etoricoxib 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB - DRUGBANK DB01628 C18H15ClN2O2S small molecule M01AH05 202409-33-4 DRUGBANK 12177 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Shen J (2006) 17181859 179252 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12178 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Nakano M (2007) 17258197 179253 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12179 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wang HJ (2006) 17037745 179254 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12180 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hall MN (2007) 17301265 179255 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12181 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Brzozowski T (2006) 17033106 179256 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12182 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 10426 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Bhat AS (2005) 15792781 65577 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10427 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Walton LJ (1999) 10393680 178381 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10428 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Gierse JK (1995) 7832763 178380 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10429 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10430 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Bhat AS (2007) 17150210 178382 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 10431 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Cryer B (1998) 9626023 178378 774 Mefenamic acid CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473 mefenamic acid|nu-mefenamic 25 DRUGBANK DB00784 C15H15NO2 small molecule M01AG01 61-68-7 DRUGBANK 8219 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Talley JJ (2000) 10715145 177027 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 8220 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hood WF (2003) 12644588 177026 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 8221 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Jain KK (2000) 11060833 177030 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 8222 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Gierse JK (2005) 15494548 177031 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 8223 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 8224 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Tacconelli S (2003) 12564662 177029 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 8225 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yuan JJ (2002) 12167567 177028 570 Valdecoxib - - DRUGBANK DB00580 C16H14N2O3S small molecule M01AH03 181695-72-7 DRUGBANK 12565 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kawai S (1998) 9650852 159681 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12566 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yamazaki R (2002) 12065695 179564 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12567 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kawai S (1998) 9831331 179562 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12568 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ottonello L (2009) 19338579 179563 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12569 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yood MU (2006) 17024689 179560 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12570 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Zhou XP (2009) 19952416 179561 981 Oxaprozin Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine apo-oxaprozin|rhoxal-oxaprozin DRUGBANK DB00991 C18H15NO3 small molecule M01AE12 21256-18-8 DRUGBANK 12745 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12746 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Stolfi C (2008) 17981262 179660 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12749 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wiggins JB (2009) 19743890 179656 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12747 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 12748 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Allgayer H (2003) 12950415 174544 1004 Balsalazide Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid balsalazide disodium|colazal|g DRUGBANK DB01014 C17H15N3O6 small molecule A07EC04 80573-04-2 DRUGBANK 16492 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kim SJ (2007) 17436372 181309 1353 Ginseng - ginsana cap 100mg|siberian gin DRUGBANK DB01404 - small molecule - 50647-08-0 DRUGBANK 16493 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yim HW (2005) 15753395 181312 1353 Ginseng - ginsana cap 100mg|siberian gin DRUGBANK DB01404 - small molecule - 50647-08-0 DRUGBANK 16494 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Seo JY (2005) 15778128 181313 1353 Ginseng - ginsana cap 100mg|siberian gin DRUGBANK DB01404 - small molecule - 50647-08-0 DRUGBANK 7232 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7233 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Galvao RI (2005) 15756931 176291 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7234 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yamada M (1997) 9152412 176290 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7235 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yilmaz H (2005) 16245223 176292 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7236 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kothekar V (2001) 11563332 176288 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 7237 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ozgocmen S (2005) 15943176 176289 461 Tenoxicam Tenoxicamum|Tnoxicam|Tenoxicam tenoxicam tablets|tenoxicam-20 DRUGBANK DB00469 C13H11N3O4S2 small molecule M01AC02 59804-37-4 DRUGBANK 16449 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Simon RA (2004) 14680616 181305 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 16450 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Shen J (2006) 17181859 179252 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 16451 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Nakano M (2007) 17258197 179253 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 16452 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wang HJ (2006) 17037745 179254 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 16453 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Brzozowski T (2006) 17033106 179256 1351 Trisalicylate-choline Tricosal - DRUGBANK DB01401 C26H29MgNO10 small molecule - - DRUGBANK 8176 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Poggi JC (2006) 17050798 176976 563 Fenoprofen 2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid nalfon tab 600mg|nalfon|fenopr DRUGBANK DB00573 C15H14O3 small molecule M01AE04 29679-58-1 DRUGBANK 12703 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wilson JE (2004) 15198222 178171 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12704 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Zuniga J (2003) 14513718 179627 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12705 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Sommerauer M (2001) 11729362 179635 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12706 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Levoin N (2002) 11814865 179634 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12707 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 12708 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kay-Mugford P (2000) 10895904 178552 999 Ketoprofen m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique nu-ketoprofen-e ect 50mg|orudi DRUGBANK DB01009 C16H14O3 small molecule M01AE53|M01AE03|M02AA10 22071-15-4 DRUGBANK 10501 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Dhir A (2007) 17604186 178398 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 10502 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target White WB (2007) 17612049 178399 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 10503 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 10504 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hassan-Alin M (2007) 17532719 178402 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 10505 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kumar P (2007) 17521299 178400 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 10506 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Albertini R (2007) 17607546 178401 778 Naproxen (+)-2-(Methoxy-2-naphthyl)-propionsaeure|(+)-(S)-Naproxen|Naproxne|(+)-Naproxen|Naproxenum|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-(+)-Naproxen|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|Naproxeno|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid ntp-naproxen sodium|naprosyn 5 DRUGBANK DB00788 C14H14O3 small molecule M01AE56|G02CC02|M02AA12|M01AE52|M01AE02 22204-53-1 DRUGBANK 2945 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Das UN (2005) 15990700 173594 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2946 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Das UN (2005) 16190133 173591 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2947 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Thuresson ED (2001) 11121413 173590 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 2948 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Levin G (2002) 11939906 173592 148 Dihomo-gamma-linolenic acid (Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid - DRUGBANK DB00154 C20H34O2 small molecule - 1783-84-2 DRUGBANK 21356 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3332 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole - - DRUGBANK DB03477 C16H11BrF3N3O2S small molecule - - DRUGBANK 27521 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target McCann ME (2004) 15077695 188559 7961 Firocoxib - - DRUGBANK DB09217 C17H20O5S small molecule - 189954-96-9 DRUGBANK 22090 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3703 Prostaglandin G2 - - DRUGBANK DB03866 C20H32O6 small molecule - - DRUGBANK 5477 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Lee YS (2007) 17175104 175138 309 Acetaminophen p-hydroxyphenolacetamide|Acetaminophene|p-acetamidophenol|Panadol|Acetaminofen|p-hydroxyacetanilide|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|p-Acetylaminophenol|Acetaminophen|Tylenol|Paracetamol|4-acetamidophenol|APAP tylenol cold and flu nighttime DRUGBANK DB00316 C8H9NO2 small molecule N02BE71|N02BE01|N02BE51 103-90-2 DRUGBANK 5478 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 309 Acetaminophen p-hydroxyphenolacetamide|Acetaminophene|p-acetamidophenol|Panadol|Acetaminofen|p-hydroxyacetanilide|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|p-Acetylaminophenol|Acetaminophen|Tylenol|Paracetamol|4-acetamidophenol|APAP tylenol cold and flu nighttime DRUGBANK DB00316 C8H9NO2 small molecule N02BE71|N02BE01|N02BE51 103-90-2 DRUGBANK 5479 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Weinheimer EM (2007) 17322116 175137 309 Acetaminophen p-hydroxyphenolacetamide|Acetaminophene|p-acetamidophenol|Panadol|Acetaminofen|p-hydroxyacetanilide|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|p-Acetylaminophenol|Acetaminophen|Tylenol|Paracetamol|4-acetamidophenol|APAP tylenol cold and flu nighttime DRUGBANK DB00316 C8H9NO2 small molecule N02BE71|N02BE01|N02BE51 103-90-2 DRUGBANK 5480 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hinz B (2008) 17884974 175136 309 Acetaminophen p-hydroxyphenolacetamide|Acetaminophene|p-acetamidophenol|Panadol|Acetaminofen|p-hydroxyacetanilide|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|p-Acetylaminophenol|Acetaminophen|Tylenol|Paracetamol|4-acetamidophenol|APAP tylenol cold and flu nighttime DRUGBANK DB00316 C8H9NO2 small molecule N02BE71|N02BE01|N02BE51 103-90-2 DRUGBANK 16414 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Graham GG (2004) 15035793 179201 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16415 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Elvira C (2001) 15348270 179208 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16416 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chae HJ (2004) 15106733 179207 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16417 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Fiebich BL (2004) 15070163 179206 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 16418 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wu KK (2003) 15199473 179209 1347 Magnesium salicylate Magnesium salicylate anhydrous diurex water pills|herbogesic| DRUGBANK DB01397 C14H10MgO6 small molecule - 18917-89-0 DRUGBANK 5614 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Pilane CM (2005) 15668944 175250 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5615 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Jerde TJ (2005) 15667901 175249 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5616 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Yokota A (2005) 15831440 175248 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5617 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Armstrong PJ (2005) 15770365 175247 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5618 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Zhang GS (2004) 15730717 175251 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 23862 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Rainsford KD (2006) 16846549 181954 4546 Nimesulide - - DRUGBANK DB04743 C13H12N2O5S small molecule M01AX17|M02AA26 51803-78-2 DRUGBANK 23863 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4546 Nimesulide - - DRUGBANK DB04743 C13H12N2O5S small molecule M01AX17|M02AA26 51803-78-2 DRUGBANK 10564 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Cipolla G (2002) 12208114 174550 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10565 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Generini S (2002) 12463455 174551 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10566 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Mifflin RC (2004) 14742690 174552 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10567 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Pruzanski W (1997) 9256165 174553 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10568 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Distrutti E (2006) 16855178 174554 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 27422 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Talley JJ (2000) 10794682 188524 7221 Parecoxib - - DRUGBANK DB08439 C19H18N2O4S small molecule M01AH04 198470-84-7 DRUGBANK 24839 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Gamache DA (2000) 10850857 181753 5639 Nepafenac AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac ilevro|nevanac DRUGBANK DB06802 C15H14N2O2 small molecule S01BC10 78281-72-8 DRUGBANK 23849 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Vidal C (2007) 17015640 181969 4529 Licofelone LCF|ML3000 - DRUGBANK DB04725 C23H22ClNO2 small molecule - 156897-06-2 DRUGBANK 11281 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 11282 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Llorens O (2002) 11885959 178800 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 11283 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 860 Suprofen alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL - DRUGBANK DB00870 C14H12O3S small molecule M01AE07 40828-46-4 DRUGBANK 24286 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens unknown target Almansa C (2004) 15481993 181866 4878 Cimicoxib - - DRUGBANK DB05095 C16H13ClFN3O3S small molecule - 265114-23-6 DRUGBANK 7368 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens negative modulator target Payvandi F (2004) 15598423 176374 472 Lenalidomide 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501 revlimid DRUGBANK DB00480 C13H13N3O3 small molecule L04AX04 191732-72-6 DRUGBANK 7369 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens negative modulator target Zeldis JB (2003) 12720152 176373 472 Lenalidomide 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501 revlimid DRUGBANK DB00480 C13H13N3O3 small molecule L04AX04 191732-72-6 DRUGBANK 16614 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Dhir A (2007) 17604186 178398 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16615 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target White WB (2007) 17612049 178399 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16616 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16617 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Hassan-Alin M (2007) 17532719 178402 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16618 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Kumar P (2007) 17521299 178400 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 16619 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Albertini R (2007) 17607546 178401 1367 Antrafenine - - DRUGBANK DB01419 C30H26F6N4O2 small molecule - 55300-29-3 DRUGBANK 7390 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7391 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Ahmad SR (2002) 12093311 176398 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7392 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Scheiman JM (2002) 12086292 176394 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7393 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Reddy BS (2002) 12086402 176395 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7394 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Lu S (2002) 12104042 176396 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 7395 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Sigthorsson G (2002) 12055598 176397 474 Celecoxib P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib lupin-celecoxib|bio-celecoxib| DRUGBANK DB00482 C17H14F3N3O2S small molecule L01XX33|M01AH01 169590-42-5 DRUGBANK 10755 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Takada Y (2004) 15489888 178495 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10756 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Arifah AK (2002) 12213119 178494 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10757 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 10758 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Beretta C (2005) 15939622 178489 802 Phenylbutazone Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona alka phenyl tab|novo-butazone DRUGBANK DB00812 C19H20N2O2 small molecule M01AA01|M02AA01|M01BA01 50-33-9 DRUGBANK 16673 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Brune K (2001) 11695253 181415 1383 Antipyrine 1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon auralgan eardrops|antipyrine a DRUGBANK DB01435 C11H12N2O small molecule S02DA03|N02BB51|N02BB71|N02BB01 60-80-0 DRUGBANK 27585 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Zheng L (2007) 17259377 181291 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12105 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Graham GG (2004) 15035793 179201 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12106 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chae HJ (2004) 15106733 179207 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12107 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Fiebich BL (2004) 15070163 179206 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12108 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Vane JR (1971) 5284360 179204 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12109 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Wu KK (2003) 15199473 179209 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 12110 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Elvira C (2001) 15348270 179208 926 Salicylic acid 2-Carboxyphenol|Salicylic acid|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol neutrogena oil free acne stres DRUGBANK DB00936 C7H6O3 small molecule N02BA04|D01AE12|S01BC08 69-72-7 DRUGBANK 17311 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Brandt KD (1990) 2277128 181583 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 17312 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 17313 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 17314 111715 5743 - PTGS2 COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1538 Tiaprofenic acid Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid surgam|tiaprofenic-200 - tab|a DRUGBANK DB01600 C14H12O3S small molecule M01AE11 33005-95-7 DRUGBANK 24358 111717 5745 - PTH1R PFE|PTHR|PTHR1 9606 Homo sapiens activator target Jin L (2000) 10837469 181751 5390 Parathyroid hormone PTH(1-84)|parathyroid hormone (1-84) human recombinant|PTH|hPTH|Parathyrin|Preotact|Parathormone (human recombinant)|rhPTH|Parathyroid hormone|parathyroid hormone (rDNA)|rPTH|rhPTH(1-84)|hPTH(1-84)|rPTH(1-84)|Parathormone natpara (parathyroid hormone) DRUGBANK DB05829 C408H674N126O126S2 biologic H05AA03 9002-64-6 DRUGBANK 24547 111717 5745 - PTH1R PFE|PTHR|PTHR1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 5544 Teriparatide Teriparatide recombinant human forteo DRUGBANK DB06285 C181H291N55O51S2 biologic H05AA02 52232-67-4 DRUGBANK 24357 111718 5746 - PTH2R PTHR2 9606 Homo sapiens activator target Jin L (2000) 10837469 181751 5390 Parathyroid hormone PTH(1-84)|parathyroid hormone (1-84) human recombinant|PTH|hPTH|Parathyrin|Preotact|Parathormone (human recombinant)|rhPTH|Parathyroid hormone|parathyroid hormone (rDNA)|rPTH|rhPTH(1-84)|hPTH(1-84)|rPTH(1-84)|Parathormone natpara (parathyroid hormone) DRUGBANK DB05829 C408H674N126O126S2 biologic H05AA03 9002-64-6 DRUGBANK 25260 111719 5747 - PTK2 FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6064 7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE - - DRUGBANK DB07248 C20H19N5O3 small molecule - - DRUGBANK 25476 111719 5747 - PTK2 FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6271 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE - - DRUGBANK DB07460 C23H25ClN6O3 small molecule - - DRUGBANK 22540 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3920 N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester) Compound 6 - DRUGBANK DB04088 C34H35N3O12 small molecule - - DRUGBANK 22541 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3920 N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester) Compound 6 - DRUGBANK DB04088 C34H35N3O12 small molecule - - DRUGBANK 21784 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3557 4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid - - DRUGBANK DB03714 C17H17F2N2O7P small molecule - - DRUGBANK 21785 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3557 4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid - - DRUGBANK DB03714 C17H17F2N2O7P small molecule - - DRUGBANK 21786 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3557 4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid - - DRUGBANK DB03714 C17H17F2N2O7P small molecule - - DRUGBANK 14042 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens inhibitor target Murakami H (1997) 9145236 180301 1121 Tiludronate Tiludronic acid|Acide tiludronique|Tiludronate|Acido tiludronico|Acidum tiludronicum - DRUGBANK DB01133 C7H9ClO6P2S small molecule M05BA05 89987-06-4 DRUGBANK 19553 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2512 Sp7343-Sp7964 - - DRUGBANK DB02620 C19H27N5O5S2 small molecule - - DRUGBANK 19554 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2512 Sp7343-Sp7964 - - DRUGBANK DB02620 C19H27N5O5S2 small molecule - - DRUGBANK 20682 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3022 {[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid - - DRUGBANK DB03154 C12H10F4O6P2 small molecule - - DRUGBANK 20683 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3022 {[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid - - DRUGBANK DB03154 C12H10F4O6P2 small molecule - - DRUGBANK 20684 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3022 {[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid - - DRUGBANK DB03154 C12H10F4O6P2 small molecule - - DRUGBANK 18459 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1992 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid - - DRUGBANK DB02072 C10H9NO5S2 small molecule - - DRUGBANK 18460 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1992 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid - - DRUGBANK DB02072 C10H9NO5S2 small molecule - - DRUGBANK 18461 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1992 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid - - DRUGBANK DB02072 C10H9NO5S2 small molecule - - DRUGBANK 22996 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4112 {4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid - - DRUGBANK DB04285 C31H25F2N4O3PS small molecule - - DRUGBANK 22997 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4112 {4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid - - DRUGBANK DB04285 C31H25F2N4O3PS small molecule - - DRUGBANK 25655 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6457 N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE - - DRUGBANK DB07651 C21H24F2N3O6P small molecule - - DRUGBANK 25735 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6531 5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE - - DRUGBANK DB07730 C9H7NO4S small molecule - - DRUGBANK 19976 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2709 7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid - - DRUGBANK DB02827 C18H14N2O9S2 small molecule - - DRUGBANK 19977 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2709 7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid - - DRUGBANK DB02827 C18H14N2O9S2 small molecule - - DRUGBANK 19978 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2709 7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid - - DRUGBANK DB02827 C18H14N2O9S2 small molecule - - DRUGBANK 26623 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7368 5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE - - DRUGBANK DB08591 C15H14N2O4S small molecule - - DRUGBANK 19629 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2542 {[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid) - - DRUGBANK DB02651 C29H23F6N3O6P2 small molecule - - DRUGBANK 19630 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2542 {[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid) - - DRUGBANK DB02651 C29H23F6N3O6P2 small molecule - - DRUGBANK 26592 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7327 (3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER - - DRUGBANK DB08549 C19H21N3O6S small molecule - - DRUGBANK 25144 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5952 5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE - - DRUGBANK DB07134 C12H9ClN2O3S2 small molecule - - DRUGBANK 26420 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7156 PARA-(BENZOYL)-PHENYLALANINE - - DRUGBANK DB08371 C16H15NO3 small molecule - - DRUGBANK 25300 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6105 5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB07289 C20H16BrNO5S small molecule - - DRUGBANK 24916 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5707 3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER - - DRUGBANK DB06887 C16H23N3O6S small molecule - - DRUGBANK 21686 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3516 2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid - - DRUGBANK DB03670 C10H10N2O5S small molecule - - DRUGBANK 21687 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3516 2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid - - DRUGBANK DB03670 C10H10N2O5S small molecule - - DRUGBANK 25139 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5948 4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB07130 C13H9BrO5S small molecule - - DRUGBANK 19911 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2666 N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid - - DRUGBANK DB02784 C18H23BrN4O7 small molecule - - DRUGBANK 19912 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2666 N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid - - DRUGBANK DB02784 C18H23BrN4O7 small molecule - - DRUGBANK 22683 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3973 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide - - DRUGBANK DB04142 C19H17Br2NO5S small molecule - - DRUGBANK 22684 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3973 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide - - DRUGBANK DB04142 C19H17Br2NO5S small molecule - - DRUGBANK 19166 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2323 [[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid, - - DRUGBANK DB02420 C9H10N2O3 small molecule - - DRUGBANK 19167 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2323 [[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid, - - DRUGBANK DB02420 C9H10N2O3 small molecule - - DRUGBANK 19550 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2507 Compound 19 - - DRUGBANK DB02615 C27H29NO4S small molecule - - DRUGBANK 19551 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2507 Compound 19 - - DRUGBANK DB02615 C27H29NO4S small molecule - - DRUGBANK 21668 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 21669 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 26784 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7555 (4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid - - DRUGBANK DB08783 C16H23NO6Se small molecule - - DRUGBANK 17866 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1750 Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide - - DRUGBANK DB01820 C29H31N3O7 small molecule - - DRUGBANK 17867 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1750 Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide - - DRUGBANK DB01820 C29H31N3O7 small molecule - - DRUGBANK 22363 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3835 6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid - - DRUGBANK DB04001 C11H8N2O5 small molecule - - DRUGBANK 22364 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3835 6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid - - DRUGBANK DB04001 C11H8N2O5 small molecule - - DRUGBANK 22365 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3835 6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid - - DRUGBANK DB04001 C11H8N2O5 small molecule - - DRUGBANK 22337 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3816 Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid - - DRUGBANK DB03982 C19H13NO5 small molecule - - DRUGBANK 22338 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3816 Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid - - DRUGBANK DB03982 C19H13NO5 small molecule - - DRUGBANK 22339 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3816 Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid - - DRUGBANK DB03982 C19H13NO5 small molecule - - DRUGBANK 23625 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4337 2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid - - DRUGBANK DB04525 C30H37N3O10 small molecule - - DRUGBANK 23626 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4337 2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid - - DRUGBANK DB04525 C30H37N3O10 small molecule - - DRUGBANK 20221 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2854 PNU177836 - - DRUGBANK DB02977 C31H47N3O9 small molecule - - DRUGBANK 20222 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2854 PNU177836 - - DRUGBANK DB02977 C31H47N3O9 small molecule - - DRUGBANK 22803 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4032 [(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid - - DRUGBANK DB04204 C18H20F4O6P2 small molecule - - DRUGBANK 22804 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4032 [(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid - - DRUGBANK DB04204 C18H20F4O6P2 small molecule - - DRUGBANK 22805 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4032 [(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid - - DRUGBANK DB04204 C18H20F4O6P2 small molecule - - DRUGBANK 19667 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2553 Novo Nordisk a/S Compound - - DRUGBANK DB02662 C9H6INO5 small molecule - - DRUGBANK 19668 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2553 Novo Nordisk a/S Compound - - DRUGBANK DB02662 C9H6INO5 small molecule - - DRUGBANK 19669 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2553 Novo Nordisk a/S Compound - - DRUGBANK DB02662 C9H6INO5 small molecule - - DRUGBANK 18346 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1937 Compound 9 5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid - DRUGBANK DB02014 C21H16FNO7 small molecule - - DRUGBANK 18347 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1937 Compound 9 5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid - DRUGBANK DB02014 C21H16FNO7 small molecule - - DRUGBANK 18348 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1937 Compound 9 5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid - DRUGBANK DB02014 C21H16FNO7 small molecule - - DRUGBANK 21490 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3406 N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid - - DRUGBANK DB03557 C32H41F4N5O13P2S small molecule - - DRUGBANK 21491 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3406 N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid - - DRUGBANK DB03557 C32H41F4N5O13P2S small molecule - - DRUGBANK 20491 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2973 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid - - DRUGBANK DB03102 C10H9NO6S small molecule - - DRUGBANK 20492 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2973 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid - - DRUGBANK DB03102 C10H9NO6S small molecule - - DRUGBANK 20493 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2973 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid - - DRUGBANK DB03102 C10H9NO6S small molecule - - DRUGBANK 21365 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3338 4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid - - DRUGBANK DB03483 C32H34F4N4O12P2 small molecule - - DRUGBANK 21366 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3338 4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid - - DRUGBANK DB03483 C32H34F4N4O12P2 small molecule - - DRUGBANK 24850 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5650 4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB06829 C19H20BrNO5S small molecule - - DRUGBANK 20945 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3176 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide - - DRUGBANK DB03311 C26H19Br2N3O7S3 small molecule - - DRUGBANK 20946 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3176 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide - - DRUGBANK DB03311 C26H19Br2N3O7S3 small molecule - - DRUGBANK 26029 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6796 ISOTHIAZOLIDINONE ANALOG - - DRUGBANK DB08003 C23H26N4O6S small molecule - - DRUGBANK 17754 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17755 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 26028 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6795 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID - - DRUGBANK DB08001 C22H19NO8 small molecule - - DRUGBANK 25201 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6014 4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB07197 C13H9BrO6S small molecule - - DRUGBANK 25306 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6114 3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID - - DRUGBANK DB07298 C10H7NO5S small molecule - - DRUGBANK 19200 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2339 2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid - - DRUGBANK DB02436 C27H33N3O9 small molecule - - DRUGBANK 19201 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2339 2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid - - DRUGBANK DB02436 C27H33N3O9 small molecule - - DRUGBANK 26624 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7370 1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE - - DRUGBANK DB08593 C8H8N2O3S small molecule - - DRUGBANK 25303 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6111 2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID - - DRUGBANK DB07295 C19H13NO6 small molecule - - DRUGBANK 25504 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6291 4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN - - DRUGBANK DB07480 C13H14O8P2 small molecule - - DRUGBANK 25726 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6522 3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER - - DRUGBANK DB07719 C16H23N3O6S small molecule - - DRUGBANK 18812 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2168 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide - - DRUGBANK DB02259 C23H18Br2N2O7S2 small molecule - - DRUGBANK 18813 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2168 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide - - DRUGBANK DB02259 C23H18Br2N2O7S2 small molecule - - DRUGBANK 26165 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6939 4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid - - DRUGBANK DB08147 C24H21NO4 small molecule - - DRUGBANK 17683 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1668 3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid - - DRUGBANK DB01734 C13H9NO5 small molecule - - DRUGBANK 17684 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1668 3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid - - DRUGBANK DB01734 C13H9NO5 small molecule - - DRUGBANK 17685 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1668 3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid - - DRUGBANK DB01734 C13H9NO5 small molecule - - DRUGBANK 19557 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2514 2-(Oxalyl-Amino)-Benzoic Acid - - DRUGBANK DB02622 C9H7NO5 small molecule - - DRUGBANK 19558 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2514 2-(Oxalyl-Amino)-Benzoic Acid - - DRUGBANK DB02622 C9H7NO5 small molecule - - DRUGBANK 19559 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2514 2-(Oxalyl-Amino)-Benzoic Acid - - DRUGBANK DB02622 C9H7NO5 small molecule - - DRUGBANK 26441 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7181 6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID - - DRUGBANK DB08397 C12H9F2O5P small molecule - - DRUGBANK 25275 111736 5770 - PTPN1 PTP1B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6079 [{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid - - DRUGBANK DB07263 C22H18BrF2O4P small molecule - - DRUGBANK 8809 111741 5775 - PTPN4 MEG|PTPMEG|PTPMEG1 9606 Homo sapiens inhibitor target Opas EE (1997) 9310349 177440 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 19903 111745 5781 - PTPN11 BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2662 Dodecane-Trimethylamine - - DRUGBANK DB02779 C15H34N small molecule - - DRUGBANK 19904 111745 5781 - PTPN11 BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2662 Dodecane-Trimethylamine - - DRUGBANK DB02779 C15H34N small molecule - - DRUGBANK 19905 111745 5781 - PTPN11 BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2662 Dodecane-Trimethylamine - - DRUGBANK DB02779 C15H34N small molecule - - DRUGBANK 25002 111751 5787 - PTPRB HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5807 {4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID - - DRUGBANK DB06989 C19H21NO7S small molecule - - DRUGBANK 25136 111751 5787 - PTPRB HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5945 {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID - - DRUGBANK DB07127 C21H21N5O5S small molecule - - DRUGBANK 26691 111751 5787 - PTPRB HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7452 (4-ETHYLPHENYL)SULFAMIC ACID - - DRUGBANK DB08678 C8H11NO3S small molecule - - DRUGBANK 25072 111751 5787 - PTPRB HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5886 (4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID - - DRUGBANK DB07068 C21H32N2O9S small molecule - - DRUGBANK 8813 111755 5791 RP11-380J17.1 PTPRE HPTPE|PTPE|R-PTP-EPSILON 9606 Homo sapiens inhibitor target Schmidt A (1996) 8610169 177441 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 8810 111766 5802 - PTPRS PTPSIGMA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 8811 111766 5802 - PTPRS PTPSIGMA 9606 Homo sapiens inhibitor target Schmidt A (1996) 8610169 177441 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 8812 111766 5802 - PTPRS PTPSIGMA 9606 Homo sapiens inhibitor target Opas EE (1997) 9310349 177440 620 Alendronic acid ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique pms-alendronate|jamp-alendrona DRUGBANK DB00630 C4H13NO7P2 small molecule M05BB03|M05BA04|M05BB06|M05BB05 66376-36-1 DRUGBANK 13533 111766 5802 - PTPRS PTPSIGMA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1065 Etidronic acid Acetodiphosphonic acid|1,1,1-Ethanetriol diphosphonate|acidum etidronicum|acide tidronique|Etidronsure|cido etidrnico|(1-hydroxy-ethylidene)diphosphonic acid|Etidronate|1-Hydroxyethane-1,1-diphosphonic acid|1-Hydroxyethylidene-1,1-diphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonic acid|(1-Hydroxyethylidene)bis(phosphonic acid)|1-Hydroxyethane-1,1-bisphosphonic acid|Hydroxyethanediphosphonic acid|1-Hydroxyethylidene-1,1-bisphosphonate|1-hydroxyethane 1,1-diphosphonic acid|1-Hydroxyethanediphosphonic acid|Oxyethylidenediphosphonic acid|1-Hydroxyethane-1,1-diphosphonate|Ethane-1-hydroxy-1,1-bisphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonate|1-Hydroxy-1,1-diphosphonoethane|(1-Hydroxyethylidene)diphosphonic acid|EHDP|HEDP|(Hydroxyethylidene)diphosphonic acid|(1-Hydroxyethylidene)bisphosphonic acid|(1-Hydroxyethylene)diphosphonic acid act etidronate|didrocal|mylan- DRUGBANK DB01077 C2H8O7P2 small molecule M05BA01|M05BB01 2809-21-4 DRUGBANK 13534 111766 5802 - PTPRS PTPSIGMA 9606 Homo sapiens inhibitor target Schmidt A (1996) 8610169 177441 1065 Etidronic acid Acetodiphosphonic acid|1,1,1-Ethanetriol diphosphonate|acidum etidronicum|acide tidronique|Etidronsure|cido etidrnico|(1-hydroxy-ethylidene)diphosphonic acid|Etidronate|1-Hydroxyethane-1,1-diphosphonic acid|1-Hydroxyethylidene-1,1-diphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonic acid|(1-Hydroxyethylidene)bis(phosphonic acid)|1-Hydroxyethane-1,1-bisphosphonic acid|Hydroxyethanediphosphonic acid|1-Hydroxyethylidene-1,1-bisphosphonate|1-hydroxyethane 1,1-diphosphonic acid|1-Hydroxyethanediphosphonic acid|Oxyethylidenediphosphonic acid|1-Hydroxyethane-1,1-diphosphonate|Ethane-1-hydroxy-1,1-bisphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonate|1-Hydroxy-1,1-diphosphonoethane|(1-Hydroxyethylidene)diphosphonic acid|EHDP|HEDP|(Hydroxyethylidene)diphosphonic acid|(1-Hydroxyethylidene)bisphosphonic acid|(1-Hydroxyethylene)diphosphonic acid act etidronate|didrocal|mylan- DRUGBANK DB01077 C2H8O7P2 small molecule M05BA01|M05BB01 2809-21-4 DRUGBANK 22120 111769 5805 - PTS PTPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3723 Biopterin - - DRUGBANK DB03886 C9H11N5O3 small molecule - - DRUGBANK 18107 111774 5816 CITF22-126G10.2 PVALB D22S749 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 20755 111775 5817 - PVR CD155|HVED|NECL5|Necl-5|PVS|TAGE4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3071 Sphingosine - - DRUGBANK DB03203 C18H37NO2 small molecule - 123-78-4 DRUGBANK 26252 111775 5817 - PVR CD155|HVED|NECL5|Necl-5|PVS|TAGE4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 3268 111789 5831 - PYCR1 ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR 9606 Homo sapiens unknown target Wang ZQ (2007) 16777263 173742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3269 111789 5831 - PYCR1 ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR 9606 Homo sapiens unknown target Forlani G (2007) 17474756 173743 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3765 111789 5831 - PYCR1 ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR 9606 Homo sapiens unknown target Hu CA (2007) 16874462 174037 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3766 111789 5831 - PYCR1 ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR 9606 Homo sapiens unknown target Huang TC (2007) 17536821 174039 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3767 111789 5831 - PYCR1 ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR 9606 Homo sapiens unknown target Meng Z (2006) 16600630 174038 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 2380 111790 5832 - ALDH18A1 ARCL3A|GSAS|P5CS|PYCS 9606 Homo sapiens unknown target Morita Y (2003) 12513997 59313 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2381 111790 5832 - ALDH18A1 ARCL3A|GSAS|P5CS|PYCS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2382 111790 5832 - ALDH18A1 ARCL3A|GSAS|P5CS|PYCS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2383 111790 5832 - ALDH18A1 ARCL3A|GSAS|P5CS|PYCS 9606 Homo sapiens unknown target Krishna RV (1979) 114173 173231 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2384 111790 5832 - ALDH18A1 ARCL3A|GSAS|P5CS|PYCS 9606 Homo sapiens unknown target Kamoun P (1998) 9622938 173232 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 1432 111792 5834 RP5-965G21.1 PYGB GPBB 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1433 111792 5834 RP5-965G21.1 PYGB GPBB 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 25322 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6131 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide - - DRUGBANK DB07315 C17H15ClN2O3 small molecule - - DRUGBANK 19065 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19066 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 21845 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3586 Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate - - DRUGBANK DB03744 C22H20ClN3O4 small molecule - - DRUGBANK 21846 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3586 Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate - - DRUGBANK DB03744 C22H20ClN3O4 small molecule - - DRUGBANK 21847 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3586 Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate - - DRUGBANK DB03744 C22H20ClN3O4 small molecule - - DRUGBANK 18942 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2227 1-N-Acetyl-Beta-D-Glucosamine - - DRUGBANK DB02320 C8H15NO6 small molecule - - DRUGBANK 18943 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2227 1-N-Acetyl-Beta-D-Glucosamine - - DRUGBANK DB02320 C8H15NO6 small molecule - - DRUGBANK 23620 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23621 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 26903 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 7604 Uric Acid 2,6,8-Trihydroxypurine|Urate|7,9-dihydro-1H-purine-2,6,8(3H)-trione - DRUGBANK DB08844 C5H4N4O3 small molecule - 69-93-2 DRUGBANK 26904 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 7604 Uric Acid 2,6,8-Trihydroxypurine|Urate|7,9-dihydro-1H-purine-2,6,8(3H)-trione - DRUGBANK DB08844 C5H4N4O3 small molecule - 69-93-2 DRUGBANK 25997 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6763 N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA - - DRUGBANK DB07968 C15H12ClFN2O4 small molecule - - DRUGBANK 20909 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3153 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide - - DRUGBANK DB03288 C18H24ClN3O3 small molecule - - DRUGBANK 20910 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3153 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide - - DRUGBANK DB03288 C18H24ClN3O3 small molecule - - DRUGBANK 20911 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3153 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide - - DRUGBANK DB03288 C18H24ClN3O3 small molecule - - DRUGBANK 1614 111794 5836 - PYGL GSD6 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1615 111794 5836 - PYGL GSD6 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1616 111794 5836 - PYGL GSD6 9606 Homo sapiens cofactor target Beauchamp NJ (2007) 17705025 172596 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2140 111794 5836 - PYGL GSD6 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2141 111794 5836 - PYGL GSD6 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 25415 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6211 1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid - - DRUGBANK DB07396 C20H17ClF3N3O4 small molecule - - DRUGBANK 25414 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6210 4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid - - DRUGBANK DB07395 C16H8ClF5N2O5 small molecule - - DRUGBANK 18505 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2009 CP-526423 bis[5-chloro-1h-indol-2-yl-carbonyl-aminoethyl]-ethylene glycol|1,2-bis(2-(5-chloroindole-2-carbonylamino)ethoxy)ethane - DRUGBANK DB02089 C24H24Cl2N4O4 small molecule - - DRUGBANK 18506 111794 5836 - PYGL GSD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2009 CP-526423 bis[5-chloro-1h-indol-2-yl-carbonyl-aminoethyl]-ethylene glycol|1,2-bis(2-(5-chloroindole-2-carbonylamino)ethoxy)ethane - DRUGBANK DB02089 C24H24Cl2N4O4 small molecule - - DRUGBANK 25820 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6591 (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE - - DRUGBANK DB07792 C20H19ClN4O4S small molecule - - DRUGBANK 25821 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6592 (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE - - DRUGBANK DB07793 C18H15ClN4O3S small molecule - - DRUGBANK 26544 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7279 (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol - - DRUGBANK DB08500 C18H21NO6 small molecule - - DRUGBANK 26545 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7282 (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol - - DRUGBANK DB08503 C15H21NO6 small molecule - - DRUGBANK 21360 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3334 8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB03479 C9H14N2O7 small molecule - - DRUGBANK 21361 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3334 8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB03479 C9H14N2O7 small molecule - - DRUGBANK 21362 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3334 8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB03479 C9H14N2O7 small molecule - - DRUGBANK 22525 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22526 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22527 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 20203 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2841 8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One - - DRUGBANK DB02964 C8H12N2O6S small molecule - - DRUGBANK 20204 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2841 8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One - - DRUGBANK DB02964 C8H12N2O6S small molecule - - DRUGBANK 20205 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2841 8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One - - DRUGBANK DB02964 C8H12N2O6S small molecule - - DRUGBANK 23671 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4354 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide - - DRUGBANK DB04544 C9H16N2O7 small molecule - - DRUGBANK 23672 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4354 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide - - DRUGBANK DB04544 C9H16N2O7 small molecule - - DRUGBANK 23673 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4354 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide - - DRUGBANK DB04544 C9H16N2O7 small molecule - - DRUGBANK 23794 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4450 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID - - DRUGBANK DB04645 C20H20Cl2N2O5 small molecule - - DRUGBANK 20562 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3001 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole - - DRUGBANK DB03133 C14H17N2O5 small molecule - - DRUGBANK 20563 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3001 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole - - DRUGBANK DB03133 C14H17N2O5 small molecule - - DRUGBANK 20564 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3001 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole - - DRUGBANK DB03133 C14H17N2O5 small molecule - - DRUGBANK 25831 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6605 (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL - - DRUGBANK DB07807 C15H23NO3 small molecule - - DRUGBANK 25070 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5884 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE - - DRUGBANK DB07066 C16H12ClN3O2S small molecule - - DRUGBANK 26172 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6943 (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol - - DRUGBANK DB08151 C14H17NO6 small molecule - - DRUGBANK 22045 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3673 N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide - - DRUGBANK DB03835 C10H15N3O8 small molecule - - DRUGBANK 22046 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3673 N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide - - DRUGBANK DB03835 C10H15N3O8 small molecule - - DRUGBANK 22047 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3673 N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide - - DRUGBANK DB03835 C10H15N3O8 small molecule - - DRUGBANK 21034 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3217 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole - - DRUGBANK DB03354 C9H14N2O6 small molecule - - DRUGBANK 21035 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3217 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole - - DRUGBANK DB03354 C9H14N2O6 small molecule - - DRUGBANK 21036 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3217 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole - - DRUGBANK DB03354 C9H14N2O6 small molecule - - DRUGBANK 17921 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1773 3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB01843 C8H13N3O7 small molecule - - DRUGBANK 17922 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1773 3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB01843 C8H13N3O7 small molecule - - DRUGBANK 17923 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1773 3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB01843 C8H13N3O7 small molecule - - DRUGBANK 18939 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2227 1-N-Acetyl-Beta-D-Glucosamine - - DRUGBANK DB02320 C8H15NO6 small molecule - - DRUGBANK 18940 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2227 1-N-Acetyl-Beta-D-Glucosamine - - DRUGBANK DB02320 C8H15NO6 small molecule - - DRUGBANK 18941 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2227 1-N-Acetyl-Beta-D-Glucosamine - - DRUGBANK DB02320 C8H15NO6 small molecule - - DRUGBANK 19219 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2348 3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB02447 C8H12N2O8 small molecule - - DRUGBANK 19220 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2348 3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB02447 C8H12N2O8 small molecule - - DRUGBANK 19221 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2348 3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione - - DRUGBANK DB02447 C8H12N2O8 small molecule - - DRUGBANK 20770 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3086 N-Acetyl-N'-Beta-D-Glucopyranosyl Urea - - DRUGBANK DB03218 C9H16N2O7 small molecule - - DRUGBANK 20771 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3086 N-Acetyl-N'-Beta-D-Glucopyranosyl Urea - - DRUGBANK DB03218 C9H16N2O7 small molecule - - DRUGBANK 20772 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3086 N-Acetyl-N'-Beta-D-Glucopyranosyl Urea - - DRUGBANK DB03218 C9H16N2O7 small molecule - - DRUGBANK 17874 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1753 Beta-D-Glucopyranose Spirohydantoin - - DRUGBANK DB01823 C8H12N2O7 small molecule - - DRUGBANK 17875 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1753 Beta-D-Glucopyranose Spirohydantoin - - DRUGBANK DB01823 C8H12N2O7 small molecule - - DRUGBANK 17876 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1753 Beta-D-Glucopyranose Spirohydantoin - - DRUGBANK DB01823 C8H12N2O7 small molecule - - DRUGBANK 24999 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5804 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE - - DRUGBANK DB06986 C16H13ClN2O2S small molecule - - DRUGBANK 20011 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 20012 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 20013 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 19763 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2607 C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide - - DRUGBANK DB02719 C7H13NO7 small molecule - - DRUGBANK 19764 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2607 C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide - - DRUGBANK DB02719 C7H13NO7 small molecule - - DRUGBANK 19765 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2607 C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide - - DRUGBANK DB02719 C7H13NO7 small molecule - - DRUGBANK 20416 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2938 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid - - DRUGBANK DB03067 C28H18N4O11 small molecule - - DRUGBANK 20417 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2938 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid - - DRUGBANK DB03067 C28H18N4O11 small molecule - - DRUGBANK 20418 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2938 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid - - DRUGBANK DB03067 C28H18N4O11 small molecule - - DRUGBANK 19766 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2608 Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide - - DRUGBANK DB02720 C7H13NO6 small molecule - - DRUGBANK 19767 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2608 Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide - - DRUGBANK DB02720 C7H13NO6 small molecule - - DRUGBANK 19768 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2608 Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide - - DRUGBANK DB02720 C7H13NO6 small molecule - - DRUGBANK 23612 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23613 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23614 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 19390 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2416 Indirubin-5-Sulphonate - - DRUGBANK DB02519 C16H10N2O5S small molecule - - DRUGBANK 19391 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2416 Indirubin-5-Sulphonate - - DRUGBANK DB02519 C16H10N2O5S small molecule - - DRUGBANK 19392 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2416 Indirubin-5-Sulphonate - - DRUGBANK DB02519 C16H10N2O5S small molecule - - DRUGBANK 19083 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19084 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19085 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 22430 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3876 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid - - DRUGBANK DB04044 C21H14N2O8 small molecule - - DRUGBANK 18307 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18308 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18309 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 1469 111795 5837 - PYGM - 9606 Homo sapiens cofactor target Kurganov BI (2000) 11052666 172501 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1470 111795 5837 - PYGM - 9606 Homo sapiens cofactor target Okada M (2001) 11508701 172500 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1471 111795 5837 - PYGM - 9606 Homo sapiens cofactor target Livanova NB (2002) 12460107 172503 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1472 111795 5837 - PYGM - 9606 Homo sapiens cofactor target Geremia S (2002) 12217700 172502 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1473 111795 5837 - PYGM - 9606 Homo sapiens cofactor target Okada M (1999) 11228757 172504 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 21395 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 21396 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 21397 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3351 Flavopiridol Alvocidib freebase|Alvocidib - DRUGBANK DB03496 C21H20ClNO5 small molecule - 146426-40-6 DRUGBANK 23791 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4447 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID - - DRUGBANK DB04642 C21H21Cl3N2O5 small molecule - - DRUGBANK 23792 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4448 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID - - DRUGBANK DB04643 C18H15Cl3N2O5 small molecule - - DRUGBANK 23793 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4449 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID - - DRUGBANK DB04644 C20H20Cl2N2O5 small molecule - - DRUGBANK 23717 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23718 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23719 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 19529 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2498 2-Deoxy-Glucose-6-Phosphate - - DRUGBANK DB02604 C6H13O8P small molecule - - DRUGBANK 19530 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2498 2-Deoxy-Glucose-6-Phosphate - - DRUGBANK DB02604 C6H13O8P small molecule - - DRUGBANK 19531 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2498 2-Deoxy-Glucose-6-Phosphate - - DRUGBANK DB02604 C6H13O8P small molecule - - DRUGBANK 22439 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3887 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium - - DRUGBANK DB04055 C20H21ClNO6 small molecule - - DRUGBANK 22440 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3887 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium - - DRUGBANK DB04055 C20H21ClNO6 small molecule - - DRUGBANK 22441 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3887 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium - - DRUGBANK DB04055 C20H21ClNO6 small molecule - - DRUGBANK 25975 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6744 ({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID - - DRUGBANK DB07949 C18H13N3O4 small molecule - - DRUGBANK 21077 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3242 5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide - - DRUGBANK DB03383 C23H23ClFN3O3 small molecule - - DRUGBANK 20854 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3118 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole - - DRUGBANK DB03250 C14H17NO5S small molecule - - DRUGBANK 21656 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3504 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose - - DRUGBANK DB03657 C8H15NO7 small molecule - - DRUGBANK 21657 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3504 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose - - DRUGBANK DB03657 C8H15NO7 small molecule - - DRUGBANK 21658 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3504 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose - - DRUGBANK DB03657 C8H15NO7 small molecule - - DRUGBANK 20906 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3151 C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide - - DRUGBANK DB03286 C7H14N4O6 small molecule - - DRUGBANK 20907 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3151 C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide - - DRUGBANK DB03286 C7H14N4O6 small molecule - - DRUGBANK 20908 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3151 C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide - - DRUGBANK DB03286 C7H14N4O6 small molecule - - DRUGBANK 26358 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7108 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID - - DRUGBANK DB08322 C23H20O10 small molecule - - DRUGBANK 22384 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3847 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide - - DRUGBANK DB04013 C9H16N2O8 small molecule - - DRUGBANK 22385 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3847 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide - - DRUGBANK DB04013 C9H16N2O8 small molecule - - DRUGBANK 22386 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3847 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide - - DRUGBANK DB04013 C9H16N2O8 small molecule - - DRUGBANK 21092 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3251 (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester - - DRUGBANK DB03392 C8H18NO8P small molecule - - DRUGBANK 21093 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3251 (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester - - DRUGBANK DB03392 C8H18NO8P small molecule - - DRUGBANK 21094 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3251 (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester - - DRUGBANK DB03392 C8H18NO8P small molecule - - DRUGBANK 23009 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4122 N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea - - DRUGBANK DB04295 C14H18N2O7 small molecule - - DRUGBANK 23010 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4122 N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea - - DRUGBANK DB04295 C14H18N2O7 small molecule - - DRUGBANK 23011 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4122 N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea - - DRUGBANK DB04295 C14H18N2O7 small molecule - - DRUGBANK 19005 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2253 Fluoro-Phosphite Ion - - DRUGBANK DB02348 FO3P small molecule - 10163-15-2 DRUGBANK 19006 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2253 Fluoro-Phosphite Ion - - DRUGBANK DB02348 FO3P small molecule - 10163-15-2 DRUGBANK 19007 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2253 Fluoro-Phosphite Ion - - DRUGBANK DB02348 FO3P small molecule - 10163-15-2 DRUGBANK 19263 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 19264 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 19265 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 22790 111795 5837 - PYGM - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4023 Heptulose-2-Phosphate - - DRUGBANK DB04195 C7H15O9P small molecule - - DRUGBANK 22791 111795 5837 - PYGM - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4023 Heptulose-2-Phosphate - - DRUGBANK DB04195 C7H15O9P small molecule - - DRUGBANK 22792 111795 5837 - PYGM - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4023 Heptulose-2-Phosphate - - DRUGBANK DB04195 C7H15O9P small molecule - - DRUGBANK 3279 111798 5860 - QDPR DHPR|PKU2|SDR33C1 9606 Homo sapiens unknown target Lee PL (2000) 10814540 173748 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3280 111798 5860 - QDPR DHPR|PKU2|SDR33C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3281 111798 5860 - QDPR DHPR|PKU2|SDR33C1 9606 Homo sapiens unknown target Nakanishi N (1986) 3086306 173749 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3282 111798 5860 - QDPR DHPR|PKU2|SDR33C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3283 111798 5860 - QDPR DHPR|PKU2|SDR33C1 9606 Homo sapiens unknown target van der Heiden C (1982) 6820434 173747 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22019 111798 5860 - QDPR DHPR|PKU2|SDR33C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 19259 111806 5868 - RAB5A RAB5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2367 L-methionine (S)-S-oxide - - DRUGBANK DB02467 C5H11NO3S small molecule - - DRUGBANK 23058 111806 5868 - RAB5A RAB5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 22647 111806 5868 - RAB5A RAB5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22648 111806 5868 - RAB5A RAB5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22649 111806 5868 - RAB5A RAB5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 25860 111813 5875 - RABGGTA PTAR3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 23479 111813 5875 - RABGGTA PTAR3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25804 111813 5875 - RABGGTA PTAR3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 25859 111814 5876 RP4-682C21.3 RABGGTB GGTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 23478 111814 5876 RP4-682C21.3 RABGGTB GGTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25803 111814 5876 RP4-682C21.3 RABGGTB GGTB 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 7636 111817 5879 MIG5 RAC1 Rac-1|TC-25|p21-Rac1 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7637 111818 5880 - RAC2 EN-7|Gx|HSPC022|p21-Rac2 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 23304 111825 5888 - RAD51 BRCC5|HRAD51|HsRad51|HsT16930|MRMV2|RAD51A|RECA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 6488 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Cascone T (2007) 17272980 175818 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6489 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Huether A (2007) 17266941 175819 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6490 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Smalley KS (2009) 18794803 175816 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6491 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Lu X (2010) 20812347 175817 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6492 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Adnane L (2006) 16757355 175807 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6493 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Wilhelm SM (2008) 18852116 175815 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6494 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Gridelli C (2007) 17296815 175811 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6495 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens inhibitor target Gollob JA (2006) 16890795 175820 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 24257 111831 5894 - RAF1 CMD1NN|CRAF|NS5|Raf-1|c-Raf 9606 Homo sapiens unknown target Gokhale PC (2002) 12429653 181807 4765 LErafAON - - DRUGBANK DB04973 - biologic - - DRUGBANK 23092 111834 5898 - RALA RAL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23070 111837 5901 OK/SW-cl.81 RAN ARA24|Gsp1|TC4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23100 111846 5911 RP11-128N14.2 RAP2A K-REV|KREV|RAP2|RbBP-30 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23101 111846 5911 RP11-128N14.2 RAP2A K-REV|KREV|RAP2|RbBP-30 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 22631 111846 5911 RP11-128N14.2 RAP2A K-REV|KREV|RAP2|RbBP-30 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22632 111846 5911 RP11-128N14.2 RAP2A K-REV|KREV|RAP2|RbBP-30 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 4315 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Shroot B (1998) 9557255 174402 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4316 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Griffiths CE (1998) 9990415 174403 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4317 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Kim MJ (2000) 10651997 174406 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4318 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Michel S (1998) 9990413 174404 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4319 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Shroot B (1997) 9204085 174405 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 12473 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens unknown target Dahl AR (2000) 10955779 179494 972 Isotretinoin 13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA clarus|absorica|ran-isotretino DRUGBANK DB00982 C20H28O2 small molecule D10BA01|D10AD04|D10AD54 4759-48-2 DRUGBANK 12474 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens unknown target Shroot B (1997) 9204085 174405 972 Isotretinoin 13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA clarus|absorica|ran-isotretino DRUGBANK DB00982 C20H28O2 small molecule D10BA01|D10AD04|D10AD54 4759-48-2 DRUGBANK 12475 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens unknown target Vu-Dac N (1998) 9691099 179492 972 Isotretinoin 13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA clarus|absorica|ran-isotretino DRUGBANK DB00982 C20H28O2 small molecule D10BA01|D10AD04|D10AD54 4759-48-2 DRUGBANK 12476 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens unknown target Taylor LE (1995) 7601910 179493 972 Isotretinoin 13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA clarus|absorica|ran-isotretino DRUGBANK DB00982 C20H28O2 small molecule D10BA01|D10AD04|D10AD54 4759-48-2 DRUGBANK 12477 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens unknown target Zouboulis CC (2006) 16983322 179491 972 Isotretinoin 13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA clarus|absorica|ran-isotretino DRUGBANK DB00982 C20H28O2 small molecule D10BA01|D10AD04|D10AD54 4759-48-2 DRUGBANK 7132 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Tippmann F (2009) 19144697 176230 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7134 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Tian K (1997) 9153406 176228 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7135 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Saurat JH (1999) 10459139 176229 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7133 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Orfanos CE (1997) 9074840 176227 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 10605 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Baumann L (2005) 16144296 176638 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10606 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Nagpal S (2000) 10828316 178442 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10607 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Chandraratna RA (1996) 9035701 178440 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10608 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Yen A (2004) 15383624 178441 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10609 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Meder W (2003) 14675762 178439 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10610 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Wang Q (2001) 11519864 178438 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 7696 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Rasooly R (2005) 16339527 176637 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7697 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Schrage K (2006) 16420438 176636 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7698 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Cheng C (2008) 18321241 176635 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7699 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Milliano MT (2005) 16253547 176634 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7700 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Ritter M (2006) 16424870 109390 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7701 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7702 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Baumann L (2005) 16144296 176638 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 11975 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Harnish DC (1990) 1965892 179137 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11974 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Orfanos CE (1997) 9074840 176227 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11976 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Billoni N (1997) 9298126 179136 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11977 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Saurat JH (1999) 10459139 176229 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11978 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Zitnik RJ (1994) 8301142 179138 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 24188 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Miwako I (2007) 17925887 182054 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24189 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Jimi S (2007) 17611697 182025 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24190 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24191 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Unknown Authors (2004) 15563242 181873 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24192 111849 5914 - RARA NR1B1|RAR 9606 Homo sapiens agonist target Sanda T (2005) 15843826 181888 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 4320 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Shroot B (1998) 9557255 174402 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4321 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4322 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Michel S (1998) 9990413 174404 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4323 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Shroot B (1997) 9204085 174405 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 24193 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Miwako I (2007) 17925887 182054 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24194 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Jimi S (2007) 17611697 182025 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24195 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Unknown Authors (2004) 15563242 181873 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 24196 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Sanda T (2005) 15843826 181888 4737 Tamibarotene Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80 - DRUGBANK DB04942 C22H25NO3 small molecule - 94497-51-5 DRUGBANK 7136 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Zouboulis CC (2001) 11586072 176232 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7137 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Berggren Soederlund M (1995) 7755585 176231 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7138 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Tippmann F (2009) 19144697 176230 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 10611 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Arechalde A (2000) 18034539 178437 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10612 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Jones PH (2003) 12942109 178443 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10613 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Chandraratna RA (1996) 9035701 178440 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10614 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Orlandi A (2004) 15102095 178444 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 7703 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Mizuiri H (2005) 16128742 176642 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7704 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Nalbandian A (2005) 16316409 176643 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7705 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Garnock-Jones KP (2009) 19678713 176640 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7706 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Milliano MT (2005) 16253547 176634 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7707 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Husson M (2006) 16531051 176639 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7708 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Liu Z (2005) 16297713 176641 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 11979 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Billoni N (1997) 9298126 179136 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11980 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens agonist target Zitnik RJ (1994) 8301142 179138 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 20065 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens unknown target Alvarez R (2004) 15546741 181870 2758 TTNPB Arotinoic acid|CCRIS 3297|Arotinoid acid|Tocris-0761|(E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1 -propenyl] benzoic acid - DRUGBANK DB02877 C24H28O2 small molecule - 71441-28-6 DRUGBANK 20066 111850 5915 - RARB HAP|MCOPS12|NR1B2|RRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2758 TTNPB Arotinoic acid|CCRIS 3297|Arotinoid acid|Tocris-0761|(E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1 -propenyl] benzoic acid - DRUGBANK DB02877 C24H28O2 small molecule - 71441-28-6 DRUGBANK 4332 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4333 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4334 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 25302 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6110 3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID - - DRUGBANK DB07294 C23H26FNO4 small molecule - - DRUGBANK 10155 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10156 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10157 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10158 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10159 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Kamei Y (1993) 8394693 178222 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10160 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Reddy AP (1992) 1332684 178220 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10161 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Borger DR (2000) 10792999 178221 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 7145 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7146 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7147 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 24355 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5348 LGD-1550 - - DRUGBANK DB05785 - small molecule - - DRUGBANK 24332 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5229 R667 - - DRUGBANK DB05467 - small molecule - - DRUGBANK 10600 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Arechalde A (2000) 18034539 178437 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10601 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10602 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10603 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10604 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 21345 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3321 BMS184394 - - DRUGBANK DB03466 C26H28O3 small molecule - - DRUGBANK 21346 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3321 BMS184394 - - DRUGBANK DB03466 C26H28O3 small molecule - - DRUGBANK 21347 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3321 BMS184394 - - DRUGBANK DB03466 C26H28O3 small molecule - - DRUGBANK 20897 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3145 Dodecyl-Alpha-D-Maltoside - - DRUGBANK DB03279 C24H46O11 small molecule - - DRUGBANK 20898 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3145 Dodecyl-Alpha-D-Maltoside - - DRUGBANK DB03279 C24H46O11 small molecule - - DRUGBANK 20899 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3145 Dodecyl-Alpha-D-Maltoside - - DRUGBANK DB03279 C24H46O11 small molecule - - DRUGBANK 19254 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2366 4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid - - DRUGBANK DB02466 C24H26O3 small molecule - - DRUGBANK 19255 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2366 4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid - - DRUGBANK DB02466 C24H26O3 small molecule - - DRUGBANK 19256 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2366 4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid - - DRUGBANK DB02466 C24H26O3 small molecule - - DRUGBANK 7722 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Parrella E (2006) 16788091 176651 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7723 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Li M (2006) 16880407 176653 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7725 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Dzhagalov I (2007) 17277115 176652 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7724 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Garnock-Jones KP (2009) 19678713 176640 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7726 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 11986 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11987 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11988 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 18809 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2167 SR11254 - - DRUGBANK DB02258 C26H27NO3 small molecule - - DRUGBANK 18810 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2167 SR11254 - - DRUGBANK DB02258 C26H27NO3 small molecule - - DRUGBANK 18811 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2167 SR11254 - - DRUGBANK DB02258 C26H27NO3 small molecule - - DRUGBANK 25044 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5849 R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID - - DRUGBANK DB07031 C23H26FNO4 small molecule - - DRUGBANK 19825 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2627 CD564 - - DRUGBANK DB02741 C26H26O3 small molecule - - DRUGBANK 19826 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2627 CD564 - - DRUGBANK DB02741 C26H26O3 small molecule - - DRUGBANK 19827 111851 5916 - RARG NR1B3|RARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2627 CD564 - - DRUGBANK DB02741 C26H26O3 small molecule - - DRUGBANK 10146 111853 5918 - RARRES1 LXNL|TIG1 9606 Homo sapiens agonist target Zirn B (2005) 15897880 178216 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10147 111853 5918 - RARRES1 LXNL|TIG1 9606 Homo sapiens agonist target Youssef EM (2004) 15059893 178215 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 362 111860 5925 RP11-174I10.1 RB1 OSRC|PPP1R130|RB|p105-Rb|pRb|pp110 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 363 111860 5925 RP11-174I10.1 RB1 OSRC|PPP1R130|RB|p105-Rb|pRb|pp110 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 839 111860 5925 RP11-174I10.1 RB1 OSRC|PPP1R130|RB|p105-Rb|pRb|pp110 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 840 111860 5925 RP11-174I10.1 RB1 OSRC|PPP1R130|RB|p105-Rb|pRb|pp110 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 841 111860 5925 RP11-174I10.1 RB1 OSRC|PPP1R130|RB|p105-Rb|pRb|pp110 9606 Homo sapiens unknown target Biener Y (1990) 1701386 172180 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 7142 111881 5947 - RBP1 CRABP-I|CRBP|CRBP1|CRBPI|RBPC 9606 Homo sapiens agonist target Berni R (1993) 8375617 176233 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 3539 111881 5947 - RBP1 CRABP-I|CRBP|CRBP1|CRBPI|RBPC 9606 Homo sapiens unknown target Quadro L (2005) 15994349 173894 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3540 111881 5947 - RBP1 CRABP-I|CRBP|CRBP1|CRBPI|RBPC 9606 Homo sapiens unknown target Yapi HF (2005) 15951260 173895 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3541 111881 5947 - RBP1 CRABP-I|CRBP|CRBP1|CRBPI|RBPC 9606 Homo sapiens unknown target Harrison EH (2005) 16011460 173896 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3542 111881 5947 - RBP1 CRABP-I|CRBP|CRBP1|CRBPI|RBPC 9606 Homo sapiens unknown target Paci E (2005) 16156801 173892 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3543 111881 5947 - RBP1 CRABP-I|CRBP|CRBP1|CRBPI|RBPC 9606 Homo sapiens unknown target Folli C (2005) 16157297 173893 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3517 111883 5949 - RBP3 D10S64|D10S65|D10S66|IRBP|RBPI|RP66 9606 Homo sapiens unknown target Qtaishat NM (2005) 15935345 173876 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3518 111883 5949 - RBP3 D10S64|D10S65|D10S66|IRBP|RBPI|RP66 9606 Homo sapiens unknown target Salvador-Silva M (2005) 15928609 173877 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3519 111883 5949 - RBP3 D10S64|D10S65|D10S66|IRBP|RBPI|RP66 9606 Homo sapiens unknown target Wu Q (2007) 17602665 173875 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3520 111883 5949 - RBP3 D10S64|D10S65|D10S66|IRBP|RBPI|RP66 9606 Homo sapiens unknown target Duncan T (2007) 17200663 173878 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3521 111883 5949 - RBP3 D10S64|D10S65|D10S66|IRBP|RBPI|RP66 9606 Homo sapiens unknown target Kolesnikov AV (2007) 17049961 173879 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 26261 111890 5957 - RCVRN RCV1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 3001 111892 5959 - RDH5 9cRDH|HSD17B9|RDH1|SDR9C5 9606 Homo sapiens unknown target Dalfo D (2007) 17608724 173635 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3512 111892 5959 - RDH5 9cRDH|HSD17B9|RDH1|SDR9C5 9606 Homo sapiens unknown target Gidlof AC (2006) 16837774 173874 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3515 111892 5959 - RDH5 9cRDH|HSD17B9|RDH1|SDR9C5 9606 Homo sapiens unknown target Zhang M (2007) 17435174 173873 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3514 111892 5959 - RDH5 9cRDH|HSD17B9|RDH1|SDR9C5 9606 Homo sapiens unknown target Belyaeva OV (2006) 16860536 173872 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3513 111892 5959 - RDH5 9cRDH|HSD17B9|RDH1|SDR9C5 9606 Homo sapiens unknown target Dalfo D (2007) 17608724 173635 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3516 111892 5959 - RDH5 9cRDH|HSD17B9|RDH1|SDR9C5 9606 Homo sapiens unknown target Maeda A (2006) 16566595 173871 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 21132 111894 5962 - RDX DFNB24 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21133 111894 5962 - RDX DFNB24 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21134 111894 5962 - RDX DFNB24 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 23601 111899 5967 - REG1A ICRF|P19|PSP|PSPS|PSPS1|PTP|REG 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 21793 111899 5967 - REG1A ICRF|P19|PSP|PSPS|PSPS1|PTP|REG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 21794 111899 5967 - REG1A ICRF|P19|PSP|PSPS|PSPS1|PTP|REG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 17927 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1774 Dimethylformamide - - DRUGBANK DB01844 C3H7NO small molecule - 68-12-2 DRUGBANK 17928 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1774 Dimethylformamide - - DRUGBANK DB01844 C3H7NO small molecule - 68-12-2 DRUGBANK 17929 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1774 Dimethylformamide - - DRUGBANK DB01844 C3H7NO small molecule - 68-12-2 DRUGBANK 18886 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2203 1-Hydroxy-3-Methylbutane - - DRUGBANK DB02296 C5H12O small molecule - - DRUGBANK 18887 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2203 1-Hydroxy-3-Methylbutane - - DRUGBANK DB02296 C5H12O small molecule - - DRUGBANK 18888 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2203 1-Hydroxy-3-Methylbutane - - DRUGBANK DB02296 C5H12O small molecule - - DRUGBANK 4340 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 205 Remikiren - - DRUGBANK DB00212 C33H50N4O6S small molecule C09XA01 126222-34-2 DRUGBANK 4341 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target van Paassen P (1999) 10583449 174413 205 Remikiren - - DRUGBANK DB00212 C33H50N4O6S small molecule C09XA01 126222-34-2 DRUGBANK 4342 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Hilgers KF (1994) 8206619 174415 205 Remikiren - - DRUGBANK DB00212 C33H50N4O6S small molecule C09XA01 126222-34-2 DRUGBANK 4343 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Kiowski W (1994) 7994817 174414 205 Remikiren - - DRUGBANK DB00212 C33H50N4O6S small molecule C09XA01 126222-34-2 DRUGBANK 4344 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Clozel JP (1993) 8319997 174417 205 Remikiren - - DRUGBANK DB00212 C33H50N4O6S small molecule C09XA01 126222-34-2 DRUGBANK 4345 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target MacFadyen RJ (1995) 7769797 174416 205 Remikiren - - DRUGBANK DB00212 C33H50N4O6S small molecule C09XA01 126222-34-2 DRUGBANK 20336 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2898 2-Methyl-3-(2-Aminothiazolo)Propanal - - DRUGBANK DB03024 C7H10N2OS small molecule - - DRUGBANK 24925 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5718 N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE - - DRUGBANK DB06899 C20H26N6O2S small molecule - - DRUGBANK 21098 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 3253 Enalkiren - - DRUGBANK DB03395 C35H56N6O6 small molecule - 113082-98-7 DRUGBANK 27802 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Glassman HN (1990) 1705633 195971 3253 Enalkiren - - DRUGBANK DB03395 C35H56N6O6 small molecule - 113082-98-7 DRUGBANK 22300 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3802 1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine - - DRUGBANK DB03968 C7H13NO small molecule - - DRUGBANK 22301 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3802 1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine - - DRUGBANK DB03968 C7H13NO small molecule - - DRUGBANK 22302 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3802 1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine - - DRUGBANK DB03968 C7H13NO small molecule - - DRUGBANK 25182 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5991 6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE - - DRUGBANK DB07174 C20H27N5O3 small molecule - - DRUGBANK 24986 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5786 6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB06967 C22H25N5O small molecule - - DRUGBANK 26127 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6892 6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine - - DRUGBANK DB08099 C25H31N5O small molecule - - DRUGBANK 25254 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6060 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB07244 C19H19F2N5 small molecule - - DRUGBANK 25064 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5877 N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE - - DRUGBANK DB07059 C20H26N6O3 small molecule - - DRUGBANK 25122 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5931 (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE - - DRUGBANK DB07113 C24H25F2N5O3 small molecule - - DRUGBANK 19943 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2685 3-Phenyl-1,2-Propandiol - - DRUGBANK DB02803 C9H12O2 small molecule - - DRUGBANK 19944 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2685 3-Phenyl-1,2-Propandiol - - DRUGBANK DB02803 C9H12O2 small molecule - - DRUGBANK 19945 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2685 3-Phenyl-1,2-Propandiol - - DRUGBANK DB02803 C9H12O2 small molecule - - DRUGBANK 21823 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3579 2-Cyclopropylmethylenepropanal - - DRUGBANK DB03736 C7H12O small molecule - - DRUGBANK 21824 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3579 2-Cyclopropylmethylenepropanal - - DRUGBANK DB03736 C7H12O small molecule - - DRUGBANK 21825 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3579 2-Cyclopropylmethylenepropanal - - DRUGBANK DB03736 C7H12O small molecule - - DRUGBANK 23244 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4209 1-Hydroxy-2-Amino-3-Cyclohexylpropane - - DRUGBANK DB04387 C9H19NO small molecule - - DRUGBANK 23245 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4209 1-Hydroxy-2-Amino-3-Cyclohexylpropane - - DRUGBANK DB04387 C9H19NO small molecule - - DRUGBANK 23246 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4209 1-Hydroxy-2-Amino-3-Cyclohexylpropane - - DRUGBANK DB04387 C9H19NO small molecule - - DRUGBANK 23235 111904 5972 - REN HNFJ2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4201 N-Methyl-N-(Methylbenzyl)Formamide - - DRUGBANK DB04379 C10H13NO small molecule - - DRUGBANK 27445 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Wood JM (2003) 12927775 188528 7758 Aliskiren - rasilez hct|tekturna hct|amtur DRUGBANK DB09026 C30H53N3O6 small molecule C09XA53|C09XA52|C09DX02|C09XA02|C09XA54 173334-57-1 DRUGBANK 27446 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Gradman AH (2006) 16965731 188529 7758 Aliskiren - rasilez hct|tekturna hct|amtur DRUGBANK DB09026 C30H53N3O6 small molecule C09XA53|C09XA52|C09DX02|C09XA02|C09XA54 173334-57-1 DRUGBANK 27447 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Nussberger J (2002) 11799102 188526 7758 Aliskiren - rasilez hct|tekturna hct|amtur DRUGBANK DB09026 C30H53N3O6 small molecule C09XA53|C09XA52|C09DX02|C09XA02|C09XA54 173334-57-1 DRUGBANK 27448 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Menard J (2006) 16467656 188527 7758 Aliskiren - rasilez hct|tekturna hct|amtur DRUGBANK DB09026 C30H53N3O6 small molecule C09XA53|C09XA52|C09DX02|C09XA02|C09XA54 173334-57-1 DRUGBANK 27449 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 7758 Aliskiren - rasilez hct|tekturna hct|amtur DRUGBANK DB09026 C30H53N3O6 small molecule C09XA53|C09XA52|C09DX02|C09XA02|C09XA54 173334-57-1 DRUGBANK 27450 111904 5972 - REN HNFJ2 9606 Homo sapiens inhibitor target Azizi M (2006) 16508564 188525 7758 Aliskiren - rasilez hct|tekturna hct|amtur DRUGBANK DB09026 C30H53N3O6 small molecule C09XA53|C09XA52|C09DX02|C09XA02|C09XA54 173334-57-1 DRUGBANK 2327 111905 5973 - RENBP RBP|RNBP 9606 Homo sapiens unknown target Lee YC (2007) 17349707 173198 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2328 111905 5973 - RENBP RBP|RNBP 9606 Homo sapiens unknown target Takahashi S (2005) 16011304 173195 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2329 111905 5973 - RENBP RBP|RNBP 9606 Homo sapiens unknown target Ferrero MA (2007) 17565386 173197 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2330 111905 5973 - RENBP RBP|RNBP 9606 Homo sapiens unknown target Lee YC (2007) 17292397 173196 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 17820 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1739 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB01809 C16H19N5 small molecule - - DRUGBANK 26939 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens antagonist target Kurzrock R (2011) 21606412 182188 7619 Cabozantinib - cometriq DRUGBANK DB08875 C28H24FN3O5 small molecule L01XE26 849217-68-1 DRUGBANK 8684 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens inhibitor target de Groot JW (2006) 16782438 177343 609 Imatinib Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib imatinib mesylate|pms-imatinib DRUGBANK DB00619 C29H31N7O small molecule L01XE01 152459-95-5 DRUGBANK 6518 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens inhibitor target Carlomagno F (2006) 16507829 175814 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6519 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens inhibitor target Wilhelm S (2006) 17016424 175812 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 6520 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens inhibitor target Wilhelm SM (2004) 15466206 175813 390 Sorafenib N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide nexavar DRUGBANK DB00398 C21H16ClF3N4O3 small molecule L01XE05 284461-73-0 DRUGBANK 26974 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens inhibitor target De Falco V (2013) 23526464 182237 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 26764 111911 5979 - RET CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7537 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE - - DRUGBANK DB08764 C22H24BrFN4O2 small molecule - - DRUGBANK 23071 111941 6009 - RHEB RHEB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23072 111941 6009 - RHEB RHEB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23073 111941 6009 - RHEB RHEB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 22636 111941 6009 - RHEB RHEB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22637 111941 6009 - RHEB RHEB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22638 111941 6009 - RHEB RHEB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 21070 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3240 Hexadecanal Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde - DRUGBANK DB03381 C16H32O small molecule - 629-80-1 DRUGBANK 21071 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3240 Hexadecanal Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde - DRUGBANK DB03381 C16H32O small molecule - 629-80-1 DRUGBANK 21072 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3240 Hexadecanal Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde - DRUGBANK DB03381 C16H32O small molecule - 629-80-1 DRUGBANK 23453 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4264 Heptyl 1-Thiohexopyranoside - - DRUGBANK DB04450 C13H26O5S small molecule - - DRUGBANK 14338 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Ishizawa Y (2000) 10913255 180410 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14339 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Keller C (2001) 11157886 180414 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 22516 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3911 Heptane-1,2,3-Triol - - DRUGBANK DB04079 C7H16O3 small molecule - - DRUGBANK 22517 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3911 Heptane-1,2,3-Triol - - DRUGBANK DB04079 C7H16O3 small molecule - - DRUGBANK 22518 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3911 Heptane-1,2,3-Triol - - DRUGBANK DB04079 C7H16O3 small molecule - - DRUGBANK 17498 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1583 N-Acetylmethionine Methionamine|Methionin|DL-n-acetylmethionine|N-acetyl-d-methionine|Acetylmethionin|Thiomedon|DL-acetylmethionine|N-acetyl-DL-methionine|N-acetyl(methyl)homocysteine|L-(n-acetyl)methionine|Acetylmethionine|N-acetyl-S-methylhomocysteine|Acetyl-DL-methionine|Acetyl-l-methionine|N-acetyl-l-methionine - DRUGBANK DB01646 C7H13NO3S small molecule - 65-82-7 DRUGBANK 23603 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23604 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23605 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 21950 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21951 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21952 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 20678 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3020 B-2-Octylglucoside - - DRUGBANK DB03152 C14H28O6 small molecule - - DRUGBANK 19287 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19288 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19289 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 22853 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22691 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 17676 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1663 3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol - - DRUGBANK DB01728 C37H74NO8P small molecule - - DRUGBANK 17677 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1663 3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol - - DRUGBANK DB01728 C37H74NO8P small molecule - - DRUGBANK 17678 111942 6010 - RHO CSNBAD1|OPN2|RP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1663 3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol - - DRUGBANK DB01728 C37H74NO8P small molecule - - DRUGBANK 3562 111949 6017 - RLBP1 CRALBP 9606 Homo sapiens unknown target Salvador-Silva M (2005) 15928609 173877 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3563 111949 6017 - RLBP1 CRALBP 9606 Homo sapiens unknown target Wenzel A (2007) 17251447 173908 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3564 111949 6017 - RLBP1 CRALBP 9606 Homo sapiens unknown target Muniz A (2006) 17014079 173909 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3565 111949 6017 - RLBP1 CRALBP 9606 Homo sapiens unknown target Vogel JS (2007) 17652763 173910 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 20240 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2864 Cysteine-S-Acetamide - - DRUGBANK DB02987 C5H10N2O3S small molecule - - DRUGBANK 20241 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2864 Cysteine-S-Acetamide - - DRUGBANK DB02987 C5H10N2O3S small molecule - - DRUGBANK 20242 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2864 Cysteine-S-Acetamide - - DRUGBANK DB02987 C5H10N2O3S small molecule - - DRUGBANK 21928 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3631 5-Amino-1h-Pyrimidine-2,4-Dione - - DRUGBANK DB03792 C4H5N3O2 small molecule - - DRUGBANK 21929 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3631 5-Amino-1h-Pyrimidine-2,4-Dione - - DRUGBANK DB03792 C4H5N3O2 small molecule - - DRUGBANK 21930 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3631 5-Amino-1h-Pyrimidine-2,4-Dione - - DRUGBANK DB03792 C4H5N3O2 small molecule - - DRUGBANK 22143 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 22144 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 22145 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 21250 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3304 2'-Deoxyuridine 3'-Monophosphate - - DRUGBANK DB03448 C9H13N2O8P small molecule - - DRUGBANK 21251 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3304 2'-Deoxyuridine 3'-Monophosphate - - DRUGBANK DB03448 C9H13N2O8P small molecule - - DRUGBANK 21252 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3304 2'-Deoxyuridine 3'-Monophosphate - - DRUGBANK DB03448 C9H13N2O8P small molecule - - DRUGBANK 21245 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3303 Uridylyl-2'-5'-Phospho-Adenosine - - DRUGBANK DB03447 C19H24N7O12P small molecule - - DRUGBANK 21246 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3303 Uridylyl-2'-5'-Phospho-Adenosine - - DRUGBANK DB03447 C19H24N7O12P small molecule - - DRUGBANK 21247 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3303 Uridylyl-2'-5'-Phospho-Adenosine - - DRUGBANK DB03447 C19H24N7O12P small molecule - - DRUGBANK 17918 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1772 3'-Phosphate-Adenosine-5'-Diphosphate - - DRUGBANK DB01842 C10H16N5O13P3 small molecule - - DRUGBANK 17919 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1772 3'-Phosphate-Adenosine-5'-Diphosphate - - DRUGBANK DB01842 C10H16N5O13P3 small molecule - - DRUGBANK 17920 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1772 3'-Phosphate-Adenosine-5'-Diphosphate - - DRUGBANK DB01842 C10H16N5O13P3 small molecule - - DRUGBANK 21428 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3367 Uridine-2',3'-Vanadate - - DRUGBANK DB03512 C9H12N2O9V small molecule - - DRUGBANK 21429 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3367 Uridine-2',3'-Vanadate - - DRUGBANK DB03512 C9H12N2O9V small molecule - - DRUGBANK 21430 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3367 Uridine-2',3'-Vanadate - - DRUGBANK DB03512 C9H12N2O9V small molecule - - DRUGBANK 20685 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3023 1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione - - DRUGBANK DB03155 C9H12FN2O8P small molecule - - DRUGBANK 20686 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3023 1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione - - DRUGBANK DB03155 C9H12FN2O8P small molecule - - DRUGBANK 20687 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3023 1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione - - DRUGBANK DB03155 C9H12FN2O8P small molecule - - DRUGBANK 19029 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2268 2'-Monophosphoadenosine-5'-Diphosphate - - DRUGBANK DB02363 C10H16N5O13P3 small molecule - - DRUGBANK 19030 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2268 2'-Monophosphoadenosine-5'-Diphosphate - - DRUGBANK DB02363 C10H16N5O13P3 small molecule - - DRUGBANK 19031 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2268 2'-Monophosphoadenosine-5'-Diphosphate - - DRUGBANK DB02363 C10H16N5O13P3 small molecule - - DRUGBANK 26676 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7435 1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione - - DRUGBANK DB08661 C14H21N3O4 small molecule - - DRUGBANK 7800 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7801 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7802 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7803 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Dodge RW (1994) 7986344 176721 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7804 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Loh SN (1996) 8700871 176723 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7805 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Nasiri H (2005) 16302208 176722 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 18527 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 18528 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 18529 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 19946 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2687 1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione - - DRUGBANK DB02805 C9H13N2O9P small molecule - - DRUGBANK 19947 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2687 1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione - - DRUGBANK DB02805 C9H13N2O9P small molecule - - DRUGBANK 19948 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2687 1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione - - DRUGBANK DB02805 C9H13N2O9P small molecule - - DRUGBANK 21890 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3606 2'-cytidylic acid cytidine 2'-phosphate|2'-CMP|2'-cytidinephosphoric acid|Cytidine-2'-monophosphate|Cytidine, 2'-phosphate - DRUGBANK DB03765 C9H14N3O8P small molecule - 85-94-9 DRUGBANK 21891 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3606 2'-cytidylic acid cytidine 2'-phosphate|2'-CMP|2'-cytidinephosphoric acid|Cytidine-2'-monophosphate|Cytidine, 2'-phosphate - DRUGBANK DB03765 C9H14N3O8P small molecule - 85-94-9 DRUGBANK 21892 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3606 2'-cytidylic acid cytidine 2'-phosphate|2'-CMP|2'-cytidinephosphoric acid|Cytidine-2'-monophosphate|Cytidine, 2'-phosphate - DRUGBANK DB03765 C9H14N3O8P small molecule - 85-94-9 DRUGBANK 19753 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2602 3'-Uridinemonophosphate - - DRUGBANK DB02714 C9H13N2O9P small molecule - - DRUGBANK 19754 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2602 3'-Uridinemonophosphate - - DRUGBANK DB02714 C9H13N2O9P small molecule - - DRUGBANK 19755 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2602 3'-Uridinemonophosphate - - DRUGBANK DB02714 C9H13N2O9P small molecule - - DRUGBANK 22972 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22973 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22974 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 23502 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19480 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2469 2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate - - DRUGBANK DB02573 C19H25N8O9P small molecule - - DRUGBANK 19481 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2469 2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate - - DRUGBANK DB02573 C19H25N8O9P small molecule - - DRUGBANK 19482 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2469 2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate - - DRUGBANK DB02573 C19H25N8O9P small molecule - - DRUGBANK 27642 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27643 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27644 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 2026 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 18119 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18120 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18121 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 20722 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3054 U-Pi-a-Pi - - DRUGBANK DB03186 C19H27N7O20P4 small molecule - - DRUGBANK 20723 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3054 U-Pi-a-Pi - - DRUGBANK DB03186 C19H27N7O20P4 small molecule - - DRUGBANK 20724 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3054 U-Pi-a-Pi - - DRUGBANK DB03186 C19H27N7O20P4 small molecule - - DRUGBANK 23584 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4326 Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester - - DRUGBANK DB04514 C19H24N7O13P small molecule - - DRUGBANK 23585 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4326 Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester - - DRUGBANK DB04514 C19H24N7O13P small molecule - - DRUGBANK 23586 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4326 Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester - - DRUGBANK DB04514 C19H24N7O13P small molecule - - DRUGBANK 18178 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1885 Cytidine-3'-Monophosphate - - DRUGBANK DB01961 C9H14N3O8P small molecule - - DRUGBANK 18179 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1885 Cytidine-3'-Monophosphate - - DRUGBANK DB01961 C9H14N3O8P small molecule - - DRUGBANK 18180 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1885 Cytidine-3'-Monophosphate - - DRUGBANK DB01961 C9H14N3O8P small molecule - - DRUGBANK 26628 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7373 5'-deoxy-5'-piperidin-1-ylthymidine - - DRUGBANK DB08596 C15H23N3O4 small molecule - - DRUGBANK 21805 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3569 Purine Riboside-5'-Monophosphate - - DRUGBANK DB03726 C10H13N4O7P small molecule - - DRUGBANK 21806 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3569 Purine Riboside-5'-Monophosphate - - DRUGBANK DB03726 C10H13N4O7P small molecule - - DRUGBANK 21807 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3569 Purine Riboside-5'-Monophosphate - - DRUGBANK DB03726 C10H13N4O7P small molecule - - DRUGBANK 20978 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Listgarten JN (1995) 15299807 181858 3190 deoxycytidylyl-3',5'-guanosine - - DRUGBANK DB03326 C19H25N8O10P small molecule - 52474-59-6 DRUGBANK 20979 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3190 deoxycytidylyl-3',5'-guanosine - - DRUGBANK DB03326 C19H25N8O10P small molecule - 52474-59-6 DRUGBANK 17840 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17841 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17842 111964 6035 - RNASE1 RAC1|RIB1|RNS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 18525 111965 6036 - RNASE2 EDN|RAF3|RNS2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 18526 111965 6036 - RNASE2 EDN|RAF3|RNS2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 17825 111965 6036 - RNASE2 EDN|RAF3|RNS2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17826 111965 6036 - RNASE2 EDN|RAF3|RNS2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 22978 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22979 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 18523 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 18524 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2018 Adenosine-2'-5'-Diphosphate - - DRUGBANK DB02098 C10H15N5O10P2 small molecule - - DRUGBANK 16553 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Horiguchi T (1999) 10028377 181356 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16554 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Ishioka S (1999) 10804983 181357 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16555 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Obase Y (2001) 11476469 181354 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16556 111966 6037 - RNASE3 ECP|RNS3 9606 Homo sapiens unknown target Kanazawa H (2004) 15136379 181355 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 21248 111967 6038 - RNASE4 RAB1|RNS4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3304 2'-Deoxyuridine 3'-Monophosphate - - DRUGBANK DB03448 C9H13N2O8P small molecule - - DRUGBANK 21249 111967 6038 - RNASE4 RAB1|RNS4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3304 2'-Deoxyuridine 3'-Monophosphate - - DRUGBANK DB03448 C9H13N2O8P small molecule - - DRUGBANK 26757 112020 6093 - ROCK1 P160ROCK|ROCK-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7529 (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE - - DRUGBANK DB08756 C14H21N3O small molecule - - DRUGBANK 26184 112020 6093 - ROCK1 P160ROCK|ROCK-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6954 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE - - DRUGBANK DB08162 C14H17N3O2S small molecule - - DRUGBANK 23828 112020 6093 - ROCK1 P160ROCK|ROCK-I 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4511 HYDROXYFASUDIL - - DRUGBANK DB04707 C14H17N3O3S small molecule - - DRUGBANK 23829 112020 6093 - ROCK1 P160ROCK|ROCK-I 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 4511 HYDROXYFASUDIL - - DRUGBANK DB04707 C14H17N3O3S small molecule - - DRUGBANK 25909 112020 6093 - ROCK1 P160ROCK|ROCK-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6673 (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE - - DRUGBANK DB07876 C16H21N3O2S small molecule - - DRUGBANK 23665 112022 6095 - RORA NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4350 Cholesterol - - DRUGBANK DB04540 C27H46O small molecule - 57-88-5 DRUGBANK 23666 112022 6095 - RORA NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4350 Cholesterol - - DRUGBANK DB04540 C27H46O small molecule - 57-88-5 DRUGBANK 23667 112022 6095 - RORA NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4350 Cholesterol - - DRUGBANK DB04540 C27H46O small molecule - 57-88-5 DRUGBANK 18246 112022 6095 - RORA NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1914 Cholesterol-Sulfate - - DRUGBANK DB01990 C27H46O4S small molecule - - DRUGBANK 18247 112022 6095 - RORA NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1914 Cholesterol-Sulfate - - DRUGBANK DB01990 C27H46O4S small molecule - - DRUGBANK 18248 112022 6095 - RORA NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1914 Cholesterol-Sulfate - - DRUGBANK DB01990 C27H46O4S small molecule - - DRUGBANK 13392 112023 6096 - RORB NR1F2|ROR-BETA|RZR-BETA|RZRB|bA133M9.1 9606 Homo sapiens agonist target Becker-Andre M (1994) 7961794 179959 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 24037 112042 6122 OK/SW-cl.32 RPL3 ASC-1|L3|TARBP-B 9606 Homo sapiens antagonist target Tujebajeva RM (1992) 1730056 181644 4665 Omacetaxine mepesuccinate ()-homoharringtonine|Homoharringtonin|(2'R,3S,4S,5R)-()-homoharringtonine|Homoharringtonine|HHT synribo DRUGBANK DB04865 C29H39NO9 small molecule L01XX40 26833-87-4 DRUGBANK 24038 112042 6122 OK/SW-cl.32 RPL3 ASC-1|L3|TARBP-B 9606 Homo sapiens antagonist target Tujebajeva RM (1989) 2583270 181659 4665 Omacetaxine mepesuccinate ()-homoharringtonine|Homoharringtonin|(2'R,3S,4S,5R)-()-homoharringtonine|Homoharringtonine|HHT synribo DRUGBANK DB04865 C29H39NO9 small molecule L01XX40 26833-87-4 DRUGBANK 19334 112042 6122 OK/SW-cl.32 RPL3 ASC-1|L3|TARBP-B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 25387 112042 6122 OK/SW-cl.32 RPL3 ASC-1|L3|TARBP-B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 26488 112042 6122 OK/SW-cl.32 RPL3 ASC-1|L3|TARBP-B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 26486 112052 6132 - RPL8 L8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25385 112052 6132 - RPL8 L8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19332 112052 6132 - RPL8 L8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 26489 112055 6135 RP11-223J15.3 RPL11 DBA7|GIG34|L11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25388 112055 6135 RP11-223J15.3 RPL11 DBA7|GIG34|L11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19327 112055 6135 RP11-223J15.3 RPL11 DBA7|GIG34|L11 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 26478 112058 6138 TCBAP0781 RPL15 DBA12|EC45|L15|RPL10|RPLY10|RPYL10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25378 112058 6138 TCBAP0781 RPL15 DBA12|EC45|L15|RPL10|RPLY10|RPYL10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19323 112058 6138 TCBAP0781 RPL15 DBA12|EC45|L15|RPL10|RPLY10|RPYL10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 26477 112063 6143 - RPL19 L19 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25377 112063 6143 - RPL19 L19 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19322 112063 6143 - RPL19 L19 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 26484 112067 6147 - RPL23A L23A|MDA20 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25383 112067 6147 - RPL23A L23A|MDA20 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19330 112067 6147 - RPL23A L23A|MDA20 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 23922 112086 6167 - RPL37 L37 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4607 Virginiamycin S1 Staphylomycin S1|Staphylomycin S|Virginiamycin factor S|Virginiamycin factor S1 - DRUGBANK DB04805 C43H49N7O10 small molecule - 23152-29-6 DRUGBANK 19333 112086 6167 - RPL37 L37 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 25386 112086 6167 - RPL37 L37 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 23763 112086 6167 - RPL37 L37 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4411 PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE - - DRUGBANK DB04602 C12H19N6O6P small molecule - - DRUGBANK 26487 112086 6167 - RPL37 L37 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 23866 112109 6195 RP11-492M19.2 RPS6KA1 HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4554 Purvalanol A 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv - DRUGBANK DB04751 C19H25ClN6O small molecule - 212844-53-6 DRUGBANK 12183 112111 6197 RP11-393H10.3 RPS6KA3 CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2 9606 Homo sapiens unknown target Stevenson MA (1999) 10553090 179248 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12677 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Culligan K (2004) 15075397 179619 995 Hydroxyurea Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid hydrea cap 500mg|mylan-hydroxy DRUGBANK DB01005 CH4N2O2 small molecule L01XX05 127-07-1 DRUGBANK 12678 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Jiang W (2010) 20462199 179621 995 Hydroxyurea Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid hydrea cap 500mg|mylan-hydroxy DRUGBANK DB01005 CH4N2O2 small molecule L01XX05 127-07-1 DRUGBANK 12679 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Davies BW (2009) 20005847 179620 995 Hydroxyurea Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid hydrea cap 500mg|mylan-hydroxy DRUGBANK DB01005 CH4N2O2 small molecule L01XX05 127-07-1 DRUGBANK 12680 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Zhou B (2003) 14583450 7216 995 Hydroxyurea Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid hydrea cap 500mg|mylan-hydroxy DRUGBANK DB01005 CH4N2O2 small molecule L01XX05 127-07-1 DRUGBANK 4677 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Kantarjian HM (2007) 17852710 174594 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4678 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Sampat K (2009) 19715446 174595 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4679 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Kline JP (2005) 16316309 174590 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4680 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4681 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Takahashi T (1999) 9923554 174593 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 8815 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Lech-Maranda E (2009) 19519505 177447 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8816 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Pession A (2010) 20631817 177446 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8817 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Harned TM (2008) 18728851 177445 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8818 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Musto P (2008) 18780321 177444 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8819 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Unknown Authors (2004) 15230627 177443 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8820 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8821 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8822 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Kantarjian HM (2007) 17852710 174594 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 8823 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 621 Clofarabine CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine clolar DRUGBANK DB00631 C10H11ClFN5O3 small molecule L01BB06 123318-82-1 DRUGBANK 13494 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Lech-Maranda E (2009) 19519505 177447 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13495 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13496 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Robak T (2009) 19325518 179995 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 13497 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1061 Fludarabine 2-fluoro ARA-A|2-F-ARAA fludarabine phosphate for inje DRUGBANK DB01073 C10H12FN5O4 small molecule L01BB05 21679-14-1 DRUGBANK 6961 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Nakahira S (2007) 17131328 176080 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6962 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Smid K (2006) 17065054 176081 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6963 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Bepler G (2006) 16966686 176082 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6964 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Kwon WS (2006) 16708051 176077 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6965 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Rosell R (2006) 16807441 176079 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6966 112154 6240 - RRM1 R1|RIR1|RR1 9606 Homo sapiens inhibitor target Cerqueira NM (2007) 17636467 176078 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 4682 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Kantarjian HM (2007) 17852710 174594 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4683 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Sampat K (2009) 19715446 174595 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4684 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Kline JP (2005) 16316309 174590 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4685 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4686 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Takahashi T (1999) 9923554 174593 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 24306 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Narasimhan J (1992) 1335254 181637 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 24307 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Chitambar CR (2004) 15651176 181878 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 24308 112155 6241 - RRM2 R2|RR2|RR2M 9606 Homo sapiens inhibitor target Straus DJ (2003) 12776257 181818 5038 Gallium nitrate Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate ganite DRUGBANK DB05260 GaN3O9 small molecule - 13494-90-1 DRUGBANK 4330 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Kim MJ (2000) 10651997 174406 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4331 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Bernard BA (1993) 8142113 174407 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 26087 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6856 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE - - DRUGBANK DB08063 C24H20N2O3 small molecule - - DRUGBANK 5316 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Rizvi N (2001) 14700480 175074 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5317 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Tsai DE (2008) 18765556 175075 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5318 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Yen WC (2006) 16495926 175076 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5319 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Yen WC (2005) 15897247 175077 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5320 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Rigas JR (2005) 15632250 175072 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5321 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Lowe MN (2001) 11702369 175073 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5322 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Tooker P (2007) 17483357 175078 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5323 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Lalloyer F (2006) 17008586 175079 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5324 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Farol LT (2004) 15056048 175080 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 7148 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Orfanos CE (1997) 9074840 176227 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7149 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Tian K (1997) 9153406 176228 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 25898 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6660 2-chloro-5-nitro-N-phenylbenzamide - - DRUGBANK DB07863 C13H9ClN2O3 small molecule - - DRUGBANK 26632 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7378 tributylstannanyl - - DRUGBANK DB08601 C12H27Sn small molecule - - DRUGBANK 10060 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Kolluri SK (2005) 15699354 178172 739 Etodolac Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid taro-etodolac 200 mg|etodolac| DRUGBANK DB00749 C17H21NO3 small molecule M01AB08 41340-25-4 DRUGBANK 7727 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Garnock-Jones KP (2009) 19678713 176640 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7728 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Mizuguchi Y (2006) 16946489 176655 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7729 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Calleja C (2006) 16751185 176654 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7730 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Fukasawa H (2006) 16819260 176657 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7731 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Zhelyaznik N (2006) 16782282 176656 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7732 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Bartholin L (2006) 16428452 120010 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7733 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Cheng C (2008) 18321241 176635 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 11989 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Billoni N (1997) 9298126 179136 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11990 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Zitnik RJ (1994) 8301142 179138 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11991 112168 6256 - RXRA NR2B1 9606 Homo sapiens agonist target Orfanos CE (1997) 9074840 176227 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 25571 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6366 (5BETA)-PREGNANE-3,20-DIONE - - DRUGBANK DB07557 C21H32O2 small molecule - - DRUGBANK 26448 112168 6256 - RXRA NR2B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7186 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID - - DRUGBANK DB08402 C18H11Cl2N3O4 small molecule - - DRUGBANK 4327 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4328 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4329 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Kim MJ (2000) 10651997 174406 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 10148 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Nagasawa H (2005) 16392701 178217 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10149 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Schrage K (2006) 16420438 176636 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10150 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Hoegberg P (2005) 16109390 176650 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10151 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Stafslien DK (2007) 17184907 178219 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10152 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Redfern CP (2004) 15379735 178218 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 26200 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6967 (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID - - DRUGBANK DB08175 C16H28O3 small molecule - - DRUGBANK 5325 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Rizvi N (2001) 14700480 175074 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5326 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Tsai DE (2008) 18765556 175075 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5327 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Yen WC (2006) 16495926 175076 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5328 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Yen WC (2005) 15897247 175077 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5329 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Rigas JR (2005) 15632250 175072 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5330 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Lowe MN (2001) 11702369 175073 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5331 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5332 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5333 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Tooker P (2007) 17483357 175078 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5334 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Lalloyer F (2006) 17008586 175079 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5335 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Farol LT (2004) 15056048 175080 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 7143 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7144 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 10615 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Nagpal S (2000) 10828316 178442 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10616 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 10617 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 789 Tazarotene Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac tazorac|fabior|avage DRUGBANK DB00799 C21H21NO2S small molecule D05AX05 118292-40-3 DRUGBANK 25955 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6725 N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE - - DRUGBANK DB07929 C23H28N2O4 small molecule - - DRUGBANK 18103 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1866 6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid - - DRUGBANK DB01941 C24H29NO2 small molecule - - DRUGBANK 18104 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1866 6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid - - DRUGBANK DB01941 C24H29NO2 small molecule - - DRUGBANK 25087 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5898 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE - - DRUGBANK DB07080 C17H12F9NO3S small molecule - - DRUGBANK 7715 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Hoegberg P (2005) 16109390 176650 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7716 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Garnock-Jones KP (2009) 19678713 176640 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7717 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Brtko J (2007) 17491551 176647 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7718 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Germain P (2006) 17132853 176644 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7719 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Schrage K (2006) 16420438 176636 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7720 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Bergheim I (2005) 16277658 176649 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7721 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Cheng C (2008) 18321241 176635 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 11984 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11985 112169 6257 DADB-100D22.1 RXRB DAUDI6|H-2RIIBP|NR2B2|RCoR-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 4324 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4325 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 4326 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Kim MJ (2000) 10651997 174406 203 Adapalene Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid tactupump forte|differin - gel DRUGBANK DB00210 C28H28O3 small molecule D10AD53|D10AD03 106685-40-9 DRUGBANK 10141 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Koda T (2007) 17161848 178213 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10145 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Schrage K (2006) 16420438 176636 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10142 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Wang J (2004) 14993281 178214 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10143 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target He JC (2007) 17182884 176646 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10144 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Day RM (2006) 16456186 176645 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 5307 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Rizvi N (2001) 14700480 175074 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5308 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Tsai DE (2008) 18765556 175075 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5309 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Yen WC (2006) 16495926 175076 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5310 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Yen WC (2005) 15897247 175077 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5311 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Rigas JR (2005) 15632250 175072 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5312 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Lowe MN (2001) 11702369 175073 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5313 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Tooker P (2007) 17483357 175078 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5314 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Lalloyer F (2006) 17008586 175079 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 5315 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Farol LT (2004) 15056048 175080 300 Bexarotene p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn targretin|bexarotene DRUGBANK DB00307 C24H28O2 small molecule L01XX25 153559-49-0 DRUGBANK 7139 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7140 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7141 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Orfanos CE (1997) 9074840 176227 451 Acitretin Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum acitretin|soriatane DRUGBANK DB00459 C21H26O3 small molecule D05BB02 55079-83-9 DRUGBANK 7709 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Garnock-Jones KP (2009) 19678713 176640 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7710 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target He JC (2007) 17182884 176646 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7711 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Brtko J (2007) 17491551 176647 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7712 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Germain P (2006) 17132853 176644 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7713 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Day RM (2006) 16456186 176645 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 7714 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Adamczewski Z (2006) 17006844 176648 513 Alitretinoin Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin toctino|panretin DRUGBANK DB00523 C20H28O2 small molecule D11AH04|L01XX22 5300-03-8 DRUGBANK 11981 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11982 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 11983 112170 6258 - RXRG NR2B3|RXRC 9606 Homo sapiens agonist target Billoni N (1997) 9298126 179136 916 Etretinate - - DRUGBANK DB00926 C23H30O3 small molecule D05BB01 54350-48-0 DRUGBANK 4260 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens unknown target Daly JW (2007) 17514358 174335 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 14972 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14973 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Paul-Pletzer K (2002) 12167662 180683 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14974 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Gerbershagen MU (2003) 12666006 180682 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14975 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Flewellen EH (1980) 7362049 180681 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14976 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Tonner PH (1995) 7488490 180687 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14977 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Britt BA (1984) 6704779 180686 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14978 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Harrison GG (1998) 9924249 180685 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14979 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Zhao X (2006) 16945924 180684 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 14980 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens antagonist target Krause T (2004) 15023108 180688 1207 Dantrolene Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium dantrium cap 100mg|ryanodex da DRUGBANK DB01219 C14H10N4O5 small molecule M03CA01 7261-97-4 DRUGBANK 23894 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens agonist target Wolner I (2005) 16056233 181902 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 27906 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens modulator target Lanner JT (2010) 20961976 195999 7831 Tetracaine Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate denti-care denti-freeze topica DRUGBANK DB09085 C15H24N2O2 small molecule D04AB06|N01BA03|C05AD02|S01HA03 94-24-6 DRUGBANK 27907 112173 6261 - RYR1 CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR 9606 Homo sapiens modulator target Laver DR (2011) 21624373 196008 7831 Tetracaine Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate denti-care denti-freeze topica DRUGBANK DB09085 C15H24N2O2 small molecule D04AB06|N01BA03|C05AD02|S01HA03 94-24-6 DRUGBANK 27908 112174 6262 RP4-626J7.1 RYR2 ARVC2|ARVD2|RYR-2|RyR|VTSIP 9606 Homo sapiens modulator target Lanner JT (2010) 20961976 195999 7831 Tetracaine Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate denti-care denti-freeze topica DRUGBANK DB09085 C15H24N2O2 small molecule D04AB06|N01BA03|C05AD02|S01HA03 94-24-6 DRUGBANK 27909 112174 6262 RP4-626J7.1 RYR2 ARVC2|ARVD2|RYR-2|RyR|VTSIP 9606 Homo sapiens modulator target Laver DR (2011) 21624373 196008 7831 Tetracaine Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate denti-care denti-freeze topica DRUGBANK DB09085 C15H24N2O2 small molecule D04AB06|N01BA03|C05AD02|S01HA03 94-24-6 DRUGBANK 10282 112179 6271 RP1-178F15.1 S100A1 S100|S100-alpha|S100A 9606 Homo sapiens antagonist target Okada M (2002) 11944917 178307 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10283 112181 6273 RP11-49N14.8 S100A2 CAN19|S100L 9606 Homo sapiens antagonist target Okada M (2002) 11944917 178307 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10939 112183 6275 - S100A4 18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98 9606 Homo sapiens inhibitor target Malashkevich VN (2010) 20421509 178593 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10940 112183 6275 - S100A4 18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 23529 112186 6278 - S100A7 PSOR1|S100A7c 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4288 1-Anilino-8-Naphthalene Sulfonate - - DRUGBANK DB04474 C16H13NO3S small molecule - - DRUGBANK 12903 112191 6283 - S100A12 CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6 9606 Homo sapiens antagonist target Kishimoto K (2006) 16864903 178308 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12904 112191 6283 - S100A12 CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6 9606 Homo sapiens antagonist target Shishibori T (1999) 10051426 179753 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12905 112191 6283 - S100A12 CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6 9606 Homo sapiens antagonist target Okada M (2002) 11944917 178307 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 10278 112191 6283 - S100A12 CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6 9606 Homo sapiens antagonist target Kishimoto K (2006) 16864903 178308 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 10279 112191 6283 - S100A12 CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6 9606 Homo sapiens antagonist target Okada M (2002) 11944917 178307 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 12906 112192 6284 - S100A13 - 9606 Homo sapiens antagonist target Shishibori T (1999) 10051426 179753 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12907 112192 6284 - S100A13 - 9606 Homo sapiens antagonist target Matsunaga H (2006) 16519964 179755 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12908 112192 6284 - S100A13 - 9606 Homo sapiens antagonist target Mouta Carreira C (1998) 9712836 2875 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12909 112192 6284 - S100A13 - 9606 Homo sapiens antagonist target Okada M (2002) 11944917 178307 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 12910 112192 6284 - S100A13 - 9606 Homo sapiens antagonist target Landriscina M (2000) 10921913 179754 1015 Amlexanox Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo apthera DRUGBANK DB01025 C16H14N2O4 small molecule R03DX01|A01AD07 68302-57-8 DRUGBANK 10280 112192 6284 - S100A13 - 9606 Homo sapiens unknown target Okada M (2002) 11944917 178307 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 23483 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25017 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5822 2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide - - DRUGBANK DB07004 C13H17N3O2S small molecule - - DRUGBANK 24964 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5760 (Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide - - DRUGBANK DB06941 C13H19N5S small molecule - - DRUGBANK 10281 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Okada M (2002) 11944917 178307 758 Olopatadine Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine patanol|act olopatadine 0.1%|o DRUGBANK DB00768 C21H23NO3 small molecule R01AC08|S01GX09 113806-05-6 DRUGBANK 16236 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Lee TS (2007) 17515952 181217 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16237 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Liang J (2007) 17612632 181216 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16238 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Friel LA (2007) 17624933 181215 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16239 112193 6285 - S100B NEF|S100|S100-B|S100beta 9606 Homo sapiens unknown target Marlatt NM (2007) 17536784 181214 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 12671 112194 6286 - S100P MIG9 9606 Homo sapiens antagonist target Arumugam T (2006) 17179482 179615 993 Cromoglicic acid Acide Cromoglicique|Cromoglicate|Acido Cromoglicico|5-[3-(2-Carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid|Cromolyn|Acidum Cromoglicicum|Cromoglycate|Cromoglicic Acid anti-allergy eye drops|vistacr DRUGBANK DB01003 C23H16O11 small molecule A07EB01|R03BC01|S01GX01|S01GX51|R01AC01|R03AK04|R03AK05|R01AC51|D11AH03 16110-51-3 DRUGBANK 27039 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 27040 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 61 Human Serum Albumin Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin sterile diluent for allergenic DRUGBANK DB00062 C2936H4624N786O889S41 biologic - 9048-46-8 DRUGBANK 27041 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Danesh J (1999) 10361047 172127 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 27042 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 27043 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 27044 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Grehan S (1997) 9200475 172129 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 27045 112196 6288 - SAA1 PIG4|SAA|SAA2|TP53I4 9606 Homo sapiens unknown target Danesh J (2000) 10903648 172128 63 Serum albumin iodonated Serum albumin precursor - DRUGBANK DB00064 C2936H4624N786O889S41 biologic - 9048-49-1 DRUGBANK 2173 112208 6301 RP11-352P4.2 SARS SERRS|SERS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2174 112208 6301 RP11-352P4.2 SARS SERRS|SERS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2175 112208 6301 RP11-352P4.2 SARS SERRS|SERS 9606 Homo sapiens unknown target Zhang Y (2007) 16950556 173080 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2176 112208 6301 RP11-352P4.2 SARS SERRS|SERS 9606 Homo sapiens unknown target McClendon CL (2006) 16517553 173078 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2177 112208 6301 RP11-352P4.2 SARS SERRS|SERS 9606 Homo sapiens unknown target Follis KE (2005) 16081124 173079 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 23787 112210 6303 - SAT1 DC21|KFSD|KFSDX|SAT|SSAT|SSAT-1 9606 Homo sapiens unknown target Bewley MC (2006) 16455797 181928 4439 N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine BE3 - DRUGBANK DB04633 C11H27N3 small molecule - - DRUGBANK 23788 112210 6303 - SAT1 DC21|KFSD|KFSDX|SAT|SSAT|SSAT-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4439 N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine BE3 - DRUGBANK DB04633 C11H27N3 small molecule - - DRUGBANK 3211 112214 6307 - MSMO1 DESP4|ERG25|SC4MOL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3212 112214 6307 - MSMO1 DESP4|ERG25|SC4MOL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 23611 112223 6317 - SERPINB3 HsT1196|SCC|SCCA-1|SCCA-PD|SCCA1|T4-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 22207 112223 6317 - SERPINB3 HsT1196|SCC|SCCA-1|SCCA-PD|SCCA1|T4-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3765 D-Serine - - DRUGBANK DB03929 C3H7NO3 small molecule - 312-84-5 DRUGBANK 24292 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens unknown target Sage D (2007) 17663442 182034 5011 Tetrodotoxin - - DRUGBANK DB05232 C11H17N3O8 small molecule - 4368-28-9 DRUGBANK 11836 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11837 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11838 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11839 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11840 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11841 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11842 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11843 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 24167 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Breckenridge CB (2009) 19766671 182128 4727 Permethrin Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate kwellada-p crme rinse|leader l DRUGBANK DB04930 C21H20Cl2O3 small molecule P03AC04|P03AC54 52645-53-1 DRUGBANK 24168 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Liu N (2009) 19960691 182137 4727 Permethrin Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate kwellada-p crme rinse|leader l DRUGBANK DB04930 C21H20Cl2O3 small molecule P03AC04|P03AC54 52645-53-1 DRUGBANK 24169 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Chang C (2009) 19171193 182097 4727 Permethrin Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate kwellada-p crme rinse|leader l DRUGBANK DB04930 C21H20Cl2O3 small molecule P03AC04|P03AC54 52645-53-1 DRUGBANK 24170 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Cao Z (2011) 20881019 182168 4727 Permethrin Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate kwellada-p crme rinse|leader l DRUGBANK DB04930 C21H20Cl2O3 small molecule P03AC04|P03AC54 52645-53-1 DRUGBANK 24171 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target McMahon C (2003) 14651650 181838 4727 Permethrin Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate kwellada-p crme rinse|leader l DRUGBANK DB04930 C21H20Cl2O3 small molecule P03AC04|P03AC54 52645-53-1 DRUGBANK 5441 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 24024 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Lalevee N (2003) 12890054 181825 4655 Dronedarone N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589 multaq DRUGBANK DB04855 C31H44N2O5S small molecule C01BD07 141626-36-0 DRUGBANK 17259 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens unknown target McLean MJ (1988) 2450203 181564 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 5004 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Ceulemans B (2004) 15508261 174792 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5005 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Ceulemans B (2004) 15526956 174793 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5006 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Coppola G (2002) 11948006 174796 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5007 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Korff C (2007) 17621480 174794 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 5008 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Nieto Barrera M (2003) 12861512 174795 266 Topiramate Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato dom-topiramate|act topiramate| DRUGBANK DB00273 C12H21NO8S small molecule N03AX11 97240-79-4 DRUGBANK 16679 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Aizawa N (2010) 20976818 181418 1386 Phenazopyridine 3-(Phenylazo)-2,6-pyridinediamine|Fenazopiridina pyronium tab 200mg|phenazopyri DRUGBANK DB01438 C11H11N5 small molecule G04BX06 94-78-0 DRUGBANK 16680 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Ragsdale DS (1996) 8799190 181417 1386 Phenazopyridine 3-(Phenylazo)-2,6-pyridinediamine|Fenazopiridina pyronium tab 200mg|phenazopyri DRUGBANK DB01438 C11H11N5 small molecule G04BX06 94-78-0 DRUGBANK 4855 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Tate SK (2005) 15805193 174679 245 Phenytoin Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione phenytoin sodium injection usp DRUGBANK DB00252 C15H12N2O2 small molecule N03AB52|N03AB02 57-41-0 DRUGBANK 4856 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Tate SK (2006) 17001291 174678 245 Phenytoin Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione phenytoin sodium injection usp DRUGBANK DB00252 C15H12N2O2 small molecule N03AB52|N03AB02 57-41-0 DRUGBANK 4857 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Mantegazza M (2010) 20298965 174680 245 Phenytoin Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione phenytoin sodium injection usp DRUGBANK DB00252 C15H12N2O2 small molecule N03AB52|N03AB02 57-41-0 DRUGBANK 13970 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1109 Phenacemide Phenurone - DRUGBANK DB01121 C9H10N2O2 small molecule N03AX07 63-98-9 DRUGBANK 13971 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1109 Phenacemide Phenurone - DRUGBANK DB01121 C9H10N2O2 small molecule N03AX07 63-98-9 DRUGBANK 13972 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1109 Phenacemide Phenurone - DRUGBANK DB01121 C9H10N2O2 small molecule N03AX07 63-98-9 DRUGBANK 13973 112228 6323 - SCN1A EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI 9606 Homo sapiens inhibitor target Wong MG (1986) 3959032 180264 1109 Phenacemide Phenurone - DRUGBANK DB01121 C9H10N2O2 small molecule N03AX07 63-98-9 DRUGBANK 11704 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11705 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11706 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11707 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11708 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11709 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11710 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5435 112229 6324 - SCN1B ATFB13|BRGDA5|GEFSP1 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 24291 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens unknown target Sage D (2007) 17663442 182034 5011 Tetrodotoxin - - DRUGBANK DB05232 C11H17N3O8 small molecule - 4368-28-9 DRUGBANK 10798 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Haeseler G (2008) 18574460 178526 808 Propofol Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan pms-propofol|propofol-ii injec DRUGBANK DB00818 C12H18O small molecule N01AX10 2078-54-8 DRUGBANK 8018 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 545 Lamotrigine Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal ratio-lamotrigine|dom-lamotrig DRUGBANK DB00555 C9H7Cl2N5 small molecule N03AX09 84057-84-1 DRUGBANK 8019 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 545 Lamotrigine Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal ratio-lamotrigine|dom-lamotrig DRUGBANK DB00555 C9H7Cl2N5 small molecule N03AX09 84057-84-1 DRUGBANK 8020 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Lipkind GM (2005) 16174788 176847 545 Lamotrigine Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal ratio-lamotrigine|dom-lamotrig DRUGBANK DB00555 C9H7Cl2N5 small molecule N03AX09 84057-84-1 DRUGBANK 5442 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 11824 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11825 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11826 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11827 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11828 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11829 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11830 112231 6326 - SCN2A BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11685 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11686 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11687 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11688 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11689 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11690 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11691 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5439 112232 6327 UNQ326/PRO386 SCN2B ATFB14 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 24290 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens unknown target Sage D (2007) 17663442 182034 5011 Tetrodotoxin - - DRUGBANK DB05232 C11H17N3O8 small molecule - 4368-28-9 DRUGBANK 11810 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11811 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11812 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11813 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11814 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11815 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11816 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5445 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 24471 112233 6328 - SCN3A NAC3|Nav1.3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5534 Lacosamide Erlosamide|SPM 927|Harkoseride|Vimpat vimpat DRUGBANK DB06218 C13H18N2O3 small molecule N03AX18 175481-36-4 DRUGBANK 11817 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11818 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11819 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11820 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11821 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11822 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11823 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 10796 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Haeseler G (2008) 18574460 178526 808 Propofol Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan pms-propofol|propofol-ii injec DRUGBANK DB00818 C12H18O small molecule N01AX10 2078-54-8 DRUGBANK 8303 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Jones NG (2004) 15574747 177091 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8304 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Voilley N (2004) 15032643 177092 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 8305 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Yang YC (2005) 15824190 177093 576 Diclofenac 2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco dom-diclofenac|diclofenac sodi DRUGBANK DB00586 C14H11Cl2NO2 small molecule D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05 15307-86-5 DRUGBANK 5440 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 14698 112234 6329 - SCN4A HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1 9606 Homo sapiens inhibitor target Desaphy JF (2004) 14608015 180558 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 11658 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11659 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11660 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11661 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11662 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11663 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11664 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5436 112235 6330 - SCN4B ATFB17|LQT10|Navbeta4 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 10067 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 740 Prilocaine O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum relador pak plus|iv infusion c DRUGBANK DB00750 C13H20N2O small molecule N01BB54|N01BB04 721-50-6 DRUGBANK 10068 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 740 Prilocaine O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum relador pak plus|iv infusion c DRUGBANK DB00750 C13H20N2O small molecule N01BB54|N01BB04 721-50-6 DRUGBANK 10069 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 740 Prilocaine O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum relador pak plus|iv infusion c DRUGBANK DB00750 C13H20N2O small molecule N01BB54|N01BB04 721-50-6 DRUGBANK 10125 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Lenkowski PW (2004) 15066664 176695 744 Ethotoin 3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione peganone DRUGBANK DB00754 C11H12N2O2 small molecule N03AB01 86-35-1 DRUGBANK 10126 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 744 Ethotoin 3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione peganone DRUGBANK DB00754 C11H12N2O2 small molecule N03AB01 86-35-1 DRUGBANK 10127 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 744 Ethotoin 3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione peganone DRUGBANK DB00754 C11H12N2O2 small molecule N03AB01 86-35-1 DRUGBANK 10128 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 744 Ethotoin 3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione peganone DRUGBANK DB00754 C11H12N2O2 small molecule N03AB01 86-35-1 DRUGBANK 8072 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 554 Carbamazepine Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine tegretol cr tab 200mg|carbamaz DRUGBANK DB00564 C15H12N2O small molecule N03AF01 298-46-4 DRUGBANK 8073 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Yang YC (2010) 20526191 176913 554 Carbamazepine Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine tegretol cr tab 200mg|carbamaz DRUGBANK DB00564 C15H12N2O small molecule N03AF01 298-46-4 DRUGBANK 8074 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 554 Carbamazepine Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine tegretol cr tab 200mg|carbamaz DRUGBANK DB00564 C15H12N2O small molecule N03AF01 298-46-4 DRUGBANK 8075 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Yang YC (2002) 12391287 176914 554 Carbamazepine Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine tegretol cr tab 200mg|carbamaz DRUGBANK DB00564 C15H12N2O small molecule N03AF01 298-46-4 DRUGBANK 8076 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Lipkind GM (2010) 20643904 176915 554 Carbamazepine Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine tegretol cr tab 200mg|carbamaz DRUGBANK DB00564 C15H12N2O small molecule N03AF01 298-46-4 DRUGBANK 10336 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 766 Oxcarbazepine OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide jamp-oxcarbazepine|trileptal 3 DRUGBANK DB00776 C15H12N2O2 small molecule N03AF02 28721-07-5 DRUGBANK 10337 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Vohora D (2010) 20502724 178335 766 Oxcarbazepine OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide jamp-oxcarbazepine|trileptal 3 DRUGBANK DB00776 C15H12N2O2 small molecule N03AF02 28721-07-5 DRUGBANK 10338 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 766 Oxcarbazepine OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide jamp-oxcarbazepine|trileptal 3 DRUGBANK DB00776 C15H12N2O2 small molecule N03AF02 28721-07-5 DRUGBANK 14699 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Shimizu W (2000) 11196553 174870 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14700 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Liu H (2003) 12601084 180559 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14701 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Priori SG (2000) 10961955 180562 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14702 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Benhorin J (2000) 10758053 180563 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14703 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Cerrone M (2001) 11307783 180560 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14704 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Nagatomo T (2000) 10617684 180561 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14705 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14706 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Viswanathan PC (2001) 11535580 180564 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 14707 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Ramos E (2004) 15272045 180565 1183 Flecainide (+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine flecainide|tambocor|flecainide DRUGBANK DB01195 C17H20F6N2O3 small molecule C01BC04 54143-55-4 DRUGBANK 5082 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5083 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Shimizu W (2000) 11196553 174870 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5084 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Sugao M (2005) 15897781 174868 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5085 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Fujiki A (2004) 15028073 174869 273 Disopyramide Disopyramidum|Disopiramida rythmodan cap 150mg|norpace ca DRUGBANK DB00280 C21H29N3O small molecule C01BA03 3737-09-5 DRUGBANK 5093 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Karoly R (2010) 20585544 174878 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5094 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Cerne A (2006) 16840798 174886 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5095 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Itoh H (2007) 17445919 174884 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5096 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Wallace CH (2006) 17016511 174885 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5097 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Fedida D (2006) 16686685 174883 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5098 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Muroi Y (2009) 19088384 174879 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 4689 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Rajamani S (2008) 19077543 174602 236 Ranolazine - ranexa DRUGBANK DB00243 C24H33N3O4 small molecule C01EB18 95635-55-5 DRUGBANK 4690 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Hale SL (2006) 17220471 174603 236 Ranolazine - ranexa DRUGBANK DB00243 C24H33N3O4 small molecule C01EB18 95635-55-5 DRUGBANK 11633 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Itoh H (2005) 15877619 179012 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11634 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Stokoe KS (2007) 17023504 179013 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11635 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Grant AO (2005) 16138883 179016 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11636 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Ohgo T (2007) 17556186 179014 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11637 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Napolitano C (2006) 16972995 179015 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11638 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11639 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Tella SR (1998) 9476974 177548 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11640 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Sheets MF (2010) 20685573 175038 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11628 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Satish OS (2005) 15880981 179008 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11629 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Antzelevitch C (2006) 17038146 179007 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11630 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Wright SN (1999) 9876137 179006 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11263 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens antagonist target Thimann DA (2012) 23258970 178790 858 Benzonatate Benzononatine|3,6,9,12,15,18,21,24,27-Nonaoxaoctacosyl 4-butylaminobenzoate|Benzonatat|Benzonatate|P-Butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester|2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate|Nonaethyleneglycol monomethyl ether P-N-butylaminobenzoate|Benzonatato|4-(Butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester|2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl P-(butylamino)benzoate|Benzonatatum zonatuss|benzonatate|tessalon DRUGBANK DB00868 C30H53NO11 small molecule R05DB01 104-31-4 DRUGBANK 10008 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Song JH (1997) 9262334 178121 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10009 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Weiss S (2010) 20590601 178120 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10010 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10011 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Schwartz G (2002) 12440368 178119 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10012 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 16631 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Hoogendijk MG (2009) 20022821 181394 1374 Ajmaline (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline - DRUGBANK DB01426 C20H26N2O2 small molecule C01BA05 4360-12-7 DRUGBANK 16632 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Khodorov BI (1983) 6088360 181395 1374 Ajmaline (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline - DRUGBANK DB01426 C20H26N2O2 small molecule C01BA05 4360-12-7 DRUGBANK 16633 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Barajas-Martinez HM (2008) 18599870 181392 1374 Ajmaline (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline - DRUGBANK DB01426 C20H26N2O2 small molecule C01BA05 4360-12-7 DRUGBANK 16634 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Hermida JS (2010) 21126620 181393 1374 Ajmaline (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline - DRUGBANK DB01426 C20H26N2O2 small molecule C01BA05 4360-12-7 DRUGBANK 16635 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Leoni AL (2010) 20174578 181390 1374 Ajmaline (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline - DRUGBANK DB01426 C20H26N2O2 small molecule C01BA05 4360-12-7 DRUGBANK 16636 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Hoogendijk MG (2011) 20870038 181391 1374 Ajmaline (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline - DRUGBANK DB01426 C20H26N2O2 small molecule C01BA05 4360-12-7 DRUGBANK 16649 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Sato R (1991) 1660104 181404 1377 Aprindine Aprindine|Compound 99170|Aprindina|Aprindinum - DRUGBANK DB01429 C22H30N2 small molecule C01BB04 37640-71-4 DRUGBANK 16650 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Kamiya K (1991) 1653644 181405 1377 Aprindine Aprindine|Compound 99170|Aprindina|Aprindinum - DRUGBANK DB01429 C22H30N2 small molecule C01BB04 37640-71-4 DRUGBANK 4095 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Jaillon P (1989) 2688391 174237 185 Indecainide Indecainide|Indecainidum|Indecainida - DRUGBANK DB00192 C20H24N2O small molecule - 74517-78-5 DRUGBANK 4096 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 185 Indecainide Indecainide|Indecainidum|Indecainida - DRUGBANK DB00192 C20H24N2O small molecule - 74517-78-5 DRUGBANK 4097 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Steinberg MI (1984) 6206315 174238 185 Indecainide Indecainide|Indecainidum|Indecainida - DRUGBANK DB00192 C20H24N2O small molecule - 74517-78-5 DRUGBANK 4098 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 185 Indecainide Indecainide|Indecainidum|Indecainida - DRUGBANK DB00192 C20H24N2O small molecule - 74517-78-5 DRUGBANK 4099 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 185 Indecainide Indecainide|Indecainidum|Indecainida - DRUGBANK DB00192 C20H24N2O small molecule - 74517-78-5 DRUGBANK 4100 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Holland DR (1989) 2476626 174239 185 Indecainide Indecainide|Indecainidum|Indecainida - DRUGBANK DB00192 C20H24N2O small molecule - 74517-78-5 DRUGBANK 15108 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1216 Encainide (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide - DRUGBANK DB01228 C22H28N2O2 small molecule C01BC08 66778-36-7 DRUGBANK 15109 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Guo J (2006) 16751287 180732 1216 Encainide (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide - DRUGBANK DB01228 C22H28N2O2 small molecule C01BC08 66778-36-7 DRUGBANK 15110 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Starmer CF (1991) 1653123 180731 1216 Encainide (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide - DRUGBANK DB01228 C22H28N2O2 small molecule C01BC08 66778-36-7 DRUGBANK 15111 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Krishnan SC (1998) 9835260 180730 1216 Encainide (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide - DRUGBANK DB01228 C22H28N2O2 small molecule C01BC08 66778-36-7 DRUGBANK 15112 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1216 Encainide (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide - DRUGBANK DB01228 C22H28N2O2 small molecule C01BC08 66778-36-7 DRUGBANK 7768 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Lenkowski PW (2004) 15066664 176695 522 Mephenytoin - - DRUGBANK DB00532 C12H14N2O2 small molecule N03AB04|N03AB54 50-12-4 DRUGBANK 7769 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 522 Mephenytoin - - DRUGBANK DB00532 C12H14N2O2 small molecule N03AB04|N03AB54 50-12-4 DRUGBANK 7770 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Swadron SP (2004) 15001403 174682 522 Mephenytoin - - DRUGBANK DB00532 C12H14N2O2 small molecule N03AB04|N03AB54 50-12-4 DRUGBANK 15945 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Itoh H (2005) 15877619 179012 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15946 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Stokoe KS (2007) 17023504 179013 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15947 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Grant AO (2005) 16138883 179016 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15948 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Ohgo T (2007) 17556186 179014 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15949 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Napolitano C (2006) 16972995 179015 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15950 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15951 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Tella SR (1998) 9476974 177548 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 15952 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Sheets MF (2010) 20685573 175038 1311 Quinidine barbiturate - - DRUGBANK DB01346 C32H36N4O5 small molecule - - DRUGBANK 14522 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1170 Propafenone 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone propafenone|apo-propafenone|pr DRUGBANK DB01182 C21H27NO3 small molecule C01BC03 54063-53-5 DRUGBANK 14523 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1170 Propafenone 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone propafenone|apo-propafenone|pr DRUGBANK DB01182 C21H27NO3 small molecule C01BC03 54063-53-5 DRUGBANK 7261 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 465 Hexylcaine Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum - DRUGBANK DB00473 C16H23NO2 small molecule - 532-77-4 DRUGBANK 7262 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 465 Hexylcaine Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum - DRUGBANK DB00473 C16H23NO2 small molecule - 532-77-4 DRUGBANK 7263 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 465 Hexylcaine Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum - DRUGBANK DB00473 C16H23NO2 small molecule - 532-77-4 DRUGBANK 11776 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11777 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11778 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11779 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11780 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11781 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11782 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 9130 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens unknown target Milberg P (2005) 15944809 177625 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9432 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 670 Moricizine Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine - DRUGBANK DB00680 C22H25N3O4S small molecule C01BG01 31883-05-3 DRUGBANK 9433 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 670 Moricizine Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine - DRUGBANK DB00680 C22H25N3O4S small molecule C01BG01 31883-05-3 DRUGBANK 9434 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 670 Moricizine Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine - DRUGBANK DB00680 C22H25N3O4S small molecule C01BG01 31883-05-3 DRUGBANK 9435 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Ahmmed GU (2002) 12402511 177783 670 Moricizine Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine - DRUGBANK DB00680 C22H25N3O4S small molecule C01BG01 31883-05-3 DRUGBANK 5434 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 4858 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Mitiushin VM (1978) 150666 174681 245 Phenytoin Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione phenytoin sodium injection usp DRUGBANK DB00252 C15H12N2O2 small molecule N03AB52|N03AB02 57-41-0 DRUGBANK 4859 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Swadron SP (2004) 15001403 174682 245 Phenytoin Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione phenytoin sodium injection usp DRUGBANK DB00252 C15H12N2O2 small molecule N03AB52|N03AB02 57-41-0 DRUGBANK 13028 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13029 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Brugada J (1999) 11225790 179818 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13030 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Weiss R (2002) 11839626 179819 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13031 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Brugada R (2000) 10662748 179816 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13032 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen SM (2000) 11155778 179817 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13033 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Brugada J (1999) 10443304 179815 1024 Procainamide Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide apo-procainamide cap 375mg|pro DRUGBANK DB01035 C13H21N3O small molecule C01BA02 51-06-9 DRUGBANK 13314 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1044 Tocainide 2-amino-N-(2,6-Dimethylphenyl)propanamide|Tocainidum|2-Amino-N-(2,6-dimethylphenyl)propionamid|Tocainida|Alanyl-2,6-xylidide|2-Amino-2',6'-propionoxylidide tonocard tab 400 mg DRUGBANK DB01056 C11H16N2O small molecule C01BB03 41708-72-9 DRUGBANK 13315 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Georgijevic Milic L (2000) 10953551 179920 1044 Tocainide 2-amino-N-(2,6-Dimethylphenyl)propanamide|Tocainidum|2-Amino-N-(2,6-dimethylphenyl)propionamid|Tocainida|Alanyl-2,6-xylidide|2-Amino-2',6'-propionoxylidide tonocard tab 400 mg DRUGBANK DB01056 C11H16N2O small molecule C01BB03 41708-72-9 DRUGBANK 15828 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Lenkowski PW (2004) 15066664 176695 1288 Fosphenytoin Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin fosphenytoin|cerebyx|fosphenyt DRUGBANK DB01320 C16H15N2O6P small molecule N03AB05 93390-81-9 DRUGBANK 15829 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Mantegazza M (2010) 20298965 174680 1288 Fosphenytoin Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin fosphenytoin|cerebyx|fosphenyt DRUGBANK DB01320 C16H15N2O6P small molecule N03AB05 93390-81-9 DRUGBANK 15830 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1288 Fosphenytoin Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin fosphenytoin|cerebyx|fosphenyt DRUGBANK DB01320 C16H15N2O6P small molecule N03AB05 93390-81-9 DRUGBANK 15831 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Swadron SP (2004) 15001403 174682 1288 Fosphenytoin Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin fosphenytoin|cerebyx|fosphenyt DRUGBANK DB01320 C16H15N2O6P small molecule N03AB05 93390-81-9 DRUGBANK 6256 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Shimizu W (2000) 11196553 174870 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 6257 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 6258 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Fabritz L (2003) 12650887 175676 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 6259 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Napolitano C (2006) 16168489 175677 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 6260 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Valdivia CR (2002) 12123767 175674 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 6261 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Wang HW (2003) 12676070 175675 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 6262 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chinushi M (2003) 12604879 175678 371 Mexiletine 1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine teva-mexiletine|mexitil cap 20 DRUGBANK DB00379 C11H17NO small molecule C01BB02 31828-71-4 DRUGBANK 7742 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Louro SR (1998) 9742684 176670 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7743 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7744 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Oka M (2002) 12354567 176672 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7745 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Ryan SE (1996) 8798723 176671 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7746 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7747 112236 6331 - SCN5A CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 5438 112237 6332 - SCN7A NaG|Nav2.1|Nav2.2|SCN6A 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 24293 112238 6334 - SCN8A CERIII|CIAT|EIEE13|MED|NaCh6|Nav1.6|PN4 9606 Homo sapiens unknown target Sage D (2007) 17663442 182034 5011 Tetrodotoxin - - DRUGBANK DB05232 C11H17N3O8 small molecule - 4368-28-9 DRUGBANK 5437 112238 6334 - SCN8A CERIII|CIAT|EIEE13|MED|NaCh6|Nav1.6|PN4 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 11763 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11764 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11765 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11766 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11767 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11768 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11769 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 4687 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Rajamani S (2008) 19077543 174602 236 Ranolazine - ranexa DRUGBANK DB00243 C24H33N3O4 small molecule C01EB18 95635-55-5 DRUGBANK 4688 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 236 Ranolazine - ranexa DRUGBANK DB00243 C24H33N3O4 small molecule C01EB18 95635-55-5 DRUGBANK 5086 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Muroi Y (2009) 19088384 174879 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5087 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Karoly R (2010) 20585544 174878 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5088 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens inhibitor target Sheets PL (2007) 17430993 174880 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 24412 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens modulator target Suter MR (2013) 23221868 182223 5525 Rufinamide RUF 331|Xilep|Banzel banzel DRUGBANK DB06201 C10H8F2N4O small molecule N03AF03 106308-44-5 DRUGBANK 5444 112239 6335 - SCN9A ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 10714 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 797 Proparacaine Proxymetacaine|Proparacaine|Proximetacaina|Proxymetacainum alcaine|fluorescein sodium and DRUGBANK DB00807 C16H26N2O3 small molecule S01HA04 499-67-2 DRUGBANK 10715 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 797 Proparacaine Proxymetacaine|Proparacaine|Proximetacaina|Proxymetacainum alcaine|fluorescein sodium and DRUGBANK DB00807 C16H26N2O3 small molecule S01HA04 499-67-2 DRUGBANK 10716 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Tella SR (1998) 9476974 177548 797 Proparacaine Proxymetacaine|Proparacaine|Proximetacaina|Proxymetacainum alcaine|fluorescein sodium and DRUGBANK DB00807 C16H26N2O3 small molecule S01HA04 499-67-2 DRUGBANK 11440 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 882 Oxybuprocaine Oxyriprocaine|BNX|4-Amino-3-N-butoxy-benzoesaeure-diaethylaminoaethylester|4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester|Oxibuprocaina|Benoxil|4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid|Butoxyaminobenzoyldiethylaminoethanol|Oxybuprocainum|Oxybucaine|Benoxinate fluress|fluorox|minims benoxin DRUGBANK DB00892 C17H28N2O3 small molecule D04AB03|S01HA02 99-43-4 DRUGBANK 11441 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Hung CH (2009) 19429093 178921 882 Oxybuprocaine Oxyriprocaine|BNX|4-Amino-3-N-butoxy-benzoesaeure-diaethylaminoaethylester|4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester|Oxibuprocaina|Benoxil|4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid|Butoxyaminobenzoyldiethylaminoethanol|Oxybuprocainum|Oxybucaine|Benoxinate fluress|fluorox|minims benoxin DRUGBANK DB00892 C17H28N2O3 small molecule D04AB03|S01HA02 99-43-4 DRUGBANK 11442 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 882 Oxybuprocaine Oxyriprocaine|BNX|4-Amino-3-N-butoxy-benzoesaeure-diaethylaminoaethylester|4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester|Oxibuprocaina|Benoxil|4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid|Butoxyaminobenzoyldiethylaminoethanol|Oxybuprocainum|Oxybucaine|Benoxinate fluress|fluorox|minims benoxin DRUGBANK DB00892 C17H28N2O3 small molecule D04AB03|S01HA02 99-43-4 DRUGBANK 7739 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7740 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Ryan SE (1996) 8798723 176671 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7738 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Louro SR (1998) 9742684 176670 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 7741 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 517 Cinchocaine alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine nupercainal anesthetic ont 1%| DRUGBANK DB00527 C20H29N3O2 small molecule S01HA06|D04AB02|C05AD04|N01BB06|S02DA04 85-79-0 DRUGBANK 8973 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 635 Dyclonine Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone sucrets extra strength mint fl DRUGBANK DB00645 C18H27NO2 small molecule N01BX02|R02AD04 586-60-7 DRUGBANK 8974 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Roghani S (1999) 10355012 177547 635 Dyclonine Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone sucrets extra strength mint fl DRUGBANK DB00645 C18H27NO2 small molecule N01BX02|R02AD04 586-60-7 DRUGBANK 8975 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 635 Dyclonine Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone sucrets extra strength mint fl DRUGBANK DB00645 C18H27NO2 small molecule N01BX02|R02AD04 586-60-7 DRUGBANK 8976 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Tella SR (1998) 9476974 177548 635 Dyclonine Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone sucrets extra strength mint fl DRUGBANK DB00645 C18H27NO2 small molecule N01BX02|R02AD04 586-60-7 DRUGBANK 11617 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11618 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 7259 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 465 Hexylcaine Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum - DRUGBANK DB00473 C16H23NO2 small molecule - 532-77-4 DRUGBANK 7260 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 465 Hexylcaine Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum - DRUGBANK DB00473 C16H23NO2 small molecule - 532-77-4 DRUGBANK 13614 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1074 Benzocaine p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina insect bite relief|benzodent|v DRUGBANK DB01086 C9H11NO2 small molecule R02AD01|D04AB04|N01BA05|C05AD03 94-09-7 DRUGBANK 13615 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Hanck DA (2009) 19661462 180062 1074 Benzocaine p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina insect bite relief|benzodent|v DRUGBANK DB01086 C9H11NO2 small molecule R02AD01|D04AB04|N01BA05|C05AD03 94-09-7 DRUGBANK 13616 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1074 Benzocaine p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina insect bite relief|benzodent|v DRUGBANK DB01086 C9H11NO2 small molecule R02AD01|D04AB04|N01BA05|C05AD03 94-09-7 DRUGBANK 13617 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Lipkind GM (2005) 16174788 176847 1074 Benzocaine p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina insect bite relief|benzodent|v DRUGBANK DB01086 C9H11NO2 small molecule R02AD01|D04AB04|N01BA05|C05AD03 94-09-7 DRUGBANK 13618 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Ahern CA (2008) 17967784 180063 1074 Benzocaine p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina insect bite relief|benzodent|v DRUGBANK DB01086 C9H11NO2 small molecule R02AD01|D04AB04|N01BA05|C05AD03 94-09-7 DRUGBANK 14364 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14365 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Wong K (1993) 8418714 180421 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14366 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 9821 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9823 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Creveling CR (1990) 2167458 178031 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9822 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Katalymov LL (1995) 8581044 178030 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9825 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Braeu ME (1998) 9768788 178029 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9824 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 5239 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 289 Ropivacaine Ropivacainum|(S)-()-1-propyl-2',6'-pipecoloxylidide|L-N-n-propylpipecolic acid-2,6-xylidide|Ropivacaine|Ropivacaina|(S)-ropivacaine ropivacaine hydrochloride|ropi DRUGBANK DB00296 C17H26N2O small molecule N01BB09 84057-95-4 DRUGBANK 5240 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 289 Ropivacaine Ropivacainum|(S)-()-1-propyl-2',6'-pipecoloxylidide|L-N-n-propylpipecolic acid-2,6-xylidide|Ropivacaine|Ropivacaina|(S)-ropivacaine ropivacaine hydrochloride|ropi DRUGBANK DB00296 C17H26N2O small molecule N01BB09 84057-95-4 DRUGBANK 5241 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Liu BG (2000) 10781449 175035 289 Ropivacaine Ropivacainum|(S)-()-1-propyl-2',6'-pipecoloxylidide|L-N-n-propylpipecolic acid-2,6-xylidide|Ropivacaine|Ropivacaina|(S)-ropivacaine ropivacaine hydrochloride|ropi DRUGBANK DB00296 C17H26N2O small molecule N01BB09 84057-95-4 DRUGBANK 12317 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 951 Mepivacaine 1-methyl-2',6'-pipecoloxylidide|Carbocaine|Mepivacainum|Mepivacaina|N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide|DL-Mepivacaine|(+-)-1-Methyl-2',6'-pipecoloxylidide|N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide mepivacaine hydrochloride and DRUGBANK DB00961 C15H22N2O small molecule N01BB03|N01BB53 96-88-8 DRUGBANK 12318 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Leffler A (2010) 20044988 179360 951 Mepivacaine 1-methyl-2',6'-pipecoloxylidide|Carbocaine|Mepivacainum|Mepivacaina|N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide|DL-Mepivacaine|(+-)-1-Methyl-2',6'-pipecoloxylidide|N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide mepivacaine hydrochloride and DRUGBANK DB00961 C15H22N2O small molecule N01BB03|N01BB53 96-88-8 DRUGBANK 12319 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 951 Mepivacaine 1-methyl-2',6'-pipecoloxylidide|Carbocaine|Mepivacainum|Mepivacaina|N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide|DL-Mepivacaine|(+-)-1-Methyl-2',6'-pipecoloxylidide|N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide mepivacaine hydrochloride and DRUGBANK DB00961 C15H22N2O small molecule N01BB03|N01BB53 96-88-8 DRUGBANK 5090 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Muroi Y (2009) 19088384 174879 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5091 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Karoly R (2010) 20585544 174878 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5092 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Ekberg J (2006) 17077153 174882 274 Lidocaine 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide scar zone burn gel|sting relie DRUGBANK DB00281 C14H22N2O small molecule C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01 137-58-6 DRUGBANK 5432 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 24472 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5534 Lacosamide Erlosamide|SPM 927|Harkoseride|Vimpat vimpat DRUGBANK DB06218 C13H18N2O3 small molecule N03AX18 175481-36-4 DRUGBANK 12664 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 992 Levobupivacaine Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine - DRUGBANK DB01002 C18H28N2O small molecule N01BB10 27262-47-1 DRUGBANK 12665 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Vladimirov M (2000) 10969308 179612 992 Levobupivacaine Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine - DRUGBANK DB01002 C18H28N2O small molecule N01BB10 27262-47-1 DRUGBANK 12666 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 992 Levobupivacaine Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine - DRUGBANK DB01002 C18H28N2O small molecule N01BB10 27262-47-1 DRUGBANK 12667 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Braeu ME (2000) 11094008 179614 992 Levobupivacaine Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine - DRUGBANK DB01002 C18H28N2O small molecule N01BB10 27262-47-1 DRUGBANK 12668 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Ueta K (2006) 16418020 179613 992 Levobupivacaine Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine - DRUGBANK DB01002 C18H28N2O small molecule N01BB10 27262-47-1 DRUGBANK 5245 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Sheets MF (2010) 20685573 175038 290 Bupivacaine 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina bupivacaine hydrochloride inje DRUGBANK DB00297 C18H28N2O small molecule N01BB01|N01BB51 38396-39-3 DRUGBANK 5246 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 290 Bupivacaine 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina bupivacaine hydrochloride inje DRUGBANK DB00297 C18H28N2O small molecule N01BB01|N01BB51 38396-39-3 DRUGBANK 5247 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 290 Bupivacaine 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina bupivacaine hydrochloride inje DRUGBANK DB00297 C18H28N2O small molecule N01BB01|N01BB51 38396-39-3 DRUGBANK 14449 112240 6336 - SCN10A FEPS2|Nav1.8|PN3|SNS|hPN3 9606 Homo sapiens inhibitor target Pubill D (1999) 10344632 180467 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 8415 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Otulakowski G (2007) 17556672 177165 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8416 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Ji HL (2004) 15084585 177166 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8417 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Kelly O (2003) 12928313 177167 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8418 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 6331 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6332 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6333 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6334 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Busch AE (1996) 8772124 175715 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6335 112241 6337 - SCNN1A BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1 9606 Homo sapiens inhibitor target Wagner CA (2001) 11509829 175716 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 8392 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Yamagata T (2002) 12396248 177143 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8393 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Brooks HL (2002) 11882592 177146 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8394 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Planes C (2005) 15681398 177147 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8395 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Lebowitz J (2003) 12746257 177144 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8396 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Kamide K (2004) 15198480 177145 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 6344 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6345 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6346 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Busch AE (1996) 8772124 175715 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6347 112242 6338 hCG_23853 SCNN1B BESC1|ENaCb|ENaCbeta|SCNEB 9606 Homo sapiens inhibitor target Wagner CA (2001) 11509829 175716 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 8397 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Ji HL (2004) 14660613 177151 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8398 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Ji HL (2006) 16423824 177150 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8399 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Yamamura H (2004) 14726523 177148 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8400 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Yamamura H (2005) 16107516 177149 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8401 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Yamamura H (2005) 16033954 177152 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 6341 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6342 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6343 112243 6339 RP5-902P8.9 SCNN1D ENaCd|ENaCdelta|SCNED|dNaCh 9606 Homo sapiens inhibitor target Wagner CA (2001) 11509829 175716 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 8387 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Viemann M (2001) 11344206 177142 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8388 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Yamagata T (2002) 12396248 177143 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8389 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Iwai N (2001) 11463765 177140 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8390 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Akcay A (2002) 12503866 177141 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8391 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Ludwig M (2004) 15547682 177139 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 6336 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6337 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6338 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Busch AE (1996) 8772124 175715 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6339 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Hiraoka Y (2003) 12827214 175717 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 6340 112244 6340 - SCNN1G BESC3|ENaCg|ENaCgamma|PHA1|SCNEG 9606 Homo sapiens inhibitor target Wagner CA (2001) 11509829 175716 376 Triamterene 6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno triamterene and hydrochlorothi DRUGBANK DB00384 C12H11N7 small molecule C03DB02 396-01-0 DRUGBANK 236 112248 6344 - SCTR SR 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 21 Secretin - secretin inj 75unit/vial DRUGBANK DB00021 C130H219N43O42 biologic V04CK01 - DRUGBANK 237 112248 6344 - SCTR SR 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 21 Secretin - secretin inj 75unit/vial DRUGBANK DB00021 C130H219N43O42 biologic V04CK01 - DRUGBANK 238 112248 6344 - SCTR SR 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 21 Secretin - secretin inj 75unit/vial DRUGBANK DB00021 C130H219N43O42 biologic V04CK01 - DRUGBANK 13308 112251 6347 - CCL2 GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF 9606 Homo sapiens inhibitor target Frydas S (2005) 15698514 179916 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13309 112251 6347 - CCL2 GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF 9606 Homo sapiens inhibitor target Conti P (2002) 11936838 179915 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 16507 112251 6347 - CCL2 GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF 9606 Homo sapiens inhibitor target Boucher A (2000) 11056242 181321 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16508 112251 6347 - CCL2 GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF 9606 Homo sapiens inhibitor target Jolicoeur C (2001) 11216879 181320 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 18946 112255 6352 - CCL5 D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2229 Heparin Disaccharide I-S - - DRUGBANK DB02322 C12H15NO19S3 small molecule - - DRUGBANK 18947 112255 6352 - CCL5 D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2229 Heparin Disaccharide I-S - - DRUGBANK DB02322 C12H15NO19S3 small molecule - - DRUGBANK 19016 112255 6352 - CCL5 D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2258 Heparin Disaccharide Iii-S - - DRUGBANK DB02353 C12H16NO16S2 small molecule - - DRUGBANK 19017 112255 6352 - CCL5 D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2258 Heparin Disaccharide Iii-S - - DRUGBANK DB02353 C12H16NO16S2 small molecule - - DRUGBANK 225 112285 6383 - SDC2 CD362|HSPG|HSPG1|SYND2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 226 112285 6383 - SDC2 CD362|HSPG|HSPG1|SYND2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 227 112285 6383 - SDC2 CD362|HSPG|HSPG1|SYND2 9606 Homo sapiens agonist target Modrowski D (2000) 10734053 3718 20 Sargramostim GM-CSF leukine DRUGBANK DB00020 C639H1006N168O196S8 biologic L03AA09 123774-72-1 DRUGBANK 24844 112288 6387 - CXCL12 IRH|PBSF|SCYB12|SDF1|TLSF|TPAR1 9606 Homo sapiens binder target Koo CY (2008) 18991783 182089 5647 Tinzaparin Tinzaparin sodium innohep multi-dose vial- 10000 DRUGBANK DB06822 - small molecule B01AB10 9041-08-1 DRUGBANK 18719 112289 6388 - SDF2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2117 Malonate Ion - - DRUGBANK DB02201 C3H2O4 small molecule - 141-82-2 DRUGBANK 2256 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2257 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Ackrell BA (2002) 12231007 173154 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2258 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2259 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Takeo S (2000) 10779596 173153 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2260 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Maklashina E (2006) 16484232 173152 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 26699 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7463 UBIQUINONE-1 - - DRUGBANK DB08689 C14H18O4 small molecule - - DRUGBANK 22674 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 23801 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4462 Carboxin Carboxine|Carbathiine|2,3-Dihydro-5-carboxanilido-6-methyl-1,4-oxathiin|Carbathiin|CBX|2,3-Dihydro-6-methyl-5-phenylcarbamoyl-1,4-oxathiin - DRUGBANK DB04657 C12H13NO2S small molecule - 5234-68-4 DRUGBANK 23908 112290 6389 - SDHA CMD1GG|FP|PGL5|SDH1|SDH2|SDHF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4597 Thenoyltrifluoroacetone alpha-Thenoyltrifluoroacetone|.alpha.-Thenoyltrifluoroacetone|2-Thenoyltrifluoroacetone|Perfluoroacetyl(2-thenoyl)methane|1-Thenoyl-3,3,3-trifluoroacetone|1,1,1-Trifluoro-3-(2-thenoyl)acetone|TTFA - DRUGBANK DB04795 C8H5F3O2S small molecule - 326-91-0 DRUGBANK 2251 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Arikawa Y (2005) 16232421 68288 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2252 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Lehtonen HJ (2007) 17520677 173144 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2253 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Bayley JP (2006) 16405730 173145 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2254 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Bayley JP (2005) 16288654 173148 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2255 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Szeto SS (2007) 17636259 73680 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 26701 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7463 UBIQUINONE-1 - - DRUGBANK DB08689 C14H18O4 small molecule - - DRUGBANK 22682 112291 6390 - SDHB CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 2244 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Szeto SS (2007) 17636259 73680 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2245 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Kubo Y (2005) 16232921 68096 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2246 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Bayley JP (2006) 16405730 173145 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2247 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Bayley JP (2005) 16288654 173148 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2248 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Leibowitz G (2005) 15986240 173149 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 26697 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7463 UBIQUINONE-1 - - DRUGBANK DB08689 C14H18O4 small molecule - - DRUGBANK 22679 112292 6391 - SDHC CYB560|CYBL|PGL3|QPS1|SDH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 2239 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Sun F (2005) 15989954 173146 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2240 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Brink I (2006) 16374125 173147 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2241 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Lehtonen HJ (2007) 17520677 173144 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2242 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Bayley JP (2006) 16405730 173145 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2243 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Bayley JP (2005) 16288654 173148 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 26700 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7463 UBIQUINONE-1 - - DRUGBANK DB08689 C14H18O4 small molecule - - DRUGBANK 22670 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 10162 112293 6392 - SDHD CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS 9606 Homo sapiens inhibitor target Lokanatha V (1999) 10487417 178226 746 Hexachlorophene Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm sapoderm|phisohex DRUGBANK DB00756 C13H6Cl6O2 small molecule D08AE01 70-30-4 DRUGBANK 14073 112301 6401 RP1-117P20.2 SELE CD62E|ELAM|ELAM1|ESEL|LECAM2 9606 Homo sapiens inhibitor target Chen JW (2004) 15374848 180314 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 21795 112301 6401 RP1-117P20.2 SELE CD62E|ELAM|ELAM1|ESEL|LECAM2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 21796 112301 6401 RP1-117P20.2 SELE CD62E|ELAM|ELAM1|ESEL|LECAM2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 24827 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Rey E (2000) 11044537 181763 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 13838 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Asberg AE (2007) 17651117 180199 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13839 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Maugeri N (2007) 17549299 180198 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13840 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Simonis D (2007) 17458940 180193 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13841 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Gao Y (2005) 15995351 180197 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13842 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Koenig A (1998) 9466983 180196 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13843 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Nelson RM (1993) 7694675 180195 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 13844 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Simonis D (2007) 17629851 180194 1097 Heparin Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock calcilean inj 20000unit/0.8ml| DRUGBANK DB01109 - small molecule S01XA14|B01AB01|C05BA03|C05BA53|B01AB51 9005-49-6 DRUGBANK 21791 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 21792 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 26840 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Ludwig RJ (2006) 16525583 181934 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 26841 112303 6403 RP1-86F14.2 SELP CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL 9606 Homo sapiens inhibitor target Simonis D (2007) 17629851 180194 7583 Nadroparin - fraxiparine forte|fraxiparine DRUGBANK DB08813 - small molecule B01AB06 9041-08-1 DRUGBANK 19072 112339 6441 - SFTPD COLEC7|PSP-D|SFTP4|SP-D 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19073 112339 6441 - SFTPD COLEC7|PSP-D|SFTP4|SP-D 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 20831 112344 6446 RP1-188K17.1 SGK1 SGK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 25855 112344 6446 RP1-188K17.1 SGK1 SGK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6634 [4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid - - DRUGBANK DB07837 C25H18N2O2 small molecule - - DRUGBANK 26218 112344 6446 RP1-188K17.1 SGK1 SGK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6982 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid - - DRUGBANK DB08191 C20H14N2O2 small molecule - - DRUGBANK 6757 112359 6462 - SHBG ABP|SBP|TEBG 9606 Homo sapiens binder target Braunstein GD (2007) 17881754 175951 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 13310 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens inhibitor target Perry C (2005) 15531579 179917 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13311 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens inhibitor target Conti P (2002) 11936838 179915 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13312 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens inhibitor target Oppenheim EW (2000) 10766749 179919 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13313 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens inhibitor target Lin HB (1996) 8576220 179918 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 18445 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1987 Triglu-5-Formyl-Tetrahydrofolate - - DRUGBANK DB02067 C30H37N9O13 small molecule - - DRUGBANK 18446 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1987 Triglu-5-Formyl-Tetrahydrofolate - - DRUGBANK DB02067 C30H37N9O13 small molecule - - DRUGBANK 18447 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1987 Triglu-5-Formyl-Tetrahydrofolate - - DRUGBANK DB02067 C30H37N9O13 small molecule - - DRUGBANK 19970 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2706 N-Pyridoxyl-Glycine-5-Monophosphate - - DRUGBANK DB02824 C10H15N2O7P small molecule - - DRUGBANK 19971 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2706 N-Pyridoxyl-Glycine-5-Monophosphate - - DRUGBANK DB02824 C10H15N2O7P small molecule - - DRUGBANK 19972 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2706 N-Pyridoxyl-Glycine-5-Monophosphate - - DRUGBANK DB02824 C10H15N2O7P small molecule - - DRUGBANK 1524 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1525 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27553 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Berman HM (2000) 10592235 172122 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27749 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Bourguignon J (1988) 3143355 196042 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27750 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Trakatellis A (1994) 7526359 196047 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27751 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Jagath JR (1997) 9305893 196048 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27760 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Scarsdale JN (2000) 10656824 195950 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27761 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Rao JV (2000) 10998057 195952 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27762 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Li R (2003) 12668769 195955 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27556 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Heil SG (2001) 11386852 172643 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27555 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Berman HM (2000) 10592235 172122 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27554 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens cofactor target Ravanel S (2001) 11752472 95631 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 2780 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Gagnon D (2006) 16876889 173463 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2781 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Chang WN (2007) 17664250 172627 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2782 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Rajinikanth M (2007) 17355947 173465 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2783 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Nijhout HF (2006) 17150100 173464 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2784 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Vatsyayan R (2007) 17142057 172645 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 19940 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2682 5-Hydroxymethylene-6-Hydrofolic Acid - - DRUGBANK DB02800 C20H23N7O7 small molecule - - DRUGBANK 19941 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2682 5-Hydroxymethylene-6-Hydrofolic Acid - - DRUGBANK DB02800 C20H23N7O7 small molecule - - DRUGBANK 19942 112366 6470 - SHMT1 CSHMT|SHMT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2682 5-Hydroxymethylene-6-Hydrofolic Acid - - DRUGBANK DB02800 C20H23N7O7 small molecule - - DRUGBANK 2815 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Vatsyayan R (2007) 17142057 172645 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2760 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 27559 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Mukherjee M (2006) 16980404 172522 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2762 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2814 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Gagnon D (2006) 16876889 173463 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2761 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Bouwman RA (2007) 17905752 173449 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2759 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Chang WN (2007) 17664250 172627 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2816 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Rajinikanth M (2007) 17355947 173465 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2763 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens unknown target Kon K (2007) 17567465 173450 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 1447 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1498 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Mukherjee M (2006) 16980404 172522 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1448 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Mehta R (2008) 17918169 172495 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1449 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1500 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Bhavani S (2005) 15865438 172525 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1501 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Rajaram V (2007) 17651438 172524 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27746 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Bourguignon J (1988) 3143355 196042 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1497 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Perry C (2007) 17482557 172523 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27747 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Trakatellis A (1994) 7526359 196047 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 27748 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Jagath JR (1997) 9305893 196048 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1499 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Trivedi V (2002) 11877399 172521 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1667 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Prabhu V (1998) 9449840 172646 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1668 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Contestabile R (2001) 11737206 172644 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1669 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Vatsyayan R (2007) 17142057 172645 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27757 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Li R (2003) 12668769 195955 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1670 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Heil SG (2001) 11386852 172643 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27758 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Angelaccio S (2003) 12902326 195957 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 27759 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Appaji Rao N (2003) 12686103 195956 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1644 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1646 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1671 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Rajaram V (2007) 17651438 172524 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1645 112368 6472 - SHMT2 GLYA|HEL-S-51e|SHMT 9606 Homo sapiens cofactor target Chang WN (2007) 17664250 172627 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 10047 112371 6476 - SI - 9606 Homo sapiens inhibitor target Minai-Tehrani D (2010) 20230815 178161 737 Scopolamine 6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine se-donna pb hyos|donnatal tab| DRUGBANK DB00747 C17H21NO4 small molecule A04AD01|N05CM05|A04AD51|S01FA02 51-34-3 DRUGBANK 5115 112371 6476 - SI - 9606 Homo sapiens inhibitor target Newbrun E (1983) 6226260 174907 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5116 112371 6476 - SI - 9606 Homo sapiens inhibitor target Samulitis BK (1987) 2962844 174906 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5117 112371 6476 - SI - 9606 Homo sapiens inhibitor target Juretic D (2003) 12864906 174905 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5118 112371 6476 - SI - 9606 Homo sapiens inhibitor target Karley AJ (2005) 16169004 174904 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5119 112371 6476 - SI - 9606 Homo sapiens inhibitor target Meyer H (2004) 15322845 174903 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 25978 112391 6500 - SKP1 EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6745 1H-INDOL-3-YLACETIC ACID - - DRUGBANK DB07950 C10H9NO2 small molecule - - DRUGBANK 24996 112391 6500 - SKP1 EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5800 (2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid - - DRUGBANK DB06982 C21H30N2O4 small molecule - - DRUGBANK 17705 112391 6500 - SKP1 EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1684 Naphthalen-1-Yl-Acetic Acid - - DRUGBANK DB01750 C12H10O2 small molecule - 86-87-3 DRUGBANK 24995 112391 6500 - SKP1 EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5799 (2S)-2-(1H-indol-3-yl)pentanoic acid - - DRUGBANK DB06981 C13H15NO2 small molecule - - DRUGBANK 24994 112391 6500 - SKP1 EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5798 (2S)-2-(1H-indol-3-yl)hexanoic acid - - DRUGBANK DB06980 C14H17NO2 small molecule - - DRUGBANK 2003 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Ozawa S (2007) 17663137 172930 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2004 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Tai YH (2007) 17346885 172931 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2005 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Tao Z (2007) 17389249 172932 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2006 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Teichman S (2007) 17535962 172933 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2435 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Menaker D (2006) 16831195 173252 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2436 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Tao Z (2007) 17389249 172932 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2437 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Nickell J (2007) 16959378 173227 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2438 112396 6505 RP11-6J24.1 SLC1A1 DCBXA|EAAC1|EAAT3|SCZD18 9606 Homo sapiens unknown target Yun JY (2007) 17382927 173253 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2478 112397 6506 - SLC1A2 EAAT2|GLT-1 9606 Homo sapiens unknown target Nickell J (2007) 16959378 173227 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2479 112397 6506 - SLC1A2 EAAT2|GLT-1 9606 Homo sapiens unknown target Glowatzki E (2006) 16855093 173228 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2480 112397 6506 - SLC1A2 EAAT2|GLT-1 9606 Homo sapiens unknown target King N (2006) 16718509 173274 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2481 112397 6506 - SLC1A2 EAAT2|GLT-1 9606 Homo sapiens unknown target Beart PM (2007) 17088867 173226 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2373 112398 6507 - SLC1A3 EA6|EAAT1|GLAST|GLAST1 9606 Homo sapiens unknown target Glowatzki E (2006) 16855093 173228 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2374 112398 6507 - SLC1A3 EA6|EAAT1|GLAST|GLAST1 9606 Homo sapiens unknown target Nickell J (2007) 16959378 173227 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2375 112398 6507 - SLC1A3 EA6|EAAT1|GLAST|GLAST1 9606 Homo sapiens unknown target Beart PM (2007) 17088867 173226 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 3468 112400 6509 - SLC1A4 ASCT1|SATT 9606 Homo sapiens unknown target Wu Y (2007) 17195090 173850 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3469 112400 6509 - SLC1A4 ASCT1|SATT 9606 Homo sapiens unknown target Zhang Z (2007) 17237199 173851 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3470 112400 6509 - SLC1A4 ASCT1|SATT 9606 Homo sapiens unknown target Pinho MJ (2007) 17475673 173852 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3471 112400 6509 - SLC1A4 ASCT1|SATT 9606 Homo sapiens unknown target Zhang Z (2007) 17311416 173853 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3472 112400 6509 - SLC1A4 ASCT1|SATT 9606 Homo sapiens unknown target Takasaki C (2007) 17510490 173849 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3837 112401 6510 - SLC1A5 AAAT|ASCT2|ATBO|M7V1|M7VS1|R16|RDRC 9606 Homo sapiens unknown target Oppedisano F (2004) 15581847 174067 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3838 112401 6510 - SLC1A5 AAAT|ASCT2|ATBO|M7V1|M7VS1|R16|RDRC 9606 Homo sapiens unknown target Dun Y (2007) 17094966 173025 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 2407 112402 6511 - SLC1A6 EAAT4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2408 112402 6511 - SLC1A6 EAAT4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2409 112402 6511 - SLC1A6 EAAT4 9606 Homo sapiens unknown target Lin CL (1998) 9838098 173241 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2410 112402 6511 - SLC1A6 EAAT4 9606 Homo sapiens unknown target Gegelashvili G (1997) 9224806 173242 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2496 112403 6512 RP11-334A14.7 SLC1A7 AAAT|EAAT5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2497 112403 6512 RP11-334A14.7 SLC1A7 AAAT|EAAT5 9606 Homo sapiens unknown target Takarada T (2004) 15128272 173283 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2498 112403 6512 RP11-334A14.7 SLC1A7 AAAT|EAAT5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2499 112403 6512 RP11-334A14.7 SLC1A7 AAAT|EAAT5 9606 Homo sapiens unknown target Arriza JL (1997) 9108121 173282 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 6848 112405 6514 - SLC2A2 GLUT2 9606 Homo sapiens ligand target Schnedl WJ (1994) 7926307 175991 420 Streptozocin 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|Estreptozocina|Streptozocinium|Streptozocine|Streptozocinum|Streptozocin|Zanosar|N-D-Glucosyl-(2)-n'-nitrosomethylharnstoff|2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose|N-D-Glucosyl-(2)-n'-nitrosomethylurea|Streptozotocin zanosar|zanosar sterile powder DRUGBANK DB00428 C8H15N3O7 small molecule L01AD04 18883-66-4 DRUGBANK 6849 112405 6514 - SLC2A2 GLUT2 9606 Homo sapiens ligand target Wang Z (1998) 9421374 175990 420 Streptozocin 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|Estreptozocina|Streptozocinium|Streptozocine|Streptozocinum|Streptozocin|Zanosar|N-D-Glucosyl-(2)-n'-nitrosomethylharnstoff|2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose|N-D-Glucosyl-(2)-n'-nitrosomethylurea|Streptozotocin zanosar|zanosar sterile powder DRUGBANK DB00428 C8H15N3O7 small molecule L01AD04 18883-66-4 DRUGBANK 2222 112410 6519 - SLC3A1 ATR1|CSNU1|D2H|NBAT|RBAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 2223 112410 6519 - SLC3A1 ATR1|CSNU1|D2H|NBAT|RBAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 26982 112414 6523 RP1-127L4.1 SLC5A1 D22S675|NAGT|SGLT1 9606 Homo sapiens inhibitor target Lamos EM (2013) 23590413 182247 7651 Canagliflozin Canagliflozin anhydrous invokana|invokamet DRUGBANK DB08907 C24H25FO5S small molecule A10BX11|A10BD16 842133-18-0 DRUGBANK 27461 112415 6524 - SLC5A2 SGLT2 9606 Homo sapiens inhibitor target Vivian EM (2015) 25598831 188536 7801 Empagliflozin (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene jardiance|glyxambi|synjardy DRUGBANK DB09038 C23H27ClO7 small molecule A10BD19|A10BD20|A10BX12 864070-44-0 DRUGBANK 27462 112415 6524 - SLC5A2 SGLT2 9606 Homo sapiens antagonist target Vivian EM (2015) 25598831 188536 7801 Empagliflozin (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene jardiance|glyxambi|synjardy DRUGBANK DB09038 C23H27ClO7 small molecule A10BD19|A10BD20|A10BX12 864070-44-0 DRUGBANK 26981 112415 6524 - SLC5A2 SGLT2 9606 Homo sapiens inhibitor target Lamos EM (2013) 23590413 182247 7651 Canagliflozin Canagliflozin anhydrous invokana|invokamet DRUGBANK DB08907 C24H25FO5S small molecule A10BX11|A10BD16 842133-18-0 DRUGBANK 24559 112415 6524 - SLC5A2 SGLT2 9606 Homo sapiens antagonist target Obermeier M (2010) 19996149 182139 5548 Dapagliflozin (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol xigduo xr|farxiga|xigduo|forxi DRUGBANK DB06292 C21H25ClO6 small molecule A10BD21|A10BD15|A10BX09 461432-26-8 DRUGBANK 24560 112415 6524 - SLC5A2 SGLT2 9606 Homo sapiens inhibitor, competitive target Obermeier M (2010) 19996149 182139 5548 Dapagliflozin (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol xigduo xr|farxiga|xigduo|forxi DRUGBANK DB06292 C21H25ClO6 small molecule A10BD21|A10BD15|A10BX09 461432-26-8 DRUGBANK 26928 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Sunol C (2010) 20512624 178994 7607 Guvacine - - DRUGBANK DB08848 C6H9NO2 small molecule - 498-96-4 DRUGBANK 11601 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 896 Tiagabine Tiagabinum|Gabitril|Tiagabina gabitril|tiagabine hydrochlori DRUGBANK DB00906 C20H25NO2S2 small molecule N03AG06 115103-54-3 DRUGBANK 11602 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Sunol C (2010) 20512624 178994 896 Tiagabine Tiagabinum|Gabitril|Tiagabina gabitril|tiagabine hydrochlori DRUGBANK DB00906 C20H25NO2S2 small molecule N03AG06 115103-54-3 DRUGBANK 11603 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Henjum S (2007) 17069932 178990 896 Tiagabine Tiagabinum|Gabitril|Tiagabina gabitril|tiagabine hydrochlori DRUGBANK DB00906 C20H25NO2S2 small molecule N03AG06 115103-54-3 DRUGBANK 11604 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Pollack MH (2005) 16420077 178991 896 Tiagabine Tiagabinum|Gabitril|Tiagabina gabitril|tiagabine hydrochlori DRUGBANK DB00906 C20H25NO2S2 small molecule N03AG06 115103-54-3 DRUGBANK 11605 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Sheehan DV (2007) 18007567 178992 896 Tiagabine Tiagabinum|Gabitril|Tiagabina gabitril|tiagabine hydrochlori DRUGBANK DB00906 C20H25NO2S2 small molecule N03AG06 115103-54-3 DRUGBANK 11606 112420 6529 - SLC6A1 GABATHG|GABATR|GAT1 9606 Homo sapiens inhibitor target Foster AC (2006) 16377242 178993 896 Tiagabine Tiagabinum|Gabitril|Tiagabina gabitril|tiagabine hydrochlori DRUGBANK DB00906 C20H25NO2S2 small molecule N03AG06 115103-54-3 DRUGBANK 14997 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Salt PJ (1979) 508488 180699 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 14445 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Pubill D (1999) 10344632 180467 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14294 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Stahl SM (2004) 15361919 180395 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14295 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14296 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Bondarev ML (2003) 12909199 180396 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14297 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mitchell HA (2006) 16893531 174557 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14490 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Bareggi SR (2007) 17916059 174434 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 7097 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Dziedzicka-Wasylewska M (2006) 16554743 176210 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7098 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Anton M (2004) 14716684 176208 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7099 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1999) 10193665 176209 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7100 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Kantor L (2001) 11356924 176207 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7101 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mitchell HA (2006) 16893531 174557 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 9759 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Rubin RT (2000) 11203183 177995 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9760 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Nemeroff CB (2003) 14566196 177994 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9761 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9762 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Gilmor ML (2002) 12359676 177993 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 5799 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5800 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Cheetham SC (1996) 8684598 175370 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5801 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5802 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5522 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5523 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 24721 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Habecker BA (2006) 16573647 175597 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24722 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Gutman DA (2006) 16989291 175596 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24723 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mandela P (2006) 16879714 175595 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24724 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Boenisch H (2006) 16722247 175599 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24725 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Ksiazek P (2006) 17124432 175598 5589 Levonordefrin alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine mepivacaine hydrochloride and DRUGBANK DB06707 C9H13NO3 small molecule - 829-74-3 DRUGBANK 24415 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tzschentke TM (2007) 17656655 182030 5527 Tapentadol CG-5503|BN-200|Nucynta|Tapentadol nucynta ir|nucynta extended-re DRUGBANK DB06204 C14H23NO small molecule N02AX06 175591-23-8 DRUGBANK 5143 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mitchell HA (2006) 16893531 174557 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5144 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Westenberg HG (2009) 19238127 174925 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5145 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Sindrup SH (2005) 15910402 174924 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5146 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5147 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Beique JC (1998) 9669506 174926 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5148 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Van Ameringen M (2009) 19728573 174922 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5149 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Beique J (2000) 10884561 174918 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 16163 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inverse agonist target Fleckenstein AE (2007) 17209801 174169 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16164 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inverse agonist target Kobayashi S (2003) 14570629 181168 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16165 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inverse agonist target McMahon LR (2003) 12757963 181171 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16166 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inverse agonist target Sulzer D (2005) 15955613 174152 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 3902 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens stimulator target Rothman RB (2003) 12954796 174149 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3903 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens stimulator target Wall SC (1995) 7700252 174150 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 23948 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4638 Amineptine - - DRUGBANK DB04836 C22H28ClNO2 small molecule N06AA19 57574-09-1 DRUGBANK 23949 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4638 Amineptine - - DRUGBANK DB04836 C22H28ClNO2 small molecule N06AA19 57574-09-1 DRUGBANK 7298 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Jost W (2004) 15316838 176314 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7299 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Carter NJ (2009) 19480470 176315 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7300 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target van Groeningen CJ (1989) 2784100 176316 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7301 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Karpa KD (2002) 12481192 176317 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7302 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mirza NR (2007) 17335951 176306 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7303 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7304 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Bymaster FP (2005) 15892657 176318 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7305 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Khullar V (2010) 20432324 176319 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7306 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7307 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Beique JC (1998) 9669506 174926 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7308 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Gould GG (2007) 16650830 176321 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7309 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Hunziker ME (2005) 16199241 176320 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7310 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Schou M (2005) 16139169 176323 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7311 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Trivedi MH (2008) 18408530 176322 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7312 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Vincent S (2004) 15184278 176324 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 24678 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Deecher DC (2006) 16675639 181939 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24679 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mason JN (2007) 17673606 182036 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24680 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Perry R (2009) 19698900 182124 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24681 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Reddy S (2010) 19919295 182134 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24682 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Kamath J (2008) 19086875 182093 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24683 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Liebowitz MR (2010) 20944767 182171 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24684 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Ding YS (1997) 9181638 181720 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24685 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Yang L (2004) 15322419 175959 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24686 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Gray JD (2007) 17611273 175958 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24687 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24688 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Markowitz JS (2008) 18480678 182076 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24689 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tilley MR (2008) 18698001 175963 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24690 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Sandoval V (2001) 11160413 175960 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24691 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chuhan YS (2006) 16246598 175961 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24692 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Davids E (2002) 11862378 181789 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24693 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Williard RL (2007) 17218796 175962 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24118 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Leo RJ (2006) 16869117 181956 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24119 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Moret C (1985) 3005901 181666 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 16129 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16130 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Rothman RB (2003) 12954796 174149 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16131 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Wee S (2004) 15189772 178697 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16132 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Haughey HM (2000) 10773193 181167 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16133 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 12510 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Rothman RB (2001) 11071707 179522 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 4102 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Sagata K (2002) 11916794 174241 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4103 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Berrocoso E (2009) 19341511 174242 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4104 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Frink MC (1996) 8955860 174243 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4105 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4074 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4075 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Proietto J (2000) 11060745 174223 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4076 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4077 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Samanin R (1993) 7902561 174224 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4078 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Stephens LC (2005) 16119498 174225 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 13904 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 7629 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Codd EE (1995) 7562497 176578 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 5178 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Tatsumi M (1997) 9537821 174430 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5179 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Michelson D (2003) 12547466 174990 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5180 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Gaillez C (2007) 18033153 174991 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5181 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Purper-Ouakil D (2005) 16142049 174992 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5182 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Wernicke JF (2003) 12862507 174987 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5183 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Garnock-Jones KP (2009) 19445548 174986 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5184 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Biederman J (2002) 12456942 174985 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5185 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Kaplan S (2004) 15801334 174984 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5186 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Wernicke JF (2004) 14709944 174989 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 5187 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Spencer T (2002) 12523874 174988 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 6114 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens binder target Tatsumi M (1997) 9537821 174430 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6115 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 16698 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 8204 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8205 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Raffel DM (2006) 16954558 177014 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8206 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Zhao L (2000) 10966747 177015 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8207 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Sharpe IA (2003) 12885787 177016 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8208 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Raffel DM (2004) 15300361 177017 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8209 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Ritz MC (1990) 2120386 177018 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 14228 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14229 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14230 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Bryan-Lluka LJ (2003) 12837768 180373 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14231 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Zavosh A (1999) 10424850 180372 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14232 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Ordway GA (2005) 15814154 180371 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14233 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Weinshenker D (2002) 12137927 180375 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14234 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Zhu MY (2004) 15002740 180374 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 15303 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Jungkun G (2001) 11341486 180806 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15304 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 14425 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Galli A (1996) 8710929 180457 1158 Guanethidine N-(2-Perhydroazocin-1-ylethyl)guanidine|Azocine, 1-(2-guanidinoethyl)octahydro-|Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-|guanthidine|guanetidina|2-(1-N,N-Heptamethyleneimino)ethylguanidine|2-(1'-Azacyclooctyl)ethylguanidine|(2-(Octahydro-1-azocinyl)ethyl)guanidine|guanethidinum|Heptamethylenimine, 1-(2-guanidinoethyl)-|(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine apo guanethidine sulfate tab 1 DRUGBANK DB01170 C10H22N4 small molecule C02LF01|C02CC02|S01EX01 55-65-2 DRUGBANK 14426 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Yi E (2005) 16126010 180458 1158 Guanethidine N-(2-Perhydroazocin-1-ylethyl)guanidine|Azocine, 1-(2-guanidinoethyl)octahydro-|Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-|guanthidine|guanetidina|2-(1-N,N-Heptamethyleneimino)ethylguanidine|2-(1'-Azacyclooctyl)ethylguanidine|(2-(Octahydro-1-azocinyl)ethyl)guanidine|guanethidinum|Heptamethylenimine, 1-(2-guanidinoethyl)-|(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine apo guanethidine sulfate tab 1 DRUGBANK DB01170 C10H22N4 small molecule C02LF01|C02CC02|S01EX01 55-65-2 DRUGBANK 14427 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Joyce PI (2001) 11403930 180459 1158 Guanethidine N-(2-Perhydroazocin-1-ylethyl)guanidine|Azocine, 1-(2-guanidinoethyl)octahydro-|Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-|guanthidine|guanetidina|2-(1-N,N-Heptamethyleneimino)ethylguanidine|2-(1'-Azacyclooctyl)ethylguanidine|(2-(Octahydro-1-azocinyl)ethyl)guanidine|guanethidinum|Heptamethylenimine, 1-(2-guanidinoethyl)-|(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine apo guanethidine sulfate tab 1 DRUGBANK DB01170 C10H22N4 small molecule C02LF01|C02CC02|S01EX01 55-65-2 DRUGBANK 13777 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Heusser K (2006) 16678551 180166 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13778 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Heusser K (2007) 17284621 180167 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13779 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Sharma B (2008) 18671470 180164 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13780 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Birkenfeld AL (2005) 15944869 180165 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13781 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Berke EM (2000) 10929704 180171 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13782 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Birkenfeld AL (2002) 12417543 180163 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13783 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Gomis Barbara R (2004) 15382615 180049 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13784 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13785 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Jordan J (2005) 15685250 180168 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13786 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Krahn LE (2001) 11152984 180169 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13787 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tziomalos K (2009) 19475780 180170 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 9882 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9883 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 16263 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Fehske CJ (2009) 19427589 181230 1337 Ginkgo biloba Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree - DRUGBANK DB01381 - small molecule N06DX02|N06DA53 - DRUGBANK 14111 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14112 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14195 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Owens MJ (1995) 7475971 180359 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14196 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Owen D (1999) 10512149 180358 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14197 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14198 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Taylor DP (1995) 7649970 180360 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14199 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Davis R (1997) 9098663 180357 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 7036 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Gu X (2010) 20980153 176161 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7037 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Lomenzo SA (2005) 15743177 176160 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7868 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7869 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7870 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 23927 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Tatsumi M (1997) 9537821 174430 4623 Nomifensine (+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine - DRUGBANK DB04821 C16H18N2 small molecule N06AX04 24526-64-5 DRUGBANK 4573 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mitchell HA (2006) 16893531 174557 227 Reboxetine - - DRUGBANK DB00234 C19H23NO3 small molecule N06AX18 71620-89-8 DRUGBANK 4574 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Lin KS (2005) 15878511 174561 227 Reboxetine - - DRUGBANK DB00234 C19H23NO3 small molecule N06AX18 71620-89-8 DRUGBANK 4575 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Rauhut AS (2002) 12388649 174560 227 Reboxetine - - DRUGBANK DB00234 C19H23NO3 small molecule N06AX18 71620-89-8 DRUGBANK 4576 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Wilson AA (2003) 12623106 174562 227 Reboxetine - - DRUGBANK DB00234 C19H23NO3 small molecule N06AX18 71620-89-8 DRUGBANK 4577 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Kasper S (2000) 11249515 174558 227 Reboxetine - - DRUGBANK DB00234 C19H23NO3 small molecule N06AX18 71620-89-8 DRUGBANK 4578 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Spivak B (2006) 16633143 174559 227 Reboxetine - - DRUGBANK DB00234 C19H23NO3 small molecule N06AX18 71620-89-8 DRUGBANK 4433 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens partial agonist target Imming P (2006) 17016423 171742 219 Guanadrel Guanadrel|Guanadrelum - DRUGBANK DB00226 C10H19N3O2 small molecule - 40580-59-4 DRUGBANK 4434 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens partial agonist target Finnerty FA (1985) 3896742 174498 219 Guanadrel Guanadrel|Guanadrelum - DRUGBANK DB00226 C10H19N3O2 small molecule - 40580-59-4 DRUGBANK 4435 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens partial agonist target Malinow SH (1983) 6850722 174499 219 Guanadrel Guanadrel|Guanadrelum - DRUGBANK DB00226 C10H19N3O2 small molecule - 40580-59-4 DRUGBANK 4436 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens partial agonist target Overington JP (2006) 17139284 171741 219 Guanadrel Guanadrel|Guanadrelum - DRUGBANK DB00226 C10H19N3O2 small molecule - 40580-59-4 DRUGBANK 4437 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens partial agonist target Palmer JD (1983) 6351026 174497 219 Guanadrel Guanadrel|Guanadrelum - DRUGBANK DB00226 C10H19N3O2 small molecule - 40580-59-4 DRUGBANK 16734 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16735 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Haughey HM (2000) 10773193 181167 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16736 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Sulzer D (2005) 15955613 174152 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 24388 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 9582 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 9583 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 686 Ergotamine Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione gravergol capsules|megral tabs DRUGBANK DB00696 C33H35N5O5 small molecule N02CA02|N02CA72|N02CA52 113-15-5 DRUGBANK 11163 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Foley KF (2002) 12373557 178698 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11164 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Wee S (2004) 15189772 178697 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 23963 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Galli A (1996) 8710929 180457 4642 Debrisoquin Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum - DRUGBANK DB04840 C10H13N3 small molecule C02CC04 1131-64-2 DRUGBANK 23964 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Mitchell JR (1970) 5431666 181673 4642 Debrisoquin Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum - DRUGBANK DB04840 C10H13N3 small molecule C02CC04 1131-64-2 DRUGBANK 23965 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Joyce PI (2002) 12401623 181803 4642 Debrisoquin Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum - DRUGBANK DB04840 C10H13N3 small molecule C02CC04 1131-64-2 DRUGBANK 23966 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Yi E (2005) 16126010 180458 4642 Debrisoquin Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum - DRUGBANK DB04840 C10H13N3 small molecule C02CC04 1131-64-2 DRUGBANK 23967 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inducer target Bryan-Lluka LJ (1996) 8740147 181706 4642 Debrisoquin Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum - DRUGBANK DB04840 C10H13N3 small molecule C02CC04 1131-64-2 DRUGBANK 12047 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Cloonan SM (2010) 20141432 179179 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12048 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Saba W (2007) 17068778 179178 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12049 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Dronjak S (2007) 17984940 179182 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12050 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Arai S (2003) 12573515 179180 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 12051 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Mochizucki D (2004) 15378668 179181 924 Maprotiline Maprotilinum|Maprotylina|Maprotilina ludiomil tab 75mg|novo-maproti DRUGBANK DB00934 C20H23N small molecule N06AA21 10262-69-8 DRUGBANK 24088 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens unknown target Basile AS (2007) 17325229 181989 4689 Bicifadine - - DRUGBANK DB04889 C12H15N small molecule - 71195-57-8 DRUGBANK 6799 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6800 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Yang L (2004) 15322419 175959 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6801 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Gray JD (2007) 17611273 175958 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6802 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Williard RL (2007) 17218796 175962 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6803 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tilley MR (2008) 18698001 175963 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6804 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Sandoval V (2001) 11160413 175960 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6805 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Chuhan YS (2006) 16246598 175961 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 17082 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Rothman RB (2006) 17017961 178585 1519 Phendimetrazine (2S,3S)-3,4-dimethyl-2-phenylmorpholine bontril|phendimetrazine tartra DRUGBANK DB01579 C12H17NO small molecule - 634-03-7 DRUGBANK 7838 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7839 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Barker EL (1996) 8863842 176754 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7840 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Kim H (2006) 17018806 176751 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7841 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Roubert C (2001) 11092898 176752 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7842 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Roubert C (2001) 11502876 176753 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7843 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 17043 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17044 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17025 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Dlugos AM (2009) 19727679 181525 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17026 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Burnette WB (1996) 8794928 181527 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17027 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens negative modulator target Dlugos A (2007) 17239355 181526 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 11607 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Carrera MR (2004) 15351386 178995 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11608 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Zhao Y (2004) 15113605 178996 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11609 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Galli A (1995) 7500004 178997 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11610 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Burchett SA (1997) 9387868 178998 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 10916 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 10917 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Rothman RB (2002) 12106802 178586 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 10918 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Rothman RB (2006) 17017961 178585 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 10919 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 12111 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 927 Diethylpropion Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone tenuate dospan|diethylpropion DRUGBANK DB00937 C13H19NO small molecule A08AA03 90-84-6 DRUGBANK 12112 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 927 Diethylpropion Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone tenuate dospan|diethylpropion DRUGBANK DB00937 C13H19NO small molecule A08AA03 90-84-6 DRUGBANK 12113 112421 6530 - SLC6A2 NAT1|NET|NET1|SLC6A5 9606 Homo sapiens inhibitor target Arias HR (2009) 19897080 179213 927 Diethylpropion Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone tenuate dospan|diethylpropion DRUGBANK DB00937 C13H19NO small molecule A08AA03 90-84-6 DRUGBANK 14298 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14299 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14300 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Meyer JH (2002) 12185406 180401 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14301 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Kugaya A (2003) 12589396 180399 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14302 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Szabo Z (2004) 15787205 180398 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14303 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Stahl SM (2004) 15361919 180395 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14304 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Miller DK (2002) 12183670 180400 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 14305 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Learned-Coughlin SM (2003) 14550679 180397 1144 Bupropion Amfebutamone bupropion hydrochloride (sr)|b DRUGBANK DB01156 C13H18ClNO small molecule A08AA62|N06AX12 34911-55-2 DRUGBANK 16147 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16148 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Rothman RB (2003) 12954796 174149 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16149 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Wee S (2004) 15189772 178697 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16150 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Haughey HM (2000) 10773193 181167 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16151 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 7111 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens unknown target Melikian HE (1999) 10479674 176217 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 13799 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Balcioglu A (2000) 10974319 180174 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13800 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Berke EM (2000) 10929704 180171 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13801 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tziomalos K (2009) 19475780 180170 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13802 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Nakagawa T (2001) 15111248 180173 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13803 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Gomis Barbara R (2004) 15382615 180049 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13804 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Krahn LE (2001) 11152984 180169 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 14369 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Mansbach RS (1995) 7768269 180423 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14370 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wilcox KM (1999) 10078990 180422 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14371 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wilcox KM (2000) 11255924 180425 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14372 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wilcox KM (2001) 11605081 180424 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 27857 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Loland CJ (2012) 22537794 196013 8077 Armodafinil R-modafinil|()-2-[(R)-(diphenylmethyl)sulfinyl]acetamide armodafinil|nuvigil DRUGBANK DB06413 C15H15NO2S small molecule N06BA13 112111-43-0 DRUGBANK 27858 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens antagonist target Loland CJ (2012) 22537794 196013 8077 Armodafinil R-modafinil|()-2-[(R)-(diphenylmethyl)sulfinyl]acetamide armodafinil|nuvigil DRUGBANK DB06413 C15H15NO2S small molecule N06BA13 112111-43-0 DRUGBANK 4716 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Reith ME (2001) 11395483 174615 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4717 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Simoni D (2001) 11277529 174614 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4718 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Zou MF (2001) 11728190 174613 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4719 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Todd CL (1999) 10230713 174612 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4720 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Katz JL (2001) 11349389 174611 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 4721 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Kulkarni SS (2006) 16460947 174610 238 Benzatropine Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane cogentin inj 1mg/ml|bensylate DRUGBANK DB00245 C21H25NO small molecule N04AC01 86-13-5 DRUGBANK 5150 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Bourin M (1999) 10434156 174929 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5151 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Barkin RL (2000) 11319571 174928 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5152 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Dawson LA (1999) 10462128 174930 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5153 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Lemke MR (2007) 17187269 174931 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 3915 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Miller GM (2005) 15764732 174161 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3916 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Garcia BG (2005) 15795321 174163 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3917 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Lott DC (2005) 15602501 174162 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3918 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Kahlig KM (2005) 15728379 174165 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3919 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fone KC (2005) 15661631 174164 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3920 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Madras BK (2005) 15950014 174166 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 11242 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Kahlig KM (2005) 15728379 174165 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 11243 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 24694 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Ding YS (1997) 9181638 181720 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24695 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24696 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Volkow ND (1999) 10025684 175966 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24697 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Izenwasser S (1999) 10414438 175967 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24698 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wayment HK (1999) 10037500 175964 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24699 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Dresel SH (1999) 10199939 175965 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24700 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Markowitz JS (2008) 18480678 182076 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24701 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tilley MR (2008) 18698001 175963 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24702 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Davids E (2002) 11862378 181789 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24703 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24704 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Viggiano D (2004) 15303308 175968 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24705 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Volkow ND (1999) 10403500 175969 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24209 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens unknown target Spencer TJ (2007) 17511972 182012 4741 Altropane - - DRUGBANK DB04947 C18H21FINO2 small molecule - 180468-34-2 DRUGBANK 14491 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Bareggi SR (2007) 17916059 174434 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 12525 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inducer target Ostadali MR (2004) 17301410 179521 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 16753 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Li SM (2006) 16478825 181442 1409 Fencamfamine Fencamfamin|Fencamfamine|Fencamfaminum|Fencanfamina - DRUGBANK DB01463 C15H21N small molecule N06BA06 1209-98-9 DRUGBANK 16754 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Seyfried CA (1983) 6136281 181441 1409 Fencamfamine Fencamfamin|Fencamfamine|Fencamfaminum|Fencanfamina - DRUGBANK DB01463 C15H21N small molecule N06BA06 1209-98-9 DRUGBANK 10034 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Swanson JM (2003) 14658934 178147 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 10035 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Madras BK (2006) 16885432 178150 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 10036 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Dopheide MM (2007) 17477916 178151 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 10037 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wisor JP (2001) 11222668 178149 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 10038 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Zhou J (2004) 15537337 178148 735 Modafinil Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil auro-modafinil|ipg-modafinil|p DRUGBANK DB00745 C15H15NO2S small molecule N06BA07 68693-11-8 DRUGBANK 4093 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target John CE (2007) 17459426 174233 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4094 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Gruner JA (2009) 19928382 174236 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 16746 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16747 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Hansen JP (2002) 11861820 181439 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16748 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fitzgerald JL (1990) 1982265 181438 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 5196 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens binder target Bymaster FP (2002) 12431845 174994 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 6172 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens binder target Tatsumi M (1997) 9537821 174430 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6173 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 16709 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16710 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Haughey HM (2000) 10773193 181167 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16711 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Sulzer D (2005) 15955613 174152 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 8210 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Goettl VM (2000) 10980236 177025 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8211 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Purkerson-Parker S (2001) 11719704 177024 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8212 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8213 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Saunders C (2000) 10823899 177021 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8214 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tidjane Corera A (2001) 11248372 177020 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8215 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Kulkarni SS (2002) 12213055 177023 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8216 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Houlihan WJ (2002) 12213053 177022 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 8217 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Itzhak Y (1999) 10082805 177019 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 7313 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7314 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Hunziker ME (2005) 16199241 176320 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7315 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7316 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Pereira P (2009) 18973814 176325 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7317 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Carter NJ (2009) 19480470 176315 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 13772 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Lemke MR (2007) 17187269 174931 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13773 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13774 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Nemeroff CB (2004) 15181382 180162 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13775 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Goodnick PJ (1998) 9808077 180160 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13776 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Ghanizadeh A (2008) 18664165 180161 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 11619 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Carrera MR (2004) 15351386 178995 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11620 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Rothman RB (1999) 10420171 179003 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11621 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wilson JM (1996) 8797532 179002 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11622 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11623 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Kim DI (2003) 12672245 179004 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 9903 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 14219 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 7048 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens unknown target Lomenzo SA (1999) 10612583 176165 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7049 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens unknown target Gu X (2010) 20980153 176161 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7050 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens unknown target Lomenzo SA (2005) 15743177 176160 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 9829 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Sato T (2000) 10685879 178036 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9830 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wilcox KM (2005) 16206183 178035 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9831 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Kiyatkin EA (2006) 16956595 178034 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 14181 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Lapa GB (2005) 15627433 180352 1134 Diphenylpyraline 1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine biohisdine dm decongestant|ora DRUGBANK DB01146 C19H23NO small molecule R06AA57|R06AA07 147-20-6 DRUGBANK 23930 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens unknown target Tatsumi M (1997) 9537821 174430 4623 Nomifensine (+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine - DRUGBANK DB04821 C16H18N2 small molecule N06AX04 24526-64-5 DRUGBANK 6806 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6807 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6808 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Volkow ND (1999) 10025684 175966 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6809 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Izenwasser S (1999) 10414438 175967 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6810 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wayment HK (1999) 10037500 175964 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6811 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Dresel SH (1999) 10199939 175965 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6812 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tilley MR (2008) 18698001 175963 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6813 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Viggiano D (2004) 15303308 175968 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6814 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Volkow ND (1999) 10403500 175969 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 24391 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens binder target Tatsumi M (1997) 9537821 174430 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 11183 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Foley KF (2002) 12373557 178698 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11184 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Wee S (2004) 15189772 178697 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 16768 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16769 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Hansen JP (2002) 11861820 181439 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16770 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Fitzgerald JL (1990) 1982265 181438 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16771 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Daws LC (2000) 11041537 181445 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 15433 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Hamidovic A (2010) 20091113 180873 1243 Lisdexamfetamine Lisdexamfetamine|NRP104|lisdexamfetamine dimesylate vyvanse DRUGBANK DB01255 C15H25N3O small molecule N06BA12 608137-32-2 DRUGBANK 13906 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 17065 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Miller GM (2005) 15764732 174161 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17066 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Garcia BG (2005) 15795321 174163 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17067 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Lott DC (2005) 15602501 174162 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17068 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Kahlig KM (2005) 15728379 174165 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17069 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fone KC (2005) 15661631 174164 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17070 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Escubedo E (2009) 19897077 181534 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17071 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Madras BK (2005) 15950014 174166 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17072 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17040 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Rothman RB (2009) 19244097 181529 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17041 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Zhen J (2005) 16122767 181528 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17042 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens negative modulator target Kuczenski R (1995) 7869099 181530 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 10920 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 10921 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Rothman RB (2002) 12106802 178586 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 10922 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Rothman RB (2006) 17017961 178585 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 10923 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 820 Phenmetrazine Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin - DRUGBANK DB00830 C11H15NO small molecule - 134-49-6 DRUGBANK 12114 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Yu H (2000) 11131159 179214 927 Diethylpropion Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone tenuate dospan|diethylpropion DRUGBANK DB00937 C13H19NO small molecule A08AA03 90-84-6 DRUGBANK 12115 112422 6531 - SLC6A3 DAT|DAT1|PKDYS 9606 Homo sapiens inhibitor target Arias HR (2009) 19897080 179213 927 Diethylpropion Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone tenuate dospan|diethylpropion DRUGBANK DB00937 C13H19NO small molecule A08AA03 90-84-6 DRUGBANK 11611 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Corey JL (1994) 8302852 179001 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11612 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Barker EL (1999) 10366604 179000 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11613 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11614 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Patkar AA (2002) 12057823 178999 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11615 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Carrera MR (2004) 15351386 178995 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 16137 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16138 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Wee S (2004) 15189772 178697 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 7104 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7105 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Schloss P (1995) 7548008 174429 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7106 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Quintin P (2001) 11513817 176213 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7107 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Barkan T (2004) 15056483 176212 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7108 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Goulet M (2001) 11746710 176215 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7109 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Leboyer M (1999) 10624553 176214 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 7110 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Scholze P (2000) 10869387 176216 450 Imipramine N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin tofranil|imipramine tab 25mg|i DRUGBANK DB00458 C19H24N2 small molecule N06AA02 50-49-7 DRUGBANK 9763 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9764 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Pollock BG (2000) 11027924 176750 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9765 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Wihlbaeck AC (2001) 11530128 177997 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9766 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Preuss UW (2000) 10980326 177996 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9767 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Haughey HM (2000) 10987842 177998 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 9768 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Scholze P (2000) 10869387 176216 705 Paroxetine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine paroxetine|paroxetine-10|brisd DRUGBANK DB00715 C19H20FNO3 small molecule N06AB05 61869-08-7 DRUGBANK 5803 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5804 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Kovachich GB (1992) 1476595 175373 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5805 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Daws LC (1998) 9694957 175372 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5806 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Frazer A (1998) 9928259 175371 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5807 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rouillon F (1996) 8767026 175375 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5808 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target McDougle CJ (1998) 9672904 175374 336 Protriptyline Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine triptil tab 10mg|protriptyline DRUGBANK DB00344 C19H21N small molecule N06AA11 438-60-8 DRUGBANK 5525 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5526 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5527 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5528 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Kalia M (2005) 15877309 175187 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5529 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Gould GG (2006) 16140280 174923 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5530 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Troelsen KB (2005) 16032412 175188 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5531 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Ushijima K (2005) 16079297 175189 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 27900 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Bang-Andersen B (2011) 21486038 196006 8112 Vortioxetine 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation brintellix|trintellix DRUGBANK DB09068 C18H23N2S small molecule N06AX26 508233-74-7 DRUGBANK 23937 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4634 Zimelidine (z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine - DRUGBANK DB04832 C16H17BrN2 small molecule N06AB02 56775-88-3 DRUGBANK 23938 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4634 Zimelidine (z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine - DRUGBANK DB04832 C16H17BrN2 small molecule N06AB02 56775-88-3 DRUGBANK 23939 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Tatsumi M (1997) 9537821 174430 4634 Zimelidine (z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine - DRUGBANK DB04832 C16H17BrN2 small molecule N06AB02 56775-88-3 DRUGBANK 5134 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5135 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Westenberg HG (2009) 19238127 174925 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5136 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Sindrup SH (2005) 15910402 174924 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5137 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Shang Y (2007) 17224717 174921 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5138 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Chen F (2005) 15695064 174920 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5139 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Gould GG (2006) 16140280 174923 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5140 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Van Ameringen M (2009) 19728573 174922 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5141 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Beique J (2000) 10884561 174918 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 5142 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Malizia AL (1997) 9305421 174919 278 Venlafaxine Venlafaxine|Venlafaxinum|Venlafaxina|Elafax gd-venlafaxine xr|ran-venlafax DRUGBANK DB00285 C17H27NO2 small molecule N06AX16 93413-69-5 DRUGBANK 3939 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens binder target Fleckenstein AE (2007) 17209801 174169 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 23950 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4638 Amineptine - - DRUGBANK DB04836 C22H28ClNO2 small molecule N06AA19 57574-09-1 DRUGBANK 23951 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4638 Amineptine - - DRUGBANK DB04836 C22H28ClNO2 small molecule N06AA19 57574-09-1 DRUGBANK 6815 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Izenwasser S (1999) 10414438 175967 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6816 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Dresel SH (1999) 10199939 175965 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 6817 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Stehouwer JS (2006) 17154506 175970 414 Methylphenidate alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate methylphenidate hydrochloride DRUGBANK DB00422 C14H19NO2 small molecule N06BA04 113-45-1 DRUGBANK 10686 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 10687 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 795 Minaprine 4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine - DRUGBANK DB00805 C17H22N4O small molecule N06AX07 25905-77-5 DRUGBANK 24672 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Deecher DC (2006) 16675639 181939 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24673 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Mason JN (2007) 17673606 182036 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24674 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Perry R (2009) 19698900 182124 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24675 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Reddy S (2010) 19919295 182134 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24676 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Kamath J (2008) 19086875 182093 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24677 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Liebowitz MR (2010) 20944767 182171 5582 Desvenlafaxine O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq pristiq extended release|prist DRUGBANK DB06700 C16H25NO2 small molecule N06AX23 93413-62-8 DRUGBANK 24706 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Izenwasser S (1999) 10414438 175967 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24707 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Dresel SH (1999) 10199939 175965 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24708 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Stehouwer JS (2006) 17154506 175970 5583 Dexmethylphenidate d-threo-methylphenidate|D-TMP|Dexmethylphenidate dexmethylphenidate hydrochlori DRUGBANK DB06701 C14H19NO2 small molecule N06BA11 40431-64-9 DRUGBANK 24102 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Leo RJ (2006) 16869117 181956 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24103 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Moret C (1985) 3005901 181666 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 14482 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Zhong H (2009) 19616061 174427 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14483 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Bareggi SR (2007) 17916059 174434 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14484 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Fabre V (2003) 12876551 180470 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14485 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Burke WJ (2002) 12387707 180471 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14486 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Owens MJ (2001) 11543737 180472 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14487 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Owens JM (2002) 12232544 180473 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14488 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Waugh J (2003) 12665392 180474 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 14489 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Sanchez C (2003) 12719960 180475 1163 Escitalopram Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum escitalopram oxalate|escitalop DRUGBANK DB01175 C20H21FN2O small molecule N06AB10 128196-01-0 DRUGBANK 12511 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Rothman RB (2001) 11071707 179522 978 Dopamine 4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin dopamine hydrochloride and dex DRUGBANK DB00988 C8H11NO2 small molecule C01CA04 51-61-6 DRUGBANK 4107 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Frink MC (1996) 8955860 174243 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4108 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Driessen B (1992) 1596676 174245 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4109 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Barann M (2006) 16427041 174246 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 4083 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Mekontso-Dessap A (2006) 16380550 174231 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4084 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Zolkowska D (2006) 16644904 174230 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4085 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target John CE (2007) 17459426 174233 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4086 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rothman RB (1999) 10458725 174232 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 4087 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Johnson GJ (2003) 14675103 174234 184 Phentermine Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine phentermine resin er|fastin ca DRUGBANK DB00191 C10H15N small molecule A08AA01 122-09-8 DRUGBANK 9115 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Tatsumi M (1997) 9537821 174430 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9116 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Brown NL (1986) 2940099 177617 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 7871 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7872 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Spurlock G (1994) 7984281 176780 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 7639 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7640 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Codd EE (1995) 7562497 176578 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7641 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7642 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Henderson MG (1992) 1280529 176581 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 5195 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Tatsumi M (1997) 9537821 174430 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 6120 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens binder target Tatsumi M (1997) 9537821 174430 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6121 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens binder target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 7832 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Wisner KL (2006) 16855451 176749 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7837 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7834 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Pollock BG (2000) 11027924 176750 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7835 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rausch JL (2003) 12640215 176747 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7836 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7833 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Joyce PR (2003) 14604448 176748 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 16715 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Fleckenstein AE (2007) 17209801 174169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16716 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Imming P (2006) 17016423 171742 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16717 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Overington JP (2006) 17139284 171741 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16718 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Haughey HM (2000) 10773193 181167 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 8218 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 569 Mazindol Sanorex|Mazindolum|Mazindolo|Mazindol sanorex DRUGBANK DB00579 C16H13ClN2O small molecule A08AA05 22232-71-9 DRUGBANK 14237 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Holmes A (2002) 12464448 180378 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14239 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Hoffman AF (1998) 9422361 180377 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14238 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14241 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Gould GG (2006) 16140280 174923 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14240 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Zhou L (2006) 16300628 180376 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 15305 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Alvarez JC (1999) 10613618 180807 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15306 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15307 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Suhara T (2003) 12695316 174092 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15308 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Borkowska A (2003) 12647451 180158 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15309 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Larsen AK (2004) 14993096 180809 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15310 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Gillman PK (2007) 17471183 180808 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 15311 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Malizia AL (1997) 9305421 174919 1230 Clomipramine Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine gen-clomipramine - tab 50mg|pm DRUGBANK DB01242 C19H23ClN2 small molecule N06AA04 303-49-1 DRUGBANK 7284 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Jost W (2004) 15316838 176314 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7285 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Carter NJ (2009) 19480470 176315 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7286 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target van Groeningen CJ (1989) 2784100 176316 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7287 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Karpa KD (2002) 12481192 176317 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7288 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Mirza NR (2007) 17335951 176306 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7289 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Bymaster FP (2005) 15892657 176318 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7290 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Khullar V (2010) 20432324 176319 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7291 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Vaishnavi SN (2004) 14744476 174927 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7292 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Beique JC (1998) 9669506 174926 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7293 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Chen F (2005) 15695064 174920 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7294 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Gould GG (2007) 16650830 176321 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7295 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Hunziker ME (2005) 16199241 176320 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7296 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Trivedi MH (2008) 18408530 176322 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 7297 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Troelsen KB (2005) 16032412 175188 468 Duloxetine (S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine ipg-duloxetine|duloxetine dela DRUGBANK DB00476 C18H19NOS small molecule N06AX21 116539-59-4 DRUGBANK 13762 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13763 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Durham LK (2004) 12955294 180159 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13764 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Borkowska A (2003) 12647451 180158 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13765 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rogoz Z (2006) 16963794 180157 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13766 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Benmansour S (2002) 12151556 180156 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13767 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Benmansour S (1999) 10575045 180155 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13768 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Chen F (2005) 15606893 180154 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13769 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Iehle C (1993) 8664165 180153 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13770 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target David DJ (2001) 11243491 180152 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13771 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Muneoka K (2009) 18751896 180151 1092 Sertraline cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum ipg-sertraline|sertraline|nu-s DRUGBANK DB01104 C17H17Cl2N small molecule N06AB06 79617-96-2 DRUGBANK 13788 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Heusser K (2006) 16678551 180166 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13789 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Heusser K (2007) 17284621 180167 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13790 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Sharma B (2008) 18671470 180164 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13791 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Birkenfeld AL (2005) 15944869 180165 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13792 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Berke EM (2000) 10929704 180171 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13793 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Birkenfeld AL (2002) 12417543 180163 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13794 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Vazquez Roque MI (2007) 17544870 180172 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13795 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Gomis Barbara R (2004) 15382615 180049 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13796 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Jordan J (2005) 15685250 180168 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13797 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Krahn LE (2001) 11152984 180169 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 13798 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tziomalos K (2009) 19475780 180170 1093 Sibutramine Sibutraminum|Butramin|Sibutramina apo-sibutramine|meridia DRUGBANK DB01105 C17H26ClN small molecule A08AA10 106650-56-0 DRUGBANK 4352 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Dutta AK (2001) 11300876 174433 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4353 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Plenge P (2005) 15955412 174432 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4354 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Vicentic A (1999) 10546982 174431 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4355 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4356 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Dugar A (2001) 11180498 174437 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4357 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rasmussen TN (2009) 19500602 174436 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4358 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Maines LW (1999) 10188639 174435 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4359 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Bareggi SR (2007) 17916059 174434 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4360 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Eriksson E (1999) 10063489 174428 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4361 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Schloss P (1995) 7548008 174429 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 4362 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Zhong H (2009) 19616061 174427 208 Citalopram Citadur|Nitalapram citalopram tablets usp|q-cital DRUGBANK DB00215 C20H21FN2O small molecule N06AB04 59729-33-8 DRUGBANK 14113 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Stahl SM (2008) 19179941 180334 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14114 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1130 Doxepin Sinequan|Cidoxepin|Doxepin|Zonalon sinequan cap 75mg|alti-doxepin DRUGBANK DB01142 C19H21NO small molecule N06AA12 1668-19-5 DRUGBANK 14205 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Owens MJ (1995) 7475971 180359 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14206 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14207 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Taylor DP (1995) 7649970 180360 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14208 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Narayan M (1998) 9472845 180361 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 14209 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Davis R (1997) 9098663 180357 1137 Nefazodone Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone serzone-5ht2|nefazodone hydroc DRUGBANK DB01149 C25H32ClN5O2 small molecule N06AX06 83366-66-9 DRUGBANK 7052 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens binding target Gu X (2010) 20980153 176161 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 7053 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens binding target Lomenzo SA (2005) 15743177 176160 446 Pethidine Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl meperidine hydrochloride injec DRUGBANK DB00454 C15H21NO2 small molecule N02AB02|N02AB52|N02AG03|N02AB72 57-42-1 DRUGBANK 14662 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rothman RB (2003) 14515341 176978 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14663 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Wang X (2004) 15266556 180534 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14664 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Eddahibi S (2001) 11259539 180536 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14665 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Russell BR (2001) 11325413 180535 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 14666 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Johnson GJ (2003) 14675103 174234 1179 Dexfenfluramine (+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine - DRUGBANK DB01191 C12H16F3N small molecule A08AA04 3239-44-9 DRUGBANK 3846 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Miolo G (2002) 12208313 174086 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3847 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target McMahon LR (2001) 11166521 174087 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3848 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Yoshida K (2002) 11817517 174084 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3849 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Millan MJ (2003) 12721776 174085 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3850 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Williams K (2010) 20687077 174091 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3851 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Dell'Osso B (2005) 16316311 174090 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3852 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Kakiuchi T (2001) 11304754 174093 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3853 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Suhara T (2003) 12695316 174092 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3854 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Irons J (2005) 18568110 174088 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 3855 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Inoue K (2004) 15170064 174089 169 Fluvoxamine Fluvoxamine|Fluvoxamina|Fluvoxaminum fluvoxamine-50|fluvoxamine mal DRUGBANK DB00176 C15H21F3N2O2 small molecule N06AB08 54739-18-3 DRUGBANK 9890 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 9891 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Diamond M (2006) 16388933 178064 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 16737 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Whitworth TL (2002) 11756522 181433 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16738 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Szabo Z (2002) 11994534 181432 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16739 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Saldana SN (2004) 14700733 181431 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16740 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Bogen IL (2003) 12742084 181430 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16741 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Boot BP (2002) 12398910 181435 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16742 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Shankaran M (1999) 10607865 181434 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 24387 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 5516 Mianserin 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum - DRUGBANK DB06148 C18H20N2 small molecule N06AX03 24219-97-4 DRUGBANK 11168 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Wee S (2004) 15189772 178697 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 8177 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rothman RB (2003) 14515341 176978 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8178 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Rothman RB (2008) 18991872 176979 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8179 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Cosgrove KP (2010) 20610163 176980 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8180 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Johnson GJ (2003) 14675103 174234 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 8181 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Xie T (2006) 16452989 176977 564 Fenfluramine Fenfluramina|Fenfluraminum pondimin tab 20mg DRUGBANK DB00574 C12H16F3N small molecule A08AA02 458-24-2 DRUGBANK 24089 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens unknown target Basile AS (2007) 17325229 181989 4689 Bicifadine - - DRUGBANK DB04889 C12H15N small molecule - 71195-57-8 DRUGBANK 16774 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Whitworth TL (2002) 11756522 181433 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16775 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Szabo Z (2002) 11994534 181432 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16776 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Saldana SN (2004) 14700733 181431 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16777 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Bogen IL (2003) 12742084 181430 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16778 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Boot BP (2002) 12398910 181435 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16779 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Shankaran M (1999) 10607865 181434 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16780 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Daws LC (2000) 11041537 181445 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 13905 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 1102 Chlorphenamine Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin allergy mutli-symptom|children DRUGBANK DB01114 C16H19ClN2 small molecule R06AB54|R06AB04 132-22-9 DRUGBANK 9053 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 646 Trazodone Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona penta-trazodone tablets|ratio- DRUGBANK DB00656 C19H22ClN5O small molecule N06AX05 19794-93-5 DRUGBANK 17079 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Numachi Y (2007) 17673199 181538 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17080 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Sora I (2009) 19607959 181536 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17081 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens negative modulator target Tellez R (2010) 20226815 181537 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 27017 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Wander TJ (1986) 3816971 181668 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27018 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27019 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Richelson E (1984) 6086881 176781 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27020 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens antagonist target Wander TJ (1986) 3816971 181668 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27021 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens antagonist target Tatsumi M (1997) 9537821 174430 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 27022 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens antagonist target Richelson E (1984) 6086881 176781 7749 Butriptyline ()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine - DRUGBANK DB09016 - small molecule N06AA15 35941-65-2 DRUGBANK 24417 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Raffa RB (2012) 22698264 182203 5527 Tapentadol CG-5503|BN-200|Nucynta|Tapentadol nucynta ir|nucynta extended-re DRUGBANK DB06204 C14H23NO small molecule N02AX06 175591-23-8 DRUGBANK 7252 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Iceta R (2007) 17289086 176303 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 7253 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Tatsumi M (1997) 9537821 174430 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 7254 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Richman A (2007) 17215106 176307 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 7255 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Mirza NR (2007) 17335951 176306 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 7256 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Goeren MZ (2007) 17486443 176305 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 7257 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Sanders AC (2007) 17356573 176304 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 7258 112423 6532 - SLC6A4 5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 464 Fluoxetine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine pro-fluoxetine|olanzapine and DRUGBANK DB00472 C17H18F3NO small molecule N06CA03|N06AB03 54910-89-3 DRUGBANK 3786 112425 6534 - SLC6A7 PROT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3787 112425 6534 - SLC6A7 PROT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 2830 112426 6535 - SLC6A8 CCDS1|CRT|CRTR|CT1|CTR5 9606 Homo sapiens unknown target Lunardi G (2006) 16949212 173498 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2831 112426 6535 - SLC6A8 CCDS1|CRT|CRTR|CT1|CTR5 9606 Homo sapiens unknown target Campistol J (2007) 17385170 173499 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2832 112426 6535 - SLC6A8 CCDS1|CRT|CRTR|CT1|CTR5 9606 Homo sapiens unknown target Wang L (2007) 17486546 173431 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2833 112426 6535 - SLC6A8 CCDS1|CRT|CRTR|CT1|CTR5 9606 Homo sapiens unknown target Derave W (2006) 16849631 173496 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2834 112426 6535 - SLC6A8 CCDS1|CRT|CRTR|CT1|CTR5 9606 Homo sapiens unknown target Rosenberg EH (2006) 16763899 173497 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2788 112427 6536 - SLC6A9 GLYT1 9606 Homo sapiens unknown target Igartua I (2007) 17462677 173469 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2789 112427 6536 - SLC6A9 GLYT1 9606 Homo sapiens unknown target Wiles AL (2006) 16899062 173472 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2790 112427 6536 - SLC6A9 GLYT1 9606 Homo sapiens unknown target Sur C (2007) 17504107 173470 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2791 112427 6536 - SLC6A9 GLYT1 9606 Homo sapiens unknown target Raiteri L (2008) 17597258 173471 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2792 112427 6536 - SLC6A9 GLYT1 9606 Homo sapiens unknown target Lindsley CW (2006) 17017963 173473 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 26927 112429 6538 - SLC6A11 GAT-3|GAT3|GAT4 9606 Homo sapiens inhibitor target Sunol C (2010) 20512624 178994 7607 Guvacine - - DRUGBANK DB08848 C6H9NO2 small molecule - 498-96-4 DRUGBANK 26923 112430 6539 - SLC6A12 BGT-1|BGT1|GAT2 9606 Homo sapiens inhibitor target Ruiz-Tachiquin ME (2002) 12111824 181797 7607 Guvacine - - DRUGBANK DB08848 C6H9NO2 small molecule - 498-96-4 DRUGBANK 26924 112431 6540 - SLC6A13 GAT-2|GAT2|GAT3 9606 Homo sapiens inhibitor target Sunol C (2010) 20512624 178994 7607 Guvacine - - DRUGBANK DB08848 C6H9NO2 small molecule - 498-96-4 DRUGBANK 26925 112431 6540 - SLC6A13 GAT-2|GAT2|GAT3 9606 Homo sapiens inhibitor target Krogsgaard-Larsen P (2000) 10903390 181757 7607 Guvacine - - DRUGBANK DB08848 C6H9NO2 small molecule - 498-96-4 DRUGBANK 26926 112431 6540 - SLC6A13 GAT-2|GAT2|GAT3 9606 Homo sapiens inhibitor target Schousboe A (1979) 458448 181635 7607 Guvacine - - DRUGBANK DB08848 C6H9NO2 small molecule - 498-96-4 DRUGBANK 2061 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Rotmann A (2004) 15491978 172962 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2062 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Yeramian A (2006) 16703566 172961 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2063 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Cerec V (2007) 17065601 172847 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 1870 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Rotoli BM (2007) 17363779 172848 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1871 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Rotmann A (2007) 17329401 172844 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1872 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Vasquez R (2007) 17427197 172845 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1873 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Yang Z (2007) 17325243 172846 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1874 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Cerec V (2007) 17065601 172847 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1852 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1853 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1854 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Nicholson B (1998) 9614060 172835 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1855 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Fernandez J (2003) 14523001 172834 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1856 112432 6541 RP11-274A8.1 SLC7A1 ATRC1|CAT-1|ERR|HCAT1|REC1L 9606 Homo sapiens unknown target Lopez AB (2007) 17042743 117779 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 2072 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Yeramian A (2006) 16703566 172961 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2073 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Endo M (2003) 12679322 172969 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2074 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Cerec V (2007) 17065601 172847 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 1857 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1858 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Rotoli BM (2005) 15746185 172830 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1859 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1860 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Schwartz D (2003) 12475743 172837 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1861 112433 6542 - SLC7A2 ATRC2|CAT2|HCAT2 9606 Homo sapiens unknown target Low BC (1995) 7499219 172836 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 2075 112435 6545 - SLC7A4 CAT-4|CAT4|HCAT3|VH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2076 112435 6545 - SLC7A4 CAT-4|CAT4|HCAT3|VH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 1877 112435 6545 - SLC7A4 CAT-4|CAT4|HCAT3|VH 9606 Homo sapiens unknown target Rotmann A (2007) 17329401 172844 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1845 112435 6545 - SLC7A4 CAT-4|CAT4|HCAT3|VH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1846 112435 6545 - SLC7A4 CAT-4|CAT4|HCAT3|VH 9606 Homo sapiens unknown target Rotoli BM (2005) 15746185 172830 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1847 112435 6545 - SLC7A4 CAT-4|CAT4|HCAT3|VH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 3444 112436 6546 - SLC8A1 NCX1 9606 Homo sapiens inhibitor target Xiao YF (2004) 15358223 173836 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 2157 112436 6546 - SLC8A1 NCX1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2158 112436 6546 - SLC8A1 NCX1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2159 112436 6546 - SLC8A1 NCX1 9606 Homo sapiens unknown target Ander BP (2007) 17059813 173070 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 8402 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens inhibitor target Konstantinou-Tegou A (2001) 11604219 177153 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8403 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens inhibitor target Cuthbert AW (2003) 12872009 177155 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8404 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens inhibitor target Serrani RE (2001) 11688549 177154 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8405 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens inhibitor target Lee MG (2000) 10841524 177157 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 8406 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens inhibitor target Furukawa O (2004) 12881227 177156 584 Amiloride Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide amiloride hydrocloride|amilori DRUGBANK DB00594 C6H8ClN7O small molecule C03DB01 2609-46-3 DRUGBANK 19563 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2516 Homoserine Lactone - - DRUGBANK DB02624 C4H7NO2 small molecule - 1192-20-7 DRUGBANK 19564 112438 6548 RP4-633N17.1 SLC9A1 APNH|NHE-1|NHE1|PPP1R143 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2516 Homoserine Lactone - - DRUGBANK DB02624 C4H7NO2 small molecule - 1192-20-7 DRUGBANK 10198 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens binder target Fujiwara TM (2005) 16093448 178262 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10199 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens binder target Pressler CA (2006) 16807401 178260 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10200 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens binder target Bichet DG (2006) 16713495 178261 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10201 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10202 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10203 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 11568 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Bowes TJ (2005) 15389563 178964 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 11569 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 893 Etacrynic acid Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid sodium edecrin|ethacrynic sodi DRUGBANK DB00903 C13H12Cl2O4 small molecule C03CC01 58-54-8 DRUGBANK 4349 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Vormfelde SV (2007) 17460608 174425 207 Torasemide 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea|Torasemida|Luprac|N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide|Demadex|Torsemide|Torasemidum demadex tablets - 20mg|demadex DRUGBANK DB00214 C16H20N4O3S small molecule C03CA04 56211-40-6 DRUGBANK 4350 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 207 Torasemide 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea|Torasemida|Luprac|N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide|Demadex|Torsemide|Torasemidum demadex tablets - 20mg|demadex DRUGBANK DB00214 C16H20N4O3S small molecule C03CA04 56211-40-6 DRUGBANK 4351 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Fortuno A (1999) 10406837 174426 207 Torasemide 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea|Torasemida|Luprac|N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide|Demadex|Torsemide|Torasemidum demadex tablets - 20mg|demadex DRUGBANK DB00214 C16H20N4O3S small molecule C03CA04 56211-40-6 DRUGBANK 11419 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Thakker RV (1998) 9690036 178899 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11420 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Thakker RV (1999) 10561751 178898 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11421 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Long P (2009) 19141616 178901 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11422 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Karolyi L (1998) 9587066 178900 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11423 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 5366 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 303 Chlorthalidone Phthalamodine|2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide|Chlorphthalidolone|3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine|1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline|Chlortalidone|Phthalamudine|2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide|Chlorthalidone|3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine|1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline tenoretic|apo chlorthalidone t DRUGBANK DB00310 C14H11ClN2O4S small molecule C03BB04|C03BA04|C03EA06 77-36-1 DRUGBANK 5367 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 303 Chlorthalidone Phthalamodine|2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide|Chlorphthalidolone|3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine|1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline|Chlortalidone|Phthalamudine|2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide|Chlorthalidone|3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine|1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline tenoretic|apo chlorthalidone t DRUGBANK DB00310 C14H11ClN2O4S small molecule C03BB04|C03BA04|C03EA06 77-36-1 DRUGBANK 5368 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 303 Chlorthalidone Phthalamodine|2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide|Chlorphthalidolone|3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine|1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline|Chlortalidone|Phthalamudine|2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide|Chlorthalidone|3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine|1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline tenoretic|apo chlorthalidone t DRUGBANK DB00310 C14H11ClN2O4S small molecule C03BB04|C03BA04|C03EA06 77-36-1 DRUGBANK 10311 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10312 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 10313 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 764 Hydroflumethiazide Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum - DRUGBANK DB00774 C8H8F3N3O4S2 small molecule C03AB02|C03AH02|C03AA02 135-09-1 DRUGBANK 7788 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 7789 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inducer target Mannuzzu LM (1993) 8391582 176712 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 7790 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 7791 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inducer target Tabern DL (1970) 5455277 176713 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 9576 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Vormfelde SV (2007) 17460608 174425 685 Furosemide Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid lasix injection 10mg/ml|apo fu DRUGBANK DB00695 C12H11ClN2O5S small molecule C03EB01|C03CB01|C03CA01 54-31-9 DRUGBANK 9577 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 685 Furosemide Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid lasix injection 10mg/ml|apo fu DRUGBANK DB00695 C12H11ClN2O5S small molecule C03EB01|C03CB01|C03CA01 54-31-9 DRUGBANK 9578 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Brater DC (2000) 10653443 177874 685 Furosemide Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid lasix injection 10mg/ml|apo fu DRUGBANK DB00695 C12H11ClN2O5S small molecule C03EB01|C03CB01|C03CA01 54-31-9 DRUGBANK 9579 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Davies DL (1975) 1092541 177873 685 Furosemide Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid lasix injection 10mg/ml|apo fu DRUGBANK DB00695 C12H11ClN2O5S small molecule C03EB01|C03CB01|C03CA01 54-31-9 DRUGBANK 15839 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Ellison DH (2003) 12538756 181097 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15840 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Ko B (2009) 19636250 181096 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15841 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Duarte JD (2010) 20528637 181099 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15842 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Gamba G (2009) 19474192 181098 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 4558 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4559 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 4560 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 225 Methyclothiazide Enduron methyclothiazide|duretic 5mg DRUGBANK DB00232 C9H11Cl2N3O4S2 small molecule C03AA08|C03AB08 135-07-9 DRUGBANK 12849 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12850 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Hasannejad H (2004) 14610216 179734 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12851 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Smith SM (2010) 20187262 179733 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 12852 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Li J (2007) 17414671 179732 1011 Trichlormethiazide Naqua - DRUGBANK DB01021 C8H8Cl3N3O4S2 small molecule C03AB06|C03AA06|C03EA02 133-67-5 DRUGBANK 20141 112446 6557 - SLC12A1 BSC1|NKCC2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2804 Piretanide - - DRUGBANK DB02925 C17H18N2O5S small molecule C03CA03 55837-27-9 DRUGBANK 11414 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Akar F (2001) 11443057 178893 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11415 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Wall SM (2001) 11292635 178895 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11416 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Jiang G (2001) 11698253 178894 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11417 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Evans RL (2000) 10831596 178897 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11418 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Panet R (2000) 10567922 178896 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 10204 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10205 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens unknown target Hebert SC (2003) 12920401 178263 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10206 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 15835 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Ellison DH (2003) 12538756 181097 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15836 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Ko B (2009) 19636250 181096 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15837 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Duarte JD (2010) 20528637 181099 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15838 112447 6558 - SLC12A2 BSC|BSC2|NKCC1|PPP1R141 9606 Homo sapiens inhibitor target Gamba G (2009) 19474192 181098 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 12640 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12641 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Barry EL (1997) 9038817 179607 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12642 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Ran XW (2005) 16078592 179606 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12643 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Kurschat C (2003) 12772080 179605 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12644 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Abuladze N (1998) 9596079 179604 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12645 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Monroy A (2000) 10894798 176048 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 12646 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Turner ST (2005) 16172412 179603 989 Hydrochlorothiazide HCTZ|Microzide|Esidrix amlodipine, valsartan, hydroch DRUGBANK DB00999 C7H8ClN3O4S2 small molecule C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01 58-93-5 DRUGBANK 6920 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 6921 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Vallon V (2008) 18216144 176047 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 6922 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Monroy A (2000) 10894798 176048 428 Bendroflumethiazide Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid corzide|naturetin 5mg|nadolol DRUGBANK DB00436 C15H14F3N3O4S2 small molecule C03AA01|C03EA13|C03AB01 73-48-3 DRUGBANK 11356 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Thakker RV (2000) 11014932 178860 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11357 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Schmidt H (2001) 11456284 178861 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11358 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Reinalter SC (2004) 15283765 178862 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11359 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Maki N (2004) 15069170 178859 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 11360 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Wilson FH (2003) 12515852 9939 870 Chlorothiazide Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux chlorothiazide sodium|sodium d DRUGBANK DB00880 C7H6ClN3O4S2 small molecule C03AA04|C03AB04|C03AH01 58-94-6 DRUGBANK 8057 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 8058 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 552 Benzthiazide Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide - DRUGBANK DB00562 C15H14ClN3O4S3 small molecule - 91-33-8 DRUGBANK 13952 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 13953 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1107 Diazoxide Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide proglycem|proglycem susp 50mg/ DRUGBANK DB01119 C8H7ClN2O2S small molecule C02DA01|V03AH01 364-98-7 DRUGBANK 15832 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Frindt G (2002) 12217863 181095 1292 Polythiazide Renese - DRUGBANK DB01324 C11H13ClF3N3O4S3 small molecule C03AA05|C03AB05 346-18-9 DRUGBANK 15833 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1292 Polythiazide Renese - DRUGBANK DB01324 C11H13ClF3N3O4S3 small molecule C03AA05|C03AB05 346-18-9 DRUGBANK 15834 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Monroy A (2000) 10894798 176048 1292 Polythiazide Renese - DRUGBANK DB01324 C11H13ClF3N3O4S3 small molecule C03AA05|C03AB05 346-18-9 DRUGBANK 15846 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Ellison DH (2003) 12538756 181097 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15847 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Ko B (2009) 19636250 181096 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15848 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Duarte JD (2010) 20528637 181099 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 15849 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Gamba G (2009) 19474192 181098 1293 Quinethazone Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum - DRUGBANK DB01325 C10H12ClN3O3S small molecule C03BB02|C03BA02 73-49-4 DRUGBANK 7734 112448 6559 - SLC12A3 NCC|NCCT|TSC 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 514 Metolazone Metolazona|Mtolazone|7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide|2-Methyl-3-O-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone|7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-O-tolyl-6-quinazolinesulfonamide|Metolazon|Zaroxolyn|Metolazonum zaroxolyn tab 10mg|metolazone| DRUGBANK DB00524 C16H16ClN3O3S small molecule C03BA08|C03EA12 17560-51-9 DRUGBANK 11411 112449 6560 - SLC12A4 KCC1 9606 Homo sapiens inhibitor target Reid KH (2000) 10793196 178891 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 11412 112449 6560 - SLC12A4 KCC1 9606 Homo sapiens inhibitor target Jean-Xavier C (2006) 16807348 178892 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 10207 112449 6560 - SLC12A4 KCC1 9606 Homo sapiens unknown target Capo-Aponte JE (2007) 17418819 178266 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10208 112449 6560 - SLC12A4 KCC1 9606 Homo sapiens unknown target Misri S (2006) 16949074 178264 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10209 112449 6560 - SLC12A4 KCC1 9606 Homo sapiens unknown target Klein T (2006) 16943364 178265 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 2225 112450 6561 - SLC13A1 NAS1|NaSi-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2226 112450 6561 - SLC13A1 NAS1|NaSi-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2227 112450 6561 - SLC13A1 NAS1|NaSi-1 9606 Homo sapiens unknown target Lee A (2000) 11161786 173140 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 27223 112452 6564 RP11-130L10.1 SLC15A1 HPECT1|HPEPT1|PEPT1 9606 Homo sapiens unknown target Luckner P (2005) 15567297 174805 1041 Benzylpenicillin Benzylpenicilline|Free penicillin II|Penicillin G|Benzylpenicillinic acid|6-(2-phenylacetamido)penicillanic acid|PG|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Benzylpenicillin|Bencilpenicilina|PCG|Benzylpenicillinum penicillin g potassium inj 100 DRUGBANK DB01053 C16H18N2O4S small molecule S01AA14|J01CE01 61-33-6 DRUGBANK 27246 112452 6564 RP11-130L10.1 SLC15A1 HPECT1|HPEPT1|PEPT1 9606 Homo sapiens unknown target Luckner P (2005) 15567297 174805 1200 Ceftriaxone (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum ceftriaxone|ceftriaxone sodium DRUGBANK DB01212 C18H18N8O7S3 small molecule J01DD04|J01DD54 73384-59-5 DRUGBANK 27124 112452 6564 RP11-130L10.1 SLC15A1 HPECT1|HPEPT1|PEPT1 9606 Homo sapiens unknown target Luckner P (2005) 15567297 174805 703 Oxacillin Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin oxacillin DRUGBANK DB00713 C19H19N3O5S small molecule J01CF04 66-79-5 DRUGBANK 27083 112452 6564 RP11-130L10.1 SLC15A1 HPECT1|HPEPT1|PEPT1 9606 Homo sapiens unknown target Luckner P (2005) 15567297 174805 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27103 112452 6564 RP11-130L10.1 SLC15A1 HPECT1|HPEPT1|PEPT1 9606 Homo sapiens unknown target Luckner P (2005) 15567297 174805 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27087 112452 6564 RP11-130L10.1 SLC15A1 HPECT1|HPEPT1|PEPT1 9606 Homo sapiens unknown target Biegel A (2005) 15974593 188481 409 Phenoxymethylpenicillin (2S,5R,6R)-3,3-DIMETHYL-7-oxo-6-(2-phenoxyacetamido)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid|PV|Fenoximetilpenicilina|V-cillin|Phenoxymethylpenicilline|Phenoxymethylenepenicillinic acid|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|6-phenoxyacetamidopenicillanic acid|Penicillin Phenoxymethyl|Phenoxymethylpenicillinum|Penicillin V|Oracillin|Fenospen|Phenoxomethylpenicillin|Phenoxymethyl Penicillin nadopen v tab 500000iu|pvf 500 DRUGBANK DB00417 C16H18N2O5S small molecule J01CE02 87-08-1 DRUGBANK 27079 112453 6565 - SLC15A2 PEPT2 9606 Homo sapiens unknown target Pedretti A (2011) 21741846 188479 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27105 112453 6565 - SLC15A2 PEPT2 9606 Homo sapiens unknown target Pedretti A (2011) 21741846 188479 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27225 112453 6565 - SLC15A2 PEPT2 9606 Homo sapiens unknown target Pedretti A (2011) 21741846 188479 1041 Benzylpenicillin Benzylpenicilline|Free penicillin II|Penicillin G|Benzylpenicillinic acid|6-(2-phenylacetamido)penicillanic acid|PG|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Benzylpenicillin|Bencilpenicilina|PCG|Benzylpenicillinum penicillin g potassium inj 100 DRUGBANK DB01053 C16H18N2O4S small molecule S01AA14|J01CE01 61-33-6 DRUGBANK 27126 112453 6565 - SLC15A2 PEPT2 9606 Homo sapiens unknown target Pedretti A (2011) 21741846 188479 703 Oxacillin Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin oxacillin DRUGBANK DB00713 C19H19N3O5S small molecule J01CF04 66-79-5 DRUGBANK 1730 112454 6566 RP4-580L15.1 SLC16A1 HHF7|MCT|MCT1|MCT1D 9606 Homo sapiens unknown target Duerr JM (2007) 17583564 172699 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1731 112454 6566 RP4-580L15.1 SLC16A1 HHF7|MCT|MCT1|MCT1D 9606 Homo sapiens unknown target Han M (2006) 16110503 172702 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1732 112454 6566 RP4-580L15.1 SLC16A1 HHF7|MCT|MCT1|MCT1D 9606 Homo sapiens unknown target Philp A (2005) 16326938 172701 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1733 112454 6566 RP4-580L15.1 SLC16A1 HHF7|MCT|MCT1|MCT1D 9606 Homo sapiens unknown target Shimada A (2006) 16213084 172700 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1734 112454 6566 RP4-580L15.1 SLC16A1 HHF7|MCT|MCT1|MCT1D 9606 Homo sapiens unknown target Shimoyama Y (2007) 17606506 172703 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1754 112455 6567 RP11-449M9.1 SLC16A2 AHDS|DXS128|DXS128E|MCT 7|MCT 8|MCT7|MCT8|MRX22|XPCT 9606 Homo sapiens unknown target Bonen A (2006) 16604139 172691 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 17073 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17074 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Henry JP (1998) 9587917 181169 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17075 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 16153 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16154 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Henry JP (1998) 9587917 181169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16155 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 4307 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens unknown target Ashe KM (2011) 21712771 174390 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 6096 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens binder target Erickson JD (1996) 8643547 175581 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 16712 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16713 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Henry JP (1998) 9587917 181169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16714 112458 6570 - SLC18A1 CGAT|VAT1|VMAT1 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 11237 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inducer target Sulzer D (1995) 7751968 174151 855 Benzphetamine Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine benzphetamine|didrex|regimex|b DRUGBANK DB00865 C17H21N small molecule - 156-08-1 DRUGBANK 4305 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 4301 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Erickson JD (1992) 1438304 174389 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 4302 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sievert MK (2007) 17559790 174388 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 4303 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 4304 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Naudon L (1995) 8525459 174387 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 4300 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Mandela P (2010) 20176067 174386 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 4306 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 199 Reserpine Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate hydropres 25 tab|serpasil 0.25 DRUGBANK DB00206 C33H40N2O9 small molecule C02AA02|C02LA01|C02LA71|C02LA51|C02AA52 50-55-5 DRUGBANK 24769 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens unknown target Docherty JR (2008) 18500382 182079 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 24770 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens unknown target Sulzer D (2005) 15955613 174152 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 13654 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Fulton SC (1976) 11134 180087 1077 Deserpidine 11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum - DRUGBANK DB01089 C32H38N2O8 small molecule C02LA03|C02AA05 131-01-1 DRUGBANK 13655 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Loeffler LJ (1979) 574544 180086 1077 Deserpidine 11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum - DRUGBANK DB01089 C32H38N2O8 small molecule C02LA03|C02AA05 131-01-1 DRUGBANK 13656 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Erickson JD (1992) 1438304 174389 1077 Deserpidine 11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum - DRUGBANK DB01089 C32H38N2O8 small molecule C02LA03|C02AA05 131-01-1 DRUGBANK 13657 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sievert MK (2007) 17559790 174388 1077 Deserpidine 11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum - DRUGBANK DB01089 C32H38N2O8 small molecule C02LA03|C02AA05 131-01-1 DRUGBANK 13658 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Naudon L (1995) 8525459 174387 1077 Deserpidine 11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum - DRUGBANK DB01089 C32H38N2O8 small molecule C02LA03|C02AA05 131-01-1 DRUGBANK 13659 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Mandela P (2010) 20176067 174386 1077 Deserpidine 11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum - DRUGBANK DB01089 C32H38N2O8 small molecule C02LA03|C02AA05 131-01-1 DRUGBANK 16159 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16160 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Henry JP (1998) 9587917 181169 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 16161 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1325 Ephedra Chinese jointfir|Ma huang|Indian jointfir stacker 2 nasal decongestant|e DRUGBANK DB01363 - small molecule - - DRUGBANK 24001 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Kim YS (2009) 19571144 182117 4646 Tetrabenazine 1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina tetrabenazine tablets|nitoman| DRUGBANK DB04844 C19H27NO3 small molecule N07XX06 58-46-8 DRUGBANK 24005 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Zheng G (2007) 17233532 181982 4646 Tetrabenazine 1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina tetrabenazine tablets|nitoman| DRUGBANK DB04844 C19H27NO3 small molecule N07XX06 58-46-8 DRUGBANK 24002 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Gros Y (2010) 20007701 182140 4646 Tetrabenazine 1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina tetrabenazine tablets|nitoman| DRUGBANK DB04844 C19H27NO3 small molecule N07XX06 58-46-8 DRUGBANK 24003 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Wimalasena K (2011) 20135628 182146 4646 Tetrabenazine 1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina tetrabenazine tablets|nitoman| DRUGBANK DB04844 C19H27NO3 small molecule N07XX06 58-46-8 DRUGBANK 24004 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Goland R (2009) 19223416 182098 4646 Tetrabenazine 1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina tetrabenazine tablets|nitoman| DRUGBANK DB04844 C19H27NO3 small molecule N07XX06 58-46-8 DRUGBANK 24000 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4646 Tetrabenazine 1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina tetrabenazine tablets|nitoman| DRUGBANK DB04844 C19H27NO3 small molecule N07XX06 58-46-8 DRUGBANK 24715 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Parker EM (1988) 3129549 147713 5588 Isometheptene Isometheptene nodolor|prodrin|isometheptene DRUGBANK DB06706 C9H19N small molecule A03AX10 503-01-5 DRUGBANK 24716 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (1995) 7751968 174151 5588 Isometheptene Isometheptene nodolor|prodrin|isometheptene DRUGBANK DB06706 C9H19N small molecule A03AX10 503-01-5 DRUGBANK 24717 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 5588 Isometheptene Isometheptene nodolor|prodrin|isometheptene DRUGBANK DB06706 C9H19N small molecule A03AX10 503-01-5 DRUGBANK 24718 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Valdivia LF (2004) 15094323 181847 5588 Isometheptene Isometheptene nodolor|prodrin|isometheptene DRUGBANK DB06706 C9H19N small molecule A03AX10 503-01-5 DRUGBANK 16764 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Hansen JP (2002) 11861820 181439 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 16765 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Biezonski DK (2010) 20002520 181440 1418 4-Methoxyamphetamine Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine - DRUGBANK DB01472 C10H15NO small molecule - 64-13-1 DRUGBANK 6350 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target FORD RV (1958) 13505370 175719 378 Alseroxylon Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab - DRUGBANK DB00386 - small molecule - 8063-17-0 DRUGBANK 6351 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 378 Alseroxylon Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab - DRUGBANK DB00386 - small molecule - 8063-17-0 DRUGBANK 6352 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 378 Alseroxylon Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab - DRUGBANK DB00386 - small molecule - 8063-17-0 DRUGBANK 6353 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 378 Alseroxylon Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab - DRUGBANK DB00386 - small molecule - 8063-17-0 DRUGBANK 6354 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target SCHLAGEL CA (1957) 13438725 175720 378 Alseroxylon Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab - DRUGBANK DB00386 - small molecule - 8063-17-0 DRUGBANK 16749 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Hansen JP (2002) 11861820 181439 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16750 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Biezonski DK (2010) 20002520 181440 1401 3,4-Methylenedioxymethamphetamine Ecstasy|MDMA - DRUGBANK DB01454 C11H15NO2 small molecule - 42542-10-9 DRUGBANK 16170 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 27799 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Ellis JD (2011) 21370280 196004 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16171 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Yasumoto S (2009) 19429089 181176 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16172 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (1995) 7751968 174151 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16173 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 16174 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Horton DB (2011) 21177475 181175 1326 Ephedrine (-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine nasal jelly thuna's|balminil n DRUGBANK DB01364 C10H15NO small molecule R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02 299-42-3 DRUGBANK 17047 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17048 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Yasumoto S (2009) 19429089 181176 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17049 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (1995) 7751968 174151 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17050 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17051 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Horton DB (2011) 21177475 181175 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17033 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inducer target Sulzer D (1995) 7751968 174151 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17034 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inducer target Sulzer D (2005) 15955613 174152 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 3904 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Teng L (1998) 9648873 174154 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3905 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (1995) 7751968 174151 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3906 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3907 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Eiden LE (2011) 21272013 174153 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 6078 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens binder target Erickson JD (1996) 8643547 175581 360 Norepinephrine 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol norepinephrine bitartrate|levo DRUGBANK DB00368 C8H11NO3 small molecule C01CA03 51-41-2 DRUGBANK 16699 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Fleckenstein AE (2007) 17209801 174169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16700 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Henry JP (1998) 9587917 181169 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 16701 112459 6571 - SLC18A2 SVAT|SVMT|VAT2|VMAT2 9606 Homo sapiens inhibitor target Sulzer D (2005) 15955613 174152 1390 MMDA 3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE - DRUGBANK DB01442 C11H15NO3 small molecule - 13674-05-0 DRUGBANK 27219 112466 6579 - SLCO1A2 OATP|OATP-A|OATP1A2|SLC21A3 9606 Homo sapiens unknown target Vavricka SR (2002) 12085361 188499 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 8252 112470 6583 - SLC22A4 OCTN1 9606 Homo sapiens unknown target Amat di San Filippo C (2003) 14506273 177043 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8253 112470 6583 - SLC22A4 OCTN1 9606 Homo sapiens unknown target Lamhonwah AM (2005) 16246312 177042 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8254 112470 6583 - SLC22A4 OCTN1 9606 Homo sapiens unknown target Lash LH (2006) 16997449 177041 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8255 112470 6583 - SLC22A4 OCTN1 9606 Homo sapiens unknown target Kristufek D (2002) 12181285 177044 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8262 112471 6584 - SLC22A5 CDSP|OCTN2|OCTN2VT 9606 Homo sapiens unknown target Hou JW (2002) 12635840 177053 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8263 112471 6584 - SLC22A5 CDSP|OCTN2|OCTN2VT 9606 Homo sapiens unknown target Lahjouji K (2002) 12175785 177050 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8264 112471 6584 - SLC22A5 CDSP|OCTN2|OCTN2VT 9606 Homo sapiens unknown target Ohashi R (2002) 12183691 177051 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8265 112471 6584 - SLC22A5 CDSP|OCTN2|OCTN2VT 9606 Homo sapiens unknown target Friedrich A (2003) 12644265 177052 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8266 112471 6584 - SLC22A5 CDSP|OCTN2|OCTN2VT 9606 Homo sapiens unknown target Kristufek D (2002) 12181285 177044 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 27920 112492 6608 - SMO FZD11|Gx|SMOH 9606 Homo sapiens antagonist target Burness CB (2015) 26323341 196029 7888 Sonidegib Erismodegib|N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide odomzo DRUGBANK DB09143 C26H26F3N3O3 small molecule L01XX48 956697-53-3 DRUGBANK 26891 112492 6608 - SMO FZD11|Gx|SMOH 9606 Homo sapiens antagonist target Sandhiya S (2013) 23662017 182250 7595 Vismodegib Hedgehog Antagonist GDC-0449|Erivedge|GDC-0449|Vismodegibum erivedge DRUGBANK DB08828 C19H14Cl2N2O3S small molecule L01XX43 879085-55-9 DRUGBANK 27886 112492 6608 - SMO FZD11|Gx|SMOH 9606 Homo sapiens agonist target Porcu G (2015) 26658258 196037 8094 Halcinonide (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one|Halcinonidum|Halcinonide|Halcinonid|Halcinonida halog cream 0.1%|halog ont 0.1 DRUGBANK DB06786 C24H32ClFO5 small molecule D07AD02 3093-35-4 DRUGBANK 27887 112492 6608 - SMO FZD11|Gx|SMOH 9606 Homo sapiens activator target Porcu G (2015) 26658258 196037 8094 Halcinonide (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one|Halcinonidum|Halcinonide|Halcinonid|Halcinonida halog cream 0.1%|halog ont 0.1 DRUGBANK DB06786 C24H32ClFO5 small molecule D07AD02 3093-35-4 DRUGBANK 13145 112492 6608 - SMO FZD11|Gx|SMOH 9606 Homo sapiens agonist target Wang J (2010) 20439738 179890 1036 Fluocinonide Lidex|Fluocinonide|Fluocinonido|Vanos|Fluocinonidum fluocinonide|lidex ont 0.05%|l DRUGBANK DB01047 C26H32F2O7 small molecule D07AC08|C05AA11|D07CC05 356-12-7 DRUGBANK 6302 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens unknown target Kornhuber J (2011) 21909365 175698 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 7328 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens unknown target Yoshida Y (1985) 2419314 176337 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 14266 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens inhibitor target Zeidan YH (2006) 16803890 180388 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14267 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens inhibitor target Hurwitz R (1994) 7945993 180386 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14268 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens inhibitor target Kornhuber J (2010) 20502000 180387 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14269 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens inhibitor target Koelzer M (2004) 14960314 180384 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14270 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens inhibitor target Testai FD (2004) 14689449 180385 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 14271 112493 6609 - SMPD1 ASM|ASMASE|NPD 9606 Homo sapiens inhibitor target Erdreich-Epstein A (2005) 15705795 180383 1139 Desipramine N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin pms-desipramine - tab 100mg|de DRUGBANK DB01151 C18H22N2 small molecule N06AA01 50-47-5 DRUGBANK 1965 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Korhonen VP (2001) 11160858 172890 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1966 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Theiss C (2002) 11950995 172905 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1967 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Lopatin AN (2000) 11040105 172904 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1968 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Cason AL (2003) 14508504 172907 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1969 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Wang X (2011) 21318872 172906 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1970 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Wang X (2004) 15459188 172901 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1971 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Kobayashi M (2006) 16651710 172900 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1972 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Schwartz CE (2011) 21318891 172903 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1973 112495 6611 - SMS MRSR|SPMSY|SRS|SpS 9606 Homo sapiens ligand target Krauss M (2006) 16515550 172902 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 19099 112498 6614 - SIGLEC1 CD169|SIGLEC-1|SN|dJ1009E24.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 21790 112498 6614 - SIGLEC1 CD169|SIGLEC-1|SN|dJ1009E24.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3564 O-Sialic Acid - - DRUGBANK DB03721 C11H19NO9 small molecule - - DRUGBANK 1068 112500 6616 - SNAP25 RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 1069 112500 6616 - SNAP25 RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2 9606 Homo sapiens inhibitor target Straughan D (2006) 16831062 172264 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 1070 112500 6616 - SNAP25 RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2 9606 Homo sapiens inhibitor target Flynn TC (2004) 15222581 172260 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 1071 112500 6616 - SNAP25 RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2 9606 Homo sapiens inhibitor target Frassoni C (2005) 15749336 172261 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 1072 112500 6616 - SNAP25 RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2 9606 Homo sapiens inhibitor target Okada M (2004) 15484814 172262 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 1073 112500 6616 - SNAP25 RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2 9606 Homo sapiens inhibitor target Zhou JY (2003) 14644446 172263 80 Botulinum Toxin Type A IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA botox cosmetic|dysport|botox|x DRUGBANK DB00083 C6760H10447N1743O2010S32 biologic - 93384-43-1 DRUGBANK 13681 112529 6646 RP11-215I23.1 SOAT1 ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT 9606 Homo sapiens inhibitor target Chung MY (2004) 15114505 180100 1082 Hesperetin Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin - DRUGBANK DB01094 C16H14O6 small molecule - 520-33-2 DRUGBANK 13682 112529 6646 RP11-215I23.1 SOAT1 ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT 9606 Homo sapiens inhibitor target Wilcox LJ (2001) 11352979 180099 1082 Hesperetin Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin - DRUGBANK DB01094 C16H14O6 small molecule - 520-33-2 DRUGBANK 12415 112529 6646 RP11-215I23.1 SOAT1 ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT 9606 Homo sapiens inhibitor target Wang HH (2008) 18442485 179432 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12416 112529 6646 RP11-215I23.1 SOAT1 ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT 9606 Homo sapiens inhibitor target Costet P (2010) 20227438 179433 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12417 112529 6646 RP11-215I23.1 SOAT1 ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT 9606 Homo sapiens inhibitor target Singh A (2009) 19669185 179434 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 21076 112530 6647 - SOD1 ALS|ALS1|HEL-S-44|IPOA|SOD|hSod1|homodimer 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3241 S-Oxy Cysteine - - DRUGBANK DB03382 C3H6NO3S small molecule - - DRUGBANK 23386 112531 6648 RP1-56L9.2 SOD2 IPOB|MNSOD|MVCD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4251 3-Fluorotyrosine 3-fluoro-L-tyrosine - DRUGBANK DB04436 C9H10FNO3 small molecule - 403-90-7 DRUGBANK 23387 112531 6648 RP1-56L9.2 SOD2 IPOB|MNSOD|MVCD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4251 3-Fluorotyrosine 3-fluoro-L-tyrosine - DRUGBANK DB04436 C9H10FNO3 small molecule - 403-90-7 DRUGBANK 23388 112531 6648 RP1-56L9.2 SOD2 IPOB|MNSOD|MVCD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4251 3-Fluorotyrosine 3-fluoro-L-tyrosine - DRUGBANK DB04436 C9H10FNO3 small molecule - 403-90-7 DRUGBANK 20918 112531 6648 RP1-56L9.2 SOD2 IPOB|MNSOD|MVCD6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 20919 112531 6648 RP1-56L9.2 SOD2 IPOB|MNSOD|MVCD6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 20920 112531 6648 RP1-56L9.2 SOD2 IPOB|MNSOD|MVCD6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 3191 112535 6652 - SORD HEL-S-95n|SORD1 9606 Homo sapiens unknown target Klimacek M (2007) 17343568 173708 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3192 112535 6652 - SORD HEL-S-95n|SORD1 9606 Homo sapiens unknown target Ido Y (2007) 17508915 173682 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 23535 112535 6652 - SORD HEL-S-95n|SORD1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4291 Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine - - DRUGBANK DB04478 C11H19N5O3S small molecule - - DRUGBANK 23536 112535 6652 - SORD HEL-S-95n|SORD1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4291 Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine - - DRUGBANK DB04478 C11H19N5O3S small molecule - - DRUGBANK 18704 112557 6675 - UAP1 AGX|AGX1|AGX2|SPAG2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18705 112557 6675 - UAP1 AGX|AGX1|AGX2|SPAG2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 21103 112557 6675 - UAP1 AGX|AGX1|AGX2|SPAG2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21104 112557 6675 - UAP1 AGX|AGX1|AGX2|SPAG2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 22983 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4102 N-Acetyl Serotonin - - DRUGBANK DB04275 C12H14N2O2 small molecule - - DRUGBANK 19587 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2528 Oxaloacetate Ion - - DRUGBANK DB02637 C4H3O5 small molecule - - DRUGBANK 19588 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2528 Oxaloacetate Ion - - DRUGBANK DB02637 C4H3O5 small molecule - - DRUGBANK 19589 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2528 Oxaloacetate Ion - - DRUGBANK DB02637 C4H3O5 small molecule - - DRUGBANK 21309 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21310 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21311 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 22116 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3723 Biopterin - - DRUGBANK DB03886 C9H11N5O3 small molecule - - DRUGBANK 22117 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3723 Biopterin - - DRUGBANK DB03886 C9H11N5O3 small molecule - - DRUGBANK 22118 112575 6697 - SPR SDR38C1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3723 Biopterin - - DRUGBANK DB03886 C9H11N5O3 small molecule - - DRUGBANK 21118 112589 6711 - SPTBN1 ELF|HEL102|SPTB2|betaSpII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21119 112589 6711 - SPTBN1 ELF|HEL102|SPTB2|betaSpII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21120 112589 6711 - SPTBN1 ELF|HEL102|SPTB2|betaSpII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 16221 112589 6711 - SPTBN1 ELF|HEL102|SPTB2|betaSpII 9606 Homo sapiens agonist target Wallis CJ (1992) 1537825 181204 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 11200 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Klobucnikova V (2003) 12963042 61237 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11201 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Wentzinger LF (2002) 12226513 178725 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11202 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Darkes MJ (2002) 12477372 178724 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11203 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Krishnan-Natesan S (2009) 19874252 178723 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11204 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Ryder NS (1992) 1543672 178722 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11205 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Sander CS (2002) 12100530 178721 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11206 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Leber R (2003) 14638499 61876 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 11207 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 847 Terbinafine Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine kroger antifungal|goodsense te DRUGBANK DB00857 C21H25N small molecule D01BA02|D01AE15 91161-71-6 DRUGBANK 26909 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Abe I (2001) 11520216 181775 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 9988 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 725 Naftifine Naftifinum|Naftifine|Naftifin|Naftin|Naftifina naftin crm 1%|naftin gel 1%|na DRUGBANK DB00735 C21H21N small molecule D01AE22 65472-88-0 DRUGBANK 9989 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Ryder NS (1992) 1287164 178103 725 Naftifine Naftifinum|Naftifine|Naftifin|Naftin|Naftifina naftin crm 1%|naftin gel 1%|na DRUGBANK DB00735 C21H21N small molecule D01AE22 65472-88-0 DRUGBANK 9990 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Ryder NS (1985) 3877503 178102 725 Naftifine Naftifinum|Naftifine|Naftifin|Naftin|Naftifina naftin crm 1%|naftin gel 1%|na DRUGBANK DB00735 C21H21N small molecule D01AE22 65472-88-0 DRUGBANK 9991 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Mukherjee PK (2003) 12499173 178101 725 Naftifine Naftifinum|Naftifine|Naftifin|Naftin|Naftifina naftin crm 1%|naftin gel 1%|na DRUGBANK DB00735 C21H21N small molecule D01AE22 65472-88-0 DRUGBANK 9992 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Favre B (1996) 8834895 40846 725 Naftifine Naftifinum|Naftifine|Naftifin|Naftin|Naftifina naftin crm 1%|naftin gel 1%|na DRUGBANK DB00735 C21H21N small molecule D01AE22 65472-88-0 DRUGBANK 9993 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Vanden Bossche H (1991) 1951574 174676 725 Naftifine Naftifinum|Naftifine|Naftifin|Naftin|Naftifina naftin crm 1%|naftin gel 1%|na DRUGBANK DB00735 C21H21N small molecule D01AE22 65472-88-0 DRUGBANK 13666 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Gao PH (2005) 16079485 180092 1079 Butenafine N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine dr. scholl's athlete's foot cr DRUGBANK DB01091 C23H27N small molecule D01AE23 101828-21-1 DRUGBANK 13667 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Singal A (2008) 18624686 180093 1079 Butenafine N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine dr. scholl's athlete's foot cr DRUGBANK DB01091 C23H27N small molecule D01AE23 101828-21-1 DRUGBANK 13668 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Iwatani W (1993) 8494375 180090 1079 Butenafine N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine dr. scholl's athlete's foot cr DRUGBANK DB01091 C23H27N small molecule D01AE23 101828-21-1 DRUGBANK 13669 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Ramam M (2007) 17642865 180091 1079 Butenafine N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine dr. scholl's athlete's foot cr DRUGBANK DB01091 C23H27N small molecule D01AE23 101828-21-1 DRUGBANK 13670 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1079 Butenafine N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine dr. scholl's athlete's foot cr DRUGBANK DB01091 C23H27N small molecule D01AE23 101828-21-1 DRUGBANK 13671 112591 6713 - SQLE - 9606 Homo sapiens inhibitor target Mukherjee PK (2003) 12499173 178101 1079 Butenafine N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine dr. scholl's athlete's foot cr DRUGBANK DB01091 C23H27N small molecule D01AE23 101828-21-1 DRUGBANK 20429 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2949 PASBN - - DRUGBANK DB03078 C14H13O5P small molecule - - DRUGBANK 23564 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4308 RU81843 - - DRUGBANK DB04495 C30H34N3O7P small molecule - - DRUGBANK 23565 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4308 RU81843 - - DRUGBANK DB04495 C30H34N3O7P small molecule - - DRUGBANK 23566 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4308 RU81843 - - DRUGBANK DB04495 C30H34N3O7P small molecule - - DRUGBANK 26219 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6983 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE - - DRUGBANK DB08192 C16H18N2O2S small molecule - - DRUGBANK 18663 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2091 Malonic acid Propanedioic acid|Malonate - DRUGBANK DB02175 C3H4O4 small molecule - 141-82-2 DRUGBANK 18664 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2091 Malonic acid Propanedioic acid|Malonate - DRUGBANK DB02175 C3H4O4 small molecule - 141-82-2 DRUGBANK 18665 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2091 Malonic acid Propanedioic acid|Malonate - DRUGBANK DB02175 C3H4O4 small molecule - 141-82-2 DRUGBANK 20509 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2985 PAS219 - - DRUGBANK DB03114 C14H19O5P small molecule - - DRUGBANK 22148 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3739 Oxalic Acid - - DRUGBANK DB03902 C2H2O4 small molecule - 144-62-7 DRUGBANK 22149 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3739 Oxalic Acid - - DRUGBANK DB03902 C2H2O4 small molecule - 144-62-7 DRUGBANK 22150 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3739 Oxalic Acid - - DRUGBANK DB03902 C2H2O4 small molecule - 144-62-7 DRUGBANK 18138 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1871 RU78262 - - DRUGBANK DB01947 C7H7O5P small molecule - - DRUGBANK 23864 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4554 Purvalanol A 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv - DRUGBANK DB04751 C19H25ClN6O small molecule - 212844-53-6 DRUGBANK 20926 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3163 Phenylphosphate - - DRUGBANK DB03298 C6H7O4P small molecule - - DRUGBANK 20927 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3163 Phenylphosphate - - DRUGBANK DB03298 C6H7O4P small molecule - - DRUGBANK 20928 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3163 Phenylphosphate - - DRUGBANK DB03298 C6H7O4P small molecule - - DRUGBANK 21553 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3439 RU82209 - - DRUGBANK DB03591 C31H34F2N3O6P small molecule - - DRUGBANK 21554 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3439 RU82209 - - DRUGBANK DB03591 C31H34F2N3O6P small molecule - - DRUGBANK 21555 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3439 RU82209 - - DRUGBANK DB03591 C31H34F2N3O6P small molecule - - DRUGBANK 25995 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6761 [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile - - DRUGBANK DB07966 C22H19N7 small molecule - - DRUGBANK 26513 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7243 N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE - - DRUGBANK DB08462 C17H14N4O small molecule - - DRUGBANK 18048 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1834 RU85493 - - DRUGBANK DB01908 C32H36N3O9P small molecule - - DRUGBANK 18049 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1834 RU85493 - - DRUGBANK DB01908 C32H36N3O9P small molecule - - DRUGBANK 18050 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1834 RU85493 - - DRUGBANK DB01908 C32H36N3O9P small molecule - - DRUGBANK 17552 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1614 RU84687 N-acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]-3-formyl-O-phosphonotyrosinamide - DRUGBANK DB01678 C31H34N3O8P small molecule - - DRUGBANK 20112 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2788 RU78783 - - DRUGBANK DB02908 C7H10O6P2 small molecule - - DRUGBANK 20113 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2788 RU78783 - - DRUGBANK DB02908 C7H10O6P2 small molecule - - DRUGBANK 20114 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2788 RU78783 - - DRUGBANK DB02908 C7H10O6P2 small molecule - - DRUGBANK 24911 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5702 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea - - DRUGBANK DB06882 C24H25N5O small molecule - - DRUGBANK 24913 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5703 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea - - DRUGBANK DB06883 C20H23N5O small molecule - - DRUGBANK 20769 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3085 DPI59 - - DRUGBANK DB03217 C11H11O4P small molecule - - DRUGBANK 20497 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2975 RU82129 - - DRUGBANK DB03104 C33H33N3O6 small molecule - - DRUGBANK 20498 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2975 RU82129 - - DRUGBANK DB03104 C33H33N3O6 small molecule - - DRUGBANK 20499 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2975 RU82129 - - DRUGBANK DB03104 C33H33N3O6 small molecule - - DRUGBANK 18964 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2241 RU83876 - - DRUGBANK DB02336 C30H35N3O9P2 small molecule - - DRUGBANK 18965 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2241 RU83876 - - DRUGBANK DB02336 C30H35N3O9P2 small molecule - - DRUGBANK 18966 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2241 RU83876 - - DRUGBANK DB02336 C30H35N3O9P2 small molecule - - DRUGBANK 26606 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7341 (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide - - DRUGBANK DB08564 C20H20BrN5O small molecule - - DRUGBANK 22039 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3666 RU78299 - - DRUGBANK DB03828 C9H9O6P small molecule - - DRUGBANK 22521 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3912 RU78191 - - DRUGBANK DB04080 C9H8O4 small molecule - - DRUGBANK 21781 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3556 RU85053 - - DRUGBANK DB03712 C33H35N3O7 small molecule - - DRUGBANK 21782 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3556 RU85053 - - DRUGBANK DB03712 C33H35N3O7 small molecule - - DRUGBANK 21783 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3556 RU85053 - - DRUGBANK DB03712 C33H35N3O7 small molecule - - DRUGBANK 21620 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3475 ISO24 - - DRUGBANK DB03628 C9H12NO4P small molecule - - DRUGBANK 22939 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22940 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22941 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 17979 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1796 RU79256 - - DRUGBANK DB01866 C8H8O5S small molecule - - DRUGBANK 19871 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2647 RU79072 - - DRUGBANK DB02762 C10H7N2O4P small molecule - - DRUGBANK 20874 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3134 RU82197 - - DRUGBANK DB03268 C32H33N3O6 small molecule - - DRUGBANK 20875 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3134 RU82197 - - DRUGBANK DB03268 C32H33N3O6 small molecule - - DRUGBANK 20876 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3134 RU82197 - - DRUGBANK DB03268 C32H33N3O6 small molecule - - DRUGBANK 26075 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6847 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine - - DRUGBANK DB08054 C17H16N6 small molecule - - DRUGBANK 26965 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens inhibitor target O'Hare T (2009) 19878872 182132 7645 Ponatinib AP24534|AP 24534|Ponatinibum iclusig DRUGBANK DB08901 C29H27F3N6O small molecule L01XE24 943319-70-8 DRUGBANK 20932 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3171 RU78300 - - DRUGBANK DB03306 C8H9O6P small molecule - - DRUGBANK 18185 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1886 Phosphonotyrosine - - DRUGBANK DB01962 C9H12NO6P small molecule - 21820-51-9 DRUGBANK 18186 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1886 Phosphonotyrosine - - DRUGBANK DB01962 C9H12NO6P small molecule - 21820-51-9 DRUGBANK 26074 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6846 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine - - DRUGBANK DB08053 C17H19N5O2 small molecule - - DRUGBANK 27502 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens inhibitor target Hilberg F (2008) 18559524 188554 7826 Nintedanib methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ofev DRUGBANK DB09079 C31H33N5O4 small molecule L01XE31 656247-17-5 DRUGBANK 26073 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6845 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine - - DRUGBANK DB08052 C17H17N7 small molecule - - DRUGBANK 25665 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6468 N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE - - DRUGBANK DB07662 C17H13BrN4O small molecule - - DRUGBANK 19194 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2335 RU90395 - - DRUGBANK DB02432 C35H36FN3O9 small molecule - - DRUGBANK 19195 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2335 RU90395 - - DRUGBANK DB02432 C35H36FN3O9 small molecule - - DRUGBANK 19196 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2335 RU90395 - - DRUGBANK DB02432 C35H36FN3O9 small molecule - - DRUGBANK 21439 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3379 RU79073 - - DRUGBANK DB03525 C9H12NO4P small molecule - - DRUGBANK 25339 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6151 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL - - DRUGBANK DB07335 C14H15N5O small molecule - - DRUGBANK 20331 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2897 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine - - DRUGBANK DB03023 C15H17ClN5 small molecule - - DRUGBANK 18029 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1820 N6-Benzyl Adenosine-5'-Diphosphate - - DRUGBANK DB01893 C17H21N5O10P2 small molecule - - DRUGBANK 18030 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1820 N6-Benzyl Adenosine-5'-Diphosphate - - DRUGBANK DB01893 C17H21N5O10P2 small molecule - - DRUGBANK 15403 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens multitarget target Schittenhelm MM (2006) 16397263 180858 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15404 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens multitarget target Quintas-Cardama A (2006) 17155893 180859 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15405 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens multitarget target Chen X (2002) 11752352 171740 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15406 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens multitarget target Kamath AV (2008) 17429625 180862 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15407 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens multitarget target Nam S (2005) 16230377 180861 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15408 112592 6714 RP5-823N20.1 SRC ASV|SRC1|c-SRC|p60-Src 9606 Homo sapiens multitarget target Serrels A (2006) 17148760 180860 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 27742 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Rabe T (2000) 11075290 175560 8156 Norgestrel LD norgestrel|17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one|Methylnorethindrone low-ogestrel|ovrette tablets|e DRUGBANK DB09389 C21H28O2 small molecule G03FB01|G03FA10|G03AA06 6533-00-2 DRUGBANK 14956 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Suzuki R (2010) 20460827 180666 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14957 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Thigpen AE (1992) 1314830 180669 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14958 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Levy MA (1995) 7734398 180668 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14959 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Tian G (1994) 8117686 180670 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14960 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Smith AB (2009) 19707263 180280 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14003 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Rittmaster RS (2009) 19200641 180286 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14004 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Keam SJ (2008) 18318566 180285 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14005 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Shah SK (2009) 19091347 180279 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14006 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Xu Y (2006) 16818707 180283 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14007 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Goldenberg L (2009) 19543428 180282 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14008 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Aggarwal S (2010) 19879888 180281 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14009 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Smith AB (2009) 19707263 180280 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14010 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14011 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Rathnayake D (2010) 20426708 180284 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 6044 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Rabe T (2000) 11075290 175560 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6045 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens inhibitor target Hammond GL (2001) 11521119 175561 359 Levonorgestrel 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton option 2|levonest|sronyx|avian DRUGBANK DB00367 C21H28O2 small molecule G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09 797-63-7 DRUGBANK 6763 112593 6715 - SRD5A1 S5AR 1 9606 Homo sapiens antagonist target Corvol P (1975) 166833 175954 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 14948 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Xu Y (2006) 16818707 180283 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14949 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Goldenberg L (2009) 19543428 180282 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14950 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Smith AB (2009) 19707263 180280 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14951 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Joseph MA (2005) 16019620 180665 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14952 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Ha SJ (2003) 12670724 180664 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14953 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Suzuki R (2010) 20460827 180666 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 14954 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Bowman CJ (2003) 12773767 180663 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 6761 112594 6716 - SRD5A2 - 9606 Homo sapiens antagonist target Corvol P (1975) 166833 175954 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 13994 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Rittmaster RS (2009) 19200641 180286 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 13995 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Keam SJ (2008) 18318566 180285 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 13996 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Shah SK (2009) 19091347 180279 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 13997 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Xu Y (2006) 16818707 180283 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 13998 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Goldenberg L (2009) 19543428 180282 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 13999 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Aggarwal S (2010) 19879888 180281 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14000 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Smith AB (2009) 19707263 180280 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14001 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 14002 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Rathnayake D (2010) 20426708 180284 1114 Dutasteride (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide teva-dutasteride|med-dutasteri DRUGBANK DB01126 C27H30F6N2O2 small molecule G04CB02|G04CA52 164656-23-9 DRUGBANK 7977 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7978 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7979 112594 6716 - SRD5A2 - 9606 Homo sapiens inhibitor target Stamatiadis D (1988) 3207614 176812 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 14955 112596 6718 - AKR1D1 3o5bred|CBAS2|SRD5B1 9606 Homo sapiens inhibitor target Drury JE (2009) 19515843 180667 1204 Finasteride Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida auro-finasteride 1mg|act finas DRUGBANK DB01216 C23H36N2O2 small molecule D11AX10|G04CB01|G04CA51 98319-26-7 DRUGBANK 25465 112596 6718 - AKR1D1 3o5bred|CBAS2|SRD5B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6258 5-beta-DIHYDROTESTOSTERONE - - DRUGBANK DB07447 C19H30O2 small molecule - - DRUGBANK 25570 112596 6718 - AKR1D1 3o5bred|CBAS2|SRD5B1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6366 (5BETA)-PREGNANE-3,20-DIONE - - DRUGBANK DB07557 C21H32O2 small molecule - - DRUGBANK 7976 112596 6718 - AKR1D1 3o5bred|CBAS2|SRD5B1 9606 Homo sapiens inhibitor target Stamatiadis D (1988) 3207614 176812 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 3803 112611 6733 - SRPK2 SFRSK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 19813 112611 6733 - SRPK2 SFRSK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2621 Purvalanol - - DRUGBANK DB02733 C20H25ClN6O3 small molecule - - DRUGBANK 23299 112611 6733 - SRPK2 SFRSK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 11084 112628 6750 - SST SMST 9606 Homo sapiens binder target McIntosh C (1984) 6142843 178675 837 Cysteamine Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol cystaran|cystagon|procysbi del DRUGBANK DB00847 C2H7NS small molecule A16AA04|S01XA21 60-23-1 DRUGBANK 11085 112628 6750 - SST SMST 9606 Homo sapiens binder target McIntosh CH (1988) 2901134 178674 837 Cysteamine Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol cystaran|cystagon|procysbi del DRUGBANK DB00847 C2H7NS small molecule A16AA04|S01XA21 60-23-1 DRUGBANK 11086 112628 6750 - SST SMST 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 837 Cysteamine Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol cystaran|cystagon|procysbi del DRUGBANK DB00847 C2H7NS small molecule A16AA04|S01XA21 60-23-1 DRUGBANK 11087 112628 6750 - SST SMST 9606 Homo sapiens binder target Ahren B (1989) 2653642 178673 837 Cysteamine Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol cystaran|cystagon|procysbi del DRUGBANK DB00847 C2H7NS small molecule A16AA04|S01XA21 60-23-1 DRUGBANK 11088 112628 6750 - SST SMST 9606 Homo sapiens binder target Terry LC (1985) 4080089 178672 837 Cysteamine Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol cystaran|cystagon|procysbi del DRUGBANK DB00847 C2H7NS small molecule A16AA04|S01XA21 60-23-1 DRUGBANK 1266 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Matrone C (2004) 15103227 172415 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1267 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Ruan W (2006) 16223973 172414 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1268 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Jaquet P (2006) 16625841 172413 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1269 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Wang ZZ (2005) 16438887 172411 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1270 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Schmid HA (2006) 16625842 172410 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 24618 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Zatelli MC (2007) 17395978 181999 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 24619 112629 6751 - SSTR1 SRIF-2|SS-1-R|SS1-R|SS1R 9606 Homo sapiens unknown target Bruns C (2002) 11980628 181791 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 1271 112630 6752 - SSTR2 - 9606 Homo sapiens binder target Yim CB (2009) 19537708 172416 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1272 112630 6752 - SSTR2 - 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 24620 112630 6752 - SSTR2 - 9606 Homo sapiens unknown target Zatelli MC (2007) 17395978 181999 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 24621 112630 6752 - SSTR2 - 9606 Homo sapiens unknown target Bruns C (2002) 11980628 181791 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 27890 112630 6752 - SSTR2 - 9606 Homo sapiens agonist target Buil-Bruna N (2016) 26416534 196032 7782 Lanreotide Lanreotide acetate|Lanreotide|Somatuline Depot somatuline autogel|somatuline DRUGBANK DB06791 C54H69N11O10S2 small molecule H01CB03 108736-35-2 DRUGBANK 24098 112630 6752 - SSTR2 - 9606 Homo sapiens inducer target Fortune BE (2009) 19708854 182125 4694 Vapreotide Vapreotidum|Vapreotida - DRUGBANK DB04894 C57H70N12O9S2 small molecule H01CB04 103222-11-3 DRUGBANK 24622 112631 6753 - SSTR3 SS-3-R|SS3-R|SS3R|SSR-28 9606 Homo sapiens unknown target Zatelli MC (2007) 17395978 181999 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 24623 112631 6753 - SSTR3 SS-3-R|SS3-R|SS3R|SSR-28 9606 Homo sapiens unknown target Bruns C (2002) 11980628 181791 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 1261 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Bronstein MD (2006) 16809928 172409 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1262 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Jaquet P (2006) 16625841 172413 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1263 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Xie Y (2005) 16086874 172412 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1264 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Wang ZZ (2005) 16438887 172411 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 1265 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Schmid HA (2006) 16625842 172410 99 Octreotide Octreotida|Octreotidum|Octrotide sandostatin lar 20mg|sandostat DRUGBANK DB00104 C49H66N10O10S2 small molecule H01CB02 83150-76-9 DRUGBANK 24616 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Zatelli MC (2007) 17395978 181999 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 24617 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens unknown target Bruns C (2002) 11980628 181791 5568 Pasireotide Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida signifor lar|signifor DRUGBANK DB06663 C58H66N10O9 small molecule H01CB05 396091-73-9 DRUGBANK 27889 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens agonist target Buil-Bruna N (2016) 26416534 196032 7782 Lanreotide Lanreotide acetate|Lanreotide|Somatuline Depot somatuline autogel|somatuline DRUGBANK DB06791 C54H69N11O10S2 small molecule H01CB03 108736-35-2 DRUGBANK 24097 112633 6755 - SSTR5 SS-5-R 9606 Homo sapiens agonist target Fortune BE (2009) 19708854 182125 4694 Vapreotide Vapreotidum|Vapreotida - DRUGBANK DB04894 C57H70N12O9S2 small molecule H01CB04 103222-11-3 DRUGBANK 130 112645 6768 - ST14 ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14 9606 Homo sapiens unknown target Kirchhofer D (2003) 12815039 171795 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 131 112645 6768 - ST14 ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14 9606 Homo sapiens unknown target Suzuki M (2004) 14747469 171794 13 Urokinase uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator kinlytic (urokinase for inject DRUGBANK DB00013 C1376H2145N383O406S18 biologic B01AD04 9039-53-6 DRUGBANK 20532 112645 6768 - ST14 ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 20533 112645 6768 - ST14 ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2996 Benzamidine - - DRUGBANK DB03127 C7H9N2 small molecule - 618-39-3 DRUGBANK 15422 112654 6777 - STAT5B STAT5 9606 Homo sapiens inhibitor target Nam S (2007) 17431118 180869 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15423 112654 6777 - STAT5B STAT5 9606 Homo sapiens inhibitor target Fiskus W (2006) 17020995 180868 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 14495 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens inhibitor target Bamforth KJ (1992) 1397064 180477 1164 Cyclizine 1-(Diphenylmethyl)-4-methylpiperazine|Cyclizine|()-1-diphenylmethyl-4-methylpiperazine|(N-Benzhydryl)(n'-methyl)diethylenediamine|Cyclizinum|1-Benzhydryl-4-methylpiperazin|N-methyl-N'-benzhydrylpiperazine|(+-)-1-Diphenylmethyl-4-methylpiperazine|N-Benzhydryl-N'-methylpiperazine|Ciclizina megral tabs|marzine inj 50mg/m DRUGBANK DB01176 C18H22N2 small molecule R06AE53|R06AE03 82-92-8 DRUGBANK 17827 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17828 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17829 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 21019 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3209 3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol - - DRUGBANK DB03346 C12H6Cl4O2 small molecule - - DRUGBANK 21020 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3209 3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol - - DRUGBANK DB03346 C12H6Cl4O2 small molecule - - DRUGBANK 21021 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3209 3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol - - DRUGBANK DB03346 C12H6Cl4O2 small molecule - - DRUGBANK 20108 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2782 3'-Phosphate-Adenosine-5'-Phosphate Sulfate - - DRUGBANK DB02902 C10H15N5O13P2S small molecule - - DRUGBANK 20109 112660 6783 - SULT1E1 EST|EST-1|ST1E1|STE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2782 3'-Phosphate-Adenosine-5'-Phosphate Sulfate - - DRUGBANK DB02902 C10H15N5O13P2S small molecule - - DRUGBANK 2153 112661 6785 - ELOVL4 ADMD|CT118|ISQMR|SCA34|STGD2|STGD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2154 112661 6785 - ELOVL4 ADMD|CT118|ISQMR|SCA34|STGD2|STGD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 25562 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6355 N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE - - DRUGBANK DB07545 C21H18F3N5O small molecule - - DRUGBANK 25191 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6003 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE - - DRUGBANK DB07186 C23H24N6O2S small molecule - - DRUGBANK 25827 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6599 N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide - - DRUGBANK DB07801 C22H29N7O2 small molecule - - DRUGBANK 26091 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6859 N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE - - DRUGBANK DB08066 C17H13N5O small molecule - - DRUGBANK 26090 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6858 2-(1H-pyrazol-3-yl)-1H-benzimidazole - - DRUGBANK DB08065 C10H8N4 small molecule - - DRUGBANK 19298 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 19299 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2380 Phosphonothreonine - - DRUGBANK DB02482 C4H10NO6P small molecule - - DRUGBANK 25369 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6178 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea - - DRUGBANK DB07362 C19H17F3N8OS small molecule - - DRUGBANK 25367 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6176 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea - - DRUGBANK DB07360 C19H15F3N6OS2 small molecule - - DRUGBANK 25368 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6177 1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea - - DRUGBANK DB07361 C18H15ClN6OS2 small molecule - - DRUGBANK 25278 112666 6790 RP5-1167H4.6 AURKA AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6082 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one - - DRUGBANK DB07266 C21H24N4O small molecule - - DRUGBANK 23365 112686 6817 OK/SW-cl.88 SULT1A1 HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4233 P-Nitrophenol - - DRUGBANK DB04417 C6H5NO3 small molecule - 100-02-7 DRUGBANK 23366 112686 6817 OK/SW-cl.88 SULT1A1 HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4233 P-Nitrophenol - - DRUGBANK DB04417 C6H5NO3 small molecule - 100-02-7 DRUGBANK 17830 112686 6817 OK/SW-cl.88 SULT1A1 HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17831 112686 6817 OK/SW-cl.88 SULT1A1 HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 19913 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2671 Pregnenolone - - DRUGBANK DB02789 C21H32O2 small molecule - - DRUGBANK 19914 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2671 Pregnenolone - - DRUGBANK DB02789 C21H32O2 small molecule - - DRUGBANK 19915 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2671 Pregnenolone - - DRUGBANK DB02789 C21H32O2 small molecule - - DRUGBANK 17610 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17611 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17612 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17838 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17839 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 20936 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3174 N-Cyclohexyltaurine CHES - DRUGBANK DB03309 C8H17NO3S small molecule - - DRUGBANK 20937 112689 6820 - SULT2B1 HSST2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3174 N-Cyclohexyltaurine CHES - DRUGBANK DB03309 C8H17NO3S small molecule - - DRUGBANK 22340 112690 6821 - SUOX - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3817 (Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V) - - DRUGBANK DB03983 C10H13MoN5O8PS3 small molecule - - DRUGBANK 22341 112690 6821 - SUOX - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3817 (Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V) - - DRUGBANK DB03983 C10H13MoN5O8PS3 small molecule - - DRUGBANK 22342 112690 6821 - SUOX - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3817 (Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V) - - DRUGBANK DB03983 C10H13MoN5O8PS3 small molecule - - DRUGBANK 23419 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4259 Mercury Diiodide - - DRUGBANK DB04445 HgI2 small molecule - - DRUGBANK 23420 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4259 Mercury Diiodide - - DRUGBANK DB04445 HgI2 small molecule - - DRUGBANK 20029 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2736 Aetiocholanolone - - DRUGBANK DB02854 C19H30O2 small molecule - 53-42-9 DRUGBANK 20030 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2736 Aetiocholanolone - - DRUGBANK DB02854 C19H30O2 small molecule - 53-42-9 DRUGBANK 20031 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2736 Aetiocholanolone - - DRUGBANK DB02854 C19H30O2 small molecule - 53-42-9 DRUGBANK 17607 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17608 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17609 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17832 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17833 112691 6822 - SULT2A1 DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 11860 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Hu S (2000) 10773014 51241 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 11861 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Sunaga Y (2001) 11716850 178081 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 11862 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Dornhorst A (2001) 11728565 178079 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 11863 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Hansen AM (2002) 12196472 178078 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 11864 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Waengler B (2004) 15219283 179056 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 11865 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Waengler B (2004) 15380228 179057 902 Repaglinide Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW apo-repaglinide|repaglinide an DRUGBANK DB00912 C27H36N2O4 small molecule A10BD14|A10BX02 135062-02-1 DRUGBANK 4418 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Kramer W (1996) 8911984 174486 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4419 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Kramer W (1995) 8529521 174484 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 4420 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Mueller G (1994) 8172912 174485 215 Glimepiride Glimepirida|Glimpiride|Amaryl|Glimepiridum ratio-glimepiride|avandaryl|du DRUGBANK DB00222 C24H34N4O5S small molecule A10BB12|A10BD06|A10BD04 93479-97-1 DRUGBANK 13404 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Reimann F (2001) 11574406 179962 1055 Glipizide Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024 glucotrol|glipizide|glipizidee DRUGBANK DB01067 C21H27N5O4S small molecule A10BB07 29094-61-9 DRUGBANK 13405 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Lawrence CL (2001) 11484080 179963 1055 Glipizide Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024 glucotrol|glipizide|glipizidee DRUGBANK DB01067 C21H27N5O4S small molecule A10BB07 29094-61-9 DRUGBANK 13406 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Proks P (2002) 12475777 174487 1055 Glipizide Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024 glucotrol|glipizide|glipizidee DRUGBANK DB01067 C21H27N5O4S small molecule A10BB07 29094-61-9 DRUGBANK 13407 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Harrower A (2000) 11078469 179964 1055 Glipizide Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024 glucotrol|glipizide|glipizidee DRUGBANK DB01067 C21H27N5O4S small molecule A10BB07 29094-61-9 DRUGBANK 13408 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Gribble FM (2000) 11078468 179965 1055 Glipizide Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024 glucotrol|glipizide|glipizidee DRUGBANK DB01067 C21H27N5O4S small molecule A10BB07 29094-61-9 DRUGBANK 15389 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Reimann F (2001) 11574406 179962 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 15390 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Lawrence CL (2001) 11484080 179963 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 15391 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Proks P (2002) 12475777 174487 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 15392 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Harrower A (2000) 11078469 179964 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 15393 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Gribble FM (2000) 11078468 179965 1239 Gliquidone Glurenorm - DRUGBANK DB01251 C27H33N3O6S small molecule A10BB08 33342-05-1 DRUGBANK 9249 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Mizuno CS (2008) 18220763 177706 662 Chlorpropamide N-Propyl-n'-(P-chlorobenzenesulfonyl)urea|N-(P-Chlorobenzenesulfonyl)-n'-propylurea|Chlorpropamide|4-chloro-N-((Propylamino)carbonyl)benzenesulfonamide|N-Propyl-n'-P-chlorophenylsulfonylcarbamide|1-(P-Chlorobenzenesulfonyl)-3-propylurea|1-(P-Chlorophenylsulfonyl)-3-propylurea|Chlorpropamidum|Clorpropamida|N-(4-Chlorophenylsulfonyl)-n'-propylurea|Chlorpropamid|1-Propyl-3-(P-chlorobenzenesulfonyl)urea|4-chloro-N-[(Propylamino)carbonyl]benzenesulfonamide chlorpropamide|apo chlorpropam DRUGBANK DB00672 C10H13ClN2O3S small molecule A10BB02 94-20-2 DRUGBANK 15395 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Sunaga Y (2001) 11716850 178081 1240 Mitiglinide - - DRUGBANK DB01252 C19H25NO3 small molecule A10BX08 145375-43-5 DRUGBANK 15396 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Nagamatsu S (2006) 17003348 180854 1240 Mitiglinide - - DRUGBANK DB01252 C19H25NO3 small molecule A10BX08 145375-43-5 DRUGBANK 15397 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Ogawa K (2007) 17592198 180855 1240 Mitiglinide - - DRUGBANK DB01252 C19H25NO3 small molecule A10BX08 145375-43-5 DRUGBANK 13987 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Mizuno CS (2008) 18220763 177706 1112 Tolbutamide 3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea orinase 1gm|novo-butamide 500m DRUGBANK DB01124 C12H18N2O3S small molecule V04CA01|A10BB03 64-77-7 DRUGBANK 9929 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Hu S (2000) 10773014 51241 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 9930 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Norman P (2001) 12764427 178080 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 9931 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Sunaga Y (2001) 11716850 178081 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 9932 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Dornhorst A (2001) 11728565 178079 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 9933 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Hansen AM (2002) 12196472 178078 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 9934 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inhibitor target Chachin M (2003) 12604678 178077 721 Nateglinide - starlix|starlix 180mg|nateglin DRUGBANK DB00731 C19H27NO3 small molecule A10BX03 105816-04-4 DRUGBANK 3723 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens unknown target Nakamura A (2007) 17325510 174028 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3724 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens unknown target Bryan J (2007) 16897043 174022 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3725 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens unknown target Tanaka K (2007) 17457130 174026 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3726 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens unknown target Bienengraeber M (2006) 16931986 174027 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 12768 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Hambrock A (2002) 12107069 179673 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12769 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Serrano-Martin X (2006) 17015627 179676 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12770 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Ueda K (1999) 9990013 179677 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12771 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Babenko AP (2002) 12213829 179674 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12772 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Dabrowski M (2002) 12031979 179675 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12773 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Hambrock A (2002) 12145099 179665 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12774 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens modulator target Nielsen FE (2002) 12213059 179678 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 13965 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens binder target Reimann F (2001) 11574406 179962 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13966 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens binder target Lawrence CL (2001) 11484080 179963 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13967 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens binder target Proks P (2002) 12475777 174487 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13968 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens binder target Harrower A (2000) 11078469 179964 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13969 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens binder target Gribble FM (2000) 11078468 179965 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 16271 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Hambrock A (2002) 12107069 179673 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16272 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Hambrock A (2002) 12145099 179665 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16273 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Ueda K (1999) 9990013 179677 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16274 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Babenko AP (2002) 12213829 179674 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16275 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Dabrowski M (2002) 12031979 179675 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 16276 112700 6833 - ABCC8 ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2 9606 Homo sapiens inducer target Nielsen FE (2002) 12213059 179678 1338 Glycodiazine Glidiazine|Glymidine - DRUGBANK DB01382 C13H15N3O4S small molecule A10BC01 339-44-6 DRUGBANK 544 112710 6843 - VAMP1 SPAX1|SYB1|VAMP-1 9606 Homo sapiens binder target Imming P (2006) 17016423 171742 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 545 112710 6843 - VAMP1 SPAX1|SYB1|VAMP-1 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 546 112710 6843 - VAMP1 SPAX1|SYB1|VAMP-1 9606 Homo sapiens binder target Overington JP (2006) 17139284 171741 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 547 112711 6844 - VAMP2 SYB2|VAMP-2 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 548 112711 6844 - VAMP2 SYB2|VAMP-2 9606 Homo sapiens binder target Liu W (2003) 14573702 172010 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 25197 112717 6850 - SYK p72-Syk 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6011 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide - - DRUGBANK DB07194 C20H23N5O2S small molecule - - DRUGBANK 26411 112717 6850 - SYK p72-Syk 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7146 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide - - DRUGBANK DB08361 C18H24N6O small molecule - - DRUGBANK 18322 112717 6850 - SYK p72-Syk 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18323 112717 6850 - SYK p72-Syk 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 24857 112717 6850 - SYK p72-Syk 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5655 N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide - - DRUGBANK DB06834 C21H22N4O2 small molecule - - DRUGBANK 25169 112717 6850 - SYK p72-Syk 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5977 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one - - DRUGBANK DB07159 C22H23FN6O5 small molecule - - DRUGBANK 26918 112717 6850 - SYK p72-Syk 9606 Homo sapiens inhibitor target Cozza G (2006) 16610779 181936 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 17522 112719 6853 RP1-230G1.2 SYN1 SYN1a|SYN1b|SYNI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 17523 112719 6853 RP1-230G1.2 SYN1 SYN1a|SYN1b|SYNI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 17524 112719 6853 RP1-230G1.2 SYN1 SYN1a|SYN1b|SYNI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 25194 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6006 (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid - - DRUGBANK DB07189 C29H24N2O4 small molecule - - DRUGBANK 25993 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6759 (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE - - DRUGBANK DB07964 C17H22N2O5S2 small molecule - - DRUGBANK 25156 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5963 (2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE - - DRUGBANK DB07145 C25H27N3O4 small molecule - - DRUGBANK 25083 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5897 3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol - - DRUGBANK DB07079 C13H16O3S2 small molecule - - DRUGBANK 25244 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6049 N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan - - DRUGBANK DB07233 C22H22N2O5S small molecule - - DRUGBANK 24966 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5762 (3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol - - DRUGBANK DB06943 C14H17NO3S2 small molecule - - DRUGBANK 25158 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5965 methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate - - DRUGBANK DB07147 C24H24N2O5 small molecule - - DRUGBANK 25130 112731 6868 - ADAM17 ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5939 4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE - - DRUGBANK DB07121 C17H23N3O5S2 small molecule - - DRUGBANK 27467 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Darmani NA (2015) 25687374 188541 7809 Netupitant 2-[3,5-Bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]propanamide akynzeo DRUGBANK DB09048 C30H32F6N4O small molecule - 290297-26-6 DRUGBANK 9250 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 663 Aprepitant 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum emend|emend tri-pack DRUGBANK DB00673 C23H21F7N4O3 small molecule A04AD12 170729-80-3 DRUGBANK 9251 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Bergstroem M (2004) 15121485 177709 663 Aprepitant 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum emend|emend tri-pack DRUGBANK DB00673 C23H21F7N4O3 small molecule A04AD12 170729-80-3 DRUGBANK 9252 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Brands KM (2003) 12590540 177713 663 Aprepitant 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum emend|emend tri-pack DRUGBANK DB00673 C23H21F7N4O3 small molecule A04AD12 170729-80-3 DRUGBANK 9253 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Rodgers J (2007) 17643344 177712 663 Aprepitant 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum emend|emend tri-pack DRUGBANK DB00673 C23H21F7N4O3 small molecule A04AD12 170729-80-3 DRUGBANK 9254 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Poli-Bigelli S (2003) 12784346 177711 663 Aprepitant 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum emend|emend tri-pack DRUGBANK DB00673 C23H21F7N4O3 small molecule A04AD12 170729-80-3 DRUGBANK 9255 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Zhao MM (2002) 12227806 177710 663 Aprepitant 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum emend|emend tri-pack DRUGBANK DB00673 C23H21F7N4O3 small molecule A04AD12 170729-80-3 DRUGBANK 15000 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Okamoto T (2003) 12818951 180700 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 24099 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 4694 Vapreotide Vapreotidum|Vapreotida - DRUGBANK DB04894 C57H70N12O9S2 small molecule H01CB04 103222-11-3 DRUGBANK 24100 112732 6869 - TACR1 NK1R|NKIR|SPR|TAC1R 9606 Homo sapiens antagonist target Betoin F (1995) 7556407 181684 4694 Vapreotide Vapreotidum|Vapreotida - DRUGBANK DB04894 C57H70N12O9S2 small molecule H01CB04 103222-11-3 DRUGBANK 24051 112733 6870 - TACR3 HH11|NK-3R|NK3R|NKR|TAC3RL 9606 Homo sapiens unknown target Tian G (2007) 17172464 181978 4672 Osanetant - - DRUGBANK DB04872 C35H41Cl2N3O2 small molecule - 160492-56-8 DRUGBANK 2993 112760 6897 - TARS ThrRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 2994 112760 6897 - TARS ThrRS 9606 Homo sapiens unknown target Ruan B (2005) 15507440 173631 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 2995 112760 6897 - TARS ThrRS 9606 Homo sapiens unknown target Cusack S (1998) 9493271 173632 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 2996 112760 6897 - TARS ThrRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 2997 112760 6897 - TARS ThrRS 9606 Homo sapiens unknown target Torres-Larios A (2003) 12875846 173633 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 1778 112761 6898 - TAT - 9606 Homo sapiens unknown target Rege AA (1987) 2890101 172738 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1779 112761 6898 - TAT - 9606 Homo sapiens unknown target De-Eknamkul W (1989) 16666560 172739 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1780 112761 6898 - TAT - 9606 Homo sapiens unknown target Luong TN (1997) 9356140 172736 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1781 112761 6898 - TAT - 9606 Homo sapiens unknown target Patrizio M (2001) 11299302 172737 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 2211 112761 6898 - TAT - 9606 Homo sapiens unknown target Dong S (2007) 17389761 173127 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 1415 112761 6898 - TAT - 9606 Homo sapiens cofactor target Biagini MR (2006) 16570355 172479 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1416 112761 6898 - TAT - 9606 Homo sapiens cofactor target Kim SY (2006) 16466641 172478 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1417 112761 6898 - TAT - 9606 Homo sapiens cofactor target Shaffer WA (2002) 12441383 172480 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1418 112761 6898 - TAT - 9606 Homo sapiens cofactor target Venhorst J (2003) 12798391 172477 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1419 112761 6898 - TAT - 9606 Homo sapiens cofactor target Clayton TA (2007) 16902803 172481 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2356 112761 6898 - TAT - 9606 Homo sapiens unknown target Ozturk M (2006) 16840830 173217 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 14856 112777 6915 - TBXA2R BDPLT13|TXA2-R 9606 Homo sapiens antagonist target Ragni M (1996) 8697470 180633 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14857 112777 6915 - TBXA2R BDPLT13|TXA2-R 9606 Homo sapiens antagonist target Hempelmann RG (1999) 10522750 180636 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14858 112777 6915 - TBXA2R BDPLT13|TXA2-R 9606 Homo sapiens antagonist target Soyka R (1994) 8289199 180637 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14859 112777 6915 - TBXA2R BDPLT13|TXA2-R 9606 Homo sapiens antagonist target Carvalho MH (1997) 9272380 180634 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14860 112777 6915 - TBXA2R BDPLT13|TXA2-R 9606 Homo sapiens antagonist target Heinisch G (1996) 8831771 180635 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14861 112777 6915 - TBXA2R BDPLT13|TXA2-R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 10548 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens antagonist target Stenson WF (1983) 6135423 178412 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 24334 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5264 NM-702 - - DRUGBANK DB05505 - small molecule - - DRUGBANK 14850 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target De Cree J (1993) 8376914 180632 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14851 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Tytgat GN (2002) 11856082 180630 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14852 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Carty E (2000) 10848666 180631 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14853 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Park SJ (1999) 11270983 180629 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14854 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Unknown Authors (1994) 8313547 180628 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 14855 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1195 Ridogrel Ridogrel|R-68070|Ridogrelum - DRUGBANK DB01207 C18H17F3N2O3 small molecule - 110140-89-1 DRUGBANK 20390 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 2924 Dazoxiben Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum - DRUGBANK DB03052 C12H12N2O3 small molecule - - DRUGBANK 20391 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2924 Dazoxiben Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum - DRUGBANK DB03052 C12H12N2O3 small molecule - - DRUGBANK 20392 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 2924 Dazoxiben Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum - DRUGBANK DB03052 C12H12N2O3 small molecule - - DRUGBANK 20393 112778 6916 - TBXAS1 BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 2924 Dazoxiben Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum - DRUGBANK DB03052 C12H12N2O3 small molecule - - DRUGBANK 23373 112789 6927 - HNF1A HNF-1A|HNF1|IDDM20|LFB1|MODY3|TCF-1|TCF1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4235 Norleucine - - DRUGBANK DB04419 C6H13NO2 small molecule - - DRUGBANK 4162 112807 6947 - TCN1 HC|TC-1|TC1|TCI 9606 Homo sapiens unknown target MacDonald CM (1977) 844253 174323 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4163 112807 6947 - TCN1 HC|TC-1|TC1|TCI 9606 Homo sapiens unknown target Rothenberg SP (1984) 6726060 174322 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 27543 112815 6955 - TRA IMD7|TCRA|TCRD|TRA@|TRAC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2626 3-Indolebutyric Acid - - DRUGBANK DB02740 C12H13NO2 small molecule - 133-32-4 DRUGBANK 18629 112860 7001 - PRDX2 HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 18630 112860 7001 - PRDX2 HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 22433 112860 7001 - PRDX2 HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3880 N-Carbamoyl-Alanine - - DRUGBANK DB04048 C4H8N2O3 small molecule - - DRUGBANK 22434 112860 7001 - PRDX2 HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3880 N-Carbamoyl-Alanine - - DRUGBANK DB04048 C4H8N2O3 small molecule - - DRUGBANK 27080 112869 7010 - TEK CD202B|TIE-2|TIE2|VMCM|VMCM1 9606 Homo sapiens unknown target Gong XW (2012) 22406116 188480 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 26240 112869 7010 - TEK CD202B|TIE-2|TIE2|VMCM|VMCM1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7012 N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE - - DRUGBANK DB08221 C24H18F3N5O small molecule - - DRUGBANK 7498 112874 7015 - TERT CMM9|DKCA2|DKCB4|EST2|PFBMFT1|TCS1|TP2|TRT|hEST2|hTRT 9606 Homo sapiens inhibitor target Leeansyah E (2013) 23303810 176483 487 Zidovudine AZT|ZDV|Azidothymidine|Zidovudin|Zidovudinum trizivir|retrovir (azt)|apo-la DRUGBANK DB00495 C10H13N5O4 small molecule J05AR01|J05AF01|J05AR05|J05AR04 30516-87-1 DRUGBANK 24179 112874 7015 - TERT CMM9|DKCA2|DKCB4|EST2|PFBMFT1|TCS1|TP2|TRT|hEST2|hTRT 9606 Homo sapiens unknown target Kokhaei P (2007) 17258078 181984 4733 GV1001 - - DRUGBANK DB04937 - biologic - - DRUGBANK 16217 112876 7018 PRO1400 TF PRO1557|PRO2086|TFQTL1 9606 Homo sapiens unknown target Nagaoka MH (2005) 16139893 181200 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16218 112876 7018 PRO1400 TF PRO1557|PRO2086|TFQTL1 9606 Homo sapiens unknown target Nolte E (2001) 11327511 181201 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16219 112876 7018 PRO1400 TF PRO1557|PRO2086|TFQTL1 9606 Homo sapiens unknown target Mizutani K (2005) 16301797 181202 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 16220 112876 7018 PRO1400 TF PRO1557|PRO2086|TFQTL1 9606 Homo sapiens unknown target Beardmore J (2007) 17629565 181203 1331 Aluminium Aluminio|Aluminium|13Al|Al|Aluminum humco aluminum acetate (burrow DRUGBANK DB01370 Al small molecule - 7429-90-5 DRUGBANK 20459 112890 7032 - TFF2 SML1|SP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 24830 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens inhibitor target Mousa SA (2004) 15179449 181849 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 24831 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens inhibitor target Bendz B (2000) 10847421 181752 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 24832 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens inhibitor target Naumnik B (2011) 20682597 182162 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 445 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens unknown target Hansen CB (2001) 11238112 171940 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 446 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens unknown target Lee AY (2003) 12974870 171937 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 447 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens unknown target Stassens P (1996) 8700900 171939 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 448 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens unknown target Narita M (1995) 7559599 171938 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 449 112893 7035 - TFPI EPI|LACI|TFI|TFPI1 9606 Homo sapiens unknown target Mine S (2002) 11772005 171941 36 Coagulation factor VIIa Recombinant Human rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa niastase rt|novoseven rt|niast DRUGBANK DB00036 C1972H3076N560O597S28 biologic B02BD08 102786-61-8 DRUGBANK 812 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Chang NS (1998) 9850732 172163 69 Hyaluronidase Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1 wydase injection liq 150 units DRUGBANK DB00070 C2455H3775N617O704S21 biologic B06AA03 488712-31-8 DRUGBANK 813 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Chang NS (2001) 11327694 172166 69 Hyaluronidase Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1 wydase injection liq 150 units DRUGBANK DB00070 C2455H3775N617O704S21 biologic B06AA03 488712-31-8 DRUGBANK 814 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Locci P (1995) 7648625 172165 69 Hyaluronidase Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1 wydase injection liq 150 units DRUGBANK DB00070 C2455H3775N617O704S21 biologic B06AA03 488712-31-8 DRUGBANK 815 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Chang NS (1997) 9435505 172164 69 Hyaluronidase Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1 wydase injection liq 150 units DRUGBANK DB00070 C2455H3775N617O704S21 biologic B06AA03 488712-31-8 DRUGBANK 27375 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Chang NS (1998) 9850732 172163 7766 Hyaluronidase (Human Recombinant) Hyaluronidase recombinant human|Recombinant human hyaluronidase hylenex recombinant DRUGBANK DB06205 - biologic - - DRUGBANK 27376 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Chang NS (2001) 11327694 172166 7766 Hyaluronidase (Human Recombinant) Hyaluronidase recombinant human|Recombinant human hyaluronidase hylenex recombinant DRUGBANK DB06205 - biologic - - DRUGBANK 27377 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Locci P (1995) 7648625 172165 7766 Hyaluronidase (Human Recombinant) Hyaluronidase recombinant human|Recombinant human hyaluronidase hylenex recombinant DRUGBANK DB06205 - biologic - - DRUGBANK 27378 112898 7040 - TGFB1 CED|DPD1|LAP|TGFB|TGFbeta 9606 Homo sapiens inhibitor target Chang NS (1997) 9435505 172164 7766 Hyaluronidase (Human Recombinant) Hyaluronidase recombinant human|Recombinant human hyaluronidase hylenex recombinant DRUGBANK DB06205 - biologic - - DRUGBANK 20956 112901 7043 - TGFB3 ARVD|ARVD1|RNHF|TGF-beta3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 20957 112901 7043 - TGFB3 ARVD|ARVD1|RNHF|TGF-beta3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 20958 112901 7043 - TGFB3 ARVD|ARVD1|RNHF|TGF-beta3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 22193 112904 7046 RP11-96L7.1 TGFBR1 AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3758 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline - - DRUGBANK DB03921 C17H12N4 small molecule - - DRUGBANK 23385 112904 7046 RP11-96L7.1 TGFBR1 AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4249 Naphthyridine Inhibitor - - DRUGBANK DB04434 C17H15N5 small molecule - - DRUGBANK 23537 112904 7046 RP11-96L7.1 TGFBR1 AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4293 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole - - DRUGBANK DB04480 C18H16FN3 small molecule - - DRUGBANK 26499 112904 7046 RP11-96L7.1 TGFBR1 AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7232 N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine - - DRUGBANK DB08450 C21H16N6 small molecule - - DRUGBANK 25164 112904 7046 RP11-96L7.1 TGFBR1 AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5970 N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide - - DRUGBANK DB07152 C19H15FN6O small molecule - - DRUGBANK 25279 112904 7046 RP11-96L7.1 TGFBR1 AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6083 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine - - DRUGBANK DB07267 C19H15N5 small molecule - - DRUGBANK 22489 112906 7048 - TGFBR2 AAT3|FAA3|LDS1B|LDS2|LDS2B|MFS2|RIIC|TAAD2|TGFR-2|TGFbeta-RII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22490 112906 7048 - TGFBR2 AAT3|FAA3|LDS1B|LDS2|LDS2B|MFS2|RIIC|TAAD2|TGFR-2|TGFbeta-RII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 23087 112910 7052 RP5-1054A22.2 TGM2 G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23088 112910 7052 RP5-1054A22.2 TGM2 G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 18213 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18214 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 17971 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 17972 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 23093 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23094 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 20675 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3020 B-2-Octylglucoside - - DRUGBANK DB03152 C14H28O6 small molecule - - DRUGBANK 20676 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3020 B-2-Octylglucoside - - DRUGBANK DB03152 C14H28O6 small molecule - - DRUGBANK 20677 112911 7053 - TGM3 TGE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3020 B-2-Octylglucoside - - DRUGBANK DB03152 C14H28O6 small molecule - - DRUGBANK 1783 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1784 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Fusetti F (1998) 9642259 12571 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1785 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target McQuade PS (1983) 6621777 172743 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1786 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Schallreuter KU (2003) 12565907 172742 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1787 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Ogawa S (2006) 16581181 172741 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1788 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Fukami MH (1990) 1973034 172740 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 10250 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Shore PA (1975) 1168577 178289 755 Metyrosine Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine demser DRUGBANK DB00765 C10H13NO3 small molecule C02KB01 672-87-7 DRUGBANK 10251 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 755 Metyrosine Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine demser DRUGBANK DB00765 C10H13NO3 small molecule C02KB01 672-87-7 DRUGBANK 10252 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Nasrallah HA (1977) 17374 178292 755 Metyrosine Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine demser DRUGBANK DB00765 C10H13NO3 small molecule C02KB01 672-87-7 DRUGBANK 10253 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Yoshimoto Y (2005) 15710413 178291 755 Metyrosine Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine demser DRUGBANK DB00765 C10H13NO3 small molecule C02KB01 672-87-7 DRUGBANK 10254 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Moore KE (1980) 7409209 178290 755 Metyrosine Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine demser DRUGBANK DB00765 C10H13NO3 small molecule C02KB01 672-87-7 DRUGBANK 21477 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3401 Meta-Tyrosine - - DRUGBANK DB03552 C9H11NO3 small molecule - - DRUGBANK 21478 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3401 Meta-Tyrosine - - DRUGBANK DB03552 C9H11NO3 small molecule - - DRUGBANK 21479 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3401 Meta-Tyrosine - - DRUGBANK DB03552 C9H11NO3 small molecule - - DRUGBANK 5935 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens cofactor target Chen X (2002) 11752352 171740 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5936 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens cofactor target Schwarz EJ (1999) 10543618 175473 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5937 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens cofactor target Koshimura K (1999) 10197775 175474 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5938 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens cofactor target Ichinose H (1999) 10464780 175475 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5939 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens cofactor target Schallreuter KU (1999) 10643998 175476 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5940 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens cofactor target Flatmark T (1999) 10411647 175477 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 2200 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Rostrup M (2008) 17520326 173119 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2201 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Chen X (2002) 11752352 171740 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2202 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Olsovska J (2007) 17604359 173120 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2203 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Bodnar I (2007) 17451064 173121 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2204 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Ugriumov MV (2007) 17578016 173122 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2205 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens binder target Richards AB (2007) 17561836 173123 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 23335 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23336 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 23337 112912 7054 - TH DYT14|DYT5b|TYH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 689 112914 7056 - THBD AHUS6|BDCA3|CD141|THPH12|THRM|TM 9606 Homo sapiens unknown target McCachren SS (1991) 1660324 172084 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 690 112914 7056 - THBD AHUS6|BDCA3|CD141|THPH12|THRM|TM 9606 Homo sapiens unknown target Pineda AO (2004) 15252033 172080 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 691 112914 7056 - THBD AHUS6|BDCA3|CD141|THPH12|THRM|TM 9606 Homo sapiens unknown target Shirai T (1988) 2836377 172081 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 692 112914 7056 - THBD AHUS6|BDCA3|CD141|THPH12|THRM|TM 9606 Homo sapiens unknown target Gresele P (2002) 11804648 172082 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 693 112914 7056 - THBD AHUS6|BDCA3|CD141|THPH12|THRM|TM 9606 Homo sapiens unknown target Boffa MC (1987) 3039877 172083 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 13287 112914 7056 - THBD AHUS6|BDCA3|CD141|THPH12|THRM|TM 9606 Homo sapiens modulator target Palayoor ST (2012) 22668799 179903 1039 Ibuprofen Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin advil cold and sinus nighttime DRUGBANK DB01050 C13H18O2 small molecule M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51 15687-27-1 DRUGBANK 7016 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7017 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7018 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7019 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Nakajima Y (2010) 20615127 176152 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7020 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Bernal J (2007) 17315033 174854 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 5061 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5062 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Kariv R (2003) 12955882 174848 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5063 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Jiang W (2004) 15283690 174849 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5064 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Timmer DC (2003) 14596673 174846 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5065 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Mai W (2004) 15240882 174847 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5066 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Sciaudone MP (2004) 15235154 174845 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 25445 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6238 {4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid - - DRUGBANK DB07425 C20H24O4 small molecule - - DRUGBANK 17111 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17112 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17113 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17114 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Nakajima Y (2010) 20615127 176152 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17115 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Mai W (2004) 15240882 174847 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17116 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Kariv R (2003) 12955882 174848 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17117 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Jiang W (2004) 15283690 174849 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17118 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Timmer DC (2003) 14596673 174846 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17119 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Bernal J (2007) 17315033 174854 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17120 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Sciaudone MP (2004) 15235154 174845 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 20711 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3044 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid - - DRUGBANK DB03176 C17H16Cl2O4 small molecule - - DRUGBANK 7600 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Bernal J (2007) 17315033 174854 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7601 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Kariv R (2003) 12955882 174848 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7602 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Jiang W (2004) 15283690 174849 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7603 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Timmer DC (2003) 14596673 174846 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7604 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Mai W (2004) 15240882 174847 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7605 112923 7067 - THRA AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1 9606 Homo sapiens agonist target Sciaudone MP (2004) 15235154 174845 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 21581 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3452 [4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid - - DRUGBANK DB03604 C14H9I3O4 small molecule - - DRUGBANK 21582 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3452 [4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid - - DRUGBANK DB03604 C14H9I3O4 small molecule - - DRUGBANK 7021 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7022 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Marazuela M (2008) 18816177 176154 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7023 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Grasberger H (2005) 16053391 176155 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 7024 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Sivakumar T (2010) 20151830 176153 443 Levothyroxine O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4 pms-levothyroxine sodium tab 3 DRUGBANK DB00451 C15H11I4NO4 small molecule H03AA01 51-48-9 DRUGBANK 17121 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Grasberger H (2005) 16053391 176155 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17122 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17123 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Marazuela M (2008) 18816177 176154 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17124 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17125 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17126 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Sivakumar T (2010) 20151830 176153 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17127 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Wu SY (2005) 16099238 174850 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17128 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Yen PM (2003) 12776178 174853 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17129 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Gonzalez-Sancho JM (2003) 12668276 174852 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 17130 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Bernal J (2007) 17315033 174854 1523 Liotrix Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar - DRUGBANK DB01583 C30H21I7N2Na2O8 small molecule - 8065-29-0 DRUGBANK 24284 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4822 KB2115 Eprotirome - DRUGBANK DB05035 - small molecule - - DRUGBANK 5067 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5068 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5069 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5070 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Kullak-Ublick GA (2001) 11159893 174851 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5071 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Wu SY (2005) 16099238 174850 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5072 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Yen PM (2003) 12776178 174853 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5073 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Gonzalez-Sancho JM (2003) 12668276 174852 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 5074 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Bernal J (2007) 17315033 174854 272 Liothyronine Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine triostat|liothyronine sodium|n DRUGBANK DB00279 C15H12I3NO4 small molecule H03AA02|H03AA03 6893-02-3 DRUGBANK 21924 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3627 GC-24 - - DRUGBANK DB03788 C24H24O4 small molecule - - DRUGBANK 21925 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3627 GC-24 - - DRUGBANK DB03788 C24H24O4 small molecule - - DRUGBANK 20715 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3049 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione - - DRUGBANK DB03181 C20H21N3O4 small molecule - - DRUGBANK 20716 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3049 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione - - DRUGBANK DB03181 C20H21N3O4 small molecule - - DRUGBANK 20717 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3049 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione - - DRUGBANK DB03181 C20H21N3O4 small molecule - - DRUGBANK 18539 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2026 [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid - - DRUGBANK DB02106 C23H23Br2NO5 small molecule - - DRUGBANK 18540 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2026 [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid - - DRUGBANK DB02106 C23H23Br2NO5 small molecule - - DRUGBANK 25444 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6238 {4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid - - DRUGBANK DB07425 C20H24O4 small molecule - - DRUGBANK 26115 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6878 1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE - - DRUGBANK DB08085 C15H20O small molecule - - DRUGBANK 24287 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4974 MB07811 - - DRUGBANK DB05192 - small molecule - - DRUGBANK 20708 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3044 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid - - DRUGBANK DB03176 C17H16Cl2O4 small molecule - - DRUGBANK 20709 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3044 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid - - DRUGBANK DB03176 C17H16Cl2O4 small molecule - - DRUGBANK 20710 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3044 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid - - DRUGBANK DB03176 C17H16Cl2O4 small molecule - - DRUGBANK 7607 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7608 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7609 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7610 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Wu SY (2005) 16099238 174850 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7611 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Yen PM (2003) 12776178 174853 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7612 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Gonzalez-Sancho JM (2003) 12668276 174852 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 7613 112924 7068 - THRB C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2 9606 Homo sapiens agonist target Bernal J (2007) 17315033 174854 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 19230 112938 7083 - TK1 TK2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2352 Thymidine-5'-Triphosphate - - DRUGBANK DB02452 C10H17N2O14P3 small molecule - - DRUGBANK 19231 112938 7083 - TK1 TK2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2352 Thymidine-5'-Triphosphate - - DRUGBANK DB02452 C10H17N2O14P3 small molecule - - DRUGBANK 17570 112938 7083 - TK1 TK2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1627 Dithioerythritol (2r,3s)-1,4-Dimercaptobutane-2,3-Diol - DRUGBANK DB01692 C4H10O2S2 small molecule - 6892-68-8 DRUGBANK 17571 112938 7083 - TK1 TK2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1627 Dithioerythritol (2r,3s)-1,4-Dimercaptobutane-2,3-Diol - DRUGBANK DB01692 C4H10O2S2 small molecule - 6892-68-8 DRUGBANK 19227 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2352 Thymidine-5'-Triphosphate - - DRUGBANK DB02452 C10H17N2O14P3 small molecule - - DRUGBANK 19228 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2352 Thymidine-5'-Triphosphate - - DRUGBANK DB02452 C10H17N2O14P3 small molecule - - DRUGBANK 19229 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2352 Thymidine-5'-Triphosphate - - DRUGBANK DB02452 C10H17N2O14P3 small molecule - - DRUGBANK 23542 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 23543 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 23544 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 19504 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2488 2'-Deoxycytidine dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC - DRUGBANK DB02594 C9H13N3O4 small molecule - 951-77-9 DRUGBANK 19505 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2488 2'-Deoxycytidine dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC - DRUGBANK DB02594 C9H13N3O4 small molecule - 951-77-9 DRUGBANK 19506 112939 7084 - TK2 MTDPS2|MTTK|SCA31 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2488 2'-Deoxycytidine dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC - DRUGBANK DB02594 C9H13N3O4 small molecule - 951-77-9 DRUGBANK 18243 112948 7093 - TLL2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1913 Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome - - DRUGBANK DB01989 C36H52N6O9P small molecule - - DRUGBANK 18244 112948 7093 - TLL2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1913 Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome - - DRUGBANK DB01989 C36H52N6O9P small molecule - - DRUGBANK 18245 112948 7093 - TLL2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1913 Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome - - DRUGBANK DB01989 C36H52N6O9P small molecule - - DRUGBANK 561 112952 7097 - TLR2 CD282|TIL4 9606 Homo sapiens unknown target Welty DM (2003) 14617145 172016 44 OspA lipoprotein Outer surface protein A precursor - DRUGBANK DB00045 C1198H2012N322O422S2 biologic - - DRUGBANK 22288 112952 7097 - TLR2 CD282|TIL4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 22289 112952 7097 - TLR2 CD282|TIL4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 19882 112954 7099 - TLR4 ARMD10|CD284|TLR-4|TOLL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2652 3-Hydroxy-Myristic Acid - - DRUGBANK DB02767 C14H28O3 small molecule - - DRUGBANK 24176 112954 7099 - TLR4 ARMD10|CD284|TLR-4|TOLL 9606 Homo sapiens unknown target Shimamoto A (2006) 16820585 181952 4730 Eritoran - - DRUGBANK DB04933 C66H126N2O19P2 small molecule - 185955-34-4 DRUGBANK 24177 112954 7099 - TLR4 ARMD10|CD284|TLR-4|TOLL 9606 Homo sapiens unknown target Kim HM (2007) 17803912 182045 4730 Eritoran - - DRUGBANK DB04933 C66H126N2O19P2 small molecule - 185955-34-4 DRUGBANK 27670 112954 7099 - TLR4 ARMD10|CD284|TLR-4|TOLL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 26254 112954 7099 - TLR4 ARMD10|CD284|TLR-4|TOLL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 14552 112954 7099 - TLR4 ARMD10|CD284|TLR-4|TOLL 9606 Homo sapiens inhibitor target Lewis SS (2012) 22520687 180516 1171 Naloxone Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum naloxone hydrochloride|naloxon DRUGBANK DB01183 C19H21NO4 small molecule V03AB15 465-65-6 DRUGBANK 403 112978 7123 - CLEC3B TN|TNA 9606 Homo sapiens unknown target Westergaard UB (2003) 12694198 4045 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 404 112978 7123 - CLEC3B TN|TNA 9606 Homo sapiens unknown target Vuckovic B (2007) 17853709 171915 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 405 112978 7123 - CLEC3B TN|TNA 9606 Homo sapiens unknown target Kamper EF (1997) 9034981 171914 31 Tenecteplase t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA tnkase DRUGBANK DB00031 C2561H3919N747O781S40 biologic B01AD11 191588-94-0 DRUGBANK 15783 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Lapaque N (2006) 16469053 181079 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15784 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Chen JT (2006) 16431966 181067 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15785 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Yi HA (2005) 16445576 181077 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15786 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Bitler CM (2005) 15930455 181076 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 15787 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Delcommenne M (2002) 12244074 181078 1278 Glucosamine 2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine remaxazon external patch DRUGBANK DB01296 C6H13NO5 small molecule M01AX05 3416-24-8 DRUGBANK 78 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 79 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Park YC (1999) 10206649 144893 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 80 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Moreland LW (1999) 10375846 171766 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 81 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Grell M (1999) 10357816 171767 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 82 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Calabrese LH (1999) 10405518 171768 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 83 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Sandborn WJ (1999) 10338381 171769 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 11181 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Wu Z (2014) 24365491 178701 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 11182 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 768 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Mori S (2006) 16622728 172132 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 769 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Danese S (2006) 16456024 172133 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 770 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Magro F (2005) 15674127 172134 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 771 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Popa C (2005) 15804598 172135 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 772 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Shen C (2005) 15691299 172136 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 773 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Mimura T (2007) 17642244 172137 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 774 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Maini RN (2002) 12110154 172138 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 775 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Braun J (2005) 16052578 172139 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 776 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 777 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Sapienza MS (2004) 15481318 172141 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 778 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Tobin AM (2005) 15691217 172140 64 Infliximab Ig gamma-1 chain C region remicade|remsima|inflectra DRUGBANK DB00065 C6428H9912N1694O1987S46 biologic L04AB02 170277-31-3 DRUGBANK 24232 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Vincent JL (2000) 10829362 181750 4750 Afelimomab MAK 195F|Fab 2 - DRUGBANK DB04956 - biologic L04AB03 156227-98-4 DRUGBANK 8577 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Jang CH (2006) 16418198 177263 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8581 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Wozniacka A (2006) 16761500 177262 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8579 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Lim EJ (2006) 16870179 177261 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8578 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Dias-Melicio LA (2007) 17456179 177260 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8580 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Rachmilewitz D (2006) 16670522 177259 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 26980 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens neutralizer target Chimenti MS (2013) 23620660 182248 7648 Certolizumab pegol CDP870 cimzia DRUGBANK DB08904 C2115H3252N556O673S16 biologic L04AB05 428863-50-7 DRUGBANK 615 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Chen X (2002) 11752352 171740 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 616 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Flendrie M (2003) 14532145 172043 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 617 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Lorenz HM (2002) 12044041 172044 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 618 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Bang LM (2004) 15046527 172045 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 619 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Klinkhoff A (2004) 15200343 172046 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 620 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Aguillon JC (2003) 15022409 172042 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 16525 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Izeboud CA (1999) 10071758 181338 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16526 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Laan TT (2005) 16261833 181334 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16527 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Izeboud CA (2004) 15021963 181335 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16528 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target van den Hoven R (2006) 17139543 181336 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 16529 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Yoshimura T (2000) 11193379 181337 1356 Clenbuterol 4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum - DRUGBANK DB01407 C12H18Cl2N2O small molecule R03AC14|R03CC13 37148-27-9 DRUGBANK 26984 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Gertz MA (2013) 22917017 182210 7654 Pomalidomide - pomalyst DRUGBANK DB08910 C13H11N3O4 small molecule L04AX06 19171-19-8 DRUGBANK 16570 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Ichiyama T (2003) 12801316 181363 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16571 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Ichiyama T (2007) 17430359 181370 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16572 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Tomari S (2003) 12801315 181364 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16643 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Kumar A (1999) 10075051 181402 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16644 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Haddad JJ (2002) 11805217 181403 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16645 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Bergman MR (1999) 10444479 181400 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16646 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Marx D (2002) 11969359 181401 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 16647 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Giroir BP (1992) 1611705 181399 1375 Amrinone Inamrinone|Amrinonum|Amcoral|Amrinona inocor liq 5mg/ml DRUGBANK DB01427 C10H9N3O small molecule C01CE01 60719-84-8 DRUGBANK 13090 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13091 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Richardson P (2002) 12046682 179856 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13092 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Fu LM (2002) 12102294 179854 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13093 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Vescovo G (2002) 12167383 179855 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13094 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Enomoto N (2002) 12105857 179852 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13095 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Rajkumar SV (2001) 12113124 179853 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 13096 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens inhibitor target Turk BE (1996) 8755512 179851 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 27638 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 9205 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antagonist target van der Poll T (1996) 8609227 177679 658 Epinephrine (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine dentsply 2% lidocaine with epi DRUGBANK DB00668 C9H13NO3 small molecule A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14 51-43-4 DRUGBANK 24624 112979 7124 DADB-70P7.1 TNF DIF|TNF-alpha|TNFA|TNFSF2 9606 Homo sapiens antibody target Mittal M (2010) 21079302 182177 5569 Golimumab - simponi aria|simponi i.v.|simp DRUGBANK DB06674 C6530H10068N1752O2026S44 biologic L04AB06 476181-74-5 DRUGBANK 23813 112980 7125 - TNNC2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4486 Octylphenoxy polyethoxyethanol Anapoe-305|alkylphenol-hydroxypolyoxyetheylene - DRUGBANK DB04682 C22H38O5 small molecule - 9036-19-5 DRUGBANK 12890 112980 7125 - TNNC2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12891 112980 7125 - TNNC2 - 9606 Homo sapiens unknown target Bostroem SL (1988) 3178884 179747 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 16232 112980 7125 - TNNC2 - 9606 Homo sapiens agonist target Kreutziger KL (2011) 21035455 181213 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16233 112980 7125 - TNNC2 - 9606 Homo sapiens agonist target Dweck D (2010) 20371872 181212 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16234 112980 7125 - TNNC2 - 9606 Homo sapiens agonist target Robertson IM (2010) 20801130 181211 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16235 112980 7125 - TNNC2 - 9606 Homo sapiens agonist target Martin SR (2011) 21250664 181210 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 26871 112984 7130 - TNFAIP6 TSG-6|TSG6 9606 Homo sapiens binder target Lee TH (1992) 1730767 181645 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26872 112984 7130 - TNFAIP6 TSG-6|TSG6 9606 Homo sapiens binder target Kohda D (1996) 8797823 181708 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26873 112984 7130 - TNFAIP6 TSG-6|TSG6 9606 Homo sapiens binder target Wisniewski HG (1994) 7516184 9390 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 21419 112986 7132 - TNFRSF1A CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3362 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One - - DRUGBANK DB03507 C21H20N4O4S2 small molecule - - DRUGBANK 21420 112986 7132 - TNFRSF1A CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3362 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One - - DRUGBANK DB03507 C21H20N4O4S2 small molecule - - DRUGBANK 21421 112986 7132 - TNFRSF1A CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3362 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One - - DRUGBANK DB03507 C21H20N4O4S2 small molecule - - DRUGBANK 62 112987 7133 - TNFRSF1B CD120b|TBPII|TNF-R-II|TNF-R75|TNFBR|TNFR1B|TNFR2|TNFR80|p75|p75TNFR 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 22237 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3780 5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One - - DRUGBANK DB03944 C22H23N3O4S small molecule - - DRUGBANK 15342 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target MacLachlan LK (1990) 2351672 180825 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15343 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Abusamhadneh E (2001) 11591369 180824 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15344 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Kleerekoper Q (1998) 9525919 178594 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15345 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Wang X (2002) 12060657 12566 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 23582 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4325 N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide - - DRUGBANK DB04513 C16H21ClN2O2S small molecule - - DRUGBANK 16249 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens stimulator target Chen X (2002) 11752352 171740 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 16240 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens agonist target Dweck D (2010) 20371872 181212 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16241 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens agonist target Parvatiyar MS (2010) 20566645 181219 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16242 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens agonist target Swindle N (2010) 20459070 181218 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16243 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens agonist target Baylor SM (2011) 20599552 181220 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 12892 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Bostroem SL (1988) 3178884 179747 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 10941 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Kleerekoper Q (1998) 9525919 178594 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10942 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 11949 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens potentiator target Chen X (2002) 11752352 171740 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 11950 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens potentiator target Lehmann A (2003) 12975736 179119 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 11951 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens potentiator target Levijoki J (2000) 10731446 179118 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 11952 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens potentiator target Kleerekoper Q (1999) 10446160 179122 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 11953 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens potentiator target Sorsa T (2001) 11113122 179120 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 11954 112988 7134 - TNNC1 CMD1Z|CMH13|TN-C|TNC|TNNC 9606 Homo sapiens potentiator target Sorsa T (2003) 12967628 179121 912 Levosimendan Levosimedan|Levosimendanum|Simdax - DRUGBANK DB00922 C14H12N6O small molecule C01CX08 141505-33-1 DRUGBANK 23583 112991 7137 - TNNI3 CMD1FF|CMD2A|CMH7|RCM1|TNNC1|cTnI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4325 N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide - - DRUGBANK DB04513 C16H21ClN2O2S small molecule - - DRUGBANK 24335 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Walker J (2004) 15562618 181872 5274 Sodium stibogluconate Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate|Antimony (v) derivative OF sodium gluconate|Sodium stibogluconate|Stibinol|Stibogluconate de sodium|Estibogluconato sodico|Myostibin|Natrii stibogluconas|Stibanose|Stibanate|Stibatin|Antimony sodium gluconate|Pentostam - DRUGBANK DB05630 C12H35Na3O26Sb2 small molecule P01CB02 16037-91-5 DRUGBANK 24336 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Chakraborty AK (1988) 2835038 181661 5274 Sodium stibogluconate Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate|Antimony (v) derivative OF sodium gluconate|Sodium stibogluconate|Stibinol|Stibogluconate de sodium|Estibogluconato sodico|Myostibin|Natrii stibogluconas|Stibanose|Stibanate|Stibatin|Antimony sodium gluconate|Pentostam - DRUGBANK DB05630 C12H35Na3O26Sb2 small molecule P01CB02 16037-91-5 DRUGBANK 24337 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 5274 Sodium stibogluconate Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate|Antimony (v) derivative OF sodium gluconate|Sodium stibogluconate|Stibinol|Stibogluconate de sodium|Estibogluconato sodico|Myostibin|Natrii stibogluconas|Stibanose|Stibanate|Stibatin|Antimony sodium gluconate|Pentostam - DRUGBANK DB05630 C12H35Na3O26Sb2 small molecule P01CB02 16037-91-5 DRUGBANK 10221 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Nakagawa H (2006) 16309825 178271 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10222 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Ishikawa T (2006) 16454746 178270 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10223 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Yoshikawa M (2004) 15255290 178273 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10224 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Ramesh M (2010) 19852077 178272 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10225 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Yang X (2005) 15975002 178275 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10226 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Yoshikawa M (2004) 15170677 178274 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10227 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Chabot GG (1997) 9342501 178276 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10228 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 24072 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Carvajal RD (2007) 17325867 181991 4682 Edotecarin ED-749|Edotecarina|Edotecarinum - DRUGBANK DB04882 C29H28N4O11 small molecule - 174402-32-5 DRUGBANK 24073 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Saif MW (2005) 15929804 181893 4682 Edotecarin ED-749|Edotecarina|Edotecarinum - DRUGBANK DB04882 C29H28N4O11 small molecule - 174402-32-5 DRUGBANK 24250 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Bases RE (1997) 9169823 181719 4759 Lucanthone 1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona - DRUGBANK DB04967 C20H24N2OS small molecule - 479-50-5 DRUGBANK 24251 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Dassonneville L (1999) 10487533 181741 4759 Lucanthone 1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona - DRUGBANK DB04967 C20H24N2OS small molecule - 479-50-5 DRUGBANK 23818 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 4494 Camptothecin (+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone - DRUGBANK DB04690 C20H16N2O4 small molecule - 7689-03-4 DRUGBANK 23819 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Teicher BA (2008) 18061144 182062 4494 Camptothecin (+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone - DRUGBANK DB04690 C20H16N2O4 small molecule - 7689-03-4 DRUGBANK 23820 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target van der Merwe M (2008) 18056711 96060 4494 Camptothecin (+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone - DRUGBANK DB04690 C20H16N2O4 small molecule - 7689-03-4 DRUGBANK 23821 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4494 Camptothecin (+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone - DRUGBANK DB04690 C20H16N2O4 small molecule - 7689-03-4 DRUGBANK 12966 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Dennis MJ (1997) 9122737 179783 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12961 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12962 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Streltsov SA (2002) 12437383 179786 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12963 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Aisner J (2003) 12855624 179787 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12964 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Herben VM (1996) 8853931 179784 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12965 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Schmidt F (2001) 11166732 179785 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12960 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Zhang J (2002) 12520736 179790 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12967 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target strel'tsov SA (2001) 11443926 179788 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 12968 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens inhibitor target Kollmannsberger C (1999) 9885371 179789 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 26181 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6951 4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE - - DRUGBANK DB08159 C20H15NO4 small molecule - - DRUGBANK 25362 113003 7150 RP3-511B24.1 TOP1 TOPI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6170 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM - - DRUGBANK DB07354 C19H16NO4 small molecule - - DRUGBANK 14496 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1165 Idarubicin Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin idarubicin hydrochloride|idamy DRUGBANK DB01177 C26H27NO9 small molecule L01DB06 58957-92-9 DRUGBANK 14497 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Bigioni M (1994) 8036155 180481 1165 Idarubicin Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin idarubicin hydrochloride|idamy DRUGBANK DB01177 C26H27NO9 small molecule L01DB06 58957-92-9 DRUGBANK 14498 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Zhou R (1999) 10523799 180480 1165 Idarubicin Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin idarubicin hydrochloride|idamy DRUGBANK DB01177 C26H27NO9 small molecule L01DB06 58957-92-9 DRUGBANK 14499 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Gonzalez-Cid M (2002) 11836027 180482 1165 Idarubicin Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin idarubicin hydrochloride|idamy DRUGBANK DB01177 C26H27NO9 small molecule L01DB06 58957-92-9 DRUGBANK 14500 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target De Renzo A (1999) 10203104 180478 1165 Idarubicin Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin idarubicin hydrochloride|idamy DRUGBANK DB01177 C26H27NO9 small molecule L01DB06 58957-92-9 DRUGBANK 14501 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Willmore E (2002) 12034365 180479 1165 Idarubicin Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin idarubicin hydrochloride|idamy DRUGBANK DB01177 C26H27NO9 small molecule L01DB06 58957-92-9 DRUGBANK 14505 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14506 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Zhang YL (1992) 1331331 180483 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14507 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Kamal A (2005) 16061385 180485 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14508 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Ruckdeschel JC (1991) 1845848 180484 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14509 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Terada T (1992) 1334447 180487 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14510 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Iida A (2000) 10783066 180486 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 7222 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 459 Enoxacin Enoxacina|Enoxacin|Enoxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid|1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid|noxacine|Enoxacinum - DRUGBANK DB00467 C15H17FN4O3 small molecule J01MA04 74011-58-8 DRUGBANK 7223 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Snyder RD (1999) 10089819 176273 459 Enoxacin Enoxacina|Enoxacin|Enoxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid|1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid|noxacine|Enoxacinum - DRUGBANK DB00467 C15H17FN4O3 small molecule J01MA04 74011-58-8 DRUGBANK 7224 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Maki T (2008) 18471102 176272 459 Enoxacin Enoxacina|Enoxacin|Enoxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid|1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid|noxacine|Enoxacinum - DRUGBANK DB00467 C15H17FN4O3 small molecule J01MA04 74011-58-8 DRUGBANK 27835 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens unknown target Kurata T (2007) 17628745 195980 8071 Amrubicin - - DRUGBANK DB06263 C25H25NO9 small molecule L01DB10 110267-81-7 DRUGBANK 10303 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Moneypenny CG (2006) 16377807 178321 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 10304 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Lopez-Lazaro M (2005) 16309315 178320 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 10305 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Winnicka K (2007) 17514873 176107 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 10306 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target de Lucio B (2005) 16271071 176106 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 10307 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Uesaka T (2007) 17361331 176109 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 10308 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 12608 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Koehn H (2007) 17351394 179591 987 Doxorubicin 14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriamycin rdf inj 50mg/vial|a DRUGBANK DB00997 C27H29NO11 small molecule L01DB01 23214-92-8 DRUGBANK 12609 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hayashi S (2006) 17016621 179590 987 Doxorubicin 14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriamycin rdf inj 50mg/vial|a DRUGBANK DB00997 C27H29NO11 small molecule L01DB01 23214-92-8 DRUGBANK 12610 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Azarova AM (2007) 17578914 178322 987 Doxorubicin 14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriamycin rdf inj 50mg/vial|a DRUGBANK DB00997 C27H29NO11 small molecule L01DB01 23214-92-8 DRUGBANK 12611 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 987 Doxorubicin 14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriamycin rdf inj 50mg/vial|a DRUGBANK DB00997 C27H29NO11 small molecule L01DB01 23214-92-8 DRUGBANK 12612 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Rody A (2007) 17010609 179588 987 Doxorubicin 14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriamycin rdf inj 50mg/vial|a DRUGBANK DB00997 C27H29NO11 small molecule L01DB01 23214-92-8 DRUGBANK 12613 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Menendez JA (2006) 17089011 179589 987 Doxorubicin 14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriamycin rdf inj 50mg/vial|a DRUGBANK DB00997 C27H29NO11 small molecule L01DB01 23214-92-8 DRUGBANK 24258 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens unknown target Atkinson SJ (2007) 17340571 181994 4767 Banoxantrone AQ4N - DRUGBANK DB04975 - small molecule - 136470-65-0 DRUGBANK 17488 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 17489 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 14834 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Wang H (2001) 11278845 180621 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 14835 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Takeda K (1998) 9631585 180620 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 14836 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target McPherson JP (1998) 9494516 180618 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 14837 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Ko MW (2008) 18687447 180619 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 14838 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Satherley K (2000) 11004693 180616 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 14839 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Mao Y (1999) 10451375 180617 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 14840 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1192 Mitoxantrone Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione mitoxantrone injection|mitoxan DRUGBANK DB01204 C22H28N4O6 small molecule L01DB07 65271-80-9 DRUGBANK 23747 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Robinson MJ (1992) 1323952 176727 4386 Fleroxacin FLRX|Fleroxacinum|Quinodis|Megalocin|Megalone|Fleroxicin|Megalone (TN)|Fleroxacine|Fleroxacin|Megalocin (TN)|Megalosin|Fleroxacino - DRUGBANK DB04576 - small molecule J01MA08 79660-72-3 DRUGBANK 23748 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4386 Fleroxacin FLRX|Fleroxacinum|Quinodis|Megalocin|Megalone|Fleroxicin|Megalone (TN)|Fleroxacine|Fleroxacin|Megalocin (TN)|Megalosin|Fleroxacino - DRUGBANK DB04576 - small molecule J01MA08 79660-72-3 DRUGBANK 23749 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hussy P (1986) 3015015 176728 4386 Fleroxacin FLRX|Fleroxacinum|Quinodis|Megalocin|Megalone|Fleroxicin|Megalone (TN)|Fleroxacine|Fleroxacin|Megalocin (TN)|Megalosin|Fleroxacino - DRUGBANK DB04576 - small molecule J01MA08 79660-72-3 DRUGBANK 14862 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1196 Sparfloxacin Sparfloxacin|cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid - DRUGBANK DB01208 C19H22F2N4O3 small molecule J01MA09 110871-86-8 DRUGBANK 7811 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Robinson MJ (1992) 1323952 176727 527 Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum riva-ciprofloxacin|cipro tab 2 DRUGBANK DB00537 C17H18FN3O3 small molecule S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03 85721-33-1 DRUGBANK 7812 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 527 Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum riva-ciprofloxacin|cipro tab 2 DRUGBANK DB00537 C17H18FN3O3 small molecule S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03 85721-33-1 DRUGBANK 7813 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hussy P (1986) 3015015 176728 527 Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum riva-ciprofloxacin|cipro tab 2 DRUGBANK DB00537 C17H18FN3O3 small molecule S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03 85721-33-1 DRUGBANK 27466 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target McKeage K (2015) 25808831 188540 7808 Finafloxacin gastrochinolon|gastroquinolone|8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid xtoro DRUGBANK DB09047 C20H19FN4O4 small molecule - 209342-40-5 DRUGBANK 4405 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 211 Moxifloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid moxeza|jamp-moxifloxacin|bio-m DRUGBANK DB00218 C21H24FN3O4 small molecule S01AE07|J01MA14 151096-09-2 DRUGBANK 4406 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Wohlkonig A (2010) 20802486 174459 211 Moxifloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid moxeza|jamp-moxifloxacin|bio-m DRUGBANK DB00218 C21H24FN3O4 small molecule S01AE07|J01MA14 151096-09-2 DRUGBANK 4407 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Reuveni D (2010) 20596674 174458 211 Moxifloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid moxeza|jamp-moxifloxacin|bio-m DRUGBANK DB00218 C21H24FN3O4 small molecule S01AE07|J01MA14 151096-09-2 DRUGBANK 9484 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 675 Trovafloxacin - trovan tablets 200mg|trovan ta DRUGBANK DB00685 C20H15F3N4O3 small molecule J01MA13 147059-72-1 DRUGBANK 14389 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Divo AA (1988) 2847647 180431 1153 Ofloxacin Ofloxacine|8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid|Ofloxacino|OFLX|Ofloxacinum novo-ofloxacin|floxin tablets DRUGBANK DB01165 C18H20FN3O4 small molecule J01MA01|S02AA16|J01RA09|S01AE01 82419-36-1 DRUGBANK 14090 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1125 Levofloxacin (S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid|(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid|(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid|L-ofloxacin|Levofloxacine|(S)-Ofloxacin|Ofloxacin S-(-)-form|(-)-Ofloxacin|Levofloxacinum|Levofloxacino ava-levofloxacin|pms-levofloxa DRUGBANK DB01137 C18H20FN3O4 small molecule J01RA05|J01MA12|A02BD10|S01AE05 100986-85-4 DRUGBANK 9571 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Aubel-Sadron G (1984) 6380596 177851 684 Daunorubicin Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine daunoxome|cerubidine 20mg/vial DRUGBANK DB00694 C27H29NO10 small molecule L01DB02 20830-81-3 DRUGBANK 9572 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Zunino F (1990) 1963303 177852 684 Daunorubicin Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine daunoxome|cerubidine 20mg/vial DRUGBANK DB00694 C27H29NO10 small molecule L01DB02 20830-81-3 DRUGBANK 12400 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens unknown target Felix CA (1995) 7756657 179417 960 Dactinomycin Actinomycin D|Dactinomycine|ActD|Dactinomycin|Actinomycin C1|Actinomycin iv|2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide|Dactinomycinum|Dactinomicina|Meractinomycin cosmegen DRUGBANK DB00970 C62H86N12O16 small molecule L01DA01 50-76-0 DRUGBANK 5025 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 5026 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Finlay GJ (2000) 10691026 174815 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 5027 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Matsumoto Y (2001) 11473732 174814 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 5028 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Ferlin MG (2000) 11006484 174816 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 5029 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Lee MS (1992) 1311390 174813 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 5030 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Arimondo P (2000) 11716434 174812 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 5031 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Nitiss JL (1992) 1322791 23092 269 Amsacrine 4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine amsa pd inj 50mg/ml DRUGBANK DB00276 C21H19N3O3S small molecule L01XX01 51264-14-3 DRUGBANK 24247 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4759 Lucanthone 1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona - DRUGBANK DB04967 C20H24N2OS small molecule - 479-50-5 DRUGBANK 24248 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Bases RE (1997) 9169823 181719 4759 Lucanthone 1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona - DRUGBANK DB04967 C20H24N2OS small molecule - 479-50-5 DRUGBANK 24249 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Dassonneville L (1999) 10487533 181741 4759 Lucanthone 1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona - DRUGBANK DB04967 C20H24N2OS small molecule - 479-50-5 DRUGBANK 7436 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 479 Pefloxacin Pefloxacin|Pefloxacino|Labocton|Pefloxacine|PFLX|Pefloxacinum - DRUGBANK DB00487 C17H20FN3O3 small molecule J01MA03 70458-92-3 DRUGBANK 13318 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1047 Norfloxacin Norfloxacine|NFLX|1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure|Norfloxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|Norfloxacinum|1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid riva-norfloxacin|ntp-norfloxac DRUGBANK DB01059 C16H18FN3O3 small molecule J01MA06|S01AE02|J01RA13 70458-96-7 DRUGBANK 12438 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 968 Lomefloxacin LFLX|Lomefloxacino|Lomefloxacine|1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Lomefloxacinum - DRUGBANK DB00978 C17H19F2N3O3 small molecule S01AE04|J01MA07 98079-51-7 DRUGBANK 6982 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 436 Teniposide Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid teniposide|vumon DRUGBANK DB00444 C32H32O13S small molecule L01CB02 29767-20-2 DRUGBANK 6983 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Umanskaya ON (2006) 16480143 176110 436 Teniposide Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid teniposide|vumon DRUGBANK DB00444 C32H32O13S small molecule L01CB02 29767-20-2 DRUGBANK 6984 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Winnicka K (2007) 17514873 176107 436 Teniposide Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid teniposide|vumon DRUGBANK DB00444 C32H32O13S small molecule L01CB02 29767-20-2 DRUGBANK 6985 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target de Lucio B (2005) 16271071 176106 436 Teniposide Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid teniposide|vumon DRUGBANK DB00444 C32H32O13S small molecule L01CB02 29767-20-2 DRUGBANK 6986 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Uesaka T (2007) 17361331 176109 436 Teniposide Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid teniposide|vumon DRUGBANK DB00444 C32H32O13S small molecule L01CB02 29767-20-2 DRUGBANK 6987 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Faure P (1996) 8702194 176108 436 Teniposide Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid teniposide|vumon DRUGBANK DB00444 C32H32O13S small molecule L01CB02 29767-20-2 DRUGBANK 6988 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Petit T (2004) 14728934 176113 437 Epirubicin Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine epirubicin hydrochloride for i DRUGBANK DB00445 C27H29NO11 small molecule L01DB03 56420-45-2 DRUGBANK 6989 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Knoop AS (2005) 16234514 176114 437 Epirubicin Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine epirubicin hydrochloride for i DRUGBANK DB00445 C27H29NO11 small molecule L01DB03 56420-45-2 DRUGBANK 6990 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Liang CH (2007) 17639997 176115 437 Epirubicin Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine epirubicin hydrochloride for i DRUGBANK DB00445 C27H29NO11 small molecule L01DB03 56420-45-2 DRUGBANK 6264 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6265 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hasinoff BB (2001) 11179439 175688 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6266 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hasinoff BB (2007) 17652819 175683 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6267 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hasinoff BB (2000) 11046078 175682 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6268 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hasinoff BB (1999) 10194547 175681 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6269 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Langer SW (2001) 11332155 175687 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6270 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Renodon-Corniere A (2003) 12911317 175686 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6271 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Hasinoff BB (2002) 11984069 175685 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6272 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Kik K (2006) 17115008 175684 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6348 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Perabo FG (2005) 16019763 175718 377 Valrubicin Valrubicin|(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)--L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8-valerate|Valrubicinum|2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate|Valrubicina|Valrubicine|Valstar valtaxin|valstar DRUGBANK DB00385 C34H36F3NO13 small molecule L01DB09 56124-62-0 DRUGBANK 6349 113006 7153 - TOP2A TOP2|TP2A 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 377 Valrubicin Valrubicin|(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)--L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8-valerate|Valrubicinum|2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate|Valrubicina|Valrubicine|Valstar valtaxin|valstar DRUGBANK DB00385 C34H36F3NO13 small molecule L01DB09 56124-62-0 DRUGBANK 24333 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5250 99mTc-ciprofloxacin - - DRUGBANK DB05488 C17H18FN3O3 small molecule - - DRUGBANK 23278 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23279 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23280 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 12401 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Felix CA (1995) 7756657 179417 960 Dactinomycin Actinomycin D|Dactinomycine|ActD|Dactinomycin|Actinomycin C1|Actinomycin iv|2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide|Dactinomycinum|Dactinomicina|Meractinomycin cosmegen DRUGBANK DB00970 C62H86N12O16 small molecule L01DA01 50-76-0 DRUGBANK 10309 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens inhibitor target Azarova AM (2007) 17578914 178322 763 Etoposide Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum etoposide - liq iv 20mg/ml|eto DRUGBANK DB00773 C29H32O13 small molecule L01CB01 33419-42-0 DRUGBANK 26670 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7425 3'-THIO-THYMIDINE-5'-PHOSPHATE - - DRUGBANK DB08651 C10H15N2O7PS small molecule - - DRUGBANK 9573 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens inhibitor target Aubel-Sadron G (1984) 6380596 177851 684 Daunorubicin Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine daunoxome|cerubidine 20mg/vial DRUGBANK DB00694 C27H29NO10 small molecule L01DB02 20830-81-3 DRUGBANK 9574 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens inhibitor target Zunino F (1990) 1963303 177852 684 Daunorubicin Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine daunoxome|cerubidine 20mg/vial DRUGBANK DB00694 C27H29NO10 small molecule L01DB02 20830-81-3 DRUGBANK 6273 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6274 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 6275 113008 7155 - TOP2B TOPIIB|top2beta 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 372 Dexrazoxane 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum dexrazoxane hydrochloride|zine DRUGBANK DB00380 C11H16N4O4 small molecule V03AF02 24584-09-6 DRUGBANK 26413 113010 7157 - TP53 BCC7|LFS1|P53|TRP53 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7148 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine - - DRUGBANK DB08363 C16H18N2 small molecule - - DRUGBANK 12156 113010 7157 - TP53 BCC7|LFS1|P53|TRP53 9606 Homo sapiens acetylation target Alfonso LF (2009) 21475861 179244 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 5946 113019 7166 - TPH1 TPRH|TRPH 9606 Homo sapiens cofactor target Chamas F (1999) 10381000 175483 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5947 113019 7166 - TPH1 TPRH|TRPH 9606 Homo sapiens cofactor target Serova LI (2004) 15223360 175485 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5948 113019 7166 - TPH1 TPRH|TRPH 9606 Homo sapiens cofactor target Haavik J (1989) 2665179 175484 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5949 113019 7166 - TPH1 TPRH|TRPH 9606 Homo sapiens cofactor target Martinez A (2001) 11472242 175487 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 5950 113019 7166 - TPH1 TPRH|TRPH 9606 Homo sapiens cofactor target Ikemoto K (2002) 12414107 175486 352 Sapropterin 5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin kuvan DRUGBANK DB00360 C9H15N5O3 small molecule A16AX07 62989-33-7 DRUGBANK 17581 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1630 N-Hydroxy-4-Phosphono-Butanamide - - DRUGBANK DB01695 C4H8NO5P small molecule - 146086-80-8 DRUGBANK 17582 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1630 N-Hydroxy-4-Phosphono-Butanamide - - DRUGBANK DB01695 C4H8NO5P small molecule - 146086-80-8 DRUGBANK 17583 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1630 N-Hydroxy-4-Phosphono-Butanamide - - DRUGBANK DB01695 C4H8NO5P small molecule - 146086-80-8 DRUGBANK 23434 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23435 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23436 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 19794 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19795 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19796 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 20565 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3003 [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid - - DRUGBANK DB03135 C3H8NO5P small molecule - - DRUGBANK 20566 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3003 [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid - - DRUGBANK DB03135 C3H8NO5P small molecule - - DRUGBANK 20567 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3003 [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid - - DRUGBANK DB03135 C3H8NO5P small molecule - - DRUGBANK 21062 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3238 2-Carboxyethylphosphonic Acid - - DRUGBANK DB03379 C3H7O5P small molecule - - DRUGBANK 21063 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3238 2-Carboxyethylphosphonic Acid - - DRUGBANK DB03379 C3H7O5P small molecule - - DRUGBANK 21064 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3238 2-Carboxyethylphosphonic Acid - - DRUGBANK DB03379 C3H7O5P small molecule - - DRUGBANK 23577 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 23578 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 23579 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4322 3-Phosphoglyceric Acid - - DRUGBANK DB04510 C3H7O7P small molecule - - DRUGBANK 20947 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3179 Fluorotryptophane 5-Fluoro-L-tryptophan - DRUGBANK DB03314 C11H11FN2O2 small molecule - 16626-02-1 DRUGBANK 20948 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3179 Fluorotryptophane 5-Fluoro-L-tryptophan - DRUGBANK DB03314 C11H11FN2O2 small molecule - 16626-02-1 DRUGBANK 20949 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3179 Fluorotryptophane 5-Fluoro-L-tryptophan - DRUGBANK DB03314 C11H11FN2O2 small molecule - 16626-02-1 DRUGBANK 23131 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23132 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23133 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 20345 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20346 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20347 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20561 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3000 3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid - - DRUGBANK DB03132 C10H11NO3S3 small molecule - - DRUGBANK 25405 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6202 3-(BUTYLSULPHONYL)-PROPANOIC ACID - - DRUGBANK DB07387 C7H14O4S small molecule - - DRUGBANK 22138 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 22139 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 22140 113020 7167 - TPI1 HEL-S-49|TIM|TPI|TPID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 15382 113025 7172 - TPMT - 9606 Homo sapiens inhibitor target Lennard L (1998) 9780130 180849 1238 Olsalazine Dipentum dipentum DRUGBANK DB01250 C14H10N2O6 small molecule A07EC03 15722-48-2 DRUGBANK 15383 113025 7172 - TPMT - 9606 Homo sapiens inhibitor target Lennard L (2002) 12117866 180848 1238 Olsalazine Dipentum dipentum DRUGBANK DB01250 C14H10N2O6 small molecule A07EC03 15722-48-2 DRUGBANK 15384 113025 7172 - TPMT - 9606 Homo sapiens inhibitor target Lewis LD (1997) 9357398 180850 1238 Olsalazine Dipentum dipentum DRUGBANK DB01250 C14H10N2O6 small molecule A07EC03 15722-48-2 DRUGBANK 15385 113025 7172 - TPMT - 9606 Homo sapiens inhibitor target Shipkova M (2004) 14752016 180847 1238 Olsalazine Dipentum dipentum DRUGBANK DB01250 C14H10N2O6 small molecule A07EC03 15722-48-2 DRUGBANK 10239 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Sugawara M (1999) 10365684 176826 753 Methimazole 1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole phl-methimazole|tapazole 5mg t DRUGBANK DB00763 C4H6N2S small molecule H03BB52|H03BB02 60-56-0 DRUGBANK 10240 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Manzon RG (2001) 11241400 176827 753 Methimazole 1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole phl-methimazole|tapazole 5mg t DRUGBANK DB00763 C4H6N2S small molecule H03BB52|H03BB02 60-56-0 DRUGBANK 10241 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Magnusson RP (1992) 1320313 178284 753 Methimazole 1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole phl-methimazole|tapazole 5mg t DRUGBANK DB00763 C4H6N2S small molecule H03BB52|H03BB02 60-56-0 DRUGBANK 10242 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Chiovato L (1991) 1663395 178285 753 Methimazole 1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole phl-methimazole|tapazole 5mg t DRUGBANK DB00763 C4H6N2S small molecule H03BB52|H03BB02 60-56-0 DRUGBANK 10243 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 753 Methimazole 1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole phl-methimazole|tapazole 5mg t DRUGBANK DB00763 C4H6N2S small molecule H03BB52|H03BB02 60-56-0 DRUGBANK 10244 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Ferreira AC (2003) 12755690 176829 753 Methimazole 1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole phl-methimazole|tapazole 5mg t DRUGBANK DB00763 C4H6N2S small molecule H03BB52|H03BB02 60-56-0 DRUGBANK 6378 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Taurog A (1976) 1278093 175733 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6379 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Guilhem I (2006) 17042691 175732 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6380 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Humar M (2008) 18055877 175731 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6381 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Perrild H (1994) 7952157 175730 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6382 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Magnusson RP (1984) 6706930 175735 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6383 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Nakashima T (1979) 476986 175734 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6384 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 6385 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Orgiazzi J (1994) 7528484 175729 381 Carbimazole Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol - DRUGBANK DB00389 C7H10N2O2S small molecule H03BB01 22232-54-8 DRUGBANK 7993 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Sugawara M (1999) 10365684 176826 540 Propylthiouracil Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone propyl-thyracil|apo-propylthio DRUGBANK DB00550 C7H10N2OS small molecule H03BA02 51-52-5 DRUGBANK 7994 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Manzon RG (2001) 11241400 176827 540 Propylthiouracil Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone propyl-thyracil|apo-propylthio DRUGBANK DB00550 C7H10N2OS small molecule H03BA02 51-52-5 DRUGBANK 7995 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Schmutzler C (2007) 17379648 176825 540 Propylthiouracil Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone propyl-thyracil|apo-propylthio DRUGBANK DB00550 C7H10N2OS small molecule H03BA02 51-52-5 DRUGBANK 7996 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 540 Propylthiouracil Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone propyl-thyracil|apo-propylthio DRUGBANK DB00550 C7H10N2OS small molecule H03BA02 51-52-5 DRUGBANK 7997 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Taurog A (1989) 2656250 176828 540 Propylthiouracil Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone propyl-thyracil|apo-propylthio DRUGBANK DB00550 C7H10N2OS small molecule H03BA02 51-52-5 DRUGBANK 7998 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens inhibitor target Ferreira AC (2003) 12755690 176829 540 Propylthiouracil Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone propyl-thyracil|apo-propylthio DRUGBANK DB00550 C7H10N2OS small molecule H03BA02 51-52-5 DRUGBANK 7606 113026 7173 - TPO MSA|TDH2A|TPX 9606 Homo sapiens unknown target Visser TJ (2006) 16617153 176565 500 Dextrothyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine choloxin tablet 4mg|choloxin t DRUGBANK DB00509 C15H11I4NO4 small molecule C10AX01 51-49-0 DRUGBANK 24876 113029 7177 - TPSAB1 TPS1|TPS2|TPSB1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5670 1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine - - DRUGBANK DB06849 C22H24N2O2 small molecule - - DRUGBANK 24875 113029 7177 - TPSAB1 TPS1|TPS2|TPSB1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5669 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine - - DRUGBANK DB06848 C23H24N2O2S2 small molecule - - DRUGBANK 8642 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Barzilay E (2004) 14660597 177313 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8643 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Chavany C (1996) 8617772 5846 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8644 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Lawson B (1998) 9428803 177314 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 21787 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3562 N-Ethyl-5'-Carboxamido Adenosine - - DRUGBANK DB03719 C12H16N6O4 small molecule - - DRUGBANK 21788 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3562 N-Ethyl-5'-Carboxamido Adenosine - - DRUGBANK DB03719 C12H16N6O4 small molecule - - DRUGBANK 21789 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3562 N-Ethyl-5'-Carboxamido Adenosine - - DRUGBANK DB03719 C12H16N6O4 small molecule - - DRUGBANK 26517 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7245 METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE - - DRUGBANK DB08464 C18H18ClNO8 small molecule - - DRUGBANK 21879 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3600 Radicicol - - DRUGBANK DB03758 C18H23ClO6 small molecule - - DRUGBANK 20165 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2813 1-Methoxy-2-(2-Methoxyethoxy)Ethane - - DRUGBANK DB02935 C6H14O3 small molecule - - DRUGBANK 20166 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2813 1-Methoxy-2-(2-Methoxyethoxy)Ethane - - DRUGBANK DB02935 C6H14O3 small molecule - - DRUGBANK 20167 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2813 1-Methoxy-2-(2-Methoxyethoxy)Ethane - - DRUGBANK DB02935 C6H14O3 small molecule - - DRUGBANK 26519 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7246 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE - - DRUGBANK DB08465 C18H20ClNO7 small molecule - - DRUGBANK 18532 113036 7184 - HSP90B1 ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2023 2-Chlorodideoxyadenosine - - DRUGBANK DB02103 C10H12ClN5O2 small molecule - 114849-58-0 DRUGBANK 23275 113054 7203 RP11-443G18.6 CCT3 CCT-gamma|CCTG|PIG48|TCP-1-gamma|TRIC5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 251 113104 7253 - TSHR CHNG1|LGR3|hTSHR-I 9606 Homo sapiens agonist target Conway GS (1996) 9039330 171854 24 Thyrotropin Alfa Thyrotropin-a|TSH|Thyrotrophin-alfa|Thyroid stimulating hormone|Thytrophin|Thyrotropin|rTSH|Thyrotropin-alpha|Thyrotrophin-alpha thyrogen DRUGBANK DB00024 C975H1513N267O304S26 biologic H01AB01|V04CJ01 194100-83-9 DRUGBANK 252 113104 7253 - TSHR CHNG1|LGR3|hTSHR-I 9606 Homo sapiens agonist target Szkudlinski MW (2004) 15571461 171855 24 Thyrotropin Alfa Thyrotropin-a|TSH|Thyrotrophin-alfa|Thyroid stimulating hormone|Thytrophin|Thyrotropin|rTSH|Thyrotropin-alpha|Thyrotrophin-alpha thyrogen DRUGBANK DB00024 C975H1513N267O304S26 biologic H01AB01|V04CJ01 194100-83-9 DRUGBANK 253 113104 7253 - TSHR CHNG1|LGR3|hTSHR-I 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 24 Thyrotropin Alfa Thyrotropin-a|TSH|Thyrotrophin-alfa|Thyroid stimulating hormone|Thytrophin|Thyrotropin|rTSH|Thyrotropin-alpha|Thyrotrophin-alpha thyrogen DRUGBANK DB00024 C975H1513N267O304S26 biologic H01AB01|V04CJ01 194100-83-9 DRUGBANK 19868 113114 7263 LL22NC01-146D10.3 TST RDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2646 S-Mercaptocysteine - - DRUGBANK DB02761 C3H7NO2S2 small molecule - 5652-32-4 DRUGBANK 3127 113115 7264 - TSTA3 FX|P35B|SDR4E1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3128 113115 7264 - TSTA3 FX|P35B|SDR4E1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 17776 113123 7272 RP3-357D13.2 TTK CT96|ESK|MPH1|MPS1|MPS1L1|PYT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1714 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One - - DRUGBANK DB01782 C14H8N2O small molecule - - DRUGBANK 18371 113126 7275 - TUB rd5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1951 L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate - - DRUGBANK DB02028 C9H19O17P3 small molecule - - DRUGBANK 14511 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Kim ND (2010) 20810285 180492 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14512 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Li CM (2010) 20814887 180493 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14513 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Screpanti E (2010) 20657644 180490 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14514 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Alam MA (2009) 19286405 180491 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14515 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Labruere R (2010) 20979080 180489 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 14516 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Clark PI (1992) 1411635 180488 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 20306 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20307 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 7854 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Yasui M (2010) 20691709 176761 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 7855 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Gan PP (2010) 20442307 176760 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 7856 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens inhibitor target Vilpo JA (2000) 11168494 176759 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 18002 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 18003 113128 7277 - TUBA4A H2-ALPHA|TUBA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 20288 113129 7278 - TUBA3C TUBA2|bA408E5.3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20289 113129 7278 - TUBA3C TUBA2|bA408E5.3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 17984 113129 7278 - TUBA3C TUBA2|bA408E5.3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17985 113129 7278 - TUBA3C TUBA2|bA408E5.3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 8125 113134 7283 - TUBG1 CDCBM4|GCP-1|TUBG|TUBGCP1 9606 Homo sapiens adduct target Correia JJ (1991) 1818332 176945 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8126 113134 7283 - TUBG1 CDCBM4|GCP-1|TUBG|TUBGCP1 9606 Homo sapiens adduct target Islam MN (2004) 15579115 176944 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8127 113134 7283 - TUBG1 CDCBM4|GCP-1|TUBG|TUBGCP1 9606 Homo sapiens adduct target Gupta S (2003) 14619954 176946 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8128 113134 7283 - TUBG1 CDCBM4|GCP-1|TUBG|TUBGCP1 9606 Homo sapiens adduct target Jordan A (1998) 9664292 176943 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8129 113134 7283 - TUBG1 CDCBM4|GCP-1|TUBG|TUBGCP1 9606 Homo sapiens adduct target Jordan MA (2007) 18220533 176942 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 23095 113135 7284 - TUFM COXPD4|EF-TuMT|EFTU|P43 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23096 113135 7284 - TUFM COXPD4|EF-TuMT|EFTU|P43 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23097 113135 7284 - TUFM COXPD4|EF-TuMT|EFTU|P43 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 22577 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3938 Fotemustine Fotemustinum|(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate|Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate|Fotemustina - DRUGBANK DB04106 C9H19ClN3O5P small molecule L01AD05 - DRUGBANK 22578 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3938 Fotemustine Fotemustinum|(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate|Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate|Fotemustina - DRUGBANK DB04106 C9H19ClN3O5P small molecule L01AD05 - DRUGBANK 14410 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens inhibitor target Lu J (2007) 17640917 173367 1157 Arsenic trioxide Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide trisenox DRUGBANK DB01169 As2O3 small molecule L01XX27 1327-53-3 DRUGBANK 20622 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20623 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20624 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21512 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3415 Spermidine 1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane - DRUGBANK DB03566 C7H19N3 small molecule - 124-20-9 DRUGBANK 21513 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3415 Spermidine 1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane - DRUGBANK DB03566 C7H19N3 small molecule - 124-20-9 DRUGBANK 21514 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3415 Spermidine 1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane - DRUGBANK DB03566 C7H19N3 small molecule - 124-20-9 DRUGBANK 24330 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5211 PX-12 1-methylpropyl 2-imidazolyl disulfide - DRUGBANK DB05448 C7H12N2S2 small molecule - - DRUGBANK 18969 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 18970 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 18971 113147 7296 - TXNRD1 GRIM-12|TR|TR1|TRXR1|TXNR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 26213 113148 7297 - TYK2 IMD35|JTK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6975 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile - - DRUGBANK DB08183 C16H20N6O small molecule - - DRUGBANK 23836 113148 7297 - TYK2 IMD35|JTK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4520 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE - - DRUGBANK DB04716 C18H16FN3O small molecule - - DRUGBANK 8914 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Hanauske AR (2001) 11524555 177528 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8915 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Adjei AA (2001) 11742712 177529 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8916 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Schultz RM (2002) 11848474 177524 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8917 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Molina JR (2003) 14596699 177525 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8918 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Norman P (2001) 11763166 177526 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8919 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Adjei AA (2002) 12023793 177527 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8920 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Pivot X (2001) 11531245 177521 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8921 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Kindler HL (2002) 12571811 177522 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8922 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Adjei AA (2001) 11252887 177523 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8923 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Giovannetti E (2005) 15795320 176083 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 8924 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 632 Pemetrexed - alimta|pemetrexed|pemetrexed d DRUGBANK DB00642 C20H21N5O6 small molecule L01BA04 137281-23-3 DRUGBANK 21462 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3392 10-Propargyl-5,8-Dideazafolic Acid - - DRUGBANK DB03541 C24H23N5O6 small molecule - - DRUGBANK 21972 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 21973 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 21974 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 7916 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Fernandez-Contreras ME (2006) 16596248 176790 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 7917 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Rustum YM (2004) 15353299 176791 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 7918 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Ploylearmsaeng SA (2006) 16719540 176789 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 7919 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Formentini A (2007) 16538493 176788 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 7920 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Garcia V (2006) 16609021 176787 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 7921 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 7922 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Huang CL (2006) 16563096 176087 534 Fluorouracil 5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU efudex crm 5%|carac|fluorourac DRUGBANK DB00544 C4H3FN2O2 small molecule L01BC02|L01BC52 51-21-8 DRUGBANK 17483 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 17484 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 26526 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7259 N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide - - DRUGBANK DB08478 C9H9ClF3N5 small molecule - - DRUGBANK 5563 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Kuwa K (2000) 10697523 175207 315 Floxuridine beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR floxuridine DRUGBANK DB00322 C9H11FN2O5 small molecule - 50-91-9 DRUGBANK 5564 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Murakami Y (2000) 10891536 175210 315 Floxuridine beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR floxuridine DRUGBANK DB00322 C9H11FN2O5 small molecule - 50-91-9 DRUGBANK 5565 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Ferguson PJ (1999) 10482907 175009 315 Floxuridine beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR floxuridine DRUGBANK DB00322 C9H11FN2O5 small molecule - 50-91-9 DRUGBANK 5566 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Kuwa K (2000) 10697524 175209 315 Floxuridine beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR floxuridine DRUGBANK DB00322 C9H11FN2O5 small molecule - 50-91-9 DRUGBANK 5567 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Kubota T (1999) 10553409 175208 315 Floxuridine beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR floxuridine DRUGBANK DB00322 C9H11FN2O5 small molecule - 50-91-9 DRUGBANK 6883 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6884 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Baessler R (1966) 6010427 176022 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6885 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Bijnsdorp IV (2008) 18600528 176023 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6886 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Madeira VM (1973) 4719131 176020 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6887 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Overman MJ (2008) 18798063 176021 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6888 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Temmink OH (2004) 15571283 176017 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6889 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Emura T (2004) 14719072 176016 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6890 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Hong DS (2006) 16902987 176015 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6891 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Temmink OH (2006) 16010590 176014 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6892 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Shintani M (2010) 20372850 176013 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6893 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Temmink OH (2007) 17179993 176012 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6894 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target De Clercq E (2004) 15125867 176011 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6895 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Oberg B (1984) 6436227 176024 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6896 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Bijnsdorp IV (2010) 19816940 176019 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 6897 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Bijnsdorp IV (2010) 19886911 176018 424 Trifluridine FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine apo-trifluridine ophthalmic so DRUGBANK DB00432 C10H11F3N2O5 small molecule S01AD02|L01BC59 70-00-8 DRUGBANK 25588 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6384 6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE - - DRUGBANK DB07577 C12H14N4 small molecule - - DRUGBANK 26739 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7507 6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE - - DRUGBANK DB08734 C14H18Cl3N5O2 small molecule - - DRUGBANK 6948 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6949 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6950 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6951 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Rosowsky A (1999) 10090784 176071 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6952 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Oefner C (2009) 19622858 176070 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6953 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Gamarro F (1995) 8538681 176068 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 6954 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Reche P (1996) 8920005 176069 432 Trimethoprim Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima polytrim|septra injection|poly DRUGBANK DB00440 C14H18N4O3 small molecule J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01 738-70-5 DRUGBANK 13738 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1089 Capecitabine Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate capecitabine|teva-capecitabine DRUGBANK DB01101 C15H22FN3O6 small molecule L01BC06 154361-50-9 DRUGBANK 13739 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Fischel JL (2006) 16926630 180132 1089 Capecitabine Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate capecitabine|teva-capecitabine DRUGBANK DB01101 C15H22FN3O6 small molecule L01BC06 154361-50-9 DRUGBANK 13740 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Carlini LE (2005) 15709193 180135 1089 Capecitabine Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate capecitabine|teva-capecitabine DRUGBANK DB01101 C15H22FN3O6 small molecule L01BC06 154361-50-9 DRUGBANK 13741 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Eliason JF (2004) 15134221 180134 1089 Capecitabine Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate capecitabine|teva-capecitabine DRUGBANK DB01101 C15H22FN3O6 small molecule L01BC06 154361-50-9 DRUGBANK 13742 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Li KM (2005) 15866500 180136 1089 Capecitabine Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate capecitabine|teva-capecitabine DRUGBANK DB01101 C15H22FN3O6 small molecule L01BC06 154361-50-9 DRUGBANK 13743 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Patel A (2004) 15132128 180133 1089 Capecitabine Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate capecitabine|teva-capecitabine DRUGBANK DB01101 C15H22FN3O6 small molecule L01BC06 154361-50-9 DRUGBANK 6967 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6968 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Giovannetti E (2005) 15795320 176083 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6969 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Rosell R (2004) 15655942 176084 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6970 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Zhao XD (2006) 17166391 176085 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6971 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Giovannetti E (2006) 16818496 176086 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6972 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Huang CL (2006) 16563096 176087 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6973 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Marce S (2006) 16818276 176088 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 26527 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7260 N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide - - DRUGBANK DB08479 C10H15N5O2 small molecule - - DRUGBANK 24842 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Shimanovsky A (2013) 23409799 182231 5645 Pralatrexate N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid|PDX|10-Propargyl-10-deazaaminopterin|Pralatrexatum|Pralatrexato|Folotyn|(2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid|(2S)-2-((4-((1RS)-1-((2,4-diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid|HSDB 7786 folotyn DRUGBANK DB06813 C23H23N7O5 small molecule L01BA05 146464-95-1 DRUGBANK 23653 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23654 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 5206 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5207 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5208 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Cao S (1999) 10430100 175007 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5209 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Yin MB (1999) 10047461 175006 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5210 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Chen VJ (1999) 10598555 175012 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5211 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Orlandi L (1999) 10496350 175010 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5212 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Yang Z (2008) 18773878 175011 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5213 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Ferguson PJ (1999) 10482907 175009 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 5214 113149 7298 OK/SW-cl.29 TYMS HST422|TMS|TS 9606 Homo sapiens inhibitor target Grem JL (1999) 10499608 175008 286 Raltitrexed ZD1694|Raltitrexed|Tomudex tomudex DRUGBANK DB00293 C21H22N4O6S small molecule L01BA03 112887-68-0 DRUGBANK 3216 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens unknown target Zafar KS (2006) 16790533 173717 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3217 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens unknown target Jadhav JP (2007) 17292452 173716 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 8501 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Chen YR (2009) 19159217 177195 590 Monobenzone Benzyl p-hydroxyphenyl ether|MONOBENZYL ether OF hydroquinone|4-Benzyloxy-phenol|Hydroquinone monobenzyl ether|Monobenzonum|Hydrochinon monobenzylether|Monobenzyl hydroquinone|4-Benzyloxyphenol|4-(Benzyloxyl)phenol|4-(Benzyloxy)phenol|p-(Benzyloxy)phenol|Monobenzone|p-Hydroxyphenyl benzyl ether|4-(Phenylmethoxy)phenol|Hydroquinone benzyl ether|Monobenzona benoquin crm 20% DRUGBANK DB00600 C13H12O2 small molecule D11AX13 103-16-2 DRUGBANK 27932 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Patil S (2016) 27519292 196041 8199 Hydroquinone p-hydroxyphenol|p-Benzenediol|benzene-1,4-diol|Eldoquin|1,4-dihydroxybenzene|p-Hydroquinone|1,4-benzenediol|4-Hydroxyphenol|quinol elastiderm decolletage skin li DRUGBANK DB09526 C6H6O2 small molecule D11AX11 123-31-9 DRUGBANK 13304 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Sugumaran M (1986) 3094574 179914 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13305 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Khan KM (2006) 16750372 179913 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13306 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Woolery GL (1984) 6234942 179912 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 13307 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Ahmad VU (2004) 15577244 179911 1043 Mimosine Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine - DRUGBANK DB01055 C8H10N2O4 small molecule - 500-44-7 DRUGBANK 7983 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Nazzaro-Porro M (1987) 2963038 176817 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7984 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Schallreuter KU (1990) 2114832 176814 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7985 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Nazzaro-Porro M (1979) 448162 176819 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7986 113150 7299 - TYR ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3 9606 Homo sapiens inhibitor target Picardo M (1985) 4004885 176818 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 19428 113162 7314 - UBB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2439 (4s)-5-Fluoro-L-Leucine - - DRUGBANK DB02542 C6H12FNO2 small molecule - - DRUGBANK 19429 113162 7314 - UBB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2439 (4s)-5-Fluoro-L-Leucine - - DRUGBANK DB02542 C6H12FNO2 small molecule - - DRUGBANK 19430 113162 7314 - UBB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2439 (4s)-5-Fluoro-L-Leucine - - DRUGBANK DB02542 C6H12FNO2 small molecule - - DRUGBANK 23499 113164 7316 - UBC HMG20 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 22597 113165 7317 CTD-2522E6.1 UBA1 A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3951 Hexatantalum Dodecabromide - - DRUGBANK DB04119 Br12Ta6 small molecule - - DRUGBANK 22598 113165 7317 CTD-2522E6.1 UBA1 A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3951 Hexatantalum Dodecabromide - - DRUGBANK DB04119 Br12Ta6 small molecule - - DRUGBANK 22599 113165 7317 CTD-2522E6.1 UBA1 A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3951 Hexatantalum Dodecabromide - - DRUGBANK DB04119 Br12Ta6 small molecule - - DRUGBANK 19162 113170 7322 - UBE2D2 E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2321 (R,R)-2,3-Butanediol - - DRUGBANK DB02418 C4H10O2 small molecule - 24347-58-8 DRUGBANK 19163 113170 7322 - UBE2D2 E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2321 (R,R)-2,3-Butanediol - - DRUGBANK DB02418 C4H10O2 small molecule - 24347-58-8 DRUGBANK 19164 113170 7322 - UBE2D2 E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2321 (R,R)-2,3-Butanediol - - DRUGBANK DB02418 C4H10O2 small molecule - 24347-58-8 DRUGBANK 26421 113203 7356 - SCGB1A1 CC10|CC16|CCPBP|CCSP|UGB|UP-1|UP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7158 4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL - - DRUGBANK DB08373 C14H10Cl4O4S2 small molecule - - DRUGBANK 27463 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens antagonist target Poole RM (2014) 25239269 188537 7802 Eliglustat N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1-pyrrolidinyl)-2-propanyl]octanamide cerdelga DRUGBANK DB09039 C23H36N2O4 small molecule A16AX10 491833-29-5 DRUGBANK 6707 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Moyses C (2003) 12803929 175940 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6708 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6709 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Treiber A (2007) 17624027 175939 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6710 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Pastores GM (2006) 18221193 175938 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6711 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Ficicioglu C (2008) 18728838 175933 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6712 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Weinreb NJ (2005) 16247743 175932 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6713 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Chien YH (2007) 17603755 175935 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6714 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Wraith JE (2009) 19956552 175934 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6715 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target McCormack PL (2003) 14609352 175937 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 6716 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens inhibitor target Giraldo P (2006) 16627252 175936 411 Miglustat N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline zavesca|sandoz miglustat DRUGBANK DB00419 C10H21NO4 small molecule A16AX06 72599-27-0 DRUGBANK 24351 113204 7357 - UGCG GCS|GLCT1 9606 Homo sapiens unknown target McEachern KA (2007) 17509920 182011 5299 Genz-112638 - - DRUGBANK DB05715 - small molecule - - DRUGBANK 3043 113205 7358 - UGDH GDH|UDP-GlcDH|UDPGDH|UGD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3044 113205 7358 - UGDH GDH|UDP-GlcDH|UDPGDH|UGD 9606 Homo sapiens unknown target Castellani AA (1986) 3804697 173650 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3045 113205 7358 - UGDH GDH|UDP-GlcDH|UDPGDH|UGD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3046 113205 7358 - UGDH GDH|UDP-GlcDH|UDPGDH|UGD 9606 Homo sapiens unknown target Alary J (1992) 1472079 173651 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21138 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 21139 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 22942 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22943 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 19188 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 19189 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 18521 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2017 Cytidine - - DRUGBANK DB02097 C9H13N3O5 small molecule - - DRUGBANK 18522 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2017 Cytidine - - DRUGBANK DB02097 C9H13N3O5 small molecule - - DRUGBANK 22371 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3839 Uridine 5'-Triphosphate - - DRUGBANK DB04005 C9H15N2O15P3 small molecule - 63-39-8 DRUGBANK 22372 113217 7371 - UCK2 TSA903|UK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3839 Uridine 5'-Triphosphate - - DRUGBANK DB04005 C9H15N2O15P3 small molecule - 63-39-8 DRUGBANK 20081 113218 7372 OK/SW-cl.21 UMPS OPRT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2770 6-Hydroxyuridine-5'-Phosphate - - DRUGBANK DB02890 C9H13N2O10P small molecule - - DRUGBANK 20082 113218 7372 OK/SW-cl.21 UMPS OPRT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2770 6-Hydroxyuridine-5'-Phosphate - - DRUGBANK DB02890 C9H13N2O10P small molecule - - DRUGBANK 20083 113218 7372 OK/SW-cl.21 UMPS OPRT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2770 6-Hydroxyuridine-5'-Phosphate - - DRUGBANK DB02890 C9H13N2O10P small molecule - - DRUGBANK 25003 113220 7374 - UNG DGU|HIGM4|HIGM5|UDG|UNG1|UNG15|UNG2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5808 4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID - - DRUGBANK DB06990 C15H14N4O6 small molecule - - DRUGBANK 25768 113220 7374 - UNG DGU|HIGM4|HIGM5|UDG|UNG1|UNG15|UNG2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6561 3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid - - DRUGBANK DB07760 C15H14N4O6 small molecule - - DRUGBANK 25125 113220 7374 - UNG DGU|HIGM4|HIGM5|UDG|UNG1|UNG15|UNG2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5934 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE - - DRUGBANK DB07116 C14H18NO6P small molecule - - DRUGBANK 25085 113222 7376 - NR1H2 LXR-b|LXRB|NER|NER-I|RIP15|UNR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5898 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE - - DRUGBANK DB07080 C17H12F9NO3S small molecule - - DRUGBANK 25091 113222 7376 - NR1H2 LXR-b|LXRB|NER|NER-I|RIP15|UNR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5900 1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL - - DRUGBANK DB07082 C11H8F9NO small molecule - - DRUGBANK 21926 113222 7376 - NR1H2 LXR-b|LXRB|NER|NER-I|RIP15|UNR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3630 (3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid - - DRUGBANK DB03791 C33H37ClF3NO3 small molecule - - DRUGBANK 21927 113222 7376 - NR1H2 LXR-b|LXRB|NER|NER-I|RIP15|UNR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3630 (3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid - - DRUGBANK DB03791 C33H37ClF3NO3 small molecule - - DRUGBANK 22061 113222 7376 - NR1H2 LXR-b|LXRB|NER|NER-I|RIP15|UNR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3685 Benzenesulfonyl - - DRUGBANK DB03848 C6H6O2S small molecule - - DRUGBANK 22062 113222 7376 - NR1H2 LXR-b|LXRB|NER|NER-I|RIP15|UNR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3685 Benzenesulfonyl - - DRUGBANK DB03848 C6H6O2S small molecule - - DRUGBANK 25456 113224 7378 - UPP1 UDRPASE|UP|UPASE|UPP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6250 1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE - - DRUGBANK DB07437 C14H16N2O4 small molecule - - DRUGBANK 25793 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25772 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25420 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26503 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22672 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 25639 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6442 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE - - DRUGBANK DB07636 C14H17NO3S small molecule - - DRUGBANK 26366 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23914 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26705 113227 7381 - UQCRB MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 25800 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25779 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25427 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26510 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22680 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 26373 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23921 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 23859 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4544 Myxothiazol (2Z,6E)-7-{2'-[(2E,4E)-1,6-DIMETHYLHEPTA-2,4-DIENYL]-2,4'-BI-1,3-THIAZOL-4-YL}-3,5-DIMETHOXY-4-METHYLHEPTA-2,6-DIENAMIDE - DRUGBANK DB04741 C25H33N3O3S2 small molecule - 76706-55-3 DRUGBANK 26710 113230 7384 - UQCRC1 D3S3191|QCR1|UQCR1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 25799 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25778 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25426 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26509 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22678 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 26372 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23920 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26716 113231 7385 - UQCRC2 MC3DN5|QCR2|UQCR2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 25794 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25773 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25421 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26504 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22673 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 25641 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6442 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE - - DRUGBANK DB07636 C14H17NO3S small molecule - - DRUGBANK 26367 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23915 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26711 113232 7386 - UQCRFS1 RIP1|RIS1|RISP|UQCR5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 25796 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25775 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25423 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26506 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22675 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 26369 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23917 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26713 113234 7388 - UQCRH QCR6|UQCR8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 21808 113235 7389 RP11-69J16.2 UROD PCT|UPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3570 Coproporphyrin I - - DRUGBANK DB03727 C36H40N4O8 small molecule - - DRUGBANK 21809 113235 7389 RP11-69J16.2 UROD PCT|UPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3570 Coproporphyrin I - - DRUGBANK DB03727 C36H40N4O8 small molecule - - DRUGBANK 23472 113235 7389 RP11-69J16.2 UROD PCT|UPD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4275 Coproporphyrin Iii - - DRUGBANK DB04461 C36H40N4O8 small molecule - - DRUGBANK 23473 113235 7389 RP11-69J16.2 UROD PCT|UPD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4275 Coproporphyrin Iii - - DRUGBANK DB04461 C36H40N4O8 small molecule - - DRUGBANK 3507 113250 7407 DAAP-21F2.2 VARS G7A|VARS1|VARS2 9606 Homo sapiens unknown target Zhu B (2007) 17095543 173521 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 3508 113250 7407 DAAP-21F2.2 VARS G7A|VARS1|VARS2 9606 Homo sapiens unknown target Laforest MJ (2005) 15710393 173869 155 L-Valine (S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine freamine iii|primene 10%|2.5% DRUGBANK DB00161 C5H11NO2 small molecule - 72-18-4 DRUGBANK 27146 113255 7412 - VCAM1 CD106|INCAM-100 9606 Homo sapiens unknown target Arevalo E (2008) 18165316 188487 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 14070 113255 7412 - VCAM1 CD106|INCAM-100 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14071 113255 7412 - VCAM1 CD106|INCAM-100 9606 Homo sapiens inhibitor target Chen JW (2004) 15374848 180314 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14072 113255 7412 - VCAM1 CD106|INCAM-100 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 23274 113258 7415 - VCP ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 16245 113259 7416 - VDAC1 PORIN|VDAC-1 9606 Homo sapiens inhibitor target Zhang DW (1989) 2469483 181222 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 16246 113259 7416 - VDAC1 PORIN|VDAC-1 9606 Homo sapiens inhibitor target Zhang DW (1990) 1694685 181223 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 16247 113260 7417 RP11-375G3.1 VDAC2 POR 9606 Homo sapiens inhibitor target Zhang DW (1989) 2469483 181222 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 16248 113260 7417 RP11-375G3.1 VDAC2 POR 9606 Homo sapiens inhibitor target Zhang DW (1990) 1694685 181223 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 16250 113262 7419 - VDAC3 HD-VDAC3|VDAC-3 9606 Homo sapiens inhibitor target Zhang DW (1989) 2469483 181222 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 16251 113262 7419 - VDAC3 HD-VDAC3|VDAC-3 9606 Homo sapiens inhibitor target Zhang DW (1990) 1694685 181223 1333 Aluminium monostearate Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium - DRUGBANK DB01375 C18H37AlO4 small molecule - 7047-84-9 DRUGBANK 2930 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Jurutka PW (2007) 18290715 112374 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2931 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2932 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Ewing AK (2007) 17519354 115875 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2933 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Gallagher JC (2010) 20525913 173579 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2934 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Marks HD (2007) 17207992 173578 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2935 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Straube S (2010) 20091647 173580 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2936 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Mikhak B (2007) 17440943 173581 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2937 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Carvallo L (2007) 17218095 104088 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 2938 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Liu W (2006) 16949927 173577 147 Ergocalciferol Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol vitamines pour bebes et enfant DRUGBANK DB00153 C28H44O small molecule A11CC01 50-14-6 DRUGBANK 11853 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 900 Paricalcitol 19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar paricalcitol|zemplar DRUGBANK DB00910 C27H44O3 small molecule H05BX02 131918-61-1 DRUGBANK 11854 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 900 Paricalcitol 19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar paricalcitol|zemplar DRUGBANK DB00910 C27H44O3 small molecule H05BX02 131918-61-1 DRUGBANK 11855 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 900 Paricalcitol 19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar paricalcitol|zemplar DRUGBANK DB00910 C27H44O3 small molecule H05BX02 131918-61-1 DRUGBANK 11856 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Brancaccio D (2009) 19494617 179054 900 Paricalcitol 19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar paricalcitol|zemplar DRUGBANK DB00910 C27H44O3 small molecule H05BX02 131918-61-1 DRUGBANK 11857 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Andress DL (2005) 16076355 179052 900 Paricalcitol 19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar paricalcitol|zemplar DRUGBANK DB00910 C27H44O3 small molecule H05BX02 131918-61-1 DRUGBANK 11858 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Wu-Wong JR (2010) 20204178 179053 900 Paricalcitol 19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar paricalcitol|zemplar DRUGBANK DB00910 C27H44O3 small molecule H05BX02 131918-61-1 DRUGBANK 22908 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4085 Seocalcitol (5Z,7E,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,25-triol|22-24-DIENE-24A,26A,27A,TRIHOMO-1ALPHA,25-DIHYDROXYVITAMIN D3 - DRUGBANK DB04258 C30H46O3 small molecule - 134404-52-7 DRUGBANK 22909 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4085 Seocalcitol (5Z,7E,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,25-triol|22-24-DIENE-24A,26A,27A,TRIHOMO-1ALPHA,25-DIHYDROXYVITAMIN D3 - DRUGBANK DB04258 C30H46O3 small molecule - 134404-52-7 DRUGBANK 2825 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 140 Calcidiol Calcidiol|25-Hydroxyvitamin D3|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|Calcifediolum|Calcifediol Anhydrous|Calcifediol|25(OH)D3|3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol|(3S,5Z,7e)-9,10-Secocholesta-5,7,10-triene-3,25-diol|(3,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol|(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|25-hydroxycholecalciferol - DRUGBANK DB00146 C27H44O2 small molecule A11CC06 19356-17-3 DRUGBANK 2826 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Reinhart GA (2004) 15503649 173130 140 Calcidiol Calcidiol|25-Hydroxyvitamin D3|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|Calcifediolum|Calcifediol Anhydrous|Calcifediol|25(OH)D3|3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol|(3S,5Z,7e)-9,10-Secocholesta-5,7,10-triene-3,25-diol|(3,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol|(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|25-hydroxycholecalciferol - DRUGBANK DB00146 C27H44O2 small molecule A11CC06 19356-17-3 DRUGBANK 18894 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 2207 Calcipotriol Daivonex|Calcipotriene|Dovonex|Calcipotriol calcipotriene|enstilar|dovonex DRUGBANK DB02300 C27H40O3 small molecule D05AX52|D05AX02 112965-21-6 DRUGBANK 18895 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 2207 Calcipotriol Daivonex|Calcipotriene|Dovonex|Calcipotriol calcipotriene|enstilar|dovonex DRUGBANK DB02300 C27H40O3 small molecule D05AX52|D05AX02 112965-21-6 DRUGBANK 18896 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 2207 Calcipotriol Daivonex|Calcipotriene|Dovonex|Calcipotriol calcipotriene|enstilar|dovonex DRUGBANK DB02300 C27H40O3 small molecule D05AX52|D05AX02 112965-21-6 DRUGBANK 13472 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Qaw F (1993) 8380156 179980 1058 Dihydrotachysterol Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10 hytakerol DRUGBANK DB01070 C28H46O small molecule A11CC02 67-96-9 DRUGBANK 13473 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Qaw FS (1992) 1336906 179981 1058 Dihydrotachysterol Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10 hytakerol DRUGBANK DB01070 C28H46O small molecule A11CC02 67-96-9 DRUGBANK 13474 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1058 Dihydrotachysterol Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10 hytakerol DRUGBANK DB01070 C28H46O small molecule A11CC02 67-96-9 DRUGBANK 13475 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1058 Dihydrotachysterol Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10 hytakerol DRUGBANK DB01070 C28H46O small molecule A11CC02 67-96-9 DRUGBANK 13476 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1058 Dihydrotachysterol Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10 hytakerol DRUGBANK DB01070 C28H46O small molecule A11CC02 67-96-9 DRUGBANK 13477 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Gallagher JC (2010) 20525913 173579 1058 Dihydrotachysterol Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10 hytakerol DRUGBANK DB01070 C28H46O small molecule A11CC02 67-96-9 DRUGBANK 27854 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens suppressor target Ritter CS (2011) 21169421 196001 8075 Doxercalciferol 1-Hydroxyergocalciferol|Doxercalciferolum|(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol|Doxercalciferol|1-Hydroxyvitamin D2|1alpha-hydroxyvitamin D2|1-alpha-hydroxyergocalciferol|1-Hydroxyergocalciferol doxercalciferol|hectorol DRUGBANK DB06410 C28H44O2 small molecule H05BX03 54573-75-0 DRUGBANK 16675 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Fujishima T (2010) 20435140 173968 1384 Alfacalcidol 1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol one alpha caps 1mcg|one alpha DRUGBANK DB01436 C27H44O2 small molecule A11CC03|M05BB06 41294-56-8 DRUGBANK 16676 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 1384 Alfacalcidol 1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol one alpha caps 1mcg|one alpha DRUGBANK DB01436 C27H44O2 small molecule A11CC03|M05BB06 41294-56-8 DRUGBANK 16677 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Reinhart GA (2004) 15503649 173130 1384 Alfacalcidol 1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol one alpha caps 1mcg|one alpha DRUGBANK DB01436 C27H44O2 small molecule A11CC03|M05BB06 41294-56-8 DRUGBANK 26745 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7515 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) - - DRUGBANK DB08742 C26H34O3 small molecule - - DRUGBANK 2213 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 130 Calcitriol 1alpha,25-Dihydroxyvitamin D3|(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1-alpha-25-Dihydroxyvitamin D3|1alpha,25(OH)2D3|1,25-dihydroxycholecalciferol|Calcitriolum|1,25-dihydroxycholecalciferol|1,25-DHCC|1,25-dihydroxyvitamin D3|Decostriol|Calcitriol|Rocaltrol|5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol|(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1,25(OH)2D3|1alpha,25-Dihydroxycholecalciferol|(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol|Calcijex rocaltrol oral solution 1mcg/m DRUGBANK DB00136 C27H44O3 small molecule A11CC04|D05AX03 32222-06-3 DRUGBANK 2214 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens antagonist target Reinhart GA (2004) 15503649 173130 130 Calcitriol 1alpha,25-Dihydroxyvitamin D3|(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1-alpha-25-Dihydroxyvitamin D3|1alpha,25(OH)2D3|1,25-dihydroxycholecalciferol|Calcitriolum|1,25-dihydroxycholecalciferol|1,25-DHCC|1,25-dihydroxyvitamin D3|Decostriol|Calcitriol|Rocaltrol|5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol|(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1,25(OH)2D3|1alpha,25-Dihydroxycholecalciferol|(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol|Calcijex rocaltrol oral solution 1mcg/m DRUGBANK DB00136 C27H44O3 small molecule A11CC04|D05AX03 32222-06-3 DRUGBANK 26725 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7470 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL - - DRUGBANK DB08696 C23H36O2 small molecule - - DRUGBANK 21255 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3307 1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3 - - DRUGBANK DB03451 C29H48O4 small molecule - - DRUGBANK 21256 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3307 1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3 - - DRUGBANK DB03451 C29H48O4 small molecule - - DRUGBANK 23909 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4598 Inecalcitol 9,10-seco-14bh-19-norcholesta-5(z),7(e)-dien-1(r),3(r),25-triol-23-yne|19-nor-14-epi-23-yne-1,25 dihydroxyvitamin D3 - DRUGBANK DB04796 C26H40O3 small molecule - 163217-09-2 DRUGBANK 3633 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Fujishima T (2010) 20435140 173968 162 Cholecalciferol (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Activated 7-dehydrocholesterol|Vitamin D3|Oleovitamin D3|(+)-vitamin D3|CC|Cholecalciferol|delta-D|(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol|calciol|Colecalciferol|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol port a mins super calcium 750 DRUGBANK DB00169 C27H44O small molecule M05BX53|A11CC05|M05BB03|M05BB07|M05BB05|M05BB04|M05BB08 67-97-0 DRUGBANK 3634 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 162 Cholecalciferol (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Activated 7-dehydrocholesterol|Vitamin D3|Oleovitamin D3|(+)-vitamin D3|CC|Cholecalciferol|delta-D|(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol|calciol|Colecalciferol|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol port a mins super calcium 750 DRUGBANK DB00169 C27H44O small molecule M05BX53|A11CC05|M05BB03|M05BB07|M05BB05|M05BB04|M05BB08 67-97-0 DRUGBANK 3635 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens agonist target Reinhart GA (2004) 15503649 173130 162 Cholecalciferol (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Activated 7-dehydrocholesterol|Vitamin D3|Oleovitamin D3|(+)-vitamin D3|CC|Cholecalciferol|delta-D|(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol|calciol|Colecalciferol|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol port a mins super calcium 750 DRUGBANK DB00169 C27H44O small molecule M05BX53|A11CC05|M05BB03|M05BB07|M05BB05|M05BB04|M05BB08 67-97-0 DRUGBANK 25545 113264 7421 - VDR NR1I1|PPP1R163 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6340 (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol - - DRUGBANK DB07530 C24H32F6O3 small molecule - - DRUGBANK 21863 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21864 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21865 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 24824 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens inhibitor target Norrby K (2010) 21091776 182178 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 24825 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens inhibitor target Marchetti M (2007) 17692905 182038 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 24826 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens inhibitor target Takahashi H (2005) 16041398 181901 5634 Dalteparin Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin fragmin inj.-liq 2500 iu(anti- DRUGBANK DB06779 - small molecule B01AB04 9041-08-1 DRUGBANK 14066 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target de Boer RA (2001) 11378004 180311 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14067 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Shyu KG (2005) 15732037 180310 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14068 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Shyu KG (2005) 15942707 180313 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 14069 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Saijonmaa O (2004) 15071347 180312 1124 Carvedilol (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol novo-carvedilol tablets|mylan- DRUGBANK DB01136 C24H26N2O4 small molecule C07AG02 72956-09-3 DRUGBANK 15606 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Ferrara N (2006) 17031284 180966 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15607 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Gaudreault J (2007) 18046235 180967 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15608 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Kourlas H (2007) 18035187 180964 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15609 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Spitzer MS (2008) 19668384 180965 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15610 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Pieramici DJ (2006) 17049020 180962 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15611 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Nguyen QD (2006) 17046701 180963 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15612 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Michels S (2005) 15973626 180960 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15613 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Rosenfeld PJ (2006) 16935211 180961 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15614 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Gaudreault J (2005) 15671306 180959 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 15615 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Bakri SJ (2007) 18054637 180958 1257 Ranibizumab rhuFab V2 lucentis DRUGBANK DB01270 C2158H3282N562O681S12 biologic S01LA04 347396-82-1 DRUGBANK 20456 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20457 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 20458 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 12802 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens inhibitor target Yao JS (2004) 15256478 179704 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12803 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens inhibitor target Sasamura H (2002) 11875741 179702 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12804 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens inhibitor target Rocchetti R (2005) 16224178 179703 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 26951 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens binder target Browning DJ (2012) 22813448 182207 7629 Aflibercept VEGF Trap|Ziv-Aflibercept|VEGF Trap-Eye eylea|zaltrap DRUGBANK DB08885 C4318H6788N1164O1304S32 biologic L01XX44|S01LA05 862111-32-8 DRUGBANK 1387 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1388 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Gerber HP (2005) 15705858 172458 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 13961 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Mamputu JC (2004) 14746574 180261 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13962 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Kimura T (2007) 17602961 180260 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13963 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Mamputu JC (2002) 12126787 180263 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 13964 113265 7422 RP1-261G23.1 VEGFA MVCD1|VEGF|VPF 9606 Homo sapiens unknown target Li L (2006) 17046555 180262 1108 Gliclazide 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea sandoz gliclazide|glic|nu-glic DRUGBANK DB01120 C15H21N3O3S small molecule A10BB09 21187-98-4 DRUGBANK 26952 113266 7423 - VEGFB VEGFL|VRF 9606 Homo sapiens binder target Browning DJ (2012) 22813448 182207 7629 Aflibercept VEGF Trap|Ziv-Aflibercept|VEGF Trap-Eye eylea|zaltrap DRUGBANK DB08885 C4318H6788N1164O1304S32 biologic L01XX44|S01LA05 862111-32-8 DRUGBANK 27673 113277 7436 RP11-320E16.1 VLDLR CARMQ1|CHRMQ1|VLDLRCH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 3450 113281 7442 - TRPV1 VR1 9606 Homo sapiens inducer target Matta JA (2007) 17038422 173841 153 Icosapent all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA natelle one|gesticare dha|ulti DRUGBANK DB00159 C20H30O2 small molecule - 10417-94-4 DRUGBANK 27883 113281 7442 - TRPV1 VR1 9606 Homo sapiens agonist target Anand P (2011) 21852280 196010 8093 Capsaicin - coralite medicated heat|capzas DRUGBANK DB06774 C18H27NO3 small molecule M02AB01|N01BX04 404-86-4 DRUGBANK 27884 113281 7442 - TRPV1 VR1 9606 Homo sapiens agonist target Wallace M (2011) 21158551 196000 8093 Capsaicin - coralite medicated heat|capzas DRUGBANK DB06774 C18H27NO3 small molecule M02AB01|N01BX04 404-86-4 DRUGBANK 3632 113281 7442 - TRPV1 VR1 9606 Homo sapiens inducer target Riera CE (2007) 17567713 173964 161 Aspartame Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame - DRUGBANK DB00168 C14H18N2O5 small molecule - 22839-47-0 DRUGBANK 2155 113281 7442 - TRPV1 VR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2156 113281 7442 - TRPV1 VR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 664 113287 7448 - VTN V75|VN|VNT 9606 Homo sapiens unknown target Ibbotson T (2003) 12749745 172056 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 665 113287 7448 - VTN V75|VN|VNT 9606 Homo sapiens unknown target Romagnoli E (2007) 17160551 172061 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 259 113289 7450 - VWF F8VWF|VWD 9606 Homo sapiens binder target Altieri DC (1986) 2942172 171865 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 260 113289 7450 - VWF F8VWF|VWD 9606 Homo sapiens binder target Gill JC (2003) 14750934 171864 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 261 113289 7450 - VWF F8VWF|VWD 9606 Homo sapiens binder target Smith KJ (1990) 2128855 171863 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 262 113289 7450 - VWF F8VWF|VWD 9606 Homo sapiens binder target Shord SS (2000) 10938981 171862 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 263 113289 7450 - VWF F8VWF|VWD 9606 Homo sapiens binder target Lillicrap D (2002) 11858481 171861 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 23662 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4347 L-Tryptophanamide - - DRUGBANK DB04537 C11H13N3O small molecule - - DRUGBANK 2876 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens inhibitor target Zhu L (2006) 17114500 173528 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2877 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens inhibitor target Tsuchiya W (2006) 17150540 173524 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2878 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens inhibitor target Retailleau P (2007) 17428498 173525 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2879 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens inhibitor target Yadav MC (2007) 17661345 173526 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2880 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens inhibitor target Yang XL (2006) 16724112 173527 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 17887 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1761 Tryptophanyl-5'amp - - DRUGBANK DB01831 C21H24N7O8P small molecule - - DRUGBANK 17888 113292 7453 - WARS GAMMA-2|IFI53|IFP53 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1761 Tryptophanyl-5'amp - - DRUGBANK DB01831 C21H24N7O8P small molecule - - DRUGBANK 17679 113293 7454 - WAS IMD2|SCNX|THC|THC1|WASP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1665 (S)-Wiskostatin - - DRUGBANK DB01731 C17H18Br2N2O small molecule - - DRUGBANK 25019 113303 7465 - WEE1 WEE1A|WEE1hu 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5824 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE - - DRUGBANK DB07006 C24H20N2O5 small molecule - - DRUGBANK 23768 113303 7465 - WEE1 WEE1A|WEE1hu 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4417 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE - - DRUGBANK DB04608 C20H12N2O3 small molecule - - DRUGBANK 26414 113303 7465 - WEE1 WEE1A|WEE1hu 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7150 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide - - DRUGBANK DB08365 C20H15BrClN3O4 small molecule - - DRUGBANK 25233 113303 7465 - WEE1 WEE1A|WEE1hu 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6042 N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE - - DRUGBANK DB07226 C21H12ClN3O3 small molecule - - DRUGBANK 25269 113303 7465 - WEE1 WEE1A|WEE1hu 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6073 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione - - DRUGBANK DB07257 C19H15ClN2O3 small molecule - - DRUGBANK 25277 113303 7465 - WEE1 WEE1A|WEE1hu 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6081 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID - - DRUGBANK DB07265 C23H16N2O5 small molecule - - DRUGBANK 17559 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1620 4-[5-Pyridin-4-Yl-1h-[1,2,4]Triazol-3-Yl]-Pyridine-2-Carbonitrile - - DRUGBANK DB01685 C13H8N6 small molecule - - DRUGBANK 24309 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Baldus S (2005) 16214034 181912 5039 Oxypurinol DHPP|6-hydroxy allopurinol|Oxoallopurinol|Oxipurinolum|1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol|Oxipurinol|1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione|Alloxanthine|Oxyprim|metabolite of allopurinol|Alloxanthin - DRUGBANK DB05262 C5H4N4O2 small molecule - 2465-59-0 DRUGBANK 24310 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Iwanaga T (2005) 16135657 181909 5039 Oxypurinol DHPP|6-hydroxy allopurinol|Oxoallopurinol|Oxipurinolum|1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol|Oxipurinol|1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione|Alloxanthine|Oxyprim|metabolite of allopurinol|Alloxanthin - DRUGBANK DB05262 C5H4N4O2 small molecule - 2465-59-0 DRUGBANK 8256 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Di Giacomo C (1993) 8255367 177045 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 27805 113335 7498 - XDH XO|XOR 9606 Homo sapiens antagonist target Bruce SP (2006) 17132810 195972 8063 Febuxostat Febuxostatum|Fbuxostat|2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid|Febuxostat uloric|febuxostat DRUGBANK DB04854 C16H16N2O3S small molecule M04AA03 144060-53-7 DRUGBANK 27680 113335 7498 - XDH XO|XOR 9606 Homo sapiens antagonist target Berman HM (2000) 10592235 172122 8063 Febuxostat Febuxostatum|Fbuxostat|2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid|Febuxostat uloric|febuxostat DRUGBANK DB04854 C16H16N2O3S small molecule M04AA03 144060-53-7 DRUGBANK 21431 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Porter DJ (1994) 7961725 181691 3371 Eniluracil 5-Ethynyluracil|5-ethynyl-2,4(1H,3H)-Pyrimidinedione|Compound 776C - DRUGBANK DB03516 C6H4N2O2 small molecule - 59989-18-3 DRUGBANK 20653 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20654 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20655 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 6927 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6928 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Higgins P (2009) 20029618 176059 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6929 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Pacher P (2006) 16507884 176058 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6930 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target George J (2009) 19436671 176053 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6931 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Taha MO (2009) 19376361 176052 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6932 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Okamoto K (2008) 18409526 176051 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6933 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Dincer HE (2002) 12184468 176050 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6934 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Suzuki I (2009) 19584965 176057 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6935 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Carro MD (2010) 19654053 176056 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6936 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Terkeltaub R (2010) 20046204 176055 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 6937 113335 7498 - XDH XO|XOR 9606 Homo sapiens inhibitor target Kelley WN (1970) 5415686 176054 429 Allopurinol 4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100 riva-purinol 300mg tablets|all DRUGBANK DB00437 C5H4N4O small molecule M04AA01|M04AA51 315-30-0 DRUGBANK 22050 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3678 Y-700 - - DRUGBANK DB03841 C16H17N3O3 small molecule - - DRUGBANK 20980 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3192 dioxothiomolybdenum(VI) ion - - DRUGBANK DB03328 HMoO2S small molecule - - DRUGBANK 20981 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3192 dioxothiomolybdenum(VI) ion - - DRUGBANK DB03328 HMoO2S small molecule - - DRUGBANK 20982 113335 7498 - XDH XO|XOR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3192 dioxothiomolybdenum(VI) ion - - DRUGBANK DB03328 HMoO2S small molecule - - DRUGBANK 22286 113352 7518 - XRCC4 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 22287 113352 7518 - XRCC4 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 15424 113357 7525 - YES1 HsT441|P61-YES|Yes|c-yes 9606 Homo sapiens inhibitor target Trevino JG (2006) 16507911 180870 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15425 113357 7525 - YES1 HsT441|P61-YES|Yes|c-yes 9606 Homo sapiens inhibitor target Margutti S (2007) 17541990 180871 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 15426 113357 7525 - YES1 HsT441|P61-YES|Yes|c-yes 9606 Homo sapiens inhibitor target Lindauer M (2010) 20072833 180857 1242 Dasatinib Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum sprycel DRUGBANK DB01254 C22H26ClN7O2S small molecule L01XE06 302962-49-8 DRUGBANK 17772 113363 7531 - YWHAE 14-3-3E|HEL2|KCIP-1|MDCR|MDS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1713 Fusicoccin - - DRUGBANK DB01780 C36H56O12 small molecule - 20108-30-9 DRUGBANK 17773 113363 7531 - YWHAE 14-3-3E|HEL2|KCIP-1|MDCR|MDS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1713 Fusicoccin - - DRUGBANK DB01780 C36H56O12 small molecule - 20108-30-9 DRUGBANK 17774 113363 7531 - YWHAE 14-3-3E|HEL2|KCIP-1|MDCR|MDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1713 Fusicoccin - - DRUGBANK DB01780 C36H56O12 small molecule - 20108-30-9 DRUGBANK 18320 113367 7535 - ZAP70 SRK|STCD|STD|TZK|ZAP-70 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18321 113367 7535 - ZAP70 SRK|STCD|STD|TZK|ZAP-70 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 8950 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Lubega GW (1993) 8139621 177533 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8951 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Wampande EM (2007) 17662615 177537 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8954 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8953 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Ochola DO (2002) 12099434 177535 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8952 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Oxberry ME (2001) 11444621 177536 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8955 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target MacDonald LM (2004) 15500920 177534 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 20292 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20293 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 17988 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17989 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 8110 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens adduct target Correia JJ (1991) 1818332 176945 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8111 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens adduct target Islam MN (2004) 15579115 176944 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8112 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens adduct target Gupta S (2003) 14619954 176946 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8113 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens adduct target Jordan A (1998) 9664292 176943 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8114 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens adduct target Jordan MA (2007) 18220533 176942 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 7676 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Ramirez T (2001) 11343808 176619 508 Albendazole Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate albenza DRUGBANK DB00518 C12H15N3O2S small molecule P02CA03 54965-21-8 DRUGBANK 7677 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 508 Albendazole Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate albenza DRUGBANK DB00518 C12H15N3O2S small molecule P02CA03 54965-21-8 DRUGBANK 7678 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens inhibitor target Chu SW (2009) 19846910 176618 508 Albendazole Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate albenza DRUGBANK DB00518 C12H15N3O2S small molecule P02CA03 54965-21-8 DRUGBANK 25583 113603 7846 - TUBA1A B-ALPHA-1|LIS3|TUBA3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6382 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE - - DRUGBANK DB07574 C22H25NO6S small molecule - - DRUGBANK 24840 113607 7852 - CXCR4 CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM 9606 Homo sapiens antagonist target Uy GL (2008) 18847313 182086 5642 Plerixafor Mozobil|AMD3100|LM3100 mozobil DRUGBANK DB06809 C28H54N8 small molecule L03AX16 110078-46-1 DRUGBANK 24841 113607 7852 - CXCR4 CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM 9606 Homo sapiens antagonist target Jujo K (2013) 23204107 182222 5642 Plerixafor Mozobil|AMD3100|LM3100 mozobil DRUGBANK DB06809 C28H54N8 small molecule L03AX16 110078-46-1 DRUGBANK 7028 113607 7852 - CXCR4 CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM 9606 Homo sapiens antagonist target Litovchick A (2001) 11747436 176158 444 Framycetin Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine sofra tulle 10 x 10cm|sofracor DRUGBANK DB00452 C23H46N6O13 small molecule S01AA07|D09AA01|R01AX08 119-04-0 DRUGBANK 7029 113607 7852 - CXCR4 CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM 9606 Homo sapiens antagonist target Borkow G (2003) 14638394 176159 444 Framycetin Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine sofra tulle 10 x 10cm|sofracor DRUGBANK DB00452 C23H46N6O13 small molecule S01AA07|D09AA01|R01AX08 119-04-0 DRUGBANK 25734 113617 7867 - MAPKAPK3 3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6529 2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE - - DRUGBANK DB07728 C18H14FN3O small molecule - - DRUGBANK 26408 113617 7867 - MAPKAPK3 3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7143 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE - - DRUGBANK DB08358 C21H16N4O small molecule - - DRUGBANK 23089 113624 7879 - RAB7A PRO2706|RAB7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 2263 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Yogeeswari P (2005) 15853764 173155 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2264 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Ahn SJ (2007) 17584458 173157 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2265 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Popov VN (2007) 17619587 173156 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2266 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2267 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Wang C (2006) 16942602 173159 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2268 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Chiribau CB (2006) 16689938 173158 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3298 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3299 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 7784 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 7785 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Oda Y (1968) 5692397 176711 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 7786 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 7787 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 524 Chlormerodrin Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina - DRUGBANK DB00534 C5H11ClHgN2O2 small molecule - 62-37-3 DRUGBANK 5446 113645 7915 - ALDH5A1 SSADH|SSDH 9606 Homo sapiens inhibitor target Johannessen CU (2003) 12847559 175116 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 27630 113649 7919 DAAP-97M17.4 DDX39B BAT1|D6S81E|UAP56 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27631 113649 7919 DAAP-97M17.4 DDX39B BAT1|D6S81E|UAP56 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27632 113649 7919 DAAP-97M17.4 DDX39B BAT1|D6S81E|UAP56 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 3017 113653 7923 DADB-100D22.4 HSD17B8 D6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3018 113653 7923 DADB-100D22.4 HSD17B8 D6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21272 113653 7923 DADB-100D22.4 HSD17B8 D6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 25841 113667 7941 - PLA2G7 LDL-PLA2|LP-PLA2|PAFAD|PAFAH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6619 (1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE - - DRUGBANK DB07821 C7H17O2P small molecule - - DRUGBANK 7210 113705 8001 - GLRA3 - 9606 Homo sapiens antagonist target Yang Z (2007) 17714449 176265 458 Picrotoxin cocculin - DRUGBANK DB00466 C30H34O13 small molecule - 124-87-8 DRUGBANK 2823 113705 8001 - GLRA3 - 9606 Homo sapiens unknown target Heinze L (2007) 17154252 173433 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2824 113705 8001 - GLRA3 - 9606 Homo sapiens unknown target Majumdar S (2007) 17550639 173452 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 8505 113705 8001 - GLRA3 - 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 8506 113705 8001 - GLRA3 - 9606 Homo sapiens agonist target McCavera S (2009) 19336526 177199 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 8507 113705 8001 - GLRA3 - 9606 Homo sapiens agonist target Berman HM (2000) 10592235 172122 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 8508 113705 8001 - GLRA3 - 9606 Homo sapiens agonist target Yates DM (2004) 15313134 177200 592 Ivermectin Ivermectin|Ivermectine|Ivermectinum|Ivermectina ivermectin|sklice|rosiver|stro DRUGBANK DB00602 C95H146O28 small molecule D11AX22|P02CF01 70288-86-7 DRUGBANK 6881 113705 8001 - GLRA3 - 9606 Homo sapiens antagonist target Heusinkveld HJ (2010) 20600211 176009 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 6882 113705 8001 - GLRA3 - 9606 Homo sapiens antagonist target Vale C (2003) 12614680 176005 423 Lindane gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride kwellada lotion 1%|lindane lot DRUGBANK DB00431 C6H6Cl6 small molecule P03AB02 58-89-9 DRUGBANK 4159 113724 8029 RP11-416D8.1 CUBN IFCR|MGA1|gp280 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4160 113724 8029 RP11-416D8.1 CUBN IFCR|MGA1|gp280 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4161 113724 8029 RP11-416D8.1 CUBN IFCR|MGA1|gp280 9606 Homo sapiens unknown target Seetharam B (2003) 14585166 174321 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 23506 113835 8192 - CLPP DFNB81|PRLTS3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 24914 113843 8204 - NRIP1 RIP140 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5704 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE - - DRUGBANK DB06884 C17H20N2O2 small molecule - - DRUGBANK 1916 113891 8284 - KDM5D HY|HYA|JARID1D|SMCY 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1917 113891 8284 - KDM5D HY|HYA|JARID1D|SMCY 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 13391 113893 8288 - EPX EPO|EPP|EPX-PEN 9606 Homo sapiens inhibitor target Lu T (2008) 18516076 179958 1053 Melatonin 5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide - DRUGBANK DB01065 C13H16N2O2 small molecule N05CH01 73-31-4 DRUGBANK 13749 113986 8398 CTA-228A9.2 PLA2G6 CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta 9606 Homo sapiens inhibitor target Sastry BV (1999) 10229494 180139 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13750 113986 8398 CTA-228A9.2 PLA2G6 CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta 9606 Homo sapiens inhibitor target Nuttle LC (1999) 10199854 180138 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13751 113986 8398 CTA-228A9.2 PLA2G6 CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta 9606 Homo sapiens inhibitor target Lohmann CH (1999) 10449625 180140 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13752 113986 8398 CTA-228A9.2 PLA2G6 CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta 9606 Homo sapiens inhibitor target Schwartz Z (2000) 10653606 180142 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 13753 113986 8398 CTA-228A9.2 PLA2G6 CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta 9606 Homo sapiens inhibitor target Sylvia VL (2001) 11455568 180141 1091 Quinacrine Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine - DRUGBANK DB01103 C23H30ClN3O small molecule P01AX05 83-89-6 DRUGBANK 20179 113999 8411 - EEA1 MST105|MSTP105|ZFYVE2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2820 Inositol 1,3-Bisphosphate - - DRUGBANK DB02942 C6H14O12P2 small molecule - - DRUGBANK 20180 113999 8411 - EEA1 MST105|MSTP105|ZFYVE2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2820 Inositol 1,3-Bisphosphate - - DRUGBANK DB02942 C6H14O12P2 small molecule - - DRUGBANK 1901 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1902 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1903 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Vaz FM (2000) 10709635 172871 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1904 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Dunn WA (1984) 6432788 172870 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1905 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Rebouche CJ (1991) 1962562 172869 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2230 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2231 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2232 114008 8424 - BBOX1 BBH|BBOX|G-BBH|gamma-BBH 9606 Homo sapiens unknown target Yoshisue K (2000) 10820142 173141 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 13678 114015 8435 - SOAT2 ACACT2|ACAT2|ARGP2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1082 Hesperetin Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin - DRUGBANK DB01094 C16H14O6 small molecule - 520-33-2 DRUGBANK 13679 114015 8435 - SOAT2 ACACT2|ACAT2|ARGP2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1082 Hesperetin Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin - DRUGBANK DB01094 C16H14O6 small molecule - 520-33-2 DRUGBANK 13680 114015 8435 - SOAT2 ACACT2|ACAT2|ARGP2 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1082 Hesperetin Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin - DRUGBANK DB01094 C16H14O6 small molecule - 520-33-2 DRUGBANK 19675 114045 8467 - SMARCA5 ISWI|SNF2H|WCRF135|hISWI|hSNF2H 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2561 4-Deoxy-Alpha-D-Glucose - - DRUGBANK DB02670 C6H12O5 small molecule - - DRUGBANK 19676 114045 8467 - SMARCA5 ISWI|SNF2H|WCRF135|hISWI|hSNF2H 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2561 4-Deoxy-Alpha-D-Glucose - - DRUGBANK DB02670 C6H12O5 small molecule - - DRUGBANK 19677 114045 8467 - SMARCA5 ISWI|SNF2H|WCRF135|hISWI|hSNF2H 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2561 4-Deoxy-Alpha-D-Glucose - - DRUGBANK DB02670 C6H12O5 small molecule - - DRUGBANK 19086 114045 8467 - SMARCA5 ISWI|SNF2H|WCRF135|hISWI|hSNF2H 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19087 114045 8467 - SMARCA5 ISWI|SNF2H|WCRF135|hISWI|hSNF2H 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19088 114045 8467 - SMARCA5 ISWI|SNF2H|WCRF135|hISWI|hSNF2H 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 13369 114075 8503 RP4-533D7.2 PIK3R3 p55|p55-GAMMA 9606 Homo sapiens agonist target Slomiany BL (2004) 15381832 179935 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13370 114075 8503 RP4-533D7.2 PIK3R3 p55|p55-GAMMA 9606 Homo sapiens agonist target Slomiany BL (2005) 15985706 179934 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13371 114075 8503 RP4-533D7.2 PIK3R3 p55|p55-GAMMA 9606 Homo sapiens agonist target Slomiany BL (2004) 15527548 179937 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13372 114075 8503 RP4-533D7.2 PIK3R3 p55|p55-GAMMA 9606 Homo sapiens agonist target Machida K (2005) 15618457 179936 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 13373 114075 8503 RP4-533D7.2 PIK3R3 p55|p55-GAMMA 9606 Homo sapiens agonist target Slomiany BL (2004) 15110780 179938 1052 Isoprenaline (+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline isuprel mistometer aem 0.25%|i DRUGBANK DB01064 C11H17NO3 small molecule R03AK02|R03AB02|C01CA02|R03CB01|R03CB51 7683-59-2 DRUGBANK 10473 114082 8510 RP11-345P4.2 MMP23B MIFR|MIFR-1|MMP22|MMP23A 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10474 114082 8510 RP11-345P4.2 MMP23B MIFR|MIFR-1|MMP22|MMP23A 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 19234 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2357 Undecyl-Phosphinic Acid Butyl Ester - - DRUGBANK DB02457 C15H33O2P small molecule - - DRUGBANK 13572 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Bray GA (2008) 18987274 180041 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13573 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Henness S (2006) 16956313 180040 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13574 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Curran MP (2004) 15563254 180043 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13575 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Nelson RH (2005) 16259579 180042 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13576 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Heck AM (2000) 10730683 180038 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13577 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Ballinger A (2002) 12007529 180039 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13578 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Wong NN (2001) 11728255 180036 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 13579 114085 8513 RP11-186O14.1 LIPF GL|HGL|HLAL 9606 Homo sapiens inhibitor target Drew BS (2008) 18200802 180037 1071 Orlistat (-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin xenical|xenical 120mg capsule| DRUGBANK DB01083 C29H53NO5 small molecule A08AB01 96829-58-2 DRUGBANK 2707 114097 8527 - DGKD DGKdelta|dgkd-2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2708 114097 8527 - DGKD DGKdelta|dgkd-2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2709 114097 8527 - DGKD DGKdelta|dgkd-2 9606 Homo sapiens unknown target Bregoli L (2001) 11309392 173414 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2710 114097 8527 - DGKD DGKdelta|dgkd-2 9606 Homo sapiens unknown target Sakane F (1996) 8626538 84998 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 22326 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3812 Tyrosinal - - DRUGBANK DB03978 C9H11NO2 small molecule - - DRUGBANK 22327 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3812 Tyrosinal - - DRUGBANK DB03978 C9H11NO2 small molecule - - DRUGBANK 22328 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3812 Tyrosinal - - DRUGBANK DB03978 C9H11NO2 small molecule - - DRUGBANK 26647 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7393 4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE - - DRUGBANK DB08617 C11H12F3NO2 small molecule - - DRUGBANK 26419 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7156 PARA-(BENZOYL)-PHENYLALANINE - - DRUGBANK DB08371 C16H15NO3 small molecule - - DRUGBANK 2212 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Bonnefond L (2007) 17401211 173128 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 25209 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6022 N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE - - DRUGBANK DB07205 C15H24N5O7P small molecule - - DRUGBANK 17744 114134 8565 - YARS CMTDIC|TYRRS|YRS|YTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1699 Beta-(2-Naphthyl)-Alanine - - DRUGBANK DB01766 C13H13NO2 small molecule - - DRUGBANK 22173 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22174 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22175 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 3592 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens ligand target Kim SY (2006) 16466641 172478 158 Pyridoxine 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol pyridoxine-s tab 50mg|vitamin DRUGBANK DB00165 C8H11NO3 small molecule A11HA02 65-23-6 DRUGBANK 3593 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens ligand target Newman JA (2006) 16978644 173493 158 Pyridoxine 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol pyridoxine-s tab 50mg|vitamin DRUGBANK DB00165 C8H11NO3 small molecule A11HA02 65-23-6 DRUGBANK 3594 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens ligand target Adams JB (2006) 16494569 173494 158 Pyridoxine 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol pyridoxine-s tab 50mg|vitamin DRUGBANK DB00165 C8H11NO3 small molecule A11HA02 65-23-6 DRUGBANK 3595 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens ligand target Nagahashi Y (2008) 18256491 173934 158 Pyridoxine 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol pyridoxine-s tab 50mg|vitamin DRUGBANK DB00165 C8H11NO3 small molecule A11HA02 65-23-6 DRUGBANK 23876 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4572 O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL - - DRUGBANK DB04770 C19H25N5O2 small molecule - - DRUGBANK 23879 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4578 (2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol Aftin-4|(2R)-2-({6-[Benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-1-butanol - DRUGBANK DB04776 C20H28N6O small molecule - - DRUGBANK 2827 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Newman JA (2006) 16978644 173493 141 Pyridoxal 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde|Pyridoxaldehyde|2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine|Piridoxal|3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde - DRUGBANK DB00147 C8H9NO3 small molecule - 66-72-8 DRUGBANK 2828 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Adams JB (2006) 16494569 173494 141 Pyridoxal 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde|Pyridoxaldehyde|2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine|Piridoxal|3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde - DRUGBANK DB00147 C8H9NO3 small molecule - 66-72-8 DRUGBANK 2829 114135 8566 PRED79 PDXK C21orf124|C21orf97|HEL-S-1a|PKH|PNK 9606 Homo sapiens unknown target Tang L (2005) 15985434 173495 141 Pyridoxal 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde|Pyridoxaldehyde|2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine|Piridoxal|3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde - DRUGBANK DB00147 C8H9NO3 small molecule - 66-72-8 DRUGBANK 7364 114160 8600 RP11-86N24.2 TNFSF11 CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf 9606 Homo sapiens inhibitor target Melchert M (2007) 17369076 176369 472 Lenalidomide 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501 revlimid DRUGBANK DB00480 C13H13N3O3 small molecule L04AX04 191732-72-6 DRUGBANK 7365 114160 8600 RP11-86N24.2 TNFSF11 CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf 9606 Homo sapiens inhibitor target Akobeng AK (2009) 19370685 176370 472 Lenalidomide 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501 revlimid DRUGBANK DB00480 C13H13N3O3 small molecule L04AX04 191732-72-6 DRUGBANK 24612 114160 8600 RP11-86N24.2 TNFSF11 CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf 9606 Homo sapiens antibody target Westenfeld R (2006) 16702197 181943 5566 Denosumab - prolia|xgeva DRUGBANK DB06643 C6404H9912N1724O2004S50 biologic M05BX04 615258-40-7 DRUGBANK 24613 114160 8600 RP11-86N24.2 TNFSF11 CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf 9606 Homo sapiens antibody target Lipton A (2008) 18685421 182083 5566 Denosumab - prolia|xgeva DRUGBANK DB06643 C6404H9912N1724O2004S50 biologic M05BX04 615258-40-7 DRUGBANK 27969 114160 8600 RP11-86N24.2 TNFSF11 CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf 9606 Homo sapiens antagonist target Reuter S (2012) 21955206 196011 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 1982 114164 8604 - SLC25A12 AGC1|ARALAR 9606 Homo sapiens unknown target Satrustegui J (2007) 17237342 172923 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1983 114164 8604 - SLC25A12 AGC1|ARALAR 9606 Homo sapiens unknown target Contreras L (2007) 17213189 172922 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1984 114164 8604 - SLC25A12 AGC1|ARALAR 9606 Homo sapiens unknown target Correia C (2006) 17151801 172921 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1985 114164 8604 - SLC25A12 AGC1|ARALAR 9606 Homo sapiens unknown target Satrustegui J (2007) 17497669 172920 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 4233 114177 8622 PIG22 PDE8B ADSD|PPNAD3 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4234 114177 8622 PIG22 PDE8B ADSD|PPNAD3 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 11933 114177 8622 PIG22 PDE8B ADSD|PPNAD3 9606 Homo sapiens inhibitor target Castillo JG (1990) 1702263 179104 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 2275 114183 8630 - HSD17B6 HSE|RODH|SDR9C6 9606 Homo sapiens unknown target Bayley JP (2006) 16405730 173145 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2276 114183 8630 - HSD17B6 HSE|RODH|SDR9C6 9606 Homo sapiens unknown target Gupta D (2004) 15646028 173164 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2277 114183 8630 - HSD17B6 HSE|RODH|SDR9C6 9606 Homo sapiens unknown target Goel HC (2005) 15639001 173165 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2278 114183 8630 - HSD17B6 HSE|RODH|SDR9C6 9606 Homo sapiens unknown target Huang LS (2006) 16371358 173166 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2279 114183 8630 - HSD17B6 HSE|RODH|SDR9C6 9606 Homo sapiens unknown target Dudkina NV (2005) 15713802 88002 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 15638 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Claud P (2001) 11302941 180984 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15639 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Barrand MA (1985) 4091799 180985 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15640 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Vidrio H (2005) 16116337 180986 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15641 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Groenvall JL (2000) 11061213 180987 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15642 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Vidrio H (2003) 12970383 180982 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15643 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Barrand MA (1984) 6150080 180983 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15644 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Vidrio H (2004) 15255812 180988 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15645 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Lyles GA (1989) 2568436 180989 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15646 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Vidrio H (2007) 17385063 180991 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15647 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Groenvall JL (1998) 9740313 180990 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 15648 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Lizcano JM (1996) 8694842 178357 1262 Hydralazine Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone hydralazine-10 tab 10mg|hydral DRUGBANK DB01275 C8H8N4 small molecule C02DB02|C02LG02 86-54-4 DRUGBANK 23151 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4159 6-hydroxydopa quinone 2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone - DRUGBANK DB04334 C9H9NO5 small molecule - - DRUGBANK 23152 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4159 6-hydroxydopa quinone 2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone - DRUGBANK DB04334 C9H9NO5 small molecule - - DRUGBANK 23153 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4159 6-hydroxydopa quinone 2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone - DRUGBANK DB04334 C9H9NO5 small molecule - - DRUGBANK 10402 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Chiche F (2009) 19201819 178346 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10403 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Biasi D (1995) 8539478 178356 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10404 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Lizcano JM (1996) 8694842 178357 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10405 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Kumar D (1998) 9570326 178354 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10406 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target Tipnis UR (1992) 1483111 178355 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10407 114192 8639 - AOC3 HPAO|SSAO|VAP-1|VAP1 9606 Homo sapiens inhibitor target MacKenzie EM (2008) 17768678 178353 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 3182 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3183 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Pineda JA (1989) 2615366 173675 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3184 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Pineda JA (1990) 2146972 173706 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3185 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3186 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Nicolas JC (1983) 6584048 173707 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 17586 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1633 Rutin rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside - DRUGBANK DB01698 C27H30O16 small molecule C05CA01|C05CA51 153-18-4 DRUGBANK 17587 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1633 Rutin rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside - DRUGBANK DB01698 C27H30O16 small molecule C05CA01|C05CA51 153-18-4 DRUGBANK 11592 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 895 Bimatoprost Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide latisse|lumigan rc|bimatoprost DRUGBANK DB00905 C25H37NO4 small molecule S01EE03 155206-00-1 DRUGBANK 18416 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1977 (5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid - - DRUGBANK DB02056 C20H32O5 small molecule - 41598-07-6 DRUGBANK 18417 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1977 (5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid - - DRUGBANK DB02056 C20H32O5 small molecule - 41598-07-6 DRUGBANK 18418 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1977 (5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid - - DRUGBANK DB02056 C20H32O5 small molecule - 41598-07-6 DRUGBANK 25706 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6504 3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN - - DRUGBANK DB07700 C25H33NO3 small molecule - - DRUGBANK 16884 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 1476 4-Androstenedione 4-Androstene-3,17-dione - DRUGBANK DB01536 C19H26O2 small molecule - 63-05-8 DRUGBANK 16885 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 1476 4-Androstenedione 4-Androstene-3,17-dione - DRUGBANK DB01536 C19H26O2 small molecule - 63-05-8 DRUGBANK 18838 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 18839 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 18840 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 18841 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Lovering AL (2004) 14996743 159435 2175 Flufenamic Acid - - DRUGBANK DB02266 C14H10F3NO2 small molecule M01AG03 530-78-9 DRUGBANK 21320 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21321 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21322 114196 8644 - AKR1C3 DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 3711 114199 8647 - ABCB11 ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP 9606 Homo sapiens unknown target Snow KL (2007) 17126857 174019 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3712 114199 8647 - ABCB11 ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP 9606 Homo sapiens unknown target Suchy FJ (2006) 16819395 174018 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 12775 114199 8647 - ABCB11 ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP 9606 Homo sapiens inhibitor target Byrne JA (2002) 12404239 172310 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12776 114199 8647 - ABCB11 ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP 9606 Homo sapiens inhibitor target Horikawa M (2004) 15618715 179679 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12777 114199 8647 - ABCB11 ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP 9606 Homo sapiens inhibitor target Kemp DC (2004) 15465654 179680 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 27141 114199 8647 - ABCB11 ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP 9606 Homo sapiens unknown target Wang EJ (2003) 12739759 172309 835 Clofazimine Clofazimine|Clofazimina|Clofaziminum|Clofazimin|Riminophenazine|Lamprene - DRUGBANK DB00845 C27H22Cl2N4 small molecule J04BA01 2030-63-9 DRUGBANK 25544 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6340 (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol - - DRUGBANK DB07530 C24H32F6O3 small molecule - - DRUGBANK 25203 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6015 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE - - DRUGBANK DB07198 C15H9NO3 small molecule - - DRUGBANK 25128 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5937 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL - - DRUGBANK DB07119 C16H11ClO2 small molecule - - DRUGBANK 25023 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5827 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL - - DRUGBANK DB07009 C17H11NO3 small molecule - - DRUGBANK 17493 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 24952 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5746 [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE - - DRUGBANK DB06927 C16H11NO3 small molecule - - DRUGBANK 24934 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5727 (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID - - DRUGBANK DB06908 C24H23ClN2O4 small molecule - - DRUGBANK 24855 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5653 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL - - DRUGBANK DB06832 C15H10FNO3 small molecule - - DRUGBANK 25162 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5968 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME - - DRUGBANK DB07150 C17H13NO2 small molecule - - DRUGBANK 26744 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7515 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) - - DRUGBANK DB08742 C26H34O3 small molecule - - DRUGBANK 25248 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6052 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL - - DRUGBANK DB07236 C17H11NO3 small molecule - - DRUGBANK 26263 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 25732 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6527 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid - - DRUGBANK DB07724 C19H19NO6S small molecule - - DRUGBANK 24905 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5695 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE - - DRUGBANK DB06875 C17H10FNO2 small molecule - - DRUGBANK 25086 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5898 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE - - DRUGBANK DB07080 C17H12F9NO3S small molecule - - DRUGBANK 23797 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4457 (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE - - DRUGBANK DB04652 C21H30O4 small molecule - - DRUGBANK 25221 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6031 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID - - DRUGBANK DB07215 C23H21F3N2O4S small molecule - - DRUGBANK 26994 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7659 Aleglitazar - - DRUGBANK DB08915 C24H23NO5S small molecule - 475479-34-6 DRUGBANK 25240 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6046 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE - - DRUGBANK DB07230 C15H9BrO3 small molecule - - DRUGBANK 25572 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6366 (5BETA)-PREGNANE-3,20-DIONE - - DRUGBANK DB07557 C21H32O2 small molecule - - DRUGBANK 26239 114200 8648 - NCOA1 F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7011 (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid - - DRUGBANK DB08220 C27H32O4 small molecule - - DRUGBANK 10711 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 796 Pentoxifylline Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin trental tab 400mg|gapeam budib DRUGBANK DB00806 C13H18N4O3 small molecule C04AD03 6493-05-6 DRUGBANK 11224 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Wang H (2008) 17959709 174363 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11225 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Sung BJ (2003) 12955149 178758 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11226 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Saenz de Tejada I (2001) 11890515 178759 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11227 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Zoraghi R (2007) 17979301 174365 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11228 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11229 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Scheen AJ (2003) 14626653 178756 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11230 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Blount MA (2006) 16926278 178757 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11231 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Kim NN (2001) 11669467 178754 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 11232 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Carrier S (2003) 12625845 178755 852 Vardenafil Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra staxyn|levitra DRUGBANK DB00862 C23H32N6O4S small molecule G04BE09 224785-90-4 DRUGBANK 12424 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Kruuse C (2006) 16886928 179449 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 12425 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Santini F (2005) 16080974 179452 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 12426 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Jackson EK (2007) 17308037 179450 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 12427 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Kulkarni SK (2004) 15672122 179451 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 12428 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 21564 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3445 Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine - - DRUGBANK DB03597 C17H22IN3O6S small molecule - - DRUGBANK 21565 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3445 Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine - - DRUGBANK DB03597 C17H22IN3O6S small molecule - - DRUGBANK 4215 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4216 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 22954 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22955 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 4275 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Wang H (2008) 17959709 174363 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4276 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Carson CC (2003) 12614192 174362 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4277 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Corbin JD (2002) 12414329 174361 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4278 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Rybalkin SD (2003) 12554648 174360 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4279 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Kruuse C (2003) 12477710 174367 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4280 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Wang J (1999) 12567500 174366 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4281 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Zoraghi R (2007) 17979301 174365 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4282 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Wang H (2006) 16735511 174364 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 4283 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 196 Sildenafil 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine revatio|pb-sildenafil|auro-sil DRUGBANK DB00203 C22H30N6O4S small molecule G04BE03 139755-83-2 DRUGBANK 5052 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 270 Theophylline 1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin theo-24|idm tab|theolair|theop DRUGBANK DB00277 C7H8N4O2 small molecule R03DA54|R03DA74|R03DB04|R03DA04 58-55-9 DRUGBANK 24475 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Kedia GT (2013) 23372609 182228 5536 Avanafil (S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide|Stendra|TA-1790 stendra DRUGBANK DB06237 C23H26ClN7O3 small molecule G04BE10 330784-47-9 DRUGBANK 26735 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7502 5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide - - DRUGBANK DB08729 C15H19N5O4S2 small molecule - - DRUGBANK 10817 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Zoraghi R (2007) 17979301 174365 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10818 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10819 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Curran M (2003) 14498756 178543 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10820 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Rotella DP (2003) 12625031 178547 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10821 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Montorsi F (2003) 12603396 178546 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10822 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Roumeguere T (2003) 12891884 178545 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10823 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Eardley I (2002) 12074215 178544 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 18203 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18204 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 25986 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6749 3-isobutyl-1-methyl-7H-xanthine 3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine - DRUGBANK DB07954 C10H14N4O2 small molecule - 28822-58-4 DRUGBANK 24513 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Gur S (2008) 18491987 182078 5539 Udenafil DA-8159|Udenafil - DRUGBANK DB06267 C25H36N6O4S small molecule G04BE11 268203-93-6 DRUGBANK 24515 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Ahn GJ (2009) 19465935 182110 5539 Udenafil DA-8159|Udenafil - DRUGBANK DB06267 C25H36N6O4S small molecule G04BE11 268203-93-6 DRUGBANK 24514 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 5539 Udenafil DA-8159|Udenafil - DRUGBANK DB06267 C25H36N6O4S small molecule G04BE11 268203-93-6 DRUGBANK 24516 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Kouvelas D (2009) 19860692 182131 5539 Udenafil DA-8159|Udenafil - DRUGBANK DB06267 C25H36N6O4S small molecule G04BE11 268203-93-6 DRUGBANK 24517 114205 8654 - PDE5A CGB-PDE|CN5A|PDE5 9606 Homo sapiens inhibitor target Zhao C (2011) 21054754 182174 5539 Udenafil DA-8159|Udenafil - DRUGBANK DB06267 C25H36N6O4S small molecule G04BE11 268203-93-6 DRUGBANK 3373 114208 8659 RP11-128M10.1 ALDH4A1 ALDH4|P5CD|P5CDh 9606 Homo sapiens unknown target Inagaki E (2006) 16934832 173780 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 2324 114245 8702 UNQ552/PRO1109 B4GALT4 B4Gal-T4|beta4Gal-T4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2325 114245 8702 UNQ552/PRO1109 B4GALT4 B4Gal-T4|beta4Gal-T4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2326 114245 8702 UNQ552/PRO1109 B4GALT4 B4Gal-T4|beta4Gal-T4 9606 Homo sapiens unknown target Buelter T (2001) 11948877 173194 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2322 114246 8703 - B4GALT3 beta4Gal-T3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2323 114246 8703 - B4GALT3 beta4Gal-T3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2315 114247 8704 - B4GALT2 B4Gal-T2|B4Gal-T3|beta4Gal-T2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2316 114247 8704 - B4GALT2 B4Gal-T2|B4Gal-T3|beta4Gal-T2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 18789 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2154 4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide - - DRUGBANK DB02243 C31H42N4O5S small molecule - - DRUGBANK 18790 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2154 4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide - - DRUGBANK DB02243 C31H42N4O5S small molecule - - DRUGBANK 17983 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1799 [1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester - - DRUGBANK DB01871 C27H28N2O5 small molecule - - DRUGBANK 21518 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3422 WRR-99 - - DRUGBANK DB03573 C19H28N2O5 small molecule - - DRUGBANK 21454 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3388 Benzoyl-Arginine-Alanine-Methyl Ketone - - DRUGBANK DB03536 C18H29N5O4 small molecule - - DRUGBANK 25936 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6709 HOMOPHENYLALANINYLMETHANE - - DRUGBANK DB07913 C11H15NO small molecule - - DRUGBANK 21741 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3535 WRR-112 - - DRUGBANK DB03691 C19H28N2O5 small molecule - - DRUGBANK 17821 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1740 [1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester - - DRUGBANK DB01810 C23H24N2O5 small molecule - - DRUGBANK 26776 114261 8722 - CTSF CATSF|CLN13 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7547 BENZOYL-TYROSINE-ALANINE-METHYL KETONE - - DRUGBANK DB08775 C21H24N2O5 small molecule - - DRUGBANK 23636 114263 8724 RP3-429G5.4 SNX3 Grd19|MCOPS8|SDP3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 27641 114270 8732 RP3-488C13.1 RNGTT CAP1A|HCE|HCE1|hCAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 23067 114299 8766 - RAB11A YL8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23068 114299 8766 - RAB11A YL8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23069 114299 8766 - RAB11A YL8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 17973 114299 8766 - RAB11A YL8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 17974 114299 8766 - RAB11A YL8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 17975 114299 8766 - RAB11A YL8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1794 5'-Guanosine-Diphosphate-Monothiophosphate - - DRUGBANK DB01864 C10H16N5O13P3S small molecule - - DRUGBANK 2269 114329 8801 - SUCLG2 GBETA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2270 114329 8801 - SUCLG2 GBETA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2250 114330 8802 - SUCLG1 GALPHA|MTDPS9|SUCLA1 9606 Homo sapiens unknown target Ostergaard E (2007) 17668387 173151 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2284 114331 8803 RP11-528D24.2 SUCLA2 A-BETA|MTDPS5|SCS-betaA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2285 114331 8803 RP11-528D24.2 SUCLA2 A-BETA|MTDPS5|SCS-betaA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2286 114331 8803 RP11-528D24.2 SUCLA2 A-BETA|MTDPS5|SCS-betaA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 482 114356 8829 RP11-342D11.1 NRP1 BDCA4|CD304|NP1|NRP|VEGF165R 9606 Homo sapiens unknown target Friedl A (1997) 9094999 171969 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 484 114356 8829 RP11-342D11.1 NRP1 BDCA4|CD304|NP1|NRP|VEGF165R 9606 Homo sapiens unknown target Beer HD (2000) 10821861 171956 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 483 114356 8829 RP11-342D11.1 NRP1 BDCA4|CD304|NP1|NRP|VEGF165R 9606 Homo sapiens unknown target Wang F (1999) 9890894 171958 38 Palifermin FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7 kepivance DRUGBANK DB00039 C721H1142N202O204S9 biologic V03AF08 162394-19-6 DRUGBANK 24101 114356 8829 RP11-342D11.1 NRP1 BDCA4|CD304|NP1|NRP|VEGF165R 9606 Homo sapiens unknown target Vinores SA (2007) 17717967 182042 4695 Pegaptanib EYE 001|NX1838|Pegaptanib sodium|Pegaptanib Octasodium|NX 1838 macugen DRUGBANK DB04895 C294H342F13N107Na28O188P28[C2H4O]2n biologic S01LA03 222716-86-1 DRUGBANK 2546 114360 8833 - GMPS - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2547 114360 8833 - GMPS - 9606 Homo sapiens unknown target Myers RS (2005) 16142895 68640 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2548 114360 8833 - GMPS - 9606 Homo sapiens unknown target Boehlein SK (1994) 7907328 173302 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2549 114360 8833 - GMPS - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2550 114360 8833 - GMPS - 9606 Homo sapiens unknown target Ravasio S (2002) 12069605 173303 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 27867 114368 8841 - HDAC3 HD3|RPD3|RPD3-2 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27699 114368 8841 - HDAC3 HD3|RPD3|RPD3-2 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 19434 114368 8841 - HDAC3 HD3|RPD3|RPD3-2 9606 Homo sapiens inhibitor target Xu WS (2007) 17694093 181632 2443 Vorinostat Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH zolinza DRUGBANK DB02546 C14H20N2O3 small molecule L01XX38 149647-78-9 DRUGBANK 24338 114368 8841 - HDAC3 HD3|RPD3|RPD3-2 9606 Homo sapiens unknown target Beckers T (2007) 17455259 182004 5277 MGCD-0103 MGCD0103 - DRUGBANK DB05651 - small molecule - - DRUGBANK 8760 114370 8843 - HCAR3 GPR109B|HCA3|HM74|PUMAG|Puma-g 9606 Homo sapiens agonist target Tunaru S (2003) 12563315 177430 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8761 114370 8843 - HCAR3 GPR109B|HCA3|HM74|PUMAG|Puma-g 9606 Homo sapiens agonist target Tunaru S (2005) 16099840 177425 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8762 114370 8843 - HCAR3 GPR109B|HCA3|HM74|PUMAG|Puma-g 9606 Homo sapiens agonist target Zhang Y (2005) 16018973 177424 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8763 114370 8843 - HCAR3 GPR109B|HCA3|HM74|PUMAG|Puma-g 9606 Homo sapiens agonist target Wise A (2003) 12522134 177427 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8764 114370 8843 - HCAR3 GPR109B|HCA3|HM74|PUMAG|Puma-g 9606 Homo sapiens agonist target Taggart AK (2005) 15929991 177429 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8765 114370 8843 - HCAR3 GPR109B|HCA3|HM74|PUMAG|Puma-g 9606 Homo sapiens agonist target Benyo Z (2005) 16322797 177428 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 26329 114375 8850 - KAT2B CAF|P/CAF|PCAF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7078 N-(3-AMINOPROPYL)-2-NITROBENZENAMINE - - DRUGBANK DB08291 C9H13N3O2 small molecule - - DRUGBANK 26215 114375 8850 - KAT2B CAF|P/CAF|PCAF 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6978 (3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE - - DRUGBANK DB08186 C13H13NO small molecule - - DRUGBANK 18408 114376 8851 - CDK5R1 CDK5P35|CDK5R|NCK5A|p23|p25|p35|p35nck5a 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1973 Indirubin-3'-Monoxime - - DRUGBANK DB02052 C16H11N3O2 small molecule - - DRUGBANK 25371 114376 8851 - CDK5R1 CDK5P35|CDK5R|NCK5A|p23|p25|p35|p35nck5a 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6180 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE - - DRUGBANK DB07364 C16H17N3O small molecule - - DRUGBANK 3100 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3101 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3102 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Russo J (2002) 11872149 173679 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3103 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Lamb AL (1999) 10320326 173680 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 10131 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Mic FA (2004) 15069081 178208 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10132 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Mic FA (2004) 15366004 178209 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10133 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Everts HB (2005) 15950969 173901 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10134 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Bordelon T (2004) 15299009 178210 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10135 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Doxakis E (2005) 15950488 178207 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 3523 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Szatmari I (2006) 16982809 173883 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3524 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Nakazawa N (2007) 17270546 173882 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3525 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Isken A (2007) 17098734 173881 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3526 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Halilagic A (2007) 17184764 119197 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3527 114379 8854 - ALDH1A2 RALDH(II)|RALDH2|RALDH2-T 9606 Homo sapiens unknown target Asson-Batres MA (2006) 16538685 173884 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 17598 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens activator target Kohalmy K (2007) 17591676 181619 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 15372 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens binder target Ikezoe T (2004) 15492266 180841 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 12429 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Xue Y (2007) 17327420 178363 967 Ethinyl Estradiol 17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol sronyx|linessa 21|levonorgestr DRUGBANK DB00977 C20H24O2 small molecule G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06 57-63-6 DRUGBANK 14981 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Cheng J (2010) 20627999 180689 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14982 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Ma X (2007) 17442842 180690 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 3566 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Rabovsky A (2006) 16603143 173919 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3567 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Meijerman I (2006) 16880233 173920 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 10414 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Xue Y (2007) 17327420 178363 773 Estradiol Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone climara 100|sandoz estradiol d DRUGBANK DB00783 C18H24O2 small molecule G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08 50-28-2 DRUGBANK 23517 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4280 SR12813 - - DRUGBANK DB04466 C24H42O7P2 small molecule - 126411-39-0 DRUGBANK 23518 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4280 SR12813 - - DRUGBANK DB04466 C24H42O7P2 small molecule - 126411-39-0 DRUGBANK 18026 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1819 Hyperforin Hiperforina|Hyperforine - DRUGBANK DB01892 C35H52O4 small molecule - 11079-53-1 DRUGBANK 18027 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1819 Hyperforin Hiperforina|Hyperforine - DRUGBANK DB01892 C35H52O4 small molecule - 11079-53-1 DRUGBANK 7760 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target van Erp NP (2009) 19733976 175838 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 7761 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Harmsen S (2009) 18839173 176682 520 Erlotinib OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib pms-erlotinib|tarceva|teva-erl DRUGBANK DB00530 C22H23N3O4 small molecule L01XE03 183321-74-6 DRUGBANK 25084 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5898 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE - - DRUGBANK DB07080 C17H12F9NO3S small molecule - - DRUGBANK 15118 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens inducer target Harmsen S (2009) 18839173 176682 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 13123 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Cheng J (2009) 19460945 179874 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13124 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Chen J (2006) 16480505 179875 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 26930 114380 8856 - NR1I2 BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR 9606 Homo sapiens agonist target Sharma D (2013) 23583259 182246 7609 Rilpivirine 4-{[4-({4-[(e)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile|TMC 278|TMC278 complera|odefsey|edurant DRUGBANK DB08864 C22H18N6 small molecule J05AG05|J05AR08|J05AR19 500287-72-9 DRUGBANK 3653 114382 8858 - PROZ PZ 9606 Homo sapiens activator target Imming P (2006) 17016423 171742 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3654 114382 8858 - PROZ PZ 9606 Homo sapiens activator target Overington JP (2006) 17139284 171741 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 24361 114389 8869 UNQ2510/PRO5998 ST3GAL5 SATI|SIAT9|SIATGM3S|ST3GalV 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5426 99mTc-14 F7 Mab - - DRUGBANK DB05867 - biologic - - DRUGBANK 1556 114398 8879 - SGPL1 S1PL|SPL 9606 Homo sapiens cofactor target Ikeda M (2004) 15522238 172560 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1557 114398 8879 - SGPL1 S1PL|SPL 9606 Homo sapiens cofactor target Bobbin RP (2001) 11377878 172559 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 3718 114402 8883 HPP1 NAE1 A-116A10.1|APPBP1|ula-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3719 114402 8883 HPP1 NAE1 A-116A10.1|APPBP1|ula-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3601 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Griffin JB (2002) 12214555 173939 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3602 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Dey S (2002) 11955628 173940 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3603 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Prasad PD (1999) 10334869 173941 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 1814 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Janoria KG (2006) 17038304 172759 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1815 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Camporeale G (2007) 17374649 172761 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1816 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Luo S (2006) 16749865 172760 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1817 114403 8884 - SLC5A6 SMVT 9606 Homo sapiens unknown target Reidling JC (2007) 17135299 172762 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 8653 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens suppressor target Imming P (2006) 17016423 171742 607 Paramethadione Parametadiona|Paramethadionum|Paradione|Parametadione|Paramethadione - DRUGBANK DB00617 C7H11NO3 small molecule N03AC01 115-67-3 DRUGBANK 8654 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens suppressor target Overington JP (2006) 17139284 171741 607 Paramethadione Parametadiona|Paramethadionum|Paradione|Parametadione|Paramethadione - DRUGBANK DB00617 C7H11NO3 small molecule N03AC01 115-67-3 DRUGBANK 8103 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8104 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 16307 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Clozel JP (1997) 9481612 181243 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16308 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target McNulty MM (2004) 15562257 181244 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16309 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16310 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Massie BM (1997) 9375939 181245 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 23978 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23979 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23980 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Uebele VN (2009) 19582593 182118 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23981 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Santi CM (2002) 11784784 181784 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 9132 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9133 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 6796 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6797 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 11731 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Murata M (2010) 20502722 179028 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11732 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11733 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11734 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11735 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11736 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11737 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11738 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Murata M (2004) 14965331 179030 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11739 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11740 114425 8911 RP1-172B20.4 CACNA1I Cav3.3|ca(v)3.3 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 13299 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Perez-Reyes E (2009) 18974361 174771 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 8090 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8091 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 15326 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15327 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Bezprozvanny I (1995) 7565636 180816 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 16296 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Coste B (2007) 17190903 181240 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16297 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Perez-Reyes E (2004) 14993472 181241 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16298 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Brueggemann LI (2005) 15498818 181242 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16299 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Clozel JP (1997) 9481612 181243 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16300 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target McNulty MM (2004) 15562257 181244 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16301 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Massie BM (1997) 9375939 181245 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16302 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Cribbs LL (1998) 9670923 181246 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16303 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 11795 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Murata M (2010) 20502722 179028 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11796 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11797 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11798 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11799 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11800 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11801 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11802 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Murata M (2004) 14965331 179030 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11803 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11804 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 6766 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6767 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 4971 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4972 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Perez-Reyes E (2009) 18974361 174771 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 13932 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 13933 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Lewalter T (2010) 20221978 180238 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 13913 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1103 Nifedipine Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine nifedipine|adalat xl plus|adal DRUGBANK DB01115 C17H18N2O6 small molecule C08CA55|C08CA05|C08GA01 21829-25-4 DRUGBANK 23971 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23972 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23973 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23974 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Uebele VN (2009) 19582593 182118 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23975 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Santi CM (2002) 11784784 181784 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 12865 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12866 114426 8912 - CACNA1H CACNA1HB|Cav3.2|ECA6|EIG6 9606 Homo sapiens inhibitor target Perez-Reyes E (2009) 18974361 174771 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 11711 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Murata M (2010) 20502722 179028 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11721 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11713 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11714 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11715 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11716 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11712 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11718 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Murata M (2004) 14965331 179030 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11719 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11720 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11717 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11722 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5837 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 339 Trimethadione Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone tridione DRUGBANK DB00347 C6H9NO3 small molecule N03AC02 127-48-0 DRUGBANK 5838 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Shen H (2007) 17291698 175408 339 Trimethadione Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone tridione DRUGBANK DB00347 C6H9NO3 small molecule N03AC02 127-48-0 DRUGBANK 5839 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 339 Trimethadione Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone tridione DRUGBANK DB00347 C6H9NO3 small molecule N03AC02 127-48-0 DRUGBANK 5840 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 339 Trimethadione Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone tridione DRUGBANK DB00347 C6H9NO3 small molecule N03AC02 127-48-0 DRUGBANK 5841 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Barton ME (2005) 16171802 175407 339 Trimethadione Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone tridione DRUGBANK DB00347 C6H9NO3 small molecule N03AC02 127-48-0 DRUGBANK 8383 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Gomora JC (2001) 11641441 177137 583 Ethosuximide (+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide zarontin|zarontin cap 250mg|et DRUGBANK DB00593 C7H11NO2 small molecule N03AD01|N03AD51 77-67-8 DRUGBANK 8384 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Wang G (2008) 19005061 177136 583 Ethosuximide (+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide zarontin|zarontin cap 250mg|et DRUGBANK DB00593 C7H11NO2 small molecule N03AD01|N03AD51 77-67-8 DRUGBANK 8385 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 583 Ethosuximide (+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide zarontin|zarontin cap 250mg|et DRUGBANK DB00593 C7H11NO2 small molecule N03AD01|N03AD51 77-67-8 DRUGBANK 8386 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Matthews EA (2001) 11274992 177138 583 Ethosuximide (+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide zarontin|zarontin cap 250mg|et DRUGBANK DB00593 C7H11NO2 small molecule N03AD01|N03AD51 77-67-8 DRUGBANK 16311 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Clozel JP (1997) 9481612 181243 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16312 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target McNulty MM (2004) 15562257 181244 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16313 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Massie BM (1997) 9375939 181245 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16314 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Monteil A (2000) 10692398 181247 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16315 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 16316 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Lee TS (2006) 16899990 180228 1340 Mibefradil - - DRUGBANK DB01388 C29H38FN3O3 small molecule C08CX01 116644-53-2 DRUGBANK 23982 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23983 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23984 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Uebele VN (2009) 19582593 182118 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 23985 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Santi CM (2002) 11784784 181784 4643 Flunarizine Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina flunarizine|sibelium cap 5mg|n DRUGBANK DB04841 C26H26F2N2 small molecule N07CA03 52468-60-7 DRUGBANK 9112 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Tfelt-Hansen P (2009) 19125880 177613 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9113 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 9114 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Freeze BS (2006) 16699084 177616 651 Verapamil D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum verapamil hydrochloride inject DRUGBANK DB00661 C27H38N2O4 small molecule C08DA01|C08DA51|C09BB10 52-53-9 DRUGBANK 24294 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Gomora JC (2001) 11641441 177137 5025 Methsuximide Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine celontin|celontin cap 300mg DRUGBANK DB05246 C12H13NO2 small molecule N03AD03 77-41-8 DRUGBANK 24295 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Wang G (2008) 19005061 177136 5025 Methsuximide Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine celontin|celontin cap 300mg DRUGBANK DB05246 C12H13NO2 small molecule N03AD03 77-41-8 DRUGBANK 24296 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Coulter DA (1989) 2545161 181655 5025 Methsuximide Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine celontin|celontin cap 300mg DRUGBANK DB05246 C12H13NO2 small molecule N03AD03 77-41-8 DRUGBANK 24297 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Matthews EA (2001) 11274992 177138 5025 Methsuximide Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine celontin|celontin cap 300mg DRUGBANK DB05246 C12H13NO2 small molecule N03AD03 77-41-8 DRUGBANK 6786 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6787 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 8088 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Singh BN (1986) 3530295 176934 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 8089 114427 8913 - CACNA1G Ca(V)T.1|Cav3.1|NBR13 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 558 Cinnarizine 1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum - DRUGBANK DB00568 C26H28N2 small molecule N07CA02|N07CA52 298-57-7 DRUGBANK 1545 114454 8942 - KYNU KYNUU 9606 Homo sapiens cofactor target Rooseboom M (2002) 12204580 172554 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1546 114454 8942 - KYNU KYNUU 9606 Homo sapiens cofactor target Lima S (2007) 17300176 172555 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1547 114454 8942 - KYNU KYNUU 9606 Homo sapiens cofactor target Walsh HA (2002) 11985583 172552 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1548 114454 8942 - KYNU KYNUU 9606 Homo sapiens cofactor target Momany C (2004) 14756555 172553 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 25073 114454 8942 - KYNU KYNUU 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5887 3-Hydroxyhippuric acid - - DRUGBANK DB07069 C9H9NO4 small molecule - - DRUGBANK 3478 114454 8942 - KYNU KYNUU 9606 Homo sapiens unknown target Lima S (2007) 17300176 172555 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3479 114454 8942 - KYNU KYNUU 9606 Homo sapiens unknown target Christensen M (2007) 17334708 173855 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 5129 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5130 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Gelb MH (2006) 16763908 174913 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5131 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Zhang H (2006) 16702880 174914 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5132 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Yamagishi S (2009) 19275550 174916 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 5133 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Okumiya T (2006) 16359900 174917 277 Acarbose Acarbose|Acarbosum|Precose|Acarbosa|Glucobay acarbose|glucobay|precose DRUGBANK DB00284 C25H43NO18 small molecule A10BF01|A10BD17 56180-94-0 DRUGBANK 7471 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Fukaya N (2009) 19818342 176466 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7472 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7473 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Rossi EJ (2006) 16817895 176468 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7474 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Mooradian AD (1999) 9951949 176469 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7475 114462 8972 - MGAM MG|MGA 9606 Homo sapiens antagonist target Fukaya N (2009) 19818342 176466 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7476 114462 8972 - MGAM MG|MGA 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7477 114462 8972 - MGAM MG|MGA 9606 Homo sapiens antagonist target Rossi EJ (2006) 16817895 176468 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7478 114462 8972 - MGAM MG|MGA 9606 Homo sapiens antagonist target Mooradian AD (1999) 9951949 176469 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 24060 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4678 Voglibose Basen - DRUGBANK DB04878 C10H21NO7 small molecule A10BF03 83480-29-9 DRUGBANK 24061 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Matsumura M (2009) 19568704 182116 4678 Voglibose Basen - DRUGBANK DB04878 C10H21NO7 small molecule A10BF03 83480-29-9 DRUGBANK 24062 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Fujimori Y (2009) 19281809 182100 4678 Voglibose Basen - DRUGBANK DB04878 C10H21NO7 small molecule A10BF03 83480-29-9 DRUGBANK 24063 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Iwasa M (2010) 20351564 182150 4678 Voglibose Basen - DRUGBANK DB04878 C10H21NO7 small molecule A10BF03 83480-29-9 DRUGBANK 24064 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Abe M (2010) 20025554 182141 4678 Voglibose Basen - DRUGBANK DB04878 C10H21NO7 small molecule A10BF03 83480-29-9 DRUGBANK 24065 114462 8972 - MGAM MG|MGA 9606 Homo sapiens inhibitor target Satoh N (2006) 16713439 181945 4678 Voglibose Basen - DRUGBANK DB04878 C10H21NO7 small molecule A10BF03 83480-29-9 DRUGBANK 3946 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3947 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3948 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3949 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 27166 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27579 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27032 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens agonist target Walker N (2014) 25517706 182256 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 27033 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens agonist target Houlihan LM (2001) 11553677 181776 7759 Cytisine Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin - DRUGBANK DB09028 C11H14N2O small molecule - 485-35-8 DRUGBANK 9349 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9350 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9351 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9352 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9353 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9354 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 15623 114463 8973 - CHRNA6 CHNRA6 9606 Homo sapiens partial agonist target Mihalak KB (2006) 16766716 180971 1260 Varenicline CP-526,555 chantix|champix|gd-varenicline DRUGBANK DB01273 C13H13N3 small molecule N07BA03 249296-44-4 DRUGBANK 2237 114464 8974 UNQ290/PRO330 P4HA2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2238 114464 8974 UNQ290/PRO330 P4HA2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3763 114464 8974 UNQ290/PRO330 P4HA2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3764 114464 8974 UNQ290/PRO330 P4HA2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 1899 114467 8985 - PLOD3 LH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1900 114467 8985 - PLOD3 LH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2228 114467 8985 - PLOD3 LH3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2229 114467 8985 - PLOD3 LH3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 20819 114468 8986 - RPS6KA4 MSK2|RSK-B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 10863 114471 8989 - TRPA1 ANKTM1|FEPS 9606 Homo sapiens inducer target Namer B (2005) 15931068 178572 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10864 114471 8989 - TRPA1 ANKTM1|FEPS 9606 Homo sapiens inducer target Chen X (2002) 11752352 171740 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10865 114471 8989 - TRPA1 ANKTM1|FEPS 9606 Homo sapiens inducer target Macpherson LJ (2006) 16829128 178571 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10866 114471 8989 - TRPA1 ANKTM1|FEPS 9606 Homo sapiens inducer target Story GM (2003) 12654248 178565 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10129 114514 9052 - GPRC5A GPCR5A|PEIG-1|RAI3|RAIG1|TIG1 9606 Homo sapiens unknown target Xu J (2005) 15677768 178205 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 10130 114514 9052 - GPRC5A GPCR5A|PEIG-1|RAI3|RAIG1|TIG1 9606 Homo sapiens unknown target Inoue S (2004) 15086536 178206 745 Tretinoin ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl) tretinoin gel microsphere|viti DRUGBANK DB00755 C20H28O2 small molecule L01XX14|D10AD01|D10AD51 302-79-4 DRUGBANK 1604 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens cofactor target Frazzon J (2002) 12196163 172589 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1605 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens cofactor target Ollagnier-De-Choudens S (2002) 12119030 172588 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1606 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens cofactor target Cupp-Vickery JR (2003) 12860127 172590 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1607 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens cofactor target You D (2007) 17469805 172587 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1608 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens cofactor target Forlani F (2005) 16310786 172586 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 3502 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target Zeng J (2007) 17660944 173867 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3503 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target You D (2007) 17469805 172587 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 2909 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target Ding B (2005) 15828873 173559 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2910 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target Ding H (2005) 15985427 173562 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2911 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target Yang J (2006) 16877383 173560 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2912 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target Layer G (2006) 16603772 173561 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2913 114516 9054 HUSSY-08 NFS1 IscS|NIFS 9606 Homo sapiens unknown target You D (2007) 17469805 172587 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2271 114520 9058 - SLC13A2 NADC1|NaCT|NaDC-1|SDCT1 9606 Homo sapiens unknown target Hagos Y (2006) 16735460 173160 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2272 114520 9058 - SLC13A2 NADC1|NaCT|NaDC-1|SDCT1 9606 Homo sapiens unknown target Takahashi R (2006) 16188913 173161 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2273 114520 9058 - SLC13A2 NADC1|NaCT|NaDC-1|SDCT1 9606 Homo sapiens unknown target Hall JA (2005) 16030212 173162 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2274 114520 9058 - SLC13A2 NADC1|NaCT|NaDC-1|SDCT1 9606 Homo sapiens unknown target Burckhardt BC (2005) 15561973 173163 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 19664 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2552 Adenosine-5'-Diphosphate-2',3'-Vanadate - - DRUGBANK DB02661 C10H13N5O12P2V small molecule - - DRUGBANK 19665 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2552 Adenosine-5'-Diphosphate-2',3'-Vanadate - - DRUGBANK DB02661 C10H13N5O12P2V small molecule - - DRUGBANK 19666 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2552 Adenosine-5'-Diphosphate-2',3'-Vanadate - - DRUGBANK DB02661 C10H13N5O12P2V small molecule - - DRUGBANK 21768 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3552 Adenosine-5'-Phosphosulfate - - DRUGBANK DB03708 C10H14N5O10PS small molecule - - DRUGBANK 21769 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3552 Adenosine-5'-Phosphosulfate - - DRUGBANK DB03708 C10H14N5O10PS small molecule - - DRUGBANK 21770 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3552 Adenosine-5'-Phosphosulfate - - DRUGBANK DB03708 C10H14N5O10PS small molecule - - DRUGBANK 22498 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22499 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22500 114522 9061 - PAPSS1 ATPSK1|PAPSS|SK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 737 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 738 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 55 Gemtuzumab ozogamicin - - DRUGBANK DB00056 - biologic - 220578-59-6 DRUGBANK 1369 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 1370 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 106 Daclizumab Ig gamma-1 chain C region|Anti-IL-2|Humanized antiCD25 zenapax 5mg/ml DRUGBANK DB00111 C6332H9808N1678O1989S42 biologic L04AC01 152923-56-3 DRUGBANK 327 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens antagonist target Siberil S (2007) 17911465 171892 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 328 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens antagonist target Baerenwaldt A (2010) 20441428 171893 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 329 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens antagonist target Negi VS (2007) 17351760 171891 28 Immune Globulin Human Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human gamastan s/d|octagam 10%|immun DRUGBANK DB00028 C6332H9826N1692O1980S42 biologic - 9007-83-4 DRUGBANK 621 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 622 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 50 Adalimumab Ig gamma-1 chain C region humira DRUGBANK DB00051 C6428H9912N1694O1987S46 biologic L04AB04 331731-18-1 DRUGBANK 656 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 657 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 53 Abciximab 7E3|7E3 antibody|antiGPIIBIIIa|C7E3 reopro DRUGBANK DB00054 C6462H9964N1690O2049S48 biologic B01AC13 143653-53-6 DRUGBANK 1034 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1035 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 76 Ibritumomab tiuxetan mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab zevalin DRUGBANK DB00078 C6382H9830N1672O1979S54 biologic - 206181-63-7 DRUGBANK 1154 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 1155 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 88 Alefacept ASP0485 amevive DRUGBANK DB00092 C2306H3594N610O694S26 biologic L04AA15 222535-22-0 DRUGBANK 31 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 32 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2 Cetuximab Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum erbitux DRUGBANK DB00002 C6484H10042N1732O2023S36 biologic L01XC06 205923-56-4 DRUGBANK 84 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Hart SP (2000) 10800083 171764 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 85 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Ranheim EA (1995) 7535196 171770 5 Etanercept p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor enbrel DRUGBANK DB00005 C2224H3475N621O698S36 biologic L04AB01 185243-69-0 DRUGBANK 940 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 941 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 72 Rituximab Ig gamma-1 chain C region|AntiCD20 rituxan DRUGBANK DB00073 C6416H9874N1688O1987S44 biologic L01XC02 174722-31-7 DRUGBANK 909 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 910 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 71 Trastuzumab Anti HER2|Ig gamma-1 chain C region herceptin|perjeta-herceptin DRUGBANK DB00072 C6470H10012N1726O2013S42 biologic L01XC03 180288-69-1 DRUGBANK 1314 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1315 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 103 Natalizumab Anti-alpha4 integrin|Anti-VLA4 tysabri DRUGBANK DB00108 - biologic L04AA23 189261-10-7 DRUGBANK 1171 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1172 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 91 Efalizumab antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva raptiva DRUGBANK DB00095 - biologic L04AA21 214745-43-4 DRUGBANK 1106 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1107 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 83 Alemtuzumab - mabcampath|lemtrada|campath DRUGBANK DB00087 C6468H10066N1732O2005S40 biologic L04AA34 216503-57-0 DRUGBANK 1061 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 1062 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 78 Tositumomab Ig gamma-1 chain C region bexxar therapy DRUGBANK DB00081 C6416H9874N1688O1987S44 biologic - 208921-02-2 DRUGBANK 974 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 975 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 73 Basiliximab chimeric mouse-human antiCD25|Ig gamma-1 chain C region simulect DRUGBANK DB00074 C6378H9844N1698O1997S48 biologic L04AC02 179045-86-4 DRUGBANK 1391 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1392 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 107 Bevacizumab antiVEGF|Avastin avastin DRUGBANK DB00112 C6538H10034N1716O2033S44 biologic L01XC07 216974-75-3 DRUGBANK 1002 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1003 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 74 Muromonab Anti-CD3|Muromonab-CD3 okt3|orthoclone okt 3 sterile DRUGBANK DB00075 C6460H9946N1720O2043S56 biologic L04AA02 140608-64-6 DRUGBANK 1318 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1319 114556 9103 - FCGR2C CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 105 Palivizumab anti-RSV|Synagis synagis DRUGBANK DB00110 - biologic J06BB16 188039-54-5 DRUGBANK 1742 114568 9120 - SLC16A6 MCT6|MCT7 9606 Homo sapiens unknown target Bonen A (2006) 16604139 172691 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1736 114569 9121 - SLC16A5 MCT5|MCT6 9606 Homo sapiens unknown target Bonen A (2006) 16604139 172691 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1755 114570 9122 RP5-1074L1.3 SLC16A4 MCT4|MCT5 9606 Homo sapiens unknown target Bonen A (2006) 16604139 172691 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1756 114570 9122 RP5-1074L1.3 SLC16A4 MCT4|MCT5 9606 Homo sapiens unknown target Kay HH (2007) 17275903 172720 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1757 114570 9122 RP5-1074L1.3 SLC16A4 MCT4|MCT5 9606 Homo sapiens unknown target Shimada A (2006) 16213084 172700 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1758 114570 9122 RP5-1074L1.3 SLC16A4 MCT4|MCT5 9606 Homo sapiens unknown target Pierre K (2005) 15953344 172692 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1759 114570 9122 RP5-1074L1.3 SLC16A4 MCT4|MCT5 9606 Homo sapiens unknown target Han M (2006) 16110503 172702 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1735 114571 9123 - SLC16A3 MCT 3|MCT 4|MCT-3|MCT-4|MCT3|MCT4 9606 Homo sapiens unknown target Shimada A (2006) 16213084 172700 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 20647 114579 9131 RP3-438D16.2 AIFM1 AIF|CMT2D|CMTX4|COWCK|COXPD6|NADMR|NAMSD|PDCD8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20648 114579 9131 RP3-438D16.2 AIFM1 AIF|CMT2D|CMTX4|COWCK|COXPD6|NADMR|NAMSD|PDCD8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20649 114579 9131 RP3-438D16.2 AIFM1 AIF|CMT2D|CMTX4|COWCK|COXPD6|NADMR|NAMSD|PDCD8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 24223 114580 9132 - KCNQ4 DFNA2|DFNA2A|KV7.4 9606 Homo sapiens unknown target Schroder RL (2001) 11378159 181772 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24224 114580 9132 - KCNQ4 DFNA2|DFNA2A|KV7.4 9606 Homo sapiens unknown target Hirano K (2007) 17184917 181979 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24225 114580 9132 - KCNQ4 DFNA2|DFNA2A|KV7.4 9606 Homo sapiens unknown target Borlak J (2006) 16713428 181944 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 22956 114593 9146 - HGS HRS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 2767 114599 9152 - SLC6A5 GLYT-2|GLYT2|HKPX3|NET1 9606 Homo sapiens unknown target Eulenburg V (2006) 16884688 173434 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 13262 114615 9177 - HTR3B 5-HT3B 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13263 114615 9177 - HTR3B 5-HT3B 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13264 114615 9177 - HTR3B 5-HT3B 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13265 114615 9177 - HTR3B 5-HT3B 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 27182 114615 9177 - HTR3B 5-HT3B 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 1718 114629 9194 - SLC16A7 MCT2 9606 Homo sapiens unknown target Bonen A (2006) 16604139 172691 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1719 114629 9194 - SLC16A7 MCT2 9606 Homo sapiens unknown target Yoshida Y (2007) 17556391 172693 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1720 114629 9194 - SLC16A7 MCT2 9606 Homo sapiens unknown target Pierre K (2005) 15953344 172692 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1721 114629 9194 - SLC16A7 MCT2 9606 Homo sapiens unknown target Hinoi E (2006) 16766717 172695 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1722 114629 9194 - SLC16A7 MCT2 9606 Homo sapiens unknown target de Laplanche E (2006) 16597615 172694 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 23825 114646 9212 - AURKB AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4507 HESPERIDIN - - DRUGBANK DB04703 - small molecule - - DRUGBANK 25345 114646 9212 - AURKB AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6156 N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine - - DRUGBANK DB07340 C21H27N7O small molecule - - DRUGBANK 3528 114658 9227 - LRAT LCA14 9606 Homo sapiens unknown target Liu L (2005) 16174770 173886 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3529 114658 9227 - LRAT LCA14 9606 Homo sapiens unknown target Kaschula CH (2006) 16054134 173885 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3544 114675 9249 RP11-514N2.1 DHRS3 DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3546 114675 9249 RP11-514N2.1 DHRS3 DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3547 114675 9249 RP11-514N2.1 DHRS3 DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1 9606 Homo sapiens unknown target Haeseleer F (1998) 9705317 173897 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3545 114675 9249 RP11-514N2.1 DHRS3 DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1 9606 Homo sapiens unknown target Chai Z (2003) 12697717 173898 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3548 114675 9249 RP11-514N2.1 DHRS3 DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1 9606 Homo sapiens unknown target Cerignoli F (2002) 11861404 173899 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 13301 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Perez-Reyes E (2009) 18974361 174771 1042 Nitrendipine Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009 - DRUGBANK DB01054 C18H20N2O6 small molecule C08CA08|C09BB06 39562-70-4 DRUGBANK 15336 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 15337 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Bezprozvanny I (1995) 7565636 180816 1232 Bepridil Bepridil|Bepadin - DRUGBANK DB01244 C24H34N2O small molecule C08EA02 64706-54-3 DRUGBANK 12589 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Gazulla J (2006) 16899342 174529 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12590 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Hota D (2007) 17982508 179581 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12591 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Hoffmann U (2010) 20588320 179582 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 12592 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Hendrich J (2008) 18299583 179583 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 4983 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 4984 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Perez-Reyes E (2009) 18974361 174771 263 Isradipine Isradipino|Dynacirc|Isradipinum isradipine DRUGBANK DB00270 C19H21N3O5 small molecule C08CA03 75695-93-1 DRUGBANK 13934 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 13935 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Lewalter T (2010) 20221978 180238 1106 Amiodarone 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum cordarone intravenous - liq iv DRUGBANK DB01118 C25H29I2NO3 small molecule C01BD01 1951-25-3 DRUGBANK 6794 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6795 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 12886 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Cohen CJ (1992) 1281221 174770 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 12887 114678 9254 - CACNA2D2 CACNA2D 9606 Homo sapiens inhibitor target Perez-Reyes E (2009) 18974361 174771 1013 Felodipine (+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate sandoz felodipine|renedil|rene DRUGBANK DB01023 C18H19Cl2NO4 small molecule C08CA02|C09BB05 72509-76-3 DRUGBANK 26407 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7143 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE - - DRUGBANK DB08358 C21H16N4O small molecule - - DRUGBANK 25431 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6220 (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE - - DRUGBANK DB07406 C21H24N6O3S small molecule - - DRUGBANK 18334 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 18335 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1934 Staurosporine - - DRUGBANK DB02010 C28H26N4O3 small molecule - 62996-74-1 DRUGBANK 25733 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6529 2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE - - DRUGBANK DB07728 C18H14FN3O small molecule - - DRUGBANK 25451 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6243 (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one - - DRUGBANK DB07430 C21H18N4OS small molecule - - DRUGBANK 25452 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6244 (3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one - - DRUGBANK DB07431 C13H15N3O2S small molecule - - DRUGBANK 25245 114683 9261 - MAPKAPK2 MAPKAP-K2|MK-2|MK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6050 3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione - - DRUGBANK DB07234 C17H15N3O2 small molecule - - DRUGBANK 22822 114684 9262 - STK17B DRAK2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 17963 114686 9265 tcag7.847 CYTH3 ARNO3|GRP1|PSCD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17964 114686 9265 tcag7.847 CYTH3 ARNO3|GRP1|PSCD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17965 114686 9265 tcag7.847 CYTH3 ARNO3|GRP1|PSCD3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 21006 114686 9265 tcag7.847 CYTH3 ARNO3|GRP1|PSCD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3207 Inositol-(1,3,4,5,6)-Pentakisphosphate - - DRUGBANK DB03344 C6H17O21P5 small molecule - - DRUGBANK 21007 114686 9265 tcag7.847 CYTH3 ARNO3|GRP1|PSCD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3207 Inositol-(1,3,4,5,6)-Pentakisphosphate - - DRUGBANK DB03344 C6H17O21P5 small molecule - - DRUGBANK 21008 114686 9265 tcag7.847 CYTH3 ARNO3|GRP1|PSCD3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3207 Inositol-(1,3,4,5,6)-Pentakisphosphate - - DRUGBANK DB03344 C6H17O21P5 small molecule - - DRUGBANK 17960 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17961 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17962 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 21129 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21130 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21131 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 25353 114687 9266 - CYTH2 ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6164 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE - - DRUGBANK DB07348 C16H24O4 small molecule - - DRUGBANK 26899 114723 9311 - ASIC3 ACCN3|DRASIC|SLNAC1|TNaC1 9606 Homo sapiens agonist target Li WG (2010) 21143836 182181 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 24609 114724 9312 - KCNB2 KV2.2 9606 Homo sapiens antagonist target Judge SI (2006) 16472864 181930 5565 Dalfampridine Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina fampyra|ampyra DRUGBANK DB06637 C5H6N2 small molecule N07XX07 504-24-5 DRUGBANK 26316 114725 9313 - MMP20 AI2A2|MMP-20 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7059 N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID - - DRUGBANK DB08271 C13H20N2O5S small molecule - - DRUGBANK 27541 114725 9313 - MMP20 AI2A2|MMP-20 9606 Homo sapiens inhibitor target Lebrasseur NK (2007) 17606858 179841 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 27542 114725 9313 - MMP20 AI2A2|MMP-20 9606 Homo sapiens inhibitor target Duhaney TA (2007) 17353509 179842 1028 Fenofibrate Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen fibricor|riva-fenofibrate micr DRUGBANK DB01039 C20H21ClO4 small molecule C10AB11|C10BA03|C10AB05|C10BA04 49562-28-9 DRUGBANK 10491 114725 9313 - MMP20 AI2A2|MMP-20 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10492 114725 9313 - MMP20 AI2A2|MMP-20 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 498 114746 9340 - GLP2R - 9606 Homo sapiens unknown target Boushey RP (2001) 11212269 171980 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 499 114746 9340 - GLP2R - 9606 Homo sapiens unknown target Estall JL (2005) 15817468 171981 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 500 114746 9340 - GLP2R - 9606 Homo sapiens unknown target Munroe DG (1999) 9990065 171982 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 501 114746 9340 - GLP2R - 9606 Homo sapiens unknown target Brubaker PL (2003) 12529935 171977 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 502 114746 9340 - GLP2R - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 503 114746 9340 - GLP2R - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 39 Glucagon recombinant Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum glucagon|glucagen|glucagon amp DRUGBANK DB00040 C165H249N49O51S1 biologic H04AA01 16941-32-5 DRUGBANK 26964 114746 9340 - GLP2R - 9606 Homo sapiens agonist target Burness CB (2013) 23729002 182251 7644 Teduglutide Teduglutide Recombinant|Glucagon-like peptide ii (2-glycine) (human)|(Gly2)glp-2|ALX-0600|HGDGSFSDEMNTILDNLAARDFINWLIQTKITD|ALX 0600|Gly(2)-glp-2|Teduglutide [rDNA origin]|His-gly-asp-gly-ser-phe-ser-asp-glu-met-asn-thr-ile-leu-asp-asn-leu-ala-ala-arg-asp-phe-ile-asn-trp-leu-ile-gln-thr-lys-ile-thr-asp|Gattex revestive|gattex DRUGBANK DB08900 C164H252N44O55S biologic A16AX08 197922-42-2 DRUGBANK 23598 114750 9344 UNQ2971/PRO7431 TAOK2 MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 26479 114752 9349 - RPL23 L23|rpL17 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25379 114752 9349 - RPL23 L23|rpL17 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19324 114752 9349 - RPL23 L23|rpL17 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 27102 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens unknown target Takeda M (2002) 11909604 176187 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 12981 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens inhibitor target Jung KY (2001) 11669456 173965 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12979 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens inhibitor target Takeda M (2001) 11426832 179797 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12980 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12982 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens inhibitor target Hashimoto T (2004) 15377641 179798 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12978 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens inhibitor target Takeda M (2002) 12130730 175259 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 27247 114759 9356 - SLC22A6 HOAT1|OAT1|PAHT|ROAT1 9606 Homo sapiens unknown target Takeda M (2002) 11909604 176187 1200 Ceftriaxone (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum ceftriaxone|ceftriaxone sodium DRUGBANK DB01212 C18H18N8O7S3 small molecule J01DD04|J01DD54 73384-59-5 DRUGBANK 3778 114761 9360 - PPIG CARS-Cyp|CYP|SCAF10|SRCyp 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3779 114761 9360 - PPIG CARS-Cyp|CYP|SCAF10|SRCyp 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 21940 114768 9367 - RAB9A RAB9 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21941 114768 9367 - RAB9A RAB9 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 23103 114768 9367 - RAB9A RAB9 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23104 114768 9367 - RAB9A RAB9 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 27100 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens unknown target Takeda M (2002) 11909604 176187 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 12987 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens inhibitor target Takeda M (2002) 12130730 175259 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12988 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12992 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens inhibitor target Kusuhara H (1999) 10224140 174964 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12990 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens inhibitor target Takeda M (2001) 11426832 179797 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12991 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens inhibitor target Sweet DH (2003) 12488248 179800 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12989 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens inhibitor target Jung KY (2001) 11669456 173965 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 27224 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens unknown target Takeda M (2002) 12130730 175259 1041 Benzylpenicillin Benzylpenicilline|Free penicillin II|Penicillin G|Benzylpenicillinic acid|6-(2-phenylacetamido)penicillanic acid|PG|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Benzylpenicillin|Bencilpenicilina|PCG|Benzylpenicillinum penicillin g potassium inj 100 DRUGBANK DB01053 C16H18N2O4S small molecule S01AA14|J01CE01 61-33-6 DRUGBANK 27250 114777 9376 - SLC22A8 OAT3 9606 Homo sapiens unknown target Takeda M (2002) 11909604 176187 1200 Ceftriaxone (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum ceftriaxone|ceftriaxone sodium DRUGBANK DB01212 C18H18N8O7S3 small molecule J01DD04|J01DD54 73384-59-5 DRUGBANK 19652 114778 9377 - COX5A COX|COX-VA|VA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2550 Cholic Acid - cholbam DRUGBANK DB02659 C24H40O5 small molecule A05AA03 81-25-4 DRUGBANK 23504 114778 9377 - COX5A COX|COX-VA|VA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 18674 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2096 Myristoyl-Coa - - DRUGBANK DB02180 C35H62N7O17P3S small molecule - 3130-72-1 DRUGBANK 18675 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2096 Myristoyl-Coa - - DRUGBANK DB02180 C35H62N7O17P3S small molecule - 3130-72-1 DRUGBANK 18676 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2096 Myristoyl-Coa - - DRUGBANK DB02180 C35H62N7O17P3S small molecule - 3130-72-1 DRUGBANK 18853 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2180 S-(2-Oxo)Pentadecylcoa - - DRUGBANK DB02271 C36H64N7O17P3S small molecule - - DRUGBANK 18854 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2180 S-(2-Oxo)Pentadecylcoa - - DRUGBANK DB02271 C36H64N7O17P3S small molecule - - DRUGBANK 18855 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2180 S-(2-Oxo)Pentadecylcoa - - DRUGBANK DB02271 C36H64N7O17P3S small molecule - - DRUGBANK 25856 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6635 (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE - - DRUGBANK DB07838 C17H12N2O4S2 small molecule - - DRUGBANK 25066 114794 9397 RP11-455B2.2 NMT2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5879 1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL - - DRUGBANK DB07061 C22H32N2O small molecule - - DRUGBANK 2147 114810 9415 - FADS2 D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13 9606 Homo sapiens ligand target Xiang M (2006) 16988497 173067 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2148 114810 9415 - FADS2 D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13 9606 Homo sapiens ligand target Baylin A (2007) 17284757 158289 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2149 114810 9415 - FADS2 D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13 9606 Homo sapiens ligand target Li MC (2004) 15481543 173069 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2150 114810 9415 - FADS2 D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13 9606 Homo sapiens ligand target Portolesi R (2007) 17409318 173068 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2151 114810 9415 - FADS2 D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13 9606 Homo sapiens ligand target Ge L (2003) 12713571 158520 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 2152 114810 9415 - FADS2 D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13 9606 Homo sapiens ligand target Tan L (2011) 21210105 110703 126 Alpha-Linolenic Acid 9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid folcaps omega-3|ultimatecare o DRUGBANK DB00132 C18H30O2 small molecule - 463-40-1 DRUGBANK 11641 114817 9424 - KCNK6 K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2 9606 Homo sapiens inhibitor target Patel AJ (2000) 10887187 179018 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 11642 114817 9424 - KCNK6 K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2 9606 Homo sapiens inhibitor target Guerard NC (2008) 18582585 179017 898 Quinidine CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine cardioquin tablets|quinidex ex DRUGBANK DB00908 C20H24N2O2 small molecule C01BA51|C01BA01|C01BA71 56-54-2 DRUGBANK 5341 114817 9424 - KCNK6 K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2 9606 Homo sapiens inhibitor target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5342 114817 9424 - KCNK6 K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2 9606 Homo sapiens inhibitor target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 24010 114821 9429 - ABCG2 ABC15|ABCP|BCRP|BCRP1|BMDP|CD338|CDw338|EST157481|GOUT1|MRX|MXR|MXR1|UAQTL1 9606 Homo sapiens unknown target Minderman H (2004) 15014037 181844 4652 Biricodar dicitrate biricodar - DRUGBANK DB04851 C46H57N3O21 small molecule - 174254-13-8 DRUGBANK 2596 114836 9446 RP11-99N20.1 GSTO1 GSTO 1-1|GSTTLp28|HEL-S-21|P28|SPG-R 9606 Homo sapiens unknown target Tulayakul P (2007) 17537474 173335 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2597 114836 9446 RP11-99N20.1 GSTO1 GSTO 1-1|GSTTLp28|HEL-S-21|P28|SPG-R 9606 Homo sapiens unknown target Harju TH (2007) 17617905 173336 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 23833 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4518 ISOPENTENYL PYROPHOSPHATE - - DRUGBANK DB04714 C5H12O7P2 small molecule - - DRUGBANK 19449 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2449 Geranyl Diphosphate - - DRUGBANK DB02552 C10H20O7P2 small molecule - - DRUGBANK 26577 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7307 (6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID) - - DRUGBANK DB08529 C17H34O6P2 small molecule - - DRUGBANK 25807 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 25862 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6638 GERANYLGERANYL DIPHOSPHATE - - DRUGBANK DB07841 C20H36O7P2 small molecule - - DRUGBANK 6527 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens inhibitor target Guo RT (2007) 17535895 175844 391 Zoledronic acid Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid reclast|act zoledronic acid co DRUGBANK DB00399 C5H10N2O7P2 small molecule M05BA08|M05BB08 118072-93-8 DRUGBANK 24956 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5750 (1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID) - - DRUGBANK DB06931 C9H22O7P2 small molecule - - DRUGBANK 25904 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6670 (1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID) - - DRUGBANK DB07873 C12H28O7P2 small molecule - - DRUGBANK 25435 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6224 [2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID - - DRUGBANK DB07410 C20H18O8P2 small molecule - - DRUGBANK 25229 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6037 (2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM - - DRUGBANK DB07221 C16H38O6P3 small molecule - - DRUGBANK 23822 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4499 FARNESYL THIOPYROPHOSPHATE - - DRUGBANK DB04695 C15H28O6P2S small molecule - - DRUGBANK 24851 114842 9453 - GGPS1 GGPPS|GGPPS1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5651 (1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID) - - DRUGBANK DB06830 C7H18O7P2 small molecule - - DRUGBANK 1835 114854 9468 - PCYT1B CCTB|CTB 9606 Homo sapiens product of target Imming P (2006) 17016423 171742 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1836 114854 9468 - PCYT1B CCTB|CTB 9606 Homo sapiens product of target Overington JP (2006) 17139284 171741 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1837 114854 9468 - PCYT1B CCTB|CTB 9606 Homo sapiens product of target Wang L (2005) 15798219 172775 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 26758 114860 9475 - ROCK2 ROCK-II 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7529 (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE - - DRUGBANK DB08756 C14H21N3O small molecule - - DRUGBANK 26185 114860 9475 - ROCK2 ROCK-II 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6954 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE - - DRUGBANK DB08162 C14H17N3O2S small molecule - - DRUGBANK 25288 114864 9479 - MAPK8IP1 IB1|JIP-1|JIP1|PRKM8IP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6092 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE - - DRUGBANK DB07276 C18H19N3O4 small molecule - - DRUGBANK 17775 114864 9479 - MAPK8IP1 IB1|JIP-1|JIP1|PRKM8IP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1714 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One - - DRUGBANK DB01782 C14H8N2O small molecule - - DRUGBANK 25285 114864 9479 - MAPK8IP1 IB1|JIP-1|JIP1|PRKM8IP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6088 N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE - - DRUGBANK DB07272 C18H19BrN4O4 small molecule - - DRUGBANK 25226 114864 9479 - MAPK8IP1 IB1|JIP-1|JIP1|PRKM8IP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6034 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE - - DRUGBANK DB07218 C12H10ClN3O2 small molecule - - DRUGBANK 1455 114894 9517 - SPTLC2 HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a 9606 Homo sapiens cofactor target Ikushiro H (2001) 11279212 172497 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1456 114894 9517 - SPTLC2 HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a 9606 Homo sapiens cofactor target Hanada K (2003) 12782147 172496 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1457 114894 9517 - SPTLC2 HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a 9606 Homo sapiens cofactor target Gable K (2002) 11781309 17464 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1458 114894 9517 - SPTLC2 HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a 9606 Homo sapiens cofactor target Tamura K (2001) 11726713 56201 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1459 114894 9517 - SPTLC2 HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a 9606 Homo sapiens cofactor target Tamura K (2000) 11171191 53696 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2163 114894 9517 - SPTLC2 HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a 9606 Homo sapiens unknown target Yard BA (2007) 17559874 72070 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 3252 114933 9563 RP3-510D11.3 H6PD CORTRD1|G6PDH|GDH 9606 Homo sapiens unknown target Takenaka M (2007) 17531229 173733 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3253 114933 9563 RP3-510D11.3 H6PD CORTRD1|G6PDH|GDH 9606 Homo sapiens unknown target Siu E (2007) 17269701 173732 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3254 114933 9563 RP3-510D11.3 H6PD CORTRD1|G6PDH|GDH 9606 Homo sapiens unknown target Markova EV (2006) 16898590 173735 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3255 114933 9563 RP3-510D11.3 H6PD CORTRD1|G6PDH|GDH 9606 Homo sapiens unknown target Lu Y (2007) 17171348 173734 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3256 114933 9563 RP3-510D11.3 H6PD CORTRD1|G6PDH|GDH 9606 Homo sapiens unknown target Zhang M (2007) 17298031 173736 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3879 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Bowery NG (1993) 8388192 174129 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3880 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Belley M (1999) 10658574 174128 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3881 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Lehmann A (2009) 19303900 174134 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3882 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Martin SC (1999) 10328880 174135 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3883 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Jones KA (2000) 11008066 174132 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3884 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Pittman QJ (1999) 10545129 174133 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3885 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Filippov AK (2000) 10751439 174130 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 3886 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Braun M (2004) 15235087 174131 174 Baclofen beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen lioresal intrathecal 2mg/ml|ri DRUGBANK DB00181 C10H12ClNO2 small molecule M03BX01 1134-47-0 DRUGBANK 27722 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Bowery NG (1993) 8388192 174129 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27723 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Belley M (1999) 10658574 174128 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27724 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Lehmann A (2009) 19303900 174134 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27725 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Martin SC (1999) 10328880 174135 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27726 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Jones KA (2000) 11008066 174132 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27727 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Pittman QJ (1999) 10545129 174133 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27728 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Filippov AK (2000) 10751439 174130 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27729 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Braun M (2004) 15235087 174131 7636 Arbaclofen Placarbil - - DRUGBANK DB08892 - small molecule - 847353-30-4 DRUGBANK 27705 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Bowery NG (1993) 8388192 174129 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27706 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Belley M (1999) 10658574 174128 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27707 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Lehmann A (2009) 19303900 174134 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27708 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Martin SC (1999) 10328880 174135 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27709 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Jones KA (2000) 11008066 174132 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27710 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Pittman QJ (1999) 10545129 174133 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27711 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Filippov AK (2000) 10751439 174130 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 27712 114938 9568 - GABBR2 GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099 9606 Homo sapiens agonist target Braun M (2004) 15235087 174131 7635 Arbaclofen (R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440 - DRUGBANK DB08891 - small molecule - 69308-37-8 DRUGBANK 22015 114956 9588 - PRDX6 1-Cys|AOP2|HEL-S-128m|NSGPx|PRX|aiPLA2|p29 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 27640 114956 9588 - PRDX6 1-Cys|AOP2|HEL-S-128m|NSGPx|PRX|aiPLA2|p29 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 3896 114970 9607 - CARTPT CART 9606 Homo sapiens agonist target Vicentic A (2006) 16713658 174148 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3897 114970 9607 - CARTPT CART 9606 Homo sapiens agonist target Loos RJ (2005) 15597110 174143 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3898 114970 9607 - CARTPT CART 9606 Homo sapiens agonist target Muehlhaeusler BS (2005) 15661821 174147 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3899 114970 9607 - CARTPT CART 9606 Homo sapiens agonist target Scruggs P (2005) 15680473 174146 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3900 114970 9607 - CARTPT CART 9606 Homo sapiens agonist target McAlister ED (2004) 15644956 174145 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3901 114970 9607 - CARTPT CART 9606 Homo sapiens agonist target Oliveira VX (2005) 15680478 174144 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3732 114980 9619 - ABCG1 ABC8|WHITE1 9606 Homo sapiens unknown target Lage H (2006) 16842213 174013 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3733 114980 9619 - ABCG1 ABC8|WHITE1 9606 Homo sapiens unknown target Materna V (2006) 16876126 174033 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3734 114980 9619 - ABCG1 ABC8|WHITE1 9606 Homo sapiens unknown target Pinkett HW (2007) 17158291 174032 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3735 114980 9619 - ABCG1 ABC8|WHITE1 9606 Homo sapiens unknown target Girardin F (2006) 17117613 174031 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3736 114980 9619 - ABCG1 ABC8|WHITE1 9606 Homo sapiens unknown target Thomas AC (2006) 16902423 174030 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 27862 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27694 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 5424 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Rosenberg G (2007) 17514356 175109 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5425 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Kanai H (2004) 15289798 175113 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5426 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Beutler AS (2005) 15850602 175112 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5427 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Michaelis M (2004) 15242819 175111 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5428 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Ylisastigui L (2004) 15166525 175115 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5429 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Stockhausen MT (2005) 15685243 175114 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 5430 115083 9734 - HDAC9 HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR 9606 Homo sapiens inhibitor target Kawano T (2010) 20811699 123468 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 25669 115096 9748 - SLK LOSK|STK2|bA16H23.1|se20-9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6470 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE - - DRUGBANK DB07664 C15H13F2N7O2S2 small molecule - - DRUGBANK 25878 115096 9748 - SLK LOSK|STK2|bA16H23.1|se20-9 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6650 [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE - - DRUGBANK DB07853 C22H19N7 small molecule - - DRUGBANK 27865 115106 9759 - HDAC4 AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27697 115106 9759 - HDAC4 AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27827 115106 9759 - HDAC4 AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA 9606 Homo sapiens inhibitor target VanderMolen KM (2011) 21587264 196007 8066 Romidepsin chromodax|istodax istodax DRUGBANK DB06176 C24H36N4O6S2 small molecule L01XX39 128517-07-7 DRUGBANK 25913 115106 9759 - HDAC4 AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6676 N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide - - DRUGBANK DB07879 C18H16N4O3S small molecule - - DRUGBANK 26644 115106 9759 - HDAC4 AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7390 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL - - DRUGBANK DB08613 C19H16F3N3O3S small molecule - - DRUGBANK 2700 115135 9791 - PTDSS1 LMHD|PSS1|PSSA 9606 Homo sapiens unknown target Kuge O (2003) 12761285 173410 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2701 115135 9791 - PTDSS1 LMHD|PSS1|PSSA 9606 Homo sapiens unknown target Ohsawa T (2004) 15130088 173411 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2702 115135 9791 - PTDSS1 LMHD|PSS1|PSSA 9606 Homo sapiens unknown target Steenbergen R (2006) 16627002 173412 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2703 115135 9791 - PTDSS1 LMHD|PSS1|PSSA 9606 Homo sapiens unknown target Kuge O (2003) 12912985 173409 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 26983 115156 9817 - KEAP1 INrf2|KLHL19 9606 Homo sapiens binder target Oh CJ (2012) 23056222 182212 7652 Dimethyl fumarate trans-1,2-Ethylenedicarboxylic acid dimethyl ester|trans-Butenedioic acid dimethyl ester|Tecfidera|(e)-But-2-enedioic acid dimethyl ester|BG-12|1,2-Bis(methoxycarbonyl)-trans-ethylene|Fumaric acid, dimethyl ester|dimethyl (E) butenedioate|Dimethyl trans-ethylenedicarboxylate tecfidera DRUGBANK DB08908 - small molecule N07XX09 624-49-7 DRUGBANK 2864 115173 9836 - LCMT2 PPM2|TYW4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2865 115173 9836 - LCMT2 PPM2|TYW4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 14813 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target Johannessen Landmark C (2007) 18072813 180609 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14814 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target Gillard M (2006) 16556440 180608 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14815 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target Lambeng N (2006) 16434140 180603 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14816 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target Stahl SM (2004) 15367040 180607 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14817 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target Newton HB (2007) 17431542 180606 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14818 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target Lynch BA (2004) 15210974 180605 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 14819 115229 9900 PSEC0174 SV2A SV2 9606 Homo sapiens agonist target De Smedt T (2007) 17461889 180604 1190 Levetiracetam Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam levetiracetam extended-release DRUGBANK DB01202 C8H14N2O2 small molecule N03AX14 102767-28-2 DRUGBANK 18830 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 18831 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 22937 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22938 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22275 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 22276 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 17834 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17835 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 22335 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 22336 115280 9955 UNQ2551/PRO6180 HS3ST3A1 30ST3A1|3OST3A1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3815 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid - - DRUGBANK DB03981 C6H8O8S small molecule - - DRUGBANK 17843 115282 9957 - HS3ST1 3OST|3OST1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17844 115282 9957 - HS3ST1 3OST|3OST1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17845 115282 9957 - HS3ST1 3OST|3OST1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 1947 115288 9963 - SLC23A1 SLC23A2|SVCT1|YSPL3 9606 Homo sapiens unknown target Kang JS (2007) 17008880 172884 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1948 115288 9963 - SLC23A1 SLC23A2|SVCT1|YSPL3 9606 Homo sapiens unknown target Perez MJ (2007) 17645691 172885 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1949 115288 9963 - SLC23A1 SLC23A2|SVCT1|YSPL3 9606 Homo sapiens unknown target Johnston L (2007) 17258485 172886 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1950 115288 9963 - SLC23A1 SLC23A2|SVCT1|YSPL3 9606 Homo sapiens unknown target Savini I (2008) 17541511 172887 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1951 115288 9963 - SLC23A1 SLC23A2|SVCT1|YSPL3 9606 Homo sapiens unknown target Steiling H (2007) 17664139 172883 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 18019 115295 9970 - NR1I3 CAR|CAR1|MB67 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1816 16,17-Androstene-3-Ol - - DRUGBANK DB01889 C19H30O small molecule - 7148-51-8 DRUGBANK 25573 115295 9970 - NR1I3 CAR|CAR1|MB67 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6366 (5BETA)-PREGNANE-3,20-DIONE - - DRUGBANK DB07557 C21H32O2 small molecule - - DRUGBANK 17613 115295 9970 - NR1I3 CAR|CAR1|MB67 9606 Homo sapiens activator target Kohalmy K (2007) 17591676 181619 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 19431 115296 9971 - NR1H4 BAR|FXR|HRR-1|HRR1|RIP14 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2442 Fexaramine - - DRUGBANK DB02545 C32H36N2O3 small molecule - 574013-66-4 DRUGBANK 19432 115296 9971 - NR1H4 BAR|FXR|HRR-1|HRR1|RIP14 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2442 Fexaramine - - DRUGBANK DB02545 C32H36N2O3 small molecule - 574013-66-4 DRUGBANK 24822 115296 9971 - NR1H4 BAR|FXR|HRR-1|HRR1|RIP14 9606 Homo sapiens unknown target Xu Y (2010) 20104269 182142 5633 Chenodeoxycholic acid Chenodeoxycholic acid|Anthropodesoxycholic acid|Anthropodeoxycholic acid|Chenodiol|Chenocholic acid|7alpha-Hydroxylithocholic acid|Gallodesoxycholic acid|CDCA|Chenic acid|3alpha,7alpha-Dihydroxy-5beta-cholanic acid|Chenodesoxycholic acid|Chenix chenodiol|chenodal DRUGBANK DB06777 C24H40O4 small molecule A05AA01 474-25-9 DRUGBANK 24823 115296 9971 - NR1H4 BAR|FXR|HRR-1|HRR1|RIP14 9606 Homo sapiens unknown target Makishima M (1999) 10334992 181736 5633 Chenodeoxycholic acid Chenodeoxycholic acid|Anthropodesoxycholic acid|Anthropodeoxycholic acid|Chenodiol|Chenocholic acid|7alpha-Hydroxylithocholic acid|Gallodesoxycholic acid|CDCA|Chenic acid|3alpha,7alpha-Dihydroxy-5beta-cholanic acid|Chenodesoxycholic acid|Chenix chenodiol|chenodal DRUGBANK DB06777 C24H40O4 small molecule A05AA01 474-25-9 DRUGBANK 26238 115296 9971 - NR1H4 BAR|FXR|HRR-1|HRR1|RIP14 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7011 (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid - - DRUGBANK DB08220 C27H32O4 small molecule - - DRUGBANK 10215 115311 9990 - SLC12A6 ACCPN|KCC3|KCC3A|KCC3B 9606 Homo sapiens unknown target Capo-Aponte JE (2007) 17418819 178266 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10216 115311 9990 - SLC12A6 ACCPN|KCC3|KCC3A|KCC3B 9606 Homo sapiens unknown target Misri S (2006) 16949074 178264 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10217 115311 9990 - SLC12A6 ACCPN|KCC3|KCC3A|KCC3B 9606 Homo sapiens unknown target Klein T (2006) 16943364 178265 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 19213 115325 10007 - GNPDA1 GNP1|GNPDA|GNPI|GPI|HLN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2346 2-Deoxy-2-Amino Glucitol-6-Phosphate - - DRUGBANK DB02445 C6H16NO8P small molecule - - DRUGBANK 19214 115325 10007 - GNPDA1 GNP1|GNPDA|GNPI|GPI|HLN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2346 2-Deoxy-2-Amino Glucitol-6-Phosphate - - DRUGBANK DB02445 C6H16NO8P small molecule - - DRUGBANK 19067 115325 10007 - GNPDA1 GNP1|GNPDA|GNPI|GPI|HLN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19068 115325 10007 - GNPDA1 GNP1|GNPDA|GNPI|GPI|HLN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 22252 115325 10007 - GNPDA1 GNP1|GNPDA|GNPI|GPI|HLN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3787 16g - - DRUGBANK DB03951 C8H16NO9P small molecule - - DRUGBANK 22253 115325 10007 - GNPDA1 GNP1|GNPDA|GNPI|GPI|HLN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3787 16g - - DRUGBANK DB03951 C8H16NO9P small molecule - - DRUGBANK 27866 115330 10013 JM21 HDAC6 CPBHM|HD6|PPP1R90 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27698 115330 10013 JM21 HDAC6 CPBHM|HD6|PPP1R90 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 19433 115330 10013 JM21 HDAC6 CPBHM|HD6|PPP1R90 9606 Homo sapiens inhibitor target Xu WS (2007) 17694093 181632 2443 Vorinostat Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH zolinza DRUGBANK DB02546 C14H20N2O3 small molecule L01XX38 149647-78-9 DRUGBANK 27822 115330 10013 JM21 HDAC6 CPBHM|HD6|PPP1R90 9606 Homo sapiens inhibitor target VanderMolen KM (2011) 21587264 196007 8066 Romidepsin chromodax|istodax istodax DRUGBANK DB06176 C24H36N4O6S2 small molecule L01XX39 128517-07-7 DRUGBANK 27863 115331 10014 - HDAC5 HD5|NY-CO-9 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27695 115331 10014 - HDAC5 HD5|NY-CO-9 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 24579 115336 10019 - SH2B3 IDDM20|LNK 9606 Homo sapiens inhibitor target Deeks ED (2012) 23072642 182214 5557 Pazopanib GW 78603|GW786034|Pazopanibum votrient DRUGBANK DB06589 C21H23N7O2S small molecule L01XE11 444731-52-6 DRUGBANK 25243 115350 10038 - PARP2 ADPRT2|ADPRTL2|ADPRTL3|ARTD2|PARP-2|pADPRT-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6048 Veliparib 2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide|(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium - DRUGBANK DB07232 C13H16N4O small molecule - 912444-00-9 DRUGBANK 27481 115350 10038 - PARP2 ADPRT2|ADPRTL2|ADPRTL3|ARTD2|PARP-2|pADPRT-2 9606 Homo sapiens inhibitor target Verhagen CV (2015) 25981132 188550 7821 Olaparib 4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one lynparza DRUGBANK DB09074 - small molecule L01XX46 763113-22-0 DRUGBANK 25685 115351 10039 - PARP3 ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6483 2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one - - DRUGBANK DB07677 C8H10N2OS small molecule - - DRUGBANK 26394 115351 10039 - PARP3 ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7133 N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE - - DRUGBANK DB08348 C17H17N3O2 small molecule - - DRUGBANK 26079 115351 10039 - PARP3 ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6851 4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one - - DRUGBANK DB08058 C21H21FN4O2 small molecule - - DRUGBANK 27480 115351 10039 - PARP3 ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3 9606 Homo sapiens inhibitor target Verhagen CV (2015) 25981132 188550 7821 Olaparib 4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one lynparza DRUGBANK DB09074 - small molecule L01XX46 763113-22-0 DRUGBANK 1782 115367 10056 HSPC173 FARSB FARSLB|FRSB|PheHB|PheRS 9606 Homo sapiens unknown target Kotik-Kogan O (2005) 16338408 172735 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 3715 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens unknown target Zhao JL (2006) 16845255 174020 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3716 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens unknown target Yang YJ (2007) 16829188 174021 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3717 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens unknown target Bryan J (2007) 16897043 174022 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 12754 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens modulator target Zhao JL (2006) 16845255 174020 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12755 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens modulator target Rainbow RD (2004) 14672537 179663 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12756 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens modulator target Felsch H (2004) 15023854 179662 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12757 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens modulator target Hambrock A (2002) 12145099 179665 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 12758 115371 10060 - ABCC9 ABC37|ATFB12|CANTU|CMD1O|SUR2 9606 Homo sapiens modulator target Wang YH (2007) 17294036 179664 1006 Glyburide 1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase diabeta 5mg|euglucon|ntp-glybu DRUGBANK DB01016 C23H28ClN3O5S small molecule A10BB01 10238-21-8 DRUGBANK 25089 115373 10062 - NR1H3 LXR-a|LXRA|RLD-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5898 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE - - DRUGBANK DB07080 C17H12F9NO3S small molecule - - DRUGBANK 26088 115373 10062 - NR1H3 LXR-a|LXRA|RLD-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6856 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE - - DRUGBANK DB08063 C24H20N2O3 small molecule - - DRUGBANK 25956 115373 10062 - NR1H3 LXR-a|LXRA|RLD-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6725 N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE - - DRUGBANK DB07929 C23H28N2O4 small molecule - - DRUGBANK 26201 115373 10062 - NR1H3 LXR-a|LXRA|RLD-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6967 (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID - - DRUGBANK DB08175 C16H28O3 small molecule - - DRUGBANK 26288 115399 10092 RP1-127C7.3 ARPC5 ARC16|dJ127C7.3|p16-Arc 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26281 115399 10092 RP1-127C7.3 ARPC5 ARC16|dJ127C7.3|p16-Arc 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 26289 115400 10093 - ARPC4 ARC20|P20-ARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26282 115400 10093 - ARPC4 ARC20|P20-ARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 26286 115401 10094 - ARPC3 ARC21|p21-Arc 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26279 115401 10094 - ARPC3 ARC21|p21-Arc 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 26283 115402 10095 - ARPC1B ARC41|p40-ARC|p41-ARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26276 115402 10095 - ARPC1B ARC41|p40-ARC|p41-ARC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 26284 115403 10096 - ACTR3 ARP3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26277 115403 10096 - ACTR3 ARP3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 26285 115404 10097 - ACTR2 ARP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26278 115404 10097 - ACTR2 ARP2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 3791 115411 10105 RP11-342M3.4 PPIF CYP3|CyP-M|Cyp-D|CypD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3792 115411 10105 RP11-342M3.4 PPIF CYP3|CyP-M|Cyp-D|CypD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 18487 115411 10105 RP11-342M3.4 PPIF CYP3|CyP-M|Cyp-D|CypD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1998 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane - - DRUGBANK DB02078 C8H18O4 small molecule - - DRUGBANK 1119 115411 10105 RP11-342M3.4 PPIF CYP3|CyP-M|Cyp-D|CypD 9606 Homo sapiens binder target Handschumacher RE (1984) 6238408 172296 87 Cyclosporine Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine neoral 10mg|neoral oral soluti DRUGBANK DB00091 C62H111N11O12 small molecule L04AD01|S01XA18 59865-13-3 DRUGBANK 26193 115411 10105 RP11-342M3.4 PPIF CYP3|CyP-M|Cyp-D|CypD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6960 7-AMINO-4-METHYL-CHROMEN-2-ONE - - DRUGBANK DB08168 C10H9NO2 small molecule - - DRUGBANK 26287 115415 10109 PRO2446 ARPC2 ARC34|PNAS-139|p34-Arc 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7026 (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one - - DRUGBANK DB08236 C15H11BrClNO2S small molecule - - DRUGBANK 26280 115415 10109 PRO2446 ARPC2 ARC34|PNAS-139|p34-Arc 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7025 N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide - - DRUGBANK DB08235 C16H16N2OS small molecule - - DRUGBANK 25660 115438 10135 - NAMPT 1110035O14Rik|PBEF|PBEF1|VF|VISFATIN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6462 N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-PYRIDIN-3-YLPROPANAMIDE - - DRUGBANK DB07656 C24H31N3O2 small molecule - - DRUGBANK 3152 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Xu H (2007) 17542618 173697 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3153 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Xu H (2006) 17002315 173698 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3154 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Xu H (2007) 17223709 173699 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 22808 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4035 N-(5-Amino-5-Carboxypentyl)Glutamic Acid - - DRUGBANK DB04207 C11H20N2O6 small molecule - - DRUGBANK 22809 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4035 N-(5-Amino-5-Carboxypentyl)Glutamic Acid - - DRUGBANK DB04207 C11H20N2O6 small molecule - - DRUGBANK 22810 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4035 N-(5-Amino-5-Carboxypentyl)Glutamic Acid - - DRUGBANK DB04207 C11H20N2O6 small molecule - - DRUGBANK 2453 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2454 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Gaziola SA (1997) 9249048 173265 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2452 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Goncalves-Butruille M (1996) 12226216 173264 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2456 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Noda C (1978) 687635 173263 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2455 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 18975 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 18976 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 18977 115459 10157 - AASS LKR/SDH|LKRSDH|LORSDH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 27764 115467 10165 - SLC25A13 ARALAR2|CITRIN|CTLN2 9606 Homo sapiens unknown target Saheki T (2007) 17591776 195979 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 27765 115467 10165 - SLC25A13 ARALAR2|CITRIN|CTLN2 9606 Homo sapiens unknown target Ikeda S (2007) 17354380 195978 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 27557 115467 10165 - SLC25A13 ARALAR2|CITRIN|CTLN2 9606 Homo sapiens unknown target Satrustegui J (2007) 17237342 172923 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 27558 115467 10165 - SLC25A13 ARALAR2|CITRIN|CTLN2 9606 Homo sapiens unknown target Contreras L (2007) 17213189 172922 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 27766 115467 10165 - SLC25A13 ARALAR2|CITRIN|CTLN2 9606 Homo sapiens unknown target Ikeda S (2007) 17228780 195975 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2057 115468 10166 RP11-346L13.4 SLC25A15 D13S327|HHH|ORC1|ORNT1 9606 Homo sapiens unknown target Korman SH (2004) 14759633 172959 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2058 115468 10166 RP11-346L13.4 SLC25A15 D13S327|HHH|ORC1|ORNT1 9606 Homo sapiens unknown target Camacho JA (2006) 16940241 172960 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 3747 115485 10188 - TNK2 ACK|ACK-1|ACK1|p21cdc42Hs 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3748 115485 10188 - TNK2 ACK|ACK-1|ACK1|p21cdc42Hs 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 23215 115485 10188 - TNK2 ACK|ACK-1|ACK1|p21cdc42Hs 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4189 Debromohymenialdisine - - DRUGBANK DB04367 C11H10N5O2 small molecule - - DRUGBANK 23216 115485 10188 - TNK2 ACK|ACK-1|ACK1|p21cdc42Hs 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4189 Debromohymenialdisine - - DRUGBANK DB04367 C11H10N5O2 small molecule - - DRUGBANK 17716 115491 10196 - PRMT3 HRMT1L3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 16918 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens unknown target Law PY (1985) 2982865 181499 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16919 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens unknown target Pfeiffer A (1982) 6287305 181498 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16920 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens unknown target Cvejic S (1996) 8626742 181500 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16921 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens unknown target Pfeiffer A (1982) 6124875 181473 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16922 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens unknown target Chang KJ (1981) 6270660 181497 1488 Diprenorphine Diprenorfin - DRUGBANK DB01548 C26H35NO4 small molecule - 14357-78-9 DRUGBANK 16859 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Maneckjee R (1988) 2828423 181475 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16860 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Audigier Y (1980) 6247160 181474 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16861 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Pfeiffer A (1982) 6124875 181473 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16862 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Stojilkovic SS (1987) 3036471 181472 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16863 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Pesce G (1987) 3037028 181471 1442 Etorphine Etorphinum - DRUGBANK DB01497 C25H33NO4 small molecule - 14521-96-1 DRUGBANK 16983 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Koman A (1987) 2855368 181514 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16984 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Ho CL (1985) 2985086 181515 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16985 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Maneckjee R (1988) 2828423 181475 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16986 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Ishizuka Y (1987) 2835832 181512 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 16987 115501 10206 - TRIM13 CAR|DLEU5|LEU5|RFP2|RNF77 9606 Homo sapiens agonist target Liebmann C (1991) 1654566 181513 1505 Dihydromorphine - - DRUGBANK DB01565 C17H21NO3 small molecule - 509-60-4 DRUGBANK 15699 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1266 Galsulfase Arylsufatase B|ARSB naglazyme DRUGBANK DB01279 C2534H3851N691O719S16 biologic A16AB08 552858-79-4 DRUGBANK 15700 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target White JT (2008) 18709516 181016 1266 Galsulfase Arylsufatase B|ARSB naglazyme DRUGBANK DB01279 C2534H3851N691O719S16 biologic A16AB08 552858-79-4 DRUGBANK 15616 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1258 Idursulfase Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase elaprase DRUGBANK DB01271 C2654H4000N688O774S14 biologic A16AB09 50936-59-9 DRUGBANK 15617 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1258 Idursulfase Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase elaprase DRUGBANK DB01271 C2654H4000N688O774S14 biologic A16AB09 50936-59-9 DRUGBANK 15618 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target Burrow TA (2008) 19707363 180970 1258 Idursulfase Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase elaprase DRUGBANK DB01271 C2654H4000N688O774S14 biologic A16AB09 50936-59-9 DRUGBANK 15619 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target Wraith JE (2008) 18038146 180968 1258 Idursulfase Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase elaprase DRUGBANK DB01271 C2654H4000N688O774S14 biologic A16AB09 50936-59-9 DRUGBANK 15620 115520 10226 - PLIN3 M6PRBP1|PP17|TIP47 9606 Homo sapiens unknown target Clarke LA (2008) 18201153 180969 1258 Idursulfase Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase elaprase DRUGBANK DB01271 C2654H4000N688O774S14 biologic A16AB09 50936-59-9 DRUGBANK 13869 115536 10242 hCG_1646471 KCNMB2 - 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13870 115536 10242 hCG_1646471 KCNMB2 - 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9809 115536 10242 hCG_1646471 KCNMB2 - 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 21893 115537 10243 - GPHN GEPH|GPH|GPHRYN|HKPX1|MOCODC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3607 Propanoic Acid - - DRUGBANK DB03766 C3H6O2 small molecule - 79-09-4 DRUGBANK 21894 115537 10243 - GPHN GEPH|GPH|GPHRYN|HKPX1|MOCODC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3607 Propanoic Acid - - DRUGBANK DB03766 C3H6O2 small molecule - 79-09-4 DRUGBANK 21895 115537 10243 - GPHN GEPH|GPH|GPHRYN|HKPX1|MOCODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3607 Propanoic Acid - - DRUGBANK DB03766 C3H6O2 small molecule - 79-09-4 DRUGBANK 18132 115537 10243 - GPHN GEPH|GPH|GPHRYN|HKPX1|MOCODC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 21938 115541 10247 - HRSP12 P14.5|PSP|UK114 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21939 115541 10247 - HRSP12 P14.5|PSP|UK114 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 2806 115543 10249 - GLYAT ACGNAT|CAT|GAT 9606 Homo sapiens unknown target Narasipura SD (2006) 17146584 71952 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2807 115543 10249 - GLYAT ACGNAT|CAT|GAT 9606 Homo sapiens unknown target Zhou CX (2007) 17143481 173483 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 15685 115557 10266 - RAMP2 - 9606 Homo sapiens agonist target Roth JD (2009) 19273748 181015 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15686 115557 10266 - RAMP2 - 9606 Homo sapiens agonist target Qi T (2008) 18593822 181014 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15687 115557 10266 - RAMP2 - 9606 Homo sapiens agonist target Qi T (2010) 20015292 181010 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15688 115557 10266 - RAMP2 - 9606 Homo sapiens agonist target Hay DL (2004) 15494035 181012 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15689 115557 10266 - RAMP2 - 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15690 115557 10266 - RAMP2 - 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15671 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Roth JD (2009) 19273748 181015 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15672 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Qi T (2008) 18593822 181014 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15673 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Lutz TA (2010) 20357016 181011 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15674 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Qi T (2010) 20015292 181010 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15675 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Nyholm B (2001) 11772274 181013 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15676 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Hay DL (2004) 15494035 181012 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15677 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15678 115558 10267 - RAMP1 - 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15691 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Roth JD (2009) 19273748 181015 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15692 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Qi T (2008) 18593822 181014 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15693 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Lutz TA (2010) 20357016 181011 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15694 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Qi T (2010) 20015292 181010 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15695 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Nyholm B (2001) 11772274 181013 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15696 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Hay DL (2004) 15494035 181012 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15697 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 15698 115559 10268 - RAMP3 - 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 1265 Pramlintide - symlinpen DRUGBANK DB01278 C171H267N51O53S2 biologic A10BX05 151126-32-8 DRUGBANK 16811 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens unknown target Su TP (2009) 19278957 181451 1434 Dimethyltryptamine - - DRUGBANK DB01488 C12H16N2 small molecule - 61-50-7 DRUGBANK 17630 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Waterhouse RN (2007) 17447254 181623 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 9662 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens antagonist target Herz A (1997) 9040115 177911 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9663 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens antagonist target Wee S (2009) 19484223 177910 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 9664 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens antagonist target Helm S (2008) 18354714 177912 694 Naltrexone N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one revia - tab 50mg|revia|naltrex DRUGBANK DB00704 C20H23NO4 small molecule N07BB04|A08AA62 16590-41-3 DRUGBANK 5532 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Villard V (2011) 21427517 175190 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 5533 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Werling LL (2007) 17689532 175182 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 9017 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Pal A (2007) 17622576 177568 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9018 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Mamolo MG (2008) 18069094 177569 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9019 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Chien CC (1995) 8788445 177572 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9020 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Colabufo NA (2009) 20021350 177571 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 9021 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Dun Y (2007) 17898305 177570 642 Pentazocine Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina pentazocine hcl and acetaminop DRUGBANK DB00652 C19H27NO small molecule N02AD01 359-83-1 DRUGBANK 27014 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Ring RM (2013) 23863923 182253 7747 Captodiame Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine - DRUGBANK DB09014 C21H29NS2 small molecule N05BB02 486-17-9 DRUGBANK 6610 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens antagonist target Lang A (1994) 7800667 175884 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 6611 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens antagonist target Okuyama S (1999) 10562961 175883 401 Remoxipride Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida - DRUGBANK DB00409 C16H23BrN2O3 small molecule N05AL04 80125-14-0 DRUGBANK 7654 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Shin EJ (2005) 15723099 176586 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7644 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7655 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Shin EJ (2007) 17386960 176587 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7645 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7646 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Chou YC (1999) 10064839 176582 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7656 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Church AJ (2005) 15716633 176585 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7657 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 21521 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3424 Phencyclidine 1-(1-Phenylcyclohexyl)piperidine|PCP - DRUGBANK DB03575 C17H25N small molecule - 77-10-1 DRUGBANK 21522 115569 10280 RP11-443P11.3 SIGMAR1 ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3424 Phencyclidine 1-(1-Phenylcyclohexyl)piperidine|PCP - DRUGBANK DB03575 C17H25N small molecule - 77-10-1 DRUGBANK 17517 115583 10295 - BCKDK BCKDKD|BDK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 17518 115583 10295 - BCKDK BCKDKD|BDK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 17519 115583 10295 - BCKDK BCKDKD|BDK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1596 Adenosine-5'-Diphosphate Monothiophosphate - - DRUGBANK DB01660 C10H16N5O12P3S small molecule - - DRUGBANK 19121 115610 10327 RP4-697E16.2 AKR1A1 ALDR1|ALR|ARM|DD3|HEL-S-6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2288 Tolrestat - - DRUGBANK DB02383 C16H14F3NO3S small molecule A10XA01 82964-04-3 DRUGBANK 21334 115610 10327 RP4-697E16.2 AKR1A1 ALDR1|ALR|ARM|DD3|HEL-S-6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 2881 115633 10352 - WARS2 TrpRS 9606 Homo sapiens inhibitor target Paley EL (2006) 17114825 173529 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2882 115633 10352 - WARS2 TrpRS 9606 Homo sapiens inhibitor target Yang XL (2006) 16724112 173527 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2883 115633 10352 - WARS2 TrpRS 9606 Homo sapiens inhibitor target Retailleau P (2007) 17428498 173525 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2884 115633 10352 - WARS2 TrpRS 9606 Homo sapiens inhibitor target Banin E (2006) 16639024 173531 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 2885 115633 10352 - WARS2 TrpRS 9606 Homo sapiens inhibitor target Charriere F (2006) 16636268 173530 144 L-Tryptophan (S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp 2.5% travasol amino acid injec DRUGBANK DB00150 C11H12N2O2 small molecule N06AX02 73-22-3 DRUGBANK 27164 115648 10369 RP5-1119A7.17 CACNG2 MRD10 9606 Homo sapiens unknown target Hendricson AW (2003) 12970385 188490 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 20294 115651 10376 - TUBA1B K-ALPHA-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20295 115651 10376 - TUBA1B K-ALPHA-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 17990 115651 10376 - TUBA1B K-ALPHA-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17991 115651 10376 - TUBA1B K-ALPHA-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 25586 115651 10376 - TUBA1B K-ALPHA-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6382 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE - - DRUGBANK DB07574 C22H25NO6S small molecule - - DRUGBANK 20304 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20305 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 24006 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens inhibitor target Goodin S (2008) 18945860 182087 4647 Ixabepilone Azaepothilone B|Aza-epothilone B ixempra DRUGBANK DB04845 C27H42N2O5S small molecule L01DC04 219989-84-1 DRUGBANK 24007 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens inhibitor target Denduluri N (2008) 18321240 182068 4647 Ixabepilone Azaepothilone B|Aza-epothilone B ixempra DRUGBANK DB04845 C27H42N2O5S small molecule L01DC04 219989-84-1 DRUGBANK 24008 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens inhibitor target Vahdat L (2008) 18378531 182071 4647 Ixabepilone Azaepothilone B|Aza-epothilone B ixempra DRUGBANK DB04845 C27H42N2O5S small molecule L01DC04 219989-84-1 DRUGBANK 18000 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 18001 115654 10381 - TUBB3 CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 20298 115655 10382 - TUBB4A DYT4|TUBB4|beta-5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20299 115655 10382 - TUBB4A DYT4|TUBB4|beta-5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 17994 115655 10382 - TUBB4A DYT4|TUBB4|beta-5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17995 115655 10382 - TUBB4A DYT4|TUBB4|beta-5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 20302 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20303 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 8956 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Lubega GW (1993) 8139621 177533 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8957 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Wampande EM (2007) 17662615 177537 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8960 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8959 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Ochola DO (2002) 12099434 177535 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8958 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Oxberry ME (2001) 11444621 177536 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 8961 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target MacDonald LM (2004) 15500920 177534 633 Mebendazole Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ vermox tablets 100 mg|mebendaz DRUGBANK DB00643 C16H13N3O3 small molecule P02CA01|P02CA51 31431-39-7 DRUGBANK 24142 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4710 Oxibendazole methyl 5-[n-propoxy]benzimidazole-2-carbamate|Methyl 5-propoxy-2-benzimidazolecarbamate|(5-Propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester|Oxibendazolum|5-Propoxy-2-benzimidazolecarbamic acid methyl ester|Oxybendazole|Oxibendazolo|OBZ|Methyl (5-propoxy-1H-benzimidazol-2-yl)carbamate|Methyl 5-n-propoxy-2-benzimidazole carbamate - DRUGBANK DB04910 C12H15N3O3 small molecule - 20559-55-1 DRUGBANK 7679 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Solana HD (2002) 11980387 176620 508 Albendazole Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate albenza DRUGBANK DB00518 C12H15N3O2S small molecule P02CA03 54965-21-8 DRUGBANK 7680 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Chu SW (2009) 19846910 176618 508 Albendazole Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate albenza DRUGBANK DB00518 C12H15N3O2S small molecule P02CA03 54965-21-8 DRUGBANK 7681 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 508 Albendazole Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate albenza DRUGBANK DB00518 C12H15N3O2S small molecule P02CA03 54965-21-8 DRUGBANK 17998 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17999 115656 10383 RP13-122B23.2 TUBB4B Beta2|TUBB2|TUBB2C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 2726 115668 10396 - ATP8A1 ATPASEII|ATPIA|ATPP2 9606 Homo sapiens unknown target Paterson JK (2006) 16618126 69306 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2727 115668 10396 - ATP8A1 ATPASEII|ATPIA|ATPP2 9606 Homo sapiens unknown target Wolfs JL (2005) 15971000 173427 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2728 115668 10396 - ATP8A1 ATPASEII|ATPIA|ATPP2 9606 Homo sapiens unknown target Bettache N (2003) 12697835 173429 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2729 115668 10396 - ATP8A1 ATPASEII|ATPIA|ATPP2 9606 Homo sapiens unknown target Mandal D (2005) 16179347 173428 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2531 115676 10404 - CPQ LDP|PGCP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2532 115676 10404 - CPQ LDP|PGCP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2533 115676 10404 - CPQ LDP|PGCP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 20502 115692 10423 - CDIPT PIS|PIS1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 2977 Myo-Inositol - - DRUGBANK DB03106 C6H12O6 small molecule - - DRUGBANK 26259 115718 10455 RP5-1013A10.1 ECI2 ACBD2|DRS-1|DRS1|HCA88|PECI|dJ1013A10.3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 26360 115724 10461 - MERTK MER|RP38|Tyro12|c-Eyk|c-mer 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7111 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE - - DRUGBANK DB08325 C16H19ClN6O small molecule - - DRUGBANK 3771 115728 10465 - PPIH CYP-20|CYPH|SnuCyp-20|USA-CYP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3772 115728 10465 - PPIH CYP-20|CYPH|SnuCyp-20|USA-CYP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 17534 115731 10468 - FST FS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1602 D-Myo-Inositol-Hexasulphate - - DRUGBANK DB01666 C6H12O24S6 small molecule - - DRUGBANK 24153 115758 10495 RP5-875H3.1 ENOX2 APK1|COVA1|tNOX 9606 Homo sapiens unknown target Morre DJ (2007) 17518268 182015 4714 Phenoxodiol NV-06|Dehydroequol|3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol|Haginin E|NV06|Idronoxil - DRUGBANK DB04915 C15H12O3 small molecule - 81267-65-4 DRUGBANK 26199 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6967 (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID - - DRUGBANK DB08175 C16H28O3 small molecule - - DRUGBANK 25959 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6728 dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate - - DRUGBANK DB07932 C22H18O7 small molecule - - DRUGBANK 17497 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1582 Genistein Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol - DRUGBANK DB01645 C15H10O5 small molecule - 446-72-0 DRUGBANK 25711 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6511 (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL - - DRUGBANK DB07707 C20H28O3 small molecule - - DRUGBANK 25713 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6512 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL - - DRUGBANK DB07708 C13H9ClN2O2 small molecule - - DRUGBANK 25717 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6515 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL - - DRUGBANK DB07712 C15H14N2O2 small molecule - - DRUGBANK 25094 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5904 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB07086 C16H20O3 small molecule - - DRUGBANK 25096 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5905 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB07087 C17H24O3 small molecule - - DRUGBANK 20258 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2874 Methyltrienolone Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one - DRUGBANK DB02998 C19H24O2 small molecule - 965-93-5 DRUGBANK 25198 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6012 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB07195 C18H24O3 small molecule - - DRUGBANK 26355 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7106 DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE - - DRUGBANK DB08320 C24H24O7 small molecule - - DRUGBANK 25088 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5898 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE - - DRUGBANK DB07080 C17H12F9NO3S small molecule - - DRUGBANK 26067 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6840 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol - - DRUGBANK DB08047 C17H13F3N2O2 small molecule - - DRUGBANK 26069 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6841 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL - - DRUGBANK DB08048 C13H10N2O3 small molecule - - DRUGBANK 25686 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6484 (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL - - DRUGBANK DB07678 C22H30O2 small molecule - - DRUGBANK 26633 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7378 tributylstannanyl - - DRUGBANK DB08601 C12H27Sn small molecule - - DRUGBANK 24923 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5717 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol - - DRUGBANK DB06898 C13H12N4O small molecule - - DRUGBANK 26626 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7372 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL - - DRUGBANK DB08595 C17H22O2 small molecule - - DRUGBANK 26773 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7545 RALOXIFENE CORE - - DRUGBANK DB08773 C14H10O2S small molecule - - DRUGBANK 24900 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5691 17-METHYL-17-ALPHA-DIHYDROEQUILENIN - - DRUGBANK DB06871 C19H22O2 small molecule - - DRUGBANK 26442 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7182 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE - - DRUGBANK DB08398 C13H12N4 small molecule - - DRUGBANK 25899 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6660 2-chloro-5-nitro-N-phenylbenzamide - - DRUGBANK DB07863 C13H9ClN2O3 small molecule - - DRUGBANK 26449 115761 10499 - NCOA2 GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7186 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID - - DRUGBANK DB08402 C18H11Cl2N3O4 small molecule - - DRUGBANK 18390 115779 10524 - KAT5 ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1962 S-Acetyl-Cysteine - - DRUGBANK DB02039 C5H9NO3S small molecule - - DRUGBANK 18391 115779 10524 - KAT5 ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1962 S-Acetyl-Cysteine - - DRUGBANK DB02039 C5H9NO3S small molecule - - DRUGBANK 18392 115779 10524 - KAT5 ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1962 S-Acetyl-Cysteine - - DRUGBANK DB02039 C5H9NO3S small molecule - - DRUGBANK 18259 115779 10524 - KAT5 ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18260 115779 10524 - KAT5 ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18261 115779 10524 - KAT5 ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 1941 115790 10536 - LEPREL2 GRCB|HSU47926|P3H3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1942 115790 10536 - LEPREL2 GRCB|HSU47926|P3H3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2289 115790 10536 - LEPREL2 GRCB|HSU47926|P3H3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2290 115790 10536 - LEPREL2 GRCB|HSU47926|P3H3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3799 115790 10536 - LEPREL2 GRCB|HSU47926|P3H3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3800 115790 10536 - LEPREL2 GRCB|HSU47926|P3H3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 23142 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4152 Phosphatidylethanolamine - - DRUGBANK DB04327 C41H83NO8P small molecule - - DRUGBANK 23143 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4152 Phosphatidylethanolamine - - DRUGBANK DB04327 C41H83NO8P small molecule - - DRUGBANK 678 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Liaw PC (2004) 15118520 172074 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 680 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Castellino FJ (2002) 12353077 172071 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 679 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Cerchiara E (2007) 17566522 172067 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 681 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Ruf W (2003) 12871285 172073 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 682 115797 10544 - PROCR CCCA|CCD41|EPCR 9606 Homo sapiens unknown target Fukudome K (1998) 9529319 172072 54 Drotrecogin alfa Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized xigris (5mg/vial)|xigris (20m DRUGBANK DB00055 C1786H2779N509O519S29 biologic B01AD10 98530-76-8 DRUGBANK 1526 115809 10558 RP11-118F2.1 SPTLC1 HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI 9606 Homo sapiens cofactor target Ikushiro H (2001) 11279212 172497 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1527 115809 10558 RP11-118F2.1 SPTLC1 HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI 9606 Homo sapiens cofactor target Hanada K (2003) 12782147 172496 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1528 115809 10558 RP11-118F2.1 SPTLC1 HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI 9606 Homo sapiens cofactor target Gable K (2002) 11781309 17464 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2160 115809 10558 RP11-118F2.1 SPTLC1 HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI 9606 Homo sapiens unknown target Yard BA (2007) 17559874 72070 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2926 115811 10560 RP1-206D15.4 SLC19A2 TC1|THMD1|THT1|THTR1|TRMA 9606 Homo sapiens binder target Labay V (1999) 10391221 173573 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 2927 115811 10560 RP1-206D15.4 SLC19A2 TC1|THMD1|THT1|THTR1|TRMA 9606 Homo sapiens binder target Diaz GA (1999) 10391223 173574 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 2928 115811 10560 RP1-206D15.4 SLC19A2 TC1|THMD1|THT1|THTR1|TRMA 9606 Homo sapiens binder target Liberman MC (2006) 16642288 173575 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 2929 115811 10560 RP1-206D15.4 SLC19A2 TC1|THMD1|THT1|THTR1|TRMA 9606 Homo sapiens binder target Fleming JC (1999) 10391222 48745 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 21200 115829 10578 - GNLY 519|D2S69E|LAG-2|LAG2|NKG5|TLA519 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3290 3[N-Morpholino]Propane Sulfonic Acid - - DRUGBANK DB03434 C7H15NO4S small molecule - - DRUGBANK 21201 115829 10578 - GNLY 519|D2S69E|LAG-2|LAG2|NKG5|TLA519 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3290 3[N-Morpholino]Propane Sulfonic Acid - - DRUGBANK DB03434 C7H15NO4S small molecule - - DRUGBANK 27244 115847 10599 - SLCO1B1 HBLRR|LST-1|LST1|OATP-C|OATP1B1|OATP2|OATPC|SLC21A6 9606 Homo sapiens unknown target De Bruyn T (2013) 23571415 188504 1199 Clarithromycin Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum mylan-clarithromycin|ran-clari DRUGBANK DB01211 C38H69NO13 small molecule J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09 81103-11-9 DRUGBANK 27221 115847 10599 - SLCO1B1 HBLRR|LST-1|LST1|OATP-C|OATP1B1|OATP2|OATPC|SLC21A6 9606 Homo sapiens unknown target Vavricka SR (2002) 12085361 188499 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 2039 115852 10606 - PAICS ADE2|ADE2H1|AIRC|PAIS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2040 115852 10606 - PAICS ADE2|ADE2H1|AIRC|PAIS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 26426 115871 10627 - MYL12A HEL-S-24|MLC-2B|MLCB|MRCL3|MRLC3|MYL2B 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7163 4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID - - DRUGBANK DB08378 C14H16N2O5 small molecule - - DRUGBANK 1774 115909 10667 RP1-236A3.1 FARS2 COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1775 115909 10667 RP1-236A3.1 FARS2 COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1776 115909 10667 RP1-236A3.1 FARS2 COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2 9606 Homo sapiens unknown target Kodama K (2006) 16969782 172734 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1777 115909 10667 RP1-236A3.1 FARS2 COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2 9606 Homo sapiens unknown target Kotik-Kogan O (2005) 16338408 172735 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 22964 115915 10673 RP11-153I24.1 TNFSF13B BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22965 115915 10673 RP11-153I24.1 TNFSF13B BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 20959 115915 10673 RP11-153I24.1 TNFSF13B BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 20960 115915 10673 RP11-153I24.1 TNFSF13B BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 9399 115921 10682 - EBP CDPX2|CHO2|CPX|CPXD 9606 Homo sapiens unknown target Paul R (1998) 9618436 177737 665 Tamoxifen 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine pms-tamoxifen|tamone - (20 m DRUGBANK DB00675 C26H29NO small molecule L02BA01 10540-29-1 DRUGBANK 10218 115947 10723 - SLC12A7 KCC4 9606 Homo sapiens unknown target Capo-Aponte JE (2007) 17418819 178266 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10219 115947 10723 - SLC12A7 KCC4 9606 Homo sapiens unknown target Misri S (2006) 16949074 178264 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10220 115947 10723 - SLC12A7 KCC4 9606 Homo sapiens unknown target Klein T (2006) 16943364 178265 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 24589 115969 10746 - MAP3K2 MEKK2|MEKK2B 9606 Homo sapiens inhibitor target Ahmad S (2013) 23134735 182217 5562 Bosutinib SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate bosulif DRUGBANK DB06616 C26H29Cl2N5O3 small molecule L01XE14 380843-75-4 DRUGBANK 23629 115970 10747 - MASP2 MAP19|MASP-2|MASP1P1|sMAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4339 Beta-Hydroxyasparagine 3-Hydroxyasparagine - DRUGBANK DB04527 C4H8N2O4 small molecule - 16712-79-1 DRUGBANK 3143 116011 10797 - MTHFD2 NMDMC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3144 116011 10797 - MTHFD2 NMDMC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 1672 116011 10797 - MTHFD2 NMDMC 9606 Homo sapiens cofactor target Salmassi TM (2003) 12949177 172636 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 7245 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Nayak A (2004) 15013935 176301 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 7246 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Zhang YJ (2004) 15456537 176300 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 7247 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 7248 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Langlois A (2006) 16815146 176297 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 7249 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Hamacher J (2006) 16815057 176299 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 7250 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Alfieri AB (2007) 17199874 176298 463 Montelukast Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid riva-montelukast fc|sandoz mon DRUGBANK DB00471 C35H36ClNO3S small molecule R03DC53|R03DC03 158966-92-8 DRUGBANK 9775 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens suppressor target Yazid S (2010) 20558817 178002 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9776 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens suppressor target Radeau T (1993) 8386571 178003 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9777 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens suppressor target Overington JP (2006) 17139284 171741 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9778 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens suppressor target Monteseirin J (2005) 16164449 178004 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9779 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens suppressor target Imming P (2006) 17016423 171742 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 8319 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Foller M (2009) 19826192 177107 577 Cinalukast 3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast - DRUGBANK DB00587 C23H28N2O3S small molecule - 128312-51-6 DRUGBANK 8320 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 577 Cinalukast 3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast - DRUGBANK DB00587 C23H28N2O3S small molecule - 128312-51-6 DRUGBANK 8321 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Adelroth E (1997) 9042047 177108 577 Cinalukast 3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast - DRUGBANK DB00587 C23H28N2O3S small molecule - 128312-51-6 DRUGBANK 7987 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Wang S (2000) 11006272 176822 539 Zafirlukast Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219 accolate|zafirlukast|accolate DRUGBANK DB00549 C31H33N3O6S small molecule R03DC01 107753-78-6 DRUGBANK 7988 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Cazzola M (2000) 11061985 176823 539 Zafirlukast Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219 accolate|zafirlukast|accolate DRUGBANK DB00549 C31H33N3O6S small molecule R03DC01 107753-78-6 DRUGBANK 7989 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target O'Byrne PM (1997) 9042024 176820 539 Zafirlukast Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219 accolate|zafirlukast|accolate DRUGBANK DB00549 C31H33N3O6S small molecule R03DC01 107753-78-6 DRUGBANK 7990 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Murata Y (2002) 11979731 176821 539 Zafirlukast Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219 accolate|zafirlukast|accolate DRUGBANK DB00549 C31H33N3O6S small molecule R03DC01 107753-78-6 DRUGBANK 7991 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 539 Zafirlukast Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219 accolate|zafirlukast|accolate DRUGBANK DB00549 C31H33N3O6S small molecule R03DC01 107753-78-6 DRUGBANK 7992 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Heise CE (2000) 10851239 12727 539 Zafirlukast Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219 accolate|zafirlukast|accolate DRUGBANK DB00549 C31H33N3O6S small molecule R03DC01 107753-78-6 DRUGBANK 16564 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Shirasaki H (2006) 16864492 181369 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16565 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Yoo SH (2001) 11264758 181368 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16566 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16567 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Ding Q (2006) 17112405 181367 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16568 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Ogasawara H (2002) 11854273 181366 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 16569 116014 10800 - CYSLTR1 CYSLT1|CYSLT1R|CYSLTR|HMTMF81 9606 Homo sapiens antagonist target Ishinaga H (2005) 15475658 181365 1360 Pranlukast ONO-RS 411 - DRUGBANK DB01411 C27H23N5O4 small molecule R03DC02 103177-37-3 DRUGBANK 1639 116052 10840 - ALDH1L1 10-FTHFDH|10-fTHF|FDH|FTHFD 9606 Homo sapiens cofactor target Oleinik NV (2006) 16712799 172624 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1640 116052 10840 - ALDH1L1 10-FTHFDH|10-fTHF|FDH|FTHFD 9606 Homo sapiens cofactor target Anguera MC (2006) 16627483 172625 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1641 116052 10840 - ALDH1L1 10-FTHFDH|10-fTHF|FDH|FTHFD 9606 Homo sapiens cofactor target Krupenko SA (2001) 11320079 172626 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1642 116052 10840 - ALDH1L1 10-FTHFDH|10-fTHF|FDH|FTHFD 9606 Homo sapiens cofactor target Krupenko SA (1999) 10585460 172622 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1643 116052 10840 - ALDH1L1 10-FTHFDH|10-fTHF|FDH|FTHFD 9606 Homo sapiens cofactor target Fu TF (1999) 10395731 172623 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1560 116053 10841 - FTCD LCHC1 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1561 116053 10841 - FTCD LCHC1 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1650 116053 10841 - FTCD LCHC1 9606 Homo sapiens cofactor target Kohls D (1999) 10329787 172632 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1651 116053 10841 - FTCD LCHC1 9606 Homo sapiens cofactor target Bashour AM (1998) 9677387 172631 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1652 116053 10841 - FTCD LCHC1 9606 Homo sapiens cofactor target Cook RJ (2001) 11488596 172630 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 1653 116053 10841 - FTCD LCHC1 9606 Homo sapiens cofactor target Kohls D (2000) 10673422 172629 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 2509 116053 10841 - FTCD LCHC1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2510 116053 10841 - FTCD LCHC1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2511 116053 10841 - FTCD LCHC1 9606 Homo sapiens unknown target Gao YS (1998) 9837973 173285 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 20861 116053 10841 - FTCD LCHC1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3124 (6R)-Folinic acid (6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate - DRUGBANK DB03256 C20H23N7O7 small molecule - 73951-54-9 DRUGBANK 20862 116053 10841 - FTCD LCHC1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3124 (6R)-Folinic acid (6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate - DRUGBANK DB03256 C20H23N7O7 small molecule - 73951-54-9 DRUGBANK 20863 116053 10841 - FTCD LCHC1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3124 (6R)-Folinic acid (6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate - DRUGBANK DB03256 C20H23N7O7 small molecule - 73951-54-9 DRUGBANK 12420 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 12421 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor target Fujishige K (1999) 10373451 179448 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 12422 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 965 Dipyridamole Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin dipyridamole for injection|nov DRUGBANK DB00975 C24H40N8O4 small molecule B01AC07 58-32-2 DRUGBANK 26430 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7168 2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline - - DRUGBANK DB08384 C25H20N4O small molecule - - DRUGBANK 26854 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens antagonist target McNeely W (1998) 9617597 181728 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 26855 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens antagonist target De Miguel LS (2000) 10998082 181761 7584 Triflusal Triflusal - DRUGBANK DB08814 - small molecule B01AC18 - DRUGBANK 4217 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4218 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 26429 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7167 4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole - - DRUGBANK DB08383 C21H18N2O2S small molecule - - DRUGBANK 26837 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor target Rundfeldt C (2010) 20967473 182172 7582 Tofisopam Tofizopam|Emandaxin - DRUGBANK DB08811 C22H26N2O4 small molecule N05BA23 22345-47-7 DRUGBANK 26436 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7175 6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE - - DRUGBANK DB08391 C22H21N5O3 small molecule - - DRUGBANK 26433 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7171 2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline - - DRUGBANK DB08387 C25H20N4O small molecule - - DRUGBANK 26432 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7170 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline - - DRUGBANK DB08386 C24H18N4O small molecule - - DRUGBANK 26435 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7173 6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE - - DRUGBANK DB08389 C24H23N3O3 small molecule - - DRUGBANK 13893 116057 10846 - PDE10A HSPDE10A 9606 Homo sapiens inhibitor target Weber M (2009) 19066855 136813 1101 Papaverine Mesotina papaverine hydrochloride injec DRUGBANK DB01113 C20H21NO4 small molecule G04BE02|G04BE52|A03AD01 58-74-2 DRUGBANK 7653 116068 10857 - PGRMC1 HPR6.6|MPR 9606 Homo sapiens binder target Chou YC (1999) 10064839 176582 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 20256 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2873 2-(Thiomethylene)-4-Methylpentanoic Acid - - DRUGBANK DB02996 C7H14O2S small molecule - - DRUGBANK 22108 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 18399 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1968 N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid - - DRUGBANK DB02046 C21H26N3O6P small molecule - - DRUGBANK 18741 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2127 Furoyl-Leucine - - DRUGBANK DB02215 C11H15NO4 small molecule - - DRUGBANK 26738 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7506 (2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE - - DRUGBANK DB08733 C20H33N5O5S small molecule - - DRUGBANK 20461 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 18803 116072 10863 - ADAM28 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2164 GM6001 - - DRUGBANK DB02255 C20H28N4O4 small molecule - - DRUGBANK 27097 116073 10864 RP11-480N24.7 SLC22A7 NLT|OAT2 9606 Homo sapiens unknown target Khamdang S (2003) 12650826 176188 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 3309 116081 10873 - ME3 NADP-ME 9606 Homo sapiens unknown target Rzem R (2007) 17603759 173752 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3310 116081 10873 - ME3 NADP-ME 9606 Homo sapiens unknown target Luo C (2006) 16740313 173759 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3311 116081 10873 - ME3 NADP-ME 9606 Homo sapiens unknown target Wei H (2006) 17080607 173758 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 21703 116081 10873 - ME3 NADP-ME 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3526 Tartronate - - DRUGBANK DB03680 C3H2O5 small molecule - - DRUGBANK 21704 116081 10873 - ME3 NADP-ME 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3526 Tartronate - - DRUGBANK DB03680 C3H2O5 small molecule - - DRUGBANK 21705 116081 10873 - ME3 NADP-ME 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3526 Tartronate - - DRUGBANK DB03680 C3H2O5 small molecule - - DRUGBANK 10475 116099 10893 RP4-614O4.10-001 MMP24 MMP-24|MMP25|MT-MMP 5|MT-MMP5|MT5-MMP|MT5MMP|MTMMP5 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10476 116099 10893 RP4-614O4.10-001 MMP24 MMP-24|MMP25|MT-MMP 5|MT-MMP5|MT5-MMP|MT5MMP|MTMMP5 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 3522 116107 10901 UNQ851/PRO1800 DHRS4 CR|NRDR|PHCR|PSCD|SCAD-SRL|SDR-SRL|SDR25C1|SDR25C2 9606 Homo sapiens unknown target Du K (2007) 17534402 173880 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 17938 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1790 Cordycepin Triphosphate - - DRUGBANK DB01860 C10H16N5O12P3 small molecule - 73-04-1 DRUGBANK 17939 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1790 Cordycepin Triphosphate - - DRUGBANK DB01860 C10H16N5O12P3 small molecule - 73-04-1 DRUGBANK 17940 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1790 Cordycepin Triphosphate - - DRUGBANK DB01860 C10H16N5O12P3 small molecule - 73-04-1 DRUGBANK 22134 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3733 Triphospate - - DRUGBANK DB03896 H5O10P3 small molecule - - DRUGBANK 22135 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3733 Triphospate - - DRUGBANK DB03896 H5O10P3 small molecule - - DRUGBANK 22136 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3733 Triphospate - - DRUGBANK DB03896 H5O10P3 small molecule - - DRUGBANK 18633 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 18634 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 18635 116119 10914 - PAPOLA PAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 3696 116139 10939 - AFG3L2 SCA28|SPAX5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3697 116139 10939 - AFG3L2 SCA28|SPAX5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 25795 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25774 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25422 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26505 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 26368 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23916 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26712 116172 10975 - UQCR11 0710008D09Rik|QCR10|UQCR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 25748 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6547 3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID - - DRUGBANK DB07746 C16H16FNO4S small molecule - - DRUGBANK 25329 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6138 2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID - - DRUGBANK DB07322 C17H17NO4S small molecule - - DRUGBANK 25330 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6139 2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID - - DRUGBANK DB07323 C22H25FN2O4S small molecule - - DRUGBANK 18913 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2217 3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium - - DRUGBANK DB02310 C17H19N2 small molecule - - DRUGBANK 18914 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2217 3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium - - DRUGBANK DB02310 C17H19N2 small molecule - - DRUGBANK 2185 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens product of target Addlagatta A (2006) 16823043 173090 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2186 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens product of target Hu X (2006) 17114291 173089 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2187 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens product of target Nonato MC (2006) 16540317 173088 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2188 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens product of target Sheppard GS (2006) 16789740 173087 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2189 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens product of target Upadhya R (2006) 16917013 68115 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 22582 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3940 (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide - - DRUGBANK DB04108 C19H26N2O2S small molecule - - DRUGBANK 22583 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3940 (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide - - DRUGBANK DB04108 C19H26N2O2S small molecule - - DRUGBANK 22584 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3940 (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide - - DRUGBANK DB04108 C19H26N2O2S small molecule - - DRUGBANK 20445 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2957 N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide - - DRUGBANK DB03086 C17H27N3O2 small molecule - - DRUGBANK 20446 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2957 N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide - - DRUGBANK DB03086 C17H27N3O2 small molecule - - DRUGBANK 20447 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2957 N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide - - DRUGBANK DB03086 C17H27N3O2 small molecule - - DRUGBANK 20084 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2773 D-Methionine - - DRUGBANK DB02893 C5H11NO2S small molecule - 348-67-4 DRUGBANK 20085 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2773 D-Methionine - - DRUGBANK DB02893 C5H11NO2S small molecule - 348-67-4 DRUGBANK 21099 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3254 (E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide - - DRUGBANK DB03396 C18H32N2O7 small molecule - - DRUGBANK 21100 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3254 (E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide - - DRUGBANK DB03396 C18H32N2O7 small molecule - - DRUGBANK 25316 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6125 5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID - - DRUGBANK DB07309 C13H9BrClNO4S small molecule - - DRUGBANK 16626 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens inhibitor target Shim JS (2010) 21088277 181386 1370 Nitroxoline 5-Nitro-8-hydroxyquinoline|5NOK|8-Hydroxy-5-nitroquinoline|Nitroxolinum|5-Nitrox|5-Nitro-8-quinolinol|Nitroxolina|5-NOK|5-Nitro-8-oxyquinoline - DRUGBANK DB01422 C9H6N2O3 small molecule J01XX07 4008-48-4 DRUGBANK 25395 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6193 N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE - - DRUGBANK DB07377 C15H22ClN3O3S small molecule - - DRUGBANK 22141 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 22142 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3737 2-Methyl-2-Propanol - - DRUGBANK DB03900 C4H10O small molecule - - DRUGBANK 23120 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4149 Ovalicin - - DRUGBANK DB04324 C16H26O5 small molecule - - DRUGBANK 23121 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4149 Ovalicin - - DRUGBANK DB04324 C16H26O5 small molecule - - DRUGBANK 23122 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4149 Ovalicin - - DRUGBANK DB04324 C16H26O5 small molecule - - DRUGBANK 26661 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7407 (CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER - - DRUGBANK DB08633 C19H28ClNO6 small molecule - - DRUGBANK 19608 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens ligand target Chen X (2002) 11752352 171740 2531 Fumagillin - - DRUGBANK DB02640 C26H36O7 small molecule P01AX10 23110-15-8 DRUGBANK 25320 116184 10988 - METAP2 MAP2|MNPEP|p67|p67eIF2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6129 5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID - - DRUGBANK DB07313 C14H13NO4S small molecule - - DRUGBANK 3839 116187 10991 - SLC38A3 G17|NAT1|SN1|SNAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3840 116187 10991 - SLC38A3 G17|NAT1|SN1|SNAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 1691 116187 10991 - SLC38A3 G17|NAT1|SN1|SNAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1692 116187 10991 - SLC38A3 G17|NAT1|SN1|SNAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1693 116187 10991 - SLC38A3 G17|NAT1|SN1|SNAT3 9606 Homo sapiens unknown target Eppig JJ (2005) 15843493 172663 112 L-Histidine His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00117 C6H9N3O2 small molecule - 71-00-1 DRUGBANK 1589 116189 10993 - SDS SDH 9606 Homo sapiens cofactor target Yamada T (2003) 14596599 172578 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1590 116189 10993 - SDS SDH 9606 Homo sapiens cofactor target Sun L (2005) 15689518 172579 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1591 116189 10993 - SDS SDH 9606 Homo sapiens cofactor target Cicchillo RM (2004) 15155761 172580 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1592 116189 10993 - SDS SDH 9606 Homo sapiens cofactor target Ogawa H (2006) 16580895 172576 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1593 116189 10993 - SDS SDH 9606 Homo sapiens cofactor target Sun L (2003) 14646100 172577 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2168 116189 10993 - SDS SDH 9606 Homo sapiens unknown target Velayudhan J (2004) 14688104 173076 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2169 116189 10993 - SDS SDH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2170 116189 10993 - SDS SDH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2171 116189 10993 - SDS SDH 9606 Homo sapiens unknown target Wong HC (1979) 500557 173075 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2172 116189 10993 - SDS SDH 9606 Homo sapiens unknown target Snell K (1974) 4377655 173077 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 23295 116195 11004 RP11-269F19.1 KIF2C CT139|KNSL6|MCAK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23296 116195 11004 RP11-269F19.1 KIF2C CT139|KNSL6|MCAK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23297 116195 11004 RP11-269F19.1 KIF2C CT139|KNSL6|MCAK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 11178 116206 11016 - ATF7 ATFA 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 3596 116209 11019 HUSSY-01 LIAS LAS|LIP1|LS|PDHLD 9606 Homo sapiens unknown target Yasuno R (1998) 9808738 46858 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3597 116209 11019 HUSSY-01 LIAS LAS|LIP1|LS|PDHLD 9606 Homo sapiens unknown target Morikawa T (2001) 11389890 119780 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3598 116209 11019 HUSSY-01 LIAS LAS|LIP1|LS|PDHLD 9606 Homo sapiens unknown target Wrenger C (2004) 15225307 173938 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3599 116209 11019 HUSSY-01 LIAS LAS|LIP1|LS|PDHLD 9606 Homo sapiens unknown target Ollagnier-de Choudens S (1999) 10403368 173937 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3600 116209 11019 HUSSY-01 LIAS LAS|LIP1|LS|PDHLD 9606 Homo sapiens unknown target Guenther S (2005) 16246025 173936 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 22697 116223 11034 - DSTN ACTDP|ADF|HEL32|bA462D18.2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22101 116277 11096 - ADAMTS5 ADAM-TS 11|ADAM-TS 5|ADAM-TS5|ADAMTS-11|ADAMTS-5|ADAMTS11|ADMP-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3717 Batimastat - - DRUGBANK DB03880 C23H31N3O4S2 small molecule - 130370-60-4 DRUGBANK 24969 116277 11096 - ADAMTS5 ADAM-TS 11|ADAM-TS 5|ADAM-TS5|ADAMTS-11|ADAMTS-5|ADAMTS11|ADMP-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5764 N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide - - DRUGBANK DB06945 C19H18F3NO6S small molecule - - DRUGBANK 24861 116277 11096 - ADAMTS5 ADAM-TS 11|ADAM-TS 5|ADAM-TS5|ADAMTS-11|ADAMTS-5|ADAMTS11|ADMP-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5658 (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide - - DRUGBANK DB06837 C20H22N2O5 small molecule - - DRUGBANK 3209 116289 11112 - HIBADH NS5ATP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3210 116289 11112 - HIBADH NS5ATP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 2220 116309 11136 - SLC7A9 BAT1|CSNU3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 2221 116309 11136 - SLC7A9 BAT1|CSNU3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 21728 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21729 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21730 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 22947 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 19836 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2631 Uridine - - DRUGBANK DB02745 C9H12N2O6 small molecule - 58-96-8 DRUGBANK 19837 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2631 Uridine - - DRUGBANK DB02745 C9H12N2O6 small molecule - 58-96-8 DRUGBANK 19838 116328 11157 - LSM6 YDR378C 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2631 Uridine - - DRUGBANK DB02745 C9H12N2O6 small molecule - 58-96-8 DRUGBANK 9615 116358 11188 - NISCH I-1|IR1|IRAS|hIRAS 9606 Homo sapiens agonist target Rolon PA (1977) 893017 177890 687 Tizanidine Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin tizanidine hydrochloride|zanaf DRUGBANK DB00697 C9H8ClN5S small molecule M03BX02 51322-75-9 DRUGBANK 26902 116358 11188 - NISCH I-1|IR1|IRAS|hIRAS 9606 Homo sapiens agonist target Li G (1994) 7906055 181690 7602 Agmatine (4-aminobutyl) guanidine - DRUGBANK DB08838 C5H14N4 small molecule - 306-60-5 DRUGBANK 27522 116358 11188 - NISCH I-1|IR1|IRAS|hIRAS 9606 Homo sapiens agonist target Ernsberger P (1993) 8380858 188560 7986 Moxonidine - - DRUGBANK DB09242 C9H12ClN5O small molecule C02LC05|C02AC05 75438-57-2 DRUGBANK 3797 116381 11212 - PROSC - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3798 116381 11212 - PROSC - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 1522 116381 11212 - PROSC - 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1523 116381 11212 - PROSC - 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 11783 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11784 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target De Simone G (2005) 15837316 179044 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11785 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11786 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11787 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11788 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 26921 116403 11238 - CA5B CA-VB 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 2961 116404 11240 RP1-37C10.6 PADI2 PAD-H19|PAD2|PDI2 9606 Homo sapiens unknown target Dong S (2005) 15854045 173604 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 23935 116412 11251 - PTGDR2 CD294|CRTH2|DL1R|DP2|GPR44 9606 Homo sapiens unknown target Hata AN (2005) 15563582 161179 4630 Zomepirac Zomepiracum|5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid - DRUGBANK DB04828 C15H14ClNO3 small molecule M01AB04 33369-31-2 DRUGBANK 8549 116412 11251 - PTGDR2 CD294|CRTH2|DL1R|DP2|GPR44 9606 Homo sapiens antagonist target Hata AN (2005) 15563582 161179 595 Sulindac cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum sulindac|clinoril tab 150mg|ap DRUGBANK DB00605 C20H17FO3S small molecule M01AB02 38194-50-2 DRUGBANK 5609 116412 11251 - PTGDR2 CD294|CRTH2|DL1R|DP2|GPR44 9606 Homo sapiens unknown target Hata AN (2005) 16030019 168216 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5610 116412 11251 - PTGDR2 CD294|CRTH2|DL1R|DP2|GPR44 9606 Homo sapiens unknown target Hata AN (2005) 15563582 161179 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 5611 116412 11251 - PTGDR2 CD294|CRTH2|DL1R|DP2|GPR44 9606 Homo sapiens unknown target Mathiesen JM (2005) 15870392 175245 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 19828 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2628 Kifunensine - - DRUGBANK DB02742 C8H12N2O6 small molecule - 109944-15-2 DRUGBANK 19829 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2628 Kifunensine - - DRUGBANK DB02742 C8H12N2O6 small molecule - 109944-15-2 DRUGBANK 20756 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3074 Duvoglustat 1 deoxynojirimycin|1-deoxynojirimycin|1,5-dideoxy-1,5-imino-D-glucitol|D-1-deoxynojirimycin|Deoxynojirimycin|5-amino-1,5-dideoxy-D-glucopyranose|DNJ|1-deoxy-nojirimycin|1,5-deoxy-1,5-imino-D-mannitol - DRUGBANK DB03206 C6H13NO4 small molecule - 19130-96-2 DRUGBANK 19170 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2325 Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside - - DRUGBANK DB02422 C13H24O10S small molecule - - DRUGBANK 19171 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2325 Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside - - DRUGBANK DB02422 C13H24O10S small molecule - - DRUGBANK 18156 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 18157 116414 11253 RP11-350O14.2 MAN1B1 ERMAN1|MANA-ER|MRT15 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 3789 116415 11254 RP3-452H17.1 SLC6A14 BMIQ11 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3790 116415 11254 RP3-452H17.1 SLC6A14 BMIQ11 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 9176 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens agonist target Minick DJ (2007) 17575572 177667 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9177 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens agonist target Arrang JM (2007) 17652997 177666 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9178 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens agonist target Petroianu G (2006) 16599255 177665 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9179 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens agonist target Garduno-Torres B (2006) 16715497 177668 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 6146 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target Pytliak M (2010) 20945968 175621 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6147 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target Millan MJ (2000) 10762339 175610 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6148 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target de Boer TH (1988) 3419539 175611 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 6149 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target Fernandez J (2005) 15771415 175310 362 Mirtazapine Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine dom-mirtazapine|ratio-mirtazap DRUGBANK DB00370 C17H19N3 small molecule N06AX11 85650-52-8 DRUGBANK 24665 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target Lacour M (2001) 11700150 181781 5580 Betahistine 2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine pms-betahistine|serc 8 mg|teva DRUGBANK DB06698 C8H12N2 small molecule N07CA01 5638-76-6 DRUGBANK 24666 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target Barak N (2008) 18447604 182074 5580 Betahistine 2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine pms-betahistine|serc 8 mg|teva DRUGBANK DB06698 C8H12N2 small molecule N07CA01 5638-76-6 DRUGBANK 24667 116416 11255 - HRH3 GPCR97|HH3R 9606 Homo sapiens antagonist target Gbahou F (2010) 20530654 182156 5580 Betahistine 2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine pms-betahistine|serc 8 mg|teva DRUGBANK DB06698 C8H12N2 small molecule N07CA01 5638-76-6 DRUGBANK 11756 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11757 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11758 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11759 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11760 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11761 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11762 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5443 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 11624 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 11625 116436 11280 - SCN11A FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 897 Cocaine Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina cocaine hydrochloride top sol DRUGBANK DB00907 C17H21NO4 small molecule N01BC01|S02DA02|R02AD03|S01HA01 50-36-2 DRUGBANK 13155 116442 11309 - SLCO2B1 OATP-B|OATP2B1|OATPB|SLC21A9 9606 Homo sapiens inhibitor target Lu WJ (2006) 16707409 179896 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 27220 116442 11309 - SLCO2B1 OATP-B|OATP2B1|OATPB|SLC21A9 9606 Homo sapiens unknown target Karlgren M (2012) 22541068 188500 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 17756 116446 11315 CTA-215D11.1 PARK7 DJ-1|DJ1|HEL-S-67p 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17757 116446 11315 CTA-215D11.1 PARK7 DJ-1|DJ1|HEL-S-67p 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 11169 116487 22809 - ATF5 ATFX|HMFN0395 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 22284 116496 22820 - COPG1 COPG 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 22285 116496 22820 - COPG1 COPG 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3798 S-(Dimethylarsenic)Cysteine - - DRUGBANK DB03963 C5H12AsNO2S small molecule - - DRUGBANK 11176 116586 22926 - ATF6 ATF6A 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 26884 116587 22927 RP11-172F4.4 HABP4 IHABP-4|IHABP4|Ki-1/57|SERBP1L 9606 Homo sapiens binder target Huang L (2000) 10887182 181756 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 17726 116594 22934 - RPIA RPI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1690 D-4-Phosphoerythronic Acid - - DRUGBANK DB01756 C4H9O8P small molecule - - DRUGBANK 17727 116594 22934 - RPIA RPI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1690 D-4-Phosphoerythronic Acid - - DRUGBANK DB01756 C4H9O8P small molecule - - DRUGBANK 17728 116594 22934 - RPIA RPI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1690 D-4-Phosphoerythronic Acid - - DRUGBANK DB01756 C4H9O8P small molecule - - DRUGBANK 25184 116604 22949 RP11-16L21.1 PTGR1 LTB4DH|PGR1|ZADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5994 (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID - - DRUGBANK DB07177 C20H30O5 small molecule - - DRUGBANK 22458 116604 22949 RP11-16L21.1 PTGR1 LTB4DH|PGR1|ZADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3898 Para-Coumaric Acid - - DRUGBANK DB04066 C9H8O3 small molecule - - DRUGBANK 21300 116604 22949 RP11-16L21.1 PTGR1 LTB4DH|PGR1|ZADH3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21009 116609 22955 - SCMH1 Scml3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 3713 116627 22978 RP11-30H12.3 NT5C2 GMP|NT5B|PNT5|SPG45|SPG65|cN-II 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3714 116627 22978 RP11-30H12.3 NT5C2 GMP|NT5B|PNT5|SPG45|SPG65|cN-II 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 10745 116627 22978 RP11-30H12.3 NT5C2 GMP|NT5B|PNT5|SPG45|SPG65|cN-II 9606 Homo sapiens inducer target Imming P (2006) 17016423 171742 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 10746 116627 22978 RP11-30H12.3 NT5C2 GMP|NT5B|PNT5|SPG45|SPG65|cN-II 9606 Homo sapiens inducer target Overington JP (2006) 17139284 171741 801 Ribavirin 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina victrelis triple|ribasphere ri DRUGBANK DB00811 C8H12N4O5 small molecule J05AB04 36791-04-5 DRUGBANK 1549 116681 23042 - PDXDC1 LP8165 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1550 116681 23042 - PDXDC1 LP8165 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 25928 116785 23173 - METAP1 MAP1A|MetAP1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6700 3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE - - DRUGBANK DB07903 C14H16N4O2S small molecule - - DRUGBANK 25927 116785 23173 - METAP1 MAP1A|MetAP1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6699 TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE - - DRUGBANK DB07902 C14H16N4O3S small molecule - - DRUGBANK 25926 116785 23173 - METAP1 MAP1A|MetAP1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6698 5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE - - DRUGBANK DB07901 C18H17ClN4 small molecule - - DRUGBANK 23119 116785 23173 - METAP1 MAP1A|MetAP1A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4149 Ovalicin - - DRUGBANK DB04324 C16H26O5 small molecule - - DRUGBANK 7467 116802 23193 - GANAB G2AN|GLUII 9606 Homo sapiens antagonist target Fukaya N (2009) 19818342 176466 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 7468 116802 23193 - GANAB G2AN|GLUII 9606 Homo sapiens antagonist target Hirata A (2009) 19085811 176467 483 Miglitol Miglitolum|Glyset|Miglitol glyset|miglitol DRUGBANK DB00491 C8H17NO5 small molecule A10BF02 72432-03-2 DRUGBANK 26362 116813 23205 - ACSBG1 BG|BG1|BGM|GR-LACS|LPD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7112 2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE - - DRUGBANK DB08326 C10H6N2O2S2 small molecule - - DRUGBANK 24243 116934 23352 RP5-1126H10.1 UBR4 RBAF600|ZUBR1|p600 9606 Homo sapiens unknown target Huh KW (2005) 16061792 145574 4753 HspE7 HPV E7 Peptide Epitope Vaccine|HPV 16 E7/HSP65 Vaccine - DRUGBANK DB04959 - biologic - - DRUGBANK 2871 116968 23395 - LARS2 LEURS|PRLTS4 9606 Homo sapiens unknown target Ma JJ (2006) 17144674 173515 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2872 116968 23395 - LARS2 LEURS|PRLTS4 9606 Homo sapiens unknown target Lue SW (2007) 17378584 173520 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2873 116968 23395 - LARS2 LEURS|PRLTS4 9606 Homo sapiens unknown target Vu MT (2007) 17407263 173517 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2874 116968 23395 - LARS2 LEURS|PRLTS4 9606 Homo sapiens unknown target Hsu JL (2006) 16774921 70697 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2875 116968 23395 - LARS2 LEURS|PRLTS4 9606 Homo sapiens unknown target Zhu B (2007) 17095543 173521 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 21357 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3333 2'-O-Acetyl Adenosine-5-Diphosphoribose - - DRUGBANK DB03478 C17H25N5O15P2 small molecule - - DRUGBANK 21358 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3333 2'-O-Acetyl Adenosine-5-Diphosphoribose - - DRUGBANK DB03478 C17H25N5O15P2 small molecule - - DRUGBANK 21359 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3333 2'-O-Acetyl Adenosine-5-Diphosphoribose - - DRUGBANK DB03478 C17H25N5O15P2 small molecule - - DRUGBANK 19735 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 19736 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 19737 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2590 Nicotinamide Nicotinic amide|Niacinamide neogen dermalogy real fresh fo DRUGBANK DB02701 C6H6N2O small molecule A11HA01 98-92-0 DRUGBANK 23886 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens inhibitor target Schuetz A (2007) 17355872 181995 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 18427 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18428 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18429 116980 23408 - SIRT5 SIR2L5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18430 116982 23410 - SIRT3 SIR2L3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 1760 116996 23428 - SLC7A8 LAT2|LPI-PC1 9606 Homo sapiens unknown target Shennan DB (2002) 12101005 172729 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1761 116996 23428 - SLC7A8 LAT2|LPI-PC1 9606 Homo sapiens unknown target Nemoto T (2003) 12498902 172728 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1762 116996 23428 - SLC7A8 LAT2|LPI-PC1 9606 Homo sapiens unknown target Rossier G (1999) 10574970 447 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1763 116996 23428 - SLC7A8 LAT2|LPI-PC1 9606 Homo sapiens unknown target Babu E (2003) 12930836 172727 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 1764 116996 23428 - SLC7A8 LAT2|LPI-PC1 9606 Homo sapiens unknown target Satoh S (1997) 9349567 172726 115 L-Phenylalanine -phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine freamine iii|primene 10%|2.5% DRUGBANK DB00120 C9H11NO2 small molecule - 63-91-2 DRUGBANK 3473 116996 23428 - SLC7A8 LAT2|LPI-PC1 9606 Homo sapiens unknown target Broeer S (2007) 17504263 173029 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 2743 117027 23464 - GCAT KBL 9606 Homo sapiens unknown target Bashir Q (2006) 17146529 173438 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 1423 117027 23464 - GCAT KBL 9606 Homo sapiens cofactor target Schmidt A (2001) 11318637 172483 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 8752 117035 23475 - QPRT HEL-S-90n|QPRTase 9606 Homo sapiens binder target Zheng XQ (2005) 15837705 177421 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8753 117035 23475 - QPRT HEL-S-90n|QPRTase 9606 Homo sapiens binder target Shin DH (2005) 15753098 177420 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8754 117035 23475 - QPRT HEL-S-90n|QPRTase 9606 Homo sapiens binder target Fukuwatari T (2001) 11758903 177422 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 26480 117068 23521 - RPL13A L13A|TSTA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25380 117068 23521 - RPL13A L13A|TSTA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19325 117068 23521 - RPL13A L13A|TSTA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 3073 117076 23530 hCG_17428 NNT GCCD4 9606 Homo sapiens unknown target Kabus A (2007) 17216441 173664 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 17739 117076 23530 hCG_17428 NNT GCCD4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1696 7-thionicotinamide-adenine-dinucleotide phosphate TATP - DRUGBANK DB01763 C21H28N7O16P3S small molecule - - DRUGBANK 17740 117076 23530 hCG_17428 NNT GCCD4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1696 7-thionicotinamide-adenine-dinucleotide phosphate TATP - DRUGBANK DB01763 C21H28N7O16P3S small molecule - - DRUGBANK 21328 117076 23530 hCG_17428 NNT GCCD4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21329 117076 23530 hCG_17428 NNT GCCD4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21330 117076 23530 hCG_17428 NNT GCCD4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 1723 117083 23539 RP5-1039K5.14-003 SLC16A8 MCT3|REMP 9606 Homo sapiens unknown target Jansen S (2006) 16514190 172696 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 21948 117085 23541 - SEC14L2 C22orf6|SPF|TAP|TAP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 21949 117085 23541 - SEC14L2 C22orf6|SPF|TAP|TAP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3635 Palmitic Acid Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure sha-lem DRUGBANK DB03796 C16H32O2 small molecule - 57-10-3 DRUGBANK 3568 117085 23541 - SEC14L2 C22orf6|SPF|TAP|TAP1 9606 Homo sapiens unknown target Ni J (2007) 17252538 173921 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3569 117085 23541 - SEC14L2 C22orf6|SPF|TAP|TAP1 9606 Homo sapiens unknown target Neuzil J (2006) 16579965 173922 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 2482 117093 23549 - DNPEP ASPEP|DAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2483 117093 23549 - DNPEP ASPEP|DAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2484 117093 23549 - DNPEP ASPEP|DAP 9606 Homo sapiens unknown target Watanabe J (2007) 17928682 173275 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2949 117107 23564 DADB-110M10.5 DDAH2 DDAH|DDAHII|G6a|HEL-S-277|NG30 9606 Homo sapiens unknown target Tran CT (2000) 10950934 173595 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2950 117107 23564 DADB-110M10.5 DDAH2 DDAH|DDAHII|G6a|HEL-S-277|NG30 9606 Homo sapiens unknown target Tain YL (2007) 17653133 173596 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 27072 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Knuckley B (2008) 17964793 188476 200 Azithromycin Azithromycinum|Azitromicina|Azithromycine azithromycin for injection|riv DRUGBANK DB00207 C38H72N2O12 small molecule J01FA10|J01RA07|S01AA26 83905-01-5 DRUGBANK 25467 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6260 N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE - - DRUGBANK DB07449 C14H20N4O2 small molecule - - DRUGBANK 27136 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Knuckley B (2008) 17964793 188476 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 27227 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Knuckley B (2008) 17964793 188476 1070 Streptomycin Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM streptomycin sulfate injection DRUGBANK DB01082 C21H39N7O12 small molecule J04AM01|A07AA04|A07AA54|J01GA01 57-92-1 DRUGBANK 2978 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Wang Y (2004) 15345777 113170 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2979 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Chang X (2006) 16355400 173620 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2980 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Yamamoto K (2005) 16271291 173621 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2981 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Wysocka J (2005) 16146736 173618 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2982 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Okazaki Y (2006) 16412378 173619 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 27075 117111 23569 - PADI4 PAD|PAD4|PADI5|PDI4|PDI5 9606 Homo sapiens unknown target Knuckley B (2008) 17964793 188476 247 Doxycycline Doxycyclin|6-deoxy-5-oxytetracycline|Supracyclin|Doxycycline (anhydrous)|(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide|Vibramycin|Jenacyclin|Doxiciclina|Doxycyclinum|5-Hydroxy-alpha-6-deoxytetracycline|6alpha-Deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline acticlate|doxycycline tablets| DRUGBANK DB00254 C22H24N2O8 small molecule J01AA02|A01AB22 564-25-0 DRUGBANK 2958 117114 23576 RP4-621F18.1 DDAH1 DDAH|HEL-S-16 9606 Homo sapiens unknown target Tran CT (2000) 10950934 173595 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2959 117114 23576 RP4-621F18.1 DDAH1 DDAH|HEL-S-16 9606 Homo sapiens unknown target Arrigoni FI (2003) 12615801 173603 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2960 117114 23576 RP4-621F18.1 DDAH1 DDAH|HEL-S-16 9606 Homo sapiens unknown target Mishima T (2004) 14766200 173602 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 13811 117153 23620 - NTSR2 NTR2 9606 Homo sapiens partial antagonist target Chalon P (1996) 8647296 180177 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13812 117153 23620 - NTSR2 NTR2 9606 Homo sapiens partial antagonist target Richard F (2001) 11723247 180180 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 13813 117153 23620 - NTSR2 NTR2 9606 Homo sapiens partial antagonist target Botto JM (1997) 9080465 180181 1094 Levocabastine Levocabastina|Levocabastin|Levocabastinum livostin sus nas 0.5mg/ml|livo DRUGBANK DB01106 C26H29FN2O2 small molecule S01GX02|R01AC02 79516-68-0 DRUGBANK 25739 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6536 N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide - - DRUGBANK DB07735 C18H28N2O3S small molecule - - DRUGBANK 25740 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6537 (2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide - - DRUGBANK DB07736 C14H20FN3OS small molecule - - DRUGBANK 25738 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6535 N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide - - DRUGBANK DB07734 C16H24N2OS small molecule - - DRUGBANK 25582 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6381 (2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol - - DRUGBANK DB07573 C15H23NO3 small molecule - - DRUGBANK 25349 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6161 4-(2-aminoethyl)-2-cyclohexylphenol - - DRUGBANK DB07345 C14H21NO small molecule - - DRUGBANK 24955 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5749 N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide - - DRUGBANK DB06930 C19H18N4O small molecule - - DRUGBANK 25350 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6162 4-(2-aminoethyl)-2-ethylphenol - - DRUGBANK DB07346 C10H15NO small molecule - - DRUGBANK 24362 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens inhibitor target Albert JS (2009) 21544959 182186 5500 CTS-21166 - - DRUGBANK DB06073 - small molecule - - DRUGBANK 24363 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens inhibitor target Panza F (2009) 19655822 182121 5500 CTS-21166 - - DRUGBANK DB06073 - small molecule - - DRUGBANK 25742 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6539 N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide - - DRUGBANK DB07738 C18H27BrN2O3S small molecule - - DRUGBANK 25551 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6345 2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one - - DRUGBANK DB07535 C14H14N4O small molecule - - DRUGBANK 26018 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6789 N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE - - DRUGBANK DB07994 C26H23N5O small molecule - - DRUGBANK 26017 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6788 N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE - - DRUGBANK DB07993 C20H18N4 small molecule - - DRUGBANK 25296 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6100 N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE - - DRUGBANK DB07284 C17H16N4 small molecule - - DRUGBANK 25256 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6061 6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE - - DRUGBANK DB07245 C20H20N2O small molecule - - DRUGBANK 25210 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6023 6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE - - DRUGBANK DB07206 C15H15N3 small molecule - - DRUGBANK 25119 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5928 4-(4-FLUOROBENZYL)PIPERIDINE - - DRUGBANK DB07110 C12H16FN small molecule - - DRUGBANK 25100 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5907 N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide - - DRUGBANK DB07089 C22H22ClN3O2S small molecule - - DRUGBANK 19054 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2283 MMI-175 - - DRUGBANK DB02378 C38H62N6O8 small molecule - - DRUGBANK 19055 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2283 MMI-175 - - DRUGBANK DB02378 C38H62N6O8 small molecule - - DRUGBANK 25905 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6671 (6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one - - DRUGBANK DB07874 C19H21N3O2 small molecule - - DRUGBANK 25183 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5992 N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide - - DRUGBANK DB07175 C18H18N4O2S small molecule - - DRUGBANK 25295 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6097 N~3~-BENZYLPYRIDINE-2,3-DIAMINE - - DRUGBANK DB07281 C12H13N3 small molecule - - DRUGBANK 25032 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5837 N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE - - DRUGBANK DB07019 C24H33N3O4S small molecule - - DRUGBANK 25741 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6538 (2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide - - DRUGBANK DB07737 C15H22FN3OS small molecule - - DRUGBANK 25438 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6229 4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine - - DRUGBANK DB07415 C19H19FN4O4 small molecule - - DRUGBANK 25310 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6119 N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE - - DRUGBANK DB07303 C18H18N4O small molecule - - DRUGBANK 26750 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7522 3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE - - DRUGBANK DB08749 C25H30N4O2 small molecule - - DRUGBANK 25535 117154 23621 - BACE1 ASP2|BACE|HSPC104 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6330 (6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one - - DRUGBANK DB07519 C21H25N3O2 small molecule - - DRUGBANK 11699 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11700 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11701 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11702 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11703 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 10814 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target Berman HM (2000) 10592235 172122 809 Acetazolamide Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide diamox pws 500mg/vial|diamox i DRUGBANK DB00819 C4H6N4O3S2 small molecule S01EC01 59-66-5 DRUGBANK 26916 117162 23632 UNQ690/PRO1335 CA14 CAXiV 9606 Homo sapiens inhibitor target Innocenti A (2010) 20185318 182147 7605 Ellagic Acid 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione - DRUGBANK DB08846 C14H6O8 small molecule - 476-66-4 DRUGBANK 19883 117170 23643 - LY96 ESOP-1|MD-2|MD2|ly-96 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2652 3-Hydroxy-Myristic Acid - - DRUGBANK DB02767 C14H28O3 small molecule - - DRUGBANK 26258 117170 23643 - LY96 ESOP-1|MD-2|MD2|ly-96 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 27660 117170 23643 - LY96 ESOP-1|MD-2|MD2|ly-96 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 11157 117176 23649 - POLA2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 841 Dacarbazine DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide dacarbazine|dacarbazine for in DRUGBANK DB00851 C6H10N6O small molecule L01AX04 4342-03-4 DRUGBANK 11158 117176 23649 - POLA2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 841 Dacarbazine DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide dacarbazine|dacarbazine for in DRUGBANK DB00851 C6H10N6O small molecule L01AX04 4342-03-4 DRUGBANK 11159 117176 23649 - POLA2 - 9606 Homo sapiens unknown target Loenn U (1987) 3098406 178695 841 Dacarbazine DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide dacarbazine|dacarbazine for in DRUGBANK DB00851 C6H10N6O small molecule L01AX04 4342-03-4 DRUGBANK 24395 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens activator target Dean O (2011) 21118657 182180 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 2215 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens unknown target Tomi M (2003) 12898700 173139 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 2216 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens unknown target Bridges CC (2005) 16014042 173138 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 2217 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens unknown target Hosoya K (2002) 12065721 173137 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 2218 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens unknown target Ruiz E (2003) 12498985 173136 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 2219 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens unknown target Tomi M (2002) 11867597 173135 132 L-Cystine ,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine - DRUGBANK DB00138 C6H12N2O4S2 small molecule - 56-89-3 DRUGBANK 10003 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inducer target Dunlop J (2003) 12629173 178114 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10004 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inducer target Azbill RD (2000) 10899284 178115 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10005 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inducer target Hayashida K (2010) 20059984 178116 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10006 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inducer target Gosselin RD (2010) 20226190 178117 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 10007 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inducer target Wokke J (1996) 8813989 178118 730 Riluzole Riluzolum|Riluzole|Riluzol mylan-riluzole|rilutek|apo-ril DRUGBANK DB00740 C8H5F3N2OS small molecule N07XX02 1744-22-5 DRUGBANK 2459 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens unknown target Natale NR (2006) 16719820 173268 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 10546 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 10547 117179 23657 - SLC7A11 CCBR1|xCT 9606 Homo sapiens inhibitor target Gout PW (2001) 11587223 178411 785 Sulfasalazine Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid ratio-sulfasalazine tab 500mg| DRUGBANK DB00795 C18H14N4O5S small molecule A07EC01 599-79-1 DRUGBANK 2198 117245 23743 - BHMT2 - 9606 Homo sapiens product of target Imming P (2006) 17016423 171742 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2199 117245 23743 - BHMT2 - 9606 Homo sapiens product of target Overington JP (2006) 17139284 171741 128 L-Methionine L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin 2.5% travasol amino acid injec DRUGBANK DB00134 C5H11NO2S small molecule V03AB26 63-68-3 DRUGBANK 2712 117262 23761 RP5-858B16.2 PISD DJ858B16|PSD|PSDC|PSSC|dJ858B16.2 9606 Homo sapiens unknown target Roggero R (2004) 15273086 63769 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2713 117262 23761 RP5-858B16.2 PISD DJ858B16|PSD|PSDC|PSSC|dJ858B16.2 9606 Homo sapiens unknown target Buergermeister M (2004) 15522832 173417 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2714 117262 23761 RP5-858B16.2 PISD DJ858B16|PSD|PSDC|PSSC|dJ858B16.2 9606 Homo sapiens unknown target Buergermeister M (2004) 15522831 64580 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2715 117262 23761 RP5-858B16.2 PISD DJ858B16|PSD|PSDC|PSSC|dJ858B16.2 9606 Homo sapiens unknown target Wu WI (2004) 14660568 173416 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2716 117262 23761 RP5-858B16.2 PISD DJ858B16|PSD|PSDC|PSSC|dJ858B16.2 9606 Homo sapiens unknown target Voelker DR (2005) 16246067 69182 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 12973 117295 24145 UNQ2529/PRO6028 PANX1 MRS1|PX1|UNQ2529 9606 Homo sapiens antagonist target Silverman W (2008) 18596212 179795 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12974 117295 24145 UNQ2529/PRO6028 PANX1 MRS1|PX1|UNQ2529 9606 Homo sapiens antagonist target Ransford GA (2009) 19213873 179794 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12975 117295 24145 UNQ2529/PRO6028 PANX1 MRS1|PX1|UNQ2529 9606 Homo sapiens antagonist target Bunse S (2009) 19780818 179796 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12976 117295 24145 UNQ2529/PRO6028 PANX1 MRS1|PX1|UNQ2529 9606 Homo sapiens antagonist target Ma W (2009) 19023039 179793 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12977 117295 24145 UNQ2529/PRO6028 PANX1 MRS1|PX1|UNQ2529 9606 Homo sapiens antagonist target Silverman WR (2009) 19416975 179792 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 21589 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3456 Diminazene Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate - DRUGBANK DB03608 C14H15N7 small molecule - 536-71-0 DRUGBANK 21590 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3456 Diminazene Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate - DRUGBANK DB03608 C14H15N7 small molecule - 536-71-0 DRUGBANK 21942 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21943 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 12581 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 12582 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens inhibitor target Venardos K (2004) 15191400 179571 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 12583 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens inhibitor target Gundimeda U (2009) 19578042 179570 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 12584 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens inhibitor target Rigobello MP (2002) 12163349 179573 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 12585 117352 25824 SBBI10 PRDX5 ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V 9606 Homo sapiens inhibitor target Rigobello MP (2005) 16036347 179572 985 Auranofin Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen ridaura DRUGBANK DB00995 C20H34AuO9PS small molecule M01CB03 34031-32-8 DRUGBANK 3782 117457 25973 - PARS2 MT-PRORS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3783 117457 25973 - PARS2 MT-PRORS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 1629 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens cofactor target Morel CF (2006) 16714133 137281 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1630 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens cofactor target Chandler RJ (2006) 16843692 172608 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1631 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens cofactor target Ben-Omran TI (2007) 17431913 172609 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1632 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens cofactor target Lerner-Ellis JP (2006) 16311595 172607 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 4175 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4176 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4177 117458 25974 RP11-291L19.3 MMACHC cblC 9606 Homo sapiens unknown target Lerner-Ellis JP (2006) 16311595 172607 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 3075 117618 26227 RP4-683H9.1 PHGDH 3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3076 117618 26227 RP4-683H9.1 PHGDH 3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3077 117618 26227 RP4-683H9.1 PHGDH 3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA 9606 Homo sapiens unknown target Grant GA (1989) 2692566 173667 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3078 117618 26227 RP4-683H9.1 PHGDH 3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA 9606 Homo sapiens unknown target Goldsmith LA (1976) 945314 173666 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3079 117618 26227 RP4-683H9.1 PHGDH 3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA 9606 Homo sapiens unknown target Grant GA (2002) 12183470 173668 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 20370 117620 26229 - B3GAT3 GLCATI|glcUAT-I 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2913 UDP-alpha-D-glucuronic acid UDPglucuronate|UDP-alpha-D-glucuronate|Uridine-5'-diphosphate-glucuronic acid|UDP-glucuronate|uridine diphosphate glucuronic acid|UDP-Glucuronic Acid|UDP-D-glucuronate - DRUGBANK DB03041 C15H22N2O18P2 small molecule - 2616-64-0 DRUGBANK 20371 117620 26229 - B3GAT3 GLCATI|glcUAT-I 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2913 UDP-alpha-D-glucuronic acid UDPglucuronate|UDP-alpha-D-glucuronate|Uridine-5'-diphosphate-glucuronic acid|UDP-glucuronate|uridine diphosphate glucuronic acid|UDP-Glucuronic Acid|UDP-D-glucuronate - DRUGBANK DB03041 C15H22N2O18P2 small molecule - 2616-64-0 DRUGBANK 21212 117620 26229 - B3GAT3 GLCATI|glcUAT-I 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21213 117620 26229 - B3GAT3 GLCATI|glcUAT-I 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 22823 117658 26275 - HIBCH HIBYLCOAH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 20737 117662 26279 UNQ768 PLA2G2D PLA2IID|SPLASH|sPLA2-IID|sPLA2S 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3061 Stearic acid Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure for sope|obeo baby bubble|jinh DRUGBANK DB03193 C18H36O2 small molecule - 57-11-4 DRUGBANK 20738 117662 26279 UNQ768 PLA2G2D PLA2IID|SPLASH|sPLA2-IID|sPLA2S 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3061 Stearic acid Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure for sope|obeo baby bubble|jinh DRUGBANK DB03193 C18H36O2 small molecule - 57-11-4 DRUGBANK 20739 117662 26279 UNQ768 PLA2G2D PLA2IID|SPLASH|sPLA2-IID|sPLA2S 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3061 Stearic acid Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure for sope|obeo baby bubble|jinh DRUGBANK DB03193 C18H36O2 small molecule - 57-11-4 DRUGBANK 27672 117662 26279 UNQ768 PLA2G2D PLA2IID|SPLASH|sPLA2-IID|sPLA2S 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 3221 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3222 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Ismail SA (2005) 16239728 173719 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3223 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3224 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Graciet E (2003) 12492483 173720 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3225 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Maeda K (2004) 15488735 173721 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 18720 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2120 6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One - - DRUGBANK DB02205 C19H22O4 small molecule - - DRUGBANK 20988 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3195 N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine - - DRUGBANK DB03331 C30H30N6O6 small molecule - - DRUGBANK 20989 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3195 N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine - - DRUGBANK DB03331 C30H30N6O6 small molecule - - DRUGBANK 20990 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3195 N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine - - DRUGBANK DB03331 C30H30N6O6 small molecule - - DRUGBANK 23532 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4290 N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine - - DRUGBANK DB04477 C29H32N6O6 small molecule - - DRUGBANK 23533 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4290 N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine - - DRUGBANK DB04477 C29H32N6O6 small molecule - - DRUGBANK 23534 117681 26330 HSD35 GAPDHS GAPD2|GAPDH-2|GAPDS|HSD-35 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4290 N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine - - DRUGBANK DB04477 C29H32N6O6 small molecule - - DRUGBANK 2385 117922 26873 - OPLAH 5-Opase|OPLA|OPLAHD 9606 Homo sapiens unknown target Nishimura A (2001) 11302195 173234 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2386 117922 26873 - OPLAH 5-Opase|OPLA|OPLAHD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2387 117922 26873 - OPLAH 5-Opase|OPLA|OPLAHD 9606 Homo sapiens unknown target Seddon AP (1984) 6145710 173235 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2388 117922 26873 - OPLAH 5-Opase|OPLA|OPLAHD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2389 117922 26873 - OPLAH 5-Opase|OPLA|OPLAHD 9606 Homo sapiens unknown target Van der Werf P (1973) 4514988 173233 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2922 117952 27010 - TPK1 HTPK1|PP20|THMD5 9606 Homo sapiens ligand target de Jong L (2004) 15514058 173572 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 2923 117952 27010 - TPK1 HTPK1|PP20|THMD5 9606 Homo sapiens ligand target Melnick J (2004) 15150256 173571 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 2924 117952 27010 - TPK1 HTPK1|PP20|THMD5 9606 Homo sapiens ligand target Pylypchuk SIu (2001) 11642045 173570 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 2925 117952 27010 - TPK1 HTPK1|PP20|THMD5 9606 Homo sapiens ligand target Bellyei S (2005) 15664409 173569 146 Thiamine Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium vitamin b complex 100 tab|mult DRUGBANK DB00152 C12H17N4OS small molecule A11DA01 59-43-8 DRUGBANK 23874 117952 27010 - TPK1 HTPK1|PP20|THMD5 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4570 Pyrithiamine Pyrophosphate - - DRUGBANK DB04768 C14H21N4O7P2 small molecule - - DRUGBANK 14617 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14618 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 15200 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 15201 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1224 Sevoflurane Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum ultane|sevorane af|sevoflurane DRUGBANK DB01236 C4H3F7O small molecule N01AB08 28523-86-6 DRUGBANK 14319 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14320 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 16223 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens agonist target Bonza MC (2010) 20573858 181206 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 16224 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens agonist target Shi X (1998) 9787799 181207 1332 Calcium - super cal mag plus|g.a.s. comp DRUGBANK DB01373 Ca small molecule A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08 7440-70-2 DRUGBANK 10107 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10108 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Kosk-Kosicka D (1993) 8214757 174516 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 10109 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 743 Isoflurane 1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane isoflurane usp|terrell|isoflur DRUGBANK DB00753 C3H2ClF5O small molecule N01AB06 26675-46-7 DRUGBANK 12925 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12926 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 12927 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Lopez MM (1995) 7499320 179763 1017 Methoxyflurane Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano - DRUGBANK DB01028 C3H4Cl2F2O small molecule N02BG09 76-38-0 DRUGBANK 4449 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Kosk-Kosicka D (1993) 8214757 174516 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4450 117963 27032 HUSSY-28 ATP2C1 ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1 9606 Homo sapiens inhibitor target Kosk-Kosicka D (1994) 7873420 174517 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 17545 117965 27034 - ACAD8 ACAD-8|ARC42 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1611 Methacrylyl-Coenzyme A - - DRUGBANK DB01675 C25H40N7O17P3S small molecule - 6008-91-9 DRUGBANK 17546 117965 27034 - ACAD8 ACAD-8|ARC42 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1611 Methacrylyl-Coenzyme A - - DRUGBANK DB01675 C25H40N7O17P3S small molecule - 6008-91-9 DRUGBANK 20612 117965 27034 - ACAD8 ACAD-8|ARC42 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20613 117965 27034 - ACAD8 ACAD-8|ARC42 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21837 117967 27036 - SIGLEC7 AIRM1|CD328|CDw328|D-siglec|QA79|SIGLEC-7|SIGLEC19P|SIGLECP2|p75|p75/AIRM1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 21838 117967 27036 - SIGLEC7 AIRM1|CD328|CDw328|D-siglec|QA79|SIGLEC-7|SIGLEC19P|SIGLECP2|p75|p75/AIRM1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 17954 117981 27071 HSPC066 DAPP1 BAM32 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17955 117981 27071 HSPC066 DAPP1 BAM32 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17579 117990 27087 - B3GAT1 CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 17580 117990 27087 - B3GAT1 CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 21223 117990 27087 - B3GAT1 CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21224 117990 27087 - B3GAT1 CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 25797 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25776 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25424 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26507 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22676 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 26370 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23918 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26714 117991 27089 - UQCRQ MC3DN4|QCR8|QP-C|QPC|UQCR7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 13877 117996 27094 - KCNMB3 BKBETA3|HBETA3|K(VCA)BETA-3|KCNMB2|KCNMBL|SLO-BETA-3|SLOBETA3 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13878 117996 27094 - KCNMB3 BKBETA3|HBETA3|K(VCA)BETA-3|KCNMB2|KCNMBL|SLO-BETA-3|SLOBETA3 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9813 117996 27094 - KCNMB3 BKBETA3|HBETA3|K(VCA)BETA-3|KCNMB2|KCNMBL|SLO-BETA-3|SLOBETA3 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 26251 117997 27095 CDABP0066 TRAPPC3 BET3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 26387 117997 27095 CDABP0066 TRAPPC3 BET3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7128 S-PALMITOYL-L-CYSTEINE - - DRUGBANK DB08342 C19H37NO3S small molecule - - DRUGBANK 9015 118010 27115 RP11-472E5.2 PDE7B bA472E5.1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 9016 118010 27115 RP11-472E5.2 PDE7B bA472E5.1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 641 Dyphylline Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine protophylline sup 500mg adulte DRUGBANK DB00651 C10H14N4O4 small molecule R03DB01|R03DA01|R03DA51 479-18-5 DRUGBANK 4229 118010 27115 RP11-472E5.2 PDE7B bA472E5.1 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4230 118010 27115 RP11-472E5.2 PDE7B bA472E5.1 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 11931 118010 27115 RP11-472E5.2 PDE7B bA472E5.1 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 11932 118010 27115 RP11-472E5.2 PDE7B bA472E5.1 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 910 Ketotifen Ketotifenum|Ketotifene|Ketotifeno nu-ketotifen syrup - 1mg/5ml|z DRUGBANK DB00920 C19H19NOS small molecule R06AX17|S01GX08 34580-13-7 DRUGBANK 2543 118044 27165 - GLS2 GA|GLS|LGA|hLGA 9606 Homo sapiens unknown target Dossena L (2007) 17373776 173300 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2544 118044 27165 - GLS2 GA|GLS|LGA|hLGA 9606 Homo sapiens unknown target Yoshimune K (2006) 16793004 173301 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2545 118044 27165 - GLS2 GA|GLS|LGA|hLGA 9606 Homo sapiens unknown target Kita K (2007) 17321558 173299 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2785 118081 27232 - GNMT - 9606 Homo sapiens unknown target Luka Z (2007) 17158459 173468 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2786 118081 27232 - GNMT - 9606 Homo sapiens unknown target Velichkova P (2005) 16851960 173467 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2787 118081 27232 - GNMT - 9606 Homo sapiens unknown target Soriano A (2006) 17154529 173466 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 22959 118081 27232 - GNMT - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22960 118081 27232 - GNMT - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 1694 118081 27232 - GNMT - 9606 Homo sapiens cofactor target Rowling MJ (2001) 11435507 172668 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1695 118081 27232 - GNMT - 9606 Homo sapiens cofactor target Luka Z (2002) 11810299 172669 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1696 118081 27232 - GNMT - 9606 Homo sapiens cofactor target Moller MT (2003) 12697024 12306 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1697 118081 27232 - GNMT - 9606 Homo sapiens cofactor target Uthus EO (2003) 12742526 172666 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 1698 118081 27232 - GNMT - 9606 Homo sapiens cofactor target Rowling MJ (2002) 12221207 172667 113 S-Adenosylmethionine SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine - DRUGBANK DB00118 C15H23N6O5S small molecule - 29908-03-0 DRUGBANK 17709 118081 27232 - GNMT - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 26790 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7562 1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID - - DRUGBANK DB08790 C10H8N2O2 small molecule - - DRUGBANK 25620 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6421 Tranilast 2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid - DRUGBANK DB07615 C18H17NO5 small molecule - 53902-12-8 DRUGBANK 25621 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6422 4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid - - DRUGBANK DB07616 C17H13FN2O3S small molecule - - DRUGBANK 18033 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1824 2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride - - DRUGBANK DB01897 C24H16N7O2S small molecule - - DRUGBANK 18034 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1824 2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride - - DRUGBANK DB01897 C24H16N7O2S small molecule - - DRUGBANK 22501 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22502 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 26349 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7099 nocodazole - - DRUGBANK DB08313 C14H11N3O3S small molecule - - DRUGBANK 26723 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7469 3-(4-nitrophenyl)-1H-pyrazole - - DRUGBANK DB08695 C9H7N3O2 small molecule - - DRUGBANK 2664 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2665 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Urade Y (1993) 8415655 173378 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2666 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Aritake K (2006) 16547010 152941 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2667 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2668 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2669 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Inoue T (2004) 15113825 152402 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 25619 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6420 PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE - - DRUGBANK DB07614 C12H9N3S small molecule - - DRUGBANK 25618 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6419 3-phenyl-5-(1H-pyrazol-3-yl)isoxazole - - DRUGBANK DB07613 C12H9N3O small molecule - - DRUGBANK 25938 118128 27306 - HPGDS GSTS|GSTS1-1|PGD2|PGDS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6713 4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE - - DRUGBANK DB07917 C22H27N5O small molecule - - DRUGBANK 13887 118157 27345 - KCNMB4 - 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13888 118157 27345 - KCNMB4 - 9606 Homo sapiens inhibitor target Alvarez J (1992) 1376313 180213 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 9814 118157 27345 - KCNMB4 - 9606 Homo sapiens binder target Benham CD (1985) 2580269 178026 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 25348 118161 27349 AL022237.1 MCAT FASN2C|MCT|MT|NET62|fabD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6160 3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL - - DRUGBANK DB07344 C12H26O6 small molecule - - DRUGBANK 27241 118182 28234 - SLCO1B3 HBLRR|LST-2|LST-3TM13|LST3|OATP-8|OATP1B3|OATP8|SLC21A8 9606 Homo sapiens unknown target De Bruyn T (2013) 23571415 188504 1199 Clarithromycin Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum mylan-clarithromycin|ran-clari DRUGBANK DB01211 C38H69NO13 small molecule J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09 81103-11-9 DRUGBANK 27218 118182 28234 - SLCO1B3 HBLRR|LST-2|LST-3TM13|LST3|OATP-8|OATP1B3|OATP8|SLC21A8 9606 Homo sapiens unknown target Vavricka SR (2002) 12085361 188499 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 22698 118320 28442 - IGHV3-23 DP47|IGHV323|V3-23|VH26 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 19823 118489 28639 - TRBC1 BV05S1J2.2|TCRB|TCRBC1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2626 3-Indolebutyric Acid - - DRUGBANK DB02740 C12H13NO2 small molecule - 133-32-4 DRUGBANK 26333 118625 28776 - IGLV7-43 IGLV743|V3-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7082 4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION - - DRUGBANK DB08295 C14H17N2O6 small molecule - - DRUGBANK 26320 118625 28776 - IGLV7-43 IGLV743|V3-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7061 4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION - - DRUGBANK DB08273 C14H16IN2O6 small molecule - - DRUGBANK 17504 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1586 7-Methyl-Gpppa P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE - DRUGBANK DB01649 C21H30N10O17P3 small molecule - - DRUGBANK 17505 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1586 7-Methyl-Gpppa P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE - DRUGBANK DB01649 C21H30N10O17P3 small molecule - - DRUGBANK 21556 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3441 N7-Methyl-Guanosine-5'-Monophosphate - - DRUGBANK DB03593 C11H17N5O8P small molecule - - DRUGBANK 21557 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3441 N7-Methyl-Guanosine-5'-Monophosphate - - DRUGBANK DB03593 C11H17N5O8P small molecule - - DRUGBANK 22268 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3793 7-methyl-guanosine-5'-triphosphate-5'-guanosine mRNA cap analog N7-Methyl GpppG - DRUGBANK DB03958 C21H30N10O18P3 small molecule - - DRUGBANK 22269 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3793 7-methyl-guanosine-5'-triphosphate-5'-guanosine mRNA cap analog N7-Methyl GpppG - DRUGBANK DB03958 C21H30N10O18P3 small molecule - - DRUGBANK 25649 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6450 5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine - - DRUGBANK DB07644 C16H15ClN4O small molecule - - DRUGBANK 18173 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 18174 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 25647 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6448 5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine - - DRUGBANK DB07642 C21H24FN5O small molecule - - DRUGBANK 25648 118787 28960 HSPC015 DCPS DCS1|HINT-5|HINT5|HSL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6449 5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine - - DRUGBANK DB07643 C21H23Cl2N5O small molecule - - DRUGBANK 25792 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6577 FAMOXADONE - - DRUGBANK DB07778 C22H18N2O4 small molecule - - DRUGBANK 25771 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6564 (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE - - DRUGBANK DB07763 C16H12F2N2O3 small molecule - - DRUGBANK 25419 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6215 METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE - - DRUGBANK DB07401 C22H17N3O5 small molecule - - DRUGBANK 26502 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7234 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE - - DRUGBANK DB08453 C18H25NO2 small molecule - - DRUGBANK 22671 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3972 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol - - DRUGBANK DB04141 C12H24O6 small molecule - - DRUGBANK 25640 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6442 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE - - DRUGBANK DB07636 C14H17NO3S small molecule - - DRUGBANK 26365 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7116 METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE - - DRUGBANK DB08330 C19H18O3 small molecule - - DRUGBANK 23913 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4601 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol - DRUGBANK DB04799 C18H25NO3S small molecule - 43152-58-5 DRUGBANK 26704 118920 29796 HSPC119 UQCR10 HSPC051|HSPC151|QCR9|UCCR7.2|UCRC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 12409 118936 29881 - NPC1L1 NPC11L1 9606 Homo sapiens inhibitor target von Bergmann K (2005) 15992510 179430 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12410 118936 29881 - NPC1L1 NPC11L1 9606 Homo sapiens inhibitor target Garcia-Calvo M (2005) 15928087 179431 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12411 118936 29881 - NPC1L1 NPC11L1 9606 Homo sapiens inhibitor target Altmann SW (2004) 14976318 179429 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12412 118936 29881 - NPC1L1 NPC11L1 9606 Homo sapiens inhibitor target Sudhop T (2005) 15737409 179428 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12413 118936 29881 - NPC1L1 NPC11L1 9606 Homo sapiens inhibitor target Wang J (2005) 15679830 179427 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 12414 118936 29881 - NPC1L1 NPC11L1 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 963 Ezetimibe Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc liptruzet|mar-ezetimibe|zetia| DRUGBANK DB00973 C24H21F2NO3 small molecule C10BA02|C10BA05|C10BA06|C10AX09 163222-33-1 DRUGBANK 3295 118962 29920 RP4-559A3.4 PYCR2 P5CR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3296 118962 29920 RP4-559A3.4 PYCR2 P5CR2 9606 Homo sapiens unknown target Murahama M (2001) 11479381 173755 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3297 118962 29920 RP4-559A3.4 PYCR2 P5CR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3780 118962 29920 RP4-559A3.4 PYCR2 P5CR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3788 118962 29920 RP4-559A3.4 PYCR2 P5CR2 9606 Homo sapiens unknown target Murahama M (2001) 11479381 173755 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3781 118962 29920 RP4-559A3.4 PYCR2 P5CR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 21126 118965 29924 - EPN1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21127 118965 29924 - EPN1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 21128 118965 29924 - EPN1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3258 D-Myo-Inositol-1,4,5-Triphosphate - - DRUGBANK DB03401 C6H15O15P3 small molecule - - DRUGBANK 20953 118965 29924 - EPN1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 20954 118965 29924 - EPN1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 20955 118965 29924 - EPN1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3181 1,4-Diethylene Dioxide - - DRUGBANK DB03316 C4H8O2 small molecule - - DRUGBANK 2962 118980 29943 - PADI1 HPAD10|PAD1|PDI|PDI1 9606 Homo sapiens unknown target Iida A (2004) 15150696 173605 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 1474 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens cofactor target Battchikova N (1996) 8695645 172505 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1475 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens cofactor target Kapetaniou EG (2006) 16532449 172507 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1476 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens cofactor target Hester G (1999) 10024454 172506 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1477 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1478 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1479 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens cofactor target Berman HM (2000) 10592235 172122 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2462 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2463 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2464 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens unknown target Katsura Y (2004) 15103612 173269 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2465 119001 29968 - PSAT1 EPIP|NLS2|PSA|PSAT|PSATD 9606 Homo sapiens unknown target Hester G (1999) 10024454 172506 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 19586 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2527 9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid - - DRUGBANK DB02636 C17H11NO8 small molecule - - DRUGBANK 19861 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2643 Indolylpropionic Acid - - DRUGBANK DB02758 C11H11NO2 small molecule - - DRUGBANK 23846 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4529 Licofelone LCF|ML3000 - DRUGBANK DB04725 C23H22ClNO2 small molecule - 156897-06-2 DRUGBANK 25990 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6753 (2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID - - DRUGBANK DB07958 C15H18N2O3 small molecule - - DRUGBANK 21538 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3433 Oxyphenbutazone Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona oxybutazone tab 100mg|oxyphenb DRUGBANK DB03585 C19H20N2O3 small molecule S01BC02|M01AA03|M02AA04 129-20-4 DRUGBANK 21539 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3433 Oxyphenbutazone Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona oxybutazone tab 100mg|oxyphenb DRUGBANK DB03585 C19H20N2O3 small molecule S01BC02|M01AA03|M02AA04 129-20-4 DRUGBANK 21540 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3433 Oxyphenbutazone Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona oxybutazone tab 100mg|oxyphenb DRUGBANK DB03585 C19H20N2O3 small molecule S01BC02|M01AA03|M02AA04 129-20-4 DRUGBANK 19223 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2349 N-Tridecanoic Acid - - DRUGBANK DB02448 C13H26O2 small molecule - 638-53-9 DRUGBANK 22503 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22504 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22505 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 25976 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6745 1H-INDOL-3-YLACETIC ACID - - DRUGBANK DB07950 C10H9NO2 small molecule - - DRUGBANK 25522 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6311 (2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one - - DRUGBANK DB07500 C21H22O4 small molecule - - DRUGBANK 19925 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2677 P-Anisic Acid - - DRUGBANK DB02795 C8H8O3 small molecule - 100-09-4 DRUGBANK 19926 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2677 P-Anisic Acid - - DRUGBANK DB02795 C8H8O3 small molecule - 100-09-4 DRUGBANK 19927 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2677 P-Anisic Acid - - DRUGBANK DB02795 C8H8O3 small molecule - 100-09-4 DRUGBANK 26496 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7229 3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL - - DRUGBANK DB08447 C14H20N2O small molecule - - DRUGBANK 4564 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 226 Aminosalicylic Acid PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate paser|nemasol sodium tab 500mg DRUGBANK DB00233 C7H7NO3 small molecule J04AA03|J04AA02|J04AA01 65-49-6 DRUGBANK 18158 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 18159 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 18160 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 25000 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5805 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE - - DRUGBANK DB06987 C14H22N2O3 small molecule - - DRUGBANK 23860 119038 30814 - PLA2G2E GIIE sPLA2|sPLA2-IIE 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4546 Nimesulide - - DRUGBANK DB04743 C13H12N2O5S small molecule M01AX17|M02AA26 51803-78-2 DRUGBANK 4668 119071 50484 - RRM2B MTDPS8A|MTDPS8B|P53R2 9606 Homo sapiens inhibitor target Kantarjian HM (2007) 17852710 174594 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4669 119071 50484 - RRM2B MTDPS8A|MTDPS8B|P53R2 9606 Homo sapiens inhibitor target Sampat K (2009) 19715446 174595 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4670 119071 50484 - RRM2B MTDPS8A|MTDPS8B|P53R2 9606 Homo sapiens inhibitor target Kline JP (2005) 16316309 174590 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4671 119071 50484 - RRM2B MTDPS8A|MTDPS8B|P53R2 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 4672 119071 50484 - RRM2B MTDPS8A|MTDPS8B|P53R2 9606 Homo sapiens inhibitor target Takahashi T (1999) 9923554 174593 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 9749 119105 50632 RP11-122K13.5 CALY DRD1IP|NSG3 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 704 Apomorphine (-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin apokyn DRUGBANK DB00714 C17H17NO2 small molecule G04BE07|N04BC07 58-00-4 DRUGBANK 5982 119105 50632 RP11-122K13.5 CALY DRD1IP|NSG3 9606 Homo sapiens unknown target Chen X (2002) 11752352 171740 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 10934 119105 50632 RP11-122K13.5 CALY DRD1IP|NSG3 9606 Homo sapiens antagonist target Madrid PB (2007) 17407813 178591 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10935 119105 50632 RP11-122K13.5 CALY DRD1IP|NSG3 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 10936 119105 50632 RP11-122K13.5 CALY DRD1IP|NSG3 9606 Homo sapiens antagonist target Seeman P (1976) 945467 178588 821 Trifluoperazine 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine pms trifluoperazine hcl syrup DRUGBANK DB00831 C21H24F3N3S small molecule N05AB06 117-89-5 DRUGBANK 3530 119119 50700 - RDH8 PRRDH|SDR28C2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3531 119119 50700 - RDH8 PRRDH|SDR28C2 9606 Homo sapiens unknown target Han W (2006) 17081426 173889 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3532 119119 50700 - RDH8 PRRDH|SDR28C2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3533 119119 50700 - RDH8 PRRDH|SDR28C2 9606 Homo sapiens unknown target Han W (2003) 14661078 173887 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3534 119119 50700 - RDH8 PRRDH|SDR28C2 9606 Homo sapiens unknown target Fishman GA (2004) 14718298 173888 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3302 119131 50814 - NSDHL H105E3|SDR31E1|XAP104 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3303 119131 50814 - NSDHL H105E3|SDR31E1|XAP104 9606 Homo sapiens unknown target Cunningham D (2005) 15805545 173756 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3304 119131 50814 - NSDHL H105E3|SDR31E1|XAP104 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 26885 119166 50939 - IMPG2 IPM200|RP56|SPACRCAN 9606 Homo sapiens binder target Acharya S (2000) 10702256 181746 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 10824 119167 50940 - PDE11A PPNAD2 9606 Homo sapiens inhibitor target Weeks JL (2007) 17696499 178549 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 10825 119167 50940 - PDE11A PPNAD2 9606 Homo sapiens inhibitor target Weeks JL (2009) 19641165 178548 810 Tadalafil (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis act tadalafil|mylan-tadalafil| DRUGBANK DB00820 C22H19N3O4 small molecule G04BE08 171596-29-5 DRUGBANK 4221 119167 50940 - PDE11A PPNAD2 9606 Homo sapiens inhibitor, competitive target Ribeiro JA (2010) 20164566 174341 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 4222 119167 50940 - PDE11A PPNAD2 9606 Homo sapiens inhibitor, competitive target Essayan DM (2001) 11692087 174342 194 Caffeine Cafine|1,3,7-trimethylpurine-2,6-dione|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Caffeine|Thein|1,3,7-Trimethyl-2,6-dioxopurine|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Theine|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Teina stay awake maximum strength|fi DRUGBANK DB00201 C8H10N4O2 small molecule N06BC01|V04CG30 58-08-2 DRUGBANK 2566 119228 51022 RP11-101E13.4 GLRX2 CGI-133|GRX2 9606 Homo sapiens unknown target Hashemy SI (2007) 17355958 173314 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2567 119228 51022 RP11-101E13.4 GLRX2 CGI-133|GRX2 9606 Homo sapiens unknown target Sagemark J (2007) 17546662 173313 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2568 119228 51022 RP11-101E13.4 GLRX2 CGI-133|GRX2 9606 Homo sapiens unknown target Sheng J (2007) 17401194 173312 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 19125 119248 51056 - LAP3 HEL-S-106|LAP|LAPEP|PEPS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2291 Leucine Phosphonic Acid - - DRUGBANK DB02386 C5H14NO3P small molecule - - DRUGBANK 19126 119248 51056 - LAP3 HEL-S-106|LAP|LAPEP|PEPS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2291 Leucine Phosphonic Acid - - DRUGBANK DB02386 C5H14NO3P small molecule - - DRUGBANK 19127 119248 51056 - LAP3 HEL-S-106|LAP|LAPEP|PEPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2291 Leucine Phosphonic Acid - - DRUGBANK DB02386 C5H14NO3P small molecule - - DRUGBANK 26767 119248 51056 - LAP3 HEL-S-106|LAP|LAPEP|PEPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7539 L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S - - DRUGBANK DB08766 C15H19NO3S2 small molecule - - DRUGBANK 25466 119248 51056 - LAP3 HEL-S-106|LAP|LAPEP|PEPS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6259 (2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid - - DRUGBANK DB07448 C19H24NO4P small molecule - - DRUGBANK 2629 119252 51060 UNQ713/PRO1376 TXNDC12 AG1|AGR1|ERP16|ERP18|ERP19|PDIA16|TLP19|hAG-1|hTLP19 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2630 119252 51060 UNQ713/PRO1376 TXNDC12 AG1|AGR1|ERP16|ERP18|ERP19|PDIA16|TLP19|hAG-1|hTLP19 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2206 119258 51067 CGI-04 YARS2 MLASA2|MT-TYRRS|TYRRS 9606 Homo sapiens unknown target Zhang Y (2005) 15840835 173124 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2207 119258 51067 CGI-04 YARS2 MLASA2|MT-TYRRS|TYRRS 9606 Homo sapiens unknown target Kobayashi T (2003) 12754495 173125 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2208 119258 51067 CGI-04 YARS2 MLASA2|MT-TYRRS|TYRRS 9606 Homo sapiens unknown target Kiga D (2002) 12097643 173126 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2209 119258 51067 CGI-04 YARS2 MLASA2|MT-TYRRS|TYRRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 2210 119258 51067 CGI-04 YARS2 MLASA2|MT-TYRRS|TYRRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 129 L-Tyrosine (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid primene 10%|2.5% travasol amin DRUGBANK DB00135 C9H11NO3 small molecule - 60-18-4 DRUGBANK 3250 119270 51079 CGI-39 NDUFA13 B16.6|CDA016|GRIM-19|GRIM19 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3251 119270 51079 CGI-39 NDUFA13 B16.6|CDA016|GRIM-19|GRIM19 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 1467 119280 51091 - SEPSECS LP|PCH2D|SLA|SLA/LP 9606 Homo sapiens cofactor target Kernebeck T (2001) 11481605 172499 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1468 119280 51091 - SEPSECS LP|PCH2D|SLA|SLA/LP 9606 Homo sapiens cofactor target Xu XM (2007) 17194211 172498 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 3537 119298 51109 CGI-82 RDH11 ARSDR1|CGI82|HCBP12|MDT1|PSDR1|RALR1|RDJCSS|SCALD|SDR7C1 9606 Homo sapiens unknown target Gallego O (2006) 16787387 173890 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 26485 119308 51121 - RPL26L1 RPL26P1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25384 119308 51121 - RPL26L1 RPL26P1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19331 119308 51121 - RPL26L1 RPL26P1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 23060 119315 51128 - SAR1B ANDD|CMRD|GTBPB|SARA2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 26622 119322 51135 RP11-210N13.4 IRAK4 IPD1|IRAK-4|NY-REN-64|REN64 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7367 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE - - DRUGBANK DB08590 C22H24N4O6 small molecule - - DRUGBANK 1510 119346 51166 - AADAT KAT2|KATII 9606 Homo sapiens cofactor target Cooper AJ (2004) 15016471 172530 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1511 119346 51166 - AADAT KAT2|KATII 9606 Homo sapiens cofactor target Goh DL (2002) 12126930 172531 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2442 119346 51166 - AADAT KAT2|KATII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2443 119346 51166 - AADAT KAT2|KATII 9606 Homo sapiens unknown target Kocki T (2003) 12850557 173255 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2444 119346 51166 - AADAT KAT2|KATII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 20028 119349 51170 PSEC0029 HSD17B11 17-BETA-HSD11|17-BETA-HSDXI|17BHSD11|DHRS8|PAN1B|RETSDR2|SDR16C2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2736 Aetiocholanolone - - DRUGBANK DB02854 C19H30O2 small molecule - 53-42-9 DRUGBANK 2310 119351 51172 - NAGPA APAA|UCE 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2311 119351 51172 - NAGPA APAA|UCE 9606 Homo sapiens unknown target Chavez CA (2007) 17927214 173188 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2312 119351 51172 - NAGPA APAA|UCE 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2313 119351 51172 - NAGPA APAA|UCE 9606 Homo sapiens unknown target Mullis KG (1994) 8294420 173186 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2314 119351 51172 - NAGPA APAA|UCE 9606 Homo sapiens unknown target Kornfeld R (1998) 9722550 173187 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 8120 119352 51174 - TUBD1 TUBD 9606 Homo sapiens adduct target Correia JJ (1991) 1818332 176945 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8121 119352 51174 - TUBD1 TUBD 9606 Homo sapiens adduct target Islam MN (2004) 15579115 176944 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8122 119352 51174 - TUBD1 TUBD 9606 Homo sapiens adduct target Gupta S (2003) 14619954 176946 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8123 119352 51174 - TUBD1 TUBD 9606 Homo sapiens adduct target Jordan A (1998) 9664292 176943 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8124 119352 51174 - TUBD1 TUBD 9606 Homo sapiens adduct target Jordan MA (2007) 18220533 176942 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8130 119353 51175 RP1-142L7.1 TUBE1 TUBE|dJ142L7.2 9606 Homo sapiens adduct target Correia JJ (1991) 1818332 176945 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8131 119353 51175 RP1-142L7.1 TUBE1 TUBE|dJ142L7.2 9606 Homo sapiens adduct target Islam MN (2004) 15579115 176944 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8132 119353 51175 RP1-142L7.1 TUBE1 TUBE|dJ142L7.2 9606 Homo sapiens adduct target Gupta S (2003) 14619954 176946 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8133 119353 51175 RP1-142L7.1 TUBE1 TUBE|dJ142L7.2 9606 Homo sapiens adduct target Jordan A (1998) 9664292 176943 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8134 119353 51175 RP1-142L7.1 TUBE1 TUBE|dJ142L7.2 9606 Homo sapiens adduct target Jordan MA (2007) 18220533 176942 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 20823 119356 51179 RP5-871G17.1 HAO2 GIG16|HAOX2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 19982 119357 51181 - DCXR DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2713 Dihydrogenphosphate Ion - - DRUGBANK DB02831 H2O4P small molecule - 29505-79-1 DRUGBANK 19983 119357 51181 - DCXR DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2713 Dihydrogenphosphate Ion - - DRUGBANK DB02831 H2O4P small molecule - 29505-79-1 DRUGBANK 21325 119357 51181 - DCXR DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21326 119357 51181 - DCXR DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21327 119357 51181 - DCXR DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 27650 119357 51181 - DCXR DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 7366 119360 51185 AD-006 CRBN MRT2|MRT2A 9606 Homo sapiens inhibitor target Zhu YX (2013) 22966948 176371 472 Lenalidomide 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501 revlimid DRUGBANK DB00480 C13H13N3O3 small molecule L04AX04 191732-72-6 DRUGBANK 13097 119360 51185 AD-006 CRBN MRT2|MRT2A 9606 Homo sapiens inhibitor target Zhu YX (2013) 22966948 176371 1030 Thalidomide alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide thalomid DRUGBANK DB01041 C13H10N2O4 small molecule L04AX02 50-35-1 DRUGBANK 26985 119360 51185 AD-006 CRBN MRT2|MRT2A 9606 Homo sapiens inhibitor target McCurdy AR (2013) 23730498 182252 7654 Pomalidomide - pomalyst DRUGBANK DB08910 C13H11N3O4 small molecule L04AX06 19171-19-8 DRUGBANK 26986 119360 51185 AD-006 CRBN MRT2|MRT2A 9606 Homo sapiens inhibitor target Lopez-Girona A (2012) 22552008 150660 7654 Pomalidomide - pomalyst DRUGBANK DB08910 C13H11N3O4 small molecule L04AX06 19171-19-8 DRUGBANK 26987 119360 51185 AD-006 CRBN MRT2|MRT2A 9606 Homo sapiens inhibitor target Ito T (2010) 20223979 126437 7654 Pomalidomide - pomalyst DRUGBANK DB08910 C13H11N3O4 small molecule L04AX06 19171-19-8 DRUGBANK 26483 119362 51187 My024 RSL24D1 C15orf15|HRP-L30-iso|L30|RLP24|RPL24|RPL24L|TVAS3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25382 119362 51187 My024 RSL24D1 C15orf15|HRP-L30-iso|L30|RLP24|RPL24|RPL24L|TVAS3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19329 119362 51187 My024 RSL24D1 C15orf15|HRP-L30-iso|L30|RLP24|RPL24|RPL24L|TVAS3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 20752 119392 51228 - GLTP - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3071 Sphingosine - - DRUGBANK DB03203 C18H37NO2 small molecule - 123-78-4 DRUGBANK 20753 119392 51228 - GLTP - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3071 Sphingosine - - DRUGBANK DB03203 C18H37NO2 small molecule - 123-78-4 DRUGBANK 20754 119392 51228 - GLTP - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3071 Sphingosine - - DRUGBANK DB03203 C18H37NO2 small molecule - 123-78-4 DRUGBANK 23510 119392 51228 - GLTP - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 23511 119392 51228 - GLTP - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 27655 119392 51228 - GLTP - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 21572 119392 51228 - GLTP - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3448 Decanoic Acid Capric acid - DRUGBANK DB03600 C10H20O2 small molecule - 334-48-5 DRUGBANK 22839 119392 51228 - GLTP - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4052 Oleic Acid - sha-lem DRUGBANK DB04224 C18H34O2 small molecule - 112-80-1 DRUGBANK 22840 119392 51228 - GLTP - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4052 Oleic Acid - sha-lem DRUGBANK DB04224 C18H34O2 small molecule - 112-80-1 DRUGBANK 2793 119422 51268 - PIPOX LPIPOX 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2794 119422 51268 - PIPOX LPIPOX 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 9857 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens agonist target Gibson SJ (2002) 12470615 178055 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9858 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens agonist target Akira S (2003) 12527213 178057 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9859 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens agonist target Ambach A (2004) 15072849 178056 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9860 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens agonist target Dummer R (2003) 14616353 178052 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9861 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens agonist target Chen X (2002) 11752352 171740 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9862 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens agonist target Otero M (2004) 15068862 178058 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 24029 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens unknown target Horsmans Y (2005) 16116638 181905 4660 Isatoribine 7-Thia-8-oxoguanosine|7-TOG|7-Deaza-7-thia-8-oxoguanosine - DRUGBANK DB04860 C10H12N4O6S small molecule - 122970-40-5 DRUGBANK 17325 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 1549 Hydroxychloroquine 7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin pms-hydroxychloroquine|apo-hyd DRUGBANK DB01611 C18H26ClN3O small molecule P01BA02 118-42-3 DRUGBANK 17326 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens antagonist target Trevani AS (2003) 14579285 177266 1549 Hydroxychloroquine 7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin pms-hydroxychloroquine|apo-hyd DRUGBANK DB01611 C18H26ClN3O small molecule P01BA02 118-42-3 DRUGBANK 17327 119436 51284 UNQ248/PRO285 TLR7 TLR7-like 9606 Homo sapiens antagonist target Sun S (2007) 18220957 181586 1549 Hydroxychloroquine 7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin pms-hydroxychloroquine|apo-hyd DRUGBANK DB01611 C18H26ClN3O small molecule P01BA02 118-42-3 DRUGBANK 8052 119456 51305 - KCNK9 K2p9.1|KT3.2|TASK-3|TASK3 9606 Homo sapiens inhibitor target Anderson-Beck R (1995) 7617294 176878 551 Doxapram Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram dopram|dopram inj 20mg/ml|dopr DRUGBANK DB00561 C24H30N2O2 small molecule R07AB01 309-29-5 DRUGBANK 8053 119456 51305 - KCNK9 K2p9.1|KT3.2|TASK-3|TASK3 9606 Homo sapiens inhibitor target Yost CS (2007) 17227289 176877 551 Doxapram Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram dopram|dopram inj 20mg/ml|dopr DRUGBANK DB00561 C24H30N2O2 small molecule R07AB01 309-29-5 DRUGBANK 8054 119456 51305 - KCNK9 K2p9.1|KT3.2|TASK-3|TASK3 9606 Homo sapiens inhibitor target Peers C (1991) 1667613 176876 551 Doxapram Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram dopram|dopram inj 20mg/ml|dopr DRUGBANK DB00561 C24H30N2O2 small molecule R07AB01 309-29-5 DRUGBANK 14354 119456 51305 - KCNK9 K2p9.1|KT3.2|TASK-3|TASK3 9606 Homo sapiens binder target Lazarenko RM (2010) 20519544 180418 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14355 119456 51305 - KCNK9 K2p9.1|KT3.2|TASK-3|TASK3 9606 Homo sapiens binder target Pandit JJ (2010) 20217349 180419 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 9854 119462 51311 UNQ249/PRO286 TLR8 CD288 9606 Homo sapiens agonist target Gorden KB (2005) 15661881 178054 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9855 119462 51311 UNQ249/PRO286 TLR8 CD288 9606 Homo sapiens agonist target Zhu J (2008) 18439678 178053 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 9856 119462 51311 UNQ249/PRO286 TLR8 CD288 9606 Homo sapiens agonist target Dummer R (2003) 14616353 178052 714 Imiquimod R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine aldara p|apo-imiquimod|vyloma| DRUGBANK DB00724 C14H16N4 small molecule D06BB10 99011-02-6 DRUGBANK 1502 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1503 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1504 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens cofactor target Skoeldberg F (2004) 15070923 172526 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2898 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2899 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2900 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens unknown target Daniels KM (1982) 7131091 173555 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2901 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens unknown target Chan-Palay V (1982) 6953423 173557 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2902 119512 51380 - CSAD CSD|PCAP 9606 Homo sapiens unknown target Guion-Rain M-C (1975) 236774 173556 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 26385 119523 51399 CGI-104 TRAPPC4 HSPC172|PTD009|SBDN|SYNBINDIN|TRS23 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7128 S-PALMITOYL-L-CYSTEINE - - DRUGBANK DB08342 C19H37NO3S small molecule - - DRUGBANK 12170 119531 51422 - PRKAG2 AAKG|AAKG2|CMH6|H91620p|WPWS 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12171 119531 51422 - PRKAG2 AAKG|AAKG2|CMH6|H91620p|WPWS 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 25455 119532 51426 - POLK DINB1|DINP|POLQ 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6248 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE - - DRUGBANK DB07435 C20H16O3 small molecule - - DRUGBANK 25656 119532 51426 - POLK DINB1|DINP|POLQ 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6458 1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE - - DRUGBANK DB07652 C12H15F2O6P small molecule - - DRUGBANK 26290 119532 51426 - POLK DINB1|DINP|POLQ 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7027 2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate) - - DRUGBANK DB08237 C21H22N5O7P small molecule - - DRUGBANK 2866 119549 51451 CGI-68 LCMT1 LCMT|PPMT1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2867 119549 51451 CGI-68 LCMT1 LCMT|PPMT1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 23587 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4328 2-Deoxy-Glucitol-6-Phosphate - - DRUGBANK DB04516 C6H15O8P small molecule - - DRUGBANK 23588 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4328 2-Deoxy-Glucitol-6-Phosphate - - DRUGBANK DB04516 C6H15O8P small molecule - - DRUGBANK 23589 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4328 2-Deoxy-Glucitol-6-Phosphate - - DRUGBANK DB04516 C6H15O8P small molecule - - DRUGBANK 17913 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1770 2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate - - DRUGBANK DB01840 C7H15O7P small molecule - - DRUGBANK 17914 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1770 2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate - - DRUGBANK DB01840 C7H15O7P small molecule - - DRUGBANK 17915 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1770 2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate - - DRUGBANK DB01840 C7H15O7P small molecule - - DRUGBANK 22483 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22484 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22485 119562 51477 - ISYNA1 INO1|INOS|IPS|IPS 1|IPS-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 3114 119563 51478 RP11-331H2.1 HSD17B7 PRAP|SDR37C1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3115 119563 51478 RP11-331H2.1 HSD17B7 PRAP|SDR37C1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 19887 119569 51493 HSPC117 RTCB C22orf28|DJ149A16.6|FAAP 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 2859 119584 51520 - LARS HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl 9606 Homo sapiens unknown target Ma JJ (2006) 17144674 173515 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2860 119584 51520 - LARS HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl 9606 Homo sapiens unknown target Vu MT (2007) 17407263 173517 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2861 119584 51520 - LARS HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl 9606 Homo sapiens unknown target Dohm JC (2006) 16955236 173516 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2862 119584 51520 - LARS HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl 9606 Homo sapiens unknown target Hsu JL (2006) 16774921 70697 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 2863 119584 51520 - LARS HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl 9606 Homo sapiens unknown target Karkhanis VA (2006) 16956879 173518 143 L-Leucine (2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid freamine iii|primene 10%|2.5% DRUGBANK DB00149 C6H13NO2 small molecule - 61-90-5 DRUGBANK 1530 119599 51540 - SCLY SCL|hSCL 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1531 119599 51540 - SCLY SCL|hSCL 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1450 119599 51540 - SCLY SCL|hSCL 9606 Homo sapiens cofactor target Heidenreich T (2005) 15561708 87295 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1532 119599 51540 - SCLY SCL|hSCL 9606 Homo sapiens cofactor target Berman HM (2000) 10592235 172122 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2411 119608 51557 - LGSN GLULD1|LGS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2412 119608 51557 - LGSN GLULD1|LGS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 27864 119613 51564 - HDAC7 HD7A|HDAC7A 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27696 119613 51564 - HDAC7 HD7A|HDAC7A 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 23017 119613 51564 - HDAC7 HD7A|HDAC7A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4124 7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide - - DRUGBANK DB04297 C17H22N2O3 small molecule - - DRUGBANK 3604 119630 51601 - LIPT1 - 9606 Homo sapiens unknown target Gueguen V (1999) 10473591 173944 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3605 119630 51601 - LIPT1 - 9606 Homo sapiens unknown target Macherel D (1996) 8617275 173945 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3606 119630 51601 - LIPT1 - 9606 Homo sapiens unknown target Fujiwara K (2007) 17570395 173942 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3607 119630 51601 - LIPT1 - 9606 Homo sapiens unknown target Guenther S (2005) 16246025 173936 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 3608 119630 51601 - LIPT1 - 9606 Homo sapiens unknown target Fujiwara K (2005) 16043486 173943 159 Lipoic Acid Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid strovite one caplets DRUGBANK DB00166 C8H14O2S2 small molecule A16AX01 62-46-4 DRUGBANK 17717 119637 51611 AD-018 DPH5 CGI-30|HSPC143|NPD015 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 2077 119677 51686 RP11-98D18.13-004 OAZ3 AZ3|OAZ-t|TISP15 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2078 119677 51686 RP11-98D18.13-004 OAZ3 AZ3|OAZ-t|TISP15 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2963 119686 51702 hCG_25124 PADI3 PAD3|PDI3 9606 Homo sapiens unknown target Iida A (2004) 15150696 173605 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2964 119686 51702 hCG_25124 PADI3 PAD3|PDI3 9606 Homo sapiens unknown target Kanno T (2000) 11069618 173606 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2965 119686 51702 hCG_25124 PADI3 PAD3|PDI3 9606 Homo sapiens unknown target Dong S (2006) 16671893 108543 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 20617 119690 51706 UNQ3049/PRO9865 CYB5R1 B5R.1|B5R1|B5R2|NQO3A2|humb5R2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 27550 119695 51716 - CES1P1 CES1A2|CES1A3|CES4|CESR|PCE-3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7389 1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE - - DRUGBANK DB08612 C11H19F3OS small molecule - - DRUGBANK 21140 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 21141 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 21142 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 21677 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3511 P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate - - DRUGBANK DB03664 C19H28N7O24P5 small molecule - - DRUGBANK 21678 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3511 P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate - - DRUGBANK DB03664 C19H28N7O24P5 small molecule - - DRUGBANK 21679 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3511 P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate - - DRUGBANK DB03664 C19H28N7O24P5 small molecule - - DRUGBANK 21206 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21207 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21208 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 6974 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens inhibitor target Maring JG (2005) 16041392 176089 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6975 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens inhibitor target Lam W (2007) 17565005 176092 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6976 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens inhibitor target Vernejoul F (2006) 17000136 176091 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 6977 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens inhibitor target Hsu CH (2005) 15550676 176090 433 Gemcitabine Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine gemcitabine hydrochloride|gemc DRUGBANK DB00441 C9H11F2N3O4 small molecule L01BC05 95058-81-4 DRUGBANK 23401 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23402 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23403 119700 51727 RP11-511I2.1 CMPK1 CK|CMK|CMPK|UMK|UMP-CMPK|UMPK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 18495 119719 51762 - RAB8B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2002 Phosphoaminophosphonic Acid Guanylate Ester - - DRUGBANK DB02082 C10H17N6O13P3 small molecule - - DRUGBANK 18496 119719 51762 - RAB8B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2002 Phosphoaminophosphonic Acid Guanylate Ester - - DRUGBANK DB02082 C10H17N6O13P3 small molecule - - DRUGBANK 18497 119719 51762 - RAB8B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2002 Phosphoaminophosphonic Acid Guanylate Ester - - DRUGBANK DB02082 C10H17N6O13P3 small molecule - - DRUGBANK 23064 119719 51762 - RAB8B - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23065 119719 51762 - RAB8B - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23066 119719 51762 - RAB8B - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 25879 119722 51765 RP6-213H19.1 STK26 MASK|MST4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6650 [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE - - DRUGBANK DB07853 C22H19N7 small molecule - - DRUGBANK 20296 119733 51807 - TUBA8 TUBAL2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20297 119733 51807 - TUBA8 TUBAL2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 17992 119733 51807 - TUBA8 TUBAL2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17993 119733 51807 - TUBA8 TUBAL2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 23191 119744 53343 PSEC0099 NUDT9 NUDT10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4176 [(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate - - DRUGBANK DB04352 C5H11O8P small molecule - - DRUGBANK 23192 119744 53343 PSEC0099 NUDT9 NUDT10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4176 [(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate - - DRUGBANK DB04352 C5H11O8P small molecule - - DRUGBANK 19081 119744 53343 PSEC0099 NUDT9 NUDT10 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19082 119744 53343 PSEC0099 NUDT9 NUDT10 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 12162 119791 53632 - PRKAG3 AMPKG3 9606 Homo sapiens activator target Din FV (2012) 22406476 179247 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 12163 119791 53632 - PRKAG3 AMPKG3 9606 Homo sapiens activator target Hawley SA (2012) 22517326 179246 935 Acetylsalicylic acid 2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin medique medi seltzer|asatab 80 DRUGBANK DB00945 C9H8O4 small molecule N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01 50-78-2 DRUGBANK 26933 119793 53637 - S1PR5 EDG8|Edg-8|S1P5|SPPR-1|SPPR-2 9606 Homo sapiens modulator target Zu Heringdorf DM (2013) 23579459 182245 7612 Fingolimod Fingolimodum gilenya DRUGBANK DB08868 C19H33NO2 small molecule L04AA27 162359-55-9 DRUGBANK 26934 119793 53637 - S1PR5 EDG8|Edg-8|S1P5|SPPR-1|SPPR-2 9606 Homo sapiens modulator target Bhabak KP (2013) 23579456 182244 7612 Fingolimod Fingolimodum gilenya DRUGBANK DB08868 C19H33NO2 small molecule L04AA27 162359-55-9 DRUGBANK 26361 119824 53944 - CSNK1G1 CK1gamma1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7111 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE - - DRUGBANK DB08325 C16H19ClN6O small molecule - - DRUGBANK 8582 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens unknown target Huang LY (2005) 16148144 177269 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8583 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens unknown target Rutz M (2004) 15307186 177268 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8584 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens unknown target Lenert P (2005) 15762869 177267 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8585 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens unknown target Trevani AS (2003) 14579285 177266 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 8586 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens unknown target Merrell MA (2006) 16849519 177265 598 Chloroquine Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina aralen|chloroquine|teva-chloro DRUGBANK DB00608 C18H26ClN3 small molecule P01BA01 54-05-7 DRUGBANK 17328 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens antagonist target Trevani AS (2003) 14579285 177266 1549 Hydroxychloroquine 7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin pms-hydroxychloroquine|apo-hyd DRUGBANK DB01611 C18H26ClN3O small molecule P01BA02 118-42-3 DRUGBANK 17329 119902 54106 UNQ5798/PRO19605 TLR9 CD289 9606 Homo sapiens antagonist target Sun S (2007) 18220957 181586 1549 Hydroxychloroquine 7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin pms-hydroxychloroquine|apo-hyd DRUGBANK DB01611 C18H26ClN3O small molecule P01BA02 118-42-3 DRUGBANK 4676 119903 54107 - POLE3 CHARAC17|CHRAC17|YBL1|p17 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 22323 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3811 N-Trimethyllysine - - DRUGBANK DB03977 C9H21N2O2 small molecule - - DRUGBANK 22324 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3811 N-Trimethyllysine - - DRUGBANK DB03977 C9H21N2O2 small molecule - - DRUGBANK 22325 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3811 N-Trimethyllysine - - DRUGBANK DB03977 C9H21N2O2 small molecule - - DRUGBANK 22891 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4076 Zinc Substituted Heme C - - DRUGBANK DB04249 C34H34N4O4Zn small molecule - - DRUGBANK 22892 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4076 Zinc Substituted Heme C - - DRUGBANK DB04249 C34H34N4O4Zn small molecule - - DRUGBANK 22893 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4076 Zinc Substituted Heme C - - DRUGBANK DB04249 C34H34N4O4Zn small molecule - - DRUGBANK 22211 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3770 Protoporphyrin Ix Containing Zn - - DRUGBANK DB03934 C34H32N4O4Zn small molecule - - DRUGBANK 22212 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3770 Protoporphyrin Ix Containing Zn - - DRUGBANK DB03934 C34H32N4O4Zn small molecule - - DRUGBANK 22213 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3770 Protoporphyrin Ix Containing Zn - - DRUGBANK DB03934 C34H32N4O4Zn small molecule - - DRUGBANK 20963 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3182 Heme C - - DRUGBANK DB03317 C34H34FeN4O4 small molecule - - DRUGBANK 20964 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3182 Heme C - - DRUGBANK DB03317 C34H34FeN4O4 small molecule - - DRUGBANK 20965 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3182 Heme C - - DRUGBANK DB03317 C34H34FeN4O4 small molecule - - DRUGBANK 18554 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2030 Protoporphyrin Ix Containing Co - - DRUGBANK DB02110 C34H32CoN4O4 small molecule - - DRUGBANK 18555 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2030 Protoporphyrin Ix Containing Co - - DRUGBANK DB02110 C34H32CoN4O4 small molecule - - DRUGBANK 18556 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2030 Protoporphyrin Ix Containing Co - - DRUGBANK DB02110 C34H32CoN4O4 small molecule - - DRUGBANK 12814 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens negative modulator target Heo K (2006) 16469440 179715 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12815 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens negative modulator target Zhu S (2002) 11986668 179714 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12816 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens negative modulator target Chu HC (2005) 15665864 179716 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12817 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens negative modulator target Matsuki S (2003) 14680842 179713 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12818 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens negative modulator target Mansson R (2007) 17067803 179712 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 12819 119922 54205 - CYCS CYC|HCS|THC4 9606 Homo sapiens negative modulator target Kim HS (2009) 18977395 179697 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 17576 119926 54210 - TREM1 CD354|TREM-1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 17577 119926 54210 - TREM1 CD354|TREM-1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 14327 119933 54331 - GNG2 - 9606 Homo sapiens unknown target Milovic S (2004) 15175324 180409 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14328 119933 54331 - GNG2 - 9606 Homo sapiens unknown target Streiff J (2003) 12826849 180408 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14329 119933 54331 - GNG2 - 9606 Homo sapiens unknown target Ishizawa Y (2000) 10913255 180410 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14330 119933 54331 - GNG2 - 9606 Homo sapiens unknown target Yoshimura H (2003) 12657848 180411 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14331 119933 54331 - GNG2 - 9606 Homo sapiens unknown target Zang WJ (2000) 11961592 180407 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 20838 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20839 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20840 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 23231 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4196 4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole - - DRUGBANK DB04374 C14H25N3O2S small molecule - - DRUGBANK 18649 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2080 N-Sulfo-Flavin Mononucleotide - - DRUGBANK DB02164 C17H21N4O12PS small molecule - - DRUGBANK 18650 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2080 N-Sulfo-Flavin Mononucleotide - - DRUGBANK DB02164 C17H21N4O12PS small molecule - - DRUGBANK 18651 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2080 N-Sulfo-Flavin Mononucleotide - - DRUGBANK DB02164 C17H21N4O12PS small molecule - - DRUGBANK 20414 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2935 3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline - - DRUGBANK DB03064 C14H23NO3 small molecule - - DRUGBANK 24993 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5797 5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid - - DRUGBANK DB06979 C15H27N3O2S small molecule - - DRUGBANK 25065 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5878 3-(INDOL-3-YL) LACTATE - - DRUGBANK DB07060 C11H11NO3 small molecule - - DRUGBANK 25931 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6703 (2S)-2-HYDROXYOCTANOIC ACID - - DRUGBANK DB07907 C8H16O3 small molecule - - DRUGBANK 18867 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2188 Benzoylformic Acid - - DRUGBANK DB02279 C8H6O3 small molecule - 611-73-4 DRUGBANK 18868 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2188 Benzoylformic Acid - - DRUGBANK DB02279 C8H6O3 small molecule - 611-73-4 DRUGBANK 18869 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2188 Benzoylformic Acid - - DRUGBANK DB02279 C8H6O3 small molecule - 611-73-4 DRUGBANK 22115 119941 54363 - HAO1 GOX|GOX1|HAOX1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3721 3-Phenylpyruvic Acid - - DRUGBANK DB03884 C9H8O3 small molecule - - DRUGBANK 1960 119994 54498 RP4-779E11.4 SMOX C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO 9606 Homo sapiens ligand target Wang Y (2003) 12727196 172899 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1961 119994 54498 RP4-779E11.4 SMOX C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO 9606 Homo sapiens ligand target Binda C (2001) 11258887 172898 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1962 119994 54498 RP4-779E11.4 SMOX C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO 9606 Homo sapiens ligand target Vujcic S (2002) 12141946 172897 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1963 119994 54498 RP4-779E11.4 SMOX C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO 9606 Homo sapiens ligand target Bacchi CJ (2004) 15133083 172896 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1964 119994 54498 RP4-779E11.4 SMOX C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO 9606 Homo sapiens ligand target Vujcic S (2003) 12477380 172895 121 Spermine N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine - DRUGBANK DB00127 C10H26N4 small molecule - 71-44-3 DRUGBANK 1914 120060 54583 PNAS-118 EGLN1 C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1915 120060 54583 PNAS-118 EGLN1 C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 26693 120060 54583 PNAS-118 EGLN1 C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7461 N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE - - DRUGBANK DB08687 C12H9ClN2O4 small molecule - - DRUGBANK 25121 120060 54583 PNAS-118 EGLN1 C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5930 N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE - - DRUGBANK DB07112 C12H9IN2O4 small molecule - - DRUGBANK 23932 120073 54600 - UGT1A9 HLUGP4|LUGP4|UDPGT|UDPGT 1-9|UGT-1I|UGT1-09|UGT1-9|UGT1.9|UGT1AI|UGT1I 9606 Homo sapiens unknown target Uesawa Y (2007) 16897040 181957 4626 Phenolphthalein 3,3-Bis(p-hydroxyphenyl)phthalide|Alpha-di(p-hydroxyphenyl)phthalide|Fenolftaleina|Phenolphthaleinum|Fenolftalein|3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1(3H)-one|3,3-Bis(4-hydroxyphenyl)phthalide|Phenolphtaleine|Dihydroxyphthalophenone|3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone|Phenophthalein agarol eml strawberry|pilules DRUGBANK DB04824 C20H14O4 small molecule A06AB04 77-09-8 DRUGBANK 23682 120073 54600 - UGT1A9 HLUGP4|LUGP4|UDPGT|UDPGT 1-9|UGT-1I|UGT1-09|UGT1-9|UGT1.9|UGT1AI|UGT1I 9606 Homo sapiens unknown target Mano Y (2006) 16278927 181918 4362 Niflumic Acid Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico - DRUGBANK DB04552 C13H9F3N2O2 small molecule M02AA17|M01AX02 4394-00-7 DRUGBANK 8250 120098 54677 - CROT COT 9606 Homo sapiens unknown target Cordente AG (2004) 15155769 177040 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 8251 120098 54677 - CROT COT 9606 Homo sapiens unknown target Cordente AG (2006) 16681386 177039 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 22042 120098 54677 - CROT COT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3670 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium - - DRUGBANK DB03832 C15H30NO4 small molecule - - DRUGBANK 22043 120098 54677 - CROT COT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3670 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium - - DRUGBANK DB03832 C15H30NO4 small molecule - - DRUGBANK 22044 120098 54677 - CROT COT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3670 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium - - DRUGBANK DB03832 C15H30NO4 small molecule - - DRUGBANK 19623 120098 54677 - CROT COT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2539 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium - - DRUGBANK DB02648 C7H16NO3 small molecule - 461-06-3 DRUGBANK 19624 120098 54677 - CROT COT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2539 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium - - DRUGBANK DB02648 C7H16NO3 small molecule - 461-06-3 DRUGBANK 19625 120098 54677 - CROT COT 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2539 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium - - DRUGBANK DB02648 C7H16NO3 small molecule - 461-06-3 DRUGBANK 1943 120100 54681 - P4HTM EGLN4|HIFPH4|P4H-TM|PH-4|PH4|PHD4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1944 120100 54681 - P4HTM EGLN4|HIFPH4|P4H-TM|PH-4|PH4|PHD4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 23437 120177 54822 - TRPM7 ALSPDC|CHAK|CHAK1|LTRPC7|LTrpC-7|TRP-PLIK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23298 120177 54822 - TRPM7 ALSPDC|CHAK|CHAK1|LTRPC7|LTrpC-7|TRP-PLIK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 3538 120232 54884 UNQ439/PRO872 RETSAT - 9606 Homo sapiens unknown target Moise AR (2007) 17253779 173891 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 22815 120275 54935 RP11-190A12.1 DUSP23 DUSP25|LDP-3|MOSP|VHZ 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4042 4-Nitrophenyl Phosphate - - DRUGBANK DB04214 C6H6NO6P small molecule - 330-13-2 DRUGBANK 21171 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21172 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21173 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 17463 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 17464 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 17465 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1569 Alpha-Phosphoribosylpyrophosphoric Acid 5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate - DRUGBANK DB01632 C5H13O14P3 small molecule - 13270-65-0 DRUGBANK 22633 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22634 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22635 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 21711 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21712 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21713 120301 54963 RP4-591C20.1 UCKL1 UCK1L|URKL1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 1572 120363 55034 - MOCOS HMCS|MCS|MOS 9606 Homo sapiens cofactor target Mendel RR (2006) 16784786 172565 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1573 120363 55034 - MOCOS HMCS|MCS|MOS 9606 Homo sapiens cofactor target Anantharaman V (2002) 11886751 172564 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1574 120363 55034 - MOCOS HMCS|MCS|MOS 9606 Homo sapiens cofactor target Heidenreich T (2005) 15561708 87295 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1575 120363 55034 - MOCOS HMCS|MCS|MOS 9606 Homo sapiens cofactor target Bittner F (2001) 11553608 87807 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 24187 120417 55107 - ANO1 DOG1|ORAOV2|TAOS2|TMEM16A 9606 Homo sapiens antagonist target Tradtrantip L (2010) 19808995 182129 4736 Crofelemer SP-303|Provir fulyzaq DRUGBANK DB04941 - small molecule - 148465-45-6 DRUGBANK 2032 120459 55157 RP3-383J4.2 DARS2 ASPRS|LBSL|MT-ASPRS 9606 Homo sapiens unknown target Eiler S (1999) 10562565 172941 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2033 120459 55157 RP3-383J4.2 DARS2 ASPRS|LBSL|MT-ASPRS 9606 Homo sapiens unknown target Cavarelli J (1994) 8313877 37601 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2034 120459 55157 RP3-383J4.2 DARS2 ASPRS|LBSL|MT-ASPRS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2035 120459 55157 RP3-383J4.2 DARS2 ASPRS|LBSL|MT-ASPRS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2036 120459 55157 RP3-383J4.2 DARS2 ASPRS|LBSL|MT-ASPRS 9606 Homo sapiens unknown target Fender A (2006) 16597625 172942 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 20827 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20828 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20829 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 1427 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens cofactor target Gospe SM (2006) 16538088 172471 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1428 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens cofactor target Hwang IK (2005) 16207494 172484 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1429 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens cofactor target Mills PB (2005) 15772097 172485 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1430 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens cofactor target Hoffmann GF (2007) 17216302 172486 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1431 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens cofactor target Pearl PL (2006) 17032564 172487 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 21017 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 21018 120463 55163 - PNPO HEL-S-302|PDXPO 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 2490 120488 55191 - NADSYN1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2491 120488 55191 - NADSYN1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 1939 120510 55214 - P3H2 LEPREL1|MCVD|MLAT4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1940 120510 55214 - P3H2 LEPREL1|MCVD|MLAT4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2282 120510 55214 - P3H2 LEPREL1|MCVD|MLAT4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2283 120510 55214 - P3H2 LEPREL1|MCVD|MLAT4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3795 120510 55214 - P3H2 LEPREL1|MCVD|MLAT4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3796 120510 55214 - P3H2 LEPREL1|MCVD|MLAT4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 1945 120513 55217 - TMLHE AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1946 120513 55217 - TMLHE AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2291 120513 55217 - TMLHE AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2292 120513 55217 - TMLHE AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 1922 120532 55239 - OGFOD1 TPA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1923 120532 55239 - OGFOD1 TPA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 27067 120535 55244 - SLC47A1 MATE1 9606 Homo sapiens unknown target Wittwer MB (2013) 23241029 188472 192 Erythromycin Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|Erythromycinum|Abomacetin erythro-base tab 250mg usp|ery DRUGBANK DB00199 C37H67NO13 small molecule J01FA01|S01AA17|D10AF52|D10AF02 114-07-8 DRUGBANK 27639 120547 55256 HMFT1638 ADI1 APL1|ARD|Fe-ARD|MTCBP1|Ni-ARD|SIPL|mtnD 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 1558 120590 55304 RP5-1077I2.1 SPTLC3 C20orf38|LCB2B|LCB3|SPT3|SPTLC2L|dJ718P11|dJ718P11.1|hLCB2b 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1559 120590 55304 RP5-1077I2.1 SPTLC3 C20orf38|LCB2B|LCB3|SPT3|SPTLC2L|dJ718P11|dJ718P11.1|hLCB2b 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 20824 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20825 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20826 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 2300 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens ligand target Bertollo CM (2006) 16962092 173177 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2301 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens ligand target Werner R (2005) 16081269 173176 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2302 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens ligand target Hirano G (2011) 21308351 173175 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2303 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens ligand target Solovieva IM (2005) 15668000 173174 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2304 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens ligand target Sandoval FJ (2005) 16183635 173173 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2305 120594 55312 RP11-422N19.2 RFK RIFK 9606 Homo sapiens ligand target Ishchuk OP (2007) 17290783 72680 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2704 120692 55512 - SMPD3 NSMASE2 9606 Homo sapiens unknown target Krut O (2006) 16517606 173413 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2705 120692 55512 - SMPD3 NSMASE2 9606 Homo sapiens unknown target Marchesini N (2003) 12566438 59548 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 26876 120727 55576 - STAB2 FEEL2|FELE-2|FELL2|FEX2|HARE 9606 Homo sapiens binder target Harris EN (2008) 18434317 182073 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26877 120727 55576 - STAB2 FEEL2|FELE-2|FELL2|FEX2|HARE 9606 Homo sapiens binder target Politz O (2002) 11829752 181786 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26878 120727 55576 - STAB2 FEEL2|FELE-2|FELL2|FEX2|HARE 9606 Homo sapiens binder target Harris EN (2007) 17145755 181977 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 26879 120727 55576 - STAB2 FEEL2|FELE-2|FELL2|FEX2|HARE 9606 Homo sapiens binder target Zhou B (2003) 12626425 181812 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 2317 120728 55577 - NAGK GNK|HSA242910 9606 Homo sapiens unknown target Yang C (2006) 16857666 173191 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2318 120728 55577 - NAGK GNK|HSA242910 9606 Homo sapiens unknown target Weihofen WA (2006) 17010375 173190 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2321 120728 55577 - NAGK GNK|HSA242910 9606 Homo sapiens unknown target Nishimasu H (2007) 17229727 173193 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2319 120728 55577 - NAGK GNK|HSA242910 9606 Homo sapiens unknown target An HJ (2006) 16674097 173192 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 2320 120728 55577 - NAGK GNK|HSA242910 9606 Homo sapiens unknown target Uehara T (2004) 15489439 173189 135 N-Acetyl-D-glucosamine aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc - DRUGBANK DB00141 C8H15NO6 small molecule - 7512-17-6 DRUGBANK 3956 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3957 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3958 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3959 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 9280 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9281 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9282 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9283 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9284 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9285 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 27181 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27583 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 26893 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens inhibitor target Akk G (2003) 12824448 181823 7601 Tetraethylammonium TEA - DRUGBANK DB08837 C8H20N small molecule - 66-40-0 DRUGBANK 26894 120731 55584 - CHRNA9 HSA243342|NACHRA9 9606 Homo sapiens agonist target Akk G (2003) 12824448 181823 7601 Tetraethylammonium TEA - DRUGBANK DB08837 C8H20N small molecule - 66-40-0 DRUGBANK 2706 120766 55627 - SMPD4 NET13|NSMASE-3|NSMASE3 9606 Homo sapiens unknown target Krut O (2006) 16517606 173413 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 26313 120794 55662 - HIF1AN FIH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7052 N-(carboxycarbonyl)-D-phenylalanine - - DRUGBANK DB08263 C11H11NO5 small molecule - 856680-67-6 DRUGBANK 3623 120824 55699 - IARS2 ILERS 9606 Homo sapiens unknown target Fukunaga R (2006) 16697013 173960 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3624 120824 55699 - IARS2 ILERS 9606 Homo sapiens unknown target Zhu B (2007) 17095543 173521 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3625 120824 55699 - IARS2 ILERS 9606 Homo sapiens unknown target Fukunaga R (2005) 15663927 173961 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3626 120824 55699 - IARS2 ILERS 9606 Homo sapiens unknown target Wang P (2003) 12783542 173955 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 3627 120824 55699 - IARS2 ILERS 9606 Homo sapiens unknown target Fukunaga R (2004) 14672940 173954 160 L-Isoleucine Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine freamine iii|primene 10%|2.5% DRUGBANK DB00167 C6H13NO2 small molecule - 73-32-5 DRUGBANK 6287 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Miyashita Y (2010) 20097194 175689 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6288 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Ogihara T (2009) 19634509 175694 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6289 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Murakami M (2001) 11426839 175690 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6290 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Qu YL (1998) 10374627 175691 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6291 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 6292 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Furukawa T (1997) 9249249 175693 373 Amlodipine 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate amlodipine and benazepril hydr DRUGBANK DB00381 C20H25ClN2O5 small molecule C08CA01|C10BX09|C08GA02|C10BX07|C09XA53|C09BB03|C09DB01|C09BB07|C09BB04|C09BX01|C09DB02|C10BX03|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09DX03|C09XA54|C10BX11 88150-42-9 DRUGBANK 24758 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Miyashita Y (2010) 20097194 175689 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24759 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Ogihara T (2009) 19634509 175694 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24760 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Murakami M (2001) 11426839 175690 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24761 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Qu YL (1998) 10374627 175691 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24762 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Furukawa T (1999) 10525060 175692 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 24763 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens inhibitor target Furukawa T (1997) 9249249 175693 5594 Nilvadipine Nivadil - DRUGBANK DB06712 C19H19N3O6 small molecule C08CA10 75530-68-6 DRUGBANK 6764 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens unknown target Melander A (1977) 872489 175956 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 6765 120911 55799 - CACNA2D3 HSA272268 9606 Homo sapiens unknown target Sorrentino R (2000) 10942165 175955 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 11692 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Leppik IE (2004) 15511691 179038 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11693 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Kothare SV (2008) 18433351 179039 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11694 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Sobieszek G (2004) 14704463 179034 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11695 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Schulze-Bonhage A (2010) 20001433 179035 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11696 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Zaccara G (2009) 19557119 179036 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11697 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Janszky J (2009) 20025128 179037 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11698 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens inhibitor target Sonsalla PK (2010) 19948168 179031 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 5433 120912 55800 - SCN3B ATFB16|BRGDA7|HSA243396|SCNB3 9606 Homo sapiens unknown target Farber NB (2002) 12192617 175117 306 Valproic Acid 2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico dom-valproic acid syrup|divalp DRUGBANK DB00313 C8H16O2 small molecule N03AG01 99-66-1 DRUGBANK 26695 120958 55856 HT012 ACOT13 PNAS-27|THEM2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7462 undecan-2-one - - DRUGBANK DB08688 C11H22O small molecule - - DRUGBANK 27098 120967 55867 - SLC22A11 OAT4|hOAT4 9606 Homo sapiens unknown target Takeda M (2002) 11909604 176187 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 12985 120967 55867 - SLC22A11 OAT4|hOAT4 9606 Homo sapiens inhibitor target Hashimoto T (2004) 15377641 179798 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12984 120967 55867 - SLC22A11 OAT4|hOAT4 9606 Homo sapiens inhibitor target Enomoto A (2002) 12023506 179799 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12983 120967 55867 - SLC22A11 OAT4|hOAT4 9606 Homo sapiens inhibitor target Takeda M (2002) 12130730 175259 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 12986 120967 55867 - SLC22A11 OAT4|hOAT4 9606 Homo sapiens inhibitor target Babu E (2002) 12063169 173967 1021 Probenecid Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida probenecid|probenecid and colc DRUGBANK DB01032 C13H19NO4S small molecule M04AB01 57-66-9 DRUGBANK 27248 120967 55867 - SLC22A11 OAT4|hOAT4 9606 Homo sapiens unknown target Takeda M (2002) 11909604 176187 1200 Ceftriaxone (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum ceftriaxone|ceftriaxone sodium DRUGBANK DB01212 C18H18N8O7S3 small molecule J01DD04|J01DD54 73384-59-5 DRUGBANK 27860 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27692 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 26191 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6960 7-AMINO-4-METHYL-CHROMEN-2-ONE - - DRUGBANK DB08168 C10H9NO2 small molecule - - DRUGBANK 19471 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2461 4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide - - DRUGBANK DB02565 C16H25N3O3 small molecule - - DRUGBANK 19472 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2461 4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide - - DRUGBANK DB02565 C16H25N3O3 small molecule - - DRUGBANK 19473 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2461 4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide - - DRUGBANK DB02565 C16H25N3O3 small molecule - - DRUGBANK 25597 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6393 5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE - - DRUGBANK DB07586 C24H23N3O4 small molecule - - DRUGBANK 23014 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4124 7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide - - DRUGBANK DB04297 C17H22N2O3 small molecule - - DRUGBANK 23015 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4124 7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide - - DRUGBANK DB04297 C17H22N2O3 small molecule - - DRUGBANK 23016 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4124 7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide - - DRUGBANK DB04297 C17H22N2O3 small molecule - - DRUGBANK 20131 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2796 N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide - - DRUGBANK DB02917 C17H15N3O4S2 small molecule - - DRUGBANK 20132 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2796 N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide - - DRUGBANK DB02917 C17H15N3O4S2 small molecule - - DRUGBANK 20133 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2796 N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide - - DRUGBANK DB02917 C17H15N3O4S2 small molecule - - DRUGBANK 25359 120968 55869 CDA07 HDAC8 CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6166 (2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide - - DRUGBANK DB07350 C16H16N2O3 small molecule - - DRUGBANK 27937 120973 55879 - GABRQ THETA 9606 Homo sapiens antagonist target Carta M (2006) 16806306 195970 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27938 120973 55879 - GABRQ THETA 9606 Homo sapiens antagonist target Mascia MP (2007) 17234181 195976 8251 Thiocolchicoside Thiocolchicine 2-glucoside analog|TCC - DRUGBANK DB11582 C27H33NO10S small molecule M03BX05|M03BX55 602-41-5 DRUGBANK 27788 120973 55879 - GABRQ THETA 9606 Homo sapiens unknown target Davies M (2003) 12921221 195958 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27174 120973 55879 - GABRQ THETA 9606 Homo sapiens unknown target Santhakumar V (2007) 17591544 178935 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 6556 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Verster JC (2004) 14978513 175867 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 6557 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 396 Alprazolam Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax nu-alpraz tab 0.5mg|alprazolam DRUGBANK DB00404 C17H13ClN4 small molecule N05BA12 28981-97-7 DRUGBANK 4009 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 179 Lorazepam Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam pms-lorazepam tab 0.5mg|apo-lo DRUGBANK DB00186 C15H10Cl2N2O2 small molecule N05BA06|N05CD06|N05BA56 846-49-1 DRUGBANK 11497 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11498 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 4587 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Mehta AK (1999) 10209232 174569 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 4588 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Yamakura T (2001) 11264449 174568 230 Butabarbital Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital butisol sodium tab 30mg|butiso DRUGBANK DB00237 C10H16N2O3 small molecule - 125-40-6 DRUGBANK 11039 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11040 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 13409 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 13410 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1056 Clonazepam 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum pms-clonazepam tab 1.0mg|klono DRUGBANK DB01068 C15H10ClN3O3 small molecule N03AE01 1622-61-3 DRUGBANK 4051 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Smeyatsky N (1992) 1585214 174217 182 Ethchlorvynol 3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol placidyl cap 200mg|placidyl ca DRUGBANK DB00189 C7H9ClO small molecule N05CM08 113-18-8 DRUGBANK 10908 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10909 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 13158 120973 55879 - GABRQ THETA 9606 Homo sapiens agonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13159 120973 55879 - GABRQ THETA 9606 Homo sapiens agonist target Tvrdeic A (2003) 12955907 179898 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13160 120973 55879 - GABRQ THETA 9606 Homo sapiens agonist target Tvrdeic A (1991) 1664802 179897 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 5718 120973 55879 - GABRQ THETA 9606 Homo sapiens unknown target Bymaster FP (1996) 8822531 175320 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 5847 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 5848 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 341 Clobazam Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione onfi|clobazam-10|apo-clobazam DRUGBANK DB00349 C16H13ClN2O2 small molecule N05BA09 22316-47-8 DRUGBANK 14630 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 14631 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 1177 Desflurane (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether suprane DRUGBANK DB01189 C3H2F6O small molecule N01AB07 57041-67-5 DRUGBANK 8766 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Moehler H (2002) 11752090 174537 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 8767 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Riss J (2008) 18384456 174202 618 Clorazepate Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate novo-clopate cap 3.75mg|cloraz DRUGBANK DB00628 C16H11ClN2O3 small molecule - 23887-31-2 DRUGBANK 7268 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Skerritt JH (1983) 6135616 176313 467 Chlordiazepoxide Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum chlordiazepoxide hydrochloride DRUGBANK DB00475 C16H14ClN3O small molecule N05BA02 58-25-3 DRUGBANK 9472 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9473 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 16950 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 4542 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4543 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Giersch A (2010) 20138190 174534 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4453 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Grasshoff C (2006) 16973644 174521 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4454 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Greenblatt EP (2001) 11465594 174520 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 4455 120973 55879 - GABRQ THETA 9606 Homo sapiens positive allosteric modulator target Franks NP (2006) 16402123 174522 221 Enflurane Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether enflurane|ethrane liq inh|ethr DRUGBANK DB00228 C3H2ClF5O small molecule N01AB04 13838-16-9 DRUGBANK 17614 120973 55879 - GABRQ THETA 9606 Homo sapiens antagonist target Sousa A (1997) 9262347 181622 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 17274 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17275 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 7898 120973 55879 - GABRQ THETA 9606 Homo sapiens binder target Wei HB (1990) 1966571 176782 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 9073 120973 55879 - GABRQ THETA 9606 Homo sapiens positive modulator target Williams SH (2005) 16300039 177608 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9544 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9545 120973 55879 - GABRQ THETA 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 3708 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3709 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens unknown target Schuler AJ (2004) 14704009 174017 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3707 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens unknown target Starai VJ (2002) 12493915 174016 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3710 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 2134 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens product of target Reger AS (2007) 17497934 173058 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2135 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens product of target Linne U (2007) 17303131 173059 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2136 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens product of target Ingram-Smith C (2006) 16981708 69339 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2137 120989 55902 RP5-1161H23.2 ACSS2 ACAS2|ACECS|ACS|ACSA|dJ1161H23.1 9606 Homo sapiens product of target Ingram-Smith C (2007) 17350930 173057 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 19309 120993 55907 - CMAS CSS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2383 Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid - - DRUGBANK DB02485 C20H31N4O16P small molecule - - DRUGBANK 19310 120993 55907 - CMAS CSS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2383 Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid - - DRUGBANK DB02485 C20H31N4O16P small molecule - - DRUGBANK 19311 120993 55907 - CMAS CSS 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2383 Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid - - DRUGBANK DB02485 C20H31N4O16P small molecule - - DRUGBANK 3173 121013 55967 - NDUFA12 B17.2|DAP13 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3174 121013 55967 - NDUFA12 B17.2|DAP13 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 1568 121128 56267 RP11-82K18.3 CCBL2 KAT3|KATIII 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1569 121128 56267 RP11-82K18.3 CCBL2 KAT3|KATIII 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2514 121128 56267 RP11-82K18.3 CCBL2 KAT3|KATIII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2515 121128 56267 RP11-82K18.3 CCBL2 KAT3|KATIII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 23042 121129 56269 - IRGC CINEMA|IFGGE|IRGC1|Iigp5|R30953_1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 21999 121129 56269 - IRGC CINEMA|IFGGE|IRGC1|Iigp5|R30953_1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 24226 121149 56479 RP11-257K9.5 KCNQ5 Kv7.5 9606 Homo sapiens unknown target Hirano K (2007) 17184917 181979 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24227 121149 56479 RP11-257K9.5 KCNQ5 Kv7.5 9606 Homo sapiens unknown target Borlak J (2006) 16713428 181944 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 24228 121149 56479 RP11-257K9.5 KCNQ5 Kv7.5 9606 Homo sapiens unknown target Hermann R (2003) 12545144 181809 4747 Ezogabine Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate potiga DRUGBANK DB04953 C16H18FN3O2 small molecule N03AX21 150812-12-7 DRUGBANK 10464 121151 56547 - MMP26 - 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10465 121151 56547 - MMP26 - 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 18040 121155 56605 RP5-985L19.2 ERO1LB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1829 1-Ethyl-Pyrrolidine-2,5-Dione - - DRUGBANK DB01902 C6H9NO2 small molecule - - DRUGBANK 18041 121155 56605 RP5-985L19.2 ERO1LB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1829 1-Ethyl-Pyrrolidine-2,5-Dione - - DRUGBANK DB01902 C6H9NO2 small molecule - - DRUGBANK 18042 121155 56605 RP5-985L19.2 ERO1LB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1829 1-Ethyl-Pyrrolidine-2,5-Dione - - DRUGBANK DB01902 C6H9NO2 small molecule - - DRUGBANK 20598 121155 56605 RP5-985L19.2 ERO1LB - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20599 121155 56605 RP5-985L19.2 ERO1LB - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20600 121155 56605 RP5-985L19.2 ERO1LB - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 4675 121168 56655 - POLE4 YHHQ1|p12 9606 Homo sapiens inhibitor target Zhenchuk A (2009) 19576186 174592 235 Cladribine 2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine leustatin 1mg/ml|cladribine in DRUGBANK DB00242 C10H12ClN5O3 small molecule L01BB04 4291-63-8 DRUGBANK 2235 121179 56670 - SUCNR1 GPR91 9606 Homo sapiens unknown target Macaulay IC (2007) 17192395 173142 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3300 121231 56901 - NDUFA4L2 NUOMS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3301 121231 56901 - NDUFA4L2 NUOMS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 1799 121249 56922 - MCCC1 MCC-B|MCCA 9606 Homo sapiens unknown target Friebel D (2006) 16773504 172752 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 11680 121259 56934 hucep-15 CA10 CA-RPX|CARPX 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11681 121259 56934 hucep-15 CA10 CA-RPX|CARPX 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11682 121259 56934 hucep-15 CA10 CA-RPX|CARPX 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11683 121259 56934 hucep-15 CA10 CA-RPX|CARPX 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11684 121259 56934 hucep-15 CA10 CA-RPX|CARPX 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 18747 121277 56953 - NT5M dNT-2|dNT2|mdN 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2129 Dpb-T - - DRUGBANK DB02217 C17H19N2O8P small molecule - - DRUGBANK 18748 121277 56953 - NT5M dNT-2|dNT2|mdN 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2129 Dpb-T - - DRUGBANK DB02217 C17H19N2O8P small molecule - - DRUGBANK 18749 121277 56953 - NT5M dNT-2|dNT2|mdN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2129 Dpb-T - - DRUGBANK DB02217 C17H19N2O8P small molecule - - DRUGBANK 23807 121277 56953 - NT5M dNT-2|dNT2|mdN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4476 cyclic 3',5'-thymidine monophosphate D4T-MP|2',3'-dideoxy-2',3-didehydrothymidine 5'-monophosphate|3',5'-Cyclic dtmp|Cyclic tmp|2',3'-dehydro-2',3'-deoxy-thymidine 5'-monophosphate|cTMP|d4TMP - DRUGBANK DB04672 C10H13N2O7P small molecule - - DRUGBANK 19122 121325 57016 - AKR1B10 AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2288 Tolrestat - - DRUGBANK DB02383 C16H14F3NO3S small molecule A10XA01 82964-04-3 DRUGBANK 26772 121325 57016 - AKR1B10 AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7544 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID - - DRUGBANK DB08772 C19H12F3N3O3S small molecule - - DRUGBANK 21293 121325 57016 - AKR1B10 AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 1584 121330 57026 RP1-37E16.5 PDXP CIN|PLP|dJ37E16.5 9606 Homo sapiens cofactor target Hwang IK (2007) 17531224 172470 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1585 121330 57026 RP1-37E16.5 PDXP CIN|PLP|dJ37E16.5 9606 Homo sapiens cofactor target Kim DW (2005) 16336786 172572 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1586 121330 57026 RP1-37E16.5 PDXP CIN|PLP|dJ37E16.5 9606 Homo sapiens cofactor target Jang YM (2003) 14522954 172573 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1587 121330 57026 RP1-37E16.5 PDXP CIN|PLP|dJ37E16.5 9606 Homo sapiens cofactor target Tirrell IM (2006) 16336194 172574 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1588 121330 57026 RP1-37E16.5 PDXP CIN|PLP|dJ37E16.5 9606 Homo sapiens cofactor target McCarty MF (2000) 11000053 172575 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 14362 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14363 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 13662 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1078 Pentolinium Pentolonum|Pentolonium|Pentolineum - DRUGBANK DB01090 C15H32N2 small molecule - 144-44-5 DRUGBANK 13663 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1078 Pentolinium Pentolonum|Pentolonium|Pentolineum - DRUGBANK DB01090 C15H32N2 small molecule - 144-44-5 DRUGBANK 13664 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target McKay DB (1993) 8516349 180089 1078 Pentolinium Pentolonum|Pentolonium|Pentolineum - DRUGBANK DB01090 C15H32N2 small molecule - 144-44-5 DRUGBANK 13665 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Cachelin AB (1995) 7761270 180088 1078 Pentolinium Pentolonum|Pentolonium|Pentolineum - DRUGBANK DB01090 C15H32N2 small molecule - 144-44-5 DRUGBANK 4265 121345 57053 - CHRNA10 - 9606 Homo sapiens agonist target Jonsson M (2006) 16571968 174353 195 Succinylcholine Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine succinylcholine chloride injec DRUGBANK DB00202 C14H30N2O4 small molecule M03AB01 306-40-1 DRUGBANK 27186 121345 57053 - CHRNA10 - 9606 Homo sapiens unknown target Hendrickson LM (2013) 23641218 188488 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 27584 121345 57053 - CHRNA10 - 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 9298 121345 57053 - CHRNA10 - 9606 Homo sapiens allosteric modulator target Guillou C (2000) 20480924 177724 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9299 121345 57053 - CHRNA10 - 9606 Homo sapiens allosteric modulator target Scott LJ (2000) 11129124 177725 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9300 121345 57053 - CHRNA10 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2000) 10971048 177719 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9301 121345 57053 - CHRNA10 - 9606 Homo sapiens allosteric modulator target Woodruff-Pak DS (2002) 12481195 177718 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9302 121345 57053 - CHRNA10 - 9606 Homo sapiens allosteric modulator target Lilienfeld S (2002) 12177686 177716 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 9303 121345 57053 - CHRNA10 - 9606 Homo sapiens allosteric modulator target Olin J (2002) 12137632 177715 664 Galantamine Galanthamine|(-)-Galanthamine reminyl -(12mg)|pms-galantam DRUGBANK DB00674 C17H21NO3 small molecule N06DA04 357-70-0 DRUGBANK 13918 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1104 Trimethaphan Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum - DRUGBANK DB01116 C22H25N2OS small molecule C02BA01 7187-66-8 DRUGBANK 13919 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1104 Trimethaphan Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum - DRUGBANK DB01116 C22H25N2OS small molecule C02BA01 7187-66-8 DRUGBANK 13920 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Loiacono R (1993) 8232788 180230 1104 Trimethaphan Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum - DRUGBANK DB01116 C22H25N2OS small molecule C02BA01 7187-66-8 DRUGBANK 13921 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Kurenny DE (1994) 7963258 180231 1104 Trimethaphan Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum - DRUGBANK DB01116 C22H25N2OS small molecule C02BA01 7187-66-8 DRUGBANK 5630 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5631 121345 57053 - CHRNA10 - 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 3962 121345 57053 - CHRNA10 - 9606 Homo sapiens agonist target Zaniewska M (2010) 20081230 174183 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3963 121345 57053 - CHRNA10 - 9606 Homo sapiens agonist target Jackson KJ (2010) 20400469 174182 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3964 121345 57053 - CHRNA10 - 9606 Homo sapiens agonist target Narahashi T (2000) 11006350 174181 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 3965 121345 57053 - CHRNA10 - 9606 Homo sapiens agonist target Mansvelder HD (2009) 19560048 174180 177 Nicotine ()-nicotine|Nikotin|(R,S)-nicotine|(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine|(RS)-nicotine|(+-)-Nicotine|Nicotin up and up nicotine|nicoderm tr DRUGBANK DB00184 C10H14N2 small molecule N07BA01 54-11-5 DRUGBANK 9786 121371 57105 PSEC0146 CYSLTR2 CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21 9606 Homo sapiens antagonist target Yazid S (2010) 20558817 178002 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9787 121371 57105 PSEC0146 CYSLTR2 CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9788 121371 57105 PSEC0146 CYSLTR2 CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 9789 121371 57105 PSEC0146 CYSLTR2 CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21 9606 Homo sapiens antagonist target Monteseirin J (2005) 16164449 178004 706 Nedocromil 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil alocril|mireze|tilade inhaler DRUGBANK DB00716 C19H17NO7 small molecule S01GX04|R01AC07|R03BC03 69049-73-6 DRUGBANK 26511 121382 57118 RP11-462F15.1 CAMK1D CKLiK|CaM-K1|CaMKID 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7235 N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE - - DRUGBANK DB08454 C18H15N5 small molecule - - DRUGBANK 26035 121424 57172 RP1-272L16.2 CAMK1G CLICK3|CLICKIII|VWS1|dJ272L16.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6802 5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE - - DRUGBANK DB08009 C22H27ClN4O2 small molecule - - DRUGBANK 26785 121509 57407 - NMRAL1 HSCARG|SDR48A1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7556 2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID - - DRUGBANK DB08784 C12H9ClN2O2 small molecule - - DRUGBANK 11413 121538 57468 RP11-465L10.5 SLC12A5 KCC2 9606 Homo sapiens inhibitor target Reid KH (2000) 10793196 178891 877 Bumetanide 3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid burinex tab 5mg|bumetanide|bur DRUGBANK DB00887 C17H20N2O5S small molecule C03EB02|C03CA02|C03CB02 28395-03-1 DRUGBANK 10210 121538 57468 RP11-465L10.5 SLC12A5 KCC2 9606 Homo sapiens unknown target Tornberg J (2007) 16936706 178268 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10211 121538 57468 RP11-465L10.5 SLC12A5 KCC2 9606 Homo sapiens unknown target Takayama C (2007) 17134779 178269 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10212 121538 57468 RP11-465L10.5 SLC12A5 KCC2 9606 Homo sapiens unknown target Capo-Aponte JE (2007) 17418819 178266 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10213 121538 57468 RP11-465L10.5 SLC12A5 KCC2 9606 Homo sapiens unknown target Takayama C (2006) 17008020 178267 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 10214 121538 57468 RP11-465L10.5 SLC12A5 KCC2 9606 Homo sapiens unknown target Misri S (2006) 16949074 178264 751 Potassium Chloride Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix isolyte r in 5% dextrose|acid DRUGBANK DB00761 ClK small molecule B05XA01|A12BA51|A12BA01 7447-40-7 DRUGBANK 3459 121569 57505 RP11-444E17.1 AARS2 AARSL|COXPD8|LKENP|MT-ALARS|MTALARS 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3460 121569 57505 RP11-444E17.1 AARS2 AARSL|COXPD8|LKENP|MT-ALARS|MTALARS 9606 Homo sapiens unknown target McClain WH (1996) 8601277 173846 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3461 121569 57505 RP11-444E17.1 AARS2 AARSL|COXPD8|LKENP|MT-ALARS|MTALARS 9606 Homo sapiens unknown target Buechter DD (1995) 7742303 173845 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3462 121569 57505 RP11-444E17.1 AARS2 AARSL|COXPD8|LKENP|MT-ALARS|MTALARS 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3463 121569 57505 RP11-444E17.1 AARS2 AARSL|COXPD8|LKENP|MT-ALARS|MTALARS 9606 Homo sapiens unknown target Nagan MC (2000) 10871402 173847 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 26110 121642 57591 RP5-1042K10.11-009 MKL1 BSAC|MAL|MRTF-A 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6873 LATRUNCULIN B - - DRUGBANK DB08080 C20H29NO5S small molecule - - DRUGBANK 17950 121697 57664 - PLEKHA4 PEPP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 17951 121697 57664 - PLEKHA4 PEPP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1793 Inositol 1,3,4,5-Tetrakisphosphate - - DRUGBANK DB01863 C6H16O18P4 small molecule - - DRUGBANK 3535 121698 57665 UNQ529/PRO1072 RDH14 PAN2|SDR7C4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3536 121698 57665 UNQ529/PRO1072 RDH14 PAN2|SDR7C4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 25708 121747 57727 RP11-465L10.6 NCOA5 CIA|bA465L10.6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6506 (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL - - DRUGBANK DB07702 C18H24O3 small molecule - - DRUGBANK 27839 121782 57823 UNQ576/PRO1138 SLAMF7 19A|CD319|CRACC|CS1 9606 Homo sapiens modulator target Markham A (2016) 26809244 196038 8073 Elotuzumab Immunoglobulin G1, anti-(human protein CS1) (human-mouse HuLuc63 heavy chain), disulfide with human-mouse HuLuc63 kappa-chain, dimer|HuLuc63|Immunoglobulin G1, anti-(human SLAM family member 7 (CD2-like receptor activating cytotoxic cells, CD319 antigen)), humanized mouse monoclonal HuLuc63 gamma-1 heavy chain (222-214')-disulfide with humanized mouse monoclonal HuLuc63 kappa light chain (228-228'';231-231'')-bisdisulfide dimer empliciti DRUGBANK DB06317 C6476H9982N1714O2016S42 biologic - 915296-00-3 DRUGBANK 22737 121804 58190 - CTDSP1 NIF3|NLI-IF|NLIIF|SCP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 22738 121804 58190 - CTDSP1 NIF3|NLI-IF|NLIIF|SCP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 22739 121804 58190 - CTDSP1 NIF3|NLI-IF|NLIIF|SCP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 22944 121804 58190 - CTDSP1 NIF3|NLI-IF|NLIIF|SCP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22945 121804 58190 - CTDSP1 NIF3|NLI-IF|NLIIF|SCP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22946 121804 58190 - CTDSP1 NIF3|NLI-IF|NLIIF|SCP1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 25935 121811 58478 MSTP145 ENOPH1 E1|MASA|MST145|mtnC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6708 2-OXOHEPTYLPHOSPHONIC ACID - - DRUGBANK DB07912 C7H15O4P small molecule - - DRUGBANK 26384 121815 58485 - TRAPPC1 BET5|MUM2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7128 S-PALMITOYL-L-CYSTEINE - - DRUGBANK DB08342 C19H37NO3S small molecule - - DRUGBANK 18902 121818 58488 - PCTP PC-TP|STARD2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2213 Palmitoyl-Linoleoyl Phosphatidylcholine - - DRUGBANK DB02306 C42H80NO8P small molecule - - DRUGBANK 18903 121818 58488 - PCTP PC-TP|STARD2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2213 Palmitoyl-Linoleoyl Phosphatidylcholine - - DRUGBANK DB02306 C42H80NO8P small molecule - - DRUGBANK 23229 121818 58488 - PCTP PC-TP|STARD2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4194 Di-Linoleoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04372 C44H80NO8P small molecule - - DRUGBANK 23230 121818 58488 - PCTP PC-TP|STARD2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4194 Di-Linoleoyl-3-Sn-Phosphatidylcholine - - DRUGBANK DB04372 C44H80NO8P small molecule - - DRUGBANK 9556 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Chrysant SG (2004) 15286086 177842 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9557 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Edling O (1995) 7473177 177841 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9558 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9559 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 681 Moexipril Moexiprilum|Univasc|Moexipril|Uniretic univasc|moexipril hydrochlorid DRUGBANK DB00691 C27H34N2O7 small molecule C09AA13|C09BA13 103775-10-6 DRUGBANK 9839 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Piepho RW (2000) 11030016 174112 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9840 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Song JC (2002) 11929321 174114 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9841 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 9842 121864 59272 UNQ868/PRO1885 ACE2 ACEH 9606 Homo sapiens inhibitor target Parish RC (1992) 1536695 178041 712 Lisinopril Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril ava-lisinopril hct|apo-lisinop DRUGBANK DB00722 C21H31N3O5 small molecule C09AA03|C09BA03|C09BB03|C10BX07 83915-83-7 DRUGBANK 7360 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens binder target Nguyen T (2001) 11179435 175198 469 Chlorpromazine Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine chlorpromanyl 20 syr|chlorprom DRUGBANK DB00477 C17H19ClN2S small molecule N05AA01 50-53-3 DRUGBANK 5561 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens binder target Nguyen T (2001) 11179435 175198 314 Amitriptyline 3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene amitriptyline hydrochloride|ip DRUGBANK DB00321 C20H23N small molecule N06AA09|N06CA01 50-48-6 DRUGBANK 9180 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens agonist target Yu B (2010) 20618322 177670 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9181 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens agonist target Cowden JM (2010) 20573261 177671 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 9182 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens agonist target Blaya B (2010) 20632959 177669 657 Histamine Phosphate 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate histamine positive skin test c DRUGBANK DB00667 C5H15N3O8P2 small molecule V04CG03 51-74-1 DRUGBANK 6007 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens antagonist target Smits RA (2006) 16854056 175522 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6008 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6009 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens antagonist target Sugata Y (2007) 17346280 94071 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 6010 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens antagonist target Adachi N (2006) 16860312 175521 355 Clozapine Clozapine|Clozapina|Clozapin|Clozapinum sandoz clozapine|auro-clozapin DRUGBANK DB00363 C18H19ClN4 small molecule N05AH02 5786-21-0 DRUGBANK 7914 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens binder target Lim HD (2005) 15947036 176785 533 Amoxapine 2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum asendin tab 25mg|asendin - tab DRUGBANK DB00543 C17H16ClN3O small molecule N06AA17 14028-44-5 DRUGBANK 5735 121882 59340 - HRH4 AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R 9606 Homo sapiens antagonist target Shahid M (2009) 18308814 175311 326 Olanzapine Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina olanzapine and fluoxetine|sand DRUGBANK DB00334 C17H20N4S small molecule N05AH03 132539-06-1 DRUGBANK 25528 121884 59342 MSTP034 SCPEP1 HSCP1|RISC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6317 L-BENZYLSUCCINIC ACID - - DRUGBANK DB07506 C11H12O4 small molecule - - DRUGBANK 21829 121921 60490 MDS018 PPCDC PPC-DC|coaC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3581 Pantothenoylaminoethenethiol - - DRUGBANK DB03738 C11H20N2O4S small molecule - - DRUGBANK 21830 121921 60490 MDS018 PPCDC PPC-DC|coaC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3581 Pantothenoylaminoethenethiol - - DRUGBANK DB03738 C11H20N2O4S small molecule - - DRUGBANK 21831 121921 60490 MDS018 PPCDC PPC-DC|coaC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3581 Pantothenoylaminoethenethiol - - DRUGBANK DB03738 C11H20N2O4S small molecule - - DRUGBANK 20830 121921 60490 MDS018 PPCDC PPC-DC|coaC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 24927 121962 63036 - CELA2A ELA2A|PE-1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5720 2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL - - DRUGBANK DB06901 C10H16O2 small molecule - - DRUGBANK 1517 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens cofactor target Strisovsky K (2005) 16185077 172541 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1518 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens cofactor target Schell MJ (2004) 15306409 172537 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1519 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens cofactor target Strisovsky K (2003) 12560076 172538 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1520 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens cofactor target Hashimoto A (2005) 16289454 172539 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1521 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens cofactor target Uo T (2002) 12596860 172540 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 2161 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens unknown target Fujitani Y (2007) 17499824 77309 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2162 121963 63826 - SRR ILV1|ISO1 9606 Homo sapiens unknown target Ying-Luan Z (2007) 17663143 173072 127 L-Serine L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine freamine iii|primene 10%|2.75% DRUGBANK DB00133 C3H7NO3 small molecule - 56-45-1 DRUGBANK 2233 122037 64064 FKSG25 OXCT2 SCOTT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2234 122037 64064 FKSG25 OXCT2 SCOTT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 10458 122039 64066 UNQ2503/PRO5992 MMP27 MMP-27 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10459 122039 64066 UNQ2503/PRO5992 MMP27 MMP-27 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 1818 122050 64087 - MCCC2 MCCB 9606 Homo sapiens unknown target Luedke A (2007) 17254330 172764 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1819 122050 64087 - MCCC2 MCCB 9606 Homo sapiens unknown target de Queiroz MS (2007) 17266990 172763 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1820 122050 64087 - MCCC2 MCCB 9606 Homo sapiens unknown target Jitrapakdee S (2007) 17659996 73562 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 1821 122050 64087 - MCCC2 MCCB 9606 Homo sapiens unknown target Santoro N (2006) 16707089 172748 116 Biotin Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina balanced b 125 srt|nata komple DRUGBANK DB00121 C10H16N2O3S small molecule A11HA05 58-85-5 DRUGBANK 22240 122060 64100 - ELSPBP1 E12|EDDM12|EL149|HE12 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3781 Phosphocholine - - DRUGBANK DB03945 C5H15NO4P small molecule - 107-73-3 DRUGBANK 22241 122060 64100 - ELSPBP1 E12|EDDM12|EL149|HE12 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3781 Phosphocholine - - DRUGBANK DB03945 C5H15NO4P small molecule - 107-73-3 DRUGBANK 22242 122060 64100 - ELSPBP1 E12|EDDM12|EL149|HE12 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3781 Phosphocholine - - DRUGBANK DB03945 C5H15NO4P small molecule - 107-73-3 DRUGBANK 23029 122085 64146 - PDF - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4135 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide - - DRUGBANK DB04310 C19H35N3O5 small molecule - 13434-13-4 DRUGBANK 23219 122085 64146 - PDF - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 4190 Bb-3497 - - DRUGBANK DB04368 C16H31N3O4 small molecule - 235784-88-0 DRUGBANK 1933 122098 64175 PSEC0109 P3H1 GROS1|LEPRE1|OI8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1934 122098 64175 PSEC0109 P3H1 GROS1|LEPRE1|OI8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2280 122098 64175 PSEC0109 P3H1 GROS1|LEPRE1|OI8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2281 122098 64175 PSEC0109 P3H1 GROS1|LEPRE1|OI8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 3793 122098 64175 PSEC0109 P3H1 GROS1|LEPRE1|OI8 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3794 122098 64175 PSEC0109 P3H1 GROS1|LEPRE1|OI8 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 10462 122149 64386 - MMP25 MMP-25|MMP20|MMP20A|MMPL1|MT-MMP 6|MT-MMP6|MT6-MMP|MT6MMP|MTMMP6 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10463 122149 64386 - MMP25 MMP-25|MMP20|MMP20A|MMPL1|MT-MMP 6|MT-MMP6|MT6-MMP|MT6MMP|MTMMP6 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 18353 122201 64499 - TPSB2 TPS2|tryptaseB|tryptaseC 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1941 Amido Phenyl Pyruvic Acid - - DRUGBANK DB02018 C10H10N2O3 small molecule - - DRUGBANK 18354 122201 64499 - TPSB2 TPS2|tryptaseB|tryptaseC 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1941 Amido Phenyl Pyruvic Acid - - DRUGBANK DB02018 C10H10N2O3 small molecule - - DRUGBANK 23873 122201 64499 - TPSB2 TPS2|tryptaseB|tryptaseC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4567 [4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE - - DRUGBANK DB04764 C26H29N3O small molecule - - DRUGBANK 24983 122201 64499 - TPSB2 TPS2|tryptaseB|tryptaseC 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5781 (5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone - - DRUGBANK DB06962 C26H24N2O3 small molecule - - DRUGBANK 22568 122308 64802 RP11-807G9.1 NMNAT1 LCA9|NMNAT|PNAT1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 22569 122308 64802 RP11-807G9.1 NMNAT1 LCA9|NMNAT|PNAT1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 20796 122308 64802 RP11-807G9.1 NMNAT1 LCA9|NMNAT|PNAT1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3095 Nicotinamide Mononucleotide - - DRUGBANK DB03227 C11H16N2O8P small molecule - - DRUGBANK 20797 122308 64802 RP11-807G9.1 NMNAT1 LCA9|NMNAT|PNAT1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3095 Nicotinamide Mononucleotide - - DRUGBANK DB03227 C11H16N2O8P small molecule - - DRUGBANK 4308 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Boeynaems JM (2005) 15816504 174397 201 Ticlopidine Ticlopidinum|Ticlopidina dom-ticlopidine|ticlopidine|my DRUGBANK DB00208 C14H14ClNS small molecule B01AC05 55142-85-3 DRUGBANK 4309 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Zhan C (2007) 17110146 174400 201 Ticlopidine Ticlopidinum|Ticlopidina dom-ticlopidine|ticlopidine|my DRUGBANK DB00208 C14H14ClNS small molecule B01AC05 55142-85-3 DRUGBANK 4310 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 201 Ticlopidine Ticlopidinum|Ticlopidina dom-ticlopidine|ticlopidine|my DRUGBANK DB00208 C14H14ClNS small molecule B01AC05 55142-85-3 DRUGBANK 4311 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Gachet C (2005) 15955565 174398 201 Ticlopidine Ticlopidinum|Ticlopidina dom-ticlopidine|ticlopidine|my DRUGBANK DB00208 C14H14ClNS small molecule B01AC05 55142-85-3 DRUGBANK 4312 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Storey RF (2001) 11454254 174399 201 Ticlopidine Ticlopidinum|Ticlopidina dom-ticlopidine|ticlopidine|my DRUGBANK DB00208 C14H14ClNS small molecule B01AC05 55142-85-3 DRUGBANK 24129 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens unknown target Storey RF (2007) 17980251 182060 4702 AZD6140 - - DRUGBANK DB04902 - small molecule - - DRUGBANK 24130 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens unknown target Springthorpe B (2007) 17827008 182046 4702 AZD6140 - - DRUGBANK DB04902 - small molecule - - DRUGBANK 10178 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Wihlborg AK (2004) 15308557 178244 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10179 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Dorsam RT (2003) 14668029 178245 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10180 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Chen X (2002) 11752352 171740 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10181 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Savi P (2006) 16835302 178240 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10182 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target van Gestel MA (2003) 12615691 178241 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10183 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Herbert JM (2003) 15199474 178242 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10184 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Gladding P (2008) 19463375 178243 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10185 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Wang L (2004) 15291969 178239 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 10186 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Taubert D (2004) 15269827 178238 748 Clopidogrel (+)-Clopidogrel|Clopidogrelum ipg-clopidogrel|mar-clopidogre DRUGBANK DB00758 C16H16ClNO2S small molecule B01AC04 113665-84-2 DRUGBANK 15289 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens agonist target Yang J (2002) 12297509 180798 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 15290 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens agonist target Kobsar AL (2010) 20085435 180797 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 15291 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens agonist target Cattaneo M (2007) 17155953 180796 1228 Epoprostenol Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX epoprostenol sodium|flolan|car DRUGBANK DB01240 C20H32O5 small molecule B01AC09 35121-78-9 DRUGBANK 27859 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens inhibitor target Gan XD (2015) 26402735 196030 7773 Cangrelor [dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid kengreal DRUGBANK DB06441 C17H25Cl2F3N5O12P3S2 small molecule B01AC25 163706-06-7 DRUGBANK 6214 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 6215 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 366 Treprostinil [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost remodulin|tyvaso|orenitram DRUGBANK DB00374 C23H34O5 small molecule B01AC21 81846-19-7 DRUGBANK 24423 122309 64805 - P2RY12 ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999 9606 Homo sapiens antagonist target Dovlatova NL (2008) 18485086 182077 5529 Prasugrel Effient|Prasugrel effient DRUGBANK DB06209 C20H20FNO3S small molecule B01AC22 150322-43-3 DRUGBANK 2293 122322 64849 RP1-257E24.1 SLC13A3 NADC3|SDCT2 9606 Homo sapiens unknown target Hagos Y (2006) 16735460 173160 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2294 122322 64849 RP1-257E24.1 SLC13A3 NADC3|SDCT2 9606 Homo sapiens unknown target Oshiro N (2005) 15944208 173169 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2295 122322 64849 RP1-257E24.1 SLC13A3 NADC3|SDCT2 9606 Homo sapiens unknown target Burckhardt BC (2005) 15561973 173163 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2296 122322 64849 RP1-257E24.1 SLC13A3 NADC3|SDCT2 9606 Homo sapiens unknown target Yodoya E (2006) 16524379 173171 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 2297 122322 64849 RP1-257E24.1 SLC13A3 NADC3|SDCT2 9606 Homo sapiens unknown target Wolff NA (2007) 17526543 173170 133 Succinic acid HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin - DRUGBANK DB00139 C4H6O4 small molecule - 110-15-6 DRUGBANK 1724 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1725 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 1726 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Tamaki N (1989) 2632679 172697 114 Pyruvic acid CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid - DRUGBANK DB00119 C3H4O3 small molecule - 127-17-3 DRUGBANK 2732 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2733 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2734 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Baker PR (2004) 15240345 173432 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2735 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Takada Y (1984) 6703688 172467 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 1400 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1401 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1402 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens cofactor target Lee IS (1995) 7592550 172466 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1403 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens cofactor target Takada Y (1984) 6703688 172467 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 3464 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3465 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3466 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Takada Y (1984) 6703688 172467 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3467 122342 64902 - AGXT2 AGT2|DAIBAT 9606 Homo sapiens unknown target Okuno E (1988) 2907870 173848 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3680 122381 65061 - CDK15 ALS2CR7|PFTAIRE2|PFTK2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3681 122381 65061 - CDK15 ALS2CR7|PFTAIRE2|PFTK2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3755 122418 65263 - PYCRL - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3756 122418 65263 - PYCRL - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3757 122418 65263 - PYCRL - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 9436 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Zhu Y (2007) 17510308 177788 672 Warfarin Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin coumadin tab 3mg|taro-warfarin DRUGBANK DB00682 C19H16O4 small molecule B01AA03 81-81-2 DRUGBANK 9437 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 672 Warfarin Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin coumadin tab 3mg|taro-warfarin DRUGBANK DB00682 C19H16O4 small molecule B01AA03 81-81-2 DRUGBANK 9438 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Yin T (2006) 17161452 177784 672 Warfarin Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin coumadin tab 3mg|taro-warfarin DRUGBANK DB00682 C19H16O4 small molecule B01AA03 81-81-2 DRUGBANK 9439 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Gebauer M (2007) 17275317 177785 672 Warfarin Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin coumadin tab 3mg|taro-warfarin DRUGBANK DB00682 C19H16O4 small molecule B01AA03 81-81-2 DRUGBANK 9440 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Limdi NA (2008) 17653141 177786 672 Warfarin Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin coumadin tab 3mg|taro-warfarin DRUGBANK DB00682 C19H16O4 small molecule B01AA03 81-81-2 DRUGBANK 9441 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Osman A (2007) 17413769 177787 672 Warfarin Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin coumadin tab 3mg|taro-warfarin DRUGBANK DB00682 C19H16O4 small molecule B01AA03 81-81-2 DRUGBANK 16604 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Rettie AE (2006) 16869821 181381 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 16605 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Montes R (2006) 16611310 181379 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 16606 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Zhou SF (2009) 19515014 174101 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 16607 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Gonzalez-Conejero R (2007) 17596133 181382 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 16608 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 16609 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Schalekamp T (2006) 16815313 181378 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 16610 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Bodin L (2005) 15790782 181380 1366 Acenocoumarol Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone sintrom DRUGBANK DB01418 C19H15NO6 small molecule B01AA07 152-72-7 DRUGBANK 4940 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4941 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4942 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 4943 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Wallin R (1986) 2424118 174761 259 Dicoumarol bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) - DRUGBANK DB00266 C19H12O6 small molecule B01AA01 66-76-2 DRUGBANK 7521 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 490 Phenindione Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion - DRUGBANK DB00498 C15H10O2 small molecule B01AA02 83-12-5 DRUGBANK 7522 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Mentre F (1998) 9465843 176507 490 Phenindione Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion - DRUGBANK DB00498 C15H10O2 small molecule B01AA02 83-12-5 DRUGBANK 7523 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 490 Phenindione Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion - DRUGBANK DB00498 C15H10O2 small molecule B01AA02 83-12-5 DRUGBANK 7524 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 490 Phenindione Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion - DRUGBANK DB00498 C15H10O2 small molecule B01AA02 83-12-5 DRUGBANK 12184 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Reitsma PH (2005) 16201835 179259 936 Phenprocoumon Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin - DRUGBANK DB00946 C18H16O3 small molecule B01AA04 435-97-2 DRUGBANK 12185 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 936 Phenprocoumon Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin - DRUGBANK DB00946 C18H16O3 small molecule B01AA04 435-97-2 DRUGBANK 12186 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Schalekamp T (2007) 17192772 179261 936 Phenprocoumon Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin - DRUGBANK DB00946 C18H16O3 small molecule B01AA04 435-97-2 DRUGBANK 12187 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Thijssen HH (1988) 3207986 179260 936 Phenprocoumon Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin - DRUGBANK DB00946 C18H16O3 small molecule B01AA04 435-97-2 DRUGBANK 12188 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens inhibitor target Thijssen HH (1989) 2706010 179262 936 Phenprocoumon Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin - DRUGBANK DB00946 C18H16O3 small molecule B01AA04 435-97-2 DRUGBANK 3649 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens cofactor target Stafford DW (2005) 16102054 173991 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3650 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3651 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3652 122472 79001 MSTP134 VKORC1 EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR 9606 Homo sapiens cofactor target Oldenburg J (2006) 16677080 173992 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 10855 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Chen X (2002) 11752352 171740 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10856 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Eccles R (1994) 7529306 178570 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10857 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Story GM (2003) 12654248 178565 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10858 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Behrendt HJ (2004) 14757700 178567 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10859 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Bandell M (2004) 15046718 178566 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10860 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Andersson DA (2004) 15190109 178569 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 10861 122512 79054 - TRPM8 LTRPC6|TRPP8 9606 Homo sapiens inducer target Stein RJ (2004) 15311065 178568 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 26388 122538 79090 - TRAPPC6A TRS33 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7128 S-PALMITOYL-L-CYSTEINE - - DRUGBANK DB08342 C19H37NO3S small molecule - - DRUGBANK 10460 122566 79148 UNQ1893/PRO4339 MMP28 EPILYSIN|MM28|MMP-25|MMP-28|MMP25 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10461 122566 79148 UNQ1893/PRO4339 MMP28 EPILYSIN|MM28|MMP-25|MMP-28|MMP25 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 16695 122725 79581 - SLC52A2 BVVLS2|D15Ertd747e|GPCR41|GPR172A|PAR1|RFT3|RFVT2|hRFT3 9606 Homo sapiens agonist target Castelli MP (2002) 12098579 181419 1388 Gamma Hydroxybutyric Acid 3-carboxypropoxy acid|4-hydroxy-butyric acid|gamma-Hydroxybutyrate|4-hydroxybutanoic acid|-Hydroxybutyric acid|GHB|4-hydroxybutanoate|oxy-n-butyric acid|4-Hydroxybutyric acid|gamma-Hydroxybutyric acid - DRUGBANK DB01440 C4H7O3 small molecule - 591-81-1 DRUGBANK 16696 122725 79581 - SLC52A2 BVVLS2|D15Ertd747e|GPCR41|GPR172A|PAR1|RFT3|RFVT2|hRFT3 9606 Homo sapiens agonist target Castelli MP (2003) 14535954 181420 1388 Gamma Hydroxybutyric Acid 3-carboxypropoxy acid|4-hydroxy-butyric acid|gamma-Hydroxybutyrate|4-hydroxybutanoic acid|-Hydroxybutyric acid|GHB|4-hydroxybutanoate|oxy-n-butyric acid|4-Hydroxybutyric acid|gamma-Hydroxybutyric acid - DRUGBANK DB01440 C4H7O3 small molecule - 591-81-1 DRUGBANK 2894 122730 79587 OK/SW-cl.10 CARS2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2895 122730 79587 OK/SW-cl.10 CARS2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 19844 122761 79631 - EFTUD1 FAM42A|HsT19294|RIA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2635 S-(Methylmercury)-L-Cysteine - - DRUGBANK DB02750 C4H9HgNO2S small molecule - - DRUGBANK 27676 122761 79631 - EFTUD1 FAM42A|HsT19294|RIA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3467 Deoxycholic Acid 7-deoxycholic acid|Desoxycholsure|3alpha,12alpha-Dihydroxy-5beta-cholanic acid|desoxycholic acid|deoxycholate|(3,5,12)-3,12-dihydroxycholan-24-oic acid belkyra|kybella DRUGBANK DB03619 C24H40O4 small molecule - 83-44-3 DRUGBANK 23043 122761 79631 - EFTUD1 FAM42A|HsT19294|RIA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 6762 122772 79644 - SRD5A3 CDG1P|CDG1Q|KRIZI|SRD5A2L|SRD5A2L1 9606 Homo sapiens antagonist target Corvol P (1975) 166833 175954 413 Spironolactone Spironolactone|Spironolactonum|Spironolattone|Espironolactona apo-spirozide tab|ntp-spironol DRUGBANK DB00421 C24H32O4S small molecule C03DA01 52-01-7 DRUGBANK 1935 122801 79676 - OGFOD2 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1936 122801 79676 - OGFOD2 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 3835 122846 79731 - NARS2 SLM5|asnRS 9606 Homo sapiens unknown target Iwasaki W (2006) 16753178 174065 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3836 122846 79731 - NARS2 SLM5|asnRS 9606 Homo sapiens unknown target Roy H (2003) 12874385 174066 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 2400 122862 79751 - SLC25A22 EIEE3|GC1|NET44 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2401 122862 79751 - SLC25A22 EIEE3|GC1|NET44 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 23416 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23417 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23418 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 25481 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6279 (3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one - - DRUGBANK DB07468 C18H16N2O2 small molecule - - DRUGBANK 26321 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7064 N-METHYL O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE - - DRUGBANK DB08276 C9H13BeF3N2O9P2 small molecule - - DRUGBANK 25482 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6280 (3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one - - DRUGBANK DB07469 C18H16N2O2 small molecule - - DRUGBANK 20529 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2995 Mant-Adp - - DRUGBANK DB03126 C18H22N6O10P2 small molecule - - DRUGBANK 20530 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2995 Mant-Adp - - DRUGBANK DB03126 C18H22N6O10P2 small molecule - - DRUGBANK 20531 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2995 Mant-Adp - - DRUGBANK DB03126 C18H22N6O10P2 small molecule - - DRUGBANK 25483 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6281 (3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one - - DRUGBANK DB07470 C17H14N2O2 small molecule - - DRUGBANK 18133 122884 79784 FP17425 MYH14 DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1868 (S)-blebbistatin - - DRUGBANK DB01944 C18H16N2O2 small molecule - - DRUGBANK 2999 122980 79896 - THNSL1 TSH1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 3000 122980 79896 - THNSL1 TSH1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 1451 122980 79896 - THNSL1 TSH1 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1452 122980 79896 - THNSL1 TSH1 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1999 123142 80150 - ASRGL1 ALP|ALP1|CRASH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2000 123142 80150 - ASRGL1 ALP|ALP1|CRASH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 3841 123142 80150 - ASRGL1 ALP|ALP1|CRASH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 3842 123142 80150 - ASRGL1 ALP|ALP1|CRASH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 167 L-Asparagine (S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn - DRUGBANK DB00174 C4H8N2O3 small molecule - 70-47-3 DRUGBANK 2998 123188 80222 RP11-54A4.9 TARS2 COXPD21|TARSL1|thrRS 9606 Homo sapiens unknown target Caillet J (2007) 17644600 173634 150 L-Threonine L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine freamine iii|primene 10%|2.5% DRUGBANK DB00156 C4H9NO3 small molecule - 72-19-5 DRUGBANK 2907 123266 80704 - SLC19A3 BBGD|THMD2|THTR2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 2908 123266 80704 - SLC19A3 BBGD|THMD2|THTR2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 145 L-Cysteine (2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid vamin n|primene 10%|primene 10 DRUGBANK DB00151 C3H7NO2S small molecule - 52-90-4 DRUGBANK 3628 123327 80834 - TAS1R2 GPR71|T1R2|TR2 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 161 Aspartame Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame - DRUGBANK DB00168 C14H18N2O5 small molecule - 22839-47-0 DRUGBANK 3629 123327 80834 - TAS1R2 GPR71|T1R2|TR2 9606 Homo sapiens agonist target Cui M (2006) 17168764 173962 161 Aspartame Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame - DRUGBANK DB00168 C14H18N2O5 small molecule - 22839-47-0 DRUGBANK 3630 123327 80834 - TAS1R2 GPR71|T1R2|TR2 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 161 Aspartame Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame - DRUGBANK DB00168 C14H18N2O5 small molecule - 22839-47-0 DRUGBANK 3631 123327 80834 - TAS1R2 GPR71|T1R2|TR2 9606 Homo sapiens agonist target Xu H (2004) 15353592 173963 161 Aspartame Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame - DRUGBANK DB00168 C14H18N2O5 small molecule - 22839-47-0 DRUGBANK 15373 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Gligorov J (2004) 15161985 180838 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15374 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Matesanz R (2008) 18559268 180843 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15375 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Snyder JP (2001) 11309480 180842 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 15376 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Belani CP (2004) 15698529 180844 1236 Docetaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous taxotere|docetaxel for injecti DRUGBANK DB01248 C43H53NO14 small molecule L01CD02 114977-28-5 DRUGBANK 20290 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20291 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 15119 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15120 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Kovacs P (2007) 17314054 180739 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15121 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15122 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Cheung CH (2009) 19575780 180738 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 15123 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Horwitz SB (1992) 1350385 180740 1217 Paclitaxel 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel abraxane|paclitaxel injection, DRUGBANK DB01229 C47H51NO14 small molecule L01CD01 33069-62-4 DRUGBANK 17986 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17987 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 24185 123347 81027 - TUBB1 - 9606 Homo sapiens unknown target Dabydeen DA (2006) 16940412 181964 4735 E7389 - - DRUGBANK DB04940 - small molecule - - DRUGBANK 5361 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 302 Vindesine 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide eldisine inj 5mg/2ml DRUGBANK DB00309 C43H55N5O7 small molecule L01CA03 53643-48-4 DRUGBANK 5362 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 302 Vindesine 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide eldisine inj 5mg/2ml DRUGBANK DB00309 C43H55N5O7 small molecule L01CA03 53643-48-4 DRUGBANK 5363 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Fiebig HH (2007) 17878523 175089 302 Vindesine 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide eldisine inj 5mg/2ml DRUGBANK DB00309 C43H55N5O7 small molecule L01CA03 53643-48-4 DRUGBANK 5364 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Natsume T (2000) 10920282 175088 302 Vindesine 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide eldisine inj 5mg/2ml DRUGBANK DB00309 C43H55N5O7 small molecule L01CA03 53643-48-4 DRUGBANK 5365 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Yoshida M (2007) 17465195 175090 302 Vindesine 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide eldisine inj 5mg/2ml DRUGBANK DB00309 C43H55N5O7 small molecule L01CA03 53643-48-4 DRUGBANK 16381 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Acharya BR (2009) 19527023 181275 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16382 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Cerquaglia C (2005) 15720245 181277 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16383 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Finkelstein Y (2010) 20586571 181276 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16384 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16385 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16386 123347 81027 - TUBB1 - 9606 Homo sapiens inhibitor target Li CM (2010) 20814887 180493 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 5343 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5344 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 7085 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 13859 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13860 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Kikuchi K (2005) 15778703 180212 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 14383 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 8371 123351 81033 - KCNH6 ERG-2|ERG2|HERG2|Kv11.2|hERG-2 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 2717 123499 81490 - PTDSS2 PSS2 9606 Homo sapiens unknown target Dygas A (2003) 12833164 173418 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2718 123499 81490 - PTDSS2 PSS2 9606 Homo sapiens unknown target Grandmaison PA (2004) 14984733 173419 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2719 123499 81490 - PTDSS2 PSS2 9606 Homo sapiens unknown target Bergo MO (2002) 12361952 173421 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2720 123499 81490 - PTDSS2 PSS2 9606 Homo sapiens unknown target Wen Z (2007) 17387686 173420 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 2721 123499 81490 - PTDSS2 PSS2 9606 Homo sapiens unknown target Vance JE (2004) 15052332 173422 138 Phosphatidyl serine PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine - DRUGBANK DB00144 C13H24NO10P small molecule - 1446756-47-3 DRUGBANK 14848 123515 81551 - STMN4 RB3 9606 Homo sapiens antagonist target Wu WW (2008) 18162179 180627 1194 Lomustine Chloroethylcyclohexylnitrosourea|CCNU|Lomustina|Belustine|Cecenu|Cyclohexyl chloroethyl nitrosourea|1-(2-Chloroethyl)-3-cyclohexylnitrosourea|Lomustinum|CeeNU|CINU|1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea|N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea gleostine|lomustine|ceenu DRUGBANK DB01206 C9H16ClN3O2 small molecule L01AD02 13010-47-4 DRUGBANK 14849 123515 81551 - STMN4 RB3 9606 Homo sapiens antagonist target Liang XJ (2008) 18593927 180626 1194 Lomustine Chloroethylcyclohexylnitrosourea|CCNU|Lomustina|Belustine|Cecenu|Cyclohexyl chloroethyl nitrosourea|1-(2-Chloroethyl)-3-cyclohexylnitrosourea|Lomustinum|CeeNU|CINU|1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea|N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea gleostine|lomustine|ceenu DRUGBANK DB01206 C9H16ClN3O2 small molecule L01AD02 13010-47-4 DRUGBANK 25587 123515 81551 - STMN4 RB3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6382 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE - - DRUGBANK DB07574 C22H25NO6S small molecule - - DRUGBANK 4170 123571 81693 UNQ513/PRO1028 AMN PRO1028|amnionless 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4171 123571 81693 UNQ513/PRO1028 AMN PRO1028|amnionless 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4172 123571 81693 UNQ513/PRO1028 AMN PRO1028|amnionless 9606 Homo sapiens unknown target Seetharam B (2003) 14585166 174321 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 2395 123744 83733 - SLC25A18 GC2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2396 123744 83733 - SLC25A18 GC2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2069 123796 83884 - SLC25A2 ORC2|ORNT2 9606 Homo sapiens unknown target Begum L (2002) 11997094 172949 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2070 123796 83884 - SLC25A2 ORC2|ORNT2 9606 Homo sapiens unknown target Camacho JA (2003) 12948741 172968 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2071 123796 83884 - SLC25A2 ORC2|ORNT2 9606 Homo sapiens unknown target Camacho JA (2006) 16940241 172960 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 25705 123814 83903 - GSG2 HASPIN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6503 3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine - - DRUGBANK DB07698 C18H14ClN5 small molecule - - DRUGBANK 26030 123814 83903 - GSG2 HASPIN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6797 (2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol - - DRUGBANK DB08004 C17H21N5O small molecule - - DRUGBANK 23764 123814 83903 - GSG2 HASPIN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4413 5-iodotubercidin - - DRUGBANK DB04604 C11H13IN4O4 small molecule - 24386-93-4 DRUGBANK 26021 123814 83903 - GSG2 HASPIN 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6790 N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE - - DRUGBANK DB07995 C20H20BrN3O2S small molecule - - DRUGBANK 27861 123818 83933 RP3-402G11.7 HDAC10 HD10 9606 Homo sapiens inhibitor target Geng L (2006) 17145876 195973 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 27693 123818 83933 RP3-402G11.7 HDAC10 HD10 9606 Homo sapiens inhibitor target Beckers T (2007) 17455259 182004 8079 Panobinostat (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat farydak DRUGBANK DB06603 C21H23N3O2 small molecule L01XX42 404950-80-7 DRUGBANK 26111 124102 84501 - SPIRE2 Spir-2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6873 LATRUNCULIN B - - DRUGBANK DB08080 C20H29NO5S small molecule - - DRUGBANK 3740 124122 84532 RP4-568C11.1 ACSS1 ACAS2L|ACECS1|AceCS2L 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 3741 124122 84532 RP4-568C11.1 ACSS1 ACAS2L|ACECS1|AceCS2L 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 164 Adenosine triphosphate Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP - DRUGBANK DB00171 C10H16N5O13P3 small molecule - 56-65-5 DRUGBANK 2110 124122 84532 RP4-568C11.1 ACSS1 ACAS2L|ACECS1|AceCS2L 9606 Homo sapiens product of target Imming P (2006) 17016423 171742 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 2111 124122 84532 RP4-568C11.1 ACSS1 ACAS2L|ACECS1|AceCS2L 9606 Homo sapiens product of target Overington JP (2006) 17139284 171741 125 Adenosine monophosphate Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate - DRUGBANK DB00131 C10H14N5O7P small molecule - 61-19-8 DRUGBANK 20766 124199 84680 - ACCS ACS|PHACS 9606 Homo sapiens unknown target Satoh S (1989) 16667107 181938 3082 Vinylglycine L-vinylglycine|(2s)-2-Aminobut-3-Enoicacid|(2s)-2-Amino-3-Butenoic Acid - DRUGBANK DB03214 C4H7NO2 small molecule - 52773-87-2 DRUGBANK 3480 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Jadhao SB (2004) 15122758 173858 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3481 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3482 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3483 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Yang RZ (2002) 11863375 173856 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3484 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Rajamohan F (2006) 16495081 173857 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 1576 124217 84706 - GPT2 ALT2 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1577 124217 84706 - GPT2 ALT2 9606 Homo sapiens cofactor target Welch S (1975) 241701 172566 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1578 124217 84706 - GPT2 ALT2 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 10396 124217 84706 - GPT2 ALT2 9606 Homo sapiens inhibitor target Todd KG (2009) 19203467 178349 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10397 124217 84706 - GPT2 ALT2 9606 Homo sapiens inhibitor target McKenna KF (1991) 1881457 178348 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 10398 124217 84706 - GPT2 ALT2 9606 Homo sapiens inhibitor target Tanay VA (2001) 11775064 178350 770 Phenelzine Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen nardil|phenelzine sulfate DRUGBANK DB00780 C8H12N2 small molecule N06AF03 51-71-8 DRUGBANK 2460 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2461 124217 84706 - GPT2 ALT2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 20300 124259 84790 - TUBA1C TUBA6|bcm948 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20301 124259 84790 - TUBA1C TUBA6|bcm948 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 17996 124259 84790 - TUBA1C TUBA6|bcm948 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 17997 124259 84790 - TUBA1C TUBA6|bcm948 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 25584 124259 84790 - TUBA1C TUBA6|bcm948 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6382 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE - - DRUGBANK DB07574 C22H25NO6S small molecule - - DRUGBANK 2088 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2089 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Hosokawa H (1997) 9079705 172838 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 2090 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 123 L-Ornithine (S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid primene 10%|primene 10%-liq iv DRUGBANK DB00129 C5H12N2O2 small molecule - 70-26-8 DRUGBANK 1892 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Huang Y (2007) 17234578 172862 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1893 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Rotmann A (2007) 17329401 172844 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1862 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1863 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Hosokawa H (1997) 9079705 172838 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1864 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1865 124329 84889 - SLC7A3 ATRC3|CAT-3|CAT3 9606 Homo sapiens unknown target Humphrey BD (2006) 16406639 172839 118 L-Lysine Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid freamine iii|primene 10%|2.5% DRUGBANK DB00123 C6H14N2O2 small molecule B05XB03 56-87-1 DRUGBANK 1570 124425 85007 PP9286 PHYKPL AGXT2L2|PHLU 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1571 124425 85007 PP9286 PHYKPL AGXT2L2|PHLU 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 3476 124425 85007 PP9286 PHYKPL AGXT2L2|PHLU 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3477 124425 85007 PP9286 PHYKPL AGXT2L2|PHLU 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 23934 124494 85366 - MYLK2 KMLC|MLCK|MLCK2|skMLCK 9606 Homo sapiens unknown target Lamers JM (1985) 2933041 179746 4627 Prenylamine N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-1-propanamine|Prenilamina|N-(3'-Phenyl-2-propyl)-1,1-diphenyl-3-propyloamine|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin|N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine|DL-prenylamine|1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane|Prenylaminum|N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine - DRUGBANK DB04825 C24H27N small molecule C01DX52|C01DX02 390-64-7 DRUGBANK 18114 124581 87769 RP11-151A6.2 GGACT A2LD1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 25517 124609 89832 - CHRFAM7A CHRNA7|CHRNA7-DR1|D-10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6305 (3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE - - DRUGBANK DB07494 C24H30NO small molecule - - DRUGBANK 26007 124609 89832 - CHRFAM7A CHRNA7|CHRNA7-DR1|D-10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6775 (E)-imidacloprid (2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine - DRUGBANK DB07980 C9H10ClN5O2 small molecule - 138261-41-3 DRUGBANK 25727 124609 89832 - CHRFAM7A CHRNA7|CHRNA7-DR1|D-10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6523 EPIBATIDINE - - DRUGBANK DB07720 C11H13ClN2 small molecule - - DRUGBANK 26649 124609 89832 - CHRFAM7A CHRNA7|CHRNA7-DR1|D-10 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7396 {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide - - DRUGBANK DB08620 C10H9ClN4S small molecule - - DRUGBANK 5345 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Doggrell SA (2005) 15926871 175081 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 5346 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Foster RH (1997) 9257085 175082 301 Ibutilide Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid ibutilide fumarate|corvert inj DRUGBANK DB00308 C20H36N2O3S small molecule C01BD05 122647-31-8 DRUGBANK 7086 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 449 Prazosin Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine prazosin hydrochloride|alti-pr DRUGBANK DB00457 C19H21N5O4 small molecule C02LE01|C02CA01 19216-56-9 DRUGBANK 13871 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Hatton CJ (1996) 8760033 180211 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13872 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Kikuchi K (2005) 15778703 180212 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 14384 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 1150 Terazosin Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine hytrin-7 tabs 1mg-7 tabs 2mg-1 DRUGBANK DB01162 C19H25N5O4 small molecule G04CA03 63590-64-7 DRUGBANK 8372 124667 90134 - KCNH7 ERG3|HERG3|Kv11.3 9606 Homo sapiens inhibitor target Thomas D (2004) 15098086 176200 580 Doxazosin 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosinum|Doxazosin mesilate|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|Doxazosina|Doxazosin mesylate|Doxazosine|Doxazosin cardura-1 tab 1mg|doxazosin-2| DRUGBANK DB00590 C23H25N5O5 small molecule C02CA04 74191-85-8 DRUGBANK 296 124712 90411 - MCFD2 F5F8D|F5F8D2|LMAN1IP|SDNSF 9606 Homo sapiens modulator target Imming P (2006) 17016423 171742 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 297 124712 90411 - MCFD2 F5F8D|F5F8D2|LMAN1IP|SDNSF 9606 Homo sapiens modulator target Overington JP (2006) 17139284 171741 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 298 124712 90411 - MCFD2 F5F8D|F5F8D2|LMAN1IP|SDNSF 9606 Homo sapiens modulator target Zhang B (2005) 15886209 171877 25 Antihemophilic Factor (Recombinant) rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant) kogenate fs|kryobulin vh 500 u DRUGBANK DB00025 C11794H18314N3220O3553S83 biologic - - DRUGBANK 2001 124869 91703 - ACY3 ACY-3|HCBP1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2002 124869 91703 - ACY3 ACY-3|HCBP1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 2810 124929 92292 - GLYATL1 GATF-C|GNAT 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2811 124929 92292 - GLYATL1 GATF-C|GNAT 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 3094 124950 92483 - LDHAL6B LDH6B|LDHAL6|LDHL 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3095 124950 92483 - LDHAL6B LDH6B|LDHAL6|LDHL 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 24245 125094 94025 - MUC16 CA125 9606 Homo sapiens unknown target Berek JS (2004) 15268682 181855 4758 Oregovomab Oregovamab|B43.13|MOAB B43.13|Monoclonal antibody B43.13 - DRUGBANK DB04964 - biologic - - DRUGBANK 24246 125094 94025 - MUC16 CA125 9606 Homo sapiens unknown target Unknown Authors (2006) 17073521 181974 4758 Oregovomab Oregovamab|B43.13|MOAB B43.13|Monoclonal antibody B43.13 - DRUGBANK DB04964 - biologic - - DRUGBANK 368 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 369 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 30 Insulin Human Inhaled insulin|Regular Insulin, human|Insulin Human Regular|Insulin (human)|Insulin human|Insulin regular|Insulin Recombinant Human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin injection human biosynthetic|Insulin Recombinant Purified Human humulin r u-500 kwikpen|humuli DRUGBANK DB00030 C257H383N65O77S6 biologic - 11061-68-0 DRUGBANK 858 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 857 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Plaisance V (2006) 16831872 145324 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 859 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 860 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Torii S (2004) 15028737 172189 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 861 125120 94121 RP11-524D16__A.2 SYTL4 SLP4 9606 Homo sapiens unknown target Gomi H (2005) 16216924 172188 70 Insulin Pork Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine - DRUGBANK DB00071 C257H387N65O76S6 biologic A10AE03|A10AD03|A10AC03|A10AB03 12584-58-6 DRUGBANK 1920 125184 112398 - EGLN2 EIT6|HIF-PH1|HIFPH1|HPH-1|HPH-3|PHD1 9606 Homo sapiens unknown target Bruegge K (2007) 17627521 172876 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1921 125184 112398 - EGLN2 EIT6|HIF-PH1|HIFPH1|HPH-1|HPH-3|PHD1 9606 Homo sapiens unknown target Nytko KJ (2007) 17627474 127532 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1912 125185 112399 - EGLN3 HIFP4H3|HIFPH3|PHD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1913 125185 112399 - EGLN3 HIFP4H3|HIFPH3|PHD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 3561 125200 112724 PSEC0082 RDH13 SDR7C3 9606 Homo sapiens unknown target Keller B (2007) 17512723 173905 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3784 125210 112849 - L3HYPDH C14orf149 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 3785 125210 112849 - L3HYPDH C14orf149 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 165 L-Proline (2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid freamine iii|primene 10%|2.5% DRUGBANK DB00172 C5H9NO2 small molecule - 147-85-3 DRUGBANK 1533 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens cofactor target Graham DE (2002) 11980912 172545 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1534 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens cofactor target Kidron H (2007) 16997906 172544 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1535 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens cofactor target Patel CN (2004) 15583399 172546 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1536 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens cofactor target Shah R (2007) 17305368 172543 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1537 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens cofactor target Arena ME (2001) 11168717 172542 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1866 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens unknown target Yang HQ (2007) 17287563 172840 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1867 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens unknown target Regunathan S (2006) 17025265 172841 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1868 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens unknown target Wu N (2008) 17653850 172842 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1869 125246 113451 - AZIN2 ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp 9606 Homo sapiens unknown target Kotil K (2006) 16703907 172843 119 L-Arginine (2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid 2.5% travasol amino acid injec DRUGBANK DB00125 C6H14N4O2 small molecule B05XB01 74-79-3 DRUGBANK 1551 125255 113675 - SDSL SDH 2|SDS-RS1|TDH|cSDH 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1552 125255 113675 - SDSL SDH 2|SDS-RS1|TDH|cSDH 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 23857 125341 114771 - PGLYRP3 PGRP-Ialpha|PGRPIA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4539 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE - - DRUGBANK DB04736 C37H59N7O20 small molecule - - DRUGBANK 9157 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Imming P (2006) 17016423 171742 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9158 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Overington JP (2006) 17139284 171741 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9159 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Valle RF (2003) 14644830 177656 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9160 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Hugues JN (1998) 9622415 177657 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9161 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Suh J (2004) 14687742 177654 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9162 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Batzer FR (2006) 17097577 177655 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9163 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Saltiel E (1991) 1830521 177652 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9164 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Barbieri RL (1990) 2137975 177653 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9165 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Garner C (1994) 7996307 177651 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9166 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Chrisp P (1990) 2140979 177658 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 9167 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Letassy NA (1990) 2151003 177659 656 Nafarelin Nafarelin|Nafarelina|Nafarline|Nafarelinum synarel nas sol 2mg/ml|synarel DRUGBANK DB00666 C66H83N17O13 small molecule H01CA02 76932-56-4 DRUGBANK 8968 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Li JH (2005) 15635044 177546 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8969 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Morgan K (2006) 16916952 177544 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8970 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Silver MR (2006) 16720727 177545 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8971 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Montagnani Marelli M (2006) 16712461 177543 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 8972 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens agonist target Mamputha S (2007) 16973761 177540 634 Gonadorelin GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH factrel pws 500mcg/vial|reliso DRUGBANK DB00644 C55H75N17O13 small molecule V04CM01|H01CA01 33515-09-2 DRUGBANK 16503 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens negative modulator target Imming P (2006) 17016423 171742 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16504 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens negative modulator target Menon M (1986) 3004220 181317 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16505 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens negative modulator target Overington JP (2006) 17139284 171741 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 16506 125366 114814 - GNRHR2 GnRH-II-R 9606 Homo sapiens negative modulator target Dmowski WP (1990) 2404115 181318 1355 Danazol Cyclomen|Danazolum|Danocrine cyclomen|danazol DRUGBANK DB01406 C22H27NO2 small molecule G03XA01 17230-88-5 DRUGBANK 15006 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Harrison NL (1985) 2858237 180702 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 15007 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Radovanovic D (2004) 14740534 180703 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 15008 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Sinner B (2008) 18175098 180701 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 15009 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Smothers CT (2007) 17502428 173484 1209 Ketamine KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine ketamine hydrochloride injecti DRUGBANK DB01221 C13H16ClNO small molecule N01AX03 6740-88-1 DRUGBANK 14343 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Perouansky M (1996) 8968191 180413 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14476 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 11523 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Xu M (2011) 21163614 178947 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11524 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Wang J (2011) 21289476 178946 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11525 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Nishimura FT (2009) 21204417 178945 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11526 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Nishimura FT (2009) 21204407 178944 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11527 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11528 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 12606 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 2440 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2441 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 16932 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens unknown target Yuede CM (2010) 20613880 181507 1489 Rolicyclidine Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine - DRUGBANK DB01549 C16H23N small molecule - 2201-39-0 DRUGBANK 16933 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens unknown target Willoch F (1999) 20641908 181506 1489 Rolicyclidine Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine - DRUGBANK DB01549 C16H23N small molecule - 2201-39-0 DRUGBANK 21523 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 3424 Phencyclidine 1-(1-Phenylcyclohexyl)piperidine|PCP - DRUGBANK DB03575 C17H25N small molecule - 77-10-1 DRUGBANK 21524 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 3424 Phencyclidine 1-(1-Phenylcyclohexyl)piperidine|PCP - DRUGBANK DB03575 C17H25N small molecule - 77-10-1 DRUGBANK 14446 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14447 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Kornhuber J (1995) 8788072 180466 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14448 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 24114 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24115 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 12199 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 12200 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 939 Felbamate Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate felbamate|felbatol DRUGBANK DB00949 C11H14N2O4 small molecule N03AX10 25451-15-4 DRUGBANK 4121 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Hara K (2005) 15845694 174256 186 Tramadol (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol theratramadol-90|tramadol/acet DRUGBANK DB00193 C16H25NO2 small molecule N02AX02|N02AX52 27203-92-5 DRUGBANK 5632 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5633 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Sotgiu ML (2009) 19717013 175293 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 5634 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 325 Methadone ()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone diskets|methadose dispersible| DRUGBANK DB00333 C21H27NO small molecule N07BC02|N02AC52 76-99-3 DRUGBANK 13112 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Schrattenholz A (2006) 16719808 179870 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13113 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Smothers CT (2007) 17502428 173484 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13114 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Foster AC (2006) 16377242 178993 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13115 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Chatterton JE (2002) 11823786 179869 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 13116 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Rogawski MA (2003) 14530799 179868 1032 Memantine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine act memantine|mematine hydroch DRUGBANK DB01043 C12H21N small molecule N06DX01|N06DA52|N06DA53 19982-08-2 DRUGBANK 7648 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7649 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Wong BY (1988) 2897648 176584 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7650 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7651 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Kamel IR (2008) 18812887 176583 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 7652 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Chou YC (1999) 10064839 176582 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 5193 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 16869 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Stirling JM (1989) 2538766 181476 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 16870 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Geldenhuys WJ (2007) 17157509 181478 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 14360 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 14361 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1149 Chloroprocaine Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum chloroprocaine hydrochloride|n DRUGBANK DB01161 C13H19ClN2O2 small molecule N01BA04 133-16-4 DRUGBANK 5413 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 9817 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9818 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9819 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Nishizawa N (2002) 11812692 178028 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 9820 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Hahnenkamp K (2006) 16299047 178027 711 Procaine Procaina|4-Aminobenzoic acid 2-diethylaminoethyl ester|Procaine|beta-(Diethylamino)ethyl 4-aminobenzoate|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|beta-(Diethylamino)ethyl P-aminobenzoate|-(diethylamino)ethyl p-aminobenzoate novocain 20 mg/ml|novocain liq DRUGBANK DB00721 C13H20N2O2 small molecule S01HA05|C05AD05|N01BA52|N01BA02 59-46-1 DRUGBANK 24401 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens activator target Lipton SA (2002) 12183209 181801 5519 Acetylcysteine (R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid parvolex|parvolex liq iv 200mg DRUGBANK DB06151 C5H9NO3S small molecule V03AB23|S01XA08|R05CB01 616-91-1 DRUGBANK 6396 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6397 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6398 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Reynolds IJ (1988) 2849655 175765 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 6399 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Jevtovic-Todorovic V (2003) 12681372 175766 384 Ethopropazine Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine parsitan 50mg DRUGBANK DB00392 C19H24N2S small molecule N04AA05 522-00-9 DRUGBANK 17604 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 11873 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Blanpied TA (2005) 15800186 179065 905 Amantadine Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane symmetrel syrup 10mg/ml|gapeam DRUGBANK DB00915 C10H17N small molecule N04BB01 768-94-5 DRUGBANK 11874 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Hesselink MB (1999) 10443547 179064 905 Amantadine Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane symmetrel syrup 10mg/ml|gapeam DRUGBANK DB00915 C10H17N small molecule N04BB01 768-94-5 DRUGBANK 24811 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 24801 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 6705 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 9099 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9100 125508 116443 - GRIN3A GluN3A|NMDAR-L|NR3A 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 17601 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens agonist target Compagnone NA (1998) 9539798 181620 1643 Dehydroepiandrosterone 3-beta-Hydroxy-5-androsten-17-one|DHA|5-Dehydroepiandrosterone|5-DHEA|DHEA|Prasterone prastera DRUGBANK DB01708 C19H28O2 small molecule A14AA07|G03EA03 53-43-0 DRUGBANK 14349 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Perouansky M (1996) 8968191 180413 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14473 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 1162 Phenobarbital Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure phenobarbital sodium injection DRUGBANK DB01174 C12H12N2O3 small molecule N03AA02 50-06-6 DRUGBANK 24108 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens inhibitor target Kohno T (2012) 22716121 182205 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 24109 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens inhibitor target Shuto S (1995) 7636857 181687 4696 Milnacipran Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran milnacipran hydrochloride|save DRUGBANK DB04896 C15H22N2O small molecule N06AX17 92623-85-3 DRUGBANK 12603 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens unknown target Shimoyama M (2000) 10781913 179586 986 Gabapentin Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum gapeam budibac|neurontin 600mg DRUGBANK DB00996 C9H17NO2 small molecule N03AX12 60142-96-3 DRUGBANK 24808 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Warach S (2005) 16340185 181922 5616 Gavestinel - - DRUGBANK DB06741 - small molecule - 153436-22-7 DRUGBANK 5410 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 305 Pentobarbital 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid nembutal sodium inj 50mg/ml|no DRUGBANK DB00312 C11H18N2O3 small molecule N05CA01 76-74-4 DRUGBANK 24798 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Ebert B (1995) 7624018 181686 5615 Ketobemidone Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum - DRUGBANK DB06738 C15H21NO2 small molecule N02AB01|N02AG02 469-79-4 DRUGBANK 6702 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Daniell LC (1994) 7862741 175103 410 Secobarbital 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital seconal sodium pulvule 240 0.1 DRUGBANK DB00418 C12H18N2O3 small molecule N05CA06 76-73-3 DRUGBANK 2541 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 2542 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 9093 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Witkiewitz K (2012) 22346357 177609 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 9094 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Mann K (2008) 18540918 177610 649 Acamprosate N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid campral|acamprosate calcium DRUGBANK DB00659 C5H11NO4S small molecule N07BB03 77337-76-9 DRUGBANK 2817 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens unknown target Smothers CT (2007) 17502428 173484 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 5190 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens blocker target Ludolph AG (2010) 20423340 174993 282 Atomoxetine Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina riva-atomoxetine|strattera|pms DRUGBANK DB00289 C17H21NO small molecule N06BA09 83015-26-3 DRUGBANK 16871 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Stirling JM (1989) 2538766 181476 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 16872 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Geldenhuys WJ (2007) 17157509 181478 1460 Tenocyclidine TCP - DRUGBANK DB01520 C15H23NS small molecule - 21500-98-1 DRUGBANK 14450 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Imming P (2006) 17016423 171742 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14451 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Kornhuber J (1995) 8788072 180466 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 14452 125509 116444 - GRIN3B GluN3B|NR3B 9606 Homo sapiens antagonist target Overington JP (2006) 17139284 171741 1161 Orphenadrine o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine norgesic forte|orphenadrine ci DRUGBANK DB01173 C18H23NO small molecule M03BC51|N04AB02|M03BC01 83-98-7 DRUGBANK 10229 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Nakagawa H (2006) 16309825 178271 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10230 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Ishikawa T (2006) 16454746 178270 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10231 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Yoshikawa M (2004) 15255290 178273 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10232 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Ramesh M (2010) 19852077 178272 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10233 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Yang X (2005) 15975002 178275 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10234 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Yoshikawa M (2004) 15170677 178274 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10235 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Chabot GG (1997) 9342501 178276 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10236 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10237 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Chen X (2002) 11752352 171740 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 10238 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 752 Irinotecan Biotecan|Camptothecin-11 irinotecan hydrochloride injec DRUGBANK DB00762 C33H38N4O6 small molecule L01XX19 97682-44-5 DRUGBANK 12969 125510 116447 - TOP1MT - 9606 Homo sapiens inhibitor target Kosovsky MJ (1993) 8390858 179791 1019 Topotecan 9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum topotecan|topotecan injection| DRUGBANK DB01030 C23H23N3O5 small molecule L01XX17 123948-87-8 DRUGBANK 10493 125624 118856 - MMP21 MMP-21 9606 Homo sapiens inhibitor target Heath EI (2000) 10852638 178392 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 10494 125624 118856 - MMP21 MMP-21 9606 Homo sapiens inhibitor target Belotti D (2000) 10669951 178393 776 Marimastat BB-2516|Marimastat - DRUGBANK DB00786 C15H29N3O5 small molecule - 154039-60-8 DRUGBANK 22194 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3759 Feruloyl Coenzyme A - - DRUGBANK DB03923 C31H44N7O20P3S small molecule - - DRUGBANK 22195 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3759 Feruloyl Coenzyme A - - DRUGBANK DB03923 C31H44N7O20P3S small molecule - - DRUGBANK 22196 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3759 Feruloyl Coenzyme A - - DRUGBANK DB03923 C31H44N7O20P3S small molecule - - DRUGBANK 20712 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3047 Sinapoyl Coenzyme A - - DRUGBANK DB03179 C32H44N7O20P3S small molecule - - DRUGBANK 20713 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3047 Sinapoyl Coenzyme A - - DRUGBANK DB03179 C32H44N7O20P3S small molecule - - DRUGBANK 20714 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3047 Sinapoyl Coenzyme A - - DRUGBANK DB03179 C32H44N7O20P3S small molecule - - DRUGBANK 17710 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17711 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17712 125625 118881 UNQ766/PRO1558 COMTD1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 2569 125638 119391 RP11-127L20.2 GSTO2 GSTO 2-2|bA127L20.1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2570 125638 119391 RP11-127L20.2 GSTO2 GSTO 2-2|bA127L20.1 9606 Homo sapiens unknown target Board PG (2007) 17226937 173316 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2571 125638 119391 RP11-127L20.2 GSTO2 GSTO 2-2|bA127L20.1 9606 Homo sapiens unknown target Whitbread AK (2003) 12618591 173315 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2572 125638 119391 RP11-127L20.2 GSTO2 GSTO 2-2|bA127L20.1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2573 125638 119391 RP11-127L20.2 GSTO2 GSTO 2-2|bA127L20.1 9606 Homo sapiens unknown target Whitbread AK (2006) 16399380 173317 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 1937 125741 121642 - ALKBH2 ABH2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1938 125741 121642 - ALKBH2 ABH2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 26389 125777 122553 - TRAPPC6B TPC6 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7128 S-PALMITOYL-L-CYSTEINE - - DRUGBANK DB08342 C19H37NO3S small molecule - - DRUGBANK 21425 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3365 6-O-Phosphoryl Inosine Monophosphate - - DRUGBANK DB03510 C10H14N4O11P2 small molecule - - DRUGBANK 21426 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3365 6-O-Phosphoryl Inosine Monophosphate - - DRUGBANK DB03510 C10H14N4O11P2 small molecule - - DRUGBANK 21427 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3365 6-O-Phosphoryl Inosine Monophosphate - - DRUGBANK DB03510 C10H14N4O11P2 small molecule - - DRUGBANK 23077 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23078 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23079 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 1997 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 1998 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 122 L-Aspartic Acid L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid primene 10%|aminosyn ii 5% inj DRUGBANK DB00128 C4H7NO4 small molecule - 56-84-8 DRUGBANK 23370 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4234 Adenylosuccinic Acid N(6)-(1,2-dicarboxyethyl)AMP|N-[9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purin-6-yl]aspartic acid|N(6)-(1,2-dicarboxyethyl)-AMP|Aspartyl adenylate - DRUGBANK DB04418 C14H18N5O11P small molecule - 19046-78-7 DRUGBANK 23371 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4234 Adenylosuccinic Acid N(6)-(1,2-dicarboxyethyl)AMP|N-[9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purin-6-yl]aspartic acid|N(6)-(1,2-dicarboxyethyl)-AMP|Aspartyl adenylate - DRUGBANK DB04418 C14H18N5O11P small molecule - 19046-78-7 DRUGBANK 23372 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4234 Adenylosuccinic Acid N(6)-(1,2-dicarboxyethyl)AMP|N-[9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purin-6-yl]aspartic acid|N(6)-(1,2-dicarboxyethyl)-AMP|Aspartyl adenylate - DRUGBANK DB04418 C14H18N5O11P small molecule - 19046-78-7 DRUGBANK 23712 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23713 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23714 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 18546 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2029 Hadacidin - - DRUGBANK DB02109 C3H5NO4 small molecule - - DRUGBANK 18547 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2029 Hadacidin - - DRUGBANK DB02109 C3H5NO4 small molecule - - DRUGBANK 18548 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2029 Hadacidin - - DRUGBANK DB02109 C3H5NO4 small molecule - - DRUGBANK 22641 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22642 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22643 125783 122622 - ADSSL1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 11175 125807 122953 - JDP2 JUNDM2 9606 Homo sapiens unknown target Fiebich BL (2012) 21631396 178700 842 Pseudoephedrine L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|D-Pseudoephedrine|Pseudoephedrinum|D-Isoephedrine|D-Psi-ephedrine|Pseudoefedrina|Pseudoephedrine|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|D-Psi-2-methylamino-1-phenyl-1-propanol|L(+)-Psi-ephedrine|(+)-threo-Ephedrine|trans-Ephedrine|(+)-Psi-ephedrine|Psi-ephedrin children's tylenol cold liquid DRUGBANK DB00852 C10H15NO small molecule R01BA52|R01BA02 90-82-4 DRUGBANK 8272 125814 123096 - SLC25A29 C14orf69|CACL|ORNT3 9606 Homo sapiens unknown target Sekoguchi E (2003) 12882971 177055 573 L-Carnitine (S)-Carnitine|Karnitin|L-Carnitine|Levocarnitinum|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Carnitor|Levocarnitin|Lvocarnitine|Carnitene|Vitamin bt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium|(-)-L-Carnitine|Carnitine|(-)-L-Carnitin|Carnicor - DRUGBANK DB00583 C7H15NO3 small molecule A16AA01 541-15-1 DRUGBANK 1664 125820 123263 - MTFMT COXPD15|FMT1 9606 Homo sapiens cofactor target Li Y (2000) 10781559 51297 111 Tetrahydrofolic acid Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid - DRUGBANK DB00116 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 24312 125848 124056 - NOXO1 P41NOX|P41NOXA|P41NOXB|P41NOXC|SH3PXD5|SNX28 9606 Homo sapiens antagonist target Kusumoto K (2005) 15458921 181865 5042 Ecabet Ecabet sodium|Ecabet - DRUGBANK DB05265 C20H28O5S small molecule - 33159-27-2 DRUGBANK 2413 125866 124454 - EARS2 COXPD12|MSE1 9606 Homo sapiens unknown target Sekine S (2006) 17161369 173243 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 21375 125875 124583 - CANT1 DBQD|SCAN-1|SCAN1|SHAPY 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3341 Phosphomethylphosphonic Acid Guanosyl Ester - - DRUGBANK DB03486 C11H17N5O10P2 small molecule - - DRUGBANK 21376 125875 124583 - CANT1 DBQD|SCAN-1|SCAN1|SHAPY 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3341 Phosphomethylphosphonic Acid Guanosyl Ester - - DRUGBANK DB03486 C11H17N5O10P2 small molecule - - DRUGBANK 21866 125875 124583 - CANT1 DBQD|SCAN-1|SCAN1|SHAPY 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21867 125875 124583 - CANT1 DBQD|SCAN-1|SCAN1|SHAPY 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 26386 125945 126003 - TRAPPC5 TRS31 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7128 S-PALMITOYL-L-CYSTEINE - - DRUGBANK DB08342 C19H37NO3S small molecule - - DRUGBANK 3277 125981 126328 - NDUFA11 B14.7|CI-B14.7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3278 125981 126328 - NDUFA11 B14.7|CI-B14.7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 549 126085 127833 - SYT2 MYSPC|SytII 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 550 126085 127833 - SYT2 MYSPC|SytII 9606 Homo sapiens unknown target Poulain B (2009) 19576489 172011 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 551 126085 127833 - SYT2 MYSPC|SytII 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 41 Botulinum Toxin Type B RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor myobloc DRUGBANK DB00042 - biologic - 93384-44-2 DRUGBANK 22820 126370 133688 - UGT3A1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4044 Quercetin 3,5,7,3',4'-Pentahydroxyflavone - DRUGBANK DB04216 C15H10O7 small molecule - 117-39-5 DRUGBANK 17933 126370 133688 - UGT3A1 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1782 Kaempherol - - DRUGBANK DB01852 C15H10O6 small molecule - 520-18-3 DRUGBANK 3910 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Miller GM (2005) 15764732 174161 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3911 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234900 174160 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3912 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Wolinsky TD (2007) 17212650 174157 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3913 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Reese EA (2007) 17218486 174158 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 3914 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234899 174159 175 Amphetamine beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine pms-amphetamines xr|act amphet DRUGBANK DB00182 C9H13N small molecule N06BA01 300-62-9 DRUGBANK 17035 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Miller GM (2005) 15764732 174161 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17036 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234900 174160 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17037 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Wolinsky TD (2007) 17212650 174157 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17038 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Reese EA (2007) 17218486 174158 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17039 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234899 174159 1516 Dextroamphetamine (+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine act amphetamine xr|dextroamphe DRUGBANK DB01576 C9H13N small molecule N06BA02 51-64-9 DRUGBANK 17058 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Grandy DK (2007) 17888514 181532 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17059 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Borowsky B (2001) 11459929 181533 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17060 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Reese EA (2007) 17218486 174158 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17061 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234899 174159 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17062 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234900 174160 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17063 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Wolinsky TD (2007) 17212650 174157 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 17064 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Miller GM (2005) 15764732 174161 1517 Methamphetamine d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine desoxyn|methamphetamine hydroc DRUGBANK DB01577 C10H15N small molecule N06BA03 537-46-2 DRUGBANK 24771 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Miller GM (2005) 15764732 174161 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 24772 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234900 174160 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 24773 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Wolinsky TD (2007) 17212650 174157 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 24774 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Reese EA (2007) 17218486 174158 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 24775 126416 134864 RP11-295F4.9 TAAR1 TA1|TAR1|TRAR1 9606 Homo sapiens agonist target Xie Z (2007) 17234899 174159 5596 Propylhexedrine - benzedrex 09-19-2014 DRUGBANK DB06714 C10H21N small molecule - 101-40-6 DRUGBANK 26427 126617 140465 - MYL6B MLC1SA 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7163 4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID - - DRUGBANK DB08378 C14H16N2O5 small molecule - - DRUGBANK 2795 126644 140679 - SLC32A1 VGAT|VIAAT 9606 Homo sapiens unknown target Fujii M (2007) 17418495 173476 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2796 126644 140679 - SLC32A1 VGAT|VIAAT 9606 Homo sapiens unknown target Uchigashima M (2007) 17652600 173474 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2797 126644 140679 - SLC32A1 VGAT|VIAAT 9606 Homo sapiens unknown target Aubrey KR (2007) 17554001 173475 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 26481 126711 140801 - RPL10L RPL10_5_1358 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25381 126711 140801 - RPL10L RPL10_5_1358 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6190 Anisomycin - - DRUGBANK DB07374 C14H19NO4 small molecule - 22862-76-6 DRUGBANK 19326 126711 140801 - RPL10L RPL10_5_1358 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2391 Alpha-Hydroxy-Beta-Phenyl-Propionic Acid - - DRUGBANK DB02494 C9H10O3 small molecule - - DRUGBANK 26886 126823 143903 UNQ208/PRO234 LAYN - 9606 Homo sapiens binder target Bono P (2001) 11294894 181771 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 3558 126895 145226 - RDH12 LCA13|LCA3|RP53|SDR7C2 9606 Homo sapiens unknown target Thompson DA (2005) 16269441 173906 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3559 126895 145226 - RDH12 LCA13|LCA3|RP53|SDR7C2 9606 Homo sapiens unknown target Maeda A (2006) 17032653 173907 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 3560 126895 145226 - RDH12 LCA13|LCA3|RP53|SDR7C2 9606 Homo sapiens unknown target Keller B (2007) 17512723 173905 156 Vitamin A Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol infant's multiple vitamin drop DRUGBANK DB00162 C20H30O small molecule D10AD02|R01AX02|S01XA02|A11CA01 68-26-8 DRUGBANK 25185 126915 145482 - PTGR2 HEL-S-298|PGR2|ZADH1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5994 (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID - - DRUGBANK DB07177 C20H30O5 small molecule - - DRUGBANK 5608 126915 145482 - PTGR2 HEL-S-298|PGR2|ZADH1 9606 Homo sapiens inhibitor target Wu YH (2008) 19000823 175244 321 Indomethacin Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina indocid cap 25mg|tivorbex|apo DRUGBANK DB00328 C19H16ClNO4 small molecule M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03 53-86-1 DRUGBANK 26880 126950 145864 UNQ238/PRO271 HAPLN3 EXLD1|HsT19883 9606 Homo sapiens binder target Spicer AP (2003) 12663660 181813 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 3645 127558 154807 - VKORC1L1 - 9606 Homo sapiens cofactor target Stafford DW (2005) 16102054 173991 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3646 127558 154807 - VKORC1L1 - 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3647 127558 154807 - VKORC1L1 - 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 3648 127558 154807 - VKORC1L1 - 9606 Homo sapiens cofactor target Oldenburg J (2006) 16677080 173992 163 Menadione Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone - DRUGBANK DB00170 C11H8O2 small molecule B02BA02 58-27-5 DRUGBANK 17653 127645 158067 RP11-143F18.1 AK8 AK 8|C9orf98|DDX31 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17654 127645 158067 RP11-143F18.1 AK8 AK 8|C9orf98|DDX31 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17655 127645 158067 RP11-143F18.1 AK8 AK 8|C9orf98|DDX31 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 3189 127750 160287 - LDHAL6A LDH6A 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3190 127750 160287 - LDHAL6A LDH6A 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 2397 127816 162417 - NAGS AGAS|ARGA 9606 Homo sapiens unknown target Xu Y (2007) 17347518 173237 136 L-Glutamic Acid (S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu primene 10%|aminosyn ii 5% inj DRUGBANK DB00142 C5H9NO4 small molecule - 56-86-0 DRUGBANK 1833 127819 162466 - PHOSPHO1 - 9606 Homo sapiens product of target Imming P (2006) 17016423 171742 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 1834 127819 162466 - PHOSPHO1 - 9606 Homo sapiens product of target Overington JP (2006) 17139284 171741 117 Choline Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine nata komplete|vitamin b comple DRUGBANK DB00122 C5H14NO small molecule N02BA03 62-49-7 DRUGBANK 10862 127821 162514 - TRPV3 OLMS|VRL3 9606 Homo sapiens inducer target Macpherson LJ (2006) 16829128 178571 815 Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol western family pain relieving| DRUGBANK DB00825 C10H20O small molecule - 2216-51-5 DRUGBANK 26393 127917 165631 - PARP15 ARTD7|BAL3|pART7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7133 N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE - - DRUGBANK DB08348 C17H17N3O2 small molecule - - DRUGBANK 1635 127933 166785 - MMAA cblA 9606 Homo sapiens cofactor target Dobson CM (2006) 16697227 172611 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1636 127933 166785 - MMAA cblA 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1637 127933 166785 - MMAA cblA 9606 Homo sapiens cofactor target Lerner-Ellis JP (2004) 15523652 172612 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 1638 127933 166785 - MMAA cblA 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 110 Cyanocobalamin Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin vitamin b complex 100 tab|mult DRUGBANK DB00115 C63H89CoN14O14P small molecule B03BA01|B03AE01|B03BA51 68-19-9 DRUGBANK 4185 127933 166785 - MMAA cblA 9606 Homo sapiens unknown target Rosenblatt DS (1987) 20301409 174330 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4186 127933 166785 - MMAA cblA 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4187 127933 166785 - MMAA cblA 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 13258 128062 170572 - HTR3C - 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13259 128062 170572 - HTR3C - 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13260 128062 170572 - HTR3C - 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13261 128062 170572 - HTR3C - 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 27162 128062 170572 - HTR3C - 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 21195 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3287 (2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile - - DRUGBANK DB03430 C8H7NO2 small molecule - - DRUGBANK 21196 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3287 (2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile - - DRUGBANK DB03430 C8H7NO2 small molecule - - DRUGBANK 21197 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3287 (2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile - - DRUGBANK DB03430 C8H7NO2 small molecule - - DRUGBANK 18682 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2101 2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One - - DRUGBANK DB02185 C9H9NO5 small molecule - - DRUGBANK 19113 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19114 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19115 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19266 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 19267 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 19268 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2371 Nojirimycine Tetrazole - - DRUGBANK DB02471 C6H10N4O4 small molecule - - DRUGBANK 26473 128236 197021 UNQ3022/PRO9820 LCTL KLG|KLPH 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7212 PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE - - DRUGBANK DB08430 C12H15NO7S small molecule - - DRUGBANK 25897 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6659 7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE - - DRUGBANK DB07862 C15H19N5 small molecule - - DRUGBANK 26227 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6994 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE - - DRUGBANK DB08203 C15H19N5O2 small molecule - - DRUGBANK 18088 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1854 5-Chloryl-2,4,6-Quinazolinetriamine - - DRUGBANK DB01929 C8H8ClN5O2 small molecule - - DRUGBANK 23027 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4132 5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine - - DRUGBANK DB04306 C15H14N4S small molecule - - DRUGBANK 19151 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2305 5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine - - DRUGBANK DB02402 C15H14N4O2 small molecule - - DRUGBANK 18297 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1925 5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine - - DRUGBANK DB02001 C18H19N5OS small molecule - - DRUGBANK 22752 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3993 5-Phenylsulfanyl-2,4-Quinazolinediamine - - DRUGBANK DB04163 C14H12N4S small molecule - - DRUGBANK 18168 128354 200895 - DHFRL1 DHFRP4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1882 5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine - - DRUGBANK DB01958 C18H20N4S small molecule - - DRUGBANK 13226 128355 200909 - HTR3D 5HT3D 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13227 128355 200909 - HTR3D 5HT3D 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13228 128355 200909 - HTR3D 5HT3D 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13229 128355 200909 - HTR3D 5HT3D 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 27161 128355 200909 - HTR3D 5HT3D 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 11033 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11034 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 832 Oxazepam Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam oxazepam 15mg tablets|apo oxaz DRUGBANK DB00842 C15H11ClN2O2 small molecule N05BA04 604-75-1 DRUGBANK 11491 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 11492 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 887 Triazolam Triazolam|Halcion|Triazolamum penta-triazolam tablets|halcio DRUGBANK DB00897 C17H12Cl2N4 small molecule N05CD05 28911-01-5 DRUGBANK 10660 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Iorio LC (1984) 6738302 178448 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 10661 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Wamsley JK (1985) 2867566 178449 791 Halazepam Paxipam|Halazpam|Halazepamum|Halazepam - DRUGBANK DB00801 C17H12ClF3N2O small molecule N05BA13 23092-17-3 DRUGBANK 7958 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Lahti RA (1983) 6320036 176808 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 7959 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Sethy VH (1984) 6148400 176809 536 Adinazolam Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine - DRUGBANK DB00546 C19H18ClN5 small molecule N05BA07 37115-32-5 DRUGBANK 14936 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Miller LG (1987) 2889803 180661 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 14937 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Braestrup C (1978) 639854 180662 1203 Estazolam Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine prosom tab 2mg|prosom tab 1mg| DRUGBANK DB01215 C16H11ClN4 small molecule N05CD04 29975-16-4 DRUGBANK 9466 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 9467 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 673 Midazolam Buccolam|Midazolam|Dormicum|Midazolamum midazolam injection sdz|midazo DRUGBANK DB00683 C18H13ClFN3 small molecule N05CD08 59467-70-8 DRUGBANK 10901 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 10902 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 819 Diazepam Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium pms-diazepam solution 1mg/ml|d DRUGBANK DB00829 C16H13ClN2O small molecule N05BA01 439-14-5 DRUGBANK 17268 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17269 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1534 Nitrazepam Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson sandoz nitrazepam|nitrazepam-1 DRUGBANK DB01595 C15H11N3O3 small molecule N05CD02 146-22-5 DRUGBANK 17234 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Walash MI (1994) 7849137 181561 1533 Cinolazepam 7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01594 C18H13ClFN3O2 small molecule N05CD13 75696-02-5 DRUGBANK 17164 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Schove LT (1994) 7773620 181550 1527 Prazepam Centrax|Prazepamum - DRUGBANK DB01588 C19H17ClN2O small molecule N05BA11 2955-38-6 DRUGBANK 16946 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16947 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 1498 Bromazepam Bromazepamum|Lectopam alti-bromazepam 1.5mg tablets| DRUGBANK DB01558 C14H10BrN3O small molecule N05BA08 1812-30-2 DRUGBANK 16966 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Mandrioli R (2008) 18855614 181508 1499 Clotiazepam Clotiazepamum|Rize - DRUGBANK DB01559 C16H15ClN2OS small molecule N05BA21 33671-46-4 DRUGBANK 4536 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 4537 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 224 Temazepam Restoril strazepam|nu-temazepam|phl-tem DRUGBANK DB00231 C16H13ClN2O2 small molecule N05CD07 846-50-4 DRUGBANK 17191 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Billard W (1988) 2892106 181552 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 17192 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Meldrum BS (1986) 3017690 181553 1528 Quazepam Doral|Quazepamum doral|quazepam DRUGBANK DB01589 C17H11ClF4N2S small molecule N05CD10 36735-22-5 DRUGBANK 9538 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Moehler H (2002) 11752090 174537 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 9539 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Riss J (2008) 18384456 174202 680 Flurazepam Insumin|Flurazpam|Flurazepam|Flurazepamum dalmane|somnol 30mg|flurazepam DRUGBANK DB00690 C21H23ClFN3O small molecule N05CD01 17617-23-1 DRUGBANK 17009 128361 200959 - GABRR3 - 9606 Homo sapiens potentiator target Nakatsuka I (1985) 2857046 181520 1507 Fludiazepam Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one - DRUGBANK DB01567 C16H12ClFN2O small molecule N05BA17 3900-31-0 DRUGBANK 14517 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Wolff J (1991) 2011590 180494 1167 Podofilox Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT wartec|condyline|podofilox|con DRUGBANK DB01179 C22H22O8 small molecule D06BB04 518-28-5 DRUGBANK 20308 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 20309 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2886 Epothilone B Patupilone|()-epothilone B|Epo B - DRUGBANK DB03010 C27H41NO6S small molecule - 152044-54-7 DRUGBANK 18004 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 18005 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1801 Epothilone D Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B - DRUGBANK DB01873 C27H41NO5S small molecule - 189453-10-9 DRUGBANK 8135 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens adduct target Correia JJ (1991) 1818332 176945 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8136 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens adduct target Islam MN (2004) 15579115 176944 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8137 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens adduct target Gupta S (2003) 14619954 176946 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8138 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens adduct target Jordan A (1998) 9664292 176943 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 8139 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens adduct target Jordan MA (2007) 18220533 176942 560 Vinblastine Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine vinblastine sulphate injection DRUGBANK DB00570 C46H58N4O9 small molecule L01CA01 865-21-4 DRUGBANK 16387 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Acharya BR (2009) 19527023 181275 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16388 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Li CM (2010) 20814887 180493 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16389 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Cerquaglia C (2005) 15720245 181277 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 16390 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Yee KW (2005) 16166440 181278 1344 Colchicine Colchicina|Colchicinum|Colchicin colcrys|euro-colchicine|colchi DRUGBANK DB01394 C22H25NO6 small molecule M04AC01 64-86-8 DRUGBANK 5957 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 353 Vinorelbine Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine vinorelbine tartrate injection DRUGBANK DB00361 C45H54N4O8 small molecule L01CA04 71486-22-1 DRUGBANK 5958 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 353 Vinorelbine Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine vinorelbine tartrate injection DRUGBANK DB00361 C45H54N4O8 small molecule L01CA04 71486-22-1 DRUGBANK 5959 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Chang AY (1995) 7740336 175496 353 Vinorelbine Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine vinorelbine tartrate injection DRUGBANK DB00361 C45H54N4O8 small molecule L01CA04 71486-22-1 DRUGBANK 5960 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Kruczynski A (1998) 9515574 175497 353 Vinorelbine Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine vinorelbine tartrate injection DRUGBANK DB00361 C45H54N4O8 small molecule L01CA04 71486-22-1 DRUGBANK 5961 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Seve P (2010) 20403547 175495 353 Vinorelbine Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine vinorelbine tartrate injection DRUGBANK DB00361 C45H54N4O8 small molecule L01CA04 71486-22-1 DRUGBANK 7857 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Imming P (2006) 17016423 171742 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 7858 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Gan PP (2010) 20442307 176760 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 7859 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Overington JP (2006) 17139284 171741 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 7860 128444 203068 DAAP-285E11.4 TUBB CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5 9606 Homo sapiens inhibitor target Kurtzberg LS (2009) 19277662 176762 531 Vincristine 22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine oncovin solution 1mg/ml|vincri DRUGBANK DB00541 C46H56N4O10 small molecule L01CA02 57-22-7 DRUGBANK 2818 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Broeer A (2006) 16052352 173487 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2819 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Bermingham JR (2004) 15058382 173486 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2820 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Metzner L (2004) 14718599 173485 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2821 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2822 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 3495 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3496 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 3497 128503 206358 - SLC36A1 Dct1|LYAAT1|PAT1|TRAMD3 9606 Homo sapiens unknown target Miyauchi S (2005) 16373326 173862 154 L-Alanine (S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine freamine iii|primene 10%|2.5% DRUGBANK DB00160 C3H7NO2 small molecule - 56-41-7 DRUGBANK 2812 128607 219970 - GLYATL2 BXMAS2-10|GATF-B 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 2813 128607 219970 - GLYATL2 BXMAS2-10|GATF-B 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 139 Glycine Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll 2.5% travasol amino acid injec DRUGBANK DB00145 C2H5NO2 small molecule B05CX03 56-40-6 DRUGBANK 23090 128683 221079 - ARL5B ARL8 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 1918 128686 221120 - ALKBH3 ABH3|DEPC-1|DEPC1|PCA1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 1919 128686 221120 - ALKBH3 ABH3|DEPC-1|DEPC1|PCA1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 2554 128713 221357 - GSTA5 - 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2555 128713 221357 - GSTA5 - 9606 Homo sapiens unknown target McDonagh PD (1999) 10085232 173308 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2556 128713 221357 - GSTA5 - 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2557 128713 221357 - GSTA5 - 9606 Homo sapiens unknown target McLeod R (1997) 9331086 173306 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2558 128713 221357 - GSTA5 - 9606 Homo sapiens unknown target Kazi S (2002) 12076520 173307 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 27526 129116 255738 PSEC0052 PCSK9 FH3|HCHOLA3|LDLCQ1|NARC-1|NARC1|PC9 9606 Homo sapiens inhibitor target Devito F (2015) 26455563 188563 8046 Alirocumab - praluent DRUGBANK DB09302 C6472H9996N1736O2032S42 biologic - 1245916-14-6 DRUGBANK 2654 129206 257202 - GPX6 GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2655 129206 257202 - GPX6 GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1 9606 Homo sapiens cofactor target Myllylae V (1986) 3532684 173373 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2656 129206 257202 - GPX6 GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2657 129206 257202 - GPX6 GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1 9606 Homo sapiens cofactor target Giovannini C (2008) 17588737 173305 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2658 129206 257202 - GPX6 GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1 9606 Homo sapiens cofactor target Brigelius-Flohe R (2006) 17081103 173374 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 22756 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3996 2-Aminobenzoic Acid - - DRUGBANK DB04166 C7H7NO2 small molecule - - DRUGBANK 22757 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3996 2-Aminobenzoic Acid - - DRUGBANK DB04166 C7H7NO2 small molecule - - DRUGBANK 22758 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3996 2-Aminobenzoic Acid - - DRUGBANK DB04166 C7H7NO2 small molecule - - DRUGBANK 22966 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22967 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22968 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 20635 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20636 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20637 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20765 129252 259307 UNQ636/PRO1265 IL4I1 FIG1|LAAO|LAO 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3082 Vinylglycine L-vinylglycine|(2s)-2-Aminobut-3-Enoicacid|(2s)-2-Amino-3-Butenoic Acid - DRUGBANK DB03214 C4H7NO2 small molecule - 52773-87-2 DRUGBANK 3585 129297 266629 - SEC14L3 TAP2 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3586 129297 266629 - SEC14L3 TAP2 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3587 129297 266629 - SEC14L3 TAP2 9606 Homo sapiens unknown target Ye X (2004) 15040456 173929 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3590 129974 284904 - SEC14L4 TAP3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 3591 129974 284904 - SEC14L4 TAP3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 157 Vitamin E (R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol maltlevol liq|mnps formula sup DRUGBANK DB00163 C29H50O2 small molecule - 59-02-9 DRUGBANK 13222 130056 285242 - HTR3E 5-HT3-E|5-HT3E|5-HT3c1 9606 Homo sapiens antagonist target Korneyev AY (1996) 8786706 179892 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13223 130056 285242 - HTR3E 5-HT3-E|5-HT3E|5-HT3c1 9606 Homo sapiens antagonist target Markstein R (1985) 2869188 179893 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13224 130056 285242 - HTR3E 5-HT3-E|5-HT3E|5-HT3c1 9606 Homo sapiens antagonist target Flynn BL (1999) 10084415 179894 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 13225 130056 285242 - HTR3E 5-HT3-E|5-HT3E|5-HT3c1 9606 Homo sapiens antagonist target Wadworth AN (1992) 1606351 179895 1038 Ergoloid mesylate Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids hydergine tablets, 1mg DRUGBANK DB01049 C30H41N5O8S small molecule C04AE51|C04AE01 8067-24-1 DRUGBANK 27165 130056 285242 - HTR3E 5-HT3-E|5-HT3E|5-HT3c1 9606 Homo sapiens unknown target Dopico AM (2009) 19270242 188491 888 Ethanol thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured lisa frank bubblegum antisepti DRUGBANK DB00898 C2H6O small molecule D08AX08|V03AB16|V03AZ01 64-17-5 DRUGBANK 1424 130074 285313 - IGSF10 CMF608 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1425 130074 285313 - IGSF10 CMF608 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1426 130074 285313 - IGSF10 CMF608 9606 Homo sapiens cofactor target Berman HM (2000) 10592235 172122 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 22798 130457 317749 - DHRS4L2 SDR25C3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4028 Matairesinol 3R,4R-Bis((4-hydroxy-3-methoxyphenyl)methyl)dihydro-2(3H)-furanone|Artigenin congener|(-)-Matairesinol|Dibenzylbutyrolactone lignanolide|(alphaR,betaR)-alpha,beta-Bis(4-hydroxy-3-methoxybenzyl)butyrolactone - DRUGBANK DB04200 C20H22O6 small molecule - 580-72-3 DRUGBANK 4183 130605 326625 - MMAB ATR|CFAP23|cblB|cob 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 4184 130605 326625 - MMAB ATR|CFAP23|cblB|cob 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 193 Hydroxocobalamin Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine hydro cobex inj 1000mcg/ml|hyd DRUGBANK DB00200 C62H89CoN13O15P small molecule V03AB33|B03BA03|B03BA53 13422-51-0 DRUGBANK 8755 130748 338442 - HCAR2 GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g 9606 Homo sapiens agonist target Zellner C (2005) 15580557 177423 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8756 130748 338442 - HCAR2 GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g 9606 Homo sapiens agonist target Tunaru S (2005) 16099840 177425 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8757 130748 338442 - HCAR2 GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g 9606 Homo sapiens agonist target Zhang Y (2005) 16018973 177424 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8758 130748 338442 - HCAR2 GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g 9606 Homo sapiens agonist target Wise A (2003) 12522134 177427 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 8759 130748 338442 - HCAR2 GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g 9606 Homo sapiens agonist target Soga T (2003) 12646212 177426 617 Niacin Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor b-3 500mg continuous released| DRUGBANK DB00627 C6H5NO2 small molecule C10BA01|C10AD02|C10AD52|C04AC01 59-67-6 DRUGBANK 1566 130959 339896 - GADL1 ADC|CSADC|HuADC|HuCSADC 9606 Homo sapiens cofactor target Imming P (2006) 17016423 171742 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 1567 130959 339896 - GADL1 ADC|CSADC|HuADC|HuCSADC 9606 Homo sapiens cofactor target Overington JP (2006) 17139284 171741 109 Pyridoxal Phosphate Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate - DRUGBANK DB00114 C8H10NO6P small molecule A11HA06 54-47-7 DRUGBANK 24011 131028 340273 tcag7.1091 ABCB5 ABCB5alpha|ABCB5beta|EST422562 9606 Homo sapiens unknown target Minderman H (2004) 15014037 181844 4652 Biricodar dicitrate biricodar - DRUGBANK DB04851 C46H57N3O21 small molecule - 174254-13-8 DRUGBANK 25837 131319 344752 - AADACL2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6613 GIBBERELLIN A4 - - DRUGBANK DB07815 C19H24O5 small molecule - - DRUGBANK 25836 131319 344752 - AADACL2 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6612 GIBBERELLIN A3 - - DRUGBANK DB07814 C19H22O6 small molecule - - DRUGBANK 25585 131483 347733 RP11-506K6.1 TUBB2B PMGYSA|bA506K6.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6382 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE - - DRUGBANK DB07574 C22H25NO6S small molecule - - DRUGBANK 19515 131564 349565 FKSG76 NMNAT3 PNAT-3|PNAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2490 Alpha,Beta-Methyleneadenosine-5'-Triphosphate - - DRUGBANK DB02596 C11H18N5O12P3 small molecule - - DRUGBANK 19516 131564 349565 FKSG76 NMNAT3 PNAT-3|PNAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2490 Alpha,Beta-Methyleneadenosine-5'-Triphosphate - - DRUGBANK DB02596 C11H18N5O12P3 small molecule - - DRUGBANK 22564 131564 349565 FKSG76 NMNAT3 PNAT-3|PNAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 22565 131564 349565 FKSG76 NMNAT3 PNAT-3|PNAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 20792 131564 349565 FKSG76 NMNAT3 PNAT-3|PNAT3 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3095 Nicotinamide Mononucleotide - - DRUGBANK DB03227 C11H16N2O8P small molecule - - DRUGBANK 20793 131564 349565 FKSG76 NMNAT3 PNAT-3|PNAT3 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3095 Nicotinamide Mononucleotide - - DRUGBANK DB03227 C11H16N2O8P small molecule - - DRUGBANK 2956 131667 353238 - PADI6 hPADVI 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 2957 131667 353238 - PADI6 hPADVI 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 149 L-Citrulline N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid - DRUGBANK DB00155 C6H13N3O3 small molecule - 372-75-8 DRUGBANK 21725 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21726 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21727 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 23514 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 23515 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 23516 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 19094 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19095 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19096 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 23199 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 23200 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 23201 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 21227 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21228 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21229 131861 360203 RP11-98L5.1 GLT6D1 GLTDC1|GT6M7 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 2677 131875 373156 HDCMD47P GSTK1 GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2678 131875 373156 HDCMD47P GSTK1 GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2679 131875 373156 HDCMD47P GSTK1 GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1 9606 Homo sapiens unknown target Robinson A (2004) 14709161 173384 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2680 131875 373156 HDCMD47P GSTK1 GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 3358 131889 374291 - NDUFS7 CI-20|CI-20KD|MY017|PSST 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3359 131889 374291 - NDUFS7 CI-20|CI-20KD|MY017|PSST 9606 Homo sapiens unknown target Albracht SP (1993) 8369340 173774 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3360 131889 374291 - NDUFS7 CI-20|CI-20KD|MY017|PSST 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3361 131889 374291 - NDUFS7 CI-20|CI-20KD|MY017|PSST 9606 Homo sapiens unknown target Hyslop SJ (1996) 8938450 173773 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 3362 131889 374291 - NDUFS7 CI-20|CI-20KD|MY017|PSST 9606 Homo sapiens unknown target Schuler F (1999) 10097178 173772 151 NADH DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced) - DRUGBANK DB00157 C21H29N7O14P2 small molecule - 58-68-4 DRUGBANK 11670 132020 377677 - CA13 CAXIII 9606 Homo sapiens inhibitor target Farooq MU (2008) 18782051 179029 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11671 132020 377677 - CA13 CAXIII 9606 Homo sapiens inhibitor target Unknown Authors (2007) 17582922 179041 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11672 132020 377677 - CA13 CAXIII 9606 Homo sapiens inhibitor target Biton V (2007) 17762320 179040 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11673 132020 377677 - CA13 CAXIII 9606 Homo sapiens inhibitor target De Simone G (2009) 19703035 179043 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 11674 132020 377677 - CA13 CAXIII 9606 Homo sapiens inhibitor target Supuran CT (2008) 18537527 179042 899 Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole zonegran|direct rx|zonisamide DRUGBANK DB00909 C8H8N2O3S small molecule N03AX15 68291-97-4 DRUGBANK 25124 132020 377677 - CA13 CAXIII 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 5933 N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide - - DRUGBANK DB07115 C14H15ClN2O4S2 small molecule - - DRUGBANK 14334 132263 387129 - NPSR1 ASRT2|GPR154|GPRA|NPSR|PGR14|VRR1 9606 Homo sapiens unknown target Ishizawa Y (2002) 11961111 180412 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14335 132263 387129 - NPSR1 ASRT2|GPR154|GPRA|NPSR|PGR14|VRR1 9606 Homo sapiens unknown target Streiff J (2003) 12826849 180408 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 14336 132263 387129 - NPSR1 ASRT2|GPR154|GPRA|NPSR|PGR14|VRR1 9606 Homo sapiens unknown target Ishizawa Y (2000) 10913255 180410 1147 Halothane Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane fluothane liq inh 1000mg/gm|ha DRUGBANK DB01159 C2HBrClF3 small molecule N01AB01 151-67-7 DRUGBANK 19080 132267 387266 - KRTAP5-3 KRTAP5-9|KRTAP5.3 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 21056 133150 389434 - IYD C6orf71|DEHAL1|TDH4|dJ422F24.1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3235 3,5-Diiodotyrosine - - DRUGBANK DB03374 C9H9I2NO3 small molecule - 300-39-0 DRUGBANK 20138 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2803 D-Limonene 1,2-Epoxide - - DRUGBANK DB02924 C10H16O small molecule - - DRUGBANK 20139 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2803 D-Limonene 1,2-Epoxide - - DRUGBANK DB02924 C10H16O small molecule - - DRUGBANK 20140 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2803 D-Limonene 1,2-Epoxide - - DRUGBANK DB02924 C10H16O small molecule - - DRUGBANK 21778 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 3555 6-Hydroxy-6-Methyl-Heptan-3-One - - DRUGBANK DB03711 C8H16O2 small molecule - - DRUGBANK 21779 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 3555 6-Hydroxy-6-Methyl-Heptan-3-One - - DRUGBANK DB03711 C8H16O2 small molecule - - DRUGBANK 21780 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3555 6-Hydroxy-6-Methyl-Heptan-3-One - - DRUGBANK DB03711 C8H16O2 small molecule - - DRUGBANK 20448 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2958 2-(Sec-Butyl)Thiazole - - DRUGBANK DB03087 C7H11NS small molecule - - DRUGBANK 20449 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2958 2-(Sec-Butyl)Thiazole - - DRUGBANK DB03087 C7H11NS small molecule - - DRUGBANK 20450 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2958 2-(Sec-Butyl)Thiazole - - DRUGBANK DB03087 C7H11NS small molecule - - DRUGBANK 17731 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 1693 2-Methoxy-3-Isopropylpyrazine - - DRUGBANK DB01760 C8H12N2O small molecule - 25773-40-4 DRUGBANK 17732 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 1693 2-Methoxy-3-Isopropylpyrazine - - DRUGBANK DB01760 C8H12N2O small molecule - 25773-40-4 DRUGBANK 17733 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 1693 2-Methoxy-3-Isopropylpyrazine - - DRUGBANK DB01760 C8H12N2O small molecule - 25773-40-4 DRUGBANK 23580 134206 392399 - LCN9 9230102I19Rik|HEL129 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 4324 2-Isobutyl-3-Methoxypyrazine - - DRUGBANK DB04512 C9H14N2O small molecule - - DRUGBANK 26869 135639 404037 - HAPLN4 BRAL2 9606 Homo sapiens binder target Spicer AP (2003) 12663660 181813 7587 Hyaluronic acid Hyaluronan|Hyaluronate clapiel hyalon serum|hyaluroni DRUGBANK DB08818 C28H44N2O23 small molecule S01KA01|M09AX01|S01KA51|D03AX05|R01AX09 9004-61-9 DRUGBANK 18541 135647 404203 UNQ844/PRO1782 SPINK6 BUSI2|UNQ844 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 2027 Leucine - Reduced Carbonyl - - DRUGBANK DB02107 C6H15N small molecule - - DRUGBANK 18542 135647 404203 UNQ844/PRO1782 SPINK6 BUSI2|UNQ844 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 2027 Leucine - Reduced Carbonyl - - DRUGBANK DB02107 C6H15N small molecule - - DRUGBANK 18543 135647 404203 UNQ844/PRO1782 SPINK6 BUSI2|UNQ844 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2027 Leucine - Reduced Carbonyl - - DRUGBANK DB02107 C6H15N small molecule - - DRUGBANK 19069 136219 440021 - KRTAP5-2 KRTAP5-8|KRTAP5.2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 20452 136219 440021 - KRTAP5-2 KRTAP5-8|KRTAP5.2 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2959 Pyroglutamic Acid - - DRUGBANK DB03088 C5H7NO3 small molecule - 98-79-3 DRUGBANK 26603 136896 440786 - LOC440786 - 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 7340 4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID - - DRUGBANK DB08562 C19H19NO3 small molecule - - DRUGBANK 2622 138926 493869 UNQ847/PRO1785 GPX8 EPLA847|GPx-8|GSHPx-8|UNQ847 9606 Homo sapiens unknown target Imming P (2006) 17016423 171742 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2623 138926 493869 UNQ847/PRO1785 GPX8 EPLA847|GPx-8|GSHPx-8|UNQ847 9606 Homo sapiens unknown target Overington JP (2006) 17139284 171741 137 Glutathione Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH amo endosol extra|bss plus|nav DRUGBANK DB00143 C10H17N3O6S small molecule V03AB32 70-18-8 DRUGBANK 2845 139227 548596 - CKMT1A CKMT1 9606 Homo sapiens ligand target Wyss M (1990) 2394753 173508 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2846 139227 548596 - CKMT1A CKMT1 9606 Homo sapiens ligand target Muehlebach SM (1996) 8662608 173509 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2847 139227 548596 - CKMT1A CKMT1 9606 Homo sapiens ligand target Imming P (2006) 17016423 171742 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2848 139227 548596 - CKMT1A CKMT1 9606 Homo sapiens ligand target Slenzka K (1996) 11538605 173507 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2849 139227 548596 - CKMT1A CKMT1 9606 Homo sapiens ligand target Wallimann T (1992) 1731757 173504 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 2850 139227 548596 - CKMT1A CKMT1 9606 Homo sapiens ligand target Overington JP (2006) 17139284 171741 142 Creatine ((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid - DRUGBANK DB00148 C4H9N3O2 small molecule - 57-00-1 DRUGBANK 26895 200913 16531 RP24-486D21.1 Kcnma1 5730414M22Rik|BKCa|MaxiK|Slo|Slo1|mSlo|mSlo1 10090 Mus musculus inhibitor target Latorre R (1982) 6278496 181675 7601 Tetraethylammonium TEA - DRUGBANK DB08837 C8H20N small molecule - 66-40-0 DRUGBANK 26896 200913 16531 RP24-486D21.1 Kcnma1 5730414M22Rik|BKCa|MaxiK|Slo|Slo1|mSlo|mSlo1 10090 Mus musculus inhibitor target Lang DG (1990) 1698974 181643 7601 Tetraethylammonium TEA - DRUGBANK DB08837 C8H20N small molecule - 66-40-0 DRUGBANK 9904 247238 25187 - Htr2c 5-HT2C|5-HTR2C|5HT-1C 10116 Rattus norvegicus binder target Berger M (1996) 8863001 178063 716 Trimipramine Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent nu-trimipramine tab 100mg|trim DRUGBANK DB00726 C20H26N2 small molecule N06AA06 739-71-9 DRUGBANK 7849 247238 25187 - Htr2c 5-HT2C|5-HTR2C|5HT-1C 10116 Rattus norvegicus antagonist target Jenck F (1993) 8453978 176756 530 Nortriptyline Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl nu-nortriptyline - cap 25mg|pa DRUGBANK DB00540 C19H21N small molecule N06AA10 72-69-5 DRUGBANK 7634 575724 653361 - NCF1 NCF1A|NOXO2|SH3PXD1A|p47phox 9606 Homo sapiens inhibitor target Zhang W (2004) 14734632 176580 504 Dextromethorphan Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum tylenol cold and flu nighttime DRUGBANK DB00514 C18H25NO small molecule N07XX59|R05DA09 125-71-3 DRUGBANK 22013 575839 653509 RP11-589B3.2 SFTPA1 COLEC4|PSAP|PSP-A|PSPA|SFTP1|SFTPA1B|SP-A|SP-A1|SPA|SPA1 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 25697 609057 728635 - DHRS4L1 SDR25C4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6494 METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE - - DRUGBANK DB07689 C21H24N8O3 small molecule - - DRUGBANK 21331 609057 728635 - DHRS4L1 SDR25C4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21458 609057 728635 - DHRS4L1 SDR25C4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 3392 10-Propargyl-5,8-Dideazafolic Acid - - DRUGBANK DB03541 C24H23N5O6 small molecule - - DRUGBANK 25781 609057 728635 - DHRS4L1 SDR25C4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 6566 METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE - - DRUGBANK DB07765 C22H26N8O3 small molecule - - DRUGBANK 19411 609057 728635 - DHRS4L1 SDR25C4 9606 Homo sapiens unknown target Berman HM (2000) 10592235 172122 2429 2,4,6-Triaminoquinazoline - - DRUGBANK DB02532 C8H9N5 small molecule - - DRUGBANK 22303 849164 944762 b0031 dapB ECK0032|JW0029 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3803 3-Acetyl Pyridine Adenine Dinucleotide - - DRUGBANK DB03969 C22H28N6O14P2 small molecule - - DRUGBANK 22304 849164 944762 b0031 dapB ECK0032|JW0029 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3803 3-Acetyl Pyridine Adenine Dinucleotide - - DRUGBANK DB03969 C22H28N6O14P2 small molecule - - DRUGBANK 22918 849164 944762 b0031 dapB ECK0032|JW0029 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4094 Dipicolinic Acid - - DRUGBANK DB04267 C7H5NO4 small molecule - - DRUGBANK 22919 849164 944762 b0031 dapB ECK0032|JW0029 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4094 Dipicolinic Acid - - DRUGBANK DB04267 C7H5NO4 small molecule - - DRUGBANK 23834 849179 944777 b0029 ispH ECK0030|JW0027|lytB|yaaE 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4518 ISOPENTENYL PYROPHOSPHATE - - DRUGBANK DB04714 C5H12O7P2 small molecule - - DRUGBANK 17787 849179 944777 b0029 ispH ECK0030|JW0027|lytB|yaaE 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 1717 Dimethylallyl Diphosphate - - DRUGBANK DB01785 C5H12O7P2 small molecule - 358-72-5 DRUGBANK 20576 849182 944780 b0064 araC ECK0065|JW0063 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3010 Alpha-L-Arabinose - - DRUGBANK DB03142 C5H10O5 small molecule - - DRUGBANK 20577 849182 944780 b0064 araC ECK0065|JW0063 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3010 Alpha-L-Arabinose - - DRUGBANK DB03142 C5H10O5 small molecule - - DRUGBANK 22451 849182 944780 b0064 araC ECK0065|JW0063 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3894 Beta-D-Fucose - - DRUGBANK DB04062 C6H12O5 small molecule - - DRUGBANK 22452 849182 944780 b0064 araC ECK0065|JW0063 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3894 Beta-D-Fucose - - DRUGBANK DB04062 C6H12O5 small molecule - - DRUGBANK 18708 849190 944789 b3786 wecB ECK3778|JW5600|nfrC|rffE|yifF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18709 849190 944789 b3786 wecB ECK3778|JW5600|nfrC|rffE|yifF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 21214 849190 944789 b3786 wecB ECK3778|JW5600|nfrC|rffE|yifF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21215 849190 944789 b3786 wecB ECK3778|JW5600|nfrC|rffE|yifF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 19761 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2606 5-Formyl-6-Hydrofolic Acid - - DRUGBANK DB02718 C20H21N7O7 small molecule - - DRUGBANK 19762 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2606 5-Formyl-6-Hydrofolic Acid - - DRUGBANK DB02718 C20H21N7O7 small molecule - - DRUGBANK 21615 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3472 5,10-Dideazatetrahydrofolic Acid - - DRUGBANK DB03625 C21H25N5O6 small molecule - - DRUGBANK 21616 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3472 5,10-Dideazatetrahydrofolic Acid - - DRUGBANK DB03625 C21H25N5O6 small molecule - - DRUGBANK 21273 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21274 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 22154 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 22155 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3741 Urea - uramaxin|umecta mousse urea|ca DRUGBANK DB03904 CH4N2O small molecule - 57-13-6 DRUGBANK 19027 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2268 2'-Monophosphoadenosine-5'-Diphosphate - - DRUGBANK DB02363 C10H16N5O13P3 small molecule - - DRUGBANK 19028 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2268 2'-Monophosphoadenosine-5'-Diphosphate - - DRUGBANK DB02363 C10H16N5O13P3 small molecule - - DRUGBANK 18349 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1938 Dihydrofolic Acid - - DRUGBANK DB02015 C19H21N7O6 small molecule - 4033-27-6 DRUGBANK 18350 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1938 Dihydrofolic Acid - - DRUGBANK DB02015 C19H21N7O6 small molecule - 4033-27-6 DRUGBANK 25274 849191 944790 b0048 folA ECK0049|JW0047|tmrA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6078 1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE - - DRUGBANK DB07262 C10H11F3N4S small molecule - - DRUGBANK 21551 849192 944791 b0085 murE ECK0086|JW0083 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3438 2,6-Diaminopimelic Acid - - DRUGBANK DB03590 C7H14N2O4 small molecule - - DRUGBANK 21552 849192 944791 b0085 murE ECK0086|JW0083 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3438 2,6-Diaminopimelic Acid - - DRUGBANK DB03590 C7H14N2O4 small molecule - - DRUGBANK 18920 849192 944791 b0085 murE ECK0086|JW0083 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2221 Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate - - DRUGBANK DB02314 C28H43N5O23P2 small molecule - - DRUGBANK 18921 849192 944791 b0085 murE ECK0086|JW0083 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2221 Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate - - DRUGBANK DB02314 C28H43N5O23P2 small molecule - - DRUGBANK 21983 849192 944791 b0085 murE ECK0086|JW0083 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 21984 849192 944791 b0085 murE ECK0086|JW0083 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 24156 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli unknown target Davies TA (2007) 17470659 182006 4716 Ceftobiprole Ceftobiprole Medocaril zevtera|zeftera DRUGBANK DB04918 C20H22N8O6S2 small molecule J01DI01 209467-52-7 DRUGBANK 15883 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Shigi Y (1981) 7018389 181107 1300 Ceftizoxime CEFIZOX|Syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid|Ceftizoxime|Ceftizoxima|Ceftizoximum|7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid cefizox DRUGBANK DB01332 C13H13N5O5S2 small molecule J01DD07 68401-81-0 DRUGBANK 4944 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Tsuchiya K (1981) 6941742 174762 260 Cefmenoxime (6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-((1-methyl-1H-5-tetraazolylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure|Cefmenoxima|(6R,7R)-7-[[(2e)-2-(2-amino-1,3-Thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (iupac)|Cefmenoximum - DRUGBANK DB00267 C16H17N9O5S3 small molecule J01DD05 65085-01-0 DRUGBANK 15874 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 16600 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Wise R (1990) 2120175 181376 1364 Ceftibuten cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum cedax|ceftibuten DRUGBANK DB01415 C15H14N4O6S2 small molecule J01DD14 97519-39-6 DRUGBANK 16603 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Boaretti M (1991) 12041787 181377 1365 Cefpodoxime Cefpodoxima|Cefpodoximum cefpodoxime proxetil|orelox DRUGBANK DB01416 C15H17N5O6S2 small molecule J01DD13 80210-62-4 DRUGBANK 5018 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target de la Rosa EJ (1985) 3898066 174802 267 Cefmetazole Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum - DRUGBANK DB00274 C15H17N7O5S3 small molecule J01DC09 56796-20-4 DRUGBANK 5270 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Kohler J (1999) 10223931 175063 296 Ertapenem (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM invanz DRUGBANK DB00303 C22H25N3O7S small molecule J01DH03 153832-46-3 DRUGBANK 16594 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Grassi GG (1993) 8150771 181375 1362 Cefepime Cefepima|(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|Cefepime|Cefepimum cefepime hydrochloride and dex DRUGBANK DB01413 C19H24N6O5S2 small molecule J01RA06|J01DE01 88040-23-7 DRUGBANK 6862 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 6863 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Fass RJ (1986) 3943292 175998 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 15865 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Rake JB (1984) 6376452 181105 1296 Cefonicid Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum - DRUGBANK DB01328 C18H18N6O8S3 small molecule J01DC06 61270-58-4 DRUGBANK 15881 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 6940 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Hayes MV (1983) 6413485 176060 430 Ceftazidime (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum ceptaz injection - pws iv 2g DRUGBANK DB00438 C22H22N6O7S2 small molecule J01DD52|J01DD02 78439-06-2 DRUGBANK 15860 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 15861 849200 944799 b0084 ftsI ECK0085|JW0082|pbpB|sep 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 26453 849206 944805 b1094 acpP ECK1080|JW1080 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7188 S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE - - DRUGBANK DB08404 C17H33N2O7PS small molecule - - DRUGBANK 26454 849206 944805 b1094 acpP ECK1080|JW1080 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7189 S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE - - DRUGBANK DB08405 C18H35N2O7PS small molecule - - DRUGBANK 23454 849206 944805 b1094 acpP ECK1080|JW1080 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4264 Heptyl 1-Thiohexopyranoside - - DRUGBANK DB04450 C13H26O5S small molecule - - DRUGBANK 18597 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2053 Xanthine - - DRUGBANK DB02134 C5H4N4O2 small molecule - 69-89-6 DRUGBANK 18598 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2053 Xanthine - - DRUGBANK DB02134 C5H4N4O2 small molecule - 69-89-6 DRUGBANK 19052 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 19053 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 22231 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3778 Carboxylic PRPP CPRPP - DRUGBANK DB03942 C6H15O13P3 small molecule - - DRUGBANK 22232 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3778 Carboxylic PRPP CPRPP - DRUGBANK DB03942 C6H15O13P3 small molecule - - DRUGBANK 18211 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18212 849218 944817 b0238 gpt ECK0239|JW0228|gpp|gxu 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 17543 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1609 Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine - - DRUGBANK DB01673 C23H36N4O20P2 small molecule - - DRUGBANK 17544 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1609 Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine - - DRUGBANK DB01673 C23H36N4O20P2 small molecule - - DRUGBANK 18918 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2221 Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate - - DRUGBANK DB02314 C28H43N5O23P2 small molecule - - DRUGBANK 18919 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2221 Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate - - DRUGBANK DB02314 C28H43N5O23P2 small molecule - - DRUGBANK 26133 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6905 N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID - - DRUGBANK DB08112 C23H19FN2O7S small molecule - - DRUGBANK 26131 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6901 N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID - - DRUGBANK DB08108 C23H20N2O7S small molecule - - DRUGBANK 26130 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6900 N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID - - DRUGBANK DB08107 C20H25NO7S small molecule - - DRUGBANK 26129 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6899 N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID - - DRUGBANK DB08106 C19H23NO7S small molecule - - DRUGBANK 26128 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6898 N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID - - DRUGBANK DB08105 C19H23NO7S small molecule - - DRUGBANK 21981 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 21982 849219 944818 b0088 murD ECK0089|JW0086 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 18361 849225 944824 b0099 mutT ECK0100|JW0097|nudA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1946 8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate - - DRUGBANK DB02023 C10H14N5O8P small molecule - - DRUGBANK 18362 849225 944824 b0099 mutT ECK0100|JW0097|nudA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1946 8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate - - DRUGBANK DB02023 C10H14N5O8P small molecule - - DRUGBANK 18239 849234 944834 b0114 aceE ECK0113|JW0110 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1911 Thiamin Diphosphate - - DRUGBANK DB01987 C12H18N4O7P2S small molecule - 154-87-0 DRUGBANK 18240 849234 944834 b0114 aceE ECK0113|JW0110 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1911 Thiamin Diphosphate - - DRUGBANK DB01987 C12H18N4O7P2S small molecule - 154-87-0 DRUGBANK 21946 849239 944839 b0134 panB ECK0133|JW0130|panA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3634 2-Dehydropantoate - - DRUGBANK DB03795 C6H10O4 small molecule - - DRUGBANK 21947 849239 944839 b0134 panB ECK0133|JW0130|panA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3634 2-Dehydropantoate - - DRUGBANK DB03795 C6H10O4 small molecule - - DRUGBANK 15884 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Shigi Y (1981) 7018389 181107 1300 Ceftizoxime CEFIZOX|Syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid|Ceftizoxime|Ceftizoxima|Ceftizoximum|7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid cefizox DRUGBANK DB01332 C13H13N5O5S2 small molecule J01DD07 68401-81-0 DRUGBANK 27831 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Matthews SJ (2009) 19243706 195987 8069 Doripenem - doribax DRUGBANK DB06211 C15H24N4O6S2 small molecule J01DH04 - DRUGBANK 27832 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli antagonist target Matthews SJ (2009) 19243706 195987 8069 Doripenem - doribax DRUGBANK DB06211 C15H24N4O6S2 small molecule J01DH04 - DRUGBANK 23727 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Labia R (1985) 3918982 181671 4380 Latamoxef LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum - DRUGBANK DB04570 C20H20N6O9S small molecule J01DD06 64952-97-2 DRUGBANK 17298 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Nicolau DP (2008) 18076336 181572 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 27622 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Zhanel GG (2007) 17488146 181573 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 16601 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Wise R (1990) 2120175 181376 1364 Ceftibuten cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum cedax|ceftibuten DRUGBANK DB01415 C15H14N4O6S2 small molecule J01DD14 97519-39-6 DRUGBANK 15880 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 5017 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target de la Rosa EJ (1985) 3898066 174802 267 Cefmetazole Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum - DRUGBANK DB00274 C15H17N7O5S3 small molecule J01DC09 56796-20-4 DRUGBANK 16595 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1363 Cefacetrile Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary] - DRUGBANK DB01414 C13H13N3O6S small molecule J01DB10 10206-21-0 DRUGBANK 16596 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1363 Cefacetrile Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary] - DRUGBANK DB01414 C13H13N3O6S small molecule J01DB10 10206-21-0 DRUGBANK 5268 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Kohler J (1999) 10223931 175063 296 Ertapenem (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM invanz DRUGBANK DB00303 C22H25N3O7S small molecule J01DH03 153832-46-3 DRUGBANK 6860 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 6861 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Fass RJ (1986) 3943292 175998 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 15866 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Rake JB (1984) 6376452 181105 1296 Cefonicid Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum - DRUGBANK DB01328 C18H18N6O8S3 small molecule J01DC06 61270-58-4 DRUGBANK 15873 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 6939 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Hayes MV (1983) 6413485 176060 430 Ceftazidime (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum ceptaz injection - pws iv 2g DRUGBANK DB00438 C22H22N6O7S2 small molecule J01DD52|J01DD02 78439-06-2 DRUGBANK 15856 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 15857 849243 944843 b0149 mrcB ECK0148|JW0145|pbpF|ponB 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 20110 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2787 2-Amino-Vinyl-Phosphate - - DRUGBANK DB02907 C2H6NO4P small molecule - - DRUGBANK 20111 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2787 2-Amino-Vinyl-Phosphate - - DRUGBANK DB02907 C2H6NO4P small molecule - - DRUGBANK 19102 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19103 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19780 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2612 Delta-2-Albomycin A1 - - DRUGBANK DB02724 C37H57FeN12O18S small molecule - - DRUGBANK 19781 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2612 Delta-2-Albomycin A1 - - DRUGBANK DB02724 C37H57FeN12O18S small molecule - - DRUGBANK 19158 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2318 N-Octyl-2-Hydroxyethyl Sulfoxide - - DRUGBANK DB02415 C10H22O2S small molecule - - DRUGBANK 19159 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2318 N-Octyl-2-Hydroxyethyl Sulfoxide - - DRUGBANK DB02415 C10H22O2S small molecule - - DRUGBANK 19160 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2318 N-Octyl-2-Hydroxyethyl Sulfoxide - - DRUGBANK DB02415 C10H22O2S small molecule - - DRUGBANK 21519 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3423 Ferricrocin-Iron - - DRUGBANK DB03574 C28H44FeN9O13 small molecule - - DRUGBANK 21520 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3423 Ferricrocin-Iron - - DRUGBANK DB03574 C28H44FeN9O13 small molecule - - DRUGBANK 27661 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27662 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27663 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 23627 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4338 L-Glycero-D-Manno-Heptopyranose - - DRUGBANK DB04526 C7H14O7 small molecule - - DRUGBANK 23628 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4338 L-Glycero-D-Manno-Heptopyranose - - DRUGBANK DB04526 C7H14O7 small molecule - - DRUGBANK 22834 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4048 Rifamycin Cgp 4832 - - DRUGBANK DB04220 C49H65N3O15 small molecule - - DRUGBANK 22835 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4048 Rifamycin Cgp 4832 - - DRUGBANK DB04220 C49H65N3O15 small molecule - - DRUGBANK 19727 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2589 3-Deoxy-D-Glucosamine - - DRUGBANK DB02700 C6H13NO4 small molecule - - DRUGBANK 19728 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2589 3-Deoxy-D-Glucosamine - - DRUGBANK DB02700 C6H13NO4 small molecule - - DRUGBANK 21473 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3397 3-Deoxy-D-Manno-Oct-2-Ulosonic Acid - - DRUGBANK DB03548 C8H14O8 small molecule - - DRUGBANK 21474 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3397 3-Deoxy-D-Manno-Oct-2-Ulosonic Acid - - DRUGBANK DB03548 C8H14O8 small molecule - - DRUGBANK 26250 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 19565 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2518 Phenylferricrocin-Iron - - DRUGBANK DB02626 C34H51FeN9O12 small molecule - - DRUGBANK 19566 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2518 Phenylferricrocin-Iron - - DRUGBANK DB02626 C34H51FeN9O12 small molecule - - DRUGBANK 22424 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3871 3-Oxo-Pentadecanoic Acid - - DRUGBANK DB04039 C15H28O3 small molecule - - DRUGBANK 22425 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3871 3-Oxo-Pentadecanoic Acid - - DRUGBANK DB04039 C15H28O3 small molecule - - DRUGBANK 22426 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3871 3-Oxo-Pentadecanoic Acid - - DRUGBANK DB04039 C15H28O3 small molecule - - DRUGBANK 20046 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2747 Glucosamine 4-Phosphate - - DRUGBANK DB02865 C6H14NO8P small molecule - - DRUGBANK 20047 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2747 Glucosamine 4-Phosphate - - DRUGBANK DB02865 C6H14NO8P small molecule - - DRUGBANK 19879 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2652 3-Hydroxy-Myristic Acid - - DRUGBANK DB02767 C14H28O3 small molecule - - DRUGBANK 19880 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2652 3-Hydroxy-Myristic Acid - - DRUGBANK DB02767 C14H28O3 small molecule - - DRUGBANK 19881 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2652 3-Hydroxy-Myristic Acid - - DRUGBANK DB02767 C14H28O3 small molecule - - DRUGBANK 17850 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1744 2-Tridecanoyloxy-Pentadecanoic Acid - - DRUGBANK DB01814 C28H54O4 small molecule - - DRUGBANK 17851 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1744 2-Tridecanoyloxy-Pentadecanoic Acid - - DRUGBANK DB01814 C28H54O4 small molecule - - DRUGBANK 20507 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2982 Glucosamine 1-Phosphate - - DRUGBANK DB03111 C6H14NO8P small molecule - - DRUGBANK 20508 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2982 Glucosamine 1-Phosphate - - DRUGBANK DB03111 C6H14NO8P small molecule - - DRUGBANK 19541 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 19542 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 19543 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 22742 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 22743 849256 944856 b0150 fhuA ECK0149|JW0146|T1|tonA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 23184 849264 944864 b0118 acnB ECK0117|JW0114|yacI|yacJ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4175 Aconitate Ion - - DRUGBANK DB04351 C6H3O6 small molecule - - DRUGBANK 23185 849264 944864 b0118 acnB ECK0117|JW0114|yacI|yacJ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4175 Aconitate Ion - - DRUGBANK DB04351 C6H3O6 small molecule - - DRUGBANK 23832 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4518 ISOPENTENYL PYROPHOSPHATE - - DRUGBANK DB04714 C5H12O7P2 small molecule - - DRUGBANK 25806 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6579 FARNESYL DIPHOSPHATE - - DRUGBANK DB07780 C15H28O7P2 small molecule - - DRUGBANK 25434 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6223 (1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID - - DRUGBANK DB07409 C20H20O7P2 small molecule - - DRUGBANK 25446 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6239 [1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID) - - DRUGBANK DB07426 C20H20O8P2 small molecule - - DRUGBANK 25436 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6224 [2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID - - DRUGBANK DB07410 C20H18O8P2 small molecule - - DRUGBANK 23823 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4499 FARNESYL THIOPYROPHOSPHATE - - DRUGBANK DB04695 C15H28O6P2S small molecule - - DRUGBANK 25429 849274 944874 b0174 ispU ECK0173|JW0169|rth|uppS|yaeS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6218 (1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID - - DRUGBANK DB07404 C20H20O7P2 small molecule - - DRUGBANK 23507 849281 944881 b2688 gshA ECK2683|JW2663|gshI 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 23508 849281 944881 b2688 gshA ECK2683|JW2663|gshI 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 23509 849281 944881 b2688 gshA ECK2683|JW2663|gshI 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 19535 849317 944919 b0052 pdxA ECK0053|JW0051 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2502 4-Hydroxy-L-Threonine-5-Monophosphate - - DRUGBANK DB02609 C4H10NO7P small molecule - - DRUGBANK 19536 849317 944919 b0052 pdxA ECK0053|JW0051 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2502 4-Hydroxy-L-Threonine-5-Monophosphate - - DRUGBANK DB02609 C4H10NO7P small molecule - - DRUGBANK 17671 849387 944990 b0331 prpB ECK0329|JW0323|yahQ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17672 849387 944990 b0331 prpB ECK0329|JW0323|yahQ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 22623 849391 944996 b0337 codA ECK0334|JW0328 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3966 5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine - - DRUGBANK DB04135 C4H5FN2O2 small molecule - - DRUGBANK 22624 849391 944996 b0337 codA ECK0334|JW0328 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3966 5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine - - DRUGBANK DB04135 C4H5FN2O2 small molecule - - DRUGBANK 22222 849391 944996 b0337 codA ECK0334|JW0328 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3775 4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One - - DRUGBANK DB03939 C4H6N2O2 small molecule - - DRUGBANK 22223 849391 944996 b0337 codA ECK0334|JW0328 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3775 4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One - - DRUGBANK DB03939 C4H6N2O2 small molecule - - DRUGBANK 22592 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3948 Allolactose - - DRUGBANK DB04116 C12H22O11 small molecule - - DRUGBANK 22593 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3948 Allolactose - - DRUGBANK DB04116 C12H22O11 small molecule - - DRUGBANK 19575 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2524 4-nitrophenyl-beta-D-galactoside p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose - DRUGBANK DB02632 C12H15NO8 small molecule - 3150-24-1 DRUGBANK 19576 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2524 4-nitrophenyl-beta-D-galactoside p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose - DRUGBANK DB02632 C12H15NO8 small molecule - 3150-24-1 DRUGBANK 18015 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1813 D-Galctopyranosyl-1-On - - DRUGBANK DB01885 C6H10O6 small molecule - 15892-28-1 DRUGBANK 18016 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1813 D-Galctopyranosyl-1-On - - DRUGBANK DB01885 C6H10O6 small molecule - 15892-28-1 DRUGBANK 17946 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1792 Isopropyl beta-D-thiogalactopyranoside isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG - DRUGBANK DB01862 C9H18O5S small molecule - 367-93-1 DRUGBANK 17947 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1792 Isopropyl beta-D-thiogalactopyranoside isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG - DRUGBANK DB01862 C9H18O5S small molecule - 367-93-1 DRUGBANK 23512 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 23513 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4279 Lactose - lactol|lac-tol pwr 50gm/pck DRUGBANK DB04465 C12H22O11 small molecule - 63-42-3 DRUGBANK 18884 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2201 (5r,6s,7s,8s)-5-Hydroxymethyl-6,7,8-Trihydroxy-Tetrazolo[1,5-a]Piperidine - - DRUGBANK DB02294 C6H10N4O4 small molecule - - DRUGBANK 18885 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2201 (5r,6s,7s,8s)-5-Hydroxymethyl-6,7,8-Trihydroxy-Tetrazolo[1,5-a]Piperidine - - DRUGBANK DB02294 C6H10N4O4 small molecule - - DRUGBANK 18078 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1845 1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose - - DRUGBANK DB01920 C12H15NO8 small molecule - - DRUGBANK 18079 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1845 1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose - - DRUGBANK DB01920 C12H15NO8 small molecule - - DRUGBANK 22731 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3985 2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose - - DRUGBANK DB04155 C12H21FO10 small molecule - - DRUGBANK 22732 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3985 2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose - - DRUGBANK DB04155 C12H21FO10 small molecule - - DRUGBANK 23634 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23635 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23240 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4204 2-Deoxy-Beta-D-Galactose - - DRUGBANK DB04382 C6H12O5 small molecule - - DRUGBANK 23241 849400 945006 b0344 lacZ ECK0341|JW0335 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4204 2-Deoxy-Beta-D-Galactose - - DRUGBANK DB04382 C6H12O5 small molecule - - DRUGBANK 26335 849401 945007 b0345 lacI ECK0342|JW0336 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7084 ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE - - DRUGBANK DB08297 C12H15NO7 small molecule - - DRUGBANK 23701 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4370 4,7-Dioxosebacic Acid - - DRUGBANK DB04560 C10H14O6 small molecule - - DRUGBANK 23702 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4370 4,7-Dioxosebacic Acid - - DRUGBANK DB04560 C10H14O6 small molecule - - DRUGBANK 23703 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4370 4,7-Dioxosebacic Acid - - DRUGBANK DB04560 C10H14O6 small molecule - - DRUGBANK 18814 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2169 4-Oxosebacic Acid - - DRUGBANK DB02260 C10H16O5 small molecule - - DRUGBANK 18815 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2169 4-Oxosebacic Acid - - DRUGBANK DB02260 C10H16O5 small molecule - - DRUGBANK 18816 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2169 4-Oxosebacic Acid - - DRUGBANK DB02260 C10H16O5 small molecule - - DRUGBANK 23645 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23646 849410 945017 b0369 hemB ECK0366|JW0361|ncf 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 21651 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3496 [{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate - - DRUGBANK DB03649 C6H9ClN2O6P2 small molecule - - DRUGBANK 21652 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3496 [{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate - - DRUGBANK DB03649 C6H9ClN2O6P2 small molecule - - DRUGBANK 20183 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2825 Fosmidomycin - - DRUGBANK DB02948 C4H10NO5P small molecule - - DRUGBANK 20184 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2825 Fosmidomycin - - DRUGBANK DB02948 C4H10NO5P small molecule - - DRUGBANK 22961 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22962 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 19338 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2393 1-Deoxy-D-xylulose 5-phosphate - - DRUGBANK DB02496 C5H11O7P small molecule - 190079-18-6 DRUGBANK 19339 849411 945019 b0173 dxr ECK0172|JW0168|ispC|yaeM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2393 1-Deoxy-D-xylulose 5-phosphate - - DRUGBANK DB02496 C5H11O7P small molecule - 190079-18-6 DRUGBANK 18166 849412 945021 b0368 tauD ECK0365|JW0360|ssiD|yaiG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1880 2-Aminoethanesulfonic Acid - - DRUGBANK DB01956 C2H7NO3S small molecule - 107-35-7 DRUGBANK 18167 849412 945021 b0368 tauD ECK0365|JW0360|ssiD|yaiG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1880 2-Aminoethanesulfonic Acid - - DRUGBANK DB01956 C2H7NO3S small molecule - 107-35-7 DRUGBANK 19965 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2705 Phosphonoacetic Acid - - DRUGBANK DB02823 C2H5O5P small molecule - 4408-78-0 DRUGBANK 19966 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2705 Phosphonoacetic Acid - - DRUGBANK DB02823 C2H5O5P small molecule - 4408-78-0 DRUGBANK 22417 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3863 Serine Vanadate SVA - DRUGBANK DB04031 C3H7NO7V small molecule - - DRUGBANK 22418 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3863 Serine Vanadate SVA - DRUGBANK DB04031 C3H7NO7V small molecule - - DRUGBANK 23599 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 23600 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4334 Phosphonoserine - - DRUGBANK DB04522 C3H8NO6P small molecule - - DRUGBANK 21404 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3353 Mercaptomethyl Phosphonate - - DRUGBANK DB03498 CH3O3PS small molecule - - DRUGBANK 21405 849430 945041 b0383 phoA ECK0378|JW0374|psiA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3353 Mercaptomethyl Phosphonate - - DRUGBANK DB03498 CH3O3PS small molecule - - DRUGBANK 19450 849446 945057 b2746 ispF ECK2741|JW2716|ygbB 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2449 Geranyl Diphosphate - - DRUGBANK DB02552 C10H20O7P2 small molecule - - DRUGBANK 19364 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2405 Isopentyl Pyrophosphate - - DRUGBANK DB02508 C5H14O7P2 small molecule - - DRUGBANK 19365 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2405 Isopentyl Pyrophosphate - - DRUGBANK DB02508 C5H14O7P2 small molecule - - DRUGBANK 19366 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2405 Isopentyl Pyrophosphate - - DRUGBANK DB02508 C5H14O7P2 small molecule - - DRUGBANK 18850 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2179 Dimethylallyl S-Thiolodiphosphate - - DRUGBANK DB02270 C5H14O6P2S small molecule - - DRUGBANK 18851 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2179 Dimethylallyl S-Thiolodiphosphate - - DRUGBANK DB02270 C5H14O6P2S small molecule - - DRUGBANK 18852 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2179 Dimethylallyl S-Thiolodiphosphate - - DRUGBANK DB02270 C5H14O6P2S small molecule - - DRUGBANK 22746 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 22747 849453 945064 b0421 ispA ECK0415|JW0411 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 22692 849463 945074 b0452 tesB ECK0446|JW0442 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22693 849463 945074 b0452 tesB ECK0446|JW0442 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22694 849463 945074 b0452 tesB ECK0446|JW0442 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 25581 849471 945082 b0437 clpP ECK0431|JW0427|lopP|wseA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6379 N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE - - DRUGBANK DB07571 C24H32N2O5 small molecule - - DRUGBANK 22701 849473 945084 b0451 amtB ECK0445|JW0441|ybaG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 17883 849473 945084 b0451 amtB ECK0445|JW0441|ybaG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1758 Methylamine - - DRUGBANK DB01828 CH5N small molecule - 74-89-5 DRUGBANK 17884 849473 945084 b0451 amtB ECK0445|JW0441|ybaG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1758 Methylamine - - DRUGBANK DB01828 CH5N small molecule - 74-89-5 DRUGBANK 17651 849486 945097 b0474 adk ECK0468|JW0463|dnaW|plsA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17652 849486 945097 b0474 adk ECK0468|JW0463|dnaW|plsA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 27677 849497 945108 b0462 acrB ECK0456|JW0451|acrE 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3467 Deoxycholic Acid 7-deoxycholic acid|Desoxycholsure|3alpha,12alpha-Dihydroxy-5beta-cholanic acid|desoxycholic acid|deoxycholate|(3,5,12)-3,12-dihydroxycholan-24-oic acid belkyra|kybella DRUGBANK DB03619 C24H40O4 small molecule - 83-44-3 DRUGBANK 22037 849497 945108 b0462 acrB ECK0456|JW0451|acrE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3663 Rhodamine 6G Basic red 1|R6G|CI basic red 1|Calcozine rhodamine 6GX - DRUGBANK DB03825 C28H31ClN2O3 small molecule - 989-38-8 DRUGBANK 22038 849497 945108 b0462 acrB ECK0456|JW0451|acrE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3663 Rhodamine 6G Basic red 1|R6G|CI basic red 1|Calcozine rhodamine 6GX - DRUGBANK DB03825 C28H31ClN2O3 small molecule - 989-38-8 DRUGBANK 22811 849497 945108 b0462 acrB ECK0456|JW0451|acrE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4037 Dequadin - - DRUGBANK DB04209 C30H40N4 small molecule - - DRUGBANK 22812 849497 945108 b0462 acrB ECK0456|JW0451|acrE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4037 Dequadin - - DRUGBANK DB04209 C30H40N4 small molecule - - DRUGBANK 19032 849516 945127 b0494 tesA ECK0488|JW0483|apeA|pldC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2269 2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid - - DRUGBANK DB02364 C7H16NO6P small molecule - - DRUGBANK 19033 849516 945127 b0494 tesA ECK0488|JW0483|apeA|pldC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2269 2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid - - DRUGBANK DB02364 C7H16NO6P small molecule - - DRUGBANK 22702 849517 945128 b1256 ompW ECK1250|JW1248|yciD 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22868 849517 945128 b1256 ompW ECK1250|JW1248|yciD 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 23236 849538 945150 b0516 allC ECK0509|JW0504|glxB7|ylbB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4202 Diureido-Acetate - - DRUGBANK DB04380 C4H7N4O4 small molecule - - DRUGBANK 23237 849538 945150 b0516 allC ECK0509|JW0504|glxB7|ylbB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4202 Diureido-Acetate - - DRUGBANK DB04380 C4H7N4O4 small molecule - - DRUGBANK 15879 849607 945222 b0632 dacA ECK0625|JW0627|pfv 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 5016 849607 945222 b0632 dacA ECK0625|JW0627|pfv 511145 Escherichia coli inhibitor target de la Rosa EJ (1985) 3898066 174802 267 Cefmetazole Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum - DRUGBANK DB00274 C15H17N7O5S3 small molecule J01DC09 56796-20-4 DRUGBANK 15871 849607 945222 b0632 dacA ECK0625|JW0627|pfv 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 5752 849616 945231 b0618 citC ECK0611|JW0610|ybeO 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 5753 849616 945231 b0618 citC ECK0611|JW0610|ybeO 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 20610 849618 945235 b2036 glf ECK2030|JW2021|yefE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20611 849618 945235 b2036 glf ECK2030|JW2021|yefE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 27829 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Matthews SJ (2009) 19243706 195987 8069 Doripenem - doribax DRUGBANK DB06211 C15H24N4O6S2 small molecule J01DH04 - DRUGBANK 27830 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli antagonist target Matthews SJ (2009) 19243706 195987 8069 Doripenem - doribax DRUGBANK DB06211 C15H24N4O6S2 small molecule J01DH04 - DRUGBANK 14387 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Licht J (1993) 8190989 180429 1151 Amdinocillin Penicillin HX|Mecillinam - DRUGBANK DB01163 C15H23N3O3S small molecule J01CA11 32887-01-7 DRUGBANK 14388 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Neu HC (1983) 6311012 180430 1151 Amdinocillin Penicillin HX|Mecillinam - DRUGBANK DB01163 C15H23N3O3S small molecule J01CA11 32887-01-7 DRUGBANK 17292 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Luchi M (2000) 11061029 181574 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 17293 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Neu HC (1985) 3873871 181575 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 17294 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Nicolau DP (2008) 18076336 181572 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 17295 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Zhanel GG (2007) 17488146 181573 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 16599 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Wise R (1990) 2120175 181376 1364 Ceftibuten cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum cedax|ceftibuten DRUGBANK DB01415 C15H14N4O6S2 small molecule J01DD14 97519-39-6 DRUGBANK 12198 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Lei Y (1989) 2683579 179276 938 Mezlocillin (2S,5R,6R)-3,3-Dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Mezlin|6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid|Mezlocilina|Mezlocilline|Mezlocillin|Mezlocillinum - DRUGBANK DB00948 C21H25N5O8S2 small molecule J01CA10 51481-65-3 DRUGBANK 16593 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Grassi GG (1993) 8150771 181375 1362 Cefepime Cefepima|(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|Cefepime|Cefepimum cefepime hydrochloride and dex DRUGBANK DB01413 C19H24N6O5S2 small molecule J01RA06|J01DE01 88040-23-7 DRUGBANK 5271 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Kohler J (1999) 10223931 175063 296 Ertapenem (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM invanz DRUGBANK DB00303 C22H25N3O7S small molecule J01DH03 153832-46-3 DRUGBANK 15864 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Rake JB (1984) 6376452 181105 1296 Cefonicid Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum - DRUGBANK DB01328 C18H18N6O8S3 small molecule J01DC06 61270-58-4 DRUGBANK 15875 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 6941 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Hayes MV (1983) 6413485 176060 430 Ceftazidime (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum ceptaz injection - pws iv 2g DRUGBANK DB00438 C22H22N6O7S2 small molecule J01DD52|J01DD02 78439-06-2 DRUGBANK 15862 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 15863 849623 945240 b0635 mrdA ECK0628|JW0630|pbpA 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 19211 849667 945290 b0678 nagB ECK0666|JW0664|glmD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2346 2-Deoxy-2-Amino Glucitol-6-Phosphate - - DRUGBANK DB02445 C6H16NO8P small molecule - - DRUGBANK 19212 849667 945290 b0678 nagB ECK0666|JW0664|glmD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2346 2-Deoxy-2-Amino Glucitol-6-Phosphate - - DRUGBANK DB02445 C6H16NO8P small molecule - - DRUGBANK 18661 849667 945290 b0678 nagB ECK0666|JW0664|glmD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2087 D-Fructose-6-Phosphate (Open Form) - - DRUGBANK DB02171 C6H15O9P small molecule - - DRUGBANK 18662 849667 945290 b0678 nagB ECK0666|JW0664|glmD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2087 D-Fructose-6-Phosphate (Open Form) - - DRUGBANK DB02171 C6H15O9P small molecule - - DRUGBANK 22250 849667 945290 b0678 nagB ECK0666|JW0664|glmD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3787 16g - - DRUGBANK DB03951 C8H16NO9P small molecule - - DRUGBANK 22251 849667 945290 b0678 nagB ECK0666|JW0664|glmD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3787 16g - - DRUGBANK DB03951 C8H16NO9P small molecule - - DRUGBANK 23782 849677 945300 b0724 sdhB ECK0713|JW0714 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4437 Atpenin A5 AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE - DRUGBANK DB04631 C15H21Cl2NO5 small molecule - 119509-24-9 DRUGBANK 25677 849677 945300 b0724 sdhB ECK0713|JW0714 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6477 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL - - DRUGBANK DB07671 C13H18N2O5 small molecule - - DRUGBANK 26706 849677 945300 b0724 sdhB ECK0713|JW0714 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 4900 849690 945313 b0381 ddlA ECK0376|JW0372 511145 Escherichia coli inhibitor target Noda M (2004) 15302885 174720 253 Cycloserine D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS seromycin cap 250mg|cycloserin DRUGBANK DB00260 C3H6N2O2 small molecule J04AB01 68-41-7 DRUGBANK 4901 849690 945313 b0381 ddlA ECK0376|JW0372 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 253 Cycloserine D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS seromycin cap 250mg|cycloserin DRUGBANK DB00260 C3H6N2O2 small molecule J04AB01 68-41-7 DRUGBANK 4902 849690 945313 b0381 ddlA ECK0376|JW0372 511145 Escherichia coli inhibitor target Chen X (2002) 11752352 171740 253 Cycloserine D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS seromycin cap 250mg|cycloserin DRUGBANK DB00260 C3H6N2O2 small molecule J04AB01 68-41-7 DRUGBANK 4903 849690 945313 b0381 ddlA ECK0376|JW0372 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 253 Cycloserine D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS seromycin cap 250mg|cycloserin DRUGBANK DB00260 C3H6N2O2 small molecule J04AB01 68-41-7 DRUGBANK 4904 849690 945313 b0381 ddlA ECK0376|JW0372 511145 Escherichia coli inhibitor target Belanger AE (2000) 11073937 174721 253 Cycloserine D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS seromycin cap 250mg|cycloserin DRUGBANK DB00260 C3H6N2O2 small molecule J04AB01 68-41-7 DRUGBANK 4905 849690 945313 b0381 ddlA ECK0376|JW0372 511145 Escherichia coli inhibitor target McCoy AJ (2005) 15948948 174719 253 Cycloserine D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS seromycin cap 250mg|cycloserin DRUGBANK DB00260 C3H6N2O2 small molecule J04AB01 68-41-7 DRUGBANK 23784 849692 945316 b0721 sdhC ECK0710|JW0711|cybA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4437 Atpenin A5 AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE - DRUGBANK DB04631 C15H21Cl2NO5 small molecule - 119509-24-9 DRUGBANK 25679 849692 945316 b0721 sdhC ECK0710|JW0711|cybA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6477 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL - - DRUGBANK DB07671 C13H18N2O5 small molecule - - DRUGBANK 26708 849692 945316 b0721 sdhC ECK0710|JW0711|cybA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 23783 849698 945322 b0722 sdhD ECK0711|JW0712 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4437 Atpenin A5 AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE - DRUGBANK DB04631 C15H21Cl2NO5 small molecule - 119509-24-9 DRUGBANK 25678 849698 945322 b0722 sdhD ECK0711|JW0712 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6477 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL - - DRUGBANK DB07671 C13H18N2O5 small molecule - - DRUGBANK 26707 849698 945322 b0722 sdhD ECK0711|JW0712 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 21467 849715 945339 b1738 chbB ECK1736|JW1727|celA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3395 S-Phosphocysteine - - DRUGBANK DB03544 C3H8NO5PS small molecule - - DRUGBANK 21468 849715 945339 b1738 chbB ECK1736|JW1727|celA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3395 S-Phosphocysteine - - DRUGBANK DB03544 C3H8NO5PS small molecule - - DRUGBANK 19168 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2324 Uridine-5'-Diphosphate-Mannose - - DRUGBANK DB02421 C15H24N2O17P2 small molecule - - DRUGBANK 19169 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2324 Uridine-5'-Diphosphate-Mannose - - DRUGBANK DB02421 C15H24N2O17P2 small molecule - - DRUGBANK 22555 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3929 Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose - - DRUGBANK DB04097 C15H23FN2O16P2 small molecule - - DRUGBANK 22556 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3929 Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose - - DRUGBANK DB04097 C15H23FN2O16P2 small molecule - - DRUGBANK 23195 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 23196 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 21107 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21108 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 19916 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2672 Phenyl-Uridine-5'-Diphosphate - - DRUGBANK DB02790 C15H18N2O12P2 small molecule - - DRUGBANK 19917 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2672 Phenyl-Uridine-5'-Diphosphate - - DRUGBANK DB02790 C15H18N2O12P2 small molecule - - DRUGBANK 21216 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21217 849730 945354 b0759 galE ECK0748|JW0742|galD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21721 849733 945357 b0758 galT ECK0747|JW0741|galB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21722 849733 945357 b0758 galT ECK0747|JW0741|galB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 17944 849733 945357 b0758 galT ECK0747|JW0741|galB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1791 Glucose-Uridine-C1,5'-Diphosphate - - DRUGBANK DB01861 C15H24N2O17P2 small molecule - - DRUGBANK 17945 849733 945357 b0758 galT ECK0747|JW0741|galB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1791 Glucose-Uridine-C1,5'-Diphosphate - - DRUGBANK DB01861 C15H24N2O17P2 small molecule - - DRUGBANK 21225 849733 945357 b0758 galT ECK0747|JW0741|galB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21226 849733 945357 b0758 galT ECK0747|JW0741|galB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21859 849746 945370 b0775 bioB ECK0764|JW0758 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21860 849746 945370 b0775 bioB ECK0764|JW0758 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21905 849746 945370 b0775 bioB ECK0764|JW0758 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3616 D-Dethiobiotin - - DRUGBANK DB03775 C10H18N2O3 small molecule - - DRUGBANK 21906 849746 945370 b0775 bioB ECK0764|JW0758 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3616 D-Dethiobiotin - - DRUGBANK DB03775 C10H18N2O3 small molecule - - DRUGBANK 21907 849746 945370 b0775 bioB ECK0764|JW0758 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3616 D-Dethiobiotin - - DRUGBANK DB03775 C10H18N2O3 small molecule - - DRUGBANK 18859 849752 945376 b0774 bioA ECK0763|JW0757 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2183 7-Keto-8-Aminopelargonic Acid - - DRUGBANK DB02274 C9H17NO3 small molecule - 4707-58-8 DRUGBANK 18860 849752 945376 b0774 bioA ECK0763|JW0757 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2183 7-Keto-8-Aminopelargonic Acid - - DRUGBANK DB02274 C9H17NO3 small molecule - 4707-58-8 DRUGBANK 22532 849752 945376 b0774 bioA ECK0763|JW0757 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22533 849752 945376 b0774 bioA ECK0763|JW0757 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 19782 849752 945376 b0774 bioA ECK0763|JW0757 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2613 2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid - - DRUGBANK DB02725 C10H16N2O2 small molecule - - DRUGBANK 19783 849752 945376 b0774 bioA ECK0763|JW0757 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2613 2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid - - DRUGBANK DB02725 C10H16N2O2 small molecule - - DRUGBANK 21176 849754 945378 b2183 rsuA ECK2177|JW2171|yejD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21177 849754 945378 b2183 rsuA ECK2177|JW2171|yejD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21714 849754 945378 b2183 rsuA ECK2177|JW2171|yejD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21715 849754 945378 b2183 rsuA ECK2177|JW2171|yejD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 20696 849760 945384 b0776 bioF ECK0765|JW0759 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3028 N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate - - DRUGBANK DB03160 C17H27N2O8P small molecule - - DRUGBANK 20697 849760 945384 b0776 bioF ECK0765|JW0759 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3028 N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate - - DRUGBANK DB03160 C17H27N2O8P small molecule - - DRUGBANK 17644 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1650 7,8-Diamino-Nonanoic Acid - - DRUGBANK DB01715 C9H20N2O2 small molecule - - DRUGBANK 17645 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1650 7,8-Diamino-Nonanoic Acid - - DRUGBANK DB01715 C9H20N2O2 small molecule - - DRUGBANK 20177 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2819 3-(1-Aminoethyl)Nonanedioic Acid - - DRUGBANK DB02941 C11H21NO4 small molecule - - DRUGBANK 20178 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2819 3-(1-Aminoethyl)Nonanedioic Acid - - DRUGBANK DB02941 C11H21NO4 small molecule - - DRUGBANK 21613 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3471 7-(Carboxyamino)-8-Amino-Nonanoic Acid - - DRUGBANK DB03624 C10H20N2O4 small molecule - - DRUGBANK 21614 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3471 7-(Carboxyamino)-8-Amino-Nonanoic Acid - - DRUGBANK DB03624 C10H20N2O4 small molecule - - DRUGBANK 21908 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3616 D-Dethiobiotin - - DRUGBANK DB03775 C10H18N2O3 small molecule - - DRUGBANK 21909 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3616 D-Dethiobiotin - - DRUGBANK DB03775 C10H18N2O3 small molecule - - DRUGBANK 21910 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3616 D-Dethiobiotin - - DRUGBANK DB03775 C10H18N2O3 small molecule - - DRUGBANK 20142 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2805 Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid - - DRUGBANK DB02927 C10H21N2O7P small molecule - - DRUGBANK 20143 849762 945387 b0778 bioD ECK0767|JW0761 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2805 Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid - - DRUGBANK DB02927 C10H21N2O7P small molecule - - DRUGBANK 23785 849776 945402 b0723 sdhA ECK0712|JW0713 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4437 Atpenin A5 AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE - DRUGBANK DB04631 C15H21Cl2NO5 small molecule - 119509-24-9 DRUGBANK 25680 849776 945402 b0723 sdhA ECK0712|JW0713 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6477 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL - - DRUGBANK DB07671 C13H18N2O5 small molecule - - DRUGBANK 26702 849776 945402 b0723 sdhA ECK0712|JW0713 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 22733 849806 945432 b0822 ybiV ECK0812|JW0806|supH 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 22734 849806 945432 b0822 ybiV ECK0812|JW0806|supH 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 12750 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli inhibitor target Winstanley PA (1995) 7786001 179661 1005 Sulfamethoxazole 3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole septra injection|roubac tab 16 DRUGBANK DB01015 C10H11N3O3S small molecule J01EC01|J01EE01 723-46-6 DRUGBANK 12751 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 1005 Sulfamethoxazole 3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole septra injection|roubac tab 16 DRUGBANK DB01015 C10H11N3O3S small molecule J01EC01|J01EE01 723-46-6 DRUGBANK 12752 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 1005 Sulfamethoxazole 3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole septra injection|roubac tab 16 DRUGBANK DB01015 C10H11N3O3S small molecule J01EC01|J01EE01 723-46-6 DRUGBANK 19202 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2340 (5r)-5-Amino-6-Hydroxyhexylcarbamic Acid - - DRUGBANK DB02437 C7H16N2O3 small molecule - - DRUGBANK 19203 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2340 (5r)-5-Amino-6-Hydroxyhexylcarbamic Acid - - DRUGBANK DB02437 C7H16N2O3 small molecule - - DRUGBANK 22040 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3668 Phosphorylated Dihydropteroate - - DRUGBANK DB03830 C14H13N6O6P small molecule - - DRUGBANK 22041 849825 945451 b2315 folC ECK2309|JW2312|dedC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3668 Phosphorylated Dihydropteroate - - DRUGBANK DB03830 C14H13N6O6P small molecule - - DRUGBANK 5269 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target Kohler J (1999) 10223931 175063 296 Ertapenem (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM invanz DRUGBANK DB00303 C22H25N3O7S small molecule J01DH03 153832-46-3 DRUGBANK 15876 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 5014 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target de la Rosa EJ (1985) 3898066 174802 267 Cefmetazole Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum - DRUGBANK DB00274 C15H17N7O5S3 small molecule J01DC09 56796-20-4 DRUGBANK 6854 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target Pfaller MA (1984) 6426381 176000 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 6855 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 6856 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target Fass RJ (1986) 3943292 175998 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 15869 849829 945455 b0839 dacC ECK0829|JW0823 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 18073 849854 945480 b0854 potF ECK0845|JW0838 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 18074 849854 945480 b0854 potF ECK0845|JW0838 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1842 Putrescine - - DRUGBANK DB01917 C4H12N2 small molecule - 110-60-1 DRUGBANK 20836 849857 945483 b0851 nfsA ECK0842|JW0835|mda18|mdaA|snrA|ybjB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20837 849857 945483 b0851 nfsA ECK0842|JW0835|mda18|mdaA|snrA|ybjB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 9621 849857 945483 b0851 nfsA ECK0842|JW0835|mda18|mdaA|snrA|ybjB 511145 Escherichia coli potentiator target Imming P (2006) 17016423 171742 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9622 849857 945483 b0851 nfsA ECK0842|JW0835|mda18|mdaA|snrA|ybjB 511145 Escherichia coli potentiator target Overington JP (2006) 17139284 171741 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9623 849857 945483 b0851 nfsA ECK0842|JW0835|mda18|mdaA|snrA|ybjB 511145 Escherichia coli potentiator target Lightfoot RT (2000) 10832075 177894 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9624 849857 945483 b0851 nfsA ECK0842|JW0835|mda18|mdaA|snrA|ybjB 511145 Escherichia coli potentiator target Kutty R (2005) 16187099 177895 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 26482 849864 945490 b0885 aat ECK0876|JW0868|ycaA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7219 Puromycin - - DRUGBANK DB08437 C22H29N7O5 small molecule - 53-79-2 DRUGBANK 25951 849871 945497 b0875 aqpZ ECK0866|JW0859|bniP 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6720 octyl beta-D-galactopyranoside - - DRUGBANK DB07924 C14H28O6 small molecule - - DRUGBANK 25355 849871 945497 b0875 aqpZ ECK0866|JW0859|bniP 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6165 (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE - - DRUGBANK DB07349 C19H36O10P small molecule - - DRUGBANK 20674 849871 945497 b0875 aqpZ ECK0866|JW0859|bniP 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3020 B-2-Octylglucoside - - DRUGBANK DB03152 C14H28O6 small molecule - - DRUGBANK 25950 849871 945497 b0875 aqpZ ECK0866|JW0859|bniP 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6719 octyl alpha-L-altropyranoside - - DRUGBANK DB07923 C14H28O6 small molecule - - DRUGBANK 20895 849888 945514 b0903 pflB ECK0894|JW0886|pfl 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3144 D-Treitol - - DRUGBANK DB03278 C4H10O4 small molecule - - DRUGBANK 20896 849888 945514 b0903 pflB ECK0894|JW0886|pfl 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3144 D-Treitol - - DRUGBANK DB03278 C4H10O4 small molecule - - DRUGBANK 22229 849888 945514 b0903 pflB ECK0894|JW0886|pfl 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 22230 849888 945514 b0903 pflB ECK0894|JW0886|pfl 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3776 Oxamic Acid - - DRUGBANK DB03940 C2H3NO3 small molecule - 471-47-6 DRUGBANK 18264 849888 945514 b0903 pflB ECK0894|JW0886|pfl 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18265 849888 945514 b0903 pflB ECK0894|JW0886|pfl 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 21465 849893 945519 b1262 trpC ECK1256|JW1254|trpF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3394 1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate - - DRUGBANK DB03543 C12H18NO9P small molecule - - DRUGBANK 21466 849893 945519 b1262 trpC ECK1256|JW1254|trpF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3394 1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate - - DRUGBANK DB03543 C12H18NO9P small molecule - - DRUGBANK 23144 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4153 Shikimate-3-Phosphate - - DRUGBANK DB04328 C7H11O8P small molecule - - DRUGBANK 23145 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4153 Shikimate-3-Phosphate - - DRUGBANK DB04328 C7H11O8P small molecule - - DRUGBANK 20512 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2987 5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate - - DRUGBANK DB03116 C10H16O14P2 small molecule - - DRUGBANK 20513 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2987 5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate - - DRUGBANK DB03116 C10H16O14P2 small molecule - - DRUGBANK 18110 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18111 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 23663 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4349 Glyphosate - - DRUGBANK DB04539 C3H9NO5P small molecule - 1071-83-6 DRUGBANK 23664 849902 945528 b0908 aroA ECK0899|JW0891 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4349 Glyphosate - - DRUGBANK DB04539 C3H9NO5P small molecule - 1071-83-6 DRUGBANK 23690 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4365 Cytidine-5'-Diphosphate - - DRUGBANK DB04555 C9H15N3O11P2 small molecule - 63-38-7 DRUGBANK 23691 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4365 Cytidine-5'-Diphosphate - - DRUGBANK DB04555 C9H15N3O11P2 small molecule - 63-38-7 DRUGBANK 21145 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 21146 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 19232 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2356 Cytosine Arabinose-5'-Phosphate - - DRUGBANK DB02456 C9H14N3O8P small molecule - - DRUGBANK 19233 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2356 Cytosine Arabinose-5'-Phosphate - - DRUGBANK DB02456 C9H14N3O8P small molecule - - DRUGBANK 20069 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2764 2',3'-Dideoxycytidine-5'-Monophosphate - - DRUGBANK DB02883 C9H14N3O6P small molecule - - DRUGBANK 20070 849909 945535 b0910 cmk ECK0901|JW0893|mssA|ycaF|ycaG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2764 2',3'-Dideoxycytidine-5'-Monophosphate - - DRUGBANK DB02883 C9H14N3O6P small molecule - - DRUGBANK 20226 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2858 Vitamin B6 Complexed with 2-Amino-Hexanoic Acid - - DRUGBANK DB02981 C14H23N2O7P small molecule - - DRUGBANK 20227 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2858 Vitamin B6 Complexed with 2-Amino-Hexanoic Acid - - DRUGBANK DB02981 C14H23N2O7P small molecule - - DRUGBANK 21621 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3476 Pyridoxal-5'-Phosphate-N-Oxide - - DRUGBANK DB03629 C8H10NO7P small molecule - - DRUGBANK 21622 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3476 Pyridoxal-5'-Phosphate-N-Oxide - - DRUGBANK DB03629 C8H10NO7P small molecule - - DRUGBANK 23519 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4281 Pyridoxyl-Alanine-5-Phosphate PP3|LPG-PLP|n-(5'-phosphopyridoxyl)-l-alanine|Vitamin B6 complexed with alanine|alanyl-pyridoxal-5'-phosphate - DRUGBANK DB04467 C11H17N2O7P small molecule - - DRUGBANK 23520 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4281 Pyridoxyl-Alanine-5-Phosphate PP3|LPG-PLP|n-(5'-phosphopyridoxyl)-l-alanine|Vitamin B6 complexed with alanine|alanyl-pyridoxal-5'-phosphate - DRUGBANK DB04467 C11H17N2O7P small molecule - - DRUGBANK 21672 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3509 Vitamin B6 Complexed with 2-Amino-Pentanoic Acid - - DRUGBANK DB03662 C13H21N2O7P small molecule - - DRUGBANK 21673 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3509 Vitamin B6 Complexed with 2-Amino-Pentanoic Acid - - DRUGBANK DB03662 C13H21N2O7P small molecule - - DRUGBANK 19862 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2643 Indolylpropionic Acid - - DRUGBANK DB02758 C11H11NO2 small molecule - - DRUGBANK 19863 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2643 Indolylpropionic Acid - - DRUGBANK DB02758 C11H11NO2 small molecule - - DRUGBANK 19864 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2643 Indolylpropionic Acid - - DRUGBANK DB02758 C11H11NO2 small molecule - - DRUGBANK 18363 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1947 3-phenylpropionic acid 3PP|3-Phenyl-propionic acid|3-Phenylpropanoic acid|Hydrocinnamic acid|Phenylpropanoate|beta-Phenylpropionic acid - DRUGBANK DB02024 C9H10O2 small molecule - 501-52-0 DRUGBANK 18364 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1947 3-phenylpropionic acid 3PP|3-Phenyl-propionic acid|3-Phenylpropanoic acid|Hydrocinnamic acid|Phenylpropanoate|beta-Phenylpropionic acid - DRUGBANK DB02024 C9H10O2 small molecule - 501-52-0 DRUGBANK 23018 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4126 Maleic Acid - - DRUGBANK DB04299 C4H4O4 small molecule - 110-16-7 DRUGBANK 23019 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4126 Maleic Acid - - DRUGBANK DB04299 C4H4O4 small molecule - 110-16-7 DRUGBANK 22534 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 22535 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3915 N'-Pyridoxyl-Lysine-5'-Monophosphate - - DRUGBANK DB04083 C14H24N3O7P small molecule - - DRUGBANK 21480 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3402 Glutaric Acid - - DRUGBANK DB03553 C5H8O4 small molecule - 110-94-1 DRUGBANK 21481 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3402 Glutaric Acid - - DRUGBANK DB03553 C5H8O4 small molecule - 110-94-1 DRUGBANK 21853 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3592 Isovaleric Acid - - DRUGBANK DB03750 C5H10O2 small molecule - 503-74-2 DRUGBANK 21854 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3592 Isovaleric Acid - - DRUGBANK DB03750 C5H10O2 small molecule - 503-74-2 DRUGBANK 17474 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1576 N-Methyl-Pyridoxal-5'-Phosphate - - DRUGBANK DB01639 C9H13NO6P small molecule - - DRUGBANK 17475 849927 945553 b0928 aspC ECK0919|JW0911 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1576 N-Methyl-Pyridoxal-5'-Phosphate - - DRUGBANK DB01639 C9H13NO6P small molecule - - DRUGBANK 25093 849928 945554 b0929 ompF ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5902 N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide - - DRUGBANK DB07084 C22H27NO7 small molecule - - DRUGBANK 22855 849928 945554 b0929 ompF ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22856 849928 945554 b0929 ompF ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22857 849928 945554 b0929 ompF ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 20834 849930 945556 b0945 pyrD ECK0936|JW0928 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20835 849930 945556 b0945 pyrD ECK0936|JW0928 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 18823 849930 945556 b0945 pyrD ECK0936|JW0928 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 18824 849930 945556 b0945 pyrD ECK0936|JW0928 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 18105 849930 945556 b0945 pyrD ECK0936|JW0928 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18106 849930 945556 b0945 pyrD ECK0936|JW0928 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 21998 849942 945568 b0954 fabA ECK0945|JW0937 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3651 2-Decenoyl N-Acetyl Cysteamine - - DRUGBANK DB03813 C14H25NO2S small molecule - - DRUGBANK 22862 849945 945571 b0957 ompA ECK0948|JW0940|con|tolG|tut 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22863 849945 945571 b0957 ompA ECK0948|JW0940|con|tolG|tut 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22864 849945 945571 b0957 ompA ECK0948|JW0940|con|tolG|tut 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 20388 849974 945600 b1014 putA ECK1005|JW0999|poaA|putC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2923 Tetrahydrofuran-2-Carboxylic Acid - - DRUGBANK DB03051 C5H8O3 small molecule - - DRUGBANK 20389 849974 945600 b1014 putA ECK1005|JW0999|poaA|putC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2923 Tetrahydrofuran-2-Carboxylic Acid - - DRUGBANK DB03051 C5H8O3 small molecule - - DRUGBANK 23331 849974 945600 b1014 putA ECK1005|JW0999|poaA|putC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4219 Lactic Acid - dianeal pd 102 capd solution w DRUGBANK DB04398 C3H6O3 small molecule G01AD01 50-21-5 DRUGBANK 23332 849974 945600 b1014 putA ECK1005|JW0999|poaA|putC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4219 Lactic Acid - dianeal pd 102 capd solution w DRUGBANK DB04398 C3H6O3 small molecule G01AD01 50-21-5 DRUGBANK 20604 849974 945600 b1014 putA ECK1005|JW0999|poaA|putC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20605 849974 945600 b1014 putA ECK1005|JW0999|poaA|putC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 19787 849979 945605 b0754 aroG ECK0743|JW0737 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19788 849979 945605 b0754 aroG ECK0743|JW0737 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 17859 849979 945605 b0754 aroG ECK0743|JW0737 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 17860 849979 945605 b0754 aroG ECK0743|JW0737 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1749 Phosphoenolpyruvate - - DRUGBANK DB01819 C3H5O6P small molecule - 138-08-9 DRUGBANK 21296 850017 945645 b1093 fabG ECK1079|JW1079 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21297 850017 945645 b1093 fabG ECK1079|JW1079 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 18443 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1986 N7-Methyl-Formycin A - - DRUGBANK DB02066 C11H14N5O4 small molecule - - DRUGBANK 18444 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1986 N7-Methyl-Formycin A - - DRUGBANK DB02066 C11H14N5O4 small molecule - - DRUGBANK 21821 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3578 9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine - - DRUGBANK DB03735 C11H14N4O3 small molecule - - DRUGBANK 21822 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3578 9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine - - DRUGBANK DB03735 C11H14N4O3 small molecule - - DRUGBANK 21443 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3381 9-Beta-D-Xylofuranosyl-Adenine - - DRUGBANK DB03528 C10H13N5O4 small molecule - - DRUGBANK 21444 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3381 9-Beta-D-Xylofuranosyl-Adenine - - DRUGBANK DB03528 C10H13N5O4 small molecule - - DRUGBANK 22254 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3788 9-(6-Deoxy-Beta-D-Allofuranosyl)-6-Methylpurine - - DRUGBANK DB03952 C12H16N4O4 small molecule - - DRUGBANK 22255 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3788 9-(6-Deoxy-Beta-D-Allofuranosyl)-6-Methylpurine - - DRUGBANK DB03952 C12H16N4O4 small molecule - - DRUGBANK 20163 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2812 9-(6-Deoxy-Alpha-L-Talofuranosyl)-6-Methylpurine - - DRUGBANK DB02934 C12H16N4O4 small molecule - - DRUGBANK 20164 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2812 9-(6-Deoxy-Alpha-L-Talofuranosyl)-6-Methylpurine - - DRUGBANK DB02934 C12H16N4O4 small molecule - - DRUGBANK 20090 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Bennett EM (2003) 12937174 181829 2776 Methylthioinosine Me6MPR|6-methyl-9-ribofuranosylpurine-6-thiol|6-(Methylthio)purine ribonucleoside|6-methylmercaptopurine riboside|6-S-methyl-6-thioinosine|6-methylmercaptopurine ribonucleoside|6-methyl MP-riboside|6-MMPR|6-methyl MP riboside|6-methylthiopurine riboside|6-methylthioinosine|methylmercaptopurine riboside|MMPR - DRUGBANK DB02896 C11H14N4O4S small molecule - 342-69-8 DRUGBANK 23392 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4256 2-Fluoroadenosine 6-amino-2-fluoro-9--D-ribofuranosylpurine|2-(6-amino-2-fluoro-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol - DRUGBANK DB04441 C10H12FN5O4 small molecule - 146-78-1 DRUGBANK 23393 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4256 2-Fluoroadenosine 6-amino-2-fluoro-9--D-ribofuranosylpurine|2-(6-amino-2-fluoro-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol - DRUGBANK DB04441 C10H12FN5O4 small molecule - 146-78-1 DRUGBANK 22796 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4026 Formycin B - - DRUGBANK DB04198 C10H11N4O5 small molecule - - DRUGBANK 22797 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4026 Formycin B - - DRUGBANK DB04198 C10H11N4O5 small molecule - - DRUGBANK 18560 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2033 6-Methylpurine - - DRUGBANK DB02113 C6H6N4 small molecule - 2004-03-7 DRUGBANK 18561 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2033 6-Methylpurine - - DRUGBANK DB02113 C6H6N4 small molecule - 2004-03-7 DRUGBANK 20181 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2824 2-Fluoro-2'-Deoxyadenosine - - DRUGBANK DB02947 C10H12FN5O3 small molecule - - DRUGBANK 20182 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2824 2-Fluoro-2'-Deoxyadenosine - - DRUGBANK DB02947 C10H12FN5O3 small molecule - - DRUGBANK 20702 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3040 Tubercidin Sparsomycin A|Tubercidine|TBN|Toyocamycin|7-Deazadenosine|7-deazaadenosine - DRUGBANK DB03172 C11H14N4O4 small molecule - 69-33-0 DRUGBANK 20703 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3040 Tubercidin Sparsomycin A|Tubercidine|TBN|Toyocamycin|7-Deazadenosine|7-deazaadenosine - DRUGBANK DB03172 C11H14N4O4 small molecule - 69-33-0 DRUGBANK 22346 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3820 6-Methyl-Formycin A - - DRUGBANK DB03986 C11H15N5O4 small molecule - - DRUGBANK 22347 850026 945654 b4384 deoD ECK4376|JW4347|pup 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3820 6-Methyl-Formycin A - - DRUGBANK DB03986 C11H15N5O4 small molecule - - DRUGBANK 27675 850044 945672 b1415 aldA ECK1408|JW1412|ald 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3467 Deoxycholic Acid 7-deoxycholic acid|Desoxycholsure|3alpha,12alpha-Dihydroxy-5beta-cholanic acid|desoxycholic acid|deoxycholate|(3,5,12)-3,12-dihydroxycholan-24-oic acid belkyra|kybella DRUGBANK DB03619 C24H40O4 small molecule - 83-44-3 DRUGBANK 17948 850046 945674 b0342 lacA ECK0339|JW0333 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1792 Isopropyl beta-D-thiogalactopyranoside isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG - DRUGBANK DB01862 C9H18O5S small molecule - 367-93-1 DRUGBANK 17949 850046 945674 b0342 lacA ECK0339|JW0333 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1792 Isopropyl beta-D-thiogalactopyranoside isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG - DRUGBANK DB01862 C9H18O5S small molecule - 367-93-1 DRUGBANK 18266 850046 945674 b0342 lacA ECK0339|JW0333 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18267 850046 945674 b0342 lacA ECK0339|JW0333 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 19577 850046 945674 b0342 lacA ECK0339|JW0333 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2524 4-nitrophenyl-beta-D-galactoside p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose - DRUGBANK DB02632 C12H15NO8 small molecule - 3150-24-1 DRUGBANK 19578 850046 945674 b0342 lacA ECK0339|JW0333 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2524 4-nitrophenyl-beta-D-galactoside p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose - DRUGBANK DB02632 C12H15NO8 small molecule - 3150-24-1 DRUGBANK 21510 850054 945682 b1123 potD ECK1109|JW1109 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3415 Spermidine 1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane - DRUGBANK DB03566 C7H19N3 small molecule - 124-20-9 DRUGBANK 21511 850054 945682 b1123 potD ECK1109|JW1109 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3415 Spermidine 1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane - DRUGBANK DB03566 C7H19N3 small molecule - 124-20-9 DRUGBANK 17930 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1778 Isocitrate Calcium Complex - - DRUGBANK DB01848 C6H7CaO7 small molecule - - DRUGBANK 17931 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1778 Isocitrate Calcium Complex - - DRUGBANK DB01848 C6H7CaO7 small molecule - - DRUGBANK 17669 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 17670 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1662 Isocitric Acid - - DRUGBANK DB01727 C6H8O7 small molecule - 320-77-4 DRUGBANK 21275 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21276 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 18691 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2106 2-Oxalosuccinic Acid - - DRUGBANK DB02190 C6H6O7 small molecule - - DRUGBANK 18692 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2106 2-Oxalosuccinic Acid - - DRUGBANK DB02190 C6H6O7 small molecule - - DRUGBANK 22990 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4106 3-Isopropylmalic Acid - - DRUGBANK DB04279 C7H12O5 small molecule - - DRUGBANK 22991 850074 945702 b1136 icd ECK1122|JW1122|icdA|icdE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4106 3-Isopropylmalic Acid - - DRUGBANK DB04279 C7H12O5 small molecule - - DRUGBANK 19123 850101 945731 b1461 pptA ECK1455|JW1456|ydcE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2289 (E)-2-Fluoro-P-Hydroxycinnamate - - DRUGBANK DB02384 C9H6FO3 small molecule - - DRUGBANK 19124 850101 945731 b1461 pptA ECK1455|JW1456|ydcE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2289 (E)-2-Fluoro-P-Hydroxycinnamate - - DRUGBANK DB02384 C9H6FO3 small molecule - - DRUGBANK 21934 850101 945731 b1461 pptA ECK1455|JW1456|ydcE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21935 850101 945731 b1461 pptA ECK1455|JW1456|ydcE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 20277 850125 945758 b1635 gstA ECK1631|JW1627|gst 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20278 850125 945758 b1635 gstA ECK1631|JW1627|gst 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2879 Glutathione Sulfonic Acid - - DRUGBANK DB03003 C10H17N3O9S small molecule - - DRUGBANK 20007 850140 945773 b1002 agp ECK0993|JW0987 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 20008 850140 945773 b1002 agp ECK0993|JW0987 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 18486 850142 945775 b1209 lolB ECK1197|JW1200|hemM|ychC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 1998 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane - - DRUGBANK DB02078 C8H18O4 small molecule - - DRUGBANK 22899 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4080 CB1954 - - DRUGBANK DB04253 C9H8N4O5 small molecule - - DRUGBANK 22900 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4080 CB1954 - - DRUGBANK DB04253 C9H8N4O5 small molecule - - DRUGBANK 22901 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4080 CB1954 - - DRUGBANK DB04253 C9H8N4O5 small molecule - - DRUGBANK 23256 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4213 Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] - - DRUGBANK DB04392 C19H12O6 small molecule - - DRUGBANK 23257 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4213 Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] - - DRUGBANK DB04392 C19H12O6 small molecule - - DRUGBANK 23258 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4213 Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] - - DRUGBANK DB04392 C19H12O6 small molecule - - DRUGBANK 20847 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20848 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20798 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3096 5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide - - DRUGBANK DB03228 C11H12Cl2N4O5 small molecule - - DRUGBANK 20799 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3096 5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide - - DRUGBANK DB03228 C11H12Cl2N4O5 small molecule - - DRUGBANK 20800 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3096 5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide - - DRUGBANK DB03228 C11H12Cl2N4O5 small molecule - - DRUGBANK 22976 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22977 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22661 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3969 2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide - - DRUGBANK DB04138 C14H16Br2N4O7 small molecule - - DRUGBANK 22662 850145 945778 b0578 nfsB ECK0570|JW0567|dprA|nfnB|nfsI|ntr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3969 2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide - - DRUGBANK DB04138 C14H16Br2N4O7 small molecule - - DRUGBANK 17707 850146 945779 b1212 prmC ECK1200|JW1203|hemK 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 17708 850146 945779 b1212 prmC ECK1200|JW1203|hemK 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 23480 850147 945780 b1225 narH ECK1219|JW1216|chlC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25356 850147 945780 b1225 narH ECK1219|JW1216|chlC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6165 (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE - - DRUGBANK DB07349 C19H36O10P small molecule - - DRUGBANK 23482 850149 945782 b1224 narG ECK1218|JW1215|chlC|narC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25358 850149 945782 b1224 narG ECK1218|JW1215|chlC|narC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6165 (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE - - DRUGBANK DB07349 C19H36O10P small molecule - - DRUGBANK 18825 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 18826 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli inhibitor target Chen X (2002) 11752352 171740 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 18827 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 2171 Orotic Acid - - DRUGBANK DB02262 C5H4N2O4 small molecule - 65-86-1 DRUGBANK 22896 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4079 N-Carbamoyl-L-Aspartate - - DRUGBANK DB04252 C5H8N2O5 small molecule - - DRUGBANK 22897 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4079 N-Carbamoyl-L-Aspartate - - DRUGBANK DB04252 C5H8N2O5 small molecule - - DRUGBANK 18586 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2048 Dihydroorotic Acid - - DRUGBANK DB02129 C5H6N2O4 small molecule - 155-54-4 DRUGBANK 18587 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2048 Dihydroorotic Acid - - DRUGBANK DB02129 C5H6N2O4 small molecule - 155-54-4 DRUGBANK 21975 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 21976 850154 945787 b1062 pyrC ECK1047|JW1049 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 23481 850175 945808 b1227 narI ECK1221|JW1218|chlI 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 25357 850175 945808 b1227 narI ECK1221|JW1218|chlI 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6165 (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE - - DRUGBANK DB07349 C19H36O10P small molecule - - DRUGBANK 19884 850210 945843 b1252 tonB ECK1246|JW5195|T1rec|exbA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2652 3-Hydroxy-Myristic Acid - - DRUGBANK DB02767 C14H28O3 small molecule - - DRUGBANK 26270 850210 945843 b1252 tonB ECK1246|JW5195|T1rec|exbA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 27674 850210 945843 b1252 tonB ECK1246|JW5195|T1rec|exbA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 22696 850210 945843 b1252 tonB ECK1246|JW5195|T1rec|exbA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 2308 850215 945848 b1662 ribC ECK1658|JW1654|ribE 511145 Escherichia coli unknown target Long Q (2010) 20148904 173180 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 2309 850215 945848 b1662 ribC ECK1658|JW1654|ribE 511145 Escherichia coli unknown target Kim RR (2010) 20143812 173181 134 Riboflavin Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine vitamin b complex 100 tab|mult DRUGBANK DB00140 C17H20N4O6 small molecule A11HA04 83-88-5 DRUGBANK 17481 850229 945862 b1274 topA ECK1268|JW1266|asuA?|supX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 17482 850229 945862 b1274 topA ECK1268|JW1266|asuA?|supX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 22806 850229 945862 b1274 topA ECK1268|JW1266|asuA?|supX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4033 Thymidine-3',5'-Diphosphate - - DRUGBANK DB04205 C10H16N2O11P2 small molecule - - DRUGBANK 22807 850229 945862 b1274 topA ECK1268|JW1266|asuA?|supX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4033 Thymidine-3',5'-Diphosphate - - DRUGBANK DB04205 C10H16N2O11P2 small molecule - - DRUGBANK 17836 850229 945862 b1274 topA ECK1268|JW1266|asuA?|supX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 17837 850229 945862 b1274 topA ECK1268|JW1266|asuA?|supX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1742 Adenosine-3'-5'-Diphosphate - - DRUGBANK DB01812 C10H15N5O10P2 small molecule - - DRUGBANK 20351 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2903 4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole - - DRUGBANK DB03030 C15H14N2S small molecule - - DRUGBANK 20352 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2903 4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole - - DRUGBANK DB03030 C15H14N2S small molecule - - DRUGBANK 20353 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2903 4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole - - DRUGBANK DB03030 C15H14N2S small molecule - - DRUGBANK 21450 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3386 3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide - - DRUGBANK DB03534 C22H26N4O2 small molecule - - DRUGBANK 21451 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3386 3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide - - DRUGBANK DB03534 C22H26N4O2 small molecule - - DRUGBANK 21452 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3386 3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide - - DRUGBANK DB03534 C22H26N4O2 small molecule - - DRUGBANK 17567 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1626 Indole Naphthyridinone - - DRUGBANK DB01691 C22H22N4O2 small molecule - - DRUGBANK 17568 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1626 Indole Naphthyridinone - - DRUGBANK DB01691 C22H22N4O2 small molecule - - DRUGBANK 17569 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 1626 Indole Naphthyridinone - - DRUGBANK DB01691 C22H22N4O2 small molecule - - DRUGBANK 22414 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3862 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole - - DRUGBANK DB04030 C25H22N2O3 small molecule - - DRUGBANK 22415 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3862 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole - - DRUGBANK DB04030 C25H22N2O3 small molecule - - DRUGBANK 22416 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3862 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole - - DRUGBANK DB04030 C25H22N2O3 small molecule - - DRUGBANK 19074 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19075 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 17976 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1795 3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide - - DRUGBANK DB01865 C19H20N4O small molecule - - DRUGBANK 17977 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1795 3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide - - DRUGBANK DB01865 C19H20N4O small molecule - - DRUGBANK 17978 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 1795 3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide - - DRUGBANK DB01865 C19H20N4O small molecule - - DRUGBANK 26314 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7054 2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL - - DRUGBANK DB08265 C14H13BN2O3S small molecule - - DRUGBANK 26636 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7382 6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL - - DRUGBANK DB08605 C9H13BN2O3S2 small molecule - - DRUGBANK 26635 850237 945870 b1288 fabI ECK1283|JW1281|envM|gts|qmeA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7381 Triclosan 2,4,4'-Trichloro-2'-hydroxydiphenyl ether|Triclosanum|5-Chloro-2-(2,4-dichloro-phenoxy)-phenol|Triclosan astound antibacterial|lysol i. DRUGBANK DB08604 C12H7Cl3O2 small molecule D08AE04|D09AA06 3380-34-5 DRUGBANK 23344 850243 945876 b1444 patD ECK1438|JW1439|prr|ydcW 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4221 [Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde - - DRUGBANK DB04401 C5H12NO small molecule - - DRUGBANK 23345 850243 945876 b1444 patD ECK1438|JW1439|prr|ydcW 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4221 [Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde - - DRUGBANK DB04401 C5H12NO small molecule - - DRUGBANK 22689 850256 945889 b1319 ompG ECK1315|JW1312 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22852 850256 945889 b1319 ompG ECK1315|JW1312 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 23126 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 23127 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4150 2-Phenylethylamine - - DRUGBANK DB04325 C8H12N small molecule - 64-04-0 DRUGBANK 23149 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4159 6-hydroxydopa quinone 2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone - DRUGBANK DB04334 C9H9NO5 small molecule - - DRUGBANK 23150 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4159 6-hydroxydopa quinone 2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone - DRUGBANK DB04334 C9H9NO5 small molecule - - DRUGBANK 21623 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3478 3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine - - DRUGBANK DB03631 C9H10N2O4 small molecule - - DRUGBANK 21624 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3478 3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine - - DRUGBANK DB03631 C9H10N2O4 small molecule - - DRUGBANK 18670 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2094 Phenylacetaldehyde - - DRUGBANK DB02178 C8H8O small molecule - 122-78-1 DRUGBANK 18671 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2094 Phenylacetaldehyde - - DRUGBANK DB02178 C8H8O small molecule - 122-78-1 DRUGBANK 17515 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1593 2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid - - DRUGBANK DB01657 C18H20N2O4 small molecule - - DRUGBANK 17516 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1593 2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid - - DRUGBANK DB01657 C18H20N2O4 small molecule - - DRUGBANK 17470 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1571 2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine - - DRUGBANK DB01634 C14H16N4O4 small molecule - - DRUGBANK 17471 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1571 2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine - - DRUGBANK DB01634 C14H16N4O4 small molecule - - DRUGBANK 20144 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2806 3-Amino-6-Hydroxy-Tyrosine - - DRUGBANK DB02928 C9H12N2O4 small molecule - - DRUGBANK 20145 850303 945939 b1386 tynA ECK1383|JW1381|maoA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2806 3-Amino-6-Hydroxy-Tyrosine - - DRUGBANK DB02928 C9H12N2O4 small molecule - - DRUGBANK 21664 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 21665 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 13014 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Young K (2006) 16436705 179809 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13015 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Price AC (2001) 11050088 179803 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13016 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Heath RJ (2001) 11591436 179802 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13017 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Heath RJ (2004) 15043388 179805 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13018 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Khandekar SS (2003) 12570782 179804 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13019 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Omura S (1976) 791237 179807 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13020 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli inhibitor target Heath RJ (2002) 12021787 179806 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 23623 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4336 Malonyl-Coenzyme A - - DRUGBANK DB04524 C24H38N7O19P3S small molecule - 524-14-1 DRUGBANK 23624 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4336 Malonyl-Coenzyme A - - DRUGBANK DB04524 C24H38N7O19P3S small molecule - 524-14-1 DRUGBANK 18931 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2223 1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid - - DRUGBANK DB02316 C22H21Cl2NO5 small molecule - - DRUGBANK 18932 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2223 1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid - - DRUGBANK DB02316 C22H21Cl2NO5 small molecule - - DRUGBANK 18933 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2223 1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid - - DRUGBANK DB02316 C22H21Cl2NO5 small molecule - - DRUGBANK 18388 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1962 S-Acetyl-Cysteine - - DRUGBANK DB02039 C5H9NO3S small molecule - - DRUGBANK 18389 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1962 S-Acetyl-Cysteine - - DRUGBANK DB02039 C5H9NO3S small molecule - - DRUGBANK 18249 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18250 850364 946003 b1091 fabH ECK1077|JW1077 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 25941 850396 946035 b1474 fdnG ECK1468|JW1470 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 25942 850399 946038 b1476 fdnI ECK1470|JW1472 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 22524 850482 946122 b0172 frr ECK0171|JW0167|rrf 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3914 Decyloxy-Methanol - - DRUGBANK DB04082 C11H24O2 small molecule - - DRUGBANK 5754 850492 946132 b0871 poxB ECK0862|JW0855 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 5755 850492 946132 b0871 poxB ECK0862|JW0855 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 20801 850505 946145 b1056 yceI ECK1041|JW1043 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3100 2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol - - DRUGBANK DB03232 C46H70O small molecule - - DRUGBANK 20802 850505 946145 b1056 yceI ECK1041|JW1043 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3100 2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol - - DRUGBANK DB03232 C46H70O small molecule - - DRUGBANK 19841 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2634 Pyromellitic Acid - - DRUGBANK DB02749 C10H6O8 small molecule - 89-05-4 DRUGBANK 19842 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2634 Pyromellitic Acid - - DRUGBANK DB02749 C10H6O8 small molecule - 89-05-4 DRUGBANK 19843 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2634 Pyromellitic Acid - - DRUGBANK DB02749 C10H6O8 small molecule - 89-05-4 DRUGBANK 22952 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22953 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 21257 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3308 3-Trimethylsilylsuccinic Acid - - DRUGBANK DB03452 C7H14O4Si small molecule - - DRUGBANK 21258 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3308 3-Trimethylsilylsuccinic Acid - - DRUGBANK DB03452 C7H14O4Si small molecule - - DRUGBANK 21406 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 21407 850507 946147 b1611 fumC ECK1606|JW1603 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3354 Malate Ion - - DRUGBANK DB03499 C4H5O5 small molecule - - DRUGBANK 18582 850511 946151 b1619 hdhA ECK1614|JW1611|hsd|hsdH 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2042 Glycochenodeoxycholic Acid - - DRUGBANK DB02123 C26H43NO5 small molecule - 640-79-9 DRUGBANK 18583 850511 946151 b1619 hdhA ECK1614|JW1611|hsd|hsdH 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2042 Glycochenodeoxycholic Acid - - DRUGBANK DB02123 C26H43NO5 small molecule - 640-79-9 DRUGBANK 18627 850522 946162 b1636 pdxY ECK1632|JW1628|ydgS 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 18628 850522 946162 b1636 pdxY ECK1632|JW1628|ydgS 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 20383 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2921 S-Selanyl Cysteine - - DRUGBANK DB03049 C3H7NO2SSe small molecule - - DRUGBANK 20384 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2921 S-Selanyl Cysteine - - DRUGBANK DB03049 C3H7NO2SSe small molecule - - DRUGBANK 22828 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Mihara H (2002) 11983074 181792 4045 L-2-amino-3-butynoic acid (S)-2-Amino-4-pentynoic acid|L-C-Propargylglycine|(S)-2-Amino-3-butynoic acid - DRUGBANK DB04217 C4H5NO2 small molecule - 73537-09-4 DRUGBANK 19869 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2646 S-Mercaptocysteine - - DRUGBANK DB02761 C3H7NO2S2 small molecule - 5652-32-4 DRUGBANK 19870 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2646 S-Mercaptocysteine - - DRUGBANK DB02761 C3H7NO2S2 small molecule - 5652-32-4 DRUGBANK 18992 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 18993 850545 946185 b1680 sufS ECK1676|JW1670|csdB|ynhB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 19839 850602 946242 b0411 tsx ECK0405|JW0401|T6rec|nupA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2631 Uridine - - DRUGBANK DB02745 C9H12N2O6 small molecule - 58-96-8 DRUGBANK 19840 850602 946242 b0411 tsx ECK0405|JW0401|T6rec|nupA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2631 Uridine - - DRUGBANK DB02745 C9H12N2O6 small molecule - 58-96-8 DRUGBANK 23538 850602 946242 b0411 tsx ECK0405|JW0401|T6rec|nupA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 23539 850602 946242 b0411 tsx ECK0405|JW0401|T6rec|nupA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 21533 850618 946259 b1745 astB ECK1743|JW1734|ydjT 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3430 N~2~-Succinylornithine - - DRUGBANK DB03582 C9H16N2O5 small molecule - - DRUGBANK 21534 850618 946259 b1745 astB ECK1743|JW1734|ydjT 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3430 N~2~-Succinylornithine - - DRUGBANK DB03582 C9H16N2O5 small molecule - - DRUGBANK 19349 850618 946259 b1745 astB ECK1743|JW1734|ydjT 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2398 N~2~-Succinylarginine - - DRUGBANK DB02501 C10H18N4O5 small molecule - - DRUGBANK 19350 850618 946259 b1745 astB ECK1743|JW1734|ydjT 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2398 N~2~-Succinylarginine - - DRUGBANK DB02501 C10H18N4O5 small molecule - - DRUGBANK 18700 850678 946321 b0090 murG ECK0091|JW0088 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18701 850678 946321 b0090 murG ECK0091|JW0088 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2112 Uridine-Diphosphate-N-Acetylgalactosamine - - DRUGBANK DB02196 C17H27N3O17P2 small molecule - - DRUGBANK 18130 850694 946337 b1812 pabB ECK1810|JW1801 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18131 850694 946337 b1812 pabB ECK1810|JW1801 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 26698 850701 946344 b1185 dsbB ECK1173|JW5182|dsbX|iarB|roxB|ycgA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7463 UBIQUINONE-1 - - DRUGBANK DB08689 C14H18O4 small molecule - - DRUGBANK 26709 850701 946344 b1185 dsbB ECK1173|JW5182|dsbX|iarB|roxB|ycgA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7464 UBIQUINONE-2 - - DRUGBANK DB08690 C19H26O4 small molecule - - DRUGBANK 22706 850717 946360 b0622 pagP ECK0615|JW0617|crcA|ybeG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22707 850717 946360 b0622 pagP ECK0615|JW0617|crcA|ybeG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22708 850717 946360 b0622 pagP ECK0615|JW0617|crcA|ybeG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22299 850717 946360 b0622 pagP ECK0615|JW0617|crcA|ybeG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3801 Dodecyl Sulfate - - DRUGBANK DB03967 C12H26O4S small molecule - - DRUGBANK 22928 850724 946367 b1850 eda ECK1851|JW1839|hga|kdgA|kga 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22929 850724 946367 b1850 eda ECK1851|JW1839|hga|kdgA|kga 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 18780 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2147 Glycinamide Ribonucleotide - - DRUGBANK DB02236 C7H13N2O8P small molecule - - DRUGBANK 18781 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2147 Glycinamide Ribonucleotide - - DRUGBANK DB02236 C7H13N2O8P small molecule - - DRUGBANK 22176 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22177 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 20149 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2808 Phosphothiophosphoric Acid-Adenylate Ester - - DRUGBANK DB02930 C10H16N5O12P3S small molecule - - DRUGBANK 20150 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2808 Phosphothiophosphoric Acid-Adenylate Ester - - DRUGBANK DB02930 C10H16N5O12P3S small molecule - - DRUGBANK 23272 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23273 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 21198 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3290 3[N-Morpholino]Propane Sulfonic Acid - - DRUGBANK DB03434 C7H15NO4S small molecule - - DRUGBANK 21199 850725 946368 b1849 purT ECK1850|JW1838 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3290 3[N-Morpholino]Propane Sulfonic Acid - - DRUGBANK DB03434 C7H15NO4S small molecule - - DRUGBANK 21380 850750 946393 b1882 cheY ECK1883|JW1871 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3342 3-Aminosuccinimide - - DRUGBANK DB03487 C4H6N2O2 small molecule - - DRUGBANK 21381 850750 946393 b1882 cheY ECK1883|JW1871 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3342 3-Aminosuccinimide - - DRUGBANK DB03487 C4H6N2O2 small molecule - - DRUGBANK 22735 850750 946393 b1882 cheY ECK1883|JW1871 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 22736 850750 946393 b1882 cheY ECK1883|JW1871 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3986 Aspartate Beryllium Trifluoride - - DRUGBANK DB04156 C4H8BeF3NO4 small molecule - - DRUGBANK 19241 850750 946393 b1882 cheY ECK1883|JW1871 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2361 S-Methyl Phosphocysteine - - DRUGBANK DB02461 C4H10NO5PS small molecule - - DRUGBANK 19242 850750 946393 b1882 cheY ECK1883|JW1871 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2361 S-Methyl Phosphocysteine - - DRUGBANK DB02461 C4H10NO5PS small molecule - - DRUGBANK 21382 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3343 Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-Alpha-D-Galactose - - DRUGBANK DB03488 C15H23FN2O16P2 small molecule - - DRUGBANK 21383 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3343 Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-Alpha-D-Galactose - - DRUGBANK DB03488 C15H23FN2O16P2 small molecule - - DRUGBANK 18305 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18306 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 23197 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 23198 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4178 Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester - - DRUGBANK DB04355 C15H24N2O17P2 small molecule - - DRUGBANK 21210 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21211 850762 946405 b1896 otsA ECK1895|JW5312|pexA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 20574 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3010 Alpha-L-Arabinose - - DRUGBANK DB03142 C5H10O5 small molecule - - DRUGBANK 20575 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3010 Alpha-L-Arabinose - - DRUGBANK DB03142 C5H10O5 small molecule - - DRUGBANK 20817 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3114 Beta-L-Arabinose - - DRUGBANK DB03246 C5H10O5 small molecule - 5328-37-0 DRUGBANK 20818 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3114 Beta-L-Arabinose - - DRUGBANK DB03246 C5H10O5 small molecule - 5328-37-0 DRUGBANK 21370 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3340 Alpha-D-Fucose - - DRUGBANK DB03485 C6H12O5 small molecule - - DRUGBANK 21371 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3340 Alpha-D-Fucose - - DRUGBANK DB03485 C6H12O5 small molecule - - DRUGBANK 22449 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3894 Beta-D-Fucose - - DRUGBANK DB04062 C6H12O5 small molecule - - DRUGBANK 22450 850766 946409 b1901 araF ECK1899|JW1889 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3894 Beta-D-Fucose - - DRUGBANK DB04062 C6H12O5 small molecule - - DRUGBANK 25954 850778 946421 b1916 sdiA ECK1915|JW1901|uvrX 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6724 N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE - - DRUGBANK DB07928 C12H21NO3 small molecule - - DRUGBANK 22709 850784 946427 b4291 fecA ECK4281|JW4251 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22710 850784 946427 b4291 fecA ECK4281|JW4251 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22711 850784 946427 b4291 fecA ECK4281|JW4251 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22519 850784 946427 b4291 fecA ECK4281|JW4251 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3911 Heptane-1,2,3-Triol - - DRUGBANK DB04079 C7H16O3 small molecule - - DRUGBANK 22520 850784 946427 b4291 fecA ECK4281|JW4251 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3911 Heptane-1,2,3-Triol - - DRUGBANK DB04079 C7H16O3 small molecule - - DRUGBANK 21340 850857 946508 b1982 amn ECK1977|JW1963 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3319 Formycin-5'-Monophosphate - - DRUGBANK DB03464 C10H13N5O7P small molecule - - DRUGBANK 21341 850857 946508 b1982 amn ECK1977|JW1963 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3319 Formycin-5'-Monophosphate - - DRUGBANK DB03464 C10H13N5O7P small molecule - - DRUGBANK 23439 850878 946531 b2020 hisD ECK2015|JW2002 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23440 850878 946531 b2020 hisD ECK2015|JW2002 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 22506 850878 946531 b2020 hisD ECK2015|JW2002 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22507 850878 946531 b2020 hisD ECK2015|JW2002 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 21994 850878 946531 b2020 hisD ECK2015|JW2002 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3649 Histidinol - - DRUGBANK DB03811 C6H9N3O small molecule - - DRUGBANK 21995 850878 946531 b2020 hisD ECK2015|JW2002 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3649 Histidinol - - DRUGBANK DB03811 C6H9N3O small molecule - - DRUGBANK 17525 850896 946549 b2019 hisG ECK2014|JW2001 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1597 Phosphoribosyl Atp - - DRUGBANK DB01661 C15H19N5O20P4 small molecule - - DRUGBANK 17526 850896 946549 b2019 hisG ECK2014|JW2001 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1597 Phosphoribosyl Atp - - DRUGBANK DB01661 C15H19N5O20P4 small molecule - - DRUGBANK 18607 850898 946551 b2021 hisC ECK2016|JW2003 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 18608 850898 946551 b2021 hisC ECK2016|JW2003 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 22358 850898 946551 b2021 hisC ECK2016|JW2003 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3831 Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester - - DRUGBANK DB03997 C6H11N3O4P small molecule - - DRUGBANK 22359 850898 946551 b2021 hisC ECK2016|JW2003 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3831 Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester - - DRUGBANK DB03997 C6H11N3O4P small molecule - - DRUGBANK 17846 850898 946551 b2021 hisC ECK2016|JW2003 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1743 Pyridoxyl-Glutamic Acid-5'-Monophosphate - - DRUGBANK DB01813 C13H20N2O9P small molecule - - DRUGBANK 17847 850898 946551 b2021 hisC ECK2016|JW2003 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1743 Pyridoxyl-Glutamic Acid-5'-Monophosphate - - DRUGBANK DB01813 C13H20N2O9P small molecule - - DRUGBANK 23098 850906 946559 b2051 wcaH ECK2045|JW5335|gmm|nudD|yefC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23099 850906 946559 b2051 wcaH ECK2045|JW5335|gmm|nudD|yefC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 20091 850910 946563 b2052 wcaG ECK2046|JW2037|fcl|yefB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2777 Acetylphosphate - - DRUGBANK DB02897 C2H5O5P small molecule - - DRUGBANK 20092 850910 946563 b2052 wcaG ECK2046|JW2037|fcl|yefB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2777 Acetylphosphate - - DRUGBANK DB02897 C2H5O5P small molecule - - DRUGBANK 21323 850910 946563 b2052 wcaG ECK2046|JW2037|fcl|yefB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21324 850910 946563 b2052 wcaG ECK2046|JW2037|fcl|yefB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 9617 850934 946587 b1378 pfo ECK1374|JW1372|nifJ|soi-9|ydbK 511145 Escherichia coli potentiator target Imming P (2006) 17016423 171742 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9619 850934 946587 b1378 pfo ECK1374|JW1372|nifJ|soi-9|ydbK 511145 Escherichia coli potentiator target Breeze AS (1983) 6363380 177892 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9618 850934 946587 b1378 pfo ECK1374|JW1372|nifJ|soi-9|ydbK 511145 Escherichia coli potentiator target Sisson G (2002) 12069963 177893 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9620 850934 946587 b1378 pfo ECK1374|JW1372|nifJ|soi-9|ydbK 511145 Escherichia coli potentiator target Overington JP (2006) 17139284 171741 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 18955 850940 946593 b2065 dcd ECK2059|JW2050|dus|paxA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2238 Deoxyuridine-5'-Triphosphate - - DRUGBANK DB02333 C9H15N2O14P3 small molecule - - DRUGBANK 18956 850940 946593 b2065 dcd ECK2059|JW2050|dus|paxA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2238 Deoxyuridine-5'-Triphosphate - - DRUGBANK DB02333 C9H15N2O14P3 small molecule - - DRUGBANK 20866 850940 946593 b2065 dcd ECK2059|JW2050|dus|paxA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3126 2'-Deoxycytidine-5'-Triphosphate - - DRUGBANK DB03258 C9H16N3O13P3 small molecule - 2056-98-6 DRUGBANK 20867 850940 946593 b2065 dcd ECK2059|JW2050|dus|paxA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3126 2'-Deoxycytidine-5'-Triphosphate - - DRUGBANK DB03258 C9H16N3O13P3 small molecule - 2056-98-6 DRUGBANK 23715 850970 946624 b0125 hpt ECK0124|JW5009 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23716 850970 946624 b0125 hpt ECK0124|JW5009 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 18617 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2068 Methionine Phosphonate - - DRUGBANK DB02151 C4H12NO3PS small molecule - - DRUGBANK 18618 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2068 Methionine Phosphonate - - DRUGBANK DB02151 C4H12NO3PS small molecule - - DRUGBANK 22029 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3654 Difluoromethionine - - DRUGBANK DB03816 C5H9F2NO2S small molecule - - DRUGBANK 22030 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3654 Difluoromethionine - - DRUGBANK DB03816 C5H9F2NO2S small molecule - - DRUGBANK 22392 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3849 Methionine Phosphinate - - DRUGBANK DB04015 C4H12NO2PS small molecule - - DRUGBANK 22393 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3849 Methionine Phosphinate - - DRUGBANK DB04015 C4H12NO2PS small molecule - - DRUGBANK 18769 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2141 5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine - - DRUGBANK DB02229 C15H25N7O7S2 small molecule - - DRUGBANK 18770 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2141 5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine - - DRUGBANK DB02229 C15H25N7O7S2 small molecule - - DRUGBANK 21964 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3638 Trifluoromethionine - - DRUGBANK DB03799 C5H8F3NO2S small molecule - - DRUGBANK 21965 850988 946643 b2114 metG ECK2107|JW2101 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3638 Trifluoromethionine - - DRUGBANK DB03799 C5H8F3NO2S small molecule - - DRUGBANK 10163 850996 946653 b2133 dld ECK2126|JW2121 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 746 Hexachlorophene Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm sapoderm|phisohex DRUGBANK DB00756 C13H6Cl6O2 small molecule D08AE01 70-30-4 DRUGBANK 10164 850996 946653 b2133 dld ECK2126|JW2121 511145 Escherichia coli inhibitor target Wang JL (1978) 570044 178227 746 Hexachlorophene Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm sapoderm|phisohex DRUGBANK DB00756 C13H6Cl6O2 small molecule D08AE01 70-30-4 DRUGBANK 10165 850996 946653 b2133 dld ECK2126|JW2121 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 746 Hexachlorophene Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm sapoderm|phisohex DRUGBANK DB00756 C13H6Cl6O2 small molecule D08AE01 70-30-4 DRUGBANK 20631 850996 946653 b2133 dld ECK2126|JW2121 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20632 850996 946653 b2133 dld ECK2126|JW2121 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 15882 851004 946662 b2134 pbpG ECK2127|JW5355|psv|yohB 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 23242 851005 946663 b2143 cdd ECK2136|JW2131 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4207 3-Deazacytidine - - DRUGBANK DB04385 C10H14N2O5 small molecule - - DRUGBANK 23243 851005 946663 b2143 cdd ECK2136|JW2131 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4207 3-Deazacytidine - - DRUGBANK DB04385 C10H14N2O5 small molecule - - DRUGBANK 20419 851005 946663 b2143 cdd ECK2136|JW2131 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2939 Zebularine pyrimidin-2-one beta-ribofuranoside|Pyrimidin-2-one beta-D-ribofuranoside|1-beta-D-ribofuranosyl-2(1H)-pyrimidinone|1-beta-D-ribofuranosylpyrimidin-2(1H)-one|Pyrimidin-2-one ribonucleoside|DHZ - DRUGBANK DB03068 C9H12N2O5 small molecule - 3690-10-6 DRUGBANK 20420 851005 946663 b2143 cdd ECK2136|JW2131 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2939 Zebularine pyrimidin-2-one beta-ribofuranoside|Pyrimidin-2-one beta-D-ribofuranoside|1-beta-D-ribofuranosyl-2(1H)-pyrimidinone|1-beta-D-ribofuranosylpyrimidin-2(1H)-one|Pyrimidin-2-one ribonucleoside|DHZ - DRUGBANK DB03068 C9H12N2O5 small molecule - 3690-10-6 DRUGBANK 26456 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7191 PLATENSIMYCIN - - DRUGBANK DB08407 C24H27NO7 small molecule - - DRUGBANK 27664 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 13000 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Schujman GE (2001) 11325930 179801 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13001 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Price AC (2001) 11050088 179803 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13002 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Heath RJ (2001) 11591436 179802 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13003 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Heath RJ (2004) 15043388 179805 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13004 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Khandekar SS (2003) 12570782 179804 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13005 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Omura S (1976) 791237 179807 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13006 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli inhibitor target Heath RJ (2002) 12021787 179806 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 26415 851007 946665 b1095 fabF ECK1081|JW1081|cvc|fabJ|vtr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7151 3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid - - DRUGBANK DB08366 C24H29NO7 small molecule - - DRUGBANK 24893 851075 946734 b2261 menC ECK2255|JW2256 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5684 2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID - - DRUGBANK DB06864 C11H12O6 small molecule - - DRUGBANK 18800 851075 946734 b2261 menC ECK2255|JW2256 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2160 O-Succinylbenzoate - - DRUGBANK DB02251 C11H10O5 small molecule - 27415-09-4 DRUGBANK 23012 851135 946794 b2312 purF ECK2306|JW2309|ade|purC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4123 5-Oxo-L-Norleucine - - DRUGBANK DB04296 C6H11NO3 small molecule - - DRUGBANK 23013 851135 946794 b2312 purF ECK2306|JW2309|ade|purC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4123 5-Oxo-L-Norleucine - - DRUGBANK DB04296 C6H11NO3 small molecule - - DRUGBANK 18215 851135 946794 b2312 purF ECK2306|JW2309|ade|purC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18216 851135 946794 b2312 purF ECK2306|JW2309|ade|purC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 22233 851135 946794 b2312 purF ECK2306|JW2309|ade|purC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3778 Carboxylic PRPP CPRPP - DRUGBANK DB03942 C6H15O13P3 small molecule - - DRUGBANK 22234 851135 946794 b2312 purF ECK2306|JW2309|ade|purC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3778 Carboxylic PRPP CPRPP - DRUGBANK DB03942 C6H15O13P3 small molecule - - DRUGBANK 23024 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4129 4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One - - DRUGBANK DB04302 C11H14O2S small molecule - 82079-32-1 DRUGBANK 23025 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4129 4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One - - DRUGBANK DB04302 C11H14O2S small molecule - 82079-32-1 DRUGBANK 23026 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4129 4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One - - DRUGBANK DB04302 C11H14O2S small molecule - 82079-32-1 DRUGBANK 21573 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3448 Decanoic Acid Capric acid - DRUGBANK DB03600 C10H20O2 small molecule - 334-48-5 DRUGBANK 21574 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3448 Decanoic Acid Capric acid - DRUGBANK DB03600 C10H20O2 small molecule - 334-48-5 DRUGBANK 21575 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3448 Decanoic Acid Capric acid - DRUGBANK DB03600 C10H20O2 small molecule - 334-48-5 DRUGBANK 13007 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Kauppinen S (1988) 3076376 29664 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13008 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Slabaugh MB (1998) 9681003 179808 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13009 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Price AC (2001) 11050088 179803 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13010 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Heath RJ (2001) 11591436 179802 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13011 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Heath RJ (2004) 15043388 179805 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13012 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Khandekar SS (2003) 12570782 179804 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 13013 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli inhibitor target Omura S (1976) 791237 179807 1023 Cerulenin Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide - DRUGBANK DB01034 C12H17NO3 small molecule - 17397-89-6 DRUGBANK 26409 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7144 2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE - - DRUGBANK DB08359 C12H12N2OS small molecule - - DRUGBANK 27652 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27653 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 27654 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 8062 Lauric Acid Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid vitafol plus DRUGBANK DB03017 C12H24O2 small molecule - 143-07-7 DRUGBANK 26654 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7403 (5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE - - DRUGBANK DB08628 C10H12O2S small molecule - - DRUGBANK 26653 851140 946799 b2323 fabB ECK2317|JW2320|fabC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7402 (5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE - - DRUGBANK DB08627 C12H16O2S small molecule - - DRUGBANK 20832 851147 946806 b1638 pdxH ECK1634|JW1630 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20833 851147 946806 b1638 pdxH ECK1634|JW1630 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 21010 851147 946806 b1638 pdxH ECK1634|JW1630 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 21011 851147 946806 b1638 pdxH ECK1634|JW1630 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3208 Beta-Mercaptoethanol 2-Sulfhydryl-Ethanol - DRUGBANK DB03345 C2H6OS small molecule - 60-24-2 DRUGBANK 18164 851153 946812 b2328 mepA ECK2322|JW2325 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 18165 851153 946812 b2328 mepA ECK2322|JW2325 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1879 1,4-Butanediol - - DRUGBANK DB01955 C4H10O2 small molecule - 110-63-4 DRUGBANK 22703 851161 946820 b2344 fadL ECK2338|JW2341|ttr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22704 851161 946820 b2344 fadL ECK2338|JW2341|ttr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22705 851161 946820 b2344 fadL ECK2338|JW2341|ttr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22865 851161 946820 b2344 fadL ECK2338|JW2341|ttr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22866 851161 946820 b2344 fadL ECK2338|JW2341|ttr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22867 851161 946820 b2344 fadL ECK2338|JW2341|ttr 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22712 851184 946843 b4311 nanC ECK4302|JW5778|yjhA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22730 851209 946869 b2412 zipA ECK2407|JW2404 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3984 N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide - - DRUGBANK DB04154 C20H17N5O small molecule - - DRUGBANK 22189 851209 946869 b2412 zipA ECK2407|JW2404 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3753 4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine - - DRUGBANK DB03916 C22H26ClN7 small molecule - - DRUGBANK 18693 851209 946869 b2412 zipA ECK2407|JW2404 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2107 (7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One - - DRUGBANK DB02191 C15H16N2O small molecule - - DRUGBANK 18197 851209 946869 b2412 zipA ECK2407|JW2404 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 1891 N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide - - DRUGBANK DB01967 C21H29N3O3S small molecule - - DRUGBANK 18595 851218 946878 b2407 xapA ECK2401|JW2398|pndA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2053 Xanthine - - DRUGBANK DB02134 C5H4N4O2 small molecule - 69-89-6 DRUGBANK 18596 851218 946878 b2407 xapA ECK2401|JW2398|pndA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2053 Xanthine - - DRUGBANK DB02134 C5H4N4O2 small molecule - 69-89-6 DRUGBANK 19048 851218 946878 b2407 xapA ECK2401|JW2398|pndA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 19049 851218 946878 b2407 xapA ECK2401|JW2398|pndA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2282 Guanine - - DRUGBANK DB02377 C5H4N5O small molecule - 73-40-5 DRUGBANK 20173 851285 946946 b1740 nadE ECK1738|JW1729|efg|ntrL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2815 Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate - - DRUGBANK DB02937 C11H19AsN5O12P2 small molecule - - DRUGBANK 20174 851285 946946 b1740 nadE ECK1738|JW1729|efg|ntrL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2815 Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate - - DRUGBANK DB02937 C11H19AsN5O12P2 small molecule - - DRUGBANK 22562 851285 946946 b1740 nadE ECK1738|JW1729|efg|ntrL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 22563 851285 946946 b1740 nadE ECK1738|JW1729|efg|ntrL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 22744 851285 946946 b1740 nadE ECK1738|JW1729|efg|ntrL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 22745 851285 946946 b1740 nadE ECK1738|JW1729|efg|ntrL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 18784 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2147 Glycinamide Ribonucleotide - - DRUGBANK DB02236 C7H13N2O8P small molecule - - DRUGBANK 18785 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2147 Glycinamide Ribonucleotide - - DRUGBANK DB02236 C7H13N2O8P small molecule - - DRUGBANK 22916 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4091 (10R)-10-Formyl-5,8,10-Trideazafolic Acid - - DRUGBANK DB04264 C23H22N4O8 small molecule - - DRUGBANK 22917 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4091 (10R)-10-Formyl-5,8,10-Trideazafolic Acid - - DRUGBANK DB04264 C23H22N4O8 small molecule - - DRUGBANK 19423 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2437 (10S)-10-Formyl-5,8,10-Trideazafolic Acid - - DRUGBANK DB02540 C23H22N4O8 small molecule - - DRUGBANK 19424 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2437 (10S)-10-Formyl-5,8,10-Trideazafolic Acid - - DRUGBANK DB02540 C23H22N4O8 small molecule - - DRUGBANK 19920 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2676 N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide - - DRUGBANK DB02794 C30H37N6O15P small molecule - - DRUGBANK 19921 851312 946973 b2500 purN ECK2496|JW2485|ade 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2676 N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide - - DRUGBANK DB02794 C30H37N6O15P small molecule - - DRUGBANK 21996 851328 946989 b2514 hisS ECK2510|JW2498 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3649 Histidinol - - DRUGBANK DB03811 C6H9N3O small molecule - - DRUGBANK 21997 851328 946989 b2514 hisS ECK2510|JW2498 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3649 Histidinol - - DRUGBANK DB03811 C6H9N3O small molecule - - DRUGBANK 22799 851328 946989 b2514 hisS ECK2510|JW2498 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4029 Histidyl-Adenosine Monophosphate - - DRUGBANK DB04201 C16H20N8O8P small molecule - - DRUGBANK 22800 851328 946989 b2514 hisS ECK2510|JW2498 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4029 Histidyl-Adenosine Monophosphate - - DRUGBANK DB04201 C16H20N8O8P small molecule - - DRUGBANK 19377 851378 947039 b2564 pdxJ ECK2562|JW2548 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19378 851378 947039 b2564 pdxJ ECK2562|JW2548 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2412 3-Phosphoglycerol - - DRUGBANK DB02515 C3H9O6P small molecule - - DRUGBANK 19336 851378 947039 b2564 pdxJ ECK2562|JW2548 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2393 1-Deoxy-D-xylulose 5-phosphate - - DRUGBANK DB02496 C5H11O7P small molecule - 190079-18-6 DRUGBANK 19337 851378 947039 b2564 pdxJ ECK2562|JW2548 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2393 1-Deoxy-D-xylulose 5-phosphate - - DRUGBANK DB02496 C5H11O7P small molecule - 190079-18-6 DRUGBANK 18730 851378 947039 b2564 pdxJ ECK2562|JW2548 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2122 Pyridoxine-5'-Phosphate - - DRUGBANK DB02209 C8H12NO6P small molecule - 447-05-2 DRUGBANK 18731 851378 947039 b2564 pdxJ ECK2562|JW2548 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2122 Pyridoxine-5'-Phosphate - - DRUGBANK DB02209 C8H12NO6P small molecule - 447-05-2 DRUGBANK 18092 851379 947040 b2568 lepB ECK2566|JW2552|lep 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1859 N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide - - DRUGBANK DB01934 C42H60N6O11 small molecule - - DRUGBANK 18093 851379 947040 b2568 lepB ECK2566|JW2552|lep 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1859 N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide - - DRUGBANK DB01934 C42H60N6O11 small molecule - - DRUGBANK 18490 851379 947040 b2568 lepB ECK2566|JW2552|lep 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2000 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene - - DRUGBANK DB02080 C21H36O4 small molecule - - DRUGBANK 24929 851379 947040 b2568 lepB ECK2566|JW2552|lep 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5723 (5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE - - DRUGBANK DB06904 C13H17NO5S small molecule - - DRUGBANK 26668 851418 947081 b2599 pheA ECK2596|JW2580 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7422 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID - - DRUGBANK DB08648 C10H12O6 small molecule - - DRUGBANK 20079 851455 947121 b1281 pyrF ECK1276|JW1273 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2770 6-Hydroxyuridine-5'-Phosphate - - DRUGBANK DB02890 C9H13N2O10P small molecule - - DRUGBANK 20080 851455 947121 b1281 pyrF ECK1276|JW1273 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2770 6-Hydroxyuridine-5'-Phosphate - - DRUGBANK DB02890 C9H13N2O10P small molecule - - DRUGBANK 21684 851455 947121 b1281 pyrF ECK1276|JW1273 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3514 1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid - - DRUGBANK DB03668 C9H13N2O10P small molecule - - DRUGBANK 21685 851455 947121 b1281 pyrF ECK1276|JW1273 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3514 1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid - - DRUGBANK DB03668 C9H13N2O10P small molecule - - DRUGBANK 22573 851471 947137 b3549 tag ECK3536|JW3518|tagA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3936 3-Methyladenine - - DRUGBANK DB04104 C6H7N5 small molecule - - DRUGBANK 22574 851471 947137 b3549 tag ECK3536|JW3518|tagA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3936 3-Methyladenine - - DRUGBANK DB04104 C6H7N5 small molecule - - DRUGBANK 15858 851484 947152 b2519 pbpC ECK2515|JW2503|yfgN 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 15859 851484 947152 b2519 pbpC ECK2515|JW2503|yfgN 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 23464 851497 947165 b2679 proX ECK2673|JW2654|osrA|proU 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4269 Trimethyl Glycine - - DRUGBANK DB04455 C5H12NO2 small molecule - - DRUGBANK 23465 851497 947165 b2679 proX ECK2673|JW2654|osrA|proU 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4269 Trimethyl Glycine - - DRUGBANK DB04455 C5H12NO2 small molecule - - DRUGBANK 22994 851497 947165 b2679 proX ECK2673|JW2654|osrA|proU 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4111 Proline Betaine - - DRUGBANK DB04284 C7H14NO2 small molecule - - DRUGBANK 22995 851497 947165 b2679 proX ECK2673|JW2654|osrA|proU 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4111 Proline Betaine - - DRUGBANK DB04284 C7H14NO2 small molecule - - DRUGBANK 21773 851516 947184 b2701 mltB ECK2696|JW2671 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3553 Bicine - - DRUGBANK DB03709 C6H13NO4 small molecule - - DRUGBANK 21774 851516 947184 b2701 mltB ECK2696|JW2671 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3553 Bicine - - DRUGBANK DB03709 C6H13NO4 small molecule - - DRUGBANK 19509 851516 947184 b2701 mltB ECK2696|JW2671 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2489 Bulgecin A - - DRUGBANK DB02595 C16H30N3O14S2 small molecule - 92953-54-3 DRUGBANK 19510 851516 947184 b2701 mltB ECK2696|JW2671 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2489 Bulgecin A - - DRUGBANK DB02595 C16H30N3O14S2 small molecule - 92953-54-3 DRUGBANK 18108 851539 947207 b2739 ygbM ECK2734|JW2709 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18109 851539 947207 b2739 ygbM ECK2734|JW2709 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 19984 851563 947231 b2763 cysI ECK2758|JW2733 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2714 Siroheme - - DRUGBANK DB02832 C42H42FeN4O16 small molecule - 52553-42-1 DRUGBANK 19985 851563 947231 b2763 cysI ECK2758|JW2733 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2714 Siroheme - - DRUGBANK DB02832 C42H42FeN4O16 small molecule - 52553-42-1 DRUGBANK 26547 851583 947253 b0932 pepN ECK0923|JW0915 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7285 N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine - - DRUGBANK DB08506 C21H27N2O5P small molecule - - DRUGBANK 20805 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3105 2,3-Dihydroxy-5-Oxo-Hexanedioate - - DRUGBANK DB03237 C6H6O7 small molecule - - DRUGBANK 20806 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3105 2,3-Dihydroxy-5-Oxo-Hexanedioate - - DRUGBANK DB03237 C6H6O7 small molecule - - DRUGBANK 21819 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3577 Xylarohydroxamate - - DRUGBANK DB03734 C5H8NO7 small molecule - - DRUGBANK 21820 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3577 Xylarohydroxamate - - DRUGBANK DB03734 C5H8NO7 small molecule - - DRUGBANK 21579 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3451 Glucarate - - DRUGBANK DB03603 C6H8O8 small molecule - 87-73-0 DRUGBANK 21580 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3451 Glucarate - - DRUGBANK DB03603 C6H8O8 small molecule - 87-73-0 DRUGBANK 20760 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3080 4-Deoxyglucarate - - DRUGBANK DB03212 C6H8O7 small molecule - - DRUGBANK 20761 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3080 4-Deoxyglucarate - - DRUGBANK DB03212 C6H8O7 small molecule - - DRUGBANK 27633 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27634 851588 947258 b2787 gudD ECK2781|JW2758|ygcX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 23314 851602 947272 b3404 envZ ECK3391|JW3367|cpr|ompB|perA|tpo 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23315 851602 947272 b3404 envZ ECK3391|JW3367|cpr|ompB|perA|tpo 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 17909 851603 947273 b2799 fucO ECK2794|JW2770 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1769 1,2-Propanediol - - DRUGBANK DB01839 C3H8O2 small molecule - 57-55-6 DRUGBANK 17910 851603 947273 b2799 fucO ECK2794|JW2770 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1769 1,2-Propanediol - - DRUGBANK DB01839 C3H8O2 small molecule - 57-55-6 DRUGBANK 18434 851603 947273 b2799 fucO ECK2794|JW2770 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 18435 851603 947273 b2799 fucO ECK2794|JW2770 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1980 Adenosine-5-Diphosphoribose ADPR - DRUGBANK DB02059 C15H23N5O14P2 small molecule - - DRUGBANK 20341 851610 947282 b2800 fucA ECK2795|JW2771|fucC|prd 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20342 851610 947282 b2800 fucA ECK2795|JW2771|fucC|prd 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 23137 851610 947282 b2800 fucA ECK2795|JW2771|fucC|prd 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 23138 851610 947282 b2800 fucA ECK2795|JW2771|fucC|prd 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4151 1,3-Dihydroxyacetonephosphate - - DRUGBANK DB04326 C3H7O6P small molecule - - DRUGBANK 20856 851640 947313 b2838 lysA ECK2836|JW2806 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3120 D-Lysine (R)-2,6-diaminohexanoic acid|D-2,6-Diaminohexanoic acid|D-Lysin - DRUGBANK DB03252 C6H14N2O2 small molecule - 923-27-3 DRUGBANK 20857 851640 947313 b2838 lysA ECK2836|JW2806 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3120 D-Lysine (R)-2,6-diaminohexanoic acid|D-2,6-Diaminohexanoic acid|D-Lysin - DRUGBANK DB03252 C6H14N2O2 small molecule - 923-27-3 DRUGBANK 22025 851640 947313 b2838 lysA ECK2836|JW2806 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22026 851640 947313 b2838 lysA ECK2836|JW2806 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22007 851686 947363 b2893 dsbC ECK2888|JW2861|xprA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22008 851686 947363 b2893 dsbC ECK2888|JW2861|xprA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22550 851707 947385 b2908 pepP ECK2903|JW2876 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3924 Apstatin - - DRUGBANK DB04092 C23H33N5O5 small molecule - - DRUGBANK 22551 851707 947385 b2908 pepP ECK2903|JW2876 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3924 Apstatin - - DRUGBANK DB04092 C23H33N5O5 small molecule - - DRUGBANK 20514 851729 947408 b2919 scpB ECK2915|JW2886|mmcD|ygfG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2988 2-Carboxypropyl-Coenzyme A - - DRUGBANK DB03117 C25H42N7O18P3S small molecule - - DRUGBANK 20515 851729 947408 b2919 scpB ECK2915|JW2886|mmcD|ygfG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2988 2-Carboxypropyl-Coenzyme A - - DRUGBANK DB03117 C25H42N7O18P3S small molecule - - DRUGBANK 20339 851736 947415 b2925 fbaA ECK2921|JW2892|ald|fba|fda 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20340 851736 947415 b2925 fbaA ECK2921|JW2892|ald|fba|fda 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 17854 851774 947454 b2957 ansB ECK2952|JW2924 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1747 Threonine-Aspartic Ester - - DRUGBANK DB01817 C8H16N2O6 small molecule - - DRUGBANK 17855 851774 947454 b2957 ansB ECK2952|JW2924 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1747 Threonine-Aspartic Ester - - DRUGBANK DB01817 C8H16N2O6 small molecule - - DRUGBANK 18937 851810 947493 b3011 yqhD ECK3003|JW2978 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2226 5,6-Dihydroxy-Nadp - - DRUGBANK DB02319 C21H32N7O19P3 small molecule - - DRUGBANK 18938 851810 947493 b3011 yqhD ECK3003|JW2978 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2226 5,6-Dihydroxy-Nadp - - DRUGBANK DB02319 C21H32N7O19P3 small molecule - - DRUGBANK 10787 851816 947499 b3019 parC ECK3010|JW2987 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 10788 851816 947499 b3019 parC ECK3010|JW2987 511145 Escherichia coli inhibitor target Zweerink MM (1986) 3010848 178524 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 10789 851816 947499 b3019 parC ECK3010|JW2987 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 17700 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1681 Coprogen - - DRUGBANK DB01747 C35H53FeN6O13 small molecule - 31418-71-0 DRUGBANK 17701 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1681 Coprogen - - DRUGBANK DB01747 C35H53FeN6O13 small molecule - 31418-71-0 DRUGBANK 19778 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2612 Delta-2-Albomycin A1 - - DRUGBANK DB02724 C37H57FeN12O18S small molecule - - DRUGBANK 19779 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2612 Delta-2-Albomycin A1 - - DRUGBANK DB02724 C37H57FeN12O18S small molecule - - DRUGBANK 21230 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli antagonist target Imming P (2006) 17016423 171742 3292 Gallichrome - - DRUGBANK DB03436 C28H44GaN9O13 small molecule - - DRUGBANK 21231 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli antagonist target Clarke TE (2000) 10742172 181747 3292 Gallichrome - - DRUGBANK DB03436 C28H44GaN9O13 small molecule - - DRUGBANK 21232 851827 947510 b0152 fhuD ECK0151|JW0148 511145 Escherichia coli antagonist target Overington JP (2006) 17139284 171741 3292 Gallichrome - - DRUGBANK DB03436 C28H44GaN9O13 small molecule - - DRUGBANK 21029 851838 947521 b3035 tolC ECK3026|JW5503|colE1-i|mtcB|mukA|refI|toc|weeA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3213 Cobalt Hexammine Ion - - DRUGBANK DB03350 CoH12N6 small molecule - - DRUGBANK 21030 851838 947521 b3035 tolC ECK3026|JW5503|colE1-i|mtcB|mukA|refI|toc|weeA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3213 Cobalt Hexammine Ion - - DRUGBANK DB03350 CoH12N6 small molecule - - DRUGBANK 23254 851885 947569 b1412 azoR ECK1405|JW1409|acpD 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4213 Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] - - DRUGBANK DB04392 C19H12O6 small molecule - - DRUGBANK 8226 851899 947583 b3076 ebgA ECK3066|JW5511 511145 Escherichia coli unknown target Cook GC (1978) 97820 177034 571 Lactulose Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose lactulose solution usp - liq 6 DRUGBANK DB00581 C12H22O11 small molecule A06AD61|A06AD11 4618-18-2 DRUGBANK 8227 851899 947583 b3076 ebgA ECK3066|JW5511 511145 Escherichia coli unknown target Hall BG (1998) 9718732 177035 571 Lactulose Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose lactulose solution usp - liq 6 DRUGBANK DB00581 C12H22O11 small molecule A06AD61|A06AD11 4618-18-2 DRUGBANK 8228 851899 947583 b3076 ebgA ECK3066|JW5511 511145 Escherichia coli unknown target Noone C (1986) 3089818 177032 571 Lactulose Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose lactulose solution usp - liq 6 DRUGBANK DB00581 C12H22O11 small molecule A06AD61|A06AD11 4618-18-2 DRUGBANK 8229 851899 947583 b3076 ebgA ECK3066|JW5511 511145 Escherichia coli unknown target Bjarnason I (1996) 8949640 177033 571 Lactulose Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose lactulose solution usp - liq 6 DRUGBANK DB00581 C12H22O11 small molecule A06AD61|A06AD11 4618-18-2 DRUGBANK 8230 851899 947583 b3076 ebgA ECK3066|JW5511 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 571 Lactulose Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose lactulose solution usp - liq 6 DRUGBANK DB00581 C12H22O11 small molecule A06AD61|A06AD11 4618-18-2 DRUGBANK 8231 851899 947583 b3076 ebgA ECK3066|JW5511 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 571 Lactulose Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose lactulose solution usp - liq 6 DRUGBANK DB00581 C12H22O11 small molecule A06AD61|A06AD11 4618-18-2 DRUGBANK 7809 851906 947590 b3172 argG Arg6|ECK3161|JW3140|argE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 7810 851906 947590 b3172 argG Arg6|ECK3161|JW3140|argE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 526 Guanidine Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE guanidine hydrochloride DRUGBANK DB00536 CH5N3 small molecule - 113-00-8 DRUGBANK 22511 851906 947590 b3172 argG Arg6|ECK3161|JW3140|argE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22512 851906 947590 b3172 argG Arg6|ECK3161|JW3140|argE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 20849 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20850 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 20664 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20665 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21753 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3542 5-Mercaptoethanol-2-Decenoyl-Coenzyme A - - DRUGBANK DB03698 C33H54N7O18P3S2 small molecule - - DRUGBANK 21754 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3542 5-Mercaptoethanol-2-Decenoyl-Coenzyme A - - DRUGBANK DB03698 C33H54N7O18P3S2 small molecule - - DRUGBANK 21314 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21315 851910 947594 b3081 fadH ECK3071|JW3052|ygjL 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 20343 851957 947644 b3137 kbaY ECK3125|JW3106|agaY|kba|yraC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20344 851957 947644 b3137 kbaY ECK3125|JW3106|agaY|kba|yraC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 21861 851986 947673 b3163 nlpI ECK3151|JW3132|yhbM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 21862 851986 947673 b3163 nlpI ECK3151|JW3132|yhbM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 18828 851992 947679 b1779 gapA ECK1777|JW1768 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2172 Glyceraldehyde-3-Phosphate - - DRUGBANK DB02263 C3H7O6P small molecule - 142-10-9 DRUGBANK 18829 851992 947679 b1779 gapA ECK1777|JW1768 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2172 Glyceraldehyde-3-Phosphate - - DRUGBANK DB02263 C3H7O6P small molecule - 142-10-9 DRUGBANK 22000 851992 947679 b1779 gapA ECK1777|JW1768 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22001 851992 947679 b1779 gapA ECK1777|JW1768 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 21709 851996 947683 b2255 arnA ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21710 851996 947683 b2255 arnA ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 20864 851996 947683 b2255 arnA ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3124 (6R)-Folinic acid (6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate - DRUGBANK DB03256 C20H23N7O7 small molecule - 73951-54-9 DRUGBANK 20865 851996 947683 b2255 arnA ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3124 (6R)-Folinic acid (6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate - DRUGBANK DB03256 C20H23N7O7 small molecule - 73951-54-9 DRUGBANK 15794 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 1280 Sulfacytine 1-ethyl-N-sulfanilylcytosine|N-sulfanilyl-l-ethylcytosine|Sulfacitina|Renoquid|Sulfacitinum|1-ethyl N4-sulfanilylcytosin - DRUGBANK DB01298 C12H14N4O3S small molecule - 17784-12-2 DRUGBANK 15795 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hughes J (1975) 1195474 181084 1280 Sulfacytine 1-ethyl-N-sulfanilylcytosine|N-sulfanilyl-l-ethylcytosine|Sulfacitina|Renoquid|Sulfacitinum|1-ethyl N4-sulfanilylcytosin - DRUGBANK DB01298 C12H14N4O3S small molecule - 17784-12-2 DRUGBANK 15796 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 1280 Sulfacytine 1-ethyl-N-sulfanilylcytosine|N-sulfanilyl-l-ethylcytosine|Sulfacitina|Renoquid|Sulfacitinum|1-ethyl N4-sulfanilylcytosin - DRUGBANK DB01298 C12H14N4O3S small molecule - 17784-12-2 DRUGBANK 8844 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Patel OG (2004) 14700578 177461 624 Sulfacetamide N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide sulfacetamide sodium and predn DRUGBANK DB00634 C8H10N2O3S small molecule D10AF06|S01AB04 144-80-9 DRUGBANK 27773 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hevener KE (2009) 19434845 195990 624 Sulfacetamide N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide sulfacetamide sodium and predn DRUGBANK DB00634 C8H10N2O3S small molecule D10AF06|S01AB04 144-80-9 DRUGBANK 8845 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target BROWN GM (1962) 13873645 177463 624 Sulfacetamide N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide sulfacetamide sodium and predn DRUGBANK DB00634 C8H10N2O3S small molecule D10AF06|S01AB04 144-80-9 DRUGBANK 4918 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 256 Sulfisoxazole 3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide sulfizole tab 500mg|sulfisoxaz DRUGBANK DB00263 C11H13N3O3S small molecule S01AB02|J01EB05 127-69-5 DRUGBANK 4919 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Jorgensen JH (2005) 16000430 174736 256 Sulfisoxazole 3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide sulfizole tab 500mg|sulfisoxaz DRUGBANK DB00263 C11H13N3O3S small molecule S01AB02|J01EB05 127-69-5 DRUGBANK 4920 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Fiebelkorn KR (2005) 15673729 174737 256 Sulfisoxazole 3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide sulfizole tab 500mg|sulfisoxaz DRUGBANK DB00263 C11H13N3O3S small molecule S01AB02|J01EB05 127-69-5 DRUGBANK 4921 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hong YL (1995) 7486915 174738 256 Sulfisoxazole 3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide sulfizole tab 500mg|sulfisoxaz DRUGBANK DB00263 C11H13N3O3S small molecule S01AB02|J01EB05 127-69-5 DRUGBANK 8198 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 566 Sulfamethizole Sulfamethizolum|Sulfamethylthiadiazole|Sulfamthizol|Sulfamethizol|Rufol|Sulfamethizole|Sulfametizol - DRUGBANK DB00576 C9H10N4O2S2 small molecule B05CA04|S01AB01|J01EB02|D06BA04 144-82-1 DRUGBANK 8199 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Watanabe H (1990) 2372557 176998 566 Sulfamethizole Sulfamethizolum|Sulfamethylthiadiazole|Sulfamthizol|Sulfamethizol|Rufol|Sulfamethizole|Sulfametizol - DRUGBANK DB00576 C9H10N4O2S2 small molecule B05CA04|S01AB01|J01EB02|D06BA04 144-82-1 DRUGBANK 8200 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 566 Sulfamethizole Sulfamethizolum|Sulfamethylthiadiazole|Sulfamthizol|Sulfamethizol|Rufol|Sulfamethizole|Sulfametizol - DRUGBANK DB00576 C9H10N4O2S2 small molecule B05CA04|S01AB01|J01EB02|D06BA04 144-82-1 DRUGBANK 17105 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Thijssen HH (1973) 4577373 181546 1521 Sulfamerazine Sulfamethyldiazine|2-(Sulfanilamido)-4-methylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin|4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide|N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide|Sulphamerazine|Sulfamerazina|2-Sulfa-4-methylpyrimidine|2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine|N-(4-Methyl-2-pyrimidyl)sulfanilamide|Sulfamerazinum|2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine trisulfaminic sus|trisulfamini DRUGBANK DB01581 C11H12N4O2S small molecule J01ED07|J01EE07|D06BA06 127-79-7 DRUGBANK 17106 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Friaza V (2010) 21084778 181545 1521 Sulfamerazine Sulfamethyldiazine|2-(Sulfanilamido)-4-methylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin|4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide|N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide|Sulphamerazine|Sulfamerazina|2-Sulfa-4-methylpyrimidine|2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine|N-(4-Methyl-2-pyrimidyl)sulfanilamide|Sulfamerazinum|2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine trisulfaminic sus|trisulfamini DRUGBANK DB01581 C11H12N4O2S small molecule J01ED07|J01EE07|D06BA06 127-79-7 DRUGBANK 17107 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hong YL (1995) 7486915 174738 1521 Sulfamerazine Sulfamethyldiazine|2-(Sulfanilamido)-4-methylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin|4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide|N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide|Sulphamerazine|Sulfamerazina|2-Sulfa-4-methylpyrimidine|2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine|N-(4-Methyl-2-pyrimidyl)sulfanilamide|Sulfamerazinum|2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine trisulfaminic sus|trisulfamini DRUGBANK DB01581 C11H12N4O2S small molecule J01ED07|J01EE07|D06BA06 127-79-7 DRUGBANK 17108 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Thijssen HH (1973) 4577373 181546 1522 Sulfamethazine N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|SMZ|Sulphadimethylpyrimidine|Sulfametazina|Sulfamezathine|N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide|2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|Sulfadimidinum|2-Sulfanilamido-4,6-dimethylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin|Sulfadimethylpyrimidine|Sulphamethazine|Sulfadimidina|Sulfadimidine|Sulfadimethyldiazine|6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin|4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide|Sulfametazyny|4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide|N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide|2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|4,6-Dimethyl-2-sulfanilamidopyrimidine trisulfaminic sus|trisulfamini DRUGBANK DB01582 C12H14N4O2S small molecule J01EB03|J01EE05 57-68-1 DRUGBANK 17109 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Friaza V (2010) 21084778 181545 1522 Sulfamethazine N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|SMZ|Sulphadimethylpyrimidine|Sulfametazina|Sulfamezathine|N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide|2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|Sulfadimidinum|2-Sulfanilamido-4,6-dimethylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin|Sulfadimethylpyrimidine|Sulphamethazine|Sulfadimidina|Sulfadimidine|Sulfadimethyldiazine|6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin|4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide|Sulfametazyny|4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide|N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide|2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|4,6-Dimethyl-2-sulfanilamidopyrimidine trisulfaminic sus|trisulfamini DRUGBANK DB01582 C12H14N4O2S small molecule J01EB03|J01EE05 57-68-1 DRUGBANK 17110 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hong YL (1995) 7486915 174738 1522 Sulfamethazine N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|SMZ|Sulphadimethylpyrimidine|Sulfametazina|Sulfamezathine|N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide|2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|Sulfadimidinum|2-Sulfanilamido-4,6-dimethylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin|Sulfadimethylpyrimidine|Sulphamethazine|Sulfadimidina|Sulfadimidine|Sulfadimethyldiazine|6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin|4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide|Sulfametazyny|4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide|N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide|2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|4,6-Dimethyl-2-sulfanilamidopyrimidine trisulfaminic sus|trisulfamini DRUGBANK DB01582 C12H14N4O2S small molecule J01EB03|J01EE05 57-68-1 DRUGBANK 4897 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Prabhu V (1997) 9127492 174718 252 Sulfanilamide P-Aminobenzenesulfonamide|Streptocide|Sulfamine|Para-aminobenzenesulfonamide|4-Azanylbenzenesulfonamide|4-Aminobenzene sulfonic acid amide|SA|Sulfanilamide|Prontosil album|Sulphanilamide|P-Aminobenzenesulfamide avc vaginal|avc cream - 15%|av DRUGBANK DB00259 C6H8N2O2S small molecule D06BA05|J01EB06 63-74-1 DRUGBANK 4898 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Djapa LY (2006) 16487326 71891 252 Sulfanilamide P-Aminobenzenesulfonamide|Streptocide|Sulfamine|Para-aminobenzenesulfonamide|4-Azanylbenzenesulfonamide|4-Aminobenzene sulfonic acid amide|SA|Sulfanilamide|Prontosil album|Sulphanilamide|P-Aminobenzenesulfamide avc vaginal|avc cream - 15%|av DRUGBANK DB00259 C6H8N2O2S small molecule D06BA05|J01EB06 63-74-1 DRUGBANK 4899 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Nzila A (2006) 16997145 174717 252 Sulfanilamide P-Aminobenzenesulfonamide|Streptocide|Sulfamine|Para-aminobenzenesulfonamide|4-Azanylbenzenesulfonamide|4-Aminobenzene sulfonic acid amide|SA|Sulfanilamide|Prontosil album|Sulphanilamide|P-Aminobenzenesulfamide avc vaginal|avc cream - 15%|av DRUGBANK DB00259 C6H8N2O2S small molecule D06BA05|J01EB06 63-74-1 DRUGBANK 12753 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hong YL (1995) 7486915 174738 1005 Sulfamethoxazole 3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole septra injection|roubac tab 16 DRUGBANK DB01015 C10H11N3O3S small molecule J01EC01|J01EE01 723-46-6 DRUGBANK 24792 852004 947691 b3177 folP ECK3166|JW3144|dhpS 511145 Escherichia coli inhibitor target Hong YL (1995) 7486915 174738 5609 Sulfaphenazole Sulfafenazolo|Sulfaphenazolum|Sulfaphenazol|3-(P-Aminobenzenesulfonamido)-2-phenylpyrazole|N(1)-(1-Phenylpyrazol-5-yl)sulfanilamide|Sulphaphenazole|5-Sulfanilamido-1-phenylpyrazole|Sulfafenazol|Sulfabid|N'-(1-phenylpyrazol-5-yl)sulfanilamide|1-Phenyl-5-sulfanilamidopyrazole - DRUGBANK DB06729 C15H14N4O2S small molecule S01AB05|J01ED08 526-08-9 DRUGBANK 10194 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 750 Meropenem (1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate meropenem for injection|merrem DRUGBANK DB00760 C17H25N3O5S small molecule J01DH02 119478-56-7 DRUGBANK 10195 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 750 Meropenem (1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate meropenem for injection|merrem DRUGBANK DB00760 C17H25N3O5S small molecule J01DH02 119478-56-7 DRUGBANK 10196 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Ubukata K (2001) 11353613 178257 750 Meropenem (1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate meropenem for injection|merrem DRUGBANK DB00760 C17H25N3O5S small molecule J01DH02 119478-56-7 DRUGBANK 10197 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Kanazawa K (1997) 9099227 178256 750 Meropenem (1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate meropenem for injection|merrem DRUGBANK DB00760 C17H25N3O5S small molecule J01DH02 119478-56-7 DRUGBANK 23729 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Labia R (1985) 3918982 181671 4380 Latamoxef LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum - DRUGBANK DB04570 C20H20N6O9S small molecule J01DD06 64952-97-2 DRUGBANK 15878 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 5267 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Kohler J (1999) 10223931 175063 296 Ertapenem (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM invanz DRUGBANK DB00303 C22H25N3O7S small molecule J01DH03 153832-46-3 DRUGBANK 15868 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Rake JB (1984) 6376452 181105 1296 Cefonicid Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum - DRUGBANK DB01328 C18H18N6O8S3 small molecule J01DC06 61270-58-4 DRUGBANK 15872 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 6670 852006 947693 b3182 dacB ECK3171|JW3149 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 409 Phenoxymethylpenicillin (2S,5R,6R)-3,3-DIMETHYL-7-oxo-6-(2-phenoxyacetamido)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid|PV|Fenoximetilpenicilina|V-cillin|Phenoxymethylpenicilline|Phenoxymethylenepenicillinic acid|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|6-phenoxyacetamidopenicillanic acid|Penicillin Phenoxymethyl|Phenoxymethylpenicillinum|Penicillin V|Oracillin|Fenospen|Phenoxomethylpenicillin|Phenoxymethyl Penicillin nadopen v tab 500000iu|pvf 500 DRUGBANK DB00417 C16H18N2O5S small molecule J01CE02 87-08-1 DRUGBANK 10869 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 10870 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 10871 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target Samland AK (1999) 10529188 178577 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 10872 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target Kim DH (1996) 8664284 178578 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 10873 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target McCoy AJ (2003) 12562791 178579 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 10874 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target Eschenburg S (2005) 15531591 178581 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 10875 852016 947703 b3189 murA ECK3178|JW3156|mrbA|murZ 511145 Escherichia coli inhibitor target Brown ED (1995) 7608103 178580 818 Fosfomycin FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM monurol DRUGBANK DB00828 C3H7O4P small molecule J01XX01 23155-02-4 DRUGBANK 23590 852071 947759 b3805 hemC ECK3799|JW5932|popE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4329 Dipyrromethane Cofactor - - DRUGBANK DB04517 C20H24N2O8 small molecule - - DRUGBANK 23591 852071 947759 b3805 hemC ECK3799|JW5932|popE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4329 Dipyrromethane Cofactor - - DRUGBANK DB04517 C20H24N2O8 small molecule - - DRUGBANK 26350 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7100 (2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE - - DRUGBANK DB08314 C10H7BrN2O2 small molecule - - DRUGBANK 26351 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7101 2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE - - DRUGBANK DB08315 C18H17N3O2 small molecule - - DRUGBANK 26352 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7102 4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one - - DRUGBANK DB08316 C10H13N3O small molecule - - DRUGBANK 26353 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7103 5-methyl-6-phenylquinazoline-2,4-diamine - - DRUGBANK DB08317 C15H14N4 small molecule - - DRUGBANK 26162 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6936 6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine - - DRUGBANK DB08144 C13H9Br2N5 small molecule - - DRUGBANK 26104 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6869 4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine - - DRUGBANK DB08076 C15H13Cl2N5 small molecule - - DRUGBANK 26103 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6868 4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine - - DRUGBANK DB08075 C7H7N5S small molecule - - DRUGBANK 26164 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6938 7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine - - DRUGBANK DB08146 C17H15N5 small molecule - - DRUGBANK 26102 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6867 3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine - - DRUGBANK DB08074 C10H13N5 small molecule - - DRUGBANK 26354 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7104 6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine - - DRUGBANK DB08318 C11H13N5O2 small molecule - - DRUGBANK 26163 852073 947761 b3256 accC ECK3243|JW3224|fabG 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6937 6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE - - DRUGBANK DB08145 C15H15N5O2 small molecule - - DRUGBANK 23441 852088 947776 b3281 aroE ECK3268|JW3242 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23442 852088 947776 b3281 aroE ECK3268|JW3242 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 21312 852088 947776 b3281 aroE ECK3268|JW3242 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21313 852088 947776 b3281 aroE ECK3268|JW3242 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 23498 852091 947779 b3288 fmt ECK3274|JW3249|yhdD 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 26573 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7301 [HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL - - DRUGBANK DB08523 C10H15NO2 small molecule - - DRUGBANK 18124 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18125 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1867 Formic Acid Aminic acid|Hydrogen carboxylic acid|Formylic acid|Methanoic acid|Formate prenate essential|prenate elit DRUGBANK DB01942 CH2O2 small molecule - 64-18-6 DRUGBANK 18861 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2185 (S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide - - DRUGBANK DB02276 C18H28N3O8P small molecule - - DRUGBANK 18862 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2185 (S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide - - DRUGBANK DB02276 C18H28N3O8P small molecule - - DRUGBANK 18863 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2185 (S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide - - DRUGBANK DB02276 C18H28N3O8P small molecule - - DRUGBANK 23220 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4190 Bb-3497 - - DRUGBANK DB04368 C16H31N3O4 small molecule - 235784-88-0 DRUGBANK 23221 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4190 Bb-3497 - - DRUGBANK DB04368 C16H31N3O4 small molecule - 235784-88-0 DRUGBANK 23222 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4190 Bb-3497 - - DRUGBANK DB04368 C16H31N3O4 small molecule - 235784-88-0 DRUGBANK 23030 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4135 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide - - DRUGBANK DB04310 C19H35N3O5 small molecule - 13434-13-4 DRUGBANK 23031 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4135 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide - - DRUGBANK DB04310 C19H35N3O5 small molecule - 13434-13-4 DRUGBANK 23032 852092 947780 b3287 def ECK3273|JW3248|fms 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4135 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide - - DRUGBANK DB04310 C19H35N3O5 small molecule - 13434-13-4 DRUGBANK 8047 852103 947791 b3298 rpsM ECK3285|JW3260 511145 Escherichia coli adduct target da Silva LM (2010) 20431506 176875 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 8048 852103 947791 b3298 rpsM ECK3285|JW3260 511145 Escherichia coli adduct target Olson MW (2006) 16723578 176874 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 8433 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8434 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8435 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Aminov RI (2004) 15156014 177177 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8436 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Skoeld SE (1981) 6163479 177178 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8657 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 608 Demeclocycline 7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin declomycin - tab 300mg|declomy DRUGBANK DB00618 C21H21ClN2O8 small molecule D06AA01|J01AA01 127-33-3 DRUGBANK 8658 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 608 Demeclocycline 7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin declomycin - tab 300mg|declomy DRUGBANK DB00618 C21H21ClN2O8 small molecule D06AA01|J01AA01 127-33-3 DRUGBANK 7032 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 445 Clomocycline Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina - DRUGBANK DB00453 C23H25ClN2O9 small molecule J01AA11 1181-54-0 DRUGBANK 7033 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 445 Clomocycline Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina - DRUGBANK DB00453 C23H25ClN2O9 small molecule J01AA11 1181-54-0 DRUGBANK 4867 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Griffin MO (2010) 20592239 174691 247 Doxycycline Doxycyclin|6-deoxy-5-oxytetracycline|Supracyclin|Doxycycline (anhydrous)|(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide|Vibramycin|Jenacyclin|Doxiciclina|Doxycyclinum|5-Hydroxy-alpha-6-deoxytetracycline|6alpha-Deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline acticlate|doxycycline tablets| DRUGBANK DB00254 C22H24N2O8 small molecule J01AA02|A01AB22 564-25-0 DRUGBANK 12801 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Zhanel GG (2004) 14723559 179693 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 4882 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 249 Lymecycline Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline - DRUGBANK DB00256 C29H38N4O10 small molecule J01AA04 992-21-2 DRUGBANK 4883 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 249 Lymecycline Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline - DRUGBANK DB00256 C29H38N4O10 small molecule J01AA04 992-21-2 DRUGBANK 4884 852105 947793 b3296 rpsD ECK3283|JW3258|ramA|sud 511145 Escherichia coli inhibitor target Smythies JR (1972) 5087060 174706 249 Lymecycline Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline - DRUGBANK DB00256 C29H38N4O10 small molecule J01AA04 992-21-2 DRUGBANK 8634 852106 947794 b3295 rpoA ECK3282|JW3257|pez|phs|sez 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8635 852106 947794 b3295 rpoA ECK3282|JW3257|pez|phs|sez 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 8636 852106 947794 b3295 rpoA ECK3282|JW3257|pez|phs|sez 511145 Escherichia coli inhibitor target Maddix DS (1994) 7849340 177307 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 10192 852113 947801 b3307 rpsN ECK3294|JW3269 511145 Escherichia coli inhibitor target Buck MA (1990) 2200507 178254 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 8045 852113 947801 b3307 rpsN ECK3294|JW3269 511145 Escherichia coli adduct target da Silva LM (2010) 20431506 176875 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 8046 852113 947801 b3307 rpsN ECK3294|JW3269 511145 Escherichia coli adduct target Olson MW (2006) 16723578 176874 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 10193 852114 947802 b3306 rpsH ECK3293|JW3268 511145 Escherichia coli inhibitor target Buck MA (1990) 2200507 178254 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 6993 852118 947806 b3313 rplP ECK3300|JW3275 511145 Escherichia coli inhibitor target Nierhaus D (1973) 4365366 176123 438 Chloramphenicol Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide ophtho-chloram liq 0.5%|pms-ch DRUGBANK DB00446 C11H12Cl2N2O5 small molecule S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01 56-75-7 DRUGBANK 6994 852118 947806 b3313 rplP ECK3300|JW3275 511145 Escherichia coli inhibitor target Baxter RM (1987) 3549294 176125 438 Chloramphenicol Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide ophtho-chloram liq 0.5%|pms-ch DRUGBANK DB00446 C11H12Cl2N2O5 small molecule S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01 56-75-7 DRUGBANK 6995 852118 947806 b3313 rplP ECK3300|JW3275 511145 Escherichia coli inhibitor target Murray IA (1995) 7500366 176124 438 Chloramphenicol Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide ophtho-chloram liq 0.5%|pms-ch DRUGBANK DB00446 C11H12Cl2N2O5 small molecule S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01 56-75-7 DRUGBANK 10190 852123 947811 b3316 rpsS ECK3303|JW3278 511145 Escherichia coli inhibitor target Buck MA (1990) 2200507 178254 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 8043 852123 947811 b3316 rpsS ECK3303|JW3278 511145 Escherichia coli adduct target da Silva LM (2010) 20431506 176875 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 8044 852123 947811 b3316 rpsS ECK3303|JW3278 511145 Escherichia coli adduct target Olson MW (2006) 16723578 176874 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 10191 852126 947814 b3314 rpsC ECK3301|JW3276 511145 Escherichia coli inhibitor target Buck MA (1990) 2200507 178254 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 9625 852128 947816 b3321 rpsJ ECK3308|JW3283|nusE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 9626 852128 947816 b3321 rpsJ ECK3308|JW3283|nusE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 688 Nitrofurantoin Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin pms-nitrofurantoin|nitrofurant DRUGBANK DB00698 C8H6N4O5 small molecule J01XE01|J01XE51 67-20-9 DRUGBANK 16127 852130 947818 b3319 rplD ECK3306|JW3281|eryA 511145 Escherichia coli inhibitor target Scharre KA (1981) 6972981 181166 1323 Troleandomycin Troleandomycin|Triacetyloleandomycin|TAO - DRUGBANK DB01361 C41H67NO15 small molecule J01FA08 2751-09-9 DRUGBANK 11907 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 909 Spectinomycin SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum trobicin inj 400mg/ml DRUGBANK DB00919 C14H24N2O7 small molecule J01XX04 1695-77-8 DRUGBANK 11908 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Carter AP (2000) 11014183 179093 909 Spectinomycin SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum trobicin inj 400mg/ml DRUGBANK DB00919 C14H24N2O7 small molecule J01XX04 1695-77-8 DRUGBANK 11909 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 909 Spectinomycin SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum trobicin inj 400mg/ml DRUGBANK DB00919 C14H24N2O7 small molecule J01XX04 1695-77-8 DRUGBANK 11910 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Gordeev VK (1983) 6339322 179096 909 Spectinomycin SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum trobicin inj 400mg/ml DRUGBANK DB00919 C14H24N2O7 small molecule J01XX04 1695-77-8 DRUGBANK 11911 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Eisenstein BI (1980) 6103875 179094 909 Spectinomycin SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum trobicin inj 400mg/ml DRUGBANK DB00919 C14H24N2O7 small molecule J01XX04 1695-77-8 DRUGBANK 11912 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Yamagata H (1980) 6451613 179095 909 Spectinomycin SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum trobicin inj 400mg/ml DRUGBANK DB00919 C14H24N2O7 small molecule J01XX04 1695-77-8 DRUGBANK 14431 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 1160 Kanamycin Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside - DRUGBANK DB01172 C18H36N4O11 small molecule S01AA24|J01GB04|A07AA08 59-01-8 DRUGBANK 14432 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 1160 Kanamycin Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside - DRUGBANK DB01172 C18H36N4O11 small molecule S01AA24|J01GB04|A07AA08 59-01-8 DRUGBANK 14433 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Amanuma K (2000) 10625393 180463 1160 Kanamycin Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside - DRUGBANK DB01172 C18H36N4O11 small molecule S01AA24|J01GB04|A07AA08 59-01-8 DRUGBANK 14434 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Stavropoulos TA (2001) 11247671 180462 1160 Kanamycin Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside - DRUGBANK DB01172 C18H36N4O11 small molecule S01AA24|J01GB04|A07AA08 59-01-8 DRUGBANK 14435 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Gondo Y (1996) 8657204 180464 1160 Kanamycin Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside - DRUGBANK DB01172 C18H36N4O11 small molecule S01AA24|J01GB04|A07AA08 59-01-8 DRUGBANK 24659 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 5578 Arbekacin Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin - DRUGBANK DB06696 C22H44N6O10 small molecule J01GB12 51025-85-5 DRUGBANK 24660 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Funatsu G (1977) 320034 181634 5578 Arbekacin Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin - DRUGBANK DB06696 C22H44N6O10 small molecule J01GB12 51025-85-5 DRUGBANK 24661 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 5578 Arbekacin Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin - DRUGBANK DB06696 C22H44N6O10 small molecule J01GB12 51025-85-5 DRUGBANK 24662 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Carter AP (2000) 11014183 179093 5578 Arbekacin Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin - DRUGBANK DB06696 C22H44N6O10 small molecule J01GB12 51025-85-5 DRUGBANK 9480 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 674 Tobramycin Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum tobrex ophthalmic ont 3mg/gm|t DRUGBANK DB00684 C18H37N5O9 small molecule S01AA12|J01GB01 32986-56-4 DRUGBANK 9481 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 674 Tobramycin Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum tobrex ophthalmic ont 3mg/gm|t DRUGBANK DB00684 C18H37N5O9 small molecule S01AA12|J01GB01 32986-56-4 DRUGBANK 9482 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Yang G (2006) 16942021 177803 674 Tobramycin Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum tobrex ophthalmic ont 3mg/gm|t DRUGBANK DB00684 C18H37N5O9 small molecule S01AA12|J01GB01 32986-56-4 DRUGBANK 9483 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Gill AE (2004) 15332709 177802 674 Tobramycin Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum tobrex ophthalmic ont 3mg/gm|t DRUGBANK DB00684 C18H37N5O9 small molecule S01AA12|J01GB01 32986-56-4 DRUGBANK 12269 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 945 Netilmicin Netilmycin|Netilmicin|O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine|1-N-Ethylsisomicin netromycin inj 100mg/ml|netrom DRUGBANK DB00955 C21H41N5O7 small molecule J01GB07|S01AA23 56391-56-1 DRUGBANK 12270 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 945 Netilmicin Netilmycin|Netilmicin|O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine|1-N-Ethylsisomicin netromycin inj 100mg/ml|netrom DRUGBANK DB00955 C21H41N5O7 small molecule J01GB07|S01AA23 56391-56-1 DRUGBANK 10593 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Tamehiro N (2003) 14602594 178433 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 10594 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Hu H (2001) 11282646 178432 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 10595 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Schroeder R (2000) 10619838 178431 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 10596 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Gill AE (2004) 15332709 177802 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 8041 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target da Silva LM (2010) 20431506 176875 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 8042 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Olson MW (2006) 16723578 176874 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 12575 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 984 Neomycin - walgreenstriple antibiotic|lid DRUGBANK DB00994 C23H46N6O13 small molecule J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08 1404-04-2 DRUGBANK 12576 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 984 Neomycin - walgreenstriple antibiotic|lid DRUGBANK DB00994 C23H46N6O13 small molecule J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08 1404-04-2 DRUGBANK 12577 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Gill AE (2004) 15332709 177802 984 Neomycin - walgreenstriple antibiotic|lid DRUGBANK DB00994 C23H46N6O13 small molecule J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08 1404-04-2 DRUGBANK 12578 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Eisenstein BI (1980) 6103875 179094 984 Neomycin - walgreenstriple antibiotic|lid DRUGBANK DB00994 C23H46N6O13 small molecule J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08 1404-04-2 DRUGBANK 7025 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 444 Framycetin Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine sofra tulle 10 x 10cm|sofracor DRUGBANK DB00452 C23H46N6O13 small molecule S01AA07|D09AA01|R01AX08 119-04-0 DRUGBANK 7026 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Famulok M (1996) 8605174 176157 444 Framycetin Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine sofra tulle 10 x 10cm|sofracor DRUGBANK DB00452 C23H46N6O13 small molecule S01AA07|D09AA01|R01AX08 119-04-0 DRUGBANK 7027 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 444 Framycetin Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine sofra tulle 10 x 10cm|sofracor DRUGBANK DB00452 C23H46N6O13 small molecule S01AA07|D09AA01|R01AX08 119-04-0 DRUGBANK 7361 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 471 Amikacin Amikacine|Amiglyde-v|Amikacin|Briclin|1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a|Amikacinum|O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine|Amikavet|Amicacin|Amikacina amikacin sulfate|amikacin sulf DRUGBANK DB00479 C22H43N5O13 small molecule J01RA06|J01GB06|S01AA21|D06AX12 37517-28-5 DRUGBANK 7362 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 471 Amikacin Amikacine|Amiglyde-v|Amikacin|Briclin|1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a|Amikacinum|O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine|Amikavet|Amicacin|Amikacina amikacin sulfate|amikacin sulf DRUGBANK DB00479 C22H43N5O13 small molecule J01RA06|J01GB06|S01AA21|D06AX12 37517-28-5 DRUGBANK 7363 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Tolmasky ME (2000) 10702385 176368 471 Amikacin Amikacine|Amiglyde-v|Amikacin|Briclin|1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a|Amikacinum|O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine|Amikavet|Amicacin|Amikacina amikacin sulfate|amikacin sulf DRUGBANK DB00479 C22H43N5O13 small molecule J01RA06|J01GB06|S01AA21|D06AX12 37517-28-5 DRUGBANK 13570 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Kenney TJ (1994) 7928982 180033 1070 Streptomycin Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM streptomycin sulfate injection DRUGBANK DB01082 C21H39N7O12 small molecule J04AM01|A07AA04|A07AA54|J01GA01 57-92-1 DRUGBANK 13569 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Mieskes KT (2001) 11357996 180034 1070 Streptomycin Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM streptomycin sulfate injection DRUGBANK DB01082 C21H39N7O12 small molecule J04AM01|A07AA04|A07AA54|J01GA01 57-92-1 DRUGBANK 13571 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli inhibitor target Fukuda M (1997) 9364810 180035 1070 Streptomycin Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM streptomycin sulfate injection DRUGBANK DB01082 C21H39N7O12 small molecule J04AM01|A07AA04|A07AA54|J01GA01 57-92-1 DRUGBANK 23850 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Imming P (2006) 17016423 171742 4533 GENTAMICIN C1A - - DRUGBANK DB04729 C19H39N5O7 small molecule - - DRUGBANK 23851 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Overington JP (2006) 17139284 171741 4533 GENTAMICIN C1A - - DRUGBANK DB04729 C19H39N5O7 small molecule - - DRUGBANK 23852 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Tamehiro N (2003) 14602594 178433 4533 GENTAMICIN C1A - - DRUGBANK DB04729 C19H39N5O7 small molecule - - DRUGBANK 23853 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Hu H (2001) 11282646 178432 4533 GENTAMICIN C1A - - DRUGBANK DB04729 C19H39N5O7 small molecule - - DRUGBANK 23854 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Schroeder R (2000) 10619838 178431 4533 GENTAMICIN C1A - - DRUGBANK DB04729 C19H39N5O7 small molecule - - DRUGBANK 23855 852156 947845 b3342 rpsL ECK3329|JW3304|asuB|strA 511145 Escherichia coli adduct target Gill AE (2004) 15332709 177802 4533 GENTAMICIN C1A - - DRUGBANK DB04729 C19H39N5O7 small molecule - - DRUGBANK 10187 852157 947846 b3341 rpsG ECK3328|JW3303 511145 Escherichia coli inhibitor target Buck MA (1990) 2200507 178254 749 Tetracycline Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin acnecycline|medicycline cap 25 DRUGBANK DB00759 C22H24N2O8 small molecule J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02 60-54-8 DRUGBANK 5756 852165 947854 b3236 mdh ECK3225|JW3205 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 5757 852165 947854 b3236 mdh ECK3225|JW3205 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 19404 852178 947867 b3357 crp ECK3345|JW5702|cap|csm 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 19405 852178 947867 b3357 crp ECK3345|JW5702|cap|csm 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2424 Cyclic Adenosine Monophosphate cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP - DRUGBANK DB02527 C10H12N5O6P small molecule - 60-92-4 DRUGBANK 26192 852181 947870 b3363 ppiA ECK3351|JW3326|rot|rotA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6960 7-AMINO-4-METHYL-CHROMEN-2-ONE - - DRUGBANK DB08168 C10H9NO2 small molecule - - DRUGBANK 21966 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3638 Trifluoromethionine - - DRUGBANK DB03799 C5H8F3NO2S small molecule - - DRUGBANK 21967 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3638 Trifluoromethionine - - DRUGBANK DB03799 C5H8F3NO2S small molecule - - DRUGBANK 25315 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6124 5-(2-CHLOROBENZYL)-2-FUROIC ACID - - DRUGBANK DB07308 C12H9ClO3 small molecule - - DRUGBANK 25312 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6121 5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID - - DRUGBANK DB07305 C11H6ClNO5 small molecule - - DRUGBANK 25311 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6120 5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID - - DRUGBANK DB07304 C12H7F3O4 small molecule - - DRUGBANK 26734 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7491 4-(3-ethylthiophen-2-yl)benzene-1,2-diol - - DRUGBANK DB08718 C12H12O2S small molecule - - DRUGBANK 20115 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2789 5-(2-Chlorophenyl)Furan-2-Carboxylic Acid - - DRUGBANK DB02909 C11H7ClO3 small molecule - - DRUGBANK 20116 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2789 5-(2-Chlorophenyl)Furan-2-Carboxylic Acid - - DRUGBANK DB02909 C11H7ClO3 small molecule - - DRUGBANK 20117 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2789 5-(2-Chlorophenyl)Furan-2-Carboxylic Acid - - DRUGBANK DB02909 C11H7ClO3 small molecule - - DRUGBANK 25766 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6559 5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID - - DRUGBANK DB07758 C11H6Cl2O3 small molecule - - DRUGBANK 25433 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6222 5-(2-NITROPHENYL)-2-FUROIC ACID - - DRUGBANK DB07408 C11H7NO5 small molecule - - DRUGBANK 25432 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6221 5-(2-METHOXYPHENYL)-2-FUROIC ACID - - DRUGBANK DB07407 C12H10O4 small molecule - - DRUGBANK 26760 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7531 IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE - - DRUGBANK DB08758 C12H10N4O small molecule - - DRUGBANK 26759 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7530 5-(2-chlorophenyl)furan-2-carbohydrazide - - DRUGBANK DB08757 C11H9ClN2O2 small molecule - - DRUGBANK 25600 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6398 N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE - - DRUGBANK DB07591 C10H13N3O2S small molecule - - DRUGBANK 26500 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7233 N-(QUINOLIN-8-YL)METHANESULFONAMIDE - - DRUGBANK DB08451 C10H10N2O2S small molecule - - DRUGBANK 26678 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7441 4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine - - DRUGBANK DB08667 C9H7FN6 small molecule - - DRUGBANK 26677 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7440 5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine - - DRUGBANK DB08666 C10H7F3N6 small molecule - - DRUGBANK 26680 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7443 METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE - - DRUGBANK DB08669 C20H31N3O5 small molecule - - DRUGBANK 26679 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7442 3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid - - DRUGBANK DB08668 C10H8N6O2 small molecule - - DRUGBANK 26682 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7445 5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE - - DRUGBANK DB08671 C10H7F3N6 small molecule - - DRUGBANK 26681 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7444 METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE - - DRUGBANK DB08670 C22H35N3O5 small molecule - - DRUGBANK 25767 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6560 5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID - - DRUGBANK DB07759 C12H7F3O3 small molecule - - DRUGBANK 18619 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2068 Methionine Phosphonate - - DRUGBANK DB02151 C4H12NO3PS small molecule - - DRUGBANK 18620 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2068 Methionine Phosphonate - - DRUGBANK DB02151 C4H12NO3PS small molecule - - DRUGBANK 22394 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3849 Methionine Phosphinate - - DRUGBANK DB04015 C4H12NO2PS small molecule - - DRUGBANK 22395 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3849 Methionine Phosphinate - - DRUGBANK DB04015 C4H12NO2PS small molecule - - DRUGBANK 18503 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2008 Norleucine Phosphonate - - DRUGBANK DB02088 C5H14NO3P small molecule - - DRUGBANK 18504 852191 947882 b0168 map ECK0166|JW0163|pepM 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2008 Norleucine Phosphonate - - DRUGBANK DB02088 C5H14NO3P small molecule - - DRUGBANK 15885 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Shigi Y (1981) 7018389 181107 1300 Ceftizoxime CEFIZOX|Syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid|Ceftizoxime|Ceftizoxima|Ceftizoximum|7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid cefizox DRUGBANK DB01332 C13H13N5O5S2 small molecule J01DD07 68401-81-0 DRUGBANK 15886 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Sharma UK (1995) 7592463 181108 1301 Cefradine Eskacef|CED|(6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Sefril|7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid|Velosef|Cefradinum|(6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefradina|Anspor|Cefradine|Cephradine|Cephradin - DRUGBANK DB01333 C16H19N3O4S small molecule J01DB09 38821-53-3 DRUGBANK 27833 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Matthews SJ (2009) 19243706 195987 8069 Doripenem - doribax DRUGBANK DB06211 C15H24N4O6S2 small molecule J01DH04 - DRUGBANK 27834 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli antagonist target Matthews SJ (2009) 19243706 195987 8069 Doripenem - doribax DRUGBANK DB06211 C15H24N4O6S2 small molecule J01DH04 - DRUGBANK 23728 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Labia R (1985) 3918982 181671 4380 Latamoxef LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum - DRUGBANK DB04570 C20H20N6O9S small molecule J01DD06 64952-97-2 DRUGBANK 17299 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Nicolau DP (2008) 18076336 181572 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 27623 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Zhanel GG (2007) 17488146 181573 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 16602 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Wise R (1990) 2120175 181376 1364 Ceftibuten cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum cedax|ceftibuten DRUGBANK DB01415 C15H14N4O6S2 small molecule J01DD14 97519-39-6 DRUGBANK 15877 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Matsuhashi M (1978) 368000 181106 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 5015 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target de la Rosa EJ (1985) 3898066 174802 267 Cefmetazole Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum - DRUGBANK DB00274 C15H17N7O5S3 small molecule J01DC09 56796-20-4 DRUGBANK 16597 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1363 Cefacetrile Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary] - DRUGBANK DB01414 C13H13N3O6S small molecule J01DB10 10206-21-0 DRUGBANK 16598 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1363 Cefacetrile Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary] - DRUGBANK DB01414 C13H13N3O6S small molecule J01DB10 10206-21-0 DRUGBANK 5266 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Kohler J (1999) 10223931 175063 296 Ertapenem (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM invanz DRUGBANK DB00303 C22H25N3O7S small molecule J01DH03 153832-46-3 DRUGBANK 6857 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Pfaller MA (1984) 6426381 176000 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 6858 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 6859 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Fass RJ (1986) 3943292 175998 422 Cefpiramide Cefpiramidum|Cefpiramide|Cefpiramido - DRUGBANK DB00430 C25H24N8O7S2 small molecule J01DD11 70797-11-4 DRUGBANK 15867 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Rake JB (1984) 6376452 181105 1296 Cefonicid Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum - DRUGBANK DB01328 C18H18N6O8S3 small molecule J01DC06 61270-58-4 DRUGBANK 15870 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Matsubara N (1980) 6448021 175999 1297 Cefoperazone Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure - DRUGBANK DB01329 C25H27N9O8S2 small molecule J01DD62|J01DD12 62893-19-0 DRUGBANK 6938 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Hayes MV (1983) 6413485 176060 430 Ceftazidime (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum ceptaz injection - pws iv 2g DRUGBANK DB00438 C22H22N6O7S2 small molecule J01DD52|J01DD02 78439-06-2 DRUGBANK 15854 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Truesdell SE (1989) 2722720 181104 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 15855 852216 947907 b3396 mrcA ECK3383|JW3359|ponA 511145 Escherichia coli inhibitor target Yotsuji A (1988) 3266730 179123 1295 Cefazolin CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin kefzol add-vantage inj 500mg/v DRUGBANK DB01327 C14H14N8O4S3 small molecule J01DB04 25953-19-9 DRUGBANK 21736 852225 947916 b3412 bioH ECK3399|JW3375|bioB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3533 3-Hydroxy-Propanoic Acid - - DRUGBANK DB03688 C3H6O3 small molecule - - DRUGBANK 21737 852225 947916 b3412 bioH ECK3399|JW3375|bioB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3533 3-Hydroxy-Propanoic Acid - - DRUGBANK DB03688 C3H6O3 small molecule - - DRUGBANK 21944 852230 947921 b3418 malT ECK3405|JW3381|malA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21945 852230 947921 b3418 malT ECK3405|JW3381|malA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 19076 852231 947922 b3417 malP ECK3404|JW5689|blu|malA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19077 852231 947922 b3417 malP ECK3404|JW5689|blu|malA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 20009 852231 947922 b3417 malP ECK3404|JW5689|blu|malA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 20010 852231 947922 b3417 malP ECK3404|JW5689|blu|malA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2725 Alpha-D-Glucose-1-Phosphate - - DRUGBANK DB02843 C6H13O9P small molecule - 59-56-3 DRUGBANK 20974 852231 947922 b3417 malP ECK3404|JW5689|blu|malA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 20975 852231 947922 b3417 malP ECK3404|JW5689|blu|malA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 22695 852245 947936 b3424 glpG ECK3410|JW5687 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 22169 852246 947937 b3437 gntK ECK3422|JW3400 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22170 852246 947937 b3437 gntK ECK3422|JW3400 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 18470 852246 947937 b3437 gntK ECK3422|JW3400 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 18471 852246 947937 b3437 gntK ECK3422|JW3400 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1996 6-Phosphogluconic Acid - - DRUGBANK DB02076 C6H13O10P small molecule - - DRUGBANK 21055 852290 947981 b3476 nikA ECK3460|JW3441|hydC|hydD 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3235 3,5-Diiodotyrosine - - DRUGBANK DB03374 C9H9I2NO3 small molecule - 300-39-0 DRUGBANK 5749 852322 948014 b3500 gor ECK3485|JW3467|gorA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 5750 852322 948014 b3500 gor ECK3485|JW3467|gorA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 5751 852322 948014 b3500 gor ECK3485|JW3467|gorA 511145 Escherichia coli inhibitor target Vega-Teijido M (2006) 16275032 175331 328 Nitrofural Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin - DRUGBANK DB00336 C6H6N4O4 small molecule S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03 59-87-0 DRUGBANK 20640 852322 948014 b3500 gor ECK3485|JW3467|gorA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20641 852322 948014 b3500 gor ECK3485|JW3467|gorA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 18603 852375 948067 b2662 gabT ECK2656|JW2637 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 18604 852375 948067 b2662 gabT ECK2656|JW2637 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 19909 852375 948067 b2662 gabT ECK2656|JW2637 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2665 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate - - DRUGBANK DB02783 C10H15N2O8P small molecule - - DRUGBANK 19910 852375 948067 b2662 gabT ECK2656|JW2637 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2665 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate - - DRUGBANK DB02783 C10H15N2O8P small molecule - - DRUGBANK 17574 852403 948096 b3575 yiaK ECK3564|JW3547 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 17575 852403 948096 b3575 yiaK ECK3564|JW3547 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1629 D-tartaric acid D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid - DRUGBANK DB01694 C4H6O6 small molecule - 147-71-7 DRUGBANK 17764 852441 948134 b3619 hldD ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1707 Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester - - DRUGBANK DB01774 C16H25N5O15P2 small molecule - - DRUGBANK 17765 852441 948134 b3619 hldD ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1707 Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester - - DRUGBANK DB01774 C16H25N5O15P2 small molecule - - DRUGBANK 21294 852441 948134 b3619 hldD ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 21295 852441 948134 b3619 hldD ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 22187 852445 948138 b3617 kbl ECK3607|JW3592 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3752 2-Amino-3-Ketobutyric Acid - - DRUGBANK DB03915 C4H7NO3 small molecule - - DRUGBANK 22188 852445 948138 b3617 kbl ECK3607|JW3592 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3752 2-Amino-3-Ketobutyric Acid - - DRUGBANK DB03915 C4H7NO3 small molecule - - DRUGBANK 21202 852476 948169 b3656 yicI ECK3646|JW3631 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3290 3[N-Morpholino]Propane Sulfonic Acid - - DRUGBANK DB03434 C7H15NO4S small molecule - - DRUGBANK 21203 852476 948169 b3656 yicI ECK3646|JW3631 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3290 3[N-Morpholino]Propane Sulfonic Acid - - DRUGBANK DB03434 C7H15NO4S small molecule - - DRUGBANK 21541 852476 948169 b3656 yicI ECK3646|JW3631 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3434 5(R)-5-Fluoro-Beta-D-Xylopyranosyl-Enzyme Intermediate - - DRUGBANK DB03586 C5H8FO5 small molecule - - DRUGBANK 21542 852476 948169 b3656 yicI ECK3646|JW3631 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3434 5(R)-5-Fluoro-Beta-D-Xylopyranosyl-Enzyme Intermediate - - DRUGBANK DB03586 C5H8FO5 small molecule - - DRUGBANK 22023 852476 948169 b3656 yicI ECK3646|JW3631 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22024 852476 948169 b3656 yicI ECK3646|JW3631 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 23293 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23294 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 10790 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli inhibitor target Hirai K (1986) 3532944 178525 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 10791 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 10792 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli inhibitor target Chen X (2002) 11752352 171740 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 10793 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 10794 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli inhibitor target Zweerink MM (1986) 3010848 178524 807 Rosoxacin Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl - DRUGBANK DB00817 C17H14N2O3 small molecule J01MB01 40034-42-2 DRUGBANK 22296 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli unknown target Tsai FT (1997) 9144789 181718 3800 Clorobiocin Chlorobiocin - DRUGBANK DB03966 C35H36ClN2O11 small molecule - 39868-96-7 DRUGBANK 22297 852513 948211 b3699 gyrB Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA 511145 Escherichia coli unknown target Hooper DC (1982) 6295263 181676 3800 Clorobiocin Chlorobiocin - DRUGBANK DB03966 C35H36ClN2O11 small molecule - 39868-96-7 DRUGBANK 25011 852520 948218 b3701 dnaN ECK3693|JW3678 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5816 [(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid - - DRUGBANK DB06998 C14H13Br2NO5S2 small molecule - - DRUGBANK 19980 852539 948237 b3728 pstS ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2713 Dihydrogenphosphate Ion - - DRUGBANK DB02831 H2O4P small molecule - 29505-79-1 DRUGBANK 19981 852539 948237 b3728 pstS ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2713 Dihydrogenphosphate Ion - - DRUGBANK DB02831 H2O4P small molecule - 29505-79-1 DRUGBANK 19935 852539 948237 b3728 pstS ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2681 N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide - - DRUGBANK DB02799 C20H21N3O5 small molecule - - DRUGBANK 19936 852539 948237 b3728 pstS ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2681 N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide - - DRUGBANK DB02799 C20H21N3O5 small molecule - - DRUGBANK 19937 852539 948237 b3728 pstS ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2681 N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide - - DRUGBANK DB02799 C20H21N3O5 small molecule - - DRUGBANK 21531 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3429 Glucose-6-Phosphate - - DRUGBANK DB03581 C6H13O9P small molecule - 56-73-5 DRUGBANK 21532 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3429 Glucose-6-Phosphate - - DRUGBANK DB03581 C6H13O9P small molecule - 56-73-5 DRUGBANK 19215 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2346 2-Deoxy-2-Amino Glucitol-6-Phosphate - - DRUGBANK DB02445 C6H16NO8P small molecule - - DRUGBANK 19216 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2346 2-Deoxy-2-Amino Glucitol-6-Phosphate - - DRUGBANK DB02445 C6H16NO8P small molecule - - DRUGBANK 19636 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2548 Glucosamine 6-Phosphate - - DRUGBANK DB02657 C6H14NO8P small molecule - 3616-42-0 DRUGBANK 19637 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2548 Glucosamine 6-Phosphate - - DRUGBANK DB02657 C6H14NO8P small molecule - 3616-42-0 DRUGBANK 19217 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2347 Glutamine Hydroxamate HGA - DRUGBANK DB02446 C5H10N2O4 small molecule - - DRUGBANK 19218 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2347 Glutamine Hydroxamate HGA - DRUGBANK DB02446 C5H10N2O4 small molecule - - DRUGBANK 18303 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18304 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 22009 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22010 852543 948241 b3729 glmS ECK3722|JW3707 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 21105 852548 948246 b3730 glmU ECK3723|JW3708|tms|yieA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 21106 852548 948246 b3730 glmU ECK3723|JW3708|tms|yieA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3255 Uridine-Diphosphate-N-Acetylglucosamine - - DRUGBANK DB03397 C17H27N3O17P2 small molecule - - DRUGBANK 22020 852548 948246 b3730 glmU ECK3723|JW3708|tms|yieA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 22021 852548 948246 b3730 glmU ECK3723|JW3708|tms|yieA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3652 2-(N-Morpholino)-Ethanesulfonic Acid - - DRUGBANK DB03814 C6H13NO4S small molecule - - DRUGBANK 18271 852548 948246 b3730 glmU ECK3723|JW3708|tms|yieA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18272 852548 948246 b3730 glmU ECK3723|JW3708|tms|yieA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 20468 852549 948247 b3736 atpF ECK3729|JW3714|papF|uncF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2962 4-Amido-4-Carbamoyl-Butyric Acid - - DRUGBANK DB03091 C5H10N2O3 small molecule - - DRUGBANK 20469 852549 948247 b3736 atpF ECK3729|JW3714|papF|uncF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2962 4-Amido-4-Carbamoyl-Butyric Acid - - DRUGBANK DB03091 C5H10N2O3 small molecule - - DRUGBANK 18094 852562 948260 b3752 rbsK ECK3746|JW3731 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1861 Ribose - - DRUGBANK DB01936 C5H10O5 small molecule - 50-69-1 DRUGBANK 18095 852562 948260 b3752 rbsK ECK3746|JW3731 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1861 Ribose - - DRUGBANK DB01936 C5H10O5 small molecule - 50-69-1 DRUGBANK 22178 852562 948260 b3752 rbsK ECK3746|JW3731 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 22179 852562 948260 b3752 rbsK ECK3746|JW3731 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3746 Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate - - DRUGBANK DB03909 C11H18N5O12P3 small molecule - - DRUGBANK 23397 852562 948260 b3752 rbsK ECK3746|JW3731 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23398 852562 948260 b3752 rbsK ECK3746|JW3731 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23000 852563 948261 b3751 rbsB ECK3745|JW3730|prlB|rbsP 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4113 beta-D-Ribopyranose - - DRUGBANK DB04286 C5H10O5 small molecule - - DRUGBANK 23001 852563 948261 b3751 rbsB ECK3745|JW3730|prlB|rbsP 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4113 beta-D-Ribopyranose - - DRUGBANK DB04286 C5H10O5 small molecule - - DRUGBANK 22071 852571 948269 b2747 ispD ECK2742|JW2717|ygbP 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3691 Pentane-1,5-Diamine - - DRUGBANK DB03854 C5H14N2 small molecule - - DRUGBANK 22072 852571 948269 b2747 ispD ECK2742|JW2717|ygbP 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3691 Pentane-1,5-Diamine - - DRUGBANK DB03854 C5H14N2 small molecule - - DRUGBANK 21734 852571 948269 b2747 ispD ECK2742|JW2717|ygbP 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3532 4-Diphosphocytidyl-2-C-Methyl-D-Erythritol - - DRUGBANK DB03687 C14H25N3O14P2 small molecule - - DRUGBANK 21735 852571 948269 b2747 ispD ECK2742|JW2717|ygbP 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3532 4-Diphosphocytidyl-2-C-Methyl-D-Erythritol - - DRUGBANK DB03687 C14H25N3O14P2 small molecule - - DRUGBANK 19192 852571 948269 b2747 ispD ECK2742|JW2717|ygbP 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 19193 852571 948269 b2747 ispD ECK2742|JW2717|ygbP 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 22351 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3827 4-Methyl Valeric Acid - - DRUGBANK DB03993 C6H12O2 small molecule - - DRUGBANK 22352 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3827 4-Methyl Valeric Acid - - DRUGBANK DB03993 C6H12O2 small molecule - - DRUGBANK 17848 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1743 Pyridoxyl-Glutamic Acid-5'-Monophosphate - - DRUGBANK DB01813 C13H20N2O9P small molecule - - DRUGBANK 17849 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1743 Pyridoxyl-Glutamic Acid-5'-Monophosphate - - DRUGBANK DB01813 C13H20N2O9P small molecule - - DRUGBANK 21482 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3402 Glutaric Acid - - DRUGBANK DB03553 C5H8O4 small molecule - 110-94-1 DRUGBANK 21483 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3402 Glutaric Acid - - DRUGBANK DB03553 C5H8O4 small molecule - 110-94-1 DRUGBANK 22453 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3895 2-Methylleucine - - DRUGBANK DB04063 C7H15NO2 small molecule - - DRUGBANK 22454 852580 948278 b3770 ilvE ECK3762|JW5606 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3895 2-Methylleucine - - DRUGBANK DB04063 C7H15NO2 small molecule - - DRUGBANK 21742 852605 948307 b3821 pldA ECK3815|JW3794 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3536 1-Hexadecanosulfonyl-O-L-Serine - - DRUGBANK DB03692 C19H39NO5S small molecule - - DRUGBANK 21743 852605 948307 b3821 pldA ECK3815|JW3794 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3536 1-Hexadecanosulfonyl-O-L-Serine - - DRUGBANK DB03692 C19H39NO5S small molecule - - DRUGBANK 21744 852605 948307 b3821 pldA ECK3815|JW3794 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3536 1-Hexadecanosulfonyl-O-L-Serine - - DRUGBANK DB03692 C19H39NO5S small molecule - - DRUGBANK 20147 852615 948318 b3822 recQ ECK3816|JW5855 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2808 Phosphothiophosphoric Acid-Adenylate Ester - - DRUGBANK DB02930 C10H16N5O12P3S small molecule - - DRUGBANK 20148 852615 948318 b3822 recQ ECK3816|JW5855 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2808 Phosphothiophosphoric Acid-Adenylate Ester - - DRUGBANK DB02930 C10H16N5O12P3S small molecule - - DRUGBANK 22970 852646 948349 b3857 mobA ECK3849|JW3829|chlB|mob|narB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22971 852646 948349 b3857 mobA ECK3849|JW3829|chlB|mob|narB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22639 852646 948349 b3857 mobA ECK3849|JW3829|chlB|mob|narB 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22640 852646 948349 b3857 mobA ECK3849|JW3829|chlB|mob|narB 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 26696 852650 948353 b3860 dsbA ECK3852|JW3832|dsf|iarA|ppfA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7463 UBIQUINONE-1 - - DRUGBANK DB08689 C14H18O4 small molecule - - DRUGBANK 26474 852653 948356 b3863 polA ECK3855|JW3835|resA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7214 THYMIDINE-5'-THIOPHOSPHATE - - DRUGBANK DB08432 C10H15N2O7PS small molecule - - DRUGBANK 7980 852653 948356 b3863 polA ECK3855|JW3835|resA 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7981 852653 948356 b3863 polA ECK3855|JW3835|resA 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 7982 852653 948356 b3863 polA ECK3855|JW3835|resA 511145 Escherichia coli inhibitor target Galhaup I (1989) 2475996 176813 538 Azelaic Acid Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico azelex|finacea|vp-zel|azelaic DRUGBANK DB00548 C9H16O4 small molecule D10AX03 123-99-9 DRUGBANK 19144 852697 948400 b3903 rhaA ECK3896|JW5561 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2302 L-Rhamnitol - - DRUGBANK DB02399 C6H14O5 small molecule - - DRUGBANK 19145 852697 948400 b3903 rhaA ECK3896|JW5561 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2302 L-Rhamnitol - - DRUGBANK DB02399 C6H14O5 small molecule - - DRUGBANK 20198 852697 948400 b3903 rhaA ECK3896|JW5561 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2838 L-Rhamnose - - DRUGBANK DB02961 C6H12O5 small molecule - 3615-41-6 DRUGBANK 20199 852697 948400 b3903 rhaA ECK3896|JW5561 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2838 L-Rhamnose - - DRUGBANK DB02961 C6H12O5 small molecule - 3615-41-6 DRUGBANK 20337 852698 948401 b3902 rhaD ECK3895|JW3873 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 20338 852698 948401 b3902 rhaD ECK3895|JW3873 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2900 Phosphoglycolohydroxamic Acid - - DRUGBANK DB03026 C2H6NO6P small molecule - 51528-59-7 DRUGBANK 22491 852719 948422 b3927 glpF ECK3919|JW3898 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22492 852719 948422 b3927 glpF ECK3919|JW3898 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 20171 852720 948423 b3926 glpK ECK3918|JW3897 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2815 Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate - - DRUGBANK DB02937 C11H19AsN5O12P2 small molecule - - DRUGBANK 20172 852720 948423 b3926 glpK ECK3918|JW3897 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2815 Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate - - DRUGBANK DB02937 C11H19AsN5O12P2 small molecule - - DRUGBANK 23677 852720 948423 b3926 glpK ECK3918|JW3897 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4361 beta-D-fructofuranose 1,6-bisphosphate 1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate - DRUGBANK DB04551 C6H14O12P2 small molecule - 488-69-7 DRUGBANK 23678 852720 948423 b3926 glpK ECK3918|JW3897 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4361 beta-D-fructofuranose 1,6-bisphosphate 1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate - DRUGBANK DB04551 C6H14O12P2 small molecule - 488-69-7 DRUGBANK 20596 852729 948432 b3941 metF ECK3933|JW3913 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20597 852729 948432 b3941 metF ECK3933|JW3913 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 23112 852753 948457 b3956 ppc ECK3947|JW3928|asp|glu 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4142 3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid - - DRUGBANK DB04317 C4H5Cl2O5P small molecule - - DRUGBANK 23113 852753 948457 b3956 ppc ECK3947|JW3928|asp|glu 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4142 3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid - - DRUGBANK DB04317 C4H5Cl2O5P small molecule - - DRUGBANK 21936 852758 948462 b3961 oxyR ECK3953|JW3933|momR|mor 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 21937 852758 948462 b3961 oxyR ECK3953|JW3933|momR|mor 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3632 Benzoic Acid - larynsol loz|hyophen|mrx liq|c DRUGBANK DB03793 C7H6O2 small molecule V04CG30|A16AX11 65-85-0 DRUGBANK 23399 852760 948464 b3959 argB ECK3950|JW5553 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 23400 852760 948464 b3959 argB ECK3950|JW5553 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4258 Tetrafluoroaluminate Ion - - DRUGBANK DB04444 AlF4 small molecule - - DRUGBANK 22473 852760 948464 b3959 argB ECK3950|JW5553 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3907 N-Acetyl-L-Glutamate - - DRUGBANK DB04075 C7H11NO5 small molecule - 1188-37-0 DRUGBANK 22474 852760 948464 b3959 argB ECK3950|JW5553 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3907 N-Acetyl-L-Glutamate - - DRUGBANK DB04075 C7H11NO5 small molecule - 1188-37-0 DRUGBANK 23284 852760 948464 b3959 argB ECK3950|JW5553 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23285 852760 948464 b3959 argB ECK3950|JW5553 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 22427 852764 948468 b3966 btuB ECK3958|JW3938|bfe|cer|dcrC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3871 3-Oxo-Pentadecanoic Acid - - DRUGBANK DB04039 C15H28O3 small molecule - - DRUGBANK 22869 852764 948468 b3966 btuB ECK3958|JW3938|bfe|cer|dcrC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22870 852764 948468 b3966 btuB ECK3958|JW3938|bfe|cer|dcrC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22871 852764 948468 b3966 btuB ECK3958|JW3938|bfe|cer|dcrC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 22715 852764 948468 b3966 btuB ECK3958|JW3938|bfe|cer|dcrC 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 25304 852766 948470 b3972 murB ECK3964|JW3940|yijB 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6112 (5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE - - DRUGBANK DB07296 C21H13ClO3 small molecule - - DRUGBANK 23310 852773 948479 b3974 coaA ECK3966|JW3942|panK|rts|ts-9 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23311 852773 948479 b3974 coaA ECK3966|JW3942|panK|rts|ts-9 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 17781 852773 948479 b3974 coaA ECK3966|JW3942|panK|rts|ts-9 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1715 Pantothenic acid D-pantothenic acid|(+)-Pantothenic acid|Vitamin B5|Pantothenate vitamin b complex 100 tab|arma DRUGBANK DB01783 C9H17NO5 small molecule A11HA31|D03AX04 79-83-4 DRUGBANK 17782 852773 948479 b3974 coaA ECK3966|JW3942|panK|rts|ts-9 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1715 Pantothenic acid D-pantothenic acid|(+)-Pantothenic acid|Vitamin B5|Pantothenate vitamin b complex 100 tab|arma DRUGBANK DB01783 C9H17NO5 small molecule A11HA31|D03AX04 79-83-4 DRUGBANK 18273 852773 948479 b3974 coaA ECK3966|JW3942|panK|rts|ts-9 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18274 852773 948479 b3974 coaA ECK3966|JW3942|panK|rts|ts-9 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 8632 852781 948487 b3988 rpoC ECK3979|JW3951|tabB 511145 Escherichia coli inhibitor target Maddix DS (1994) 7849340 177307 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 13125 852781 948487 b3988 rpoC ECK3979|JW3951|tabB 511145 Escherichia coli inhibitor target Campbell EA (2001) 11290327 179878 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13126 852781 948487 b3988 rpoC ECK3979|JW3951|tabB 511145 Escherichia coli inhibitor target Villain-Guillot P (2007) 17331884 179879 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13127 852781 948487 b3988 rpoC ECK3979|JW3951|tabB 511145 Escherichia coli inhibitor target Tupin A (2010) 20185278 179880 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13128 852781 948487 b3988 rpoC ECK3979|JW3951|tabB 511145 Escherichia coli inhibitor target Wehrli W (1983) 6356275 179876 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13129 852781 948487 b3988 rpoC ECK3979|JW3951|tabB 511145 Escherichia coli inhibitor target White RJ (1971) 4942761 179877 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 8633 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Maddix DS (1994) 7849340 177307 605 Rifabutin Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin mycobutin|rifabutin DRUGBANK DB00615 C46H62N4O11 small molecule J04AB04 72559-06-9 DRUGBANK 24178 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli unknown target Fujii K (1995) 7492091 181682 4731 Rifalazil 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin - DRUGBANK DB04934 C51H64N4O13 small molecule - 129791-92-0 DRUGBANK 14983 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14984 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Chen X (2002) 11752352 171740 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14985 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14986 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Scarpignato C (2006) 16498249 180694 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14987 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Koo HL (2009) 19898648 180695 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14988 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Vitali B (2007) 17408927 180691 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14989 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Pimentel M (2009) 19243285 180692 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 14990 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Ojetti V (2009) 19442033 180693 1208 Rifaximin Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin xifaxan|zaxine DRUGBANK DB01220 C43H51N3O11 small molecule D06AX11|A07AA11 80621-81-4 DRUGBANK 13130 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Campbell EA (2001) 11290327 179878 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13131 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Villain-Guillot P (2007) 17331884 179879 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13132 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Tupin A (2010) 20185278 179880 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13133 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target Wehrli W (1983) 6356275 179876 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 13134 852782 948488 b3987 rpoB ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG 511145 Escherichia coli inhibitor target White RJ (1971) 4942761 179877 1034 Rifampicin Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv rifadin cap 300mg|rifadin iv|r DRUGBANK DB01045 C43H58N4O12 small molecule J04AM02|J04AM06|J04AB02|J04AM05 13292-46-1 DRUGBANK 21598 852816 948522 b4019 metH ECK4011|JW3979 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3462 Methylcobalamin methyl(III)cobalamin|Methylcobalamin|Co-methylcobalamin|mecobalamin|MeCbl maxaron forte|b-combo|methaver DRUGBANK DB03614 C63H91CoN13O14P small molecule B03BA05 13422-55-4 DRUGBANK 21599 852816 948522 b4019 metH ECK4011|JW3979 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3462 Methylcobalamin methyl(III)cobalamin|Methylcobalamin|Co-methylcobalamin|mecobalamin|MeCbl maxaron forte|b-combo|methaver DRUGBANK DB03614 C63H91CoN13O14P small molecule B03BA05 13422-55-4 DRUGBANK 18053 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1840 D-Glucose in Linear Form - - DRUGBANK DB01914 C6H12O6 small molecule - 815-92-9 DRUGBANK 18054 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1840 D-Glucose in Linear Form - - DRUGBANK DB01914 C6H12O6 small molecule - 815-92-9 DRUGBANK 19061 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19062 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 22353 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3829 Cyclo-Hepta-Amylose - - DRUGBANK DB03995 C42H70O35 small molecule - - DRUGBANK 22354 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3829 Cyclo-Hepta-Amylose - - DRUGBANK DB03995 C42H70O35 small molecule - - DRUGBANK 26244 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7017 1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE - - DRUGBANK DB08227 C13H22N2O3 small molecule - - DRUGBANK 20969 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 20970 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3188 Maltose Maltose anhydrous|D-(+)-maltose - DRUGBANK DB03323 C12H22O11 small molecule - 69-79-4 DRUGBANK 23630 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23631 852832 948538 b4034 malE ECK4026|JW3994|malJ 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 18872 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2190 Formycin - - DRUGBANK DB02281 C10H12N5O4 small molecule - 6742-12-7 DRUGBANK 18873 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2190 Formycin - - DRUGBANK DB02281 C10H12N5O4 small molecule - 6742-12-7 DRUGBANK 26638 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7383 (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL - - DRUGBANK DB08606 C13H19N5OS small molecule - - DRUGBANK 3825 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3826 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Singh V (2005) 16128565 174058 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3827 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3828 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Walker RD (1975) 1125818 174059 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 3829 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Singh V (2007) 17298059 174057 166 Adenine A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4 leukotrap solx a additive|as 3 DRUGBANK DB00173 C5H5N5 small molecule - 73-24-5 DRUGBANK 20160 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2811 5'-Deoxy-5'-(Methylthio)-Tubercidin - - DRUGBANK DB02933 C12H16N4O3S small molecule - - DRUGBANK 20161 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2811 5'-Deoxy-5'-(Methylthio)-Tubercidin - - DRUGBANK DB02933 C12H16N4O3S small molecule - - DRUGBANK 20162 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2811 5'-Deoxy-5'-(Methylthio)-Tubercidin - - DRUGBANK DB02933 C12H16N4O3S small molecule - - DRUGBANK 18641 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2074 (1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol - - DRUGBANK DB02158 C12H19N5O2S small molecule - - DRUGBANK 18642 852836 948542 b0159 mtn ECK0158|JW0155|mtnN|pfs|yadA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2074 (1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol - - DRUGBANK DB02158 C12H19N5O2S small molecule - - DRUGBANK 22881 852839 948545 b4039 ubiC ECK4031|JW5713|sdgG? 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4070 P-Hydroxybenzoic Acid - - DRUGBANK DB04242 C7H6O3 small molecule - - DRUGBANK 22882 852839 948545 b4039 ubiC ECK4031|JW5713|sdgG? 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4070 P-Hydroxybenzoic Acid - - DRUGBANK DB04242 C7H6O3 small molecule - - DRUGBANK 18588 852839 948545 b4039 ubiC ECK4031|JW5713|sdgG? 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2049 4-Hydroxy-3-Methoxybenzoate - - DRUGBANK DB02130 C8H7O4 small molecule - 121-34-6 DRUGBANK 18589 852839 948545 b4039 ubiC ECK4031|JW5713|sdgG? 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2049 4-Hydroxy-3-Methoxybenzoate - - DRUGBANK DB02130 C8H7O4 small molecule - 121-34-6 DRUGBANK 19502 852856 948562 b4055 aphA ECK4047|JW4015|hobH|napA|yjbP 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2488 2'-Deoxycytidine dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC - DRUGBANK DB02594 C9H13N3O4 small molecule - 951-77-9 DRUGBANK 19503 852856 948562 b4055 aphA ECK4047|JW4015|hobH|napA|yjbP 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2488 2'-Deoxycytidine dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC - DRUGBANK DB02594 C9H13N3O4 small molecule - 951-77-9 DRUGBANK 20961 852865 948571 b4070 nrfA ECK4063|JW4031 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3182 Heme C - - DRUGBANK DB03317 C34H34FeN4O4 small molecule - - DRUGBANK 20962 852865 948571 b4070 nrfA ECK4063|JW4031 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3182 Heme C - - DRUGBANK DB03317 C34H34FeN4O4 small molecule - - DRUGBANK 18994 852878 948584 b4079 fdhF ECK4072|JW4040 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 18995 852878 948584 b4079 fdhF ECK4072|JW4040 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2250 Selenocysteine Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine - DRUGBANK DB02345 C3H7NO2Se small molecule - 10236-58-5 DRUGBANK 22349 852897 948604 b4088 alsB ECK4081|JW4049|yjcX 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3823 D-Allopyranose D-Allose - DRUGBANK DB03989 C6H12O6 small molecule - 2595-97-3 DRUGBANK 22350 852897 948604 b4088 alsB ECK4081|JW4049|yjcX 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3823 D-Allopyranose D-Allose - DRUGBANK DB03989 C6H12O6 small molecule - 2595-97-3 DRUGBANK 18957 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2238 Deoxyuridine-5'-Triphosphate - - DRUGBANK DB02333 C9H15N2O14P3 small molecule - - DRUGBANK 18958 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2238 Deoxyuridine-5'-Triphosphate - - DRUGBANK DB02333 C9H15N2O14P3 small molecule - - DRUGBANK 18193 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1889 2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate - - DRUGBANK DB01965 C9H16N3O13P3 small molecule - - DRUGBANK 18194 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1889 2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate - - DRUGBANK DB01965 C9H16N3O13P3 small molecule - - DRUGBANK 21158 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3270 Deoxyuridine-5'-Diphosphate - - DRUGBANK DB03413 C9H14N2O11P2 small molecule - - DRUGBANK 21159 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3270 Deoxyuridine-5'-Diphosphate - - DRUGBANK DB03413 C9H14N2O11P2 small molecule - - DRUGBANK 21970 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 21971 852900 948607 b3640 dut ECK3630|JW3615|dnaS|sof 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 26260 852944 948652 b1187 fadR ECK1175|JW1176|dec|ole|oleR|thdB 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 19056 852950 948658 b4139 aspA ECK4133|JW4099 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19057 852950 948658 b4139 aspA ECK4133|JW4099 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 22308 852952 948660 b4137 cutA ECK4131|JW4097|cutA1|cycY 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3809 Mercuribenzoic Acid - - DRUGBANK DB03975 C7H5HgO2 small molecule - - DRUGBANK 22309 852952 948660 b4137 cutA ECK4131|JW4097|cutA1|cycY 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3809 Mercuribenzoic Acid - - DRUGBANK DB03975 C7H5HgO2 small molecule - - DRUGBANK 25944 852958 948666 b4153 frdB ECK4149|JW4114 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 25513 852958 948666 b4153 frdB ECK4149|JW4114 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6301 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL - - DRUGBANK DB07490 C14H11ClN2O5 small molecule - - DRUGBANK 25939 852959 948667 b4154 frdA ECK4150|JW4115 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 25511 852959 948667 b4154 frdA ECK4150|JW4115 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6301 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL - - DRUGBANK DB07490 C14H11ClN2O5 small molecule - - DRUGBANK 9924 852959 948667 b4154 frdA ECK4150|JW4115 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 720 Thiabendazole Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole mintezol chewable tab 500mg DRUGBANK DB00730 C10H7N3S small molecule D01AC06|P02CA02 148-79-8 DRUGBANK 9925 852959 948667 b4154 frdA ECK4150|JW4115 511145 Escherichia coli inhibitor target Chen X (2002) 11752352 171740 720 Thiabendazole Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole mintezol chewable tab 500mg DRUGBANK DB00730 C10H7N3S small molecule D01AC06|P02CA02 148-79-8 DRUGBANK 9926 852959 948667 b4154 frdA ECK4150|JW4115 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 720 Thiabendazole Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole mintezol chewable tab 500mg DRUGBANK DB00730 C10H7N3S small molecule D01AC06|P02CA02 148-79-8 DRUGBANK 9927 852959 948667 b4154 frdA ECK4150|JW4115 511145 Escherichia coli inhibitor target Ge Z (2000) 11031122 178075 720 Thiabendazole Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole mintezol chewable tab 500mg DRUGBANK DB00730 C10H7N3S small molecule D01AC06|P02CA02 148-79-8 DRUGBANK 25943 852960 948668 b4151 frdD ECK4147|JW4112 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 25512 852960 948668 b4151 frdD ECK4147|JW4112 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6301 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL - - DRUGBANK DB07490 C14H11ClN2O5 small molecule - - DRUGBANK 23007 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4120 7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid - - DRUGBANK DB04293 C16H16ClN3O4 small molecule - - DRUGBANK 23008 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4120 7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid - - DRUGBANK DB04293 C16H16ClN3O4 small molecule - - DRUGBANK 23206 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4182 Benzo[B]Thiophene-2-Boronic Acid - - DRUGBANK DB04360 C8H7BO2S small molecule - - DRUGBANK 23207 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4182 Benzo[B]Thiophene-2-Boronic Acid - - DRUGBANK DB04360 C8H7BO2S small molecule - - DRUGBANK 22421 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3867 Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate - - DRUGBANK DB04035 C10H15BN4O6S small molecule - - DRUGBANK 19894 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19895 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 25953 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6723 3-{[(4-CARBOXY-2-HYDROXYANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB07927 C12H9NO7S2 small molecule - - DRUGBANK 24945 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5741 2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid - - DRUGBANK DB06922 C22H15NO6 small molecule - - DRUGBANK 25844 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6622 4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one - - DRUGBANK DB07824 C7H10N6O small molecule - - DRUGBANK 25845 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6623 (3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid - - DRUGBANK DB07825 C13H13NO4 small molecule - - DRUGBANK 25843 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6621 (2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid - - DRUGBANK DB07823 C12H15NO4 small molecule - - DRUGBANK 21445 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3382 Acylated Ceftazidime - - DRUGBANK DB03530 C17H19N5O7S2 small molecule - - DRUGBANK 21446 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3382 Acylated Ceftazidime - - DRUGBANK DB03530 C17H19N5O7S2 small molecule - - DRUGBANK 26345 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7093 3-{[(3-NITROANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB08306 C11H8N2O6S2 small molecule - - DRUGBANK 25874 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6647 (1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid - - DRUGBANK DB07850 C9H13N3O2S small molecule - - DRUGBANK 19496 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2482 Moxalactam Derivative - - DRUGBANK DB02588 C18H18N2O9 small molecule - - DRUGBANK 19497 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2482 Moxalactam Derivative - - DRUGBANK DB02588 C18H18N2O9 small molecule - - DRUGBANK 19498 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2482 Moxalactam Derivative - - DRUGBANK DB02588 C18H18N2O9 small molecule - - DRUGBANK 26594 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7329 (1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID - - DRUGBANK DB08551 C14H14BNO5S small molecule - - DRUGBANK 20572 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3008 4-Carboxyphenylboronic Acid - - DRUGBANK DB03140 C7H7BO4 small molecule - - DRUGBANK 20573 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3008 4-Carboxyphenylboronic Acid - - DRUGBANK DB03140 C7H7BO4 small molecule - - DRUGBANK 20035 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2740 3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid - - DRUGBANK DB02858 C16H14BNO6S3 small molecule - - DRUGBANK 20036 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2740 3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid - - DRUGBANK DB02858 C16H14BNO6S3 small molecule - - DRUGBANK 20037 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2740 3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid - - DRUGBANK DB02858 C16H14BNO6S3 small molecule - - DRUGBANK 18791 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2156 Hydrolyzed Cephalothin - - DRUGBANK DB02247 C14H16N2O5S2 small molecule - - DRUGBANK 18792 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2156 Hydrolyzed Cephalothin - - DRUGBANK DB02247 C14H16N2O5S2 small molecule - - DRUGBANK 18793 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2156 Hydrolyzed Cephalothin - - DRUGBANK DB02247 C14H16N2O5S2 small molecule - - DRUGBANK 19351 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2400 4-(Carboxyvin-2-Yl)Phenylboronic Acid - - DRUGBANK DB02503 C9H9BO4 small molecule - - DRUGBANK 19352 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2400 4-(Carboxyvin-2-Yl)Phenylboronic Acid - - DRUGBANK DB02503 C9H9BO4 small molecule - - DRUGBANK 19353 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2400 4-(Carboxyvin-2-Yl)Phenylboronic Acid - - DRUGBANK DB02503 C9H9BO4 small molecule - - DRUGBANK 18517 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2014 N-2-Thiophen-2-Yl-Acetamide Boronic Acid - - DRUGBANK DB02094 C7H10BNO3S small molecule - - DRUGBANK 18518 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2014 N-2-Thiophen-2-Yl-Acetamide Boronic Acid - - DRUGBANK DB02094 C7H10BNO3S small molecule - - DRUGBANK 18519 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2014 N-2-Thiophen-2-Yl-Acetamide Boronic Acid - - DRUGBANK DB02094 C7H10BNO3S small molecule - - DRUGBANK 21233 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3293 2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid - - DRUGBANK DB03437 C14H19N5O5S2 small molecule - - DRUGBANK 21234 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3293 2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid - - DRUGBANK DB03437 C14H19N5O5S2 small molecule - - DRUGBANK 25123 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5932 4-[(METHYLSULFONYL)AMINO]BENZOIC ACID - - DRUGBANK DB07114 C8H9NO4S small molecule - - DRUGBANK 7064 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli potentiator target Imming P (2006) 17016423 171742 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 7065 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli potentiator target Oelschlaeger P (2005) 15722450 176183 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 7066 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli potentiator target Overington JP (2006) 17139284 171741 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 7067 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli potentiator target Bethel CR (2006) 16982784 176185 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 7068 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli potentiator target Diaz N (2005) 15689162 176184 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 26595 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7330 (1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid - - DRUGBANK DB08552 C13H14BNO3S small molecule - - DRUGBANK 26650 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7399 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID - - DRUGBANK DB08623 C14H14N2O5S2 small molecule - - DRUGBANK 14182 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli inducer target Imming P (2006) 17016423 171742 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 14183 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli inducer target Ruppe E (2006) 16971653 180353 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 14184 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli inducer target Overington JP (2006) 17139284 171741 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 14185 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli inducer target Guan XZ (2004) 15631796 180354 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 14186 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli inducer target Mirelis B (2006) 16792938 175447 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 26615 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7350 3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID - - DRUGBANK DB08573 C11H8ClNO4S2 small molecule - - DRUGBANK 26378 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7122 TERT-BUTYL [(1R)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE - - DRUGBANK DB08336 C11H19N3O3 small molecule - - DRUGBANK 26379 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7123 TERT-BUTYL [(1S)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE - - DRUGBANK DB08337 C11H19N3O3 small molecule - - DRUGBANK 25667 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6469 2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID - - DRUGBANK DB07663 C18H13NO7 small molecule - - DRUGBANK 25829 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6601 2-phenyl-1H-imidazole-4-carboxylic acid - - DRUGBANK DB07803 C10H8N2O2 small molecule - - DRUGBANK 26423 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7160 PCNOTAXIME GROUP - - DRUGBANK DB08375 C14H15N5O6S2 small molecule - - DRUGBANK 25558 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6351 4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid - - DRUGBANK DB07541 C17H14BNO8S3 small molecule - - DRUGBANK 21659 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3505 2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid - - DRUGBANK DB03658 C16H21N3O5S small molecule - - DRUGBANK 21660 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3505 2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid - - DRUGBANK DB03658 C16H21N3O5S small molecule - - DRUGBANK 18031 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1823 M-Aminophenylboronic Acid - - DRUGBANK DB01896 C6H8BNO2 small molecule - - DRUGBANK 18032 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1823 M-Aminophenylboronic Acid - - DRUGBANK DB01896 C6H8BNO2 small molecule - - DRUGBANK 26737 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 7504 2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid - - DRUGBANK DB08731 C23H17NO6 small molecule - - DRUGBANK 19567 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2519 4,4'-Biphenyldiboronic Acid - - DRUGBANK DB02627 C12H12B2O4 small molecule - - DRUGBANK 19568 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2519 4,4'-Biphenyldiboronic Acid - - DRUGBANK DB02627 C12H12B2O4 small molecule - - DRUGBANK 19569 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2519 4,4'-Biphenyldiboronic Acid - - DRUGBANK DB02627 C12H12B2O4 small molecule - - DRUGBANK 25062 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5875 (3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid - - DRUGBANK DB07057 C11H11NO4 small molecule - - DRUGBANK 19931 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2679 3-Nitrophenylboronic Acid - - DRUGBANK DB02797 C6H6BNO4 small molecule - 13331-27-6 DRUGBANK 19932 852961 948669 b4150 ampC ECK4146|JW4111|ampA 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2679 3-Nitrophenylboronic Acid - - DRUGBANK DB02797 C6H6BNO4 small molecule - 13331-27-6 DRUGBANK 25945 852972 948680 b4152 frdC ECK4148|JW4113 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 25514 852972 948680 b4152 frdC ECK4148|JW4113 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6301 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL - - DRUGBANK DB07490 C14H11ClN2O5 small molecule - - DRUGBANK 18849 852982 948690 b4171 miaA ECK4167|JW4129|trpX 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2179 Dimethylallyl S-Thiolodiphosphate - - DRUGBANK DB02270 C5H14O6P2S small molecule - - DRUGBANK 23265 852983 948691 b4170 mutL ECK4166|JW4128 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 23266 852983 948691 b4170 mutL ECK4166|JW4128 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4216 Phosphoaminophosphonic Acid-Adenylate Ester - - DRUGBANK DB04395 C10H17N6O12P3 small molecule - - DRUGBANK 22478 852983 948691 b4170 mutL ECK4166|JW4128 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 22479 852983 948691 b4170 mutL ECK4166|JW4128 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3909 Glycerol - - DRUGBANK DB04077 C3H8O3 small molecule A06AG04|A06AX01 - DRUGBANK 27624 852983 948691 b4170 mutL ECK4166|JW4128 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 27625 852983 948691 b4170 mutL ECK4166|JW4128 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 8061 Isopropyl Alcohol - labsco sterile alcohol prep pa DRUGBANK DB02325 C3H8O small molecule - 67-63-0 DRUGBANK 23470 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4274 (C8-S)-Hydantocidin 5'-Phosphate [8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE - DRUGBANK DB04460 C13H22N3O13P small molecule - - DRUGBANK 23471 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4274 (C8-S)-Hydantocidin 5'-Phosphate [8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE - DRUGBANK DB04460 C13H22N3O13P small molecule - - DRUGBANK 19996 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2718 Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate - - DRUGBANK DB02836 C10H14N5O13P3 small molecule - - DRUGBANK 19997 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2718 Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate - - DRUGBANK DB02836 C10H14N5O13P3 small molecule - - DRUGBANK 19673 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2557 (C8-R)-Hydantocidin 5'-Phosphate [8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE - DRUGBANK DB02666 C13H22N3O13P small molecule - - DRUGBANK 19674 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2557 (C8-R)-Hydantocidin 5'-Phosphate [8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE - DRUGBANK DB02666 C13H22N3O13P small molecule - - DRUGBANK 19696 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2572 2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine - - DRUGBANK DB02682 C10H15N4O10P2S small molecule - - DRUGBANK 19697 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2572 2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine - - DRUGBANK DB02682 C10H15N4O10P2S small molecule - - DRUGBANK 23080 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23081 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 20594 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3014 2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate - - DRUGBANK DB03146 C10H15N4O10P2S small molecule - - DRUGBANK 20595 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3014 2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate - - DRUGBANK DB03146 C10H15N4O10P2S small molecule - - DRUGBANK 19320 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2390 Hydantocidin-5'-Phosphate - - DRUGBANK DB02493 C7H11N2O9P small molecule - - DRUGBANK 19321 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2390 Hydantocidin-5'-Phosphate - - DRUGBANK DB02493 C7H11N2O9P small molecule - - DRUGBANK 23720 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 23721 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4376 Inosinic Acid - - DRUGBANK DB04566 C10H13N4O8P small molecule - 131-99-7 DRUGBANK 18549 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2029 Hadacidin - - DRUGBANK DB02109 C3H5NO4 small molecule - - DRUGBANK 18550 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2029 Hadacidin - - DRUGBANK DB02109 C3H5NO4 small molecule - - DRUGBANK 20196 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2831 (Carboxyhydroxyamino)Ethanoic Acid - - DRUGBANK DB02954 C3H5NO5 small molecule - - DRUGBANK 20197 852987 948695 b4177 purA ECK4173|JW4135 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2831 (Carboxyhydroxyamino)Ethanoic Acid - - DRUGBANK DB02954 C3H5NO5 small molecule - - DRUGBANK 23496 852997 948705 b4192 ulaG ECK4188|JW5868|yjfR 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4278 N-Formylmethionine - - DRUGBANK DB04464 C6H11NO3S small molecule - - DRUGBANK 22073 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3692 L-Threonohydroxamate 4-Phosphate - - DRUGBANK DB03855 C4H12NO8P small molecule - - DRUGBANK 22074 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3692 L-Threonohydroxamate 4-Phosphate - - DRUGBANK DB03855 C4H12NO8P small molecule - - DRUGBANK 18080 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1848 L-Xylulose 5-Phosphate - - DRUGBANK DB01923 C5H13O7P small molecule - 60802-29-1 DRUGBANK 18081 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1848 L-Xylulose 5-Phosphate - - DRUGBANK DB01923 C5H13O7P small molecule - 60802-29-1 DRUGBANK 17508 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1591 L-Guluronic Acid 6-Phosphate - - DRUGBANK DB01655 C6H13O10P small molecule - - DRUGBANK 17509 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1591 L-Guluronic Acid 6-Phosphate - - DRUGBANK DB01655 C6H13O10P small molecule - - DRUGBANK 22419 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3866 Ribulose-5-Phosphate - - DRUGBANK DB04034 C5H11O8P small molecule - - DRUGBANK 22420 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3866 Ribulose-5-Phosphate - - DRUGBANK DB04034 C5H11O8P small molecule - - DRUGBANK 19573 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2522 L-Xylitol 5-Phosphate - - DRUGBANK DB02630 C5H13O8P small molecule - 64913-51-5 DRUGBANK 19574 853006 948714 b4196 ulaD ECK4192|JW4154|sgaH|yjfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2522 L-Xylitol 5-Phosphate - - DRUGBANK DB02630 C5H13O8P small molecule - 64913-51-5 DRUGBANK 19184 853049 948760 b4241 treR ECK4236|JW4200 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2333 Trehalose-6-Phosphate - - DRUGBANK DB02430 C12H23O14P small molecule - 4484-88-2 DRUGBANK 19185 853049 948760 b4241 treR ECK4236|JW4200 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2333 Trehalose-6-Phosphate - - DRUGBANK DB02430 C12H23O14P small molecule - 4484-88-2 DRUGBANK 21469 853058 948771 b4243 ridA ECK4238|JW5755|yjgF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3395 S-Phosphocysteine - - DRUGBANK DB03544 C3H8NO5PS small molecule - - DRUGBANK 21470 853058 948771 b4243 ridA ECK4238|JW5755|yjgF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3395 S-Phosphocysteine - - DRUGBANK DB03544 C3H8NO5PS small molecule - - DRUGBANK 20206 853061 948774 b4254 argI ECK4247|JW4211 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2842 Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine - - DRUGBANK DB02965 C5H15N4O6PS small molecule - - DRUGBANK 20207 853061 948774 b4254 argI ECK4247|JW4211 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2842 Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine - - DRUGBANK DB02965 C5H15N4O6PS small molecule - - DRUGBANK 22431 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3879 [Pterin-6-Yl Methanyl]-Phosphonophosphate - - DRUGBANK DB04047 C7H9N5O8P2 small molecule - - DRUGBANK 22432 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3879 [Pterin-6-Yl Methanyl]-Phosphonophosphate - - DRUGBANK DB04047 C7H9N5O8P2 small molecule - - DRUGBANK 23769 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4419 7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin Analogue of Pterin Substrate|2-amino-6-hydroxymethyl-7-methyl-7-phenethyl-7,8-dihydro-3h-pteridin-4-one - DRUGBANK DB04610 C16H19N5O2 small molecule - - DRUGBANK 19511 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2490 Alpha,Beta-Methyleneadenosine-5'-Triphosphate - - DRUGBANK DB02596 C11H18N5O12P3 small molecule - - DRUGBANK 19512 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2490 Alpha,Beta-Methyleneadenosine-5'-Triphosphate - - DRUGBANK DB02596 C11H18N5O12P3 small molecule - - DRUGBANK 22740 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3988 6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin - - DRUGBANK DB04158 C17H24N10O17P4 small molecule - - DRUGBANK 22741 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3988 6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin - - DRUGBANK DB04158 C17H24N10O17P4 small molecule - - DRUGBANK 20746 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3065 6-Hydroxymethylpterin - - DRUGBANK DB03197 C7H7N5O2 small molecule - - DRUGBANK 20747 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3065 6-Hydroxymethylpterin - - DRUGBANK DB03197 C7H7N5O2 small molecule - - DRUGBANK 18578 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2038 6-Hydroxymethyl-7,8-Dihydropterin - - DRUGBANK DB02119 C7H9N5O2 small molecule - 3672-03-5 DRUGBANK 18579 853075 948792 b0142 folK ECK0141|JW0138 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2038 6-Hydroxymethyl-7,8-Dihydropterin - - DRUGBANK DB02119 C7H9N5O2 small molecule - 3672-03-5 DRUGBANK 25940 853077 948794 b1475 fdnH ECK1469|JW1471 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6714 2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE - - DRUGBANK DB07918 C16H21NO2 small molecule - - DRUGBANK 19204 853133 948853 b4328 iadA ECK4319|JW4291|yjiF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2340 (5r)-5-Amino-6-Hydroxyhexylcarbamic Acid - - DRUGBANK DB02437 C7H16N2O3 small molecule - - DRUGBANK 19205 853133 948853 b4328 iadA ECK4319|JW4291|yjiF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2340 (5r)-5-Amino-6-Hydroxyhexylcarbamic Acid - - DRUGBANK DB02437 C7H16N2O3 small molecule - - DRUGBANK 21977 853133 948853 b4328 iadA ECK4319|JW4291|yjiF 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 21978 853133 948853 b4328 iadA ECK4319|JW4291|yjiF 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3640 Lysine Nz-Carboxylic Acid - - DRUGBANK DB03801 C7H14N2O4 small molecule - - DRUGBANK 20976 853135 948855 b1637 tyrS ECK1633|JW1629 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3189 Tyrosyladenylate - - DRUGBANK DB03325 C19H23N7O8S small molecule - - DRUGBANK 20977 853135 948855 b1637 tyrS ECK1633|JW1629 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3189 Tyrosyladenylate - - DRUGBANK DB03325 C19H23N7O8S small molecule - - DRUGBANK 17729 853135 948855 b1637 tyrS ECK1633|JW1629 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1691 3-Iodo-Tyrosine - - DRUGBANK DB01758 C9H10INO3 small molecule - 70-78-0 DRUGBANK 17730 853135 948855 b1637 tyrS ECK1633|JW1629 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1691 3-Iodo-Tyrosine - - DRUGBANK DB01758 C9H10INO3 small molecule - 70-78-0 DRUGBANK 17472 853137 948857 b2976 glcB ECK2970|JW2943|glc 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1575 Sorbitol L-Gulitol|D-()-sorbitol|D-Sorbit|D-Sorbitol|D-glucitol|()-sorbitol|G-ol sorbitol-mannitol|cystosol w 3 DRUGBANK DB01638 C6H14O6 small molecule V04CC01|A06AG07|A06AD18|B05CX02 50-70-4 DRUGBANK 17473 853137 948857 b2976 glcB ECK2970|JW2943|glc 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1575 Sorbitol L-Gulitol|D-()-sorbitol|D-Sorbit|D-Sorbitol|D-glucitol|()-sorbitol|G-ol sorbitol-mannitol|cystosol w 3 DRUGBANK DB01638 C6H14O6 small molecule V04CC01|A06AG07|A06AD18|B05CX02 50-70-4 DRUGBANK 23168 853137 948857 b2976 glcB ECK2970|JW2943|glc 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4168 Glyoxalate, Glyoxylate - - DRUGBANK DB04343 C2H2O3 small molecule - 298-12-4 DRUGBANK 23169 853137 948857 b2976 glcB ECK2970|JW2943|glc 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4168 Glyoxalate, Glyoxylate - - DRUGBANK DB04343 C2H2O3 small molecule - 298-12-4 DRUGBANK 21338 853178 948901 b4382 deoA ECK4374|JW4345|TP|tpp|ttg 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3317 Thymine - - DRUGBANK DB03462 C5H6N2O2 small molecule - 65-71-4 DRUGBANK 21339 853178 948901 b4382 deoA ECK4374|JW4345|TP|tpp|ttg 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3317 Thymine - - DRUGBANK DB03462 C5H6N2O2 small molecule - 65-71-4 DRUGBANK 22538 853179 948902 b4381 deoC ECK4373|JW4344|dra|thyR|tlr 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3919 Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate - - DRUGBANK DB04087 C5H13O7P small molecule - - DRUGBANK 22539 853179 948902 b4381 deoC ECK4373|JW4344|dra|thyR|tlr 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3919 Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate - - DRUGBANK DB04087 C5H13O7P small molecule - - DRUGBANK 19507 853185 948908 b4392 slt ECK4384|JW4355|sltY 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2489 Bulgecin A - - DRUGBANK DB02595 C16H30N3O14S2 small molecule - 92953-54-3 DRUGBANK 19508 853185 948908 b4392 slt ECK4384|JW4355|sltY 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2489 Bulgecin A - - DRUGBANK DB02595 C16H30N3O14S2 small molecule - 92953-54-3 DRUGBANK 23540 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 23541 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 19694 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2571 Meta Vanadate - - DRUGBANK DB02681 O19V7 small molecule - - DRUGBANK 19695 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2571 Meta Vanadate - - DRUGBANK DB02681 O19V7 small molecule - - DRUGBANK 24902 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5692 1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE - - DRUGBANK DB06872 C13H14N2O4S small molecule - - DRUGBANK 24903 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 5693 1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE - - DRUGBANK DB06873 C21H22N2O5 small molecule - - DRUGBANK 20489 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2972 Ribose-1-Phosphate - - DRUGBANK DB03101 C5H11O8P small molecule - - DRUGBANK 20490 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2972 Ribose-1-Phosphate - - DRUGBANK DB03101 C5H11O8P small molecule - - DRUGBANK 25458 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6251 1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE - - DRUGBANK DB07439 C21H22N2O6 small molecule - - DRUGBANK 25457 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6250 1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE - - DRUGBANK DB07437 C14H16N2O4 small molecule - - DRUGBANK 18807 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2165 2'-Deoxyuridine - - DRUGBANK DB02256 C9H12N2O5 small molecule - 951-78-0 DRUGBANK 18808 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2165 2'-Deoxyuridine - - DRUGBANK DB02256 C9H12N2O5 small molecule - 951-78-0 DRUGBANK 17455 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1566 5-Fluorouridine 5-Fur|5-Fluorouracil 1beta-D-ribofuranoside|FUrd|5-Fluoro-uridine - DRUGBANK DB01629 C9H11FN2O6 small molecule - 316-46-1 DRUGBANK 17456 853235 948987 b3831 udp ECK3825|JW3808 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1566 5-Fluorouridine 5-Fur|5-Fluorouracil 1beta-D-ribofuranoside|FUrd|5-Fluoro-uridine - DRUGBANK DB01629 C9H11FN2O6 small molecule - 316-46-1 DRUGBANK 19385 853245 948997 b0038 caiB ECK0039|JW0037|yaaN 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2413 O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine - - DRUGBANK DB02516 C28H49N8O18P3S small molecule - - DRUGBANK 19386 853245 948997 b0038 caiB ECK0039|JW0037|yaaN 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2413 O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine - - DRUGBANK DB02516 C28H49N8O18P3S small molecule - - DRUGBANK 18262 853245 948997 b0038 caiB ECK0039|JW0037|yaaN 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18263 853245 948997 b0038 caiB ECK0039|JW0037|yaaN 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 8429 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8430 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8431 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Aminov RI (2004) 15156014 177177 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 8432 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Skoeld SE (1981) 6163479 177178 585 Oxytetracycline Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline - DRUGBANK DB00595 C22H24N2O9 small molecule D06AA03|J01AA06|J01AA56|G01AA07|S01AA04 79-57-2 DRUGBANK 15797 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Carrasco-Pancorbo A (2008) 18501371 181085 1282 Rolitetracycline Pyrrolidino-methyl-tetracycline|Rolitetracyclinum|Reverin|Synterin|N-(Pyrrolidinomethyl)tetracycline|N-(1-Pyrrolidinylmethyl)-tetracycline|Rolitetraciclina reverin 275mg DRUGBANK DB01301 C27H33N3O8 small molecule J01AA09 751-97-3 DRUGBANK 15798 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Griffin MO (2010) 20592239 174691 1282 Rolitetracycline Pyrrolidino-methyl-tetracycline|Rolitetracyclinum|Reverin|Synterin|N-(Pyrrolidinomethyl)tetracycline|N-(1-Pyrrolidinylmethyl)-tetracycline|Rolitetraciclina reverin 275mg DRUGBANK DB01301 C27H33N3O8 small molecule J01AA09 751-97-3 DRUGBANK 8655 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 608 Demeclocycline 7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin declomycin - tab 300mg|declomy DRUGBANK DB00618 C21H21ClN2O8 small molecule D06AA01|J01AA01 127-33-3 DRUGBANK 8656 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 608 Demeclocycline 7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin declomycin - tab 300mg|declomy DRUGBANK DB00618 C21H21ClN2O8 small molecule D06AA01|J01AA01 127-33-3 DRUGBANK 7030 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 445 Clomocycline Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina - DRUGBANK DB00453 C23H25ClN2O9 small molecule J01AA11 1181-54-0 DRUGBANK 7031 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 445 Clomocycline Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina - DRUGBANK DB00453 C23H25ClN2O9 small molecule J01AA11 1181-54-0 DRUGBANK 8039 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli adduct target da Silva LM (2010) 20431506 176875 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 8040 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli adduct target Olson MW (2006) 16723578 176874 550 Tigecycline Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide tygacil|tigecycline DRUGBANK DB00560 C29H39N5O8 small molecule J01AA12 220620-09-7 DRUGBANK 4864 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Griffin MO (2010) 20592239 174691 247 Doxycycline Doxycyclin|6-deoxy-5-oxytetracycline|Supracyclin|Doxycycline (anhydrous)|(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide|Vibramycin|Jenacyclin|Doxiciclina|Doxycyclinum|5-Hydroxy-alpha-6-deoxytetracycline|6alpha-Deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline acticlate|doxycycline tablets| DRUGBANK DB00254 C22H24N2O8 small molecule J01AA02|A01AB22 564-25-0 DRUGBANK 12792 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Zhanel GG (2004) 14723559 179693 1007 Minocycline Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide solodyn|phl-minocycline|apo-mi DRUGBANK DB01017 C23H27N3O7 small molecule J01AA08|A01AB23 10118-90-8 DRUGBANK 4879 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Imming P (2006) 17016423 171742 249 Lymecycline Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline - DRUGBANK DB00256 C29H38N4O10 small molecule J01AA04 992-21-2 DRUGBANK 4880 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Overington JP (2006) 17139284 171741 249 Lymecycline Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline - DRUGBANK DB00256 C29H38N4O10 small molecule J01AA04 992-21-2 DRUGBANK 4881 853248 949000 b3230 rpsI ECK3219|JW3199 511145 Escherichia coli inhibitor target Smythies JR (1972) 5087060 174706 249 Lymecycline Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline - DRUGBANK DB00256 C29H38N4O10 small molecule J01AA04 992-21-2 DRUGBANK 22759 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4000 4-Bromo-3-Hydroxy-3-Methyl Butyl Diphosphate - - DRUGBANK DB04170 C5H13BrO8P2 small molecule - - DRUGBANK 22760 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4000 4-Bromo-3-Hydroxy-3-Methyl Butyl Diphosphate - - DRUGBANK DB04170 C5H13BrO8P2 small molecule - - DRUGBANK 17802 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1730 4-Hydroxy-3-Methyl Butyl Diphosphate - - DRUGBANK DB01799 C5H14O8P2 small molecule - - DRUGBANK 17803 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1730 4-Hydroxy-3-Methyl Butyl Diphosphate - - DRUGBANK DB01799 C5H14O8P2 small molecule - - DRUGBANK 20698 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3033 2-Dimethylamino-Ethyl-Diphosphate - - DRUGBANK DB03165 C4H13NO7P2 small molecule - - DRUGBANK 20699 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3033 2-Dimethylamino-Ethyl-Diphosphate - - DRUGBANK DB03165 C4H13NO7P2 small molecule - - DRUGBANK 19280 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2378 (S)-4-Bromo-3-Hydroxy-3-Methylbutyl Diphosphate - - DRUGBANK DB02480 C5H13BrO8P2 small molecule - - DRUGBANK 19281 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2378 (S)-4-Bromo-3-Hydroxy-3-Methylbutyl Diphosphate - - DRUGBANK DB02480 C5H13BrO8P2 small molecule - - DRUGBANK 22748 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 22749 853265 949020 b2889 idi ECK2884|JW2857|ygfV 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3990 Diphosphate - - DRUGBANK DB04160 O7P2 small molecule - 2466-09-3 DRUGBANK 20362 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2910 LY341770 - - DRUGBANK DB03038 C20H19N9O4 small molecule - - DRUGBANK 20363 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2910 LY341770 - - DRUGBANK DB03038 C20H19N9O4 small molecule - - DRUGBANK 20097 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2779 N-Carboxymethionine - - DRUGBANK DB02899 C6H11NO4S small molecule - - DRUGBANK 20098 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2779 N-Carboxymethionine - - DRUGBANK DB02899 C6H11NO4S small molecule - - DRUGBANK 20099 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2779 N-Carboxymethionine - - DRUGBANK DB02899 C6H11NO4S small molecule - - DRUGBANK 23466 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4271 2'-Deoxyguanosine-5'-Monophosphate - - DRUGBANK DB04457 C10H14N5O7P small molecule - 902-04-5 DRUGBANK 23467 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4271 2'-Deoxyguanosine-5'-Monophosphate - - DRUGBANK DB04457 C10H14N5O7P small molecule - 902-04-5 DRUGBANK 18762 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2135 Ly231514 Tetra Glu - - DRUGBANK DB02223 C35H41N8O15 small molecule - - DRUGBANK 18763 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2135 Ly231514 Tetra Glu - - DRUGBANK DB02223 C35H41N8O15 small molecule - - DRUGBANK 23567 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4316 Sp-722 - - DRUGBANK DB04503 C17H20N2O9S small molecule - - DRUGBANK 23568 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4316 Sp-722 - - DRUGBANK DB04503 C17H20N2O9S small molecule - - DRUGBANK 23569 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4316 Sp-722 - - DRUGBANK DB04503 C17H20N2O9S small molecule - - DRUGBANK 21888 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3603 5-Fluoro-2'-Deoxyuridine-5'-Monophosphate - - DRUGBANK DB03761 C9H12FN2O8P small molecule - - DRUGBANK 21889 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3603 5-Fluoro-2'-Deoxyuridine-5'-Monophosphate - - DRUGBANK DB03761 C9H12FN2O8P small molecule - - DRUGBANK 21968 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 21969 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3639 2'-deoxyuridylic acid dUMP - DRUGBANK DB03800 C9H13N2O8P small molecule - - DRUGBANK 18897 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2208 5,10-Methylene-6-Hydrofolic Acid - - DRUGBANK DB02301 C20H21N7O6 small molecule - - DRUGBANK 18898 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2208 5,10-Methylene-6-Hydrofolic Acid - - DRUGBANK DB02301 C20H21N7O6 small molecule - - DRUGBANK 19848 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2637 Tosyl-D-Proline - - DRUGBANK DB02752 C12H15NO4S small molecule - - DRUGBANK 19849 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2637 Tosyl-D-Proline - - DRUGBANK DB02752 C12H15NO4S small molecule - - DRUGBANK 19850 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2637 Tosyl-D-Proline - - DRUGBANK DB02752 C12H15NO4S small molecule - - DRUGBANK 20887 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3140 2'-5'dideoxyuridine - - DRUGBANK DB03274 C9H12N2O4 small molecule - - DRUGBANK 20888 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3140 2'-5'dideoxyuridine - - DRUGBANK DB03274 C9H12N2O4 small molecule - - DRUGBANK 18377 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1954 (6s)-5,6,7,8-Tetrahydrofolate - - DRUGBANK DB02031 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 18378 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1954 (6s)-5,6,7,8-Tetrahydrofolate - - DRUGBANK DB02031 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 21459 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3392 10-Propargyl-5,8-Dideazafolic Acid - - DRUGBANK DB03541 C24H23N5O6 small molecule - - DRUGBANK 21460 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3392 10-Propargyl-5,8-Dideazafolic Acid - - DRUGBANK DB03541 C24H23N5O6 small molecule - - DRUGBANK 21461 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3392 10-Propargyl-5,8-Dideazafolic Acid - - DRUGBANK DB03541 C24H23N5O6 small molecule - - DRUGBANK 21492 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3407 Sp-876 - - DRUGBANK DB03558 C20H25N3O10S small molecule - - DRUGBANK 21493 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3407 Sp-876 - - DRUGBANK DB03558 C20H25N3O10S small molecule - - DRUGBANK 20688 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3025 N,O-Didansyl-L-Tyrosine - - DRUGBANK DB03157 C33H33N3O7S2 small molecule - - DRUGBANK 20689 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3025 N,O-Didansyl-L-Tyrosine - - DRUGBANK DB03157 C33H33N3O7S2 small molecule - - DRUGBANK 18805 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2165 2'-Deoxyuridine - - DRUGBANK DB02256 C9H12N2O5 small molecule - 951-78-0 DRUGBANK 18806 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2165 2'-Deoxyuridine - - DRUGBANK DB02256 C9H12N2O5 small molecule - 951-78-0 DRUGBANK 22031 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3656 N-[Tosyl-D-Prolinyl]Amino-Ethanethiol - - DRUGBANK DB03818 C14H20N2O3S2 small molecule - - DRUGBANK 22032 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3656 N-[Tosyl-D-Prolinyl]Amino-Ethanethiol - - DRUGBANK DB03818 C14H20N2O3S2 small molecule - - DRUGBANK 22033 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3656 N-[Tosyl-D-Prolinyl]Amino-Ethanethiol - - DRUGBANK DB03818 C14H20N2O3S2 small molecule - - DRUGBANK 23445 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23446 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23641 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23642 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 26149 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 6923 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID - - DRUGBANK DB08131 C20H23N5O4 small molecule - - DRUGBANK 19257 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2367 L-methionine (S)-S-oxide - - DRUGBANK DB02467 C5H11NO3S small molecule - - DRUGBANK 19258 853279 949035 b2827 thyA ECK2823|JW2795 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2367 L-methionine (S)-S-oxide - - DRUGBANK DB02467 C5H11NO3S small molecule - - DRUGBANK 19100 853285 949041 b2150 mglB ECK2143|JW2137 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19101 853285 949041 b2150 mglB ECK2143|JW2137 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 22714 853286 949042 b2155 cirA ECK2148|JW2142|cir|feuA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 3978 Lauryl Dimethylamine-N-Oxide - - DRUGBANK DB04147 C14H31NO small molecule - - DRUGBANK 19161 853286 949042 b2155 cirA ECK2148|JW2142|cir|feuA 511145 Escherichia coli unknown target Berman HM (2000) 10592235 172122 2318 N-Octyl-2-Hydroxyethyl Sulfoxide - - DRUGBANK DB02415 C10H22O2S small molecule - - DRUGBANK 21143 853291 949047 b3639 dfp ECK3629|JW5642|coaBC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 21144 853291 949047 b3639 dfp ECK3629|JW5642|coaBC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3260 Cytidine-5'-Monophosphate - - DRUGBANK DB03403 C9H14N3O8P small molecule - 84-52-6 DRUGBANK 19190 853291 949047 b3639 dfp ECK3629|JW5642|coaBC 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 19191 853291 949047 b3639 dfp ECK3629|JW5642|coaBC 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 20629 853298 949054 b0888 trxB ECK0879|JW0871 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20630 853298 949054 b0888 trxB ECK0879|JW0871 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 17565 853303 949060 b0103 coaE ECK0103|JW0100|yacE 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 1625 Bis(Adenosine)-5'-Triphosphate - - DRUGBANK DB01690 C20H27N10O16P3 small molecule - - DRUGBANK 17566 853303 949060 b0103 coaE ECK0103|JW0100|yacE 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 1625 Bis(Adenosine)-5'-Triphosphate - - DRUGBANK DB01690 C20H27N10O16P3 small molecule - - DRUGBANK 23323 853324 949083 b0343 lacY ECK0340|JW0334 511145 Escherichia coli unknown target Imming P (2006) 17016423 171742 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 23324 853324 949083 b0343 lacY ECK0340|JW0334 511145 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4217 Thiodigalactoside - - DRUGBANK DB04396 C12H22O10S small molecule - 51555-87-4 DRUGBANK 23452 853623 935928 BSU30190 bioI - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 4264 Heptyl 1-Thiohexopyranoside - - DRUGBANK DB04450 C13H26O5S small molecule - - DRUGBANK 18666 853625 935930 BSU34100 rsbQ - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2091 Malonic acid Propanedioic acid|Malonate - DRUGBANK DB02175 C3H4O4 small molecule - 141-82-2 DRUGBANK 18667 853625 935930 BSU34100 rsbQ - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2091 Malonic acid Propanedioic acid|Malonate - DRUGBANK DB02175 C3H4O4 small molecule - 141-82-2 DRUGBANK 20921 853625 935930 BSU34100 rsbQ - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 20922 853625 935930 BSU34100 rsbQ - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3162 Benzylsulfinic Acid - - DRUGBANK DB03297 C7H8O2S small molecule - - DRUGBANK 23178 853625 935930 BSU34100 rsbQ - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4173 S-1,2-Propanediol - - DRUGBANK DB04349 C3H8O2 small molecule - - DRUGBANK 23179 853625 935930 BSU34100 rsbQ - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4173 S-1,2-Propanediol - - DRUGBANK DB04349 C3H8O2 small molecule - - DRUGBANK 21723 853655 935960 BSU15550 pyrF - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 21724 853655 935960 BSU15550 pyrF - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3530 Uridine-5'-Monophosphate - - DRUGBANK DB03685 C9H13N2O9P small molecule - 58-97-9 DRUGBANK 18220 853738 936046 BSU06490 purF - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 18221 853738 936046 BSU06490 purF - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1896 Guanosine-5'-Monophosphate - - DRUGBANK DB01972 C10H14N5O8P small molecule - 85-32-5 DRUGBANK 21841 853827 936136 BSU07980 pdaA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 21842 853827 936136 BSU07980 pdaA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3583 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose - - DRUGBANK DB03740 C8H15NO6 small molecule - - DRUGBANK 27110 853842 936151 BSU18090 parE - 224308 Bacillus subtilis unknown target Butler MM (2007) 17074800 188482 527 Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum riva-ciprofloxacin|cipro tab 2 DRUGBANK DB00537 C17H18FN3O3 small molecule S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03 85721-33-1 DRUGBANK 18310 853852 936161 BSU08180 malA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 18311 853852 936161 BSU08180 malA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1931 Alpha-D-Glucose-6-Phosphate - - DRUGBANK DB02007 C6H13O9P small molecule - - DRUGBANK 25342 853994 936311 BSU10140 hemY - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 6154 5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID - - DRUGBANK DB07338 C14H7ClF3NO5 small molecule - - DRUGBANK 21515 854094 936411 BSU11660 tenI - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3419 Tris-Hydroxymethyl-Methyl-Ammonium - - DRUGBANK DB03570 C4H12NO3 small molecule - - DRUGBANK 21516 854094 936411 BSU11660 tenI - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3419 Tris-Hydroxymethyl-Methyl-Ammonium - - DRUGBANK DB03570 C4H12NO3 small molecule - - DRUGBANK 17541 854192 936509 BSU31980 dhbE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1608 2,3-Dihydroxy-Benzoic Acid - - DRUGBANK DB01672 C7H6O4 small molecule - 303-38-8 DRUGBANK 17542 854192 936509 BSU31980 dhbE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1608 2,3-Dihydroxy-Benzoic Acid - - DRUGBANK DB01672 C7H6O4 small molecule - 303-38-8 DRUGBANK 20093 854261 936581 BSU37660 eutD - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2777 Acetylphosphate - - DRUGBANK DB02897 C2H5O5P small molecule - - DRUGBANK 20094 854261 936581 BSU37660 eutD - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2777 Acetylphosphate - - DRUGBANK DB02897 C2H5O5P small molecule - - DRUGBANK 18959 854285 936605 BSU28050 maf - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2238 Deoxyuridine-5'-Triphosphate - - DRUGBANK DB02333 C9H15N2O14P3 small molecule - - DRUGBANK 18960 854285 936605 BSU28050 maf - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2238 Deoxyuridine-5'-Triphosphate - - DRUGBANK DB02333 C9H15N2O14P3 small molecule - - DRUGBANK 19885 854285 936605 BSU28050 maf - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19886 854285 936605 BSU28050 maf - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2656 Sucrose - childrens emetrol dye free gra DRUGBANK DB02772 C12H22O11 small molecule - 57-50-1 DRUGBANK 19800 854299 936619 BSU35020 nagBA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 19801 854299 936619 BSU35020 nagBA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2614 2-Phosphoglycolic Acid - - DRUGBANK DB02726 C2H5O6P small molecule - 13147-57-4 DRUGBANK 22985 854299 936619 BSU35020 nagBA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4104 Fructose -6-Phosphate - - DRUGBANK DB04277 C6H13O9P small molecule - - DRUGBANK 22986 854299 936619 BSU35020 nagBA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4104 Fructose -6-Phosphate - - DRUGBANK DB04277 C6H13O9P small molecule - - DRUGBANK 19638 854301 936621 BSU35010 nagA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2548 Glucosamine 6-Phosphate - - DRUGBANK DB02657 C6H14NO8P small molecule - 3616-42-0 DRUGBANK 19639 854301 936621 BSU35010 nagA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2548 Glucosamine 6-Phosphate - - DRUGBANK DB02657 C6H14NO8P small molecule - 3616-42-0 DRUGBANK 19307 854488 936809 BSU35740 tagD - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2382 Cytidine 5'-Diphosphoglycerol - - DRUGBANK DB02484 C12H21N3O13P2 small molecule - - DRUGBANK 19308 854488 936809 BSU35740 tagD - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2382 Cytidine 5'-Diphosphoglycerol - - DRUGBANK DB02484 C12H21N3O13P2 small molecule - - DRUGBANK 19186 854488 936809 BSU35740 tagD - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 19187 854488 936809 BSU35740 tagD - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2334 Cytidine-5'-Triphosphate - - DRUGBANK DB02431 C9H16N3O14P3 small molecule - 65-47-4 DRUGBANK 23189 854525 936846 BSU35930 rbsD - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4176 [(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate - - DRUGBANK DB04352 C5H11O8P small molecule - - DRUGBANK 23190 854525 936846 BSU35930 rbsD - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4176 [(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate - - DRUGBANK DB04352 C5H11O8P small molecule - - DRUGBANK 22998 854525 936846 BSU35930 rbsD - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4113 beta-D-Ribopyranose - - DRUGBANK DB04286 C5H10O5 small molecule - - DRUGBANK 22999 854525 936846 BSU35930 rbsD - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4113 beta-D-Ribopyranose - - DRUGBANK DB04286 C5H10O5 small molecule - - DRUGBANK 19933 854661 936985 BSU00510 prs - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2680 Alpha-Methylene Adenosine Monophosphate - - DRUGBANK DB02798 C11H16N5O6P small molecule - - DRUGBANK 19934 854661 936985 BSU00510 prs - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2680 Alpha-Methylene Adenosine Monophosphate - - DRUGBANK DB02798 C11H16N5O6P small molecule - - DRUGBANK 20669 854661 936985 BSU00510 prs - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3016 Phosphomethylphosphonic Acid Adenosyl Ester - - DRUGBANK DB03148 C11H17N5O9P2 small molecule - - DRUGBANK 20670 854661 936985 BSU00510 prs - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3016 Phosphomethylphosphonic Acid Adenosyl Ester - - DRUGBANK DB03148 C11H17N5O9P2 small molecule - - DRUGBANK 22235 854676 937000 BSU00470 purR - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3778 Carboxylic PRPP CPRPP - DRUGBANK DB03942 C6H15O13P3 small molecule - - DRUGBANK 22236 854676 937000 BSU00470 purR - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3778 Carboxylic PRPP CPRPP - DRUGBANK DB03942 C6H15O13P3 small molecule - - DRUGBANK 22114 854757 937084 BSU37730 bacB - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 3721 3-Phenylpyruvic Acid - - DRUGBANK DB03884 C9H8O3 small molecule - - DRUGBANK 21670 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 21671 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3508 Cysteinesulfonic Acid - - DRUGBANK DB03661 C3H7NO5S small molecule - - DRUGBANK 22774 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4012 (S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid - - DRUGBANK DB04182 C9H17NO6S small molecule - - DRUGBANK 22775 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4012 (S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid - - DRUGBANK DB04182 C9H17NO6S small molecule - - DRUGBANK 18944 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2228 5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol - - DRUGBANK DB02321 C9H17NO6S small molecule - - DRUGBANK 18945 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2228 5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol - - DRUGBANK DB02321 C9H17NO6S small molecule - - DRUGBANK 23376 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4237 2-Amino-4-Mercapto-Butyric Acid - - DRUGBANK DB04422 C4H9NO2S small molecule - - DRUGBANK 23377 854778 937106 BSU30670 luxS - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4237 2-Amino-4-Mercapto-Butyric Acid - - DRUGBANK DB04422 C4H9NO2S small molecule - - DRUGBANK 23443 854858 937204 BSU32150 paiA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23444 854858 937204 BSU32150 paiA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 18278 854858 937204 BSU32150 paiA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18279 854858 937204 BSU32150 paiA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 21204 854907 937253 BSU37910 spsA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 21205 854907 937253 BSU37910 spsA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3291 Uridine-5'-Diphosphate - - DRUGBANK DB03435 C9H14N2O12P2 small molecule - 58-98-0 DRUGBANK 25810 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 6581 4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE - - DRUGBANK DB07782 C6H8F3N3O7P2 small molecule - - DRUGBANK 20592 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3013 4-Methyl-5-Hydroxyethylthiazole Phosphate - - DRUGBANK DB03145 C6H10NO4PS small molecule - - DRUGBANK 20593 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3013 4-Methyl-5-Hydroxyethylthiazole Phosphate - - DRUGBANK DB03145 C6H10NO4PS small molecule - - DRUGBANK 17788 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1719 4-Imino-5-Methidyl-2-Methylpyrimidine - - DRUGBANK DB01788 C6H7N3 small molecule - - DRUGBANK 17789 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1719 4-Imino-5-Methidyl-2-Methylpyrimidine - - DRUGBANK DB01788 C6H7N3 small molecule - - DRUGBANK 20071 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2766 4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine - - DRUGBANK DB02885 C6H4F3N3 small molecule - - DRUGBANK 20072 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2766 4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine - - DRUGBANK DB02885 C6H4F3N3 small molecule - - DRUGBANK 21166 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3273 Thiamin Phosphate - - DRUGBANK DB03416 C12H17N4O4PS small molecule - 532-40-1 DRUGBANK 21167 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3273 Thiamin Phosphate - - DRUGBANK DB03416 C12H17N4O4PS small molecule - 532-40-1 DRUGBANK 18801 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2163 Trifluoro-thiamin phosphate FTP - DRUGBANK DB02254 C12H13F3N4O4PS small molecule - - DRUGBANK 18802 854970 937316 BSU38290 thiE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2163 Trifluoro-thiamin phosphate FTP - DRUGBANK DB02254 C12H13F3N4O4PS small molecule - - DRUGBANK 22409 855155 937502 BSU27920 obgE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3855 Guanosine-5',3'-Tetraphosphate - - DRUGBANK DB04022 C10H17N5O17P4 small molecule - - DRUGBANK 22410 855155 937502 BSU27920 obgE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3855 Guanosine-5',3'-Tetraphosphate - - DRUGBANK DB04022 C10H17N5O17P4 small molecule - - DRUGBANK 18096 855182 937529 BSU39340 hutP - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1863 L-Histidine Beta Naphthylamide - - DRUGBANK DB01938 C16H16N4O small molecule - - DRUGBANK 18097 855182 937529 BSU39340 hutP - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1863 L-Histidine Beta Naphthylamide - - DRUGBANK DB01938 C16H16N4O small molecule - - DRUGBANK 18098 855182 937529 BSU39340 hutP - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 1863 L-Histidine Beta Naphthylamide - - DRUGBANK DB01938 C16H16N4O small molecule - - DRUGBANK 22566 855465 937818 BSU25640 nadD - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 22567 855465 937818 BSU25640 nadD - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 21503 855531 937885 BSU25300 cdd - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3411 Tetrahydrodeoxyuridine - - DRUGBANK DB03562 C9H14N2O5 small molecule - - DRUGBANK 21504 855531 937885 BSU25300 cdd - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3411 Tetrahydrodeoxyuridine - - DRUGBANK DB03562 C9H14N2O5 small molecule - - DRUGBANK 23085 855637 938009 BSU28190 engB - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 23086 855637 938009 BSU28190 engB - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4140 Guanosine-5'-Diphosphate - - DRUGBANK DB04315 C10H15N5O11P2 small molecule - 146-91-8 DRUGBANK 22653 855637 938009 BSU28190 engB - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22654 855637 938009 BSU28190 engB - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3968 Guanosine-5'-Triphosphate - - DRUGBANK DB04137 C10H16N5O14P3 small molecule - 86-01-1 DRUGBANK 22932 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 22933 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4099 Citric Acid 2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure medique medi seltzer|purg-odan DRUGBANK DB04272 C6H8O7 small molecule A09AB04 77-92-9 DRUGBANK 23639 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 23640 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4342 S,S-(2-Hydroxyethyl)Thiocysteine - - DRUGBANK DB04530 C5H11NO3S2 small molecule - - DRUGBANK 18643 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2075 R-1,2-Propanediol - - DRUGBANK DB02159 C3H8O2 small molecule - 4254-14-2 DRUGBANK 18644 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2075 R-1,2-Propanediol - - DRUGBANK DB02159 C3H8O2 small molecule - 4254-14-2 DRUGBANK 23180 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4173 S-1,2-Propanediol - - DRUGBANK DB04349 C3H8O2 small molecule - - DRUGBANK 23181 855803 938183 BSU29130 icd - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4173 S-1,2-Propanediol - - DRUGBANK DB04349 C3H8O2 small molecule - - DRUGBANK 23447 855814 938194 BSU04620 acpS - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 23448 855814 938194 BSU04620 acpS - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4261 1,4-Dithiothreitol - - DRUGBANK DB04447 C4H10O2S2 small molecule - - DRUGBANK 18280 855814 938194 BSU04620 acpS - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 18281 855814 938194 BSU04620 acpS - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1916 Coenzyme A CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA - DRUGBANK DB01992 C21H36N7O16P3S small molecule - 85-61-0 DRUGBANK 19513 855957 938339 BSU03130 nadE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2490 Alpha,Beta-Methyleneadenosine-5'-Triphosphate - - DRUGBANK DB02596 C11H18N5O12P3 small molecule - - DRUGBANK 19514 855957 938339 BSU03130 nadE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2490 Alpha,Beta-Methyleneadenosine-5'-Triphosphate - - DRUGBANK DB02596 C11H18N5O12P3 small molecule - - DRUGBANK 22560 855957 938339 BSU03130 nadE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 22561 855957 938339 BSU03130 nadE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3931 Deamido-Nad+ - - DRUGBANK DB04099 C21H27N6O15P2 small molecule - - DRUGBANK 27138 855957 938339 BSU03130 nadE - 224308 Bacillus subtilis unknown target Velu SE (2003) 12852767 188484 788 Gentamicin Gentamicin sandoz pentasone|garasone opht DRUGBANK DB00798 C21H43N5O7 small molecule S01AA11|S03AA06|J01GB03|D06AX07|S02AA14 1403-66-3 DRUGBANK 17916 855974 938356 BSU03040 amyE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1771 4,6-Dideoxyglucose - - DRUGBANK DB01841 C6H12O4 small molecule - - DRUGBANK 17917 855974 938356 BSU03040 amyE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1771 4,6-Dideoxyglucose - - DRUGBANK DB01841 C6H12O4 small molecule - - DRUGBANK 19058 855974 938356 BSU03040 amyE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 19059 855974 938356 BSU03040 amyE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2284 Beta-D-Glucose Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous - DRUGBANK DB02379 C6H12O6 small molecule - 492-61-5 DRUGBANK 18580 855974 938356 BSU03040 amyE - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2039 6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol - - DRUGBANK DB02120 C7H13NO4 small molecule - 38231-86-6 DRUGBANK 18581 855974 938356 BSU03040 amyE - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2039 6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol - - DRUGBANK DB02120 C7H13NO4 small molecule - 38231-86-6 DRUGBANK 26523 856007 938389 BSU02700 estA - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 7256 [(4R)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE - - DRUGBANK DB08475 C12H23O5P small molecule - - DRUGBANK 26591 856007 938389 BSU02700 estA - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 7326 [(4S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE - - DRUGBANK DB08548 C12H23O5P small molecule - - DRUGBANK 22906 856067 938449 BSU02100 cypC - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 4084 Palmitoleic Acid - - DRUGBANK DB04257 C16H30O2 small molecule - 373-49-9 DRUGBANK 22907 856067 938449 BSU02100 cypC - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 4084 Palmitoleic Acid - - DRUGBANK DB04257 C16H30O2 small molecule - 373-49-9 DRUGBANK 17646 856126 938508 BSU01370 adk - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 17647 856126 938508 BSU01370 adk - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1652 Bis(Adenosine)-5'-Pentaphosphate - - DRUGBANK DB01717 C20H29N10O22P5 small molecule - - DRUGBANK 20213 856137 938519 BSU38300 thiM - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2846 4-Methyl-5-Hydroxyethylthiazole - - DRUGBANK DB02969 C6H9NOS small molecule - - DRUGBANK 20214 856137 938519 BSU38300 thiM - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2846 4-Methyl-5-Hydroxyethylthiazole - - DRUGBANK DB02969 C6H9NOS small molecule - - DRUGBANK 17752 856137 938519 BSU38300 thiM - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 17753 856137 938519 BSU38300 thiM - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1702 Double Oxidized Cysteine - - DRUGBANK DB01769 C3H6NO4S small molecule - - DRUGBANK 20587 856417 938802 BSU07630 nosA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 20588 856417 938802 BSU07630 nosA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3012 N-Omega-Hydroxy-L-Arginine - - DRUGBANK DB03144 C6H14N4O3 small molecule - - DRUGBANK 18375 856417 938802 BSU07630 nosA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1954 (6s)-5,6,7,8-Tetrahydrofolate - - DRUGBANK DB02031 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 18376 856417 938802 BSU07630 nosA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1954 (6s)-5,6,7,8-Tetrahydrofolate - - DRUGBANK DB02031 C19H23N7O6 small molecule - 135-16-0 DRUGBANK 26406 856485 938881 BSU01660 ybbD - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 7142 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE - - DRUGBANK DB08357 C8H18O3 small molecule - - DRUGBANK 22750 856549 938949 BSU23250 ribH - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3992 5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione - - DRUGBANK DB04162 C9H14N4O8 small molecule - - DRUGBANK 22751 856549 938949 BSU23250 ribH - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3992 5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione - - DRUGBANK DB04162 C9H14N4O8 small molecule - - DRUGBANK 26471 856605 939005 BSU22690 aroH - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 7209 PREPHENIC ACID - - DRUGBANK DB08427 C10H10O6 small molecule - - DRUGBANK 18625 856605 939005 BSU22690 aroH - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 18626 856605 939005 BSU22690 aroH - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2070 3-Sulfinoalanine - - DRUGBANK DB02153 C3H7NO4S small molecule - 1115-65-7 DRUGBANK 26669 856605 939005 BSU22690 aroH - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 7422 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID - - DRUGBANK DB08648 C10H12O6 small molecule - - DRUGBANK 22407 856663 939064 BSU22070 xpt - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3855 Guanosine-5',3'-Tetraphosphate - - DRUGBANK DB04022 C10H17N5O17P4 small molecule - - DRUGBANK 22408 856663 939064 BSU22070 xpt - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3855 Guanosine-5',3'-Tetraphosphate - - DRUGBANK DB04022 C10H17N5O17P4 small molecule - - DRUGBANK 18035 856852 939259 BSU13900 ptsH - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1826 Nd1-Phosphonohistidine - - DRUGBANK DB01899 C6H11N3O5P small molecule - - DRUGBANK 18036 856852 939259 BSU13900 ptsH - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1826 Nd1-Phosphonohistidine - - DRUGBANK DB01899 C6H11N3O5P small molecule - - DRUGBANK 20441 856969 939377 BSU11670 thiO - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2956 Hydroxyacetic Acid Hydroxyethanoic Acid - DRUGBANK DB03085 C2H4O3 small molecule - 79-14-1 DRUGBANK 20442 856969 939377 BSU11670 thiO - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2956 Hydroxyacetic Acid Hydroxyethanoic Acid - DRUGBANK DB03085 C2H4O3 small molecule - 79-14-1 DRUGBANK 19751 856969 939377 BSU11670 thiO - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2601 Acetylamino-Acetic Acid - - DRUGBANK DB02713 C4H7NO3 small molecule - 543-24-8 DRUGBANK 19752 856969 939377 BSU11670 thiO - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2601 Acetylamino-Acetic Acid - - DRUGBANK DB02713 C4H7NO3 small molecule - 543-24-8 DRUGBANK 20658 856969 939377 BSU11670 thiO - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 20659 856969 939377 BSU11670 thiO - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3015 Flavin adenine dinucleotide Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide - DRUGBANK DB03147 C27H33N9O15P2 small molecule - 146-14-5 DRUGBANK 21886 857144 939555 BSU17680 thyA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 3603 5-Fluoro-2'-Deoxyuridine-5'-Monophosphate - - DRUGBANK DB03761 C9H12FN2O8P small molecule - - DRUGBANK 21887 857144 939555 BSU17680 thyA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 3603 5-Fluoro-2'-Deoxyuridine-5'-Monophosphate - - DRUGBANK DB03761 C9H12FN2O8P small molecule - - DRUGBANK 18051 857353 939772 BSU10130 hemH - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1837 N-Methylmesoporphyrin - - DRUGBANK DB01911 C35H40N4O4 small molecule - 142234-85-3 DRUGBANK 18052 857353 939772 BSU10130 hemH - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1837 N-Methylmesoporphyrin - - DRUGBANK DB01911 C35H40N4O4 small molecule - 142234-85-3 DRUGBANK 18686 857353 939772 BSU10130 hemH - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 2104 N-Methylmesoporphyrin Containing Copper - - DRUGBANK DB02188 C35H39CuN4O4 small molecule - - DRUGBANK 18687 857353 939772 BSU10130 hemH - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 2104 N-Methylmesoporphyrin Containing Copper - - DRUGBANK DB02188 C35H39CuN4O4 small molecule - - DRUGBANK 18359 857387 939807 BSU11650 tenA - 224308 Bacillus subtilis unknown target Imming P (2006) 17016423 171742 1945 4-Amino-5-Hydroxymethyl-2-Methylpyrimidine - - DRUGBANK DB02022 C6H9N3O small molecule - 73-67-6 DRUGBANK 18360 857387 939807 BSU11650 tenA - 224308 Bacillus subtilis unknown target Overington JP (2006) 17139284 171741 1945 4-Amino-5-Hydroxymethyl-2-Methylpyrimidine - - DRUGBANK DB02022 C6H9N3O small molecule - 73-67-6 DRUGBANK 27109 857574 940002 BSU00070 gyrA - 224308 Bacillus subtilis unknown target Butler MM (2007) 17074800 188482 527 Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum riva-ciprofloxacin|cipro tab 2 DRUGBANK DB00537 C17H18FN3O3 small molecule S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03 85721-33-1 DRUGBANK 17296 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Nicolau DP (2008) 18076336 181572 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 17297 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Zhanel GG (2007) 17488146 181573 1536 Imipenem (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure primaxin iv|imipenem and cilas DRUGBANK DB01598 C12H17N3O4S small molecule J01DH51 74431-23-5 DRUGBANK 7483 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Imming P (2006) 17016423 171742 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 7484 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Georgopapadakou NH (1983) 6338822 176474 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 7485 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Overington JP (2006) 17139284 171741 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 7486 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Selakovitch-Chenu L (1993) 8510666 176473 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 7487 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Krauss J (1997) 9145848 176472 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 5914 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Mock CN (1995) 7487468 175445 347 Aztreonam Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid cayston|azactam|aztreonam DRUGBANK DB00355 C13H17N5O8S2 small molecule J01DF01 78110-38-0 DRUGBANK 5915 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Fung-Tomc J (1997) 9145861 175444 347 Aztreonam Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid cayston|azactam|aztreonam DRUGBANK DB00355 C13H17N5O8S2 small molecule J01DF01 78110-38-0 DRUGBANK 5916 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Overington JP (2006) 17139284 171741 347 Aztreonam Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid cayston|azactam|aztreonam DRUGBANK DB00355 C13H17N5O8S2 small molecule J01DF01 78110-38-0 DRUGBANK 5917 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Rittenbury MS (1990) 2244291 175446 347 Aztreonam Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid cayston|azactam|aztreonam DRUGBANK DB00355 C13H17N5O8S2 small molecule J01DF01 78110-38-0 DRUGBANK 5918 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Imming P (2006) 17016423 171742 347 Aztreonam Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid cayston|azactam|aztreonam DRUGBANK DB00355 C13H17N5O8S2 small molecule J01DF01 78110-38-0 DRUGBANK 23725 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Ishikawa M (1999) 9841767 181734 4380 Latamoxef LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum - DRUGBANK DB04570 C20H20N6O9S small molecule J01DD06 64952-97-2 DRUGBANK 23726 857707 940139 BSU04140 pbpC - 224308 Bacillus subtilis inhibitor target Labia R (1985) 3918982 181671 4380 Latamoxef LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum - DRUGBANK DB04570 C20H20N6O9S small molecule J01DD06 64952-97-2 DRUGBANK 25519 950578 8303012 BSU18239 yngHB - 224308 Bacillus subtilis unknown target Berman HM (2000) 10592235 172122 6308 5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL - - DRUGBANK DB07497 C10H16N2O2S small molecule - - DRUGBANK 21174 971411 2703370 HHV1gp004 UL2 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 21175 971411 2703370 HHV1gp004 UL2 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 3276 Uracil - - DRUGBANK DB03419 C4H4N2O2 small molecule - 66-22-8 DRUGBANK 27194 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Champness JN (1998) 9715911 188493 994 Ganciclovir 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one cytovene - pws 500mg/10m/-vial DRUGBANK DB01004 C9H13N5O4 small molecule S01AD09|J05AB06 82410-32-0 DRUGBANK 27137 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 potentiator target Bennett MS (1999) 9989588 178394 777 Aciclovir Aciclovirum|Acycloguanosine|Acyclovir apo-acyclovir - tab 800mg|zovi DRUGBANK DB00787 C8H11N5O3 small molecule J05AB01|D06BB53|D06BB03|S01AD03 59277-89-3 DRUGBANK 27305 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 2876 9-Hydroxypropyladenine, S-Isomer - - DRUGBANK DB03000 C8H11N5O small molecule - - DRUGBANK 27306 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 2876 9-Hydroxypropyladenine, S-Isomer - - DRUGBANK DB03000 C8H11N5O small molecule - - DRUGBANK 27290 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 2397 6-(Dihydroxy-Isobutyl)-Thymine - - DRUGBANK DB02500 C9H14N2O4 small molecule - - DRUGBANK 27291 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 2397 6-(Dihydroxy-Isobutyl)-Thymine - - DRUGBANK DB02500 C9H14N2O4 small molecule - - DRUGBANK 27283 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 2231 5-Iodo-2'-Deoxyuridine-5'-Monophosphate - - DRUGBANK DB02324 C9H12IN2O8P small molecule - - DRUGBANK 27284 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 2231 5-Iodo-2'-Deoxyuridine-5'-Monophosphate - - DRUGBANK DB02324 C9H12IN2O8P small molecule - - DRUGBANK 27259 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 27260 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 1580 Thymidine-5'-Phosphate 5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide - DRUGBANK DB01643 C10H15N2O8P small molecule - 365-07-1 DRUGBANK 27301 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 2650 9-Hydroxypropyladenine, R-Isomer - - DRUGBANK DB02765 C8H11N5O small molecule - - DRUGBANK 27302 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 2650 9-Hydroxypropyladenine, R-Isomer - - DRUGBANK DB02765 C8H11N5O small molecule - - DRUGBANK 27536 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Imming P (2006) 17016423 171742 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 27537 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Hinata N (2006) 16834676 177004 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 27538 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Overington JP (2006) 17139284 171741 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 27539 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Teh BS (2004) 15050332 177003 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 27540 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Satoh T (2004) 15145177 177005 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 27342 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 3970 6-Hydroxypropylthymine - - DRUGBANK DB04139 C8H12N2O3 small molecule - - DRUGBANK 27343 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 3970 6-Hydroxypropylthymine - - DRUGBANK DB04139 C8H12N2O3 small molecule - - DRUGBANK 27287 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 2392 9-(4-hydroxybutyl)-N2-phenylguanine HBPG - DRUGBANK DB02495 C15H17N5O2 small molecule - - DRUGBANK 27288 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 2392 9-(4-hydroxybutyl)-N2-phenylguanine HBPG - DRUGBANK DB02495 C15H17N5O2 small molecule - - DRUGBANK 27289 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Berman HM (2000) 10592235 172122 2392 9-(4-hydroxybutyl)-N2-phenylguanine HBPG - DRUGBANK DB02495 C15H17N5O2 small molecule - - DRUGBANK 27531 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Imming P (2006) 17016423 171742 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 27532 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Overington JP (2006) 17139284 171741 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 27533 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Suzuki M (2006) 16797734 174260 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 27534 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 inducer target Henrot A (2002) 12122323 174259 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 27317 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 3146 P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate - - DRUGBANK DB03280 C20H30N7O23P5 small molecule - - DRUGBANK 27318 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 3146 P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate - - DRUGBANK DB03280 C20H30N7O23P5 small molecule - - DRUGBANK 27535 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Wild K (1997) 9336833 174669 242 Idoxuridine 5-Iododeoxyuridine|Joddeoxiuridin|IdU|1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil|5-iodo-2'-deoxyuridine|(+)-5-Iodo-2'-deoxyuridine|2'-Deoxy-5-iodouridine|Idoxuridinum|1beta-D-2'-Deoxyribofuranosyl-5-iodouracil|Iodoxuridine|1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil|Iododeoxyridine|Idoxuridin|Idoxuridine|5-Iodouracil deoxyriboside|Idoxuridina sandoz idoxuridine|herplex|her DRUGBANK DB00249 C9H11IN2O5 small molecule D06BB01|J05AB02|S01AD01 54-42-2 DRUGBANK 27303 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 2800 (South)-Methanocarba-Thymidine - - DRUGBANK DB02921 C12H16N2O4 small molecule - - DRUGBANK 27304 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 2800 (South)-Methanocarba-Thymidine - - DRUGBANK DB02921 C12H16N2O4 small molecule - - DRUGBANK 27335 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 3643 5-Bromothienyldeoxyuridine - - DRUGBANK DB03804 C13H13BrN2O5S small molecule - - DRUGBANK 27336 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 3643 5-Bromothienyldeoxyuridine - - DRUGBANK DB03804 C13H13BrN2O5S small molecule - - DRUGBANK 27337 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Berman HM (2000) 10592235 172122 3643 5-Bromothienyldeoxyuridine - - DRUGBANK DB03804 C13H13BrN2O5S small molecule - - DRUGBANK 27319 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 3177 5-Bromovinyldeoxyuridine - - DRUGBANK DB03312 C11H13BrN2O5 small molecule - - DRUGBANK 27320 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 3177 5-Bromovinyldeoxyuridine - - DRUGBANK DB03312 C11H13BrN2O5 small molecule - - DRUGBANK 27350 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Imming P (2006) 17016423 171742 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 27351 971415 2703374 HHV1gp034 UL23 - 10298 Human Herpesvirus 1 unknown target Overington JP (2006) 17139284 171741 4298 Deoxythymidine Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine - DRUGBANK DB04485 C10H14N2O5 small molecule - 50-89-5 DRUGBANK 12672 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Imming P (2006) 17016423 171742 994 Ganciclovir 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one cytovene - pws 500mg/10m/-vial DRUGBANK DB01004 C9H13N5O4 small molecule S01AD09|J05AB06 82410-32-0 DRUGBANK 12673 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Boivin G (2005) 16173018 179618 994 Ganciclovir 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one cytovene - pws 500mg/10m/-vial DRUGBANK DB01004 C9H13N5O4 small molecule S01AD09|J05AB06 82410-32-0 DRUGBANK 12674 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Overington JP (2006) 17139284 171741 994 Ganciclovir 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one cytovene - pws 500mg/10m/-vial DRUGBANK DB01004 C9H13N5O4 small molecule S01AD09|J05AB06 82410-32-0 DRUGBANK 12675 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Wang JT (2005) 16298966 179616 994 Ganciclovir 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one cytovene - pws 500mg/10m/-vial DRUGBANK DB01004 C9H13N5O4 small molecule S01AD09|J05AB06 82410-32-0 DRUGBANK 12676 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Shi R (2006) 16705640 179617 994 Ganciclovir 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one cytovene - pws 500mg/10m/-vial DRUGBANK DB01004 C9H13N5O4 small molecule S01AD09|J05AB06 82410-32-0 DRUGBANK 10495 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Imming P (2006) 17016423 171742 777 Aciclovir Aciclovirum|Acycloguanosine|Acyclovir apo-acyclovir - tab 800mg|zovi DRUGBANK DB00787 C8H11N5O3 small molecule J05AB01|D06BB53|D06BB03|S01AD03 59277-89-3 DRUGBANK 10496 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Liu S (2006) 16638752 178395 777 Aciclovir Aciclovirum|Acycloguanosine|Acyclovir apo-acyclovir - tab 800mg|zovi DRUGBANK DB00787 C8H11N5O3 small molecule J05AB01|D06BB53|D06BB03|S01AD03 59277-89-3 DRUGBANK 10497 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Overington JP (2006) 17139284 171741 777 Aciclovir Aciclovirum|Acycloguanosine|Acyclovir apo-acyclovir - tab 800mg|zovi DRUGBANK DB00787 C8H11N5O3 small molecule J05AB01|D06BB53|D06BB03|S01AD03 59277-89-3 DRUGBANK 10498 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Suzuki M (2006) 16797734 174260 777 Aciclovir Aciclovirum|Acycloguanosine|Acyclovir apo-acyclovir - tab 800mg|zovi DRUGBANK DB00787 C8H11N5O3 small molecule J05AB01|D06BB53|D06BB03|S01AD03 59277-89-3 DRUGBANK 10499 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Sergerie Y (2008) 17913252 175604 777 Aciclovir Aciclovirum|Acycloguanosine|Acyclovir apo-acyclovir - tab 800mg|zovi DRUGBANK DB00787 C8H11N5O3 small molecule J05AB01|D06BB53|D06BB03|S01AD03 59277-89-3 DRUGBANK 5255 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Imming P (2006) 17016423 171742 292 Penciclovir 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine denavir DRUGBANK DB00299 C10H15N5O3 small molecule J05AB13|D06BB06 39809-25-1 DRUGBANK 5256 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Chen X (2002) 11752352 171740 292 Penciclovir 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine denavir DRUGBANK DB00299 C10H15N5O3 small molecule J05AB13|D06BB06 39809-25-1 DRUGBANK 5257 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Agut H (2009) 19895215 175045 292 Penciclovir 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine denavir DRUGBANK DB00299 C10H15N5O3 small molecule J05AB13|D06BB06 39809-25-1 DRUGBANK 5258 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Scott GM (2005) 16033961 175044 292 Penciclovir 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine denavir DRUGBANK DB00299 C10H15N5O3 small molecule J05AB13|D06BB06 39809-25-1 DRUGBANK 5259 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Deval J (2009) 19228073 175046 292 Penciclovir 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine denavir DRUGBANK DB00299 C10H15N5O3 small molecule J05AB13|D06BB06 39809-25-1 DRUGBANK 8201 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Imming P (2006) 17016423 171742 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 8202 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Overington JP (2006) 17139284 171741 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 8203 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Scott GM (2005) 16033961 175044 567 Valaciclovir Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine sandoz valacyclovir|direct rx| DRUGBANK DB00577 C13H20N6O4 small molecule J05AB11 124832-26-4 DRUGBANK 7755 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Imming P (2006) 17016423 171742 519 Foscarnet Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid foscarnet sodium|foscavir DRUGBANK DB00529 CH3O5P small molecule J05AD01 4428-95-9 DRUGBANK 7756 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Bonnafous P (2007) 17926642 176679 519 Foscarnet Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid foscarnet sodium|foscavir DRUGBANK DB00529 CH3O5P small molecule J05AD01 4428-95-9 DRUGBANK 7757 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Overington JP (2006) 17139284 171741 519 Foscarnet Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid foscarnet sodium|foscavir DRUGBANK DB00529 CH3O5P small molecule J05AD01 4428-95-9 DRUGBANK 7758 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Tchesnokov EP (2006) 16415021 176680 519 Foscarnet Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid foscarnet sodium|foscavir DRUGBANK DB00529 CH3O5P small molecule J05AD01 4428-95-9 DRUGBANK 7759 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Ducancelle A (2007) 17197042 176681 519 Foscarnet Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid foscarnet sodium|foscavir DRUGBANK DB00529 CH3O5P small molecule J05AD01 4428-95-9 DRUGBANK 6836 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Imming P (2006) 17016423 171742 418 Famciclovir FCV|BRL-42810|9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine|Famvir|Famciclovir|2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate|Famciclovirum|Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester ava-famciclovir|pms-famciclovi DRUGBANK DB00426 C14H19N5O4 small molecule J05AB09|S01AD07 104227-87-4 DRUGBANK 6837 971473 2703462 HHV1gp046 UL30 - 10298 Human Herpesvirus 1 inhibitor target Schmid-Wendtner MH (2004) 15452407 175977 418 Famciclovir FCV|BRL-42810|9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine|Famvir|Famciclovir|2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate|Famciclovirum|Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester ava-famciclovir|pms-famciclovi DRUGBANK DB00426 C14H19N5O4 small molecule J05AB09|S01AD07 104227-87-4 DRUGBANK 4124 971723 3783681 - BALF5 - 10376 Human Herpesvirus 4 inhibitor target Imming P (2006) 17016423 171742 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 4125 971723 3783681 - BALF5 - 10376 Human Herpesvirus 4 inhibitor target Overington JP (2006) 17139284 171741 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 4126 971723 3783681 - BALF5 - 10376 Human Herpesvirus 4 inhibitor target Suzuki M (2006) 16797734 174260 187 Vidarabine 9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine - DRUGBANK DB00194 C10H13N5O4 small molecule S01AD06|J05AB03 24356-66-9 DRUGBANK 8833 971755 3783713 HHV4_BLLF1 BLLF1 - 10376 Human Herpesvirus 4 intercalation target Imming P (2006) 17016423 171742 622 Docosanol Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol abreva DRUGBANK DB00632 C22H46O small molecule D06BB11 661-19-8 DRUGBANK 8834 971755 3783713 HHV4_BLLF1 BLLF1 - 10376 Human Herpesvirus 4 intercalation target Treister NS (2010) 20210688 177450 622 Docosanol Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol abreva DRUGBANK DB00632 C22H46O small molecule D06BB11 661-19-8 DRUGBANK 8835 971755 3783713 HHV4_BLLF1 BLLF1 - 10376 Human Herpesvirus 4 intercalation target Overington JP (2006) 17139284 171741 622 Docosanol Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol abreva DRUGBANK DB00632 C22H46O small molecule D06BB11 661-19-8 DRUGBANK 8836 971755 3783713 HHV4_BLLF1 BLLF1 - 10376 Human Herpesvirus 4 intercalation target Leung DT (2004) 15571473 177449 622 Docosanol Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol abreva DRUGBANK DB00632 C22H46O small molecule D06BB11 661-19-8 DRUGBANK 8837 971755 3783713 HHV4_BLLF1 BLLF1 - 10376 Human Herpesvirus 4 intercalation target Pope LE (1998) 9864049 177448 622 Docosanol Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol abreva DRUGBANK DB00632 C22H46O small molecule D06BB11 661-19-8 DRUGBANK 22894 971775 3783733 - BVRF2 - 10376 Human Herpesvirus 4 unknown target Imming P (2006) 17016423 171742 4078 Monoisopropyl Ester Phosphonic Acid Group - - DRUGBANK DB04251 C3H9O3P small molecule - - DRUGBANK 22895 971775 3783733 - BVRF2 - 10376 Human Herpesvirus 4 unknown target Overington JP (2006) 17139284 171741 4078 Monoisopropyl Ester Phosphonic Acid Group - - DRUGBANK DB04251 C3H9O3P small molecule - - DRUGBANK 27549 1205537 155030 HIV1gp2 gag - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 27299 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Imming P (2006) 17016423 171742 2617 SD146 - - DRUGBANK DB02729 C49H42N8O5 small molecule - 183854-21-9 DRUGBANK 27300 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Overington JP (2006) 17139284 171741 2617 SD146 - - DRUGBANK DB02729 C49H42N8O5 small molecule - 183854-21-9 DRUGBANK 4429 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wittayanarakul K (2008) 17849388 174468 217 Indinavir (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous crixivan DRUGBANK DB00224 C36H47N5O4 small molecule J05AE02 150378-17-9 DRUGBANK 4430 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Hoetelmans RM (1997) 9297727 174493 217 Indinavir (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous crixivan DRUGBANK DB00224 C36H47N5O4 small molecule J05AE02 150378-17-9 DRUGBANK 4431 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Stein DS (1996) 8724039 174492 217 Indinavir (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous crixivan DRUGBANK DB00224 C36H47N5O4 small molecule J05AE02 150378-17-9 DRUGBANK 4432 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dandache S (2007) 17638694 174467 217 Indinavir (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous crixivan DRUGBANK DB00224 C36H47N5O4 small molecule J05AE02 150378-17-9 DRUGBANK 27428 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7281 5-(3,5-DICHLOROPHENYL)THIO-4-ISOPROPYL-1-(PYRIDIN-4-YL-METHYL)-1H-IMIDAZOL-2-YL-METHYL CARBAMATE - - DRUGBANK DB08502 C20H20Cl2N4O2S small molecule - - DRUGBANK 27297 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Imming P (2006) 17016423 171742 2591 XV638 - - DRUGBANK DB02702 C41H38N6O5S2 small molecule - 183854-11-7 DRUGBANK 27298 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Overington JP (2006) 17139284 171741 2591 XV638 - - DRUGBANK DB02702 C41H38N6O5S2 small molecule - 183854-11-7 DRUGBANK 27403 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6596 N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA - - DRUGBANK DB07797 C15H16ClFN4OS small molecule - - DRUGBANK 15143 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dandache S (2007) 17638694 174467 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 15144 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Hoetelmans RM (1997) 9297727 174493 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 15145 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Vella S (1996) 11322246 180749 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 15146 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wittayanarakul K (2008) 17849388 174468 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 15147 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Rhee SY (2010) 20660676 180751 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 15148 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Alcaro S (2009) 19537723 180750 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 15149 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dandache S (2008) 19040279 180752 1220 Saquinavir Saquinavir Mesylate|SQV invirase|fortovase roche|invir DRUGBANK DB01232 C38H50N6O5 small molecule J05AE01 127779-20-8 DRUGBANK 27415 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6980 6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL - - DRUGBANK DB08188 C17H22N2O3 small molecule - - DRUGBANK 27392 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6008 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE - - DRUGBANK DB07191 C20H15BrN6O small molecule - - DRUGBANK 27423 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7226 3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile - - DRUGBANK DB08444 C20H14BrN5O small molecule - - DRUGBANK 7570 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wittayanarakul K (2008) 17849388 174468 495 Ritonavir Norvir|Ritonavir|Ritonavirum technivie|norvir sec|kaletra|n DRUGBANK DB00503 C37H48N6O5S2 small molecule J05AX66|J05AR10|J05AX67|J05AE03 155213-67-5 DRUGBANK 7571 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Garriga C (2007) 17854027 174469 495 Ritonavir Norvir|Ritonavir|Ritonavirum technivie|norvir sec|kaletra|n DRUGBANK DB00503 C37H48N6O5S2 small molecule J05AX66|J05AR10|J05AX67|J05AE03 155213-67-5 DRUGBANK 7572 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Hoetelmans RM (1997) 9297727 174493 495 Ritonavir Norvir|Ritonavir|Ritonavirum technivie|norvir sec|kaletra|n DRUGBANK DB00503 C37H48N6O5S2 small molecule J05AX66|J05AR10|J05AX67|J05AE03 155213-67-5 DRUGBANK 7573 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Das A (2007) 17627597 176551 495 Ritonavir Norvir|Ritonavir|Ritonavirum technivie|norvir sec|kaletra|n DRUGBANK DB00503 C37H48N6O5S2 small molecule J05AX66|J05AR10|J05AX67|J05AE03 155213-67-5 DRUGBANK 7574 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Markowitz M (1995) 7477168 176552 495 Ritonavir Norvir|Ritonavir|Ritonavirum technivie|norvir sec|kaletra|n DRUGBANK DB00503 C37H48N6O5S2 small molecule J05AX66|J05AR10|J05AX67|J05AE03 155213-67-5 DRUGBANK 27405 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6624 2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide - - DRUGBANK DB07826 C21H16ClNO3 small molecule - - DRUGBANK 27393 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6148 ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE - - DRUGBANK DB07332 C17H16Cl2N2O2 small molecule - - DRUGBANK 27414 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6946 3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile - - DRUGBANK DB08154 C21H13Cl2N3O2 small molecule - - DRUGBANK 27413 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6706 PHENYLALANINDIOL - - DRUGBANK DB07910 C9H13NO2 small molecule - - DRUGBANK 27440 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7456 1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE - - DRUGBANK DB08682 C16H18ClNO4S small molecule - - DRUGBANK 27394 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6283 (R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE - - DRUGBANK DB07472 C17H15NOS small molecule - - DRUGBANK 27410 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6668 6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE - - DRUGBANK DB07871 C18H22ClNO2 small molecule - - DRUGBANK 9632 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wittayanarakul K (2008) 17849388 174468 691 Amprenavir Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir agenerase DRUGBANK DB00701 C25H35N3O6S small molecule J05AE05 161814-49-9 DRUGBANK 9633 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dandache S (2007) 17638694 174467 691 Amprenavir Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir agenerase DRUGBANK DB00701 C25H35N3O6S small molecule J05AE05 161814-49-9 DRUGBANK 9634 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Unknown Authors (1999) 10436772 177902 691 Amprenavir Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir agenerase DRUGBANK DB00701 C25H35N3O6S small molecule J05AE05 161814-49-9 DRUGBANK 9635 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Sadler BM (1999) 10390223 177901 691 Amprenavir Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir agenerase DRUGBANK DB00701 C25H35N3O6S small molecule J05AE05 161814-49-9 DRUGBANK 27433 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7306 2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE - - DRUGBANK DB08528 C15H14N2O2S small molecule - - DRUGBANK 27437 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7453 2-METHYL-FURAN-3-CARBOTHIOIC ACID [4-CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)-PHENYL]-AMIDE - - DRUGBANK DB08679 C17H18ClNO2S small molecule - - DRUGBANK 27426 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7241 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile - - DRUGBANK DB08460 C20H13Cl2N5O2 small molecule - - DRUGBANK 27391 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6001 6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione - - DRUGBANK DB07184 C16H26N2O3S small molecule - - DRUGBANK 27395 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6284 (R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER - - DRUGBANK DB07473 C18H15NO3S small molecule - - DRUGBANK 27406 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6661 4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE - - DRUGBANK DB07864 C17H16FNO2 small molecule - - DRUGBANK 27409 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6666 6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE - - DRUGBANK DB07869 C18H22ClNO2S small molecule - - DRUGBANK 27407 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6664 6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE - - DRUGBANK DB07867 C18H22ClNO2 small molecule - - DRUGBANK 27408 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6665 6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE - - DRUGBANK DB07868 C18H22ClNOS small molecule - - DRUGBANK 27412 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6689 1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE - - DRUGBANK DB07892 C14H16N2O4S small molecule - - DRUGBANK 15506 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dierynck I (2007) 17928344 179988 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15508 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Chen X (2002) 11752352 171740 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15509 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target De Meyer S (2005) 15917527 180920 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15510 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Kovalevsky AY (2006) 16480273 180922 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15511 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Tremblay CL (2008) 19209258 180923 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15512 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target McKeage K (2009) 19323590 180919 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15507 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Ghosh AK (2007) 17900913 180921 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 15513 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wang YF (2007) 17696515 180918 1251 Darunavir N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114 pat-darunavir|prezista|prezcob DRUGBANK DB01264 C27H37N3O7S small molecule J05AE10|J05AR14 206361-99-1 DRUGBANK 27411 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6681 ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE - - DRUGBANK DB07884 C14H17FN2O3 small molecule - - DRUGBANK 27436 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7439 6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE - - DRUGBANK DB08665 C15H14N4O3 small molecule - - DRUGBANK 27402 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6580 N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA - - DRUGBANK DB07781 C16H16FN5OS small molecule - - DRUGBANK 27424 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7228 3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile - - DRUGBANK DB08446 C19H10BrClFN5O small molecule - - DRUGBANK 27438 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7454 N-[4-CLORO-3-(T-BUTYLOXOME)PHENYL-2-METHYL-3-FURAN-CARBOTHIAMIDE - - DRUGBANK DB08680 C17H19ClN2O2S small molecule - - DRUGBANK 27389 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 5729 [4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE - - DRUGBANK DB06910 C25H30N2O3 small molecule - - DRUGBANK 27439 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7455 1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE - - DRUGBANK DB08681 C14H18ClNO3S small molecule - - DRUGBANK 27416 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7002 5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide - - DRUGBANK DB08211 C13H14BrN3O3S small molecule - - DRUGBANK 12030 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Muzammil S (2007) 17360759 179171 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12031 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Koh Y (2007) 17635930 179170 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12032 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Temesgen Z (2007) 17712762 179166 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12033 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Tenore SB (2009) 20428639 179167 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12034 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Luna B (2007) 18158073 179165 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12035 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Croom KF (2005) 16060700 179168 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12036 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Hsieh SM (2009) 19751502 179169 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 12037 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Chen X (2002) 11752352 171740 922 Tipranavir - aptivus DRUGBANK DB00932 C31H33F3N2O5S small molecule J05AE09 174484-41-4 DRUGBANK 27417 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7074 NAPHTHYLOXYACETIC ACID - - DRUGBANK DB08286 C12H10O3 small molecule - - DRUGBANK 24079 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Hazen R (2007) 17620375 182027 4687 Brecanavir BCV - DRUGBANK DB04887 C33H41N3O10S2 small molecule - 313682-08-5 DRUGBANK 24080 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Ford SL (2006) 16723584 181948 4687 Brecanavir BCV - DRUGBANK DB04887 C33H41N3O10S2 small molecule - 313682-08-5 DRUGBANK 24081 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Reddy YS (2007) 17261626 181985 4687 Brecanavir BCV - DRUGBANK DB04887 C33H41N3O10S2 small molecule - 313682-08-5 DRUGBANK 15822 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Chen X (2002) 11752352 171740 1287 Fosamprenavir Fosamprenavir telzir|lexiva DRUGBANK DB01319 C25H36N3O9PS small molecule J05AE07 226700-79-4 DRUGBANK 15823 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Furfine ES (2004) 14982766 181094 1287 Fosamprenavir Fosamprenavir telzir|lexiva DRUGBANK DB01319 C25H36N3O9PS small molecule J05AE07 226700-79-4 DRUGBANK 15824 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wire MB (2006) 16485915 181091 1287 Fosamprenavir Fosamprenavir telzir|lexiva DRUGBANK DB01319 C25H36N3O9PS small molecule J05AE07 226700-79-4 DRUGBANK 15825 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wood R (2004) 14693528 181090 1287 Fosamprenavir Fosamprenavir telzir|lexiva DRUGBANK DB01319 C25H36N3O9PS small molecule J05AE07 226700-79-4 DRUGBANK 15826 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Hoffman RM (2007) 18042502 181093 1287 Fosamprenavir Fosamprenavir telzir|lexiva DRUGBANK DB01319 C25H36N3O9PS small molecule J05AE07 226700-79-4 DRUGBANK 15827 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Sension M (2004) 15116286 181092 1287 Fosamprenavir Fosamprenavir telzir|lexiva DRUGBANK DB01319 C25H36N3O9PS small molecule J05AE07 226700-79-4 DRUGBANK 27420 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7164 6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one - - DRUGBANK DB08379 C17H12ClFN2O2 small molecule - - DRUGBANK 27427 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7274 S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate - - DRUGBANK DB08494 C19H20ClN3O4S2 small molecule - - DRUGBANK 13485 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dierynck I (2007) 17928344 179988 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13486 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Lopez-Cortes LF (2008) 20116610 179989 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13487 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Chen X (2002) 11752352 171740 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13488 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Dandache S (2007) 17638694 174467 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13489 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Le Tiec C (2005) 16176117 179994 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13490 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wood R (2008) 19053892 179993 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13491 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Menendez-Arias L (2008) 18054799 179992 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13492 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Busti AJ (2004) 15585441 179991 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 13493 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Pyrko P (2007) 18006837 179990 1060 Atazanavir ATV|Atazanavirum|Zrivada|ATZ|Latazanavir reyataz|evotaz DRUGBANK DB01072 C38H52N6O7 small molecule J05AR15|J05AE08 198904-31-3 DRUGBANK 27425 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7240 3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile - - DRUGBANK DB08459 C20H12Cl2N4O2 small molecule - - DRUGBANK 27434 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7375 4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE - - DRUGBANK DB08598 C16H20ClN3S small molecule - - DRUGBANK 27418 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7157 1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA - - DRUGBANK DB08372 C16H19FN4OS small molecule - - DRUGBANK 27382 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Stoddart CA (2007) 18043758 188519 5556 Bevirimat PA-457|YK-FH312 - DRUGBANK DB06581 C36H56O6 small molecule - 174022-42-5 DRUGBANK 27435 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 7408 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL - - DRUGBANK DB08634 C22H24N2O3 small molecule - - DRUGBANK 27275 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Imming P (2006) 17016423 171742 2022 DMP450 - - DRUGBANK DB02102 C33H38N4O3 small molecule - - DRUGBANK 27276 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Overington JP (2006) 17139284 171741 2022 DMP450 - - DRUGBANK DB02102 C33H38N4O3 small molecule - - DRUGBANK 27404 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 unknown target Berman HM (2000) 10592235 172122 6618 6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL - - DRUGBANK DB07820 C19H26N2O3 small molecule - - DRUGBANK 17315 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Wittayanarakul K (2008) 17849388 174468 1539 Lopinavir LPV kaletra DRUGBANK DB01601 C37H48N4O5 small molecule J05AR10 192725-17-0 DRUGBANK 17316 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Garriga C (2007) 17854027 174469 1539 Lopinavir LPV kaletra DRUGBANK DB01601 C37H48N4O5 small molecule J05AR10 192725-17-0 DRUGBANK 17317 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Chen X (2002) 11752352 171740 1539 Lopinavir LPV kaletra DRUGBANK DB01601 C37H48N4O5 small molecule J05AR10 192725-17-0 DRUGBANK 17318 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Reddy GS (2007) 17696512 181585 1539 Lopinavir LPV kaletra DRUGBANK DB01601 C37H48N4O5 small molecule J05AR10 192725-17-0 DRUGBANK 17319 1205538 155348 HIV1gp1 gag-pol - 11676 Human Immunodeficiency Virus 1 inhibitor target Unknown Authors (2001) 11151088 181584 1539 Lopinavir LPV kaletra DRUGBANK DB01601 C37H48N4O5 small molecule J05AR10 192725-17-0 DRUGBANK 13928 1210638 3885966 PFF0160c PFF0160c - 36329 Plasmodium falciparum inhibitor target Cushion MT (2000) 10681344 180237 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13929 1210638 3885966 PFF0160c PFF0160c - 36329 Plasmodium falciparum inhibitor target Chen X (2002) 11752352 171740 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13930 1210638 3885966 PFF0160c PFF0160c - 36329 Plasmodium falciparum inhibitor target Ittarat I (1995) 7726490 180235 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 13931 1210638 3885966 PFF0160c PFF0160c - 36329 Plasmodium falciparum inhibitor target Seymour KK (1994) 7909690 180234 1105 Atovaquone Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone malarone pediatric|mylan-atova DRUGBANK DB01117 C22H19ClO3 small molecule P01AX06 95233-18-4 DRUGBANK 19275 1218551 3635457 C4_01440W_A NMT1 NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 2376 [Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine - - DRUGBANK DB02477 C33H52N6O4 small molecule - - DRUGBANK 19276 1218551 3635457 C4_01440W_A NMT1 NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 2376 [Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine - - DRUGBANK DB02477 C33H52N6O4 small molecule - - DRUGBANK 18672 1218551 3635457 C4_01440W_A NMT1 NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 2096 Myristoyl-Coa - - DRUGBANK DB02180 C35H62N7O17P3S small molecule - 3130-72-1 DRUGBANK 18673 1218551 3635457 C4_01440W_A NMT1 NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 2096 Myristoyl-Coa - - DRUGBANK DB02180 C35H62N7O17P3S small molecule - 3130-72-1 DRUGBANK 20411 1218551 3635457 C4_01440W_A NMT1 NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 2933 (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone - - DRUGBANK DB03062 C23H24N4O3 small molecule - - DRUGBANK 20412 1218551 3635457 C4_01440W_A NMT1 NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 2933 (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone - - DRUGBANK DB03062 C23H24N4O3 small molecule - - DRUGBANK 4627 1218855 3635917 C2_02460W_A ERG7 CaO19.1570|CA3994|CAWG_04014|CaO19.9143|C2_02460W|orf6.6427|orf6.480|IPF19258.2|CaO6.6427|Contig4-2925_0007|CaO6.480|orf19.1570|IPF8270.1|C2_02460W_B|orf19.9143 237561 Candida albicans inhibitor target Gebre-Hiwot A (1993) 8144423 174574 232 Oxiconazole Oxiconazol|Oxiconazole|Oxiconazolum oxizole|oxiconazole nitrate|ox DRUGBANK DB00239 C18H13Cl4N3O small molecule D01AC11|G01AF17 64211-45-6 DRUGBANK 17852 1219931 3636837 C1_02990C_A XOG1 C1_02990C|orf6.1982|orf19.2990|CaO19.10507|EXG|Contig4-2184_0004|CA0822|orf19.10507|EXG1|IPF14073.2|IPF24307.1|CaO19.2990|C1_02990C_B|CaO6.1982|CAWG_01085 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 1746 Castanospermine (1S,6S,7R,8R,8aR)-1,6,7,8-tetrahydroxyindolizidine|1,6,7,8-tetrahydroxyoctahydroindolizine|(1S-(1,6,7,8,8))-octahydro-1,6,7,8-indolizinetetrol - DRUGBANK DB01816 C8H15NO4 small molecule - 79831-76-8 DRUGBANK 17853 1219931 3636837 C1_02990C_A XOG1 C1_02990C|orf6.1982|orf19.2990|CaO19.10507|EXG|Contig4-2184_0004|CA0822|orf19.10507|EXG1|IPF14073.2|IPF24307.1|CaO19.2990|C1_02990C_B|CaO6.1982|CAWG_01085 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 1746 Castanospermine (1S,6S,7R,8R,8aR)-1,6,7,8-tetrahydroxyindolizidine|1,6,7,8-tetrahydroxyoctahydroindolizine|(1S-(1,6,7,8,8))-octahydro-1,6,7,8-indolizinetetrol - DRUGBANK DB01816 C8H15NO4 small molecule - 79831-76-8 DRUGBANK 12689 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Chau AS (2006) 16966400 70318 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12690 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Fliri AF (2005) 15625110 179625 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12691 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Ballard SA (1988) 3202901 179626 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12692 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Preissner S (2010) 19934256 172211 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12693 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Guinea J (2006) 16966178 68500 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 12694 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Bellamine A (2004) 15314102 174269 997 Tioconazole Vagistat-1|Tioconazolum|Tioconazol leader tioconastat 1 1 dose tr DRUGBANK DB01007 C16H13Cl3N2OS small molecule G01AF08|D01AC07 65899-73-2 DRUGBANK 14272 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Imming P (2006) 17016423 171742 1141 Sertaconazole Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo ertaczo DRUGBANK DB01153 C20H15Cl3N2OS small molecule G01AF19|D01AC14 99592-32-2 DRUGBANK 14273 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Overington JP (2006) 17139284 171741 1141 Sertaconazole Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo ertaczo DRUGBANK DB01153 C20H15Cl3N2OS small molecule G01AF19|D01AC14 99592-32-2 DRUGBANK 14274 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Berman HM (2000) 10592235 172122 1141 Sertaconazole Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo ertaczo DRUGBANK DB01153 C20H15Cl3N2OS small molecule G01AF19|D01AC14 99592-32-2 DRUGBANK 14275 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Croxtall JD (2009) 19275277 90682 1141 Sertaconazole Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo ertaczo DRUGBANK DB01153 C20H15Cl3N2OS small molecule G01AF19|D01AC14 99592-32-2 DRUGBANK 14276 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Agut J (1992) 1627191 179759 1141 Sertaconazole Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo ertaczo DRUGBANK DB01153 C20H15Cl3N2OS small molecule G01AF19|D01AC14 99592-32-2 DRUGBANK 14277 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Agut J (1992) 1627190 179760 1141 Sertaconazole Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo ertaczo DRUGBANK DB01153 C20H15Cl3N2OS small molecule G01AF19|D01AC14 99592-32-2 DRUGBANK 8232 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Thompson GR (2010) 19947892 177036 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8233 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Xu Y (2010) 20362444 177037 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8234 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Overington JP (2006) 17139284 171741 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8235 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Imming P (2006) 17016423 171742 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8236 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Morales IJ (2003) 12606318 59714 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8237 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Berman HM (2000) 10592235 172122 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8238 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Xu J (2011) 21420761 177038 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8239 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Li X (2004) 14657086 61965 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8240 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Sanguinetti M (2005) 15673750 65194 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8241 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Thompson GR (2010) 19947892 177036 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8242 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Xu Y (2010) 20362444 177037 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8243 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Overington JP (2006) 17139284 171741 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8244 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Imming P (2006) 17016423 171742 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8245 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Morales IJ (2003) 12606318 59714 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8246 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Berman HM (2000) 10592235 172122 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8247 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Xu J (2011) 21420761 177038 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8248 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Li X (2004) 14657086 61965 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 8249 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Sanguinetti M (2005) 15673750 65194 572 Voriconazole (AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend apo-voriconazole|teva-voricona DRUGBANK DB00582 C16H14F3N5O small molecule J02AC03 137234-62-9 DRUGBANK 13863 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Edlind T (2002) 12366848 58606 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13864 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Georgopapadakou NH (1996) 8834867 180214 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13865 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target White TC (1998) 9564569 180215 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 13866 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Ghannoum MA (1999) 10515900 180216 1098 Miconazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole aloe vesta antifungal|triple p DRUGBANK DB01110 C18H14Cl4N2O small molecule S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09 22916-47-8 DRUGBANK 4852 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Berman HM (2000) 10592235 172122 244 Terconazole Terazol 3 terconazole|terazol 3 vaginal DRUGBANK DB00251 C26H31Cl2N5O3 small molecule G01AG02 67915-31-5 DRUGBANK 4853 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Cauwenbergh G (1989) 2677363 174677 244 Terconazole Terazol 3 terconazole|terazol 3 vaginal DRUGBANK DB00251 C26H31Cl2N5O3 small molecule G01AG02 67915-31-5 DRUGBANK 4854 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Vanden Bossche H (1991) 1951574 174676 244 Terconazole Terazol 3 terconazole|terazol 3 vaginal DRUGBANK DB00251 C26H31Cl2N5O3 small molecule G01AG02 67915-31-5 DRUGBANK 14012 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Pietila MP (2006) 16543605 180287 1115 Econazole (+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate econazole nitrate|ecostatin va DRUGBANK DB01127 C18H15Cl3N2O small molecule G01AF05|D01AC03 27220-47-9 DRUGBANK 14013 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Imming P (2006) 17016423 171742 1115 Econazole (+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate econazole nitrate|ecostatin va DRUGBANK DB01127 C18H15Cl3N2O small molecule G01AF05|D01AC03 27220-47-9 DRUGBANK 14014 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Berman HM (2000) 10592235 172122 1115 Econazole (+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate econazole nitrate|ecostatin va DRUGBANK DB01127 C18H15Cl3N2O small molecule G01AF05|D01AC03 27220-47-9 DRUGBANK 14015 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Strushkevich N (2010) 20149798 180289 1115 Econazole (+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate econazole nitrate|ecostatin va DRUGBANK DB01127 C18H15Cl3N2O small molecule G01AF05|D01AC03 27220-47-9 DRUGBANK 14016 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Jackson CJ (2000) 11064188 180288 1115 Econazole (+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate econazole nitrate|ecostatin va DRUGBANK DB01127 C18H15Cl3N2O small molecule G01AF05|D01AC03 27220-47-9 DRUGBANK 14017 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Warrilow AG (2010) 20625155 174707 1115 Econazole (+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate econazole nitrate|ecostatin va DRUGBANK DB01127 C18H15Cl3N2O small molecule G01AF05|D01AC03 27220-47-9 DRUGBANK 15496 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Chau AS (2004) 15155210 63282 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15497 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Imming P (2006) 17016423 171742 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15498 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Overington JP (2006) 17139284 171741 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15499 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Berman HM (2000) 10592235 172122 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15500 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Li X (2004) 14657086 61965 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15501 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Kwon DS (2007) 17516880 180913 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15502 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Groll AH (2005) 16107193 180917 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15503 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Warrilow AG (2010) 20660663 180916 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15504 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Schiller DS (2007) 18035188 180915 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 15505 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Bhattacharya M (2010) 20622401 180914 1250 Posaconazole - posanol|noxafil DRUGBANK DB01263 C37H42F2N8O4 small molecule J02AC04 171228-49-2 DRUGBANK 23902 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Berg D (1984) 6372801 181679 4596 Bifonazole Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole - DRUGBANK DB04794 C22H18N2 small molecule D01AC60|D01AC10 60628-96-8 DRUGBANK 23903 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Carrillo-Munoz AJ (2006) 16964330 174576 4596 Bifonazole Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole - DRUGBANK DB04794 C22H18N2 small molecule D01AC60|D01AC10 60628-96-8 DRUGBANK 23904 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Rossello A (2002) 12383016 174575 4596 Bifonazole Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole - DRUGBANK DB04794 C22H18N2 small molecule D01AC60|D01AC10 60628-96-8 DRUGBANK 23905 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Berg D (1984) 6396116 181680 4596 Bifonazole Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole - DRUGBANK DB04794 C22H18N2 small molecule D01AC60|D01AC10 60628-96-8 DRUGBANK 4885 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Gachotte D (1997) 9326581 19002 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4886 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Henry KW (2000) 10991846 52547 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4887 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Lorenz RT (1991) 1929324 25650 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4888 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Warrilow AG (2010) 20625155 174707 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4889 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Berman HM (2000) 10592235 172122 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4890 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Gachotte D (1997) 9326581 19002 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4891 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Henry KW (2000) 10991846 52547 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4892 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Lorenz RT (1991) 1929324 25650 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4893 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Warrilow AG (2010) 20625155 174707 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4894 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans antagonist target Berman HM (2000) 10592235 172122 250 Clotrimazole Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole myclo solution|clotrimazole ex DRUGBANK DB00257 C22H17ClN2 small molecule A01AB18|G01AF02|D01AC01 23593-75-1 DRUGBANK 4133 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Chau AS (2006) 16966400 70318 189 Fluconazole Triflucan|Fluconazolum|2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol|Diflucan|Elazor|Biozole|Fluconazol|2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol diflucan tab 100mg|monicure co DRUGBANK DB00196 C13H12F2N6O small molecule J01RA07|D01AC15|J02AC01 86386-73-4 DRUGBANK 4134 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Guinea J (2006) 16966178 68500 189 Fluconazole Triflucan|Fluconazolum|2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol|Diflucan|Elazor|Biozole|Fluconazol|2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol diflucan tab 100mg|monicure co DRUGBANK DB00196 C13H12F2N6O small molecule J01RA07|D01AC15|J02AC01 86386-73-4 DRUGBANK 4135 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Bellamine A (2004) 15314102 174269 189 Fluconazole Triflucan|Fluconazolum|2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol|Diflucan|Elazor|Biozole|Fluconazol|2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol diflucan tab 100mg|monicure co DRUGBANK DB00196 C13H12F2N6O small molecule J01RA07|D01AC15|J02AC01 86386-73-4 DRUGBANK 27008 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Niwano Y (1999) 10520160 181742 7672 Luliconazole - luzu DRUGBANK DB08933 C14H9Cl2N3S2 small molecule D01AC18 187164-19-8 DRUGBANK 12914 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Imming P (2006) 17016423 171742 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12915 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Overington JP (2006) 17139284 171741 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12916 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Berman HM (2000) 10592235 172122 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12917 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Croxtall JD (2009) 19275277 90682 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12918 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Warrilow AG (2010) 20625155 174707 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12919 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Agut J (1992) 1627191 179759 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12920 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Agut J (1992) 1627190 179760 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 12921 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Borgers M (2005) 16375669 179761 1016 Ketoconazole Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum nizoral shp 2%|nizoral a-d|tev DRUGBANK DB01026 C26H28Cl2N4O4 small molecule G01AF11|J02AB02|D01AC08 65277-42-1 DRUGBANK 4628 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Carrillo-Munoz AJ (2006) 16964330 174576 232 Oxiconazole Oxiconazol|Oxiconazole|Oxiconazolum oxizole|oxiconazole nitrate|ox DRUGBANK DB00239 C18H13Cl4N3O small molecule D01AC11|G01AF17 64211-45-6 DRUGBANK 4629 1224602 3641571 C5_00660C_A ERG11 orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2 237561 Candida albicans inhibitor target Rossello A (2002) 12383016 174575 232 Oxiconazole Oxiconazol|Oxiconazole|Oxiconazolum oxizole|oxiconazole nitrate|ox DRUGBANK DB00239 C18H13Cl4N3O small molecule D01AC11|G01AF17 64211-45-6 DRUGBANK 13711 1226461 3643463 C2_05190W_A CDC21 orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102 237561 Candida albicans inhibitor target Imming P (2006) 17016423 171742 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13712 1226461 3643463 C2_05190W_A CDC21 orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102 237561 Candida albicans inhibitor target Rehemtulla A (2004) 15274300 182268 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13713 1226461 3643463 C2_05190W_A CDC21 orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102 237561 Candida albicans inhibitor target Overington JP (2006) 17139284 171741 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13714 1226461 3643463 C2_05190W_A CDC21 orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102 237561 Candida albicans inhibitor target Wang ZH (1998) 9524100 182267 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 13715 1226461 3643463 C2_05190W_A CDC21 orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102 237561 Candida albicans inhibitor target Fox BA (1999) 10029312 182266 1087 Flucytosine 5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn) ancobon|flucytosine DRUGBANK DB01099 C4H4FN3O small molecule D01AE21|J02AX01 2022-85-7 DRUGBANK 7735 1229551 3646458 C1_08590C_A ERG1 Contig4-2020_0009|CaO19.406|CAWG_00567|IPF19729.1|CaO19.8036|CA1353|CaO6.2816|C1_08590C_B|orf19.8036|orf6.2816|IPF26914.1|C1_08590C|orf19.406|Contig4-2020_0010 237561 Candida albicans inhibitor target Barrett-Bee K (1995) 8852337 40923 515 Tolnaftate Tolnaftatum|m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester|N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide|Separin|Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester|Tolnaphthate|2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate|O-2-Naphthyl m,N-dimethylthiocarbanilate|Tolnaftato|Tinactin fungicure gel|healthy accents DRUGBANK DB00525 C19H17NOS small molecule D01AE18 2398-96-1 DRUGBANK 7736 1229551 3646458 C1_08590C_A ERG1 Contig4-2020_0009|CaO19.406|CAWG_00567|IPF19729.1|CaO19.8036|CA1353|CaO6.2816|C1_08590C_B|orf19.8036|orf6.2816|IPF26914.1|C1_08590C|orf19.406|Contig4-2020_0010 237561 Candida albicans inhibitor target Georgopapadakou NH (1992) 1416865 176666 515 Tolnaftate Tolnaftatum|m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester|N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide|Separin|Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester|Tolnaphthate|2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate|O-2-Naphthyl m,N-dimethylthiocarbanilate|Tolnaftato|Tinactin fungicure gel|healthy accents DRUGBANK DB00525 C19H17NOS small molecule D01AE18 2398-96-1 DRUGBANK 7737 1229551 3646458 C1_08590C_A ERG1 Contig4-2020_0009|CaO19.406|CAWG_00567|IPF19729.1|CaO19.8036|CA1353|CaO6.2816|C1_08590C_B|orf19.8036|orf6.2816|IPF26914.1|C1_08590C|orf19.406|Contig4-2020_0010 237561 Candida albicans inhibitor target Ryder NS (1986) 3524433 176667 515 Tolnaftate Tolnaftatum|m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester|N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide|Separin|Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester|Tolnaphthate|2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate|O-2-Naphthyl m,N-dimethylthiocarbanilate|Tolnaftato|Tinactin fungicure gel|healthy accents DRUGBANK DB00525 C19H17NOS small molecule D01AE18 2398-96-1 DRUGBANK 23247 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 4209 1-Hydroxy-2-Amino-3-Cyclohexylpropane - - DRUGBANK DB04387 C9H19NO small molecule - - DRUGBANK 23248 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 4209 1-Hydroxy-2-Amino-3-Cyclohexylpropane - - DRUGBANK DB04387 C9H19NO small molecule - - DRUGBANK 20466 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 2961 Ethylaminobenzylmethylcarbonyl Group - - DRUGBANK DB03090 C11H15NO small molecule - - DRUGBANK 20467 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 2961 Ethylaminobenzylmethylcarbonyl Group - - DRUGBANK DB03090 C11H15NO small molecule - - DRUGBANK 20810 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 3109 1-Amino-1-Carbonyl Pentane - - DRUGBANK DB03241 C6H13NO small molecule - - DRUGBANK 20811 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 3109 1-Amino-1-Carbonyl Pentane - - DRUGBANK DB03241 C6H13NO small molecule - - DRUGBANK 21661 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 3506 Butylamine 1-aminobutane|1-butanamine|n-butylamine - DRUGBANK DB03659 C4H11N small molecule - 109-73-9 DRUGBANK 21662 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 3506 Butylamine 1-aminobutane|1-butanamine|n-butylamine - DRUGBANK DB03659 C4H11N small molecule - 109-73-9 DRUGBANK 23457 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Imming P (2006) 17016423 171742 4265 4-Methylpiperazin-1-Yl Carbonyl Group - - DRUGBANK DB04451 C6H12N2O small molecule - - DRUGBANK 23458 1230426 3647333 CR_07800W_A SAP2 PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W 237561 Candida albicans unknown target Overington JP (2006) 17139284 171741 4265 4-Methylpiperazin-1-Yl Carbonyl Group - - DRUGBANK DB04451 C6H12N2O small molecule - - DRUGBANK 19938 1239943 876747 MPN348 MPN348 H91_orf164 272634 Mycoplasma pneumoniae unknown target Imming P (2006) 17016423 171742 2682 5-Hydroxymethylene-6-Hydrofolic Acid - - DRUGBANK DB02800 C20H23N7O7 small molecule - - DRUGBANK 19939 1239943 876747 MPN348 MPN348 H91_orf164 272634 Mycoplasma pneumoniae unknown target Overington JP (2006) 17139284 171741 2682 5-Hydroxymethylene-6-Hydrofolic Acid - - DRUGBANK DB02800 C20H23N7O7 small molecule - - DRUGBANK 27292 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Imming P (2006) 17016423 171742 2429 2,4,6-Triaminoquinazoline - - DRUGBANK DB02532 C8H9N5 small molecule - - DRUGBANK 27293 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Overington JP (2006) 17139284 171741 2429 2,4,6-Triaminoquinazoline - - DRUGBANK DB02532 C8H9N5 small molecule - - DRUGBANK 27285 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Imming P (2006) 17016423 171742 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 27286 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Overington JP (2006) 17139284 171741 2243 Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate - - DRUGBANK DB02338 C21H30N7O17P3 small molecule - - DRUGBANK 27348 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Imming P (2006) 17016423 171742 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 27349 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Overington JP (2006) 17139284 171741 4220 7,8-Dihydrobiopterin D-erythro-7,8-dihydrobiopterin - DRUGBANK DB04400 C9H13N5O3 small molecule - 6779-87-9 DRUGBANK 27329 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Imming P (2006) 17016423 171742 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 27330 1969430 5651987 LMJF_23_0270 PTR1 - 347515 Leishmania major unknown target Overington JP (2006) 17139284 171741 3316 2'-Monophosphoadenosine 5'-Diphosphoribose - - DRUGBANK DB03461 C21H28N7O17P3 small molecule - - DRUGBANK 27344 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 4139 1-Methylcytosine - - DRUGBANK DB04314 C5H7N3O small molecule - - DRUGBANK 27345 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 4139 1-Methylcytosine - - DRUGBANK DB04314 C5H7N3O small molecule - - DRUGBANK 27331 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 3348 7-Methylguanosine - - DRUGBANK DB03493 C11H16N5O5 small molecule - - DRUGBANK 27332 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 3348 7-Methylguanosine - - DRUGBANK DB03493 C11H16N5O5 small molecule - - DRUGBANK 27340 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 3935 3-Methylcytosine - - DRUGBANK DB04103 C5H8N3O small molecule - - DRUGBANK 27341 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 3935 3-Methylcytosine - - DRUGBANK DB04103 C5H8N3O small molecule - - DRUGBANK 27327 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 3220 7n-Methyl-8-Hydroguanosine-5'-Triphosphate - - DRUGBANK DB03358 C11H20N5O14P3 small molecule - - DRUGBANK 27328 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 3220 7n-Methyl-8-Hydroguanosine-5'-Triphosphate - - DRUGBANK DB03358 C11H20N5O14P3 small molecule - - DRUGBANK 27311 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 3032 6-Amino-1-Methylpurine - - DRUGBANK DB03164 C6H7N5 small molecule - - DRUGBANK 27312 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 3032 6-Amino-1-Methylpurine - - DRUGBANK DB03164 C6H7N5 small molecule - - DRUGBANK 27261 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 27262 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 1686 S-Adenosyl-L-Homocysteine - - DRUGBANK DB01752 C14H20N6O5S small molecule - 979-92-0 DRUGBANK 27269 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 27270 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 1884 7n-Methyl-8-Hydroguanosine-5'-Diphosphate - - DRUGBANK DB01960 C11H19N5O11P2 small molecule - - DRUGBANK 27271 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 1902 7,9-Dimethylguanine - - DRUGBANK DB01978 C7H10N5O small molecule - 55235-22-8 DRUGBANK 27272 3508905 3707551 VACWR095 J3R - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 1902 7,9-Dimethylguanine - - DRUGBANK DB01978 C7H10N5O small molecule - 55235-22-8 DRUGBANK 27281 3508994 3707640 VACWR025 C3L - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 27282 3508994 3707640 VACWR025 C3L - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 2173 O2-Sulfo-Glucuronic Acid - - DRUGBANK DB02264 C6H10O10S small molecule - - DRUGBANK 27357 3508994 3707640 VACWR025 C3L - 10245 Vaccinia Virus unknown target Ganesh VK (2005) 16086578 188506 4588 Suramin Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride - DRUGBANK DB04786 C51H40N6O23S6 small molecule P01CX02 145-63-1 DRUGBANK 27338 3508994 3707640 VACWR025 C3L - 10245 Vaccinia Virus unknown target Imming P (2006) 17016423 171742 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 27339 3508994 3707640 VACWR025 C3L - 10245 Vaccinia Virus unknown target Overington JP (2006) 17139284 171741 3794 N,O6-Disulfo-Glucosamine - - DRUGBANK DB03959 C6H13NO11S2 small molecule - - DRUGBANK 27544 4054743 1263511 D616_p97100 ompP Fpla031 83333 Escherichia coli unknown target Imming P (2006) 17016423 171742 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 27545 4054743 1263511 D616_p97100 ompP Fpla031 83333 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 27546 4054743 1263511 D616_p97100 ompP Fpla031 83333 Escherichia coli unknown target Berman HM (2000) 10592235 172122 4061 (Hydroxyethyloxy)Tri(Ethyloxy)Octane - - DRUGBANK DB04233 C16H34O5 small molecule - - DRUGBANK 27547 4054815 1263584 D616_p97085 ssb Fpla062 83333 Escherichia coli unknown target Imming P (2006) 17016423 171742 4071 5-Methyluridine 5'-Monophosphate - - DRUGBANK DB04243 C10H15N2O9P small molecule - - DRUGBANK 27548 4054815 1263584 D616_p97085 ssb Fpla062 83333 Escherichia coli unknown target Overington JP (2006) 17139284 171741 4071 5-Methyluridine 5'-Monophosphate - - DRUGBANK DB04243 C10H15N2O9P small molecule - - DRUGBANK 27265 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 1831 D-Xylitol - - DRUGBANK DB01904 C5H12O5 small molecule - 488-81-3 DRUGBANK 27266 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 1831 D-Xylitol - - DRUGBANK DB01904 C5H12O5 small molecule - 488-81-3 DRUGBANK 27263 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 1800 Acetylgalactosamine-4-Sulfate - - DRUGBANK DB01872 C8H15NO9S small molecule - - DRUGBANK 27264 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 1800 Acetylgalactosamine-4-Sulfate - - DRUGBANK DB01872 C8H15NO9S small molecule - - DRUGBANK 27309 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 3024 D-Glucuronic Acid D-(+)-glucuronate|D-glucuronate|alpha-delta-glucuronic acid|Glucuronic acid|Glucosiduronic acid|alpha-D-glucopyranuronic acid|alpha-D-glucuronic acid|Glucuronate|GCU|delta-(+)-glucuronic acid|delta-glucuronate|delta-(+)-glucuronate|D-(+)-glucuronic acid|alpha-delta-glucopyranuronic acid|Glucosiduronate - DRUGBANK DB03156 C6H10O7 small molecule - 6556-12-3 DRUGBANK 27310 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 3024 D-Glucuronic Acid D-(+)-glucuronate|D-glucuronate|alpha-delta-glucuronic acid|Glucuronic acid|Glucosiduronic acid|alpha-D-glucopyranuronic acid|alpha-D-glucuronic acid|Glucuronate|GCU|delta-(+)-glucuronic acid|delta-glucuronate|delta-(+)-glucuronate|D-(+)-glucuronic acid|alpha-delta-glucopyranuronic acid|Glucosiduronate - DRUGBANK DB03156 C6H10O7 small molecule - 6556-12-3 DRUGBANK 27046 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 27047 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Botzki A (2004) 15322107 172874 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 27048 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 27049 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Li S (2001) 11278838 172873 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 27050 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Okorukwu ON (2003) 14567553 172872 120 Vitamin C Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate zinc plus lozenges|vitamin c 1 DRUGBANK DB00126 C6H8O6 small molecule - 50-81-7 DRUGBANK 27421 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 7220 (2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID - - DRUGBANK DB08438 C22H40O8 small molecule - - DRUGBANK 27355 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 4358 4-Deoxy-D-Glucuronic Acid - - DRUGBANK DB04548 C6H10O6 small molecule - - DRUGBANK 27356 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 4358 4-Deoxy-D-Glucuronic Acid - - DRUGBANK DB04548 C6H10O6 small molecule - - DRUGBANK 27279 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 2102 N-Acetyl-D-Galactosamine 6-Sulfate - - DRUGBANK DB02186 C8H15NO9S small molecule - 157296-99-6 DRUGBANK 27280 4178412 930127 SP_0314 SP_0314 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 2102 N-Acetyl-D-Galactosamine 6-Sulfate - - DRUGBANK DB02186 C8H15NO9S small molecule - 157296-99-6 DRUGBANK 27363 4178437 930153 SP_0336 SP_0336 - 170187 Streptococcus pneumoniae unknown target Davies TA (2007) 17470659 182006 4716 Ceftobiprole Ceftobiprole Medocaril zevtera|zeftera DRUGBANK DB04918 C20H22N8O6S2 small molecule J01DI01 209467-52-7 DRUGBANK 27234 4178437 930153 SP_0336 SP_0336 - 170187 Streptococcus pneumoniae inhibitor target Nagai K (2002) 11959556 188503 1138 Cefprozil Cefprozilum|Cefprozil anhydrous|Cefprozilo|Cefzil ava-cefprozil|cefzil powder fo DRUGBANK DB01150 C18H19N3O5S small molecule J01DC10 92665-29-7 DRUGBANK 27369 4178552 930269 SP_0369 SP_0369 - 170187 Streptococcus pneumoniae unknown target Dalhoff A (2003) 12886052 188515 5283 faropenem medoxomil SUN-A0026|Faropenem daloxate|SUN-208 - DRUGBANK DB05659 C17H19NO8S small molecule - 141702-36-5 DRUGBANK 27235 4178552 930269 SP_0369 SP_0369 - 170187 Streptococcus pneumoniae inhibitor target Nagai K (2002) 11959556 188503 1138 Cefprozil Cefprozilum|Cefprozil anhydrous|Cefprozilo|Cefzil ava-cefprozil|cefzil powder fo DRUGBANK DB01150 C18H19N3O5S small molecule J01DC10 92665-29-7 DRUGBANK 27201 4179035 930756 SP_0806 gyrB - 170187 Streptococcus pneumoniae inhibitor target Kim OK (2001) 11178337 188497 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27202 4179035 930756 SP_0806 gyrB - 170187 Streptococcus pneumoniae inhibitor target Mdluli K (2007) 17970226 188498 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27203 4179035 930756 SP_0806 gyrB - 170187 Streptococcus pneumoniae inhibitor target Hosaka M (2003) 12835539 188496 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27204 4179035 930756 SP_0806 gyrB - 170187 Streptococcus pneumoniae inhibitor target Rafii F (2005) 15673722 176445 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27205 4179035 930756 SP_0806 gyrB - 170187 Streptococcus pneumoniae inhibitor target Harding I (2000) 11131958 188494 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27206 4179035 930756 SP_0806 gyrB - 170187 Streptococcus pneumoniae inhibitor target Kays MB (2007) 17253913 188495 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27212 4179081 930802 SP_0852 SP_0852 - 170187 Streptococcus pneumoniae inhibitor target Mdluli K (2007) 17970226 188498 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27213 4179081 930802 SP_0852 SP_0852 - 170187 Streptococcus pneumoniae inhibitor target Hosaka M (2003) 12835539 188496 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27214 4179081 930802 SP_0852 SP_0852 - 170187 Streptococcus pneumoniae inhibitor target Rafii F (2005) 15673722 176445 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27215 4179081 930802 SP_0852 SP_0852 - 170187 Streptococcus pneumoniae inhibitor target Harding I (2000) 11131958 188494 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27216 4179081 930802 SP_0852 SP_0852 - 170187 Streptococcus pneumoniae inhibitor target Kays MB (2007) 17253913 188495 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27207 4179084 930805 SP_0855 SP_0855 - 170187 Streptococcus pneumoniae inhibitor target Mdluli K (2007) 17970226 188498 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27208 4179084 930805 SP_0855 SP_0855 - 170187 Streptococcus pneumoniae inhibitor target Hosaka M (2003) 12835539 188496 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27209 4179084 930805 SP_0855 SP_0855 - 170187 Streptococcus pneumoniae inhibitor target Rafii F (2005) 15673722 176445 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27210 4179084 930805 SP_0855 SP_0855 - 170187 Streptococcus pneumoniae inhibitor target Harding I (2000) 11131958 188494 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27211 4179084 930805 SP_0855 SP_0855 - 170187 Streptococcus pneumoniae inhibitor target Kays MB (2007) 17253913 188495 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27387 4179084 930805 SP_0855 SP_0855 - 170187 Streptococcus pneumoniae antagonist target Carter NJ (2009) 20030427 188523 5630 Besifloxacin Besifloxacin|SS734 besivance DRUGBANK DB06771 C19H21ClFN3O3 small molecule S01AE08 141388-76-3 DRUGBANK 27370 4179442 931164 SP_1673 SP_1673 - 170187 Streptococcus pneumoniae unknown target Dalhoff A (2003) 12886052 188515 5283 faropenem medoxomil SUN-A0026|Faropenem daloxate|SUN-208 - DRUGBANK DB05659 C17H19NO8S small molecule - 141702-36-5 DRUGBANK 27236 4179442 931164 SP_1673 SP_1673 - 170187 Streptococcus pneumoniae inhibitor target Nagai K (2002) 11959556 188503 1138 Cefprozil Cefprozilum|Cefprozil anhydrous|Cefprozilo|Cefzil ava-cefprozil|cefzil powder fo DRUGBANK DB01150 C18H19N3O5S small molecule J01DC10 92665-29-7 DRUGBANK 27233 4179442 931164 SP_1673 SP_1673 - 170187 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 27346 4179734 931459 SP_1371 SP_1371 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 4153 Shikimate-3-Phosphate - - DRUGBANK DB04328 C7H11O8P small molecule - - DRUGBANK 27347 4179734 931459 SP_1371 SP_1371 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 4153 Shikimate-3-Phosphate - - DRUGBANK DB04328 C7H11O8P small molecule - - DRUGBANK 27352 4179734 931459 SP_1371 SP_1371 - 170187 Streptococcus pneumoniae inhibitor target Imming P (2006) 17016423 171742 4349 Glyphosate - - DRUGBANK DB04539 C3H9NO5P small molecule - 1071-83-6 DRUGBANK 27353 4179734 931459 SP_1371 SP_1371 - 170187 Streptococcus pneumoniae inhibitor target Chen X (2002) 11752352 171740 4349 Glyphosate - - DRUGBANK DB04539 C3H9NO5P small molecule - 1071-83-6 DRUGBANK 27354 4179734 931459 SP_1371 SP_1371 - 170187 Streptococcus pneumoniae inhibitor target Overington JP (2006) 17139284 171741 4349 Glyphosate - - DRUGBANK DB04539 C3H9NO5P small molecule - 1071-83-6 DRUGBANK 27195 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae inhibitor target Kim OK (2001) 11178337 188497 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27196 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae inhibitor target Mdluli K (2007) 17970226 188498 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27197 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae inhibitor target Hosaka M (2003) 12835539 188496 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27198 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae inhibitor target Rafii F (2005) 15673722 176445 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27199 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae inhibitor target Harding I (2000) 11131958 188494 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27200 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae inhibitor target Kays MB (2007) 17253913 188495 1033 Gatifloxacin Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine tequin|tequin iv|gatifloxacin| DRUGBANK DB01044 C19H22FN3O4 small molecule S01AE06|J01MA16 112811-59-3 DRUGBANK 27386 4180008 931733 SP_1219 SP_1219 - 170187 Streptococcus pneumoniae antagonist target Carter NJ (2009) 20030427 188523 5630 Besifloxacin Besifloxacin|SS734 besivance DRUGBANK DB06771 C19H21ClFN3O3 small molecule S01AE08 141388-76-3 DRUGBANK 27267 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 1838 2,2':6',2''-Terpyridine Platinum(Ii) - - DRUGBANK DB01912 C15H11N3Pt small molecule - - DRUGBANK 27268 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 1838 2,2':6',2''-Terpyridine Platinum(Ii) - - DRUGBANK DB01912 C15H11N3Pt small molecule - - DRUGBANK 27307 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 2907 Dextrofloxacine - - DRUGBANK DB03034 C18H20FN3O4 small molecule - - DRUGBANK 27308 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 2907 Dextrofloxacine - - DRUGBANK DB03034 C18H20FN3O4 small molecule - - DRUGBANK 27294 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 27295 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 27296 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 2505 Decylamine-N,N-Dimethyl-N-Oxide - - DRUGBANK DB02613 C12H27NO small molecule - - DRUGBANK 27333 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 27334 4180268 931994 SP_1937 SP_1937 - 170187 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 3596 Tris Tromethamine|Tris(hydroxymethyl)aminomethane|THAM sooryehan hyo fermented sun bl DRUGBANK DB03754 C4H11NO3 small molecule - 77-86-1 DRUGBANK 27390 4180562 933049 spr1514 murF - 171101 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 5789 2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE - - DRUGBANK DB06970 C19H20ClN3O3S2 small molecule - - DRUGBANK 27442 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 7566 Azidocillin Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid - DRUGBANK DB08795 C16H17N5O4S small molecule J01CE04 17243-38-8 DRUGBANK 27091 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 27118 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 597 Nafcillin (2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid unipen injection pws 500mg/via DRUGBANK DB00607 C21H22N2O5S small molecule J01CF06 147-52-4 DRUGBANK 27256 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1541 Meticillin 6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin - DRUGBANK DB01603 C17H20N2O6S small molecule J01CF03 61-32-5 DRUGBANK 27076 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 312 Piperacillin Pipracilline|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Piperacillina|Piperacillin|Piperacillin Anhydrous|Piperacillinum|Piperacilina jamp-pip/taz|pipracil pharmacy DRUGBANK DB00319 C23H27N5O7S small molecule J01CA12|J01CR05 66258-76-2 DRUGBANK 27113 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Mitsuoka K (2007) 17142565 176927 557 Cephalexin Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid dom-cephalexin 250 - sus 250mg DRUGBANK DB00567 C16H17N3O4S small molecule J01DB01 15686-71-2 DRUGBANK 27114 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 557 Cephalexin Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid dom-cephalexin 250 - sus 250mg DRUGBANK DB00567 C16H17N3O4S small molecule J01DB01 15686-71-2 DRUGBANK 27239 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1151 Amdinocillin Penicillin HX|Mecillinam - DRUGBANK DB01163 C15H23N3O3S small molecule J01CA11 32887-01-7 DRUGBANK 27232 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1135 Cloxacillin (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN nu-cloxi capsules 500mg|nu-clo DRUGBANK DB01147 C19H18ClN3O5S small molecule J01CF02 61-72-3 DRUGBANK 27125 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 703 Oxacillin Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin oxacillin DRUGBANK DB00713 C19H19N3O5S small molecule J01CF04 66-79-5 DRUGBANK 27084 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27323 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 3178 Cephalosporin C - - DRUGBANK DB03313 C16H22N3O8S small molecule - - DRUGBANK 27253 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 27095 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 477 Dicloxacillin Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid dicloxacillin sodium DRUGBANK DB00485 C19H17Cl2N3O5S small molecule J01CF01 3116-76-5 DRUGBANK 27104 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27130 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Neu HC (1975) 1095502 178113 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27131 4181047 933569 spr1823 pbp2a - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27229 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Ocheltree SM (2004) 14600253 188502 1128 Cefadroxil D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX cefadroxil|nu-cefadroxil, 500 DRUGBANK DB01140 C16H17N3O5S small molecule J01DB05 66592-87-8 DRUGBANK 27230 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1128 Cefadroxil D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX cefadroxil|nu-cefadroxil, 500 DRUGBANK DB01140 C16H17N3O5S small molecule J01DB05 66592-87-8 DRUGBANK 27443 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 7566 Azidocillin Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid - DRUGBANK DB08795 C16H17N5O4S small molecule J01CE04 17243-38-8 DRUGBANK 27090 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 27226 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Yamada M (2007) 17724158 188501 1054 Cefditoren - cefditoren pivoxil|spectracef DRUGBANK DB01066 C19H18N6O5S3 small molecule J01DD16 104145-95-1 DRUGBANK 27119 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 597 Nafcillin (2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid unipen injection pws 500mg/via DRUGBANK DB00607 C21H22N2O5S small molecule J01CF06 147-52-4 DRUGBANK 27258 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1541 Meticillin 6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin - DRUGBANK DB01603 C17H20N2O6S small molecule J01CF03 61-32-5 DRUGBANK 27078 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 312 Piperacillin Pipracilline|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Piperacillina|Piperacillin|Piperacillin Anhydrous|Piperacillinum|Piperacilina jamp-pip/taz|pipracil pharmacy DRUGBANK DB00319 C23H27N5O7S small molecule J01CA12|J01CR05 66258-76-2 DRUGBANK 27115 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 557 Cephalexin Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid dom-cephalexin 250 - sus 250mg DRUGBANK DB00567 C16H17N3O4S small molecule J01DB01 15686-71-2 DRUGBANK 27240 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1151 Amdinocillin Penicillin HX|Mecillinam - DRUGBANK DB01163 C15H23N3O3S small molecule J01CA11 32887-01-7 DRUGBANK 27249 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Tomberg J (2010) 20704258 188505 1200 Ceftriaxone (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum ceftriaxone|ceftriaxone sodium DRUGBANK DB01212 C18H18N8O7S3 small molecule J01DD04|J01DD54 73384-59-5 DRUGBANK 27127 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 703 Oxacillin Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin oxacillin DRUGBANK DB00713 C19H19N3O5S small molecule J01CF04 66-79-5 DRUGBANK 27082 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27322 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 3178 Cephalosporin C - - DRUGBANK DB03313 C16H22N3O8S small molecule - - DRUGBANK 27254 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 27096 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 477 Dicloxacillin Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid dicloxacillin sodium DRUGBANK DB00485 C19H17Cl2N3O5S small molecule J01CF01 3116-76-5 DRUGBANK 27107 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27132 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Neu HC (1975) 1095502 178113 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27133 4181402 933948 spr1517 pbp2b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27315 4181864 934448 spr1232 aroC - 171101 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 27316 4181864 934448 spr1232 aroC - 171101 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 3115 Riboflavin Monophosphate - - DRUGBANK DB03247 C17H21N4O9P small molecule - 146-17-8 DRUGBANK 27325 4181864 934448 spr1232 aroC - 171101 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 3213 Cobalt Hexammine Ion - - DRUGBANK DB03350 CoH12N6 small molecule - - DRUGBANK 27326 4181864 934448 spr1232 aroC - 171101 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 3213 Cobalt Hexammine Ion - - DRUGBANK DB03350 CoH12N6 small molecule - - DRUGBANK 27431 4181932 934523 spr1310 def - 171101 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 7302 2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE - - DRUGBANK DB08524 C16H15NO4 small molecule - - DRUGBANK 27432 4181932 934523 spr1310 def - 171101 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 7303 HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE - - DRUGBANK DB08525 C10H14N2O2 small molecule - - DRUGBANK 27430 4181932 934523 spr1310 def - 171101 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 7301 [HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL - - DRUGBANK DB08523 C10H15NO2 small molecule - - DRUGBANK 27313 4182131 934744 spr0304 pbpX - 171101 Streptococcus pneumoniae unknown target Imming P (2006) 17016423 171742 3058 N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate - - DRUGBANK DB03190 C20H36O12 small molecule - - DRUGBANK 27314 4182131 934744 spr0304 pbpX - 171101 Streptococcus pneumoniae unknown target Overington JP (2006) 17139284 171741 3058 N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate - - DRUGBANK DB03190 C20H36O12 small molecule - - DRUGBANK 27231 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1128 Cefadroxil D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX cefadroxil|nu-cefadroxil, 500 DRUGBANK DB01140 C16H17N3O5S small molecule J01DB05 66592-87-8 DRUGBANK 27441 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 7566 Azidocillin Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid - DRUGBANK DB08795 C16H17N5O4S small molecule J01CE04 17243-38-8 DRUGBANK 27089 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 27193 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 990 Cyclacillin Ciclacilline|Bastcillin|Ultracillin|Citosarin|(1-Aminocyclohexyl)penicillin|Aminocyclohexylpenicillin|Ciclacillin|Cyclapen-W|Syngacillin|Vipicil|Calthor|6-(1-Aminocyclohexylcarboxamido)penicillanic acid|(2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Wyvital|Cyclapen|Cyclacillin|Ciclacillinum|Ciclacilina|Vastcillin|6-(1-Aminocyclohexanecarboxamido)penicillanic acid|Ciclacillum - DRUGBANK DB01000 C15H23N3O4S small molecule - 3485-14-1 DRUGBANK 27117 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 597 Nafcillin (2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid unipen injection pws 500mg/via DRUGBANK DB00607 C21H22N2O5S small molecule J01CF06 147-52-4 DRUGBANK 27255 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1541 Meticillin 6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin - DRUGBANK DB01603 C17H20N2O6S small molecule J01CF03 61-32-5 DRUGBANK 27112 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 557 Cephalexin Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid dom-cephalexin 250 - sus 250mg DRUGBANK DB00567 C16H17N3O4S small molecule J01DB01 15686-71-2 DRUGBANK 27237 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1151 Amdinocillin Penicillin HX|Mecillinam - DRUGBANK DB01163 C15H23N3O3S small molecule J01CA11 32887-01-7 DRUGBANK 27122 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 703 Oxacillin Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin oxacillin DRUGBANK DB00713 C19H19N3O5S small molecule J01CF04 66-79-5 DRUGBANK 27081 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27321 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 3178 Cephalosporin C - - DRUGBANK DB03313 C16H22N3O8S small molecule - - DRUGBANK 27251 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 27093 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 477 Dicloxacillin Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid dicloxacillin sodium DRUGBANK DB00485 C19H17Cl2N3O5S small molecule J01CF01 3116-76-5 DRUGBANK 27099 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27419 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 7160 PCNOTAXIME GROUP - - DRUGBANK DB08375 C14H15N5O6S2 small molecule - - DRUGBANK 27088 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Hayes MV (1983) 6413485 176060 430 Ceftazidime (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum ceptaz injection - pws iv 2g DRUGBANK DB00438 C22H22N6O7S2 small molecule J01DD52|J01DD02 78439-06-2 DRUGBANK 27128 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Neu HC (1975) 1095502 178113 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27129 4182173 934791 spr0329 pbpA - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27228 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1128 Cefadroxil D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX cefadroxil|nu-cefadroxil, 500 DRUGBANK DB01140 C16H17N3O5S small molecule J01DB05 66592-87-8 DRUGBANK 27444 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 7566 Azidocillin Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid - DRUGBANK DB08795 C16H17N5O4S small molecule J01CE04 17243-38-8 DRUGBANK 27092 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 448 Cefalotin 7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin keflin neutral inj 1gm|keflin DRUGBANK DB00456 C16H16N2O6S2 small molecule J01DB03 153-61-7 DRUGBANK 27429 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae unknown target Berman HM (2000) 10592235 172122 7287 N-BENZOYL-D-ALANINE - - DRUGBANK DB08508 C10H11NO3 small molecule - - DRUGBANK 27120 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 597 Nafcillin (2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid unipen injection pws 500mg/via DRUGBANK DB00607 C21H22N2O5S small molecule J01CF06 147-52-4 DRUGBANK 27257 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1541 Meticillin 6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin - DRUGBANK DB01603 C17H20N2O6S small molecule J01CF03 61-32-5 DRUGBANK 27077 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 312 Piperacillin Pipracilline|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Piperacillina|Piperacillin|Piperacillin Anhydrous|Piperacillinum|Piperacilina jamp-pip/taz|pipracil pharmacy DRUGBANK DB00319 C23H27N5O7S small molecule J01CA12|J01CR05 66258-76-2 DRUGBANK 27116 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 557 Cephalexin Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid dom-cephalexin 250 - sus 250mg DRUGBANK DB00567 C16H17N3O4S small molecule J01DB01 15686-71-2 DRUGBANK 27238 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1151 Amdinocillin Penicillin HX|Mecillinam - DRUGBANK DB01163 C15H23N3O3S small molecule J01CA11 32887-01-7 DRUGBANK 27123 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 703 Oxacillin Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin oxacillin DRUGBANK DB00713 C19H19N3O5S small molecule J01CF04 66-79-5 DRUGBANK 27085 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Sala-Rabanal M (2006) 16627568 175919 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27086 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 407 Ampicillin D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC penbritin pws 250mg/5ml|ampici DRUGBANK DB00415 C16H19N3O4S small molecule S01AA19|J01CR01|J01CA51|J01CA01 69-53-4 DRUGBANK 27324 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 3178 Cephalosporin C - - DRUGBANK DB03313 C16H22N3O8S small molecule - - DRUGBANK 27252 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 1299 Cefoxitin Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid mefoxin pws inj 10gm/vial|mefo DRUGBANK DB01331 C16H17N3O7S2 small molecule J01DC01 35607-66-0 DRUGBANK 27094 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 477 Dicloxacillin Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid dicloxacillin sodium DRUGBANK DB00485 C19H17Cl2N3O5S small molecule J01CF01 3116-76-5 DRUGBANK 27101 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 485 Cefotaxime (6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid claforan add-vantage vials 1gm DRUGBANK DB00493 C16H17N5O7S2 small molecule J01DD51|J01DD01 63527-52-6 DRUGBANK 27134 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Neu HC (1975) 1095502 178113 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27135 4182263 934893 spr1909 pbp1b - 171101 Streptococcus pneumoniae inhibitor target Williamson R (1980) 7447421 175169 729 Hetacillin Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum - DRUGBANK DB00739 C19H23N3O4S small molecule J01CA18 3511-16-8 DRUGBANK 27277 4252304 3199069 syc0881_c hemL - 269084 Synechococcus elongatus unknown target Imming P (2006) 17016423 171742 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 27278 4252304 3199069 syc0881_c hemL - 269084 Synechococcus elongatus unknown target Overington JP (2006) 17139284 171741 2061 Pyridoxamine-5'-Phosphate - - DRUGBANK DB02142 C8H13N2O5P small molecule - - DRUGBANK 27273 4252304 3199069 syc0881_c hemL - 269084 Synechococcus elongatus unknown target Imming P (2006) 17016423 171742 1975 Gabaculine - - DRUGBANK DB02054 C7H7NO2 small molecule - 87980-11-8 DRUGBANK 27274 4252304 3199069 syc0881_c hemL - 269084 Synechococcus elongatus unknown target Overington JP (2006) 17139284 171741 1975 Gabaculine - - DRUGBANK DB02054 C7H7NO2 small molecule - 87980-11-8 DRUGBANK 27396 4351372 923550 MT1988 MT1988 - 83331 Mycobacterium tuberculosis unknown target Berman HM (2000) 10592235 172122 6307 1,3-DIPHENYLUREA - - DRUGBANK DB07496 C13H12N2O small molecule - - DRUGBANK 27529 4351464 923642 MT1933 MT1933 - 83331 Mycobacterium tuberculosis unknown target Berman HM (2000) 10592235 172122 7422 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID - - DRUGBANK DB08648 C10H12O6 small molecule - - DRUGBANK 27528 4352387 924569 MT1417 MT1417 - 83331 Mycobacterium tuberculosis unknown target Berman HM (2000) 10592235 172122 7021 MYRISTIC ACID - - DRUGBANK DB08231 C14H28O2 small molecule - - DRUGBANK 27530 4359045 13316550 RVBD_1761c RVBD_1761c - 83332 Mycobacterium tuberculosis unknown target Berman HM (2000) 10592235 172122 7008 2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL - - DRUGBANK DB08217 C9H17NOS small molecule - - DRUGBANK